Citrus Sinensis ID: 013028

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-
Protein Sequence
MGNCLRKNPQDPNRQLDIARPPAAGVTRIPRQNRTSTVEEKRTPSDSSKAVQENRRKHRRRDYRLREWKTSVFSSSQKEKHSKKYRERTMPESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTSLRTSTHTTRTRSFEQRPLKQRMSNLVI
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHccccccccccccccccEEEEEEcccccHHHcccccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHcccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHccccccccccccHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEcccccEcccccccccEEEEEEEEcccccccHHHHHHHHHHHHHHccccHEEEEEEEEccccEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEcccccccccEEEEEEcccccccHHHHHcccccccccHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mgnclrknpqdpnrqldiarppaagvtriprqnrtstveekrtpsdsskAVQENRRKhrrrdyrlrewktsvfsssqkekhskkyrertmpeslpvaardlpavsfhrdeVFHAYKLKYFCHGLLEAATRkfseknligqggfgdvYIGYINSCAMTAARRKNADFAVAVKRLRrkgsqgqdeWENELRFLSrlnhpnvvklmgyccddqhrLLVYEYVTrgsledhllneddteLNWERRIKIALGAARGLEHlhtywrpvihrdvkasnvlldddfnakisdfglakfgplgdkshistrvlgtrgyfapeyiatghltlktdVYSFGVVLLEILSGKTAAMRRTNglagnwakpylsnKLALHQIIDEKLGRNIQMEEAQEFAEIILRClnsdpknrptMSEVVAALEQLQLNMgscyqtslrtsthttrtrsfeqrplkqRMSNLVI
Flexible Loop (DISEMBL)
mgnclrknpqdpnrqldiarppaagvtriprqnrtstveekrtpsdsskavqenrrkhrrrdyrlrewktsvfsssqkekhskkyrertmpeslpvaARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRlrrkgsqgqdeweNELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLedhllneddtelnWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFglakfgplgdkshiSTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTslrtsthttrtrsfeqrplkqrmsnlvi
Low Complexity Region (SEG)
MGNCLRKNPQDPNRQLDIARPPAAGVTRIPRQNRTSTVEEKRTPSDSSKAVQENrrkhrrrdyrlrEWKTSVFSSSQKEKHSKKYRERTMPESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQtslrtsthttrtrsFEQRPLKQRMSNLVI
Disordered region (IsUnstruct)
***************************************************************************************************DLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR********EWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLN***********VVAALEQLQLNMGSCY******************************
Disordered Region (DISOPRED)
*********************************************************************************************************************KYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE****************************************
Disordered Region (DISEMBL)
**********DPNRQLDIARPPAAGVTRIPR*****************************RDYRLREWKT*******************MPESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR********WENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTS***************************
Disordered Region (DISPRO)
*******************R*********************************************************************************************AYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN***********************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNCLRKNPQDPNRQLDIARPPAAGVTRIPRQNRTSTVEEKRTPSDSSKAVQENRRKHRRRDYRLREWKTSVFSSSQKEKHSKKYRERTMPESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTSLRTSTHTTRTRSFEQRPLKQRMSNLVI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	451	2.2.26 [Sep-21-2011]
O49840	426	Protein kinase 2B, chloro	no	no	0.674	0.713	0.5	2e-85
Q06548	410	Protein kinase APK1A, chl	yes	no	0.674	0.741	0.516	2e-85
O49839	426	Protein kinase 2A, chloro	no	no	0.667	0.706	0.511	2e-85
P46573	412	Protein kinase APK1B, chl	no	no	0.674	0.737	0.509	4e-85
P43293	389	Probable serine/threonine	no	no	0.733	0.850	0.453	2e-84
O48814	395	Serine/threonine-protein	no	no	0.745	0.850	0.450	7e-84
Q8GXZ3	410	Serine/threonine-protein	no	no	0.629	0.692	0.522	3e-83
Q8H186	389	Probable receptor-like pr	no	no	0.674	0.781	0.482	2e-81
P27450	419	Probable serine/threonine	no	no	0.638	0.687	0.501	9e-80
Q9LFP7	493	Probable receptor-like pr	no	no	0.691	0.632	0.476	2e-76

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  317 bits (811), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 154/308 (50%), Positives = 214/308 (69%), Gaps = 4/308 (1%)

Query: 110 EVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
           E+  +  LK F    L+ ATR F   +L+G+GGFG V+ G+I+   +TA++   +   VA
Sbjct: 61  EILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASK-PGSGIVVA 119

Query: 170 VKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL 229
           VK+L+ +G QG  EW  E+ +L +L+HPN+VKL+GYC + ++RLLVYE++ +GSLE+HL 
Sbjct: 120 VKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLF 179

Query: 230 NEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK 289
                 L W  R+K+A+GAA+GL  LH     VI+RD KA+N+LLD +FN+K+SDFGLAK
Sbjct: 180 RRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAK 239

Query: 290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
            GP GDK+H+ST+V+GT GY APEY+ATG LT K+DVYSFGVVLLE+LSG+ A  +   G
Sbjct: 240 AGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVG 299

Query: 350 LAG---NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           +     +WA PYL +K  L +I+D +LG     + A   A + L+CLN D K RP MSEV
Sbjct: 300 MEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEV 359

Query: 407 VAALEQLQ 414
           +A L+QL+
Sbjct: 360 LAKLDQLE 367

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  317 bits (811), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 160/310 (51%), Positives = 219/310 (70%), Gaps = 6/310 (1%)

Query: 110 EVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
           E+  +  LK F    L++ATR F   +++G+GGFG V+ G+I+  ++TA+R       +A
Sbjct: 46  EILQSPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASR-PGTGLVIA 104

Query: 170 VKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL 229
           VK+L + G QG  EW  E+ +L + +H ++VKL+GYC +D+HRLLVYE++ RGSLE+HL 
Sbjct: 105 VKKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLF 164

Query: 230 NED--DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
                   L+W+ R+K+ALGAA+GL  LH+    VI+RD K SN+LLD ++NAK+SDFGL
Sbjct: 165 RRGLYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGL 224

Query: 288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMR-R 346
           AK GP+GDKSH+STRV+GT GY APEY+ATGHLT K+DVYSFGVVLLE+LSG+ A  + R
Sbjct: 225 AKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNR 284

Query: 347 TNGLAG--NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS 404
            +G      WAKPYL NK  + ++ID +L     MEEA + A + LRCL ++ K RP MS
Sbjct: 285 PSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMS 344

Query: 405 EVVAALEQLQ 414
           EVV+ LE +Q
Sbjct: 345 EVVSHLEHIQ 354

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  316 bits (810), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 159/311 (51%), Positives = 215/311 (69%), Gaps = 10/311 (3%)

Query: 110 EVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
           E+  +  LK F    L+ AT+ F + NL+G+GGFG V+ G+I+  ++TA+R   +   VA
Sbjct: 64  EILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASR-PGSGIVVA 122

Query: 170 VKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL 229
           VK+L+ +G QG  EW  E+ +L +L+HPN+V L+GYC + ++RLLVYE++ +GSLE+HL 
Sbjct: 123 VKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF 182

Query: 230 NEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK 289
                 L W  R+K+A+GAA+GL  LH     VI+RD KA+N+LLD DFNAK+SDFGLAK
Sbjct: 183 RRGAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAK 242

Query: 290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
            GP GD +H+ST+V+GT GY APEY+ATG LT K+DVYSFGVVLLE++SG+  AM  +NG
Sbjct: 243 AGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRR-AMDNSNG 301

Query: 350 LAGN------WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM 403
             GN      WA PYL +K  L +I+D KLG     + A   A + L+CLN D K RP M
Sbjct: 302 --GNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKM 359

Query: 404 SEVVAALEQLQ 414
           SEV+  LEQL+
Sbjct: 360 SEVLVTLEQLE 370

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  315 bits (807), Expect = 4e-85,   Method: Compositional matrix adjust.
 Identities = 158/310 (50%), Positives = 214/310 (69%), Gaps = 6/310 (1%)

Query: 110 EVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
           E+  +  LK F    L+AATR F   +++G+GGFG V+ G+I+   +TA++       +A
Sbjct: 47  EILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASK-PGTGVVIA 105

Query: 170 VKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL 229
           VK+L + G QG  EW  E+ +L + +HPN+VKL+GYC +D+HRLLVYE++ RGSLE+HL 
Sbjct: 106 VKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLF 165

Query: 230 NEDD--TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
                   L+W  R+K+ALGAA+GL  LH     VI+RD K SN+LLD ++NAK+SDFGL
Sbjct: 166 RRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGL 225

Query: 288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMR-R 346
           AK GP GDKSH+STR++GT GY APEY+ATGHLT K+DVYS+GVVLLE+LSG+ A  + R
Sbjct: 226 AKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNR 285

Query: 347 TNGLAG--NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS 404
             G      WA+P L+NK  L ++ID +L     MEEA + A + LRCL  + K RP M+
Sbjct: 286 PPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMN 345

Query: 405 EVVAALEQLQ 414
           EVV+ LE +Q
Sbjct: 346 EVVSHLEHIQ 355

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  313 bits (802), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 161/355 (45%), Positives = 230/355 (64%), Gaps = 24/355 (6%)

Query: 68  WKTSVFSSSQKEKHSKKYRERTMPESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEA 127
           W +S F S    K S       MP +                E+     LK F    L++
Sbjct: 18  WLSSKFLSRDGSKGSSTASFSYMPRT--------------EGEILQNANLKNFSLSELKS 63

Query: 128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENE 187
           ATR F   +++G+GGFG V+ G+I+  ++ A  +      +AVKRL ++G QG  EW  E
Sbjct: 64  ATRNFRPDSVVGEGGFGCVFKGWIDESSL-APSKPGTGIVIAVKRLNQEGFQGHREWLAE 122

Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD--TELNWERRIKIA 245
           + +L +L+HPN+VKL+GYC +++HRLLVYE++TRGSLE+HL         L+W  R+++A
Sbjct: 123 INYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMA 182

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
           LGAARGL  LH     VI+RD KASN+LLD ++NAK+SDFGLA+ GP+GD SH+STRV+G
Sbjct: 183 LGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMG 242

Query: 306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG-----NWAKPYLS 360
           T+GY APEY+ATGHL++K+DVYSFGVVLLE+LSG+ A  +  N   G     +WA+PYL+
Sbjct: 243 TQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDK--NQPVGEHNLVDWARPYLT 300

Query: 361 NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL 415
           NK  L +++D +L     +  A + A + L C++ D K+RPTM+E+V  +E+L +
Sbjct: 301 NKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHI 355

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  311 bits (797), Expect = 7e-84,   Method: Compositional matrix adjust.
 Identities = 158/351 (45%), Positives = 229/351 (65%), Gaps = 15/351 (4%)

Query: 110 EVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
           E+  +  +K F    L+ ATR F   ++IG+GGFG V+ G+++   +T  +       +A
Sbjct: 45  EILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTK-PGTGLVIA 103

Query: 170 VKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL 229
           VK+L ++G QG  EW  E+ +L +L+HPN+VKL+GYC +D+HRLLVYE++ +GSLE+HL 
Sbjct: 104 VKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLF 163

Query: 230 NEDD--TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
                   L W  R+ +AL AA+GL  LH+    VI+RD+KASN+LLD D+NAK+SDFGL
Sbjct: 164 RRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGL 223

Query: 288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRT 347
           A+ GP+GD S++STRV+GT GY APEY+++GHL  ++DVYSFGV+LLEILSGK A     
Sbjct: 224 ARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNR 283

Query: 348 NGLAGN---WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS 404
                N   WA+PYL++K  +  I+D +L      EEA   A + ++CL+ +PK+RPTM 
Sbjct: 284 PAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMD 343

Query: 405 EVVAALEQLQLNMGSCYQTS---------LRTSTHTTRTRSFEQRPLKQRM 446
           +VV AL+QLQ N+G   QT+          +T T  +  + F Q+P  + +
Sbjct: 344 QVVRALQQLQDNLGKPSQTNPVKDTKKLGFKTGTTKSSEKRFTQKPFGRHL 394

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  309 bits (791), Expect = 3e-83,   Method: Compositional matrix adjust.
 Identities = 154/295 (52%), Positives = 200/295 (67%), Gaps = 11/295 (3%)

Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW 184
           LE  T+ F    ++G+GGFG VY GYI+       +       VAVK L ++G QG  EW
Sbjct: 62  LETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLK----SLPVAVKVLNKEGLQGHREW 117

Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+ FL +L HPN+VKL+GYCC+D HRLLVYE++ RGSLE+HL  +    L+W RR+ I
Sbjct: 118 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMMI 177

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           ALGAA+GL  LH   RPVI+RD K SN+LLD D+ AK+SDFGLAK GP GD++H+STRV+
Sbjct: 178 ALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 237

Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG-----KTAAMRRTNGLAGNWAKPYL 359
           GT GY APEY+ TGHLT ++DVYSFGVVLLE+L+G     KT   +  N +  +WA+P L
Sbjct: 238 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLV--DWARPKL 295

Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           ++K  L QIID +L     +  AQ+   +   CL+ +PK RP MS+VV  LE LQ
Sbjct: 296 NDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 350

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  303 bits (776), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 150/311 (48%), Positives = 215/311 (69%), Gaps = 7/311 (2%)

Query: 110 EVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
           E+  +  +K F    L+ ATR F   +++G+GGFG V+ G+++   +T  +  ++   +A
Sbjct: 39  EILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTK-SSSGLVIA 97

Query: 170 VKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL 229
           VKRL   G QG  EW  E+ +L +L+HPN+VKL+GYC +D+ RLLVYE++ +GSLE+HL 
Sbjct: 98  VKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLF 157

Query: 230 ---NEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG 286
              N+D   L+W  RIK+AL AA+GL  LH+    VI+RD+KASN+LLD DFNAK+SDFG
Sbjct: 158 ANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFG 217

Query: 287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRR 346
           LA+ GP+G++S++STRV+GT GY APEY++TGHL  ++DVYSFGVVLLE+L G+ A    
Sbjct: 218 LARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHN 277

Query: 347 TNGLAGN---WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM 403
                 N   WA+PYL+++  +  I+D +L    + E A   A I ++CL+ +PK+RPTM
Sbjct: 278 RPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTM 337

Query: 404 SEVVAALEQLQ 414
            +VV AL QLQ
Sbjct: 338 DQVVRALVQLQ 348

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P27450|CX32_ARATH Probable serine/threonine-protein kinase Cx32, chloroplastic OS=Arabidopsis thaliana GN=At4g35600 PE=1 SV=2

 Score =  297 bits (761), Expect = 9e-80,   Method: Compositional matrix adjust.
 Identities = 147/293 (50%), Positives = 202/293 (68%), Gaps = 5/293 (1%)

Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW 184
           L+ AT+ F   +++GQGGFG VY G++++  + A  R  +   VA+KRL  +  QG  EW
Sbjct: 79  LKTATKNFKPDSMLGQGGFGKVYRGWVDATTL-APSRVGSGMIVAIKRLNSESVQGFAEW 137

Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
            +E+ FL  L+H N+VKL+GYC +D+  LLVYE++ +GSLE HL   +D    W+ RIKI
Sbjct: 138 RSEVNFLGMLSHRNLVKLLGYCREDKELLLVYEFMPKGSLESHLFRRND-PFPWDLRIKI 196

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
            +GAARGL  LH+  R VI+RD KASN+LLD +++AK+SDFGLAK GP  +KSH++TR++
Sbjct: 197 VIGAARGLAFLHSLQREVIYRDFKASNILLDSNYDAKLSDFGLAKLGPADEKSHVTTRIM 256

Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA-AMRRTNGLAG--NWAKPYLSN 361
           GT GY APEY+ATGHL +K+DV++FGVVLLEI++G TA   +R  G     +W +P LSN
Sbjct: 257 GTYGYAAPEYMATGHLYVKSDVFAFGVVLLEIMTGLTAHNTKRPRGQESLVDWLRPELSN 316

Query: 362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           K  + QI+D+ +      + A E A I L C+  DPKNRP M EVV  LE +Q
Sbjct: 317 KHRVKQIMDKGIKGQYTTKVATEMARITLSCIEPDPKNRPHMKEVVEVLEHIQ 369

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  286 bits (733), Expect = 2e-76,   Method: Compositional matrix adjust.
 Identities = 153/321 (47%), Positives = 211/321 (65%), Gaps = 9/321 (2%)

Query: 97  AARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAM 156
           ++   P +S   +E+  +  L+ F    L+ +TR F  ++L+G+GGFG V+ G+I     
Sbjct: 110 SSSSTPVIS---EELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENG- 165

Query: 157 TAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVY 216
           TA  +      VAVK L   G QG  EW  E+ FL  L HPN+VKL+GYC +D  RLLVY
Sbjct: 166 TAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVY 225

Query: 217 EYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT-YWRPVIHRDVKASNVLLD 275
           E++ RGSLE+HL       L W  R+KIALGAA+GL  LH    +PVI+RD K SN+LLD
Sbjct: 226 EFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLD 284

Query: 276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLE 335
            D+NAK+SDFGLAK  P   K+H+STRV+GT GY APEY+ TGHLT K+DVYSFGVVLLE
Sbjct: 285 ADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 344

Query: 336 ILSGKTAAMR-RTNGLAG--NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRC 392
           +L+G+ +  + R NG      WA+P+L +K   ++++D +L  +  ++ AQ+  ++  +C
Sbjct: 345 MLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQC 404

Query: 393 LNSDPKNRPTMSEVVAALEQL 413
           L+ DPK RP MS+VV AL+ L
Sbjct: 405 LSRDPKIRPKMSDVVEALKPL 425

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	451
225425764	389	PREDICTED: protein kinase 2B, chloroplas	0.689	0.799	0.631	1e-113
255558180	419	Protein kinase APK1A, chloroplast precur	0.782	0.842	0.475	5e-89
356500447	414	PREDICTED: LOW QUALITY PROTEIN: protein	0.711	0.775	0.492	2e-86
224111270	417	predicted protein [Populus trichocarpa]	0.820	0.887	0.457	2e-86
356498210	422	PREDICTED: LOW QUALITY PROTEIN: protein	0.711	0.760	0.492	2e-86
225425762	420	PREDICTED: protein kinase 2B, chloroplas	0.782	0.840	0.461	5e-86
224099729	418	predicted protein [Populus trichocarpa]	0.733	0.791	0.479	7e-85
359478936	442	PREDICTED: protein kinase APK1A, chlorop	0.705	0.719	0.493	7e-85
357486685	410	Protein kinase 2B [Medicago truncatula]	0.674	0.741	0.509	8e-85
217071950	410	unknown [Medicago truncatula]	0.674	0.741	0.509	8e-85

>gi|225425764|ref|XP_002271583.1| PREDICTED: protein kinase 2B, chloroplastic-like [Vitis vinifera]

 Score =  416 bits (1068), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 199/315 (63%), Positives = 250/315 (79%), Gaps = 4/315 (1%)

Query: 103 AVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRK 162
           A +  ++EV HAY+   F + +L AAT KFS KNLIG+GGFGDV+ G+I+SCA T A+  
Sbjct: 42  ARAIKKEEVLHAYRPTQFSYNVLHAATNKFSNKNLIGRGGFGDVFKGWIHSCAKTPAK-P 100

Query: 163 NADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRG 222
           N   A+AVKRLR K  QG + W+NEL FL++++H N+VKL+GYCC+ +H++LVYEY+ +G
Sbjct: 101 NDGQAIAVKRLRNKQPQGHEAWQNELNFLTKISHQNLVKLIGYCCECEHKILVYEYMPKG 160

Query: 223 SLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI 282
           SL+ HL  E DTEL W RRIKIA+G ARGL+HLHT  RP+IHRD+K SNVLLD DFN K+
Sbjct: 161 SLDAHLSKERDTELTWGRRIKIAVGVARGLDHLHTVPRPIIHRDLKTSNVLLDADFNPKL 220

Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
           SDFGLAK+GP   ++H+STRVLGT+GY APEYI TGHLTLK+DVYSFGVVLLEILSG +A
Sbjct: 221 SDFGLAKYGPHDHETHVSTRVLGTKGYVAPEYIGTGHLTLKSDVYSFGVVLLEILSGSSA 280

Query: 343 AMRRTNGLAGNW---AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKN 399
             R +NG+  N    AKPYLSNKL L  +ID++LG N  MEEAQE AEIIL+CLNSD  +
Sbjct: 281 VDRFSNGMLENLADHAKPYLSNKLRLPHVIDKRLGSNFSMEEAQELAEIILQCLNSDANS 340

Query: 400 RPTMSEVVAALEQLQ 414
           RPTM+EV+++LEQL+
Sbjct: 341 RPTMTEVLSSLEQLE 355

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255558180|ref|XP_002520117.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] gi|223540609|gb|EEF42172.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis]

 Score =  334 bits (857), Expect = 5e-89,   Method: Compositional matrix adjust.
 Identities = 175/368 (47%), Positives = 239/368 (64%), Gaps = 15/368 (4%)

Query: 85  YRERTMPESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFG 144
           Y ER+  E LP    +         E+  +  LK FC   L+ ATR F   +L+G+GGFG
Sbjct: 45  YSERSSSECLPTPRTE--------GEILSSPNLKAFCFNELKNATRNFRPDSLLGEGGFG 96

Query: 145 DVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMG 204
            V+ G+I+   ++AAR   +   VAVK+L+ +G QG  EW  E+R+L +L+HPN+VKL+G
Sbjct: 97  YVFKGWIDEHTLSAAR-PGSGMVVAVKKLKPEGFQGHKEWLTEVRYLGQLHHPNLVKLIG 155

Query: 205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIH 264
           YC + ++RLLVYE++ +GSLE+HL       L+W  RIK+A+GAARGL  LH     VI+
Sbjct: 156 YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRIKVAVGAARGLSFLHDAKSQVIY 215

Query: 265 RDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKT 324
           RD KASN+LLD +FNAK+SDFGLAK GP GD++H+ST+V+GT GY APEY+ATG LT K+
Sbjct: 216 RDFKASNILLDAEFNAKLSDFGLAKEGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKS 275

Query: 325 DVYSFGVVLLEILSGKTAAMRRTNGLAGN---WAKPYLSNKLALHQIIDEKLGRNIQMEE 381
           DVYSFGVVLLE+LSG+ A  +   G+  N   WAKPYLS+K  L +I+D KLG     + 
Sbjct: 276 DVYSFGVVLLELLSGRRAVDKTKVGIEQNLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKS 335

Query: 382 AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTSLRTSTHTTRTRSFEQRP 441
           A   A + L+CL+++ K RP MSEV+A LEQ++          L  S H +      + P
Sbjct: 336 AHMAANLALQCLSTEAKARPRMSEVLATLEQIE---SPKTAGRLSHSEHPSIQIPVRKSP 392

Query: 442 LKQRMSNL 449
           ++Q  S L
Sbjct: 393 MRQHHSPL 400

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356500447|ref|XP_003519043.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase 2B, chloroplastic-like [Glycine max]

 Score =  325 bits (834), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 164/333 (49%), Positives = 224/333 (67%), Gaps = 12/333 (3%)

Query: 85  YRERTMPESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFG 144
           Y E++   SLP    +         E+  +  LK F    L+ ATR F   +L+G+GGFG
Sbjct: 38  YSEKSNASSLPTPRSE--------GEILSSPNLKPFTFNELKNATRNFRPDSLLGEGGFG 89

Query: 145 DVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMG 204
            VY G+I+    TA++   +   VAVKRL+ +G QG  EW  E+ +L +L HPN+VKL+G
Sbjct: 90  YVYKGWIDEHTFTASK-PGSGMVVAVKRLKPEGFQGHKEWLTEVNYLGQLYHPNLVKLIG 148

Query: 205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIH 264
           YC + ++RLLVYE++ +GSLE+HL       L+W  R+K+A+GAARGL  LH     VI+
Sbjct: 149 YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWSVRMKVAIGAARGLSFLHNAKSQVIY 208

Query: 265 RDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKT 324
           RD KASN+LLD +FN+K+SDFGLAK GP GD++H+ST+V+GT+GY APEY+ATG LT K+
Sbjct: 209 RDFKASNILLDAEFNSKLSDFGLAKAGPTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKS 268

Query: 325 DVYSFGVVLLEILSGKTAAMRRTNGLAGN---WAKPYLSNKLALHQIIDEKLGRNIQMEE 381
           DVYSFGVVLLE+LSG+ A  +   G+  N   WAKPYLS+K  L +I+D KL      + 
Sbjct: 269 DVYSFGVVLLELLSGRRAVDKTITGMEQNLVDWAKPYLSDKRRLFRIMDTKLEGQYPQKG 328

Query: 382 AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           A   A + L+CLNS+ K RP M+EV+A LEQ++
Sbjct: 329 AFTAATLALQCLNSEAKARPPMTEVLATLEQIE 361

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224111270|ref|XP_002315799.1| predicted protein [Populus trichocarpa] gi|222864839|gb|EEF01970.1| predicted protein [Populus trichocarpa]

 Score =  325 bits (834), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 173/378 (45%), Positives = 239/378 (63%), Gaps = 8/378 (2%)

Query: 76  SQKEKHSKKYRERTMPESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEK 135
           S +  HS      T+P     ++  LP       E+  +  LK F    L+ ATR F   
Sbjct: 27  SSRTSHSSVPSSLTIPSYSGRSSECLPTPR-SEGEILSSPNLKAFSFNELKNATRNFRPD 85

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN 195
           +L+G+GGFG V+ G+I+   +TAA+   +   VAVK+L+ +G QG  EW  E+ +L +L+
Sbjct: 86  SLLGEGGFGYVFKGWIDEHTLTAAK-PGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH 144

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HPN+VKL+GYC + ++RLLVYE++ +GSLE+HL       L+W  RIK+A+GAARGL  L
Sbjct: 145 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAIRIKVAIGAARGLSFL 204

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
           H     VI+RD KASN+LLD +FNAK+SDFGLAK GP GD++H+ST+V+GT GY APEY+
Sbjct: 205 HDAKSQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 264

Query: 316 ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN---WAKPYLSNKLALHQIIDEK 372
           ATG LT K+DVYSFGVVLLE LSG+ A  +   G+  N   W KPYL +K  L +I+D K
Sbjct: 265 ATGRLTAKSDVYSFGVVLLEFLSGRRAVDKSKVGVEQNLVDWVKPYLGDKRKLFRIMDTK 324

Query: 373 LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTSLRTSTHTT 432
           LG     + A   A + L+CL+++ K RP MSEV+A LEQ++   G+     L   T  T
Sbjct: 325 LGGQYPQKGAFMAANLALQCLSTEAKVRPRMSEVLATLEQIESPKGAVKNIQLEHQTVQT 384

Query: 433 RTRSFEQRPLKQRMSNLV 450
             R   Q P++   S ++
Sbjct: 385 PVR---QSPMRHHRSPVI 399

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356498210|ref|XP_003517946.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase 2B, chloroplastic-like [Glycine max]

 Score =  325 bits (834), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 164/333 (49%), Positives = 224/333 (67%), Gaps = 12/333 (3%)

Query: 85  YRERTMPESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFG 144
           Y E++   SLP    +         E+  +  LK F    L+ ATR F   +L+G+GGFG
Sbjct: 38  YSEKSNASSLPTPRSE--------GEILSSPNLKPFTFNELKNATRNFRPDSLLGEGGFG 89

Query: 145 DVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMG 204
            VY G+I+    TA++   +   VAVKRL+ +G QG  EW  E+ +L +L HPN+VKL+G
Sbjct: 90  YVYKGWIDEHTFTASK-PGSGMVVAVKRLKPEGFQGHKEWLTEVNYLGQLYHPNLVKLIG 148

Query: 205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIH 264
           YC + ++RLLVYE++ +GSLE+HL       L+W  R+K+A+GAARGL  LH     VI+
Sbjct: 149 YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWSVRMKVAIGAARGLSFLHNAKSQVIY 208

Query: 265 RDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKT 324
           RD KASN+LLD +FN+K+SDFGLAK GP GD++H+ST+V+GT+GY APEY+ATG LT K+
Sbjct: 209 RDFKASNILLDAEFNSKLSDFGLAKAGPTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKS 268

Query: 325 DVYSFGVVLLEILSGKTAAMRRTNGLAGN---WAKPYLSNKLALHQIIDEKLGRNIQMEE 381
           DVYSFGVVLLE+LSG+ A  +   G+  N   WAKPYLS+K  L +I+D KL      + 
Sbjct: 269 DVYSFGVVLLELLSGRRAVDKTITGMEQNLVDWAKPYLSDKRRLFRIMDTKLEGQYPQKG 328

Query: 382 AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           A   A + L+CLNS+ K RP M+EV+A LEQ++
Sbjct: 329 AFTAATLALQCLNSEAKARPPMTEVLATLEQIE 361

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225425762|ref|XP_002277256.1| PREDICTED: protein kinase 2B, chloroplastic [Vitis vinifera] gi|296086406|emb|CBI31995.3| unnamed protein product [Vitis vinifera]

 Score =  324 bits (831), Expect = 5e-86,   Method: Compositional matrix adjust.
 Identities = 170/368 (46%), Positives = 238/368 (64%), Gaps = 15/368 (4%)

Query: 85  YRERTMPESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFG 144
           Y ER+  ES P    +         E+  +  LK F    L+ ATR F   +L+G+GGFG
Sbjct: 46  YSERSTAESFPTPRSE--------GEILPSPSLKAFSFNDLKNATRNFRPDSLLGEGGFG 97

Query: 145 DVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMG 204
            V+ G+I+   + AA +  +   +AVK+L+ +G QG  EW  E+ +L +L+HPN+VKL+G
Sbjct: 98  YVFKGWIDEQTL-AAVKPGSGMVIAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIG 156

Query: 205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIH 264
           YC + ++RLLVYE++ +GSLE+HL       L+W  RI++A+GAARGL  LH     VI+
Sbjct: 157 YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRIRVAIGAARGLSFLHDAESQVIY 216

Query: 265 RDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKT 324
           RD KASN+LLD +FNAK+SDFGLAK GP GD++H+ST+V+GT GY APEY+ATG LT K+
Sbjct: 217 RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKS 276

Query: 325 DVYSFGVVLLEILSGKTAAMRRTNGLAGN---WAKPYLSNKLALHQIIDEKLGRNIQMEE 381
           DVYSFGVVLLE+LSG+ A  +   G+  N   WAKPYL +K  L +I+D KL      + 
Sbjct: 277 DVYSFGVVLLELLSGRRAVDKTKIGVEQNLVDWAKPYLGDKRRLFRIMDTKLEGQYPQKG 336

Query: 382 AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTSLRTSTHTTRTRSFEQRP 441
           A   A + L+CLN++ K RP MSEV+A LEQ+Q    +     +++  HT      ++ P
Sbjct: 337 AFMAATLALQCLNTEAKVRPRMSEVLATLEQIQSPKNAAKH--IQSEQHTVSI-PVQKSP 393

Query: 442 LKQRMSNL 449
           L+Q+ S L
Sbjct: 394 LRQQHSPL 401

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224099729|ref|XP_002311595.1| predicted protein [Populus trichocarpa] gi|222851415|gb|EEE88962.1| predicted protein [Populus trichocarpa]

 Score =  320 bits (821), Expect = 7e-85,   Method: Compositional matrix adjust.
 Identities = 162/338 (47%), Positives = 229/338 (67%), Gaps = 7/338 (2%)

Query: 110 EVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
           E+  +  LK F    L++ATR F   +L+G+GGFG V+ G+I+   +TA++   +   VA
Sbjct: 61  EILSSPNLKAFSFNELKSATRNFRPDSLLGEGGFGCVFKGWIDENTLTASK-PGSGMVVA 119

Query: 170 VKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL 229
           VK+L+ +G QG  EW  E+ +L +L+HPN+VKL+GYC + ++RLLVYE++ +GSLE+HL 
Sbjct: 120 VKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCVEGENRLLVYEFMPKGSLENHLF 179

Query: 230 NEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK 289
                 L+W  R+K+A+GAARGL  LH     VI+RD KASN+LLD +FNAK+SDFGLAK
Sbjct: 180 RRGPQPLSWAVRVKVAIGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDFGLAK 239

Query: 290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
            GP GD++H+ST+V+GT GY APEY+ATG LT K+DVYSFGVVLLE+LSG+ A  +   G
Sbjct: 240 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTKVG 299

Query: 350 LAGN---WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           +  N   WAKPYL +K  L +I+D KLG     + A   A + L+CL+++ K RP MSEV
Sbjct: 300 VEQNLADWAKPYLGDKRKLFRIMDTKLGGQYPQKGAFMAANLALQCLSNEAKVRPRMSEV 359

Query: 407 VAALEQLQLNMGSCYQTSLRTSTHTTRTRSFEQRPLKQ 444
           +A LE ++   G+   +  R+   T +T    Q P++ 
Sbjct: 360 LATLENIESPKGAAKNS--RSEQQTVQT-PVRQSPMRH 394

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359478936|ref|XP_002283646.2| PREDICTED: protein kinase APK1A, chloroplastic-like [Vitis vinifera]

 Score =  320 bits (821), Expect = 7e-85,   Method: Compositional matrix adjust.
 Identities = 160/324 (49%), Positives = 219/324 (67%), Gaps = 6/324 (1%)

Query: 96  VAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCA 155
           V+   +P       ++  +  LK F    L+ ATR F   +++G+GGFG V+ G+I+  +
Sbjct: 38  VSVASVPPTPRSEGDILQSPNLKNFTFSELKMATRNFRPDSVLGEGGFGSVFKGWIDEQS 97

Query: 156 MTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLV 215
             AAR       +AVKRL  +  QG  EW  E+ +L +L HP++VKL+G+C +D+HRLLV
Sbjct: 98  FAAAR-PGTGMVIAVKRLNLESFQGHKEWLAEVNYLGQLYHPHLVKLIGFCSEDEHRLLV 156

Query: 216 YEYVTRGSLEDHLLNEDD--TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL 273
           YE++ RGSLE+HL         L+W  R+K+ALGAA+GL  LH+    VI+RD K SN+L
Sbjct: 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGLAFLHSAETKVIYRDFKTSNIL 216

Query: 274 LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVL 333
           LD ++NAK+SDFGLAK GP GDKSH+STRV+GT GY APEY+ATGHLT ++DVYSFGVVL
Sbjct: 217 LDSNYNAKLSDFGLAKDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTARSDVYSFGVVL 276

Query: 334 LEILSGKTAAMRRTNGLAGN---WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIIL 390
           LE+LSG+ A  +       N   WAKPYL+NK  + +I+D +L     +E A + + + L
Sbjct: 277 LEMLSGRRAVDKNRPSGEHNLVEWAKPYLANKRKIFRILDNRLEGQYSLEGAHKASNLAL 336

Query: 391 RCLNSDPKNRPTMSEVVAALEQLQ 414
           RCL+++ K RPTM+EVV ALEQLQ
Sbjct: 337 RCLSTEAKFRPTMTEVVTALEQLQ 360

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357486685|ref|XP_003613630.1| Protein kinase 2B [Medicago truncatula] gi|87241133|gb|ABD32991.1| Protein kinase [Medicago truncatula] gi|355514965|gb|AES96588.1| Protein kinase 2B [Medicago truncatula]

 Score =  320 bits (821), Expect = 8e-85,   Method: Compositional matrix adjust.
 Identities = 157/308 (50%), Positives = 216/308 (70%), Gaps = 4/308 (1%)

Query: 110 EVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
           E+  +  LK F    L+ ATR F   +L+G+GGFG VY G+I+    TAA+   +   VA
Sbjct: 54  EILSSPNLKAFSFNELKNATRNFRPDSLLGEGGFGHVYKGWIDEHTFTAAK-PGSGMVVA 112

Query: 170 VKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL 229
           VKRL+ +G QG  EW  E+ +L +L+HPN+VKL+GYC + ++RLLVYE++ +GSLE+HL 
Sbjct: 113 VKRLKPEGYQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 172

Query: 230 NEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK 289
                 L+W  R+K+A+GAARGL  LH     VI+RD KASN+LLD +FN+K+SDFGLAK
Sbjct: 173 RRGPQPLSWSIRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLAK 232

Query: 290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
            GP GD++H+ST+V+GT+GY APEY+ATG LT K+DVYSFGVV+LE+LSG+ A  +   G
Sbjct: 233 AGPTGDRTHVSTQVVGTQGYAAPEYVATGRLTAKSDVYSFGVVMLELLSGRRAVDKTIAG 292

Query: 350 LAGN---WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           +  N   WAKPYL +K  L +I+D KL      + A   A + L+CLN + K RP+M+EV
Sbjct: 293 VDQNLVDWAKPYLGDKRRLFRIMDSKLEGQYPQKGAFMAATLALQCLNREAKARPSMTEV 352

Query: 407 VAALEQLQ 414
           +A LEQ++
Sbjct: 353 LATLEQIE 360

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|217071950|gb|ACJ84335.1| unknown [Medicago truncatula]

 Score =  320 bits (820), Expect = 8e-85,   Method: Compositional matrix adjust.
 Identities = 157/308 (50%), Positives = 216/308 (70%), Gaps = 4/308 (1%)

Query: 110 EVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
           E+  +  LK F    L+ ATR F   +L+G+GGFG VY G+I+    TAA+   +   VA
Sbjct: 54  EILSSPNLKAFSFNELKNATRNFRPDSLLGEGGFGHVYKGWIDEHTFTAAK-PGSGMVVA 112

Query: 170 VKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL 229
           VKRL+ +G QG  EW  E+ +L +L+HPN+VKL+GYC + ++RLLVYE++ +GSLE+HL 
Sbjct: 113 VKRLKPEGYQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 172

Query: 230 NEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK 289
                 L+W  R+K+A+GAARGL  LH     VI+RD KASN+LLD +FN+K+SDFGLAK
Sbjct: 173 RRGPQPLSWSIRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLAK 232

Query: 290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
            GP GD++H+ST+V+GT+GY APEY+ATG LT K+DVYSFGVV+LE+LSG+ A  +   G
Sbjct: 233 AGPTGDRTHVSTQVVGTQGYAAPEYVATGRLTAKSDVYSFGVVMLELLSGRRAVDKTIAG 292

Query: 350 LAGN---WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           +  N   WAKPYL +K  L +I+D KL      + A   A + L+CLN + K RP+M+EV
Sbjct: 293 VDQNLVDWAKPYLGDKRRLFRIMDSKLEGQYPQKGAFMAATLALQCLNREAKARPSMTEV 352

Query: 407 VAALEQLQ 414
           +A LEQ++
Sbjct: 353 LATLEQIE 360

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	451
TAIR|locus:2058847	426	APK2B "protein kinase 2B" [Ara	0.751	0.795	0.471	1.2e-79
TAIR|locus:2053240	423	PK1B "protein kinase 1B" [Arab	0.678	0.723	0.511	3.3e-79
TAIR|locus:2205050	387	AT1G69790 [Arabidopsis thalian	0.680	0.793	0.493	8.4e-79
TAIR|locus:2012492	426	APK2A "protein kinase 2A" [Ara	0.747	0.791	0.475	8.7e-79
TAIR|locus:2180127	389	NAK [Arabidopsis thaliana (tax	0.674	0.781	0.487	3e-78
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.634	0.697	0.518	1.1e-76
TAIR|locus:2039772	395	BIK1 "botrytis-induced kinase1	0.682	0.779	0.480	3.1e-76
TAIR|locus:2205714	412	AT1G26970 [Arabidopsis thalian	0.680	0.745	0.490	1.2e-74
TAIR|locus:2057770	424	ARSK1 "root-specific kinase 1"	0.753	0.801	0.446	8.4e-74
TAIR|locus:2059642	414	Kin3 "kinase 3" [Arabidopsis t	0.654	0.712	0.488	4.6e-73

TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)]

 Score = 800 (286.7 bits), Expect = 1.2e-79, P = 1.2e-79
 Identities = 164/348 (47%), Positives = 229/348 (65%)

Query:    74 SSSQKEKHSKKYRERTMPESLPV----AARDLPAVSFHRDEVFHAYKLKYFCHGLLEAAT 129
             S+S   + S K    T+P SL +    +   LP       E+  +  LK F    L+ AT
Sbjct:    22 SASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTE-GEILSSPNLKAFTFNELKNAT 80

Query:   130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
             R F   +L+G+GGFG V+ G+I+   +TA++   +   VAVK+L+ +G QG  EW  E+ 
Sbjct:    81 RNFRPDSLLGEGGFGYVFKGWIDGTTLTASK-PGSGIVVAVKKLKTEGYQGHKEWLTEVN 139

Query:   190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
             +L +L+HPN+VKL+GYC + ++RLLVYE++ +GSLE+HL       L W  R+K+A+GAA
Sbjct:   140 YLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAIGAA 199

Query:   250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
             +GL  LH     VI+RD KA+N+LLD +FN+K+SDFGLAK GP GDK+H+ST+V+GT GY
Sbjct:   200 KGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQVMGTHGY 259

Query:   310 FAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN---WAKPYLSNKLALH 366
              APEY+ATG LT K+DVYSFGVVLLE+LSG+ A  +   G+  +   WA PYL +K  L 
Sbjct:   260 AAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDWATPYLGDKRKLF 319

Query:   367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
             +I+D +LG     + A   A + L+CLN D K RP MSEV+A L+QL+
Sbjct:   320 RIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLE 367

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)]

 Score = 796 (285.3 bits), Expect = 3.3e-79, P = 3.3e-79
 Identities = 160/313 (51%), Positives = 216/313 (69%)

Query:   110 EVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
             E+  +  LK F    L+AATR F   +++G+GGFG V+ G+I+   +TA++       +A
Sbjct:    58 EILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASK-PGTGVVIA 116

Query:   170 VKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL 229
             VK+L + G QG  EW  E+ +L + +HPN+VKL+GYC +D+HRLLVYE++ RGSLE+HL 
Sbjct:   117 VKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLF 176

Query:   230 NEDD--TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
                     L+W  R+K+ALGAA+GL  LH     VI+RD K SN+LLD ++NAK+SDFGL
Sbjct:   177 RRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGL 236

Query:   288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMR-R 346
             AK GP GDKSH+STR++GT GY APEY+ATGHLT K+DVYS+GVVLLE+LSG+ A  + R
Sbjct:   237 AKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNR 296

Query:   347 TNGLAG--NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS 404
               G      WA+P L+NK  L ++ID +L     MEEA + A + LRCL  + K RP M+
Sbjct:   297 PPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMN 356

Query:   405 EVVAALEQLQ-LN 416
             EVV+ LE +Q LN
Sbjct:   357 EVVSHLEHIQTLN 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)]

 Score = 762 (273.3 bits), Expect = 8.4e-79, Sum P(2) = 8.4e-79
 Identities = 156/316 (49%), Positives = 216/316 (68%)

Query:   110 EVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
             E+  +  LK F    L+ ATR F   ++IG+GGFG VY G+I   +++ ++   +   VA
Sbjct:    62 ELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSK-PGSGMVVA 120

Query:   170 VKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL 229
             VK+L+ +G QG  EW  E+ +L RL+H N+VKL+GYC + + RLLVYEY+ +GSLE+HL 
Sbjct:   121 VKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENHLF 180

Query:   230 NEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK 289
                   + W+ R+K+A  AARGL  LH     VI+RD KASN+LLD DFNAK+SDFGLAK
Sbjct:   181 RRGAEPIPWKTRMKVAFSAARGLSFLHE--AKVIYRDFKASNILLDVDFNAKLSDFGLAK 238

Query:   290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
              GP GD++H++T+V+GT+GY APEYIATG LT K+DVYSFGVVLLE+LSG+    +   G
Sbjct:   239 AGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSKVG 298

Query:   350 LAGN---WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
             +  N   WA PYL ++  + +I+D KLG     + A   A I LRCLN++PK RP M++V
Sbjct:   299 VERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMADV 358

Query:   407 VAALEQLQLN---MGS 419
             ++ L+QL+ +   MGS
Sbjct:   359 LSTLQQLETSSKKMGS 374

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)]

 Score = 792 (283.9 bits), Expect = 8.7e-79, P = 8.7e-79
 Identities = 168/353 (47%), Positives = 228/353 (64%)

Query:    74 SSSQKEKHSKKYRERTMPESLPVAARDL-----PAVSFHRD-EVFHAYKLKYFCHGLLEA 127
             S+S   K S K    T P  L   +        P  +   + E+  +  LK F    L+ 
Sbjct:    22 SASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLRTEGEILSSPNLKAFTFNELKN 81

Query:   128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENE 187
             AT+ F + NL+G+GGFG V+ G+I+  ++TA+R   +   VAVK+L+ +G QG  EW  E
Sbjct:    82 ATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASR-PGSGIVVAVKQLKPEGFQGHKEWLTE 140

Query:   188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L +L+HPN+V L+GYC + ++RLLVYE++ +GSLE+HL       L W  R+K+A+G
Sbjct:   141 VNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAVG 200

Query:   248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
             AA+GL  LH     VI+RD KA+N+LLD DFNAK+SDFGLAK GP GD +H+ST+V+GT 
Sbjct:   201 AAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKVIGTH 260

Query:   308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN------WAKPYLSN 361
             GY APEY+ATG LT K+DVYSFGVVLLE++SG+ A M  +NG  GN      WA PYL +
Sbjct:   261 GYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRA-MDNSNG--GNEYSLVDWATPYLGD 317

Query:   362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
             K  L +I+D KLG     + A   A + L+CLN D K RP MSEV+  LEQL+
Sbjct:   318 KRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLE 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)]

 Score = 787 (282.1 bits), Expect = 3.0e-78, P = 3.0e-78
 Identities = 152/312 (48%), Positives = 220/312 (70%)

Query:   110 EVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
             E+     LK F    L++ATR F   +++G+GGFG V+ G+I+  ++ A  +      +A
Sbjct:    46 EILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSL-APSKPGTGIVIA 104

Query:   170 VKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL 229
             VKRL ++G QG  EW  E+ +L +L+HPN+VKL+GYC +++HRLLVYE++TRGSLE+HL 
Sbjct:   105 VKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLF 164

Query:   230 NEDD--TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
                     L+W  R+++ALGAARGL  LH     VI+RD KASN+LLD ++NAK+SDFGL
Sbjct:   165 RRGTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGL 224

Query:   288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRT 347
             A+ GP+GD SH+STRV+GT+GY APEY+ATGHL++K+DVYSFGVVLLE+LSG+ A  +  
Sbjct:   225 ARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQ 284

Query:   348 ----NGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM 403
                 + L  +WA+PYL+NK  L +++D +L     +  A + A + L C++ D K+RPTM
Sbjct:   285 PVGEHNLV-DWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTM 343

Query:   404 SEVVAALEQLQL 415
             +E+V  +E+L +
Sbjct:   344 NEIVKTMEELHI 355

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009617 "response to bacterium" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 772 (276.8 bits), Expect = 1.1e-76, P = 1.1e-76
 Identities = 152/293 (51%), Positives = 198/293 (67%)

Query:   125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW 184
             LE  T+ F    ++G+GGFG VY GYI+       +       VAVK L ++G QG  EW
Sbjct:    62 LETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLK----SLPVAVKVLNKEGLQGHREW 117

Query:   185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
               E+ FL +L HPN+VKL+GYCC+D HRLLVYE++ RGSLE+HL  +    L+W RR+ I
Sbjct:   118 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMMI 177

Query:   245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
             ALGAA+GL  LH   RPVI+RD K SN+LLD D+ AK+SDFGLAK GP GD++H+STRV+
Sbjct:   178 ALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 237

Query:   305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN---WAKPYLSN 361
             GT GY APEY+ TGHLT ++DVYSFGVVLLE+L+G+ +  +       N   WA+P L++
Sbjct:   238 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLND 297

Query:   362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
             K  L QIID +L     +  AQ+   +   CL+ +PK RP MS+VV  LE LQ
Sbjct:   298 KRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 350

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)]

 Score = 768 (275.4 bits), Expect = 3.1e-76, P = 3.1e-76
 Identities = 151/314 (48%), Positives = 215/314 (68%)

Query:   110 EVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
             E+  +  +K F    L+ ATR F   ++IG+GGFG V+ G+++   +T  +       +A
Sbjct:    45 EILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTK-PGTGLVIA 103

Query:   170 VKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL 229
             VK+L ++G QG  EW  E+ +L +L+HPN+VKL+GYC +D+HRLLVYE++ +GSLE+HL 
Sbjct:   104 VKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLF 163

Query:   230 NEDD--TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
                     L W  R+ +AL AA+GL  LH+    VI+RD+KASN+LLD D+NAK+SDFGL
Sbjct:   164 RRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGL 223

Query:   288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRT 347
             A+ GP+GD S++STRV+GT GY APEY+++GHL  ++DVYSFGV+LLEILSGK A     
Sbjct:   224 ARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNR 283

Query:   348 NGLAGN---WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS 404
                  N   WA+PYL++K  +  I+D +L      EEA   A + ++CL+ +PK+RPTM 
Sbjct:   284 PAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMD 343

Query:   405 EVVAALEQLQLNMG 418
             +VV AL+QLQ N+G
Sbjct:   344 QVVRALQQLQDNLG 357

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009620 "response to fungus" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0050832 "defense response to fungus" evidence=RCA;IMP

GO:0052033 "pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)]

 Score = 753 (270.1 bits), Expect = 1.2e-74, P = 1.2e-74
 Identities = 154/314 (49%), Positives = 212/314 (67%)

Query:   110 EVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
             E+  +  LK F    L+ ATR F   ++IG+GGFG VY G+I+   ++ ++   +   VA
Sbjct:    61 ELLASPTLKAFTFNELKTATRNFRPDSVIGEGGFGYVYKGWIDERTLSPSK-PGSGMVVA 119

Query:   170 VKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQH-RLLVYEYVTRGSLEDHL 228
             VK+L+ +G QG  +W  E+  L RL+H N+VKL+GYC    H RLLVYEY+ +GSLE+HL
Sbjct:   120 VKKLKEEGFQGHRQWLAEVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSLENHL 179

Query:   229 LNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA 288
                    + W  RIK+A+GAARGL  LH     VI+RD KASN+LLD +FNAK+SDFGLA
Sbjct:   180 FRRGAEPIPWRTRIKVAIGAARGLAFLHE--AQVIYRDFKASNILLDSEFNAKLSDFGLA 237

Query:   289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTN 348
             K GP GD++H+ST+V+GT+GY APEY+ATG +T K+DVYSFGVVLLE+LSG+    +   
Sbjct:   238 KVGPTGDRTHVSTQVMGTQGYAAPEYVATGRITAKSDVYSFGVVLLELLSGRLTVDKTKV 297

Query:   349 GLAGN---WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
             G+  N   WA PYL +K  + +I+D KLG     + A   A   L+CLN +PK RP MS+
Sbjct:   298 GVERNLVDWAIPYLGDKRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQEPKLRPKMSD 357

Query:   406 VVAALEQLQLNMGS 419
             V++ LE+L++ + S
Sbjct:   358 VLSTLEELEMTLKS 371

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2057770 ARSK1 "root-specific kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 745 (267.3 bits), Expect = 8.4e-74, P = 8.4e-74
 Identities = 162/363 (44%), Positives = 224/363 (61%)

Query:    70 TSVFSSSQKEKHSKKY--------RERTMPESLPVAARDL--PAVSFH-RDEVFHAY--- 115
             TS+F    K K++ KY        + RT P    ++  D+  P+      D++ H++   
Sbjct:    12 TSLFLGCYKAKNASKYEGGEKAVMKIRTCPAFKRLSLSDISDPSSPMSVMDDLSHSFTSQ 71

Query:   116 KLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR 175
             KL+ F    L   T  FS  N++G+GGFG VY G+I+         +     VAVK L  
Sbjct:    72 KLRLFTLSELRVITHNFSRSNMLGEGGFGPVYKGFIDDKVKPGIEAQ----PVAVKALDL 127

Query:   176 KGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE 235
              G QG  EW  E+ FL +L++ ++VKL+G+CC+++ R+LVYEY+ RGSLE+ L   +   
Sbjct:   128 HGHQGHREWLAEILFLGQLSNKHLVKLIGFCCEEEQRVLVYEYMPRGSLENQLFRRNSLA 187

Query:   236 LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGD 295
             + W  R+KIALGAA+GL  LH   +PVI+RD K SN+LLD D+NAK+SDFGLAK GP G+
Sbjct:   188 MAWGIRMKIALGAAKGLAFLHEAEKPVIYRDFKTSNILLDSDYNAKLSDFGLAKDGPEGE 247

Query:   296 KSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAA----MRRTNGLA 351
              +H++TRV+GT+GY APEYI TGHLT   DVYSFGVVLLE+++GK +      RR   L 
Sbjct:   248 HTHVTTRVMGTQGYAAPEYIMTGHLTTMNDVYSFGVVLLELITGKRSMDNTRTRREQSLV 307

Query:   352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
               WA+P L ++  L +IID +L    + E AQ  A +  +CL+  PK RPTM EVV  LE
Sbjct:   308 -EWARPMLRDQRKLERIIDPRLANQHKTEAAQVAASLAYKCLSQHPKYRPTMCEVVKVLE 366

Query:   412 QLQ 414
              +Q
Sbjct:   367 SIQ 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2059642 Kin3 "kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 738 (264.8 bits), Expect = 4.6e-73, P = 4.6e-73
 Identities = 148/303 (48%), Positives = 203/303 (66%)

Query:   117 LKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK 176
             L+ F    L A+TR F  +N++G+GGFG V+ G++     T  ++ N    +AVK+L  +
Sbjct:    72 LRIFSLAELRASTRNFRSENVLGEGGFGKVFKGWLED--KTPGKQSNGT-VIAVKKLNAE 128

Query:   177 GSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-- 234
               QG +EW+ E+ FL R++HPN+VKL+GYC + +  LLVYEY+ +GSLE+HL  +     
Sbjct:   129 SFQGFEEWQCEVNFLGRVSHPNLVKLLGYCLEGEELLLVYEYMQKGSLENHLFRKGSAVQ 188

Query:   235 ELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
              L+WE R+KIA+GAA+GL  LH   + VI+RD KASN+LLD  +NAKISDFGLAK GP  
Sbjct:   189 PLSWEIRLKIAIGAAKGLAFLHASEKQVIYRDFKASNILLDGSYNAKISDFGLAKLGPSA 248

Query:   295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAA-MRRTNGLAG- 352
              +SHI+TRV+GT GY APEY+ATGHL +K+DVY FGVVL EIL+G  A    R  G    
Sbjct:   249 SQSHITTRVMGTHGYAAPEYVATGHLYVKSDVYGFGVVLAEILTGLHALDPTRPTGQHNL 308

Query:   353 -NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
               W KP+LS +  L  I+D +L      + A   A++ L+CL  +PKNRP+M EVV +LE
Sbjct:   309 TEWIKPHLSERRKLRSIMDPRLEGKYPFKSAFRVAQLALKCLGPEPKNRPSMKEVVESLE 368

Query:   412 QLQ 414
              ++
Sbjct:   369 LIE 371

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q06548	APK1A_ARATH	2, ., 7, ., 1, 1, ., 1	0.5161	0.6740	0.7414	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	451
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-66
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-64
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-64
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-61
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-60
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-56
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-54
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-45
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-44
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-36
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-36
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-33
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-33
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-33
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-32
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-32
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-31
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-31
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-30
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-29
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-29
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-29
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-29
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-28
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-27
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-27
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-26
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-26
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-26
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-25
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-25
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-25
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-25
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-24
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-24
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-24
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-24
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-23
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-23
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-23
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-23
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-23
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-23
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-22
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-22
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-22
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-21
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-21
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-20
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-20
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-20
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-20
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-20
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-20
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-20
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-20
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-20
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-20
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-19
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-19
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-19
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-18
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-18
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-17
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-17
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-16
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-16
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-15
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-14
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-14
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-14
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-14
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-13
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-13
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-13
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-12
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-12
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	9e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	3e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	8e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	9e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.002
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.003

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  211 bits (540), Expect = 7e-66
 Identities = 94/287 (32%), Positives = 146/287 (50%), Gaps = 37/287 (12%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR-KGSQGQDEWENELR 189
              +K  +G+G FG+VY G +        +    +  VAVK L+     Q  +E+  E R
Sbjct: 2   TLGKK--LGEGAFGEVYKGTLKG------KGDGKEVEVAVKTLKEDASEQQIEEFLREAR 53

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            + +L+HPN+VKL+G C +++  ++V EY+  G L D+L      EL+    +  AL  A
Sbjct: 54  IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG- 308
           RG+E+L +  +  IHRD+ A N L+ ++   KISDFGL++     D      +V G +  
Sbjct: 114 RGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY----YKVKGGKLP 167

Query: 309 --YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLA 364
             + APE +  G  T K+DV+SFGV+L EI          T G      +PY  +SN   
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIF---------TLG-----EEPYPGMSNAEV 213

Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAAL 410
           L  +      R  +      E  +++L+C   DP++RPT SE+V  L
Sbjct: 214 LEYLKKGY--RLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  208 bits (532), Expect = 1e-64
 Identities = 97/288 (33%), Positives = 146/288 (50%), Gaps = 38/288 (13%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRL 194
             +G+G FG+VY G +         +      VAVK L+   S + + ++  E R + +L
Sbjct: 1   KKLGEGAFGEVYKGKLK-------GKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL 53

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-------EDDTELNWERRIKIALG 247
            HPNVV+L+G C +++   LV EY+  G L D+L          + + L+ +  +  A+ 
Sbjct: 54  GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST-RVLGT 306
            A+G+E+L +  +  +HRD+ A N L+ +D   KISDFGL++     D     T   L  
Sbjct: 114 IAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLA 364
           R + APE +  G  T K+DV+SFGV+L EI          T G     A PY  LSN+  
Sbjct: 172 R-WMAPESLKDGIFTSKSDVWSFGVLLWEIF---------TLG-----ATPYPGLSNEEV 216

Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           L  +   K  R  + E    E  E++L C   DP++RPT SE+V  LE
Sbjct: 217 LEYL--RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  206 bits (528), Expect = 5e-64
 Identities = 94/287 (32%), Positives = 143/287 (49%), Gaps = 38/287 (13%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR-KGSQGQDEWENELR 189
              +K  +G+G FG+VY G +        +       VAVK L+     Q  +E+  E R
Sbjct: 2   TLGKK--LGEGAFGEVYKGKLK------GKGGKKKVEVAVKTLKEDASEQQIEEFLREAR 53

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            + +L+HPNVVKL+G C +++   +V EY+  G L  +L       L+    +  AL  A
Sbjct: 54  IMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIA 112

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG- 308
           RG+E+L +  +  IHRD+ A N L+ ++   KISDFGL++     D      R  G +  
Sbjct: 113 RGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD----YYRKRGGKLP 166

Query: 309 --YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLA 364
             + APE +  G  T K+DV+SFGV+L EI          T G      +PY  +SN+  
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIF---------TLG-----EQPYPGMSNEEV 212

Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAAL 410
           L  + +    R  Q      E  +++L+C   DP++RPT SE+V  L
Sbjct: 213 LEYLKNGY--RLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  198 bits (507), Expect = 7e-61
 Identities = 90/289 (31%), Positives = 144/289 (49%), Gaps = 41/289 (14%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELR 189
           +  +K  +G+G FG+VY G +          +  +  VAVK L+     + ++E+  E  
Sbjct: 2   ELGKK--LGEGAFGEVYKGTLKGD------GEGTETKVAVKTLKEGASEEEREEFLEEAS 53

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            + +L+HPN+V+L+G C   +   +V EY+  G L D L    +  L  +  +++AL  A
Sbjct: 54  IMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIA 112

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +G+E+L +  +  +HRD+ A N L+ ++   KISDFGL++     D            G 
Sbjct: 113 KGMEYLES--KNFVHRDLAARNCLVTENLVVKISDFGLSR-----DIYEDDYYRKRGGGK 165

Query: 310 F-----APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNK 362
                 APE +  G  T K+DV+SFGV+L EI          T G      +PY  +SN+
Sbjct: 166 LPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIF---------TLG-----EQPYPGMSNE 211

Query: 363 LALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAAL 410
             L  + D    R  + E    E  E++L+C   DP++RPT SE+V  L
Sbjct: 212 EVLELLEDG--YRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  194 bits (495), Expect = 8e-60
 Identities = 86/273 (31%), Positives = 134/273 (49%), Gaps = 64/273 (23%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLNH 196
           +G+GGFG VY+          AR K     VA+K ++++ S    +E   E+  L +LNH
Sbjct: 1   LGEGGFGTVYL----------ARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH 50

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           PN+VKL G   D+ H  LV EY   GSL+D LL E++ +L+ +  ++I L    GLE+LH
Sbjct: 51  PNIVKLYGVFEDENHLYLVMEYCEGGSLKD-LLKENEGKLSEDEILRILLQILEGLEYLH 109

Query: 257 TYWRPVIHRDVKASNVLLD-DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
           +    +IHRD+K  N+LLD D+   K++DFGL+K   L     +   ++GT  Y APE +
Sbjct: 110 S--NGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVL 165

Query: 316 -ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G+ + K+D++S GV+L E+                                      
Sbjct: 166 LGKGYYSEKSDIWSLGVILYEL-------------------------------------- 187

Query: 375 RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                    E  ++I + L  DP+ RP+  E++
Sbjct: 188 --------PELKDLIRKMLQKDPEKRPSAKEIL 212

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  185 bits (471), Expect = 9e-56
 Identities = 81/288 (28%), Positives = 125/288 (43%), Gaps = 49/288 (17%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRF 190
           +     +G+G FG VY           AR K     VA+K +++K  +   E    E++ 
Sbjct: 1   YEILEKLGEGSFGKVY----------LARDKKTGKLVAIKVIKKKKIKKDRERILREIKI 50

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIA 245
           L +L HPN+V+L     D+    LV EY   G L D L     L+ED+            
Sbjct: 51  LKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA-------RFYL 103

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
                 LE+LH+    ++HRD+K  N+LLD+D + K++DFGLA+   L     ++T V G
Sbjct: 104 RQILSALEYLHSKG--IVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-G 158

Query: 306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL 365
           T  Y APE +         D++S GV+L E+L+GK                P+      L
Sbjct: 159 TPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKP---------------PF-PGDDQL 202

Query: 366 HQIIDEKLGRNIQMEEA-----QEFAEIILRCLNSDPKNRPTMSEVVA 408
            ++  +                 E  ++I + L  DP+ R T  E + 
Sbjct: 203 LELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  180 bits (459), Expect = 6e-54
 Identities = 101/280 (36%), Positives = 143/280 (51%), Gaps = 41/280 (14%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLN 195
           +G G FG VY           A+ K     VAVK L+++   S+       E+R L RL+
Sbjct: 7   LGSGSFGTVYK----------AKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS 56

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HPN+V+L+    D  H  LV EY   G L D+L       L+ +   KIAL   RGLE+L
Sbjct: 57  HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYL 114

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
           H+    +IHRD+K  N+LLD++   KI+DFGLAK   L   S ++T V GT  Y APE +
Sbjct: 115 HS--NGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVL 170

Query: 316 ATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA-LHQIIDEKL 373
             G     K DV+S GV+L E+L+GK                P+    +    Q+I   L
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKP---------------PFSGENILDQLQLIRRIL 215

Query: 374 GRNIQMEE------AQEFAEIILRCLNSDPKNRPTMSEVV 407
           G  ++ +E      ++E  ++I +CLN DP  RPT  E++
Sbjct: 216 GPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  158 bits (403), Expect = 1e-45
 Identities = 84/288 (29%), Positives = 129/288 (44%), Gaps = 58/288 (20%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK--RLRRKGSQGQDEWENELRFLSR 193
            L+G+G FG VY+            +   +  +AVK   L     +  +  E E+R LS 
Sbjct: 6   ELLGRGSFGSVYLALD---------KDTGEL-MAVKSVELSGDSEEELEALEREIRILSS 55

Query: 194 LNHPNVVKLMGYCCDDQ--HRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIAL 246
           L HPN+V+  G   D++     +  EYV+ GSL   L     L E      + R+I    
Sbjct: 56  LQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIR-KYTRQI---- 110

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
               GL +LH+    ++HRD+K +N+L+D D   K++DFG AK     +    +  V GT
Sbjct: 111 --LEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK---------TAAMRRTNGLAGNWAKP 357
             + APE I         D++S G  ++E+ +GK          AA+ +  G +G    P
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI-GSSGE--PP 223

Query: 358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
            +   L+               EEA++F   + +CL  DPK RPT  E
Sbjct: 224 EIPEHLS---------------EEAKDF---LRKCLRRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  155 bits (395), Expect = 1e-44
 Identities = 85/287 (29%), Positives = 135/287 (47%), Gaps = 52/287 (18%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
            F     IG+GGFG+VY           AR K     VA+K ++ +  + +++  NE++ 
Sbjct: 1   LFEILEKIGKGGFGEVY----------KARHKRTGKEVAIKVIKLESKEKKEKIINEIQI 50

Query: 191 LSRLNHPNVVKLMG-YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI-KIALGA 248
           L +  HPN+VK  G Y   D+   +V E+ + GSL+D LL   +  L  E +I  +    
Sbjct: 51  LKKCKHPNIVKYYGSYLKKDE-LWIVMEFCSGGSLKD-LLKSTNQTLT-ESQIAYVCKEL 107

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
            +GLE+LH+    +IHRD+KA+N+LL  D   K+ DFGL+         +    ++GT  
Sbjct: 108 LKGLEYLHSN--GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPY 162

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGK--------TAAMRR--TNGLAGNWAKPY 358
           + APE I       K D++S G+  +E+  GK          A+ +  TNG       P 
Sbjct: 163 WMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP------PG 216

Query: 359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
           L N                  + + EF + + +CL  +P+ RPT  +
Sbjct: 217 LRNP----------------EKWSDEFKDFLKKCLQKNPEKRPTAEQ 247

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  134 bits (339), Expect = 1e-36
 Identities = 86/291 (29%), Positives = 134/291 (46%), Gaps = 56/291 (19%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
              IG+G FGDV +G           +K     VAVK L+   +  Q  +  E   ++ L
Sbjct: 11  GATIGKGEFGDVMLG-------DYRGQK-----VAVKCLKDDSTAAQ-AFLAEASVMTTL 57

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G         +V EY+ +GSL D+L +     +   +++  AL    G+E+
Sbjct: 58  RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF---- 310
           L    +  +HRD+ A NVL+ +D  AK+SDFGLAK    G  S          G      
Sbjct: 118 LEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS----------GKLPVKW 165

Query: 311 -APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
            APE +     + K+DV+SFG++L EI S G+                PY   ++ L  +
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRV---------------PY--PRIPLKDV 208

Query: 369 IDEKLGRNIQMEEAQ----EFAEIILRCLNSDPKNRPTMSEVVAALEQLQL 415
           +   + +  +ME  +    E  +++  C   DP  RPT  ++    EQL L
Sbjct: 209 VP-HVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQL---REQLAL 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  133 bits (337), Expect = 5e-36
 Identities = 70/294 (23%), Positives = 125/294 (42%), Gaps = 60/294 (20%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKR--LRRKGSQGQDEWENEL 188
           K+     IG+G FG VY+           RRK+      +K   L     + +++  NE+
Sbjct: 1   KYEIIKQIGKGSFGKVYL----------VRRKSDGKLYVLKEIDLSNMSEKEREDALNEV 50

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN--------EDDTELNWER 240
           + L +LNHPN++K      +     +V EY   G L   +           ++  L+W  
Sbjct: 51  KILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW-- 108

Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
            +++ L     L++LH+  R ++HRD+K  N+ L  +   K+ DFG++K   L     ++
Sbjct: 109 FVQLCLA----LKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLA 160

Query: 301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS 360
             V+GT  Y +PE         K+D++S G VL E+ + K                P+  
Sbjct: 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLK---------------HPFEG 205

Query: 361 NKLALHQIIDEKLGRNIQMEE--------AQEFAEIILRCLNSDPKNRPTMSEV 406
             L        +L   I   +        + E   ++   L  DP+ RP+++++
Sbjct: 206 ENL-------LELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  130 bits (329), Expect = 9e-35
 Identities = 80/301 (26%), Positives = 139/301 (46%), Gaps = 50/301 (16%)

Query: 136 NLIGQGGFGDVYIG-YINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSR 193
             +G+G FG V +  Y      T  +       VAVK L   G  Q + ++E E+  L  
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQ-------VAVKSLNHSGEEQHRSDFEREIEILRT 62

Query: 194 LNHPNVVKLMGYCCDDQHR---LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           L+H N+VK  G  C+        L+ EY+  GSL    L     ++N +R +  +    +
Sbjct: 63  LDHENIVKYKG-VCEKPGGRSLRLIMEYLPSGSL-RDYLQRHRDQINLKRLLLFSSQICK 120

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           G+++L +  +  IHRD+ A N+L++ +   KISDFGLAK  P  DK +   +  G    F
Sbjct: 121 GMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE-DKDYYYVKEPGESPIF 177

Query: 311 --APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
             APE + T   +  +DV+SFGV L E+ +               +  P  S      ++
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFT---------------YGDPSQSPPAEFLRM 222

Query: 369 IDEKLGRNIQ------MEEAQ----------EFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           I    G+ I       ++E +          E  +++  C  ++P++RP+ ++++  +++
Sbjct: 223 IGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282

Query: 413 L 413
           L
Sbjct: 283 L 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  128 bits (325), Expect = 2e-34
 Identities = 81/284 (28%), Positives = 125/284 (44%), Gaps = 52/284 (18%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENEL 188
            +   +LIG+G FG VY G +N         +  DF VA+K++  +    +       E+
Sbjct: 1   NYQLGDLIGRGAFGVVYKG-LN--------LETGDF-VAIKQISLEKIKEEALKSIMQEI 50

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED-----HLLNEDDTELNWERRIK 243
             L  L HPN+VK +G         ++ EY   GSL           E          + 
Sbjct: 51  DLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA----VYVY 106

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
             L   +GL +LH   + VIHRD+KA+N+L   D   K++DFG+A    L D S     V
Sbjct: 107 QVL---QGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASV 159

Query: 304 LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSN 361
           +GT  + APE I     +  +D++S G  ++E+L+G                 PY  L+ 
Sbjct: 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN---------------PPYYDLNP 204

Query: 362 KLALHQIIDEK---LGRNIQMEEAQEFAEIILRCLNSDPKNRPT 402
             AL +I+ +    L   I    + E  + +++C   DP  RPT
Sbjct: 205 MAALFRIVQDDHPPLPEGI----SPELKDFLMQCFQKDPNLRPT 244

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (324), Expect = 2e-33
 Identities = 85/285 (29%), Positives = 131/285 (45%), Gaps = 30/285 (10%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSR 193
            +G+G FG+VY+                   VA+K L +K      E E    E++ L+ 
Sbjct: 7   KLGEGSFGEVYLARDR-------------KLVALKVLAKKLESKSKEVERFLREIQILAS 53

Query: 194 LNHP-NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALGAARG 251
           LNHP N+VKL  +  D+    LV EYV  GSLED L        L+    + I       
Sbjct: 54  LNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113

Query: 252 LEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDFGLAK-FGPLGDKSHI---STRVLGT 306
           LE+LH+  + +IHRD+K  N+LLD D    K+ DFGLAK     G  S I    +  +GT
Sbjct: 114 LEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 307 RGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL 363
            GY APE +      + +  +D++S G+ L E+L+G        N  A +     +    
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL- 230

Query: 364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
                +   L  +     ++  ++++ + L  DPKNR + S  ++
Sbjct: 231 -PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  124 bits (314), Expect = 7e-33
 Identities = 83/293 (28%), Positives = 144/293 (49%), Gaps = 52/293 (17%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSR 193
            +IG G FG+V  G      +    +K  D  VA+K L+  GS  +   +   E   + +
Sbjct: 10  KVIGGGEFGEVCRG-----RLKLPGKKEID--VAIKTLK-AGSSDKQRLDFLTEASIMGQ 61

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
            +HPN+++L G     +  +++ EY+  GSL D  L E+D +    + + +  G A G++
Sbjct: 62  FDHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMK 120

Query: 254 HL--HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG--- 308
           +L    Y    +HRD+ A N+L++ +   K+SDFGL++   L D     T    T+G   
Sbjct: 121 YLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYT----TKGGKI 170

Query: 309 ---YFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNK 362
              + APE IA    T  +DV+SFG+V+ E++S G+               +PY  +SN+
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE---------------RPYWDMSNQ 215

Query: 363 LALHQIIDEKLGRNIQ--MEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             +  + D   G  +   M+      +++L C   D   RPT S++V+ L+++
Sbjct: 216 DVIKAVED---GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  124 bits (314), Expect = 9e-33
 Identities = 81/286 (28%), Positives = 130/286 (45%), Gaps = 35/286 (12%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSRLNH 196
           +GQG FG VY G           +   +  VA+K +    S  +  E+ NE   +   N 
Sbjct: 14  LGQGSFGMVYEGLAKGV-----VKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC 68

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--LNEDDTELN------WERRIKIALGA 248
            +VV+L+G     Q  L+V E + +G L+ +L     +            ++ I++A   
Sbjct: 69  HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A G+ +L    +  +HRD+ A N ++ +D   KI DFG+ +     D      + L    
Sbjct: 129 ADGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALH 366
           + APE +  G  T K+DV+SFGVVL E+ +           LA    +PY  LSN+  L 
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT-----------LA---EQPYQGLSNEEVLK 232

Query: 367 QIIDEKLGRNIQMEEAQEF-AEIILRCLNSDPKNRPTMSEVVAALE 411
            +ID         E   +   E++  C   +PK RPT  E+V++L+
Sbjct: 233 FVIDGGHLD--LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 2e-32
 Identities = 86/279 (30%), Positives = 135/279 (48%), Gaps = 44/279 (15%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRLN 195
            IG+G FGDVY G +             +  VAVK  R          +  E   L + +
Sbjct: 2   KIGKGNFGDVYKGVLKG-----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD 50

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HPN+VKL+G C   Q   +V E V  GSL   L  + +  L  ++ ++++L AA G+E+L
Sbjct: 51  HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYL 109

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR----GYFA 311
            +  +  IHRD+ A N L+ ++   KISDFG+++     ++  I T   G +     + A
Sbjct: 110 ES--KNCIHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTA 163

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE +  G  T ++DV+S+G++L E  S             G+   P +SN+    +I  E
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSL------------GDTPYPGMSNQQTRERI--E 209

Query: 372 KLGRNIQMEEAQ----EFAEIILRCLNSDPKNRPTMSEV 406
              R   M   Q    E   ++L+C   DP+NRP+ SE+
Sbjct: 210 SGYR---MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  122 bits (308), Expect = 4e-32
 Identities = 82/282 (29%), Positives = 145/282 (51%), Gaps = 42/282 (14%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG+V++G  N               VAVK L+  G+   + +  E + + +L H 
Sbjct: 14  LGAGQFGEVWMGTWNGTT-----------KVAVKTLK-PGTMSPEAFLQEAQIMKKLRHD 61

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L   C +++   +V EY+++GSL D L + +  +L   + + +A   A G+ +L +
Sbjct: 62  KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
             R  IHRD+ A N+L+ ++   KI+DFGLA+   L +    + R  G +    + APE 
Sbjct: 122 --RNYIHRDLAARNILVGENLVCKIADFGLAR---LIEDDEYTARE-GAKFPIKWTAPEA 175

Query: 315 IATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQIIDE 371
              G  T+K+DV+SFG++L EI++ G+                PY  ++N+  L Q+  E
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRV---------------PYPGMTNREVLEQV--E 218

Query: 372 KLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           +  R  +     +E  +++L+C + DP+ RPT   + + LE 
Sbjct: 219 RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  121 bits (305), Expect = 2e-31
 Identities = 73/227 (32%), Positives = 116/227 (51%), Gaps = 26/227 (11%)

Query: 128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWEN 186
           +  +F E+  +G+G FG VY G +         R +A  +VA+K L+     + Q E+  
Sbjct: 5   SAVRFLEE--LGEGAFGKVYKGEL----TGPNERLSAT-SVAIKTLKENAEPKVQQEFRQ 57

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL----NEDDTELNWERRI 242
           E   +S L HPN+V L+G C  +Q   +++EY+  G L + L+    + D    + +  +
Sbjct: 58  EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117

Query: 243 K----------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP 292
           K          IA+  A G+E+L +     +HRD+ A N L+ +    KISDFGL++   
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 293 LGDKSHI-STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS 338
             D   + S  +L  R +  PE I  G  T ++D++SFGVVL EI S
Sbjct: 176 SADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  119 bits (300), Expect = 9e-31
 Identities = 73/288 (25%), Positives = 133/288 (46%), Gaps = 28/288 (9%)

Query: 133 SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL-RRKGSQGQDEWENELRFL 191
            E   +G+G FG+V++             +  +  V VK L + K    Q E+  EL   
Sbjct: 8   QEITTLGRGEFGEVFLAK-----AKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMF 62

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL---NEDDTE----LNWERRIKI 244
            +L+H NVV+L+G C + +   ++ EY   G L+  L    ++D+      L+ ++++ +
Sbjct: 63  RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A G++HL       +HRD+ A N L+      K+S   L+K      + +     L
Sbjct: 123 CTQIALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNAL 179

Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE +     + K+DV+SFGV++ E+ +             G      LS++  
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT------------QGELPFYGLSDEEV 227

Query: 365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           L+++   KL   +         +++ RC   +PK+RP+ SE+V+AL +
Sbjct: 228 LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 1e-30
 Identities = 84/283 (29%), Positives = 133/283 (46%), Gaps = 39/283 (13%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNH 196
           +G G FG V  G           +   +  VAVK L+++    G+ E+  E   +++L+H
Sbjct: 3   LGHGNFGSVVKGVYL-------MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH 55

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P +V+L+G C  +   +LV E    G L  +L      E+      ++A   A G+ +L 
Sbjct: 56  PCIVRLIGVCKGEPL-MLVMELAPLGPLLKYLK--KRREIPVSDLKELAHQVAMGMAYLE 112

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPE 313
           +  +  +HRD+ A NVLL +   AKISDFG+++    G   + +T     R    ++APE
Sbjct: 113 S--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT--AGRWPLKWYAPE 168

Query: 314 YIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQIID 370
            I  G  + K+DV+S+GV L E  S G               AKPY  +     +  +  
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYG---------------AKPYGEMKGAEVIAML-- 211

Query: 371 EKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           E   R  + EE  QE   I+L C    P++RPT SE+ +   +
Sbjct: 212 ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 1e-30
 Identities = 81/276 (29%), Positives = 121/276 (43%), Gaps = 54/276 (19%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRL 194
           +G+G FG V             R+K+     A+K L++K     +  +    E   LSR+
Sbjct: 1   LGKGSFGKVL----------LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI 50

Query: 195 NHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHL-----LNEDDTELNWERRI--KIAL 246
           NHP +VKL  Y    + +L LV EY   G L  HL      +E+       R    +I L
Sbjct: 51  NHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERA-----RFYAAEIVL 104

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
                LE+LH+    +I+RD+K  N+LLD D + K++DFGLAK     + S  +T   GT
Sbjct: 105 A----LEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELS-SEGSRTNTFC-GT 156

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL- 365
             Y APE +         D +S GV+L E+L+GK                P+ +      
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP---------------PFYAEDRKEI 201

Query: 366 -HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNR 400
             +I+ + L        + E  ++I   L  DP  R
Sbjct: 202 YEKILKDPL--RFPEFLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  115 bits (291), Expect = 1e-29
 Identities = 77/283 (27%), Positives = 123/283 (43%), Gaps = 47/283 (16%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F     +G+G +G VY           A  K     VA+K +  +      E   E+  L
Sbjct: 5   FDILEKLGEGSYGSVY----------KAIHKETGQVVAIKVVPVEEDL--QEIIKEISIL 52

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAAR 250
            + + P +VK  G    +    +V EY   GS+ D ++   +  L  E  I   L    +
Sbjct: 53  KQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLT-EEEIAAILYQTLK 110

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GLE+LH+     IHRD+KA N+LL+++  AK++DFG++  G L D       V+GT  + 
Sbjct: 111 GLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWM 166

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGK--------TAAMRRTNGLAGNWAKPYLSNK 362
           APE I       K D++S G+  +E+  GK          A+     +  N   P LS+ 
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF----MIPNKPPPTLSD- 221

Query: 363 LALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
                            + + EF + + +CL  DP+ RP+  +
Sbjct: 222 ---------------PEKWSPEFNDFVKKCLVKDPEERPSAIQ 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  115 bits (289), Expect = 2e-29
 Identities = 75/273 (27%), Positives = 125/273 (45%), Gaps = 32/273 (11%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKR--LRRKGSQGQDEWENELR 189
           F   N IG+G FG V+             RK      A+K+  L +   + ++E  +E R
Sbjct: 2   FEILNKIGKGSFGVVF----------KVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR 51

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L++L+   +++      D     +V EY   G L   L  +    L  ++  +  +   
Sbjct: 52  VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL 111

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
            GL HLH+  + ++HRD+K+ N+ LD   N KI D G+AK   L D ++ +  ++GT  Y
Sbjct: 112 LGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYY 167

Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY-LSNKLALHQI 368
            +PE         K+DV++ GVVL E  +GK                P+  +N+ AL   
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGK---------------HPFDANNQGALILK 212

Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
           I   +   +    +Q+ A++I +CL  D + RP
Sbjct: 213 IIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 2e-29
 Identities = 76/285 (26%), Positives = 131/285 (45%), Gaps = 46/285 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG+V+ G             N    VAVK L+  G+    ++  E + + +L HP
Sbjct: 14  LGAGQFGEVWEG-----------LWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHP 61

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL-- 255
            +++L   C  ++   +V E +  GSL ++L       L   + I +A   A G+ +L  
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAP 312
             Y    IHRD+ A NVL+ ++   K++DFGLA+      K  I     G +    + AP
Sbjct: 122 QNY----IHRDLAARNVLVGENNICKVADFGLARV----IKEDIYEAREGAKFPIKWTAP 173

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E       ++K+DV+SFG++L EI++             G    P ++N     +++ ++
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVT------------YGRMPYPGMTN----AEVL-QQ 216

Query: 373 LGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           + +  +M       +E  +I+L C   DP +RPT   +   LE  
Sbjct: 217 VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  114 bits (288), Expect = 6e-29
 Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 54/288 (18%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
            +     IG+G  G+VY           A  +     VA+K++R +  Q ++   NE+  
Sbjct: 20  LYKNLEKIGEGASGEVY----------KATDRATGKEVAIKKMRLR-KQNKELIINEILI 68

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-IALGAA 249
           +    HPN+V             +V EY+  GSL D ++ ++   +N E +I  +     
Sbjct: 69  MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD-IITQNFVRMN-EPQIAYVCREVL 126

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL-AKFGPLGDKSHISTRVLGTRG 308
           +GLE+LH+  + VIHRD+K+ N+LL  D + K++DFG  A+      K +    V+GT  
Sbjct: 127 QGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN---SVVGTPY 181

Query: 309 YFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMR----------RTNGLAGNWAKP 357
           + APE I        K D++S G++ +E+  G+   +R           T G+      P
Sbjct: 182 WMAPEVI-KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI------P 234

Query: 358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
            L N         EK         + EF + + +CL  DP+ RP+  E
Sbjct: 235 PLKNP--------EKW--------SPEFKDFLNKCLVKDPEKRPSAEE 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  113 bits (285), Expect = 9e-29
 Identities = 78/290 (26%), Positives = 137/290 (47%), Gaps = 49/290 (16%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G            K     VAVK L+   +   +E+  E   +  +
Sbjct: 11  KHKLGGGQYGEVYEGVW----------KKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEI 59

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 60  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 119

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF-------GPLGDKSHISTRVLGTR 307
           L    +  IHRD+ A N L+ ++   K++DFGL++           G K  I        
Sbjct: 120 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------- 170

Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            + APE +A    ++K+DV++FGV+L EI          T G++     PY    L    
Sbjct: 171 -WTAPESLAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPGIDL---S 212

Query: 368 IIDEKLGRNIQMEEAQ----EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            + E L +  +ME  +    +  E++  C   +P +RP+ +E+  A E +
Sbjct: 213 QVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  111 bits (280), Expect = 5e-28
 Identities = 76/262 (29%), Positives = 121/262 (46%), Gaps = 21/262 (8%)

Query: 148 IGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYC 206
           +G  NS  ++    +     +AVK +R +     Q +   EL  L + N P +V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRD 266
            ++    +  EY+  GSL D +L E    +      KIA+   +GL +LH     +IHRD
Sbjct: 69  YNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEK-HKIIHRD 126

Query: 267 VKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDV 326
           VK SN+L++     K+ DFG++  G L + S   T V GT  Y APE I     ++K+D+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVS--GQLVN-SLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182

Query: 327 YSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE---KLGRNIQMEEAQ 383
           +S G+ L+E+ +G+                P       L  I++E   +L       + Q
Sbjct: 183 WSLGLSLIELATGRFP--------YPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ 234

Query: 384 EFAEIILRCLNSDPKNRPTMSE 405
           +F   +  CL  DP+ RP+  E
Sbjct: 235 DF---VNLCLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  115 bits (290), Expect = 2e-27
 Identities = 82/292 (28%), Positives = 136/292 (46%), Gaps = 32/292 (10%)

Query: 134 EKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSR 193
           E+N+I +G  G  Y G          +         VK +    S       +E+  + +
Sbjct: 694 EENVISRGKKGASYKG----------KSIKNGMQFVVKEINDVNSIP----SSEIADMGK 739

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           L HPN+VKL+G C  ++   L++EY+   +L + L N     L+WERR KIA+G A+ L 
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALR 794

Query: 254 HLHTYWRP-VIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            LH    P V+  ++    +++D      +    L+  G L       T+   +  Y AP
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLC----TDTKCFISSAYVAP 847

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGK--TAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           E   T  +T K+D+Y FG++L+E+L+GK    A    +G    WA+ Y  +   L   ID
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR-YCYSDCHLDMWID 906

Query: 371 EKLGRNIQMEEAQ--EFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSC 420
             +  ++ + + +  E   + L C  +DP  RP  ++V+  LE    +  SC
Sbjct: 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSC 958

Length = 968

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  109 bits (274), Expect = 2e-27
 Identities = 79/281 (28%), Positives = 135/281 (48%), Gaps = 43/281 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG+V++GY N               VA+K L+ +GS   + +  E   + +L HP
Sbjct: 14  LGAGQFGEVWMGYYNG-----------HTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHP 61

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L       +   ++ EY+  GSL D L   +  +L   + I +A   A G+  +  
Sbjct: 62  RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
             +  IHRD++A+N+L+ +    KI+DFGLA+   + D  + +    G +    + APE 
Sbjct: 121 --KNYIHRDLRAANILVSETLCCKIADFGLARL--IEDNEYTARE--GAKFPIKWTAPEA 174

Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           I  G  T+K+DV+SFG++L EI++             G    P ++N     ++I + L 
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVT------------YGRIPYPGMTNP----EVI-QNLE 217

Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M       +E  E++  C    P+ RPT   + + LE
Sbjct: 218 RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  109 bits (273), Expect = 4e-27
 Identities = 73/275 (26%), Positives = 131/275 (47%), Gaps = 36/275 (13%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F+ +  +G G FG+V+ G            KN    VA+K L+      Q +++ E++ L
Sbjct: 8   FTLERKLGSGYFGEVWEG----------LWKNR-VRVAIKILKSDDLLKQQDFQKEVQAL 56

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
            RL H +++ L   C   +   ++ E + +GSL   L + +   L     I +A   A G
Sbjct: 57  KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
           + +L    +  IHRD+ A N+L+ +D   K++DFGLA+   + +  ++S+       + A
Sbjct: 117 MAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTA 172

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE  + G  + K+DV+SFG++L E+ +             G    P ++N     QI   
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT------------YGQVPYPGMNNHEVYDQIT-- 218

Query: 372 KLGRNIQM----EEAQEFAEIILRCLNSDPKNRPT 402
                 +M    +  QE  +I+L C  ++P++RP+
Sbjct: 219 ---AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  108 bits (272), Expect = 6e-27
 Identities = 85/286 (29%), Positives = 128/286 (44%), Gaps = 50/286 (17%)

Query: 136 NLIGQGGFGDVYIGY-INSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           N IG G FG VY    +++             AV   R++    +   E  +E++ L  L
Sbjct: 6   NKIGGGTFGKVYTAVNLDT---------GELMAVKEIRIQDNDPKTIKEIADEMKVLELL 56

Query: 195 NHPNVVKLMGYCCDDQHRLLVY---EYVTRGSLED---HLLNEDDTELNWERRIKIALGA 248
            HPN+VK  G    + HR  VY   EY + G+LE+   H    D+  +   R   + L  
Sbjct: 57  KHPNLVKYYGV---EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI---RVYTLQL-- 108

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSH-ISTRVLGTR 307
             GL +LH+    ++HRD+K +N+ LD +   K+ DFG A    L + +  +   V    
Sbjct: 109 LEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVK--LKNNTTTMGEEVQSLA 164

Query: 308 G---YFAPEYIATGHLTLK---TDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
           G   Y APE I  G         D++S G V+LE+ +GK    R  + L   +   +   
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK----RPWSELDNEFQIMF--- 217

Query: 362 KLALHQ--IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
            +       I + L  +    E ++F   + RCL SDPK RPT SE
Sbjct: 218 HVGAGHKPPIPDSLQLS---PEGKDF---LDRCLESDPKKRPTASE 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  107 bits (270), Expect = 9e-27
 Identities = 71/273 (26%), Positives = 118/273 (43%), Gaps = 30/273 (10%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKR--LRRKGSQGQDEWENELRFLSRLN 195
           +G+G FG+           T  RR   D  V  K   L R   + + +  NE+  LS L 
Sbjct: 8   LGKGAFGEA----------TLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ 57

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HPN++    +  DD   L+  EY   G+L D ++ +       E  +         + ++
Sbjct: 58  HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI 117

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
           H     ++HRD+K  N+ L      K+ DFG++K   LG +  ++  V+GT  Y +PE  
Sbjct: 118 HK--AGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELC 173

Query: 316 ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGR 375
                  K+D+++ G VL E+L+     ++RT            +N L L   I +    
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLT-----LKRT--FDA-------TNPLNLVVKIVQGNYT 219

Query: 376 NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
            +    + E   ++   L  DP+ RPT  EV+ 
Sbjct: 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  108 bits (271), Expect = 1e-26
 Identities = 78/283 (27%), Positives = 114/283 (40%), Gaps = 54/283 (19%)

Query: 138 IGQGGFGDVYIG-YINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           +GQG  G VY   +  +  + A ++      V      RK      +   EL+ L     
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKK----IHVDGDEEFRK------QLLRELKTLRSCES 58

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALGAARG 251
           P VVK  G    +    +V EY+  GSL D L     + E            IA    +G
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-------IARQILKG 111

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
           L++LHT  R +IHRD+K SN+L++     KI+DFG++K          +   +GT  Y +
Sbjct: 112 LDYLHTK-RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMS 168

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     +   D++S G+ LLE   GK                P+L          + 
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALGKF---------------PFLPPGQP--SFFE- 210

Query: 372 KLGRNIQMEEA---------QEFAEIILRCLNSDPKNRPTMSE 405
            L + I               EF + I  CL  DPK RP+ +E
Sbjct: 211 -LMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  106 bits (268), Expect = 3e-26
 Identities = 73/309 (23%), Positives = 124/309 (40%), Gaps = 73/309 (23%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSR 193
           +IG+G F  V +          A+ K  +   A+K L ++     +     + E   L+R
Sbjct: 8   IIGEGSFSTVVL----------AKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTR 57

Query: 194 LN-HPNVVKLMGYCC-DDQHRL-LVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIA 245
           LN HP ++KL  Y    D+  L  V EY   G L  ++     L+E  T          A
Sbjct: 58  LNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF-------YA 108

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF---------GPLGDK 296
                 LE+LH+  + +IHRD+K  N+LLD D + KI+DFG AK                
Sbjct: 109 AEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 297 SHISTR---------VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRT 347
           +  S            +GT  Y +PE +        +D+++ G ++ ++L+GK       
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP------ 220

Query: 348 NGLAGNWAKPY--LSNKLALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTM 403
                    P+   +  L   +I+                +  ++I + L  DP++R  +
Sbjct: 221 ---------PFRGSNEYLTFQKILK----LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV 267

Query: 404 SEVVAALEQ 412
           +E    L+ 
Sbjct: 268 NEGYDELKA 276

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  106 bits (267), Expect = 4e-26
 Identities = 90/301 (29%), Positives = 136/301 (45%), Gaps = 35/301 (11%)

Query: 132 FSEKNLI-----GQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN 186
           F E++L      G+G FG V +     C     +  N    VAVK+L+   ++   ++E 
Sbjct: 1   FEERHLKFIQQLGKGNFGSVEL-----CRYDPLQ-DNTGEVVAVKKLQHSTAEHLRDFER 54

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
           E+  L  L H N+VK  G C     R   LV EY+  GSL D+L    +  L+  + +  
Sbjct: 55  EIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLY 113

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           A    +G+E+L +  +  +HRD+   N+L++ +   KI DFGL K  P  DK +   R  
Sbjct: 114 ASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREP 170

Query: 305 GTRGYF--APEYIATGHLTLKTDVYSFGVVLLEIL-------SGKTAAMRRTNGLAGNWA 355
           G    F  APE +     ++ +DV+SFGVVL E+        S     MR      GN  
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMM----GN-D 225

Query: 356 KPYLSNKLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K      +  H I   K    +        E   I+  C N+DP  RP+ SE+   +E +
Sbjct: 226 KQGQM--IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Query: 414 Q 414
           +
Sbjct: 284 R 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  107 bits (268), Expect = 5e-26
 Identities = 86/290 (29%), Positives = 130/290 (44%), Gaps = 55/290 (18%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F++   IG G FG VY           AR    +  VA+K++   G Q  ++W++   E+
Sbjct: 17  FTDLREIGHGSFGAVYF----------ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 66

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL------LNEDDTELNWERRI 242
           RFL +L HPN ++  G    +    LV EY   GS  D L      L E +         
Sbjct: 67  RFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA------- 118

Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
            I  GA +GL +LH++ R  IHRD+KA N+LL +    K++DFG A        S  ++ 
Sbjct: 119 AICHGALQGLAYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSF 171

Query: 303 VLGTRGYFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
           V GT  + APE I     G    K DV+S G+  +E+      A R+          P  
Sbjct: 172 V-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERK---------PPLF 215

Query: 360 S-NKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + N + AL+ I           + +  F   +  CL   P++RP+  E++
Sbjct: 216 NMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 6e-26
 Identities = 77/291 (26%), Positives = 135/291 (46%), Gaps = 52/291 (17%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNH 196
           +G G FG VY G            +     VA+K LR +   +   E  +E   ++ ++H
Sbjct: 15  LGSGAFGTVYKGV------WIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-----TELNWERRIKIALGAARG 251
           P+VV+L+G C   Q   L+ + +  G L D++ N  D       LNW  +I      A+G
Sbjct: 69  PHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
           + +L    + ++HRD+ A NVL+    + KI+DFGLAK   + +K + +        + A
Sbjct: 122 MSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA-LHQIID 370
            E I     T K+DV+S+GV + E++         T G     AKPY       +  +++
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELM---------TFG-----AKPYEGIPAVEIPDLLE 225

Query: 371 --EKLGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             E+L +      ++ M        ++++C   D ++RPT  E++    ++
Sbjct: 226 KGERLPQPPICTIDVYM--------VLVKCWMIDAESRPTFKELINEFSKM 268

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  106 bits (266), Expect = 6e-26
 Identities = 82/294 (27%), Positives = 133/294 (45%), Gaps = 45/294 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNH 196
           +G+G FG V++G    C       +N    VAVK L+   S   + ++E E   L+   H
Sbjct: 13  LGEGAFGKVFLG---ECY--HLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL------------LNEDDTELNWERRIKI 244
            N+VK  G C +    ++V+EY+  G L   L             +    EL   + ++I
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS-TRV 303
           A+  A G+ +L +  +  +HRD+   N L+  D   KI DFG+++     D   +    +
Sbjct: 128 AVQIASGMVYLAS--QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185

Query: 304 LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LS 360
           L  R +  PE I     T ++DV+SFGVVL EI + GK               +P+  LS
Sbjct: 186 LPIR-WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK---------------QPWYGLS 229

Query: 361 NKLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           N+  +  I     GR +Q       E  +I+L C   DP+ R  + ++   L++
Sbjct: 230 NEEVIECI---TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  104 bits (261), Expect = 1e-25
 Identities = 81/275 (29%), Positives = 137/275 (49%), Gaps = 37/275 (13%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLN 195
           L+G+G FG+V+ G +        + K     VAVK  +    Q  + ++ +E R L + +
Sbjct: 2   LLGKGNFGEVFKGTL--------KDKTP---VAVKTCKEDLPQELKIKFLSEARILKQYD 50

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HPN+VKL+G C   Q   +V E V  G     L  + D EL  ++ +K AL AA G+ +L
Sbjct: 51  HPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYL 109

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
            +  +  IHRD+ A N L+ ++   KISDFG+++    G  S    + +  + + APE +
Sbjct: 110 ES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEAL 166

Query: 316 ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGR 375
             G  + ++DV+S+G++L E  S             G    P ++N+ A  Q+      +
Sbjct: 167 NYGRYSSESDVWSYGILLWETFS------------LGVCPYPGMTNQQAREQV-----EK 209

Query: 376 NIQMEEAQ----EFAEIILRCLNSDPKNRPTMSEV 406
             +M   Q    +  +++ RC +  P+NRP  SE+
Sbjct: 210 GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  105 bits (263), Expect = 1e-25
 Identities = 78/254 (30%), Positives = 119/254 (46%), Gaps = 16/254 (6%)

Query: 168 VAVKRLRRK-GSQGQDEWENELRFLSRLNHPNVVKLMGYCCD--DQHRLLVYEYVTRGSL 224
           VAVK L+R+ G Q    W+ E+  L  L H N+VK  G C +   +   L+ EYV  GSL
Sbjct: 36  VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95

Query: 225 EDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD 284
            D+L       LN  + +  A     G+ +LH+  +  IHRD+ A NVLLD+D   KI D
Sbjct: 96  RDYLPKHK---LNLAQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGD 150

Query: 285 FGLAKFGPLGDKSHISTRVLGTRG----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           FGLAK  P G   H   RV         ++A E +     +  +DV+SFGV L E+L+  
Sbjct: 151 FGLAKAVPEG---HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207

Query: 341 TAAMR-RTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKN 399
            +              K      + L ++++  +         QE   ++  C  ++ K 
Sbjct: 208 DSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKF 267

Query: 400 RPTMSEVVAALEQL 413
           RPT   ++  L+++
Sbjct: 268 RPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  104 bits (260), Expect = 2e-25
 Identities = 85/294 (28%), Positives = 130/294 (44%), Gaps = 68/294 (23%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD---EWENELRFLSR 193
           L+G G FG VY G                FAV    L   G  GQ+   + E E+  LS+
Sbjct: 7   LLGSGSFGSVYEGL--------NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSK 58

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNE----DDTEL-NWERRIKIALGA 248
           L HPN+V+ +G   ++ +  +  E V  GSL   LL +     +  +  + R+I      
Sbjct: 59  LQHPNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQI------ 111

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL---- 304
             GLE+LH   R  +HRD+K +N+L+D +   K++DFG+AK         +         
Sbjct: 112 LLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSF 161

Query: 305 -GTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGK--------TAAMRRTNGLAGNW 354
            G+  + APE IA  G   L  D++S G  +LE+ +GK         AA+ +        
Sbjct: 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI------- 214

Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
                  +      I + L       EA++F   IL+CL  DP  RPT +E++ 
Sbjct: 215 ------GRSKELPPIPDHLSD-----EAKDF---ILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  104 bits (262), Expect = 3e-25
 Identities = 84/291 (28%), Positives = 133/291 (45%), Gaps = 47/291 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSRL 194
           +G G FG V    + + A   ++  +A   VAVK L  K +    E E   +EL+ +S L
Sbjct: 43  LGAGAFGKV----VEATAYGLSK-SDAVMKVAVKML--KPTAHSSEREALMSELKIMSHL 95

Query: 195 -NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
            NH N+V L+G C      L++ EY   G L + L  + ++ L  E  +  +   A+G+ 
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155

Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG----- 308
            L +  +  IHRD+ A NVLL      KI DFGLA+     D  + S  V   +G     
Sbjct: 156 FLAS--KNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYV--VKGNARLP 206

Query: 309 --YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             + APE I     T ++DV+S+G++L EI S           L  N   PY    + + 
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS-----------LGSN---PYPG--MPVD 250

Query: 367 QIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               + +    +M +      E  +I+  C ++DP  RPT  ++V  + + 
Sbjct: 251 SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  103 bits (257), Expect = 4e-25
 Identities = 82/287 (28%), Positives = 138/287 (48%), Gaps = 44/287 (15%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW--ENEL 188
           K+ +  ++G+G FG V++           RRK     V +K++  +     +    +NE 
Sbjct: 1   KYEKIRVVGRGAFGIVHL----------CRRKADQKLVIIKQIPVEQMTKDERLAAQNEC 50

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL------LNEDDTELNWERRI 242
           + L  L+HPN+++      +D+  ++V EY   G+L +++      L ++DT L++  +I
Sbjct: 51  QVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI 110

Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN-AKISDFGLAKFGPLGDKSHIST 301
            +A      L H+HT  + ++HRD+K  N+LLD      KI DFG++K   L  KS   T
Sbjct: 111 LLA------LHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT 160

Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            V+GT  Y +PE         K+D+++ G VL E+ S K A                 +N
Sbjct: 161 -VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA--------------AN 205

Query: 362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
             AL   I       I    + +  ++IL  LN DP  RP +S+++A
Sbjct: 206 LPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 5e-25
 Identities = 74/281 (26%), Positives = 132/281 (46%), Gaps = 45/281 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V++G                  VA+K +R +G+  +D++  E + + +L+HP
Sbjct: 12  LGSGQFGVVHLGKWRG-----------KIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHP 59

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N+V+L G C   +   +V EY+  G L ++L  E   +L  E  + +       +E+L +
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAMEYLES 118

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                IHRD+ A N L+ +D   K+SDFGLA++  L D+   S    GT+    +  PE 
Sbjct: 119 --NGFIHRDLAARNCLVGEDNVVKVSDFGLARY-VLDDQYTSSQ---GTKFPVKWAPPEV 172

Query: 315 IATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL 373
                 + K+DV+SFGV++ E+ S GK    R +N                  ++++  +
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----------------EVVES-V 214

Query: 374 GRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAAL 410
               ++        E   I+  C +  P++RP   ++++ L
Sbjct: 215 SAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  103 bits (259), Expect = 7e-25
 Identities = 87/302 (28%), Positives = 141/302 (46%), Gaps = 47/302 (15%)

Query: 132 FSEKNLIGQGGFGDVYI----GYINSCAMTAARRKNADFA--VAVKRLRRKGSQ-GQDEW 184
           F EK  +G+G FG+V++    G  +      A   NAD    VAVK LR   S   ++++
Sbjct: 9   FVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDF 66

Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSL---------EDHLLNEDDTE 235
             E++ LSRL+ PN+ +L+G C  D    ++ EY+  G L         E   L  +   
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126

Query: 236 LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGD 295
           L++   + +A   A G+ +L +     +HRD+   N L+  ++  KI+DFG+++     D
Sbjct: 127 LSFSTLLYMATQIASGMRYLES--LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 296 KSHISTR-VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
              +  R  L  R + A E +  G  T K+DV++FGV L EIL+      R         
Sbjct: 185 YYRVQGRAPLPIR-WMAWESVLLGKFTTKSDVWAFGVTLWEILT----LCRE-------- 231

Query: 355 AKPYLSNKLALHQIID------EKLGRNIQMEEA----QEFAEIILRCLNSDPKNRPTMS 404
            +PY    L   Q+I+         GR I +       ++  E++L C   D ++RPT  
Sbjct: 232 -QPY--EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR 288

Query: 405 EV 406
           E+
Sbjct: 289 EI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  101 bits (254), Expect = 1e-24
 Identities = 76/274 (27%), Positives = 134/274 (48%), Gaps = 31/274 (11%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG V++GY                 VA+K +R +G+  ++++  E + + +L+HP
Sbjct: 12  IGSGQFGLVWLGYWLE-----------KRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHP 59

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C +     LV+E++  G L D+L  +     + E  + + L    G+ +L +
Sbjct: 60  KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLES 118

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               VIHRD+ A N L+ ++   K+SDFG+ +F  L D+   ST       + +PE  + 
Sbjct: 119 --SNVIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFSF 175

Query: 318 GHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRN 376
              + K+DV+SFGV++ E+ S GKT    R+N          +    A  ++   +L   
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------EVVETINAGFRLYKPRLA-- 226

Query: 377 IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL 410
                +Q   E++  C    P++RP+ S ++  L
Sbjct: 227 -----SQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 2e-24
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 31/212 (14%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-----ELRFLS 192
           IG+G +G VY           AR K     VA+K+++ +    + E        E++ L 
Sbjct: 7   IGEGTYGVVY----------KARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLK 53

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED--HLLNEDDTELNWERRIK-IALGAA 249
            LNHPN++KL+          LV+E++      D   L+ +    L  E  IK       
Sbjct: 54  ELNHPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLP-ESLIKSYLYQLL 108

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +GL   H++   ++HRD+K  N+L++ +   K++DFGLA+    G      T  + TR Y
Sbjct: 109 QGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWY 164

Query: 310 FAPEYIAT-GHLTLKTDVYSFGVVLLEILSGK 340
            APE +      +   D++S G +  E+LS +
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  101 bits (254), Expect = 2e-24
 Identities = 76/285 (26%), Positives = 117/285 (41%), Gaps = 37/285 (12%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL--RRKGSQGQDEWENEL 188
            +     IG+G FG V             RRK+    +  K +       + + +  +E+
Sbjct: 1   DYEVLETIGKGSFGTVRK----------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV 50

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLL--VYEYVTRGSLEDHLLN--EDDTELNWERRIKI 244
             L  L HPN+V+      D  ++ L  V EY   G L   +    ++   +  E   +I
Sbjct: 51  NILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRI 110

Query: 245 ALGAARGLEHLHTYWRP---VIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
                  L   H    P   V+HRD+K +N+ LD + N K+ DFGLAK   LG  S  + 
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAK 168

Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL-S 360
             +GT  Y +PE +       K+D++S G ++ E+ +                  P+   
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP---------------PFTAR 213

Query: 361 NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
           N+L L   I E   R I    + E  E+I   LN DP  RP+  E
Sbjct: 214 NQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  101 bits (253), Expect = 3e-24
 Identities = 89/284 (31%), Positives = 130/284 (45%), Gaps = 42/284 (14%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSR 193
           N +G G FG+VY G     A       +    VAVK LR KG+  Q + E+  E   +S 
Sbjct: 1   NFLGSGAFGEVYEG----TATDILGPGSGPIRVAVKTLR-KGATDQEKKEFLKEAHLMSN 55

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-----LNWERRIKIALGA 248
            NHPN+VKL+G C  ++ + ++ E +  G L  +L +          L  +  + I L  
Sbjct: 56  FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115

Query: 249 ARG---LEHLHTYWRPVIHRDVKASNVLL-----DDDFNAKISDFGLAKFGPLGDKSHI- 299
           A+G   LE +H      IHRD+ A N L+     D D   KI DFGLA+     D     
Sbjct: 116 AKGCVYLEQMH-----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170

Query: 300 STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
              +L  R + APE +  G  T ++DV+SFGV++ EIL+             G    P L
Sbjct: 171 GEGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILT------------LGQQPYPAL 217

Query: 360 SNKLALHQIIDEKLGRNIQMEEAQE-FAEIILRCLNSDPKNRPT 402
           +N+  L  +     GR  + E   +   +++  C   DP  RPT
Sbjct: 218 NNQEVLQHVTAG--GRLQKPENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 4e-24
 Identities = 84/289 (29%), Positives = 123/289 (42%), Gaps = 57/289 (19%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---E 187
            F+    IG+G FG+VY             R N   A+ V  L     + +DE E+   E
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDK--------RTNQVVAIKVIDL----EEAEDEIEDIQQE 49

Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL----LNEDDTELNWERRIK 243
           ++FLS+   P + K  G         ++ EY   GS  D L    L+E            
Sbjct: 50  IQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF------- 102

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGD-KSHISTR 302
           I      GLE+LH      IHRD+KA+N+LL ++ + K++DFG++  G L    S  +T 
Sbjct: 103 ILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTF 158

Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK 362
           V GT  + APE I       K D++S G+  +E+  G                +P LS+ 
Sbjct: 159 V-GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG----------------EPPLSDL 201

Query: 363 ---LALHQIIDE---KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
                L  I       L  N   +  ++F  +   CLN DPK RP+  E
Sbjct: 202 HPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL---CLNKDPKERPSAKE 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  101 bits (253), Expect = 4e-24
 Identities = 87/314 (27%), Positives = 148/314 (47%), Gaps = 55/314 (17%)

Query: 132 FSEKNLIGQGGFGDVYIGYINS------CAMTAARRKNADFAVAVKRLRRKGSQ-GQDEW 184
           F EK  +G+G FG+V++  + +             RK     VAVK LR   ++  ++++
Sbjct: 9   FKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDF 66

Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN---EDDTE------ 235
             E++ LSRL  PN+++L+G C D+    ++ EY+  G L   L +   +D  E      
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 236 --------LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
                   +++   + +AL  A G+++L +     +HRD+   N L+ ++   KI+DFG+
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSL--NFVHRDLATRNCLVGENLTIKIADFGM 184

Query: 288 AKFGPLGDKSHISTR-VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRR 346
           ++    GD   I  R VL  R + A E I  G  T  +DV++FGV L EIL         
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIR-WMAWECILMGKFTTASDVWAFGVTLWEILMLCK----- 238

Query: 347 TNGLAGNWAKPYLSNKLALHQIID------EKLGRNIQMEE----AQEFAEIILRCLNSD 396
                    +PY   +L   Q+I+         GR + +       Q   E++L+C + D
Sbjct: 239 --------EQPY--GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRD 288

Query: 397 PKNRPTMSEVVAAL 410
            + RP+ S++ A L
Sbjct: 289 CRERPSFSDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  100 bits (250), Expect = 4e-24
 Identities = 76/281 (27%), Positives = 137/281 (48%), Gaps = 47/281 (16%)

Query: 138 IGQGGFGDVYIG-YINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           IG+G FG V  G Y                 VAVK +  K       +  E   +++L+H
Sbjct: 14  IGEGEFGAVLQGEYTGQ-------------KVAVKNI--KCDVTAQAFLEETAVMTKLHH 58

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
            N+V+L+G         +V E +++G+L + L       ++  + ++ +L  A G+E+L 
Sbjct: 59  KNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG-DKSHISTRVLGTRGYFAPEYI 315
           +  + ++HRD+ A N+L+ +D  AK+SDFGLA+ G +G D S +  +      + APE +
Sbjct: 118 S--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEAL 169

Query: 316 ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGR 375
                + K+DV+S+GV+L E+ S   A              PY   K++L + + E + +
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRA--------------PY--PKMSLKE-VKECVEK 212

Query: 376 NIQMEEAQE----FAEIILRCLNSDPKNRPTMSEVVAALEQ 412
             +ME  +        ++  C  ++PK RP+  ++   LE+
Sbjct: 213 GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  100 bits (251), Expect = 4e-24
 Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 21/214 (9%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           LIG G FG VY+G   S     A ++    +V+     RK S   D    E+  L  L H
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSM-LDALAREIALLKELQH 65

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN----EDDTELNWERRIKIALGAARGL 252
            N+V+ +G   D  H  +  EYV  GS+   L N    E+    N+ R+I       +GL
Sbjct: 66  ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGL 119

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR------VLGT 306
            +LH   R +IHRD+K +N+L+D+    KISDFG++K   L   S  +        + G+
Sbjct: 120 NYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGARPSLQGS 175

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
             + APE +     T K D++S G +++E+L+GK
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  100 bits (250), Expect = 7e-24
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 14/205 (6%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+GGFG+V      +C + A  +  A   +  KRL+++  +G+    NE + L +++  
Sbjct: 1   LGKGGFGEVC-----ACQVKATGKMYACKKLDKKRLKKR--KGEQMALNEKKILEKVSSR 53

Query: 198 NVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
            +V  + Y  + +  L LV   +  G L+ H+ N  +      R I  A     GLEHLH
Sbjct: 54  FIVS-LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA 316
              R +++RD+K  NVLLDD  N +ISD GLA     G K        GT GY APE + 
Sbjct: 113 Q--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQ 167

Query: 317 TGHLTLKTDVYSFGVVLLEILSGKT 341
                   D ++ G  L E+++G++
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRS 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 65/245 (26%), Positives = 119/245 (48%), Gaps = 33/245 (13%)

Query: 182 DEWENELRFLSRLNHPNVVKLMGY---CCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELN 237
           D  ENE++ L R++  N++K+ G+     DD  RL L+ EY TRG L + L  E D  L+
Sbjct: 63  DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--LS 120

Query: 238 WERRIKIALGAARGLEHLHTYW-RPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
           ++ ++ +A+   +GL +L+ Y  +P  ++++ + + L+ +++  KI   GL K       
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPF 178

Query: 297 SHISTRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
            +++  V     YF+ + +       T+K D+YS GVVL EI +GK              
Sbjct: 179 KNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI------------- 220

Query: 355 AKPY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
             P+  L+ K     II++     + ++   E   I+  C + D   RP + E++  L  
Sbjct: 221 --PFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278

Query: 413 LQLNM 417
            +  +
Sbjct: 279 YKFYI 283

Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  100 bits (249), Expect = 1e-23
 Identities = 88/316 (27%), Positives = 135/316 (42%), Gaps = 71/316 (22%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLNH 196
           +G+G FG V           A         VAVK L+   S  +  +  +E   L ++NH
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYT-----TVAVKMLKENASSSELRDLLSEFNLLKQVNH 62

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL----------------------LNEDDT 234
           P+V+KL G C  D   LL+ EY   GSL   L                       N D+ 
Sbjct: 63  PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 235 ELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
            L     I  A   +RG+++L      ++HRD+ A NVL+ +    KISDFGL++     
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEM--KLVHRDLAARNVLVAEGRKMKISDFGLSR----- 175

Query: 295 DKSHISTRVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
           D     + V  ++G     + A E +     T ++DV+SFGV+L EI++           
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----------- 224

Query: 350 LAGNWAKPY-------LSNKLALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNR 400
           L GN   PY       L N L        K G  ++  E  ++E   ++L C   +P  R
Sbjct: 225 LGGN---PYPGIAPERLFNLL--------KTGYRMERPENCSEEMYNLMLTCWKQEPDKR 273

Query: 401 PTMSEVVAALEQLQLN 416
           PT +++   LE++ + 
Sbjct: 274 PTFADISKELEKMMVK 289

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 99.2 bits (247), Expect = 1e-23
 Identities = 81/288 (28%), Positives = 133/288 (46%), Gaps = 49/288 (17%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL---RRKGSQGQDEWE---NELRF 190
            +G G F   Y           AR       +AVK++   R   S+ ++  E    E+R 
Sbjct: 7   QLGTGAFSSCY----------QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRL 56

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIA 245
           ++RLNHP++++++G  C+D H  L  E++  GS+  HLL+     ++   +N+  ++   
Sbjct: 57  MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVS-HLLSKYGAFKEAVIINYTEQL--- 112

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDD-FNAKISDFGLAKFGPLGDK----SHIS 300
               RGL +LH     +IHRDVK +N+L+D      +I+DFG A    L  K        
Sbjct: 113 ---LRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAA--ARLAAKGTGAGEFQ 165

Query: 301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS 360
            ++LGT  + APE +         DV+S G V++E+ + K             W     S
Sbjct: 166 GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP-----------WNAEKHS 214

Query: 361 NKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           N LAL  +I       +I    +    ++ LRCL   P++RP   E++
Sbjct: 215 NHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 98.9 bits (246), Expect = 2e-23
 Identities = 80/277 (28%), Positives = 122/277 (44%), Gaps = 41/277 (14%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNH 196
           IG+G FG+V+ G          R +  +  VAVK  R       + ++  E R L + +H
Sbjct: 3   IGRGNFGEVFSG----------RLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSH 52

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           PN+V+L+G C   Q   +V E V  G     L  E    L  +  I++   AA G+E+L 
Sbjct: 53  PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLE 111

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK------FGPLGDKSHISTRVLGTRGYF 310
           +  +  IHRD+ A N L+ +    KISDFG+++      +   G    I  +      + 
Sbjct: 112 S--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK------WT 163

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           APE +  G  + ++DV+SFG++L E  S             G      LSN+     I  
Sbjct: 164 APEALNYGRYSSESDVWSFGILLWEAFS------------LGAVPYANLSNQQTREAI-- 209

Query: 371 EKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEV 406
           E+  R    E        ++ RC   DP  RP+ S V
Sbjct: 210 EQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTV 246

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 98.6 bits (246), Expect = 2e-23
 Identities = 76/280 (27%), Positives = 123/280 (43%), Gaps = 32/280 (11%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR-KGSQGQDEWENELRFLSRLN 195
            +G G FG V  G  ++              VAVK L+  K S   D++  E   +  L+
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKV-------IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           H N+++L G        ++V E    GSL D L  +             A+  A G+ +L
Sbjct: 55  HENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR-GYFAPEY 314
            +  +  IHRD+ A N+LL  D   KI DFGL +  P  +  ++    L     + APE 
Sbjct: 114 ES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171

Query: 315 IATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQIIDE 371
           + T   +  +DV+ FGV L E+ + G+               +P+  LS    L + ID+
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGE---------------EPWAGLSGSQILKK-IDK 215

Query: 372 KLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAAL 410
           +  R  + E   Q+   ++L+C   +P +RPT + +   L
Sbjct: 216 EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 98.3 bits (245), Expect = 2e-23
 Identities = 86/293 (29%), Positives = 140/293 (47%), Gaps = 49/293 (16%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRL 194
            +IG+G FG VY G +    + +  +K      AVK L R     + +++  E   +   
Sbjct: 1   RVIGKGHFGCVYHGTL----IDSDGQK---IHCAVKSLNRITDLEEVEQFLKEGIIMKDF 53

Query: 195 NHPNVVKLMGYCCDDQHR-LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           +HPNV+ L+G C   +   L+V  Y+  G L + + +E       +  I   L  A+G+E
Sbjct: 54  SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP-TVKDLIGFGLQVAKGME 112

Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV-LGTR---GY 309
           +L +  +  +HRD+ A N +LD+ F  K++DFGLA+   + DK + S     G +    +
Sbjct: 113 YLAS--KKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHTGAKLPVKW 168

Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY-------LSNK 362
            A E + T   T K+DV+SFGV+L E++         T G     A PY       ++  
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVDSFDITVY 214

Query: 363 LALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           L          GR +   E       E++L C +  P+ RPT SE+V+ +EQ+
Sbjct: 215 LL--------QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 98.6 bits (245), Expect = 2e-23
 Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 36/278 (12%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG+V++GY N+              VAVK L+  G+     +  E   +  L H 
Sbjct: 14  LGAGQFGEVWMGYYNNST-----------KVAVKTLK-PGTMSVQAFLEEANLMKTLQHD 61

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   ++ EY+ +GSL D L +++  ++   + I  +   A G+ ++  
Sbjct: 62  KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
             +  IHRD++A+NVL+ +    KI+DFGLA+   + D  + +    G +    + APE 
Sbjct: 122 --KNYIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTARE--GAKFPIKWTAPEA 175

Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           I  G  T+K+DV+SFG++L EI++             G    P +SN   +  +  ++  
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVT------------YGKIPYPGMSNSDVMSAL--QRGY 221

Query: 375 RNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +ME    E  +I+  C     + RPT   + + L+
Sbjct: 222 RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 98.3 bits (246), Expect = 3e-23
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 37/221 (16%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN----- 186
           + +   +G+G +G VY           AR K     VA+K++R       D  E      
Sbjct: 1   YEKLEKLGEGTYGVVY----------KARDKKTGEIVALKKIR------LDNEEEGIPST 44

Query: 187 ---ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
              E+  L  L HPN+VKL+     ++   LV+EY     L+   L++    L+    IK
Sbjct: 45  ALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLK-KYLDKRPGPLS-PNLIK 101

Query: 244 -IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHIST 301
            I     RGL + H++   ++HRD+K  N+L++ D   K++DFGLA+ FG        + 
Sbjct: 102 SIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGI--PLRTYTH 157

Query: 302 RVLGTRGYFAPEYIATG--HLTLKTDVYSFGVVLLEILSGK 340
            V+ T  Y APE I  G  H +   D++S G +  E+++GK
Sbjct: 158 EVV-TLWYRAPE-ILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 98.3 bits (245), Expect = 4e-23
 Identities = 67/213 (31%), Positives = 96/213 (45%), Gaps = 18/213 (8%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSR 193
             +G G FG+VY G               +  VAVK L    S+ QDE +   E   +S+
Sbjct: 12  RALGHGAFGEVYEGLY-----RGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSK 65

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGA 248
            NH N+V+L+G   +   R ++ E +  G L+  L       E  + L  +  +  A   
Sbjct: 66  FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDD---DFNAKISDFGLAKFGPLGDKSHISTRVLG 305
           A+G ++L       IHRD+ A N LL        AKI+DFG+A+            R + 
Sbjct: 126 AKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183

Query: 306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS 338
              +  PE    G  T KTDV+SFGV+L EI S
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 99.0 bits (246), Expect = 4e-23
 Identities = 82/282 (29%), Positives = 128/282 (45%), Gaps = 39/282 (13%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F++   IG G FG VY           AR    +  VA+K++   G Q  ++W++   E+
Sbjct: 27  FTDLREIGHGSFGAVYF----------ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 76

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
           +FL R+ HPN ++  G    +    LV EY   GS  D LL      L       I  GA
Sbjct: 77  KFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAITHGA 134

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
            +GL +LH++   +IHRD+KA N+LL +    K++DFG A        +  +   +GT  
Sbjct: 135 LQGLAYLHSH--NMIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPY 186

Query: 309 YFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL 365
           + APE I     G    K DV+S G+  +E L+ +   +   N ++            AL
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMS------------AL 233

Query: 366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + I   +       E +  F   +  CL   P++RPT  E++
Sbjct: 234 YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 97.8 bits (244), Expect = 4e-23
 Identities = 81/281 (28%), Positives = 123/281 (43%), Gaps = 42/281 (14%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQDEWENELRFLSRLNH 196
           IG G    VY      C     +       VA+KR+   K     DE   E++ +S+ NH
Sbjct: 9   IGVGATAVVYAAI---CLPNNEK-------VAIKRIDLEKCQTSVDELRKEVQAMSQCNH 58

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAARGLEHL 255
           PNVVK            LV  Y++ GSL D + +        E  I   L    +GLE+L
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK--FGPLGDKSHISTRVLGTRGYFAPE 313
           H+  +  IHRD+KA N+LL +D + KI+DFG++            +    +GT  + APE
Sbjct: 119 HSNGQ--IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 314 YIATGH-LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
            +   H    K D++SFG+  +E+ +G               A PY  +K    +++   
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATG---------------AAPY--SKYPPMKVLMLT 219

Query: 373 LGRNI-QMEE-------AQEFAEIILRCLNSDPKNRPTMSE 405
           L  +   +E        ++ F ++I  CL  DP  RPT  E
Sbjct: 220 LQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 98.2 bits (244), Expect = 4e-23
 Identities = 66/224 (29%), Positives = 117/224 (52%), Gaps = 26/224 (11%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F E+  +G+  FG +Y G++    M  A+       VA+K L+   + Q   E++ E  
Sbjct: 8   RFMEE--LGECAFGKIYKGHLYLPGMDHAQ------LVAIKTLKDINNPQQWGEFQQEAS 59

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL------------NEDDT--- 234
            ++ L+HPN+V L+G    +Q   +++EY+ +G L + L+            +ED T   
Sbjct: 60  LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119

Query: 235 ELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
            L+    + IA+  A G+E+L +++   +H+D+ A N+L+ +  + KISD GL++     
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177

Query: 295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS 338
           D   +  + L    +  PE I  G  +  +D++SFGVVL EI S
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 98.3 bits (245), Expect = 5e-23
 Identities = 86/308 (27%), Positives = 132/308 (42%), Gaps = 66/308 (21%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-FLSRLN 195
            +G+G FG V        A+           VAVK L+       D  E +L   +S + 
Sbjct: 19  PLGEGAFGQVVKAE----AVGLDNPNET-STVAVKMLK------DDATEKDLSDLVSEME 67

Query: 196 -------HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL---------LNEDDTE---- 235
                  H N++ L+G C  +    +V EY   G+L D L          + DD      
Sbjct: 68  MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127

Query: 236 -LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
            L  +  +  A   ARG+E L +  +  IHRD+ A NVL+ +D   KI+DFGLA+     
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFGLAR----- 180

Query: 295 DKSHISTRVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
           D  HI      T G     + APE +     T ++DV+SFGV+L EI +           
Sbjct: 181 DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT----------- 229

Query: 350 LAGNWAKPYLSNKLALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSE 405
           L G+   PY    + + ++    L    +ME+     QE   ++  C +  P  RPT  +
Sbjct: 230 LGGS---PYPG--IPVEELFK-LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQ 283

Query: 406 VVAALEQL 413
           +V  L+++
Sbjct: 284 LVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 97.6 bits (243), Expect = 6e-23
 Identities = 80/298 (26%), Positives = 137/298 (45%), Gaps = 52/298 (17%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD--EWENELRFLSRL 194
           ++G+G FG V  G ++    +  +       VAVK ++       +  E+ +E   +   
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLK-------VAVKTMKLDIHTYSEIEEFLSEAACMKDF 58

Query: 195 NHPNVVKLMGYCCDDQHR------LLVYEYVTRGSLEDHLL----NEDDTELNWERRIKI 244
           +HPNV+KL+G C +          +++  ++  G L   LL         +L  +  +K 
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGD---KSHIST 301
            +  A G+E+L    R  IHRD+ A N +L +D    ++DFGL+K    GD   +  I+ 
Sbjct: 119 MVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY-- 358
             +    + A E +A    T K+DV++FGV + EI + G+T               PY  
Sbjct: 177 MPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT---------------PYPG 218

Query: 359 LSNKLALHQIIDEKLG--RNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           + N    H+I D      R  Q E+   E  +++  C  +DPK+RPT +++   LE +
Sbjct: 219 VEN----HEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 97.4 bits (242), Expect = 9e-23
 Identities = 78/306 (25%), Positives = 144/306 (47%), Gaps = 46/306 (15%)

Query: 131 KFSEKNLIGQGGFGDVYI----GYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWE 185
           +  EK  +G+G FG+V++    G        A         VAVK LR       ++++ 
Sbjct: 8   RLKEK--LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL 65

Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE---------- 235
            E++ +SRL +PN+++L+G C  D    ++ EY+  G L +  L++ + E          
Sbjct: 66  KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL-NQFLSQREIESTFTHANNIP 124

Query: 236 -LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
            ++    + +A+  A G+++L +     +HRD+   N L+ + +  KI+DFG+++    G
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASL--NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182

Query: 295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
           D   I  R +    + A E I  G  T  +DV++FGV L E+ +           L    
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT-----------LCKE- 230

Query: 355 AKPYLSNKLALHQIID------EKLGRNIQMEEA----QEFAEIILRCLNSDPKNRPTMS 404
            +PY  + L+  Q+I+         GR I + +         ++++RC + D K+RPT +
Sbjct: 231 -QPY--SLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN 287

Query: 405 EVVAAL 410
           ++   L
Sbjct: 288 KIHHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 97.4 bits (242), Expect = 1e-22
 Identities = 82/276 (29%), Positives = 123/276 (44%), Gaps = 39/276 (14%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSRL 194
           IG G FG VY           A   + +  VAVK++   G Q  ++W++   E++FL +L
Sbjct: 29  IGHGSFGAVYF----------ATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL 78

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN ++  G    +    LV EY   GS  D LL      L       I  GA +GL +
Sbjct: 79  KHPNTIEYKGCYLKEHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAITHGALQGLAY 136

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           LH++   +IHRD+KA N+LL +    K++DFG A       KS  +   +GT  + APE 
Sbjct: 137 LHSH--NMIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEV 188

Query: 315 IAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           I     G    K DV+S G+  +E L+ +   +   N ++            AL+ I   
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMS------------ALYHIAQN 235

Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                   E    F   +  CL   P+ RP  +E++
Sbjct: 236 DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 77/281 (27%), Positives = 138/281 (49%), Gaps = 43/281 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG+V++G  N            +  VAVK L+  G+   + +  E + + +L H 
Sbjct: 14  LGNGQFGEVWMGTWN-----------GNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHD 61

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L + +   L     + +A   A G+ ++  
Sbjct: 62  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                IHRD++++N+L+ D    KI+DFGLA+   + D  + + +  G +    + APE 
Sbjct: 121 M--NYIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 174

Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+++             G    P ++N+  L Q+      
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVT------------KGRVPYPGMNNREVLEQV-----E 217

Query: 375 RNIQMEEAQE----FAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M   Q+      E++L+C   DP+ RPT   + + LE
Sbjct: 218 RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 95.4 bits (237), Expect = 3e-22
 Identities = 74/283 (26%), Positives = 133/283 (46%), Gaps = 47/283 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G FGDV +G                  VAVK ++   +     +  E   +++L H 
Sbjct: 14  IGKGEFGDVMLG------------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 59

Query: 198 NVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           N+V+L+G   +++  L +V EY+ +GSL D+L +   + L  +  +K +L     +E+L 
Sbjct: 60  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHISTRVLGTRGYFAPEYI 315
                 +HRD+ A NVL+ +D  AK+SDFGL K      D   +  +      + APE +
Sbjct: 120 A--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEAL 171

Query: 316 ATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
                + K+DV+SFG++L EI S G+                PY   ++ L  ++  ++ 
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRV---------------PY--PRIPLKDVV-PRVE 213

Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  +M+          +++ +C + D   RP+  ++   LE +
Sbjct: 214 KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 24/208 (11%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKR--LRRKGSQGQDEWENELRFLSRLN 195
           IG+G  G V+           A+ +     VA+K+  LRR      ++   E++ L    
Sbjct: 8   IGEGAHGIVF----------KAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ 57

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD--TELNWERRIKIALGAARGLE 253
           HP VVKL+         +LV EY+    L + L +E+    E   +  +++ L   +G+ 
Sbjct: 58  HPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL---KGVA 113

Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHISTRVLGTRGYFAP 312
           ++H     ++HRD+K +N+L+  D   KI+DFGLA+ F     + + S +V  TR Y AP
Sbjct: 114 YMHA--NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY-SHQV-ATRWYRAP 169

Query: 313 EYI-ATGHLTLKTDVYSFGVVLLEILSG 339
           E +          D+++ G +  E+L+G
Sbjct: 170 ELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 95.0 bits (236), Expect = 4e-22
 Identities = 75/288 (26%), Positives = 145/288 (50%), Gaps = 35/288 (12%)

Query: 133 SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFL 191
           +++ +IG G FG+V+ G +        R++ A   VA+K L+   ++ Q  ++ +E   +
Sbjct: 8   TKQKVIGAGEFGEVFRGILK----MPGRKEVA---VAIKTLKPGYTEKQRQDFLSEASIM 60

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
            + +H N+++L G     +  +++ EY+  G+L D  L + D E +  + + +  G A G
Sbjct: 61  GQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAG 119

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---G 308
           +++L       +HRD+ A N+L++ +   K+SDFGL++   L D    +    G +    
Sbjct: 120 MKYLSDM--NYVHRDLAARNILVNSNLECKVSDFGLSRV--LEDDPEGTYTTSGGKIPIR 175

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLAL 365
           + APE IA    T  +DV+SFG+V+ E++S G+               +PY  +SN   +
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE---------------RPYWDMSNHEVM 220

Query: 366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            + I++       M+      +++L+C   D   RP   ++V  L++L
Sbjct: 221 -KAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 94.7 bits (236), Expect = 6e-22
 Identities = 84/315 (26%), Positives = 120/315 (38%), Gaps = 81/315 (25%)

Query: 128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENE 187
            T  F    +IG+G +G VY           AR K     VA+K +     + ++E + E
Sbjct: 4   PTGIFELVEVIGEGTYGKVY----------KARHKKTGQLVAIKIMDIIEDE-EEEIKEE 52

Query: 188 LRFLSRL-NHPNVVKLMG-------YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWE 239
              L +  NHPN+    G          DDQ   LV E    GS+ D L+          
Sbjct: 53  YNILRKYSNHPNIATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTD-LVK---GLRKKG 107

Query: 240 RRIK------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
           +R+K      I     RGL +LH     VIHRD+K  N+LL  +   K+ DFG+      
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGV------ 159

Query: 294 GDKSHISTRVLGTRGYF-------APEYIA-----TGHLTLKTDVYSFGVVLLEILSGKT 341
              S      LG R  F       APE IA           ++DV+S G+  +E+  GK 
Sbjct: 160 ---SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216

Query: 342 A-----AMRRTNGLAGNWAKPYLSNKLALHQIIDE---KLGRNIQMEEAQEFAEIILRCL 393
                  MR                  AL +I       L        +++F + I  CL
Sbjct: 217 PLCDMHPMR------------------ALFKIPRNPPPTLKSPENW--SKKFNDFISECL 256

Query: 394 NSDPKNRPTMSEVVA 408
             + + RP M E++ 
Sbjct: 257 IKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 94.6 bits (235), Expect = 7e-22
 Identities = 72/284 (25%), Positives = 141/284 (49%), Gaps = 33/284 (11%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG G FG+V  G +        +R+     VA+K L+   ++ Q  ++ +E   + + +
Sbjct: 11  VIGAGEFGEVCRGRLK----LPGKREIF---VAIKTLKSGYTEKQRRDFLSEASIMGQFD 63

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HPN++ L G     +  +++ E++  G+L D  L ++D +    + + +  G A G+++L
Sbjct: 64  HPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAP 312
                  +HRD+ A N+L++ +   K+SDFGL++F          T  LG +    + AP
Sbjct: 123 SEM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQII 369
           E IA    T  +DV+S+G+V+ E++S G+               +PY  +SN+  ++  I
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGE---------------RPYWDMSNQDVINA-I 224

Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++       M+      +++L C   D   RP   ++V+ L+++
Sbjct: 225 EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 94.9 bits (236), Expect = 8e-22
 Identities = 77/300 (25%), Positives = 129/300 (43%), Gaps = 49/300 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFA-VAVKRLRRKGS-QGQDEWENELRFLSRLN 195
           IGQG FG V+       A          F  VAVK L+ + S   Q +++ E   ++  +
Sbjct: 13  IGQGAFGRVFQ------ARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 66

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL----------LNEDDTE---------- 235
           HPN+VKL+G C   +   L++EY+  G L + L          L+   +           
Sbjct: 67  HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126

Query: 236 LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGD 295
           L+   ++ IA   A G+ +L    R  +HRD+   N L+ ++   KI+DFGL++     D
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184

Query: 296 KSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWA 355
               S        +  PE I     T ++DV+++GVVL EI S          G+     
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS---------YGM----- 230

Query: 356 KPYLSNKLALHQIIDEKLGRNIQM---EEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           +PY    +A  ++I      N+         E   ++  C +  P +RP+ + +   L++
Sbjct: 231 QPYYG--MAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 95.1 bits (236), Expect = 8e-22
 Identities = 82/302 (27%), Positives = 143/302 (47%), Gaps = 54/302 (17%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSR 193
           +++IG+G FG V    I        ++       A+K L+   S+    ++  EL  L +
Sbjct: 7   EDVIGEGNFGQVIRAMI--------KKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCK 58

Query: 194 L-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN----EDD----------TELNW 238
           L +HPN++ L+G C +  +  +  EY   G+L D L      E D          + L  
Sbjct: 59  LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118

Query: 239 ERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSH 298
           ++ ++ A   A G+++L    +  IHRD+ A NVL+ ++  +KI+DFGL++    G++ +
Sbjct: 119 QQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVY 172

Query: 299 ISTRV--LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
           +   +  L  R + A E +     T K+DV+SFGV+L EI+S           L G    
Sbjct: 173 VKKTMGRLPVR-WMAIESLNYSVYTTKSDVWSFGVLLWEIVS-----------LGGT--- 217

Query: 357 PYLSNKLALHQIIDEKLGRNIQMEEAQ----EFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           PY     A    + EKL +  +ME+ +    E  E++ +C    P  RP  +++   L +
Sbjct: 218 PYCGMTCAE---LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274

Query: 413 LQ 414
           + 
Sbjct: 275 ML 276

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 93.8 bits (233), Expect = 8e-22
 Identities = 70/278 (25%), Positives = 133/278 (47%), Gaps = 37/278 (13%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V  G           +    + VA+K ++ +GS  +DE+  E + + +L+H 
Sbjct: 12  LGTGQFGVVKYG-----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHE 59

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C   +   +V EY++ G L ++ L E        + +++      G+ +L +
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNY-LREHGKRFQPSQLLEMCKDVCEGMAYLES 118

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
             +  IHRD+ A N L+DD    K+SDFGL+++  + D  + S+  +G++    +  PE 
Sbjct: 119 --KQFIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEV 172

Query: 315 IATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL 373
           +     + K+DV++FGV++ E+ S GK    R  N            ++         +L
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------------SETVEKVSQGLRL 220

Query: 374 GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
            R     E  +   I+  C +   + RPT  ++++++E
Sbjct: 221 YRPHLASE--KVYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 93.9 bits (234), Expect = 9e-22
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 38/222 (17%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSC----AMTAARRKNADFAVAVKRLRRKGSQGQDEWENE 187
           F    +IG+G FG V I          AM    ++      +V+ +            NE
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL-----------NE 50

Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
            R L  LNHP +V L     D+++  LV + +  G L  HL           +++K +  
Sbjct: 51  RRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----------SQKVKFSEE 100

Query: 248 AAR--------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
             +         LE+LH+  + +IHRD+K  N+LLD+  +  I+DF +A           
Sbjct: 101 QVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--- 155

Query: 300 STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           +T   GT GY APE +     ++  D +S GV   E L GK 
Sbjct: 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 80/292 (27%), Positives = 126/292 (43%), Gaps = 54/292 (18%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNH 196
           IG G FG V +G  +   M+ AR       V VK LR   +   Q  +  E++    LNH
Sbjct: 3   IGNGWFGKVLLGEAHR-GMSKAR-------VVVKELRASATPDEQLLFLQEVQPYRELNH 54

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERR---IKIALGAARGLE 253
           PNV++ +G C +    LLV E+   G L+++L +         ++    ++A   A GL 
Sbjct: 55  PNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL 114

Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA------KFGPLGDKSHISTRVLGTR 307
            LH      IH D+   N  L  D + KI D+GLA       +    D   +  R     
Sbjct: 115 WLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----- 167

Query: 308 GYFAPEYIATGH-------LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY-- 358
            + APE +            T K++++S GV + E              L     +PY  
Sbjct: 168 -WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE--------------LFTAADQPYPD 212

Query: 359 LSNKLALHQII---DEKLGR-NIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           LS++  L Q++   D KL +  + ++ +  + E++  C   DP+ RPT  EV
Sbjct: 213 LSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 72/291 (24%), Positives = 134/291 (46%), Gaps = 48/291 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR---RKGSQGQDEWENELRFLSRL 194
           IG+G F  VY           A        VA+K+++      ++ + +   E+  L +L
Sbjct: 10  IGKGQFSVVY----------KAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL 59

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-EDDTELNWERRI-KIALGAARGL 252
           +HPNV+K +    ++    +V E    G L   + + +    L  ER I K  +     L
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           EH+H+  + ++HRD+K +NV +      K+ D GL +F     K+  +  ++GT  Y +P
Sbjct: 120 EHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSP 175

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K+D++S G +L E+     AA++           P+  +K+ L+      
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM-----AALQ----------SPFYGDKMNLY-----S 215

Query: 373 LGRNIQMEE---------AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           L + I+  +         ++E  +++ RC+N DP+ RP +S V+   +++ 
Sbjct: 216 LCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 20/210 (9%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           L+GQG FG VY+     C      R+ A   V       +  +  +  E E++ L  L H
Sbjct: 9   LLGQGAFGRVYL-----CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALGAARG 251
             +V+  G   DD+   +  EY+  GS++D L     L E  T   + R+I        G
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQI------LEG 116

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHISTRVLGTRGYF 310
           +E+LH+    ++HRD+K +N+L D   N K+ DFG +K    +         V GT  + 
Sbjct: 117 VEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           +PE I+      K DV+S G  ++E+L+ K
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 77/281 (27%), Positives = 132/281 (46%), Gaps = 43/281 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 14  LGQGCFGEVWMGTWNGTT-----------KVAIKTLK-PGTMMPEAFLQEAQIMKKLRHD 61

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V L      ++   +V E++ +GSL D L   D   L   + + +A   A G+ ++  
Sbjct: 62  KLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                IHRD++A+N+L+ D+   KI+DFGLA+   + D  + + +  G +    + APE 
Sbjct: 121 M--NYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 174

Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+++             G    P + N+  L Q+      
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVT------------KGRVPYPGMVNREVLEQV-----E 217

Query: 375 RNIQMEEAQ----EFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M   Q       E++  C   DP  RPT   + + LE
Sbjct: 218 RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 71/218 (32%), Positives = 106/218 (48%), Gaps = 37/218 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRL 194
           I +G +G V++          A++K+     A+K +++         D+   E   LS+ 
Sbjct: 1   ISKGAYGRVFL----------AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA 50

Query: 195 NHPNVVKLMGYCCDDQHRL-LVYEYVTRG---SLEDHL--LNEDDTELNWERRIKIALGA 248
             P VVKL  Y    +  L LV EY+  G   SL +++  L+ED        RI IA   
Sbjct: 51  QSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA------RIYIAEIV 103

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG------PLGDKSHISTR 302
              LE+LH+    +IHRD+K  N+L+D + + K++DFGL+K G       L D      R
Sbjct: 104 L-ALEYLHSN--GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160

Query: 303 VLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSG 339
           ++GT  Y APE I   GH +   D +S G +L E L G
Sbjct: 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 74/281 (26%), Positives = 136/281 (48%), Gaps = 43/281 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 14  LGQGCFGEVWMGTWNGTTR-----------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 61

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 62  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 121 M--NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 174

Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 217

Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   +P+ RPT   + A LE
Sbjct: 218 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 80/302 (26%), Positives = 141/302 (46%), Gaps = 41/302 (13%)

Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E A  K +    +GQG FG VY G           +   +  VA+K +    S  +  E+
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVV-----KDEPETRVAIKTVNEAASMRERIEF 56

Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-EDDTELN------ 237
            NE   +   N  +VV+L+G     Q  L++ E +TRG L+ +L +   + E N      
Sbjct: 57  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116

Query: 238 -WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
             ++ I++A   A G+ +L+      +HRD+ A N ++ +DF  KI DFG+ +     D 
Sbjct: 117 SLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174

Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + +PE +  G  T  +DV+SFGVVL EI +           LA    +
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LA---EQ 220

Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILR----CLNSDPKNRPTMSEVVAAL 410
           PY  +SN+  L  +++  L     +++     +++      C   +PK RP+  E+++++
Sbjct: 221 PYQGMSNEQVLRFVMEGGL-----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275

Query: 411 EQ 412
           ++
Sbjct: 276 KE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 81/283 (28%), Positives = 133/283 (46%), Gaps = 40/283 (14%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
             F++   IG+G FG+VY G  N       R K     VA+K +  +  + +DE E+   
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDN-------RTKEV---VAIKIIDLE--EAEDEIEDIQQ 51

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           E+  LS+ + P + +  G         ++ EY+  GS  D LL     E   E  I   L
Sbjct: 52  EITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLE---ETYIATIL 107

Query: 247 GAA-RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
               +GL++LH+  +  IHRD+KA+NVLL +  + K++DFG+A  G L D        +G
Sbjct: 108 REILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVG 163

Query: 306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLA 364
           T  + APE I       K D++S G+  +E+  G+                P    + + 
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE---------------PPNSDLHPMR 208

Query: 365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           +  +I +     ++ + ++ F E +  CLN DP+ RPT  E++
Sbjct: 209 VLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 74/279 (26%), Positives = 132/279 (47%), Gaps = 39/279 (13%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG+V++   N               VAVK ++  GS   + +  E   +  L H 
Sbjct: 14  LGAGQFGEVWMATYNKHT-----------KVAVKTMK-PGSMSVEAFLAEANVMKTLQHD 61

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +VKL      +    ++ E++ +GSL D L +++ ++    + I  +   A G+  +  
Sbjct: 62  KLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
             R  IHRD++A+N+L+      KI+DFGLA+   + D  + +    G +    + APE 
Sbjct: 121 --RNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTARE--GAKFPIKWTAPEA 174

Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           I  G  T+K+DV+SFG++L+EI++             G    P +SN   +  +   + G
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVT------------YGRIPYPGMSNPEVIRAL---ERG 219

Query: 375 RNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALE 411
             +   E   +E   I++RC  + P+ RPT   + + L+
Sbjct: 220 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 92.9 bits (231), Expect = 4e-21
 Identities = 68/226 (30%), Positives = 98/226 (43%), Gaps = 25/226 (11%)

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLL--VYEYVTRGSLEDHLLNE--DDTELNWERRI 242
           EL        P +VK  G   D+    +    EY   GSL D +  +         E+ +
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL 107

Query: 243 -KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
            KIA    +GL +LH+  R +IHRD+K SN+LL      K+ DFG++  G L + S   T
Sbjct: 108 GKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVS--GELVN-SLAGT 162

Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP---- 357
              GT  Y APE I     ++ +DV+S G+ LLE+   +           G    P    
Sbjct: 163 FT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG----PIELL 217

Query: 358 -YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT 402
            Y+ N        +   G       ++EF + I +CL  DP  RPT
Sbjct: 218 SYIVNMPNPELKDEPGNGIKW----SEEFKDFIKQCLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 92.3 bits (229), Expect = 4e-21
 Identities = 76/284 (26%), Positives = 140/284 (49%), Gaps = 35/284 (12%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSRLN 195
           +IG G FG+V  G +        +R   +  VA+K L+   ++ Q  ++ +E   + + +
Sbjct: 11  VIGAGEFGEVCSGRLK----LPGKR---EIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HPN++ L G     +  ++V EY+  GSL D  L + D +    + + +  G A G+++L
Sbjct: 64  HPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYL 122

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAP 312
                  +HRD+ A N+L++ +   K+SDFGL++   L D    +    G +    + AP
Sbjct: 123 SDM--GYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAP 178

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQII 369
           E IA    T  +DV+S+G+V+ E++S G+               +PY  +SN+  + + I
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSYGE---------------RPYWEMSNQDVI-KAI 222

Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +E       M+      +++L C   D   RP   ++V+ L++L
Sbjct: 223 EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 93.2 bits (231), Expect = 4e-21
 Identities = 83/278 (29%), Positives = 123/278 (44%), Gaps = 41/278 (14%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           FS+   IG G FG VY           AR       VA+K++   G Q  ++W++   E+
Sbjct: 17  FSDLREIGHGSFGAVYF----------ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 66

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
           RFL +L HPN ++  G    +    LV EY   GS  D LL      L       +  GA
Sbjct: 67  RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGA 124

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF-GPLGDKSHISTRVLGTR 307
            +GL +LH++   +IHRDVKA N+LL +    K+ DFG A    P       +   +GT 
Sbjct: 125 LQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTP 175

Query: 308 GYFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
            + APE I     G    K DV+S G+  +E L+ +   +   N ++            A
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMS------------A 222

Query: 365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT 402
           L+ I   +         ++ F   +  CL   P++RPT
Sbjct: 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 91.7 bits (228), Expect = 6e-21
 Identities = 81/293 (27%), Positives = 125/293 (42%), Gaps = 52/293 (17%)

Query: 135 KNLIGQGGFGDVYIG-YINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLS- 192
              IG+G FGDVY G Y++         +N   AVAVK  +   S    E     +FL  
Sbjct: 11  GRCIGEGQFGDVYQGVYMS--------PENEKIAVAVKTCKNCTSPSVRE-----KFLQE 57

Query: 193 -----RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
                + +HP++VKL+G    +    +V E    G L    L  +   L+    I  +  
Sbjct: 58  AYIMRQFDHPHIVKLIG-VITENPVWIVMELAPLGELR-SYLQVNKYSLDLASLILYSYQ 115

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS--HISTRVLG 305
            +  L +L +  +  +HRD+ A NVL+      K+ DFGL+++  L D+S    S   L 
Sbjct: 116 LSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLP 171

Query: 306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNK 362
            + + APE I     T  +DV+ FGV + EIL  G                KP+  + N 
Sbjct: 172 IK-WMAPESINFRRFTSASDVWMFGVCMWEILMLGV---------------KPFQGVKNN 215

Query: 363 LALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             + +I  E  G  + M          ++ +C   DP  RP  +E+ A L  +
Sbjct: 216 DVIGRI--EN-GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 46/228 (20%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---- 186
           ++ +   +G+G +  VY           AR K     VA+K+++    +   +  N    
Sbjct: 1   RYEKGKKLGEGTYAVVYK----------ARDKETGRIVAIKKIKLGERKEAKDGINFTAL 50

Query: 187 -ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA 245
            E++ L  L HPN++ L+       +  LV+E++           E D E   + +  I 
Sbjct: 51  REIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-----------ETDLEKVIKDKS-IV 98

Query: 246 LGAA----------RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLG 294
           L  A          RGLE+LH+ W  ++HRD+K +N+L+  D   K++DFGLA+ FG   
Sbjct: 99  LTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFG--S 154

Query: 295 DKSHISTRVLGTRGYFAPE--YIATGHLTLKTDVYSFGVVLLEILSGK 340
               ++ +V+ TR Y APE  + A  H  +  D++S G +  E+L   
Sbjct: 155 PNRKMTHQVV-TRWYRAPELLFGAR-HYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 77/287 (26%), Positives = 124/287 (43%), Gaps = 46/287 (16%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
            +     IG G +GDVY           AR       VA+K ++ +     +  + E+  
Sbjct: 4   DYELIQRIGSGTYGDVY----------KARDIATGELVAIKVIKLEPGDDFEIIQQEISM 53

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-IALGAA 249
           L    HPN+V   G         +V EY   GSL+D +       L+ E +I  +     
Sbjct: 54  LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLS-ELQIAYVCRETL 111

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR--VLGTR 307
           +GL +LH      IHRD+K +N+LL +D + K++DFG++    L   + I+ R   +GT 
Sbjct: 112 KGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVS--AQL--TATIAKRKSFIGTP 165

Query: 308 GYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGK-----TAAMRRTNGLAGNWAK-PY 358
            + APE  A    G    K D+++ G+  +E+   +        MR    ++ +    P 
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK 225

Query: 359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
           L +K        EK         +  F + I +CL  DPK RPT ++
Sbjct: 226 LKDK--------EKW--------SPVFHDFIKKCLTKDPKKRPTATK 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 79/301 (26%), Positives = 143/301 (47%), Gaps = 54/301 (17%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSR 193
           +++IG+G FG V    I        ++       A+KR++   S+    ++  EL  L +
Sbjct: 12  QDVIGEGNFGQVLKARI--------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 63

Query: 194 LN-HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--------------LNEDDTELNW 238
           L  HPN++ L+G C    +  L  EY   G+L D L               N   + L+ 
Sbjct: 64  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123

Query: 239 ERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSH 298
           ++ +  A   ARG+++L    +  IHRD+ A N+L+ +++ AKI+DFGL++    G + +
Sbjct: 124 QQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY 177

Query: 299 ISTRV--LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
           +   +  L  R + A E +     T  +DV+S+GV+L EI+S           L G    
Sbjct: 178 VKKTMGRLPVR-WMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----------LGGT--- 222

Query: 357 PYLSNKLALHQIIDEKLGRNIQMEEA----QEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           PY     A    + EKL +  ++E+      E  +++ +C    P  RP+ ++++ +L +
Sbjct: 223 PYCGMTCAE---LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279

Query: 413 L 413
           +
Sbjct: 280 M 280

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 14/211 (6%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F +  ++G+GGFG+V      +C + A  +  A   +  KR++++  +G+    NE + L
Sbjct: 2   FRQYRVLGKGGFGEVC-----ACQVRATGKMYACKRLEKKRIKKR--KGESMALNEKQIL 54

Query: 192 SRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
            ++N   VV L  Y  + +  L LV   +  G L+ H+ N  +     ER +  A     
Sbjct: 55  EKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILC 113

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GLE LH      ++RD+K  N+LLDD  + +ISD GLA   P G+   I  RV GT GY 
Sbjct: 114 GLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYM 168

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           APE +     TL  D +  G ++ E++ G++
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 48/222 (21%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-------ELRF 190
           IG+G +G VY           AR K     VA+K++R      ++E E        E++ 
Sbjct: 7   IGEGTYGQVY----------KARNKKTGELVALKKIR-----MENEKEGFPITAIREIKL 51

Query: 191 LSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
           L +L HPN+V+L             +V+EY+      DH    D T L     +K     
Sbjct: 52  LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM------DH----DLTGLLDSPEVKFTESQ 101

Query: 249 AR--------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
            +        GL++LH+    ++HRD+K SN+L+++D   K++DFGLA+     + +  +
Sbjct: 102 IKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159

Query: 301 TRVLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            RV+ T  Y  PE +  AT     + D++S G +L E+  GK
Sbjct: 160 NRVI-TLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 67/218 (30%), Positives = 97/218 (44%), Gaps = 48/218 (22%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQ-DEWENELRFLSRL 194
           +G G FG V +           R K +    A+K L +       Q +   NE R L  +
Sbjct: 9   LGTGSFGRVML----------VRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI 58

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI-KIALGAAR--- 250
            HP +V L G   DD +  LV EYV  G L  HL           R+  +     AR   
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-----------RKSGRFPEPVARFYA 107

Query: 251 -----GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR--- 302
                 LE+LH+    +++RD+K  N+LLD D   KI+DFG AK         +  R   
Sbjct: 108 AQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYT 157

Query: 303 VLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSG 339
           + GT  Y APE I + G+     D ++ G+++ E+L+G
Sbjct: 158 LCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 75/287 (26%), Positives = 132/287 (45%), Gaps = 38/287 (13%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR---RKGSQGQDEWENELRFLSRL 194
           IG+G F +VY       A     RK     VA+K+++      ++ + +   E+  L +L
Sbjct: 10  IGRGQFSEVYR------ATCLLDRK----PVALKKVQIFEMMDAKARQDCVKEIDLLKQL 59

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-EDDTELNWERRI-KIALGAARGL 252
           NHPNV+K +    +D    +V E    G L   +   +    L  ER + K  +     +
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           EH+H+  R V+HRD+K +NV +      K+ D GL +F     K+  +  ++GT  Y +P
Sbjct: 120 EHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSP 175

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK---LALHQII 369
           E I       K+D++S G +L E+     AA++           P+  +K    +L Q I
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM-----AALQ----------SPFYGDKMNLFSLCQKI 220

Query: 370 DEKLGRNIQMEE-AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL 415
           ++     +  E  +++  E++  C+  DP  RP +  V    +Q+ +
Sbjct: 221 EQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMHV 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 78/274 (28%), Positives = 131/274 (47%), Gaps = 33/274 (12%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F +  ++G+GGFG+V      +C + A  +  A   +  KR++++  +G+    NE + L
Sbjct: 2   FRQYRVLGKGGFGEVC-----ACQVRATGKMYACKKLEKKRIKKR--KGESMALNEKQIL 54

Query: 192 SRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
            ++N   VV L  Y  + +  L LV   +  G L+ H+ +  +      R +  A     
Sbjct: 55  EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICC 113

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GLE LH     +++RD+K  N+LLDD  + +ISD GLA   P G    I  RV GT GY 
Sbjct: 114 GLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYM 168

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           APE +     T   D ++ G +L E+++G++               P+   K  + +   
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQS---------------PFQQRKKKIKREEV 213

Query: 371 EKLGRNIQMEEAQEFAE----IILRCLNSDPKNR 400
           E+L + +Q E +++F+     +    L  DPK R
Sbjct: 214 ERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 89.6 bits (222), Expect = 5e-20
 Identities = 89/299 (29%), Positives = 136/299 (45%), Gaps = 35/299 (11%)

Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEW 184
           E +  K +    +GQG FG VY G           +  A+  VAVK +    S + + E+
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEGNARDII-----KGEAETRVAVKTVNESASLRERIEF 56

Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-EDDTELNWER--- 240
            NE   +      +VV+L+G     Q  L+V E +  G L+ +L +   + E N  R   
Sbjct: 57  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 241 ----RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                I++A   A G+ +L+   +  +HRD+ A N ++  DF  KI DFG+ +     D 
Sbjct: 117 TLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174

Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + APE +  G  T  +D++SFGVVL EI S           LA    +
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LA---EQ 220

Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILR-CLNSDPKNRPTMSEVVAALEQ 412
           PY  LSN+  L  ++D   G   Q +   E    ++R C   +PK RPT  E+V  L+ 
Sbjct: 221 PYQGLSNEQVLKFVMDG--GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 90.0 bits (223), Expect = 5e-20
 Identities = 79/310 (25%), Positives = 142/310 (45%), Gaps = 51/310 (16%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFA--------VAVKRLRRKGSQ-GQD 182
           F EK  +G+G FG+V++       M     K+            VAVK LR   ++  ++
Sbjct: 9   FKEK--LGEGQFGEVHLCEAE--GMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64

Query: 183 EWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSL---------EDHLLNEDD 233
           ++  E++ +SRL  PN+++L+  C       ++ EY+  G L         ++     D 
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 234 TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
             +++   I +A   A G+++L +     +HRD+   N L+  ++  KI+DFG+++    
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 294 GDKSHISTR-VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG 352
           GD   I  R VL  R + + E I  G  T  +DV++FGV L EIL+              
Sbjct: 183 GDYYRIQGRAVLPIR-WMSWESILLGKFTTASDVWAFGVTLWEILTLCK----------- 230

Query: 353 NWAKPYLSNKLALHQIID------EKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPT 402
              +PY  ++L+  Q+I+         GR + + +         +++L C   + K RP+
Sbjct: 231 --EQPY--SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS 286

Query: 403 MSEVVAALEQ 412
             E+ A L +
Sbjct: 287 FQEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.1 bits (221), Expect = 5e-20
 Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 42/284 (14%)

Query: 134 EKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSR 193
           E+ ++G+G +G VY          AAR  +    +A+K +  + S+       E+   S 
Sbjct: 12  ERVVLGKGTYGIVY----------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------LNEDDTELNWERRIKIAL 246
           L H N+V+ +G   ++    +  E V  GSL   L        + + T + + ++I    
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI---- 117

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTRVLG 305
               GL++LH     ++HRD+K  NVL++      KISDFG +K   L   +  +    G
Sbjct: 118 --LEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETFTG 171

Query: 306 TRGYFAPEYIATGH--LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL 363
           T  Y APE I  G        D++S G  ++E+ +GK   +     L    A  +     
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE----LGEPQAAMFKVGMF 227

Query: 364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
            +H  I E L       EA+ F   ILRC   DP  R +  +++
Sbjct: 228 KIHPEIPESLS-----AEAKNF---ILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 89.1 bits (222), Expect = 5e-20
 Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 58/299 (19%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE-----NELRFLS 192
           +G G FG VY+          AR K     VA+K++++K       WE      E++ L 
Sbjct: 7   LGDGTFGSVYL----------ARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLR 52

Query: 193 RLN-HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-IALGAAR 250
           +LN HPN+VKL     ++     V+EY+  G+L   L+ +   +   E  I+ I     +
Sbjct: 53  KLNEHPNIVKLKEVFRENDELYFVFEYME-GNLY-QLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 251 GLEHLHT--YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS-----TRV 303
           GL H+H   ++    HRD+K  N+L+      KI+DFGLA+         I      T  
Sbjct: 111 GLAHIHKHGFF----HRDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDY 158

Query: 304 LGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGK--------TAAMRRTNGLAGNW 354
           + TR Y APE +  +   +   D+++ G ++ E+ + +           + +   + G  
Sbjct: 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTP 218

Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQ-------EFAEIILRCLNSDPKNRPTMSEV 406
            K        L   +  +  +       Q       E  ++I   L  DPK RPT S+ 
Sbjct: 219 TKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA 277

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.8 bits (220), Expect = 6e-20
 Identities = 69/281 (24%), Positives = 129/281 (45%), Gaps = 45/281 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V++G           +  A   VA+K +  +G+  ++++  E + + +L+HP
Sbjct: 12  LGSGQFGVVHLG-----------KWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHP 59

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C   +   +V E++  G L  + L +   +L+ +  + +      G+E+L  
Sbjct: 60  KLVQLYGVCTQQKPLYIVTEFMENGCLL-NYLRQRQGKLSKDMLLSMCQDVCEGMEYLER 118

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
                IHRD+ A N L+      K+SDFG+ ++  L D+   S+       +  PE    
Sbjct: 119 --NSFIHRDLAARNCLVSSTGVVKVSDFGMTRY-VLDDEYTSSSGAKFPVKWSPPEVFNF 175

Query: 318 GHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNG------LAGN-WAKPYLSNKLALHQII 369
              + K+DV+SFGV++ E+ + GK    +++N         G    +P    KLA   + 
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP----KLASMTVY 231

Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL 410
                            E++  C +  P+ RPT +E++ A+
Sbjct: 232 -----------------EVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 89.1 bits (221), Expect = 6e-20
 Identities = 80/268 (29%), Positives = 122/268 (45%), Gaps = 30/268 (11%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQDEWENELRFLSRLNH 196
           +G+GGFG+V      +C M A  +  A   +  KRL+ RKG +G      E R L++++ 
Sbjct: 1   LGKGGFGEVS-----ACQMRATGKLYACKKLNKKRLKKRKGYEGA---MVEKRILAKVHS 52

Query: 197 PNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLE 253
             +V L  Y    +  L LV   +  G L  H+ N  E++      R          GLE
Sbjct: 53  RFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLE 111

Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE 313
           HLH   R +I+RD+K  NVLLD+D N +ISD GLA    L D    +    GT G+ APE
Sbjct: 112 HLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPE 167

Query: 314 YIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL 373
            +         D ++ GV L E+++ +     R            + NK    +I+++ +
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---------VENKELKQRILNDSV 218

Query: 374 GRNIQMEEA-QEFAEIILRCLNSDPKNR 400
               +   A + F E +   L  DP+ R
Sbjct: 219 TYPDKFSPASKSFCEAL---LAKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 89.0 bits (220), Expect = 6e-20
 Identities = 80/300 (26%), Positives = 144/300 (48%), Gaps = 54/300 (18%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRL 194
           ++IG+G FG V    I        ++       A+KR++   S+    ++  EL  L +L
Sbjct: 1   DVIGEGNFGQVLKARI--------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 52

Query: 195 -NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN----EDD----------TELNWE 239
            +HPN++ L+G C    +  L  EY   G+L D L      E D          + L+ +
Sbjct: 53  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 112

Query: 240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
           + +  A   ARG+++L    +  IHRD+ A N+L+ +++ AKI+DFGL++    G + ++
Sbjct: 113 QLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV 166

Query: 300 STRV--LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP 357
              +  L  R + A E +     T  +DV+S+GV+L EI+S           L G    P
Sbjct: 167 KKTMGRLPVR-WMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----------LGGT---P 211

Query: 358 YLSNKLALHQIIDEKLGRNIQMEEAQ----EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           Y     A    + EKL +  ++E+      E  +++ +C    P  RP+ ++++ +L ++
Sbjct: 212 YCGMTCAE---LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 89.7 bits (223), Expect = 7e-20
 Identities = 76/278 (27%), Positives = 120/278 (43%), Gaps = 55/278 (19%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSR 193
           ++G+G FG V +          A  K  D   AVK L++      D+ E    E R L+ 
Sbjct: 2   VLGKGSFGKVLL----------AELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLAL 51

Query: 194 L-NHPNVVKLMGYCC--DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
              HP + +L  + C         V EYV  G L  H+  +     +  R    A     
Sbjct: 52  AGKHPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAEIVL 107

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL-GTRGY 309
           GL+ LH   R +I+RD+K  NVLLD + + KI+DFG+ K G LG    ++T    GT  Y
Sbjct: 108 GLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTPDY 162

Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII 369
            APE ++        D ++ GV+L E+L+G++               P+           
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQS---------------PF-------EGDD 200

Query: 370 DEKLGRNIQMEEA-------QEFAEIILRCLNSDPKNR 400
           +++L ++I  +E        +E   I+   L  +P+ R
Sbjct: 201 EDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKR 238

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 88.9 bits (220), Expect = 7e-20
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)

Query: 128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWEN 186
           +T +F E+  +G+  FG VY G++   A     +     AVA+K L+ K     ++E+++
Sbjct: 5   STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQ-----AVAIKTLKDKAEGPLREEFKH 57

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL----NEDDTELNWERRI 242
           E    SRL HPN+V L+G    +Q   +++ Y +   L + L+    + D    + ++ +
Sbjct: 58  EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 243 KIALGA----------ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP 292
           K  L            A G+E L ++   V+H+D+   NVL+ D  N KISD GL +   
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSH--HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS 338
             D   +    L    + +PE I  G  ++ +D++S+GVVL E+ S
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 55/173 (31%), Positives = 87/173 (50%), Gaps = 26/173 (15%)

Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
           KIA+   + LE+LH+    VIHRDVK SNVL++ +   K+ DFG++  G L D S   T 
Sbjct: 107 KIAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVD-SVAKTI 162

Query: 303 VLGTRGYFAPEYI----ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY 358
             G + Y APE I          +K+DV+S G+ ++E+ +G+            +W  P+
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP--------YDSWKTPF 214

Query: 359 LSNKLALHQIIDE---KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
                 L Q+++E   +L       E Q+F   + +CL  + K RP   E++ 
Sbjct: 215 QQ----LKQVVEEPSPQLPAEKFSPEFQDF---VNKCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 88.2 bits (218), Expect = 1e-19
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F++   IG+G FG+V+ G  N               VA+K +  +  + +DE E+   E+
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQV----------VAIKIIDLE--EAEDEIEDIQQEI 53

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             LS+ + P V K  G         ++ EY+  GS  D L      E      +K  L  
Sbjct: 54  TVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-- 111

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
            +GL++LH+  +  IHRD+KA+NVLL +  + K++DFG+A  G L D        +GT  
Sbjct: 112 -KGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPF 166

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           + APE I       K D++S G+  +E+  G                +P  S+   +  +
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKG----------------EPPNSDMHPMRVL 210

Query: 369 --IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
             I +     +  E ++ F E I  CLN DP  RPT  E++
Sbjct: 211 FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 73/283 (25%), Positives = 132/283 (46%), Gaps = 37/283 (13%)

Query: 137 LIGQGGFGDVYIGY-INSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN 195
           LIG+G +G VY+   + +  M A ++     A    R   +         +E+  L  L+
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELP-ATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA-RGLEH 254
           H N+V+ +G+   +++  +  EYV  GS+   L      E   E+ ++        GL +
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFE---EQLVRFFTEQVLEGLAY 123

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           LH+  + ++HRD+KA N+L+D D   KISDFG++K       +  +  + G+  + APE 
Sbjct: 124 LHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 315 IATGH--LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           I +     + K D++S G V+LE+ +G+               +P+ S++ A+  +   K
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGR---------------RPW-SDEEAIAAMF--K 223

Query: 373 LGR---------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           LG          ++ M  +    + +  C   +P NRPT  E+
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 76/296 (25%), Positives = 127/296 (42%), Gaps = 40/296 (13%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K  +G+G FG V++    + + T          VAVK L+      + +++ E   L+ L
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPT-----KDKMLVAVKALKDPTLAARKDFQREAELLTNL 64

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN--------------EDDTELNWER 240
            H ++VK  G C D    ++V+EY+  G L   L                +   EL   +
Sbjct: 65  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
            + IA   A G+ +L +  +  +HRD+   N L+  +   KI DFG+++     D   + 
Sbjct: 125 MLHIASQIASGMVYLAS--QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYL 359
              +    +  PE I     T ++DV+SFGV+L EI + GK             W +  L
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-----------WFQ--L 229

Query: 360 SNKLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           SN   +  I     GR ++      +E  +I+L C   +P+ R  + E+   L  L
Sbjct: 230 SNTEVIECITQ---GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 16/206 (7%)

Query: 138 IGQGGFGDV-YIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           +G+GGFG+V  +   N+  M A ++ +       KRL++K  +     E E+  L ++N 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDK------KRLKKKSGEKMALLEKEI--LEKVNS 52

Query: 197 PNVVKLMGYCCDDQ-HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           P +V L  Y  + + H  LV   +  G L+ H+ N  +  L  ER I  +     G+ HL
Sbjct: 53  PFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL 111

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
           H+    +++RD+K  NVLLDD  N ++SD GLA     G      T+  GT GY APE +
Sbjct: 112 HSM--DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEIL 166

Query: 316 ATGHLTLKTDVYSFGVVLLEILSGKT 341
                +   D ++ G  + E+++G+T
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRT 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 88.0 bits (218), Expect = 2e-19
 Identities = 80/274 (29%), Positives = 130/274 (47%), Gaps = 33/274 (12%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F    ++G+GGFG+V      +C + A  +  A   +  KR++++  +G+    NE + L
Sbjct: 2   FRHYRVLGKGGFGEVC-----ACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKQIL 54

Query: 192 SRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
            ++N   VV L  Y  + +  L LV   +  G L+ H+ N  +   + ER +  A     
Sbjct: 55  EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GLE LH     +++RD+K  N+LLDD  + +ISD GLA   P G+   I  RV GT GY 
Sbjct: 114 GLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYM 168

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           APE +     T   D +  G ++ E++ GK+               P+   K  + +   
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKS---------------PFRQRKEKVKREEV 213

Query: 371 EKLGRNIQMEEAQEFAE----IILRCLNSDPKNR 400
           E+  +  Q E +++F+E    I  + L  DP  R
Sbjct: 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 77/294 (26%), Positives = 129/294 (43%), Gaps = 39/294 (13%)

Query: 135 KNLIGQGGFGDVYIGYI-NSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSR 193
           K  +G+G FG V++    N C       +     VAVK L+      + ++  E   L+ 
Sbjct: 10  KRELGEGAFGKVFLAECYNLCP------EQDKILVAVKTLKDASDNARKDFHREAELLTN 63

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH---------LLNEDD--TELNWERRI 242
           L H ++VK  G C +    ++V+EY+  G L            L+ E +   EL   + +
Sbjct: 64  LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
            IA   A G+ +L +  +  +HRD+   N L+ ++   KI DFG+++     D   +   
Sbjct: 124 HIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181

Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSN 361
            +    +  PE I     T ++DV+S GVVL EI + GK             W +  LSN
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-----------WYQ--LSN 228

Query: 362 KLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
              +  I     GR +Q      +E  +++L C   +P  R  + E+ + L+ L
Sbjct: 229 NEVIECITQ---GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 87.1 bits (215), Expect = 3e-19
 Identities = 82/292 (28%), Positives = 128/292 (43%), Gaps = 62/292 (21%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F++   IG+G FG+V+ G  N        R     A+ +  L     + +DE E+   E+
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDN--------RTQKVVAIKIIDLE----EAEDEIEDIQQEI 53

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             LS+ + P V K  G    D    ++ EY+  GS  D L   +   L+  +   I    
Sbjct: 54  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREI 110

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
            +GL++LH+  +  IHRD+KA+NVLL +    K++DFG+A  G L D        +GT  
Sbjct: 111 LKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPF 166

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA-----------AMRRTN--GLAGNWA 355
           + APE I       K D++S G+  +E+  G+              + + N   L GN++
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYS 226

Query: 356 KPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           KP                         +EF E    CLN +P  RPT  E++
Sbjct: 227 KPL------------------------KEFVEA---CLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 86.6 bits (214), Expect = 4e-19
 Identities = 69/288 (23%), Positives = 133/288 (46%), Gaps = 47/288 (16%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           ++     IG+G FG +Y        +  A+  +    +    L +   + ++  + E+  
Sbjct: 1   RYEIIKKIGEGSFGKIY--------LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVIL 52

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSL------EDHLLNEDDTELNWERRIKI 244
           L+++ HPN+V       ++    +V EY   G L      +  +L  +D  L+W   ++I
Sbjct: 53  LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQI 110

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD-FNAKISDFGLAKFGPLGDKSHISTRV 303
           +LG    L+H+H   R ++HRD+K+ N+ L  +   AK+ DFG+A+   L D   ++   
Sbjct: 111 SLG----LKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTC 162

Query: 304 LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL 363
           +GT  Y +PE         KTD++S G VL E+ + K                P+  N  
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK---------------HPFEGNN- 206

Query: 364 ALHQIIDEKLGRN----IQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
            LHQ++  K+ +     I    +++   +I +     P++RP+++ ++
Sbjct: 207 -LHQLV-LKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 86.0 bits (213), Expect = 5e-19
 Identities = 72/289 (24%), Positives = 119/289 (41%), Gaps = 50/289 (17%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNAD---FAVAVKRLRRKGSQGQDEWE--- 185
           F     +G+G +G VY             ++ +D   +A+    L    S  Q E E   
Sbjct: 2   FKVLKKLGKGSYGSVY-----------KVKRLSDNQFYALKEVDLG---SMSQKEREDAV 47

Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED------DTELNWE 239
           NE+R L+ +NHPN++       D     +V EY   G L   +            +  W 
Sbjct: 48  NEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW- 106

Query: 240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
              +I +   RGL+ LH   + ++HRD+K++N+LL  +   KI D G++K      K ++
Sbjct: 107 ---RIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNM 157

Query: 300 STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
           +   +GT  Y APE       + K+D++S G +L E+ +       R+           L
Sbjct: 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS--------MQDL 209

Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
             K     +   K    I    +Q+    I   L   PK RP   +++A
Sbjct: 210 RYK-----VQRGKYPP-IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 86.3 bits (214), Expect = 5e-19
 Identities = 72/280 (25%), Positives = 125/280 (44%), Gaps = 47/280 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G  G V            A  K+    VAVK++  +  Q ++   NE+  +    HP
Sbjct: 27  IGEGSTGIV----------CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76

Query: 198 NVVKLMG-YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           N+V++   Y   D+   +V E++  G+L D + +   T +N E+   + L   + L  LH
Sbjct: 77  NIVEMYSSYLVGDE-LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH 132

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA 316
              + VIHRD+K+ ++LL  D   K+SDFG      +  +      ++GT  + APE I+
Sbjct: 133 A--QGVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVIS 188

Query: 317 TGHLTLKTDVYSFGVVLLEILSGKT--------AAMRRTNGLAGNWAKPYLSNKLALHQI 368
                 + D++S G++++E++ G+          AM+R          P L N   LH++
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN----LPPKLKN---LHKV 241

Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
                        +      + R L  DP  R T +E++ 
Sbjct: 242 -------------SPRLRSFLDRMLVRDPAQRATAAELLN 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 86.1 bits (214), Expect = 5e-19
 Identities = 64/211 (30%), Positives = 94/211 (44%), Gaps = 30/211 (14%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEW-ENELRFLSRL 194
           +G GGFG V +           + K+ +   A+K ++++     GQ E   +E   L   
Sbjct: 1   LGVGGFGRVEL----------VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC 50

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALGAA 249
           NHP +VKL     D ++  ++ EY   G L   L      +E         R  IA    
Sbjct: 51  NHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTA------RFYIA-CVV 103

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
              E+LH   R +I+RD+K  N+LLD +   K+ DFG AK   L       T   GT  Y
Sbjct: 104 LAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTWTFC-GTPEY 158

Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            APE I         D +S G++L E+L+G+
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 86.2 bits (213), Expect = 6e-19
 Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 39/290 (13%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG V++     C      +      VAVK L+      + +++ E   L+ L H 
Sbjct: 13  LGEGAFGKVFLA---ECHNLLPEQDK--MLVAVKALKEASESARQDFQREAELLTVLQHQ 67

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSL---------EDHLLNEDDT----ELNWERRIKI 244
           ++V+  G C + +  L+V+EY+  G L         +  +L   +     +L   + + I
Sbjct: 68  HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           A   A G+ +L +     +HRD+   N L+      KI DFG+++     D   +  R +
Sbjct: 128 ASQIASGMVYLASL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKL 363
               +  PE I     T ++D++SFGVVL EI + GK             W +  LSN  
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-----------WYQ--LSNTE 232

Query: 364 ALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           A+  I     GR ++       E   I+  C   +P+ R  + ++ + L+
Sbjct: 233 AIECITQ---GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 9e-19
 Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 9/222 (4%)

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           EL+ +     P +V   G   ++ +  +  E++  GSL D +  +    +  E   KIA+
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGP-IPVEILGKIAV 110

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
               GL +L+   R ++HRD+K SN+L++     K+ DFG++  G L +   I+   +GT
Sbjct: 111 AVVEGLTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINS--IADTFVGT 165

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             Y +PE I  G  T+K+DV+S G+ ++E+  GK      +N        P     L L 
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGKF-PFAFSNIDDDGQDDPMGILDL-LQ 223

Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
           QI+ E   R    +  ++  + +  CL  DP  RPT  ++ A
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 73/288 (25%), Positives = 134/288 (46%), Gaps = 28/288 (9%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR--RKGSQGQDEWENELRFLSRLN 195
           +G+G FG V +   +          N    VAVK L+    G+   D  + E+  L  L 
Sbjct: 12  LGEGHFGKVELCRYDP------EGDNTGEQVAVKSLKPESGGNHIADLKK-EIEILRNLY 64

Query: 196 HPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           H N+VK  G C +D      L+ E++  GSL+++L   +  ++N ++++K A+   +G++
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMD 123

Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF-----GPLGDKSHISTRVLGTRG 308
           +L +  R  +HRD+ A NVL++ +   KI DFGL K           K  + + V     
Sbjct: 124 YLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF---- 177

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILS---GKTAAMRRTNGLAGNWAKPYLSNKLAL 365
           ++APE +      + +DV+SFGV L E+L+    +++ M     + G         +L  
Sbjct: 178 WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV- 236

Query: 366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            ++++E           +E  +++ +C    P  R T   ++   E +
Sbjct: 237 -RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 78/274 (28%), Positives = 130/274 (47%), Gaps = 33/274 (12%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F    ++G+GGFG+V      +C + A  +  A   +  KR++++  +G+    NE R L
Sbjct: 2   FRHYRVLGKGGFGEVC-----ACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKRIL 54

Query: 192 SRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
            ++N   VV L  Y  + +  L LV   +  G L+ H+ N  +   + +R I  A     
Sbjct: 55  EKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCC 113

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GLE L      +++RD+K  N+LLDD  + +ISD GLA   P G+   +  RV GT GY 
Sbjct: 114 GLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYM 168

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           APE I     T   D +  G ++ E++ G++   +R   +                + +D
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--------------REEVD 214

Query: 371 EKLGRNIQMEEAQEFAE----IILRCLNSDPKNR 400
            ++ +  Q E +++F+E    I    L  +PK R
Sbjct: 215 RRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 81/299 (27%), Positives = 141/299 (47%), Gaps = 48/299 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRK-NADFAVAVKRLRRKGSQGQ-DEWENELRFLSRL- 194
           +G+G FG V +      A+   + K N    VAVK L+   ++    +  +E+  +  + 
Sbjct: 26  LGEGCFGQVVMAE----AIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----------LNED---DTELNWER 240
            H N++ L+G C  D    ++ EY ++G+L ++L            N     + +L+++ 
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
            +  A   ARG+E+L +  +  IHRD+ A NVL+ +D   KI+DFGLA+     D  HI 
Sbjct: 142 LVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHID 194

Query: 301 TRVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWA 355
                T G     + APE +     T ++DV+SFGV+L EI +           L G+  
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-----------LGGS-- 241

Query: 356 KPYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 242 -PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 84.2 bits (208), Expect = 4e-18
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 37/282 (13%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           +K++    IGQG  G VY     +              VA+K++  +    ++   NE+ 
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQE----------VAIKQMNLQQQPKKELIINEIL 68

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            +    HPN+V  +          +V EY+  GSL D +    +T ++  +   +     
Sbjct: 69  VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL 125

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL-AKFGPLGDKSHISTRVLGTRG 308
           + LE LH+    VIHRD+K+ N+LL  D + K++DFG  A+  P  ++S  ST V GT  
Sbjct: 126 QALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPY 180

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQ 367
           + APE +       K D++S G++ +E++ G+                PYL+ N L    
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE---------------PPYLNENPLRALY 225

Query: 368 IIDEKLGRNIQMEEAQE--FAEIILRCLNSDPKNRPTMSEVV 407
           +I       +Q  E     F + + RCL  D + R +  E++
Sbjct: 226 LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 74/274 (27%), Positives = 129/274 (47%), Gaps = 30/274 (10%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQDEWENELRFLSRLN 195
           L+G G FG V+ G      +      +    VA+K ++ R G Q   E  + +  +  L+
Sbjct: 14  LLGSGVFGTVHKG------IWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           H  +V+L+G C     +L V +    GSL DH+    D+ L+ +R +   +  A+G+ +L
Sbjct: 68  HAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKGMYYL 125

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
             +   ++HR++ A N+LL  D   +I+DFG+A      DK +  +       + A E I
Sbjct: 126 EEH--RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183

Query: 316 ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID--EKL 373
             G  T ++DV+S+GV + E++S                A+PY    +  H++ D  EK 
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYG--------------AEPYAG--MRPHEVPDLLEKG 227

Query: 374 GRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEV 406
            R  Q +    +   ++++C   D   RPT  E+
Sbjct: 228 ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.0 bits (205), Expect = 6e-18
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 39/283 (13%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFA--VAVKRLRRKGSQGQDEWENELRFLSR 193
            ++G+G +G VY G  N   + A ++   D +  +A ++   K        + E+  L  
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEK-------LQEEVDLLKS 58

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT--ELNWERRIKIALGAARG 251
           L H N+V+ +G C DD    +  E+V  GS+   +LN      E  + +  K  L    G
Sbjct: 59  LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISS-ILNRFGPLPEPVFCKYTKQIL---DG 114

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK----FGPLGDKSHISTRVLGTR 307
           + +LH     V+HRD+K +NV+L  +   K+ DFG A+     G  G  S++   + GT 
Sbjct: 115 VAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172

Query: 308 GYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGKT--AAMRRTNGLAGNWAKPYLSNKLA 364
            + APE I  +G+   K+D++S G  + E+ +GK   A+M R   +       Y+     
Sbjct: 173 YWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF------YIGAHRG 225

Query: 365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           L   + +               + +  CL  D   RP+  +++
Sbjct: 226 LMPRLPDSFSAAA--------IDFVTSCLTRDQHERPSALQLL 260

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 83.1 bits (205), Expect = 6e-18
 Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 18/205 (8%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNH 196
           +G G FG V  G      +   R+K  D  VA+K L+ +  +  +DE   E   + +L++
Sbjct: 3   LGSGNFGCVKKG------VYKMRKKQID--VAIKVLKNENEKSVRDEMMREAEIMHQLDN 54

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P +V+++G  C+ +  +LV E  + G L   L  + D E+     +++    + G+++L 
Sbjct: 55  PYIVRMIG-VCEAEALMLVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLE 112

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG-DKSHISTRVLGT--RGYFAPE 313
              +  +HRD+ A NVLL +   AKISDFGL+K   LG D S+   R  G     ++APE
Sbjct: 113 G--KNFVHRDLAARNVLLVNQHYAKISDFGLSK--ALGADDSYYKARSAGKWPLKWYAPE 168

Query: 314 YIATGHLTLKTDVYSFGVVLLEILS 338
            I     + ++DV+S+G+ + E  S
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 83.1 bits (205), Expect = 6e-18
 Identities = 73/297 (24%), Positives = 136/297 (45%), Gaps = 48/297 (16%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR---RKGSQGQDEWENEL 188
           F  +  IG+G F +VY     +C +           VA+K+++      ++ + +   E+
Sbjct: 4   FRIEKKIGRGQFSEVYRA---TCLLDGV-------PVALKKVQIFDLMDAKARADCIKEI 53

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-EDDTELNWERRI-KIAL 246
             L +LNHPNV+K      +D    +V E    G L   + + +    L  E+ + K  +
Sbjct: 54  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
                LEH+H+  R V+HRD+K +NV +      K+ D GL +F     K+  +  ++GT
Sbjct: 114 QLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGT 169

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             Y +PE I       K+D++S G +L E+     AA++           P+  +K+ L+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM-----AALQ----------SPFYGDKMNLY 214

Query: 367 QIIDEKLGRNIQMEE---------AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
                 L + I+  +         ++E  +++  C+N DP+ RP ++ V    +++ 
Sbjct: 215 S-----LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 7e-18
 Identities = 65/238 (27%), Positives = 100/238 (42%), Gaps = 50/238 (21%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR----KGSQGQDEWENELRFLS 192
           +IG+G FG+V++           R K+     A+K LR+    K +Q       E   L+
Sbjct: 8   VIGRGAFGEVWL----------VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRA-ERDILA 56

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
             + P +VKL     D++H  LV EY+  G L + L+ +D       R     L  A  L
Sbjct: 57  DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA--L 114

Query: 253 EHLHT--YWRPVIHRDVKASNVLLDDDFNAKISDFGLAK--------------------- 289
           + +H   +    IHRD+K  N+L+D D + K++DFGL K                     
Sbjct: 115 DSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 290 ------FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
                       +   +   +GT  Y APE +      L+ D +S GV+L E+L G  
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 68/229 (29%), Positives = 103/229 (44%), Gaps = 51/229 (22%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--ELR 189
           F + N IG+G +G VY           AR   +   VA+K++R    +      +  E+ 
Sbjct: 9   FEKLNRIGEGTYGIVY----------RARDTTSGEIVALKKVRMDNERDGIPISSLREIT 58

Query: 190 FLSRLNHPNVVKL---------------MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT 234
            L  L HPN+V+L               M YC  D   LL                ++  
Sbjct: 59  LLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL----------------DNMP 102

Query: 235 ELNWERRIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
               E ++K + L   RGL++LH  +  +IHRD+K SN+LL D    KI+DFGLA+    
Sbjct: 103 TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLAR--TY 158

Query: 294 GDKSHISTRVLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
           G  +   T  + T  Y APE +   T + T   D+++ G +L E+L+ K
Sbjct: 159 GLPAKPMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 74/295 (25%), Positives = 131/295 (44%), Gaps = 36/295 (12%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELR 189
           F+   ++G+G FG V    + S          +   VAVK L+     S   +E+  E  
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKS-------EDGSFQKVAVKMLKADIFSSSDIEEFLREAA 53

Query: 190 FLSRLNHPNVVKLMGYCCDD--QHRL----LVYEYVTRGSLEDHLL----NEDDTELNWE 239
            +   +HPNV+KL+G       + RL    ++  ++  G L   LL     E+   L  +
Sbjct: 54  CMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQ 113

Query: 240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
             ++  +  A G+E+L +  +  IHRD+ A N +L+++    ++DFGL+K    GD    
Sbjct: 114 TLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171

Query: 300 STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY 358
                    + A E +A    T  +DV++FGV + EI++ G+T       G+  +    Y
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA----GVENSEIYNY 227

Query: 359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           L     L Q            +  ++  E++ +C + +PK RP+   +   LE +
Sbjct: 228 LIKGNRLKQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 78/298 (26%), Positives = 135/298 (45%), Gaps = 46/298 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRL-N 195
           +G+G FG V +            + N    VAVK L+   +     +  +E+  +  +  
Sbjct: 20  LGEGCFGQVVMA---EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNE--------------DDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L                  + +L ++  
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +  A   ARG+E+L +  +  IHRD+ A NVL+ +D   KI+DFGLA+     D  +I  
Sbjct: 137 VSCAYQVARGMEYLAS--QKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DVHNIDY 189

Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV+L EI +           L G+   
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT-----------LGGS--- 235

Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   I+  C ++ P  RPT  ++V  L+++
Sbjct: 236 PYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 84.1 bits (208), Expect = 4e-17
 Identities = 82/316 (25%), Positives = 134/316 (42%), Gaps = 75/316 (23%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL---RFL-- 191
           LIG+GG G+VY+ Y   C+    RR      VA+K++R      +D  EN L   RFL  
Sbjct: 9   LIGKGGMGEVYLAYDPVCS----RR------VALKKIR------EDLSENPLLKKRFLRE 52

Query: 192 ----SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIAL 246
               + L HP +V +   C D         Y+   +L+  L +    E L+ E   K ++
Sbjct: 53  AKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV 112

Query: 247 GA--------ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF-------- 290
           GA           +E++H+  + V+HRD+K  N+LL       I D+G A F        
Sbjct: 113 GAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170

Query: 291 --------GPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
                           I  +++GT  Y APE +     +  TD+Y+ GV+L ++L+  + 
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT-LSF 229

Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQE----FAEIILRCLNSDP 397
             RR  G            K++    I+       I++   +E     ++I ++ L  DP
Sbjct: 230 PYRRKKG-----------RKISYRDVILSP-----IEVAPYREIPPFLSQIAMKALAVDP 273

Query: 398 KNR-PTMSEVVAALEQ 412
             R  ++ E+   LE 
Sbjct: 274 AERYSSVQELKQDLEP 289

Length = 932

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 47/288 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQDEWENELRFLSRLNH 196
           IG G FG V +  I +     AR       V VK L+    S+ Q+E+  +      L H
Sbjct: 3   IGNGWFGKVLLSEIYT-DTGVAR-------VVVKELKANASSKEQNEFLQQGDPYRILQH 54

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI--KIALGAARGLEH 254
           PN+++ +G C +    LLV+EY   G L+ +L  E     N +  +  ++A   A G+ H
Sbjct: 55  PNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH 114

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS-HIST--RVLGTRGYFA 311
           +H +    +H D+   N  L  D   K+ D+G+   GP   K  +I T         + A
Sbjct: 115 MHKH--NFLHSDLALRNCFLTSDLTVKVGDYGI---GPSRYKEDYIETEDDKCVPLRWLA 169

Query: 312 PEYIATGHLTLKT-------DVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNK 362
           PE +   H  L T       +V++ GV L E+                N A+PY  LS++
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFE--------------NAAQPYSHLSDR 215

Query: 363 LALHQIIDEKLGR----NIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
             L+ +I ++  +     +++  ++ + E++  C  S P+ R T  EV
Sbjct: 216 EVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLS-PEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 6e-17
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 28/210 (13%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW-ENELRFLSRLN 195
            +G G FG V+        +   R     +A+ V  +       Q++   NE R L  ++
Sbjct: 8   TVGTGTFGRVH--------LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN----EDDTELNWERRIKIALGAARG 251
           HP +++L     D +   ++ EYV  G L  +L N     + T L +   I  AL     
Sbjct: 60  HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL----- 114

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
            E+LH+  + +++RD+K  N+LLD + + K++DFG AK   L D++     + GT  Y A
Sbjct: 115 -EYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT---LCGTPEYLA 166

Query: 312 PEYIA-TGHLTLKTDVYSFGVVLLEILSGK 340
           PE I   GH     D ++ G+++ E+L G 
Sbjct: 167 PEVIQSKGHNK-AVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 80.8 bits (199), Expect = 7e-17
 Identities = 73/293 (24%), Positives = 129/293 (44%), Gaps = 42/293 (14%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G            +     VA+K LR   S +   E  +E  
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIP------EGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L + + +  G L D++    D       LNW  +I  
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 118

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 119 ----AKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172

Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++   T   +  +G+  +     L     
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---TFGSKPYDGIPASEISSILEKGER 229

Query: 365 LHQ----IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           L Q     ID  +              I+++C   D  +RP   E++    ++
Sbjct: 230 LPQPPICTIDVYM--------------IMVKCWMIDADSRPKFRELIIEFSKM 268

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 80.1 bits (198), Expect = 8e-17
 Identities = 82/296 (27%), Positives = 123/296 (41%), Gaps = 72/296 (24%)

Query: 134 EKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR---KGSQGQDEWENELRF 190
           +   IG+G FG V         M     K +   +AVKR+R    +  Q +   + ++  
Sbjct: 8   DLGEIGRGAFGTVN-------KM---LHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM 57

Query: 191 LSRLNHPNVVK----------------LMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT 234
            S  + P +VK                LM    D  ++  VYE V +  + + +L     
Sbjct: 58  RSS-DCPYIVKFYGALFREGDCWICMELMDISLDKFYKY-VYE-VLKSVIPEEILG---- 110

Query: 235 ELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                   KIA+   + L +L    + +IHRDVK SN+LLD + N K+ DFG++  G L 
Sbjct: 111 --------KIAVATVKALNYLKEELK-IIHRDVKPSNILLDRNGNIKLCDFGIS--GQLV 159

Query: 295 DKSHISTRVLGTRGYFAPEYIATGHLT---LKTDVYSFGVVLLEILSGKTAAMRRTNGLA 351
           D S   TR  G R Y APE I         +++DV+S G+ L E+ +GK           
Sbjct: 160 D-SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKF---------- 208

Query: 352 GNWAKPYLS-NKL--ALHQIID---EKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
                PY   N +   L Q++      L  + + E +  F   I  CL  D   RP
Sbjct: 209 -----PYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRP 259

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 74/274 (27%), Positives = 114/274 (41%), Gaps = 49/274 (17%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFL-SR 193
           I +G FG VY+         A +R   D+  A+K L++     +++  N   E   +  +
Sbjct: 4   ISKGAFGSVYL---------AKKRSTGDY-FAIKVLKKSDMIAKNQVTNVKAERAIMMIQ 53

Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
              P V KL  Y    +  L LV EY+  G     +        +W +  +       G+
Sbjct: 54  GESPYVAKLY-YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGV 110

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           E LH   R +IHRD+K  N+L+D   + K++DFGL++ G        + + +GT  Y AP
Sbjct: 111 EDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAP 162

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I        +D +S G V+ E L G                 P+ +       + D  
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFG---------------YPPFHAE--TPDAVFDNI 205

Query: 373 LGRNIQM-EEAQEFA-----EIILRCLNSDPKNR 400
           L R I   EE +EF      ++I R L  DP  R
Sbjct: 206 LSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 71/256 (27%), Positives = 113/256 (44%), Gaps = 50/256 (19%)

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI---- 242
           EL+ L   N P +V   G    D    +  E++  GSL        D  L    RI    
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL--------DQVLKKAGRIPENI 100

Query: 243 --KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
             KI++   RGL +L      ++HRDVK SN+L++     K+ DFG++  G L D   ++
Sbjct: 101 LGKISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MA 155

Query: 301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK----------TAAM------ 344
              +GTR Y +PE +   H T+++D++S G+ L+E+  G+            AM      
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVS 215

Query: 345 --------RRTNGLAGNWAKPYLSNKLALHQIIDE---KLGRNIQMEEAQEFAEIILRCL 393
                   R  +G   +  +P    +L L  I++E   KL      +E Q+F +    CL
Sbjct: 216 EGEAKESHRPVSGHPPDSPRPMAIFEL-LDYIVNEPPPKLPSGAFSDEFQDFVDK---CL 271

Query: 394 NSDPKNRPTMSEVVAA 409
             +PK R  + E+   
Sbjct: 272 KKNPKERADLKELTKH 287

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.4 bits (195), Expect = 2e-16
 Identities = 72/256 (28%), Positives = 121/256 (47%), Gaps = 23/256 (8%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           +K++    IGQG  G V+       A+  A  +     VA+K++  +    ++   NE+ 
Sbjct: 19  KKYTRYEKIGQGASGTVFT------AIDVATGQE----VAIKQINLQKQPKKELIINEIL 68

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            +  L +PN+V  +          +V EY+  GSL D +    +T ++  +   +     
Sbjct: 69  VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECL 125

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL-AKFGPLGDKSHISTRVLGTRG 308
           + LE LH     VIHRD+K+ NVLL  D + K++DFG  A+  P  ++S  ST V GT  
Sbjct: 126 QALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPY 180

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMR----RTNGLAGNWAKPYLSNKLA 364
           + APE +       K D++S G++ +E++ G+   +     R   L      P L N   
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240

Query: 365 LHQIIDEKLGRNIQME 380
           L  I  + L R ++M+
Sbjct: 241 LSPIFRDFLNRCLEMD 256

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 69/214 (32%), Positives = 102/214 (47%), Gaps = 22/214 (10%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NEL 188
           F+   ++G+G FG V +          A RK  D   A+K L++      D+ E    E 
Sbjct: 2   FNFLMVLGKGSFGKVML----------AERKGTDELYAIKILKKDVIIQDDDVECTMVEK 51

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           R L+    P  +  +  C     RL  V EYV  G L  H+  +   +      +  A  
Sbjct: 52  RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYAAE 109

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL-GT 306
            A GL  LH+  + +I+RD+K  NV+LD + + KI+DFG+ K    G K   +TR   GT
Sbjct: 110 IAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGT 164

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
             Y APE IA        D ++FGV+L E+L+G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 81/296 (27%), Positives = 117/296 (39%), Gaps = 83/296 (28%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN- 195
            IG G  G VY            R K     +AVK++RR G++     E   R L  L+ 
Sbjct: 22  EIGSGTCGQVY----------KMRFKKTGHVMAVKQMRRTGNK-----EENKRILMDLDV 66

Query: 196 ----H--PNVVK----------------LMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD 233
               H  P +VK                LM  C D   +LL      +G + + +L    
Sbjct: 67  VLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLD---KLLKR---IQGPIPEDILG--- 117

Query: 234 TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
                    K+ +   + L +L      VIHRDVK SN+LLD   N K+ DFG++  G L
Sbjct: 118 ---------KMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGIS--GRL 165

Query: 294 GDKSHISTRVLGTRGYFAPEYI----ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
            D S   TR  G   Y APE I          ++ DV+S G+ L+E+ +G+         
Sbjct: 166 VD-SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF-------- 216

Query: 350 LAGNWAKPYLSNKL---ALHQIIDEKLGR-NIQMEEAQEFAEIILRCLNSDPKNRP 401
                  PY + K     L +I+ E+          + +F   +  CL  D + RP
Sbjct: 217 -------PYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP 265

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.9 bits (192), Expect = 4e-16
 Identities = 68/279 (24%), Positives = 125/279 (44%), Gaps = 27/279 (9%)

Query: 137 LIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL-SRL 194
            +G G FG VY +   N+     A ++      A  + +R+  +   +  +E+  +  +L
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--LNEDDTELNWERRIKIALGAARGL 252
            HPN+V+      ++    +V + +    L +H   L E       ER   I +     L
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            +LH   + ++HRD+  +N++L +D    I+DFGLAK      +S + T V+GT  Y  P
Sbjct: 127 RYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL-TSVVGTILYSCP 182

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP--YLSNKLALH-QII 369
           E +       K DV++FG +L +        +           +P  Y +N L+L  +I+
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQ-----MCTL-----------QPPFYSTNMLSLATKIV 226

Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
           +       +   +++  ++I  CL  D + RP + +V A
Sbjct: 227 EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 65/279 (23%), Positives = 120/279 (43%), Gaps = 41/279 (14%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQDEWENELRFLSRLN 195
           ++G+G FG   +           +  N+D   A+K +R  K S   ++   E   L+++ 
Sbjct: 7   VVGEGSFGRALL----------VQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK 56

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL------LNEDDTELNWERRIKIALGAA 249
           HPN+V        D H  +V EY   G L   +      L  +DT L W  ++ +     
Sbjct: 57  HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL----- 111

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
            G++H+H   + V+HRD+K+ N+ L  +   K+ DFG A+   L      +   +GT  Y
Sbjct: 112 -GVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--LTSPGAYACTYVGTPYY 166

Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII 369
             PE         K+D++S G +L E+ + K          A +W    L         +
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ------ANSWKNLILK--------V 212

Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
            +   + +    + E   +I +    +P++RP+ + +++
Sbjct: 213 CQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 68/268 (25%), Positives = 110/268 (41%), Gaps = 34/268 (12%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSRL 194
           +GQGG+G V++          A++K+    VA+KR+++      +E      E   L+  
Sbjct: 9   VGQGGYGQVFL----------AKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT 58

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA--LGAARGL 252
               +VKL+    DD++  L  EYV  G     LLN          R  +A    A   L
Sbjct: 59  KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRT-LLNNLGVLSEDHARFYMAEMFEAVDAL 117

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
             L       IHRD+K  N L+D   + K++DFGL+K          +  V+G+  Y AP
Sbjct: 118 HELG-----YIHRDLKPENFLIDASGHIKLTDFGLSKGI-----VTYANSVVGSPDYMAP 167

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E +         D +S G +L E L G           +G+       N     + +   
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG-------FPPFSGSTPNETWENLKYWKETLQRP 220

Query: 373 LGRNIQMEEAQEFAEIILRCLNSDPKNR 400
           +  + +   + E  ++I + +N DP  R
Sbjct: 221 VYDDPRFNLSDEAWDLITKLIN-DPSRR 247

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 67/208 (32%), Positives = 109/208 (52%), Gaps = 21/208 (10%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW--ENELRFLSRL 194
           ++GQG FG V++       +      +A    A+K L++   + +D    + E   L+ +
Sbjct: 3   VLGQGSFGKVFL-------VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV 55

Query: 195 NHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA-ARGL 252
           NHP +VKL  Y    + +L L+ +++  G L   L  E    +  E  +K  L   A  L
Sbjct: 56  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALAL 111

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           +HLH+    +I+RD+K  N+LLD++ + K++DFGL+K     +K   S    GT  Y AP
Sbjct: 112 DHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAP 167

Query: 313 EYI-ATGHLTLKTDVYSFGVVLLEILSG 339
           E +   GH T   D +SFGV++ E+L+G
Sbjct: 168 EVVNRRGH-TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 24/211 (11%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLS- 192
           ++G+G FG V         M A  +   +F  A+K L++      D+ E    E R L+ 
Sbjct: 2   VLGKGSFGKV---------MLAELKGTNEF-FAIKALKKDVVLEDDDVECTMVERRVLAL 51

Query: 193 RLNHPNVVKLMGYCC--DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
              HP +  L  +C     +H   V EY+  G L  H+  +     +  R    A     
Sbjct: 52  AWEHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIIC 107

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GL+ LH     +I+RD+K  NVLLD D + KI+DFG+ K    G+    ++   GT  Y 
Sbjct: 108 GLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYI 163

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           APE +         D +SFGV+L E+L G++
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 78.4 bits (193), Expect = 6e-16
 Identities = 70/214 (32%), Positives = 98/214 (45%), Gaps = 45/214 (21%)

Query: 218 YVTRGSLEDHLLNEDDTE-----LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV 272
           ++   SL D   +E+  E     L  E  I  +   ARG+E L +  R  IHRD+ A N+
Sbjct: 147 FIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNI 204

Query: 273 LLDDDFNAKISDFGLAKFGPLGD--KSHISTRVLGTR---GYFAPEYIATGHLTLKTDVY 327
           LL ++   KI DFGLA+     D  K     R    R    + APE I     T ++DV+
Sbjct: 205 LLSENNVVKICDFGLAR-----DIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVW 259

Query: 328 SFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE----KLGRNIQMEEAQ 383
           SFGV+L EI S           L    A PY   +      IDE    +L    +M   +
Sbjct: 260 SFGVLLWEIFS-----------LG---ASPYPGVQ------IDEEFCRRLKEGTRMRAPE 299

Query: 384 ----EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               E   I+L C +++P++RPT SE+V  L  L
Sbjct: 300 YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 60/288 (20%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG VY           A+ K      A K ++ +  +  +++  E+  LS   HP
Sbjct: 13  LGDGAFGKVY----------KAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHP 62

Query: 198 NVVKLM-GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-IALGAARGLEHL 255
           N+V L   Y  +++  +L+ E+   G+L D ++ E +  L  E +I+ +       L  L
Sbjct: 63  NIVGLYEAYFYENKLWILI-EFCDGGAL-DSIMLELERGLT-EPQIRYVCRQMLEALNFL 119

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR--VLGTRGYFAPE 313
           H+    VIHRD+KA N+LL  D + K++DFG++       KS +  R   +GT  + APE
Sbjct: 120 HS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKN----KSTLQKRDTFIGTPYWMAPE 173

Query: 314 YIATGHLT-----LKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
            +A           K D++S G+ L+E+     A M   +                L+ +
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIEL-----AQMEPPHH--------------ELNPM 214

Query: 369 IDEKLGRNIQMEE----------AQEFAEIILRCLNSDPKNRPTMSEV 406
              ++   I   E          +  F + +  CL  DP +RPT +E+
Sbjct: 215 ---RVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 77.5 bits (190), Expect = 8e-16
 Identities = 68/256 (26%), Positives = 118/256 (46%), Gaps = 23/256 (8%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           +K++    IGQG  G VY       AM  A  +     VA++++  +    ++   NE+ 
Sbjct: 20  KKYTRFEKIGQGASGTVYT------AMDVATGQE----VAIRQMNLQQQPKKELIINEIL 69

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            +    +PN+V  +          +V EY+  GSL D +    +T ++  +   +     
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL 126

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL-AKFGPLGDKSHISTRVLGTRG 308
           + LE LH+    VIHRD+K+ N+LL  D + K++DFG  A+  P   K    + ++GT  
Sbjct: 127 QALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPY 181

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMR----RTNGLAGNWAKPYLSNKLA 364
           + APE +       K D++S G++ +E++ G+   +     R   L      P L N   
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241

Query: 365 LHQIIDEKLGRNIQME 380
           L  I  + L R + M+
Sbjct: 242 LSAIFRDFLNRCLDMD 257

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.0 bits (189), Expect = 8e-16
 Identities = 75/289 (25%), Positives = 126/289 (43%), Gaps = 39/289 (13%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR---FLSRL 194
           +G+G FG V  G +N        + ++   VAVK ++      + E E+ L     +   
Sbjct: 7   LGEGEFGSVMEGQLN--------QDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEF 57

Query: 195 NHPNVVKLMGYCCDDQHR------LLVYEYVTRGSLEDHLL----NEDDTELNWERRIKI 244
           +HPNV++L+G C            +++  ++  G L   LL     +    L  +  +K 
Sbjct: 58  DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A G+E+L +  +  IHRD+ A N +L+++ N  ++DFGL+K    GD         
Sbjct: 118 MTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAK 175

Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKL 363
               + A E +A    T K+DV+SFGV + EI + G+T       G+  +    YL    
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP----YPGVENSEIYDYLRQGN 231

Query: 364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
            L Q  D   G             ++  C   +PK+RP+   +   LE+
Sbjct: 232 RLKQPPDCLDG----------LYSLMSSCWLLNPKDRPSFETLRCELEK 270

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 77.4 bits (191), Expect = 8e-16
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 34/214 (15%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN----ELRFLS 192
           ++G+G +G V             R K     VA+K+   K S+  ++ +     E++ L 
Sbjct: 8   VVGEGAYGVVL----------KCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLR 55

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
           +L H N+V L           LV+EYV R  LE  LL      L  +          + +
Sbjct: 56  QLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAI 113

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+    +IHRD+K  N+L+ +    K+ DFG A+       S ++  V  TR Y AP
Sbjct: 114 AYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAP 170

Query: 313 EYIATGHLTLK-------TDVYSFGVVLLEILSG 339
           E      L +         DV++ G ++ E+L G
Sbjct: 171 E------LLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 75/298 (25%), Positives = 140/298 (46%), Gaps = 46/298 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRL-N 195
           +G+G FG V +    +  +   + K A   VAVK L+   ++    +  +E+  +  +  
Sbjct: 23  LGEGCFGQVVMA--EALGIDKDKPKEA-VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNE--------------DDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L                  D ++ ++  
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +      ARG+E+L +  +  IHRD+ A NVL+ ++   KI+DFGLA+     D ++I  
Sbjct: 140 VSCTYQVARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR-----DVNNIDY 192

Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV++ EI +           L G+   
Sbjct: 193 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS--- 238

Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P +RPT  ++V  L+++
Sbjct: 239 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 77.1 bits (190), Expect = 9e-16
 Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 44/231 (19%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---- 186
           KF     IG+G +G VY           AR K+    VA+K++R       +E E     
Sbjct: 8   KFDIIGQIGEGTYGQVY----------KARDKDTGELVALKKVRL-----DNEKEGFPIT 52

Query: 187 ---ELRFLSRLNHPNVVKLMGYCCDDQHRL----------LVYEYVTR---GSLEDHLLN 230
              E++ L +LNH N+V L     D Q  L          LV+EY+     G LE  L++
Sbjct: 53  AIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH 112

Query: 231 EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF 290
                 + +           GL + H   +  +HRD+K SN+LL++    K++DFGLA+ 
Sbjct: 113 -----FSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARL 165

Query: 291 GPLGDKSHISTRVLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILSGK 340
               +    + +V+ T  Y  PE  +         DV+S G +L E+ + K
Sbjct: 166 YNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 32/216 (14%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENEL 188
           F     +G G FG V I          A+ K      A+K L+++     +       E 
Sbjct: 20  FEMGETLGTGSFGRVRI----------AKHKGTGEYYAIKCLKKREILKMKQVQHVAQEK 69

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNE----DDTELNWERRIKI 244
             L  L+HP +V +M    D+     + E+V  G L  HL       +D    +   + +
Sbjct: 70  SILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL 129

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           A       E+LH+  + +I+RD+K  N+LLD+  + K++DFG AK  P  D++     + 
Sbjct: 130 AF------EYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT---LC 176

Query: 305 GTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSG 339
           GT  Y APE I + GH     D ++ GV+L E ++G
Sbjct: 177 GTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 25/217 (11%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G  G V I          A  K+    VAVK++  +  Q ++   NE+  +   +H 
Sbjct: 30  IGEGSTGIVCI----------ATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHE 79

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVV +           +V E++  G+L D + +   T +N E+   + L   R L +LH 
Sbjct: 80  NVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHN 136

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + VIHRD+K+ ++LL  D   K+SDFG      +  +      ++GT  + APE I+ 
Sbjct: 137 --QGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISR 192

Query: 318 GHLTLKTDVYSFGVVLLEILSGKT--------AAMRR 346
                + D++S G++++E++ G+          AMRR
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR 229

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 24/211 (11%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLS- 192
           ++G+G FG V++          A  K  +   A+K L++      D+ E    E R LS 
Sbjct: 2   MLGKGSFGKVFL----------AELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 51

Query: 193 RLNHPNVVKLMGYCC--DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
              HP +  L  YC     ++   V EY+  G L  H+  +   + +  R    A     
Sbjct: 52  AWEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIIC 107

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GL+ LH+  + +++RD+K  N+LLD D + KI+DFG+ K   LGD    +    GT  Y 
Sbjct: 108 GLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYI 163

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           APE +         D +SFGV+L E+L G++
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 36/226 (15%)

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHR-----LLVYEYVTRGSLEDHLLNEDDTELNWERR 241
           E+  L  +NHPNVVK     C D         ++ E++  GSLE   + ++    +  R+
Sbjct: 122 EIEILRDVNHPNVVK-----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ 176

Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           I        G+ +LH   R ++HRD+K SN+L++   N KI+DFG+++   L        
Sbjct: 177 I------LSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCN 226

Query: 302 RVLGTRGYFAPEYIAT-----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
             +GT  Y +PE I T      +     D++S GV +LE   G+        G  G+WA 
Sbjct: 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR---FPFGVGRQGDWA- 282

Query: 357 PYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT 402
                  +L   I            ++EF   I  CL  +P  R +
Sbjct: 283 -------SLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWS 321

Length = 353

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 77/277 (27%), Positives = 125/277 (45%), Gaps = 39/277 (14%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENELRFLSRLN 195
           +G G FG V  G          + K ++  VAVK L+   +    +DE   E   + +L+
Sbjct: 3   LGSGNFGTVKKGMY--------KMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD 54

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL-NEDDTELNWERRIKIALGAARGLEH 254
           +P +V+++G  C+ +  +LV E    G L   L  N+  TE N     ++    + G+++
Sbjct: 55  NPYIVRMIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNI---TELVHQVSMGMKY 110

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG-DKSHISTRVLGT--RGYFA 311
           L       +HRD+ A NVLL     AKISDFGL+K   LG D+++   +  G     ++A
Sbjct: 111 LEET--NFVHRDLAARNVLLVTQHYAKISDFGLSK--ALGADENYYKAKTHGKWPVKWYA 166

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE +     + K+DV+SFGV++ E  S          G      KPY   K      + E
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFS---------YGQ-----KPYKGMKGNEVTQMIE 212

Query: 372 KLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEV 406
             G  ++  +    E  +++  C       RP  + V
Sbjct: 213 S-GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 78/307 (25%), Positives = 139/307 (45%), Gaps = 48/307 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAAR-RKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +G+G FG V    + + A    + R +    VAVK L+   +     +  +E+  +  + 
Sbjct: 20  LGEGCFGQV----VRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75

Query: 196 -HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL---------LNEDDTE-----LNWER 240
            H N++ L+G C  +    ++ EY  +G+L + L            D T+     L+++ 
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
            +  A   ARG+E+L +  R  IHRD+ A NVL+ +D   KI+DFGLA+         I 
Sbjct: 136 LVSCAYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKIADFGLAR-----GVHDID 188

Query: 301 TRVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWA 355
                + G     + APE +     T ++DV+SFG+++ EI +           L G+  
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT-----------LGGS-- 235

Query: 356 KPYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
            PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V AL+++ 
Sbjct: 236 -PYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294

Query: 415 LNMGSCY 421
             +   Y
Sbjct: 295 AAVSEEY 301

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 20/209 (9%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLS- 192
           ++G+G FG V +  +        + K   FAV  K L++      D+ E    E R L+ 
Sbjct: 2   VLGKGSFGKVLLAEL--------KGKGEYFAV--KALKKDVVLIDDDVECTMVEKRVLAL 51

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
              +P +  L       +H   V E++  G L  H+  +D    +  R    A     GL
Sbjct: 52  AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI--QDKGRFDLYRATFYAAEIVCGL 109

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           + LH+    +I+RD+K  NV+LD D + KI+DFG+ K    GD    ++   GT  Y AP
Sbjct: 110 QFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAP 165

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           E +     T   D +SFGV+L E+L G++
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 66/273 (24%), Positives = 127/273 (46%), Gaps = 31/273 (11%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V        ++   R     + +    LR    + +   E E + LS+L HP
Sbjct: 8   VGKGSYGEV--------SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHP 59

Query: 198 NVVKLM-GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI-KIALGAARGLEHL 255
           N+V     +  +D    +V  +   G L  H L E   +L  E ++ +  +  A  L++L
Sbjct: 60  NIVAYRESWEGEDGLLYIVMGFCEGGDLY-HKLKEQKGKLLPENQVVEWFVQIAMALQYL 118

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
           H   + ++HRD+K  NV L      K+ D G+A+   L ++  +++ ++GT  Y +PE  
Sbjct: 119 HE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMSPELF 174

Query: 316 ATGHLTLKTDVYSFGVVLLEILSGKTA-AMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +      K+DV++ G  + E+ + K A   +  N L              +++II+ KL 
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL--------------VYRIIEGKLP 220

Query: 375 RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
             +  + + E  E+I   L+  P+ RP++  ++
Sbjct: 221 P-MPKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 81/311 (26%), Positives = 136/311 (43%), Gaps = 62/311 (19%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G  G V I          AR K++   VAVK +  +  Q ++   NE+  +    H 
Sbjct: 29  IGEGSTGIVCI----------AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQ 78

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVV++       +   ++ E++  G+L D +     T LN E+   +     + L +LH+
Sbjct: 79  NVVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHS 135

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV------LGTRGYFA 311
             + VIHRD+K+ ++LL  D   K+SDFG          + IS  V      +GT  + A
Sbjct: 136 --QGVIHRDIKSDSILLTLDGRVKLSDFGFC--------AQISKDVPKRKSLVGTPYWMA 185

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGK--------TAAMRRTNGLAGNWAKPYLSNKL 363
           PE I+      + D++S G++++E++ G+          AM+R      +   P L N  
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR----DSPPPKLKNAH 241

Query: 364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCY-- 421
            +  ++             ++F E   R L  +P+ R T  E++     LQ  +  C   
Sbjct: 242 KISPVL-------------RDFLE---RMLTREPQERATAQELLDHPFLLQTGLPECLVP 285

Query: 422 ---QTSLRTST 429
              Q   RTST
Sbjct: 286 LIQQYRKRTST 296

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 69/256 (26%), Positives = 121/256 (47%), Gaps = 23/256 (8%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           +K++    IGQG  G VY       A+  A  +     VA+K++  +    ++   NE+ 
Sbjct: 19  KKYTRFEKIGQGASGTVYT------AIDIATGQE----VAIKQMNLQQQPKKELIINEIL 68

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            +    +PN+V  +          +V EY+  GSL D +    +T ++  +   +     
Sbjct: 69  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL 125

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL-AKFGPLGDKSHISTRVLGTRG 308
           + L+ LH+    VIHRD+K+ N+LL  D + K++DFG  A+  P  ++S  ST V GT  
Sbjct: 126 QALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPY 180

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMR----RTNGLAGNWAKPYLSNKLA 364
           + APE +       K D++S G++ +E++ G+   +     R   L      P L N   
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER 240

Query: 365 LHQIIDEKLGRNIQME 380
           L  +  + L R ++M+
Sbjct: 241 LSAVFRDFLNRCLEMD 256

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 46/284 (16%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           L+GQG FG VY+     C      R+ A   V       + S+     E E++ L  L H
Sbjct: 9   LLGQGAFGRVYL-----CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63

Query: 197 PNVVKLMGYCCDDQHRLLV--YEYVTRGSLEDHL-----LNEDDTELNWERRIKIALGAA 249
             +V+  G   D   + L    EY+  GS++D L     L E  T   + R+I       
Sbjct: 64  ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQI------L 116

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-VLGTRG 308
            G+ +LH+    ++HRD+K +N+L D   N K+ DFG +K       S    R V GT  
Sbjct: 117 EGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA-----AMRRTNGLAGNWAKPYLSNKL 363
           + +PE I+      K DV+S G  ++E+L+ K       AM     +A     P L + +
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHI 234

Query: 364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           +               E A++F    L C+  + ++RP+  E++
Sbjct: 235 S---------------EHARDF----LGCIFVEARHRPSAEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.5 bits (183), Expect = 5e-15
 Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 24/218 (11%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           K+ +   IG+G FG           +  ++     + +    + +   + ++E   E+  
Sbjct: 1   KYVKVKKIGEGSFGKAI--------LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAV 52

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSL------EDHLLNEDDTELNWERRIKI 244
           LS + HPN+V+      ++ +  +V +Y   G L      +  +L  +D  L+W  +I +
Sbjct: 53  LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL 112

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           AL      +H+H   R ++HRD+K+ N+ L  D   K+ DFG+A+   L     ++   +
Sbjct: 113 AL------KHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCI 162

Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
           GT  Y +PE         K+D+++ G VL E+ + K A
Sbjct: 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 75.3 bits (186), Expect = 5e-15
 Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 62/235 (26%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-------- 186
              IG G +G V           +A  K     VA+K++          +++        
Sbjct: 5   LKPIGSGAYGVVC----------SAVDKRTGRKVAIKKISN-------VFDDLIDAKRIL 47

Query: 187 -ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED-----HLLNEDDTELNWER 240
            E++ L  L H N++ L          L +    +     D      L+   +T+L+  +
Sbjct: 48  REIKLLRHLRHENIIGL----------LDILRPPSPEDFNDVYIVTELM---ETDLH--K 92

Query: 241 RIK------------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA 288
            IK                  RGL++LH+    VIHRD+K SN+L++ + + KI DFGLA
Sbjct: 93  VIKSPQPLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICDFGLA 150

Query: 289 K-FGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           +   P  D+    T  + TR Y APE + +    T   D++S G +  E+L+ K 
Sbjct: 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 74.6 bits (183), Expect = 6e-15
 Identities = 70/287 (24%), Positives = 128/287 (44%), Gaps = 43/287 (14%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRLN 195
           ++G G FG++  G    C    ++R   +  VA+  LR   S  Q   +  E   L + +
Sbjct: 12  ILGTGRFGELCRG----CLKLPSKR---ELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD 64

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           H N+V+L G        ++V EY++ G+L D  L + + +L   + + +  G A G+++L
Sbjct: 65  HSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG---YFAP 312
                  +H+ + A  VL++ D   KIS F   +     DKS      +  +    + AP
Sbjct: 124 SEM--GYVHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLWAAP 177

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQII 369
           E I   H +  +DV+SFG+V+ E++S G+               +PY  +S +  +  + 
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGE---------------RPYWDMSGQDVIKAVE 222

Query: 370 DE---KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           D       RN          +++L C   +   RP  S++ + L ++
Sbjct: 223 DGFRLPAPRNCP----NLLHQLMLDCWQKERGERPRFSQIHSILSKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 22/209 (10%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
           ++G+G FG V +          A RK  D   A+K L++      D+ E    E R L+ 
Sbjct: 7   VLGKGSFGKVML----------AERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL 56

Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            + P  +  +  C     RL  V EYV  G L  H+  +   +    + +  A   + GL
Sbjct: 57  QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGL 114

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL-GTRGYFA 311
             LH   R +I+RD+K  NV+LD + + KI+DFG+ K   +     ++TR   GT  Y A
Sbjct: 115 FFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTPDYIA 169

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           PE IA        D +++GV+L E+L+G+
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 77.2 bits (190), Expect = 6e-15
 Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 20/190 (10%)

Query: 167 AVAVKRLRRKGSQGQDE---WENELRFLSRLNHPNVVKLM--GYCCDDQHRLL-VYEYVT 220
            VA+K LR    + + +   +  E    +RL HPN+V L+  G        L  V+EYV 
Sbjct: 5   EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG--LLFAVFEYVP 62

Query: 221 RGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDD 277
             +L + L    D  L      ++ L     L   H   + ++HRD+K  N+++      
Sbjct: 63  GRTLREVLAA--DGALPAGETGRLMLQVLDALACAHN--QGIVHRDLKPQNIMVSQTGVR 118

Query: 278 FNAKISDFGLAKFGP-----LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVV 332
            +AK+ DFG+    P            +T VLGT  Y APE +    +T  +D+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 333 LLEILSGKTA 342
            LE L+G+  
Sbjct: 179 FLECLTGQRV 188

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 8e-15
 Identities = 73/276 (26%), Positives = 112/276 (40%), Gaps = 37/276 (13%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           LIG+G +G VY G       T         A+ +  L        D    E+  LS+L  
Sbjct: 8   LIGRGAYGAVYRGK---HVPT-----GRVVALKIINLDTPDDDVSDIQR-EVALLSQLRQ 58

Query: 197 ---PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
              PN+ K  G         ++ EY   GS+   +      E      I+  L A   L+
Sbjct: 59  SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA---LK 115

Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE 313
           ++H     VIHRD+KA+N+L+ +  N K+ DFG+A    L   S   +  +GT  + APE
Sbjct: 116 YIHK--VGVIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFVGTPYWMAPE 171

Query: 314 YIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL--ALHQIID 370
            I  G     K D++S G+ + E+ +G                 PY       A+  I  
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGN---------------PPYSDVDAFRAMMLIPK 216

Query: 371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
            K  R      ++   E +  CL+ +PK R +  E+
Sbjct: 217 SKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEEL 252

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 74.0 bits (182), Expect = 9e-15
 Identities = 73/304 (24%), Positives = 129/304 (42%), Gaps = 69/304 (22%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSR 193
            +L+ +G FG ++ G +         +   +  V VK ++   S+ Q      E   L  
Sbjct: 11  SDLLQEGTFGRIFYGILID------EKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG 64

Query: 194 LNHPNVVKLMGYCCDDQHRLLV-YEYVTRGSLEDHLLNEDDTELNWERRIK------IAL 246
           L+H N++ ++  C +D     V Y Y+  G+L+  L      E N  + +       +A+
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK------FGPLGDKSHIS 300
             A G+ +LH     VIH+D+ A N ++D++   KI+D  L++      +  LGD  +  
Sbjct: 125 QIACGMSYLHKR--GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182

Query: 301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYL 359
            +      + A E +     +  +DV+SFGV+L E+++ G+T               PY+
Sbjct: 183 VK------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQT---------------PYV 221

Query: 360 SNKLALHQIIDE-------KLGRNIQMEEAQ------EFAEIILRCLNSDPKNRPTMSEV 406
                    ID        K G  +    AQ      E   ++  C   DP+ RP+ S++
Sbjct: 222 E--------IDPFEMAAYLKDGYRL----AQPINCPDELFAVMACCWALDPEERPSFSQL 269

Query: 407 VAAL 410
           V  L
Sbjct: 270 VQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 40/286 (13%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLN 195
           ++G G FG VY G      +     +N    VA+K LR   S +   E  +E   ++ + 
Sbjct: 14  VLGSGAFGTVYKG------IWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKIALGAAR 250
            P V +L+G C     +L V + +  G L D++    D       LNW  +I      A+
Sbjct: 68  SPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AK 120

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           G+ +L      ++HRD+ A NVL+    + KI+DFGLA+   + +  + +        + 
Sbjct: 121 GMSYLEEV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           A E I     T ++DV+S+GV + E++         T G     AKPY  + +   +I D
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELM---------TFG-----AKPY--DGIPAREIPD 222

Query: 371 --EKLGRNIQMEE-AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             EK  R  Q      +   I+++C   D + RP   E+V    ++
Sbjct: 223 LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 70/210 (33%), Positives = 99/210 (47%), Gaps = 25/210 (11%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
           L+G+G FG V +           R K      A+K LR++    +DE  +   E R L  
Sbjct: 2   LLGKGTFGKVIL----------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 51

Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA--AR 250
             HP +  L  Y      RL  V EY   G L  HL  E    +  E R +   GA    
Sbjct: 52  TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARF-YGAEIVS 106

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            LE+LH+  R V++RD+K  N++LD D + KI+DFGL K G + D + + T   GT  Y 
Sbjct: 107 ALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYL 162

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           APE +         D +  GVV+ E++ G+
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 67/213 (31%), Positives = 97/213 (45%), Gaps = 31/213 (14%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL---RFLSR 193
           L+G+G FG V +           R K      A+K L+++    +DE  + L   R L  
Sbjct: 2   LLGKGTFGKVIL----------VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN 51

Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALG 247
             HP +  L  Y      RL  V EY   G L  HL      +ED     +   I  ALG
Sbjct: 52  TRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALG 109

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
                 +LH+    V++RD+K  N++LD D + KI+DFGL K G + D + + T   GT 
Sbjct: 110 ------YLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTP 159

Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            Y APE +         D +  GVV+ E++ G+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 42/200 (21%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENE---- 187
           + E   IG+G +G VY           AR  N    VA+K++R   S+       E    
Sbjct: 1   YEELAEIGEGAYGTVY----------KARDLNTGRFVALKKVRVPLSE-------EGIPL 43

Query: 188 --------LRFLSRLNHPNVVKLMGYC--CDDQHRL---LVYEYVTRGSLEDHLLNEDDT 234
                   L+ L    HPN+V+L+  C        L   LV+E+V +  L  +L      
Sbjct: 44  STLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKP 102

Query: 235 ELNWERRIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
            L     IK +     RG++ LH++   ++HRD+K  N+L+  D   KI+DFGLA+    
Sbjct: 103 GLP-PETIKDLMRQLLRGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLARI--Y 157

Query: 294 GDKSHISTRVLGTRGYFAPE 313
             +  + T V+ T  Y APE
Sbjct: 158 SFEMAL-TSVVVTLWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 19/160 (11%)

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI---- 242
           EL+ L   N P +V   G    D    +  E++  GSL D +L E        +RI    
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKE-------AKRIPEEI 104

Query: 243 --KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
             K+++   RGL +L    + ++HRDVK SN+L++     K+ DFG++  G L D   ++
Sbjct: 105 LGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MA 159

Query: 301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
              +GTR Y +PE +   H ++++D++S G+ L+E+  G+
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 76/271 (28%), Positives = 123/271 (45%), Gaps = 32/271 (11%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE--WENELR--FLS 192
           +IG+G +  V +           R K  +   A+K ++++     ++  W    +  F  
Sbjct: 2   VIGRGSYAKVLL----------VRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 51

Query: 193 RLNHPNVVKLMGYCCDDQHRLL-VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
             NHP +V L   C   + RL  V EYV  G L  H+  +        R     +  A  
Sbjct: 52  ASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA-- 108

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG--PLGDKSHISTRVLGTRGY 309
           L +LH   R +I+RD+K  NVLLD + + K++D+G+ K G  P GD    ++   GT  Y
Sbjct: 109 LNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT---TSTFCGTPNY 162

Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII 369
            APE +         D ++ GV++ E+++G     R    + G+   P  + +  L Q+I
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAG-----RSPFDIVGSSDNPDQNTEDYLFQVI 217

Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNR 400
            EK  R I    + + A ++   LN DPK R
Sbjct: 218 LEKQIR-IPRSLSVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 26/191 (13%)

Query: 228 LLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
           +L ED+  L+ E  +  +   A+G+  L +  +  IHRD+ A N+LL      KI DFGL
Sbjct: 203 ILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGL 260

Query: 288 AKFGPLGDKSHISTRVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
           A+     D  + S  V+         + APE I     T ++DV+S+G++L EI S    
Sbjct: 261 AR-----DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS---- 311

Query: 343 AMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRP 401
                    G+   P +      +++I E   R +  E A  E  +I+  C ++DP  RP
Sbjct: 312 --------LGSSPYPGMPVDSKFYKMIKEGY-RMLSPECAPSEMYDIMKSCWDADPLKRP 362

Query: 402 TMSEVVAALEQ 412
           T  ++V  +EQ
Sbjct: 363 TFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 46/224 (20%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFA--VAVKRLR-----RKGSQGQDEWENELR 189
           L+GQG FG VY+ Y            +AD    +AVK+++      + S+  +  E E++
Sbjct: 9   LLGQGAFGRVYLCY------------DADTGRELAVKQVQFDPESPETSKEVNALECEIQ 56

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLL--VYEYVTRGSLEDHL-----LNEDDTELNWERRI 242
            L  L H  +V+  G   D   R L    E++  GS++D L     L E+ T   + R+I
Sbjct: 57  LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQI 115

Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK------FGPLGDK 296
                   G+ +LH+    ++HRD+K +N+L D   N K+ DFG +K          G K
Sbjct: 116 ------LEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK 167

Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           S     V GT  + +PE I+      K D++S G  ++E+L+ K
Sbjct: 168 S-----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 24/209 (11%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NELRFLS- 192
           ++G+G FG V +          AR K +    AVK L++      D+ E    E R LS 
Sbjct: 2   VLGKGSFGKVML----------ARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSL 51

Query: 193 RLNHPNVVKLMGYCC-DDQHRLL-VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
             NHP + +L  YCC     RL  V E+V  G L  H+  +     +  R    A     
Sbjct: 52  ARNHPFLTQL--YCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITS 107

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            L  LH   + +I+RD+K  NVLLD + + K++DFG+ K G    K+  ++   GT  Y 
Sbjct: 108 ALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYI 163

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSG 339
           APE +         D ++ GV+L E+L G
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 22/209 (10%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
           ++G+G FG V            A RK  D   A+K L++      D+ E    E R L+ 
Sbjct: 7   VLGKGSFGKV----------MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL 56

Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
              P  +  +  C     RL  V EYV  G L   +  +          +  A   A GL
Sbjct: 57  SGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGL 114

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL-GTRGYFA 311
             LH+  + +I+RD+K  NV+LD + + KI+DFG+ K         ++T+   GT  Y A
Sbjct: 115 FFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW---DGVTTKTFCGTPDYIA 169

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           PE IA        D ++FGV+L E+L+G+
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 70/247 (28%), Positives = 107/247 (43%), Gaps = 62/247 (25%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE----- 185
           +   K  +G+G FG+VY           AR+      VA+K++        +E +     
Sbjct: 11  EILGK--LGEGTFGEVY----------KARQIKTGRVVALKKILMH-----NEKDGFPIT 53

Query: 186 --NELRFLSRLNHPNVVKL--MGYCCDDQHR------LLVYEYVTRGSLEDH----LLNE 231
              E++ L +L HPNVV L  M     D+ +       +V  Y+      DH    LL  
Sbjct: 54  ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM------DHDLSGLLEN 107

Query: 232 DDTELNWERRIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF 290
              +L  E +IK   L    G+ +LH     ++HRD+KA+N+L+D+    KI+DFGLA+ 
Sbjct: 108 PSVKLT-ESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQGILKIADFGLARP 164

Query: 291 ---------GPLGDKSHISTRVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLE----- 335
                    G  G  +   T ++ TR Y  PE +      T   D++  G V  E     
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Query: 336 -ILSGKT 341
            IL GK+
Sbjct: 225 PILQGKS 231

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 17/203 (8%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G  G V I  + S              VAVK++  +  Q ++   NE+  +    H 
Sbjct: 28  IGEGSTGIVCIATVKSSGKL----------VAVKKMDLRKQQRRELLFNEVVIMRDYQHE 77

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVV++           +V E++  G+L D + +   T +N E+   + L   + L  LH 
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHA 134

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + VIHRD+K+ ++LL  D   K+SDFG      +  +      ++GT  + APE I+ 
Sbjct: 135 --QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISR 190

Query: 318 GHLTLKTDVYSFGVVLLEILSGK 340
                + D++S G++++E++ G+
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 21/208 (10%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLN 195
           ++G G FG VY G      +     +     VA+K L    G +   E+ +E   ++ ++
Sbjct: 14  VLGSGAFGTVYKG------IWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKIALGAAR 250
           HP++V+L+G C     +L V + +  G L D++    D       LNW  +I      A+
Sbjct: 68  HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AK 120

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           G+ +L    R ++HRD+ A NVL+    + KI+DFGLA+     +K + +        + 
Sbjct: 121 GMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 178

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILS 338
           A E I     T ++DV+S+GV + E+++
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 48/229 (20%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE----- 185
           ++   + +G G +G V       C+    +       VA+K+L R     Q         
Sbjct: 16  RYQNLSPVGSGAYGQV-------CSAFDTKTGRK---VAIKKLSRPF---QSAIHAKRTY 62

Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLL---VYEYVTRGSLEDHLLNEDDTELNWERRI 242
            ELR L  ++H NV+ L+              VY  VT      HL+     +LN   + 
Sbjct: 63  RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY-LVT------HLM---GADLNNIVKC 112

Query: 243 K---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
           +         +     RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+    
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFGLAR---- 166

Query: 294 GDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKT 341
                  T  + TR Y APE +    H     D++S G ++ E+L+GKT
Sbjct: 167 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 69/217 (31%), Positives = 100/217 (46%), Gaps = 39/217 (17%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL---RRKGSQGQDEWENE---LRF 190
           +IG+GGFG+VY            R+ +     A+K L   R K  QG+    NE   L  
Sbjct: 1   IIGRGGFGEVY----------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 50

Query: 191 LSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHL-----LNEDDTELNWERRIKI 244
           +S  + P +V  M Y      +L  + + +  G L  HL      +E +           
Sbjct: 51  VSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-------Y 102

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHISTRV 303
           A     GLEH+H   R V++RD+K +N+LLD+  + +ISD GLA  F     K H S   
Sbjct: 103 AAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHAS--- 155

Query: 304 LGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSG 339
           +GT GY APE +  G       D +S G +L ++L G
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 73.0 bits (180), Expect = 4e-14
 Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 41/175 (23%)

Query: 187 ELRFLSRL-NHPNVVKLMGYCCDDQHR-------LLVYEY-------VTR-GSLED-HLL 229
           E+ FL  L +HPN+VKL+     +  +        LV+EY       V R   LED H  
Sbjct: 56  EIMFLQELGDHPNIVKLL-----NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH-- 108

Query: 230 NEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK 289
                      +  I     + L+++H+    VIHRD+K SN+LL+ D   K++DFGLA+
Sbjct: 109 -----------KRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLAR 155

Query: 290 -FGPLGD--KSHISTRVLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILSGK 340
               L +  ++ + T  + TR Y APE  + +   T   D++S G +L E+L GK
Sbjct: 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 70/240 (29%), Positives = 109/240 (45%), Gaps = 27/240 (11%)

Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR----KGSQG 180
           L+     +    +IG+G FG+V +           R K++    A+K L +    K S  
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQL----------VRHKSSQKVYAMKLLSKFEMIKRSDS 87

Query: 181 QDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWER 240
              WE E   ++  N P VV+L     DD++  +V EY+  G L + + N D  E  W +
Sbjct: 88  AFFWE-ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAK 145

Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
                +  A  L+ +H+    +IHRDVK  N+LLD   + K++DFG              
Sbjct: 146 FYTAEVVLA--LDAIHSM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201

Query: 301 TRVLGTRGYFAPEYIAT----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
           T V GT  Y +PE + +    G+   + D +S GV L E+L G T      + L G ++K
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY--ADSLVGTYSK 258

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 36/218 (16%)

Query: 134 EKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN------- 186
           EK  IG+G +G VY           AR K     VA+K++R      + E E        
Sbjct: 5   EK--IGEGTYGVVY----------KARDKLTGEIVALKKIRL-----ETEDEGVPSTAIR 47

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           E+  L  LNHPN+V+L+     +    LV+E++    L+ ++ +   T L+    IK  L
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLD-PPLIKSYL 105

Query: 247 GA-ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTRV 303
               +G+ + H+    V+HRD+K  N+L+D +   K++DFGLA+ FG P+   +H    V
Sbjct: 106 YQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EV 160

Query: 304 LGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILSGK 340
           + T  Y APE  + +   +   D++S G +  E+++ +
Sbjct: 161 V-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 77/299 (25%), Positives = 114/299 (38%), Gaps = 81/299 (27%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNAD-FAVAV--KRLRRKGSQGQDEWE 185
           T ++ +   +G G FG V            A +K    F+  V  KR  R          
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR---------- 58

Query: 186 NELRFLSRLNHPNVVKLMGYCCD------------------DQHRLLVYEYVTRGSLEDH 227
            EL+ L  L H N++ L     D                  D HRLL     T   LE  
Sbjct: 59  -ELKLLKHLRHENIISL----SDIFISPLEDIYFVTELLGTDLHRLL-----TSRPLEKQ 108

Query: 228 LLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
            +                    RGL+++H+    V+HRD+K SN+L++++ + KI DFGL
Sbjct: 109 FIQ------------YFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKICDFGL 154

Query: 288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGKTAAMRR 346
           A+      +    T  + TR Y APE + T     ++ D++S G +  E+L G       
Sbjct: 155 ARI-----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG------- 202

Query: 347 TNGLAGNWAKPYLSNKLALHQ--IIDEKLGRNIQMEEAQEFA-EIILRCLNSDPKNRPT 402
                    KP    K  ++Q  II + LG     +       E  LR + S PK  P 
Sbjct: 203 ---------KPLFPGKDHVNQFSIITDLLG-TPPDDVINTICSENTLRFVQSLPKREPV 251

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 71.4 bits (175), Expect = 7e-14
 Identities = 61/252 (24%), Positives = 112/252 (44%), Gaps = 32/252 (12%)

Query: 181 QDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLE------DHLLNEDDT 234
           Q +  +EL  L + + P ++   G    +    +  E++  GSL+      +H+L     
Sbjct: 43  QKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG---- 98

Query: 235 ELNWERRIKIALGAARGLEHLHTYWR-PVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
                   +IA+   +GL +L   W   ++HRDVK SN+L++     K+ DFG++     
Sbjct: 99  --------RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVST---- 143

Query: 294 GDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN 353
              + I+   +GT  Y APE I+     + +DV+S G+  +E+  G+    +    +  N
Sbjct: 144 QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ----IQKN 199

Query: 354 WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             +  L     L  I+DE        + +++F   I +C+   PK RP    ++     +
Sbjct: 200 --QGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257

Query: 414 QLNMGSCYQTSL 425
           Q N G+    S+
Sbjct: 258 QYNDGNAEVVSM 269

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 71.8 bits (176), Expect = 8e-14
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 24/210 (11%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NELRFLS- 192
           ++G+G FG V +          A  K  D   A+K L++      D+ +    E R L+ 
Sbjct: 2   VLGKGSFGKVML----------AELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILAL 51

Query: 193 RLNHPNVVKLMGYCC-DDQHRLL-VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
              HP +  L  +CC   + RL  V EYV  G L   +  +   + +  R    A     
Sbjct: 52  AAKHPFLTAL--HCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTL 107

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            L  LH +   VI+RD+K  N+LLD + + K++DFG+ K G L      +T   GT  Y 
Sbjct: 108 ALMFLHRH--GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYI 163

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           APE +         D ++ GV++ E+++G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 29/213 (13%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFL--- 191
           +G+G FG V         + A  +K  +   A+K L++     +DE E+   E R     
Sbjct: 7   LGRGHFGKV---------LLAEYKKTGEL-YAIKALKKGDIIARDEVESLMCEKRIFETA 56

Query: 192 SRLNHPNVVKLMGYCC--DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI-ALGA 248
           +   HP +V L  + C   + H   V EY   G L  H+     T++  E R    A   
Sbjct: 57  NSERHPFLVNL--FACFQTEDHVCFVMEYAAGGDLMMHI----HTDVFSEPRAVFYAACV 110

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
             GL++LH     +++RD+K  N+LLD +   KI+DFGL K G +G     ST   GT  
Sbjct: 111 VLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRTST-FCGTPE 166

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           + APE +     T   D +  GV++ E+L G++
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 25/213 (11%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-----ELRFLS 192
           IG+G +G V+          A   KN    VA+KR+R +  +             LR L 
Sbjct: 9   IGEGAYGKVF---------KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 59

Query: 193 RLNHPNVVKLMGYCC----DDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
              HPNVV+L   C     D + +L LV+E+V +  L  +L    +  +  E    +   
Sbjct: 60  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 118

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
             RGL+ LH++   V+HRD+K  N+L+      K++DFGLA+           T V+ T 
Sbjct: 119 LLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTL 173

Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            Y APE +         D++S G +  E+   K
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 38/284 (13%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNH 196
           IG G FG V +G +NS    A         V VK LR   S Q Q ++  E +    L H
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQ--------VVVKELRVSASVQEQMKFLEEAQPYRSLQH 54

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRI--KIALGAARGLE 253
            N+++ +G C +    LLV E+   G L+ +L +    E +  +     ++A   A GL 
Sbjct: 55  SNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL 114

Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE 313
           HLH      IH D+   N LL  D   KI D+GL+      D      ++     + APE
Sbjct: 115 HLHKN--NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172

Query: 314 YIATGHLTL-------KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
            +   H  L       +++V+S GV + E+               G+    +LS++  L 
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFE------------LGSQPYRHLSDEQVLT 220

Query: 367 QIIDE---KLGR-NIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
             + E   KL +  +++  +  + E++  C    P+ RP+  EV
Sbjct: 221 YTVREQQLKLPKPRLKLPLSDRWYEVMQFC-WLQPEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 30/215 (13%)

Query: 195 NHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR--- 250
           NHP +V L   C   + RL  V E+V+ G L  H+          +R+ K+    AR   
Sbjct: 54  NHPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHM----------QRQRKLPEEHARFYS 102

Query: 251 -----GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
                 L  LH   R +I+RD+K  NVLLD + + K++D+G+ K G +      ST   G
Sbjct: 103 AEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-IRPGDTTST-FCG 158

Query: 306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL 365
           T  Y APE +         D ++ GV++ E+++G     R    + G    P  + +  L
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG-----RSPFDIVGMSDNPDQNTEDYL 213

Query: 366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNR 400
            Q+I EK  R I    + + + ++   LN DPK R
Sbjct: 214 FQVILEKQIR-IPRSLSVKASSVLKGFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 63/220 (28%), Positives = 93/220 (42%), Gaps = 27/220 (12%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F    L+G G +G VY G          R        A+K +   G + ++E + E+  L
Sbjct: 8   FELVELVGNGTYGQVYKG----------RHVKTGQLAAIKVMDVTGDE-EEEIKQEINML 56

Query: 192 SRLNH-PNVVKLMGYCCD------DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
            + +H  N+    G          D    LV E+   GS+ D + N     L  E    I
Sbjct: 57  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 116

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                RGL HLH +   VIHRD+K  NVLL ++   K+ DFG++    L          +
Sbjct: 117 CREILRGLSHLHQH--KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI 172

Query: 305 GTRGYFAPEYIATGH-----LTLKTDVYSFGVVLLEILSG 339
           GT  + APE IA           K+D++S G+  +E+  G
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 34/218 (15%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           L+G+G FG+VY+     C      R+ A   V      ++ S+  +  E E++ L  L H
Sbjct: 9   LLGRGAFGEVYL-----CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 197 PNVVKLMGYCCDD--QHRLLVY-EYVTRGSLEDHL-----LNEDDTELNWERRIKIALGA 248
             +V+  G C  D  + +L ++ EY+  GS++D L     L E+ T   + R+I      
Sbjct: 64  DRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQI------ 115

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK------FGPLGDKSHISTR 302
            +G+ +LH+    ++HRD+K +N+L D   N K+ DFG +K          G KS     
Sbjct: 116 LQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS----- 168

Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           V GT  + +PE I+      K DV+S    ++E+L+ K
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 69/223 (30%), Positives = 102/223 (45%), Gaps = 35/223 (15%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR----KGSQGQDEWENE 187
           F    +IG+G FG+V +           R K++    A+K L +    K S     WE E
Sbjct: 45  FDVIKVIGRGAFGEVQL----------VRHKSSKQVYAMKLLSKFEMIKRSDSAFFWE-E 93

Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWER----RIK 243
              ++  N   +V+L     DD++  +V EY+  G L + + N D  E  W R     + 
Sbjct: 94  RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAEVV 152

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHISTR 302
           +AL A      +H+     IHRDVK  N+LLD   + K++DFG   K    G      T 
Sbjct: 153 LALDA------IHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTA 203

Query: 303 VLGTRGYFAPEYIAT----GHLTLKTDVYSFGVVLLEILSGKT 341
           V GT  Y +PE + +    G+   + D +S GV L E+L G T
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 21/208 (10%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL---RFLSR 193
           L+G+G FG V +           R K +    A+K L+++    +DE  + L   R L  
Sbjct: 2   LLGKGTFGKVIL----------VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN 51

Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
             HP +  L  Y    + RL  V EYV  G L  HL  E     +  R     + +A  L
Sbjct: 52  TRHPFLTSLK-YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--L 108

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           ++LH+    +++RD+K  N++LD D + KI+DFGL K G + D + + T   GT  Y AP
Sbjct: 109 DYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLAP 164

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGK 340
           E +         D +  GVV+ E++ G+
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 23/214 (10%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---- 186
           K+    L+G+G +G V       C     + K     VA+K+     S+     +     
Sbjct: 2   KYENLGLVGEGSYGMVM-----KC-----KHKETGQIVAIKKFLE--SEDDKMVKKIAMR 49

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           E+R L +L H N+V L+      +   LV+E+V    L+D  L +    L+  R  K   
Sbjct: 50  EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLF 107

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              RG+E  H++   +IHRD+K  N+L+      K+ DFG A+   L     + T  + T
Sbjct: 108 QILRGIEFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVAT 163

Query: 307 RGYFAPEYIATGHLTLK-TDVYSFGVVLLEILSG 339
           R Y APE +       +  D+++ G ++ E+L+G
Sbjct: 164 RWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 62/189 (32%), Positives = 87/189 (46%), Gaps = 36/189 (19%)

Query: 236 LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGD 295
           L  E  I  +   A+G+E L +  R  IHRD+ A N+LL ++   KI DFGLA+     D
Sbjct: 176 LTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKD 232

Query: 296 KSHISTRVLGTR---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG 352
             ++  R    R    + APE I     T+++DV+SFGV+L EI S              
Sbjct: 233 PDYV--RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG------------ 278

Query: 353 NWAKPYLSNKLALHQIIDEKLGRNIQ----ME----EAQEFAEIILRCLNSDPKNRPTMS 404
             A PY   K      IDE+  R ++    M        E  + +L C + +P  RPT S
Sbjct: 279 --ASPYPGVK------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 330

Query: 405 EVVAALEQL 413
           E+V  L  L
Sbjct: 331 ELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 68/216 (31%), Positives = 101/216 (46%), Gaps = 33/216 (15%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENE---LRFLSR 193
           +IG+GGFG+VY      C      +  A   +  KR++ K  QG+    NE   L  +S 
Sbjct: 1   IIGRGGFGEVY-----GCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVST 53

Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALG 247
            + P +V  M Y      +L  + + +  G L  HL      +E +           A  
Sbjct: 54  GDCPFIV-CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-------YATE 105

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHISTRVLGT 306
              GLEH+H   R V++RD+K +N+LLD+  + +ISD GLA  F     K H S   +GT
Sbjct: 106 IILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHAS---VGT 158

Query: 307 RGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            GY APE +  G       D +S G +L ++L G +
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHS 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 68.6 bits (168), Expect = 4e-13
 Identities = 70/280 (25%), Positives = 119/280 (42%), Gaps = 49/280 (17%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF------L 191
           +GQG F ++Y G +   +         + +V +K L            + L F      +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-------RDSLAFFETASLM 55

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-LNEDDTELNWERRIKIALGAAR 250
           S+L+H ++VKL G C  D++ ++V EYV  G L+  L   +++  L+W  ++ +A   A 
Sbjct: 56  SQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLAS 112

Query: 251 GLEHLHTYWRPVIHRDVKASNVLL-DDDFN------AKISDFGLAKFGPLGDKSHISTRV 303
            L +L    + ++H +V   N+L+     N       K+SD G+     +  +     R+
Sbjct: 113 ALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI 168

Query: 304 LGTRGYFAPEYIATGH--LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
                + APE I  G   LT+  D +SFG  LLEI S                 +  LS 
Sbjct: 169 ----PWIAPECIRNGQASLTIAADKWSFGTTLLEICS---------------NGEEPLST 209

Query: 362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
             +  +    +    + M +  E A +I +C   DP  RP
Sbjct: 210 LSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 27/221 (12%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE---WENEL 188
           F  K+L+G+G FG+V +           R K      A+K +++     Q+    +E E 
Sbjct: 3   FDVKSLVGRGHFGEVQV----------VREKATGDIYAMKVMKKSVLLAQETVSFFEEER 52

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             LS  N P + +L     D  +  LV EY   G L   LLN  + + + E   +  L  
Sbjct: 53  DILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFD-EDMAQFYL-- 108

Query: 249 ARGLEHLHT-YWRPVIHRDVKASNVLLDDDFNAKISDFG-LAKFGPLGDKSHISTRVLGT 306
           A  +  +H+ +    +HRD+K  NVL+D   + K++DFG  A+     +K   S   +GT
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGT 166

Query: 307 RGYFAPEYIAT------GHLTLKTDVYSFGVVLLEILSGKT 341
             Y APE + T      G   ++ D +S GV+  E++ G++
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 26/207 (12%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG VY           A+ K      A K +  K  +  +++  E+  L+  NHP
Sbjct: 20  LGDGAFGKVY----------KAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHP 69

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-IALGAARGLEHLH 256
            +VKL+G    D    ++ E+   G++ D ++ E D  L  E +I+ I       L++LH
Sbjct: 70  YIVKLLGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRGLT-EPQIQVICRQMLEALQYLH 127

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR--VLGTRGYFAPEY 314
           +    +IHRD+KA NVLL  D + K++DFG++      +   +  R   +GT  + APE 
Sbjct: 128 S--MKIIHRDLKAGNVLLTLDGDIKLADFGVSA----KNVKTLQRRDSFIGTPYWMAPEV 181

Query: 315 IATGHLT-----LKTDVYSFGVVLLEI 336
           +    +       K D++S G+ L+E+
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 69.5 bits (170), Expect = 7e-13
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 34/201 (16%)

Query: 223 SLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI 282
             +D    ED   L+ +  ++ +   A+G++ L +  +  IHRDV A NVLL D   AKI
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKI 253

Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEIL 337
            DFGLA+     D  + S  V+         + APE I     T+++DV+S+G++L EI 
Sbjct: 254 CDFGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 308

Query: 338 S-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEE----AQEFAEIILRC 392
           S GK+               PY    + ++    + + R  QM        E   I+  C
Sbjct: 309 SLGKS---------------PYPG--ILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC 351

Query: 393 LNSDPKNRPTMSEVVAALEQL 413
            N +P  RPT S++   +++ 
Sbjct: 352 WNLEPTERPTFSQISQLIQRQ 372

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 68.3 bits (167), Expect = 8e-13
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 31/213 (14%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE-----NELRFLS 192
           IG+G +G VY           AR +  +  +A+K++R    + +DE        E+  L 
Sbjct: 10  IGEGTYGVVY----------KARDRVTNETIALKKIRL---EQEDEGVPSTAIREISLLK 56

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAARG 251
            + H N+V+L      ++   LV+EY+    L+ H+ +  D   N  R IK  L    RG
Sbjct: 57  EMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKN-PRLIKTYLYQILRG 114

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAK-FG-PLGDKSHISTRVLGTRG 308
           + + H+    V+HRD+K  N+L+D   NA K++DFGLA+ FG P+   +H    V+ T  
Sbjct: 115 IAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH---EVV-TLW 168

Query: 309 YFAPE-YIATGHLTLKTDVYSFGVVLLEILSGK 340
           Y APE  + + H +   D++S G +  E+++ K
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 61/187 (32%), Positives = 88/187 (47%), Gaps = 28/187 (14%)

Query: 234 TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
           + L  E  I  +   ARG+E L +  R  IHRD+ A N+LL ++   KI DFGLA+    
Sbjct: 169 SPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLAR-DIY 225

Query: 294 GDKSHI---STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGL 350
            D  ++   S R+     + APE I     T ++DV+SFGV+L EI S            
Sbjct: 226 KDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG---------- 273

Query: 351 AGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQ----EFAEIILRCLNSDPKNRPTMSEV 406
               A PY    + +++   ++L    +M   +    E   I+L C   DPK RPT S +
Sbjct: 274 ----ASPYPG--VQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSAL 327

Query: 407 VAALEQL 413
           V  L  L
Sbjct: 328 VEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 20/208 (9%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL---RFLSR 193
           L+G+G FG V +           + K      A+K L+++    +DE  + L   R L  
Sbjct: 2   LLGKGTFGKVIL----------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 51

Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
             HP +  L  Y      RL  V EY   G L  HL    +   + +R           L
Sbjct: 52  SRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSAL 108

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           ++LH+  + V++RD+K  N++LD D + KI+DFGL K G + D + + T   GT  Y AP
Sbjct: 109 DYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAP 165

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGK 340
           E +         D +  GVV+ E++ G+
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 45/154 (29%), Positives = 83/154 (53%), Gaps = 7/154 (4%)

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           EL+ L   N P +V   G    D    +  E++  GSL+  L  +    +  +   K+++
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSI 110

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              +GL +L    + ++HRDVK SN+L++     K+ DFG++  G L D   ++   +GT
Sbjct: 111 AVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 165

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           R Y +PE +   H ++++D++S G+ L+E+  G+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 69/225 (30%), Positives = 99/225 (44%), Gaps = 44/225 (19%)

Query: 131 KFSEKNLI---GQGGFGDVYIGYINSCAMTAARRKNADFA-VAVKRLRRKG--SQGQ-DE 183
           K+ + N I   G G FG V +          A  KN DF  VA+KR  +     Q Q D 
Sbjct: 28  KYEDFNFIRTLGTGSFGRVIL----------ATYKNEDFPPVAIKRFEKSKIIKQKQVDH 77

Query: 184 WENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             +E + L+ +NHP  V L G   D+ +  LV E+V  G        E  T L   +R  
Sbjct: 78  VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG--------EFFTFLRRNKRFP 129

Query: 244 IALGAARG------LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
             +G           E+L +    +++RD+K  N+LLD D   K++DFG AK        
Sbjct: 130 NDVGCFYAAQIVLIFEYLQSL--NIVYRDLKPENLLLDKDGFIKMTDFGFAKV------- 180

Query: 298 HISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            + TR   + GT  Y APE +         D ++ G+ + EIL G
Sbjct: 181 -VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 19/205 (9%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL---RFLSRL 194
           IG+G FG V             R+++     A+K +R+     + E  + L     L+++
Sbjct: 1   IGKGSFGKV----------MQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV 50

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           N P +V L       +   LV  ++  G L  HL  E   +L+  R     L  A  LE+
Sbjct: 51  NCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA--LEN 108

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           LH +   VI+RD+K  N+LLD   +  + DFGL K          +    GT  Y APE 
Sbjct: 109 LHKF--NVIYRDLKPENILLDYQGHIALCDFGLCKLNM--KDDDKTNTFCGTPEYLAPEL 164

Query: 315 IATGHLTLKTDVYSFGVVLLEILSG 339
           +     T   D ++ GV+L E+L+G
Sbjct: 165 LLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 63/196 (32%), Positives = 94/196 (47%), Gaps = 15/196 (7%)

Query: 206 CCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIH 264
           C     RL LV EYV  G L  H+  +   +L  E     A      L  LH   R +I+
Sbjct: 64  CFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICIALNFLHE--RGIIY 119

Query: 265 RDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKT 324
           RD+K  NVLLD D + K++D+G+ K G LG     ST   GT  Y APE +         
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEG-LGPGDTTST-FCGTPNYIAPEILRGEEYGFSV 177

Query: 325 DVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQE 384
           D ++ GV++ E+++G++     T+        P ++ +  L Q+I EK  R I    + +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITD-------NPDMNTEDYLFQVILEKPIR-IPRFLSVK 229

Query: 385 FAEIILRCLNSDPKNR 400
            + ++   LN DPK R
Sbjct: 230 ASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 41/215 (19%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLN- 195
           IG+G F +V           A  RK   +  A+K +++   S  Q     E++ L RL+ 
Sbjct: 7   IGEGTFSEVL---------KAQSRKTGKY-YAIKCMKKHFKSLEQVNNLREIQALRRLSP 56

Query: 196 HPNVVKLMGYCCDDQHRLL----------VYEYVTRGSLEDHLLNEDDTELNWERRIKIA 245
           HPN+++L+    D +   L          +YE + +G      L E     ++  ++   
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDMNLYELI-KG--RKRPLPEK-RVKSYMYQL--- 109

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS-TRVL 304
               + L+H+H     + HRD+K  N+L+ DD   K++DFG  +    G  S    T  +
Sbjct: 110 ---LKSLDHMHR--NGIFHRDIKPENILIKDD-ILKLADFGSCR----GIYSKPPYTEYI 159

Query: 305 GTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILS 338
            TR Y APE + T G+   K D+++ G V  EILS
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 83/294 (28%), Positives = 123/294 (41%), Gaps = 62/294 (21%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NH 196
           IG+G +G VY             +K+   A AVK L    S   +E E E   L  L NH
Sbjct: 30  IGKGTYGKVY---------KVTNKKDGSLA-AVKILD-PISDVDEEIEAEYNILQSLPNH 78

Query: 197 PNVVKLMGYCCDDQHRL-----LVYEYVTRGSLEDHL--LNEDDTELNWERRIKIALGAA 249
           PNVVK  G        +     LV E    GS+ + +  L      L+      I  GA 
Sbjct: 79  PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV-----L 304
            GL+HLH     +IHRDVK +N+LL  +   K+ DFG++           STR+     +
Sbjct: 139 LGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVDFGVS-------AQLTSTRLRRNTSV 189

Query: 305 GTRGYFAPEYIATGH-----LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
           GT  + APE IA           + DV+S G+  +E+  G                 P L
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG----------------DPPL 233

Query: 360 SNKLALHQIIDEKLGRN-----IQMEE-AQEFAEIILRCLNSDPKNRPTMSEVV 407
            +   +  +   K+ RN     +  E+  + F   I +CL  D + RP+++ ++
Sbjct: 234 FDMHPVKTLF--KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 24/208 (11%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR----FLSR 193
           IG+G FG V +          A+ K      AVK L++K    + E ++ +      L  
Sbjct: 3   IGKGSFGKVLL----------AKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKN 52

Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKI-ALGAARG 251
           + HP +V L  Y      +L  V +YV  G L  HL  E       E R +  A   A  
Sbjct: 53  VKHPFLVGLH-YSFQTADKLYFVLDYVNGGELFFHLQRERSFP---EPRARFYAAEIASA 108

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
           L +LH+    +I+RD+K  N+LLD   +  ++DFGL K G    K+  ++   GT  Y A
Sbjct: 109 LGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLA 164

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSG 339
           PE +         D +  G VL E+L G
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 32/221 (14%)

Query: 143 FGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVK 201
           + D+  +G  ++  + +A   + D  VAVK++     Q       E++ + RL+H N+VK
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 202 LMGYCCDDQHRL--------------LVYEYVT---RGSLEDHLLNEDDTELNWERRIKI 244
           +          L              +V EY+       LE   L+E+   L        
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-------F 119

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDFGLAKF--GPLGDKSHIST 301
                RGL+++H+    V+HRD+K +NV ++ +D   KI DFGLA+        K ++S 
Sbjct: 120 MYQLLRGLKYIHS--ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177

Query: 302 RVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGKT 341
            ++ T+ Y +P  + +  + T   D+++ G +  E+L+GK 
Sbjct: 178 GLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 21/159 (13%)

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVT-------RGSLEDHLLNEDDTELNWE 239
           E   L  +NHP+V+++           LV   +T          L  +L       L  +
Sbjct: 107 EAMLLQNVNHPSVIRMK--------DTLVSGAITCMVLPHYSSDLYTYLTKRS-RPLPID 157

Query: 240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
           + + I      GL +LH   + +IHRDVK  N+ ++D     I D G A+F P+   + +
Sbjct: 158 QALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFL 214

Query: 300 STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS 338
              + GT    APE +A      K D++S G+VL E+L+
Sbjct: 215 G--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 49/224 (21%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-------EL 188
           N I +G +G VY           AR K     VA+K+L+      + E E        E+
Sbjct: 11  NRIEEGTYGVVY----------RARDKKTGEIVALKKLKM-----EKEKEGFPITSLREI 55

Query: 189 RFLSRLNHPNVVKL----MGYCCDDQHRL-LVYEYVTRGSLEDH----LLNEDDTELNWE 239
             L +L HPN+V +    +G    +  ++ +V EYV      +H    L+          
Sbjct: 56  NILLKLQHPNIVTVKEVVVG---SNLDKIYMVMEYV------EHDLKSLMETMKQPFLQS 106

Query: 240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFG-PLGDKS 297
               + L    G+ HLH  W  ++HRD+K SN+LL++    KI DFGLA ++G PL    
Sbjct: 107 EVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-- 162

Query: 298 HISTRVLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILSGK 340
              T+++ T  Y APE  +     +   D++S G +  E+L+ K
Sbjct: 163 --YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 59/230 (25%), Positives = 89/230 (38%), Gaps = 79/230 (34%)

Query: 120 FCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ 179
           FC  +      K+ +   IGQG FG+V+           AR K     VA+K++      
Sbjct: 7   FCDEVS-----KYEKLAKIGQGTFGEVF----------KARHKKTKQIVALKKVLM---- 47

Query: 180 GQDEWE-------NELRFLSRLNHPNVVKL---------------------MGYCCDDQH 211
            ++E E        E++ L  L H NVV L                       +C  D  
Sbjct: 48  -ENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLA 106

Query: 212 RLLVYEYVTRGSLED------HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHR 265
            LL  + V + +L +       LLN                    GL ++H     ++HR
Sbjct: 107 GLLSNKNV-KFTLSEIKKVMKMLLN--------------------GLYYIHR--NKILHR 143

Query: 266 DVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTRVLGTRGYFAPE 313
           D+KA+N+L+  D   K++DFGLA+ F      K +  T  + T  Y  PE
Sbjct: 144 DMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 41/226 (18%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENE 187
            +++    +G G +G V       C+    R       VA+K+L R  +          E
Sbjct: 15  ERYTSLKQVGSGAYGSV-------CSAIDKRTGEK---VAIKKLSRPFQSEIFAKRAYRE 64

Query: 188 LRFLSRLNHPNVVKLM--------GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWE 239
           L  L  + H NV+ L+        G    D + ++ Y       +  H L+ED  +    
Sbjct: 65  LTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVY 124

Query: 240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
           + +        GL+++H+    +IHRD+K  N+ +++D   KI DFGLA+        H 
Sbjct: 125 QMLC-------GLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGLAR--------HA 167

Query: 300 STRVLG---TRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
              + G   TR Y APE I    H     D++S G ++ E+L+GKT
Sbjct: 168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 26/207 (12%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG VY           A+ K      A K +  K  +  +++  E+  L+  +HP
Sbjct: 13  LGDGAFGKVY----------KAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 62

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA-RGLEHLH 256
           N+VKL+     + +  ++ E+   G++ D ++ E +  L  E +I++        L +LH
Sbjct: 63  NIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLT-EPQIRVVCKQTLEALNYLH 120

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR--VLGTRGYFAPEY 314
                +IHRD+KA N+L   D + K++DFG++      +   I  R   +GT  + APE 
Sbjct: 121 E--NKIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEV 174

Query: 315 IATGH-----LTLKTDVYSFGVVLLEI 336
           +            K DV+S G+ L+E+
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 44/131 (33%), Positives = 67/131 (51%), Gaps = 13/131 (9%)

Query: 214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL 273
           L+ +YV  G L  HL   +    + E R+ IA      L+HLH     +I+RD+K  N+L
Sbjct: 82  LILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLHQ--LGIIYRDIKLENIL 137

Query: 274 LDDDFNAKISDFGLAK--FGPLGDKSHISTRVLGTRGYFAPEYIAT---GHLTLKTDVYS 328
           LD + +  ++DFGL+K       ++++      GT  Y APE I     GH     D +S
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVIRGGSGGH-DKAVDWWS 193

Query: 329 FGVVLLEILSG 339
            GV+  E+L+G
Sbjct: 194 LGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELRFLSRLN 195
           IG+G +G VY           AR K     VA+K++R    ++G       E+  L  LN
Sbjct: 8   IGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 57

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HPN+VKL+     +    LV+E++ +  L+  +     + +             +GL   
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTRVLGTRGYFAPE 313
           H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+   +H    V+ T  Y APE
Sbjct: 117 HSH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPE 170

Query: 314 -YIATGHLTLKTDVYSFGVVLLEILSGK 340
             +   + +   D++S G +  E+++ +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 30/195 (15%)

Query: 226 DHLLNEDDTE-LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD 284
            +LL++D +E L     +      ARG+E L +  +  +HRD+ A NVLL      KI D
Sbjct: 223 KNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNVLLAQGKIVKICD 280

Query: 285 FGLAKFGPLGDKSHIS--TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
           FGLA+   + D +++S  +  L  + + APE I     T  +DV+S+G++L EI S    
Sbjct: 281 FGLAR-DIMHDSNYVSKGSTFLPVK-WMAPESIFDNLYTTLSDVWSYGILLWEIFS---- 334

Query: 343 AMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPK 398
                  L G    PY    + +      K+    +M +     QE  +I+++C NS+P+
Sbjct: 335 -------LGGT---PYPG--MIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPE 382

Query: 399 NRPT---MSEVVAAL 410
            RP+   +S++V +L
Sbjct: 383 KRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 9e-12
 Identities = 39/100 (39%), Positives = 57/100 (57%), Gaps = 18/100 (18%)

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL----G 305
           RGL+++H+    V+HRD+K SN+LL+ + + KI DFGLA+   + D  H  T  L     
Sbjct: 117 RGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICDFGLAR---IADPEHDHTGFLTEYVA 171

Query: 306 TRGYFAPEYIATGHLTLKT-----DVYSFGVVLLEILSGK 340
           TR Y APE +    L  K      D++S G +L E+LS +
Sbjct: 172 TRWYRAPEIM----LNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.0 bits (158), Expect = 9e-12
 Identities = 83/290 (28%), Positives = 120/290 (41%), Gaps = 54/290 (18%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NH 196
           IG+G +G V+             +KN   A AVK L        +E E E   L  L +H
Sbjct: 26  IGKGTYGKVF---------KVLNKKNGSKA-AVKILD-PIHDIDEEIEAEYNILKALSDH 74

Query: 197 PNVVKLMG-YCCDD----QHRLLVYEYVTRGSLED---HLLNEDDTELNWERRIKIALGA 248
           PNVVK  G Y   D        LV E    GS+ D     L   +  +       I   A
Sbjct: 75  PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE-RMEEPIIAYILHEA 133

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
             GL+HLH      IHRDVK +N+LL  +   K+ DFG++    L          +GT  
Sbjct: 134 LMGLQHLHV--NKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPF 189

Query: 309 YFAPEYIATGH-----LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL 363
           + APE IA           + DV+S G+  +E+  G                 P L++  
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG----------------DPPLADLH 233

Query: 364 ALHQIIDEKLGRN----IQMEE--AQEFAEIILRCLNSDPKNRPTMSEVV 407
            +  +   K+ RN    +   E  + EF + I +CL  D + RPT+S+++
Sbjct: 234 PMRALF--KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 73/275 (26%), Positives = 116/275 (42%), Gaps = 47/275 (17%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW------ENELRFL 191
           IG+G FG VY            R+K+     A+K L +K    + E        N L   
Sbjct: 1   IGKGTFGQVYQ----------VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRT 50

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA-AR 250
                P +V L      D    LV +Y++ G L  HL  E       E R K  +     
Sbjct: 51  LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVL 107

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            LEHLH Y   +++RD+K  N+LLD   +  + DFGL+K       +  +    GT  Y 
Sbjct: 108 ALEHLHKY--DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163

Query: 311 APEYI--ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           APE +    G+ T   D +S GV++ E+  G              W+  Y  +   +++ 
Sbjct: 164 APEVLLDEKGY-TKHVDFWSLGVLVFEMCCG--------------WSPFYAEDTQQMYRN 208

Query: 369 I---DEKLGRNIQMEEAQEFAEIILRCLNSDPKNR 400
           I     +  +N+  +E ++F + +   LN +P++R
Sbjct: 209 IAFGKVRFPKNVLSDEGRQFVKGL---LNRNPQHR 240

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 27/228 (11%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR----KGSQGQDEWENELRFLS 192
           +IG+G FG+V +           R K+     A+K L +    K S     WE E   ++
Sbjct: 50  VIGRGAFGEVQL----------VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE-ERDIMA 98

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
             N P VV+L     DD++  +V EY+  G L + + N D  E  W R     +  A  L
Sbjct: 99  FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLA--L 155

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           + +H+     IHRDVK  N+LLD   + K++DFG              T V GT  Y +P
Sbjct: 156 DAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 212

Query: 313 EYIAT----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
           E + +    G+   + D +S GV L E+L G T      + L G ++K
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--ADSLVGTYSK 258

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 68/277 (24%), Positives = 120/277 (43%), Gaps = 36/277 (12%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEW---ENELRFLS 192
           +G+G FG VY+           + K A     +K L+    G    +E      E + LS
Sbjct: 8   LGKGSFGTVYL----------VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLS 57

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--LNEDDTELNWERRIKIALGAAR 250
           +L+HP +VK      +     ++ EY     L+  L  L      L+  +  +  +    
Sbjct: 58  KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           G+ ++H   R ++HRD+KA N+ L ++   KI DFG+++   L     ++T   GT  Y 
Sbjct: 118 GVHYMHQ--RRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYM 172

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           +PE +       K+D++S G +L E+     A         G        N L++   I 
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCCLAHA-------FEG-------QNFLSVVLRIV 218

Query: 371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           E    ++    +++   I+   LN DP  RP+ +E++
Sbjct: 219 EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 28/214 (13%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--ELRFLSRL- 194
           IG G +G VY           AR  ++   VA+K +R + ++         E+  L RL 
Sbjct: 8   IGVGAYGTVY----------KARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLE 57

Query: 195 --NHPNVVKLMGYCC----DDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             +HPN+V+LM  C     D + ++ LV+E+V +  L  +L       L  E    +   
Sbjct: 58  AFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQ 116

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS-TRVLGT 306
             RGL+ LH     ++HRD+K  N+L+      K++DFGLA+         ++ T V+ T
Sbjct: 117 FLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVT 170

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
             Y APE +         D++S G +  E+   K
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 24/214 (11%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR----KGSQGQDEWENELRFLS 192
           ++G G +G V++       +      +     A+K L++    + ++  +    E   L 
Sbjct: 7   VLGTGAYGKVFL-------VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE 59

Query: 193 RLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA-R 250
            +     +  + Y    + +L L+ +YV+ G +  HL   D+     E  ++   G    
Sbjct: 60  HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIIL 116

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHISTRVLGTRGY 309
            LEHLH     +++RD+K  N+LLD + +  ++DFGL+K F  L ++   +    GT  Y
Sbjct: 117 ALEHLHKL--GIVYRDIKLENILLDSEGHVVLTDFGLSKEF--LSEEKERTYSFCGTIEY 172

Query: 310 FAPEYI--ATGHLTLKTDVYSFGVVLLEILSGKT 341
            APE I    GH     D +S G+++ E+L+G +
Sbjct: 173 MAPEIIRGKGGHGKA-VDWWSLGILIFELLTGAS 205

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 6/93 (6%)

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL++LH+    ++HRD+K  N+L++ +   KI DFGLA+     +  H++  V+ T+ Y
Sbjct: 114 RGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYY 170

Query: 310 FAPEYIATG--HLTLKTDVYSFGVVLLEILSGK 340
            APE I  G  H T   D++S G +  E+L  +
Sbjct: 171 RAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 68/281 (24%), Positives = 122/281 (43%), Gaps = 42/281 (14%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLNH 196
           +G+G +G VY              +     +A+K +R +  + + ++   EL  L +   
Sbjct: 9   LGKGNYGSVY----------KVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS 58

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI-KIALGAARGLEHL 255
           P +V   G    +    +  EY+  GSL+        TE   E  + +I     +GL+ L
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
                 +IHRDVK +NVL++ +   K+ DFG++  G L   + ++   +G + Y APE I
Sbjct: 119 KEEHN-IIHRDVKPTNVLVNGNGQVKLCDFGVS--GNL--VASLAKTNIGCQSYMAPERI 173

Query: 316 ATGHL------TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY----LSNKLAL 365
            +G        T+++DV+S G+ +LE+  G                 PY     +N  A 
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALG---------------RYPYPPETYANIFAQ 218

Query: 366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
              I +     +    + +  + + +CLN  P  RPT +++
Sbjct: 219 LSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQL 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 36/216 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V       CA    +       VAVK+L R  +          ELR L  + 
Sbjct: 25  VGSGAYGSV-------CAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 74

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+    D        E      L  HL+  D   +   +++       +     
Sbjct: 75  HENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 130

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG---T 306
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+        H    + G   T
Sbjct: 131 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMTGYVAT 180

Query: 307 RGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           R Y APE +    H     D++S G ++ E+L+G+T
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 25/213 (11%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--ELRFLS 192
             ++G+GG+G V+                  FA+ V +        +D      E   L 
Sbjct: 1   LKVLGKGGYGKVF-----QVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILE 55

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNE----DDTELNWERRIKIALGA 248
            + HP +V L+          L+ EY++ G L  HL  E    +DT   +   I +AL  
Sbjct: 56  AVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLAL-- 113

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGTR 307
               EHLH   + +I+RD+K  N+LLD   + K++DFGL K     G  +H      GT 
Sbjct: 114 ----EHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTI 164

Query: 308 GYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSG 339
            Y APE +  +GH     D +S G ++ ++L+G
Sbjct: 165 EYMAPEILMRSGH-GKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 69/247 (27%), Positives = 105/247 (42%), Gaps = 63/247 (25%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-----RKGSQGQDEWENELRFL 191
           +IG+G FG+V +           ++K+     A+K+LR      K        E ++  L
Sbjct: 8   VIGRGAFGEVRL----------VQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDI--L 55

Query: 192 SRLNHPNVVKLMGYCC--DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
           +  ++P VVKL  Y    D+ +  L+ EY+  G +   LL + DT    E R  IA    
Sbjct: 56  AEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMT-LLMKKDTFTEEETRFYIA-ETI 111

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-------------------- 289
             ++ +H      IHRD+K  N+LLD   + K+SDFGL                      
Sbjct: 112 LAIDSIHKL--GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169

Query: 290 ------FGPLGDKSHIST-----RVL-----GTRGYFAPE-YIATGHLTLKTDVYSFGVV 332
                   P+  K    T     R L     GT  Y APE ++ TG+   + D +S GV+
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVI 228

Query: 333 LLEILSG 339
           + E+L G
Sbjct: 229 MYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 37/214 (17%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE------NELRFL 191
           IG+G +G V+      C     R +     VA+K+      + +D+         E+R L
Sbjct: 9   IGEGSYGVVF-----KC-----RNRETGQIVAIKKF----VESEDDPVIKKIALREIRML 54

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH-LLNEDDTE---LNWERRIKIALG 247
            +L HPN+V L+      +   LV+EY       DH +LNE +     +      KI   
Sbjct: 55  KQLKHPNLVNLIEVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQ 108

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
             + +   H +    IHRDVK  N+L+      K+ DFG A+        +  T  + TR
Sbjct: 109 TLQAVNFCHKH--NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATR 164

Query: 308 GYFAPEYIATGHLTLKT--DVYSFGVVLLEILSG 339
            Y APE +  G        DV++ G V  E+L+G
Sbjct: 165 WYRAPELL-VGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 12/178 (6%)

Query: 168 VAVKRLRRKGSQGQDEWEN---ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRG 222
           VA+K+L R   Q Q   +    EL  +  +NH N++ L+      Q  L  ++  Y+   
Sbjct: 52  VAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVME 109

Query: 223 SLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI 282
            ++ +L      EL+ ER   +      G++HLH+    +IHRD+K SN+++  D   KI
Sbjct: 110 LMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKI 167

Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            DFGLA+       S + T  + TR Y APE I         D++S G ++ E++ G 
Sbjct: 168 LDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 55/177 (31%), Positives = 87/177 (49%), Gaps = 12/177 (6%)

Query: 168 VAVKRLRRKGSQGQDEWEN---ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRG 222
           VAVK+L R   Q Q   +    EL  L  +NH N++ L+      Q  L  ++  Y+   
Sbjct: 49  VAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHKNIISLLN-VFTPQKSLEEFQDVYLVME 106

Query: 223 SLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI 282
            ++ +L      EL+ ER   +      G++HLH+    +IHRD+K SN+++  D   KI
Sbjct: 107 LMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKI 164

Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            DFGLA+       + + T  + TR Y APE I         D++S G ++ E++ G
Sbjct: 165 LDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 20/206 (9%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSRLNH 196
           +G+G +  V+ G          R K  +  VA+K +R +  +G       E+  L  L H
Sbjct: 14  LGEGTYATVFKG----------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 63

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAARGLEHL 255
            N+V L      D+   LV+EY+ +  L+ ++  +D   +     +KI L    RGL + 
Sbjct: 64  ANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYM--DDCGNIMSMHNVKIFLYQILRGLAYC 120

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE-Y 314
           H   R V+HRD+K  N+L+++    K++DFGLA+   +  K++ +  V  T  Y  P+  
Sbjct: 121 HR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 176

Query: 315 IATGHLTLKTDVYSFGVVLLEILSGK 340
           + +   + + D++  G +  E+ SG+
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 52/230 (22%), Positives = 94/230 (40%), Gaps = 38/230 (16%)

Query: 136 NLIGQGGFGDVYIGY-INSCAMTAARR-KNADFAVAVKRLRRK-GSQGQD-EWENELRFL 191
             +G+G +G V   Y   +  + A ++ K  + +  V + R+  G  G       EL+ +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-------- 243
           + + H N++ L+    +     LV + +             D +   +R+I+        
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-----------ASDLKKVVDRKIRLTESQVKC 123

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-------FGPLGDK 296
           I L    GL  LH ++   +HRD+  +N+ ++     KI+DFGLA+          L   
Sbjct: 124 ILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 297 SHISTRVLGTRG-----YFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGK 340
             +  R   T       Y APE +          D++S G +  E+L+GK
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 37/216 (17%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE-----NELRFLS 192
           IG+G +G VY G          R K     VA+K++R    + ++E        E+  L 
Sbjct: 8   IGEGTYGVVYKG----------RNKKTGQIVAMKKIRL---ESEEEGVPSTAIREISLLK 54

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--LNED---DTELNWERRIKIALG 247
            L HPN+V L      +    L++E+++   L+ +L  L +    D EL      +I  G
Sbjct: 55  ELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQG 113

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTRVLG 305
                  L  + R V+HRD+K  N+L+D+    K++DFGLA+ FG P+     + T  + 
Sbjct: 114 I------LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV----RVYTHEVV 163

Query: 306 TRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILSGK 340
           T  Y APE  + +   +   D++S G +  E+ + K
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 63.2 bits (154), Expect = 6e-11
 Identities = 36/93 (38%), Positives = 53/93 (56%), Gaps = 5/93 (5%)

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    V+HRD+K SN+LL+ + + KI DFGLA+     +K    T  + TR Y
Sbjct: 119 RGLKYIHS--ANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWY 174

Query: 310 FAPEYI-ATGHLTLKTDVYSFGVVLLEILSGKT 341
            APE +      T   DV+S G +  E+L  K 
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 24/209 (11%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR----FLS 192
           +IG+G FG V +          A+RK+     AVK L++K    + E  + +      L 
Sbjct: 2   VIGKGSFGKVLL----------AKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLK 51

Query: 193 RLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKI-ALGAAR 250
            L HP +V L  Y      +L  V +YV  G L  HL  E       E R +  A   A 
Sbjct: 52  NLKHPFLVGLH-YSFQTAEKLYFVLDYVNGGELFFHLQRE---RCFLEPRARFYAAEVAS 107

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            + +LH+    +I+RD+K  N+LLD   +  ++DFGL K G   +    ++   GT  Y 
Sbjct: 108 AIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV--EPEETTSTFCGTPEYL 163

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSG 339
           APE +         D +  G VL E+L G
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 63.2 bits (153), Expect = 7e-11
 Identities = 53/180 (29%), Positives = 86/180 (47%), Gaps = 10/180 (5%)

Query: 165 DFAVAVKRLRR--KGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVT 220
           D  VA+K+L R  +          EL  +  +NH N++ L+      Q  L  ++  Y+ 
Sbjct: 42  DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN-VFTPQKSLEEFQDVYLV 100

Query: 221 RGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA 280
              ++ +L      EL+ ER   +      G++HLH+    +IHRD+K SN+++  D   
Sbjct: 101 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL 158

Query: 281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           KI DFGLA+       S + T  + TR Y APE I         D++S G ++ E++  K
Sbjct: 159 KILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 64/285 (22%), Positives = 117/285 (41%), Gaps = 53/285 (18%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G +GDVY           AR  N     A+K ++ +  +     + E+  +    H 
Sbjct: 17  IGSGTYGDVY----------KARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHS 66

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N+V   G         +  E+   GSL+D  +      L+  +   ++    +GL +LH+
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQD--IYHVTGPLSESQIAYVSRETLQGLYYLHS 124

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV------LGTRGYFA 311
             +  +HRD+K +N+LL D+ + K++DFG++        + I+  +      +GT  + A
Sbjct: 125 KGK--MHRDIKGANILLTDNGHVKLADFGVS--------AQITATIAKRKSFIGTPYWMA 174

Query: 312 PEYIAT---GHLTLKTDVYSFGVVLLEI--LSGKTAAMRRTNGL----AGNWAKPYLSNK 362
           PE  A    G      D+++ G+  +E+  L      +     L      N+  P L +K
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDK 234

Query: 363 LALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                           M+ +  F   +   L  +PK RPT  +++
Sbjct: 235 ----------------MKWSNSFHHFVKMALTKNPKKRPTAEKLL 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 29/221 (13%)

Query: 132 FSEKNLIGQGGFGDVYIG-YINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           F    ++G G +G VY G ++ +  + A +  +                 ++E + E+  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------------EDEEEEIKLEINM 65

Query: 191 LSRLNH-PNVVKLMGYCC------DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
           L + +H  N+    G          D    LV E+   GS+ D + N     L  +    
Sbjct: 66  LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY 125

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
           I     RGL HLH +   VIHRD+K  NVLL ++   K+ DFG++    L          
Sbjct: 126 ICREILRGLAHLHAH--KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTF 181

Query: 304 LGTRGYFAPEYIATGH-----LTLKTDVYSFGVVLLEILSG 339
           +GT  + APE IA           ++D++S G+  +E+  G
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 32/194 (16%)

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
           + H+H+  + +IHRD+K++N+LL  +   K+ DFG +K         +     GT  Y A
Sbjct: 156 VHHVHS--KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE       + K D++S GV+L E+L+ K               +P+  +   + +++ +
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLK---------------RPF--DGENMEEVMHK 256

Query: 372 KL-GR--NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSC--YQTSLR 426
            L GR   +    + E  EI+   L+SDPK RP+ S++        LNM  C  + + L 
Sbjct: 257 TLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKL--------LNMPICKLFISGLL 308

Query: 427 TSTHTTRTRSFEQR 440
               T    S   R
Sbjct: 309 EIVQTQPGFSGPLR 322

Length = 496

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 24/209 (11%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR----FLS 192
           +IG+G FG V +          A+RK      AVK L++K    + E ++ +      L 
Sbjct: 2   VIGKGSFGKVLL----------AKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLK 51

Query: 193 RLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKI-ALGAAR 250
            + HP +V L  Y      +L  V ++V  G L  HL  E       E R +  A   A 
Sbjct: 52  NVKHPFLVGLH-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFP---EPRARFYAAEIAS 107

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            L +LH+    +++RD+K  N+LLD   +  ++DFGL K G    +S  +T   GT  Y 
Sbjct: 108 ALGYLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGI--AQSDTTTTFCGTPEYL 163

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSG 339
           APE I         D +  G VL E+L G
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 43/133 (32%), Positives = 70/133 (52%), Gaps = 13/133 (9%)

Query: 214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA-ARGLEHLHTYWRPVIHRDVKASNV 272
           L+ +Y+  G L  HL   +  +   E+ ++I  G     LEHLH     +I+RD+K  N+
Sbjct: 82  LILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEHLHKL--GIIYRDIKLENI 136

Query: 273 LLDDDFNAKISDFGLAK-FGPLGDKSHISTRVLGTRGYFAPEYIA---TGHLTLKTDVYS 328
           LLD + +  ++DFGL+K F    D+   +    GT  Y AP+ +     GH     D +S
Sbjct: 137 LLDSNGHVVLTDFGLSKEF--HEDEVERAYSFCGTIEYMAPDIVRGGDGGH-DKAVDWWS 193

Query: 329 FGVVLLEILSGKT 341
            GV++ E+L+G +
Sbjct: 194 MGVLMYELLTGAS 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 21/214 (9%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---- 186
           KF    ++G+G +G V             R K     VA+K+   K S+  +E +     
Sbjct: 2   KFEVLGVVGEGAYGVVL----------KCRHKETKEIVAIKKF--KDSEENEEVKETTLR 49

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           EL+ L  L   N+V+L           LV+EYV +  LE  LL E    +  E+      
Sbjct: 50  ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIY 107

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              + +   H     ++HRD+K  N+L+  +   K+ DFG A+    G  ++  T  + T
Sbjct: 108 QLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVAT 164

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           R Y +PE +         D++S G +L E+  G+
Sbjct: 165 RWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 30/188 (15%)

Query: 168 VAVKRLRR--KGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ--------HRLLVYE 217
           VA+K+L R  +          ELR L  + H NV+ L+     D         + ++ + 
Sbjct: 43  VAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM 102

Query: 218 YVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD 277
               G L  H       +L+ +R   +     +GL+++H     +IHRD+K  N+ +++D
Sbjct: 103 GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNED 154

Query: 278 FNAKISDFGLAKFGPLGDKSHISTRVLG---TRGYFAPEYIATG-HLTLKTDVYSFGVVL 333
              KI DFGLA+           + + G   TR Y APE I    H T   D++S G ++
Sbjct: 155 CELKILDFGLAR--------QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIM 206

Query: 334 LEILSGKT 341
            E+L+GK 
Sbjct: 207 AEMLTGKP 214

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 20/206 (9%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSRLNH 196
           +G+G +  VY G          R K  D  VA+K +R +  +G       E+  L  L H
Sbjct: 14  LGEGTYATVYKG----------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 63

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAARGLEHL 255
            N+V L      ++   LV+EY+ +  L+ +L  +D         +K+ L    RGL + 
Sbjct: 64  ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNSINMHNVKLFLFQLLRGLNYC 120

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE-Y 314
           H   R V+HRD+K  N+L+++    K++DFGLA+   +  K++ +  V  T  Y  P+  
Sbjct: 121 HR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDIL 176

Query: 315 IATGHLTLKTDVYSFGVVLLEILSGK 340
           + +   + + D++  G +  E+ +G+
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 34/226 (15%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F    LI  G +G VY+           R K      A+K++ ++    +++ +    E 
Sbjct: 3   FETIKLISNGAYGAVYL----------VRHKETRQRFAMKKINKQNLILRNQIQQVFVER 52

Query: 189 RFLSRLNHPNVVKLMGYCCDD--QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
             L+   +P VV +  +C  +  +H  +V EYV  G     L N     ++  R +  A 
Sbjct: 53  DILTFAENPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMAR-MYFA- 108

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG------------ 294
                LE+LH Y   ++HRD+K  N+L+    + K++DFGL+K G +             
Sbjct: 109 ETVLALEYLHNY--GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 295 -DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  +  +V GT  Y APE I         D ++ G++L E L G
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 57/231 (24%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-----ELRFLS 192
           IG+G +G VY       A     +   ++A+  K+   KG + Q    +     E+  L 
Sbjct: 8   IGRGTYGRVYK------AKRKNGKDGKEYAI--KKF--KGDKEQYTGISQSACREIALLR 57

Query: 193 RLNHPNVVKLMGYCCDDQHRL--LVYEYVTRGSLEDHLLNEDDTELNWERR-IKIALGAA 249
            L H NVV L+    +   +   L+++Y      E  L       + + R+  ++++  +
Sbjct: 58  ELKHENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQI----IKFHRQAKRVSIPPS 108

Query: 250 ----------RGLEHLHTYWRPVIHRDVKASNVLLDDDFNA----KISDFGLAKF--GPL 293
                      G+ +LH+ W  V+HRD+K +N+L+  +       KI D GLA+    PL
Sbjct: 109 MVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166

Query: 294 -----GDKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILS 338
                 D       V+ T  Y APE +    H T   D+++ G +  E+L+
Sbjct: 167 KPLADLDP------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.6 bits (145), Expect = 9e-10
 Identities = 57/230 (24%), Positives = 90/230 (39%), Gaps = 66/230 (28%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN------ELRFL 191
           IG G +G V       C+   A    +   VA+K    K     D          EL+ L
Sbjct: 13  IGSGAYGVV-------CS---AIDTRSGKKVAIK----KIPHAFDVPTLAKRTLRELKIL 58

Query: 192 SRLNHPNVV--------------------KLMGYCCDDQHRLLVYEYVTRGSLEDHLLNE 231
               H N++                     LM     D H ++     +   L +  +  
Sbjct: 59  RHFKHDNIIAIRDILRPPGADFKDVYVVMDLME---SDLHHIIH----SDQPLTEEHIRY 111

Query: 232 DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF- 290
              +L             RGL+++H+    VIHRD+K SN+L+++D   +I DFG+A+  
Sbjct: 112 FLYQL------------LRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157

Query: 291 --GPLGDKSHISTRVLGTRGYFAPEYIATGH-LTLKTDVYSFGVVLLEIL 337
              P   K  + T  + TR Y APE + +    T   D++S G +  E+L
Sbjct: 158 SSSPTEHKYFM-TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 26/204 (12%)

Query: 216 YEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD 275
           Y            L  +   L++   +  +   A G+E L +  +  +HRD+ A NVL+ 
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLAARNVLIC 273

Query: 276 DDFNAKISDFGLAKFGPLGDKSHIS--TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVL 333
           +    KI DFGLA+   + D ++IS  +  L  + + APE I     T  +DV+SFG++L
Sbjct: 274 EGKLVKICDFGLAR-DIMRDSNYISKGSTFLPLK-WMAPESIFNNLYTTLSDVWSFGILL 331

Query: 334 LEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEE----AQEFAEII 389
            EI +           L G    PY   +L +++     + R  +M +    + E  EI+
Sbjct: 332 WEIFT-----------LGGT---PY--PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIM 375

Query: 390 LRCLNSDPKNRPTMSEVVAALEQL 413
            +C     + RP  S++V  +  L
Sbjct: 376 QKCWEEKFEIRPDFSQLVHLVGDL 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 54/194 (27%), Positives = 81/194 (41%), Gaps = 53/194 (27%)

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS-TRVLGTRG 308
           R L+++HT    V HRD+K  N+L + D   KI DFGLA+       + I  T  + TR 
Sbjct: 114 RALKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 309 YFAPEYIAT--GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
           Y APE   +     T   D++S G +  E+L+G                KP    K  +H
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG----------------KPLFPGKNVVH 215

Query: 367 Q--IIDEKLGR-------NIQMEEAQEF-----------------------AEIILRCLN 394
           Q  +I + LG         ++ E+A+ +                         ++ R L 
Sbjct: 216 QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLA 275

Query: 395 SDPKNRPTMSEVVA 408
            DPK+RPT  E +A
Sbjct: 276 FDPKDRPTAEEALA 289

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 29/217 (13%)

Query: 140 QGGFGDVYIGYINSCAMTA------ARRKNADFAVAVKRLRRK-------GSQGQDEWEN 186
            G FG ++I     CA+ A      ARR          +  R        GS+   + EN
Sbjct: 158 AGAFGKIFI-----CALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLEN 212

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLV---YEYVTRGSLEDHLLNEDDTELNWE-RRI 242
           E+  L RLNH N++K+      + +  ++   Y++     + D   +  D  L  + R I
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272

Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL-GDKSHIST 301
              L  A  +E++H   + +IHRD+K  N+ L+ D    + DFG A   P   ++     
Sbjct: 273 MKQLLCA--VEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAM--PFEKEREAFDY 326

Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS 338
             +GT    +PE +A       TD++S G++LL++LS
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 25/205 (12%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G +GDVY           AR  +     AVK ++ +        + E+  +    H 
Sbjct: 17  VGSGTYGDVY----------KARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC 66

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLED-HLLNEDDTELNWERRIKIALGAARGLEHLH 256
           N+V   G     +   +  EY   GSL+D + +    +EL      +  L   +GL +LH
Sbjct: 67  NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---QGLAYLH 123

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR--VLGTRGYFAPEY 314
           +  +  +HRD+K +N+LL D+ + K++DFG+A        + I+ R   +GT  + APE 
Sbjct: 124 S--KGKMHRDIKGANILLTDNGDVKLADFGVAA----KITATIAKRKSFIGTPYWMAPEV 177

Query: 315 IA---TGHLTLKTDVYSFGVVLLEI 336
            A    G      D+++ G+  +E+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 49/176 (27%), Positives = 71/176 (40%), Gaps = 36/176 (20%)

Query: 177 GSQGQDEWENELRFLSRLNHPNVVKLMG--------------YCCDDQHRLLVYEYVTRG 222
            + G+     E+  L  ++H  ++ L+               Y CD      ++ YV R 
Sbjct: 127 VTGGKTP-GREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD------LFTYVDRS 179

Query: 223 SLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI 282
                        L  E+ I I       L +LH   R +IHRDVK  N+ LD+  NA +
Sbjct: 180 G-----------PLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVL 226

Query: 283 SDFGLA-KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEIL 337
            DFG A K     D         GT    +PE +A      KTD++S G+VL E+ 
Sbjct: 227 GDFGAACKLDAHPDTPQCYGWS-GTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 55/183 (30%), Positives = 85/183 (46%), Gaps = 22/183 (12%)

Query: 168 VAVKRLRRKGSQGQDEWEN---ELRFLSRLNHPNVVKLMGYCCDD------QHRLLVYEY 218
           VA+K+L R   Q     +    EL  +  +NH N++ L+            Q   LV E 
Sbjct: 44  VAIKKLSRP-FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME- 101

Query: 219 VTRGSLEDHLLNE-DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD 277
                L D  L +    +L+ ER   +      G++HLH+    +IHRD+K SN+++  D
Sbjct: 102 -----LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSD 154

Query: 278 FNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEIL 337
              KI DFGLA+    G    ++  V+ TR Y APE I         D++S G ++ E++
Sbjct: 155 CTLKILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211

Query: 338 SGK 340
            G 
Sbjct: 212 RGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 24/209 (11%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR----FLS 192
           +IG+G FG V +          AR K  +   AVK L++K    + E ++ +      L 
Sbjct: 2   VIGKGSFGKVLL----------ARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLK 51

Query: 193 RLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKI-ALGAAR 250
            + HP +V L  +      +L  V +Y+  G L  HL  E       E R +  A   A 
Sbjct: 52  NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIAS 107

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            L +LH+    +++RD+K  N+LLD   +  ++DFGL K     + +  ++   GT  Y 
Sbjct: 108 ALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENI--EHNGTTSTFCGTPEYL 163

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSG 339
           APE +         D +  G VL E+L G
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 20/206 (9%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSRLNH 196
           +G+G +  V+ G          R K  +  VA+K +R +  +G       E+  L  L H
Sbjct: 13  LGEGTYATVFKG----------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH 62

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAARGLEHL 255
            N+V L      ++   LV+EY+    L+ +L N  +  L     +KI +    RGL + 
Sbjct: 63  ANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYC 119

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE-Y 314
           H   R ++HRD+K  N+L+++    K++DFGLA+   +  K++ +  V  T  Y  P+  
Sbjct: 120 HK--RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 175

Query: 315 IATGHLTLKTDVYSFGVVLLEILSGK 340
           + +   +   D++  G +L E+ +G+
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 30/212 (14%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V   Y      T  R+K     VAVK+L R  +          ELR L  + 
Sbjct: 23  VGSGAYGSVCSAY-----DTRLRQK-----VAVKKLSRPFQSLIHARRTYRELRLLKHMK 72

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+    D        E      L  +L+  D   +   +++       +     
Sbjct: 73  HENVIGLL----DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SNV +++D   +I DFGLA+           T  + TR Y
Sbjct: 129 RGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWY 181

Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGK 340
            APE +    H     D++S G ++ E+L GK
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 55/223 (24%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-------ELRF 190
           IG+G +G V+           A+ +     VA+KR+R       D+ E        E+  
Sbjct: 8   IGEGTYGTVF----------KAKNRETHEIVALKRVRL-----DDDDEGVPSSALREICL 52

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYV----------TRGSLEDHLLNEDDTELNWER 240
           L  L H N+V+L      D+   LV+EY             G ++  ++     +L    
Sbjct: 53  LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL---- 108

Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSH 298
                    +GL   H+    V+HRD+K  N+L++ +   K++DFGLA+ FG P+   S 
Sbjct: 109 --------LKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158

Query: 299 ISTRVLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSG 339
               V+ T  Y  P+ +  A  + T   D++S G +  E+ + 
Sbjct: 159 ---EVV-TLWYRPPDVLFGAKLYST-SIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 45/186 (24%), Positives = 84/186 (45%), Gaps = 13/186 (6%)

Query: 168 VAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH 227
           V +K  +R G+        E   L  +NHP++++L G    ++   L+   + R   + +
Sbjct: 120 VVIKAGQRGGTA------TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLY 170

Query: 228 LLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
                   +     + I     R +++LH     +IHRD+KA N+ ++   +  + DFG 
Sbjct: 171 CYLAAKRNIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFGA 228

Query: 288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRT 347
           A F P+   ++      GT    APE +A        D++S G+VL E+ +   +   + 
Sbjct: 229 ACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK- 286

Query: 348 NGLAGN 353
           +GL G+
Sbjct: 287 DGLDGD 292

Length = 391

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 59/246 (23%), Positives = 93/246 (37%), Gaps = 64/246 (26%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-----EWENELRFL 191
           L+G+G  G V++           R K      A+K L +K    ++       E E+  L
Sbjct: 8   LLGKGDVGRVFL----------VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--L 55

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR- 250
           + L+HP +  L      + +  LV +Y   G L   LL          + +      AR 
Sbjct: 56  ATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQP-----GKCLSEE--VARF 107

Query: 251 -------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-------------- 289
                   LE+LH     +++RD+K  N+LL +  +  +SDF L+K              
Sbjct: 108 YAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165

Query: 290 FGPLGDKSHISTRVL-------------GTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLE 335
            G      +                   GT  Y APE I+  GH     D ++ G++L E
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYE 224

Query: 336 ILSGKT 341
           +L G T
Sbjct: 225 MLYGTT 230

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 71/284 (25%), Positives = 120/284 (42%), Gaps = 46/284 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFA------VAVKRLRRKGSQGQDEWENELRFL 191
           +GQG F  ++ G          RR+  D+       V +K L +      + +      +
Sbjct: 3   LGQGTFTKIFKG---------IRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMM 53

Query: 192 SRLNHPNVVKLMGYC-CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           S+L+H ++V   G C C D+  ++V EYV  GSL D  L ++   +N   ++++A   A 
Sbjct: 54  SQLSHKHLVLNYGVCVCGDES-IMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAW 111

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR--- 307
            L  L    + + H +V A NVLL  + + K  +    K    G    IS  VL      
Sbjct: 112 ALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG----ISITVLPKEILL 165

Query: 308 ---GYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL 363
               +  PE I    +L+L  D +SFG  L EI SG    +   +             KL
Sbjct: 166 ERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS----------QKKL 215

Query: 364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
              Q  +++    +   +  E A +I +C++ +P  RP+   ++
Sbjct: 216 ---QFYEDRH--QLPAPKWTELANLINQCMDYEPDFRPSFRAII 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 41/222 (18%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENELRFLSRL- 194
           +GQG +G V       C+   A     +  VA+K++    S+         EL+ L    
Sbjct: 8   LGQGAYGIV-------CSARNAETSEEE-TVAIKKITNVFSKKILAKRALRELKLLRHFR 59

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK--IALGAA--- 249
            H N+  L              + V  G+  +  L E+  E +  + I+    L  A   
Sbjct: 60  GHKNITCLYDM-----------DIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQ 108

Query: 250 -------RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK---FGPLGDKSHI 299
                   GL+++H+    V+HRD+K  N+L++ D   KI DFGLA+     P  +   +
Sbjct: 109 SFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166

Query: 300 STRVLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILSGK 340
            T  + TR Y APE  ++    T   DV+S G +L E+L  K
Sbjct: 167 -TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 68/301 (22%), Positives = 113/301 (37%), Gaps = 46/301 (15%)

Query: 145 DVYIGYINSCAMTA--ARRKNADFAVAVKR--LRRKGSQGQDEWENELRFLSRLNHPNVV 200
              IG      M    A+ K  +  VAVK+  L     +     + E+    +L HPN++
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62

Query: 201 KLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAARGLEHLHTYW 259
             +     D    +V   +  GS ED LL     E   E  I   L      L+++H+  
Sbjct: 63  PYVTSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIHS-- 119

Query: 260 RPVIHRDVKASNVLLDDDFNAKISDFGLA--------KFGPLGDKSHISTRVLGTRGYFA 311
           +  IHR VKAS++LL  D    +S    +        +   + D    S + L    + +
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLS 176

Query: 312 PEYIATGHL--TLKTDVYSFGVVLLEILSGKT--AAMRRT----NGLAGNWAKP-----Y 358
           PE +         K+D+YS G+   E+ +G      M  T      + G          Y
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236

Query: 359 LSNKLALHQIIDEKLGRNIQM-----------EEAQEFAEIILRCLNSDPKNRPTMSEVV 407
              + ++ Q        N +            E   +F E+   CL  DP++RP+ S+++
Sbjct: 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVEL---CLQRDPESRPSASQLL 293

Query: 408 A 408
            
Sbjct: 294 N 294

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 36/223 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE-NELRFLSRLNH 196
           +G+G +  VY G          R +     VA+K +     +G       E+  +  L H
Sbjct: 8   LGEGTYATVYKG----------RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH 57

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-------ELNWERRIKIALGAA 249
            N+V+L      +   +LV+EY     ++  L    DT       + N  +     L   
Sbjct: 58  ENIVRLHDVIHTENKLMLVFEY-----MDKDLKKYMDTHGVRGALDPNTVKSFTYQL--L 110

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTRVLGTR 307
           +G+   H     V+HRD+K  N+L++     K++DFGLA+ FG P+   +  S  V+ T 
Sbjct: 111 KGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVV-TL 164

Query: 308 GYFAPEYIATGHLTLKT--DVYSFGVVLLEILSGKTAAMRRTN 348
            Y AP+ +  G  T  T  D++S G ++ E+++G+       N
Sbjct: 165 WYRAPD-VLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 28/212 (13%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE-NELRFLSRLNH 196
           +G+G +  VY G          + K     VA+K +R +  +G       E   L  L H
Sbjct: 13  LGEGSYATVYKG----------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH 62

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRG---SLEDHL--LNEDDTELNWERRIKIALGAARG 251
            N+V L       +   LV+EYV       ++ H   L+ ++ +L             RG
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-------FLFQLLRG 115

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
           L ++H   R ++HRD+K  N+L+ D    K++DFGLA+   +   SH  +  + T  Y  
Sbjct: 116 LSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVTLWYRP 171

Query: 312 PE-YIATGHLTLKTDVYSFGVVLLEILSGKTA 342
           P+  + +   +   D++  G + +E++ G  A
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 36/225 (16%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE---WENEL 188
           F    +IG+G FG+V +           + KNAD   A+K L +     + E   +  E 
Sbjct: 3   FEILKVIGRGAFGEVAV----------VKLKNADKVFAMKILNKWEMLKRAETACFREER 52

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-------EDHLLNEDDTELNWERR 241
             L   ++  +  L     D+ +  LV +Y   G L       ED L   +D    +   
Sbjct: 53  DVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL--PEDMARFYLAE 110

Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           + IA+ +   L +        +HRD+K  N+L+D + + +++DFG +    + D +  S+
Sbjct: 111 MVIAIDSVHQLHY--------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSS 161

Query: 302 RVLGTRGYFAPEYI-----ATGHLTLKTDVYSFGVVLLEILSGKT 341
             +GT  Y +PE +       G    + D +S GV + E+L G+T
Sbjct: 162 VAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 52.5 bits (126), Expect = 9e-08
 Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 19/150 (12%)

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNE----DDTELNWERRIKIALGAARGL 252
           PN+V L  Y   +    LV ++   G L  H+       ++    W   + +AL A    
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG-LAKFGPLGDKSHISTRVLGTRGYFA 311
             LH     ++ RD+  +N+LLDD  + +++ F   ++     D   +         Y A
Sbjct: 101 --LHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE------NMYCA 150

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           PE       T   D +S G +L E+L+GKT
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKT 180

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.4 bits (124), Expect = 2e-07
 Identities = 45/148 (30%), Positives = 69/148 (46%), Gaps = 13/148 (8%)

Query: 195 NHPNVVKLMGYCCD-DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           ++PN +KL  Y     +  +L+ +Y+  G L D L  E        ++I   L     L 
Sbjct: 67  DNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQL--VEALN 123

Query: 254 HLHTYWRPVIHRDVKASNVLLDD-DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            LH +   +IH D+K  NVL D       + D+GL K   +G  S       GT  YF+P
Sbjct: 124 DLHKH--NIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSCYD----GTLDYFSP 175

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGK 340
           E I   +  +  D ++ GV+  E+L+GK
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 12/159 (7%)

Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERR---- 241
           +EL  L+  +H  +VK       D   LL+ EY + G L   +       L ++      
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 242 --IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
              +I L     L+ +H+  R ++HRD+K++N+ L      K+ DFG +K         +
Sbjct: 174 LFYQIVLA----LDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227

Query: 300 STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS 338
           ++   GT  Y APE       + K D++S GV+L E+L+
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.1 bits (119), Expect = 1e-06
 Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 36/222 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNA--DFAVAVKRLRRKGSQGQDEWENELRFLSRLN 195
           +G+G +G VY           A+RK+   D   A+K++  +G+        E+  L  L 
Sbjct: 9   VGRGTYGHVY----------KAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELK 56

Query: 196 HPNVVKLMGYCCD--DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR--- 250
           HPNV+ L        D+   L+++Y        H++         ++ +++  G  +   
Sbjct: 57  HPNVISLQKVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLL 114

Query: 251 -----GLEHLHTYWRPVIHRDVKASNVLL----DDDFNAKISDFGLAKF--GPLGDKSHI 299
                G+ +LH  W  V+HRD+K +N+L+     +    KI+D G A+    PL   + +
Sbjct: 115 YQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172

Query: 300 STRVLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILSGK 340
              V+ T  Y APE  +   H T   D+++ G +  E+L+ +
Sbjct: 173 DPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 64/248 (25%), Positives = 99/248 (39%), Gaps = 60/248 (24%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSRL 194
           IG G FG+V             R+ + +   A+K LR+     +++  +   E   L+  
Sbjct: 9   IGIGAFGEV----------CLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA 58

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           ++  VVKL     D  +   V +Y+  G +   L+     E +  R     L  A  +E 
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCA--IES 116

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL---------AKFGPLGDKSHIS----- 300
           +H      IHRD+K  N+L+D D + K++DFGL         +K+   GD          
Sbjct: 117 VHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174

Query: 301 ----------------------TRVL-----GTRGYFAPEYIA-TGHLTLKTDVYSFGVV 332
                                  R L     GT  Y APE +  TG+  L  D +S GV+
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVI 233

Query: 333 LLEILSGK 340
           L E+L G+
Sbjct: 234 LYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 61/245 (24%), Positives = 102/245 (41%), Gaps = 52/245 (21%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F    +IG+G FG+V +           ++K+     A+K LR+     +++  +   E 
Sbjct: 3   FESLKVIGRGAFGEVRL----------VQKKDTGHIYAMKILRKADMLEKEQVAHIRAER 52

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             L   +   VVK+     D ++  L+ E++  G +   LL + DT      +  IA   
Sbjct: 53  DILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMT-LLMKKDTLSEEATQFYIA-ET 110

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA---------------KFGPL 293
              ++ +H      IHRD+K  N+LLD   + K+SDFGL                   P 
Sbjct: 111 VLAIDAIHQL--GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168

Query: 294 GD------------------KSHISTRVLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLL 334
            D                  +  ++   +GT  Y APE ++ TG+  L  D +S GV++ 
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMY 227

Query: 335 EILSG 339
           E+L G
Sbjct: 228 EMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           + +++H ++V L G C  D   ++V E+V  G L D  ++     L    + K+A   A 
Sbjct: 58  MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQLAS 116

Query: 251 GLEHLHTYWRPVIHRDVKASNVLL-----DDDFNA--KISDFGLAKFGPLG--DKSHIST 301
            L +L    + ++H +V   N+LL     D +     K+SD G+    P+    +     
Sbjct: 117 ALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PITVLSRQECVE 170

Query: 302 RVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS 360
           R+     + APE +  + +L++  D +SFG  L EI                N   P   
Sbjct: 171 RI----PWIAPECVEDSKNLSIAADKWSFGTTLWEICY--------------NGEIPLKD 212

Query: 361 NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
             LA  +   E     +     +E A+++  C+N DP  RP
Sbjct: 213 KTLAEKERFYEGQCMLVT-PSCKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 65/246 (26%), Positives = 100/246 (40%), Gaps = 54/246 (21%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    +IG+G FG+V +           ++K+     A+K LR K    + E    +R  
Sbjct: 3   FESLKVIGRGAFGEVRL----------VQKKDTGHVYAMKILR-KADMLEKEQVGHIRAE 51

Query: 190 --FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
              L   +   VVK+     D  +  L+ E++  G +   LL + DT    E +  IA  
Sbjct: 52  RDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMT-LLMKKDTLTEEETQFYIA-E 109

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA------------------- 288
               ++ +H      IHRD+K  N+LLD   + K+SDFGL                    
Sbjct: 110 TVLAIDSIHQL--GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167

Query: 289 ----KFGPLGDKSHIST----------RVLGTRGYFAPE-YIATGHLTLKTDVYSFGVVL 333
                F  +  K    T            +GT  Y APE ++ TG+  L  D +S GV++
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIM 226

Query: 334 LEILSG 339
            E+L G
Sbjct: 227 YEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 6/92 (6%)

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTRVLGTRG 308
           +G+ H H     V+HRD+K  N+L+D      KI+D GL +   +  KS+  T  + T  
Sbjct: 121 KGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLW 176

Query: 309 YFAPE-YIATGHLTLKTDVYSFGVVLLEILSG 339
           Y APE  + + H +   D++S G +  E+   
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 26/220 (11%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE---WENEL 188
           F    +IG+G FG+V +           + K+ +   A+K L +     + E   +  E 
Sbjct: 3   FEIIKVIGRGAFGEVAV----------VKMKHTERIYAMKILNKWEMLKRAETACFREER 52

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA--L 246
             L   +   +  L     D+ +  LV +Y   G L   L   +D       R  IA  +
Sbjct: 53  NVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMV 112

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
            A   +  LH      +HRD+K  NVLLD + + +++DFG +      D +  S+  +GT
Sbjct: 113 LAIHSIHQLH-----YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGT 166

Query: 307 RGYFAPEYI-----ATGHLTLKTDVYSFGVVLLEILSGKT 341
             Y +PE +       G    + D +S GV + E+L G+T
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 38/228 (16%)

Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWE 185
           +  + +   N+IG G FG VY      C  T+ +       VA+K++       QD +++
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAI---CIDTSEK-------VAIKKVL------QDPQYK 106

Query: 186 N-ELRFLSRLNHPNVVKLMGYCCDDQHRL--------LVYEYVTR---GSLEDHLLNEDD 233
           N EL  +  LNH N++ L  Y   +  +         +V E++ +     ++ +  N   
Sbjct: 107 NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHA 166

Query: 234 TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGP 292
             L   +     L   R L ++H+ +  + HRD+K  N+L+D + +  K+ DFG AK   
Sbjct: 167 LPLFLVKLYSYQL--CRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAK-NL 221

Query: 293 LGDKSHISTRVLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILSG 339
           L  +  +S   + +R Y APE  +   + T   D++S G ++ E++ G
Sbjct: 222 LAGQRSVS--YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 6e-06
 Identities = 29/84 (34%), Positives = 46/84 (54%), Gaps = 6/84 (7%)

Query: 263 IHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI-----AT 317
           +HRD+K  NVLLD + + +++DFG +    L D +  S   +GT  Y +PE +       
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182

Query: 318 GHLTLKTDVYSFGVVLLEILSGKT 341
           G    + D +S GV + E+L G+T
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 34/230 (14%)

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            +S+++H ++  + G C      ++V E+V  G L D  L ++   +    +I +A   A
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAWKITVAQQLA 127

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-------KISDFGLAKFGPLGDKSHISTR 302
             L +L    + ++H +V A N+LL     A       K+SD G++ F  L  +  +  R
Sbjct: 128 SALSYLED--KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERVE-R 183

Query: 303 VLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEI-LSGKTAAMRRTNGLAGNWAKPYLS 360
           +     + APE +  G  L+   D +SFG  LLEI   G+     RT            S
Sbjct: 184 I----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-----------S 228

Query: 361 NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL 410
            K   ++   +K    +     +E A +I +CL  +P  RP+   ++  L
Sbjct: 229 EKERFYE---KKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 47.0 bits (111), Expect = 9e-06
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 36/222 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNA--DFAVAVKRLRRKGSQGQDEWENELRFLSRLN 195
           +G+G +G VY           A+RK+   +   A+K++  +G+        E+  L  L 
Sbjct: 9   VGRGTYGHVY----------KAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELK 56

Query: 196 HPNVVKLMGYCCD--DQHRLLVYEYVTRGSLEDHLL--------NEDDTELNWERRIKIA 245
           HPNV+ L        D+   L+++Y        H++        N+   +L       + 
Sbjct: 57  HPNVIALQKVFLSHSDRKVWLLFDYAEHDLW--HIIKFHRASKANKKPMQLPRSMVKSLL 114

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLL----DDDFNAKISDFGLAKF--GPLGDKSHI 299
                G+ +LH  W  V+HRD+K +N+L+     +    KI+D G A+    PL   + +
Sbjct: 115 YQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172

Query: 300 STRVLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILSGK 340
              V+ T  Y APE  +   H T   D+++ G +  E+L+ +
Sbjct: 173 DPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 47.6 bits (113), Expect = 9e-06
 Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 20/158 (12%)

Query: 186 NELRFLSRLNHPNVVKLM------GYCC--DDQHRLLVYEYVTRGSLEDHLLNEDDTELN 237
           +E R L RL+HP V+ L+      G  C    ++R  +Y Y+                L 
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARL----------RPLG 258

Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
             +   +A      ++++H     +IHRD+K  NVL++   +  + DFG A F      +
Sbjct: 259 LAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316

Query: 298 HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLE 335
                + GT    APE +A    T   D++S G+V+ E
Sbjct: 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 27/165 (16%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F    +IG+G FG+V +           ++K+     A+K L +     +D+  +   E 
Sbjct: 3   FHTVKVIGKGAFGEVRL----------VQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAER 52

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIK 243
             L+  + P VV L     D Q+  L+ E++  G L   L+      ED T      R  
Sbjct: 53  DVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT------RFY 106

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA 288
           +A      +E +H      IHRD+K  N+L+D   + K+SDFGL+
Sbjct: 107 MA-ECVLAIEAVHKL--GFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 25/159 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR-----KGSQGQDEWENELRFLS 192
           I +G FG VY+G          R+KN     AVK +++     K    Q + E +   LS
Sbjct: 12  ISRGAFGKVYLG----------RKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED--HLLNEDDTELNWERRIKIALGAAR 250
           +   P +V L        +  LV EY+  G ++   H+    D E+     +K     A 
Sbjct: 62  K--SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA----VKYISEVAL 115

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK 289
            L++LH +   +IHRD+K  N+L+ ++ + K++DFGL+K
Sbjct: 116 ALDYLHRH--GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 27/159 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSRLNH 196
           +G+G +  VY G          R K     VA+K +R +  +G       E   L  L H
Sbjct: 13  LGEGSYATVYKG----------RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH 62

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRG---SLEDH--LLNEDDTELNWERRIKIAL-GAAR 250
            N+V L       +   LV+EY+       ++D    L+  +        +++ L    R
Sbjct: 63  ANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHN--------VRLFLFQLLR 114

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK 289
           GL + H   R V+HRD+K  N+L+ +    K++DFGLA+
Sbjct: 115 GLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 44/201 (21%), Positives = 61/201 (30%), Gaps = 47/201 (23%)

Query: 222 GSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK 281
            SL D +L      LN E    + L     L  LH        R  K+ N+LL  D   K
Sbjct: 1   VSLAD-ILEVRGRPLNEEEIWAVCLQCLGALRELH--------RQAKSGNILLTWDGLLK 51

Query: 282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           +      K                     APE I     T K D+YS G+ L E      
Sbjct: 52  LDGSVAFKTPE----QSRPDPYFM-----APEVIQGQSYTEKADIYSLGITLYE------ 96

Query: 342 AAMRRTNGLAGNWAKPY-----LSNKL-------ALHQIIDEKLGRNIQMEEAQEFAEII 389
                    A ++  PY     LS  L             D      +    A+ F + +
Sbjct: 97  ---------ALDYELPYNEERELSAILEILLNGMPADDPRDRSNLEGV--SAARSFEDFM 145

Query: 390 LRCLNSDPKNRPTMSEVVAAL 410
             C +  P+ R   +  +A  
Sbjct: 146 RLCASRLPQRREAANHYLAHC 166

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.2 bits (102), Expect = 4e-05
 Identities = 34/125 (27%), Positives = 50/125 (40%), Gaps = 15/125 (12%)

Query: 173 LRRKGSQGQDE-WENE---LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL 228
           L+   S+ +    E E   L+ L+R   P V K++     D    L+ E++     E   
Sbjct: 26  LKINPSREKGADREREVAILQLLARKGLP-VPKVLASGESDGWSYLLMEWI-----EGET 79

Query: 229 LNEDDTELNWERRIKIALGAARGLEHLHTYWRPV-IHRDVKASNVLLDDDFNAKISDFGL 287
           L+E   E      I   L     L  LH     V  H D+   N+L+DD     I D+  
Sbjct: 80  LDEVSEEEK--EDIAEQLAEL--LAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY 135

Query: 288 AKFGP 292
           A +GP
Sbjct: 136 AGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 62/264 (23%), Positives = 106/264 (40%), Gaps = 62/264 (23%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F +   +G G FG+V +          AR+ +     A+K LR+K    +++  +   E 
Sbjct: 3   FVKIKTLGIGAFGEVCL----------ARKVDTKALYAMKTLRKKDVLLRNQVAHVKAER 52

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             L+  ++  VV+L     D  +   V +Y+  G +   L+       +  R     L  
Sbjct: 53  DILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTC 112

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL---------AKFGPLGD---- 295
           A  +E +H      IHRD+K  N+L+D D + K++DFGL         +K+   GD    
Sbjct: 113 A--VESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQ 168

Query: 296 -----------------------------KSH---ISTRVLGTRGYFAPEYIATGHLTLK 323
                                        + H   ++  ++GT  Y APE +     T  
Sbjct: 169 DSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228

Query: 324 TDVYSFGVVLLEILSGKTAAMRRT 347
            D +S GV+L E+L G+   + +T
Sbjct: 229 CDWWSVGVILYEMLVGQPPFLAQT 252

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 53/210 (25%)

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL---GDKSHI- 299
           I  GA RGL +LH      IHR++KAS++L+  D    +S  GL+    L   G K+ + 
Sbjct: 106 ILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVV 161

Query: 300 ------STRVLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGKTA--AMRRT- 347
                 ST VL    + +PE +     G+  +K+D+YS G+   E+ +G+     M RT 
Sbjct: 162 YDFPQFSTSVL---PWLSPELLRQDLYGY-NVKSDIYSVGITACELATGRVPFQDMLRTQ 217

Query: 348 ---NGLAGNWAKPYLSNKLA--------------------------LHQIIDEKLGRNIQ 378
                L G    P                                    +  E+L     
Sbjct: 218 MLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSS 277

Query: 379 MEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
              +  F  ++  CL  DP+ RP+ S +++
Sbjct: 278 KTFSPAFQNLVELCLQQDPEKRPSASSLLS 307

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 44.2 bits (104), Expect = 9e-05
 Identities = 60/258 (23%), Positives = 102/258 (39%), Gaps = 64/258 (24%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F +   +G G FG+V +          A + +     A+K LR+K    +++  +   E 
Sbjct: 3   FVKIKTLGIGAFGEVCL----------ACKVDTHALYAMKTLRKKDVLNRNQVAHVKAER 52

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             L+  ++  VVKL     D  +   V +Y+  G +   L+     E+  E   +  +  
Sbjct: 53  DILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR---MEVFPEVLARFYIAE 109

Query: 249 -ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL---------AKFGPLGD--- 295
               +E +H      IHRD+K  N+L+D D + K++DFGL         +K+   G    
Sbjct: 110 LTLAIESVHKM--GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIR 167

Query: 296 ------------------------------KSH---ISTRVLGTRGYFAPEYIATGHLTL 322
                                         K H   ++  ++GT  Y APE +     T 
Sbjct: 168 QDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227

Query: 323 KTDVYSFGVVLLEILSGK 340
             D +S GV+L E+L G+
Sbjct: 228 LCDWWSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 29/95 (30%), Positives = 54/95 (56%), Gaps = 7/95 (7%)

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL ++H   + ++HRD+K  N+L+      K++DFGLA+   +  +++ S  V  T  Y
Sbjct: 114 RGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWY 169

Query: 310 FAPEYI--ATGHLTLKTDVYSFGVVLLEILSGKTA 342
             P+ +  AT + +   D++  G + +E+L G+ A
Sbjct: 170 RPPDVLLGATDYSS-ALDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 44.0 bits (103), Expect = 1e-04
 Identities = 72/302 (23%), Positives = 123/302 (40%), Gaps = 71/302 (23%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG+V+        +   +R    F       R    + + +   E+  +  L H 
Sbjct: 21  IGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72

Query: 198 NVVK---------------LMGYC-CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERR 241
           N+V+               LM +C   D  R +   Y   G +E+H +      ++  R+
Sbjct: 73  NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI------VDITRQ 126

Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-------------DDFN----AKISD 284
           +  AL     L+      R V+HRD+K  N+ L              ++ N    AKI D
Sbjct: 127 LLHALAYCHNLKDGPNGER-VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGKTA 342
           FGL+K   +   +H     +GT  Y++PE +   T     K+D+++ G ++ E+ SGKT 
Sbjct: 186 FGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Query: 343 AMRRTNGLAGNWAKPYLSNKLALHQIIDE-KLGRNIQME-EAQEFAEIILRCLNSDPKNR 400
             +  N                  Q+I E K G ++ ++ +++E   +I   LN   K R
Sbjct: 243 FHKANN----------------FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKER 286

Query: 401 PT 402
           P+
Sbjct: 287 PS 288

Length = 1021

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 37/104 (35%), Positives = 50/104 (48%), Gaps = 11/104 (10%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSRL 194
           +G G FG V    + + A    +  N    VAVK L  K S   DE E   +EL+ LS L
Sbjct: 46  LGAGAFGKV----VEATAFGLGKEDNV-LRVAVKML--KASAHTDEREALMSELKILSHL 98

Query: 195 -NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELN 237
             H N+V L+G C      L++ EY   G L + L  + +T LN
Sbjct: 99  GQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLN 142

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 50/238 (21%), Positives = 100/238 (42%), Gaps = 41/238 (17%)

Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW 184
           ++ +T++F   +L+G+G FG V         + A  RK  ++  AVK +R      +D  
Sbjct: 124 IDVSTQRFKILSLLGEGTFGKV---------VEAWDRKRKEYC-AVKIVRNVPKYTRDA- 172

Query: 185 ENELRFLSRLNHPNV------VKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW 238
           + E++F+ ++   +       +K+  Y  ++   + +        L D ++       + 
Sbjct: 173 KIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHG--PFSH 230

Query: 239 ERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD----------------DDFNAKI 282
               +I       L++ HT    ++H D+K  N+L++                D    +I
Sbjct: 231 RHLAQIIFQTGVALDYFHTELH-LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRI 289

Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            D G        D+ H  T ++ TR Y +PE +        TD++S G ++ E+ +GK
Sbjct: 290 CDLG-----GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 42/184 (22%), Positives = 72/184 (39%), Gaps = 21/184 (11%)

Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
           + EL      NHPN+V        D    +V  ++  GS +D +       ++      I
Sbjct: 47  QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYI 106

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI----SDFGLAKFGP----LGDK 296
             G  + L+++H      +HR VKAS++L+  D    +    S+  +   G     + D 
Sbjct: 107 LQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDF 164

Query: 297 SHISTRVLGTRGYFAPEYIATG--HLTLKTDVYSFGVVLLEILSGKT------AAMRRTN 348
              S +VL    + +PE +         K+D+YS G+   E+ +G        A      
Sbjct: 165 PKYSVKVL---PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 221

Query: 349 GLAG 352
            L G
Sbjct: 222 KLNG 225

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	451
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
PRK10345	210	hypothetical protein; Provisional	99.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.83
smart00090	237	RIO RIO-like kinase.	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.57
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.45
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.44
KOG1243	690	consensus Protein kinase [General function predict	99.44
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.41
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.41
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.38
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.32
COG4248	637	Uncharacterized protein with protein kinase and he	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.24
KOG3087	229	consensus Serine/threonine protein kinase [General	99.2
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.12
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.07
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.9
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.84
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.83
PRK09902	216	hypothetical protein; Provisional	98.78
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.6
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.59
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.59
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.46
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.43
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.38
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.27
PF01636	239	APH: Phosphotransferase enzyme family This family	98.24
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.17
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.16
PLN02876	822	acyl-CoA dehydrogenase	98.16
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.14
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.97
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.96
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.93
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.93
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.85
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.8
PRK10593	297	hypothetical protein; Provisional	97.77
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.74
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.71
PRK05231	319	homoserine kinase; Provisional	97.7
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.61
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.59
PLN02236	344	choline kinase	97.34
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.29
KOG2270	520	consensus Serine/threonine protein kinase involved	97.03
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.0
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.99
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.96
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.89
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.82
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.8
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.58
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.58
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.49
COG2334	331	Putative homoserine kinase type II (protein kinase	96.36
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.15
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.06
PLN02756	418	S-methyl-5-thioribose kinase	96.03
PRK06148	1013	hypothetical protein; Provisional	95.91
PRK12396	409	5-methylribose kinase; Reviewed	95.8
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.79
PRK11768	325	serine/threonine protein kinase; Provisional	95.47
PTZ00384	383	choline kinase; Provisional	95.38
PTZ00296	442	choline kinase; Provisional	94.67

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-52  Score=397.74  Aligned_cols=259  Identities=29%  Similarity=0.435  Sum_probs=213.8

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC-------HHHHHHHHHHHHhcCCCc
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-------QDEWENELRFLSRLNHPN  198 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~il~~l~h~n  198 (451)
                      +...+.|.+.+.||+|+||.|-+|.          ++.+++.||||++.+.....       ...+.+|++||+.|+|||
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~----------e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~  237 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAY----------EKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPN  237 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEE----------EcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCC
Confidence            4456789999999999999999965          55678889999998653222       234679999999999999


Q ss_pred             eeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC-
Q 013028          199 VVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD-  277 (451)
Q Consensus       199 Iv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~-  277 (451)
                      ||+++++|+..+..||||||++||+|.+++..  .+.+.+.....+++|++.||.|||+  +||+||||||+|||++.+ 
T Consensus       238 IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~  313 (475)
T KOG0615|consen  238 IVRIKDFFEVPDSSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDA  313 (475)
T ss_pred             EEEEeeeeecCCceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHH--cCcccccCCcceEEeccCC
Confidence            99999999999999999999999999999965  4667788888999999999999999  999999999999999765 


Q ss_pred             --CcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCC---CcchhhHHHHHHHHHHHhCCCccccccCCCCC
Q 013028          278 --FNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL---TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG  352 (451)
Q Consensus       278 --~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  352 (451)
                        ..+||+|||+|++.   .....+.+.|||+.|.|||++.++.+   ..++|+|||||+||.+|+|.+||.....+.. 
T Consensus       314 e~~llKItDFGlAK~~---g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-  389 (475)
T KOG0615|consen  314 EDCLLKITDFGLAKVS---GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-  389 (475)
T ss_pred             cceEEEecccchhhcc---ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-
Confidence              78999999999973   35667788999999999999976543   3478999999999999999999986554310 


Q ss_pred             CccccccchhhhhhHHhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          353 NWAKPYLSNKLALHQIIDEKLG--RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                                 ...++....+.  .......+++..+||.+||..||++|||++|+|++=.--
T Consensus       390 -----------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  390 -----------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             -----------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence                       11122222221  123445689999999999999999999999999875543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-51  Score=407.26  Aligned_cols=248  Identities=27%  Similarity=0.463  Sum_probs=216.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .+|..++.||+|+|+.||.++          +..++..||+|++.+.   .....+.+.+||+|.+.|+|||||+++++|
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~----------~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F   87 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEAR----------DLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF   87 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEE----------EcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence            479999999999999999955          5566888999999864   334456789999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      +|.+++|||+|+|..++|..++.  ..+.++|.++..+++||+.||.|||+  .+|||||||..|+||+++.++||+|||
T Consensus        88 EDs~nVYivLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   88 EDSNNVYIVLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             ecCCceEEEEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheeecCcCcEEecccc
Confidence            99999999999999999999985  46889999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ||.....  ......+++||+.|+|||++.....+..+||||+||++|.||.|++||....                 +.
T Consensus       164 LAt~le~--~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----------------vk  224 (592)
T KOG0575|consen  164 LATQLEY--DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----------------VK  224 (592)
T ss_pred             eeeeecC--cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----------------HH
Confidence            9987542  2345667899999999999999999999999999999999999999997532                 22


Q ss_pred             HHhhhhh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          367 QIIDEKL--GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       367 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      +.+....  ...+|...+.++++||.+||..||.+|||+++||..=
T Consensus       225 ety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~  270 (592)
T KOG0575|consen  225 ETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP  270 (592)
T ss_pred             HHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence            3332222  2234557788999999999999999999999999753

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-51  Score=386.90  Aligned_cols=253  Identities=30%  Similarity=0.434  Sum_probs=212.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC-CCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ..+.++.||.|..|+||++          +++.+++.+|+|++... .....+++.+|++|++..+||+||.+||+|.+.
T Consensus        80 dle~~~~lG~G~gG~V~kv----------~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~  149 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKV----------RHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN  149 (364)
T ss_pred             HhhhhhhcccCCCcEEEEE----------EEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence            5566789999999999995          56667889999999533 344567889999999999999999999999998


Q ss_pred             Ce-eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          210 QH-RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       210 ~~-~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      .. ..|+||||+||+|.+.+..  .+.+++.....|+.++++||.|||+. .+||||||||+|||++..|.+||||||.+
T Consensus       150 ~~~isI~mEYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS  226 (364)
T KOG0581|consen  150 GEEISICMEYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVS  226 (364)
T ss_pred             CceEEeehhhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEecccccc
Confidence            85 9999999999999999854  47799999999999999999999964 79999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      .....    .....++||..|||||.+.+..|+.++||||||++++|+.+|+.|+....+        ++.....-+..+
T Consensus       227 ~~lvn----S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~--------~~~~~~~Ll~~I  294 (364)
T KOG0581|consen  227 GILVN----SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP--------PYLDIFELLCAI  294 (364)
T ss_pred             HHhhh----hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC--------CCCCHHHHHHHH
Confidence            85322    256788999999999999999999999999999999999999999876411        111111122233


Q ss_pred             hhhhhcCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          369 IDEKLGRNIQME-EAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       369 ~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ++. ..+..+.. .++++++||..||++||.+|||+.|++++
T Consensus       295 v~~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  295 VDE-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             hcC-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            332 23344554 88999999999999999999999999975

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-50  Score=383.65  Aligned_cols=249  Identities=28%  Similarity=0.423  Sum_probs=202.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC--CCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .+|.+.++||+|+||+||+|.+          +.++..||||.+.+.  .....+.+..|+.||+.++|||||+++++++
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h----------~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~   79 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRH----------KKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE   79 (429)
T ss_pred             ccceehhhccCcceEEEEEeEe----------ccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence            4899999999999999999764          445688999999876  4445677889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC------CcEE
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD------FNAK  281 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~------~~~k  281 (451)
                      +++++|||||||+||+|.+++..  .+.+++..+..++.||+.||.+||+  ++||||||||+||||+..      -.+|
T Consensus        80 ~~~~i~lVMEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~LK  155 (429)
T KOG0595|consen   80 DDDFIYLVMEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPVLK  155 (429)
T ss_pred             cCCeEEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCceEE
Confidence            99999999999999999999965  4689999999999999999999999  899999999999999764      4689


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      |+|||+|+...   ......+.+|++.|||||++..++|+.|+|+||+|+|||+|++|++||...+......        
T Consensus       156 IADFGfAR~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~--------  224 (429)
T KOG0595|consen  156 IADFGFARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL--------  224 (429)
T ss_pred             ecccchhhhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH--------
Confidence            99999999754   4455667899999999999999999999999999999999999999998765431100        


Q ss_pred             hhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013028          362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV  407 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  407 (451)
                          .--.+...-...+...+..+.+|+...+..++.+|.+..+-+
T Consensus       225 ----~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  225 ----YIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             ----HHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence                000011111122333344555677777777777776655543

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=393.72  Aligned_cols=288  Identities=55%  Similarity=0.899  Sum_probs=240.4

Q ss_pred             cccccchHHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC
Q 013028          116 KLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN  195 (451)
Q Consensus       116 ~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~  195 (451)
                      ....|.+.++..+++.|.....||+|+||.||+|.+.+           +..||||.+.........+|.+|+.+|.+++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~  129 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLR  129 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCC
Confidence            45678999999999999999999999999999998765           3579999887543331455999999999999


Q ss_pred             CCceeeccceeecCC-eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceeCCCCCCcee
Q 013028          196 HPNVVKLMGYCCDDQ-HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWR-PVIHRDVKASNVL  273 (451)
Q Consensus       196 h~nIv~~~~~~~~~~-~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~iiHrDlkp~NIl  273 (451)
                      |||+|+++|+|.+.+ ..+||||||.+|+|.++|.......++|..+++|+.++|+||+|||+.+. .|||||||++|||
T Consensus       130 H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNIL  209 (361)
T KOG1187|consen  130 HPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNIL  209 (361)
T ss_pred             CcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHee
Confidence            999999999999988 59999999999999999977543389999999999999999999999653 5999999999999


Q ss_pred             eCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCC---C
Q 013028          274 LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG---L  350 (451)
Q Consensus       274 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~---~  350 (451)
                      ||+++.+||+|||+|+..+.. .........||.+|+|||++..+..+.++|||||||+|+||++|+.+.+...+.   .
T Consensus       210 LD~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~  288 (361)
T KOG1187|consen  210 LDEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS  288 (361)
T ss_pred             ECCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc
Confidence            999999999999999865431 111111118999999999998899999999999999999999999888764422   1


Q ss_pred             CCCccccccchhhhhhHHhhhhhc-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          351 AGNWAKPYLSNKLALHQIIDEKLG-RNIQM-EEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      ...|+++...+. .+.+++|..+. ..... .....+..++.+|++.+|.+||+|.||++.|+.+...
T Consensus       289 l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  289 LVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            245665555443 77888888876 44453 5677799999999999999999999999999666544

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-51  Score=369.27  Aligned_cols=256  Identities=25%  Similarity=0.421  Sum_probs=209.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccc-ee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMG-YC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~-~~  206 (451)
                      ..|.++++||+|+||+||++          .+..++..||.|.+.-..  ....++...|+.+|++|+|||||++++ .|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv----------~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f   88 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKV----------QCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF   88 (375)
T ss_pred             HHHHHHHHHcCCcchheEEe----------eeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh
Confidence            47899999999999999994          466678889999987332  233456889999999999999999998 55


Q ss_pred             ecCCe-eEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--ceeCCCCCCceeeCCCCcEE
Q 013028          207 CDDQH-RLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWRP--VIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       207 ~~~~~-~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~--iiHrDlkp~NIll~~~~~~k  281 (451)
                      .++.. ++||||||++|+|...+..  ...+.+++..+++++.|++.||..||+....  |+||||||.||+|+.+|.+|
T Consensus        89 ~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK  168 (375)
T KOG0591|consen   89 IEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK  168 (375)
T ss_pred             hccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence            54444 8999999999999998853  3457899999999999999999999984334  89999999999999999999


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      |+|||+++++.  .........+|||+||+||++.+.+|+.++||||+||++|||+.-.+||.+..              
T Consensus       169 LGDfGL~r~l~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--------------  232 (375)
T KOG0591|consen  169 LGDFGLGRFLS--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--------------  232 (375)
T ss_pred             eccchhHhHhc--chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--------------
Confidence            99999999754  23444567899999999999999999999999999999999999999998642              


Q ss_pred             hhhhhHHhhhhhcCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          362 KLALHQIIDEKLGRNIQ-MEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      -..+...+.......++ ...+.++..||..|+..||..||+...++..++
T Consensus       233 ~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  233 LLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             HHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            12233333333223344 567899999999999999999998755444443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-50  Score=378.88  Aligned_cols=239  Identities=28%  Similarity=0.419  Sum_probs=206.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc---CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|+++++||+|+||.||.          ++++.+++.+|+|++++....   ..+...+|..||..++||+||.++-.|
T Consensus        25 ~dF~~lkviGkG~fGkV~~----------Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF   94 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQ----------VRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF   94 (357)
T ss_pred             hheeeeeeeeccCCceEEE----------EEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence            4899999999999999999          556678899999999876433   345578899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      +++..+|||+||+.||+|+.+|.+  .+.++++.+..++.+|+.||.|||+  +|||||||||+|||||++|+++|+|||
T Consensus        95 Qt~~kLylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFg  170 (357)
T KOG0598|consen   95 QTEEKLYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFG  170 (357)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccc
Confidence            999999999999999999999955  5789999999999999999999999  999999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +++...  ..+....+++||+.|||||++.+..|+..+|+||||+++|||++|.+||......                 
T Consensus       171 L~k~~~--~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-----------------  231 (357)
T KOG0598|consen  171 LCKEDL--KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-----------------  231 (357)
T ss_pred             cchhcc--cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----------------
Confidence            998532  2334455689999999999999999999999999999999999999999865432                 


Q ss_pred             HHhhhhhc---CCCCHHHHHHHHHHHHHccccCCCCCC
Q 013028          367 QIIDEKLG---RNIQMEEAQEFAEIILRCLNSDPKNRP  401 (451)
Q Consensus       367 ~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RP  401 (451)
                      .+.+..+.   ...+...+.+.++|+.++|..||.+|.
T Consensus       232 ~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  232 KMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            33333222   233444678999999999999999996

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-49  Score=386.03  Aligned_cols=264  Identities=33%  Similarity=0.525  Sum_probs=222.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--HHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ...+.+.||+|+||+||+|.|+..           ..||||++.......  .+.|.+|+.+|..++|||||+++|++.+
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~-----------~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGT-----------DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCc-----------eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            344456699999999999998752           229999998654332  4589999999999999999999999998


Q ss_pred             CC-eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-ceeCCCCCCceeeCCCC-cEEEeec
Q 013028          209 DQ-HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRP-VIHRDVKASNVLLDDDF-NAKISDF  285 (451)
Q Consensus       209 ~~-~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-iiHrDlkp~NIll~~~~-~~kl~DF  285 (451)
                      .. .++|||||+++|+|.+++.......+++..++.|+.+|++||.|||+  ++ ||||||||+||||+.++ ++||+||
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~--~~~iIHrDLK~~NiLv~~~~~~~KI~DF  188 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS--EGPIIHRDLKSDNILVDLKGKTLKIADF  188 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc--CCCeeecccChhhEEEcCCCCEEEECCC
Confidence            88 79999999999999999977556889999999999999999999999  78 99999999999999998 9999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccc--cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIA--TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      |+++......  ...+...||..|||||++.  ...|+.++||||||+++|||+||..||.....             ..
T Consensus       189 Glsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------------~~  253 (362)
T KOG0192|consen  189 GLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------------VQ  253 (362)
T ss_pred             ccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------------HH
Confidence            9998532211  3334478999999999998  56899999999999999999999999875432             11


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCcc
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ  422 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~  422 (451)
                      ....++.......++...++.+..|+..||..||..||++.+++..|+.+.........
T Consensus       254 ~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~  312 (362)
T KOG0192|consen  254 VASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGP  312 (362)
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCc
Confidence            22234445556666777889999999999999999999999999999999887775333

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.7e-48  Score=354.84  Aligned_cols=263  Identities=24%  Similarity=0.354  Sum_probs=205.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|+.+.++|+|+||+||+          ++++.+++.||||++.....  ...+-..+|+++|++|+|+|+|.++++|.
T Consensus         2 ekYE~LgkvGEGSYGvV~K----------Crnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr   71 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMK----------CRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR   71 (396)
T ss_pred             cHHhhhhccccCcceEEEE----------eccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH
Confidence            4788899999999999999          66788899999999975433  22344579999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ....++||+|||+..-| +-|... ...++.+.+..+++|++.|+.|||+  +++|||||||+||||+.+|.+||||||+
T Consensus        72 rkrklhLVFE~~dhTvL-~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGF  147 (396)
T KOG0593|consen   72 RKRKLHLVFEYCDHTVL-HELERY-PNGVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGF  147 (396)
T ss_pred             hcceeEEEeeecchHHH-HHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchh
Confidence            99999999999987444 445443 3568899999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch-hhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN-KLAL  365 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~  365 (451)
                      |+...  ..+..+++++.|.+|+|||++.+ .+|+..+||||+||++.||++|.+.|.+..+-+..........+ .-..
T Consensus       148 AR~L~--~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh  225 (396)
T KOG0593|consen  148 ARTLS--APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH  225 (396)
T ss_pred             hHhhc--CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH
Confidence            99744  25667888999999999999987 79999999999999999999999887654432110000000000 0000


Q ss_pred             hHHhhh----------------hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          366 HQIIDE----------------KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       366 ~~~~~~----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+++..                .++.. -+..+.-+.+|+.+||+.||++|++.+|++.+
T Consensus       226 q~iF~~N~~F~Gv~lP~~~~~epLe~k-~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  226 QSIFSSNPFFHGVRLPEPEHPEPLERK-YPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             HHHhccCCceeeeecCCCCCccchhhh-cccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            111110                00001 11235678999999999999999999999863

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-48  Score=377.79  Aligned_cols=251  Identities=27%  Similarity=0.386  Sum_probs=212.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhc-CCCceeeccce
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRL-NHPNVVKLMGY  205 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~h~nIv~~~~~  205 (451)
                      .+|.+++.||.|+|++|++|+          ++.+++.+|||++.+...   ...+.+..|-.+|.+| .||.|++||-.
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~----------~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T  142 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAR----------EKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT  142 (604)
T ss_pred             hhcchhheeccccceeEEEee----------ecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence            489999999999999999955          556788999999976532   2234577899999999 59999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      |.|+..+|+|+||+++|+|.++|..  .+.|++..+..++.+|+.||+|||+  +|||||||||+||||+.||+++|+||
T Consensus       143 FQD~~sLYFvLe~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikITDF  218 (604)
T KOG0592|consen  143 FQDEESLYFVLEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKITDF  218 (604)
T ss_pred             eecccceEEEEEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEEeec
Confidence            9999999999999999999999955  5889999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCc-----------ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc
Q 013028          286 GLAKFGPLGDKS-----------HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW  354 (451)
Q Consensus       286 Gla~~~~~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  354 (451)
                      |.|...+.....           .....++||..|++||+|.+...+..+|||+||||||+|+.|.+||.+..+-     
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-----  293 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-----  293 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-----
Confidence            999865432211           1124589999999999999999999999999999999999999999865431     


Q ss_pred             cccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                              ..++.++.  +...++...++.+.+||.+.|..||.+|+|+.+|-++
T Consensus       294 --------liFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  294 --------LIFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             --------HHHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                    12223322  2344566667899999999999999999999888765

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-48  Score=375.19  Aligned_cols=265  Identities=26%  Similarity=0.386  Sum_probs=212.7

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHH-HHHHHHHHhcC-CCceeeccce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW-ENELRFLSRLN-HPNVVKLMGY  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~-~~E~~il~~l~-h~nIv~~~~~  205 (451)
                      ..++|.+.++||.|+||.||+|          +...++..||||.+++.-....+.. .+|++.|++|+ |||||++.++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la----------~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Ev   77 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLA----------KSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEV   77 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEe----------eecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHH
Confidence            4569999999999999999995          4667788899999986644433333 58999999999 9999999999


Q ss_pred             eecCC-eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          206 CCDDQ-HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       206 ~~~~~-~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      +.+.+ .+|+|||||+ .+|++++... ...|++..+.+|+.||+.||+|+|.  +|+.||||||+|||+.....+||+|
T Consensus        78 i~d~~~~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKiaD  153 (538)
T KOG0661|consen   78 IRDNDRILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIAD  153 (538)
T ss_pred             hhccCceEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEecc
Confidence            99887 9999999996 5999998776 7899999999999999999999999  8999999999999999888999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--------CCcc
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--------GNWA  355 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--------~~~~  355 (451)
                      ||+|+..   ......+.++.|.+|+|||+|.+ +.|+.++|+||+|||++|+.+-++.|-+..+-+.        +.-.
T Consensus       154 FGLARev---~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~  230 (538)
T KOG0661|consen  154 FGLAREV---RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPD  230 (538)
T ss_pred             ccccccc---ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCc
Confidence            9999953   34455678899999999999865 6789999999999999999999999987665322        0000


Q ss_pred             ccccchhhhhhHHhhhhhcC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          356 KPYLSNKLALHQIIDEKLGR-------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +.-+.....+...+.-.+..       ..-...+.++.+||.+||.+||++|||+.|+|++
T Consensus       231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             cccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            01111111122221111110       1112257899999999999999999999999985

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-47  Score=372.16  Aligned_cols=260  Identities=29%  Similarity=0.476  Sum_probs=219.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+.+.+++.||+|.||.||+|.|+..           ..||+|.+... ....++|.+|+++|++|+|+|||+++++|..
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~-----------~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~  272 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGS-----------TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK  272 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCC-----------CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence            34566788999999999999999863           35899999754 4456778899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +..+|||||||..|+|.++|.......+...+.+.++.|||+|++||++  +++|||||...||||+++..+||+|||||
T Consensus       273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheeeccCceEEEcccccc
Confidence            8899999999999999999988677889999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +...... -.......-..-|.|||.+....++.+||||||||+||||+| |+.|+....              ...+-+
T Consensus       351 r~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--------------n~ev~~  415 (468)
T KOG0197|consen  351 RLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--------------NEEVLE  415 (468)
T ss_pred             cccCCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--------------HHHHHH
Confidence            9422211 111111222346999999999999999999999999999999 555543322              233446


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                      .+.....-..|..+++++.++|..||+.+|++|||+..+...|+.+....
T Consensus       416 ~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  416 LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            66777777788889999999999999999999999999999999886543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-47  Score=374.32  Aligned_cols=251  Identities=27%  Similarity=0.437  Sum_probs=214.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ...|....+||+|+.|.||.+          +...++..||||.+........+-+.+|+.+|+..+|+|||.+++.|..
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A----------~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv  341 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVA----------RKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV  341 (550)
T ss_pred             hhhhcchhhhccccccceeee----------eeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc
Confidence            457888899999999999995          4566677899999987777777778999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++.+++|||||+||+|.|.+..   ..+++.+++.|+++++.||+|||.  +||+|||||.+|||++.+|.+||+|||++
T Consensus       342 ~deLWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~--~gIiHrDIKSDnILL~~~g~vKltDFGFc  416 (550)
T KOG0578|consen  342 GDELWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHA--RGIIHRDIKSDNILLTMDGSVKLTDFGFC  416 (550)
T ss_pred             cceeEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHh--cceeeeccccceeEeccCCcEEEeeeeee
Confidence            9999999999999999998843   459999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ..+....  ......+||++|||||++....|++++||||||++++||+.|.+||..+.+-             ..+.-+
T Consensus       417 aqi~~~~--~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-------------rAlyLI  481 (550)
T KOG0578|consen  417 AQISEEQ--SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------------RALYLI  481 (550)
T ss_pred             ecccccc--CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH-------------HHHHHH
Confidence            8654332  2345689999999999999999999999999999999999999998764321             011111


Q ss_pred             h-hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          369 I-DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       369 ~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      . ........+...+..+++|+.+||..|+.+|+++.|+|++
T Consensus       482 a~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  482 ATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             hhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            1 1222233456678999999999999999999999999975

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9e-47  Score=360.52  Aligned_cols=262  Identities=32%  Similarity=0.473  Sum_probs=211.8

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      +|..++.||+|+||+||++....          ++...|||.+........+.+.+|+.+|..|+|||||+++|......
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~----------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~   87 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKK----------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE   87 (313)
T ss_pred             hhhhhccccCccceEEEEEEecC----------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence            67888999999999999977543          36779999987653333667899999999999999999999754443


Q ss_pred             --eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC-CCcEEEeecCC
Q 013028          211 --HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD-DFNAKISDFGL  287 (451)
Q Consensus       211 --~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~-~~~~kl~DFGl  287 (451)
                        .+++.|||+.+|+|.+++....+ .+++..+..+++||++||.|||+  +||||+||||+||||+. ++.+||+|||+
T Consensus        88 ~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaDFG~  164 (313)
T KOG0198|consen   88 NDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLADFGL  164 (313)
T ss_pred             CeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEeccCcc
Confidence              68999999999999999977655 89999999999999999999999  89999999999999999 79999999999


Q ss_pred             cccCCC-CCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          288 AKFGPL-GDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       288 a~~~~~-~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      +..... ...........||+.|||||++..+ ....++|||||||++.||+||++||...            ......+
T Consensus       165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------------~~~~~~~  232 (313)
T KOG0198|consen  165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------------FEEAEAL  232 (313)
T ss_pred             ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------------cchHHHH
Confidence            985332 1122234457899999999999753 3345999999999999999999987642            0011111


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                      ..+......+.++...+.+..+|+.+|+..||++|||+.++|++.-..+...
T Consensus       233 ~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  233 LLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            2222233344677778899999999999999999999999999876655444

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-47  Score=366.89  Aligned_cols=266  Identities=28%  Similarity=0.382  Sum_probs=209.8

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      -.+.|+.+++||+|+||.||+          |++..+++.||+|.+....  .....-..+||.||++|+||||+++.+.
T Consensus       115 ~~~~feki~kIGeGTyg~VYk----------Ar~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~ei  184 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYK----------ARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEI  184 (560)
T ss_pred             chHHHHHHHHhcCcchhheeE----------eeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeE
Confidence            345788899999999999999          6677889999999998654  3334556899999999999999999998


Q ss_pred             eecC--CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          206 CCDD--QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       206 ~~~~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      ..+.  ..+|||+|||+. +|..++.. ....|++.++..++.||+.||+|||+  +||+|||||.+|||||.+|.+||+
T Consensus       185 vt~~~~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKia  260 (560)
T KOG0600|consen  185 VTSKLSGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIA  260 (560)
T ss_pred             EEecCCceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEec
Confidence            8776  689999999987 88887744 35689999999999999999999999  999999999999999999999999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----------
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----------  351 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----------  351 (451)
                      |||||+++..... ...+..+-|.+|+|||+|.| ..|+.++|+||.||||.||+.|++.|.+.++-..           
T Consensus       261 DFGLAr~y~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP  339 (560)
T KOG0600|consen  261 DFGLARFYTPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP  339 (560)
T ss_pred             cccceeeccCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence            9999998664332 33566788999999999987 5899999999999999999999999987766422           


Q ss_pred             --CCccccccch--hhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 --GNWAKPYLSN--KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 --~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                        ..|....+..  ...........+.. .-...+....+|+..||..||.+|.|+.++|+.
T Consensus       340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  340 TEDYWPVSKLPHATIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ChhccccccCCcccccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence              1222101100  00000000000000 011225778899999999999999999999864

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.5e-46  Score=367.42  Aligned_cols=246  Identities=29%  Similarity=0.477  Sum_probs=215.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--HHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|.+.+.||+|+||+||+|          +.+.+...||+|.+.+.....  ...+.+|++|++.|+|||||.++++|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKg----------rrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE   71 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKG----------RRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE   71 (808)
T ss_pred             cchhHHHHhcCCccceeeec----------ccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc
Confidence            47888899999999999995          477788899999998654433  456889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ...++++|+||+.| +|+.+|..  +..++++.+..|+.+++.||.|||+  .+|+|||+||.||||+.+|.+|+||||+
T Consensus        72 t~~~~~vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~  146 (808)
T KOG0597|consen   72 TSAHLWVVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGL  146 (808)
T ss_pred             ccceEEEEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhh
Confidence            99999999999977 99999944  7889999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      |+..  .....+.+.+.||+.|||||++.++.|+..+|+||||||+|||++|++||....                 +.+
T Consensus       147 Ar~m--~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----------------i~~  207 (808)
T KOG0597|consen  147 ARAM--STNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----------------ITQ  207 (808)
T ss_pred             hhhc--ccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----------------HHH
Confidence            9853  334556778899999999999999999999999999999999999999997542                 224


Q ss_pred             HhhhhhcC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          368 IIDEKLGR--NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       368 ~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ++...+..  ..+...+..+..|+...|.+||..|.|..+++.+
T Consensus       208 Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  208 LVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             HHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            44333322  3455678899999999999999999999999875

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-47  Score=344.33  Aligned_cols=235  Identities=29%  Similarity=0.395  Sum_probs=205.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|+.++.||.|+||.|.+          ++.+.++..+|+|++.+.....   .+...+|..+|+.+.||+++++++.|
T Consensus        44 ~dfe~~~tlGtGSFGrV~L----------Vr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~  113 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHL----------VREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF  113 (355)
T ss_pred             hhhhheeeeccCccceEEE----------EEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee
Confidence            4888999999999999999          5566778899999998654333   24467899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+.+++||||||++||.|+.+++.  .+++++..+..++.||+.||+|||+  .+|++|||||+|||||.+|.+||+|||
T Consensus       114 ~d~~~lymvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitDFG  189 (355)
T KOG0616|consen  114 KDNSNLYMVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITDFG  189 (355)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEecc
Confidence            999999999999999999999954  5789999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +|+...     ....+.|||+.|+|||++..+.|+.++|+|||||++|||+.|.+||....+                 .
T Consensus       190 FAK~v~-----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----------------~  247 (355)
T KOG0616|consen  190 FAKRVS-----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----------------I  247 (355)
T ss_pred             ceEEec-----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----------------H
Confidence            998532     235678999999999999999999999999999999999999999986543                 1


Q ss_pred             HHhhhhhcC--CCCHHHHHHHHHHHHHccccCCCCC
Q 013028          367 QIIDEKLGR--NIQMEEAQEFAEIILRCLNSDPKNR  400 (451)
Q Consensus       367 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~R  400 (451)
                      ++....+..  .+|...+.++++|+.++|+.|-.+|
T Consensus       248 ~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  248 QIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            333333333  3567778999999999999999998

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.6e-46  Score=336.47  Aligned_cols=263  Identities=23%  Similarity=0.375  Sum_probs=208.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--HHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .+|...++||+|.||+||+|.          +..+++.||||.++......  .....+|++.|+.++|+||+.++++|-
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~----------d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~   71 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKAR----------DTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP   71 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEE----------ecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc
Confidence            478889999999999999965          55678889999998553332  234678999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ..+.+.||+||++ .+|...+.+. ...++...+..++.++++||+|||+  +.|+||||||.|+|++.+|.+||+|||+
T Consensus        72 ~~~~l~lVfEfm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLis~~g~lKiADFGL  147 (318)
T KOG0659|consen   72 HKSNLSLVFEFMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLISSDGQLKIADFGL  147 (318)
T ss_pred             CCCceEEEEEecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEEcCCCcEEeecccc
Confidence            9999999999996 4998888654 5779999999999999999999999  8899999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-------------CC
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-------------GN  353 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-------------~~  353 (451)
                      |+.+.....  ..+..+-|..|+|||++.| +.|+..+||||.|||+.||+-|.+.|.+..+-..             ..
T Consensus       148 Ar~f~~p~~--~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~  225 (318)
T KOG0659|consen  148 ARFFGSPNR--IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQ  225 (318)
T ss_pred             hhccCCCCc--ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCccc
Confidence            997654333  3334478999999999977 6899999999999999999999877765543211             12


Q ss_pred             cccc-ccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          354 WAKP-YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       354 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      |..- ...+-..+. .+.......+-...+.++.+|+.+||..||.+|+|+.|+|++
T Consensus       226 WP~~~~lpdY~~~~-~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  226 WPEMTSLPDYVKIQ-QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CccccccccHHHHh-cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            2110 011111111 111111222334456778999999999999999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-46  Score=367.57  Aligned_cols=255  Identities=28%  Similarity=0.410  Sum_probs=212.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC----CC-cCHHHHHHHHHHHHhcC-CCceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK----GS-QGQDEWENELRFLSRLN-HPNVVKL  202 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~il~~l~-h~nIv~~  202 (451)
                      ..+|.+++.||+|+||+|++|..          ..++..||+|++.+.    .. ...+.+.+|+.+++.++ ||||+++
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~----------~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l   85 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKH----------RLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL   85 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeee----------ccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence            45899999999999999999764          444688999987764    12 23455678999999999 9999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC-CcEE
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD-FNAK  281 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~-~~~k  281 (451)
                      ++++......|+||||+.||+|++++..  .+.+.+..+..++.||+.|++|||+  +||+||||||+|||++.+ +++|
T Consensus        86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~~K  161 (370)
T KOG0583|consen   86 LEVFATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGNLK  161 (370)
T ss_pred             EEEEecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCCEE
Confidence            9999999999999999999999999966  6789999999999999999999999  899999999999999999 9999


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCccccccccccCC-CC-cchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGH-LT-LKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  359 (451)
                      |+|||++....  .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||......          
T Consensus       162 l~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----------  229 (370)
T KOG0583|consen  162 LSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----------  229 (370)
T ss_pred             EeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH----------
Confidence            99999998643  2344566789999999999998877 85 7899999999999999999999863211          


Q ss_pred             chhhhhhHHhhhhhcCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          360 SNKLALHQIIDEKLGRNIQMEE-AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                         .-...+...  ...++... +.++.+|+.+||..||.+|+|+.+++ .-.-++.
T Consensus       230 ---~l~~ki~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~  280 (370)
T KOG0583|consen  230 ---NLYRKIRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK  280 (370)
T ss_pred             ---HHHHHHhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence               001111111  22344444 88999999999999999999999999 4444554

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-46  Score=373.02  Aligned_cols=247  Identities=26%  Similarity=0.383  Sum_probs=216.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      -|++++-||.|+.|.|-+          |++..+|+.+|||++.+...   .....+++|+-||+.+.||||+++|++|+
T Consensus        13 pwkLgkTLG~Gstg~vrl----------akh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe   82 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRL----------AKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE   82 (786)
T ss_pred             ceeccccccCCCCceehh----------hhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence            578899999999999998          67888899999999986532   22356899999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +..++|+|.||++||.|++++..  .+.+++.+++.+++||+.|+.|||.  .+|+||||||+|+||+..+++||+|||+
T Consensus        83 ~~~~lylvlEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~--~~icHRDLKpENlLLd~~~nIKIADFGM  158 (786)
T KOG0588|consen   83 NKQHLYLVLEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHA--FNICHRDLKPENLLLDVKNNIKIADFGM  158 (786)
T ss_pred             cCceEEEEEEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhh--hcceeccCCchhhhhhcccCEeeeccce
Confidence            99999999999999999999955  6789999999999999999999999  7999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      |..   ...+..-.+.||++.|.|||+++|.+| +.++||||.|||||.||+|+.||+...                 +.
T Consensus       159 AsL---e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----------------ir  218 (786)
T KOG0588|consen  159 ASL---EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----------------IR  218 (786)
T ss_pred             eec---ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----------------HH
Confidence            986   444555667899999999999999998 578999999999999999999998432                 22


Q ss_pred             HHhhhhh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          367 QIIDEKL--GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       367 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      .++...-  ..+++...+.++++|+++||..||..|.|+.||+++--
T Consensus       219 ~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  219 VLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             HHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence            3333222  23467778899999999999999999999999998753

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.1e-46  Score=363.08  Aligned_cols=251  Identities=27%  Similarity=0.385  Sum_probs=206.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .++|++++.||+|+||.||+          |+.+.++..+|+|++.+.....   .+.+..|-.||....+|+||++|-.
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrL----------arKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs  209 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRL----------ARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS  209 (550)
T ss_pred             cccchhheeeccccceeEEE----------EEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence            46899999999999999999          5677789999999998764333   3456789999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      |++.+++||||||++||++..+|..  ...|+++.+..++.+++.|++.+|.  .|+|||||||+|+|||..|++||+||
T Consensus       210 FQD~~~LYLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~--~gyIHRDIKPdNlLiD~~GHiKLSDF  285 (550)
T KOG0605|consen  210 FQDKEYLYLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQ--LGYIHRDIKPDNLLIDAKGHIKLSDF  285 (550)
T ss_pred             ecCCCeeEEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHH--cCcccccCChhheeecCCCCEeeccc
Confidence            9999999999999999999999965  5789999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCC----------------------CCCc-----c------------------cccccCCCCccccccccccCCC
Q 013028          286 GLAKFGPL----------------------GDKS-----H------------------ISTRVLGTRGYFAPEYIATGHL  320 (451)
Q Consensus       286 Gla~~~~~----------------------~~~~-----~------------------~~~~~~gt~~y~aPE~l~~~~~  320 (451)
                      ||+.-...                      .+..     .                  .....+|||.|+|||++.+..|
T Consensus       286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY  365 (550)
T KOG0605|consen  286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY  365 (550)
T ss_pred             cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence            99951100                      0000     0                  0112589999999999999999


Q ss_pred             CcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhh--hcCCCCHHHHHHHHHHHHHccccCCC
Q 013028          321 TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK--LGRNIQMEEAQEFAEIILRCLNSDPK  398 (451)
Q Consensus       321 ~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~  398 (451)
                      +..+|+||||||+||||.|.+||...++.             ..+..++...  +........++++.|||.+||. ||+
T Consensus       366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~-------------~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~  431 (550)
T KOG0605|consen  366 GKECDWWSLGCIMYEMLVGYPPFCSETPQ-------------ETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPE  431 (550)
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCHH-------------HHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHH
Confidence            99999999999999999999999987653             1222333222  2222233345899999999999 999


Q ss_pred             CCCC---HHHHH
Q 013028          399 NRPT---MSEVV  407 (451)
Q Consensus       399 ~RPt---~~evl  407 (451)
                      +|.-   +.||-
T Consensus       432 ~RLG~~G~~EIK  443 (550)
T KOG0605|consen  432 NRLGSKGAEEIK  443 (550)
T ss_pred             HhcCcccHHHHh
Confidence            9975   55543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-45  Score=362.99  Aligned_cols=268  Identities=30%  Similarity=0.430  Sum_probs=207.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|++.++||+|+||.||+|.+..     ......+..||||++..... .....+.+|+.+|..+ +||||+++++++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFG-----IDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEec-----cCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            4589999999999999999987532     11233456799999875432 2235688999999999 799999999988


Q ss_pred             ecC-CeeEEEEeccCCCChhhhhccCC-----------------------------------------------------
Q 013028          207 CDD-QHRLLVYEYVTRGSLEDHLLNED-----------------------------------------------------  232 (451)
Q Consensus       207 ~~~-~~~~lV~E~~~gg~L~~~l~~~~-----------------------------------------------------  232 (451)
                      ... ...++||||+++|+|.+++....                                                     
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            764 45789999999999999885421                                                     


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCC
Q 013028          233 -------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG  305 (451)
Q Consensus       233 -------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  305 (451)
                             ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+++...............+
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence                   1347888899999999999999999  8999999999999999999999999999975322211111223345


Q ss_pred             CCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHH
Q 013028          306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQE  384 (451)
Q Consensus       306 t~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (451)
                      +..|+|||++.+..++.++|||||||++|||++ |..||......             ..+...+........+...+..
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~  305 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------------EEFCQRLKDGTRMRAPENATPE  305 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------------HHHHHHHhcCCCCCCCCCCCHH
Confidence            678999999988899999999999999999997 98887643211             0111111111112233445678


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          385 FAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       385 l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      +.+|+.+||+.||.+|||+.++++.|+.+..+
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-46  Score=351.43  Aligned_cols=249  Identities=22%  Similarity=0.395  Sum_probs=214.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHH---HHHHHHHHHhcCCCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE---WENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      ..+|++.+.||+|.||.|-++          .+...++.||||.|++.......+   +.+|++||..|+||||+.+|++
T Consensus        52 kHRyE~~etLGkGTYGKVk~A----------~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV  121 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLA----------YEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV  121 (668)
T ss_pred             hhHHHHHHHhcCCcccceeeh----------hhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh
Confidence            458999999999999999994          455678899999999876666554   5789999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      |++.+..+|||||..+|+|+|++..  .+.+++.++..|++||+.|+.|||.  ++|+|||||.+|||||.++++||+||
T Consensus       122 FENkdKIvivMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHk--nrVvHRDLKLENILLD~N~NiKIADF  197 (668)
T KOG0611|consen  122 FENKDKIVIVMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHK--NRVVHRDLKLENILLDQNNNIKIADF  197 (668)
T ss_pred             hcCCceEEEEEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhh--ccceecccchhheeecCCCCeeeecc
Confidence            9999999999999999999999954  5789999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      |++.++.   .....++++|++.|.+||++.+.+| +..+|.|||||+||.|+.|.-||++....               
T Consensus       198 GLSNly~---~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---------------  259 (668)
T KOG0611|consen  198 GLSNLYA---DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---------------  259 (668)
T ss_pred             chhhhhc---cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---------------
Confidence            9998643   3455678999999999999999888 68999999999999999999999875432               


Q ss_pred             hhHHhhhhhcCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          365 LHQIIDEKLGRNI-QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       365 ~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                        .++...-.+.+ .+..+....-||++||..||++|.|+.+|..+-.
T Consensus       260 --~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  260 --RLVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             --HHHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence              22222222222 2334566888999999999999999999988754

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-45  Score=348.84  Aligned_cols=251  Identities=27%  Similarity=0.409  Sum_probs=209.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +.|++.++||.|..++||+|.+          ...+..||||++.-.. ....+.+.+|++.|+.++||||++++..|..
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c----------~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv   95 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARC----------IPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV   95 (516)
T ss_pred             cceeEEEEEeccceeEeeeeee----------cccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence            4899999999999999999664          4456889999998443 3335889999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +..+|+||.||.+|++.+++...-...+++..+..|++++++||.|||.  +|.||||||+.||||+.+|.+||+|||.+
T Consensus        96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFgvs  173 (516)
T KOG0582|consen   96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFGVS  173 (516)
T ss_pred             cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCceee
Confidence            9999999999999999999977666779999999999999999999999  89999999999999999999999999997


Q ss_pred             cc-CCCCCCcccc-cccCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          289 KF-GPLGDKSHIS-TRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       289 ~~-~~~~~~~~~~-~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      -. +..+...... ..++||++|||||+++.  ..|+.|+||||||++.+||.+|..||....+-               
T Consensus       174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm---------------  238 (516)
T KOG0582|consen  174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM---------------  238 (516)
T ss_pred             eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH---------------
Confidence            53 2222222222 56899999999999754  57999999999999999999999999866542               


Q ss_pred             hhHHhhhhhcC------------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          365 LHQIIDEKLGR------------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~~~~~------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                        +++-..+..            +.....+.++.+++..||..||.+|||++++|+.
T Consensus       239 --kvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  239 --KVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             --HHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence              111111111            1112235689999999999999999999999874

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-45  Score=351.89  Aligned_cols=259  Identities=29%  Similarity=0.425  Sum_probs=212.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--------------cCHHHHHHHHHHHHhc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--------------QGQDEWENELRFLSRL  194 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~il~~l  194 (451)
                      .++|++.+.||+|.||.|-+|          ++..++..||||++.+...              ...+.+.+||.||+++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLa----------r~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl  165 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLA----------RDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL  165 (576)
T ss_pred             hhheehhhhhcCCccceEEEE----------eecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence            468999999999999999995          4667788999999874321              1235788999999999


Q ss_pred             CCCceeeccceeecC--CeeEEEEeccCCCChhhhhccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCc
Q 013028          195 NHPNVVKLMGYCCDD--QHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASN  271 (451)
Q Consensus       195 ~h~nIv~~~~~~~~~--~~~~lV~E~~~gg~L~~~l~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~N  271 (451)
                      .|||||+|+++..+.  +.+|||+|||..|.+...-   .+.. +++.++.+++++++.||+|||.  +|||||||||+|
T Consensus       166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDIKPsN  240 (576)
T KOG0585|consen  166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHY--QGIIHRDIKPSN  240 (576)
T ss_pred             CCcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHh--cCeeccccchhh
Confidence            999999999999864  6789999999999886543   3444 9999999999999999999999  999999999999


Q ss_pred             eeeCCCCcEEEeecCCcccCCCC---CCcccccccCCCCccccccccccCC----CCcchhhHHHHHHHHHHHhCCCccc
Q 013028          272 VLLDDDFNAKISDFGLAKFGPLG---DKSHISTRVLGTRGYFAPEYIATGH----LTLKTDVYSFGVVLLEILSGKTAAM  344 (451)
Q Consensus       272 Ill~~~~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DiwSlGvil~elltg~~pf~  344 (451)
                      +||+.+|++||+|||.+...+.+   .........+||+.|+|||.+.++.    .+.+.||||+||+||.|+.|..||.
T Consensus       241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            99999999999999999865332   2222334579999999999997632    3578999999999999999999998


Q ss_pred             cccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                      ....-             .-...++...+......+....+++||.+||.+||+.|.+..+|..+....+.
T Consensus       321 ~~~~~-------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  321 DDFEL-------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             cchHH-------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            65431             22234555555555555678899999999999999999999999888776654

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-45  Score=327.53  Aligned_cols=250  Identities=30%  Similarity=0.454  Sum_probs=216.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++++.||+|.||.||+|          +.+.+...||+|++.+..   ......+.+|++|-.+|+||||+++|++|
T Consensus        22 ~dfeigr~LgkgkFG~vYla----------rekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLA----------REKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             hhccccccccCCccccEeEe----------eeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence            48999999999999999995          466678899999997643   23346788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .++...||++||..+|+|+..|.......+++.....++.|++.||.|||.  ++||||||||+|+|++.++.+||+|||
T Consensus        92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfG  169 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFG  169 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCC
Confidence            999999999999999999999987778889999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      .+...+    .....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||.....+             ....
T Consensus       170 wsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-------------etYk  232 (281)
T KOG0580|consen  170 WSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-------------ETYK  232 (281)
T ss_pred             ceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-------------HHHH
Confidence            998533    33445689999999999999999999999999999999999999999865421             1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      .+.  .....++...+..+.+||.+||..+|.+|.+..|+++.-
T Consensus       233 rI~--k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  233 RIR--KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             HHH--HccccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence            222  223345677789999999999999999999999998753

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=357.95  Aligned_cols=252  Identities=27%  Similarity=0.393  Sum_probs=215.3

Q ss_pred             HHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcC-CCceeec
Q 013028          127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLN-HPNVVKL  202 (451)
Q Consensus       127 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~-h~nIv~~  202 (451)
                      .....|++.++||+|.||.||++.          ++.++..+|+|++.+.....   .+.+.+|+.||+++. |||||.+
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~----------~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l  101 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCR----------EKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQL  101 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEE----------ecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEE
Confidence            345689999999999999999965          44558889999998765543   368899999999999 9999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC----CC
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DF  278 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~----~~  278 (451)
                      +++|++.+.+++|||+|.||+|++.+...   .+++..+..++.|++.++.|||+  .||+||||||+|+|+..    ++
T Consensus       102 ~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~  176 (382)
T KOG0032|consen  102 KDAFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSG  176 (382)
T ss_pred             EEEEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCC
Confidence            99999999999999999999999999765   39999999999999999999999  89999999999999953    35


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                      .+|++|||+|.+...   .......+||++|+|||++....|+..+||||+||++|.|++|.+||+......        
T Consensus       177 ~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--------  245 (382)
T KOG0032|consen  177 RIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--------  245 (382)
T ss_pred             cEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--------
Confidence            799999999997543   455678899999999999988999999999999999999999999999776431        


Q ss_pred             cchhhhhhHHhhhh--hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          359 LSNKLALHQIIDEK--LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       359 ~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                           ....+....  +........+..+.++|..||..||..|+|+.++|++
T Consensus       246 -----~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  246 -----IFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             -----HHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                 111222221  2233344558899999999999999999999999995

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-44  Score=343.29  Aligned_cols=255  Identities=27%  Similarity=0.359  Sum_probs=214.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCH---HHHHHHHHHHHhcCCCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ---DEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .+.|++++.||+|.-|+||++.+.          .++..+|+|++.+......   .....|-+||..++||.++++|..
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~----------~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~  145 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELR----------GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS  145 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEec----------CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe
Confidence            347888999999999999996654          4467899999987654443   345679999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      |+.+...|||||||.||+|..+++.+....+++..+..++.+++.||+|||-  .|||+|||||+||||-++|++.|+||
T Consensus       146 fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm--lGivYRDLKPENILvredGHIMLsDF  223 (459)
T KOG0610|consen  146 FETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM--LGIVYRDLKPENILVREDGHIMLSDF  223 (459)
T ss_pred             eeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh--hceeeccCCcceeEEecCCcEEeeec
Confidence            9999999999999999999999999999999999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCC---------------------------------CCC---------------------cccccccCCCCcccc
Q 013028          286 GLAKFGPL---------------------------------GDK---------------------SHISTRVLGTRGYFA  311 (451)
Q Consensus       286 Gla~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~a  311 (451)
                      .|+.....                                 ...                     ......++||-.|+|
T Consensus       224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA  303 (459)
T KOG0610|consen  224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA  303 (459)
T ss_pred             cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence            99852211                                 000                     011223689999999


Q ss_pred             ccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHH
Q 013028          312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILR  391 (451)
Q Consensus       312 PE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  391 (451)
                      ||++.|...+.++|||+|||+||||+.|..||.+...             +..+..++...+.-.-....+..++|||++
T Consensus       304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~-------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~  370 (459)
T KOG0610|consen  304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN-------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRK  370 (459)
T ss_pred             ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc-------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHH
Confidence            9999999999999999999999999999999987654             344555555555444444667899999999


Q ss_pred             ccccCCCCCCC----HHHHHH
Q 013028          392 CLNSDPKNRPT----MSEVVA  408 (451)
Q Consensus       392 cl~~dP~~RPt----~~evl~  408 (451)
                      +|.+||.+|..    +.||-+
T Consensus       371 LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  371 LLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             HhccChhhhhccccchHHhhc
Confidence            99999999997    666643

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-46  Score=354.51  Aligned_cols=249  Identities=26%  Similarity=0.425  Sum_probs=212.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC-CCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .|+..++||+|+||.||+|.++          .+.+.||+|++.-. .....+++..|+.+|.+++++||.++|+.|..+
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~----------~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g   83 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDN----------KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG   83 (467)
T ss_pred             ccccchhccccccceeeeeeec----------cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence            6777899999999999997654          45788999999854 344567899999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ..++++||||.||++.+++..  ...+.+..+.-|+++++.||.|||+  ++.+|||||+.|||+..+|.+||+|||.+.
T Consensus        84 ~~LwiiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~s~~g~vkl~DfgVa~  159 (467)
T KOG0201|consen   84 TKLWIIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILLSESGDVKLADFGVAG  159 (467)
T ss_pred             ccHHHHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhh--cceecccccccceeEeccCcEEEEecceee
Confidence            999999999999999999943  4555888888999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ......  ....+++||++||||||+....|+.++||||||++.+||++|.+|+....+.              ....++
T Consensus       160 ql~~~~--~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------------rvlflI  223 (467)
T KOG0201|consen  160 QLTNTV--KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------------RVLFLI  223 (467)
T ss_pred             eeechh--hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--------------eEEEec
Confidence            654322  2236789999999999999889999999999999999999999998765441              111223


Q ss_pred             hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .....+......++.+++|+..||..||+.||++.++|++
T Consensus       224 pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  224 PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            3333444455677889999999999999999999999874

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-44  Score=355.20  Aligned_cols=268  Identities=26%  Similarity=0.446  Sum_probs=214.2

Q ss_pred             HHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCcee
Q 013028          123 GLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVV  200 (451)
Q Consensus       123 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv  200 (451)
                      .+.++..+.+.++..||+|.||+||+|.|+..             ||||++......  ..+.|++|+.+|++-+|.||+
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-------------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIl  451 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-------------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENIL  451 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc-------------eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhe
Confidence            44455556778899999999999999999864             999999865443  346799999999999999999


Q ss_pred             eccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          201 KLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       201 ~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      -|.|+|..... .||+.+|+|-+|+.+|+..+ ..|.....+.|+.||+.|+.|||.  ++|||||||..||+|.+++.|
T Consensus       452 LFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kV  527 (678)
T KOG0193|consen  452 LFMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKV  527 (678)
T ss_pred             eeehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcE
Confidence            99999998877 99999999999999997543 568888999999999999999999  999999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCcccccccccc---CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~  357 (451)
                      ||+||||+..-.............|...|||||++..   -+|++.+||||||+|+|||++|..|+.....+ ..-|.- 
T Consensus       528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-qIifmV-  605 (678)
T KOG0193|consen  528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-QIIFMV-  605 (678)
T ss_pred             EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-heEEEe-
Confidence            9999999974332222233334567889999999943   47899999999999999999999998732221 111100 


Q ss_pred             ccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                       .  .    ...... ...+...+++++++|+..||.+++++||.+.+||..|+.+....
T Consensus       606 -G--r----G~l~pd-~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  606 -G--R----GYLMPD-LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             -c--c----cccCcc-chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence             0  0    000000 01123345779999999999999999999999999999998864

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=362.92  Aligned_cols=241  Identities=28%  Similarity=0.423  Sum_probs=208.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcC-CCceeeccc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLN-HPNVVKLMG  204 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-h~nIv~~~~  204 (451)
                      .++|.++++||+|+||+|+++.+          +.++..+|||++++...   ...+....|..|+.... ||+++.++.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~----------k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~  436 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAEL----------KGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFS  436 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEE----------cCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccc
Confidence            45899999999999999999654          45577899999987644   34456678999988886 999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      .|+..+++|+||||+.||++..+.   ....+++..+..++..++.||.|||+  +|||+||||.+|||||.+|.+||+|
T Consensus       437 ~fQT~~~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiAD  511 (694)
T KOG0694|consen  437 CFQTKEHLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIAD  511 (694)
T ss_pred             ccccCCeEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEecc
Confidence            999999999999999999954433   34679999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ||+++...  ..+..+.+++||+.|||||++.+..|+.++|+|||||+|||||.|..||.+..++               
T Consensus       512 FGlcKe~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------------  574 (694)
T KOG0694|consen  512 FGLCKEGM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------------  574 (694)
T ss_pred             cccccccC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------
Confidence            99998533  2344677899999999999999999999999999999999999999999876553               


Q ss_pred             hhHHhhhhhcC--CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 013028          365 LHQIIDEKLGR--NIQMEEAQEFAEIILRCLNSDPKNRPTM  403 (451)
Q Consensus       365 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~  403 (451)
                        ++++..+..  .++...+.+...+++++|..||++|.-+
T Consensus       575 --e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  575 --EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence              555555543  3566778999999999999999999865

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4e-46  Score=331.41  Aligned_cols=252  Identities=25%  Similarity=0.354  Sum_probs=208.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC--CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .+.|++.++||+|.|+.||+          +.+..+++.+|+|++...  .....+++.+|+.|-+.|+||||+++.+.+
T Consensus        10 ~d~y~l~e~igkG~FSvVrR----------c~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti   79 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRR----------CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI   79 (355)
T ss_pred             chhhhHHHHHccCchHHHHH----------HHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh
Confidence            46889999999999999999          556667777888888633  334567899999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC---CCCcEEEe
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD---DDFNAKIS  283 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~---~~~~~kl~  283 (451)
                      .+....|||+|+|.|++|..-+-.  ...+++..+-..++||+++|.|||+  +||||||+||+|+||.   ....+||+
T Consensus        80 ~~~~~~ylvFe~m~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~  155 (355)
T KOG0033|consen   80 QEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLA  155 (355)
T ss_pred             cccceeEEEEecccchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeec
Confidence            999999999999999999766633  2567888889999999999999999  8999999999999994   44579999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      |||+|....   ........+||++|||||++...+|+..+|||+.|||||.|+.|.+||++....              
T Consensus       156 ~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--------------  218 (355)
T KOG0033|consen  156 DFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------------  218 (355)
T ss_pred             ccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--------------
Confidence            999998644   344455789999999999999999999999999999999999999999974321              


Q ss_pred             hh-hHHhhhhh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          364 AL-HQIIDEKL--GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       364 ~~-~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      .+ .++.....  .....+..+++.++|+++||..||.+|+|+.|+|++-.
T Consensus       219 rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW  269 (355)
T KOG0033|consen  219 RLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW  269 (355)
T ss_pred             HHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence            11 12222111  11223445789999999999999999999999987543

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-44  Score=353.06  Aligned_cols=250  Identities=26%  Similarity=0.408  Sum_probs=218.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|..++.+|+|+||.+++          ++++..+..+++|.+.-..  .........|+.++.++.|||||.+++.|.
T Consensus         4 ~~Ye~~~~iG~GafG~a~l----------vrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~   73 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALL----------VRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE   73 (426)
T ss_pred             chhhhhhhcCccccchhhh----------hhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh
Confidence            5899999999999999999          7788888899999987443  333446788999999999999999999999


Q ss_pred             cCCe-eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          208 DDQH-RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       208 ~~~~-~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      +++. ++|||+||+||+|.+.+...++..++++.+..|+.|++.|+.|||+  +.|+|||||+.|||++.++.++|+|||
T Consensus        74 ~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDfG  151 (426)
T KOG0589|consen   74 EDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDFG  151 (426)
T ss_pred             cCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecchh
Confidence            8887 9999999999999999988777889999999999999999999998  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +|+......  ......+||+.|+.||++.+.+|+.++|||||||++|||++-+++|.+..-                 .
T Consensus       152 laK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-----------------~  212 (426)
T KOG0589|consen  152 LAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-----------------S  212 (426)
T ss_pred             hhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----------------H
Confidence            999644322  245578999999999999999999999999999999999999999875432                 1


Q ss_pred             HHhh---hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          367 QIID---EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       367 ~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      .++.   ......++...+.++..+|..||..+|..||++.++|..-
T Consensus       213 ~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  213 ELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             HHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence            2322   2223456777889999999999999999999999999873

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-43  Score=355.89  Aligned_cols=265  Identities=29%  Similarity=0.428  Sum_probs=207.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|++.+.||+|+||.||+|.+..     .....+...||||++.... ....+.+.+|+.+|..+ +||||++++++|
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~-----~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~  108 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYG-----LFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC  108 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEec-----cccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            3479999999999999999987532     1234456789999987433 22345678999999999 799999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC------------------------------------------------------
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED------------------------------------------------------  232 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~------------------------------------------------------  232 (451)
                      .++...++||||++||+|.+++....                                                      
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            99999999999999999999885421                                                      


Q ss_pred             -------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCC
Q 013028          233 -------------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL  293 (451)
Q Consensus       233 -------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~  293 (451)
                                         ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+|||++.....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                               1247888999999999999999999  8999999999999999999999999999975432


Q ss_pred             CCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhhh
Q 013028          294 GDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK  372 (451)
Q Consensus       294 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (451)
                      ...........++..|+|||++.+..++.++|||||||++|||++ |..||......             ..+...+...
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-------------~~~~~~~~~~  333 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-------------SKFYKMIKEG  333 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-------------HHHHHHHHhC
Confidence            221111222334567999999988999999999999999999998 77777543211             1111222222


Q ss_pred             hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          373 LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       373 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      .....+...+.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         334 YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            22223334467899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=338.68  Aligned_cols=267  Identities=27%  Similarity=0.342  Sum_probs=206.3

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEecc--CCCcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      +..+|...+.||+|+||.|+.+.          +..++..||||.+..  ......+...+|+++|++++|+||+.++++
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~----------~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di   89 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAK----------DKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDI   89 (359)
T ss_pred             ccceecccccccCcceeeEEEEE----------EcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEee
Confidence            34577778999999999999955          556678899999973  334445667899999999999999999999


Q ss_pred             eec-----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          206 CCD-----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       206 ~~~-----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      +..     -+.+|+|+|+| +.+|...+..  +..++++.+..+++||++||.|+|+  .+|+||||||.|+|++.+..+
T Consensus        90 ~~p~~~~~f~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHS--AnViHRDLKPsNll~n~~c~l  164 (359)
T KOG0660|consen   90 FRPPSRDKFNDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHS--ANVIHRDLKPSNLLLNADCDL  164 (359)
T ss_pred             cccccccccceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhc--ccccccccchhheeeccCCCE
Confidence            865     34679999999 5699988854  4559999999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  359 (451)
                      ||||||+|+...........+..+.|.+|.|||++.. ..|+.++||||+|||+.||++|++.|.+...-..........
T Consensus       165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l  244 (359)
T KOG0660|consen  165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL  244 (359)
T ss_pred             EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence            9999999997543334455678899999999999854 789999999999999999999999997654321100000000


Q ss_pred             --chhhhhhH--------Hhhh-hhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          360 --SNKLALHQ--------IIDE-KLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       360 --~~~~~~~~--------~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                        .....+..        .+.. ......     -+..++...+|+.+||.+||.+|+|++|+|++
T Consensus       245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence              00011111        1110 000111     12346889999999999999999999999975

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-44  Score=333.70  Aligned_cols=265  Identities=26%  Similarity=0.322  Sum_probs=206.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCH--HHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ--DEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +.|+.++.|++|+||.||+          ++++.++..||+|.++......-  -.-.+||.+|.+.+|||||.+..+..
T Consensus        76 ~efe~lnrI~EGtyGiVYR----------akdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVv  145 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYR----------AKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVV  145 (419)
T ss_pred             HHHHHHhhcccCcceeEEE----------eccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence            3688889999999999999          56888899999999985432221  23468999999999999999999876


Q ss_pred             cC--CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          208 DD--QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       208 ~~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      ..  +.+|||||||+. +|..++..-. .++...++.-++.|+++||.|||.  ..|+|||||++|+|+++.|.+||+||
T Consensus       146 G~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~--~wilHRDLK~SNLLm~~~G~lKiaDF  221 (419)
T KOG0663|consen  146 GSNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHD--NWILHRDLKTSNLLLSHKGILKIADF  221 (419)
T ss_pred             ccccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhh--ceeEecccchhheeeccCCcEEeccc
Confidence            43  568999999987 8888886543 679999999999999999999999  78999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----------CC
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----------GN  353 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----------~~  353 (451)
                      |+|+.+..  ....++..+-|.+|+|||+|.+ ..|+.++|+||+|||+.||+++.+.|.+..+-..           ..
T Consensus       222 GLAR~ygs--p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte  299 (419)
T KOG0663|consen  222 GLAREYGS--PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE  299 (419)
T ss_pred             chhhhhcC--CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc
Confidence            99996543  3344667888999999999977 5799999999999999999999999887665322           00


Q ss_pred             ccccccch-----hhhhhHHhhhhhcCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          354 WAKPYLSN-----KLALHQIIDEKLGRNIQME-EAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       354 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      -.|+-+..     ...+....-..+...+... .++.-.+|+..+|..||.+|.|+.|.|+.=
T Consensus       300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~  362 (419)
T KOG0663|consen  300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE  362 (419)
T ss_pred             ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence            00111110     0011111111112222222 457889999999999999999999999863

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.1e-43  Score=344.19  Aligned_cols=270  Identities=27%  Similarity=0.449  Sum_probs=205.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhh------hhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTA------ARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKL  202 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~------~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~  202 (451)
                      .+|++.++||+|+||.||+|.+.......      ......+..||+|.+...... ...++.+|+.+|..++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            48999999999999999999876532111      122344567999998754322 34568899999999999999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeC
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNED-----------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHR  265 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHr  265 (451)
                      ++++.+.+..++||||+.+|+|.+++....                 ...+++..++.++.||+.||.|||+  .||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~ivH~  162 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS--LNFVHR  162 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH--CCcccc
Confidence            999999999999999999999999885321                 1346788899999999999999999  899999


Q ss_pred             CCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhC--CCcc
Q 013028          266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG--KTAA  343 (451)
Q Consensus       266 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg--~~pf  343 (451)
                      ||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|+++  ..||
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  242 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY  242 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence            99999999999999999999999754332222223334567889999999888899999999999999999874  4455


Q ss_pred             ccccCCCCCCccccccchhhhhhHHhhhh---hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          344 MRRTNGLAGNWAKPYLSNKLALHQIIDEK---LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      ......       ...   ......+...   .....+...+..+.+|+.+||..||.+|||+.+|...|+
T Consensus       243 ~~~~~~-------~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         243 GELTDE-------QVI---ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CcCCHH-------HHH---HHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            432111       000   0000111100   011123345678999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.3e-43  Score=340.93  Aligned_cols=252  Identities=27%  Similarity=0.403  Sum_probs=202.9

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      |+..+.||+|+||.||+|..          ..++..||||.+.....   .....+.+|+.+++.++|+||+++++++.+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~----------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~   71 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQV----------RATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEE----------ecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence            67788999999999999764          44577899999875322   223456789999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++..++||||+++|+|.+++.......+++..+..++.|++.||.|||+  +||+||||||+|||++.++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~  149 (285)
T cd05631          72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLA  149 (285)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            9999999999999999988865445578999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ......   .......||..|+|||++.+..++.++|||||||++|+|++|..||........          ...+...
T Consensus       150 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----------~~~~~~~  216 (285)
T cd05631         150 VQIPEG---ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----------REEVDRR  216 (285)
T ss_pred             EEcCCC---CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----------HHHHHHH
Confidence            864321   122345789999999999999999999999999999999999999975432100          0001111


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT-----MSEVVAA  409 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~  409 (451)
                      + ......++...+..+.+|+.+||+.||.+||+     ++++++.
T Consensus       217 ~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         217 V-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             h-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            1 11112234445678999999999999999997     7888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.3e-43  Score=353.97  Aligned_cols=266  Identities=28%  Similarity=0.414  Sum_probs=209.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|++.+.||+|+||.||+|.+...+     ...+...||||.+..... ...+.+.+|+.+++.+ +|+||++++++|
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLG-----KEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCC-----cccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            347999999999999999998764321     233456799999975432 2345678999999999 799999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC------------------------------------------------------
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED------------------------------------------------------  232 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~------------------------------------------------------  232 (451)
                      .+....++||||+++|+|.+++....                                                      
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            99999999999999999999884321                                                      


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcc
Q 013028          233 --------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSH  298 (451)
Q Consensus       233 --------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  298 (451)
                                    ...+++..++.++.||+.||.|||+  +||+||||||+|||+++++.++|+|||+++.........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                          1247888999999999999999999  899999999999999999999999999997533222111


Q ss_pred             cccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCC
Q 013028          299 ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNI  377 (451)
Q Consensus       299 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (451)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |..||......             ...............
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-------------~~~~~~~~~~~~~~~  336 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-------------SKFYKMVKRGYQMSR  336 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-------------HHHHHHHHcccCccC
Confidence            1222335567999999988899999999999999999997 99988643211             111122222222223


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          378 QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       378 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                      +...+.++.+++.+||+.||.+|||+.+|++.|+++.
T Consensus       337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            3334688999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.2e-42  Score=335.63  Aligned_cols=247  Identities=25%  Similarity=0.425  Sum_probs=202.1

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeeccceeec----
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGYCCD----  208 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~~~~----  208 (451)
                      ..||+|++|.||+|.++            +..||||.+.......   .+.+.+|+.+|.+++||||+++++++.+    
T Consensus        26 ~~i~~g~~~~v~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~   93 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN------------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD   93 (283)
T ss_pred             eEEeeCCceEEEEEEEC------------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC
Confidence            57999999999998763            5679999997654333   3567799999999999999999999876    


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ....++||||+++|+|.+++..  ...+++...+.++.+++.||.|||+. .+++||||||+|||+++++.+||+|||++
T Consensus        94 ~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~  170 (283)
T PHA02988         94 LPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLE  170 (283)
T ss_pred             CCceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhc-CCCCCCcCChhhEEECCCCcEEEcccchH
Confidence            3568999999999999999965  35688999999999999999999973 48999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ......     .....|+..|+|||++.+  ..++.++|||||||++|||++|..||......             ....
T Consensus       171 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------------~~~~  232 (283)
T PHA02988        171 KILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------------EIYD  232 (283)
T ss_pred             hhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------------HHHH
Confidence            753221     123467889999999966  68999999999999999999999998643211             1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                      .+.........+...+..+.+|+.+||+.||++|||+.++++.|+.++.
T Consensus       233 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        233 LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            2222222333444567889999999999999999999999999999864

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-43  Score=342.73  Aligned_cols=247  Identities=23%  Similarity=0.305  Sum_probs=203.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++.+.||+|+||.||+|..          ..++..||+|++.....   ...+.+.+|+.+++.++||||+++++++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   70 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRD----------RISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE   70 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEE----------cCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh
Confidence            3788999999999999999764          44577899999864321   2345678899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .++...++||||+.+|+|.+++..  ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.++|+|||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          71 HDQRFLYMLMEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             ccCCeEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEEecC
Confidence            999999999999999999999854  4568999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++.....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||......             ....
T Consensus       147 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-------------~~~~  208 (291)
T cd05612         147 FAKKLRD-----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-------------GIYE  208 (291)
T ss_pred             cchhccC-----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------HHHH
Confidence            9975321     122457899999999998888999999999999999999999998643211             1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT-----MSEVVAAL  410 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L  410 (451)
                      .+...  ...++...+..+.+|+.+||..||.+||+     +.+++++-
T Consensus       209 ~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         209 KILAG--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             HHHhC--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence            11111  12233445678999999999999999995     88888663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-43  Score=319.59  Aligned_cols=254  Identities=29%  Similarity=0.412  Sum_probs=207.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC----CcCH----HHHHHHHHHHHhcC-CCce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG----SQGQ----DEWENELRFLSRLN-HPNV  199 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~----~~~~~E~~il~~l~-h~nI  199 (451)
                      ...|...+.||+|..++|.+          +.++.++..+|+|++....    ....    +.-..|+.||+++. ||+|
T Consensus        16 y~~y~pkeilgrgvss~vrR----------ci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~I   85 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRR----------CIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYI   85 (411)
T ss_pred             HhhcChHHHhcccchhhhhh----------hhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcE
Confidence            45788889999999999988          4566677789999886321    1112    33467999999986 9999


Q ss_pred             eeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          200 VKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       200 v~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      +++.++|+.+..+++|+|+|+.|.|+|+|..  .-.+++.+...|++|+++|+.|||.  ++||||||||+|||++++.+
T Consensus        86 I~l~D~yes~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILlddn~~  161 (411)
T KOG0599|consen   86 IDLQDVYESDAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILLDDNMN  161 (411)
T ss_pred             EEeeeeccCcchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheeeccccc
Confidence            9999999999999999999999999999955  5779999999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccc------cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA------TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN  353 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  353 (451)
                      ++|+|||+|+...   .+..-...+||++|+|||.+.      ...|+..+|+|++|||+|.|+.|++|||....     
T Consensus       162 i~isDFGFa~~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----  233 (411)
T KOG0599|consen  162 IKISDFGFACQLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----  233 (411)
T ss_pred             eEEeccceeeccC---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----
Confidence            9999999999744   344556889999999999883      35688999999999999999999999986431     


Q ss_pred             ccccccchhhhhhHHhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          354 WAKPYLSNKLALHQIIDEKLG--RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                              ..-+.-+......  .....+.+...++||.+||+.||.+|.|++|+|.+--.
T Consensus       234 --------mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff  286 (411)
T KOG0599|consen  234 --------MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF  286 (411)
T ss_pred             --------HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence                    1111222222221  12234557889999999999999999999999976444

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.4e-42  Score=334.36  Aligned_cols=263  Identities=29%  Similarity=0.502  Sum_probs=211.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+|++.+.||+|+||.||+|......     .......|++|.+..... .....+.+|+.++..++||||+++++++.+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPN-----ERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCC-----CCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            37889999999999999999865431     123446799999874432 224568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDD--------------TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL  274 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll  274 (451)
                      ....+++|||+++++|.+++.....              ..+++..++.++.|++.||.|||+  .||+|+||||+||++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nil~  157 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLV  157 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccceEEE
Confidence            9999999999999999999854321              458889999999999999999999  899999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCC
Q 013028          275 DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGN  353 (451)
Q Consensus       275 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~  353 (451)
                      ++++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||......    
T Consensus       158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----  233 (283)
T cd05048         158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----  233 (283)
T ss_pred             cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence            9999999999999975432222222334466788999999988889999999999999999998 98888643211    


Q ss_pred             ccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          354 WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                                .+...+........+...+.++.+|+.+||+.||.+||++.+|++.|+.+
T Consensus       234 ----------~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         234 ----------EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             ----------HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence                      11222222222334556678999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2e-43  Score=347.55  Aligned_cols=243  Identities=26%  Similarity=0.347  Sum_probs=198.4

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeeccceeecCCee
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHR  212 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~  212 (451)
                      +.||+|+||.||++.          +..++..||||++.....   .....+.+|+.+++.++||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~Vy~~~----------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   70 (323)
T cd05571           1 KLLGKGTFGKVILVR----------EKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRL   70 (323)
T ss_pred             CeeeeCCCeEEEEEE----------ECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEE
Confidence            469999999999965          445578899999975322   2234567899999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCC
Q 013028          213 LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP  292 (451)
Q Consensus       213 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~  292 (451)
                      |+||||+.+|+|.+++..  ...+++..+..++.||+.||.|||+  .||+||||||+|||++.++.+||+|||++....
T Consensus        71 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~  146 (323)
T cd05571          71 CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence            999999999999998854  4578999999999999999999999  899999999999999999999999999987422


Q ss_pred             CCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhh
Q 013028          293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK  372 (451)
Q Consensus       293 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (451)
                      .  ........+||+.|+|||++.+..++.++|||||||++|||++|..||......             .....+... 
T Consensus       147 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------------~~~~~~~~~-  210 (323)
T cd05571         147 S--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------------KLFELILME-  210 (323)
T ss_pred             c--CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-------------HHHHHHHcC-
Confidence            1  122233567999999999999899999999999999999999999998643211             011111111 


Q ss_pred             hcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          373 LGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       373 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                       ...++...+.++.+|+.+||..||++||     ++.+++++
T Consensus       211 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         211 -EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence             1233445678899999999999999999     79998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.9e-42  Score=349.41  Aligned_cols=267  Identities=28%  Similarity=0.403  Sum_probs=210.0

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcC-CCceeeccce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLN-HPNVVKLMGY  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~-h~nIv~~~~~  205 (451)
                      ..++|+++++||+|+||.||+|++...     ........||||++...... ..+.+.+|+++|.++. ||||++++++
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~-----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~  109 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGL-----SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA  109 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEccc-----CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence            356899999999999999999986432     12233557999999754332 3456889999999996 9999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCC-----------------------------------------------------
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNED-----------------------------------------------------  232 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------------------------------------------------  232 (451)
                      |.+....|||||||++|+|.+++....                                                     
T Consensus       110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence            999999999999999999998875321                                                     


Q ss_pred             -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCc
Q 013028          233 -----------------------------------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASN  271 (451)
Q Consensus       233 -----------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~N  271 (451)
                                                               ...+++..++.++.||+.||.|||+  .+|+|+||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp~N  267 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHh
Confidence                                                     1247788889999999999999999  899999999999


Q ss_pred             eeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCC
Q 013028          272 VLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGL  350 (451)
Q Consensus       272 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  350 (451)
                      ||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...... 
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-  346 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-  346 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-
Confidence            9999999999999999975432222222233456788999999988889999999999999999997 88887543211 


Q ss_pred             CCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          351 AGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                                  ......+........+...+..+.+++.+||+.||++|||+.+|.+.|+.+.
T Consensus       347 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         347 ------------STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                        0111112222222234455678999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.6e-42  Score=345.37  Aligned_cols=250  Identities=27%  Similarity=0.379  Sum_probs=195.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +.|+.+++||+|+||.||+|.+.          .++..||||++..... .....+.+|+++++.++|+||+++++++.+
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  143 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHR----------PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH  143 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEEC----------CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc
Confidence            36777899999999999997643          4467899999864432 224568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+++|+|.+..      ...+..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus       144 ~~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DfG~~  215 (353)
T PLN00034        144 NGEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVS  215 (353)
T ss_pred             CCeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEcccccc
Confidence            99999999999999986532      34567788999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCcccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIAT-----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      ......  ........||..|+|||++..     ...+.++|||||||++|||++|+.||.....   ..|.        
T Consensus       216 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~---~~~~--------  282 (353)
T PLN00034        216 RILAQT--MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ---GDWA--------  282 (353)
T ss_pred             eecccc--cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---ccHH--------
Confidence            753321  112234579999999998732     3345689999999999999999999873211   1110        


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      .+...+........+...+.++.+||.+||..||++|||+.|++++-
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp  329 (353)
T PLN00034        283 SLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP  329 (353)
T ss_pred             HHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            00011111112223445567899999999999999999999999863

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.7e-42  Score=342.09  Aligned_cols=267  Identities=22%  Similarity=0.322  Sum_probs=205.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|++.+.||+|+||.||++..          ..++..+|+|.+..... .....+.+|+++|+.++||||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   73 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQH----------KPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY   73 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEE----------CCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            35899999999999999999664          44567899999875422 23456889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +++..++||||+++|+|.+++..  ...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.++|+|||+
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  150 (331)
T cd06649          74 SDGEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGV  150 (331)
T ss_pred             ECCEEEEEeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCcc
Confidence            99999999999999999999854  35689999999999999999999982 3699999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC------------CCcc
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA------------GNWA  355 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~------------~~~~  355 (451)
                      +.....    .......|+..|+|||++.+..++.++|||||||++|+|++|+.||........            ..+.
T Consensus       151 ~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (331)
T cd06649         151 SGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEP  226 (331)
T ss_pred             cccccc----cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCc
Confidence            874321    122345789999999999888999999999999999999999999864321100            0000


Q ss_pred             ccc-----------------cchhhhhhHHhhhhh----cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          356 KPY-----------------LSNKLALHQIIDEKL----GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       356 ~~~-----------------~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                      ...                 ...........+...    ........+.++.+|+.+||..||++|||+.++++..--
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~  304 (331)
T cd06649         227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI  304 (331)
T ss_pred             cccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence            000                 000000111111111    111122346789999999999999999999999987543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.7e-43  Score=354.50  Aligned_cols=264  Identities=25%  Similarity=0.345  Sum_probs=206.5

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CC-----ceee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HP-----NVVK  201 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~-----nIv~  201 (451)
                      +.-+|.+++.||+|+||.|.+|+          +..+++.||||+++... .-......|+.||..|+ |.     |||+
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~----------d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vr  252 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAY----------DHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVR  252 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEE----------ecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEE
Confidence            33489999999999999999976          55668899999997543 22334456999999997 53     8999


Q ss_pred             ccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC--CCc
Q 013028          202 LMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD--DFN  279 (451)
Q Consensus       202 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~--~~~  279 (451)
                      ++++|...+|+|||+|++ ..+|++++..+.-..++...+..|+.||+.||.+||+  .+|||+||||+||||.+  ...
T Consensus       253 m~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~~  329 (586)
T KOG0667|consen  253 MLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRSR  329 (586)
T ss_pred             eeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcCc
Confidence            999999999999999999 5699999988877889999999999999999999999  89999999999999964  347


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--------
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--------  351 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--------  351 (451)
                      +||+|||.|++..    .... .++.+.+|+|||++.|.+|+.+.||||||||++||++|.+.|.+..+.+.        
T Consensus       330 vKVIDFGSSc~~~----q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l  404 (586)
T KOG0667|consen  330 IKVIDFGSSCFES----QRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL  404 (586)
T ss_pred             eeEEecccccccC----Ccce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence            9999999999633    2222 67789999999999999999999999999999999999988877666432        


Q ss_pred             -------------------C-Cccccccchhh---------hhhHHhhhhhcCCCC-----------HHHHHHHHHHHHH
Q 013028          352 -------------------G-NWAKPYLSNKL---------ALHQIIDEKLGRNIQ-----------MEEAQEFAEIILR  391 (451)
Q Consensus       352 -------------------~-~~~~~~~~~~~---------~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~  391 (451)
                                         . .|...+.....         ....+.........+           ......+.+|+.+
T Consensus       405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~  484 (586)
T KOG0667|consen  405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR  484 (586)
T ss_pred             CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence                               0 11111000000         000000001111111           1235678999999


Q ss_pred             ccccCCCCCCCHHHHHHHH
Q 013028          392 CLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       392 cl~~dP~~RPt~~evl~~L  410 (451)
                      ||.+||.+|+|+.|+|++=
T Consensus       485 ~L~~dP~~R~tp~qal~Hp  503 (586)
T KOG0667|consen  485 CLEWDPAERITPAQALNHP  503 (586)
T ss_pred             HhccCchhcCCHHHHhcCc
Confidence            9999999999999999863

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.2e-42  Score=332.28  Aligned_cols=261  Identities=28%  Similarity=0.474  Sum_probs=209.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +.|.+.+.||+|+||.||+|.+...     ........||||.+...... ..+.+.+|+++|+.++|+||+++++++..
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   79 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHL-----EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE   79 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccc-----cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence            4788899999999999999876432     12244678999999755443 34678999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNED------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD  276 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~  276 (451)
                      +...++||||+++++|.+++....            ...+++..+..++.|++.||.|||+  +|++||||||+|||++.
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~nili~~  157 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNCLVGY  157 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceEEEcC
Confidence            999999999999999999986432            2457889999999999999999999  89999999999999999


Q ss_pred             CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCcc
Q 013028          277 DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWA  355 (451)
Q Consensus       277 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~  355 (451)
                      ++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......      
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~------  231 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE------  231 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH------
Confidence            99999999999974322221112223445778999999999999999999999999999998 99887643221      


Q ss_pred             ccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          356 KPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                              .....+........+...+..+.+++.+||..||++||++.|+++.|+
T Consensus       232 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         232 --------EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             --------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                    111111122222233456788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-43  Score=347.91  Aligned_cols=253  Identities=24%  Similarity=0.317  Sum_probs=202.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +|++.+.||+|+||.||+|.+.          .++..||||++....   ......+.+|+.++..++||||+++++++.
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~   71 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKK----------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ   71 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEEC----------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            6889999999999999997644          446789999997532   223456788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +++..||||||++||+|.+++..  ...+++..+..++.||+.||.|||+  .||+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~  147 (333)
T cd05600          72 DDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLIDASGHIKLTDFGL  147 (333)
T ss_pred             cCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEEEeCcC
Confidence            99999999999999999999854  4568999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +.....     ......||+.|+|||++.+..++.++|||||||++|||++|..||.......       ..........
T Consensus       148 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~  215 (333)
T cd05600         148 SKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-------TWENLKYWKE  215 (333)
T ss_pred             Cccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-------HHHHHHhccc
Confidence            975322     2345679999999999988899999999999999999999999986432210       0000000000


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+............+.++.+|+.+||..+|.+||++.++++.
T Consensus       216 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         216 TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000000000011346789999999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.1e-42  Score=332.46  Aligned_cols=267  Identities=25%  Similarity=0.439  Sum_probs=211.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ..|.+.+.||+|+||.||++...+.     ....+...+|+|.+..........+.+|+++++.++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~-----~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNL-----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccC-----CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            4788999999999999999875431     12344567999998765544556789999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNED-----------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF  278 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~  278 (451)
                      +..++||||+++++|.+++....           ...+++..+..++.|++.||.|||+  +||+||||||+|||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCC
Confidence            99999999999999999985432           2358999999999999999999999  8999999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCcccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  357 (451)
                      .++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......        
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------  229 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------  229 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence            999999999975332221112223445778999999988889999999999999999998 88887543211        


Q ss_pred             ccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                           .....+. .......+...+.++.+|+.+||+.||.+|||+.++++.|+++....
T Consensus       230 -----~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         230 -----EVIECIT-QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             -----HHHHHHH-cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence                 0111111 11111222334578999999999999999999999999999997553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.6e-43  Score=346.59  Aligned_cols=246  Identities=25%  Similarity=0.344  Sum_probs=202.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      +.|++.+.||+|+||.||+|.+.          .++..||||++....   ....+.+.+|+.+++.++||||+++++++
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   87 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHK----------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF   87 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEEC----------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            47899999999999999997643          456789999987532   22345678999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++..++||||+.||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        88 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg  163 (329)
T PTZ00263         88 QDENRVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFG  163 (329)
T ss_pred             EcCCEEEEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999999854  4568899999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||......             ....
T Consensus       164 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------------~~~~  225 (329)
T PTZ00263        164 FAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------------RIYE  225 (329)
T ss_pred             CceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-------------HHHH
Confidence            99753221     22457999999999998888999999999999999999999998643210             0111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT-----MSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~  409 (451)
                      .+....  ..++...+..+.+|+.+||+.||.+||+     +.+++++
T Consensus       226 ~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        226 KILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             HHhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            111111  1233345678999999999999999996     6888765

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.2e-42  Score=329.41  Aligned_cols=259  Identities=22%  Similarity=0.390  Sum_probs=207.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+|++.+.||+|+||.||+|.++.       .......||+|.+...... ....+.+|+.+++.++||||+++++++..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~-------~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   77 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKL-------PSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR   77 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEec-------CCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence            478899999999999999997643       1234678999999754322 23568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+  +|++||||||+|||++.++.++++|||.+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~dfg~~  154 (266)
T cd05064          78 GNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISGFRRL  154 (266)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECCCccc
Confidence            99999999999999999988653 3468999999999999999999999  89999999999999999999999999987


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ....... ........++..|+|||++.+..++.++|||||||++|||++ |..||+.....              ....
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------------~~~~  219 (266)
T cd05064         155 QEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------------DVIK  219 (266)
T ss_pred             ccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------------HHHH
Confidence            6422111 111112334568999999988999999999999999999875 99988643221              1111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      .+........+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         220 AVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            1122222233445678899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.7e-42  Score=332.58  Aligned_cols=266  Identities=27%  Similarity=0.452  Sum_probs=212.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .+|.+.+.||+|+||.||+|.....     ....+...+++|.+........+.+.+|+++++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~-----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNL-----SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeecc-----CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            3688889999999999999875432     12244566899998755544456788999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD  275 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~  275 (451)
                      ...++||||+++++|.+++....              ...+++..++.++.||+.||.|||+  +||+||||||+|||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil~~  157 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATRNCLVG  157 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEc
Confidence            99999999999999999985432              2458899999999999999999999  8999999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCc
Q 013028          276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNW  354 (451)
Q Consensus       276 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~  354 (451)
                      .++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......     
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----  232 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-----  232 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence            999999999999975332222222234456788999999988899999999999999999998 98887543221     


Q ss_pred             cccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                               .....+........+...+..+.+++.+||+.||++|||+.+|++.|+++...
T Consensus       233 ---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         233 ---------EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             ---------HHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                     01111111111222334567899999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.1e-42  Score=357.63  Aligned_cols=254  Identities=21%  Similarity=0.299  Sum_probs=204.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      .|.+.+.||+|+||.||+|....         ..+..||+|.+..........+.+|+.+|+.++||||++++++|..++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~---------~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~  138 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGS---------DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD  138 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcC---------CCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence            58899999999999999975322         225678888775444444456788999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +.||||||++||+|.+++...  ....+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DFgla  216 (478)
T PTZ00267        139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFS  216 (478)
T ss_pred             EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence            999999999999999887532  34568899999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ...............+||+.|+|||++.+..++.++|||||||++|+|++|..||.....             ...+..+
T Consensus       217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------------~~~~~~~  283 (478)
T PTZ00267        217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------------REIMQQV  283 (478)
T ss_pred             eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------------HHHHHHH
Confidence            864432222234456799999999999888999999999999999999999999864321             0111111


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .... ....+...+.++.+|+.+||..||++||++.+++..
T Consensus       284 ~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        284 LYGK-YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             HhCC-CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            1111 112333456789999999999999999999998753

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.3e-42  Score=340.88  Aligned_cols=267  Identities=30%  Similarity=0.414  Sum_probs=207.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|++.+.||.|+||.||+|.....     .+..+++.||+|++...... ..+.+..|+.++.++ +|+||++++++|
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~-----~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGI-----EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             HHHhhhhcccccCcCceEEecccccc-----ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            35899999999999999999864331     13345678999998743222 234577899999999 799999999988


Q ss_pred             ec-CCeeEEEEeccCCCChhhhhccCC-----------------------------------------------------
Q 013028          207 CD-DQHRLLVYEYVTRGSLEDHLLNED-----------------------------------------------------  232 (451)
Q Consensus       207 ~~-~~~~~lV~E~~~gg~L~~~l~~~~-----------------------------------------------------  232 (451)
                      .. +...++||||+++++|.+++....                                                     
T Consensus        81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            64 456889999999999999885321                                                     


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCC
Q 013028          233 ------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT  306 (451)
Q Consensus       233 ------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt  306 (451)
                            ...+++..+..++.||+.||.|||+  .||+||||||+|||++.++.++|+|||++................++
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                  1268899999999999999999999  89999999999999999999999999999854322211122234556


Q ss_pred             CccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHH
Q 013028          307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEF  385 (451)
Q Consensus       307 ~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (451)
                      ..|+|||++.+..++.++|||||||++|||++ |..||......             ..+...+........+...+.++
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~  305 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-------------EEFCRRLKEGTRMRAPEYATPEI  305 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-------------HHHHHHHhccCCCCCCccCCHHH
Confidence            78999999999999999999999999999998 98888642211             01111222222222334456789


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          386 AEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       386 ~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                      .+++.+||+.+|++||++.|+++.|+.+..
T Consensus       306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-44  Score=348.30  Aligned_cols=255  Identities=29%  Similarity=0.487  Sum_probs=213.3

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      ++..+....++-||.|+.|.||+|.+++            +.||||.++...       +.+|+-|++|+|+||+.|.|+
T Consensus       120 eiPFe~IsELeWlGSGaQGAVF~Grl~n------------etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGV  180 (904)
T KOG4721|consen  120 EIPFEEISELEWLGSGAQGAVFLGRLHN------------ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGV  180 (904)
T ss_pred             cCCHHHhhhhhhhccCcccceeeeeccC------------ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeee
Confidence            3344455667889999999999998764            569999886432       358889999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      |.....+|||||||..|-|...|..  ...++......|..+||.|+.|||.  +.|||||||.-||||+.+..+||+||
T Consensus       181 CtqsPcyCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~--hKIIHRDLKSPNiLIs~~d~VKIsDF  256 (904)
T KOG4721|consen  181 CTQSPCYCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHL--HKIIHRDLKSPNILISYDDVVKISDF  256 (904)
T ss_pred             ecCCceeEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHH--hhHhhhccCCCceEeeccceEEeccc
Confidence            9999999999999999999999954  6778899999999999999999999  78999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |-++...   ....+..++||..|||||++...+.+.++|||||||||||||||..|+..-...       ..      +
T Consensus       257 GTS~e~~---~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-------AI------I  320 (904)
T KOG4721|consen  257 GTSKELS---DKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-------AI------I  320 (904)
T ss_pred             cchHhhh---hhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-------ee------E
Confidence            9998532   223455789999999999999999999999999999999999999987532211       11      1


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      ..+-...+....+..+++.|+-|+..||+..|..||++.++|.+|+-...++-.
T Consensus       321 wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~  374 (904)
T KOG4721|consen  321 WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLS  374 (904)
T ss_pred             EeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhc
Confidence            122234445567788899999999999999999999999999999877555443

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.1e-42  Score=330.34  Aligned_cols=263  Identities=27%  Similarity=0.420  Sum_probs=205.3

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ..++|++.+.||+|+||.||+|.+...     .....+..||||.+..... .....+.+|+.+++.++|+||+++++++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~-----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGV-----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccC-----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            356899999999999999999886532     1223457799999864322 2234678999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED--------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF  278 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~  278 (451)
                      .++...++||||+.+++|.+++....        ...+++..++.++.|++.||.|||+  .|++|+||||+||++++++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEEcCCC
Confidence            99999999999999999999985422        1346788899999999999999999  8999999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCcccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  357 (451)
                      .++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||......        
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------  228 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------  228 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence            999999999874332221111122345778999999988889999999999999999999 67776532211        


Q ss_pred             ccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                            .....+........+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus       229 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         229 ------QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                  111111111112233445678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=340.51  Aligned_cols=241  Identities=25%  Similarity=0.349  Sum_probs=195.5

Q ss_pred             ccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       138 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      ||+|+||.||+|..          ..++..||+|++....   ......+.+|+.++..++||||+++++++.+++..++
T Consensus         1 lg~G~~g~Vy~~~~----------~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   70 (312)
T cd05585           1 IGKGSFGKVMQVRK----------RDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYL   70 (312)
T ss_pred             CCcCCCeEEEEEEE----------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEE
Confidence            79999999999764          4457789999987432   2334567789999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCC
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG  294 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  294 (451)
                      ||||+++|+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+|||++..... 
T Consensus        71 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-  145 (312)
T cd05585          71 VLAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK-  145 (312)
T ss_pred             EEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCcc-
Confidence            9999999999999854  4568999999999999999999999  8999999999999999999999999999975321 


Q ss_pred             CCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhc
Q 013028          295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG  374 (451)
Q Consensus       295 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (451)
                       .........||+.|+|||++.+..++.++|||||||++|+|++|..||......             .....+...  .
T Consensus       146 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------------~~~~~~~~~--~  209 (312)
T cd05585         146 -DDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------------EMYRKILQE--P  209 (312)
T ss_pred             -CCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-------------HHHHHHHcC--C
Confidence             122234567999999999999999999999999999999999999998643211             111111111  1


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 013028          375 RNIQMEEAQEFAEIILRCLNSDPKNRPT---MSEVVAA  409 (451)
Q Consensus       375 ~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~  409 (451)
                      ..++...+..+.+|+.+||..||.+||+   +.+++++
T Consensus       210 ~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         210 LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            2234456688999999999999999985   5666553

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.8e-42  Score=332.21  Aligned_cols=263  Identities=21%  Similarity=0.274  Sum_probs=199.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|++.+.||+|+||.||+|.+.          .++..||||++....  ....+.+.+|+++++.++|+||+++++++.+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~----------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHK----------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR   71 (287)
T ss_pred             CceEEEEecccCCEEEEEEEEC----------CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence            7899999999999999997644          456789999987542  2234567889999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++..++||||++++.|..+..  ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  147 (287)
T cd07848          72 RGKLYLVFEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFA  147 (287)
T ss_pred             CCEEEEEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence            999999999999876655442  23568999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC----Cccccccchh--
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG----NWAKPYLSNK--  362 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~----~~~~~~~~~~--  362 (451)
                      ....... ........|+..|+|||++.+..++.++|||||||++|+|++|.+||.........    ....+.....  
T Consensus       148 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd07848         148 RNLSEGS-NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK  226 (287)
T ss_pred             ccccccc-cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence            8643221 11223457899999999998888999999999999999999999998653321000    0000000000  


Q ss_pred             -----hhhhHHhhhh------hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          363 -----LALHQIIDEK------LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       363 -----~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                           ..........      .........+.++.+|+.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 0000000000      000011124577999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-42  Score=341.30  Aligned_cols=243  Identities=28%  Similarity=0.372  Sum_probs=197.9

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccceeecCCee
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHR  212 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~  212 (451)
                      +.||+|+||.||++.          +..++..||+|++....   ......+.+|+.+++.++||||++++++|.+.+..
T Consensus         1 ~~lG~G~~g~Vy~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~   70 (323)
T cd05595           1 KLLGKGTFGKVILVR----------EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   70 (323)
T ss_pred             CeeeeCCCEEEEEEE----------ECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEE
Confidence            469999999999965          44557889999997532   22334567899999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCC
Q 013028          213 LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP  292 (451)
Q Consensus       213 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~  292 (451)
                      |+||||+++|+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++....
T Consensus        71 ~lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          71 CFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            999999999999988854  4578999999999999999999999  899999999999999999999999999987422


Q ss_pred             CCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhh
Q 013028          293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK  372 (451)
Q Consensus       293 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (451)
                      .  .........||..|+|||++.+..++.++|||||||++|+|++|..||......             .....+... 
T Consensus       147 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------------~~~~~~~~~-  210 (323)
T cd05595         147 S--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------------RLFELILME-  210 (323)
T ss_pred             C--CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------------HHHHHHhcC-
Confidence            1  112233467999999999998889999999999999999999999998643221             111111111 


Q ss_pred             hcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          373 LGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       373 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                       ...++...++++.+|+.+||..||++|+     ++.++++.
T Consensus       211 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         211 -EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence             1223445678899999999999999998     89988874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.4e-42  Score=332.45  Aligned_cols=264  Identities=20%  Similarity=0.293  Sum_probs=199.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++.++||.|+||+||+|..          ..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   74 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRS----------KLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT   74 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEE----------CCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            4799999999999999999754          44577899999875432 234467789999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+++ +|.+++... ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~DfG~~  150 (288)
T cd07871          75 ERCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLA  150 (288)
T ss_pred             CCeEEEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEECcCcce
Confidence            9999999999975 898887543 3457899999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC-----------Cccc
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG-----------NWAK  356 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~-----------~~~~  356 (451)
                      ......  ........|+..|+|||++.+ ..++.++|||||||++|+|++|.+||.........           .-.+
T Consensus       151 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07871         151 RAKSVP--TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW  228 (288)
T ss_pred             eeccCC--CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence            753221  112234568899999999865 56899999999999999999999998654321100           0000


Q ss_pred             cccchhhhhhHHhhhhhcC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          357 PYLSNKLALHQIIDEKLGR----NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +.......+..........    ......+.++.+|+.+||..||.+|||+.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000000000000000000    0011235678999999999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.4e-42  Score=342.23  Aligned_cols=243  Identities=25%  Similarity=0.346  Sum_probs=198.3

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccceeecCCee
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHR  212 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~  212 (451)
                      +.||+|+||.||++.          +..++..||||++.+..   ......+.+|+.+++.++||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~Vy~~~----------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   70 (328)
T cd05593           1 KLLGKGTFGKVILVR----------EKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRL   70 (328)
T ss_pred             CeeeeCCCEEEEEEE----------ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEE
Confidence            469999999999965          44557889999997542   22345677899999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCC
Q 013028          213 LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP  292 (451)
Q Consensus       213 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~  292 (451)
                      ++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++....
T Consensus        71 ~lv~Ey~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          71 CFVMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             EEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            999999999999988854  4568999999999999999999999  899999999999999999999999999987422


Q ss_pred             CCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhh
Q 013028          293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK  372 (451)
Q Consensus       293 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (451)
                      .  ........+||+.|+|||++.+..++.++|||||||++|+|++|..||......             .....+..  
T Consensus       147 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------------~~~~~~~~--  209 (328)
T cd05593         147 T--DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------------KLFELILM--  209 (328)
T ss_pred             C--cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-------------HHHHHhcc--
Confidence            1  112233467999999999998889999999999999999999999998643211             00111111  


Q ss_pred             hcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          373 LGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       373 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      ....++...+.++.+|+.+||..||.+|+     ++.++++.
T Consensus       210 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         210 EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            11223445568899999999999999997     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.9e-43  Score=327.93  Aligned_cols=263  Identities=22%  Similarity=0.311  Sum_probs=203.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCc-eeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPN-VVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~n-Iv~~~~~~  206 (451)
                      ..|..+++||+|+||+||+|.          .+.++..||+|.++-....  ......+|+.+|+.|+|+| |+.+++++
T Consensus        11 ~~~~~~eklGeGtyg~Vykar----------~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~   80 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKAR----------SKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVI   80 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEE----------EecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeee
Confidence            367778899999999999955          5666789999999854332  3345678999999999999 99999999


Q ss_pred             ecCC------eeEEEEeccCCCChhhhhccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC
Q 013028          207 CDDQ------HRLLVYEYVTRGSLEDHLLNEDD--TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF  278 (451)
Q Consensus       207 ~~~~------~~~lV~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~  278 (451)
                      ...+      .++||+||++ .+|.+++.....  ..++...+..+++||+.||+|||+  ++|+||||||.||||+++|
T Consensus        81 ~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi~~~G  157 (323)
T KOG0594|consen   81 HTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLISSSG  157 (323)
T ss_pred             eecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEECCCC
Confidence            8877      7899999996 499999866543  467778899999999999999999  8999999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCC------
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA------  351 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~------  351 (451)
                      .+||+|||+|+....  .....+.-++|..|+|||++.+. .|+..+||||+|||++||+++++.|.+..+...      
T Consensus       158 ~lKlaDFGlAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~  235 (323)
T KOG0594|consen  158 VLKLADFGLARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR  235 (323)
T ss_pred             cEeeeccchHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence            999999999985332  22335567889999999999885 799999999999999999999999877655321      


Q ss_pred             -------CCccccccchhhhhhHHhhhhh-cCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 -------GNWAKPYLSNKLALHQIIDEKL-GRNIQ---MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 -------~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                             ..|..  ..........+.... .....   .....+..+++.+||+.+|.+|.|+..++++
T Consensus       236 ~lGtP~e~~Wp~--v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  236 LLGTPNEKDWPG--VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HcCCCCccCCCC--ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                   11111  100000000000000 00000   1112578999999999999999999999986

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-41  Score=328.47  Aligned_cols=273  Identities=29%  Similarity=0.462  Sum_probs=208.3

Q ss_pred             CC-CcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KF-SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y-~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +| .+.+.||+|+||+||++.+..      ....++..||+|.+..... .....+.+|+++|+.++||||+++++++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDP------ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE   77 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEcc------ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            44 889999999999999876542      2345577899999875432 234668899999999999999999998765


Q ss_pred             C--CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          209 D--QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       209 ~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .  ...++||||+++++|.+++..   ..+++..+..++.|++.||.|||+  ++|+|+||||+|||++.++.++|+|||
T Consensus        78 ~~~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          78 QGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             CCCceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcEEEeecc
Confidence            3  467899999999999999854   358999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcc-cccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc-cchhhh
Q 013028          287 LAKFGPLGDKSH-ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY-LSNKLA  364 (451)
Q Consensus       287 la~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~  364 (451)
                      ++.......... ......++..|+|||++.+..++.++||||||+++|+|++|..|+............... ......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05080         153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR  232 (283)
T ss_pred             cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence            998643322111 112234566799999998888999999999999999999999987543321110000000 000111


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                      +.+.+........+...+.++.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            22222222222334455788999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-42  Score=345.18  Aligned_cols=259  Identities=21%  Similarity=0.253  Sum_probs=198.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ..+|+++++||+|+||.||++.          +..++..||+|....      ..+.+|+++|+.|+||||++++++|..
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~----------d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~  154 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACI----------DNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTY  154 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEE----------ECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence            3579999999999999999965          445577899997532      346789999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ....++|||++. ++|..++..  ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.++|+|||+|
T Consensus       155 ~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll~~~~~vkL~DFG~a  229 (391)
T PHA03212        155 NKFTCLILPRYK-TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFGAA  229 (391)
T ss_pred             CCeeEEEEecCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence            999999999995 689888854  3568899999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc--------------
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW--------------  354 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~--------------  354 (451)
                      ...... .........||+.|+|||++.+..++.++|||||||++|||++|..||...........              
T Consensus       230 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~  308 (391)
T PHA03212        230 CFPVDI-NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT  308 (391)
T ss_pred             cccccc-cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence            743211 11223356899999999999888999999999999999999999988765432110000              


Q ss_pred             -ccccc-chhhhhhHHhhhhh---cC---CC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          355 -AKPYL-SNKLALHQIIDEKL---GR---NI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       355 -~~~~~-~~~~~~~~~~~~~~---~~---~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                       ...+. .....+...+....   ..   ..     ....+.++.+|+.+||+.||.+|||+.|+|+.
T Consensus       309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             00000 00001111110000   00   00     01235689999999999999999999999964

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.9e-42  Score=338.51  Aligned_cols=264  Identities=23%  Similarity=0.376  Sum_probs=202.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|++.++||.|+||.||++.+          ..++..+|+|.+..... .....+.+|+++++.++|+||++++++|.
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~----------~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   73 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSH----------KPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY   73 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEE----------CCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE
Confidence            35899999999999999999764          34567799998875422 23456889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +++..++||||+.+|+|.+++..  ...+++..+..++.+++.||.|||+. .+|+|+||||+|||++.++.+||+|||+
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~  150 (333)
T cd06650          74 SDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGV  150 (333)
T ss_pred             ECCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCc
Confidence            99999999999999999999854  35688999999999999999999972 3799999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC---------CCcccc-
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA---------GNWAKP-  357 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~---------~~~~~~-  357 (451)
                      +.....    .......|+..|+|||++.+..++.++|||||||++|+|++|..||........         ..+... 
T Consensus       151 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (333)
T cd06650         151 SGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE  226 (333)
T ss_pred             chhhhh----hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccc
Confidence            874321    122345789999999999888899999999999999999999999864332100         000000 


Q ss_pred             --------------c---cchhhhhhHHhhhhhc---CCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          358 --------------Y---LSNKLALHQIIDEKLG---RNI-QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       358 --------------~---~~~~~~~~~~~~~~~~---~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                                    +   .........+......   ... ....+.++.+|+.+||+.||++|||+.|++..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             cCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                          0   0000000011111111   111 11235779999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-41  Score=324.00  Aligned_cols=255  Identities=27%  Similarity=0.461  Sum_probs=206.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|++.++||+|+||.||+|....           +..||+|.+... ....+.+.+|+.+++.++|+||+++++.+.+.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~-----------~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNN-----------STKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE   73 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecC-----------CceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            588999999999999999987543           346899987643 23456788999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +..++||||+++++|.+++.......+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~  151 (261)
T cd05072          74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLAR  151 (261)
T ss_pred             CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccce
Confidence            999999999999999999976656778999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHH
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......              .....
T Consensus       152 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------------~~~~~  216 (261)
T cd05072         152 VIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------------DVMSA  216 (261)
T ss_pred             ecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------------HHHHH
Confidence            5432211 11223345678999999988889999999999999999998 88887543211              11111


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      +............+.++.+++.+||..+|++||+++++++.|+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         217 LQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            111111222234567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.5e-43  Score=358.71  Aligned_cols=267  Identities=30%  Similarity=0.498  Sum_probs=217.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +.+.+..++||+|+||.||+|......     -......||||.++..... .+.+|++|+++|..|+|||||+|+|+|.
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~-----p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLL-----PGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCC-----CCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            456777899999999999998765421     1244677999999876665 6789999999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccC--------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNE--------D----DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD  275 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~--------~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~  275 (451)
                      +++.+|||+|||..|+|.++|...        .    ...++..+.+.||.|||.|+.||-+  +.+|||||..+|+||.
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~--~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS--HHFVHRDLATRNCLVG  637 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--Ccccccchhhhhceec
Confidence            999999999999999999999532        1    1238899999999999999999999  8899999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCc
Q 013028          276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNW  354 (451)
Q Consensus       276 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~  354 (451)
                      ++..|||+|||+++..-..++-.......-...||+||-++.++|+.++|||||||+|||+++ |..|+.+..+      
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------  711 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------  711 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch------
Confidence            999999999999984222222222111222457999999999999999999999999999998 6666654433      


Q ss_pred             cccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                             .+-+..+-...+ -..+..++.++++||..||+.+|++||+++||-..|+..-..
T Consensus       712 -------~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  712 -------QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             -------HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                   222223333333 566788899999999999999999999999999999987554

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.3e-41  Score=327.97  Aligned_cols=261  Identities=25%  Similarity=0.451  Sum_probs=206.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +.|++.++||+|+||+||+|.+...      +......|++|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   78 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLP------GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ   78 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecC------CCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Confidence            4688889999999999999976422      233467899999874332 223568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcee
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNED---------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL  273 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIl  273 (451)
                      +...++||||+.+++|.+++....               ...+++..+..++.|++.||.|||+  +||+|+||||+|||
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~nil  156 (283)
T cd05090          79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNIL  156 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccceEE
Confidence            999999999999999999884321               2357888999999999999999999  89999999999999


Q ss_pred             eCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCC
Q 013028          274 LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAG  352 (451)
Q Consensus       274 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~  352 (451)
                      ++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.....    
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----  232 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----  232 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----
Confidence            99999999999999975332222222334456678999999988889999999999999999998 8888753221    


Q ss_pred             CccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          353 NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                                ....+.+........+...+..+.+++.+||+.||.+||++.+|++.|..
T Consensus       233 ----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 ----------QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ----------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                      11112222222222334456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-41  Score=322.79  Aligned_cols=260  Identities=26%  Similarity=0.468  Sum_probs=208.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++.+.||+|+||+||+|.+...       ......||||.+...... ....+.+|+.+++.++|+||+++++++.+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~-------~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLP-------GKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK   76 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccC-------CCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence            4788999999999999999986432       223567999998754322 34568889999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+  .+|+|+||||+|||++.++.++|+|||++
T Consensus        77 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          77 SRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             CCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECccchh
Confidence            999999999999999999986543 478999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ................++..|+|||.+.+..++.++||||||+++|+|++ |..||......              .+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------------~~~~  219 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------------DVIK  219 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--------------HHHH
Confidence            86532222112222344568999999988889999999999999999998 88887532211              1111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      .+........+...+..+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus       220 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         220 AVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1111112223344567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-42  Score=343.53  Aligned_cols=247  Identities=25%  Similarity=0.308  Sum_probs=202.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|.+.+.||+|+||.||+|.+...         ....||+|.+....   ....+.+.+|+.+++.++||||+++++++
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~  100 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNE---------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF  100 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECC---------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence            4799999999999999999865331         23579999986432   23345678899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .++...|+||||+.+|+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+|||
T Consensus       101 ~~~~~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG  176 (340)
T PTZ00426        101 KDESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFG  176 (340)
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCC
Confidence            999999999999999999999854  4568999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++.....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||......             ....
T Consensus       177 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------------~~~~  238 (340)
T PTZ00426        177 FAKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------------LIYQ  238 (340)
T ss_pred             CCeecCC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------------HHHH
Confidence            9975321     123467999999999998888999999999999999999999999753321             0111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      .+....  ..++...+..+.+++.+||+.||.+|+     ++.+++++
T Consensus       239 ~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        239 KILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            121111  123444567799999999999999995     88888875

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-41  Score=333.60  Aligned_cols=264  Identities=24%  Similarity=0.390  Sum_probs=208.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+|++.+.||+|+||.||+|.+...      .......||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~   80 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPE------GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   80 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecC------CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence            4799999999999999999986532      122234589999864322 334678889999999999999999999876


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      . ..++|+||+.+|+|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        81 ~-~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~DfG~a  156 (316)
T cd05108          81 S-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLA  156 (316)
T ss_pred             C-CceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEcccccc
Confidence            5 568999999999999998654 3458889999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +...............++..|+|||++.+..++.++|||||||++|||++ |..||.....              ..+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------------~~~~~  222 (316)
T cd05108         157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------------SEISS  222 (316)
T ss_pred             ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------------HHHHH
Confidence            86443222222222334667999999988999999999999999999997 8888754211              11122


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                      ++........+...+.++.+++.+||..+|.+||++.+++..|..+....
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         223 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             HHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            22222222233445677999999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.3e-42  Score=344.38  Aligned_cols=252  Identities=24%  Similarity=0.348  Sum_probs=198.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++.+.||+|+||+||++.          +..++..||||++.+..   ......+.+|+.++..++|+||+++++.+
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~----------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~   70 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQ----------KKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF   70 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEE----------ECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            378899999999999999965          44457789999997532   22234578899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .++...||||||++||+|.+++..  ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        71 ~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          71 QDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             ecCCeEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeecc
Confidence            999999999999999999999865  4578999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCC---------------------------------cccccccCCCCccccccccccCCCCcchhhHHHHHHH
Q 013028          287 LAKFGPLGDK---------------------------------SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVL  333 (451)
Q Consensus       287 la~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil  333 (451)
                      ++........                                 .......+||+.|+|||++.+..++.++|||||||++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil  226 (363)
T cd05628         147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (363)
T ss_pred             CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence            9874321110                                 0011245799999999999999999999999999999


Q ss_pred             HHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCC--HHHHHHHHHHHHHccccCCC---CCCCHHHHHH
Q 013028          334 LEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQ--MEEAQEFAEIILRCLNSDPK---NRPTMSEVVA  408 (451)
Q Consensus       334 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~---~RPt~~evl~  408 (451)
                      |||++|..||......             .....+........++  ...+.++.+|+.+|+. +|.   .||++.|+++
T Consensus       227 ~ell~G~~Pf~~~~~~-------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~  292 (363)
T cd05628         227 YEMLIGYPPFCSETPQ-------------ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT  292 (363)
T ss_pred             HHHHhCCCCCCCCCHH-------------HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence            9999999999653321             1111111111111111  1245778899988665 444   4689999998


Q ss_pred             H
Q 013028          409 A  409 (451)
Q Consensus       409 ~  409 (451)
                      +
T Consensus       293 h  293 (363)
T cd05628         293 N  293 (363)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-41  Score=324.39  Aligned_cols=256  Identities=26%  Similarity=0.442  Sum_probs=208.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ..|.+.+.||+|+||.||+|.+.          ..+..||+|.+... ......+.+|+++++.++|+||+++++++..+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~----------~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWK----------KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   74 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEe----------cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence            36788899999999999997754          34667999998743 33456788999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++++|.+++.......+++..++.++.|++.||.|||+  .||+||||||+|||+++++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          75 PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence            999999999999999999876555678999999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHH
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.....              ......
T Consensus       153 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------------~~~~~~  217 (263)
T cd05052         153 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------------SQVYEL  217 (263)
T ss_pred             cccccee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------------HHHHHH
Confidence            5432211 11112234567999999988899999999999999999998 8888753211              111122


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      +........+...+.++.+++.+||..||++|||+.++++.|+.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         218 LEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            222233344455678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.9e-42  Score=325.93  Aligned_cols=256  Identities=27%  Similarity=0.468  Sum_probs=211.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ...|++.++||.|+||.||+|.+..           +..+++|.+..........+.+|+.+++.++|+||+++++++.+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   73 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV   73 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec
Confidence            4578999999999999999986543           56799999986655566788999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ....++||||+++++|.+++.......+++..+..++.||+.||.|||+  .||+|+||+|+|||+++++.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~  151 (261)
T cd05148          74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLA  151 (261)
T ss_pred             CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccch
Confidence            9999999999999999999977666778999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ......  ........++..|+|||++.+..++.++||||||+++|+|++ |..||.....              .....
T Consensus       152 ~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------------~~~~~  215 (261)
T cd05148         152 RLIKED--VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------------HEVYD  215 (261)
T ss_pred             hhcCCc--cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------------HHHHH
Confidence            754321  111223345678999999988889999999999999999998 7888754321              11111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      .+........+...+..+.+++.+||..||.+|||+.++++.|+.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         216 QITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            2222223334455678899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=358.81  Aligned_cols=270  Identities=23%  Similarity=0.343  Sum_probs=219.1

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccce-
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGY-  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~-  205 (451)
                      ..-++++.+.|.+|||+.||++....+          +..||+|++-..+....+.+.+||++|+.|+ |+|||.+++. 
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~----------~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss  104 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKG----------GKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSS  104 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCC----------CceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence            345888999999999999999776543          3679999987667777788999999999998 9999999993 


Q ss_pred             eec--C----CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          206 CCD--D----QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       206 ~~~--~----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      ...  .    -.++|.||||.||.|-|++.......|++.++++|+.++++|+.+||.....|||||||-+||||+.+|.
T Consensus       105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~  184 (738)
T KOG1989|consen  105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN  184 (738)
T ss_pred             cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence            221  1    2357899999999999999866666799999999999999999999994345999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCc--cc-----ccccCCCCcccccccc---ccCCCCcchhhHHHHHHHHHHHhCCCccccccCC
Q 013028          280 AKISDFGLAKFGPLGDKS--HI-----STRVLGTRGYFAPEYI---ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG  349 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~--~~-----~~~~~gt~~y~aPE~l---~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  349 (451)
                      +||||||.|.-.......  .+     .....-|+.|+|||++   .+...+.|+|||+|||+||-|+....||..... 
T Consensus       185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-  263 (738)
T KOG1989|consen  185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-  263 (738)
T ss_pred             EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-
Confidence            999999999731111101  00     0112458899999987   467889999999999999999999999975321 


Q ss_pred             CCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCcccc
Q 013028          350 LAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTS  424 (451)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~  424 (451)
                                      ..+++..+.....+..+..+.+||+.||+.||.+||++-||++.+-.+...-.....-.
T Consensus       264 ----------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  264 ----------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             ----------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence                            14455555555556788999999999999999999999999999999987766655544

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=322.77  Aligned_cols=256  Identities=28%  Similarity=0.436  Sum_probs=206.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.+.||+|+||.||+|.++.           +..||||.+.... ...+.+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-----------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-----------TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL   72 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-----------CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence            4578999999999999999987543           3569999987543 345678899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      .+..++||||+.+++|.+++.......+++..+..++.|++.||.|||+  +||+|+||||+||+++.++.++|+|||++
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~  150 (261)
T cd05068          73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLA  150 (261)
T ss_pred             CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceE
Confidence            9999999999999999999976555678999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ......... .......+..|+|||++.+..++.++||||||+++|+|++ |..||......              ....
T Consensus       151 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------------~~~~  215 (261)
T cd05068         151 RVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--------------EVLQ  215 (261)
T ss_pred             EEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--------------HHHH
Confidence            854321111 1111223457999999988889999999999999999999 88887543211              1111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      .+........+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         216 QVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            1222222223344568899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.5e-41  Score=331.01  Aligned_cols=265  Identities=28%  Similarity=0.424  Sum_probs=210.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|.+.+.||+|+||.||+|.+..     .........||||.+..... ...+.+.+|+.+++++ +|+||+++++++
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYG-----LSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEec-----CCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            4579999999999999999987532     11334466799999875432 2345688999999999 799999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      ...+..++||||+.+|+|.+++.......+++..+..++.|++.||.|||+  ++|+|+||||+|||++.++.++|+|||
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEECCCc
Confidence            999999999999999999999876544558999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      ++................++..|+|||++.+..++.++|||||||++|+|++ |..||......             ...
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-------------~~~  253 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-------------SKF  253 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-------------HHH
Confidence            9975432221111223345778999999988889999999999999999998 88887543211             111


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      ...+........+...+..+.+|+.+||..+|++|||+.++++.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         254 YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            122222222222334467899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-41  Score=327.32  Aligned_cols=261  Identities=26%  Similarity=0.442  Sum_probs=208.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .+|...++||+|+||.||++....     .....++..+++|.+..........+.+|+++++.++|+||+++++++.++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHN-----LLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEec-----CCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            478889999999999999986532     123345667999998765555567889999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDD-------------TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD  276 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~  276 (451)
                      ...++||||+.+++|.+++.....             ..+++..++.++.||+.||.|||+  .||+|+||||+|||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~nil~~~  157 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRNCLVGQ  157 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhhEEEcC
Confidence            999999999999999999864321             358899999999999999999999  89999999999999999


Q ss_pred             CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCcc
Q 013028          277 DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWA  355 (451)
Q Consensus       277 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~  355 (451)
                      ++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |.+||......      
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------  231 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------  231 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH------
Confidence            99999999999974332211111223345678999999988899999999999999999998 88887532211      


Q ss_pred             ccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          356 KPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                              .....+........+...+..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       232 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         232 --------EAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             --------HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                    011112222222333445678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.5e-42  Score=338.50  Aligned_cols=256  Identities=23%  Similarity=0.320  Sum_probs=202.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC----CcCHHHHHHHHHHHHhcC-CCceeeccce
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG----SQGQDEWENELRFLSRLN-HPNVVKLMGY  205 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~-h~nIv~~~~~  205 (451)
                      +|++.+.||+|+||.||++...       ....++..||+|++.+..    ....+.+..|+.+++.++ |+||++++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~   73 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKV-------TGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA   73 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEc-------ccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE
Confidence            4788999999999999997642       234567889999987432    222345778999999995 9999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.++...++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          74 FQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             EecCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEeeC
Confidence            9999999999999999999999854  4568999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      |+++...... ........||..|+|||++.+. .++.++|||||||++|+|++|..||........          ...
T Consensus       150 G~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----------~~~  218 (332)
T cd05614         150 GLSKEFLSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----------QSE  218 (332)
T ss_pred             cCCccccccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----------HHH
Confidence            9997532221 1223346799999999999764 478999999999999999999999864322100          000


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      +...+ ......++...+..+.+|+.+||..||++||     ++.++++.
T Consensus       219 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         219 VSRRI-LKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             HHHHH-hcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            00111 0112233445678899999999999999999     77788765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=346.47  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=200.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++.+.||+|+||+||+|..          ..++..||||++....   ......+.+|+.+|..++||||+++++++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~   70 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQK----------KDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF   70 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEE----------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence            3788999999999999999654          4457789999997532   22334577899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .++++.||||||+.||+|.+++..  ...+++..+..++.||+.||.|||+  .||+||||||+|||++.++.++|+|||
T Consensus        71 ~~~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          71 QDENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             EcCCeEEEEECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeecc
Confidence            999999999999999999999865  3568999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcc------------------------------------cccccCCCCccccccccccCCCCcchhhHHHH
Q 013028          287 LAKFGPLGDKSH------------------------------------ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFG  330 (451)
Q Consensus       287 la~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG  330 (451)
                      ++..........                                    .....+||+.|+|||++.+..++.++||||||
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  226 (364)
T cd05599         147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG  226 (364)
T ss_pred             cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence            986432111000                                    11134699999999999889999999999999


Q ss_pred             HHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhh--hcCCCCHHHHHHHHHHHHHccccCCCCCCC---HHH
Q 013028          331 VVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK--LGRNIQMEEAQEFAEIILRCLNSDPKNRPT---MSE  405 (451)
Q Consensus       331 vil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~e  405 (451)
                      |++|+|++|..||......             .....+....  +........++++.+|+.+||. +|.+|++   +.+
T Consensus       227 ~il~el~~G~~Pf~~~~~~-------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~  292 (364)
T cd05599         227 VIMYEMLVGYPPFCSDNPQ-------------ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNE  292 (364)
T ss_pred             hHHHHhhcCCCCCCCCCHH-------------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence            9999999999998643221             0111111111  1111111346789999999997 9999998   999


Q ss_pred             HHHH
Q 013028          406 VVAA  409 (451)
Q Consensus       406 vl~~  409 (451)
                      ++++
T Consensus       293 ll~h  296 (364)
T cd05599         293 IKSH  296 (364)
T ss_pred             HhcC
Confidence            8874

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.8e-42  Score=346.17  Aligned_cols=252  Identities=24%  Similarity=0.321  Sum_probs=198.6

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .|++++.||+|+||+||+|..          ..++..||||++.....   .....+.+|+.+++.++|+||+++++++.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~----------~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~   71 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACK----------VDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ   71 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEE----------CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe
Confidence            688899999999999999754          44577899999975432   22346788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +.++.++||||++||+|.+++..  ...+++..+..++.||+.||.|||+  .||+||||||+|||++.++.++|+|||+
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          72 DKDNLYFVMDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcC
Confidence            99999999999999999999855  3568899999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCC---------------------------------------------cccccccCCCCccccccccccCCCCc
Q 013028          288 AKFGPLGDK---------------------------------------------SHISTRVLGTRGYFAPEYIATGHLTL  322 (451)
Q Consensus       288 a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~  322 (451)
                      +........                                             .......+||..|+|||++.+..++.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (381)
T cd05626         148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ  227 (381)
T ss_pred             CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence            753210000                                             00112357999999999998889999


Q ss_pred             chhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhh--hcCCCCHHHHHHHHHHHHHcc--ccCCC
Q 013028          323 KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK--LGRNIQMEEAQEFAEIILRCL--NSDPK  398 (451)
Q Consensus       323 ~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl--~~dP~  398 (451)
                      ++|||||||++|||++|..||......             .....+....  .........+.++.+|+.+|+  ..++.
T Consensus       228 ~~DiwSlG~il~elltG~~Pf~~~~~~-------------~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~  294 (381)
T cd05626         228 LCDWWSVGVILFEMLVGQPPFLAPTPT-------------ETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERL  294 (381)
T ss_pred             ccceeehhhHHHHHHhCCCCCcCCCHH-------------HHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCccccc
Confidence            999999999999999999999754321             1111121111  111112234678999998855  45556


Q ss_pred             CCCCHHHHHHH
Q 013028          399 NRPTMSEVVAA  409 (451)
Q Consensus       399 ~RPt~~evl~~  409 (451)
                      .|+++.+++.+
T Consensus       295 ~R~~~~~~l~h  305 (381)
T cd05626         295 GRNGADDIKAH  305 (381)
T ss_pred             CCCCHHHHhcC
Confidence            69999999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.2e-41  Score=331.80  Aligned_cols=263  Identities=23%  Similarity=0.311  Sum_probs=196.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|.+.+.||.|+||.||+|..          ..++..||||++..... .....+.+|+.+++.++||||+++++++.+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   74 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKS----------KVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT   74 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEE----------CCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence            5899999999999999999764          34577899999875432 223456789999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+. ++|.+++... ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  150 (303)
T cd07869          75 KETLTLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLA  150 (303)
T ss_pred             CCeEEEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECCCCcc
Confidence            999999999995 6888877543 3568899999999999999999999  89999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC---------CCccccc
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA---------GNWAKPY  358 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~---------~~~~~~~  358 (451)
                      ......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........         .......
T Consensus       151 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (303)
T cd07869         151 RAKSVP--SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT  228 (303)
T ss_pred             eeccCC--CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhh
Confidence            743211  122234568999999999865 4588999999999999999999999975321100         0000000


Q ss_pred             cchhhhhhHHhhhhhcCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          359 LSNKLALHQIIDEKLGRNI---------QMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      +..................         ....+..+.+|+.+||+.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000000000000000000         0012357889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=343.35  Aligned_cols=252  Identities=29%  Similarity=0.401  Sum_probs=204.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|.+.+.||+|+||+||+|..          ..++..||||++....   ......+..|++++..++|+||+++++++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   70 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRD----------KDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF   70 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEE----------CCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe
Confidence            3789999999999999999764          3457789999997532   23345678899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .++++.++||||+++++|.+++...  ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+|||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          71 QDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             ecCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCC
Confidence            9999999999999999999998653  678999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCC---------------------------CcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhC
Q 013028          287 LAKFGPLGD---------------------------KSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG  339 (451)
Q Consensus       287 la~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg  339 (451)
                      ++.......                           .........||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence            997543221                           00122345799999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCccccccchhhhhhHHhh--hhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 013028          340 KTAAMRRTNGLAGNWAKPYLSNKLALHQIID--EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT-MSEVVAA  409 (451)
Q Consensus       340 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~  409 (451)
                      ..||......             .....+..  ..+........+.++.+||.+||. ||.+||+ +.++++.
T Consensus       227 ~~Pf~~~~~~-------------~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         227 FPPFYSDTLQ-------------ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCCCHH-------------HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            9998753311             11112222  111111112247889999999997 9999999 9999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9e-42  Score=335.79  Aligned_cols=246  Identities=24%  Similarity=0.370  Sum_probs=199.1

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC----CcCHHHHHHHHHHHHhcCCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG----SQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~  211 (451)
                      +.||+|+||.||++....       ....+..||||++....    ......+.+|+.+|+.++||||++++++|.++..
T Consensus         2 ~~lg~G~~g~V~~~~~~~-------~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~   74 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVT-------GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK   74 (323)
T ss_pred             ceeeecCCeEEEEEEEcc-------cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence            679999999999986432       23567889999987432    1223456789999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .|+||||+.+++|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          75 LYLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             EEEEEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            9999999999999999854  4568889999999999999999999  89999999999999999999999999998742


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ..  .........||+.|+|||++.+..++.++|||||||++|||++|..||......             .....+...
T Consensus       151 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------------~~~~~~~~~  215 (323)
T cd05584         151 IH--EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------------KTIDKILKG  215 (323)
T ss_pred             cc--CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------------HHHHHHHcC
Confidence            21  122233467999999999998888999999999999999999999998643211             111122221


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                        ...++...+..+.+|+.+||..||.+||     ++.++++.
T Consensus       216 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         216 --KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence              1233445578899999999999999999     88888774

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.1e-41  Score=329.86  Aligned_cols=265  Identities=28%  Similarity=0.438  Sum_probs=209.8

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|++.+.||+|+||.||+|.+....     .......+|+|.+..... .....+.+|++++..+ +|+||+++++++
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLD-----NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCC-----CCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            458899999999999999998765421     123456799999875322 2234578899999999 799999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhcc--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCce
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLN--------------EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV  272 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~--------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NI  272 (451)
                      ..+...++||||+.+|+|.+++..              .....+++..++.++.|++.||.|||+  .+|+||||||+||
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~Ni  163 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNV  163 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccceeeE
Confidence            999999999999999999999853              224568999999999999999999999  8999999999999


Q ss_pred             eeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCC
Q 013028          273 LLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLA  351 (451)
Q Consensus       273 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~  351 (451)
                      |++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.....   
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---  240 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---  240 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---
Confidence            999999999999999985433222111222334567999999988899999999999999999997 8877653221   


Q ss_pred             CCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                                 ......+........+...+..+.+|+.+||..||++|||+.++++.|+.+.
T Consensus       241 -----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 -----------EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -----------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                       1111222222223344455678999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=346.82  Aligned_cols=251  Identities=24%  Similarity=0.326  Sum_probs=197.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +|.++++||.|+||.||++.          +..++..||||++.+..   ......+.+|+++++.++||||++++++|.
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~----------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~   71 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQ----------KKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ   71 (377)
T ss_pred             CceEeEEEeecCCEEEEEEE----------ECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            68899999999999999965          44557889999986432   222356788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +..+.||||||++||+|.+++..  ...+++..+..++.|++.||.|||+  .||+||||||+|||++.++.++|+|||+
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfGl  147 (377)
T cd05629          72 DAQYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFGL  147 (377)
T ss_pred             cCCeeEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999999854  4568999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCc---------------------------------------------ccccccCCCCccccccccccCCCCc
Q 013028          288 AKFGPLGDKS---------------------------------------------HISTRVLGTRGYFAPEYIATGHLTL  322 (451)
Q Consensus       288 a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~  322 (451)
                      ++........                                             ......+||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  227 (377)
T cd05629         148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ  227 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence            9632110000                                             0001246999999999998889999


Q ss_pred             chhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCC--HHHHHHHHHHHHHccccCCCCC
Q 013028          323 KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQ--MEEAQEFAEIILRCLNSDPKNR  400 (451)
Q Consensus       323 ~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~R  400 (451)
                      ++|||||||++|||++|..||......             .....+.........+  ...+.++.+|+.+||. +|.+|
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~-------------~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r  293 (377)
T cd05629         228 ECDWWSLGAIMFECLIGWPPFCSENSH-------------ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENR  293 (377)
T ss_pred             ceeeEecchhhhhhhcCCCCCCCCCHH-------------HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhc
Confidence            999999999999999999998643321             0111111111011111  1245789999999998 77765


Q ss_pred             ---CCHHHHHHH
Q 013028          401 ---PTMSEVVAA  409 (451)
Q Consensus       401 ---Pt~~evl~~  409 (451)
                         +++.+++.+
T Consensus       294 ~~r~~~~~~l~h  305 (377)
T cd05629         294 LGRGGAHEIKSH  305 (377)
T ss_pred             CCCCCHHHHhcC
Confidence               599999886

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=329.29  Aligned_cols=253  Identities=28%  Similarity=0.401  Sum_probs=203.4

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .|++.++||+|+||+||++..          ..++..||||.+.....   .....+.+|+.+++.++|+||+++++.+.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   70 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQV----------RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE   70 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEE----------cCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            477889999999999999764          34467899999875322   12344678999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +++..++||||+++|+|.+++.......+++..+..++.|++.||.|||+  .||+||||||+||++++++.++|+|||+
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          71 TKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             CCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHEEECCCCCEEEeeCCC
Confidence            99999999999999999988865545679999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +......   .......|+..|+|||++.+..++.++|||||||++|+|++|..||.......          ....+..
T Consensus       149 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----------~~~~~~~  215 (285)
T cd05605         149 AVEIPEG---ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----------KREEVER  215 (285)
T ss_pred             ceecCCC---CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh----------HHHHHHH
Confidence            9753321   12234578999999999988889999999999999999999999987532210          0001111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      .+. ......+...+..+.+|+.+||..||++||     ++.++++.
T Consensus       216 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         216 RVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             Hhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            111 112223445678899999999999999999     78888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=344.01  Aligned_cols=273  Identities=32%  Similarity=0.468  Sum_probs=219.4

Q ss_pred             HHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCce
Q 013028          123 GLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNV  199 (451)
Q Consensus       123 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nI  199 (451)
                      +..+...++..+.++||+|+||.||+|.+...+.      .....||||......   .....++.+|.++|+.++||||
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~------~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NV  223 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNG------FKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNV  223 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCC------ceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCE
Confidence            3344455677788999999999999999754211      012228999987422   3445678999999999999999


Q ss_pred             eeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          200 VKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       200 v~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      |++||++.+...++||||+|.||+|.++|..... .++..+.+.++.+.+.||+|||+  +++|||||..+|+|++.++.
T Consensus       224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~--k~~IHRDIAARNcL~~~~~~  300 (474)
T KOG0194|consen  224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS--KNCIHRDIAARNCLYSKKGV  300 (474)
T ss_pred             EEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH--CCCcchhHhHHHheecCCCe
Confidence            9999999999999999999999999999976543 69999999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  358 (451)
                      +||+|||+++........  .....-...|+|||.+....|+.++|||||||++||+++ |..|+.+...          
T Consensus       301 vKISDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----------  368 (474)
T KOG0194|consen  301 VKISDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN----------  368 (474)
T ss_pred             EEeCccccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH----------
Confidence            999999999864311111  101123456999999999999999999999999999999 6767654332          


Q ss_pred             cchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                         ......++........+...+..+..++.+|+..||++||||.++.+.|+.+......
T Consensus       369 ---~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  369 ---YEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ---HHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence               1222233344555556667789999999999999999999999999999999887664

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.2e-41  Score=327.38  Aligned_cols=259  Identities=25%  Similarity=0.382  Sum_probs=195.6

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhc---CCCceeeccce
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRL---NHPNVVKLMGY  205 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~nIv~~~~~  205 (451)
                      +|++.+.||+|+||+||+|....         ..+..||||.+.....  .....+.+|+.+++.+   +||||++++++
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~   72 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLK---------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV   72 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcC---------CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence            78999999999999999976422         2356799999874322  2234566788887766   69999999998


Q ss_pred             ee-----cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          206 CC-----DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       206 ~~-----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      +.     .....++||||+. ++|.+++.......+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~~~  149 (290)
T cd07862          73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQI  149 (290)
T ss_pred             EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCCCE
Confidence            85     3456899999996 599998876555678999999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC---------
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA---------  351 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~---------  351 (451)
                      +|+|||++......   .......||..|+|||++.+..++.++|||||||++|+|++|.+||........         
T Consensus       150 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~  226 (290)
T cd07862         150 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG  226 (290)
T ss_pred             EEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence            99999999754322   223345789999999999888999999999999999999999999875432100         


Q ss_pred             ----CCccccccchhhhhhHHhhhhhcC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          352 ----GNWAKPYLSNKLALHQIIDEKLGR---NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       352 ----~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                          ..|.....    .....+......   ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         227 LPGEEDWPRDVA----LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCChhhchhhhc----ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                00000000    000000000000   011123567899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-42  Score=330.53  Aligned_cols=250  Identities=25%  Similarity=0.352  Sum_probs=216.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--HHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ..-|.+.+-||+|.|.+|-+          |++.-++..||||++.+.....  ...+..|+..|+.++|||||++|++.
T Consensus        17 AGLYDLekTlG~GHFAVVKL----------ArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi   86 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKL----------ARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI   86 (864)
T ss_pred             eeeehhhhhhcCCceehhhh----------hhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh
Confidence            34788899999999999988          7888899999999998765443  34578899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC-CCCcEEEeec
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDF  285 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~-~~~~~kl~DF  285 (451)
                      .....+|||+|+=++|+|+|+|..+. ..+.++.+.+++.||+.|+.|||.  ..||||||||+||.+- .-|.+||+||
T Consensus        87 DTQTKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHq--LHVVHRDLKPENVVFFEKlGlVKLTDF  163 (864)
T KOG4717|consen   87 DTQTKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQ--LHVVHRDLKPENVVFFEKLGLVKLTDF  163 (864)
T ss_pred             cccceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhh--hhhhcccCCcceeEEeeecCceEeeec
Confidence            99999999999999999999998764 569999999999999999999999  7899999999999875 6789999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCC-cchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLT-LKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      |++..+.   .+......+|+..|-|||+|.+..|+ +++||||||||||.|++|++||.....             .+.
T Consensus       164 GFSNkf~---PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-------------SET  227 (864)
T KOG4717|consen  164 GFSNKFQ---PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-------------SET  227 (864)
T ss_pred             cccccCC---CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-------------hhh
Confidence            9997543   33445578999999999999999997 589999999999999999999975432             334


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +.-++|..  ..++...+.++++||..||..||++|.+.+||...
T Consensus       228 LTmImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  228 LTMIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhhhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            44555554  35678889999999999999999999999998764

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.6e-41  Score=325.37  Aligned_cols=264  Identities=28%  Similarity=0.433  Sum_probs=208.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +|++.+.||+|+||.||+|.....     ........+++|.+...... ....+.+|+.+++.++||||+++++.+...
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~-----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRL-----KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecC-----CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence            477889999999999999986431     12223456899988654322 235688999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCC
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNE----------------------DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDV  267 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~----------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDl  267 (451)
                      +..++||||+.+++|.+++...                      ....+++..++.++.|++.||.|||+  .+|+||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~ivH~di  153 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKLVHRDL  153 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CCeehhhh
Confidence            9999999999999999987532                      11357889999999999999999999  89999999


Q ss_pred             CCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccc
Q 013028          268 KASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRR  346 (451)
Q Consensus       268 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~  346 (451)
                      ||+|||+++++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999975322211111122345678999999988889999999999999999998 88887543


Q ss_pred             cCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          347 TNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                      ..              ..+...+........+...+.++.+++.+||+.+|++||++.++++.|+++..
T Consensus       234 ~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         234 AP--------------ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CH--------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            21              11222333323333344556789999999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.3e-41  Score=329.25  Aligned_cols=270  Identities=27%  Similarity=0.414  Sum_probs=209.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|.+.+.||+|+||.||++.+.....   ........+|+|.+.... ......+.+|+.+++.+ +|+||+++++++
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~---~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDK---EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCC---cccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            3589999999999999999987543110   011234569999987542 22345678899999999 699999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCce
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV  272 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NI  272 (451)
                      .+....++||||+.+|+|.+++....              ...+++..++.++.|++.||.|||+  .|++||||||+||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Ni  171 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNV  171 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHHhe
Confidence            99999999999999999999996532              1358899999999999999999999  8999999999999


Q ss_pred             eeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCC
Q 013028          273 LLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLA  351 (451)
Q Consensus       273 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~  351 (451)
                      |++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.....   
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---  248 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---  248 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---
Confidence            999999999999999975432111111112234567999999988889999999999999999998 7777643211   


Q ss_pred             CCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                                 ..+...+........+...+.++.+|+.+||..+|.+|||+.++++.|+.+....
T Consensus       249 -----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         249 -----------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             -----------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence                       1111222222222334455788999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.4e-42  Score=340.20  Aligned_cols=244  Identities=26%  Similarity=0.350  Sum_probs=197.2

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccceeecCCee
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHR  212 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~  212 (451)
                      +.||+|+||.||++.          +..++..||+|++....   ......+.+|++++..++||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~V~~~~----------~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~   70 (325)
T cd05594           1 KLLGKGTFGKVILVK----------EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL   70 (325)
T ss_pred             CeeeeCCCEEEEEEE----------ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEE
Confidence            469999999999965          44557889999997532   22234567899999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCC
Q 013028          213 LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP  292 (451)
Q Consensus       213 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~  292 (451)
                      |+||||+++|+|.+++..  ...+++..+..++.||+.||.|||+. +||+||||||+|||++.++.+||+|||++....
T Consensus        71 ~lv~E~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          71 CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            999999999999988854  45789999999999999999999963 589999999999999999999999999987422


Q ss_pred             CCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhh
Q 013028          293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK  372 (451)
Q Consensus       293 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (451)
                      .  .........||..|+|||++.+..++.++|||||||++|+|++|..||......              .....+. .
T Consensus       148 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------------~~~~~i~-~  210 (325)
T cd05594         148 K--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------------KLFELIL-M  210 (325)
T ss_pred             C--CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--------------HHHHHHh-c
Confidence            1  112233467999999999998889999999999999999999999998643211              1111111 0


Q ss_pred             hcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          373 LGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       373 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      ....++...+.++.+|+.+||..||++|+     ++.+++++
T Consensus       211 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         211 EEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            11223444567899999999999999997     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-41  Score=335.21  Aligned_cols=264  Identities=24%  Similarity=0.343  Sum_probs=195.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|++.++||+|+||.||+|..          ..++..||||.+....  ......+.+|+.+++.++||||+++++++..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   70 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAID----------THTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP   70 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEE----------CCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEec
Confidence            588899999999999999764          4457789999987432  2233467889999999999999999998864


Q ss_pred             C-----CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          209 D-----QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       209 ~-----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      .     ...|+||||+. ++|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+
T Consensus        71 ~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL~  145 (338)
T cd07859          71 PSRREFKDIYVVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKIC  145 (338)
T ss_pred             cCCCCCceEEEEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEc
Confidence            3     35799999995 689988854  3568999999999999999999999  899999999999999999999999


Q ss_pred             ecCCcccCCCCCC-cccccccCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcc-----
Q 013028          284 DFGLAKFGPLGDK-SHISTRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWA-----  355 (451)
Q Consensus       284 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~-----  355 (451)
                      |||+++....... ........||..|+|||++.+  ..++.++|||||||++|+|++|++||............     
T Consensus       146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~  225 (338)
T cd07859         146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG  225 (338)
T ss_pred             cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence            9999975322111 112234679999999999865  67899999999999999999999998653221000000     


Q ss_pred             ccccch-----hhhhhHHhhhhhc---CCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          356 KPYLSN-----KLALHQIIDEKLG---RNI---QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       356 ~~~~~~-----~~~~~~~~~~~~~---~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+....     .......+.....   ...   ....+..+.+++.+||..||++|||+.|+++.
T Consensus       226 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000000     0000001100000   000   01234678999999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.6e-41  Score=319.15  Aligned_cols=251  Identities=24%  Similarity=0.444  Sum_probs=200.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +.|++.+.||+|+||.||++.+..           ...+|+|.+... ......+.+|+++|+.++||||+++++++.+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-----------~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-----------QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ   71 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-----------CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccC
Confidence            368888999999999999987643           346899988643 33456788999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+  +||+|+||||+||+++.++.++|+|||++.
T Consensus        72 ~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          72 KPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             CCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCcc
Confidence            99999999999999999886432 468899999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHH
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||......             ..+ ..
T Consensus       149 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------------~~~-~~  213 (256)
T cd05114         149 YVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------------EVV-EM  213 (256)
T ss_pred             ccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------------HHH-HH
Confidence            5322111 11122334567999999988889999999999999999999 88887543211             001 11


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      +........+...+..+.+++.+||..+|++||++.++++.|
T Consensus       214 i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         214 ISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            111111122333457799999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-41  Score=320.91  Aligned_cols=259  Identities=27%  Similarity=0.458  Sum_probs=202.7

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      |.+++.||+|+||.||+|....       +......||+|.+......  ....+.+|+.+++.++|+||+++++++...
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~-------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   73 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQ-------DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEA   73 (273)
T ss_pred             CccccccCcCCCceEEEEEEec-------CCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccC
Confidence            5678999999999999987643       2234577999998753322  235688999999999999999999988665


Q ss_pred             Ce------eEEEEeccCCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          210 QH------RLLVYEYVTRGSLEDHLLNE----DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       210 ~~------~~lV~E~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      ..      .++||||+++|+|..++...    ....+++..+..++.|++.||.|||+  .+|+||||||+||++++++.
T Consensus        74 ~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~  151 (273)
T cd05035          74 SSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMT  151 (273)
T ss_pred             CccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECCCCe
Confidence            44      78999999999999888432    23468999999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  358 (451)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......         
T Consensus       152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---------  222 (273)
T cd05035         152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---------  222 (273)
T ss_pred             EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---------
Confidence            99999999985432221111222334667999999988889999999999999999999 77777532211         


Q ss_pred             cchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                           .+...+........+...+.++.+++.+||..||++|||+.++++.|+++
T Consensus       223 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         223 -----EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -----HHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                 11111112222234455678899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4e-41  Score=339.68  Aligned_cols=267  Identities=26%  Similarity=0.386  Sum_probs=209.7

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC-HHHHHHHHHHHHhcC-CCceeeccce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLN-HPNVVKLMGY  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~-h~nIv~~~~~  205 (451)
                      ..++|.++++||+|+||.||+|.+...     ........||||++....... .+.+.+|+.+|..+. ||||++++++
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~-----~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGL-----SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCC-----CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            345788899999999999999987642     133445679999997543322 346889999999998 9999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCC-----------------------------------------------------
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNED-----------------------------------------------------  232 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------------------------------------------------  232 (451)
                      +......++||||+.+|+|.+++....                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999999999999999999999985421                                                     


Q ss_pred             -------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCC
Q 013028          233 -------------------------------------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKA  269 (451)
Q Consensus       233 -------------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp  269 (451)
                                                                 ...+++..++.++.||+.||.|||+  .+|+||||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlkp  267 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLAA  267 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCCc
Confidence                                                       1246777889999999999999999  8999999999


Q ss_pred             CceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccC
Q 013028          270 SNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTN  348 (451)
Q Consensus       270 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~  348 (451)
                      +|||+++++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999975322211111223456788999999988889999999999999999998 7877653221


Q ss_pred             CCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          349 GLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                      .             ......+........+...+.++.+|+.+||..+|.+||++.+|++.|+.+.
T Consensus       348 ~-------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 N-------------EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             h-------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            1             1111222222222334445688999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.9e-42  Score=325.61  Aligned_cols=255  Identities=33%  Similarity=0.556  Sum_probs=199.8

Q ss_pred             cCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeecCCee
Q 013028          134 EKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHR  212 (451)
Q Consensus       134 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~  212 (451)
                      +.+.||.|.||.||+|.+..      .....+..|+||.+...... ..+.+.+|+++++.++||||++++|++......
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~------~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~   76 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQ------KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPL   76 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEES------TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSE
T ss_pred             EeeEEccCCCcEEEEEEEEc------ccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccc
Confidence            45789999999999999863      23455678999999653222 357789999999999999999999999988889


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCC
Q 013028          213 LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP  292 (451)
Q Consensus       213 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~  292 (451)
                      ++||||+++|+|.+++.......+++..++.|+.||+.||.|||+  ++|+|+||+++||+++.++.+||+|||++....
T Consensus        77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc
Confidence            999999999999999987756789999999999999999999999  899999999999999999999999999998642


Q ss_pred             CCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       293 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ............+...|+|||++.+..++.++||||||+++|||++ |..||....              ...+...+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--------------~~~~~~~~~~  220 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--------------NEEIIEKLKQ  220 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--------------HHHHHHHHHT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------------cccccccccc
Confidence            2222222233456678999999988889999999999999999999 667654321              1111122233


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ......+...+..+.+++..||..||++|||+.++++.|
T Consensus       221 ~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  221 GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            333344555678899999999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-41  Score=352.38  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=204.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|.+.+.||+|+||+||+|.          +..++..||||++.....  .....+.+|+.++..++|+||+++++.+
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~----------~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~  100 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAK----------RVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF  100 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEE----------EcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence            4699999999999999999965          444577899999875432  2234577899999999999999998877


Q ss_pred             ecCC--------eeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC
Q 013028          207 CDDQ--------HRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD  276 (451)
Q Consensus       207 ~~~~--------~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~  276 (451)
                      ....        ..++||||+++|+|.+++...  ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.
T Consensus       101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl~~  178 (496)
T PTZ00283        101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCS  178 (496)
T ss_pred             ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEeC
Confidence            5332        368999999999999988542  23578999999999999999999999  89999999999999999


Q ss_pred             CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccc
Q 013028          277 DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK  356 (451)
Q Consensus       277 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~  356 (451)
                      ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|..||......       
T Consensus       179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-------  251 (496)
T PTZ00283        179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-------  251 (496)
T ss_pred             CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------
Confidence            9999999999998644332233344568999999999998889999999999999999999999998643210       


Q ss_pred             cccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          357 PYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                            ..+..... ......+...++++.+|+.+||+.||.+||++.++++.
T Consensus       252 ------~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        252 ------EVMHKTLA-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ------HHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                  01111111 11122344567889999999999999999999999874

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.7e-43  Score=330.11  Aligned_cols=266  Identities=26%  Similarity=0.350  Sum_probs=199.3

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC-
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD-  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-  209 (451)
                      .|...+++|.|+||.||.|....          ++..||||.+-.....    -.+|+++|+.++|||||+++-+|... 
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e----------~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~   90 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRE----------TEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSST   90 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcC----------CCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecC
Confidence            67888999999999999987543          3778999998643321    24799999999999999999888632 


Q ss_pred             ----CeeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC-CcEEE
Q 013028          210 ----QHRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD-FNAKI  282 (451)
Q Consensus       210 ----~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~-~~~kl  282 (451)
                          -++.||||||+. +|.+.+...  .+..++.-.+.-+.+||++||.|||+  .||+||||||.|+|+|.+ |.+||
T Consensus        91 ~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKi  167 (364)
T KOG0658|consen   91 ESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKI  167 (364)
T ss_pred             CCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEe
Confidence                245689999965 999888632  34667777888899999999999999  899999999999999965 99999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcc-----c
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWA-----K  356 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~-----~  356 (451)
                      ||||.|+....+   .....+..|.+|+|||++.+ ..|+.++||||.|||+.||+-|++.|.+..........     .
T Consensus       168 cDFGSAK~L~~~---epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  168 CDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             ccCCcceeeccC---CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            999999864433   33346678999999999977 68999999999999999999999999875443210000     0


Q ss_pred             cccch---------hhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhHHh
Q 013028          357 PYLSN---------KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA--ALEQLQLN  416 (451)
Q Consensus       357 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~  416 (451)
                      +-.++         .....++....+..-.....++++.+|+.++|..+|.+|.++.|++.  .+..++..
T Consensus       245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            00000         00000111111111123344688999999999999999999999984  45666555

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.8e-41  Score=326.81  Aligned_cols=261  Identities=28%  Similarity=0.433  Sum_probs=206.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +|++.++||.|+||.||+|.+..+.     .......||||.+...... ..+.+.+|+.++..++||||+++++++.+.
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTA-----PGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCC-----CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            6788899999999999999865421     2234567999999754322 235678899999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNE--------------DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD  275 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~  275 (451)
                      ...++++||+.+++|.+++...              ....+++..+..++.|++.||.|||+  +||+||||||+|||++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~Nil~~  158 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNVLVF  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchhheEec
Confidence            9999999999999999998421              12357888899999999999999999  8999999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCc
Q 013028          276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNW  354 (451)
Q Consensus       276 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~  354 (451)
                      +++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....      
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------  232 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------  232 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence            999999999999875332222222233456778999999988889999999999999999998 7777653221      


Q ss_pred             cccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                              ..+...+........+...+..+.+|+.+||+.+|.+||++.+++..|+.
T Consensus       233 --------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 --------QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                    11112222222223345567889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.4e-42  Score=345.79  Aligned_cols=251  Identities=25%  Similarity=0.350  Sum_probs=197.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +|+++++||+|+||+||+|.          +..++..||+|++.+...   .....+.+|+.+++.++|+||+++++.|.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~----------~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~   71 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLAR----------KVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ   71 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEE----------ECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE
Confidence            68899999999999999965          445577899999875322   22346788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +++..|+||||+++|+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          72 DKDNLYFVMDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCC
Confidence            99999999999999999999854  3568899999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCC---------------------------------------------CcccccccCCCCccccccccccCCCCc
Q 013028          288 AKFGPLGD---------------------------------------------KSHISTRVLGTRGYFAPEYIATGHLTL  322 (451)
Q Consensus       288 a~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~  322 (451)
                      +.......                                             ........+||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (382)
T cd05625         148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ  227 (382)
T ss_pred             CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence            75221000                                             000112357999999999999899999


Q ss_pred             chhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhh--hcCCCCHHHHHHHHHHHHHccccCCCCC
Q 013028          323 KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK--LGRNIQMEEAQEFAEIILRCLNSDPKNR  400 (451)
Q Consensus       323 ~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~R  400 (451)
                      ++|||||||++|||++|.+||......             .....+....  .........++++.+++.+|+ .+|.+|
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~-------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R  293 (382)
T cd05625         228 LCDWWSVGVILYEMLVGQPPFLAQTPL-------------ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDR  293 (382)
T ss_pred             eeeEEechHHHHHHHhCCCCCCCCCHH-------------HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHc
Confidence            999999999999999999999753321             1111121111  111112234678899998876 599999


Q ss_pred             CC---HHHHHHH
Q 013028          401 PT---MSEVVAA  409 (451)
Q Consensus       401 Pt---~~evl~~  409 (451)
                      ++   +.+++++
T Consensus       294 ~~~~~~~ei~~h  305 (382)
T cd05625         294 LGKNGADEIKAH  305 (382)
T ss_pred             CCCCCHHHHhcC
Confidence            97   8887764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.2e-41  Score=335.15  Aligned_cols=246  Identities=26%  Similarity=0.379  Sum_probs=196.8

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHH---HhcCCCceeeccce
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFL---SRLNHPNVVKLMGY  205 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il---~~l~h~nIv~~~~~  205 (451)
                      |++.+.||+|+||.||+|.+.          .++..||||++....   ....+.+.+|+.++   ..++||||++++++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~----------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~   70 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYK----------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFAC   70 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEEC----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeE
Confidence            677899999999999997643          457789999997532   22335566776665   45679999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.++...|+||||++||+|..++..   ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus        71 ~~~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          71 FQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCcc
Confidence            9999999999999999999888743   468999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |++.....  .........|++.|+|||++.+..++.++|||||||++|+|++|..||......             ...
T Consensus       146 g~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------------~~~  210 (324)
T cd05589         146 GLCKEGMG--FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------------EVF  210 (324)
T ss_pred             cCCccCCC--CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-------------HHH
Confidence            99874221  122234567999999999999899999999999999999999999998643221             011


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      ..+...  ....+...+..+.+++.+||..||.+||     ++.++++.
T Consensus       211 ~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         211 DSIVND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             HHHHhC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            111111  1223444578899999999999999999     57777664

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.4e-41  Score=327.94  Aligned_cols=268  Identities=26%  Similarity=0.429  Sum_probs=208.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhh------hhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTA------ARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVK  201 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~------~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~  201 (451)
                      ..+|++.+.||+|+||.||+|.....+...      ..+......||+|.+..... ...+.+.+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            358999999999999999999876533211      23444567899999875432 23467889999999999999999


Q ss_pred             ccceeecCCeeEEEEeccCCCChhhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCce
Q 013028          202 LMGYCCDDQHRLLVYEYVTRGSLEDHLLNED---------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV  272 (451)
Q Consensus       202 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NI  272 (451)
                      +++++.++...++||||+.+++|.+++....         ...+++..++.++.|++.||.|||+  .||+|+||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i~H~dlkp~Ni  161 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCccccccchhce
Confidence            9999999999999999999999999986532         1368999999999999999999999  8999999999999


Q ss_pred             eeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh--CCCccccccCCC
Q 013028          273 LLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS--GKTAAMRRTNGL  350 (451)
Q Consensus       273 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt--g~~pf~~~~~~~  350 (451)
                      +++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++  |..||...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ-  240 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence            999999999999999975332222222334456778999999988889999999999999999998  55565432211 


Q ss_pred             CCCccccccchhhhhhHHhh------hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          351 AGNWAKPYLSNKLALHQIID------EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                                  ..+.....      .......+...+.++.+++.+||+.||.+|||+.+|++.|+
T Consensus       241 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 ------------QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ------------HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence                        00111100      00111122334578999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4e-42  Score=345.36  Aligned_cols=251  Identities=25%  Similarity=0.348  Sum_probs=198.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +|++++.||+|+||.||++.          +..++..||||++.+..   ......+.+|+.+|+.++|+||+++++.+.
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~----------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~   71 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVR----------KVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ   71 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEE----------ECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            68999999999999999965          44557889999986432   223456788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +++..|+||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+|||+
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG~  147 (376)
T cd05598          72 DKDNLYFVMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGL  147 (376)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence            99999999999999999999854  4568899999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCC-----------------------------------------cccccccCCCCccccccccccCCCCcchhh
Q 013028          288 AKFGPLGDK-----------------------------------------SHISTRVLGTRGYFAPEYIATGHLTLKTDV  326 (451)
Q Consensus       288 a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~Di  326 (451)
                      |..+.....                                         .......+||+.|+|||++.+..++.++||
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  227 (376)
T cd05598         148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  227 (376)
T ss_pred             CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence            752210000                                         001123579999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh--hhcCCCCHHHHHHHHHHHHHccccCCCCCC---
Q 013028          327 YSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE--KLGRNIQMEEAQEFAEIILRCLNSDPKNRP---  401 (451)
Q Consensus       327 wSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---  401 (451)
                      |||||++|+|++|..||......             .....+...  ..........+..+.+++.+|+ .+|.+|+   
T Consensus       228 wSlGvilyell~G~~Pf~~~~~~-------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~  293 (376)
T cd05598         228 WSVGVILYEMLVGQPPFLADTPA-------------ETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKN  293 (376)
T ss_pred             eeccceeeehhhCCCCCCCCCHH-------------HHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence            99999999999999999754321             000111111  1111111234677889999876 5999999   


Q ss_pred             CHHHHHHH
Q 013028          402 TMSEVVAA  409 (451)
Q Consensus       402 t~~evl~~  409 (451)
                      ++.+++++
T Consensus       294 t~~ell~h  301 (376)
T cd05598         294 GADEIKAH  301 (376)
T ss_pred             CHHHHhCC
Confidence            89999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.7e-41  Score=318.25  Aligned_cols=249  Identities=30%  Similarity=0.462  Sum_probs=197.1

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      +.||+|+||.||+|.+.          .++..+|+|.+..... .....+.+|+++++.++||||+++++++......++
T Consensus         1 ~~lg~g~~g~vy~~~~~----------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   70 (252)
T cd05084           1 ERIGRGNFGEVFSGRLR----------ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI   70 (252)
T ss_pred             CccCcccCccEEEEEEe----------cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEE
Confidence            46999999999997643          3467899998864332 234568899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCC
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG  294 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  294 (451)
                      ||||+++++|.+++... ...+++..++.++.|++.||.|||+  +||+|+||||+|||++.++.++|+|||++......
T Consensus        71 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  147 (252)
T cd05084          71 VMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG  147 (252)
T ss_pred             EEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCcccccc
Confidence            99999999999998543 3468899999999999999999999  89999999999999999999999999998743211


Q ss_pred             CCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhhhh
Q 013028          295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL  373 (451)
Q Consensus       295 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (451)
                      ...........+..|+|||.+.+..++.++|||||||++|+|++ |..||......              .....+....
T Consensus       148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------------~~~~~~~~~~  213 (252)
T cd05084         148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------------QTREAIEQGV  213 (252)
T ss_pred             cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------------HHHHHHHcCC
Confidence            11110111123456999999988889999999999999999998 77777532211              1112222222


Q ss_pred             cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          374 GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       374 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      ....+...+..+.+|+.+||..+|++|||+.++++.|+
T Consensus       214 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         214 RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            23344455678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.2e-41  Score=321.64  Aligned_cols=264  Identities=24%  Similarity=0.374  Sum_probs=205.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+|++.+.||.|+||+||+|.+...+      ......+++|.+..... ....++..|+.++..++||||+++++++..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~------~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEG------DSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCC------CceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC
Confidence            47888999999999999999875321      11123578888754322 223567788889999999999999998754


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                       ...++|+||+.+|+|.+++... ...+++..+..++.||+.||.|||+  ++++|+||||+|||++.++.+||+|||++
T Consensus        81 -~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Dfg~~  156 (279)
T cd05111          81 -ASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVA  156 (279)
T ss_pred             -CccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCCccc
Confidence             5578999999999999998653 3568999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +...............++..|+|||++.+..++.++|||||||++|||++ |..||......              ...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------------~~~~  222 (279)
T cd05111         157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--------------EVPD  222 (279)
T ss_pred             eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------------HHHH
Confidence            86433222222334456778999999988899999999999999999998 88887543211              1112


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                      ++........+...+..+.+++.+||..||.+|||+.|+++.|+.+.++-
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         223 LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             HHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence            22222222222234567899999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-41  Score=334.70  Aligned_cols=237  Identities=26%  Similarity=0.384  Sum_probs=192.0

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhc-CCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRL-NHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~  211 (451)
                      +.||+|+||+||+|..          ..++..||||++.+..   ....+.+..|+.++..+ +||||+++++++.+.+.
T Consensus         1 ~~lg~G~~g~V~~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   70 (320)
T cd05590           1 RVLGKGSFGKVMLARL----------KESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDR   70 (320)
T ss_pred             CeeeeCCCeEEEEEEE----------cCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCE
Confidence            4699999999999654          4457789999987432   23345567788888876 59999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .|+||||++||+|.+++..  ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.++|+|||++...
T Consensus        71 ~~iv~Ey~~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          71 LFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             EEEEEcCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            9999999999999998854  4568999999999999999999999  89999999999999999999999999998742


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ..  .........||+.|+|||++.+..++.++|||||||++|+|++|..||......             .....+...
T Consensus       147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------------~~~~~i~~~  211 (320)
T cd05590         147 IF--NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------------DLFEAILND  211 (320)
T ss_pred             Cc--CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------------HHHHHHhcC
Confidence            21  122234567999999999998889999999999999999999999998643221             111111111


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM  403 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  403 (451)
                        ....+...+.++.+|+.+||+.||.+||++
T Consensus       212 --~~~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         212 --EVVYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence              112333456789999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.1e-41  Score=324.80  Aligned_cols=265  Identities=28%  Similarity=0.395  Sum_probs=204.7

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ..++|++.++||+|+||.||+|...+.     ........||+|.+..... .....+.+|+.+++.++|+||+++++++
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   78 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDI-----IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV   78 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEecc-----CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            356899999999999999999875431     1223356799999864432 2234577899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED--------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF  278 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~  278 (451)
                      .+....++||||+.+|+|.+++....        ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dikp~nili~~~~  156 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCCChheEEEcCCC
Confidence            99999999999999999999985421        1345677888999999999999999  8999999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCcccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  357 (451)
                      .++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......        
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--------  228 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------  228 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence            999999999975332221111222345677999999988889999999999999999998 67776532111        


Q ss_pred             ccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                            .....+........+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus       229 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         229 ------QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                  11111111111222334467899999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.2e-41  Score=327.54  Aligned_cols=272  Identities=26%  Similarity=0.425  Sum_probs=210.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|.+.++||+|+||.||++......   .........+|+|.+..... .....+.+|+.+++.+ +||||+++++++
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~---~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGID---KSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccC---CccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            358889999999999999998754321   01123456789999874322 2345678899999999 599999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCce
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV  272 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NI  272 (451)
                      .+....++||||+.+|+|.+++....              ...+++..+..++.||+.||.|||+  +||+|+||||+||
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Ni  165 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAARNV  165 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeeccccceeE
Confidence            99999999999999999999985432              2458899999999999999999999  8999999999999


Q ss_pred             eeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCC
Q 013028          273 LLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLA  351 (451)
Q Consensus       273 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~  351 (451)
                      |++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.....   
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---  242 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---  242 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---
Confidence            999999999999999975332211111112234457999999988889999999999999999999 7777653221   


Q ss_pred             CCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                                 ..+...+........+...+.++.+++.+||..+|++|||+.++++.|+.+...+..
T Consensus       243 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~  299 (314)
T cd05099         243 -----------EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE  299 (314)
T ss_pred             -----------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence                       111112222222233444567899999999999999999999999999999876644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8e-41  Score=319.23  Aligned_cols=259  Identities=25%  Similarity=0.390  Sum_probs=207.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++.+.||+|+||.||+|...          .++..||||.+.....   .....+.+|+++++.++||||+++++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~----------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCL----------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSF   71 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEe----------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeE
Confidence            47899999999999999997643          3467899998764322   2234678899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      .+.+..++||||+++++|.+++...  ....+++..+..++.|++.||.|||+  ++|+|+||||+||+++.++.++|+|
T Consensus        72 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d  149 (267)
T cd08228          72 IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             EECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECc
Confidence            9999999999999999999887532  23558899999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ||++......  ........|+..|+|||.+.+..++.++|+||||+++|+|++|..||......            ...
T Consensus       150 ~g~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------------~~~  215 (267)
T cd08228         150 LGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------------LFS  215 (267)
T ss_pred             cccceeccch--hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------------HHH
Confidence            9998754321  11223456888999999998888999999999999999999999997543211            011


Q ss_pred             hhHHhhhhhcC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          365 LHQIIDEKLGR-NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       365 ~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                      +...+...... ......+..+.+++.+||..+|.+||++.++++.|++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         216 LCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             HHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            11111111111 122345678999999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.4e-41  Score=324.39  Aligned_cols=249  Identities=28%  Similarity=0.393  Sum_probs=195.6

Q ss_pred             ccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       138 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      ||+|+||.||++.          ...++..||+|.+.....   .....+..|+++++.++||||+++++++.++.+.++
T Consensus         1 lg~G~~g~Vy~~~----------~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~l   70 (277)
T cd05607           1 LGKGGFGEVCAVQ----------VKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCL   70 (277)
T ss_pred             CCCCCceEEEEEE----------EccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEE
Confidence            7999999999965          444577899999864321   123345679999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCC
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG  294 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  294 (451)
                      ||||++|++|.+++.......+++..+..++.|++.||.|||+  .||+||||||+|||++.++.++|+|||++......
T Consensus        71 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          71 VMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             EEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            9999999999988866555678999999999999999999999  89999999999999999999999999998754321


Q ss_pred             CCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhc
Q 013028          295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG  374 (451)
Q Consensus       295 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (451)
                         .......|+..|+|||++.+..++.++|||||||++|+|++|..||........         ..............
T Consensus       149 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~  216 (277)
T cd05607         149 ---KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA---------KEELKRRTLEDEVK  216 (277)
T ss_pred             ---ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh---------HHHHHHHhhccccc
Confidence               122345789999999999888899999999999999999999999864321100         00001111111111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          375 RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       375 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                       ......+.++.+|+.+||+.||++||++.|+++.+.
T Consensus       217 -~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         217 -FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             -cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence             011234678999999999999999999987764443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.2e-41  Score=335.09  Aligned_cols=248  Identities=27%  Similarity=0.362  Sum_probs=198.6

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCC-Cceeecccee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNH-PNVVKLMGYC  206 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h-~nIv~~~~~~  206 (451)
                      +|++.+.||+|+||.||+|..          ..++..||||++.+..   ....+.+..|..++..++| ++|+.+++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~----------~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~   70 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAER----------KGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF   70 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEE----------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Confidence            478889999999999999764          3456789999987532   2334567789999999986 5688899999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+.+..|+||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+|||
T Consensus        71 ~~~~~~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          71 QTMDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecC
Confidence            999999999999999999998854  4568999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++......  ........||..|+|||++.+..++.++|||||||++|+|++|+.||......             ....
T Consensus       147 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------------~~~~  211 (324)
T cd05587         147 MCKENIFG--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------------ELFQ  211 (324)
T ss_pred             cceecCCC--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------------HHHH
Confidence            98742211  12233567999999999999999999999999999999999999998643211             1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM-----SEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~  409 (451)
                      .+...  ....+...+.++.+++.+||..||.+|++.     .+++++
T Consensus       212 ~i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         212 SIMEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             HHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11111  122344556789999999999999999976     566543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-41  Score=341.09  Aligned_cols=252  Identities=24%  Similarity=0.310  Sum_probs=201.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .++|++.+.||+|+||.||++..          ..++..||+|++.+..   ......+.+|+.+++.++||||++++++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~  111 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRH----------KSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA  111 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEE----------CCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            35899999999999999999654          4457789999996432   2233456789999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.++...|+||||++||+|.+++..   ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~Df  186 (370)
T cd05596         112 FQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADF  186 (370)
T ss_pred             EecCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEec
Confidence            9999999999999999999998854   358889999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccC----CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG----HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      |++....... .......+||+.|+|||++.+.    .++.++|||||||++|||++|..||.....             
T Consensus       187 G~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------------  252 (370)
T cd05596         187 GTCMKMDANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------------  252 (370)
T ss_pred             cceeeccCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-------------
Confidence            9997532211 1122346799999999998643    478999999999999999999999875321             


Q ss_pred             hhhhhHHhhhhhcCCCCH--HHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 013028          362 KLALHQIIDEKLGRNIQM--EEAQEFAEIILRCLNSDPKN--RPTMSEVVAA  409 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  409 (451)
                      ......+.........+.  ..+.++.+|+.+||..+|++  |+++.+++++
T Consensus       253 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         253 VGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            111122222111111222  35788999999999999988  9999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-41  Score=327.45  Aligned_cols=270  Identities=25%  Similarity=0.417  Sum_probs=203.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchh----hhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccc
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMT----AARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~----~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      .+|++.+.||+|+||.||++........    ..........||+|.+..... .....+.+|+++++.++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            4899999999999999999876432110    011123345689999875422 23456889999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNED----------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL  274 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll  274 (451)
                      ++......++||||+.+++|.+++....          ...+++..++.++.|++.||.|||+  .|++|+||||+|||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nill  162 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFVHRDLATRNCLV  162 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCeeccccChhhEEE
Confidence            9999999999999999999999885421          1247888999999999999999999  899999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh--CCCccccccCCCCC
Q 013028          275 DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS--GKTAAMRRTNGLAG  352 (451)
Q Consensus       275 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt--g~~pf~~~~~~~~~  352 (451)
                      +.++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++  |..||.......  
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~--  240 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ--  240 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH--
Confidence            9999999999999975332222112223345678999999988889999999999999999998  455554322110  


Q ss_pred             CccccccchhhhhhHHhhh---hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          353 NWAKPYLSNKLALHQIIDE---KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                           .   .....+....   ......+...+..+.+|+.+||..||++||++.+|++.|+
T Consensus       241 -----~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 -----V---IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             -----H---HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence                 0   0000111111   0111123334678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.8e-41  Score=326.04  Aligned_cols=269  Identities=26%  Similarity=0.419  Sum_probs=209.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|.+.+.||+|+||.||+|.+....   .........||+|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccC---CCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            358889999999999999998753210   0112334579999987432 23345788999999999 799999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCce
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV  272 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NI  272 (451)
                      ......++||||+.+|+|.+++....              ...+++..+..++.||+.||.|||+  +||+||||||+||
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Ni  168 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS--QKCIHRDLAARNV  168 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH--CCeeecccccceE
Confidence            99999999999999999999986431              2357888899999999999999999  8999999999999


Q ss_pred             eeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCC
Q 013028          273 LLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLA  351 (451)
Q Consensus       273 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~  351 (451)
                      |++.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.....   
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---  245 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---  245 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence            999999999999999985433222222223345678999999988889999999999999999998 6777643221   


Q ss_pred             CCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                                 ..+...+........+...+..+.+|+.+||..+|++|||+.++++.|+++...
T Consensus       246 -----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         246 -----------EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             -----------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                       111122222222223344567899999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-41  Score=322.88  Aligned_cols=262  Identities=27%  Similarity=0.428  Sum_probs=207.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|.+.+.||+|+||.||+|.+....     .......||+|.+..... .....+.+|+.++..++|+||+++++++.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVV-----KGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccC-----CCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            458899999999999999999875421     123457799999864432 22346788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNED--------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      .....++||||+++|+|.+++....        ...+++..+..++.|++.||.|||+  .+|+|+||||+|||++.++.
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill~~~~~  157 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLT  157 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccChheEEEcCCCC
Confidence            9999999999999999999985422        2347888999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  358 (451)
                      ++|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......         
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---------  228 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---------  228 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---------
Confidence            99999999875332221112223456778999999988889999999999999999998 88877532211         


Q ss_pred             cchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                           .....+........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       229 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         229 -----EVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                 111122222222334445788999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.5e-40  Score=317.19  Aligned_cols=254  Identities=26%  Similarity=0.445  Sum_probs=203.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .+|++.++||+|+||.||+|.+..           ...||+|.+.... ...+.+.+|+++++.++|+||+++++++.+ 
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~-----------~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-   72 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNG-----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-   72 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecC-----------CceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-
Confidence            479999999999999999986543           2348999987432 345678899999999999999999998754 


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++|+|.+++.......+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||.+.
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~~~  150 (262)
T cd05071          73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLAR  150 (262)
T ss_pred             CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCcee
Confidence            567999999999999999976555678999999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHH
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......             ... ..
T Consensus       151 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------------~~~-~~  215 (262)
T cd05071         151 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------------EVL-DQ  215 (262)
T ss_pred             ecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------------HHH-HH
Confidence            5432221 11123345678999999988889999999999999999999 77776533211             001 11


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      +............+..+.+|+.+||+.||.+||++.++++.|+..
T Consensus       216 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         216 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            111111223345667899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1e-40  Score=317.54  Aligned_cols=254  Identities=27%  Similarity=0.466  Sum_probs=203.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.++||+|+||.||+|.+..           +..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~-----------~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   72 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNG-----------NTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE   72 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecC-----------CceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEECC
Confidence            3578999999999999999986543           3458999987543 345678999999999999999999998854


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                       ...++||||+++++|.+++.......+++..+..++.+++.||.|||+  .+|+|+||||+||++++++.++|+|||++
T Consensus        73 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          73 -EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             -CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceee
Confidence             567999999999999999876555678999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.....              .....
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------------~~~~~  214 (260)
T cd05070         150 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------------REVLE  214 (260)
T ss_pred             eeccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------------HHHHH
Confidence            75432211 11122345567999999988889999999999999999999 8888753221              11111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                      .+........+...+..+.+|+.+||..+|++|||+.++++.|++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         215 QVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            122222223344556789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.9e-41  Score=331.46  Aligned_cols=268  Identities=28%  Similarity=0.400  Sum_probs=204.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|++.+.||+|+||.||+|.+...     ....+++.||||++...... ....+.+|+.+|.++ +|+||+++++++
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGI-----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccC-----CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            35899999999999999999875431     13345678999999754322 235678899999999 589999999988


Q ss_pred             ecC-CeeEEEEeccCCCChhhhhccCC-----------------------------------------------------
Q 013028          207 CDD-QHRLLVYEYVTRGSLEDHLLNED-----------------------------------------------------  232 (451)
Q Consensus       207 ~~~-~~~~lV~E~~~gg~L~~~l~~~~-----------------------------------------------------  232 (451)
                      ... ...++||||+++|+|.+++....                                                     
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            654 56789999999999999885421                                                     


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccc
Q 013028          233 ------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS  300 (451)
Q Consensus       233 ------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  300 (451)
                                  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+|||++............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  238 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  238 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence                        1236788889999999999999999  89999999999999999999999999999753221111111


Q ss_pred             cccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCH
Q 013028          301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQM  379 (451)
Q Consensus       301 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (451)
                      ....++..|+|||++.+..++.++||||||+++|+|++ |..||......             ......+........+.
T Consensus       239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------------~~~~~~~~~~~~~~~~~  305 (343)
T cd05103         239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------------EEFCRRLKEGTRMRAPD  305 (343)
T ss_pred             CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------------HHHHHHHhccCCCCCCC
Confidence            22345667999999988899999999999999999997 88776432110             01111121111222233


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          380 EEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       380 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      ..+.++.+++..||+.||++|||+.+|++.|+.+...
T Consensus       306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            3456799999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.3e-41  Score=333.81  Aligned_cols=252  Identities=23%  Similarity=0.364  Sum_probs=197.1

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhc-CCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRL-NHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~  211 (451)
                      +.||+|+||.||++.+          ..++..||||++.+...   .....+..|..++..+ +||||++++++|.+...
T Consensus         1 ~~lG~G~~g~V~~~~~----------~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~   70 (329)
T cd05588           1 RVIGRGSYAKVLLVEL----------KKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESR   70 (329)
T ss_pred             CeEeeCCCeEEEEEEE----------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCE
Confidence            4699999999999764          44577899999975422   2234577899999998 59999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .||||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++...
T Consensus        71 ~~lv~e~~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          71 LFFVIEFVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            9999999999999988854  4579999999999999999999999  89999999999999999999999999998742


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ..  .........||..|+|||++.+..++.++|||||||++|+|++|..||............    ........+...
T Consensus       147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~  220 (329)
T cd05588         147 IR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN----TEDYLFQVILEK  220 (329)
T ss_pred             cc--CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccccc----chHHHHHHHHcC
Confidence            11  122234567999999999999999999999999999999999999999643221100000    000001111111


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPT------MSEVVAA  409 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~  409 (451)
                        ...++...+.++.+++.+||+.||.+|++      +.+++++
T Consensus       221 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         221 --QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence              12234455678999999999999999997      6777654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.9e-41  Score=347.61  Aligned_cols=263  Identities=20%  Similarity=0.309  Sum_probs=193.8

Q ss_pred             HHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCC------Cc
Q 013028          125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH------PN  198 (451)
Q Consensus       125 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h------~n  198 (451)
                      +.....+|++.++||+|+||+||+|.+          ...+..||||++.... .....+..|+++++.++|      .+
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~----------~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~  192 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWD----------RKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFP  192 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEE----------cCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcc
Confidence            344567999999999999999999764          3456789999996432 223455678888877754      45


Q ss_pred             eeeccceeecC-CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC
Q 013028          199 VVKLMGYCCDD-QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD  277 (451)
Q Consensus       199 Iv~~~~~~~~~-~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~  277 (451)
                      |+.++++|..+ .+.|+|||++ |++|.+++..  ...+++..+..|+.||+.||.|||+. .|||||||||+|||++.+
T Consensus       193 i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~  268 (467)
T PTZ00284        193 LMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETS  268 (467)
T ss_pred             eeeeEEEEEcCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecC
Confidence            88898888764 5789999998 7789988854  35789999999999999999999972 499999999999999866


Q ss_pred             C----------------cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 013028          278 F----------------NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT  341 (451)
Q Consensus       278 ~----------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~  341 (451)
                      +                .+||+|||++...     .......+||..|+|||++.+..|+.++|||||||++|||++|+.
T Consensus       269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~  343 (467)
T PTZ00284        269 DTVVDPVTNRALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL  343 (467)
T ss_pred             CcccccccccccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            5                4999999988632     122345689999999999999999999999999999999999999


Q ss_pred             ccccccCCCC------------CCccccccchhhhhhHHhhhhh--cC---------------CCCHHHHHHHHHHHHHc
Q 013028          342 AAMRRTNGLA------------GNWAKPYLSNKLALHQIIDEKL--GR---------------NIQMEEAQEFAEIILRC  392 (451)
Q Consensus       342 pf~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~--~~---------------~~~~~~~~~l~~li~~c  392 (451)
                      ||........            ..|......  .....++....  ..               .........+.+||.+|
T Consensus       344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  421 (467)
T PTZ00284        344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGT--EEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL  421 (467)
T ss_pred             CCCCCChHHHHHHHHHHcCCCCHHHHhhccc--hhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence            9965432100            001000000  00000000000  00               00011245688999999


Q ss_pred             cccCCCCCCCHHHHHHH
Q 013028          393 LNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       393 l~~dP~~RPt~~evl~~  409 (451)
                      |.+||++|||+.|+|++
T Consensus       422 L~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        422 LHYDRQKRLNARQMTTH  438 (467)
T ss_pred             CCcChhhCCCHHHHhcC
Confidence            99999999999999974

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.5e-41  Score=333.85  Aligned_cols=243  Identities=25%  Similarity=0.367  Sum_probs=195.9

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhc-CCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRL-NHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~  211 (451)
                      ++||+|+||.||+|...          .++..||||++....   ......+..|.+++..+ +||||+++++++.+...
T Consensus         1 ~~lG~G~~g~Vy~~~~~----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~   70 (321)
T cd05591           1 KVLGKGSFGKVMLAELK----------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDR   70 (321)
T ss_pred             CccccCCCeEEEEEEEC----------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCe
Confidence            46999999999997643          456789999987532   22334567789998876 69999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .|+||||+++|+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+|||++...
T Consensus        71 ~~lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          71 LFFVMEYVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            9999999999999988854  4568999999999999999999999  89999999999999999999999999998743


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ..  .........||..|+|||++.+..++.++|||||||++|+|++|..||......             .....+...
T Consensus       147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-------------~~~~~i~~~  211 (321)
T cd05591         147 IL--NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-------------DLFESILHD  211 (321)
T ss_pred             cc--CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-------------HHHHHHHcC
Confidence            21  122233567999999999998889999999999999999999999998643321             111112111


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRP-------TMSEVVAA  409 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~  409 (451)
                      .  ...+...+.++.+|+.+||..||++||       ++.++++.
T Consensus       212 ~--~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         212 D--VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            1  122333567899999999999999999       78888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-42  Score=305.26  Aligned_cols=263  Identities=25%  Similarity=0.386  Sum_probs=211.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.++||.|||+-||++          ++..++..+|+|++.....+..+...+|++..+.++|||+++++++...
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV----------~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~   89 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLV----------KGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLR   89 (302)
T ss_pred             CceEEEeeeecCCCceeeeee----------cccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence            469999999999999999994          4667788899999988777778888999999999999999999998764


Q ss_pred             CC-----eeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--ceeCCCCCCceeeCCCCc
Q 013028          209 DQ-----HRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLHTYWRP--VIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       209 ~~-----~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~--iiHrDlkp~NIll~~~~~  279 (451)
                      +.     ..||+++|...|+|.+.+...  ++..+++.+.+.|+.+|++||.+||+  ..  +.||||||.|||+.+.+.
T Consensus        90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~--~~~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE--KEPPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc--cCCcccccCCCcceeEecCCCc
Confidence            43     389999999999999998643  34579999999999999999999999  55  999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCccc-------ccccCCCCccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCccccccCC
Q 013028          280 AKISDFGLAKFGPLGDKSHI-------STRVLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG  349 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  349 (451)
                      ++|.|||.++..+-.-.+..       -..-..|..|+|||++.   +...+.++|||||||+||.|+.|..||......
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~  247 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ  247 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence            99999999975332111110       01124678899999984   456789999999999999999999999876553


Q ss_pred             CCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          350 LAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                      +. ..+-.          +....+........++.+.+||.+||+.||.+||++.+++..++.+.
T Consensus       248 Gg-SlaLA----------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 GG-SLALA----------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             CC-eEEEe----------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            22 11111          11122222223346788999999999999999999999999998764

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-40  Score=336.82  Aligned_cols=258  Identities=23%  Similarity=0.264  Sum_probs=196.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ...|.+.+.||+|+||.||+|.+.          ..+..||||...      ...+.+|+++|++|+|+|||++++++..
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~----------~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~  231 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHP----------DYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV  231 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEEC----------CCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence            347999999999999999997654          346779999642      1235689999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...+||||++. ++|.+++... ...+++..++.|+.||+.||.|||+  +||+||||||+||||+.++.++|+|||++
T Consensus       232 ~~~~~lv~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGla  307 (461)
T PHA03211        232 GGLTCLVLPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAA  307 (461)
T ss_pred             CCEEEEEEEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCCc
Confidence            999999999995 6888887543 3469999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh----
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA----  364 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----  364 (451)
                      +...............||..|+|||++.+..++.++|||||||+||||++|..++........   ..++......    
T Consensus       308 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~---~~~~~~~l~~~i~~  384 (461)
T PHA03211        308 CFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE---RRPYDAQILRIIRQ  384 (461)
T ss_pred             eecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc---cCCcHHHHHHHHHh
Confidence            864322222223356799999999999999999999999999999999998876544321100   0000000000    


Q ss_pred             ---------------hhHHhhhhh----cCCC-------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          365 ---------------LHQIIDEKL----GRNI-------QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       365 ---------------~~~~~~~~~----~~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                                     +...+....    ....       ....+..+.+||.+||+.||.+|||+.|+|+.
T Consensus       385 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        385 AQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                           000000000    0000       00123578999999999999999999999975

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-40  Score=321.77  Aligned_cols=275  Identities=27%  Similarity=0.426  Sum_probs=206.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec-
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD-  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-  208 (451)
                      .+|++.+.||+|+||.||+|.+..      .+...+..||+|.+........+.+.+|+++++.++||||+++++++.. 
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDP------LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   77 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecC------CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence            378889999999999999987532      2345577899999876555555678899999999999999999998653 


Q ss_pred             -CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          209 -DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       209 -~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                       ....++||||+++++|.+++... ...+++..+..++.|++.||.|||+  .||+||||||+|||++.++.++|+|||+
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          78 GRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             CCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeEEECCCcc
Confidence             35689999999999999998543 3458999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCccc-ccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc--cchhhh
Q 013028          288 AKFGPLGDKSHI-STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLA  364 (451)
Q Consensus       288 a~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~  364 (451)
                      +........... .....++..|+|||++.+..++.++|||||||++|||++|..++...............  ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence            986443221111 11122345699999998888999999999999999999987665432211000000000  000011


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      +...+........+...+..+.+|+.+||..+|++|||+.+|++.|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1122222222223344567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.8e-40  Score=316.43  Aligned_cols=259  Identities=24%  Similarity=0.420  Sum_probs=208.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++.+.||.|+||.||+|...          .++..||+|.+....   ....+.+.+|+++++.++|+||+++++++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~   71 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICL----------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF   71 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEc----------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence            47899999999999999997643          346789999886422   22345788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      .+.+..++||||+++++|.+++..  .....+++..+..++.+++.||.|||+  .||+|+||+|+||+++.++.++|+|
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d  149 (267)
T cd08224          72 IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             ecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEec
Confidence            999999999999999999998854  234568999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ||++......  ........++..|+|||.+.+..++.++|+|||||++|+|++|..||......            ...
T Consensus       150 ~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------~~~  215 (267)
T cd08224         150 LGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------------LYS  215 (267)
T ss_pred             cceeeeccCC--CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------------HHH
Confidence            9998753321  11123456888999999998888999999999999999999999987543211            000


Q ss_pred             hhHHhhhhhcCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          365 LHQIIDEKLGRNIQM-EEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                      +...+........+. ..+..+.+++.+||..+|++|||+.+|++.|+.++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         216 LCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            111111111122222 45678999999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.3e-40  Score=320.33  Aligned_cols=264  Identities=23%  Similarity=0.377  Sum_probs=206.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+|++.++||.|+||+||+|.+...+      ......||+|++..... .....+.+|+.++..++|+||+++++++..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~------~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDG------ENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCC------CccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            47889999999999999999865321      11234589999875432 234567889999999999999999999875


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      . ..+++|||+++|+|.+++... ...+++..++.++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||++
T Consensus        81 ~-~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          81 S-TVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             C-CcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCCCce
Confidence            4 578999999999999998653 3568999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....              ..+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------------~~~~~  222 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--------------REIPD  222 (279)
T ss_pred             eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------------HHHHH
Confidence            86432222111222344678999999988889999999999999999998 8887753221              11112


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                      .+........+...+.++.+++.+||..||++||++.++++.|+.+....
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         223 LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             HHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            22222222333445678999999999999999999999999998886544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-41  Score=340.11  Aligned_cols=253  Identities=25%  Similarity=0.322  Sum_probs=200.9

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccc
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      ..++|++.+.||+|+||.||++..          ..++..+|+|++.+..   ......+.+|+.+++.++||||+++++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~  110 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRH----------KSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC  110 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEE----------CCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            346899999999999999999664          4457789999986422   222345778999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      ++.++...|+||||++||+|.+++..   ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~D  185 (370)
T cd05621         111 AFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLAD  185 (370)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEe
Confidence            99999999999999999999998854   358899999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccC----CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccc
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG----HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS  360 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  360 (451)
                      ||++....... .......+||+.|+|||++.+.    .++.++|||||||++|+|++|..||.....            
T Consensus       186 FG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------------  252 (370)
T cd05621         186 FGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------------  252 (370)
T ss_pred             cccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------------
Confidence            99997543211 1122356799999999999653    378999999999999999999999965321            


Q ss_pred             hhhhhhHHhhhhhcCCCC--HHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 013028          361 NKLALHQIIDEKLGRNIQ--MEEAQEFAEIILRCLNSDPKN--RPTMSEVVAA  409 (451)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  409 (451)
                       ......+.........+  ...+..+.+++.+||..++.+  |+++.|++++
T Consensus       253 -~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         253 -VGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -HHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence             11122333222112222  234778999999999855543  8899999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.9e-41  Score=333.03  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=196.2

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhc-CCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRL-NHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~  211 (451)
                      +.||+|+||.||++..          ..++..||+|++.+...   .....+..|+.++..+ +||||+++++++.+++.
T Consensus         1 ~~lG~G~~g~V~~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   70 (329)
T cd05618           1 RVIGRGSYAKVLLVRL----------KKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   70 (329)
T ss_pred             CeeeeCCCeEEEEEEE----------CCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCE
Confidence            4699999999999764          44577899999975422   2234567889888877 69999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .++||||+++|+|..++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+++..
T Consensus        71 ~~lv~E~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          71 LFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            9999999999999988854  4578999999999999999999999  89999999999999999999999999999742


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ..  .........||..|+|||++.+..++.++|||||||++|+|++|..||.........     .......+...+..
T Consensus       147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-----~~~~~~~~~~~i~~  219 (329)
T cd05618         147 LR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-----DQNTEDYLFQVILE  219 (329)
T ss_pred             cC--CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc-----ccccHHHHHHHHhc
Confidence            21  112233567999999999999999999999999999999999999998642211100     00000011111111


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPT------MSEVVAA  409 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~  409 (451)
                       ....++...+..+.+|+.+||+.||++||+      +.+++++
T Consensus       220 -~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         220 -KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence             122345556788999999999999999998      4566554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-40  Score=316.97  Aligned_cols=255  Identities=28%  Similarity=0.490  Sum_probs=206.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+.|++.++||+|+||.||+|...           .+..||+|.+.... ....++.+|+.+++.++|+||+++++++. 
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-----------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   71 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-----------GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-   71 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-----------CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence            458999999999999999998643           24679999987443 34567899999999999999999999875 


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      .+..++||||+.+++|.+++.......+++..+..++.|++.||.|||+  .|++|+||||+||+++.++.++|+|||++
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  149 (260)
T cd05067          72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLA  149 (260)
T ss_pred             cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCcce
Confidence            4568999999999999999876666778999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||......              ....
T Consensus       150 ~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------------~~~~  214 (260)
T cd05067         150 RLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------------EVIQ  214 (260)
T ss_pred             eecCCCC-cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------------HHHH
Confidence            7543211 111223345678999999988889999999999999999999 99888643211              1111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      .+........+...+.++.+++.+||..+|++|||++++++.|+++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         215 NLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            2222222233344567899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.4e-41  Score=331.72  Aligned_cols=242  Identities=26%  Similarity=0.403  Sum_probs=192.8

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhc-CCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRL-NHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~  211 (451)
                      +.||+|+||.||+|.+.          .++..||||++....   ....+.+..|..++..+ +||||+++++++..+..
T Consensus         1 ~~lG~G~~g~Vy~~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~   70 (316)
T cd05592           1 KVLGKGSFGKVMLAELK----------GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEH   70 (316)
T ss_pred             CeeeeCCCeEEEEEEEC----------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCE
Confidence            46999999999997643          457789999987532   22334455677777654 79999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .++||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++...
T Consensus        71 ~~lv~e~~~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          71 LFFVMEYLNGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            9999999999999998854  3568999999999999999999999  89999999999999999999999999999753


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ....  ......+||..|+|||++.+..++.++|||||||++|+|++|..||......             .....+.. 
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-------------~~~~~i~~-  210 (316)
T cd05592         147 MNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-------------ELFDSILN-  210 (316)
T ss_pred             CCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-------------HHHHHHHc-
Confidence            2211  2234567999999999998889999999999999999999999998643211             01111111 


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS-EVVA  408 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~  408 (451)
                       ....++...+.++.+|+.+||..||.+||++. ++++
T Consensus       211 -~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         211 -DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence             12233444567899999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.2e-40  Score=323.76  Aligned_cols=261  Identities=27%  Similarity=0.435  Sum_probs=204.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhc-CCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRL-NHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~  207 (451)
                      ++|++.+.||.|+||.||+|.....        .....+++|.+.... ....+.+.+|++++.++ +||||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~--------~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~   73 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKD--------GLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE   73 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCC--------CCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence            4788999999999999999875432        122347888876422 22345688899999999 6999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcee
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL  273 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIl  273 (451)
                      +....++||||+++++|.+++....              ...+++..++.++.|++.||+|||+  .||+||||||+|||
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil  151 (297)
T cd05089          74 NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVL  151 (297)
T ss_pred             cCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcceEE
Confidence            9999999999999999999985421              1358899999999999999999999  89999999999999


Q ss_pred             eCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCC
Q 013028          274 LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAG  352 (451)
Q Consensus       274 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~  352 (451)
                      ++.++.+||+|||++.....   .........+..|+|||++.+..++.++|||||||++|+|++ |..||......   
T Consensus       152 l~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---  225 (297)
T cd05089         152 VGENLASKIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---  225 (297)
T ss_pred             ECCCCeEEECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence            99999999999999863211   111111123456999999988889999999999999999997 98888543211   


Q ss_pred             CccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          353 NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                                 .+...+........+...+.++.+|+.+||..+|.+|||+.++++.|+.+....
T Consensus       226 -----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         226 -----------ELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             -----------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                       111122222222334445678999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=358.54  Aligned_cols=276  Identities=29%  Similarity=0.475  Sum_probs=221.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ....++.+.||+|+||.||.|.+.+-.     .......||||.+.+.. .+...+|.+|..+|..++|||||+++|++.
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~-----~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVP-----GSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCC-----CCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            456778899999999999999986531     11225679999998653 445678999999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNE-----DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      +....+|++|||+||+|..+|+..     ....++....+.++.+||+|+.||++  +++|||||..+|+||+....+||
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~--~~fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES--KHFVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh--CCCcCcchhhhheeecccCcEEE
Confidence            999999999999999999999654     13568889999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccch
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      +|||+|+..-..+.........-...|||||.+.++.++.++|||||||++||++| |..|+....+             
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-------------  910 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-------------  910 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-------------
Confidence            99999993222221111111112246999999999999999999999999999999 5666543322             


Q ss_pred             hhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCccccc
Q 013028          362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTSL  425 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~  425 (451)
                      ...+....... .-+.+..+++.+.+||..||+.+|++||++..+++.+..+...+........
T Consensus       911 ~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~  973 (1025)
T KOG1095|consen  911 FEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPL  973 (1025)
T ss_pred             HHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCccccc
Confidence            11111222222 5566778899999999999999999999999999999999887776655444

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-41  Score=338.59  Aligned_cols=265  Identities=21%  Similarity=0.228  Sum_probs=202.9

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ...+|.+++.||.|+||.||++...        +...+..|++|.+...     ....+|+++|+.++||||+++++++.
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~--------~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~  156 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKH--------GDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR  156 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEc--------CCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe
Confidence            3458999999999999999998643        2334677999988643     23468999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      .....|+|||++. ++|.+++.  ....+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+|||+
T Consensus       157 ~~~~~~lv~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~DfG~  231 (392)
T PHA03207        157 WKSTVCMVMPKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGA  231 (392)
T ss_pred             eCCEEEEEehhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccCcc
Confidence            9999999999995 68988883  34679999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc-----------cc
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW-----------AK  356 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~-----------~~  356 (451)
                      +................||..|+|||++.+..++.++|||||||++|||++|..||...........           ..
T Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~  311 (392)
T PHA03207        232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL  311 (392)
T ss_pred             ccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence            9754433322333456899999999999888999999999999999999999999976543211000           00


Q ss_pred             cccc-hhhhhhHHh---hhhhcCCC--C-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          357 PYLS-NKLALHQII---DEKLGRNI--Q-----MEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       357 ~~~~-~~~~~~~~~---~~~~~~~~--~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      .+.. ....+...+   ........  +     ...+.++.+||.+||..||++|||+.|+|..=
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p  376 (392)
T PHA03207        312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP  376 (392)
T ss_pred             ccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            0000 000000000   00000000  0     11246788999999999999999999999863

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-40  Score=316.79  Aligned_cols=252  Identities=25%  Similarity=0.443  Sum_probs=201.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|.+.+.||+|+||+||+|.+..           ...+|||.+... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-----------~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-----------QYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ   71 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-----------CCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            368889999999999999986532           335999998743 33456788999999999999999999999998


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+  .||+|+||||+||+++.++.+||+|||++.
T Consensus        72 ~~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          72 RPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCccce
Confidence            89999999999999999886533 368999999999999999999999  899999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHH
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......              .....
T Consensus       149 ~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------------~~~~~  213 (256)
T cd05113         149 YVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------------ETVEK  213 (256)
T ss_pred             ecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------------HHHHH
Confidence            5332211 11112335567999999988889999999999999999998 88887533211              01111


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      +........+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         214 VSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            1111112223334678999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.4e-41  Score=322.17  Aligned_cols=262  Identities=28%  Similarity=0.418  Sum_probs=204.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|.+.+.||+|+||.||+|.+....     .......|++|.+..... .....+.+|+.+++.++|+||+++++++.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~-----~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRD-----GDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF   79 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCC-----CCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            357899999999999999998865410     112467799998864332 23456888999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC---c
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNED-----DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF---N  279 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~---~  279 (451)
                      +....++||||++|++|.+++....     ...+++..++.++.||+.||.|||+  ++++|+||||+|||++.++   .
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~~~~  157 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRV  157 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchheEEEeccCCCcc
Confidence            9889999999999999999985432     1358999999999999999999999  8999999999999998654   5


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  358 (451)
                      ++|+|||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||......         
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---------  228 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---------  228 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---------
Confidence            99999999975421111111112233567999999988899999999999999999997 88887643221         


Q ss_pred             cchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                           .+...+........+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       229 -----~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         229 -----EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -----HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                 111222222222334455678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.2e-42  Score=336.95  Aligned_cols=252  Identities=25%  Similarity=0.330  Sum_probs=201.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|.+.+.||+|+||+||++.          +..++..||||++.....   .....+.+|+.+++.++|+||+++++++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~----------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~   70 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVR----------EKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF   70 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEE----------ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE
Confidence            368899999999999999965          444577899999975422   2345578899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          71 QDKDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             ecCCeEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEECCCCCEEeccCC
Confidence            9999999999999999999998654 3568999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccc------cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccc
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIA------TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS  360 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  360 (451)
                      ++........ .......||..|+|||++.      ...++.++|||||||++|+|++|..||......           
T Consensus       148 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----------  215 (330)
T cd05601         148 SAARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----------  215 (330)
T ss_pred             CCeECCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----------
Confidence            9975432211 1223457899999999986      456789999999999999999999998643211           


Q ss_pred             hhhhhhHHhhhh--hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          361 NKLALHQIIDEK--LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       361 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                        .....+....  .........+..+.+|+.+||. +|.+|||+.+++++
T Consensus       216 --~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         216 --KTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             --HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence              1111221111  1111122346789999999998 99999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=314.47  Aligned_cols=250  Identities=30%  Similarity=0.487  Sum_probs=205.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +.|++.+.||.|+||.||+|...            +..||||.+..... ..+.+.+|+.+++.++|+||+++++++.++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~------------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   72 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR------------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG   72 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec------------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence            47889999999999999998643            46799999975533 456788999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++++|.+++.......+++..+..++.|++.||.|||+  .||+|+||||+||+++.++.++|+|||++.
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~~  150 (256)
T cd05039          73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAK  150 (256)
T ss_pred             CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEccccccc
Confidence            999999999999999999876555579999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHH
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ......     ....++..|+|||++.+..++.++||||||+++|+|++ |..||......              .+...
T Consensus       151 ~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------------~~~~~  211 (256)
T cd05039         151 EASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------------DVVPH  211 (256)
T ss_pred             cccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--------------HHHHH
Confidence            542111     12334567999999988889999999999999999997 88887533211              11122


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      +........+...++.+.+++.+||..+|++|||+.++++.|+++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         212 VEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            222222223344568899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1e-40  Score=325.29  Aligned_cols=264  Identities=27%  Similarity=0.458  Sum_probs=204.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhc-CCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRL-NHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~  207 (451)
                      ++|++.+.||+|+||.||+|.+...        .....+++|.+.... ......+.+|++++.++ +|+||+++++++.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~--------~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~   78 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKD--------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE   78 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccC--------CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence            4788899999999999999875321        122456888776432 22345678899999999 7999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcee
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL  273 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIl  273 (451)
                      +++..++||||+++++|.+++....              ...+++..++.++.||+.||.|||+  +||+||||||+|||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Nil  156 (303)
T cd05088          79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNIL  156 (303)
T ss_pred             CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEE
Confidence            9999999999999999999985432              2358899999999999999999999  89999999999999


Q ss_pred             eCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCC
Q 013028          274 LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAG  352 (451)
Q Consensus       274 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~  352 (451)
                      ++.++.++|+|||++.....   ........++..|+|||++.+..++.++|||||||++|+|++ |..||......   
T Consensus       157 i~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---  230 (303)
T cd05088         157 VGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---  230 (303)
T ss_pred             ecCCCcEEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---
Confidence            99999999999999863211   001111223567999999988889999999999999999998 88887543211   


Q ss_pred             CccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCC
Q 013028          353 NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSC  420 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~  420 (451)
                                 .....+........+...+..+.+|+.+||+.+|++||++.+++..|+.+.......
T Consensus       231 -----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~  287 (303)
T cd05088         231 -----------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY  287 (303)
T ss_pred             -----------HHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence                       111111111122223335678999999999999999999999999999887665443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=315.01  Aligned_cols=250  Identities=27%  Similarity=0.457  Sum_probs=200.2

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      +|++.+.||+|+||.||+|.+..           ...+|+|.+.... .....+.+|+++++.++|+||+++++++.+..
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~-----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRG-----------KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR   72 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecC-----------CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            68889999999999999986432           3468999986432 34456888999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..++||||++|++|.+++.... ..+++..+..++.|++.||.|||+  .||+||||||+||+++.++.++|+|||+++.
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~  149 (256)
T cd05059          73 PIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLARY  149 (256)
T ss_pred             ceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHhhEEECCCCcEEECCccccee
Confidence            9999999999999999986543 368999999999999999999999  8999999999999999999999999999975


Q ss_pred             CCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          291 GPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       291 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ...... .......++..|+|||++.+..++.++||||||+++|+|++ |..||......              .....+
T Consensus       150 ~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------------~~~~~~  214 (256)
T cd05059         150 VLDDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------------EVVESV  214 (256)
T ss_pred             cccccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------------HHHHHH
Confidence            322111 11112223457999999988899999999999999999999 78877543211              111112


Q ss_pred             hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ........+...+.++.+++.+||..+|++|||+.++++.|
T Consensus       215 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         215 SAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            22222233344678899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.3e-41  Score=331.89  Aligned_cols=241  Identities=27%  Similarity=0.404  Sum_probs=193.1

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhc-CCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRL-NHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~  211 (451)
                      +.||+|+||.||+|.+          ..++..||+|.+....   ......+..|..++..+ +||||+++++++.+.++
T Consensus         1 ~~lg~G~~g~V~~~~~----------~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   70 (316)
T cd05620           1 KVLGKGSFGKVLLAEL----------KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEH   70 (316)
T ss_pred             CeeeeCCCeEEEEEEE----------CCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCE
Confidence            4699999999999764          3457789999997532   22334566788888765 79999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .|+||||+.||+|.+++..  ...+++..+..++.||+.||+|||+  +||+||||||+|||++.++.++|+|||++...
T Consensus        71 ~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          71 LFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEEECCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            9999999999999998854  4568899999999999999999999  89999999999999999999999999998742


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ...  ........||..|+|||++.+..++.++|||||||++|+|++|..||......              .+...+..
T Consensus       147 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------------~~~~~~~~  210 (316)
T cd05620         147 VFG--DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------------ELFESIRV  210 (316)
T ss_pred             ccC--CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------------HHHHHHHh
Confidence            211  12234567999999999999999999999999999999999999998643211              01111111


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS-EVV  407 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl  407 (451)
                       .....+...+.++.+|+.+||..||.+||++. +++
T Consensus       211 -~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         211 -DTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             11223334567899999999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.8e-40  Score=317.60  Aligned_cols=258  Identities=26%  Similarity=0.412  Sum_probs=197.9

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      |.+++.||+|+||.||+|.+...        .....+|+|.+....  ....+.+.+|+++++.++|+||+++++++...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~--------~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   72 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQD--------DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQT   72 (272)
T ss_pred             CccccccCcccCceEEEeEEccC--------CCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccC
Confidence            35678999999999999876542        112468999886532  22345678899999999999999999977432


Q ss_pred             ------CeeEEEEeccCCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          210 ------QHRLLVYEYVTRGSLEDHLLNE----DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       210 ------~~~~lV~E~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                            ...++||||+.+|+|.+++...    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~  150 (272)
T cd05075          73 VESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMN  150 (272)
T ss_pred             CcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCCC
Confidence                  2468999999999999887421    23458899999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  358 (451)
                      ++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......         
T Consensus       151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---------  221 (272)
T cd05075         151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---------  221 (272)
T ss_pred             EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---------
Confidence            99999999985432221111122345678999999988889999999999999999999 77777532211         


Q ss_pred             cchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                           .+...+........+...+..+.+++.+||..||++|||+.++++.|+++
T Consensus       222 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         222 -----EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -----HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 11111111111122334567799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=316.45  Aligned_cols=253  Identities=27%  Similarity=0.391  Sum_probs=204.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-----CHHHHHHHHHHHHhcCCCceeeccc
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-----GQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      +.|.+.+.||.|++|.||+|..          ..++..|++|.+......     ....+.+|++++++++||||+++++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~----------~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   71 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYD----------VDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG   71 (263)
T ss_pred             CcccccceecCCCceEEEEEEE----------cCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEE
Confidence            4688999999999999999764          344678999998643221     2346788999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      ++.++...++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  .||+|+||+|+||++++++.++|+|
T Consensus        72 ~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~d  147 (263)
T cd06625          72 CLRDDETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGD  147 (263)
T ss_pred             EEccCCeEEEEEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEee
Confidence            99999999999999999999998854  3568899999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          285 FGLAKFGPLGDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       285 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      ||++......... .......|+..|+|||++.+..++.++||||||+++|+|++|..||.....             ..
T Consensus       148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------------~~  214 (263)
T cd06625         148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------------MA  214 (263)
T ss_pred             cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------------HH
Confidence            9999753321111 111345678899999999888899999999999999999999999864321             11


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..............+...+..+.+++.+||..+|++|||+.++++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         215 AIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            1112222222333455567889999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.3e-40  Score=327.30  Aligned_cols=272  Identities=27%  Similarity=0.426  Sum_probs=210.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      ..+|.+++.||+|+||.||++.+.....   ........||+|.+..... .....+.+|+++++++ +|+||+++++++
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~---~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDK---DKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCC---ccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            3479999999999999999987543210   0112234689998874322 2345788999999999 799999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCce
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV  272 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NI  272 (451)
                      .++...++||||+.+|+|.+++....              ...+++..++.++.|++.||.|||+  +||+||||||+||
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Ni  165 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRDLAARNV  165 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceE
Confidence            99999999999999999999986421              2357888999999999999999999  8999999999999


Q ss_pred             eeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCC
Q 013028          273 LLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLA  351 (451)
Q Consensus       273 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~  351 (451)
                      |++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....   
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---  242 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---  242 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---
Confidence            999999999999999975332211111222334567999999988899999999999999999998 7777653221   


Q ss_pred             CCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                                 ..+...+........+...+..+.+|+.+||+.+|.+|||+.++++.|+.+......
T Consensus       243 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~  299 (334)
T cd05100         243 -----------EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST  299 (334)
T ss_pred             -----------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence                       111122222222233445567899999999999999999999999999999865544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.6e-41  Score=316.64  Aligned_cols=251  Identities=22%  Similarity=0.382  Sum_probs=204.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +|++.++||.|+||.||++..          ..++..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+.++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~----------~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   70 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQH----------VNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD   70 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEE----------cCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC
Confidence            478889999999999999654          4457789999986432 33446778899999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++++|.+++.......+++..+..++.|++.||.|||+  +||+|+||||+||+++.++.++|+|||++.
T Consensus        71 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~  148 (255)
T cd08219          71 GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSAR  148 (255)
T ss_pred             CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCcce
Confidence            999999999999999998866556678999999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ....  .........|+..|+|||++.+..++.++|+||||+++|+|++|..||......              .....+
T Consensus       149 ~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------------~~~~~~  212 (255)
T cd08219         149 LLTS--PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--------------NLILKV  212 (255)
T ss_pred             eecc--cccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--------------HHHHHH
Confidence            5332  122233467889999999998888999999999999999999999998643211              000111


Q ss_pred             hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ........+...+..+.+|+.+||+.||++|||+.+++..
T Consensus       213 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         213 CQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1111122334456779999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.4e-41  Score=322.15  Aligned_cols=247  Identities=28%  Similarity=0.389  Sum_probs=196.1

Q ss_pred             ccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc---CHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       138 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      ||+|+||+||++..          ..++..||+|.+......   ..+.+..|+.+++.++|+||+++++++..+...++
T Consensus         1 lg~G~~g~Vy~~~~----------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~l   70 (280)
T cd05608           1 LGKGGFGEVSACQM----------RATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCL   70 (280)
T ss_pred             CCCCCceeEEEEEE----------ccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEE
Confidence            79999999999764          445678999998753222   22456789999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCC
Q 013028          215 VYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP  292 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~  292 (451)
                      ||||+++|+|.+++..  .....+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.++|+|||++....
T Consensus        71 v~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  148 (280)
T cd05608          71 VMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELK  148 (280)
T ss_pred             EEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence            9999999999887743  234568999999999999999999999  899999999999999999999999999997543


Q ss_pred             CCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhh
Q 013028          293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK  372 (451)
Q Consensus       293 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (451)
                      ...  .......||..|+|||++.+..++.++|||||||++|+|++|..||........         .......+... 
T Consensus       149 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---------~~~~~~~~~~~-  216 (280)
T cd05608         149 DGQ--SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---------NKELKQRILND-  216 (280)
T ss_pred             CCC--ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---------HHHHHHhhccc-
Confidence            221  123345789999999999999999999999999999999999999864322100         00001111111 


Q ss_pred             hcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          373 LGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       373 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                       ....+...+..+.+++.+||+.||++||     ++++++++
T Consensus       217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         217 -SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             -CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence             1123344678899999999999999999     77788764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1e-40  Score=324.01  Aligned_cols=271  Identities=24%  Similarity=0.430  Sum_probs=204.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhh------hhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAA------RRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKL  202 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~------~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~  202 (451)
                      ++|++.+.||+|+||.||++.+........      ....+...+|+|.+..... ....++.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            479999999999999999986543211100      1223456799999875432 234678899999999999999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcee
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNED---------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL  273 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIl  273 (451)
                      ++++.+++..++||||+.+++|.+++....         ...+++..+..++.|++.||.|||+  .||+|+||||+|||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dlkp~Nil  162 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCeecccCChheEE
Confidence            999999999999999999999999986432         1347788999999999999999999  89999999999999


Q ss_pred             eCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh--CCCccccccCCCC
Q 013028          274 LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS--GKTAAMRRTNGLA  351 (451)
Q Consensus       274 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt--g~~pf~~~~~~~~  351 (451)
                      ++.++.++|+|||++................++..|+|||+..+..++.++|||||||++|||++  |..||....... 
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~-  241 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-  241 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH-
Confidence            99999999999999975322221111222344667999999888889999999999999999998  667765432210 


Q ss_pred             CCccccccchhhhhhHHhhh---hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          352 GNWAKPYLSNKLALHQIIDE---KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                            ..   ......+..   ......+...+..+.+|+.+||+.||++||++.+|++.|++
T Consensus       242 ------~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 ------VI---ENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ------HH---HHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                  00   000011111   01111223345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.6e-41  Score=331.46  Aligned_cols=247  Identities=26%  Similarity=0.338  Sum_probs=198.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcC-CCceeecccee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLN-HPNVVKLMGYC  206 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-h~nIv~~~~~~  206 (451)
                      +|.+.+.||+|+||.||+|..          ..++..||||++.+...   ...+.+..|..++..+. |++|+++++++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~   70 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAER----------KGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF   70 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEE----------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE
Confidence            477889999999999999764          34567899999875422   22344667888888775 89999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+.+..++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        71 ~~~~~~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          71 QTMDRLYFVMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             ecCCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCC
Confidence            999999999999999999998854  3568999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++.....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||......             ....
T Consensus       147 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------------~~~~  211 (323)
T cd05616         147 MCKENMW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------------ELFQ  211 (323)
T ss_pred             CceecCC--CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-------------HHHH
Confidence            9974221  112233567999999999999999999999999999999999999998643211             1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM-----SEVVA  408 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~  408 (451)
                      .+...  ....+...+.++.+|+.+||+.||.+|++.     .++++
T Consensus       212 ~i~~~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         212 SIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             HHHhC--CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence            22211  122344567889999999999999999984     55554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-40  Score=314.45  Aligned_cols=256  Identities=29%  Similarity=0.503  Sum_probs=207.1

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ..++|.+.++||.|+||.||+|.+++           ...||||.+... ....+++.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-----------~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG-----------TTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCS   71 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC-----------CceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence            35689999999999999999986432           356899998743 344577899999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +....++||||+++++|.+++.......+++..+..++.+++.||.|||+  +||+|+||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~--~~i~h~di~p~nili~~~~~~~l~d~g~  149 (261)
T cd05034          72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGL  149 (261)
T ss_pred             cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcchheEEEcCCCCEEECcccc
Confidence            98899999999999999999976655679999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +....... ........++..|+|||.+.+..++.++|+|||||++|+|++ |..||......             ..+ 
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------------~~~-  214 (261)
T cd05034         150 ARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-------------EVL-  214 (261)
T ss_pred             ceeccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------------HHH-
Confidence            87543211 111112234567999999988889999999999999999998 88887532211             111 


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                      ..+........+...+.++.+++.+||..+|++||++.++++.|+.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         215 EQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1111111222333446789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.8e-41  Score=330.64  Aligned_cols=243  Identities=27%  Similarity=0.402  Sum_probs=196.2

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhc-CCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRL-NHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~  211 (451)
                      +.||+|+||+||+|.+.          .++..||||++.+..   ......+..|..++..+ +||||+++++++.+.+.
T Consensus         1 ~~lG~G~~g~V~~~~~~----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~   70 (318)
T cd05570           1 KVLGKGSFGKVLLAELK----------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDR   70 (318)
T ss_pred             CeeeeCCCeEEEEEEEC----------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCE
Confidence            46999999999997643          446789999997532   23345567899999888 59999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .|+||||++||+|.+++..  ...+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.++|+|||++...
T Consensus        71 ~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          71 LFFVMEYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             EEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            9999999999999988854  3579999999999999999999999  89999999999999999999999999998742


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ..  ........+|+..|+|||++.+..++.++|||||||++|+|++|..||......             .....+...
T Consensus       147 ~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------------~~~~~i~~~  211 (318)
T cd05570         147 IL--GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------------ELFQSILED  211 (318)
T ss_pred             Cc--CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------------HHHHHHHcC
Confidence            21  112223457899999999999999999999999999999999999998643211             111111111


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM-----SEVVAA  409 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~  409 (451)
                        ....+...+..+.+|+.+||..||++||++     .++++.
T Consensus       212 --~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         212 --EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             --CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence              122334456789999999999999999999     777754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.2e-40  Score=314.86  Aligned_cols=251  Identities=27%  Similarity=0.406  Sum_probs=199.4

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceeecCCeeE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL  213 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~  213 (451)
                      ++||+|+||.||+|.+.        ...++..+|+|++......  ..+.+.+|+.+++.++|+||+++++++. ++..+
T Consensus         1 ~~lg~G~~g~v~~~~~~--------~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~   71 (257)
T cd05116           1 GELGSGNFGTVKKGMYK--------MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWM   71 (257)
T ss_pred             CcCCCcCCcceEEeEEe--------cCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcE
Confidence            36999999999998753        2344677999998644322  3456889999999999999999999885 45678


Q ss_pred             EEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCC
Q 013028          214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL  293 (451)
Q Consensus       214 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~  293 (451)
                      +||||+++|+|.+++..  ...+++..+..++.|++.||.|||+  +||+||||||.|||++.++.++|+|||++.....
T Consensus        72 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~  147 (257)
T cd05116          72 LVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGA  147 (257)
T ss_pred             EEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence            99999999999999854  3568999999999999999999999  8999999999999999999999999999975432


Q ss_pred             CCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          294 GDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       294 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      .... .......++..|+|||++....++.++|||||||++|||++ |..||.....              ..+...+..
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------------~~~~~~i~~  213 (257)
T cd05116         148 DENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------------NEVTQMIES  213 (257)
T ss_pred             CCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------------HHHHHHHHC
Confidence            2111 11122234578999999988889999999999999999998 8888764321              112223333


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      ......+...+.++.+||.+||+.||++||++.+|.+.|+++
T Consensus       214 ~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         214 GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            323344555678899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.2e-41  Score=322.75  Aligned_cols=252  Identities=27%  Similarity=0.410  Sum_probs=202.0

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      |+..+.||+|+||.||++.+.          .++..||||.+.......   ...+.+|+.+++.++|+||+.+++.+.+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~----------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~   71 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVR----------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEc----------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence            667789999999999997644          457789999987543222   2346789999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      .+..++||||+.|++|.+++.......+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05630          72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLA  149 (285)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccce
Confidence            9999999999999999998865555679999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      .......   ......|+..|+|||++.+..++.++|||||||++|+|++|..||........          .......
T Consensus       150 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~----------~~~~~~~  216 (285)
T cd05630         150 VHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----------REEVERL  216 (285)
T ss_pred             eecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch----------HHHHHhh
Confidence            7533211   12235789999999999888999999999999999999999999875322100          0011111


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT-----MSEVVAA  409 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~  409 (451)
                      .. ......+...+.++.+|+.+||+.||.+|||     +.|++++
T Consensus       217 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         217 VK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             hh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            11 1111223345677999999999999999999     8898875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-41  Score=333.08  Aligned_cols=242  Identities=26%  Similarity=0.356  Sum_probs=195.5

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeecCCeeE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL  213 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~  213 (451)
                      +.||+|+||.||++...       ....++..||+|++.....  .....+..|+++|++++||||+++++++.++...|
T Consensus         2 ~~lg~G~~g~Vy~~~~~-------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   74 (318)
T cd05582           2 KVLGQGSFGKVFLVRKI-------TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLY   74 (318)
T ss_pred             ceeeeCCCEEEEEEEEe-------ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEE
Confidence            67999999999997542       2345678899999975322  22345678999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCC
Q 013028          214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL  293 (451)
Q Consensus       214 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~  293 (451)
                      +||||+++|+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+|||++.....
T Consensus        75 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          75 LILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             EEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            99999999999999854  4568999999999999999999999  8999999999999999999999999999975322


Q ss_pred             CCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhh
Q 013028          294 GDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL  373 (451)
Q Consensus       294 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (451)
                      .  ........||..|+|||++.+..++.++|||||||++|+|++|+.||......             .....+...  
T Consensus       151 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------------~~~~~i~~~--  213 (318)
T cd05582         151 H--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------------ETMTMILKA--  213 (318)
T ss_pred             C--CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-------------HHHHHHHcC--
Confidence            1  12233567999999999998888999999999999999999999998643211             111112111  


Q ss_pred             cCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 013028          374 GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE  405 (451)
Q Consensus       374 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  405 (451)
                      ...++...+..+.+|+.+||+.||.+||++.+
T Consensus       214 ~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         214 KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            12234445688999999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2e-40  Score=316.45  Aligned_cols=259  Identities=25%  Similarity=0.412  Sum_probs=207.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|.+.+.||+|+||.||+|..          ..++..++||.+.....   ....++.+|+.+++.++|+||+++++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~----------~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATC----------LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF   71 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEee----------cCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee
Confidence            3788899999999999999764          33467899998864322   2235678899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      .+++..++||||+++++|.+++..  .....+++..+..++.||+.||.|||+  .|++|+||||+||+++.++.++|+|
T Consensus        72 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~d  149 (267)
T cd08229          72 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             EeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECc
Confidence            999999999999999999998853  234568999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ||++.......  .......|+..|+|||++.+..++.++|+||||+++|+|++|..||......            ...
T Consensus       150 fg~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------------~~~  215 (267)
T cd08229         150 LGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------------LYS  215 (267)
T ss_pred             chhhhccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------------HHH
Confidence            99987543221  1223456889999999998888999999999999999999999998643211            000


Q ss_pred             hhHHhhhh-hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          365 LHQIIDEK-LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       365 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                      ....+... .........+..+.+++.+||..||++|||+.+|++.++++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         216 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             HhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            00111111 111112345678999999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=9e-41  Score=333.47  Aligned_cols=263  Identities=24%  Similarity=0.354  Sum_probs=197.2

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      ..++|++.+.||+|+||.||++.          +..++..||||.+....  ......+.+|+.+++.++||||++++++
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~----------~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   88 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAF----------DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV   88 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEE----------EcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeee
Confidence            45699999999999999999975          44457889999987532  2234567789999999999999999999


Q ss_pred             eecCC------eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          206 CCDDQ------HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       206 ~~~~~------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      +....      ..|+||||+++ +|.+.+.    ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~~~~~~  161 (359)
T cd07876          89 FTPQKSLEEFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT  161 (359)
T ss_pred             eccCCCccccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCC
Confidence            86543      47999999965 6766662    347889999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC-----Cc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG-----NW  354 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~-----~~  354 (451)
                      +||+|||+++...   .........||..|+|||++.+..++.++|||||||++|+|++|..||.........     ..
T Consensus       162 ~kl~Dfg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~  238 (359)
T cd07876         162 LKILDFGLARTAC---TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL  238 (359)
T ss_pred             EEEecCCCccccc---cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999997532   122233467899999999999999999999999999999999999999754321000     00


Q ss_pred             ccccc---ch-hhhhhHHhhhh---------------h---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          355 AKPYL---SN-KLALHQIIDEK---------------L---GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       355 ~~~~~---~~-~~~~~~~~~~~---------------~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ..+..   .. ...........               .   ........+..+.+|+.+||..||++|||+.|+++.-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         239 GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             CCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            00000   00 00000000000               0   0001112246789999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.8e-40  Score=318.89  Aligned_cols=273  Identities=25%  Similarity=0.425  Sum_probs=206.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .|++++.||+|+||.||++.+..      ....++..||+|.+.... ......+.+|+++++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDP------EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   78 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEcc------CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            57889999999999999987542      234567889999987443 22345788999999999999999999998775


Q ss_pred             --CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          210 --QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       210 --~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                        ...++||||++|++|.+++... ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.++|+|||+
T Consensus        79 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~~l~dfg~  155 (284)
T cd05079          79 GGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGL  155 (284)
T ss_pred             CCCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCEEECCCcc
Confidence              5689999999999999988543 2468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccc--hhhh
Q 013028          288 AKFGPLGDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS--NKLA  364 (451)
Q Consensus       288 a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~  364 (451)
                      +......... .......++..|+|||++.+..++.++|||||||++|+|+++..|+........... .+...  ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMI-GPTHGQMTVTR  234 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhc-ccccccccHHH
Confidence            9854322111 112234567789999999888899999999999999999998766543221100000 00000  0000


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      ....+........+...+..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111111112223344578899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.9e-41  Score=322.62  Aligned_cols=259  Identities=25%  Similarity=0.368  Sum_probs=194.2

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhc---CCCceeeccce
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRL---NHPNVVKLMGY  205 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l---~h~nIv~~~~~  205 (451)
                      +|++.+.||+|+||+||+|.          +..++..||+|.+......  ....+.+|+.+++.+   +||||++++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~----------~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~   70 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKAR----------DPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDV   70 (288)
T ss_pred             CceEeeEEeecCCeEEEEEE----------ECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeee
Confidence            58889999999999999965          4455788999998753222  233456778777765   69999999998


Q ss_pred             eec-----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          206 CCD-----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       206 ~~~-----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      +.+     ....++||||+. ++|.+++.......+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+
T Consensus        71 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~  147 (288)
T cd07863          71 CATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQV  147 (288)
T ss_pred             eccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCE
Confidence            864     345799999997 489888866555668999999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC---------
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA---------  351 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~---------  351 (451)
                      ||+|||++......   .......||..|+|||++.+..++.++|||||||++|+|++|.+||........         
T Consensus       148 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~  224 (288)
T cd07863         148 KLADFGLARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG  224 (288)
T ss_pred             EECccCccccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence            99999999854321   122345688999999999888999999999999999999999999864322100         


Q ss_pred             ----CCccccccchhhhhhHHhhhhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 ----GNWAKPYLSNKLALHQIIDEKLG---RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ----~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                          ..|......    ....+.....   .......+..+.+|+.+||+.||++|||+.|++..
T Consensus       225 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         225 LPPEDDWPRDVTL----PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             CCChhhCcccccc----cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                000000000    0000000000   00112345678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.3e-41  Score=337.90  Aligned_cols=251  Identities=25%  Similarity=0.357  Sum_probs=198.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .|++.+.||+|+||.||++..          ..++..||||++....   ......+.+|+.++..++|+||+++++.+.
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   71 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQK----------KDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ   71 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEE----------CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            688899999999999999664          4457789999997432   223456788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++++.||||||++||+|.+++..  ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.++|+|||+
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG~  147 (360)
T cd05627          72 DKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFGL  147 (360)
T ss_pred             cCCEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeeccC
Confidence            99999999999999999999854  4568999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCC---------------------------------cccccccCCCCccccccccccCCCCcchhhHHHHHHHH
Q 013028          288 AKFGPLGDK---------------------------------SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLL  334 (451)
Q Consensus       288 a~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~  334 (451)
                      +........                                 .......+||+.|+|||++.+..++.++|||||||++|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily  227 (360)
T cd05627         148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY  227 (360)
T ss_pred             CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence            864321100                                 00112357999999999999999999999999999999


Q ss_pred             HHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCC--HHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 013028          335 EILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQ--MEEAQEFAEIILRCLNSDPKNRPT---MSEVVAA  409 (451)
Q Consensus       335 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~  409 (451)
                      ||++|..||......             .....+........++  ...+.++.+|+.+|+. ||.+|++   +.+++++
T Consensus       228 el~tG~~Pf~~~~~~-------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         228 EMLIGYPPFCSETPQ-------------ETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             ecccCCCCCCCCCHH-------------HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            999999998654321             0111111111111111  1246789999999774 9999985   6777665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8e-41  Score=335.45  Aligned_cols=263  Identities=23%  Similarity=0.298  Sum_probs=197.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .|++.++||+|+||.||++..          ..++..||||.+....  ......+.+|+.+++.++|+||+++++++..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   70 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTD----------PRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQP   70 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEE----------CCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecC
Confidence            477889999999999999753          4457789999986432  2234567889999999999999999999987


Q ss_pred             CC-----eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          209 DQ-----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       209 ~~-----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      .+     ..|+||||+. ++|.+.+..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+
T Consensus        71 ~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili~~~~~~kL~  145 (372)
T cd07853          71 PHIDPFEEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKIC  145 (372)
T ss_pred             CCccccceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHHEEECCCCCEEec
Confidence            76     7899999996 588887744  4578999999999999999999999  899999999999999999999999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc-----ccc
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW-----AKP  357 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~-----~~~  357 (451)
                      |||+++...... ........++..|+|||++.+ ..++.++|||||||++|||++|+.||...........     ..+
T Consensus       146 Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~  224 (372)
T cd07853         146 DFGLARVEEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP  224 (372)
T ss_pred             cccceeecccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            999998543221 122334568899999999876 4579999999999999999999999965432110000     000


Q ss_pred             ccch----hhhhhHHhhhh-hcC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          358 YLSN----KLALHQIIDEK-LGR-------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       358 ~~~~----~~~~~~~~~~~-~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ....    .......+... ...       ......+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0000    00000000000 000       1112235789999999999999999999999975

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.2e-40  Score=313.43  Aligned_cols=253  Identities=27%  Similarity=0.447  Sum_probs=202.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|.+..+||.|+||.||+|.+..           ...+|+|.+... ....+.+.+|+++++.++|+||+++++++. .
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-----------~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~   72 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG-----------TTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-E   72 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC-----------CceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-C
Confidence            478899999999999999987543           234899987643 234567889999999999999999999875 4


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+.+++|.+++.......+++..+..++.|++.||.|||+  .||+|+||||+||++++++.++|+|||++.
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccce
Confidence            567999999999999999976555668999999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHH
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......             ... ..
T Consensus       151 ~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------------~~~-~~  215 (260)
T cd05069         151 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------------EVL-EQ  215 (260)
T ss_pred             EccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------------HHH-HH
Confidence            5432211 11122345678999999988889999999999999999999 88887543211             011 11


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                      +........+...+..+.+++.+||..||++||++.++++.|++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         216 VERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            11122222334556889999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.1e-41  Score=328.43  Aligned_cols=242  Identities=27%  Similarity=0.413  Sum_probs=193.1

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhc-CCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRL-NHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~  211 (451)
                      +.||+|+||.||+|.+.          .++..||||++....   ......+..|..++..+ +||||+++++++.+.+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~   70 (316)
T cd05619           1 KMLGKGSFGKVFLAELK----------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN   70 (316)
T ss_pred             CeeeeCCCEEEEEEEEC----------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCE
Confidence            46999999999997644          446789999997532   22334566788888764 79999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .++||||++||+|.+++..  ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.++|+|||++...
T Consensus        71 ~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          71 LFFVMEYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            9999999999999999854  3568899999999999999999999  89999999999999999999999999998742


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ...  ........||..|+|||++.+..++.++|||||||++|+|++|..||......              .+...+..
T Consensus       147 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------------~~~~~i~~  210 (316)
T cd05619         147 MLG--DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------------ELFQSIRM  210 (316)
T ss_pred             CCC--CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------------HHHHHHHh
Confidence            211  12233467999999999998889999999999999999999999998643211              01111111


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS-EVVA  408 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~  408 (451)
                       .....+...+.++.+|+.+||..||++||++. ++++
T Consensus       211 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         211 -DNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             -CCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence             11223334567899999999999999999997 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.8e-40  Score=313.16  Aligned_cols=251  Identities=27%  Similarity=0.422  Sum_probs=205.4

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .|.+.+.||+|++|.||+|...          .++..|++|.+....  ......+.+|+++++.++||||+++++++.+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~----------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRK----------ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD   70 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEc----------CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc
Confidence            3677889999999999997643          446779999986432  2345678899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ....++||||++|++|.+++.......+++..+..++.+++.||.|||+  .||+|+||||+||+++.++.++|+|||++
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~  148 (256)
T cd08529          71 KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVA  148 (256)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEcccccc
Confidence            9999999999999999999976555779999999999999999999999  89999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ......  ........|+..|+|||++.+..++.++|+|||||++|+|++|..||......             .....+
T Consensus       149 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------~~~~~~  213 (256)
T cd08529         149 KLLSDN--TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------------ALILKI  213 (256)
T ss_pred             eeccCc--cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------------HHHHHH
Confidence            754322  12223456888999999998888999999999999999999999998643211             011111


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      . ......++...+..+.+++.+||+.+|++||++.++++.
T Consensus       214 ~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         214 I-RGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             H-cCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1 111223333556889999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-40  Score=318.12  Aligned_cols=256  Identities=23%  Similarity=0.333  Sum_probs=201.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.+.||+|+||.||+|...          .++..||+|++..........+.+|+.+++.++||||+++++++..
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~----------~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~   77 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNL----------HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS   77 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEEC----------CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Confidence            348999999999999999997643          4467899999975544455667899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  .||+|+||+|+||+++.++.++|+|||++
T Consensus        78 ~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~  153 (267)
T cd06646          78 REKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVA  153 (267)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCccc
Confidence            9999999999999999998854  3568999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      ......  ........|+..|+|||.+.   ...++.++|||||||++|+|++|..||.........     ....... 
T Consensus       154 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-----~~~~~~~-  225 (267)
T cd06646         154 AKITAT--IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-----FLMSKSN-  225 (267)
T ss_pred             eeeccc--ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-----eeeecCC-
Confidence            753211  11123456888999999884   345788999999999999999999998643321100     0000000 


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                        .....  .......+..+.+|+.+||..+|++|||++++++.|
T Consensus       226 --~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         226 --FQPPK--LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --CCCCC--CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              00000  001123457899999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.3e-41  Score=332.06  Aligned_cols=241  Identities=25%  Similarity=0.341  Sum_probs=190.7

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHH-HHHhcCCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELR-FLSRLNHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~h~nIv~~~~~~~~~~~  211 (451)
                      +.||+|+||+||+|..          ..++..||+|++....   ......+..|.. +++.++|+||+++++++.+.+.
T Consensus         1 ~~lg~G~fg~V~~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~   70 (325)
T cd05602           1 KVIGKGSFGKVLLARH----------KAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK   70 (325)
T ss_pred             CeeeeCCCeEEEEEEE----------CCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCe
Confidence            4699999999999754          4456789999987432   122233444444 5678899999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .++||||++||+|.+++..  ...+++..+..++.||+.||.|||+  .||+||||||+|||++.++.++|+|||++...
T Consensus        71 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          71 LYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             EEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            9999999999999998854  4568888999999999999999999  89999999999999999999999999999742


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ..  ........+||+.|+|||++.+..++.++|||||||++|+|++|..||......             .....+...
T Consensus       147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------~~~~~i~~~  211 (325)
T cd05602         147 IE--HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------------EMYDNILNK  211 (325)
T ss_pred             cc--CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-------------HHHHHHHhC
Confidence            21  122234567999999999999999999999999999999999999998643221             111122211


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV  407 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  407 (451)
                      .  .......+..+.+++.+||+.||.+||++.+.+
T Consensus       212 ~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         212 P--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             C--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            1  123345578899999999999999999877443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.7e-40  Score=316.18  Aligned_cols=259  Identities=25%  Similarity=0.469  Sum_probs=204.6

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .|++.+.||+|+||.||+|.+...+       .....||||.+.... ......+..|+.+++.++||||+++++++.++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   77 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPG-------KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS   77 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCC-------CCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence            5788999999999999998865321       224579999987542 22345788999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++++|.+++... ...+++..+..++.|++.||.|||+  +|++|+||||+||+++.++.++|+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~dfg~~~  154 (269)
T cd05065          78 RPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (269)
T ss_pred             CceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECCCcccc
Confidence            9999999999999999988653 3568999999999999999999999  899999999999999999999999999987


Q ss_pred             cCCCCCCcccccccC---CCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhh
Q 013028          290 FGPLGDKSHISTRVL---GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~---gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      ...............   .+..|+|||++.+..++.++|||||||++|||++ |..||+.....              ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------------~~  220 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------------DV  220 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--------------HH
Confidence            543222111111111   2347999999988899999999999999999886 98888643211              11


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      ...+........+...+..+.+++.+||..+|.+||++.+++..|+++
T Consensus       221 ~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         221 INAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111111122223344567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5e-41  Score=330.47  Aligned_cols=238  Identities=27%  Similarity=0.357  Sum_probs=189.7

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHH-HHHhcCCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELR-FLSRLNHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~h~nIv~~~~~~~~~~~  211 (451)
                      +.||+|+||+||+|..          ..++..||||++.....   .....+..|.. +++.++||||+++++++.+.+.
T Consensus         1 ~~lg~G~~g~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~   70 (323)
T cd05575           1 KVIGKGSFGKVLLAKH----------KADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADK   70 (323)
T ss_pred             CeeeeCCCeEEEEEEE----------CCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCE
Confidence            4699999999999764          44577899999874321   22234445544 5678999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++...
T Consensus        71 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          71 LYFVLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            9999999999999998854  4578999999999999999999999  89999999999999999999999999998742


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ..  .........||+.|+|||++.+..++.++|||||||++|+|++|..||......             .....+...
T Consensus       147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------------~~~~~i~~~  211 (323)
T cd05575         147 IE--HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-------------EMYDNILNK  211 (323)
T ss_pred             cc--CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-------------HHHHHHHcC
Confidence            21  122234567999999999999899999999999999999999999998643211             011112111


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS  404 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  404 (451)
                      .  ...+...+..+.+++.+||+.||.+||++.
T Consensus       212 ~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         212 P--LRLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             C--CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            1  123334578899999999999999999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.7e-41  Score=342.25  Aligned_cols=261  Identities=23%  Similarity=0.322  Sum_probs=191.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ..+|.++++||+|+||.||+|...          .++..||||.+....    ....+|+.+|+.++|+||+++++++..
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~  130 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICI----------DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYT  130 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEEC----------CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEee
Confidence            458999999999999999997643          346789999885432    234579999999999999999987643


Q ss_pred             C--------CeeEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC
Q 013028          209 D--------QHRLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF  278 (451)
Q Consensus       209 ~--------~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~  278 (451)
                      .        ..+++||||+++ +|.+++..  .....+++..+..++.||+.||.|||+  +||+||||||+|||++.++
T Consensus       131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~~~~  207 (440)
T PTZ00036        131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNT  207 (440)
T ss_pred             cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEcCCC
Confidence            2        246799999975 77776642  234678999999999999999999999  8999999999999998654


Q ss_pred             -cEEEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC---
Q 013028          279 -NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN---  353 (451)
Q Consensus       279 -~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~---  353 (451)
                       .+||+|||+|+.....   .......||+.|+|||++.+ ..|+.++|||||||++|||++|.+||..........   
T Consensus       208 ~~vkL~DFGla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  284 (440)
T PTZ00036        208 HTLKLCDFGSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII  284 (440)
T ss_pred             CceeeeccccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence             7999999999854322   22234678999999999865 469999999999999999999999997543210000   


Q ss_pred             --ccccccchhh----hhh-----HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          354 --WAKPYLSNKL----ALH-----QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       354 --~~~~~~~~~~----~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                        ...+......    ...     .+....+...++...+.++.+|+.+||..||.+|||+.|++++
T Consensus       285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence              0000000000    000     0000001111222345789999999999999999999999955

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.4e-41  Score=329.14  Aligned_cols=244  Identities=27%  Similarity=0.363  Sum_probs=193.4

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhc-CCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRL-NHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~  211 (451)
                      +.||+|+||.||+|..          ...+..||+|++.+...   ...+.+.+|+.++..+ +|+||+.+++++.+.+.
T Consensus         1 ~~lG~G~~g~V~~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   70 (327)
T cd05617           1 RVIGRGSYAKVLLVRL----------KKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR   70 (327)
T ss_pred             CeeeeCCCeEEEEEEE----------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCE
Confidence            4699999999999754          44577899999975422   2234577899999888 59999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .|+||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++...
T Consensus        71 ~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          71 LFLVIEYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            9999999999999988854  3569999999999999999999999  89999999999999999999999999998742


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ..  ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.........       .........+..
T Consensus       147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-------~~~~~~~~~~~~  217 (327)
T cd05617         147 LG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-------NTEDYLFQVILE  217 (327)
T ss_pred             cC--CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-------ccHHHHHHHHHh
Confidence            11  122234567999999999999999999999999999999999999999643322110       001111111111


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM  403 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  403 (451)
                       ....++...+..+.+++.+||..||++|+++
T Consensus       218 -~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         218 -KPIRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence             1122444556789999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.4e-40  Score=318.66  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=198.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +|++.+.||+|+||.||+|..          ..++..||+|.+.... ......+.+|++++++++||||+++++++...
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYH----------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE   71 (279)
T ss_pred             cchheeeeccCCCeEEEEEEE----------cCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence            678889999999999999764          3456789999986542 22345688999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +..++||||+++++|..+      ..+++..+..++.|++.||.|||+  .||+|+||||+|||++.++.++|+|||++.
T Consensus        72 ~~~~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~~~  143 (279)
T cd06619          72 NRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVST  143 (279)
T ss_pred             CEEEEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence            999999999999998654      246788899999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ....    .......|+..|+|||++.+..++.++|+|||||++|+|++|..||...........      .......+.
T Consensus       144 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~------~~~~~~~~~  213 (279)
T cd06619         144 QLVN----SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM------PLQLLQCIV  213 (279)
T ss_pred             eccc----ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc------hHHHHHHHh
Confidence            4321    122345789999999999888899999999999999999999999875332111000      000011111


Q ss_pred             hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      +...........+.++.+++.+||+.||.+||++.++++..
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         214 DEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             ccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence            11111111223456799999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.2e-40  Score=316.76  Aligned_cols=266  Identities=23%  Similarity=0.387  Sum_probs=208.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|.+.+.||+|+||.||+|.+...      .......|++|++..... .....+.+|+.+++.++|+||+++++++.
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~------~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   78 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI   78 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecC------CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            45899999999999999999986542      112356799998864322 23456788999999999999999999876


Q ss_pred             c-CCeeEEEEeccCCCChhhhhccCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          208 D-DQHRLLVYEYVTRGSLEDHLLNEDD------TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       208 ~-~~~~~lV~E~~~gg~L~~~l~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      . +...++++||+.+++|.+++.....      ..+++..+..++.|++.||.|||+  .+++|+||||+||++++++.+
T Consensus        79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~~~~  156 (280)
T cd05043          79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEELQV  156 (280)
T ss_pred             cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCCCcE
Confidence            5 5678999999999999999855322      468999999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCcccccc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  359 (451)
                      ||+|||+++...............++..|+|||++.+..++.++|||||||++|++++ |..||......          
T Consensus       157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------  226 (280)
T cd05043         157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF----------  226 (280)
T ss_pred             EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH----------
Confidence            9999999975332222112223345678999999988889999999999999999999 99888643211          


Q ss_pred             chhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                          .+...+............++++.+++.+||..||++|||+.++++.|+.+...
T Consensus       227 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         227 ----EMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             ----HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                11111112222222333467899999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.3e-40  Score=312.53  Aligned_cols=251  Identities=25%  Similarity=0.418  Sum_probs=198.5

Q ss_pred             cccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEEE
Q 013028          137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLV  215 (451)
Q Consensus       137 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  215 (451)
                      .||+|+||.||+|.+..        ...+..||+|++..... ...+.+.+|+.++++++|+||+++++++. ....++|
T Consensus         2 ~ig~G~~g~v~~~~~~~--------~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv   72 (257)
T cd05115           2 ELGSGNFGCVKKGVYKM--------RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLV   72 (257)
T ss_pred             ccCCCCcccEEEEEEec--------CCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEE
Confidence            48999999999987542        23355699999875432 22456889999999999999999999886 4578999


Q ss_pred             EeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCC
Q 013028          216 YEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGD  295 (451)
Q Consensus       216 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  295 (451)
                      |||+++++|.+++... ...+++..++.++.|++.||.|||+  +|++|+||||+|||++.++.++|+|||++.......
T Consensus        73 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  149 (257)
T cd05115          73 MEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD  149 (257)
T ss_pred             EEeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence            9999999999988543 3568999999999999999999999  899999999999999999999999999997533221


Q ss_pred             Ccc-cccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhhhh
Q 013028          296 KSH-ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL  373 (451)
Q Consensus       296 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (451)
                      ... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.....              ..+...+....
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------------~~~~~~~~~~~  215 (257)
T cd05115         150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------------PEVMSFIEQGK  215 (257)
T ss_pred             cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------------HHHHHHHHCCC
Confidence            111 1111223567999999988889999999999999999996 8888764321              11122222333


Q ss_pred             cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          374 GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       374 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      ....+...+.++.+++.+||..+|++||++.+|++.|+.+
T Consensus       216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            3344555678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.7e-40  Score=312.22  Aligned_cols=249  Identities=28%  Similarity=0.431  Sum_probs=201.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee-c
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC-D  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~  208 (451)
                      ++|.+.+.||+|+||.||+|...            +..|++|.+...  ...+.+.+|+.+++.++|+||+++++++. +
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~------------~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR------------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE   71 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc------------CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence            47889999999999999997543            456899988643  33567889999999999999999999754 5


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+++++|.+++.......+++..+..++.|++.||.|||+  +||+||||||+||++++++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~  149 (256)
T cd05082          72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLT  149 (256)
T ss_pred             CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCccc
Confidence            5678999999999999999876555568999999999999999999999  89999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ......     .....++..|+|||++.+..++.++|||||||++|+|++ |..||.....              ..+..
T Consensus       150 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------------~~~~~  210 (256)
T cd05082         150 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------------KDVVP  210 (256)
T ss_pred             eecccc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------------HHHHH
Confidence            743211     122334567999999988889999999999999999997 8887753211              01111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      .+........+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         211 RVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            1222222233445578899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.9e-40  Score=318.45  Aligned_cols=263  Identities=27%  Similarity=0.410  Sum_probs=203.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|++.+.||+|+||.||++.....     ....+...||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGL-----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEccc-----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence            35789999999999999999875421     1123467899999875432 23456889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNED--------------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDV  267 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDl  267 (451)
                      ++...++||||+++|+|.+++....                    ...+++..++.++.|++.||.|||+  ++++||||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~H~dl  156 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDL  156 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCeecccc
Confidence            9999999999999999999985321                    1357888899999999999999999  89999999


Q ss_pred             CCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccc
Q 013028          268 KASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRR  346 (451)
Q Consensus       268 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~  346 (451)
                      ||+|||++.++.++|+|||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999874322211111222334567999999988899999999999999999997 77776532


Q ss_pred             cCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          347 TNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                      ...             .....+.+.. ....+...+.++.+|+.+||+.+|.+|||+.|+++.|++
T Consensus       237 ~~~-------------~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         237 AHE-------------EVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CHH-------------HHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            211             0111111111 112233456789999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.1e-40  Score=314.65  Aligned_cols=260  Identities=25%  Similarity=0.472  Sum_probs=205.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+|+..+.||+|+||.||+|.....       ......+++|.+.... ....+.+..|+++++.++|+||+++++++.+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~-------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMP-------GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK   77 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecC-------CCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence            4778889999999999999875432       1223479999986542 2234568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      .+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+  .|++|+||||+||+++.++.++|+|||++
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~  154 (268)
T cd05063          78 FKPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGLS  154 (268)
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCccc
Confidence            99999999999999999988653 3568999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccc-cccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          289 KFGPLGDKSHIS-TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       289 ~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ............ .....+..|+|||++.+..++.++|||||||++|+|++ |..||+.....              .+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------------~~~  220 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------------EVM  220 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------------HHH
Confidence            754322211111 11123457999999988889999999999999999997 99988643211              111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      ..+............+.++.+++.+||+.+|++||++.+|++.|+++
T Consensus       221 ~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         221 KAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            22222222222334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2e-40  Score=317.32  Aligned_cols=254  Identities=28%  Similarity=0.419  Sum_probs=200.5

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      ....|++.+.||.|+||.||+|.+.          .++..||+|.+... ......+.+|+.++..+ +|+||+++++++
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~----------~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   72 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHV----------KTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAF   72 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEc----------CCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEE
Confidence            3568899999999999999997643          44678999998644 34456788999999998 599999999998


Q ss_pred             ecC------CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          207 CDD------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       207 ~~~------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      ...      ...++||||+.+++|.+++.......+++..+..++.|++.||.|||+  ++|+|+||||+||++++++.+
T Consensus        73 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~  150 (272)
T cd06637          73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEV  150 (272)
T ss_pred             eecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCE
Confidence            753      467999999999999999876555678999999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA-----TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWA  355 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~  355 (451)
                      +|+|||++......  ........|+..|+|||++.     +..++.++|||||||++|+|++|..||......      
T Consensus       151 ~l~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------  222 (272)
T cd06637         151 KLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------  222 (272)
T ss_pred             EEccCCCceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------
Confidence            99999999753221  11223467899999999985     346888999999999999999999998643211      


Q ss_pred             ccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          356 KPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                             ...................+.++.+|+.+||..||.+|||+.++++.
T Consensus       223 -------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         223 -------RALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             -------HHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                   00001111111111122345789999999999999999999999863

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-40  Score=310.71  Aligned_cols=253  Identities=30%  Similarity=0.452  Sum_probs=199.1

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      ++||+|+||.||+|.+...       ......+|+|.+...... ..+.+.+|+++++.++|+||+++++++. .+..++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~-------~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   72 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMK-------SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLML   72 (257)
T ss_pred             CccCccCceeEEEeEeecc-------CCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEE
Confidence            4799999999999876432       113467999998755432 3456889999999999999999999876 456799


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCC
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG  294 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  294 (451)
                      ||||+.+|+|.+++...  ..+++..+..++.|++.||.|||+  .+|+|+||||+|||++.++.++|+|||+++.....
T Consensus        73 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          73 VMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            99999999999999653  378999999999999999999999  89999999999999999999999999999854322


Q ss_pred             CCccc-ccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhhh
Q 013028          295 DKSHI-STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK  372 (451)
Q Consensus       295 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (451)
                      ..... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.....              ..+...+...
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------------~~~~~~~~~~  214 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------------AEVIAMLESG  214 (257)
T ss_pred             CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------------HHHHHHHHcC
Confidence            21111 111223457999999988899999999999999999998 8888754321              1111222222


Q ss_pred             hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          373 LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       373 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                      .....+...+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus       215 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         215 ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            222334445678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.2e-40  Score=320.29  Aligned_cols=262  Identities=22%  Similarity=0.299  Sum_probs=189.4

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec--CCee
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD--DQHR  212 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~  212 (451)
                      +++||+|+||+||+|....        ...+..||+|.+...  .....+.+|+.+|+.++||||+++++++..  +...
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~--------~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   75 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKD--------GKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKV   75 (317)
T ss_pred             ccccccCCCeEEEEEEEcc--------CCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEE
Confidence            4789999999999987432        234678999998643  223457889999999999999999999864  4567


Q ss_pred             EEEEeccCCCChhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee----CCCCcEE
Q 013028          213 LLVYEYVTRGSLEDHLLNE-------DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL----DDDFNAK  281 (451)
Q Consensus       213 ~lV~E~~~gg~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll----~~~~~~k  281 (451)
                      ++||||+. ++|.+++...       ....+++..+..++.||+.||.|||+  +||+||||||+|||+    +.++.+|
T Consensus        76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~~~~~k  152 (317)
T cd07868          76 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVK  152 (317)
T ss_pred             EEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCCcCcEE
Confidence            99999995 5888776421       12358999999999999999999999  899999999999999    4567899


Q ss_pred             EeecCCcccCCCCCC-cccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc--
Q 013028          282 ISDFGLAKFGPLGDK-SHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP--  357 (451)
Q Consensus       282 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~--  357 (451)
                      |+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||..............  
T Consensus       153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~  232 (317)
T cd07868         153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  232 (317)
T ss_pred             EeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHH
Confidence            999999986432211 112234678999999999876 4689999999999999999999999975543321110000  


Q ss_pred             ccch---------hhhhhHH--------hhhhhcC-------------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013028          358 YLSN---------KLALHQI--------IDEKLGR-------------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV  407 (451)
Q Consensus       358 ~~~~---------~~~~~~~--------~~~~~~~-------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  407 (451)
                      ....         ...+...        .......             ........++.+|+.+||+.||.+|||+.|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l  312 (317)
T cd07868         233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  312 (317)
T ss_pred             HHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHh
Confidence            0000         0000000        0000000             00001134688999999999999999999998


Q ss_pred             HH
Q 013028          408 AA  409 (451)
Q Consensus       408 ~~  409 (451)
                      +.
T Consensus       313 ~h  314 (317)
T cd07868         313 QD  314 (317)
T ss_pred             cC
Confidence            63

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4e-41  Score=331.47  Aligned_cols=239  Identities=28%  Similarity=0.356  Sum_probs=190.1

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHH-HHHhcCCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELR-FLSRLNHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~h~nIv~~~~~~~~~~~  211 (451)
                      +.||+|+||+||+|.          +..++..||+|++.+..   ......+..|.. +++.++||||+++++++..++.
T Consensus         1 ~~lG~G~~g~V~~~~----------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~   70 (325)
T cd05604           1 KVIGKGSFGKVLLAK----------RKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEK   70 (325)
T ss_pred             CceeeCCCeEEEEEE----------ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCE
Confidence            469999999999965          44557889999997532   122334555554 4677899999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .++||||+.||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++...
T Consensus        71 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          71 LYFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             EEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            9999999999999988854  4678999999999999999999999  89999999999999999999999999998742


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ..  .........||..|+|||++.+..++.++|||||||++|+|++|..||......             .....+...
T Consensus       147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------------~~~~~~~~~  211 (325)
T cd05604         147 IA--QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------------EMYDNILHK  211 (325)
T ss_pred             CC--CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-------------HHHHHHHcC
Confidence            21  122234567999999999999999999999999999999999999998643211             011111111


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE  405 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  405 (451)
                      .  .......+..+.+++.+||..+|.+||++.+
T Consensus       212 ~--~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         212 P--LVLRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             C--ccCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            1  1223345678999999999999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.8e-40  Score=313.72  Aligned_cols=260  Identities=26%  Similarity=0.462  Sum_probs=205.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+|++.+.||+|+||.||+|.+...       ......+|+|.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~-------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLP-------GKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK   76 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecC-------CCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            4788999999999999999875321       12345799999864322 234578899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+  .+++|+||||+|||++.++.++|+|||++
T Consensus        77 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          77 SKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             CCccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeehhhchhcEEECCCCeEEeCCCCcc
Confidence            99999999999999999998654 3568999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcc-cccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          289 KFGPLGDKSH-ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       289 ~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      .......... ......++..|+|||++.+..++.++|+|||||++|++++ |..||......              ...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--------------~~~  219 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--------------DVI  219 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--------------HHH
Confidence            8543221111 1112223567999999988889999999999999999886 99887643221              001


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      ..+........+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         220 KAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            11111112222334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.3e-40  Score=327.49  Aligned_cols=242  Identities=26%  Similarity=0.361  Sum_probs=194.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcC-CCceeecccee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLN-HPNVVKLMGYC  206 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h~nIv~~~~~~  206 (451)
                      .|...+.||+|+||.||+|.          +..++..||+|++.+..   ....+.+..|..++..+. |++|+++++++
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~   70 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAE----------RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF   70 (323)
T ss_pred             CceEEEEEEecCCeEEEEEE----------ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE
Confidence            36778999999999999965          44457889999987532   223345677899998886 57788899999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+.+..|+||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+|||
T Consensus        71 ~~~~~~~lv~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          71 QTVDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             ecCCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeccc
Confidence            999999999999999999998854  3568999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++......  ........||..|+|||++.+..++.++|||||||++|+|++|..||......             ....
T Consensus       147 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------------~~~~  211 (323)
T cd05615         147 MCKEHMVD--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-------------ELFQ  211 (323)
T ss_pred             cccccCCC--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-------------HHHH
Confidence            98742211  12233457999999999998889999999999999999999999998653221             1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM  403 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  403 (451)
                      .+...  ....+...+.++.+++.+||+.+|.+|++.
T Consensus       212 ~i~~~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         212 SIMEH--NVSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHHhC--CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            22221  122344456789999999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2e-40  Score=331.59  Aligned_cols=262  Identities=24%  Similarity=0.330  Sum_probs=196.5

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      ..++|.+.+.||+|+||.||++..          ...+..||||++....  ......+.+|+.+++.++||||++++++
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~   91 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYD----------AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV   91 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEE----------CCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCcccccee
Confidence            346899999999999999999764          4456789999987532  2234567789999999999999999998


Q ss_pred             eecC------CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          206 CCDD------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       206 ~~~~------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      +...      ...|+||||+++ +|.+.+.    ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~  164 (364)
T cd07875          92 FTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT  164 (364)
T ss_pred             ecccccccccCeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCc
Confidence            7643      357999999965 7777763    347889999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC-------
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG-------  352 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~-------  352 (451)
                      +||+|||+++....   ........||..|+|||++.+..++.++|||||||++|+|++|+.||.........       
T Consensus       165 ~kL~DfG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  241 (364)
T cd07875         165 LKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL  241 (364)
T ss_pred             EEEEeCCCccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999999985321   22233467899999999999999999999999999999999999999654321000       


Q ss_pred             -Cccccccchh-hhhhHHhhh---------------hh---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          353 -NWAKPYLSNK-LALHQIIDE---------------KL---GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       353 -~~~~~~~~~~-~~~~~~~~~---------------~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                       .-...+.... ..+...+..               ..   ...........+.+|+.+||..||.+|||+.++|++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence             0000000000 000000000               00   001111224678999999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.6e-41  Score=334.59  Aligned_cols=256  Identities=25%  Similarity=0.299  Sum_probs=200.6

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeec
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKL  202 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~  202 (451)
                      ....++|++.+.||+|+||.||++..          ..++..||+|++.+..   ......+.+|+.+++.++||||+++
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~----------~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~  108 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRH----------KSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL  108 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEE----------CCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            34457999999999999999999654          4457789999986422   1223456789999999999999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      ++++.++...++||||++||+|.+++..   ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||
T Consensus       109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ikL  183 (371)
T cd05622         109 FYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKL  183 (371)
T ss_pred             EEEEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999998854   358889999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCccccccccccC----CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG----HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                      +|||++...... ........+||+.|+|||++.+.    .++.++|||||||++|+|++|..||......         
T Consensus       184 ~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---------  253 (371)
T cd05622         184 ADFGTCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---------  253 (371)
T ss_pred             EeCCceeEcCcC-CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---------
Confidence            999999754321 11122356799999999998653    3789999999999999999999998753211         


Q ss_pred             cchhhhhhHHhhhh--hcCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 013028          359 LSNKLALHQIIDEK--LGRNIQMEEAQEFAEIILRCLNSDPKN--RPTMSEVVAAL  410 (451)
Q Consensus       359 ~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L  410 (451)
                          .....+....  +........+..+.+|+.+||..++.+  |+++.+++++.
T Consensus       254 ----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         254 ----GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ----HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                1111222111  111112245788999999999844433  78999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.4e-40  Score=318.77  Aligned_cols=252  Identities=29%  Similarity=0.403  Sum_probs=200.5

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc---CHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      |+..+.||.|+||+||+|.+.          .++..||+|.+......   ....+.+|+++|+.++|+||+.+++.+.+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~----------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~   71 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVR----------ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET   71 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEC----------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec
Confidence            667788999999999997643          45778999998654222   23446789999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++..++||||+.+++|.+++.......+++..+..++.|++.||.|||+  .||+||||||+||+++.++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          72 KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence            9999999999999999988866555679999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ......   .......|+..|+|||++.+..++.++|+|||||++|+|++|..||.......          ........
T Consensus       150 ~~~~~~---~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~----------~~~~~~~~  216 (285)
T cd05632         150 VKIPEG---ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV----------KREEVDRR  216 (285)
T ss_pred             eecCCC---CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH----------HHHHHHHh
Confidence            753221   12234578999999999988899999999999999999999999986432110          00001111


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT-----MSEVVAA  409 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~  409 (451)
                      +... ...+....+..+.+|+.+||+.||++||+     +.++++.
T Consensus       217 ~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         217 VLET-EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             hhcc-ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            1000 11233345678999999999999999999     6677664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.1e-40  Score=310.89  Aligned_cols=253  Identities=27%  Similarity=0.401  Sum_probs=201.2

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      ++||+|++|.||+|.+...       ......||||.+..... ...+.+.+|+.++++++|+||+++++++.+ ...++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~-------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   72 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS-------GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMM   72 (257)
T ss_pred             CcCCccCcccEEeeeEecC-------CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEE
Confidence            4689999999999886531       22234699999986655 445678899999999999999999999988 88899


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCC
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG  294 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  294 (451)
                      ||||+++++|.+++.......+++..+..++.|++.||.|||+  +|++|+||||+||+++.++.+||+|||++......
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          73 VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             EEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh--CCccccccCcccEEEecCCEEEecccccccccccc
Confidence            9999999999999866433578999999999999999999999  89999999999999999999999999999864332


Q ss_pred             CCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhhh
Q 013028          295 DKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK  372 (451)
Q Consensus       295 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (451)
                      ... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......             .....+....
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------------~~~~~~~~~~  217 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------------QILKKIDKEG  217 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------------HHHHHHHhcC
Confidence            211 11123456788999999988889999999999999999998 99887532211             0011111111


Q ss_pred             hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          373 LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       373 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      .....+...+..+.+++.+||..+|++||++.++++.|.
T Consensus       218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            111223345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.6e-40  Score=319.59  Aligned_cols=250  Identities=25%  Similarity=0.390  Sum_probs=204.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .+|++.+.||+|+||.||+|..          ..++..|++|.+........+.+.+|+.+++.++|+||+++++.+.++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~----------~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~   89 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMD----------VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG   89 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEE----------CCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence            4899999999999999999764          344678999999866555567788999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++++|.+++..   ..+++..+..++.|++.||.|||+  .||+|+||||+|||++.++.++|+|||++.
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~dfg~~~  164 (296)
T cd06654          90 DELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (296)
T ss_pred             CEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECccccch
Confidence            999999999999999998843   357899999999999999999999  899999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH-
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI-  368 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  368 (451)
                      ......  .......|+..|+|||.+.+..++.++|||||||++|+|++|..||........             +... 
T Consensus       165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-------------~~~~~  229 (296)
T cd06654         165 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------------LYLIA  229 (296)
T ss_pred             hccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-------------HHHHh
Confidence            532211  112335688999999999888899999999999999999999999865432100             0000 


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .........+...+..+.+++.+||..+|++|||+.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            00110111233456779999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.3e-41  Score=328.23  Aligned_cols=238  Identities=27%  Similarity=0.361  Sum_probs=189.0

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHH-HHHhcCCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELR-FLSRLNHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~h~nIv~~~~~~~~~~~  211 (451)
                      ++||+|+||.||+|..          ..++..||+|++.+...   .....+..|.. +++.++||||+++++++.+.+.
T Consensus         1 ~~lg~G~~g~Vy~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~   70 (321)
T cd05603           1 KVIGKGSFGKVLLAKR----------KSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEK   70 (321)
T ss_pred             CeeeeCCCEEEEEEEE----------CCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCE
Confidence            4699999999999764          44577899999874321   22334555554 6788999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .++||||++||+|..++..  ...+++..+..++.||+.||.|||+  .||+||||||+|||++.++.+||+|||++...
T Consensus        71 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          71 LYFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             EEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            9999999999999988854  4568899999999999999999999  89999999999999999999999999998742


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ..  .........||+.|+|||++.+..++.++|||||||++|+|++|..||......             .....+...
T Consensus       147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------~~~~~i~~~  211 (321)
T cd05603         147 VE--PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-------------QMYDNILHK  211 (321)
T ss_pred             CC--CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-------------HHHHHHhcC
Confidence            21  122234567999999999998889999999999999999999999998643210             001111111


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS  404 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  404 (451)
                        ....+...+..+.+++.+||+.||.+||++.
T Consensus       212 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         212 --PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence              1223445567899999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=336.03  Aligned_cols=252  Identities=23%  Similarity=0.409  Sum_probs=207.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +.|.++..||.|+||.||++          ..+.+....|-|+|........+++.-||+||...+||+||++++.|..+
T Consensus        32 d~WeIiGELGDGAFGKVyKA----------~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e  101 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKA----------VNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE  101 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhh----------hcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc
Confidence            46788899999999999994          45566667788999877777788999999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +.++|+.|||.||-+...+... +..+.+.++..+++|++.||.|||+  ++|||||||..|||++-+|.++|+|||.+.
T Consensus       102 nkLwiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~TldGdirLADFGVSA  178 (1187)
T KOG0579|consen  102 NKLWILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILLTLDGDIRLADFGVSA  178 (1187)
T ss_pred             CceEEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEEEecCcEeeecccccc
Confidence            9999999999999988776554 5789999999999999999999999  899999999999999999999999999986


Q ss_pred             cCCCCCCcccccccCCCCcccccccc-----ccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYI-----ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l-----~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ..  .........++||++|||||++     ...+|++++||||||++|.||..+.+|-....+-             ..
T Consensus       179 Kn--~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-------------RV  243 (1187)
T KOG0579|consen  179 KN--KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------------RV  243 (1187)
T ss_pred             cc--hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-------------HH
Confidence            31  1122233468999999999997     3578999999999999999999999885532211             01


Q ss_pred             hhHHhhh-hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          365 LHQIIDE-KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +..+... ....-.+...+..+.+|+.+||..||..||++++++++
T Consensus       244 llKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  244 LLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             HHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            1111111 01112345667889999999999999999999999863

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.9e-40  Score=314.12  Aligned_cols=257  Identities=30%  Similarity=0.465  Sum_probs=200.3

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      +.||+|+||.||+|.+....    .....+..+++|.+.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~----~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDIL----GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             CccccccceeEEeeeecccc----cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence            36999999999998865421    012234678999886543 2345678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC-----cEEEee
Q 013028          215 VYEYVTRGSLEDHLLNE-----DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF-----NAKISD  284 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~-----~~kl~D  284 (451)
                      ||||+++++|.+++...     ....+++..++.++.|++.||.|||+  .+++|+||||+|||++.++     .++|+|
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999999999998643     22447889999999999999999999  8999999999999999877     899999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      ||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.....              .
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------------~  220 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------------Q  220 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--------------H
Confidence            999974332221111223345678999999988899999999999999999998 8888753221              1


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                      .....+........+...+..+.+++.+||..+|.+||++.++++.|++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         221 EVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1111222222223344557889999999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-40  Score=310.14  Aligned_cols=253  Identities=34%  Similarity=0.541  Sum_probs=205.1

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC-HHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      +.||+|+||.||+|......       ..+..|++|.+....... .+.+.+|+++++.++|+||+++++++.+....++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   73 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD-------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYL   73 (262)
T ss_pred             CccccCCceEEEEEEEecCC-------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEE
Confidence            46999999999998765321       336779999997654433 5678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          215 VYEYVTRGSLEDHLLNED-------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ||||+++++|.+++....       ...+++..+..++.|++.||.|||+  ++|+|+||+|+||+++.++.++|+|||.
T Consensus        74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l~dfg~  151 (262)
T cd00192          74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGL  151 (262)
T ss_pred             EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEEccccc
Confidence            999999999999986542       3678999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +................++..|+|||.+....++.++|||||||++|+|++ |..||.....              ..+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------------~~~~  217 (262)
T cd00192         152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------------EEVL  217 (262)
T ss_pred             ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------------HHHH
Confidence            986443222222334567889999999988889999999999999999999 5888764321              1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      ..+........+...+.++.+++.+||..+|.+|||+.++++.|+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         218 EYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            112112223344555788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.4e-40  Score=311.37  Aligned_cols=255  Identities=26%  Similarity=0.464  Sum_probs=204.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|.+.++||+|+||.||++.++.           +..+++|.+... ....+.+.+|+++++.++|+||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~-----------~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   72 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNK-----------HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK   72 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecC-----------CccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence            4689999999999999999986543           345899988643 2335678899999999999999999999887


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                       ...++||||+++++|.+++.......+++..+..++.|++.||.|||+  .|++|+||||+||+++.++.++|+|||++
T Consensus        73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             -CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCcce
Confidence             678999999999999999976556678899999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ........ .......++..|+|||++....++.++|+|||||++|+|++ |..||......              ....
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------------~~~~  214 (260)
T cd05073         150 RVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------------EVIR  214 (260)
T ss_pred             eeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--------------HHHH
Confidence            75432211 11222345667999999988889999999999999999998 88887542211              1111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      .+............+.++.+++.+||..+|++||++.++++.|+.+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         215 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             HHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            1222222223344567899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=313.80  Aligned_cols=262  Identities=24%  Similarity=0.416  Sum_probs=207.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+|++.+.||+|+||.||+|.+...+      ......+|+|.+..... .....+.+|+.+++.++|+||+++++++..
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~------~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEG------EKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCC------CCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            47889999999999999999865421      12244689998865433 234568899999999999999999999987


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                       ...++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+  .+|+|+||||+|||++.++.++|+|||++
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~dfg~~  156 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLA  156 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCCccc
Confidence             7789999999999999998654 3458999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +...............++..|+|||.+....++.++|+|||||++|||++ |..||.....              ..+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------------~~~~~  222 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------------VEIPD  222 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------------HHHHH
Confidence            86443222211122223567999999988889999999999999999998 9988754321              11122


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                      .+........+...+..+.+++.+||..||++||++.++++.|..+..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         223 LLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             HHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            222222223333455779999999999999999999999999999855

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.5e-40  Score=329.75  Aligned_cols=262  Identities=26%  Similarity=0.368  Sum_probs=196.5

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      ..++|++.+.||+|+||.||++.          +...+..||||.+.....  .....+.+|+.+++.++||||++++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   84 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAY----------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV   84 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEE----------ecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeee
Confidence            45699999999999999999965          344577899999875422  223567789999999999999999998


Q ss_pred             eecC------CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          206 CCDD------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       206 ~~~~------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      +...      ...++||||+++ +|.+.+.    ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~~  157 (355)
T cd07874          85 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT  157 (355)
T ss_pred             eeccccccccceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCCC
Confidence            8643      356999999965 6776663    358889999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--------
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--------  351 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--------  351 (451)
                      +||+|||+++...   .........||..|+|||++.+..++.++|||||||++|+|++|..||........        
T Consensus       158 ~kl~Dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (355)
T cd07874         158 LKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL  234 (355)
T ss_pred             EEEeeCcccccCC---CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999999997532   12223346789999999999888999999999999999999999999865321100        


Q ss_pred             CCccccccch-hhhhhHHhhh---------------hh---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 GNWAKPYLSN-KLALHQIIDE---------------KL---GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ~~~~~~~~~~-~~~~~~~~~~---------------~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ......+... .......+..               ..   ........+..+.+|+.+||..||.+|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            0000000000 0000000000               00   000111234678999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.9e-40  Score=310.41  Aligned_cols=251  Identities=23%  Similarity=0.374  Sum_probs=202.6

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .|++.+.||.|++|.||++..          ..++..||+|.+.....  ...+.+.+|+++++.++|+||+++++.+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~----------~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRH----------RTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG   70 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEE----------cCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC
Confidence            488899999999999999654          34467899999864322  234567889999999999999999998864


Q ss_pred             -CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          209 -DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       209 -~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                       ....++||||+++++|.+++.......+++.++..++.+++.||.|||+  .||+|+||||+||+++.++.++|+|||+
T Consensus        71 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~~  148 (257)
T cd08223          71 EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGI  148 (257)
T ss_pred             CCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEecccc
Confidence             4467999999999999999876555678999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +......  ........+++.|+|||++.+..++.++|||||||++|+|++|..||......             .....
T Consensus       149 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------------~~~~~  213 (257)
T cd08223         149 ARVLENQ--CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-------------SLVYR  213 (257)
T ss_pred             eEEeccc--CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------------HHHHH
Confidence            9754321  12233456889999999998889999999999999999999999987632210             00111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      + ........+...+..+.+++.+||+.||++|||+.++++.
T Consensus       214 ~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         214 I-IEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             H-HhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            1 1111223344567889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=311.65  Aligned_cols=242  Identities=27%  Similarity=0.373  Sum_probs=207.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHH---HHHHHHHHhcCCCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW---ENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~---~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .++|..+++||+|.||.|.+          ++.+.+++.+|+|++++......+++   ..|-.+|+..+||++..+.-.
T Consensus       167 m~dFdfLKvLGkGTFGKVIL----------~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs  236 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVIL----------CREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS  236 (516)
T ss_pred             cchhhHHHHhcCCccceEEE----------EeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh
Confidence            45888999999999999999          55677789999999987765555444   458889999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      |+..+.+|+||||..||.|+-+|.+  ...+++.....+-..|+.||.|||+  ++||.||||.+|+|||.+|++||+||
T Consensus       237 FQt~drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKitDF  312 (516)
T KOG0690|consen  237 FQTQDRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKITDF  312 (516)
T ss_pred             hccCceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEeeec
Confidence            9999999999999999999999855  4678999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |+++..  ...+..+..++||+.|+|||++....|+.++|+|.+||++|||++|+.||....++              .+
T Consensus       313 GLCKE~--I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--------------kL  376 (516)
T KOG0690|consen  313 GLCKEE--IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--------------KL  376 (516)
T ss_pred             ccchhc--ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh--------------HH
Confidence            999842  23445567899999999999999999999999999999999999999999765432              22


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP  401 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  401 (451)
                      .+++. .....++...+++.+.|+..+|..||++|.
T Consensus       377 FeLIl-~ed~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  377 FELIL-MEDLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             HHHHH-hhhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            23221 112346677789999999999999999996

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.9e-40  Score=310.39  Aligned_cols=252  Identities=24%  Similarity=0.378  Sum_probs=205.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|+..+.||.|+||.||.+.          +..++..+++|.+....  ......+.+|++++++++|+||+++++++.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~----------~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   70 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYR----------RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD   70 (256)
T ss_pred             CceEeeEecccCCceEEEEE----------EcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec
Confidence            58889999999999999954          44557789999986442  3334568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ....++||||+++++|.+++.......+++..+..++.|++.+|.|||+  .|++|+||+|+||+++.++.+||+|||++
T Consensus        71 ~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~~~~~~~kl~d~~~~  148 (256)
T cd08221          71 DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGIS  148 (256)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEEeCCCCEEECcCcce
Confidence            9999999999999999999976555678999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      .......  .......|+..|+|||++.+..++.++||||||+++|+|++|..||......             .....+
T Consensus       149 ~~~~~~~--~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------------~~~~~~  213 (256)
T cd08221         149 KILGSEY--SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-------------NLVVKI  213 (256)
T ss_pred             EEccccc--ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------------HHHHHH
Confidence            8543222  1233457899999999998888999999999999999999999988542211             111111


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      .... ....+...+.++.+++.+||..+|.+||++.++++.+
T Consensus       214 ~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         214 VQGN-YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             HcCC-CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            1111 1122344567899999999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.1e-40  Score=314.77  Aligned_cols=274  Identities=26%  Similarity=0.430  Sum_probs=210.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +.|.+.+.||+|+||.||+|.+...      ...++..+|||.+...... ..+.+.+|+++++.++|+||+++++++.+
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~------~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~   77 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPL------GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK   77 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCC------CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec
Confidence            4678889999999999999876432      2345778999999755433 35678999999999999999999999887


Q ss_pred             --CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          209 --DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       209 --~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                        +...++||||+++++|.+++.... ..+++..+..++.|++.||.|||+  .||+|+||||+||+++.++.++|+|||
T Consensus        78 ~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg  154 (284)
T cd05038          78 PGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFG  154 (284)
T ss_pred             CCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccc
Confidence              567899999999999999986532 358999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc--cchhh
Q 013028          287 LAKFGPLGDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKL  363 (451)
Q Consensus       287 la~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~--~~~~~  363 (451)
                      ++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..|+......... +....  .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~  233 (284)
T cd05038         155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVT  233 (284)
T ss_pred             cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHH
Confidence            99864422111 1111234456799999998888999999999999999999999887654322110 00000  00011


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      .+...+........+...+.++.+|+.+||+.+|++|||+.||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            12222222222223344567899999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=326.13  Aligned_cols=253  Identities=23%  Similarity=0.300  Sum_probs=196.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++.+.||+|+||+||++..          ..++..||||++.+.   .....+.+.+|+.++..++|+||+++++++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   70 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKM----------KNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF   70 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEE----------CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE
Confidence            3789999999999999999654          445778999998742   122334578899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .++.+.|+||||+.||+|.+++... ...+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.++|+|||
T Consensus        71 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          71 QDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             ecCCeEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEECCCCHHHEEECCCCCEEEEECC
Confidence            9999999999999999999998543 3568999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCcccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      ++....... ........||+.|+|||++..     ..++.++|||||||++|+|++|..||......            
T Consensus       148 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------------  214 (331)
T cd05597         148 SCLRLLADG-TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------------  214 (331)
T ss_pred             ceeecCCCC-CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------------
Confidence            987432211 111223468999999999853     45788999999999999999999998643211            


Q ss_pred             hhhhhHHhhhhhcCCC---CHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 013028          362 KLALHQIIDEKLGRNI---QMEEAQEFAEIILRCLNSDPKN--RPTMSEVVAA  409 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  409 (451)
                       .....+.........   ....+..+.+|+.+||..+++.  |+++.+++++
T Consensus       215 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         215 -ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence             011111111100111   1224678999999988654443  7899999987

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=306.22  Aligned_cols=253  Identities=21%  Similarity=0.263  Sum_probs=199.5

Q ss_pred             hcCCCcC-CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeecccee
Q 013028          129 TRKFSEK-NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~  206 (451)
                      +++|.+. ++||-|-.|.|-.++          ++.++..+|+|++...     ....+|+++--..+ |||||.++++|
T Consensus        60 tedY~is~qvLG~GinGkV~~C~----------~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy  124 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCV----------HKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY  124 (400)
T ss_pred             hhhheehhhhhccccCCceEEEE----------eccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence            4455543 579999999999865          4556777999998643     23467888755554 99999999998


Q ss_pred             ec----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC---CCCc
Q 013028          207 CD----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD---DDFN  279 (451)
Q Consensus       207 ~~----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~---~~~~  279 (451)
                      ++    ...+.+|||.|+||+|+..+....+..+++.++..|+.||+.|+.|||+  .+|.||||||+|+|.+   .+..
T Consensus       125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~--~nIAHRDlKpENLLyt~t~~na~  202 (400)
T KOG0604|consen  125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS--MNIAHRDLKPENLLYTTTSPNAP  202 (400)
T ss_pred             hhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh--cchhhccCChhheeeecCCCCcc
Confidence            74    3566799999999999999998888899999999999999999999999  8999999999999996   4668


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  359 (451)
                      +||+|||+|+.-   .......+.+.|++|+|||++...+|+...|+||+||++|.|++|.+||........       .
T Consensus       203 lKLtDfGFAK~t---~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-------s  272 (400)
T KOG0604|consen  203 LKLTDFGFAKET---QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------S  272 (400)
T ss_pred             eEeccccccccc---CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-------C
Confidence            999999999852   223344567899999999999889999999999999999999999999976543211       0


Q ss_pred             chhhhhhHHhhhhhcC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          360 SNKLALHQIIDEKLGR--NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      .  +--..+....+.-  ......++..+++|+++|..+|.+|.|+.++++.=
T Consensus       273 p--gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  273 P--GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             h--hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence            0  0001111111111  11234588999999999999999999999998753

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.6e-40  Score=320.85  Aligned_cols=264  Identities=21%  Similarity=0.308  Sum_probs=198.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|.+.++||+|+||.||+|..          ..++..||+|.+..... .....+.+|+.+++.++|+||+++++++..
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   75 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRS----------KLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT   75 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEe----------cCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee
Confidence            4799999999999999999764          34567899999874432 233457789999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++..++||||+++ +|.+++... ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+|||++
T Consensus        76 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  151 (309)
T cd07872          76 DKSLTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLA  151 (309)
T ss_pred             CCeEEEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECccccc
Confidence            9999999999975 888877543 3458899999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC-----ccc---ccc
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN-----WAK---PYL  359 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~-----~~~---~~~  359 (451)
                      ......  ........++..|+|||++.+ ..++.++|||||||++|+|++|.+||..........     +..   ..+
T Consensus       152 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  229 (309)
T cd07872         152 RAKSVP--TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW  229 (309)
T ss_pred             eecCCC--ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            753221  112234567899999998865 568999999999999999999999986543211000     000   000


Q ss_pred             chhhhhhHHhhhhhcC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          360 SNKLALHQIIDEKLGR-------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..........+.....       ......+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            0000000000000000       0111245678999999999999999999999973

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.4e-39  Score=311.55  Aligned_cols=261  Identities=26%  Similarity=0.389  Sum_probs=205.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+|.+.++||+|+||.||+|.+.+.       ......|+||.+.... ....+.+.+|+.+++.++|+||+++++++.+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~-------~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   78 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSP-------ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE   78 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecC-------CCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence            4788899999999999999986432       1234568999886543 2334578899999999999999999999876


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      . ..++||||+++|+|.+++... ...+++..+..++.+++.||.|||+  .+++|+||||+|||++.++.++|+|||++
T Consensus        79 ~-~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          79 N-PVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             C-CcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCcee
Confidence            4 568999999999999998653 3458999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ....... ........++..|+|||.+....++.++|||||||++|+|++ |..||......             ... .
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------------~~~-~  219 (270)
T cd05056         155 RYLEDES-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-------------DVI-G  219 (270)
T ss_pred             eeccccc-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-------------HHH-H
Confidence            7543221 111122234567999999988889999999999999999986 99888643221             000 1


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      .+........+...+..+.+++.+||..+|.+|||+.++++.|+++..+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         220 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            1111111223345567899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=311.97  Aligned_cols=252  Identities=28%  Similarity=0.485  Sum_probs=196.5

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhc-CCCceeeccceeecCCeeE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRL-NHPNVVKLMGYCCDDQHRL  213 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~  213 (451)
                      +.||+|+||.||+|.+..+        .....+++|.+.... ....+.+.+|++++..+ +||||+++++++......+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~--------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   72 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKD--------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   72 (270)
T ss_pred             CcCCCCCCceEEEEEEcCC--------CCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCce
Confidence            3689999999999875432        112357888886432 23345788999999999 6999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          214 LVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       214 lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      +||||+++|+|.+++....              ...+++..+..++.|++.||.|||+  .|++|+||||+|||+++++.
T Consensus        73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili~~~~~  150 (270)
T cd05047          73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYV  150 (270)
T ss_pred             EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEEcCCCe
Confidence            9999999999999985422              1357899999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  358 (451)
                      ++|+|||++.....   .........+..|+|||++....++.++|||||||++|+|++ |..||......         
T Consensus       151 ~kl~dfgl~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---------  218 (270)
T cd05047         151 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------  218 (270)
T ss_pred             EEECCCCCccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---------
Confidence            99999999863111   101111223567999999988889999999999999999997 88887542211         


Q ss_pred             cchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                           .....+........+...+.++.+|+.+||..||.+|||+.+++..|+.+.
T Consensus       219 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         219 -----ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -----HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                 111112222222233345678999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.5e-40  Score=320.86  Aligned_cols=265  Identities=23%  Similarity=0.344  Sum_probs=203.2

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +|++.+.||+|+||.||++.+.          .++..+|+|.+..... .....+.+|++++++++||||+++++++.++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~----------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHR----------PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD   71 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEc----------CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            6889999999999999997643          4467799998864322 2235578899999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +..++||||+++++|.+++..  ...+++..+..++.|+++||.|||+. .+++|+||||+|||++.++.++|+|||++.
T Consensus        72 ~~~~lv~ey~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (308)
T cd06615          72 GEISICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSG  148 (308)
T ss_pred             CEEEEEeeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCCcc
Confidence            999999999999999999854  36689999999999999999999972 489999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc----------
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL----------  359 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~----------  359 (451)
                      ....    .......|+..|+|||++.+..++.++|+|||||++|+|++|..||..........+.....          
T Consensus       149 ~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (308)
T cd06615         149 QLID----SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR  224 (308)
T ss_pred             cccc----cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence            4321    12234578899999999988889999999999999999999999986433211100000000          


Q ss_pred             ---------chhhhhhHHhhhhh---cCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          360 ---------SNKLALHQIIDEKL---GRNIQ-MEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       360 ---------~~~~~~~~~~~~~~---~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                               ..........+...   ....+ ...+.++.+|+.+||..||++|||+.++++..--
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  290 (308)
T cd06615         225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI  290 (308)
T ss_pred             cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence                     00000011111111   01111 1245679999999999999999999999988544

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.9e-40  Score=349.75  Aligned_cols=263  Identities=25%  Similarity=0.384  Sum_probs=204.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc---CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++.++||+|+||.||+|..          ..++..||||++......   ..+.+.+|+++++.++||||+++++++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d----------~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~   71 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYD----------PVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC   71 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEE----------CCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE
Confidence            4899999999999999999764          344678999999754222   235688999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED---------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD  277 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~  277 (451)
                      .+++..++||||++||+|.+++....         ...+++..++.++.||+.||.|||+  +||+||||||+|||++.+
T Consensus        72 ~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~d  149 (932)
T PRK13184         72 SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLF  149 (932)
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEEcCC
Confidence            99999999999999999999885321         1345667788999999999999999  899999999999999999


Q ss_pred             CcEEEeecCCcccCCCCCC----------------cccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 013028          278 FNAKISDFGLAKFGPLGDK----------------SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT  341 (451)
Q Consensus       278 ~~~kl~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~  341 (451)
                      +.++|+|||++........                .......+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus       150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~  229 (932)
T PRK13184        150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF  229 (932)
T ss_pred             CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence            9999999999985421110                011123579999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHHh
Q 013028          342 AAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-TMSEVVAALEQLQLN  416 (451)
Q Consensus       342 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~  416 (451)
                      ||........            ..................+..+.+++.+||..||++|| ++.++++.|+.....
T Consensus       230 PF~~~~~~ki------------~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        230 PYRRKKGRKI------------SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             CCCCcchhhh------------hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            9865321100            00000000000001123457789999999999999996 677788888887553

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-39  Score=310.56  Aligned_cols=250  Identities=30%  Similarity=0.447  Sum_probs=201.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---------HHHHHHHHHHHHhcCCCceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---------QDEWENELRFLSRLNHPNVVK  201 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~il~~l~h~nIv~  201 (451)
                      +|.+...||.|+||.||+|...          .++..+|+|.+.......         .+.+.+|+.+++.++||||++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~----------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~   70 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNA----------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQ   70 (267)
T ss_pred             CccccceeecCCCeEEEEEEec----------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeee
Confidence            4778899999999999997643          346779999887543322         145788999999999999999


Q ss_pred             ccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEE
Q 013028          202 LMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       202 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~k  281 (451)
                      +++++.++...++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  .|++|+||+|+||+++.++.++
T Consensus        71 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~--~~ivH~di~p~nil~~~~~~~~  146 (267)
T cd06628          71 YLGSSLDADHLNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHN--RGIIHRDIKGANILVDNKGGIK  146 (267)
T ss_pred             EEEEEEeCCccEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHh--cCcccccCCHHHEEEcCCCCEE
Confidence            99999999999999999999999999854  3568899999999999999999999  8999999999999999999999


Q ss_pred             EeecCCcccCCCCCC----cccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc
Q 013028          282 ISDFGLAKFGPLGDK----SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       282 l~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~  357 (451)
                      |+|||++........    ........|+..|+|||++.+..++.++|+|||||++|+|++|..||......        
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------  218 (267)
T cd06628         147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------  218 (267)
T ss_pred             ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------
Confidence            999999875431110    11122346888999999998888999999999999999999999998643210        


Q ss_pred             ccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                           ....... .......+...+..+.+++.+||+.||.+||++.++++
T Consensus       219 -----~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         219 -----QAIFKIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -----HHHHHHh-ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                 0111111 12223344556788999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1e-39  Score=316.24  Aligned_cols=252  Identities=25%  Similarity=0.382  Sum_probs=201.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +.|+++++||.|+||.||+|...          .++..+++|.+..........+.+|+.+++.++|+||+++++.+..+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~----------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNK----------ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD   81 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEEC----------CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence            57999999999999999997644          44677999999766555566788899999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++++|..++... ...+++..+..++.|++.+|.|||+  .+|+||||||+||+++.++.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~  158 (292)
T cd06644          82 GKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSA  158 (292)
T ss_pred             CeEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEEcCCCCEEEccCccce
Confidence            9999999999999998877543 3568999999999999999999999  899999999999999999999999999986


Q ss_pred             cCCCCCCcccccccCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIA-----TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ....  .........++..|+|||++.     ...++.++|||||||++|+|++|..||......             ..
T Consensus       159 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------------~~  223 (292)
T cd06644         159 KNVK--TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------------RV  223 (292)
T ss_pred             eccc--cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------------HH
Confidence            4221  112223456888999999984     345788999999999999999999988643210             00


Q ss_pred             hhHHhhhhh-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          365 LHQIIDEKL-GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...+..... ....+...+.++.+++.+||..||++||++.++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         224 LLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             HHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            011111100 111223445679999999999999999999999763

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=309.98  Aligned_cols=251  Identities=26%  Similarity=0.383  Sum_probs=204.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|++.+.||.|+||.||+|..          ..++..+++|.+........+.+.+|+++++.++||||+++++++.++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~----------~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   72 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARD----------IATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR   72 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEe----------cCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC
Confidence            5789999999999999999764          344677999999866555667889999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+.+++|.+++... ...+++..+..++.|++.||.|||+  .+|+|+||+|+||++++++.++|+|||++.
T Consensus        73 ~~~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  149 (262)
T cd06613          73 DKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSA  149 (262)
T ss_pred             CEEEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECccccch
Confidence            9999999999999999988543 2568999999999999999999999  899999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCccccccccccC---CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATG---HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      .....  ........++..|+|||++.+.   .++.++|+|||||++|+|++|..||......             ....
T Consensus       150 ~~~~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-------------~~~~  214 (262)
T cd06613         150 QLTAT--IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-------------RALF  214 (262)
T ss_pred             hhhhh--hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------------HHHH
Confidence            53321  1122345788899999999766   7899999999999999999999998653321             0000


Q ss_pred             HHhhhhh---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          367 QIIDEKL---GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       367 ~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ......+   ........+.++.+++.+||..+|.+|||+.+++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         215 LISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1111100   11123345678999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=331.89  Aligned_cols=246  Identities=33%  Similarity=0.479  Sum_probs=202.6

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .|.-++.||.|+||.||.          |++..+...||||.+.-.....   ..++..|+.+|++|+|||+|.+.|+|.
T Consensus        27 lf~dLrEIGHGSFGAVYf----------Ard~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL   96 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYF----------ARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL   96 (948)
T ss_pred             HHHHHHHhcCCccceeEE----------eeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee
Confidence            566678999999999999          4566778899999987544444   457889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      .+...+||||||- |+-.|++.-. .+++-+.++..|+.+.+.||+|||+  .+.||||||..||||++.|.|||+|||.
T Consensus        97 re~TaWLVMEYCl-GSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILLse~g~VKLaDFGS  172 (948)
T KOG0577|consen   97 REHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILLSEPGLVKLADFGS  172 (948)
T ss_pred             ccchHHHHHHHHh-ccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEecCCCeeeeccccc
Confidence            9999999999995 5777777433 4678899999999999999999999  7999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      |....      ....++||++||||||+.   .+.|+-++||||||++-.||...++|.+....             ...
T Consensus       173 Asi~~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------------MSA  233 (948)
T KOG0577|consen  173 ASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------------MSA  233 (948)
T ss_pred             hhhcC------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------------HHH
Confidence            97532      244689999999999984   47899999999999999999999988764321             111


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +..+.......-.....++.|..|+..||+.-|.+|||..++|.+
T Consensus       234 LYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  234 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             HHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            112221111222345678999999999999999999999998764

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.7e-40  Score=315.03  Aligned_cols=252  Identities=23%  Similarity=0.361  Sum_probs=200.3

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      .|++.+.||.|+||.||+|...          .++..+++|.+........+.+.+|+++++.++|+||+++++++..+.
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~----------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~   75 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNK----------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN   75 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEEC----------CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC
Confidence            4678899999999999997654          345678999987554444567888999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..++||||+++++|..++... ...+++..+..++.|++.||.|||+  .||+||||||+|||++.++.++|+|||++..
T Consensus        76 ~~~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  152 (282)
T cd06643          76 NLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGVSAK  152 (282)
T ss_pred             EEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEcccccccc
Confidence            999999999999998877542 3568999999999999999999999  8999999999999999999999999999875


Q ss_pred             CCCCCCcccccccCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          291 GPLGDKSHISTRVLGTRGYFAPEYIA-----TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       291 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      ....  ........++..|+|||++.     +..++.++|||||||++|+|++|.+||......             ...
T Consensus       153 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------------~~~  217 (282)
T cd06643         153 NTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-------------RVL  217 (282)
T ss_pred             cccc--ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-------------HHH
Confidence            3211  11223456889999999983     456788999999999999999999988643211             001


Q ss_pred             hHHhhh-hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          366 HQIIDE-KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       366 ~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ...... ......+...+.++.+|+.+||+.||.+||++.++++.-
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         218 LKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             HHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence            111110 001112334567899999999999999999999987643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.8e-40  Score=313.45  Aligned_cols=251  Identities=23%  Similarity=0.359  Sum_probs=200.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|.+.+.||+|+||.||+|..          ..++..||+|.+..........+.+|+.+++.++||||+++++++.+.
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~----------~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~   78 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARN----------VNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR   78 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEE----------cCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence            4788899999999999999754          345678999998755444455678899999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +..++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  .||+|+||||+||+++.++.++|+|||++.
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd06645          79 DKLWICMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILLTDNGHVKLADFGVSA  154 (267)
T ss_pred             CEEEEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcceeee
Confidence            999999999999999998854  4578999999999999999999999  899999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      .....  ........|+..|+|||++.   ...++.++|+|||||++|+|++|..||....+...             ..
T Consensus       155 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-------------~~  219 (267)
T cd06645         155 QITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------------LF  219 (267)
T ss_pred             EccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-------------HH
Confidence            53221  11223457899999999974   45688999999999999999999998864322100             00


Q ss_pred             HHhhhhhcCC-C--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIIDEKLGRN-I--QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~-~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .......... .  ....+..+.+++.+||..+|++|||+.++++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         220 LMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             hhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            0000000000 0  11234678999999999999999999998863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.3e-39  Score=312.49  Aligned_cols=261  Identities=26%  Similarity=0.473  Sum_probs=205.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++.+.||.|+||.||+|......     .......|++|.+...... ..+.+.+|+++++.++|+||+++++++.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIE-----EEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCC-----cCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence            47889999999999999999875432     2344567999988654333 34678899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEE
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDD-------TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~k  281 (451)
                      ....++||||+++|+|.+++.....       ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN--ARFVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh--cCcccCcCccceEEEeCCCcEE
Confidence            9999999999999999999865431       268999999999999999999999  8999999999999999999999


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccc
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLS  360 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~  360 (451)
                      |+|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......           
T Consensus       158 l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-----------  225 (275)
T cd05046         158 VSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-----------  225 (275)
T ss_pred             EcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-----------
Confidence            99999987432111 111223355677999999988889999999999999999998 67776432111           


Q ss_pred             hhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          361 NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                        ..+................+..+.+++.+||+.+|.+|||+.+++..|.
T Consensus       226 --~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         226 --EVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             --HHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence              0111111111112223345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.1e-40  Score=327.80  Aligned_cols=258  Identities=21%  Similarity=0.289  Sum_probs=192.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ...|++.+.||+|+||.||+|...          .++..||+|+....      ....|+.+++.++|+||+++++++..
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~  128 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKP----------GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS  128 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEEC----------CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence            347999999999999999997643          44677999985432      22469999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++|||++. ++|.+++... ...+++..+..|+.||+.||.|||+  +||+||||||+|||++.++.++|+|||++
T Consensus       129 ~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a  204 (357)
T PHA03209        129 GAITCMVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAA  204 (357)
T ss_pred             CCeeEEEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEecCccc
Confidence            999999999995 5888887543 4568999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc-----------
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP-----------  357 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~-----------  357 (451)
                      .....   ........||..|+|||++.+..++.++|||||||++|||+++..++....+.....+...           
T Consensus       205 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~  281 (357)
T PHA03209        205 QFPVV---APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIST  281 (357)
T ss_pred             ccccc---CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHH
Confidence            74221   1223346789999999999999999999999999999999987665543322210000000           


Q ss_pred             -------cc--chhhhhhHHhhhhhcCC---------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          358 -------YL--SNKLALHQIIDEKLGRN---------IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       358 -------~~--~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                             +.  .........+.......         .....+..+.+||.+||+.||.+|||+.|||++
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        282 LKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             hccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence                   00  00000000000000000         001124566789999999999999999999874

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-40  Score=314.64  Aligned_cols=251  Identities=31%  Similarity=0.522  Sum_probs=200.1

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHH--HHHHHHHHHHhcCCCceeeccceeecC
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD--EWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      |++++.||+|+||+||++.          +...+..+|+|++.........  ...+|+.++++++|+||+++++++.+.
T Consensus         1 y~~~~~lg~G~~g~v~~~~----------~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~   70 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAK----------NKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD   70 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEE----------ETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES
T ss_pred             CEEeEEEEeCCCEEEEEEE----------ECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc
Confidence            6778999999999999965          4555778999999865433332  234599999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++++|.+++.  ....+++..+..++.||++||.+||+  .+|+|+||||+|||++.++.++|+|||.+.
T Consensus        71 ~~~~~v~~~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~  146 (260)
T PF00069_consen   71 NYLYIVMEYCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILLDENGEVKLIDFGSSV  146 (260)
T ss_dssp             SEEEEEEEEETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred             cccccccccccccccccccc--cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccc
Confidence            99999999999999999996  34678999999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ..  ...........++..|+|||++. +..++.++||||||+++|+|++|..||.....          ..........
T Consensus       147 ~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~----------~~~~~~~~~~  214 (260)
T PF00069_consen  147 KL--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS----------DDQLEIIEKI  214 (260)
T ss_dssp             ES--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH----------HHHHHHHHHH
T ss_pred             cc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------hhhhhhhhhc
Confidence            53  12223344567899999999997 78899999999999999999999998874310          0011111111


Q ss_pred             hhhhhcCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          369 IDEKLGRNI--QMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       369 ~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      .........  .......+.+++.+||+.||++||++.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  215 LKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111111111  1112378999999999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.1e-39  Score=312.01  Aligned_cols=252  Identities=27%  Similarity=0.391  Sum_probs=190.9

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      +.||+|+||.||+|.+..        ..+...+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~--------~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   72 (269)
T cd05087           1 KEIGNGWFGKVILGEVNS--------GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLL   72 (269)
T ss_pred             CcccccCCceEEEEEEcC--------CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEE
Confidence            469999999999987542        23355689998865432 223467889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          215 VYEYVTRGSLEDHLLNED---DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      ||||+++|+|.+++....   ....++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++...
T Consensus        73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCccccccc
Confidence            999999999999986432   2346677888999999999999999  89999999999999999999999999999743


Q ss_pred             CCCCCcccccccCCCCccccccccccC-------CCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATG-------HLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      .............++..|+|||++.+.       .++.++|||||||++|||++ |..||....+.             .
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-------------~  217 (269)
T cd05087         151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE-------------Q  217 (269)
T ss_pred             cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH-------------H
Confidence            222111112234577889999998532       35789999999999999996 99888543221             0


Q ss_pred             hhhHHhh----hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          364 ALHQIID----EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       364 ~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      .....+.    ...........+..+.+++.+|+ .+|++|||+.+|+..|+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         218 VLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            0000000    00011122234567899999998 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=306.44  Aligned_cols=248  Identities=32%  Similarity=0.497  Sum_probs=197.2

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      ++||.|+||.||++.+.          . +..|++|.+...... ....+.+|++++++++|+||+++++++.+....++
T Consensus         1 ~~lg~g~~g~v~~~~~~----------~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   69 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK----------G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYI   69 (251)
T ss_pred             CccccCCCceEEEEEEe----------C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEE
Confidence            46999999999997643          2 567999998754433 34578899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCC
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG  294 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  294 (451)
                      ||||+.+++|.+++... ...+++..+..++.+++.+|.|||+  ++++||||+|+|||++.++.++|+|||++......
T Consensus        70 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  146 (251)
T cd05041          70 VMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG  146 (251)
T ss_pred             EEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence            99999999999998553 3468899999999999999999999  89999999999999999999999999999753211


Q ss_pred             CCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhhhh
Q 013028          295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL  373 (451)
Q Consensus       295 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (451)
                      ..........++..|+|||++.+..++.++|+|||||++|+|++ |..||......              .....+....
T Consensus       147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------------~~~~~~~~~~  212 (251)
T cd05041         147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------------QTRERIESGY  212 (251)
T ss_pred             cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------------HHHHHHhcCC
Confidence            11111111223556999999988889999999999999999999 77776432211              1112222222


Q ss_pred             cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          374 GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       374 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      ....+...+..+.+++.+||..+|++|||+.|+++.|+
T Consensus       213 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            22334455678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.1e-39  Score=307.41  Aligned_cols=256  Identities=29%  Similarity=0.452  Sum_probs=194.0

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceee-cCCeeE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCC-DDQHRL  213 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~~~  213 (451)
                      +.||+|+||.||+|.+...       ......||+|.+.... ....+.+.+|+.+++.++||||+++++++. .+...+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~-------~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   73 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDS-------DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPL   73 (262)
T ss_pred             CcccccCCceEEEEEEecC-------CCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcE
Confidence            4689999999999876431       1234679999885432 223456788999999999999999999775 455678


Q ss_pred             EEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCC
Q 013028          214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL  293 (451)
Q Consensus       214 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~  293 (451)
                      +||||+.+|+|.+++... ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        74 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~  150 (262)
T cd05058          74 VVLPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGLARDIYD  150 (262)
T ss_pred             EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccccccccC
Confidence            999999999999998653 2346778888999999999999999  8999999999999999999999999999974321


Q ss_pred             CCCc--ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCC-ccccccCCCCCCccccccchhhhhhHHhh
Q 013028          294 GDKS--HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT-AAMRRTNGLAGNWAKPYLSNKLALHQIID  370 (451)
Q Consensus       294 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (451)
                      ....  .......++..|+|||++.+..++.++|||||||++|||++|.. ||....              ...+...+.
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--------------~~~~~~~~~  216 (262)
T cd05058         151 KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--------------SFDITVYLL  216 (262)
T ss_pred             CcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--------------HHHHHHHHh
Confidence            1110  11122345678999999988889999999999999999999654 443211              001111111


Q ss_pred             hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                      .......+...+..+.+++.+||..+|++||++.++++.|+++..
T Consensus       217 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         217 QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            111112223345789999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-39  Score=313.24  Aligned_cols=249  Identities=24%  Similarity=0.370  Sum_probs=191.6

Q ss_pred             cccccCceEEEEEEEcCcch--------------hhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeec
Q 013028          137 LIGQGGFGDVYIGYINSCAM--------------TAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKL  202 (451)
Q Consensus       137 ~LG~G~~g~Vy~~~~~~~~~--------------~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~  202 (451)
                      .||+|+||.||+|.+...+.              ....+......|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998643211              0112333446789999875444444567889999999999999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC----
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF----  278 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~----  278 (451)
                      ++++.+....++||||+++|+|..++... ...+++..+..++.||+.||.|||+  ++|+||||||+|||++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED--KNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc--CCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999888543 4568999999999999999999999  8999999999999997643    


Q ss_pred             ---cEEEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHH-hCCCccccccCCCCCC
Q 013028          279 ---NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEIL-SGKTAAMRRTNGLAGN  353 (451)
Q Consensus       279 ---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell-tg~~pf~~~~~~~~~~  353 (451)
                         .++++|||++.....      .....++..|+|||++.+ ..++.++|||||||++|||+ +|..||.......   
T Consensus       159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---  229 (274)
T cd05076         159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---  229 (274)
T ss_pred             ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence               389999999863211      112356778999998865 56899999999999999985 6888876432210   


Q ss_pred             ccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          354 WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                                 ....+...  ...+......+.+++.+||+.+|++|||+.++++.|
T Consensus       230 -----------~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         230 -----------KERFYEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             -----------HHHHHHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence                       01111111  112222346799999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.6e-39  Score=315.30  Aligned_cols=264  Identities=23%  Similarity=0.384  Sum_probs=204.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+|+..+.||+|+||.||+|.+...+.      .....||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGE------TVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCC------cceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            478888999999999999998654321      1123589998865432 223467889999999999999999999875


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      . ..++|+||+++|+|.+++... ...+++..+..++.|++.||.|||+  ++|+|+||||+||+++.++.+||+|||++
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Dfg~~  156 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLA  156 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhh--cCeeccccccceeeecCCCceEEcccccc
Confidence            4 467999999999999998653 3468899999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +...............++..|+|||++.+..++.++|||||||++|||++ |..||.....              .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--------------~~~~~  222 (303)
T cd05110         157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--------------REIPD  222 (303)
T ss_pred             ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------------HHHHH
Confidence            85432222112223345678999999988899999999999999999997 8888753211              11112


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                      ++........+...+..+.+++..||..+|++||++.++++.|+.+....
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         223 LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             HHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            22222222222334567999999999999999999999999999886553

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=311.12  Aligned_cols=249  Identities=27%  Similarity=0.412  Sum_probs=203.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++.+.||.|+||.||+|...          .++..||+|.+.... ......+.+|+++++.++|+||+++++++.+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDK----------RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK   70 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEEC----------CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE
Confidence            37888999999999999997643          456789999987543 2334568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++|+||+++++|.+++...   .+++..+..++.|++.||.|||+  ++|+|+||+|+||+++.++.++|+|||++
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~  145 (274)
T cd06609          71 GSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVS  145 (274)
T ss_pred             CCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEcccccc
Confidence            99999999999999999998543   78999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      .......  .......++..|+|||++.+..++.++|||||||++|+|++|..||......              .....
T Consensus       146 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------------~~~~~  209 (274)
T cd06609         146 GQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------------RVLFL  209 (274)
T ss_pred             eeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------------HHHHH
Confidence            8643221  2233457888999999998888999999999999999999999998643211              01111


Q ss_pred             hhhhhcCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          369 IDEKLGRNIQME-EAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       369 ~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +........... .+..+.+++.+||..+|++|||+.++++.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         210 IPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             hhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            111122222222 56779999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=317.93  Aligned_cols=254  Identities=24%  Similarity=0.316  Sum_probs=204.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc---CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +|++.+.||+|+||.||+|...          .++..||+|.+......   ....+..|+++++.++|+||+++++.+.
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLK----------GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ   71 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEc----------CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence            6888999999999999997643          35678999999754333   3356788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++...++||||+.|++|.+++.......+++..+..++.|++.||.|||+  .||+|+||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~  149 (316)
T cd05574          72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDL  149 (316)
T ss_pred             cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecch
Confidence            99999999999999999999876556779999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCc---------------------------ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCC
Q 013028          288 AKFGPLGDKS---------------------------HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK  340 (451)
Q Consensus       288 a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~  340 (451)
                      +.........                           .......|+..|+|||++.+..++.++||||||+++|+|++|.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~  229 (316)
T cd05574         150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT  229 (316)
T ss_pred             hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence            8743221100                           0112346889999999998888999999999999999999999


Q ss_pred             CccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 013028          341 TAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT----MSEVVAA  409 (451)
Q Consensus       341 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~~  409 (451)
                      .||......             ..+..+.............+..+.+++.+||..||++|||    +.+++..
T Consensus       230 ~pf~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         230 TPFKGSNRD-------------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             CCCCCCchH-------------HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            998643321             1112222222211222225788999999999999999999    7777764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.5e-39  Score=304.15  Aligned_cols=247  Identities=31%  Similarity=0.484  Sum_probs=195.7

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      ++||+|+||.||+|...           .+..+|+|.+...... ....+.+|+++++.++||||+++++++......++
T Consensus         1 ~~ig~g~~g~vy~~~~~-----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   69 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYI   69 (250)
T ss_pred             CccCCCCCceEEEEEec-----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEE
Confidence            46999999999998643           2457999998754322 23467889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCC
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG  294 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  294 (451)
                      ||||+++++|.+++... ...+++..+..++.+++.+|.|||+  +|++|+||||+||+++.++.++|+|||++......
T Consensus        70 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  146 (250)
T cd05085          70 VMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG  146 (250)
T ss_pred             EEECCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceecccc
Confidence            99999999999988543 3458899999999999999999999  89999999999999999999999999999743211


Q ss_pred             CCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhhhh
Q 013028          295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL  373 (451)
Q Consensus       295 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (451)
                      .. .......++..|+|||++.+..++.++||||||+++|+|++ |..||......              .....+....
T Consensus       147 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------------~~~~~~~~~~  211 (250)
T cd05085         147 IY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------------QAREQVEKGY  211 (250)
T ss_pred             cc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------------HHHHHHHcCC
Confidence            11 11112234567999999988889999999999999999998 88887533211              1111111222


Q ss_pred             cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          374 GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       374 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       212 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         212 RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            22333445688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.3e-39  Score=316.65  Aligned_cols=251  Identities=24%  Similarity=0.364  Sum_probs=204.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .+|.+.+.||.|+||.||+|..          ..++..||+|.+........+.+.+|+.+++.++|+||+++++++..+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   88 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAID----------IATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG   88 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEE----------CCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            5899999999999999999763          345678999999765555566788999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++++|.+++..   ..+++..+..++.|++.||.|||+  .||+|+||||+|||++.++.++|+|||++.
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~  163 (297)
T cd06656          89 DELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (297)
T ss_pred             CEEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEECcCccce
Confidence            999999999999999998843   457889999999999999999999  899999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ......  .......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........            ...
T Consensus       164 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------------~~~  229 (297)
T cd06656         164 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------------IAT  229 (297)
T ss_pred             EccCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------------ecc
Confidence            532211  112345688899999999888899999999999999999999999965432110000            000


Q ss_pred             hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ........+...+..+.+|+.+||..+|++||++.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000111223345778999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.5e-39  Score=308.85  Aligned_cols=250  Identities=22%  Similarity=0.369  Sum_probs=191.0

Q ss_pred             CcccccCceEEEEEEEcCcchhh--hhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCCeeE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTA--ARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL  213 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~  213 (451)
                      +.||+|+||.||+|.+.......  .........|++|.+..........+..|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            46899999999999864321100  0112334568999887554444557788999999999999999999999998999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc-------EEEeecC
Q 013028          214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN-------AKISDFG  286 (451)
Q Consensus       214 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~-------~kl~DFG  286 (451)
                      +||||+++|+|..++... ...+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999998877543 3568999999999999999999999  89999999999999986654       8999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccc-cCCCCcchhhHHHHHHHHHHH-hCCCccccccCCCCCCccccccchhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEIL-SGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ++.....      .....++..|+|||++. +..++.++|||||||++|+|+ .|..||......           +   
T Consensus       158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----------~---  217 (262)
T cd05077         158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-----------E---  217 (262)
T ss_pred             CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-----------H---
Confidence            9864321      12345778899999986 467899999999999999998 476665432110           0   


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ........  .........++.+|+.+||+.||.+||++.+|++.|
T Consensus       218 ~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         218 KERFYEGQ--CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHHHhcC--ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            00111111  111222356799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-39  Score=315.24  Aligned_cols=250  Identities=26%  Similarity=0.399  Sum_probs=204.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .+|++.+.||.|+||.||+|..          ..++..|++|.+........+.+.+|+.+++.++|+||+++++++.++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~----------~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAID----------VATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG   88 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEE----------cCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence            4799999999999999999763          445778999999765555567788999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++++|.+++..   ..+++..+..++.+++.||.|||+  .|++|+||||+||+++.++.++|+|||++.
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~--~~i~H~dL~p~Nili~~~~~~kl~dfg~~~  163 (296)
T cd06655          89 DELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCA  163 (296)
T ss_pred             ceEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccch
Confidence            999999999999999998843   358999999999999999999999  899999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ......  .......++..|+|||.+.+..++.++|||||||++|+|++|..||......             .....+.
T Consensus       164 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-------------~~~~~~~  228 (296)
T cd06655         164 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------------RALYLIA  228 (296)
T ss_pred             hccccc--ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------HHHHHHH
Confidence            533221  1123356888999999998888999999999999999999999998653321             0011111


Q ss_pred             hh-hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          370 DE-KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       370 ~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .. ......+...+..+.+++.+||..||.+|||+.+++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         229 TNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             hcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            10 00111233456789999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5e-40  Score=324.53  Aligned_cols=253  Identities=22%  Similarity=0.288  Sum_probs=197.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|.+.+.||+|+||.||++..          ..++..||+|++.+..   ......+.+|+.++..++|+||+++++++
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~   70 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKM----------KHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF   70 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEE----------CCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3789999999999999999654          4457789999986421   22234577899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++..|+||||+.||+|.+++... ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        71 ~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          71 QDENYLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEecc
Confidence            9999999999999999999998653 3468999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCcccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      ++....... ........||..|+|||++.+     ..++.++|||||||++|+|++|+.||......            
T Consensus       148 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------------  214 (331)
T cd05624         148 SCLKMNQDG-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------------  214 (331)
T ss_pred             ceeeccCCC-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------------
Confidence            997533211 111223579999999999865     56889999999999999999999998643211            


Q ss_pred             hhhhhHHhhhhhcCCC---CHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 013028          362 KLALHQIIDEKLGRNI---QMEEAQEFAEIILRCLNSDPKN--RPTMSEVVAA  409 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  409 (451)
                       .....+.........   ....+.++.+++.+||..++++  |+++.+++++
T Consensus       215 -~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         215 -ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence             111112111111111   1234678999999999866544  4688888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.7e-39  Score=320.18  Aligned_cols=264  Identities=20%  Similarity=0.263  Sum_probs=194.2

Q ss_pred             cCCccccc--CceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          134 EKNLIGQG--GFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       134 ~~~~LG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++++||+|  +|++||++.          ...++..||+|.+.....  ...+.+.+|+.+++.++||||++++++|..+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~   71 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLAR----------YKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD   71 (327)
T ss_pred             hhhhccccccceEEEEEEe----------ecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC
Confidence            46789999  788999965          455678899999975422  2234577899999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +..++||||+++|+|.+++.......+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++++|||.+.
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          72 NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEEecCCcEEEcccchhh
Confidence            999999999999999999865545568999999999999999999999  899999999999999999999999998754


Q ss_pred             cCCC-CCC----cccccccCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----CCcccc
Q 013028          290 FGPL-GDK----SHISTRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----GNWAKP  357 (451)
Q Consensus       290 ~~~~-~~~----~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----~~~~~~  357 (451)
                      .... ...    ........++..|+|||++.+  ..++.++|||||||++|+|++|..||........     ......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  229 (327)
T cd08227         150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  229 (327)
T ss_pred             ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccc
Confidence            2111 100    011122356778999999965  4689999999999999999999999864321100     000000


Q ss_pred             ccc------hh-----------hhhhHH---------hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          358 YLS------NK-----------LALHQI---------IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       358 ~~~------~~-----------~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..+      +.           ......         .............++.+.+|+.+||+.||++|||+.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            000      00           000000         00000001122335789999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.7e-40  Score=323.72  Aligned_cols=253  Identities=22%  Similarity=0.295  Sum_probs=197.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|.+.++||+|+||.||++.+.          .++..+|+|++.+..   ......+..|+.++..++|+||+++++++
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   70 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLK----------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF   70 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC----------CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence            37889999999999999997654          446789999986421   22234577899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+.+..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+|||
T Consensus        71 ~~~~~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          71 QDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             ecCCEEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecc
Confidence            9999999999999999999998653 3468999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIA-----TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      ++...... ........+||+.|+|||++.     ...++.++|||||||++|||++|..||......            
T Consensus       148 ~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------------  214 (332)
T cd05623         148 SCLKLMED-GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------------  214 (332)
T ss_pred             hheecccC-CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------------
Confidence            98743211 111223457999999999985     356889999999999999999999998643211            


Q ss_pred             hhhhhHHhhhhhcCCC---CHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 013028          362 KLALHQIIDEKLGRNI---QMEEAQEFAEIILRCLNSDPKN--RPTMSEVVAA  409 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  409 (451)
                       .....+.........   ....+.++.+|+.+||..+++.  |+++.+++++
T Consensus       215 -~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         215 -ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence             111112111111111   1234678999999999765544  6899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.9e-39  Score=310.31  Aligned_cols=251  Identities=28%  Similarity=0.415  Sum_probs=188.5

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      ++||+|+||.||+|.....        .....+++|.+..... .....+.+|+.+++.++|+||+++++.+.+....++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~--------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~l   72 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRG--------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLL   72 (269)
T ss_pred             CcCCccCCceEEEEEEecC--------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEE
Confidence            4699999999999875432        2345688998764332 223467889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          215 VYEYVTRGSLEDHLLNEDD---TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      ||||+++|+|.+++.....   ...++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++...
T Consensus        73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--cCEecccccHhheEecCCCcEEEecccccccc
Confidence            9999999999999865432   335678888999999999999999  89999999999999999999999999998642


Q ss_pred             CCCCCcccccccCCCCccccccccc-------cCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIA-------TGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      .............++..|+|||++.       ...++.++|||||||++|||++ |..||....+             ..
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------------~~  217 (269)
T cd05042         151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-------------EQ  217 (269)
T ss_pred             ccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-------------HH
Confidence            2211111122334567799999873       3457889999999999999999 6666643221             11


Q ss_pred             hhhHHhhhh----hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          364 ALHQIIDEK----LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       364 ~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      .+...+...    .....+...+..+.+++..|+ .||++|||+.+|++.|
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         218 VLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             HHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            111111110    111223345677888999998 5999999999999987

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.2e-39  Score=305.41  Aligned_cols=251  Identities=29%  Similarity=0.498  Sum_probs=200.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      .|++.+.||+|+||.||+|.+..           +..+|+|.+... ......+.+|++++++++||||+++++++.+..
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~-----------~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLE-----------KRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS   72 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeC-----------CCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence            67888999999999999986542           346899988643 334567889999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..++||||+++++|.+++... ...+++..+..++.+++.+|.|||+  .+++|+||||+||+++.++.++|+|||++..
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  149 (256)
T cd05112          73 PICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLES--SNVIHRDLAARNCLVGENQVVKVSDFGMTRF  149 (256)
T ss_pred             ceEEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccccceEEEcCCCeEEECCCcceee
Confidence            999999999999999988643 3468899999999999999999999  8999999999999999999999999999875


Q ss_pred             CCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          291 GPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       291 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ..... ........++..|+|||++.+..++.++||||||+++|+|++ |..||......              .+.+.+
T Consensus       150 ~~~~~-~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------------~~~~~~  214 (256)
T cd05112         150 VLDDQ-YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--------------EVVETI  214 (256)
T ss_pred             cccCc-ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--------------HHHHHH
Confidence            32211 111122334568999999988889999999999999999998 88887543211              111111


Q ss_pred             hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      ........+...+..+.+|+.+||+.+|++|||+.++++.|.
T Consensus       215 ~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         215 NAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             hCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            111111222334678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.7e-40  Score=312.30  Aligned_cols=248  Identities=25%  Similarity=0.385  Sum_probs=192.6

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLV  215 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  215 (451)
                      +.||.|+||.||+|.....+.   ........+++|.+........+.+..|+.+++.++||||+++++++..+...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~---~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGD---YGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeeccccc---ccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            469999999999987643210   01223456888888654444456788899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc--------EEEeecCC
Q 013028          216 YEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN--------AKISDFGL  287 (451)
Q Consensus       216 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~--------~kl~DFGl  287 (451)
                      |||+++|+|.+++.... ..+++..++.++.||+.||.|||+  +||+||||||+|||++.++.        ++++|||+
T Consensus        78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999999986542 368899999999999999999999  89999999999999987654        69999999


Q ss_pred             cccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCC-CccccccCCCCCCccccccchhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGK-TAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      +.....      .....++..|+|||++.+ ..++.++|||||||++|+|++|. .||......              ..
T Consensus       155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--------------~~  214 (258)
T cd05078         155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--------------KK  214 (258)
T ss_pred             ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--------------HH
Confidence            864221      123467888999999976 45799999999999999999995 443321110              00


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      ......  ....+.....++.+|+.+||+.||++|||+.++++.|+
T Consensus       215 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         215 LQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            111111  12233444578999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=325.87  Aligned_cols=241  Identities=27%  Similarity=0.338  Sum_probs=186.9

Q ss_pred             ccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc---CHHHHHHHHHHHHhc---CCCceeeccceeecCCe
Q 013028          138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ---GQDEWENELRFLSRL---NHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       138 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l---~h~nIv~~~~~~~~~~~  211 (451)
                      ||+|+||+||+|.          +..++..||||++.+....   ....+..|..++..+   .||||+++++++.+.+.
T Consensus         1 lG~G~~g~Vy~~~----------~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~   70 (330)
T cd05586           1 IGKGTFGQVYQVR----------KKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD   70 (330)
T ss_pred             CCCCCceEEEEEE----------ECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe
Confidence            7999999999965          4455778999998643221   122344566776655   69999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .|+||||+.+|+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+|||++...
T Consensus        71 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          71 LYLVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             EEEEEcCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            9999999999999998854  4678999999999999999999999  89999999999999999999999999998742


Q ss_pred             CCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID  370 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (451)
                      ..  .........||..|+|||++.+. .++.++|||||||++|+|++|..||......             .....+..
T Consensus       147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------------~~~~~i~~  211 (330)
T cd05586         147 LT--DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------------QMYRNIAF  211 (330)
T ss_pred             CC--CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------------HHHHHHHc
Confidence            21  11223456799999999998654 5899999999999999999999998643211             00111111


Q ss_pred             hhhcCCCCHHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 013028          371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRP----TMSEVVA  408 (451)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----t~~evl~  408 (451)
                      .... ......+.++.+|+.+||..||++||    ++.++++
T Consensus       212 ~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         212 GKVR-FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCCC-CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            1110 01122467899999999999999998    5666665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.4e-39  Score=307.14  Aligned_cols=251  Identities=22%  Similarity=0.388  Sum_probs=203.8

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|++.+.||+|+||.||++..          ...+..|++|.+....  .....++.+|+.+++.++|+||+++++++.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~----------~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKS----------KEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE   70 (256)
T ss_pred             CceEEEEeccCCceEEEEEEE----------cCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC
Confidence            588899999999999999654          3456789999986432  2334578899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      .+..++||||+.+++|.+++.......+++..++.++.|++.||.|||+  .+++|+||+|+|||++.++.++|+|||++
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~~  148 (256)
T cd08218          71 NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIA  148 (256)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeeccce
Confidence            9999999999999999998866555578999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ......  ........|+..|+|||++.+..++.++|+|||||++|+|++|..||......             .....+
T Consensus       149 ~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------------~~~~~~  213 (256)
T cd08218         149 RVLNST--VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-------------NLVLKI  213 (256)
T ss_pred             eecCcc--hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-------------HHHHHH
Confidence            753221  11223346888999999998888999999999999999999999987532110             111111


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .. ......+...+.++.+++.+||+.+|.+||++.+|+++
T Consensus       214 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         214 IR-GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             hc-CCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            11 11122334456789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=309.67  Aligned_cols=250  Identities=26%  Similarity=0.354  Sum_probs=208.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      -|.++.+||+|+||.||+          +.++.++..+|||.+.  .....+++..|+.||++.+.+++|++||.|....
T Consensus        34 VFDi~~KLGEGSYGSV~K----------AIH~EsG~v~AIK~VP--V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s  101 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHK----------AIHRESGHVLAIKKVP--VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS  101 (502)
T ss_pred             HHHHHHHhcCCcchHHHH----------HHHhccCcEEEEEecC--ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence            466789999999999998          7889999999999984  3456778899999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      .+++|||||..|++.|.++. ..+.++++++..+++..++||.|||.  ..-||||||..||||+.+|..||+|||.|..
T Consensus       102 DLWIVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~--~~KIHRDIKAGNILLNT~G~AKLADFGVAGQ  178 (502)
T KOG0574|consen  102 DLWIVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHD--LKKIHRDIKAGNILLNTDGIAKLADFGVAGQ  178 (502)
T ss_pred             ceEeehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHH--HHHHHhhcccccEEEcccchhhhhhccccch
Confidence            99999999999999998754 46789999999999999999999999  6789999999999999999999999999975


Q ss_pred             CCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhh
Q 013028          291 GPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID  370 (451)
Q Consensus       291 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (451)
                      ..  +.-....+.+||+.|||||++..-.|+.++||||||++..||..|++|+..-.+-..      .+..      ...
T Consensus       179 LT--DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA------IFMI------PT~  244 (502)
T KOG0574|consen  179 LT--DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA------IFMI------PTK  244 (502)
T ss_pred             hh--hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce------eEec------cCC
Confidence            32  122223467899999999999888899999999999999999999998764332100      0000      000


Q ss_pred             hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .......+...+.++-+|++.||-.+|++|-|+.+++++
T Consensus       245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            111112355668899999999999999999999999874

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=313.37  Aligned_cols=252  Identities=25%  Similarity=0.404  Sum_probs=202.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|++.+.||.|+||.||+|.+.          .++..+|+|.+........+.+.+|+++++.++|+||+++++++.++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~----------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHK----------ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE   74 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEc----------CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence            57999999999999999997653          34678999998765444556788999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++++|.+++... ...+++..+..++.|++.||.|||+  .||+|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~~~  151 (280)
T cd06611          75 NKLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSA  151 (280)
T ss_pred             CeEEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCccch
Confidence            9999999999999999988543 3468999999999999999999999  899999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIA-----TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      .....  ........|+..|+|||++.     +..++.++|+|||||++|+|++|..||......             ..
T Consensus       152 ~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------------~~  216 (280)
T cd06611         152 KNKST--LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------------RV  216 (280)
T ss_pred             hhccc--ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------------HH
Confidence            53221  11223456899999999974     345788999999999999999999998643211             00


Q ss_pred             hhHHhhhh-hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          365 LHQIIDEK-LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...+.... .....+...+.++.+++.+||..+|.+||++.++++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         217 LLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             HHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            11111100 0111223446789999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.5e-39  Score=310.84  Aligned_cols=262  Identities=22%  Similarity=0.311  Sum_probs=197.6

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|++.+.||.|++|.||+|...          .++..||||.+....  ......+.+|+.+++.++||||+++++++.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNK----------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ   70 (285)
T ss_pred             CceEeeEecccCceEEEEEEEC----------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee
Confidence            4788899999999999997643          346789999986432  2234567889999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNED-DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +...++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+  .||+|+||||+|||++.++.++|+|||+
T Consensus        71 ~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~  147 (285)
T cd07861          71 ESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGL  147 (285)
T ss_pred             CCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECcccc
Confidence            999999999997 58888875433 3678999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-------------CC
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-------------GN  353 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-------------~~  353 (451)
                      +......  ........++..|+|||++.+ ..++.++|||||||++|+|++|++||........             ..
T Consensus       148 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
T cd07861         148 ARAFGIP--VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV  225 (285)
T ss_pred             eeecCCC--cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            9753221  122233467889999998865 4578999999999999999999999865432100             00


Q ss_pred             ccccccchhhhhhHHhhhhhcC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          354 WAKPYLSNKLALHQIIDEKLGR---NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      |.  ...........+......   ......+.++.+++.+||..||.+|||+.+|++.
T Consensus       226 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         226 WP--GVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hh--cchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00  000000000000000000   0111246788999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-40  Score=325.32  Aligned_cols=261  Identities=26%  Similarity=0.341  Sum_probs=195.0

Q ss_pred             HHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccc
Q 013028          127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       127 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      .+.++|.+.+.||+|+||+||+|..          ..++..||||.+.....  .....+.+|+.+|+.++|+||+++++
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   81 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYD----------TRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD   81 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEE----------CCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhh
Confidence            4457999999999999999999764          34567899999875322  22345678999999999999999999


Q ss_pred             eeecC------CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC
Q 013028          205 YCCDD------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF  278 (451)
Q Consensus       205 ~~~~~------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~  278 (451)
                      ++...      ...|++||++ +++|.+++..   ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~~~~~  155 (343)
T cd07878          82 VFTPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDC  155 (343)
T ss_pred             hhcccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEECCCC
Confidence            88643      3468999998 7799887742   469999999999999999999999  8999999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC------
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA------  351 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~------  351 (451)
                      .+||+|||++.....     ......||..|+|||++.+ ..++.++|||||||++|+|++|..||........      
T Consensus       156 ~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  230 (343)
T cd07878         156 ELRILDFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIME  230 (343)
T ss_pred             CEEEcCCccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            999999999985322     1234578999999999876 5789999999999999999999999864321100      


Q ss_pred             --CCccccccch--hhhhhHHhhhhhcCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 --GNWAKPYLSN--KLALHQIIDEKLGRN-------IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 --~~~~~~~~~~--~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                        ..........  ........ ..+...       .....++.+.+|+.+||..||.+|||+.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         231 VVGTPSPEVLKKISSEHARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HhCCCCHHHHHhcchhhHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              0000000000  00000000 000000       001123567899999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.9e-39  Score=306.13  Aligned_cols=250  Identities=27%  Similarity=0.428  Sum_probs=202.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|++.+.||+|+||.||++...          .++..+|||.+....  ......+.+|+++++.++||||+++++.+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRK----------ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE   70 (256)
T ss_pred             CceEEEEecccCceEEEEEEEc----------CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec
Confidence            5888899999999999997643          457789999987542  2234578899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC-CcEEEeecCC
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD-FNAKISDFGL  287 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~-~~~kl~DFGl  287 (451)
                      ++..++||||+++++|.+++.......+++..+..++.+++.+|.|||+  +||+|+||+|+||+++.+ +.++|+|||+
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~~  148 (256)
T cd08220          71 DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGI  148 (256)
T ss_pred             CCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence            9999999999999999999976555668999999999999999999999  899999999999999854 4689999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +......   .......|+..|+|||.+.+..++.++||||||+++|+|++|..||......             .....
T Consensus       149 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-------------~~~~~  212 (256)
T cd08220         149 SKILSSK---SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-------------ALVLK  212 (256)
T ss_pred             ceecCCC---ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-------------HHHHH
Confidence            9854322   1222356888999999998888999999999999999999999987543211             00111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .. .......+...+..+.+++.+||..+|++|||+.|++..
T Consensus       213 ~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         213 IM-SGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             HH-hcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            11 111122334457789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.6e-39  Score=306.30  Aligned_cols=250  Identities=26%  Similarity=0.403  Sum_probs=199.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc------CHHHHHHHHHHHHhcCCCceeeccc
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ------GQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      +|...+.||.|+||.||+|...           ++..+|||.+......      ....+.+|+++++.++|+||+++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   69 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLG   69 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEee
Confidence            4788899999999999998532           3567999988643221      1245788999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      ++.+....++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          70 TCLDDNTISIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             EeecCCeEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHhEEECCCCeEEecc
Confidence            99999999999999999999999854  3468899999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCC----CCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccc
Q 013028          285 FGLAKFGPLG----DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS  360 (451)
Q Consensus       285 FGla~~~~~~----~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  360 (451)
                      ||++......    ..........|+..|+|||++.+..++.++|+|||||++|+|++|..||......           
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----------  214 (265)
T cd06631         146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-----------  214 (265)
T ss_pred             chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-----------
Confidence            9998753211    1111223456889999999998888999999999999999999999998642211           


Q ss_pred             hhhhhhHHhhh-hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          361 NKLALHQIIDE-KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       361 ~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                        ......... ......+...+.++.+++.+||..+|.+||++.++++
T Consensus       215 --~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         215 --AAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --HHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              000111111 1122334456788999999999999999999999985

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.4e-40  Score=351.36  Aligned_cols=255  Identities=23%  Similarity=0.346  Sum_probs=197.4

Q ss_pred             HHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccc
Q 013028          127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       127 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      ....+|.++++||.|+||+||++.+          ..++..||+|.+.....  .....+..|+.+|+.|+|||||++++
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkd----------k~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d   79 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKH----------KRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID   79 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEE----------CCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEE
Confidence            3456899999999999999999654          44577899999874422  23456889999999999999999999


Q ss_pred             eeec--CCeeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceeCCCCCCceeeC
Q 013028          205 YCCD--DQHRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLHTYW-----RPVIHRDVKASNVLLD  275 (451)
Q Consensus       205 ~~~~--~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~iiHrDlkp~NIll~  275 (451)
                      +|.+  ...+||||||+++|+|.++|...  ....+++..++.|+.||+.||.|||+..     ++||||||||+||||+
T Consensus        80 ~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~  159 (1021)
T PTZ00266         80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS  159 (1021)
T ss_pred             EEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence            8864  35689999999999999988542  2356999999999999999999999831     3499999999999996


Q ss_pred             C-----------------CCcEEEeecCCcccCCCCCCcccccccCCCCcccccccccc--CCCCcchhhHHHHHHHHHH
Q 013028          276 D-----------------DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVLLEI  336 (451)
Q Consensus       276 ~-----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~el  336 (451)
                      .                 .+.+||+|||++.....   ........||+.|+|||++.+  ..++.++||||||||||+|
T Consensus       160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL  236 (1021)
T PTZ00266        160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL  236 (1021)
T ss_pred             cCccccccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence            4                 23589999999975322   122334579999999999854  4588999999999999999


Q ss_pred             HhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          337 LSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       337 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ++|..||......             ..+...+..... ......+.++.+||..||..+|.+||++.|+|.
T Consensus       237 LTGk~PF~~~~~~-------------~qli~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        237 CSGKTPFHKANNF-------------SQLISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHCCCCCCcCCcH-------------HHHHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            9999998632210             011111111110 111224678999999999999999999999995

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.8e-39  Score=305.67  Aligned_cols=247  Identities=27%  Similarity=0.485  Sum_probs=199.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|++.+.||+|+||.||+|..            .+..||+|.+...  ...+.+.+|+.+++.++||||+++++++...
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~------------~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY------------TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN   71 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc------------CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence            4789999999999999998642            3566999998643  2346788999999999999999999998754


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                       ..++||||+.+++|.+++.......+++..++.++.|++.||.|||+  .|++||||||+||+++.++.++|+|||++.
T Consensus        72 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          72 -GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             -CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCccce
Confidence             47999999999999999976555678999999999999999999999  899999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHH
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      .....     ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||......              .....
T Consensus       149 ~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------------~~~~~  209 (254)
T cd05083         149 VGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--------------EVKEC  209 (254)
T ss_pred             ecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--------------HHHHH
Confidence            53211     112234567999999988889999999999999999998 88887543211              11122


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                      +........+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         210 VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            22222223334456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-39  Score=311.28  Aligned_cols=254  Identities=24%  Similarity=0.401  Sum_probs=200.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++++.||.|+||.||++.+.          .++..||+|.+.... ......+.+|++++++++|+||+++++.+..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~----------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHR----------PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI   70 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEc----------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec
Confidence            36889999999999999997643          446789999886432 2224568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNED-DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ....++||||+++++|..++.... ...+++..+..++.+++.||.|||+. .+|+|+||||+||+++.++.++|+|||+
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~  149 (286)
T cd06622          71 EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGV  149 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence            999999999999999988875421 24689999999999999999999972 4899999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccC------CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATG------HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      +.....    .......++..|+|||++.+.      .++.++|+|||||++|+|++|..||......          ..
T Consensus       150 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----------~~  215 (286)
T cd06622         150 SGNLVA----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA----------NI  215 (286)
T ss_pred             cccccC----CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh----------hH
Confidence            874321    122334678899999998543      3588999999999999999999998542211          00


Q ss_pred             hhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...+..+. .......+...+.++.+|+.+||..+|++||++.++++.
T Consensus       216 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         216 FAQLSAIV-DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             HHHHHHHh-hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            00111111 111223445577889999999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-39  Score=313.45  Aligned_cols=266  Identities=24%  Similarity=0.333  Sum_probs=207.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++.+.||+|+||+||++...          .++..||+|++.... ....+.+.+|+++++.++||||+++++++.+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~----------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHI----------PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN   74 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEc----------CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence            47888999999999999997643          346779999886543 2335678899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ....++||||+++++|.+++..  ...+++..+..++.+++.+|.|||+. .+++|+||+|+||+++.++.++|+|||++
T Consensus        75 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~  151 (284)
T cd06620          75 ENNICMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVS  151 (284)
T ss_pred             CCEEEEEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence            9999999999999999998854  35689999999999999999999973 58999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      .....    .......|+..|+|||++.+..++.++|||||||++|+|++|..||............  ...-...+..+
T Consensus       152 ~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~~  225 (284)
T cd06620         152 GELIN----SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD--PMGILDLLQQI  225 (284)
T ss_pred             cchhh----hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh--hhHHHHHHHHH
Confidence            64221    1122457899999999998889999999999999999999999998754332110000  00000111112


Q ss_pred             hhhhhcCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          369 IDEKLGRNIQ-MEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       369 ~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                      .... ....+ ...+.++.+|+.+||..||.+|||+.|+++....++.
T Consensus       226 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         226 VQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             hhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            1111 11111 2256789999999999999999999999987655443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.1e-39  Score=304.43  Aligned_cols=256  Identities=33%  Similarity=0.549  Sum_probs=203.0

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      +++.+.||.|+||.||++.+....      ......||+|.+...... ....+..|+.+++.++|+||+++++++.+.+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   74 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLS------GEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE   74 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCC------CCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            356789999999999998765421      123478999999754333 4567889999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..++||||+++++|.+++.......+++..+..++.|++.||+|||+  .+|+|+||||+||+++.++.++|+|||++..
T Consensus        75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~--~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~  152 (258)
T smart00219       75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRD  152 (258)
T ss_pred             eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc--CCeeecccccceEEEccCCeEEEcccCCcee
Confidence            99999999999999999865443338999999999999999999999  8999999999999999999999999999985


Q ss_pred             CCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          291 GPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       291 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ......... ....++..|+|||.+.+..++.++||||||+++|+|++ |.+||.....              ......+
T Consensus       153 ~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------------~~~~~~~  217 (258)
T smart00219      153 LYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------------EEVLEYL  217 (258)
T ss_pred             ccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------------HHHHHHH
Confidence            443211111 12236788999999988889999999999999999998 6777653211              1111111


Q ss_pred             hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ........+...+.++.+++.+||..||.+|||+.++++.|
T Consensus       218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      218 KKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             hcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            12222233344678899999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=318.10  Aligned_cols=265  Identities=27%  Similarity=0.454  Sum_probs=213.9

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC-HHHHHHHHHHHHhcCCCceeeccc
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      +..++...+.++||+|.||.|.+|..+.           +..||||+++...... ..+|.+|+++|.+|+||||++++|
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvG  602 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLG  602 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecC-----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEe
Confidence            4446678889999999999999987654           5679999998665444 478999999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      +|..++.+++|||||++|+|..++..+....+.-.....|+.||+.|++||.+  .++|||||.+.|+|++.++++||+|
T Consensus       603 VC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes--~nfVHrd~a~rNcLv~~e~~iKiad  680 (807)
T KOG1094|consen  603 VCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES--LNFVHRDLATRNCLVDGEFTIKIAD  680 (807)
T ss_pred             eeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh--hchhhccccccceeecCcccEEecC
Confidence            99999999999999999999999977644334555667899999999999999  7999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh--CCCccccccCCCCCCccccccchh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS--GKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt--g~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      ||+++-.-.++........+-...|||+|.+.-++++.++|+|+||+++||+++  ...|+...+.+..          .
T Consensus       681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v----------v  750 (807)
T KOG1094|consen  681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV----------V  750 (807)
T ss_pred             cccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH----------H
Confidence            999995444555555545556678999999999999999999999999999875  4456654433211          1


Q ss_pred             hhhhHHhhhhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          363 LALHQIIDEKLG---RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       363 ~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      ++...+++..-.   ...+..++.++.+|+..||..+-++||+++++...|+..
T Consensus       751 en~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  751 ENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            112222221111   123556688999999999999999999999999988764

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-40  Score=327.09  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=213.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ...+.++||+|.||+|+.|.|...       ..+...||||.+...... ...+|.+|+.+|..|+|+|++++||+..+ 
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~p-------sgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-  182 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQP-------SGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-  182 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCC-------CCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence            455678999999999999999753       234567999999865544 56889999999999999999999999987 


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ....||||+++.|+|.+.|.......|.......++.||+.|+.||.+  ++.|||||...|+||.....+||+||||.+
T Consensus       183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeeccccee
Confidence            677899999999999999987566778889999999999999999999  899999999999999988899999999999


Q ss_pred             cCCCCCCccccc-ccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCC-CccccccCCCCCCccccccchhhhhhH
Q 013028          290 FGPLGDKSHIST-RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK-TAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       290 ~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      -....+....+. ...-...|+|||.|....++.++|||+|||+||||+++. -||-+..              ...+.+
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------------g~qIL~  326 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------------GIQILK  326 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------------HHHHHH
Confidence            655443333322 223356799999999999999999999999999999854 3433221              223445


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      .+|+......+..+++++++++..||..+|.+|||+..|.+.+
T Consensus       327 ~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  327 NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            5666666667888999999999999999999999999998443

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5e-39  Score=305.07  Aligned_cols=249  Identities=26%  Similarity=0.422  Sum_probs=191.7

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLV  215 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  215 (451)
                      +.||+|+||.||+|.+................+++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999876543211112233356888887644333 6778899999999999999999999988 778999


Q ss_pred             EeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC-------cEEEeecCCc
Q 013028          216 YEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF-------NAKISDFGLA  288 (451)
Q Consensus       216 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~-------~~kl~DFGla  288 (451)
                      |||+++|+|.+++.... ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++       .++|+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh--CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999986543 268999999999999999999999  8999999999999999887       7999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccC--CCCcchhhHHHHHHHHHHHhC-CCccccccCCCCCCccccccchhhhh
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATG--HLTLKTDVYSFGVVLLEILSG-KTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      .....      .....++..|+|||++.+.  .++.++|||||||++|+|++| ..||.......           .   
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-----------~---  215 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-----------K---  215 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-----------H---
Confidence            75322      2234566789999999766  789999999999999999995 55554332110           0   


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      ......  ....+......+.+++.+||..+|.+|||+.++++.|+
T Consensus       216 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         216 ERFYQD--QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHHhc--CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000100  01111222378999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.9e-39  Score=306.84  Aligned_cols=259  Identities=25%  Similarity=0.420  Sum_probs=199.1

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      |.+.+.||+|+||.||+|.+..       ...++..||||.+.....  ...+.+.+|+++++.++||||+++++++...
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~-------~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   73 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKS-------EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRS   73 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeec-------cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            5677899999999999987542       234567899999875432  2345678899999999999999999988654


Q ss_pred             C------eeEEEEeccCCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          210 Q------HRLLVYEYVTRGSLEDHLLNE----DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       210 ~------~~~lV~E~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      .      ..++++||+.+|+|.+++...    ....+++..+..++.|++.||.|||+  .||+||||||+||+++.++.
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~~~~  151 (273)
T cd05074          74 RAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMT  151 (273)
T ss_pred             CCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcCCCC
Confidence            2      237899999999998887422    12357889999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  358 (451)
                      ++|+|||+++...............++..|++||.+....++.++|||||||++|+|++ |.+||.....          
T Consensus       152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----------  221 (273)
T cd05074         152 VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----------  221 (273)
T ss_pred             EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----------
Confidence            99999999985432221111223345667999999988889999999999999999999 7777653221          


Q ss_pred             cchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                          ..+...+........+...+..+.+++.+||+.+|++||++.+++..|+++
T Consensus       222 ----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         222 ----SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ----HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                011111111111122334567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.9e-39  Score=311.27  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=198.9

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      ....|++.+.||.|+||.||+|...          ..+..+|+|++.... .....+..|+.++..+ +|+||+++++++
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~----------~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   82 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHV----------KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAF   82 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEc----------CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence            3468999999999999999997643          446789999986432 3345678899999998 599999999998


Q ss_pred             ec------CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          207 CD------DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       207 ~~------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      ..      ....++||||+.+|+|.+++.......+++..+..++.||+.||.|||+  .||+|+||+|+||++++++.+
T Consensus        83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA--HKVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCE
Confidence            53      4678999999999999999876555678899999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA-----TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWA  355 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~  355 (451)
                      +|+|||++......  ........|+..|+|||++.     +..++.++|||||||++|+|++|..||......      
T Consensus       161 ~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------  232 (282)
T cd06636         161 KLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM------  232 (282)
T ss_pred             EEeeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH------
Confidence            99999998743211  11223456899999999985     356888999999999999999999998643211      


Q ss_pred             ccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          356 KPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                             ...................+.++.+||.+||..||.+|||+.|+++
T Consensus       233 -------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         233 -------RALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -------hhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                   0000111111111112234678999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5e-39  Score=306.83  Aligned_cols=254  Identities=26%  Similarity=0.454  Sum_probs=202.5

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc------CHHHHHHHHHHHHhcCCCceeeccc
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ------GQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      +|+..+.||+|+||.||+|.          +..++..||+|.+......      ..+.+.+|+.+++.++|+||+++++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~----------~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   70 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQAR----------DVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG   70 (268)
T ss_pred             CccccceecCcCceEEEEEE----------EcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhc
Confidence            47788999999999999965          3445678999998743211      2356789999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC-cEEEe
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF-NAKIS  283 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~-~~kl~  283 (451)
                      ++.+.+..++||||+.+++|.+++..  ...+++..+..++.|++.||.|||+  +||+|+||+|+||+++.++ .++|+
T Consensus        71 ~~~~~~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~  146 (268)
T cd06630          71 ATCEDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIA  146 (268)
T ss_pred             eeccCCeEEEEEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEc
Confidence            99999999999999999999999854  3568899999999999999999999  8999999999999998765 59999


Q ss_pred             ecCCcccCCCCCC--cccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          284 DFGLAKFGPLGDK--SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       284 DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      |||++........  ........|+..|+|||++.+..++.++|+|||||++|+|++|..||......          ..
T Consensus       147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----------~~  216 (268)
T cd06630         147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS----------NH  216 (268)
T ss_pred             ccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc----------ch
Confidence            9999975432211  11123356888999999998888999999999999999999999998532211          00


Q ss_pred             hhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ................+...+.++.+++.+||..+|.+|||+.++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         217 LALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            11111111122233455566788999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.8e-39  Score=307.70  Aligned_cols=251  Identities=28%  Similarity=0.407  Sum_probs=204.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ..|+..++||.|+||.||+|.+.          .++..||+|.+.... ......+.+|+.+++.++|+||+++++++.+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDN----------RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK   73 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEc----------cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            36788899999999999997644          346789999987443 2334568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||++|++|.+++..   ..+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~~  148 (277)
T cd06640          74 GTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             CCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEcccccc
Confidence            9999999999999999998853   458889999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      .......  .......++..|+|||++.+..++.++|+|||||++|+|++|..||.......              ....
T Consensus       149 ~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------------~~~~  212 (277)
T cd06640         149 GQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------------VLFL  212 (277)
T ss_pred             eeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------------Hhhh
Confidence            7533221  12233567889999999988889999999999999999999999986432210              0011


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      .............+..+.+++.+||..+|++||++.+++..--
T Consensus       213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06640         213 IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF  255 (277)
T ss_pred             hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence            1112223344556788999999999999999999999988743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.7e-39  Score=304.16  Aligned_cols=249  Identities=27%  Similarity=0.407  Sum_probs=202.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|++.+.||.|+||.||+|.+..          ++..+++|.+.....  .+.+.+|+++++.++|+||+++++++.++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~----------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~   70 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKE----------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN   70 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcC----------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC
Confidence            478999999999999999987543          357799999865422  67889999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...+++|||+.+++|.+++... ...+++..+..++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||++.
T Consensus        71 ~~~~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~  147 (256)
T cd06612          71 TDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSG  147 (256)
T ss_pred             CcEEEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEcccccch
Confidence            9999999999999999988543 4578999999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ......  .......|+..|+|||++.+..++.++||||||+++|+|++|..||........             .....
T Consensus       148 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------------~~~~~  212 (256)
T cd06612         148 QLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------------IFMIP  212 (256)
T ss_pred             hcccCc--cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-------------hhhhc
Confidence            543221  122334578899999999888899999999999999999999999864332100             00000


Q ss_pred             h-hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          370 D-EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       370 ~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      . .......+...+..+.+++.+||+.||++|||+.++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         213 NKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             cCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            0 00011122334578999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=328.03  Aligned_cols=245  Identities=29%  Similarity=0.437  Sum_probs=207.3

Q ss_pred             cccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEEEE
Q 013028          137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVY  216 (451)
Q Consensus       137 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV~  216 (451)
                      +||+|.||+||.|          ++..+...+|||-+........+-+..|+.+-++|+|.|||+++|.+..+.+.-|.|
T Consensus       582 VLGKGTYG~VYA~----------RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFM  651 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAA----------RDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFM  651 (1226)
T ss_pred             EeecCceeEEEee----------ccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEe
Confidence            5999999999994          566778889999998777776777889999999999999999999999999889999


Q ss_pred             eccCCCChhhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC-CCCcEEEeecCCcccCCC
Q 013028          217 EYVTRGSLEDHLLNEDDTEL--NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDFGLAKFGPL  293 (451)
Q Consensus       217 E~~~gg~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~-~~~~~kl~DFGla~~~~~  293 (451)
                      |-++||+|.++|...- +++  ++..+..+..||++||.|||+  +.|||||||-+|||++ -.|.+||+|||-++... 
T Consensus       652 EqVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-  727 (1226)
T KOG4279|consen  652 EQVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-  727 (1226)
T ss_pred             ecCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccchhhc-
Confidence            9999999999997653 445  788888999999999999999  8999999999999996 68899999999997532 


Q ss_pred             CCCcccccccCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          294 GDKSHISTRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       294 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                       .-..+..++.||..|||||++..  ..|+.++|||||||++.||.||++||........            ....+---
T Consensus       728 -ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------------AMFkVGmy  794 (1226)
T KOG4279|consen  728 -GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------------AMFKVGMY  794 (1226)
T ss_pred             -cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------------hhhhhcce
Confidence             23445667889999999999965  4689999999999999999999999975433211            01111112


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ...+.++...+.+++.||.+|+.+||.+||++.++|+
T Consensus       795 KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  795 KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            2356788899999999999999999999999999986

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.8e-39  Score=313.48  Aligned_cols=261  Identities=21%  Similarity=0.291  Sum_probs=188.1

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec--CCee
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD--DQHR  212 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~  212 (451)
                      +.+||+|+||+||+|...+        ...+..||+|.+....  ....+.+|+.+|+.++||||+++++++..  +...
T Consensus         6 g~~lG~G~~g~Vy~~~~~~--------~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   75 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKD--------GKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKV   75 (317)
T ss_pred             ceEeccCCCeeEEEEEecC--------CCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeE
Confidence            4689999999999987543        2345779999986432  23457789999999999999999998853  5678


Q ss_pred             EEEEeccCCCChhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee----CCCCcEE
Q 013028          213 LLVYEYVTRGSLEDHLLNE-------DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL----DDDFNAK  281 (451)
Q Consensus       213 ~lV~E~~~gg~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll----~~~~~~k  281 (451)
                      ++||||+. ++|.+++...       ....+++..+..++.||+.||.|||+  ++|+||||||+|||+    +.++.+|
T Consensus        76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~k  152 (317)
T cd07867          76 WLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVK  152 (317)
T ss_pred             EEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCCCCCcEE
Confidence            99999996 4787776321       22358899999999999999999999  899999999999999    4667899


Q ss_pred             EeecCCcccCCCCCC-cccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcc--cc
Q 013028          282 ISDFGLAKFGPLGDK-SHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWA--KP  357 (451)
Q Consensus       282 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~--~~  357 (451)
                      |+|||+++....... ........||..|+|||++.+ ..++.++|||||||++|||++|.+||............  ..
T Consensus       153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~  232 (317)
T cd07867         153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD  232 (317)
T ss_pred             EeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHH
Confidence            999999986432211 112234578999999999866 45899999999999999999999999754432110000  00


Q ss_pred             ---------------ccchh------hhhhHHhhhhh---------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013028          358 ---------------YLSNK------LALHQIIDEKL---------GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV  407 (451)
Q Consensus       358 ---------------~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  407 (451)
                                     .+...      ..+...+....         ...........+.+|+.+||..||.+|||+.|+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l  312 (317)
T cd07867         233 QLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQAL  312 (317)
T ss_pred             HHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHh
Confidence                           00000      00000000000         0000111235688999999999999999999998


Q ss_pred             H
Q 013028          408 A  408 (451)
Q Consensus       408 ~  408 (451)
                      +
T Consensus       313 ~  313 (317)
T cd07867         313 Q  313 (317)
T ss_pred             c
Confidence            6

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.5e-39  Score=315.03  Aligned_cols=261  Identities=24%  Similarity=0.355  Sum_probs=197.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|.+.++||.|+||.||+|..          ..++..||+|.+.... ......+.+|+.+++.++|+||+++++++.+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~   75 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRS----------KLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT   75 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEE----------cCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec
Confidence            4799999999999999999764          3456789999987443 2234467789999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||++ ++|.+++... ...+++..+..++.||+.||.|||+  .||+|+||||+|||++.++.++|+|||++
T Consensus        76 ~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  151 (301)
T cd07873          76 EKSLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLA  151 (301)
T ss_pred             CCeEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHHHEEECCCCcEEECcCcch
Confidence            999999999996 5898887543 3468899999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-------------CCc
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-------------GNW  354 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-------------~~~  354 (451)
                      ......  ........++..|+|||++.+ ..++.++|||||||++|+|++|.+||........             ..|
T Consensus       152 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  229 (301)
T cd07873         152 RAKSIP--TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW  229 (301)
T ss_pred             hccCCC--CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc
Confidence            743221  112233467889999999865 4578899999999999999999999865432100             000


Q ss_pred             cccccchhhhhhHHhhhhhc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          355 AKPYLSNKLALHQIIDEKLG----RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      .. ..... .....-.....    .......+..+.+||.+||+.||.+|||+.|+++
T Consensus       230 ~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         230 PG-ILSNE-EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hh-hhccc-cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00 00000 00000000000    0011223567899999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.3e-39  Score=310.20  Aligned_cols=249  Identities=28%  Similarity=0.430  Sum_probs=201.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +.|+..+.||.|+||.||+|.+..          ++..||+|.+.... ....+.+.+|+++++.++|+||+++++++.+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNR----------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK   73 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcC----------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc
Confidence            357778899999999999987543          35679999987443 2334578899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+++++|.+++..   ..+++..+..++.|++.||.|||+  +|++|+||+|+||++++++.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~  148 (277)
T cd06642          74 GTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             CCceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEcccccc
Confidence            9999999999999999998743   468899999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ......  ........|+..|+|||++.+..++.++|+|||||++|+|++|..||.......              ....
T Consensus       149 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------------~~~~  212 (277)
T cd06642         149 GQLTDT--QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------------VLFL  212 (277)
T ss_pred             ccccCc--chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------------HHhh
Confidence            753321  111223467889999999988889999999999999999999999875432210              0011


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +............+..+.+++.+||..+|++||++.+++..
T Consensus       213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         213 IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             hhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            11111222333456789999999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7e-39  Score=306.07  Aligned_cols=250  Identities=25%  Similarity=0.400  Sum_probs=196.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-----CHHHHHHHHHHHHhcCCCceeeccce
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-----GQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .|...+.||+|+||.||+|..          ..++..|++|.+......     ....+.+|+.+++.++||||++++++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~----------~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   72 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYD----------VDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC   72 (266)
T ss_pred             CccccceecCCCCEEEEEEEE----------cCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence            688899999999999999764          344678999988643221     23457889999999999999999998


Q ss_pred             eec--CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          206 CCD--DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       206 ~~~--~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      +.+  ....++||||+++++|.+++..  ...+++.....++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+
T Consensus        73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l~  148 (266)
T cd06651          73 LRDRAEKTLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLG  148 (266)
T ss_pred             EEcCCCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEc
Confidence            875  3567899999999999999854  3458899999999999999999999  899999999999999999999999


Q ss_pred             ecCCcccCCCCC-CcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchh
Q 013028          284 DFGLAKFGPLGD-KSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       284 DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      |||++....... .........++..|+|||++.+..++.++|||||||++|+|++|..||.....             .
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------------~  215 (266)
T cd06651         149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------------M  215 (266)
T ss_pred             cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------------H
Confidence            999987532211 11112234588899999999888899999999999999999999999864321             1


Q ss_pred             hhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          363 LALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ..............++......+.+++ .||..+|++||+++||++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         216 AAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            111122222222334445567788888 677789999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.6e-39  Score=306.01  Aligned_cols=254  Identities=27%  Similarity=0.391  Sum_probs=198.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++.+.....||+|+||.||+|.+          ..++..|++|.+........+.+.+|+.+++.++|+||+++++++..
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~----------~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   76 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARD----------LSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE   76 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEe----------cCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc
Confidence            34455557899999999999764          34467899999876655556678999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC-CCcEEEeec
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTEL--NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD-DFNAKISDF  285 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~-~~~~kl~DF  285 (451)
                      ++..++||||+++++|.+++.... ..+  ++..+..++.||+.||.|||+  +||+||||||+||+++. ++.++|+||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~h~dl~p~nil~~~~~~~~~l~df  153 (268)
T cd06624          77 NGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDF  153 (268)
T ss_pred             CCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCeEEEecc
Confidence            999999999999999999986532 234  788888999999999999999  89999999999999976 679999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccC--CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG--HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      |++......  ........|+..|+|||++.+.  .++.++||||||+++|+|++|..||........            
T Consensus       154 g~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~------------  219 (268)
T cd06624         154 GTSKRLAGI--NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA------------  219 (268)
T ss_pred             hhheecccC--CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh------------
Confidence            998753211  1122234678899999998653  378899999999999999999999864221100            


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .............++...++++.+++.+||..+|.+|||+.++++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         220 AMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            0000101111223444566789999999999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.6e-39  Score=311.12  Aligned_cols=257  Identities=29%  Similarity=0.395  Sum_probs=198.5

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeeccc
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMG  204 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~  204 (451)
                      ....++|++.+.||+|+||.||++..          ...+..+|+|++... ......+.+|+.+++.+ +|+||+++++
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~----------~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLN----------KKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEE----------CCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeee
Confidence            34567999999999999999999764          344677999988643 22345678899999999 6999999999


Q ss_pred             eee-----cCCeeEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC
Q 013028          205 YCC-----DDQHRLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD  277 (451)
Q Consensus       205 ~~~-----~~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~  277 (451)
                      ++.     ++...++||||++|++|.+++..  .....+++..+..++.|++.||.|||+  .+|+||||||+||+++.+
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~  160 (286)
T cd06638          83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV--NKTIHRDVKGNNILLTTE  160 (286)
T ss_pred             eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh--CCccccCCCHHhEEECCC
Confidence            874     44678999999999999988753  223568899999999999999999999  899999999999999999


Q ss_pred             CcEEEeecCCcccCCCCCCcccccccCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC
Q 013028          278 FNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA-----TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG  352 (451)
Q Consensus       278 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  352 (451)
                      +.++|+|||++......  ........|+..|+|||++.     +..++.++|||||||++|+|++|..||.......  
T Consensus       161 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--  236 (286)
T cd06638         161 GGVKLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--  236 (286)
T ss_pred             CCEEEccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--
Confidence            99999999998753321  11223456899999999874     3457899999999999999999999986432210  


Q ss_pred             CccccccchhhhhhHHhhhh-hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          353 NWAKPYLSNKLALHQIIDEK-LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                                 .+....... .....+...+..+.+|+.+||+.||++|||+.|+++.+
T Consensus       237 -----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         237 -----------ALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             -----------HHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence                       000000000 00011222356799999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.8e-39  Score=306.46  Aligned_cols=252  Identities=26%  Similarity=0.419  Sum_probs=198.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc----------CHHHHHHHHHHHHhcCCCcee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ----------GQDEWENELRFLSRLNHPNVV  200 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~il~~l~h~nIv  200 (451)
                      +|.+.+.||.|+||.||+|..          ..++..+|+|.+......          ..+.+.+|+.+++.++|+||+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~----------~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~   71 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALN----------VTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIV   71 (272)
T ss_pred             ceeecceecccCceEEEEEee----------cCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcc
Confidence            578889999999999999763          344678999988532111          123577899999999999999


Q ss_pred             eccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          201 KLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       201 ~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      ++++++...+..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+  ++++|+||+|+||+++.++.+
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~~~~~~~  147 (272)
T cd06629          72 QYLGFETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS--KGILHRDLKADNLLVDADGIC  147 (272)
T ss_pred             eEEEEeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh--CCeeecCCChhhEEEcCCCeE
Confidence            9999999999999999999999999998653  578999999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccccCC--CCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGH--LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                      +|+|||++................|+..|+|||++....  ++.++|+||||+++|+|++|..||.....          
T Consensus       148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----------  217 (272)
T cd06629         148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----------  217 (272)
T ss_pred             EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----------
Confidence            999999997533221122233456888999999986644  88999999999999999999998753211          


Q ss_pred             cchhhhhhHHhhhhhcC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          359 LSNKLALHQIIDEKLGR----NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                         ..............    ......+.++.+++.+||..+|++|||+.+++..
T Consensus       218 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         218 ---IAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ---HHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence               00111111111111    1122346789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9.1e-39  Score=304.47  Aligned_cols=255  Identities=29%  Similarity=0.428  Sum_probs=203.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++.+.||.|+||+||+|...          .++..+++|++.... ......+.+|+++++.++|+||+++++.+.+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICL----------PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV   70 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEc----------CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee
Confidence            37889999999999999997643          346679999986433 2345678899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++..++|||++++++|.+++..... ..+++..+..++.|++.||.|||+  .||+|+||+|+||++++++.++|+|||+
T Consensus        71 ~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~  148 (267)
T cd06610          71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGV  148 (267)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccch
Confidence            9999999999999999999865433 578999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCc--ccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          288 AKFGPLGDKS--HISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       288 a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      +.........  .......|+..|+|||++... .++.++|+|||||++|+|++|..||.......             .
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------------~  215 (267)
T cd06610         149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------------V  215 (267)
T ss_pred             HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-------------h
Confidence            8754332222  122345689999999998766 78999999999999999999999986432210             0


Q ss_pred             hhHHhhh---hhcCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          365 LHQIIDE---KLGRNI-QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~---~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .......   .+.... ....+..+.+++.+||..||++|||+.++++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         216 LMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             HHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            0011110   000000 12346789999999999999999999999863

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-39  Score=334.88  Aligned_cols=278  Identities=22%  Similarity=0.291  Sum_probs=191.3

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhc-----CCCcEEEEEEecc---CCCcCHHHHHHHHHHHHhcCCCce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRK-----NADFAVAVKRLRR---KGSQGQDEWENELRFLSRLNHPNV  199 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~-----~~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~nI  199 (451)
                      ...+|+++++||+|+||+||+|.+..........+     ..+...+.+.+.+   ........+.+|+.+|++++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45689999999999999999987654322111111     0011111111111   112223457899999999999999


Q ss_pred             eeccceeecCCeeEEEEeccCCCChhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC
Q 013028          200 VKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED---DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD  276 (451)
Q Consensus       200 v~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~  276 (451)
                      +++++++.+.+..|+|||++. ++|.+++....   ........+..|+.||+.||.|||+  +|||||||||+|||++.
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHRDIKLENIFLNC  302 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECC
Confidence            999999999999999999995 57877764321   1223456678899999999999999  89999999999999999


Q ss_pred             CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----
Q 013028          277 DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----  351 (451)
Q Consensus       277 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----  351 (451)
                      ++.+||+|||++....... .......+||..|+|||++.+..++.++|||||||++|||++|..++........     
T Consensus       303 ~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            9999999999998643221 1223346799999999999999999999999999999999999865443221110     


Q ss_pred             ------CCccccccchhhhhhHHhhhhhcCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 ------GNWAKPYLSNKLALHQIIDEKLGRNI---------QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ------~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                            ......+.+....+...+........         ....+..+.+++.+||+.||++|||+.|+|.+
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                  00000000000011111111000000         00124567889999999999999999999874

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=321.30  Aligned_cols=261  Identities=26%  Similarity=0.437  Sum_probs=221.6

Q ss_pred             HHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeec
Q 013028          123 GLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKL  202 (451)
Q Consensus       123 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~  202 (451)
                      +..+..+.......+||-|.||.||.|+|..+.          -.||||.++. +....++|..|..+|+.++|||+|++
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkys----------lTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqL  328 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS----------LTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQL  328 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccc----------eeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHH
Confidence            445666677888899999999999999998764          3499999974 45567889999999999999999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      +|+|..+...|||+|||..|+|.++|.......++.-..+.++.||..|++||..  +++|||||...|+|+.++..+|+
T Consensus       329 LGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk--knFIHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  329 LGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             hhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH--hhhhhhhhhhhhccccccceEEe
Confidence            9999999999999999999999999998888888888899999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCCcccccccCC---CCccccccccccCCCCcchhhHHHHHHHHHHHhCC-CccccccCCCCCCccccc
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLG---TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK-TAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~g---t~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~  358 (451)
                      +||||+++..    ...++...|   ..-|.|||-|....++.++|||+|||+|||+.|-. .|+-+             
T Consensus       407 ADFGLsRlMt----gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-------------  469 (1157)
T KOG4278|consen  407 ADFGLSRLMT----GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-------------  469 (1157)
T ss_pred             eccchhhhhc----CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-------------
Confidence            9999999743    222333333   34599999999999999999999999999999843 33221             


Q ss_pred             cchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                       -+...+.+++...+..+-+..+++.+.+|++.||+++|.+||+++|+-+.|+.+.
T Consensus       470 -idlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  470 -IDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             -ccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence             1123344566677777778889999999999999999999999999999999863

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.8e-38  Score=303.84  Aligned_cols=252  Identities=25%  Similarity=0.415  Sum_probs=188.1

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      ++||+|+||.||+|.....        .....+++|.+..... ...+.+.+|+.+++.++||||+++++.+.+....++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~--------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l   72 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTD--------TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLL   72 (268)
T ss_pred             CcCCCCcCceEEEEEEEcC--------CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEE
Confidence            3699999999999864321        2234467777664332 335678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCC
Q 013028          215 VYEYVTRGSLEDHLLNED--DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP  292 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~  292 (451)
                      ||||+++|+|.+++....  ....++..+..++.||+.||.|||+  .+|+||||||+|||++.++.++|+|||++....
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~  150 (268)
T cd05086          73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY  150 (268)
T ss_pred             EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEecccccccccC
Confidence            999999999999986532  2346677788999999999999999  899999999999999999999999999986322


Q ss_pred             CCCCcccccccCCCCcccccccccc-------CCCCcchhhHHHHHHHHHHHhC-CCccccccCCCCCCccccccchhhh
Q 013028          293 LGDKSHISTRVLGTRGYFAPEYIAT-------GHLTLKTDVYSFGVVLLEILSG-KTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       293 ~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ............++..|+|||++..       ..++.++|||||||++|||+++ ..||....+             ...
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------------~~~  217 (268)
T cd05086         151 KEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------------REV  217 (268)
T ss_pred             cchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------------HHH
Confidence            1111122234567889999999743       3457899999999999999975 555532211             111


Q ss_pred             hhHHhhhh----hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          365 LHQIIDEK----LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       365 ~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      +..++...    .........++.+.+++..|| .+|++||++.+|++.|.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         218 LNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11111111    112223335678899999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.9e-39  Score=313.02  Aligned_cols=255  Identities=25%  Similarity=0.347  Sum_probs=200.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +|.+.+.||+|+||.||++..          ..++..|++|.+.....   .....+.+|+++++.++||||+++++.+.
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~----------~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRH----------KETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE   71 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEE----------CCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence            688899999999999999764          44567899999875432   22346778999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      .+++.++||||++|++|.+++..  ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll~~~~~~~l~dfg~  147 (305)
T cd05609          72 TKRHLCMVMEYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGL  147 (305)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHEEECCCCCEEEeeCCC
Confidence            99999999999999999999854  3568999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCc-------------ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc
Q 013028          288 AKFGPLGDKS-------------HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW  354 (451)
Q Consensus       288 a~~~~~~~~~-------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  354 (451)
                      ++........             .......++..|+|||.+.+..++.++|+|||||++|+|++|..||......     
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----  222 (305)
T cd05609         148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----  222 (305)
T ss_pred             ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence            8642111000             0111245788999999998888999999999999999999999998643211     


Q ss_pred             cccccchhhhhhHHhhhhhc-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          355 AKPYLSNKLALHQIIDEKLG-RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                              ............ .......+..+.+++.+||+.||++||++.++++.|+.
T Consensus       223 --------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         223 --------ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             --------HHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence                    001111111110 11112356789999999999999999997666655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.3e-38  Score=302.71  Aligned_cols=251  Identities=27%  Similarity=0.401  Sum_probs=202.4

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|++.+.||.|+||.||++..          ..++..||+|.+.....  ...+.+..|+++++.++|+||+++++.+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~----------~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRR----------KSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID   70 (265)
T ss_pred             CceeeeeeccCCCeEEEEeee----------cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec
Confidence            478889999999999999653          44567899999864332  223567889999999999999999998754


Q ss_pred             --CCeeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCceeCCCCCCceeeCCCCc
Q 013028          209 --DQHRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLH-----TYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       209 --~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH-----~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                        +...+++|||+++++|.+++...  ....+++..++.++.||+.||.|||     +  .+|+|+||+|+||+++.++.
T Consensus        71 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--~~i~h~dl~p~nili~~~~~  148 (265)
T cd08217          71 RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG--NTVLHRDLKPANIFLDANNN  148 (265)
T ss_pred             CCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc--CcceecCCCHHHEEEecCCC
Confidence              45679999999999999998543  2467899999999999999999999     7  79999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  359 (451)
                      ++|+|||++.......  .......++..|+|||++.+..++.++|+||||+++|+|++|..||.....           
T Consensus       149 ~kl~d~g~~~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------  215 (265)
T cd08217         149 VKLGDFGLAKILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----------  215 (265)
T ss_pred             EEEecccccccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----------
Confidence            9999999998643221  113345789999999999888899999999999999999999999864321           


Q ss_pred             chhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                         ..+.+.+........+...+..+.+++.+||..+|++|||+.+|++.
T Consensus       216 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         216 ---LQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ---HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence               11112222222233445567889999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.5e-39  Score=311.50  Aligned_cols=248  Identities=26%  Similarity=0.368  Sum_probs=199.6

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      .|.....||.|+||.||++..          ..++..||||.+........+.+.+|+.+++.++|+||+++++.+..++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~   92 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATE----------KHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD   92 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEE----------CCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC
Confidence            555567899999999999654          3456789999987554445567889999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..++||||+++++|.+++..   ..+++..+..++.||+.||.|||+  ++|+||||||+||++++++.++|+|||++..
T Consensus        93 ~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~  167 (292)
T cd06658          93 ELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ  167 (292)
T ss_pred             eEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence            99999999999999998743   458899999999999999999999  8999999999999999999999999999875


Q ss_pred             CCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhh
Q 013028          291 GPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID  370 (451)
Q Consensus       291 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (451)
                      ....  ........|+..|+|||++.+..++.++||||||+++|||++|..||......             ... ..+.
T Consensus       168 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------------~~~-~~~~  231 (292)
T cd06658         168 VSKE--VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-------------QAM-RRIR  231 (292)
T ss_pred             cccc--cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------HHH-HHHH
Confidence            3221  11223456889999999998888999999999999999999999998642210             000 0111


Q ss_pred             hhhcCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          371 EKLGRN--IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       371 ~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ......  .....+..+.+++.+||..||.+|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         232 DNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             hcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111111  112345679999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.3e-38  Score=304.02  Aligned_cols=252  Identities=25%  Similarity=0.353  Sum_probs=198.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--Cc---CHHHHHHHHHHHHhcCCCceeeccc
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQ---GQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~---~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      ..|++.+.||+|+||.||+|...          .++..||||.+....  ..   ..+.+.+|+.+++.++|+||+++++
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~----------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   71 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDA----------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYG   71 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEc----------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEe
Confidence            37888999999999999997643          446789999886322  11   2346788999999999999999999


Q ss_pred             eeecC--CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          205 YCCDD--QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       205 ~~~~~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      ++.+.  ...++||||+++++|.+++...  ..+++..+..++.|++.||.|||+  ++|+|+||||+|||++.++.++|
T Consensus        72 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l  147 (265)
T cd06652          72 CLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKL  147 (265)
T ss_pred             EeccCCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEE
Confidence            98764  4678999999999999988543  457889999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCC-cccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          283 SDFGLAKFGPLGDK-SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       283 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      +|||++........ ........|+..|+|||++.+..++.++|||||||++|+|++|..||.....             
T Consensus       148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------------  214 (265)
T cd06652         148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-------------  214 (265)
T ss_pred             CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-------------
Confidence            99999874321111 1112335688899999999888899999999999999999999999853211             


Q ss_pred             hhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ................+...+..+.+++.+|+. +|++||+++++++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         215 MAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             HHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            111112222222233455667789999999995 99999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.5e-39  Score=310.42  Aligned_cols=246  Identities=27%  Similarity=0.345  Sum_probs=201.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++.+.||+|+||.||++.+.          ..+..||+|++....   ....+.+.+|++++++++||||+++++++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHK----------GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF   70 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEc----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE
Confidence            36889999999999999997654          346789999986432   22345678899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .++...++||||+++++|.+++..  ...+++..+..++.||+.||.|||+  .||+|+||+|+|||++.++.++|+|||
T Consensus        71 ~~~~~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          71 QDDSNLYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             EcCCeEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCC
Confidence            999999999999999999999855  3678999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++......     .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.....             .....
T Consensus       147 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------~~~~~  208 (290)
T cd05580         147 FAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------------IQIYE  208 (290)
T ss_pred             CccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------------HHHHH
Confidence            99854322     2345688999999999888899999999999999999999999864321             01111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      .+...  ...++...+..+.+++.+||..||.+|+     ++.+++++
T Consensus       209 ~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         209 KILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             HHhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            11111  1223444568899999999999999999     77777754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=7e-39  Score=308.75  Aligned_cols=262  Identities=21%  Similarity=0.292  Sum_probs=195.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|++.+.||+|+||.||+|..          ..++..||+|.+.....  .....+.+|+++++.++|+||+++++++.+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~----------~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   70 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKN----------RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS   70 (284)
T ss_pred             CceeEEEecccCCeEEEEEEE----------CCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc
Confidence            578889999999999999764          34567899999864322  223457789999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ....++||||++ ++|.+++... ...+++..+..++.||++||.|||+  ++|+|+||||+||+++.++.++|+|||++
T Consensus        71 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~  146 (284)
T cd07839          71 DKKLTLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLA  146 (284)
T ss_pred             CCceEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccchh
Confidence            999999999996 5888877543 3568999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc---cc-chhh
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP---YL-SNKL  363 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~---~~-~~~~  363 (451)
                      ......  ........++..|+|||++.+. .++.++|||||||++|+|++|..|+........ .+...   .. ....
T Consensus       147 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~  223 (284)
T cd07839         147 RAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEE  223 (284)
T ss_pred             hccCCC--CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHHHHhCCCChH
Confidence            753221  1122334678899999998664 478999999999999999999988653222100 00000   00 0000


Q ss_pred             hh---hHHhhhhhc---------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          364 AL---HQIIDEKLG---------RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       364 ~~---~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+   ....+....         .......+.++.+|+.+||..||.+|||+.++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            00   000000000         00112245788999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.8e-38  Score=305.82  Aligned_cols=264  Identities=23%  Similarity=0.320  Sum_probs=197.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++.+.||+|+||.||+|...          .++..||+|.+....  ....+.+.+|+.+++.++|+||+++++++.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~----------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   70 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNR----------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR   70 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEEC----------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe
Confidence            37889999999999999997643          446789999986432  223456788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      .+...++||||++++.|..++..  ...+++..+..++.||+.||.|||+  .||+|+||||+||+++.++.++|+|||+
T Consensus        71 ~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (286)
T cd07847          71 RKRKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGF  146 (286)
T ss_pred             eCCEEEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECcccc
Confidence            99999999999999888776643  3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--------CCcccc-
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--------GNWAKP-  357 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--------~~~~~~-  357 (451)
                      +........  ......++..|+|||++.+ ..++.++|||||||++|+|++|..||........        ..+... 
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  224 (286)
T cd07847         147 ARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH  224 (286)
T ss_pred             ceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence            985432211  2234567889999999865 5688999999999999999999999865432100        000000 


Q ss_pred             --ccchhhhhhHHhhhhhcCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          358 --YLSNKLALHQIIDEKLGRN-----IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       358 --~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                        ...................     .....+..+.+|+.+||..+|++|||+.|++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence              0000000000000000000     001235779999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-39  Score=306.67  Aligned_cols=252  Identities=28%  Similarity=0.404  Sum_probs=199.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~  207 (451)
                      +++|++.+.||.|+||.||+|...          .++..+++|++.... ...+.+.+|+.+++.+ .|+||+++++++.
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~----------~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHK----------KTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFI   73 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEEC----------CCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence            569999999999999999997643          346779999987543 3456788999999999 6999999999997


Q ss_pred             cCC------eeEEEEeccCCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          208 DDQ------HRLLVYEYVTRGSLEDHLLNED--DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       208 ~~~------~~~lV~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      +..      ..++||||+++++|.+++....  ...+++..+..++.|++.||.|||+  .+|+|+||+|+||+++.++.
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~~~~~~  151 (275)
T cd06608          74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAE  151 (275)
T ss_pred             ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEEccCCe
Confidence            544      4899999999999999886433  5678999999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCcccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW  354 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  354 (451)
                      ++|+|||++......  ........|+..|+|||++..     ..++.++|||||||++|+|++|..||......     
T Consensus       152 ~~l~d~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----  224 (275)
T cd06608         152 VKLVDFGVSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-----  224 (275)
T ss_pred             EEECCCccceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-----
Confidence            999999998753221  122234568899999998743     35778999999999999999999998632211     


Q ss_pred             cccccchhhhhhHHhhhhh-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          355 AKPYLSNKLALHQIIDEKL-GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                              ..+..+..... ....+...+..+.+|+.+||..||++|||+.++++
T Consensus       225 --------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         225 --------RALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             --------HHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                    11111111111 11112234678999999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-38  Score=301.84  Aligned_cols=248  Identities=30%  Similarity=0.438  Sum_probs=200.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-----cCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-----QGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      +|+..+.||+|+||.||+|...          .++..|++|.+.....     ...+.+.+|+.+++.++|+||++++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~   70 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNL----------DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGT   70 (258)
T ss_pred             CccccceeeecCCceEEEEEEc----------CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeee
Confidence            4777899999999999998643          3467899999865332     234568899999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.++...++||||+++++|.+++..  ...+++..+..++.||+.||.|||+  .||+|+||+|+||+++.++.++|+||
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          71 EREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             EecCCeEEEEEEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccC
Confidence            9999999999999999999999854  3468899999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCC-CCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      |++.......   ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||......             ..
T Consensus       147 ~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------------~~  210 (258)
T cd06632         147 GMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------------AA  210 (258)
T ss_pred             ccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------------HH
Confidence            9987533221   233456889999999987666 899999999999999999999998643210             00


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ............++...+..+.+++.+||+.+|.+||++.+++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         211 VFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            11111111122334445688999999999999999999999986

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=298.51  Aligned_cols=257  Identities=22%  Similarity=0.367  Sum_probs=204.5

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~l  214 (451)
                      +.||+|+|+.|--+          ....++..+|||++.+..-.....+.+|++++.+.+ |+||++++++|++++..||
T Consensus        84 e~LGeGAyasVqtc----------v~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL  153 (463)
T KOG0607|consen   84 ELLGEGAYASVQTC----------VSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL  153 (463)
T ss_pred             HHhcCccceeeeee----------eeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence            67999999999874          466778889999999887677788999999999997 9999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC---CcEEEeecCCcccC
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD---FNAKISDFGLAKFG  291 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~---~~~kl~DFGla~~~  291 (451)
                      |||-|.||+|..+|..  ...+++.++..+..+|+.||.|||.  +||.||||||+|||..+.   ..+|||||.++.-.
T Consensus       154 VfEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~--kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHT--KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             EEecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhh--cCcccccCCccceeecCCCCcCceeeecccccccc
Confidence            9999999999999955  5789999999999999999999999  999999999999999643   46899999998632


Q ss_pred             CCCC-----CcccccccCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          292 PLGD-----KSHISTRVLGTRGYFAPEYIA-----TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       292 ~~~~-----~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      ....     ......+.+|+..|||||+..     ...|+.+.|.||||||||.||+|.+||.+.-. .+-.|.+--.- 
T Consensus       230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg-~dCGWdrGe~C-  307 (463)
T KOG0607|consen  230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG-ADCGWDRGEVC-  307 (463)
T ss_pred             ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC-CcCCccCCCcc-
Confidence            1111     111223578999999999872     24689999999999999999999999987655 23333321111 


Q ss_pred             hhhhhHHhhhhhcC--CCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          362 KLALHQIIDEKLGR--NIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       362 ~~~~~~~~~~~~~~--~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ......++...-++  +++.    ..+.+..+|+..+|..|+.+|.++.++++
T Consensus       308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            11111222222222  2222    34788999999999999999999999988

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.9e-39  Score=311.54  Aligned_cols=259  Identities=25%  Similarity=0.342  Sum_probs=203.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      .|.....||+|+||.||++..          ..++..||+|.+........+.+.+|+.+++.++||||+++++++..++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~----------~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~   91 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIARE----------KHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE   91 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEE----------cCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC
Confidence            344456799999999999754          3456789999987655555667889999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..++||||+++++|.+++..   ..+++..+..++.|++.||.|||+  .||+|+||||+||+++.++.++|+|||++..
T Consensus        92 ~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~  166 (297)
T cd06659          92 ELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ  166 (297)
T ss_pred             eEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence            99999999999999987743   458999999999999999999999  8999999999999999999999999999874


Q ss_pred             CCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhh
Q 013028          291 GPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID  370 (451)
Q Consensus       291 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (451)
                      ....  ........|+..|+|||++.+..++.++|||||||++|+|++|..||......             .....+..
T Consensus       167 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------------~~~~~~~~  231 (297)
T cd06659         167 ISKD--VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-------------QAMKRLRD  231 (297)
T ss_pred             cccc--cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------HHHHHHhc
Confidence            3221  11223456889999999998888999999999999999999999998643211             00001100


Q ss_pred             hh-hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          371 EK-LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       371 ~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      .. .........+..+.+++.+||+.+|++||++.++++.---.+..+.+
T Consensus       232 ~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~  281 (297)
T cd06659         232 SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPE  281 (297)
T ss_pred             cCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcc
Confidence            00 00111223456799999999999999999999999975444333333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=319.35  Aligned_cols=265  Identities=26%  Similarity=0.411  Sum_probs=218.5

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC-CCcCHHHHHHHHHHHHhcCCCceeeccc
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      +..++...+.++||.|.||.||+|++.+.      .++....||||..+.. .....+.|..|..+|+.++|||||+++|
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~------~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIG  458 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDP------EKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIG  458 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEeccc------ccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheee
Confidence            34455677788999999999999998753      2455667999998863 4555778999999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      +|.+. ..+||||+++-|.|..+|..+ ...++......++.||+.||.|||+  +..|||||...|||+....-+||+|
T Consensus       459 v~~e~-P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaD  534 (974)
T KOG4257|consen  459 VCVEQ-PMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLAD  534 (974)
T ss_pred             eeecc-ceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeecc
Confidence            99765 579999999999999999765 3568889999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      ||++++......-... ...-..-|||||-+.-..++.++|||.|||++||++. |..||.+-.+.+.            
T Consensus       535 FGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV------------  601 (974)
T KOG4257|consen  535 FGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV------------  601 (974)
T ss_pred             cchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce------------
Confidence            9999975533322211 1112346999999999999999999999999999876 8889876554311            


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                        -..+........++.+++.+..|+.+||.++|.+||++.++...|..+..
T Consensus       602 --I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  602 --IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             --EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence              12223344456778889999999999999999999999999999999866

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-39  Score=318.43  Aligned_cols=253  Identities=25%  Similarity=0.382  Sum_probs=199.8

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEecc--CCCcCHHHHHHHHHHHHhcC-CCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN-HPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~  205 (451)
                      ...|+++++||+||.+.||++...+           ...+|+|.+..  .+......|.+|+..|.+|+ |.+||++|++
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~-----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY  428 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSD-----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY  428 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCC-----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence            3579999999999999999965332           34466665542  34455677999999999997 9999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      -..+..+||||||= .-+|..+|.........| .+..+..|++.++.++|.  .||||-||||.|+|+-.+ .+||+||
T Consensus       429 Ev~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~--~gIVHSDLKPANFLlVkG-~LKLIDF  503 (677)
T KOG0596|consen  429 EVTDGYLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ--HGIVHSDLKPANFLLVKG-RLKLIDF  503 (677)
T ss_pred             eccCceEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH--hceeecCCCcccEEEEee-eEEeeee
Confidence            99999999999975 459999887654443334 677889999999999999  899999999999999875 8999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCC-----------CCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGH-----------LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW  354 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----------~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  354 (451)
                      |+|.........-.....+||..||+||.+....           .+.++||||||||||+|+.|++||....+      
T Consensus       504 GIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------  577 (677)
T KOG0596|consen  504 GIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------  577 (677)
T ss_pred             chhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------
Confidence            9998655444444455679999999999985432           45789999999999999999999974332      


Q ss_pred             cccccchhhhhhHHhhhhhcCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          355 AKPYLSNKLALHQIIDEKLGRNIQMEE-AQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                            ....+..+.+..-..+++... ..++.+++..||..||++||++.++|+.
T Consensus       578 ------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  578 ------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                  233344555554444444333 2349999999999999999999999874

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.2e-38  Score=305.30  Aligned_cols=264  Identities=23%  Similarity=0.309  Sum_probs=199.3

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|++.+.||.|+||.||+|.+.          .++..|++|++....  ......+.+|+.+++.++|+||+++++++.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~----------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDR----------ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH   70 (286)
T ss_pred             CceEEeecccCCCcEEEEEEEC----------CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence            5888999999999999997643          346789999987543  2334678899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+  .||+|+||||+||+++.++.++|+|||++
T Consensus        71 ~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~~~~~~~~~l~dfg~~  146 (286)
T cd07832          71 GSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA--NGIMHRDLKPANLLISADGVLKIADFGLA  146 (286)
T ss_pred             CCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence            99999999999 999999886543 669999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC-----c------cc
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN-----W------AK  356 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~-----~------~~  356 (451)
                      ........ .......|+..|+|||++.+ ..++.++|||||||++|+|++|.++|..........     .      .+
T Consensus       147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (286)
T cd07832         147 RLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETW  225 (286)
T ss_pred             ccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHH
Confidence            85432221 12334568899999999865 456899999999999999999977775432210000     0      00


Q ss_pred             cccchhhhhhHHhhhhhc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          357 PYLSNKLALHQIIDEKLG----RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +...+...+..+......    .......+..+.+|+.+||..+|.+|||+.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000000000000000    00111235789999999999999999999999874

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.6e-38  Score=305.97  Aligned_cols=250  Identities=26%  Similarity=0.395  Sum_probs=193.6

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHH-HHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRF-LSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~i-l~~l~h~nIv~~~~~~~~  208 (451)
                      +|++.+.||+|+||.||++.+          ..++..||+|.+..... .....+..|+.+ ++.++||||+++++++..
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~   71 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRH----------VPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR   71 (283)
T ss_pred             CceEEEEecccCCeEEEEEEE----------cCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence            688899999999999999764          44578899999875432 233455566665 566789999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceeCCCCCCceeeCCCCcEEEeec
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLHTYWR-PVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +...++||||++ |+|.+++...  ....+++..++.++.|++.||.|||+  + +++||||||+|||++.++.+||+||
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~df  148 (283)
T cd06617          72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDF  148 (283)
T ss_pred             CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeec
Confidence            999999999996 5887776432  23578999999999999999999998  6 8999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCcccccccccc----CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      |++.....   ........|+..|+|||++.+    ..++.++|+|||||++|+|++|..||......            
T Consensus       149 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------------  213 (283)
T cd06617         149 GISGYLVD---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------------  213 (283)
T ss_pred             cccccccc---ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------------
Confidence            99975321   112233568889999998854    45788999999999999999999998532110            


Q ss_pred             hhhhhHHhhhhhcCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          362 KLALHQIIDEKLGRNI-QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...+...... ..... ....+.++.+++.+||..+|++||++.++++.
T Consensus       214 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         214 FQQLKQVVEE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             HHHHHHHHhc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111122211 11111 12346789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.7e-39  Score=298.05  Aligned_cols=276  Identities=22%  Similarity=0.301  Sum_probs=205.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ...|+...+||+|.||.||++.-.++.      ....+.+|||.++....  .......+|+.+++.|+||||+.+..+|
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n------~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vf   96 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTN------DKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVF   96 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCC------cccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHH
Confidence            458999999999999999998533321      11144789999975422  2234568899999999999999999998


Q ss_pred             ec-CCeeEEEEeccCCCChhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC----C
Q 013028          207 CD-DQHRLLVYEYVTRGSLEDHLLNE---DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD----F  278 (451)
Q Consensus       207 ~~-~~~~~lV~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~----~  278 (451)
                      .. +..++|++||.+. +|+..|...   ....++...+..|+.||+.|++|||+  +=|+||||||.|||+..+    |
T Consensus        97 l~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG  173 (438)
T KOG0666|consen   97 LSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERG  173 (438)
T ss_pred             hccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccC
Confidence            87 7789999999987 888887532   23678999999999999999999999  559999999999999877    8


Q ss_pred             cEEEeecCCcccCCCCCCcc-cccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccc
Q 013028          279 NAKISDFGLAKFGPLGDKSH-ISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK  356 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~  356 (451)
                      .+||+|||+++.+...-..- .....+-|..|+|||+|.| ..|+.++|||+.|||+.||++-.+.|.....+....-  
T Consensus       174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~--  251 (438)
T KOG0666|consen  174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKN--  251 (438)
T ss_pred             eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCC--
Confidence            99999999999755432222 2234567899999999987 5799999999999999999999999987766543221  


Q ss_pred             cccch-hhhhhHH---------------------hhh-h--hcCCCC--------HHHHHHHHHHHHHccccCCCCCCCH
Q 013028          357 PYLSN-KLALHQI---------------------IDE-K--LGRNIQ--------MEEAQEFAEIILRCLNSDPKNRPTM  403 (451)
Q Consensus       357 ~~~~~-~~~~~~~---------------------~~~-~--~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPt~  403 (451)
                      +|..+ ...+.++                     +.. .  ......        ...++...+|+.+||+.||.+|.|+
T Consensus       252 Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta  331 (438)
T KOG0666|consen  252 PFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA  331 (438)
T ss_pred             CchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH
Confidence            11110 0000000                     000 0  000000        0013458899999999999999999


Q ss_pred             HHHHHHHHHhHH
Q 013028          404 SEVVAALEQLQL  415 (451)
Q Consensus       404 ~evl~~L~~~~~  415 (451)
                      .++++..=....
T Consensus       332 ~qAleh~yF~~d  343 (438)
T KOG0666|consen  332 EQALEHPYFTED  343 (438)
T ss_pred             HHHhcccccccC
Confidence            999987554443

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-40  Score=313.72  Aligned_cols=249  Identities=27%  Similarity=0.395  Sum_probs=206.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .+.|+.-++||+|+||.||-+..          +.+++-+|+|.+.+..   ........+|-+||..++.++||.+--+
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqv----------raTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA  253 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQV----------RATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA  253 (591)
T ss_pred             ccceeeeEEEecccccceeEEEE----------ecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence            35688889999999999998654          4456678888876432   2233445789999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      |+..+.+||||..|+||+|.-+|.+.....+++..+..++.+|+.||++||.  .+||.|||||+|||||+.|++.|+|+
T Consensus       254 feTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLKPeNILLDd~GhvRISDL  331 (591)
T KOG0986|consen  254 FETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLKPENILLDDHGHVRISDL  331 (591)
T ss_pred             ecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh--cceeeccCChhheeeccCCCeEeecc
Confidence            9999999999999999999999988877899999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |||+..+.+   ......+||.+|||||++.+..|+...|+|||||+||||+.|+.||....+....          +.+
T Consensus       332 GLAvei~~g---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----------eEv  398 (591)
T KOG0986|consen  332 GLAVEIPEG---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----------EEV  398 (591)
T ss_pred             ceEEecCCC---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH----------HHH
Confidence            999965433   3334459999999999999999999999999999999999999999876554221          111


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM  403 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  403 (451)
                      ...+. .....++...+++++++.+..|+.||.+|...
T Consensus       399 drr~~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  399 DRRTL-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             HHHHh-cchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence            11111 11234566778999999999999999999743

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.3e-38  Score=301.67  Aligned_cols=255  Identities=24%  Similarity=0.389  Sum_probs=200.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC----------CcCHHHHHHHHHHHHh-cCCCce
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG----------SQGQDEWENELRFLSR-LNHPNV  199 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~il~~-l~h~nI  199 (451)
                      .|++.+.||+|+||.||+|.+..         ..+..+|+|.+....          .....++.+|+.++.. ++|+||
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~---------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i   71 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKN---------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNI   71 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcC---------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCe
Confidence            37788999999999999987543         135679999875321          1122446778888865 789999


Q ss_pred             eeccceeecCCeeEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC
Q 013028          200 VKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD  277 (451)
Q Consensus       200 v~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~  277 (451)
                      +++++++.+++..++||||++|++|.+++..  .....+++..++.++.|++.+|.|||+. .+|+|+||+|+||+++.+
T Consensus        72 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~  150 (269)
T cd08528          72 VRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGED  150 (269)
T ss_pred             eeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEECCC
Confidence            9999999999999999999999999988743  2345689999999999999999999963 579999999999999999


Q ss_pred             CcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc
Q 013028          278 FNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       278 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~  357 (451)
                      +.++|+|||++.......   ......|+..|+|||++.+..++.++|+||||+++|+|++|..||......        
T Consensus       151 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------  219 (269)
T cd08528         151 DKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------  219 (269)
T ss_pred             CcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--------
Confidence            999999999997533221   334567888999999998888999999999999999999999987532210        


Q ss_pred             ccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                           .....+.............+..+.+++.+||+.||++||++.|+.++|+
T Consensus       220 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         220 -----SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -----HHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                 0011111111111111234578999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.3e-39  Score=309.27  Aligned_cols=264  Identities=23%  Similarity=0.342  Sum_probs=198.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++.++||+|+||.||+|.+.          ..+..||+|.+......  ..+.+.+|+++++.++||||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~----------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   70 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHK----------ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR   70 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEEC----------CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc
Confidence            36888999999999999997654          34678999998654322  2456788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++...++||||++++.|.++...  ...+++..+..++.|++.||.|||+  .+|+|+||+|+||++++++.++|+|||+
T Consensus        71 ~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~~~~~~~~l~dfg~  146 (286)
T cd07846          71 RKKRLYLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGF  146 (286)
T ss_pred             cCCeEEEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCcEEEEeeee
Confidence            99999999999999888877643  3458999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC----CCccccccchh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA----GNWAKPYLSNK  362 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~----~~~~~~~~~~~  362 (451)
                      +.......  .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||........    ..+...+....
T Consensus       147 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (286)
T cd07846         147 ARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH  224 (286)
T ss_pred             eeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhh
Confidence            87533221  22334568889999999865 4578899999999999999999988854321100    00000000000


Q ss_pred             hh---hhHHhhhhhcC---------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          363 LA---LHQIIDEKLGR---------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       363 ~~---~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..   ...+.......         ......+..+.+|+.+||..+|++||++.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            00   00000000000         0012335779999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-39  Score=321.03  Aligned_cols=250  Identities=24%  Similarity=0.362  Sum_probs=210.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--HHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ..|.+.+.||+|.|+.|.+|+++          .++..||||++.+.....  ...+.+|+++|..|+|||||+++.+.+
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~----------~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~  125 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHI----------LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE  125 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEec----------CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee
Confidence            37899999999999999997654          457789999998764433  245789999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ....+|+||||+.+|.+++++..  .....+..+..++.|+++|++|||+  ++|||||||.+||||+.+.++||+|||+
T Consensus       126 t~~~lylV~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL~~~mnikIaDfgf  201 (596)
T KOG0586|consen  126 TEATLYLVMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILLDENMNIKIADFGF  201 (596)
T ss_pred             ecceeEEEEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhh--cceeccccchhhcccccccceeeecccc
Confidence            99999999999999999999955  4566778889999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +.++.   ....-.+++|++.|.|||++.+..| ++++|+||+|++||.|++|..||++..-.....             
T Consensus       202 S~~~~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-------------  265 (596)
T KOG0586|consen  202 STFFD---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-------------  265 (596)
T ss_pred             ceeec---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc-------------
Confidence            98754   4455668899999999999998777 579999999999999999999998654431110             


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      ..+..  ...++...+.++.++++++|-.+|.+|++++++.+.-.
T Consensus       266 rvl~g--k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  266 RVLRG--KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             hheee--eecccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence            01111  12345556778999999999999999999999987543

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.1e-38  Score=307.44  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=202.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .+|.+.+.||+|+||.||+|..          ..++..|++|.+........+.+.+|+.+++.++||||+++++++..+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~----------~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~   88 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAID----------VATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG   88 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEE----------cCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence            5899999999999999999753          334667999998755445556788999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +..++||||+++++|.+++..   ..+++..+..++.|++.||.|||+  +|++|+||+|+||+++.++.++|+|||++.
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~--~gi~H~dL~p~Nili~~~~~~kL~dfg~~~  163 (293)
T cd06647          89 DELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (293)
T ss_pred             CcEEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh--CCEeeccCCHHHEEEcCCCCEEEccCccee
Confidence            999999999999999998854   357889999999999999999999  899999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ......  .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||............            ..
T Consensus       164 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------------~~  229 (293)
T cd06647         164 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------AT  229 (293)
T ss_pred             cccccc--cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------------hc
Confidence            433221  1223356888999999998888999999999999999999999998654321110000            00


Q ss_pred             hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ........+...+..+.+++.+||..+|.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000111122345679999999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.1e-38  Score=303.05  Aligned_cols=249  Identities=27%  Similarity=0.376  Sum_probs=202.4

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +|++.+.||.|+||.||+|..          ..++..||+|.+.+...   ...+.+.+|++++++++||||+++++.+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~----------~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   70 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQK----------RDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ   70 (258)
T ss_pred             CceEEEEeccCCCceEEEEEE----------ccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc
Confidence            478889999999999999754          34577899999975432   33567889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++...++||||+.|++|.+++...  ..+++..+..++.||++||.|||+  ++|+|+||+|+||++++++.++|+|||+
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          71 DEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             CCCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEEcCCCCEEEeeccc
Confidence            999999999999999999998553  578999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +.......   ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.......           ...+..
T Consensus       147 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----------~~~~~~  212 (258)
T cd05578         147 ATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----------RDQIRA  212 (258)
T ss_pred             ccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----------HHHHHH
Confidence            87533221   2234568889999999988889999999999999999999999987543210           001111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHHH
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM--SEVVA  408 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl~  408 (451)
                      .... .....+...+..+.+++.+||..||.+||++  .|+++
T Consensus       213 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         213 KQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             Hhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            1111 2223444556889999999999999999999  66553

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-38  Score=307.72  Aligned_cols=263  Identities=24%  Similarity=0.320  Sum_probs=197.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-----CHHHHHHHHHHHHhcCCCceeeccce
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-----GQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      +|.+.+.||.|+||.||+|...          .++..|+||.+......     ....+..|+++++.++|+||++++++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~----------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~   70 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDK----------ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDV   70 (298)
T ss_pred             CceeeeeeeeccccEEEEEEEC----------CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhe
Confidence            4778899999999999997654          34678999999754332     23456789999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.+++..++||||+ +++|.+++.... ..+++..+..++.||++||.|||+  +||+|+||+|+|||++.++.++|+||
T Consensus        71 ~~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          71 FGHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             eecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCChhhEEEcCCCCEEEccc
Confidence            99999999999999 889999986533 479999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC-----Ccccc--
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG-----NWAKP--  357 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~-----~~~~~--  357 (451)
                      |++.......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|.++|.........     ....+  
T Consensus       147 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~  224 (298)
T cd07841         147 GLARSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE  224 (298)
T ss_pred             eeeeeccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCch
Confidence            9998543221  12223456788999998854 56789999999999999999997776543321000     00000  


Q ss_pred             -ccchhhhhhHHhhhhhcC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          358 -YLSNKLALHQIIDEKLGR-----NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       358 -~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                       .+.....+..........     ......+..+.+++.+||..||++|||+.|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             000000000000000000     0112235789999999999999999999999983

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=307.76  Aligned_cols=263  Identities=22%  Similarity=0.313  Sum_probs=194.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++.+.||.|++|.||+|..          ..++..||||.+...... ....+.+|+++++.++|+||+++++++.+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~----------~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRS----------KLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT   74 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEE----------cCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec
Confidence            4889999999999999999764          344678999998754322 23446789999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+  .+|+|+||||+|||++.++.++|+|||++
T Consensus        75 ~~~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~  150 (291)
T cd07844          75 KKTLTLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLA  150 (291)
T ss_pred             CCeEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCHHHEEEcCCCCEEECccccc
Confidence            9999999999975 9998886543 468999999999999999999999  89999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-C-----Ccc---ccc
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-G-----NWA---KPY  358 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-~-----~~~---~~~  358 (451)
                      +......  .......++..|+|||++.+ ..++.++|||||||++|+|++|..||........ .     ...   ...
T Consensus       151 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (291)
T cd07844         151 RAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET  228 (291)
T ss_pred             cccCCCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh
Confidence            7432111  11223356788999999865 5689999999999999999999999864431000 0     000   000


Q ss_pred             cchhhhhhHHh--------hhhhcCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          359 LSNKLALHQII--------DEKLGRNI-QMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       359 ~~~~~~~~~~~--------~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      +..........        ...+.... .......+.+++.+||+.+|.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00000000000        00000000 0111267889999999999999999999886

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.8e-38  Score=299.62  Aligned_cols=251  Identities=22%  Similarity=0.408  Sum_probs=201.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|.+.+.||+|+||.||+|..+          .++..+|+|.+....  ....+.+.+|+++++.++|+||+++++.+.+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~   70 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAK----------SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE   70 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEc----------CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc
Confidence            4788899999999999997754          346679999986532  2334567899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC-cEEEeecCC
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF-NAKISDFGL  287 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~-~~kl~DFGl  287 (451)
                      ....++||||+.+++|.+++.......+++..+..++.|++.||.|||+  .+|+|+||||+||++++++ .++|+|||.
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~~  148 (257)
T cd08225          71 NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGI  148 (257)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEeccccc
Confidence            9999999999999999999876555568999999999999999999999  8999999999999998875 469999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +.....  .........|+..|+|||++.+..++.++|+||||+++|+|++|..||......             .....
T Consensus       149 ~~~~~~--~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------------~~~~~  213 (257)
T cd08225         149 ARQLND--SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-------------QLVLK  213 (257)
T ss_pred             chhccC--CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------------HHHHH
Confidence            875432  112223346888999999998888999999999999999999999987543211             01111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..... ........+..+.+++.+||..+|++|||+.+++..
T Consensus       214 ~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         214 ICQGY-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             Hhccc-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11111 112233456789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.9e-38  Score=305.85  Aligned_cols=256  Identities=29%  Similarity=0.384  Sum_probs=198.7

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeeccc
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMG  204 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~  204 (451)
                      ....++|.+.+.||.|+||.||++..          ..++..+|+|.+... ......+.+|+.+++.+ +||||+++++
T Consensus        18 ~~~~~~y~~~~~l~~g~~~~vy~~~~----------~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~   86 (291)
T cd06639          18 GDPTDTWEIIETIGKGTYGKVYKVTN----------KKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYG   86 (291)
T ss_pred             CCCCCCeEEEEEeecCCCeEEEEEEE----------CCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEE
Confidence            34567899999999999999999764          345778999998643 22345678899999999 6999999999


Q ss_pred             eeecC-----CeeEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC
Q 013028          205 YCCDD-----QHRLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD  277 (451)
Q Consensus       205 ~~~~~-----~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~  277 (451)
                      ++...     ...++||||+++++|.+++..  .....+++..+..++.|++.||.|||+  .+|+|+||||+||+++.+
T Consensus        87 ~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~nili~~~  164 (291)
T cd06639          87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNILLTTE  164 (291)
T ss_pred             EEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCC
Confidence            98753     357999999999999998753  234568999999999999999999999  899999999999999999


Q ss_pred             CcEEEeecCCcccCCCCCCcccccccCCCCccccccccccC-----CCCcchhhHHHHHHHHHHHhCCCccccccCCCCC
Q 013028          278 FNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-----HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG  352 (451)
Q Consensus       278 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  352 (451)
                      +.++|+|||++.......  .......|+..|+|||++...     .++.++|||||||++|+|++|..||......   
T Consensus       165 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---  239 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---  239 (291)
T ss_pred             CCEEEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---
Confidence            999999999987533211  112235688899999998543     3688999999999999999999998643211   


Q ss_pred             CccccccchhhhhhHHhhhh-hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          353 NWAKPYLSNKLALHQIIDEK-LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                                ..+..+.... .....+......+.+||.+||+.+|++||++.++++.
T Consensus       240 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         240 ----------KTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ----------HHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                      0011111000 0011123345679999999999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.8e-38  Score=302.92  Aligned_cols=264  Identities=22%  Similarity=0.305  Sum_probs=197.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|+..+.||.|++|.||+|..          ..++..||||.+.....  .....+.+|++++++++||||+++++++.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~----------~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   70 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARN----------KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT   70 (284)
T ss_pred             CceeeeeecCCCceEEEEEEE----------CCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc
Confidence            478889999999999999764          34567899998864322  223568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+. ++|..++.......+++..+..++.|++.||+|||+  .+++|+||+|+||+++.++.++|+|||++
T Consensus        71 ~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~~  147 (284)
T cd07860          71 ENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLA  147 (284)
T ss_pred             CCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccch
Confidence            999999999995 689888876656779999999999999999999999  89999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----------CCccc
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----------GNWAK  356 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----------~~~~~  356 (451)
                      ......  ........++..|+|||++.+. .++.++|||||||++|+|++|+.||........           ....+
T Consensus       148 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07860         148 RAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW  225 (284)
T ss_pred             hhcccC--ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence            753221  1112234568889999988664 468899999999999999999999864322100           00000


Q ss_pred             cccchhhhhhHHhhhhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          357 PYLSNKLALHQIIDEKLG---RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +...........+.....   .......+.++.++|.+||+.||.+|||+.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            000000000000000000   00011235678899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.1e-38  Score=300.86  Aligned_cols=254  Identities=26%  Similarity=0.390  Sum_probs=202.2

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +|+..+.||.|+||.||++..          ..++..+++|.+..... .....+.+|+++++.++||||+++++++..+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~----------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLH----------RPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN   71 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEE----------cCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence            677889999999999999764          34567899999875432 3345688999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+. .|++|+||||+||+++.++.++|+|||.+.
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~-~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~  149 (265)
T cd06605          72 GDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK-HKIIHRDVKPSNILVNSRGQIKLCDFGVSG  149 (265)
T ss_pred             CEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCC-CCeecCCCCHHHEEECCCCCEEEeecccch
Confidence            99999999999999999986533 6789999999999999999999984 589999999999999999999999999986


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      .....    ......++..|+|||++.+..++.++||||||+++|+|++|..||........        ..........
T Consensus       150 ~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~  217 (265)
T cd06605         150 QLVNS----LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD--------GIFELLQYIV  217 (265)
T ss_pred             hhHHH----HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc--------cHHHHHHHHh
Confidence            43211    11126788899999999888999999999999999999999999864321100        0000011111


Q ss_pred             hhhhcCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          370 DEKLGRNIQME-EAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       370 ~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .. .....+.. .+..+.++|.+||..||++|||+.+++..
T Consensus       218 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         218 NE-PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             cC-CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            11 11122222 56789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.5e-38  Score=297.83  Aligned_cols=251  Identities=31%  Similarity=0.451  Sum_probs=200.2

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|.+.+.||+|+||.||+|...          .++..|++|.+......  ....+.+|+++++.++|+||+++++++.+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~   70 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNL----------DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH   70 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEEC----------CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec
Confidence            5888899999999999997643          34678999998755443  45678899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      .+..++|+||+++++|.+++..  ...+++..+..++.+++.||.|||+  .||+|+||+|+||+++.++.++|+|||++
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~~  146 (264)
T cd06626          71 REKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCA  146 (264)
T ss_pred             CCEEEEEEecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEcccccc
Confidence            9999999999999999999854  3457889999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCccc--ccccCCCCccccccccccCC---CCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          289 KFGPLGDKSHI--STRVLGTRGYFAPEYIATGH---LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       289 ~~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~---~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      ...........  .....++..|+|||++.+..   ++.++||||||+++|+|++|..||......    +         
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~----~---------  213 (264)
T cd06626         147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----F---------  213 (264)
T ss_pred             cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch----H---------
Confidence            75432221111  12356788999999997665   889999999999999999999998643211    0         


Q ss_pred             hhhHHhhhhhcCCCCHH--HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          364 ALHQIIDEKLGRNIQME--EAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      .....+........+..  .+..+.+++.+||+.+|.+|||+.+++.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         214 QIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000111111122222  3678899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=339.86  Aligned_cols=258  Identities=25%  Similarity=0.327  Sum_probs=211.3

Q ss_pred             HHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCce
Q 013028          123 GLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNV  199 (451)
Q Consensus       123 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nI  199 (451)
                      ..+..-.++|.++++||+|+||.|.+          ++.+.++..||.|++.+.   ......-|..|-.||..-+.+-|
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~l----------Vr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wi  137 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVAL----------VRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWI  137 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEE----------EEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHH
Confidence            33445567999999999999999999          556677889999999862   23344567889999999999999


Q ss_pred             eeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          200 VKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       200 v~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      +.+.-+|.|+.++||||||++||+|..++....  .++++.+..++..|+.||+.||+  .|+|||||||+|||||..|+
T Consensus       138 v~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~--mgyVHRDiKPDNvLld~~GH  213 (1317)
T KOG0612|consen  138 VQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS--MGYVHRDIKPDNVLLDKSGH  213 (1317)
T ss_pred             HHHHHHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh--ccceeccCCcceeEecccCc
Confidence            999999999999999999999999999986543  79999999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccc----c-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA----T-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW  354 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  354 (451)
                      +||+|||.+-... .+..-.....+|||.|++||+|.    + +.|+..+|+||+||++|||+.|.+||....-      
T Consensus       214 ikLADFGsClkm~-~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------  286 (1317)
T KOG0612|consen  214 IKLADFGSCLKMD-ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------  286 (1317)
T ss_pred             EeeccchhHHhcC-CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------
Confidence            9999999986432 22233345679999999999992    3 6799999999999999999999999976432      


Q ss_pred             cccccchhhhhhHHhhhhhcCCCC--HHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 013028          355 AKPYLSNKLALHQIIDEKLGRNIQ--MEEAQEFAEIILRCLNSDPKNRPT---MSEVVAA  409 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~  409 (451)
                             .+....+++..-...+|  ...+.+..+||.+.+. +|..|..   +.++-.+
T Consensus       287 -------veTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  287 -------VETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             -------HHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence                   12223444443333334  4478999999999887 6888887   7777654

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.2e-38  Score=302.62  Aligned_cols=256  Identities=27%  Similarity=0.381  Sum_probs=199.2

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +|+..+.||.|++|.||+|...          .++..+|+|.+..... .....+.+|+++++.++||||++++++|.+.
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~----------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   71 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLK----------NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE   71 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEEC----------CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence            6788899999999999997653          3467899999875432 2346688999999999999999999988654


Q ss_pred             --CeeEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          210 --QHRLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       210 --~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                        ...++||||+++++|.+++..  .....+++..+..++.||+.||.|||+  .|++|+||+|+||+++.++.++|+||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~df  149 (287)
T cd06621          72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDF  149 (287)
T ss_pred             CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeec
Confidence              468999999999999887643  234568899999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |++......    ......++..|+|||.+.+..++.++|||||||++|+|++|..||........        ......
T Consensus       150 g~~~~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~  217 (287)
T cd06621         150 GVSGELVNS----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL--------GPIELL  217 (287)
T ss_pred             ccccccccc----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC--------ChHHHH
Confidence            998643211    11234578889999999888999999999999999999999999875422100        000001


Q ss_pred             hHHhh---hhhcCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          366 HQIID---EKLGRNI--QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       366 ~~~~~---~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ..+..   ..+....  ....++.+.+|+.+||..+|.+|||+.|+++.-
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         218 SYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             HHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence            11111   0111111  123467899999999999999999999999853

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-38  Score=300.87  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=198.6

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcC---CCceeecccee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLN---HPNVVKLMGYC  206 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~---h~nIv~~~~~~  206 (451)
                      .|++.+.||.|+||.||+|.+.          .++..|++|.+.... ......+.+|+.+++.++   ||||+++++++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~----------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~   71 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHV----------PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY   71 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEc----------CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee
Confidence            5778899999999999997643          346789999987542 334467889999999986   99999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .++...++||||+++++|.+++..   ..+++..++.++.|++.||.|||+  .||+|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          72 LKGPRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEccCC
Confidence            999999999999999999998854   368999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      ++.......  .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.........             
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------------  211 (277)
T cd06917         147 VAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------------  211 (277)
T ss_pred             ceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------------
Confidence            997643222  22234578899999998864 45789999999999999999999998643221000             


Q ss_pred             hHHhhhhhcCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          366 HQIIDEKLGRNIQM-EEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       366 ~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                       ............. ..+.++.+++.+||..||++||++.++++.
T Consensus       212 -~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         212 -MLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             -hccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence             0000000111111 145789999999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.5e-38  Score=296.95  Aligned_cols=253  Identities=30%  Similarity=0.418  Sum_probs=205.8

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +|++.+.||.|++|.||+|..          ..++..|+||++..... .....+.+|+.++..++|+||+++++++..+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~----------~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRH----------KPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE   71 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEE----------cCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence            678889999999999999764          34577899999876543 3456789999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++++|.+++...  ..+++..++.++.|++.||.|||+. .+++|+||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~-~~~~H~~l~~~ni~~~~~~~~~l~df~~~~  148 (264)
T cd06623          72 GEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK-RHIIHRDIKPSNLLINSKGEVKIADFGISK  148 (264)
T ss_pred             CeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcc-CCCccCCCCHHHEEECCCCCEEEccCccce
Confidence            9999999999999999998653  6789999999999999999999973 589999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ......  .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......          ........+.
T Consensus       149 ~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----------~~~~~~~~~~  216 (264)
T cd06623         149 VLENTL--DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP----------SFFELMQAIC  216 (264)
T ss_pred             ecccCC--CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc----------CHHHHHHHHh
Confidence            543221  1122456788999999998888999999999999999999999998654320          0001111111


Q ss_pred             hhhhcCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          370 DEKLGRNIQME-EAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       370 ~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                       .......+.. .+..+.+++.+||..+|++||++.++++.
T Consensus       217 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         217 -DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             1122223333 56789999999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9e-38  Score=300.28  Aligned_cols=249  Identities=28%  Similarity=0.423  Sum_probs=201.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +-|++.+.||.|+||.||+|...          .++..||||.+..... .....+.+|+.++..++|+||+++++++.+
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~----------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   73 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDN----------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK   73 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEEC----------CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe
Confidence            35778899999999999997643          3467899999864322 234568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+++++|.+++..   ..+++..+..++.+++.+|.|||+  .|++|+||+|+||+++.++.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~  148 (277)
T cd06641          74 DTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVA  148 (277)
T ss_pred             CCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeecccc
Confidence            9999999999999999998843   468899999999999999999999  89999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      .......  .......++..|+|||.+.+..++.++|+|||||++|+|++|..||......              .....
T Consensus       149 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------------~~~~~  212 (277)
T cd06641         149 GQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--------------KVLFL  212 (277)
T ss_pred             eecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--------------HHHHH
Confidence            7543211  1122356888999999998888899999999999999999999987532211              01111


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +............+.++.+++.+||..+|.+||++.++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         213 IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            11111222334456789999999999999999999999995

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=305.07  Aligned_cols=263  Identities=24%  Similarity=0.322  Sum_probs=199.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|++.+.||+|+||.||+|.+.          .++..|+||.+....  ....+.+.+|+++++.++|+||+++++++.+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~----------~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   71 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNK----------ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR   71 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeC----------CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence            6889999999999999997654          346789999987532  2334678899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++..++||||++++.|..+...  ...+++..+..++.|++.||.|||+  .+|+|+||+|+||++++++.++|+|||++
T Consensus        72 ~~~~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~ni~~~~~~~~kl~d~g~~  147 (288)
T cd07833          72 KGRLYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFA  147 (288)
T ss_pred             CCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEEeeecc
Confidence            9999999999988666655533  3558999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCCC--------Ccc----
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG--------NWA----  355 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~--------~~~----  355 (451)
                      ........ .......++..|+|||++.+. .++.++||||||+++|+|++|.+||.........        ...    
T Consensus       148 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (288)
T cd07833         148 RALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ  226 (288)
T ss_pred             cccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence            86443222 123346788999999999877 8899999999999999999999988643221000        000    


Q ss_pred             ccccchh-h---hhhHHh-hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          356 KPYLSNK-L---ALHQII-DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       356 ~~~~~~~-~---~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ..+..+. .   ...... ........+...+.++.+|+.+||..+|++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0000000 0   000000 000000112223688999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6.9e-38  Score=302.62  Aligned_cols=247  Identities=26%  Similarity=0.398  Sum_probs=199.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      .|...+.||.|++|.||++...          .++..+++|.+........+.+.+|+.+++.++|+||+++++++..++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~----------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~   89 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDK----------STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD   89 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEEC----------CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC
Confidence            4555679999999999997643          346789999986554444566889999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..++|+||+.|++|.+++..   ..+++..+..++.|++.||.|||+  +||+||||+|+||+++.++.++|+|||++..
T Consensus        90 ~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648          90 ELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             eEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChhhEEEcCCCcEEEcccccchh
Confidence            99999999999999998854   468899999999999999999999  8999999999999999999999999998874


Q ss_pred             CCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhh
Q 013028          291 GPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID  370 (451)
Q Consensus       291 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (451)
                      ....  ........|+..|+|||++.+..++.++|||||||++|+|++|..||......             .....+ .
T Consensus       165 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------------~~~~~~-~  228 (285)
T cd06648         165 VSKE--VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------------QAMKRI-R  228 (285)
T ss_pred             hccC--CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------------HHHHHH-H
Confidence            3221  11223356889999999998888999999999999999999999998642210             000111 1


Q ss_pred             hhhcCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          371 EKLGRN--IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       371 ~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ......  .....+..+.+++.+||..+|++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         229 DNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             hcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            111111  11224578999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=9.6e-38  Score=297.26  Aligned_cols=243  Identities=25%  Similarity=0.341  Sum_probs=197.7

Q ss_pred             ccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       138 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      ||.|+||.||++..+          .++..+++|++.....   ...+.+.+|+++++.++|+||+++++++.++...++
T Consensus         1 lg~g~~~~v~~~~~~----------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   70 (262)
T cd05572           1 LGVGGFGRVELVKVK----------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYM   70 (262)
T ss_pred             CCCCCceEEEEEEEC----------CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEE
Confidence            799999999997654          3467899999875432   234568899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCC
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG  294 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  294 (451)
                      ||||+++++|.+++..  ...+++..+..++.||+.||.|||+  .+++|+||+|+||+++.++.++|+|||++......
T Consensus        71 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          71 LMEYCLGGELWTILRD--RGLFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             EEecCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            9999999999999855  3458999999999999999999999  89999999999999999999999999999864322


Q ss_pred             CCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhc
Q 013028          295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG  374 (451)
Q Consensus       295 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (451)
                      .   ......|+..|++||++.+..++.++|+||||+++|+|++|..||.....+           .......+......
T Consensus       147 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~  212 (262)
T cd05572         147 Q---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-----------PMEIYNDILKGNGK  212 (262)
T ss_pred             c---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-----------HHHHHHHHhccCCC
Confidence            1   223457888999999998888999999999999999999999998754321           01111122221223


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 013028          375 RNIQMEEAQEFAEIILRCLNSDPKNRPT-----MSEVVA  408 (451)
Q Consensus       375 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  408 (451)
                      ...+...+.++.+++.+||..+|++||+     +.|+++
T Consensus       213 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         213 LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            3344444788999999999999999999     777766

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-38  Score=307.08  Aligned_cols=266  Identities=21%  Similarity=0.296  Sum_probs=197.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +|.+.++||+|+||.||+|.....        ..+..||||.+....   ......+.+|+.+++.++||||+++++++.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~--------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   72 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG--------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFL   72 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC--------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEe
Confidence            478889999999999999875431        257889999998633   333456788999999999999999999999


Q ss_pred             cC--CeeEEEEeccCCCChhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC----CC
Q 013028          208 DD--QHRLLVYEYVTRGSLEDHLLNE---DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DF  278 (451)
Q Consensus       208 ~~--~~~~lV~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~----~~  278 (451)
                      +.  ...++||||+++ +|.+++...   ....+++..+..++.||+.||.|||+  .+|+||||||+|||++.    ++
T Consensus        73 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~~~~~~~~~  149 (316)
T cd07842          73 EHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERG  149 (316)
T ss_pred             CCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEEcCCCCccc
Confidence            88  889999999965 777766432   22478999999999999999999999  89999999999999998    89


Q ss_pred             cEEEeecCCcccCCCCCC-cccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccc
Q 013028          279 NAKISDFGLAKFGPLGDK-SHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK  356 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~  356 (451)
                      .+||+|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|.+||...........  
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~--  227 (316)
T cd07842         150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN--  227 (316)
T ss_pred             eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccc--
Confidence            999999999985432221 111223567889999998866 4589999999999999999999999976554321000  


Q ss_pred             cccch-hhhh---------------------hHHhhhhhcCCCC-----------HHHHHHHHHHHHHccccCCCCCCCH
Q 013028          357 PYLSN-KLAL---------------------HQIIDEKLGRNIQ-----------MEEAQEFAEIILRCLNSDPKNRPTM  403 (451)
Q Consensus       357 ~~~~~-~~~~---------------------~~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~dP~~RPt~  403 (451)
                      ++... ...+                     ............+           ...+..+.+++.+||+.||++|||+
T Consensus       228 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~  307 (316)
T cd07842         228 PFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA  307 (316)
T ss_pred             hhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH
Confidence            00000 0000                     0000000000001           0234678999999999999999999


Q ss_pred             HHHHHH
Q 013028          404 SEVVAA  409 (451)
Q Consensus       404 ~evl~~  409 (451)
                      .|+++.
T Consensus       308 ~eil~~  313 (316)
T cd07842         308 EEALEH  313 (316)
T ss_pred             HHHhcC
Confidence            999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-39  Score=289.44  Aligned_cols=250  Identities=25%  Similarity=0.395  Sum_probs=196.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcC-CCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLN-HPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~  208 (451)
                      ..+.+..||.|+.|+||++.+.+          ++...|||.+.+... +..+.+...+.++..-. .|+||+++|+|..
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs----------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRS----------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcc----------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            44556789999999999976554          577899999986543 33456666777765544 8999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +..+++.||.|. ..+..++.. -..++++..+-++...+++||.||.+. ++|||||+||+|||+|+.|++||||||++
T Consensus       163 n~dV~IcMelMs-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDFGIs  239 (391)
T KOG0983|consen  163 NTDVFICMELMS-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDFGIS  239 (391)
T ss_pred             CchHHHHHHHHH-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeeccccc
Confidence            999999999983 344444433 356799999999999999999999884 78999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      .+.-   .....+...|-+.|||||.+.   ...|+.++||||||+.|+||.||..||.....+            ...+
T Consensus       240 Grlv---dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td------------Fe~l  304 (391)
T KOG0983|consen  240 GRLV---DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD------------FEVL  304 (391)
T ss_pred             ceee---cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc------------HHHH
Confidence            7532   233445567899999999994   357999999999999999999999998764322            2223


Q ss_pred             hHHhhhhhcCCCCHH--HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          366 HQIIDEKLGRNIQME--EAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..+++ ...+..+..  .++.+.+|+..||..|+.+||...++|++
T Consensus       305 tkvln-~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  305 TKVLN-EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             HHHHh-cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            33333 222222222  47899999999999999999999999874

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.7e-38  Score=301.02  Aligned_cols=243  Identities=26%  Similarity=0.330  Sum_probs=188.4

Q ss_pred             cccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--C-HHHHHHHHHHHHh---cCCCceeeccceeecCC
Q 013028          137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--G-QDEWENELRFLSR---LNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       137 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~-~~~~~~E~~il~~---l~h~nIv~~~~~~~~~~  210 (451)
                      .||+|+||.||++..          ..++..+|+|.+.+....  . ...+.+|..+++.   .+|+||+.+++++..++
T Consensus         1 ~lg~G~~g~Vy~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~   70 (279)
T cd05633           1 IIGRGGFGEVYGCRK----------ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD   70 (279)
T ss_pred             CcccCCCeEEEEEEE----------CCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC
Confidence            489999999999654          445778999998754222  1 2223445444443   46999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  .+|+|+||||+|||++.++.++|+|||++..
T Consensus        71 ~~~lv~e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          71 KLCFILDLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             eEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence            99999999999999988854  3569999999999999999999999  8999999999999999999999999999874


Q ss_pred             CCCCCCcccccccCCCCccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          291 GPLGDKSHISTRVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       291 ~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ....    ......|+..|+|||.+. +..++.++|||||||++|+|++|..||.......           ...+... 
T Consensus       147 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----------~~~~~~~-  210 (279)
T cd05633         147 FSKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----------KHEIDRM-  210 (279)
T ss_pred             cccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-----------HHHHHHH-
Confidence            3211    122346899999999986 4568999999999999999999999986532210           0011111 


Q ss_pred             hhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      ........+...+.++.+++.+||..||.+||     ++.+++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         211 TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            11112234455678899999999999999999     59888775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2e-37  Score=302.58  Aligned_cols=248  Identities=31%  Similarity=0.464  Sum_probs=196.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .+|...+.||+|+||.||+|...          .++..||+|.+.......   ...+.+|+++++.++||||+++++++
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~----------~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~   84 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDV----------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY   84 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEc----------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            47999999999999999997643          346789999986443322   24678899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++..++||||+. |+|.+++... ...+++..+..++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||
T Consensus        85 ~~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          85 LREHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             EeCCeEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEECCCCCEEEeecC
Confidence            99999999999996 5777766433 3468999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      ++.....      .....++..|+|||++.   ...++.++||||||+++|+|++|..||......             .
T Consensus       161 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-------------~  221 (307)
T cd06607         161 SASLVSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------------S  221 (307)
T ss_pred             cceecCC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-------------H
Confidence            9875321      12356788999999884   456889999999999999999999988643211             0


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ....+.............+..+.+++.+||..||++||++.+++...
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         222 ALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             HHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            00011111111111223567899999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.1e-37  Score=294.96  Aligned_cols=251  Identities=25%  Similarity=0.407  Sum_probs=205.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|.+.+.||.|+||.||++.+.          .++..|++|.+.....  .....+.+|+++++.++|+|++++++.+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~   70 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRK----------SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE   70 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEc----------CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec
Confidence            5788899999999999997643          3467899999875433  445678899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNED--DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      +...++||||+++++|.+++....  ...+++..+..++.+++.||.|||+  .|++|+||+|+||+++.++.++|+|||
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~~~~~~~~l~d~~  148 (258)
T cd08215          71 KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFG  148 (258)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHHeEEcCCCcEEECCcc
Confidence            999999999999999999886542  4679999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++.......  .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||......              ...
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------------~~~  212 (258)
T cd08215         149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------------ELA  212 (258)
T ss_pred             ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------------HHH
Confidence            997543221  2333457889999999998888999999999999999999999987543211              011


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...........+...+..+.+++.+||..+|.+|||+.++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         213 LKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1111111223344556889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.3e-37  Score=301.13  Aligned_cols=264  Identities=21%  Similarity=0.289  Sum_probs=194.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++.|.+.+.||+|+||.||+|...          .++..|++|.+...... ....+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~----------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   73 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISR----------INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH   73 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEc----------CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            358999999999999999997643          34667999998754322 2346678999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++...++||||+. ++|.+++... ...+++..+..++.|++.||.|||+  .||+|+||||+|||++.++.++|+|||+
T Consensus        74 ~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~  149 (291)
T cd07870          74 TKETLTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFGL  149 (291)
T ss_pred             cCCeEEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEEcCCCcEEEecccc
Confidence            9999999999995 6787776443 3457888889999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC---CCcc---ccccc
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA---GNWA---KPYLS  360 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~---~~~~---~~~~~  360 (451)
                      ++.....  ........++..|+|||++.+ ..++.++|||||||++|+|++|..||........   ..|.   .+...
T Consensus       150 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  227 (291)
T cd07870         150 ARAKSIP--SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED  227 (291)
T ss_pred             ccccCCC--CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence            8743221  111233457889999999865 4578899999999999999999999864332100   0000   00000


Q ss_pred             h---hhhhhHHhhhhhcCC---------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          361 N---KLALHQIIDEKLGRN---------IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       361 ~---~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      .   ...+...........         .....+..+.+++.+||..||.+|||+.|++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0   000000000000000         00112467899999999999999999999885

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.8e-38  Score=312.00  Aligned_cols=262  Identities=25%  Similarity=0.367  Sum_probs=196.7

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      +.++|++.+.||+|+||.||+|.          +..++..||||.+....  ......+.+|+.+++.++|+||++++++
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   83 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAY----------DTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV   83 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEE----------ECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeee
Confidence            45789999999999999999965          44457789999986432  2233567789999999999999999998


Q ss_pred             eecC------CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          206 CCDD------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       206 ~~~~------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      |...      ...|+||||+. ++|.+.+..    .+++..+..++.|++.||.|||+  +||+||||||+|||++.++.
T Consensus        84 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~  156 (353)
T cd07850          84 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT  156 (353)
T ss_pred             eccCCCccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCC
Confidence            8643      35799999995 588887743    28889999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----CCc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----GNW  354 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----~~~  354 (451)
                      ++|+|||++.....   ........++..|+|||++.+..++.++|||||||++|+|++|..||........     ..+
T Consensus       157 ~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  233 (353)
T cd07850         157 LKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL  233 (353)
T ss_pred             EEEccCccceeCCC---CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence            99999999985332   1223345688999999999999999999999999999999999999864321100     000


Q ss_pred             ccc---ccch----------------hhhhhHHhhhhhcC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          355 AKP---YLSN----------------KLALHQIIDEKLGR----NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       355 ~~~---~~~~----------------~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..+   +...                ...+...+......    ......+..+.+|+.+||..||.+|||+.|+|+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000   0000                00000010000000    0011346678999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.2e-37  Score=299.40  Aligned_cols=245  Identities=29%  Similarity=0.392  Sum_probs=194.0

Q ss_pred             ccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       138 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      ||+|+||+||++..+          .++..||+|.+.....   .....+.+|+++|+.++||||+++++++...+..|+
T Consensus         1 lg~g~~g~vy~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   70 (277)
T cd05577           1 LGKGGFGEVCACQVK----------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCL   70 (277)
T ss_pred             CCCCCceeEEEEEEc----------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEE
Confidence            699999999996543          4467899999864321   223446789999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCC
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG  294 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  294 (451)
                      ||||+++++|.+++.......+++..+..++.|++.||.|||+  .||+|+||+|+||+++.++.++|+|||++..... 
T Consensus        71 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-  147 (277)
T cd05577          71 VMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-  147 (277)
T ss_pred             EEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-
Confidence            9999999999999876554579999999999999999999999  8999999999999999999999999999875332 


Q ss_pred             CCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhc
Q 013028          295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG  374 (451)
Q Consensus       295 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (451)
                        ........++..|+|||++.+..++.++|||||||++|+|++|..||........          ...+..... ...
T Consensus       148 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------~~~~~~~~~-~~~  214 (277)
T cd05577         148 --GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----------KEELKRRTL-EMA  214 (277)
T ss_pred             --CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----------HHHHHhccc-ccc
Confidence              1222334678899999999888899999999999999999999999864332100          000001000 011


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 013028          375 RNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVA  408 (451)
Q Consensus       375 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  408 (451)
                      ...+...++.+.+++.+||+.||.+||     ++.++++
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         215 VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            223334578899999999999999999     6666765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.3e-37  Score=291.27  Aligned_cols=249  Identities=30%  Similarity=0.492  Sum_probs=203.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      .|+..+.||+|++|.||++...          .++..+++|++..........+.+|+.+++.++|+||+++++++....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~----------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   70 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHK----------RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD   70 (253)
T ss_pred             CceeeeeeccCCceEEEEEEEC----------CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            3778899999999999997654          346779999997655445677899999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..++++||+++++|.+++.... ..+++..+..++.|++.+|.|||+  .|++|+||+|+||++++++.++|+|||.+..
T Consensus        71 ~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~  147 (253)
T cd05122          71 ELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQ  147 (253)
T ss_pred             eEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeecccccc
Confidence            9999999999999999886532 578999999999999999999999  8999999999999999999999999999976


Q ss_pred             CCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhh
Q 013028          291 GPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID  370 (451)
Q Consensus       291 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (451)
                      ......   .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......             ....... 
T Consensus       148 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------------~~~~~~~-  210 (253)
T cd05122         148 LSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-------------KALFKIA-  210 (253)
T ss_pred             cccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-------------HHHHHHH-
Confidence            433221   33456888999999998888899999999999999999999987643211             0000111 


Q ss_pred             hhhcCCCCHHH--HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          371 EKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       371 ~~~~~~~~~~~--~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...........  +..+.+++.+||..||++|||+.++++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         211 TNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             hcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11111122222  6789999999999999999999999863

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.9e-37  Score=293.07  Aligned_cols=253  Identities=31%  Similarity=0.449  Sum_probs=205.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|...+.||+|++|.||+|...          .++..|++|.+.....  ...+.+.+|+.+++.++|+||+++++.+.+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDK----------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERD   70 (260)
T ss_pred             CceeeeEeeecCceEEEEEEEC----------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEec
Confidence            4677899999999999997654          3467899999875432  345678899999999999999999999998


Q ss_pred             C--CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          209 D--QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       209 ~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .  ...++||||+++++|.+++...  ..+++..+..++.|++.+|.|||+  .+++|+||+|+||+++.++.++|+|||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~  146 (260)
T cd06606          71 EEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFG  146 (260)
T ss_pred             CCCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEcccc
Confidence            8  8899999999999999998654  388999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      .+................++..|+|||.+.+..++.++||||||+++|+|++|..||......            .....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------------~~~~~  214 (260)
T cd06606         147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP------------MAALY  214 (260)
T ss_pred             cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------------HHHHH
Confidence            998644332211233456888999999998888999999999999999999999998643310            00111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+........++...+..+.+++.+||..||++||++.+++..
T Consensus       215 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         215 KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             hccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            1111112223444557889999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=327.21  Aligned_cols=265  Identities=26%  Similarity=0.469  Sum_probs=223.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ....+.++||.|.||.||+|.+...+       +....||||.++....+ ...+|..|..||-+++||||++|.|+...
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pg-------kre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk  701 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPG-------KREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK  701 (996)
T ss_pred             hheEEEEEEecccccceecccccCCC-------CcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence            45677899999999999999986533       34678999999865444 34679999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ..-+.||+|||++|+|+.+|+.+. +.++.-+...+++.|+.|+.||-+  +++|||||...|||++.+...|++|||++
T Consensus       702 s~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsd--m~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  702 SKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSD--MNYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             CceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhh--cCchhhhhhhhheeeccceEEEeccccce
Confidence            999999999999999999997764 669999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCC--CCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhh
Q 013028          289 KFGPLGDKSHISTRVLG--TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      +...... ....+..-|  ...|.|||.+..++++.++||||+|+++||.++ |..|+|...+.              .+
T Consensus       779 Rvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--------------dV  843 (996)
T KOG0196|consen  779 RVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------------DV  843 (996)
T ss_pred             eecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--------------HH
Confidence            9754332 122222222  357999999999999999999999999999775 88888755432              22


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      -..+...+....+.+++..|.+|++.||++|-.+||++.||+..|.++..+-.+
T Consensus       844 IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S  897 (996)
T KOG0196|consen  844 IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS  897 (996)
T ss_pred             HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence            244556666677888999999999999999999999999999999999776443

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5e-38  Score=303.58  Aligned_cols=252  Identities=29%  Similarity=0.383  Sum_probs=194.5

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcC-CCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLN-HPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~  208 (451)
                      +|...++||+|+||.||++..          ..++..||+|.+..... .....+.+|+.++.++. |+||+++++++.+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~   74 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLH----------KPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR   74 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEE----------CCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence            566678999999999999764          34567899999875432 33456788999999996 9999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          209 DQHRLLVYEYVTRGSLEDHL---LNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l---~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +...+++|||+. ++|.++.   .......+++..+..++.+++.||+|||+. .+|+||||||+|||++.++.++|+||
T Consensus        75 ~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~df  152 (288)
T cd06616          75 EGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDF  152 (288)
T ss_pred             CCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeec
Confidence            999999999985 4655543   223346799999999999999999999973 48999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccC---CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG---HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      |++......   .......|+..|+|||++.+.   .++.++|||||||++|+|++|..||.....            ..
T Consensus       153 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------------~~  217 (288)
T cd06616         153 GISGQLVDS---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS------------VF  217 (288)
T ss_pred             chhHHhccC---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch------------HH
Confidence            999753221   112234678899999999665   689999999999999999999999864321            00


Q ss_pred             hhhhHHhh---hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          363 LALHQIID---EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       363 ~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..+.....   ..+........+.++.+|+.+||+.||.+|||+.+|++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         218 DQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             HHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01111111   011111222356789999999999999999999999885

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2e-37  Score=299.12  Aligned_cols=253  Identities=28%  Similarity=0.436  Sum_probs=204.0

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ..+.|++.+.||.|+||.||+|.+.          .++..|++|.+..... ..+.+.+|+++++.++|+||+++++.+.
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~----------~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~   85 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDR----------ATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL   85 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEc----------cCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE
Confidence            3567889999999999999997654          3467799999975433 4567889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      .+...++||||+++++|.+++.... ..+++..+..++.|++.||.|||+  .||+|+||+|+||+++.++.++|+|||+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          86 VGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             ECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccch
Confidence            9999999999999999999996543 479999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +.......  .......++..|+|||++.+..++.++|+|||||++|+|++|..||......             .....
T Consensus       163 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------------~~~~~  227 (286)
T cd06614         163 AAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------------RALFL  227 (286)
T ss_pred             hhhhccch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------------HHHHH
Confidence            86433211  1123345788999999998888999999999999999999999987532211             01111


Q ss_pred             HhhhhhcC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          368 IIDEKLGR-NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       368 ~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +....... ......+..+.+++.+||+.+|.+|||+.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         228 ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             HHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11111111 1112246789999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.7e-37  Score=293.93  Aligned_cols=249  Identities=25%  Similarity=0.386  Sum_probs=203.8

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|++.++||.|+||.||++..          ..++..+++|.+.....  .....+.+|+++++.++|+||+++++++.+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~----------~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKR----------LSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD   70 (256)
T ss_pred             CceEeeeecCCCceeEEEEEE----------CCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc
Confidence            478889999999999999754          34567899999875322  234567789999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      ....++||||+++++|.+++...  ....+++..+..++.|++.||.|||+  .|++|+||+|+||+++.++.++|+|||
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~~~~~~~kl~d~g  148 (256)
T cd08530          71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLG  148 (256)
T ss_pred             CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEEecCCcEEEeecc
Confidence            99999999999999999988542  23568899999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++......    ......++..|++||.+.+..++.++|+||||+++|+|++|..||......              .+.
T Consensus       149 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------------~~~  210 (256)
T cd08530         149 ISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--------------DLR  210 (256)
T ss_pred             chhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HHH
Confidence            99864332    222356788999999998888999999999999999999999998643211              111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..+........+...+.++.+++.+||+.+|++|||+.++++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         211 YKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            2222222233445567889999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=298.42  Aligned_cols=263  Identities=21%  Similarity=0.279  Sum_probs=196.4

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      |++.++||.|++|.||+|.++          .++..||+|++.....  .....+.+|+++++.++|+||+++++++.++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~   70 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDK----------LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE   70 (283)
T ss_pred             CchheEecCCCCeEEEEEEEc----------CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC
Confidence            667899999999999997654          3467899999875432  2235678899999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +..++||||++ ++|.+++.......+++..+..++.|++.||.|||+  ++++|+||+|+||+++.++.++|+|||++.
T Consensus        71 ~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~~  147 (283)
T cd07835          71 NKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLAR  147 (283)
T ss_pred             CeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence            99999999995 689998866544578999999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----------CCcccc
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----------GNWAKP  357 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----------~~~~~~  357 (451)
                      .....  ........++..|+|||++.+. .++.++||||||+++|+|++|..||........           ....++
T Consensus       148 ~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (283)
T cd07835         148 AFGVP--VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP  225 (283)
T ss_pred             ccCCC--ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence            53221  1112233568889999988654 578999999999999999999999864322100           000000


Q ss_pred             ccchhhhhhHHhhhh---hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          358 YLSNKLALHQIIDEK---LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...........+...   .........+..+.+++.+||+.||.+|||+.|+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000000000000000   0001112234779999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=296.01  Aligned_cols=252  Identities=25%  Similarity=0.353  Sum_probs=200.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-----CcCHHHHHHHHHHHHhcCCCceeeccc
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-----SQGQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      .+|++.+.||+|+||.||+|..          ..++..||+|.+....     ......+.+|+++++.++|+||+++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~----------~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   71 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYD----------ADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYG   71 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEE----------cCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEE
Confidence            3788999999999999999763          3457789999875321     122346788999999999999999999


Q ss_pred             eeecC--CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          205 YCCDD--QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       205 ~~~~~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      ++.+.  ...++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  .||+|+||||+||+++.++.++|
T Consensus        72 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l  147 (264)
T cd06653          72 CLRDPEEKKLSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKL  147 (264)
T ss_pred             EEEcCCCCEEEEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEE
Confidence            98764  457899999999999998854  3458899999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCC-CcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          283 SDFGLAKFGPLGD-KSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       283 ~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      +|||++....... .........|+..|+|||++.+..++.++|+|||||++|+|++|..||.....             
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------  214 (264)
T cd06653         148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------------  214 (264)
T ss_pred             CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-------------
Confidence            9999997532211 11112345688999999999888899999999999999999999999863211             


Q ss_pred             hhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .....+.........++...++.+.+++.+||. +|..||++.+++.+
T Consensus       215 ~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         215 MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            111222222223344566677899999999999 57999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.2e-38  Score=302.92  Aligned_cols=264  Identities=23%  Similarity=0.304  Sum_probs=196.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +.|++.+.||.|+||.||+|.++          .++..+++|.+......  ....+.+|+.+++.++||||+++++++.
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   74 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDK----------KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV   74 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEEC----------CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEE
Confidence            47889999999999999997654          34677999998744322  2235678999999999999999999998


Q ss_pred             cC--CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          208 DD--QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       208 ~~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      ..  ...|+||||++ ++|.+++.... ..+++..+..++.|++.||.|||+  +||+|+||||+|||++.++.++|+||
T Consensus        75 ~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~~l~d~  150 (293)
T cd07843          75 GSNLDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDF  150 (293)
T ss_pred             ecCCCcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCcEEEeec
Confidence            77  88999999997 48988875532 468999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCC-------------
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-------------  351 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-------------  351 (451)
                      |++.......  .......++..|+|||++.+. .++.++|+||||+++|+|++|.+||........             
T Consensus       151 g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (293)
T cd07843         151 GLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE  228 (293)
T ss_pred             CceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence            9997543221  122334578899999998654 468999999999999999999999864332100             


Q ss_pred             CCccc--cccc-hhhhhhHHhhhhhcCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 GNWAK--PYLS-NKLALHQIIDEKLGRNIQME-EAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..|..  .+.. ....+.......+...++.. .++.+.+++.+||+.||++|||+.|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00000  0000 00000000000111112222 36779999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=316.26  Aligned_cols=244  Identities=25%  Similarity=0.307  Sum_probs=200.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~  207 (451)
                      ++.|.+...+|.|+|+.|-.+.          +..++...++|++.+....    -.+|+.++... +||||+++.+.+.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~----------~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~  386 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCE----------SSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYE  386 (612)
T ss_pred             chhhccccccCCCCccceeeee----------ccccccchhheeccccccc----cccccchhhhhcCCCcceeecceec
Confidence            5688999999999999999865          4455777999999866332    23577666655 5999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee-CCCCcEEEeecC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL-DDDFNAKISDFG  286 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll-~~~~~~kl~DFG  286 (451)
                      ++.+.|+|||++.|+.|.+.+....  .+. .++..|+.+|+.|+.|||+  +|||||||||+|||+ +..++++|+|||
T Consensus       387 ~~~~~~~v~e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrltyFG  461 (612)
T KOG0603|consen  387 DGKEIYLVMELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTYFG  461 (612)
T ss_pred             CCceeeeeehhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEEec
Confidence            9999999999999999999886532  233 7778899999999999999  899999999999999 689999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      .++..+..     ....+-|..|.|||++....|+.++||||||++||+||+|+.||.....+                .
T Consensus       462 ~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----------------~  520 (612)
T KOG0603|consen  462 FWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----------------I  520 (612)
T ss_pred             hhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----------------H
Confidence            99864432     23446688899999999999999999999999999999999999765432                1


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                      ++......+.+....++.+++|+.+||+.||.+|+++.+++..=-.
T Consensus       521 ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  521 EIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            3333333344456678999999999999999999999999875443

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.2e-37  Score=302.57  Aligned_cols=254  Identities=30%  Similarity=0.452  Sum_probs=201.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc---CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .|...+.||+|+||.||+|...          .++..||+|.+......   ....+.+|+++++.++|+|++++++++.
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~----------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   95 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDV----------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL   95 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEc----------CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            5778899999999999997643          34678999998744322   2346788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++...++||||+.| +|.+.+... ...+++..+..++.+++.||.|||+  .+|+|+||+|+||+++.++.++|+|||+
T Consensus        96 ~~~~~~lv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~  171 (317)
T cd06635          96 REHTAWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGS  171 (317)
T ss_pred             eCCeEEEEEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCC
Confidence            99999999999964 787776443 4568999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      +.....      .....|+..|+|||++.   .+.++.++|||||||++|+|++|..||.....             ...
T Consensus       172 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------------~~~  232 (317)
T cd06635         172 ASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------------MSA  232 (317)
T ss_pred             ccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-------------HHH
Confidence            874321      22356888999999973   45688999999999999999999998764221             111


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                      ...+.............+..+.+|+.+||+.+|.+||++.++++.+-.+....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            11122211112223345678999999999999999999999998776654333

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-37  Score=290.91  Aligned_cols=248  Identities=28%  Similarity=0.434  Sum_probs=202.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|++.+.||+|++|.||++...          ..+..|++|.+.....  ...+.+.+|++++.+++|+||+++++++.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNL----------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET   70 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEc----------CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe
Confidence            4788899999999999997643          3467799999976543  344678899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+++++|.+++...  ..+++..+..++.|++.+|.|||+  .||+|+||+|+||+++.++.++|+|||++
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~  146 (254)
T cd06627          71 SDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVA  146 (254)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEeccccc
Confidence            99999999999999999998543  678999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ........  ......++..|+|||.+.+..++.++||||||+++|+|++|..||......             ......
T Consensus       147 ~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-------------~~~~~~  211 (254)
T cd06627         147 TKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-------------AALFRI  211 (254)
T ss_pred             eecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-------------HHHHHH
Confidence            86432221  123456788999999998777899999999999999999999988643210             001111


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      . .......+...+..+.+++.+||..+|++|||+.+++.
T Consensus       212 ~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         212 V-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             h-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            1 11122234445688999999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.6e-37  Score=298.60  Aligned_cols=265  Identities=23%  Similarity=0.305  Sum_probs=195.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++.+.||.|++|+||+|..          ..++..||+|.+.....  .....+.+|+++++.++|+||+++++++.
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~----------~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARD----------RVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH   71 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEe----------cCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe
Confidence            4789999999999999999764          34567899999865432  22356788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC-CCcEEEeecC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD-DFNAKISDFG  286 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~-~~~~kl~DFG  286 (451)
                      ++...++||||++ ++|.+++.......+++..+..++.||+.||.|||+  ++|+|+||+|+||+++. ++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         72 SEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             cCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEcccc
Confidence            9999999999995 588888765444557888899999999999999999  89999999999999985 5679999999


Q ss_pred             CcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC-----Ccccc---
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG-----NWAKP---  357 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~-----~~~~~---  357 (451)
                      ++......  ........++..|+|||++.+ ..++.++|||||||++|+|++|.+||.........     .+..+   
T Consensus       149 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (294)
T PLN00009        149 LARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE  226 (294)
T ss_pred             cccccCCC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            99753221  112233467889999998865 46789999999999999999999998643221000     00000   


Q ss_pred             ccchhhhhhHHhhh--hhc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          358 YLSNKLALHQIIDE--KLG----RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       358 ~~~~~~~~~~~~~~--~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+.....+......  ...    .......+.++.+++.+||+.+|++||++.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000000000000  000    00112345778999999999999999999999973

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4e-37  Score=296.22  Aligned_cols=243  Identities=25%  Similarity=0.326  Sum_probs=188.5

Q ss_pred             cccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHH---HHHhcCCCceeeccceeecCC
Q 013028          137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELR---FLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       137 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~---il~~l~h~nIv~~~~~~~~~~  210 (451)
                      .||+|+||.||++.          +..++..||+|.+.+.....   ...+..|..   +++...||||+++++++.+.+
T Consensus         1 ~ig~g~~g~Vy~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~   70 (278)
T cd05606           1 IIGRGGFGEVYGCR----------KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   70 (278)
T ss_pred             CcccCCCeEEEEEE----------EecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence            48999999999965          34457789999987543221   112333433   444557999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..++||||+.||+|.+++..  ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++..
T Consensus        71 ~~~~v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          71 KLSFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             EEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            99999999999999988854  4579999999999999999999999  8999999999999999999999999999874


Q ss_pred             CCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          291 GPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       291 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ....    ......|+..|+|||++.+ ..++.++||||+||++|+|++|..||........           ...... 
T Consensus       147 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-----------~~~~~~-  210 (278)
T cd05606         147 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----------HEIDRM-  210 (278)
T ss_pred             cCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-----------HHHHHH-
Confidence            3211    1224578999999999864 4689999999999999999999999875422100           000011 


Q ss_pred             hhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      ........+...+.++.+++.+||..+|.+||     ++.++++.
T Consensus       211 ~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         211 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             hhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            11112233344578899999999999999999     99999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3e-37  Score=301.52  Aligned_cols=264  Identities=28%  Similarity=0.314  Sum_probs=194.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++.+.||.|+||.||+|.+.          .++..||+|.+......  ....+.+|+.+++.++|+||+++++++.
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDT----------TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV   76 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEEC----------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence            48999999999999999997643          45678999998743322  2234567999999999999999999987


Q ss_pred             cC--CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          208 DD--QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       208 ~~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.  +..++||||+++ +|.+++... ...+++..+..++.||+.||.|||+  .||+||||||+||+++.++.++|+||
T Consensus        77 ~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~kL~df  152 (309)
T cd07845          77 GKHLDSIFLVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADF  152 (309)
T ss_pred             cCCCCeEEEEEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECcc
Confidence            65  568999999964 888887543 3568999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----------CC
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----------GN  353 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----------~~  353 (451)
                      |++.......  .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||........           ..
T Consensus       153 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~  230 (309)
T cd07845         153 GLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE  230 (309)
T ss_pred             ceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9998543221  11223345788999999865 5689999999999999999999999864332100           00


Q ss_pred             ccccccchhhhhhHH-hhhhhcC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          354 WAKPYLSNKLALHQI-IDEKLGR---NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       354 ~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..++........... +......   ......+.++.+||.+||..||++|||+.+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000000000000000 0000000   0001136778999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=341.50  Aligned_cols=257  Identities=28%  Similarity=0.380  Sum_probs=207.8

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeecc
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLM  203 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~  203 (451)
                      ..++-++.-+.+||.|.||.||.|.          +..++...|+|-+.-..  ......+.+|+.+|..|+|||+|++|
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtav----------N~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~Yy 1300 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAV----------NLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYY 1300 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEee----------cCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccC
Confidence            3445577888999999999999966          44557778888876432  23345678999999999999999999


Q ss_pred             ceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          204 GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       204 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      |+=.+.+.++|.||||+||+|.+++..  ++-.++....-+..|++.|+.|||+  .|||||||||.||+|+.+|.+|++
T Consensus      1301 GVEvHRekv~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~--~gIVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1301 GVEVHREKVYIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHE--HGIVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred             ceeecHHHHHHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHh--cCceecCCCccceeeecCCcEEee
Confidence            999999999999999999999999843  4446666667788999999999999  899999999999999999999999


Q ss_pred             ecCCcccCCCC--CCcccccccCCCCccccccccccC---CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          284 DFGLAKFGPLG--DKSHISTRVLGTRGYFAPEYIATG---HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       284 DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                      |||.|+.....  .-...-...+||+.|||||++.+.   .-..++||||||||+.||+||+.||....+    .|+   
T Consensus      1377 DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn----e~a--- 1449 (1509)
T KOG4645|consen 1377 DFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN----EWA--- 1449 (1509)
T ss_pred             cccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc----hhH---
Confidence            99999853322  111223357899999999999663   356789999999999999999999865432    222   


Q ss_pred             cchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                            +...+...-.+.+|...+.+-.+|+.+||..||+.|.++.|++++
T Consensus      1450 ------IMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1450 ------IMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ------HHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                  223344555566777889999999999999999999999988875

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.5e-37  Score=296.80  Aligned_cols=264  Identities=20%  Similarity=0.305  Sum_probs=197.3

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +|++.++||.|++|.||+|...          .++..||||.+...... ....+.+|+.+++.++|+||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~----------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   70 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNR----------TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE   70 (284)
T ss_pred             CceEeeeeccCCceEEEEEEEC----------CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC
Confidence            4788899999999999997643          34678999998754332 345677899999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNED-DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +..++||||+++ +|.+++.... ...+++..+..++.|++.||.|||+  .|++|+||||+||++++++.++|+|||++
T Consensus        71 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~~  147 (284)
T cd07836          71 NKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLA  147 (284)
T ss_pred             CcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecchh
Confidence            999999999975 8888875432 3568999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC-----Cccccccchh
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG-----NWAKPYLSNK  362 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~-----~~~~~~~~~~  362 (451)
                      ......  ........++..|++||++.+ ..++.++|||||||++|+|++|..||.........     .+..+.....
T Consensus       148 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07836         148 RAFGIP--VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW  225 (284)
T ss_pred             hhhcCC--ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence            753221  112233457889999998865 45789999999999999999999998654321000     0000000000


Q ss_pred             hhhh--HHhhhhh-------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          363 LALH--QIIDEKL-------GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       363 ~~~~--~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..+.  ..+....       ........+..+.+++.+||+.||.+||++.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000  0000000       000112335778999999999999999999999853

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-38  Score=313.35  Aligned_cols=246  Identities=26%  Similarity=0.412  Sum_probs=195.0

Q ss_pred             CcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEec-cCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCCe
Q 013028          133 SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       133 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~  211 (451)
                      +...+||+|+|-+||+|.+...++..|-..       ||.-. ...+...+.|..|+.+|+.|+|+||+++|++|.+..+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnq-------vk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n  115 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQ-------VKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN  115 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHH-------HhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence            344789999999999987655544433221       22211 1233444788999999999999999999999998766


Q ss_pred             --eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC-CCCcEEEeecCCc
Q 013028          212 --RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDFGLA  288 (451)
Q Consensus       212 --~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~-~~~~~kl~DFGla  288 (451)
                        ..+|+|++..|+|..|+.+  .+.++...+..|++||++||.|||+....|||||||-+||+|+ ..|.+||+|+|||
T Consensus       116 ~~in~iTEL~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA  193 (632)
T KOG0584|consen  116 KTINFITELFTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA  193 (632)
T ss_pred             ceeeeeeecccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHH
Confidence              6799999999999999955  4678889999999999999999999656799999999999998 5689999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ....   ..+ ....+|||.|||||+. ...|+..+||||||++++||+|+..|+....+.                .++
T Consensus       194 tl~r---~s~-aksvIGTPEFMAPEmY-EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~----------------AQI  252 (632)
T KOG0584|consen  194 TLLR---KSH-AKSVIGTPEFMAPEMY-EENYNELVDVYAFGMCMLEMVTSEYPYSECTNP----------------AQI  252 (632)
T ss_pred             HHhh---ccc-cceeccCccccChHHH-hhhcchhhhhhhhhHHHHHHHhccCChhhhCCH----------------HHH
Confidence            8632   222 3347999999999998 488999999999999999999999998766542                233


Q ss_pred             hhhhhcCCCCHH----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          369 IDEKLGRNIQME----EAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       369 ~~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +.....+-.|..    ..+++++||.+||.. ..+|||+.|+|+.
T Consensus       253 YKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  253 YKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             HHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            333332222222    257899999999999 9999999999973

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.1e-37  Score=295.82  Aligned_cols=260  Identities=23%  Similarity=0.289  Sum_probs=191.7

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcC-CCceeeccceeecC
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLN-HPNVVKLMGYCCDD  209 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~  209 (451)
                      |++.++||.|+||.||+|..          ..++..||+|.+...... ......+|+.++.++. |+||+++++++.+.
T Consensus         1 y~~~~~lg~g~~~~v~~~~~----------~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   70 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQS----------RKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR   70 (282)
T ss_pred             CceEeeccccccceEEEEEE----------cCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC
Confidence            66788999999999999764          345678999998754222 2233457899999886 99999999999987


Q ss_pred             --CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          210 --QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       210 --~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                        +..++||||++ |+|.+.+... ...+++..+..++.|++.||.|||+  .||+|+||+|+||+++. +.++|+|||+
T Consensus        71 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~dfg~  145 (282)
T cd07831          71 KTGRLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGS  145 (282)
T ss_pred             CCCcEEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEeccc
Confidence              88999999996 5888877543 2568999999999999999999999  89999999999999999 9999999999


Q ss_pred             cccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc-chhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL-SNKLAL  365 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~  365 (451)
                      +......   .......++..|+|||++.. ..++.++|||||||++|+|++|.+||..........+..... .....+
T Consensus       146 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
T cd07831         146 CRGIYSK---PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV  222 (282)
T ss_pred             ccccccC---CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            9753321   11223567889999997644 567899999999999999999999986543211000000000 000000


Q ss_pred             hHHhhhhh--cC-----------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          366 HQIIDEKL--GR-----------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       366 ~~~~~~~~--~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...+....  ..           ......+..+.+|+.+||..+|++||++.++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         223 LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            00000000  00           0012346889999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-37  Score=294.04  Aligned_cols=246  Identities=28%  Similarity=0.398  Sum_probs=193.8

Q ss_pred             ccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       138 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      ||.|+||.||++.+.          .++..+++|.+.....   ...+.+.+|+++++.++|+||+++++.+..+...|+
T Consensus         1 lg~g~~~~vy~~~~~----------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   70 (265)
T cd05579           1 ISKGAYGRVFLAKKK----------STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYL   70 (265)
T ss_pred             CCCCCceEEEEEEEC----------CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEE
Confidence            689999999997654          3467899999875433   334568889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCC
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG  294 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  294 (451)
                      ||||+++++|.+++...  ..+++..+..++.||+.||.|||+  .+|+|+||+|+||+++.++.++|+|||++......
T Consensus        71 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          71 VMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            99999999999998653  378999999999999999999999  89999999999999999999999999998753322


Q ss_pred             CC------cccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          295 DK------SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       295 ~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ..      ........++..|+|||++.+..++.++||||||+++|+|++|..||......             .....+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------------~~~~~~  213 (265)
T cd05579         147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-------------EIFQNI  213 (265)
T ss_pred             cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-------------HHHHHH
Confidence            11      11223456788999999998888999999999999999999999998643211             011111


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      .............+..+.+++.+||+.+|++|||+..+.+.|
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         214 LNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             hcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            111111111111268899999999999999999995555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.9e-37  Score=299.18  Aligned_cols=265  Identities=21%  Similarity=0.252  Sum_probs=193.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcC-CCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLN-HPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~-h~nIv~~~~~~  206 (451)
                      ++|++.+.||+|+||.||+|.+.          .++..||||.+.....  .....+.+|+.+++.+. |+||+++++++
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~----------~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~   70 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDK----------NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVE   70 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEEC----------CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeE
Confidence            36889999999999999997654          3467899998864322  22356788999999996 69999999998


Q ss_pred             ecCCe-----eEEEEeccCCCChhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC-C
Q 013028          207 CDDQH-----RLLVYEYVTRGSLEDHLLNED---DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD-D  277 (451)
Q Consensus       207 ~~~~~-----~~lV~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~-~  277 (451)
                      ...+.     .|+||||+++ +|.+++....   ...+++..+..++.||+.||.|||+  +||+||||+|+||+++. +
T Consensus        71 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~  147 (295)
T cd07837          71 HVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQK  147 (295)
T ss_pred             eecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCC
Confidence            87665     7999999975 8888875432   3468999999999999999999999  89999999999999998 8


Q ss_pred             CcEEEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC---
Q 013028          278 FNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN---  353 (451)
Q Consensus       278 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~---  353 (451)
                      +.++|+|||++.......  .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||..........   
T Consensus       148 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~  225 (295)
T cd07837         148 GLLKIADLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF  225 (295)
T ss_pred             CeEEEeecccceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            899999999987532211  11223356788999998865 457999999999999999999999886432210000   


Q ss_pred             --cc---ccccchhhhhhHHh--hh---hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          354 --WA---KPYLSNKLALHQII--DE---KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       354 --~~---~~~~~~~~~~~~~~--~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                        ..   ...+..........  ..   ..........+.++.+||.+||..||.+||++.|++..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence              00   00000000000000  00   00000112346779999999999999999999999863

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=299.97  Aligned_cols=262  Identities=24%  Similarity=0.362  Sum_probs=204.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-----C---Cceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-----H---PNVVK  201 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----h---~nIv~  201 (451)
                      .+|.+.++||.|.|++||++++          ....+.||+|+.+- .....+....||++|++++     |   .+||+
T Consensus        78 gRY~v~rKLGWGHFSTVWLawD----------tq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~  146 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWD----------TQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQ  146 (590)
T ss_pred             ceEEEEEeccccccceeEEEee----------ccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence            6999999999999999999764          45578899999863 3334456678999999984     2   36999


Q ss_pred             ccceee----cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC-
Q 013028          202 LMGYCC----DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD-  276 (451)
Q Consensus       202 ~~~~~~----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~-  276 (451)
                      |++.|.    .+.|+|||+|++ |-+|..+|.....+.++...+..|++||+.||.|||..| ||||.||||+||||.. 
T Consensus       147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLLCST  224 (590)
T ss_pred             eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeeeecc
Confidence            999996    467999999999 779999998888889999999999999999999999974 9999999999999921 


Q ss_pred             --------------------------------------------------------------------------------
Q 013028          277 --------------------------------------------------------------------------------  276 (451)
Q Consensus       277 --------------------------------------------------------------------------------  276 (451)
                                                                                                      
T Consensus       225 e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n  304 (590)
T KOG1290|consen  225 EIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYN  304 (590)
T ss_pred             ccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 013028          277 --------------------------------------------------------------------------------  276 (451)
Q Consensus       277 --------------------------------------------------------------------------------  276 (451)
                                                                                                      
T Consensus       305 ~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~  384 (590)
T KOG1290|consen  305 NEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDI  384 (590)
T ss_pred             cccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCC
Confidence                                                                                            


Q ss_pred             -----CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC
Q 013028          277 -----DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA  351 (451)
Q Consensus       277 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  351 (451)
                           +-.+||+|||-|++..     ..++.-+.|..|+||||+.+..|+..+||||++|+++||+||...|.......-
T Consensus       385 ~~~~~di~vKIaDlGNACW~~-----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y  459 (590)
T KOG1290|consen  385 PLPECDIRVKIADLGNACWVH-----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENY  459 (590)
T ss_pred             CCCccceeEEEeeccchhhhh-----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence                 0025677777776522     223445678899999999999999999999999999999999999976544321


Q ss_pred             ------------------------CCccccccchhhhhhHHhh-------hhh--cCCCCHHHHHHHHHHHHHccccCCC
Q 013028          352 ------------------------GNWAKPYLSNKLALHQIID-------EKL--GRNIQMEEAQEFAEIILRCLNSDPK  398 (451)
Q Consensus       352 ------------------------~~~~~~~~~~~~~~~~~~~-------~~~--~~~~~~~~~~~l~~li~~cl~~dP~  398 (451)
                                              ..+.+.|+...+.+..+-.       ..+  ....+.+...++.+|+.-||+++|+
T Consensus       460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe  539 (590)
T KOG1290|consen  460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE  539 (590)
T ss_pred             CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence                                    2222333332222222110       000  1234566789999999999999999


Q ss_pred             CCCCHHHHHHH
Q 013028          399 NRPTMSEVVAA  409 (451)
Q Consensus       399 ~RPt~~evl~~  409 (451)
                      +|||+.++|+.
T Consensus       540 KR~tA~~cl~h  550 (590)
T KOG1290|consen  540 KRPTAAQCLKH  550 (590)
T ss_pred             ccccHHHHhcC
Confidence            99999999865

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.2e-37  Score=298.54  Aligned_cols=262  Identities=17%  Similarity=0.168  Sum_probs=185.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCH-H----------HHHHHHHHHHhcCCC
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-D----------EWENELRFLSRLNHP  197 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~----------~~~~E~~il~~l~h~  197 (451)
                      ..+|.+.++||+|+||+||+|.+.+..       .....+++|+......... +          ....++..+..+.|+
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~   83 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDH-------CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL   83 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCc-------ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence            358999999999999999998765421       1134466665432221111 0          112234455667899


Q ss_pred             ceeeccceeecCC----eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcee
Q 013028          198 NVVKLMGYCCDDQ----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL  273 (451)
Q Consensus       198 nIv~~~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIl  273 (451)
                      ||+++++.+....    ..+++||++. .++.+.+..  ....++..+..++.|++.||.|||+  ++|+||||||+|||
T Consensus        84 ~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nil  158 (294)
T PHA02882         84 GIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIM  158 (294)
T ss_pred             CCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEE
Confidence            9999998765443    3478888874 466666533  2346788899999999999999999  89999999999999


Q ss_pred             eCCCCcEEEeecCCcccCCCCCC-----cccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccC
Q 013028          274 LDDDFNAKISDFGLAKFGPLGDK-----SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTN  348 (451)
Q Consensus       274 l~~~~~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  348 (451)
                      ++.++.++|+|||+|+.......     ........||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus       159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            99999999999999975432111     0112234699999999999999999999999999999999999999975422


Q ss_pred             CCCCCccccccchhhh-hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          349 GLAGNWAKPYLSNKLA-LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       349 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ...  .   ....... +..+.....   .....+..+.+++..|+..+|++||++.++++.|
T Consensus       239 ~~~--~---~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        239 NGN--L---IHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             chH--H---HHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            110  0   0000000 011111111   1123367899999999999999999999999876

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.9e-37  Score=300.06  Aligned_cols=263  Identities=25%  Similarity=0.337  Sum_probs=192.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++.++||+|+||.||+|..          ..++..||||.+......  ....+.+|+++++.++||||+++++++.
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~----------~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   81 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARH----------KKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR   81 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEE----------CCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence            4799999999999999999754          345778999998643222  2234568999999999999999999987


Q ss_pred             cCC--------eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          208 DDQ--------HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       208 ~~~--------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      ...        ..++||||+. ++|.+.+... ...+++..+..++.||+.||.|||+  +||+|+||||+||+++.++.
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~  157 (310)
T cd07865          82 TKATPYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHR--NKILHRDMKAANILITKDGI  157 (310)
T ss_pred             cccccccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEECCCCc
Confidence            643        4599999996 5888877543 3468999999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCc--ccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----
Q 013028          280 AKISDFGLAKFGPLGDKS--HISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----  351 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----  351 (451)
                      ++|+|||++.........  .......++..|+|||++.+. .++.++||||||+++|+|++|..||........     
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~  237 (310)
T cd07865         158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS  237 (310)
T ss_pred             EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999754322111  122334678889999988654 478899999999999999999998864332100     


Q ss_pred             ---CCccccccchhhhh------------hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 ---GNWAKPYLSNKLAL------------HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ---~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                         ..............            .......+.   ....+..+.+||.+||..||.+|||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK---PYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcc---cccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence               00000000000000            000000000   01123567899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=296.17  Aligned_cols=263  Identities=24%  Similarity=0.324  Sum_probs=196.4

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      |.+.++||.|+||.||+|...          .++..+|+|.+....  ......+.+|+++++.++|+||+++++++.+.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~----------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   70 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNK----------KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK   70 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEEC----------CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC
Confidence            567889999999999997654          346789999998653  23345678899999999999999999999988


Q ss_pred             --CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          210 --QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       210 --~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                        ...++||||+++ +|.+++... ...+++..++.++.||+.||.|||+  .|++|+||+|+||++++++.++|+|||+
T Consensus        71 ~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g~  146 (287)
T cd07840          71 GKGSIYMVFEYMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGL  146 (287)
T ss_pred             CCCcEEEEeccccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEccccc
Confidence              889999999974 888887543 2578999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----------CCcc
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----------GNWA  355 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----------~~~~  355 (451)
                      +........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........           ....
T Consensus       147 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (287)
T cd07840         147 ARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN  225 (287)
T ss_pred             eeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Confidence            985433221 11233456788999998754 4678999999999999999999999865432100           0000


Q ss_pred             ccccchh-----hhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          356 KPYLSNK-----LALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       356 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ++.....     ..........+........+..+.+++.+||..+|.+||++.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            0000000     00000000000000111136789999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.8e-37  Score=302.77  Aligned_cols=268  Identities=21%  Similarity=0.303  Sum_probs=194.6

Q ss_pred             Cccccc--CceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceeecCCe
Q 013028          136 NLIGQG--GFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~  211 (451)
                      ..||+|  +||+||++.          +..++..||+|++......  ..+.+.+|+.+++.++||||++++++|..++.
T Consensus         4 ~~ig~g~~~~~~v~~a~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~   73 (328)
T cd08226           4 VEIGRGFCNLTSVYLAR----------HTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW   73 (328)
T ss_pred             HHhCCcccCceeEEEEE----------EcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc
Confidence            456666  999999965          4556788999998743322  23567889999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .++||||+.+++|.+++.......+++..+..++.|++.||.|||+  .||+||||||+|||++.++.++++||+.+...
T Consensus        74 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          74 LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             eEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            9999999999999999876545568999999999999999999999  89999999999999999999999999865421


Q ss_pred             CC-CCCccc----ccccCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC------CC----c
Q 013028          292 PL-GDKSHI----STRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA------GN----W  354 (451)
Q Consensus       292 ~~-~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~------~~----~  354 (451)
                      .. ......    .....++..|+|||++.+  ..++.++|||||||++|+|++|..||........      ..    +
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd08226         152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL  231 (328)
T ss_pred             hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc
Confidence            11 000000    011234567999999966  3578999999999999999999999865432100      00    0


Q ss_pred             cccccchhhh--------h-----h---------HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--H
Q 013028          355 AKPYLSNKLA--------L-----H---------QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA--L  410 (451)
Q Consensus       355 ~~~~~~~~~~--------~-----~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L  410 (451)
                      ..........        .     .         ......+........+..+.+|+++||..||++|||+.|+++.  +
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~  311 (328)
T cd08226         232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF  311 (328)
T ss_pred             cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence            0000000000        0     0         0000111112233456789999999999999999999999854  4


Q ss_pred             HHhHH
Q 013028          411 EQLQL  415 (451)
Q Consensus       411 ~~~~~  415 (451)
                      +.++.
T Consensus       312 ~~~~~  316 (328)
T cd08226         312 KQVKE  316 (328)
T ss_pred             HHHHH
Confidence            44444

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-37  Score=303.81  Aligned_cols=271  Identities=25%  Similarity=0.341  Sum_probs=198.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|.+.++||.|+||.||+|...          .++..||||.+.... ......+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   73 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHK----------PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIR   73 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEc----------CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheee
Confidence            468999999999999999997643          456789999986432 223456778999999999999999999876


Q ss_pred             cC-----CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          208 DD-----QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       208 ~~-----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      ..     ...++||||+. ++|.+++..   ..+++..+..++.|++.||.|||+  .||+||||||+|||++.++.++|
T Consensus        74 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill~~~~~~kl  147 (336)
T cd07849          74 PPSFESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKI  147 (336)
T ss_pred             cccccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEE
Confidence            54     35799999996 488877743   468999999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCC-cccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc-
Q 013028          283 SDFGLAKFGPLGDK-SHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL-  359 (451)
Q Consensus       283 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~-  359 (451)
                      +|||++........ ........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||................ 
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~  227 (336)
T cd07849         148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG  227 (336)
T ss_pred             CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            99999975332111 112234578999999998754 568999999999999999999999986432110000000000 


Q ss_pred             -chhhhhhHHhhhh-------h--cCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhHH
Q 013028          360 -SNKLALHQIIDEK-------L--GRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA--LEQLQL  415 (451)
Q Consensus       360 -~~~~~~~~~~~~~-------~--~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~  415 (451)
                       .....+..+....       .  ....     ....+.++.+|+.+||+.+|.+|||+.++++.  |+....
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             CCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence             0000000000000       0  0000     11235679999999999999999999999997  655543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5e-37  Score=297.79  Aligned_cols=247  Identities=26%  Similarity=0.385  Sum_probs=198.1

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCCe
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~  211 (451)
                      |....+||+|+||.||++...          .++..||||.+..........+.+|+.+++.++|+||+++++.+..+++
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~----------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   91 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVK----------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE   91 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEc----------CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCE
Confidence            333467999999999997643          4567899999865544455678899999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .++||||+++++|.+++..   ..+++..+..++.|++.+|.|||+  .||+|+||+|+||+++.++.++|+|||++...
T Consensus        92 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~--~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~  166 (292)
T cd06657          92 LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  166 (292)
T ss_pred             EEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence            9999999999999987743   458899999999999999999999  89999999999999999999999999998753


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ...  ........|+..|+|||++.+..++.++|+||||+++|+|++|..||......              .....+..
T Consensus       167 ~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--------------~~~~~~~~  230 (292)
T cd06657         167 SKE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------------KAMKMIRD  230 (292)
T ss_pred             ccc--cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHHHh
Confidence            321  11223456889999999998888999999999999999999999997642211              00111111


Q ss_pred             hhcCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          372 KLGRN--IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       372 ~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .....  .....+..+.+++.+||..+|.+||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         231 NLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             hCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            11111  112345678999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-37  Score=307.24  Aligned_cols=270  Identities=24%  Similarity=0.323  Sum_probs=201.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ..+|.+.+.||+|+||+||+|.          +..++..||||.+....  ......+.+|+.+++.++|+||+++++++
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~   73 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAK----------NSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIM   73 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEE----------ecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhe
Confidence            3589999999999999999965          34457889999987532  22345677899999999999999999988


Q ss_pred             ecC-----CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEE
Q 013028          207 CDD-----QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       207 ~~~-----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~k  281 (451)
                      ...     ...|+||||+. ++|.+++..  ...+++..+..++.|++.||.|||+  ++++|+||||+|||++.++.++
T Consensus        74 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~~~~~~~k  148 (337)
T cd07858          74 PPPHREAFNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLK  148 (337)
T ss_pred             ecccccccCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEE
Confidence            654     35799999995 689888854  4579999999999999999999999  8999999999999999999999


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC---------
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA---------  351 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~---------  351 (451)
                      |+|||++.......  .......++..|+|||++.. ..++.++|||||||++|+|++|.+||........         
T Consensus       149 L~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  226 (337)
T cd07858         149 ICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLG  226 (337)
T ss_pred             ECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence            99999998543221  22334567889999998864 5689999999999999999999999864321000         


Q ss_pred             CCcc--ccccchhhhhhHHhhhhh---c---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhHHh
Q 013028          352 GNWA--KPYLSNKLALHQIIDEKL---G---RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA--LEQLQLN  416 (451)
Q Consensus       352 ~~~~--~~~~~~~~~~~~~~~~~~---~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~  416 (451)
                      ....  ..+... ......+....   .   .......+.++.+|+.+||+.+|.+|||+.++++.  |+.+...
T Consensus       227 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         227 SPSEEDLGFIRN-EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             CCChHHhhhcCc-hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            0000  000000 00000000000   0   00112346789999999999999999999999988  6665443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=300.06  Aligned_cols=265  Identities=23%  Similarity=0.311  Sum_probs=203.2

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC--CC----ce
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN--HP----NV  199 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--h~----nI  199 (451)
                      ...+.+|.++..||+|+||.|-.+.++          .++..||||+++.- ....+...-|+++|+++.  .|    -+
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~----------~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rc  153 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDR----------ETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRC  153 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeec----------CCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence            344789999999999999999997654          33778999999742 233445567999999994  23    38


Q ss_pred             eeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC---
Q 013028          200 VKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD---  276 (451)
Q Consensus       200 v~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~---  276 (451)
                      |++.++|...++.|||+|.+ |.++++++..+...+++...+..++.||++++.|||+  .+++|.||||+|||+..   
T Consensus       154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~--~kl~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD--LKLTHTDLKPENILFVSSEY  230 (415)
T ss_pred             EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh--cceeecCCChheEEEeccce
Confidence            88999999999999999999 6799999988888899999999999999999999999  89999999999999932   


Q ss_pred             -----------------CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhC
Q 013028          277 -----------------DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG  339 (451)
Q Consensus       277 -----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg  339 (451)
                                       +..++|+|||.|++....     ...++.|..|+|||++.+-.|+..+||||+||||+||++|
T Consensus       231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG  305 (415)
T KOG0671|consen  231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG  305 (415)
T ss_pred             EEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence                             246899999999863322     2567899999999999999999999999999999999999


Q ss_pred             CCccccccCCCC--------CCccccccch-------------------hhhhhHHhh----hhhcCCCCHHHHHHHHHH
Q 013028          340 KTAAMRRTNGLA--------GNWAKPYLSN-------------------KLALHQIID----EKLGRNIQMEEAQEFAEI  388 (451)
Q Consensus       340 ~~pf~~~~~~~~--------~~~~~~~~~~-------------------~~~~~~~~~----~~~~~~~~~~~~~~l~~l  388 (451)
                      ...|....+...        ......+...                   ........+    ..............|.+|
T Consensus       306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL  385 (415)
T KOG0671|consen  306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL  385 (415)
T ss_pred             ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence            999876553210        0000000000                   000000000    000001123345679999


Q ss_pred             HHHccccCCCCCCCHHHHHHH
Q 013028          389 ILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       389 i~~cl~~dP~~RPt~~evl~~  409 (451)
                      +.+||.+||.+|+|+.|+|.+
T Consensus       386 l~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  386 LRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHHHccCccccccHHHHhcC
Confidence            999999999999999999864

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1e-36  Score=298.23  Aligned_cols=264  Identities=20%  Similarity=0.235  Sum_probs=193.3

Q ss_pred             CcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC--CCcCHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          133 SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       133 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      .+++.+|.|+++.||++            ..++..||||++...  .....+.+.+|+++++.++|+||+++++++.+.+
T Consensus         5 ~i~~~~~~~~~v~~~~~------------~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~   72 (314)
T cd08216           5 LIGKCFEDLMIVHLAKH------------KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS   72 (314)
T ss_pred             hhhHhhcCCceEEEEEe------------cCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC
Confidence            34455555555555543            336788999998754  2334467899999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..+++|||+++|+|.+++.......+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||.+..
T Consensus        73 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~  150 (314)
T cd08216          73 ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVS  150 (314)
T ss_pred             eEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCcceEEEecCCceEEecCcccee
Confidence            99999999999999999976555678999999999999999999999  8999999999999999999999999999864


Q ss_pred             CCCCCC-----cccccccCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC------CCcc--
Q 013028          291 GPLGDK-----SHISTRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA------GNWA--  355 (451)
Q Consensus       291 ~~~~~~-----~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~------~~~~--  355 (451)
                      ......     ........++..|+|||++..  ..++.++|||||||++|+|++|..||........      ....  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (314)
T cd08216         151 MIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL  230 (314)
T ss_pred             eccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccc
Confidence            321111     111223457778999999865  4588999999999999999999999874322100      0000  


Q ss_pred             --cc-ccchhhhhh--------HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          356 --KP-YLSNKLALH--------QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       356 --~~-~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                        .. .........        ...............+.++.+|+.+||..||++|||+.++++.-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence              00 000000000        00000011112234467899999999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.4e-37  Score=295.73  Aligned_cols=249  Identities=27%  Similarity=0.412  Sum_probs=202.3

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcC-CCceeecccee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLN-HPNVVKLMGYC  206 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-h~nIv~~~~~~  206 (451)
                      +|.+.+.||+|+||.||+|...          .++..|++|++.....   .....+.+|+++++.++ |+||+++++++
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~   71 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEK----------ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF   71 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEc----------CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence            6889999999999999997643          3577899999875322   22356788999999999 99999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++..++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  .|++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~  147 (280)
T cd05581          72 QDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFG  147 (280)
T ss_pred             cCCceEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCc
Confidence            999999999999999999999865  3479999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCc------------------ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccC
Q 013028          287 LAKFGPLGDKS------------------HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTN  348 (451)
Q Consensus       287 la~~~~~~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  348 (451)
                      ++.........                  .......++..|+|||++.+..++.++|+||||+++++|++|..||.....
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  227 (280)
T cd05581         148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE  227 (280)
T ss_pred             cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence            99754322110                  122335678899999999888899999999999999999999999864431


Q ss_pred             CCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 013028          349 GLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM----SEVVA  408 (451)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~  408 (451)
                      .             .......  ......+...+..+.+|+.+||+.+|.+||++    .++++
T Consensus       228 ~-------------~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         228 Y-------------LTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             H-------------HHHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            0             1111111  11223344457789999999999999999999    77765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=8.3e-37  Score=295.14  Aligned_cols=259  Identities=24%  Similarity=0.322  Sum_probs=201.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC----cCHHHHHHHHHHHHhcC-CCceeeccce
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS----QGQDEWENELRFLSRLN-HPNVVKLMGY  205 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~-h~nIv~~~~~  205 (451)
                      .|++.+.||.|+||.||++....       ....+..||||++.+...    ...+.+.+|++++.+++ |+||+++++.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~-------~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~   73 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVG-------GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA   73 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEec-------cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee
Confidence            37788999999999999986432       234567899999874321    22345788999999995 9999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +..+...++||||+.+|+|.+++..  ...+++..+..++.|++.+|.|||+  .+++|+||+|+||+++.++.++|+||
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df  149 (288)
T cd05583          74 FQTDTKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLTDF  149 (288)
T ss_pred             eecCCEEEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEEEC
Confidence            9999999999999999999998854  3568899999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCC--CCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGH--LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      |++....... ........|+..|+|||.+.+..  .+.++||||||+++|+|++|..||.......         ....
T Consensus       150 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---------~~~~  219 (288)
T cd05583         150 GLSKEFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---------SQSE  219 (288)
T ss_pred             cccccccccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---------hHHH
Confidence            9987533221 11223356889999999986654  7889999999999999999999985322110         0000


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                      ....+...  ....+...+..+.+++.+||+.||++|||+.++.+.|+-
T Consensus       220 ~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         220 ISRRILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHHHHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            01111111  123334456789999999999999999998888776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.2e-37  Score=305.98  Aligned_cols=268  Identities=22%  Similarity=0.290  Sum_probs=198.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++.+.||.|+||.||+|..          ..++..||+|.+....  ......+.+|+.+|+.++||||+++++++.
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~----------~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   74 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAID----------TRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR   74 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEE----------cCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence            5899999999999999999764          4457789999987542  233456778999999999999999999876


Q ss_pred             c----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          208 D----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       208 ~----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      .    ....++||||+. ++|.+++..  ...+++..+..++.||+.||.|||+  ++|+||||||+||+++.++.++|+
T Consensus        75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~  149 (334)
T cd07855          75 PPGADFKDVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIG  149 (334)
T ss_pred             ccCCCCceEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEec
Confidence            3    456899999995 689888854  3558999999999999999999999  899999999999999999999999


Q ss_pred             ecCCcccCCCCC--CcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC-------
Q 013028          284 DFGLAKFGPLGD--KSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN-------  353 (451)
Q Consensus       284 DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~-------  353 (451)
                      |||++.......  .........|+..|+|||++.+ ..++.++|||||||++|+|++|..||..........       
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g  229 (334)
T cd07855         150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG  229 (334)
T ss_pred             ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence            999997533221  1112234578999999999855 568999999999999999999999986432110000       


Q ss_pred             -ccccccc--hhhhhhHHhhhhh-cCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          354 -WAKPYLS--NKLALHQIIDEKL-GRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       354 -~~~~~~~--~~~~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                       -......  ....+........ ....     ....+.++.+++.+||+.+|.+|||+.+++..--.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~  297 (334)
T cd07855         230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL  297 (334)
T ss_pred             CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence             0000000  0000001111000 0001     12246789999999999999999999999885433

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=313.68  Aligned_cols=271  Identities=25%  Similarity=0.392  Sum_probs=203.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC-CCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .+...+.||+|+||.||+|.          ++.+|..||||.+... .....+.+.+|+++|++|+|+|||+++++=++.
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgr----------nketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~   83 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGR----------NKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETK   83 (732)
T ss_pred             ceeehhhhcCCccceeeeec----------ccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcc
Confidence            34556789999999999964          6677899999999864 344567789999999999999999999986654


Q ss_pred             C------eeEEEEeccCCCChhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC--CCC--
Q 013028          210 Q------HRLLVYEYVTRGSLEDHLLNE-DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD--DDF--  278 (451)
Q Consensus       210 ~------~~~lV~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~--~~~--  278 (451)
                      .      ...+|||||.||+|...+.+- +...+++.+.+.++.++..||.|||+  +||+||||||.||++-  .+|  
T Consensus        84 ~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~  161 (732)
T KOG4250|consen   84 FLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQS  161 (732)
T ss_pred             ccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCce
Confidence            3      457999999999999999753 34679999999999999999999998  8999999999999994  333  


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-CCccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-GNWAK  356 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-~~~~~  356 (451)
                      ..||+|||.|+-.+   .......++||..|++||++.. +.|+..+|.|||||++|++.||..||........ ....+
T Consensus       162 IyKLtDfG~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~  238 (732)
T KOG4250|consen  162 IYKLTDFGAARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW  238 (732)
T ss_pred             EEeeecccccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence            57999999999643   3346778999999999999984 8899999999999999999999999975443311 00000


Q ss_pred             ccc-----------c----hhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHhHHhcC
Q 013028          357 PYL-----------S----NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP--TMSEVVAALEQLQLNMG  418 (451)
Q Consensus       357 ~~~-----------~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--t~~evl~~L~~~~~~~~  418 (451)
                      ...           .    ....+...+..  .-.........+-..+..+|..+|.+|-  .+.+....+..|.+...
T Consensus       239 ~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~--p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v  315 (732)
T KOG4250|consen  239 HIITKKPSGVAIGAQEEENGPVEWSSTLPQ--PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV  315 (732)
T ss_pred             hhhccCCCceeEeeecccCCceeeeccCCC--cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence            000           0    00000010000  1111222334555667788888999988  77777766666655443

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.3e-36  Score=295.50  Aligned_cols=267  Identities=24%  Similarity=0.285  Sum_probs=195.9

Q ss_pred             HHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccc
Q 013028          127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       127 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      ...++|++.+.||.|+||.||+|....          ++..||+|.+....  ......+.+|+++++.++||||+++++
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~   73 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKD----------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE   73 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECC----------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeh
Confidence            445689999999999999999987543          35679999987543  223356778999999999999999999


Q ss_pred             eeecCC----------eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee
Q 013028          205 YCCDDQ----------HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL  274 (451)
Q Consensus       205 ~~~~~~----------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll  274 (451)
                      ++.+..          ..++||||+++ +|.+.+... ...+++..+..++.|++.||.|||+  .||+|+||||+||++
T Consensus        74 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili  149 (302)
T cd07864          74 IVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILL  149 (302)
T ss_pred             eecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE
Confidence            987654          78999999976 777776543 3568999999999999999999999  899999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--
Q 013028          275 DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--  351 (451)
Q Consensus       275 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--  351 (451)
                      ++++.+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++|++||........  
T Consensus       150 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~  228 (302)
T cd07864         150 NNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE  228 (302)
T ss_pred             CCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            9999999999999985432221 11222346778999998854 4578999999999999999999998864321100  


Q ss_pred             ---------CCccccccchhhhhh-----HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 ---------GNWAKPYLSNKLALH-----QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ---------~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                               ..-.++.........     ........ ......+..+.+++..||+.||.+||++.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHHHHhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                     000000000000000     00000000 0011235779999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1e-36  Score=289.92  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=194.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC-----CCcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-----GSQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      +|.+.++||+|+||.||++.+..          .+..+++|++...     .......+..|+.+++.++||||++++++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   70 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK----------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHAS   70 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC----------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHH
Confidence            58889999999999999976543          2333555555421     11223456679999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      +.+....++||||+++++|.+++..  .....+++..+..++.|++.||.|||+  .|++|+||+|+||+++. +.++|+
T Consensus        71 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~~-~~~~l~  147 (260)
T cd08222          71 FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLKN-NLLKIG  147 (260)
T ss_pred             HhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH--cCccccCCChhheEeec-CCEeec
Confidence            9999999999999999999988854  234578999999999999999999999  89999999999999976 479999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      |||++......  ........|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....             ..
T Consensus       148 d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------------~~  212 (260)
T cd08222         148 DFGVSRLLMGS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------------LS  212 (260)
T ss_pred             ccCceeecCCC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------------HH
Confidence            99998753221  2223345678899999999888899999999999999999999998753211             00


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..... ........+...+.++.+++.+||..||++||++.++++.
T Consensus       213 ~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         213 VVLRI-VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             HHHHH-HcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            00111 1111223344567889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.2e-38  Score=329.88  Aligned_cols=255  Identities=29%  Similarity=0.424  Sum_probs=191.6

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccc
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      ......|+.++.||+||||.||+          ++++-++..||||+|.-.. ......+.+|+..|.+|+|||||++|.
T Consensus       475 SRY~~DFEEL~lLGkGGFG~Vvk----------VRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYys  544 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVK----------VRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYS  544 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEE----------EeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeeh
Confidence            34566889999999999999999          6788899999999997543 222345788999999999999999987


Q ss_pred             eeec----------------------------------------------------------------------------
Q 013028          205 YCCD----------------------------------------------------------------------------  208 (451)
Q Consensus       205 ~~~~----------------------------------------------------------------------------  208 (451)
                      .|.+                                                                            
T Consensus       545 AWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~d  624 (1351)
T KOG1035|consen  545 AWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSD  624 (1351)
T ss_pred             hhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccc
Confidence            5510                                                                            


Q ss_pred             --C-----------------------------------------CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHH
Q 013028          209 --D-----------------------------------------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA  245 (451)
Q Consensus       209 --~-----------------------------------------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~  245 (451)
                        +                                         ..+||-||||+...|.+++.++.... .....+.++
T Consensus       625 edg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLF  703 (1351)
T KOG1035|consen  625 EDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLF  703 (1351)
T ss_pred             ccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHH
Confidence              0                                         13578999998876777664432111 367788999


Q ss_pred             HHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCC----------------CCCCcccccccCCCCcc
Q 013028          246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP----------------LGDKSHISTRVLGTRGY  309 (451)
Q Consensus       246 ~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y  309 (451)
                      ++|++||.|+|+  +|||||||||.||+|+.++.|||+|||+|....                .+......+..+||.-|
T Consensus       704 reIlEGLaYIH~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalY  781 (1351)
T KOG1035|consen  704 REILEGLAYIHD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALY  781 (1351)
T ss_pred             HHHHHHHHHHHh--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeee
Confidence            999999999999  899999999999999999999999999998511                01111134567899999


Q ss_pred             ccccccccC---CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcC--CCCHHHHHH
Q 013028          310 FAPEYIATG---HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGR--NIQMEEAQE  384 (451)
Q Consensus       310 ~aPE~l~~~---~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  384 (451)
                      +|||++.+.   .|+.|+|+||||+||+||+   .||....+.            ...+..+.+..+..  .+.....+.
T Consensus       782 vAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMER------------a~iL~~LR~g~iP~~~~f~~~~~~~  846 (1351)
T KOG1035|consen  782 VAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMER------------ASILTNLRKGSIPEPADFFDPEHPE  846 (1351)
T ss_pred             ecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHH------------HHHHHhcccCCCCCCcccccccchH
Confidence            999999664   5999999999999999998   345433221            11122222111111  122334566


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHH
Q 013028          385 FAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       385 l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      -..+|++||+.||.+|||+.|+|+
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhh
Confidence            778999999999999999999985

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.7e-36  Score=290.12  Aligned_cols=244  Identities=23%  Similarity=0.291  Sum_probs=189.7

Q ss_pred             hcCCCcCCcc--cccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeeccce
Q 013028          129 TRKFSEKNLI--GQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~L--G~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~  205 (451)
                      .+.|.+.+.+  |.|+||.||++.          +..++..+|+|.+........     |+.+...+ +|+||+++++.
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~----------~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~   77 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLK----------HKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYS   77 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEE----------EcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEE
Confidence            3567777776  999999999965          445577899999875422211     33333323 69999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC-cEEEee
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF-NAKISD  284 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~-~~kl~D  284 (451)
                      |...+..++||||+++++|.+++...  ..+++..+..++.|+++||.|||+  .||+||||||+||+++.++ .++|+|
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         78 VTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             EecCCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEeCCCCeEEEec
Confidence            99999999999999999999998653  479999999999999999999999  8999999999999999888 999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ||++.....      .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......       .  ....
T Consensus       154 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-------~--~~~~  218 (267)
T PHA03390        154 YGLCKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-------L--DLES  218 (267)
T ss_pred             CccceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-------h--hHHH
Confidence            999875321      123468889999999988889999999999999999999999987432210       0  0001


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT-MSEVVA  408 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~  408 (451)
                      +.....  .........+..+.+|+.+||+.+|.+||+ ++++++
T Consensus       219 ~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        219 LLKRQQ--KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHhhc--ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            111111  111223346788999999999999999996 688875

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=293.12  Aligned_cols=262  Identities=23%  Similarity=0.307  Sum_probs=197.7

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      |.+.+.||.|++|.||+|..          ..++..+++|.+......  ....+.+|+++++.++|+||+++++++.++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~----------~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   70 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARD----------KLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK   70 (283)
T ss_pred             CccceeeecCCCceEEEEEc----------CCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC
Confidence            56778999999999999764          345778999998754332  345678899999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||.+.
T Consensus        71 ~~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df~~~~  146 (283)
T cd05118          71 GDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLAR  146 (283)
T ss_pred             CCEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH--CCeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence            999999999975 8888775532 578999999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----------CCcccc
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----------GNWAKP  357 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----------~~~~~~  357 (451)
                      ......  .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........           ....+.
T Consensus       147 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (283)
T cd05118         147 SFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWP  224 (283)
T ss_pred             ecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcc
Confidence            543322  122335678889999998776 789999999999999999999988854321100           000000


Q ss_pred             ccchhhhhhHH-hhhhh---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          358 YLSNKLALHQI-IDEKL---GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       358 ~~~~~~~~~~~-~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ........... +....   ........+.++.++|.+||..||.+||++.+++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00000000000 00000   001122356889999999999999999999999863

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-37  Score=290.86  Aligned_cols=241  Identities=26%  Similarity=0.352  Sum_probs=186.7

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHH-hcCCCceeeccceeecCCe
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLS-RLNHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~-~l~h~nIv~~~~~~~~~~~  211 (451)
                      +.||.|+||.||+|..          ..++..||||.+.+.....   ...+..|..++. .++|+||+++++++..++.
T Consensus         2 ~~l~~g~~~~v~~a~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   71 (260)
T cd05611           2 KPISKGAFGSVYLAKK----------RSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDY   71 (260)
T ss_pred             ccCCcCCCeeEEEEEe----------cCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCe
Confidence            5799999999999764          3446789999986543222   123444555443 4579999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++...
T Consensus        72 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          72 LYLVMEYLNGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             EEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            9999999999999999854  3568899999999999999999999  89999999999999999999999999998743


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ..      .....|+..|+|||.+.+..++.++||||||+++|+|++|..||......             .....+...
T Consensus       148 ~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------------~~~~~~~~~  208 (260)
T cd05611         148 LE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------------AVFDNILSR  208 (260)
T ss_pred             cc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------------HHHHHHHhc
Confidence            21      23456888999999998888899999999999999999999998643211             001111111


Q ss_pred             h--hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          372 K--LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       372 ~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .  .........+..+.+++.+||+.||++||++.++.+.
T Consensus       209 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         209 RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            1  1111222356889999999999999999976544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.7e-37  Score=305.67  Aligned_cols=266  Identities=26%  Similarity=0.372  Sum_probs=196.4

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC--CCcCHHHHHHHHHHHHhc-CCCceeeccc
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRL-NHPNVVKLMG  204 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~h~nIv~~~~  204 (451)
                      +.++|++.+.||+|+||.||+|.+.          .++..+|||.+...  .......+.+|+.+++++ +|+||+++++
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~----------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~   74 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDR----------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN   74 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEc----------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceee
Confidence            3568999999999999999998654          34677999988542  222344577899999999 8999999999


Q ss_pred             eeecC--CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          205 YCCDD--QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       205 ~~~~~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      ++...  ...++||||+. ++|..++...   .+++..+..++.||+.||.|||+  .||+|+||||+|||++.++.++|
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl  148 (337)
T cd07852          75 VIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKL  148 (337)
T ss_pred             eeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEE
Confidence            88653  46799999996 5998887542   68889999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCCc---ccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC-----
Q 013028          283 SDFGLAKFGPLGDKS---HISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN-----  353 (451)
Q Consensus       283 ~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~-----  353 (451)
                      +|||++.........   .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||..........     
T Consensus       149 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~  228 (337)
T cd07852         149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV  228 (337)
T ss_pred             eeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            999999754322211   22334578999999998755 567899999999999999999999986432210000     


Q ss_pred             ccccccchhhhh-----hHHhhhhhcC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          354 WAKPYLSNKLAL-----HQIIDEKLGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       354 ~~~~~~~~~~~~-----~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...+.......+     ..++......      ......+.++.+++.+||+.||.+|||+.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000000000000     0000000000      0011136789999999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=292.86  Aligned_cols=257  Identities=25%  Similarity=0.360  Sum_probs=194.0

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhc---CCCceeecccee
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRL---NHPNVVKLMGYC  206 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l---~h~nIv~~~~~~  206 (451)
                      |++.+.||+|+||.||+|.+..          ++..||+|.+......  ....+.+|+.+++++   +|+||+++++++
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   70 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN----------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVC   70 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC----------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEE
Confidence            5678899999999999987543          4678999999743222  234566788887766   599999999999


Q ss_pred             ecCCe-----eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEE
Q 013028          207 CDDQH-----RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       207 ~~~~~-----~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~k  281 (451)
                      .+.+.     .+++|||+.+ +|.+++.......+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++
T Consensus        71 ~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~--~~i~h~~l~~~nili~~~~~~~  147 (287)
T cd07838          71 HGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQVK  147 (287)
T ss_pred             eeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhEEEccCCCEE
Confidence            88776     8999999964 89888865444568999999999999999999999  8999999999999999999999


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC----------
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA----------  351 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~----------  351 (451)
                      |+|||++.......   ......++..|+|||++.+..++.++|+|||||++|+|++|.+||........          
T Consensus       148 l~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd07838         148 IADFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGL  224 (287)
T ss_pred             EeccCcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCC
Confidence            99999997543221   12234578889999999888899999999999999999999988865432100          


Q ss_pred             ---CCccccccchhhhhhHHhhhhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          352 ---GNWAKPYLSNKLALHQIIDEKLG---RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       352 ---~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                         ..|......    ....+.....   .......+..+.+++.+||+.||.+||++.+++.
T Consensus       225 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         225 PSEEEWPRNVSL----PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CChHhcCCCccc----chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence               000000000    0000000000   0111234578899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.2e-36  Score=296.10  Aligned_cols=246  Identities=31%  Similarity=0.465  Sum_probs=194.2

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .|...++||.|+||+||+|...          .++..|++|.+.......   ...+.+|+++++.++|+||+++++++.
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~----------~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   91 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNS----------HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL   91 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEEC----------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            4777788999999999997643          446789999987443322   245788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +....++||||+. |+|.+++... ...+++..+..++.||+.+|.|||+  .||+|+||+|+||+++.++.++|+|||+
T Consensus        92 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~  167 (313)
T cd06633          92 KEHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGS  167 (313)
T ss_pred             eCCEEEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCC
Confidence            9999999999995 5787777543 3568999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      +....      ......|+..|+|||++.   ...++.++|||||||++|+|++|..||......             ..
T Consensus       168 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-------------~~  228 (313)
T cd06633         168 ASKSS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------------SA  228 (313)
T ss_pred             CcccC------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------------HH
Confidence            86421      122457888999999984   456889999999999999999999987643211             00


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .................+..+.+|+.+||+.+|.+||++.+++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         229 LYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             HHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111111111111122345679999999999999999999999964

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7.5e-37  Score=302.18  Aligned_cols=265  Identities=21%  Similarity=0.301  Sum_probs=194.3

Q ss_pred             hcCCC-cCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--------------HHHHHHHHHHHHh
Q 013028          129 TRKFS-EKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--------------QDEWENELRFLSR  193 (451)
Q Consensus       129 ~~~y~-~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~il~~  193 (451)
                      .++|. +.+.||.|+||+||+|..          ...+..||||.+.......              ...+.+|+++++.
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   76 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYD----------TLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE   76 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEE----------CCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHh
Confidence            34675 457799999999999764          3456789999986432221              1246789999999


Q ss_pred             cCCCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcee
Q 013028          194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL  273 (451)
Q Consensus       194 l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIl  273 (451)
                      ++|+||+++++++..++..++||||+. |+|.+++..  ...+++..+..++.|++.||.|||+  .||+|+||+|+||+
T Consensus        77 l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nil  151 (335)
T PTZ00024         77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIF  151 (335)
T ss_pred             CCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeE
Confidence            999999999999999999999999996 589988854  4568999999999999999999999  89999999999999


Q ss_pred             eCCCCcEEEeecCCcccCCCCC------------CcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCC
Q 013028          274 LDDDFNAKISDFGLAKFGPLGD------------KSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGK  340 (451)
Q Consensus       274 l~~~~~~kl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~  340 (451)
                      ++.++.++|+|||++.......            .........++..|+|||++.+. .++.++|||||||++|+|++|.
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~  231 (335)
T PTZ00024        152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK  231 (335)
T ss_pred             ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999999997533110            01112233568889999998664 4789999999999999999999


Q ss_pred             CccccccCCCC-------------CCcccccc-chhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 013028          341 TAAMRRTNGLA-------------GNWAKPYL-SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV  406 (451)
Q Consensus       341 ~pf~~~~~~~~-------------~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev  406 (451)
                      +||........             ..|..... .............. .......+..+.+++.+||..+|.+|||+.|+
T Consensus       232 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~  310 (335)
T PTZ00024        232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEA  310 (335)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence            99865432100             00000000 00000000000000 00011235778999999999999999999999


Q ss_pred             HHH
Q 013028          407 VAA  409 (451)
Q Consensus       407 l~~  409 (451)
                      +..
T Consensus       311 l~~  313 (335)
T PTZ00024        311 LKH  313 (335)
T ss_pred             hcC
Confidence            973

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.4e-36  Score=340.05  Aligned_cols=267  Identities=29%  Similarity=0.501  Sum_probs=204.2

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ....|...+.||+|+||.||+|.+.          .++..||||.+......    ...|++++++++|||||+++++|.
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~----------~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~  753 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSI----------KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCR  753 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEEC----------CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEE
Confidence            3456778889999999999998643          34678999998643222    135688999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTY-WRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      ++...++||||+++|+|.+++.     .++|..+..|+.|++.||+|||.. ..+|+||||||+||+++.++..++. ||
T Consensus       754 ~~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~  827 (968)
T PLN00113        754 SEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS  827 (968)
T ss_pred             cCCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence            9999999999999999999984     388999999999999999999942 1689999999999999998888775 66


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--CCccccccchhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--GNWAKPYLSNKLA  364 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~  364 (451)
                      ......      ......||..|+|||++.+..++.++|||||||++|||++|+.||........  ..|...... ...
T Consensus       828 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~  900 (968)
T PLN00113        828 LPGLLC------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS-DCH  900 (968)
T ss_pred             cccccc------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC-ccc
Confidence            654321      11223678999999999989999999999999999999999999854332111  112211111 111


Q ss_pred             hhHHhhhhhcC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCc
Q 013028          365 LHQIIDEKLGR--NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCY  421 (451)
Q Consensus       365 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~  421 (451)
                      ....++..+..  ........++.+++.+||+.||++|||+.|+++.|+.+.....+|.
T Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~  959 (968)
T PLN00113        901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCV  959 (968)
T ss_pred             hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccccc
Confidence            12222332221  2334556678899999999999999999999999999877555543

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=291.52  Aligned_cols=262  Identities=25%  Similarity=0.352  Sum_probs=195.4

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcC-CCceeeccceeecC
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLN-HPNVVKLMGYCCDD  209 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~  209 (451)
                      |.+.+.||+|+||+||+|....          ++..|+||.+...... ......+|+..+..++ |+||+++++++.++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~----------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   70 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE----------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN   70 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC----------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC
Confidence            6678899999999999987543          3667999998754322 2233457999999999 99999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +..++||||+ +|+|.+++.......+++..+..++.|++.+|.|||+  +|++|+||+|+||+++.++.++|+|||++.
T Consensus        71 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~  147 (283)
T cd07830          71 DELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLAR  147 (283)
T ss_pred             CcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeecccce
Confidence            9999999999 7899998866544578999999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC--------Cccccccc
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG--------NWAKPYLS  360 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~--------~~~~~~~~  360 (451)
                      .....   .......++..|+|||++. ...++.++|+||||+++|+|++|.+||.........        ......+.
T Consensus       148 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (283)
T cd07830         148 EIRSR---PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP  224 (283)
T ss_pred             eccCC---CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence            53221   1223456788999999884 456789999999999999999999988544321100        00000000


Q ss_pred             hhhhhhHHhhhhhc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          361 NKLALHQIIDEKLG-------RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       361 ~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +...+.........       .......+..+.+++.+||+.||++|||+.|++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         225 EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000000000       00001124779999999999999999999999763

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.5e-36  Score=292.08  Aligned_cols=256  Identities=25%  Similarity=0.336  Sum_probs=197.6

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC----cCHHHHHHHHHHHHhcC-CCceeeccce
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS----QGQDEWENELRFLSRLN-HPNVVKLMGY  205 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~-h~nIv~~~~~  205 (451)
                      .|++.+.||.|+||.||++....       ...++..||+|++.....    ...+.+.+|+++++.+. |+||+++++.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~-------~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~   73 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVS-------GHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA   73 (290)
T ss_pred             CceeeeeeccCCcceEEEEEecc-------CCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeE
Confidence            47788999999999999986432       223577899999875321    22356788999999995 9999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +..+...++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  .|++||||+|+|||++.++.++|+||
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          74 FQTDTKLHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             eecCCeEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEeeC
Confidence            9999999999999999999999854  3568899999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      |++....... ........|+..|+|||.+.+  ..++.++||||||+++|+|++|..||......          ....
T Consensus       150 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----------~~~~  218 (290)
T cd05613         150 GLSKEFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK----------NSQA  218 (290)
T ss_pred             ccceeccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc----------ccHH
Confidence            9997533221 112234568899999999865  34688999999999999999999998532111          0000


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      .+...+.. .....+...+..+.+++.+||..||++||     ++.++++.
T Consensus       219 ~~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         219 EISRRILK-SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             HHHHHhhc-cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            01111111 11223344567899999999999999997     67777664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-36  Score=294.91  Aligned_cols=253  Identities=26%  Similarity=0.398  Sum_probs=193.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcC-CCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLN-HPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~~~~~~~  207 (451)
                      +.|++.+.||.|+||.||+|.++.          ++..||||.+..... .....+..|+.++..+. |+||+++++++.
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~----------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~   84 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKK----------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI   84 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECC----------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence            478899999999999999977543          367799999975432 23345666787776665 999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++...++||||+. ++|.+++... ...+++..+..++.|++.||.|||+. .||+||||+|+||++++++.++|+|||+
T Consensus        85 ~~~~~~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~  161 (296)
T cd06618          85 TDSDVFICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGI  161 (296)
T ss_pred             cCCeEEEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECcccc
Confidence            9999999999995 5777766443 34789999999999999999999972 4899999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCC----CCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGH----LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      +......   .......++..|+|||.+.+..    ++.++||||||+++|+|++|..||......            ..
T Consensus       162 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------~~  226 (296)
T cd06618         162 SGRLVDS---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------------FE  226 (296)
T ss_pred             chhccCC---CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------------HH
Confidence            8753221   1122345788899999986543    788999999999999999999998542110            01


Q ss_pred             hhhHHhhhhhc-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          364 ALHQIIDEKLG-RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       364 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      .+...+..... .......+.++.+|+.+||..||.+||++.+++++-
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         227 VLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            11111211110 011112467899999999999999999999998763

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.1e-37  Score=301.13  Aligned_cols=271  Identities=25%  Similarity=0.313  Sum_probs=203.4

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|.+.+.||.|+||.||+|...          .++..|+||.+....  ....+.+.+|+.+++.++|+||+++++++.+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~----------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDK----------RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRP   70 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeC----------CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcc
Confidence            5888999999999999997643          446789999987543  3345678899999999999999999999987


Q ss_pred             CC-----eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          209 DQ-----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       209 ~~-----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      ..     ..|+||||+. ++|.+++..  ...+++..+..++.+|+.||.|||+  .||+|+||||+|||++.++.++|+
T Consensus        71 ~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~--~gi~H~dlkp~nili~~~~~~~L~  145 (330)
T cd07834          71 PSPEDFNDVYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKIC  145 (330)
T ss_pred             cCcccccceEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEc
Confidence            75     7899999997 588888854  3479999999999999999999999  899999999999999999999999


Q ss_pred             ecCCcccCCCCCC-cccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCC--------CC
Q 013028          284 DFGLAKFGPLGDK-SHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--------GN  353 (451)
Q Consensus       284 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--------~~  353 (451)
                      |||++........ ........++..|+|||++.+. .++.++|+||||+++|+|++|.+||........        ..
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  225 (330)
T cd07834         146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT  225 (330)
T ss_pred             ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCC
Confidence            9999986443221 0123345678899999999877 889999999999999999999999865432100        00


Q ss_pred             cccccc--chhhhhhHHhhh-hhcC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhHHh
Q 013028          354 WAKPYL--SNKLALHQIIDE-KLGR-----NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA--LEQLQLN  416 (451)
Q Consensus       354 ~~~~~~--~~~~~~~~~~~~-~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~  416 (451)
                      +.....  .........+.. ....     ......+..+.+++.+||+.+|.+|||+.+++..  |+.++..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            000000  000000000000 0000     0112246789999999999999999999999985  6555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.9e-36  Score=295.94  Aligned_cols=252  Identities=31%  Similarity=0.441  Sum_probs=197.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ..|...+.||.|+||.||+|...          .++..+++|.+.....   ....++.+|+++++.++|+||+++++++
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   84 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDV----------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY   84 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEc----------CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            35777899999999999997643          3467799998864322   2234677899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+....++||||+. |+|.+.+... ...+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||
T Consensus        85 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg  160 (308)
T cd06634          85 LREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFG  160 (308)
T ss_pred             EcCCeeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCcc
Confidence            99999999999996 5887776443 3558899999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      ++.....      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||......             .
T Consensus       161 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------------~  221 (308)
T cd06634         161 SASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------------S  221 (308)
T ss_pred             cceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------------H
Confidence            9875321      22356888999999974   356788999999999999999999987542110             0


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                      ..................+..+.+||.+||..+|++||++.++++......
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             HHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            011111111111122345678999999999999999999999998765544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-38  Score=304.17  Aligned_cols=244  Identities=25%  Similarity=0.381  Sum_probs=202.5

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeecCCee
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHR  212 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~  212 (451)
                      .+.||.|.||+||-|          +++.+++.||||+|.+..  ......+.+|+.||+.+.||.||.+...|+..+.+
T Consensus       569 devLGSGQFG~VYgg----------~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~erv  638 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGG----------KHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERV  638 (888)
T ss_pred             HhhccCCcceeeecc----------eecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence            478999999999985          466778999999998653  23346689999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC---CcEEEeecCCcc
Q 013028          213 LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD---FNAKISDFGLAK  289 (451)
Q Consensus       213 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~---~~~kl~DFGla~  289 (451)
                      +.|||-+ .|+..+.|...+.+.+++.....++.||+.||.|||.  ++|+|.||||+||||...   -++||||||+|+
T Consensus       639 FVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~--knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  639 FVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHF--KNIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             EEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh--cceeeccCCchheeeccCCCCCceeecccccee
Confidence            9999999 5688888877778899999999999999999999999  899999999999999644   369999999999


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      +..   ........+||+.|+|||+|..+.|...-|+||.|||+|--++|..||....+               .-.++-
T Consensus       716 iIg---EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---------------IndQIQ  777 (888)
T KOG4236|consen  716 IIG---EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---------------INDQIQ  777 (888)
T ss_pred             ecc---hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---------------hhHHhh
Confidence            743   23345578999999999999999999999999999999999999999864321               111221


Q ss_pred             hh--hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          370 DE--KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       370 ~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +.  .+......+.+....+||..+|+..-.+|.+..+.+.+
T Consensus       778 NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  778 NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            11  11222334557889999999999999999999887654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=294.07  Aligned_cols=241  Identities=29%  Similarity=0.380  Sum_probs=200.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHH---HHHHHHHHHhcC-CCceeeccce
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE---WENELRFLSRLN-HPNVVKLMGY  205 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~il~~l~-h~nIv~~~~~  205 (451)
                      .+|.++.+||+|+||.|.+          +..+.++..+|||++++...-..++   -..|-++|.... -|.++++...
T Consensus       349 tDFnFl~VlGKGSFGKVlL----------aerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc  418 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLL----------AERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC  418 (683)
T ss_pred             cccceEEEeccCccceeee----------ecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence            4788899999999999999          4577788999999998654332222   245777877664 7899999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      |+.-+.+|+||||+.||+|.-.++.  -+.+-+..+..++..|+-||-|||+  +|||.||||.+||||+.+|++||+||
T Consensus       419 FQTmDRLyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~--kgIiYRDLKLDNvmLd~eGHiKi~DF  494 (683)
T KOG0696|consen  419 FQTMDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADF  494 (683)
T ss_pred             hhhhhheeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhc--CCeeeeeccccceEeccCCceEeeec
Confidence            9999999999999999999888854  4677888899999999999999999  99999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |++...-.  ......+++||+.|+|||++..++|+.++|+||+||+||||+.|++||++..++             +-+
T Consensus       495 GmcKEni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-------------elF  559 (683)
T KOG0696|consen  495 GMCKENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------------ELF  559 (683)
T ss_pred             cccccccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-------------HHH
Confidence            99985322  233456789999999999999999999999999999999999999999876543             222


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP  401 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  401 (451)
                      +.+.+..  ..++-..+.+..++....|...|.+|.
T Consensus       560 ~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  560 QAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HHHHHcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence            2333332  345666788899999999999999995

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.2e-36  Score=292.93  Aligned_cols=267  Identities=24%  Similarity=0.303  Sum_probs=192.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|++.++||.|+||.||+|.+.          .++..+|||.+......  ....+.+|+++++.++|+||+++++++
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   76 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQI----------KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMA   76 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEEC----------CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhe
Confidence            358999999999999999997643          34677999998654322  234567899999999999999999987


Q ss_pred             ecCC--------eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC
Q 013028          207 CDDQ--------HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF  278 (451)
Q Consensus       207 ~~~~--------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~  278 (451)
                      .+..        ..++||||+.+ +|...+... ...+++..+..++.|+++||.|||+  +||+|+||||+|||++.++
T Consensus        77 ~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~~~~~  152 (311)
T cd07866          77 VERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQG  152 (311)
T ss_pred             ecccccccccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCC
Confidence            5433        46999999964 777766543 3579999999999999999999999  8999999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCc---------ccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccC
Q 013028          279 NAKISDFGLAKFGPLGDKS---------HISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTN  348 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~  348 (451)
                      .++|+|||++.........         .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.....
T Consensus       153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~  232 (311)
T cd07866         153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD  232 (311)
T ss_pred             CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999753321111         11223467888999998765 4588999999999999999999999864332


Q ss_pred             CCC-----------CCccccccchhhhhhH-HhhhhhcCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          349 GLA-----------GNWAKPYLSNKLALHQ-IIDEKLGRN---IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       349 ~~~-----------~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...           ..+..+.......... .........   ........+.+++.+||..||.+|||+.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         233 IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            100           0000000000000000 000000000   001123678999999999999999999999863

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-36  Score=302.14  Aligned_cols=264  Identities=23%  Similarity=0.303  Sum_probs=194.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .+|.+.+.||.|+||.||+|..          ..++..||+|.+........+.+.+|+++++.++||||+++++++...
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~----------~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~   74 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVD----------SDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS   74 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEE----------CCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence            5899999999999999999764          445778999998766555667788999999999999999999876543


Q ss_pred             --------------CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC
Q 013028          210 --------------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD  275 (451)
Q Consensus       210 --------------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~  275 (451)
                                    ...++||||++ ++|.+++..   ..+++..+..++.||+.||.|||+  .||+||||||+||+++
T Consensus        75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~Nili~  148 (342)
T cd07854          75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFIN  148 (342)
T ss_pred             ccccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEc
Confidence                          35789999996 588887743   468899999999999999999999  8999999999999997


Q ss_pred             -CCCcEEEeecCCcccCCCCCC-cccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-
Q 013028          276 -DDFNAKISDFGLAKFGPLGDK-SHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-  351 (451)
Q Consensus       276 -~~~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-  351 (451)
                       .++.++|+|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|..||........ 
T Consensus       149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~  228 (342)
T cd07854         149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM  228 (342)
T ss_pred             CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             456789999999975322111 111123467889999998754 5688899999999999999999999964432100 


Q ss_pred             ----CCccccccchhhhhhHHhhh-----hhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 ----GNWAKPYLSNKLALHQIIDE-----KLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ----~~~~~~~~~~~~~~~~~~~~-----~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                          ....................     ......     ....+.++.+|+.+||..||.+|||+.+++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence                00000000000000000000     000000     11235778999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-36  Score=299.21  Aligned_cols=262  Identities=25%  Similarity=0.353  Sum_probs=195.1

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeecc
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLM  203 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~  203 (451)
                      ....++|.+.+.||.|+||.||+|..          ..++..||||.+.....  .....+.+|+.+|+.++|+||++++
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   80 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALD----------RRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL   80 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEE----------CCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccee
Confidence            44567899999999999999999764          34567899999864322  2235678899999999999999999


Q ss_pred             ceeecCC------eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC
Q 013028          204 GYCCDDQ------HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD  277 (451)
Q Consensus       204 ~~~~~~~------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~  277 (451)
                      +++..+.      ..++||||+ +++|.+++..   ..+++..+..++.||+.||.|||+  .||+||||||+||+++.+
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~--~gi~H~dlkp~Nill~~~  154 (343)
T cd07880          81 DVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNED  154 (343)
T ss_pred             eeecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCC
Confidence            9987654      358999999 7799887743   468999999999999999999999  899999999999999999


Q ss_pred             CcEEEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----
Q 013028          278 FNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----  351 (451)
Q Consensus       278 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----  351 (451)
                      +.++|+|||++.....     ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||........     
T Consensus       155 ~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~  229 (343)
T cd07880         155 CELKILDFGLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIM  229 (343)
T ss_pred             CCEEEeeccccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999975321     1223467889999999865 4588999999999999999999999864322100     


Q ss_pred             ---CCccccccch--hhhhhHHhhhh--hc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          352 ---GNWAKPYLSN--KLALHQIIDEK--LG----RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       352 ---~~~~~~~~~~--~~~~~~~~~~~--~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                         ......+...  ...........  ..    .......+..+.+++.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               0000000000  00000000000  00    0011233567899999999999999999999994

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.3e-36  Score=322.30  Aligned_cols=146  Identities=29%  Similarity=0.398  Sum_probs=129.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|.+.++||+|+||+||+|.+.          .++..||||++.......   ...+..|+.++..++|+||+++++++
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~----------~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~   73 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKK----------NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL   73 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEEC----------CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE
Confidence            48999999999999999997654          356789999997543222   35678899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      ....+.||||||+.|++|.+++..  ...+++..++.|+.||+.||.|||.  .+||||||||+||||+.++.++|+|||
T Consensus        74 ~~~~~~~lVmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~--~gIiHrDLKP~NILl~~~g~vkL~DFG  149 (669)
T cd05610          74 QSANNVYLVMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHR--HGIIHRDLKPDNMLISNEGHIKLTDFG  149 (669)
T ss_pred             EECCEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCccHHHEEEcCCCCEEEEeCC
Confidence            999999999999999999999854  3468899999999999999999999  899999999999999999999999999


Q ss_pred             Ccc
Q 013028          287 LAK  289 (451)
Q Consensus       287 la~  289 (451)
                      +++
T Consensus       150 ls~  152 (669)
T cd05610         150 LSK  152 (669)
T ss_pred             CCc
Confidence            986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.8e-36  Score=295.14  Aligned_cols=260  Identities=24%  Similarity=0.334  Sum_probs=196.0

Q ss_pred             HHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccc
Q 013028          127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       127 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      ..+++|++.+.||.|+||.||++.          +..++..||||.+.+..  ....+.+.+|+++++.++||||+++++
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   76 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSAR----------DQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD   76 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEE----------ECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEee
Confidence            456799999999999999999965          44557789999886432  223456788999999999999999999


Q ss_pred             eeec-CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          205 YCCD-DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       205 ~~~~-~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      +|.. ....++||||+ +++|.+++..   ..+++..+..++.|+++||.|||+  ++|+|+||+|+|||++.++.++|+
T Consensus        77 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili~~~~~~~l~  150 (328)
T cd07856          77 IFISPLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKIC  150 (328)
T ss_pred             eEecCCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeECCCCCEEeC
Confidence            9875 56789999999 5688887743   457888888999999999999999  899999999999999999999999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----------
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----------  351 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----------  351 (451)
                      |||++.....     ......++..|+|||++.+ ..++.++|||||||++|+|++|..||........           
T Consensus       151 dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~  225 (328)
T cd07856         151 DFGLARIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP  225 (328)
T ss_pred             ccccccccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999874221     1223467888999998765 5789999999999999999999999864322100           


Q ss_pred             -CCccccccchhhhhhHHhhhh-hcCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 -GNWAKPYLSNKLALHQIIDEK-LGRNIQ-----MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 -~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                       ..+.......  .....+... .....+     ...+..+.++|.+||+.+|++|||+.+++..
T Consensus       226 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         226 PDDVINTICSE--NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CHHHHHhccch--hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0000000000  000000000 000111     1235789999999999999999999999776

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-36  Score=298.83  Aligned_cols=267  Identities=24%  Similarity=0.333  Sum_probs=197.5

Q ss_pred             HHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCcee
Q 013028          123 GLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVV  200 (451)
Q Consensus       123 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv  200 (451)
                      ..+....++|.+.+.||+|+||.||+|..          ..++..||+|.+....  ....+.+.+|+.++++++|+||+
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv   79 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFD----------TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI   79 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEE----------cCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccc
Confidence            44556778999999999999999999764          3456789999987532  22245677899999999999999


Q ss_pred             eccceeecC------CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee
Q 013028          201 KLMGYCCDD------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL  274 (451)
Q Consensus       201 ~~~~~~~~~------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll  274 (451)
                      ++++++...      ...++|++++ +++|.+++..   ..+++..+..++.|++.||.|||+  .||+||||||+||++
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll  153 (345)
T cd07877          80 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAV  153 (345)
T ss_pred             ceeeeeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEE
Confidence            999988643      3468899987 7899887743   358999999999999999999999  899999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC-
Q 013028          275 DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG-  352 (451)
Q Consensus       275 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~-  352 (451)
                      +.++.++|+|||++....     .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... 
T Consensus       154 ~~~~~~kl~dfg~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~  228 (345)
T cd07877         154 NEDCELKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK  228 (345)
T ss_pred             cCCCCEEEeccccccccc-----ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999987422     11234568889999999866 56889999999999999999999998543211000 


Q ss_pred             ------Ccccc-ccch--hhhhhHHhh---hhhcCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          353 ------NWAKP-YLSN--KLALHQIID---EKLGRN---IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       353 ------~~~~~-~~~~--~~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                            ....+ ....  .......+.   ......   .....+..+.+|+.+||+.||.+||++.+++..=
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         229 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence                  00000 0000  000000000   000000   0012356789999999999999999999999874

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-36  Score=297.72  Aligned_cols=265  Identities=25%  Similarity=0.344  Sum_probs=195.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ..+|.+.+.||.|+||.||+|..          ..++..||||.+....  ......+.+|+.+++.++|+||+++++++
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~   83 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAID----------KRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVF   83 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEe----------CCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhhee
Confidence            46899999999999999999764          3457789999987532  22234578899999999999999999998


Q ss_pred             ecCC------eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          207 CDDQ------HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       207 ~~~~------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      ....      ..++||||+. .+|..++    ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dlkp~NIll~~~~~~  156 (342)
T cd07879          84 TSAVSGDEFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCEL  156 (342)
T ss_pred             cccccCCCCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCE
Confidence            7543      4589999995 4776655    3468899999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC------
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN------  353 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~------  353 (451)
                      +|+|||++.....     ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||..........      
T Consensus       157 kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~  231 (342)
T cd07879         157 KILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  231 (342)
T ss_pred             EEeeCCCCcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999875321     1223567888999999866 468999999999999999999999987532110000      


Q ss_pred             -ccccccchh---hhhhHHhhh---hhcCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhHH
Q 013028          354 -WAKPYLSNK---LALHQIIDE---KLGRN---IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA--LEQLQL  415 (451)
Q Consensus       354 -~~~~~~~~~---~~~~~~~~~---~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~  415 (451)
                       ...+...+.   ......+..   .....   .....+..+.+|+.+||+.||.+||++.+++.+  ++.++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence             000000000   000000000   00000   001234678999999999999999999999965  777654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=280.88  Aligned_cols=237  Identities=31%  Similarity=0.381  Sum_probs=192.9

Q ss_pred             ccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc---CHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       138 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      ||.|+||.||++...          ..+..+++|.+......   ....+..|+++++.++|+||+++++.+.++...++
T Consensus         1 lg~G~~~~v~~~~~~----------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   70 (250)
T cd05123           1 LGKGSFGKVLLVRKK----------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYL   70 (250)
T ss_pred             CCCCCceEEEEEEEC----------CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEE
Confidence            799999999997643          34678999998754332   34568889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCC
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG  294 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  294 (451)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++......
T Consensus        71 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          71 VLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            99999999999998543  468999999999999999999999  89999999999999999999999999999753322


Q ss_pred             CCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhc
Q 013028          295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG  374 (451)
Q Consensus       295 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (451)
                      .  .......++..|++||.+.+..++.++|+||||+++|+|++|..||.....             ......+..  ..
T Consensus       147 ~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------------~~~~~~~~~--~~  209 (250)
T cd05123         147 G--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------------KEIYEKILK--DP  209 (250)
T ss_pred             C--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------------HHHHHHHhc--CC
Confidence            1  123345688899999999888889999999999999999999999854321             001111111  12


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 013028          375 RNIQMEEAQEFAEIILRCLNSDPKNRPTMSE  405 (451)
Q Consensus       375 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  405 (451)
                      ...+...+..+.+++.+||..||++||++.+
T Consensus       210 ~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         210 LRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            2344445788999999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4e-36  Score=296.71  Aligned_cols=266  Identities=24%  Similarity=0.263  Sum_probs=191.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcC-CCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLN-HPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~-h~nIv~~~~~~~  207 (451)
                      +|.+.+.||+|+||.||++.....        ..+..||+|.+.....  .....+.+|+.+++.+. |+||+++++.+.
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~--------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   72 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAET--------SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDI   72 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCC--------CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeee
Confidence            477889999999999999875432        1156799999864322  22456788999999995 999999998754


Q ss_pred             c----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          208 D----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       208 ~----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      .    ....+++|||+. ++|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+
T Consensus        73 ~~~~~~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~kl~  147 (332)
T cd07857          73 VFPGNFNELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKIC  147 (332)
T ss_pred             eccccCCcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCEEeC
Confidence            2    245789999995 689888854  4578999999999999999999999  899999999999999999999999


Q ss_pred             ecCCcccCCCCCC--cccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc-cccc-
Q 013028          284 DFGLAKFGPLGDK--SHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW-AKPY-  358 (451)
Q Consensus       284 DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~-  358 (451)
                      |||++........  ........|+..|+|||++.+ ..++.++|||||||++|+|++|.+||........... .... 
T Consensus       148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  227 (332)
T cd07857         148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG  227 (332)
T ss_pred             cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence            9999975332211  111234578999999998755 5689999999999999999999998864321000000 0000 


Q ss_pred             cchhhhhhHHhh-------hhh--cC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          359 LSNKLALHQIID-------EKL--GR-----NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       359 ~~~~~~~~~~~~-------~~~--~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ......+..+..       ...  ..     ......+..+.+|+.+||+.||.+|||+.+++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000000000       000  00     0011125679999999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-38  Score=282.75  Aligned_cols=252  Identities=26%  Similarity=0.358  Sum_probs=195.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhc-CCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRL-NHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~  208 (451)
                      +.+-+..||.|+||+|++          -.++.+++..|||.++.... ..+..+..|++...+- +.||||++||++..
T Consensus        65 ~Lqdlg~iG~G~fG~V~K----------M~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~  134 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNK----------MLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS  134 (361)
T ss_pred             hHHHHHHhcCCcchhhhh----------hhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence            334457899999999998          66778899999999986544 4556778888875554 59999999999988


Q ss_pred             CCeeEEEEeccCCCChhhhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          209 DQHRLLVYEYVTRGSLEDHL---LNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l---~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +...+|.||+|+ .+|..+.   .......++++.+-.|....+.||.||-+. ..|||||+||+||||+..|.+|||||
T Consensus       135 EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  135 EGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             CCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecc
Confidence            888999999995 4665443   344567899999999999999999999885 68999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccc--cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIA--TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      |++...   ..+...+.-.|-..|||||.+.  +..|+.++||||||++|||+.||..|+..        |..    -.+
T Consensus       213 GIcGqL---v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~--------w~s----vfe  277 (361)
T KOG1006|consen  213 GICGQL---VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK--------WDS----VFE  277 (361)
T ss_pred             cchHhH---HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch--------HHH----HHH
Confidence            999642   2233344567888899999994  35699999999999999999999988642        111    112


Q ss_pred             hhhHHhhhhhcC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          364 ALHQIIDEKLGR----NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       364 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+.+++......    ......+..+..+|..||.+|-.+||...+++++
T Consensus       278 ql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  278 QLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            222332221111    1112357889999999999999999999998764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=286.82  Aligned_cols=268  Identities=31%  Similarity=0.464  Sum_probs=207.8

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHh--cCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSR--LNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~~~~~~~~  208 (451)
                      ...+.++||+|.||.||+|.+.            ++.||||++..   ...+.|.+|-+|++.  ++|+||++|+++-..
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~------------~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr  275 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD------------NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKR  275 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc------------CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence            4566789999999999998765            47799999963   445678888888776  479999999998665


Q ss_pred             CC----eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCceeCCCCCCceeeCCC
Q 013028          209 DQ----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTY-------WRPVIHRDVKASNVLLDDD  277 (451)
Q Consensus       209 ~~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-------~~~iiHrDlkp~NIll~~~  277 (451)
                      ++    .++||+||.+.|+|.++|..   ..++|.....|+..+++||+|||+.       ...|+|||||.+||||..|
T Consensus       276 ~t~~~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D  352 (534)
T KOG3653|consen  276 GTADRMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND  352 (534)
T ss_pred             CCccccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence            54    67899999999999999965   5689999999999999999999973       2469999999999999999


Q ss_pred             CcEEEeecCCcccCCCCCCcccccccCCCCccccccccccC-CCC-----cchhhHHHHHHHHHHHhCCCccccccCCCC
Q 013028          278 FNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLT-----LKTDVYSFGVVLLEILSGKTAAMRRTNGLA  351 (451)
Q Consensus       278 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~-----~~~DiwSlGvil~elltg~~pf~~~~~~~~  351 (451)
                      +...|+|||+|..+............+||..|||||+|.+. ++.     .+.||||+|.|||||++....+..   +..
T Consensus       353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~---~~v  429 (534)
T KOG3653|consen  353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP---GPV  429 (534)
T ss_pred             CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC---CCC
Confidence            99999999999876655444444557999999999999663 232     368999999999999998876643   112


Q ss_pred             CCccccccchh------hhhhHH-hhhhhcCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          352 GNWAKPYLSNK------LALHQI-IDEKLGRNIQME-----EAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       352 ~~~~~~~~~~~------~~~~~~-~~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      ..+.-+|..+.      +.++.. +.....+.++..     ...-+.+.+..||..|++-|.|+.=|-+.+.++......
T Consensus       430 p~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  430 PEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            22333333221      122222 233333333332     357789999999999999999999999999998776654

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-36  Score=286.59  Aligned_cols=262  Identities=24%  Similarity=0.315  Sum_probs=196.2

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      |+..+.||+|+||.||+|..          ..++..|++|.+....  ....+.+..|+.+++.++|+||+++++++.+.
T Consensus         1 y~~~~~ig~g~~~~vy~~~~----------~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   70 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARD----------KKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE   70 (282)
T ss_pred             CeeehcccccCcceEEEeee----------cCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC
Confidence            56678899999999999654          4457789999997653  23345678899999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||++ ++|.+++.... ..+++..+..++.+++.||.|||+  .||+|+||+|+||++++++.++|+|||++.
T Consensus        71 ~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~  146 (282)
T cd07829          71 RKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLAR  146 (282)
T ss_pred             CceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChheEEEcCCCCEEEecCCccc
Confidence            99999999997 58999886532 468999999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCCC-----------Ccccc
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG-----------NWAKP  357 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~-----------~~~~~  357 (451)
                      ......  .......++..|+|||.+.+. .++.++|||||||++|+|++|.+||.........           ...++
T Consensus       147 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
T cd07829         147 AFGIPL--RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP  224 (282)
T ss_pred             ccCCCc--cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHH
Confidence            543221  122234567789999998765 7899999999999999999999888653321000           00000


Q ss_pred             ccchhhhhhHHhhhhh---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          358 YLSNKLALHQIIDEKL---GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...+.......+....   ........+..+.+++.+||..||++||++.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            0000000000000000   000011225789999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=259.05  Aligned_cols=254  Identities=23%  Similarity=0.343  Sum_probs=196.4

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +|.-.++||+|.||+||+          +++..+.+.||+|.++-..  ........+|+.+|+.++|.|||+++++...
T Consensus         3 ~ydkmekigegtygtvfk----------arn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs   72 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFK----------ARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_pred             chHHHHhhcCCcceeeEe----------cccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc
Confidence            566678999999999999          6677889999999987432  2334567899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +..+-+|+|||+ .+|..+.... ++.++.+.+..++.|+++||.|||+  ++|.||||||.|+|++.+|.+||+|||++
T Consensus        73 dkkltlvfe~cd-qdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfgla  148 (292)
T KOG0662|consen   73 DKKLTLVFEFCD-QDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGLA  148 (292)
T ss_pred             CceeEEeHHHhh-HHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccchh
Confidence            999999999995 4888776554 5678999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCc-cccccCCCC-------------CC
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTA-AMRRTNGLA-------------GN  353 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~p-f~~~~~~~~-------------~~  353 (451)
                      +.+.  -........+-|..|.+|.++.+. -|+...|+||.|||+.|+.....| |.+...+..             ..
T Consensus       149 rafg--ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~  226 (292)
T KOG0662|consen  149 RAFG--IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ  226 (292)
T ss_pred             hhcC--CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence            8543  233344556779999999999874 589999999999999999875444 433222111             11


Q ss_pred             ccc----------cccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          354 WAK----------PYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       354 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      |..          +.......+.++         .+.....-++|+.+.|.-+|..|.+++++++.
T Consensus       227 wps~t~lpdyk~yp~ypattswsqi---------vp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  227 WPSMTKLPDYKPYPIYPATTSWSQI---------VPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCccccCCCCcccCCccccchHHHH---------hhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            111          000001111111         12223456789999999999999999998764

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-37  Score=278.41  Aligned_cols=272  Identities=25%  Similarity=0.330  Sum_probs=205.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ..|+-+.+||+|.||.||+          |+.+++++.||+|++-..+.  .--....+|+.+|..|+|+|++.++++|.
T Consensus        17 ~~yek~~kigqGtfgeVFk----------Ar~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~   86 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFK----------ARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR   86 (376)
T ss_pred             hHHHHHHhcCCchHHHHHH----------HhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence            4777789999999999999          67778888899987653222  22345578999999999999999998875


Q ss_pred             c--------CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          208 D--------DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       208 ~--------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      .        ....||||++|+. +|..+|.+. ...++..++..++.++++||.|+|+  ..|+|||+|+.|+||+.+|.
T Consensus        87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr--~kilHRDmKaaNvLIt~dgi  162 (376)
T KOG0669|consen   87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHR--NKILHRDMKAANVLITKDGI  162 (376)
T ss_pred             hccCCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHH--hhHHhhcccHhhEEEcCCce
Confidence            3        2347999999976 888887442 4679999999999999999999999  78999999999999999999


Q ss_pred             EEEeecCCcccCCCCCC--cccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----
Q 013028          280 AKISDFGLAKFGPLGDK--SHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----  351 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----  351 (451)
                      +||+|||+++.+....+  ....+..+-|..|++||.+.+ +.|+...|||..|||+.||+++.+.+.+.++...     
T Consensus       163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is  242 (376)
T KOG0669|consen  163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS  242 (376)
T ss_pred             EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence            99999999975443322  223455677999999999876 7899999999999999999999999988776522     


Q ss_pred             ---C---CccccccchhhhhhHHhhhhhcCC---------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          352 ---G---NWAKPYLSNKLALHQIIDEKLGRN---------IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       352 ---~---~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                         .   ...||..++-.-+..+-.+.+...         .+....++..+|+.++|..||.+|++++++++.--...+
T Consensus       243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence               1   122222221111111100101000         011124578899999999999999999999987544433

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-36  Score=297.86  Aligned_cols=261  Identities=25%  Similarity=0.350  Sum_probs=194.9

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      ..++|.+.+.||+|+||.||+|...          .++..||||.+....  ......+.+|+.+++.++|+||++++++
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~----------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   82 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDT----------KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV   82 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEEC----------CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHH
Confidence            3568999999999999999997654          346789999986432  2233556789999999999999999998


Q ss_pred             eecCCe------eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          206 CCDDQH------RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       206 ~~~~~~------~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      +.....      .++|+||+ +++|.+++..   ..+++..+..++.|++.||.|||+  .||+|+||||+||+++.++.
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~  156 (343)
T cd07851          83 FTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCE  156 (343)
T ss_pred             hhccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCC
Confidence            876554      89999999 6799998854   468999999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC----Cc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG----NW  354 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~----~~  354 (451)
                      ++|+|||++......     .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.........    ..
T Consensus       157 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~  231 (343)
T cd07851         157 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL  231 (343)
T ss_pred             EEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Confidence            999999999753221     234567889999999855 46789999999999999999999998643221000    00


Q ss_pred             cc----cccch--hhhhhHHhhhhhcC---C---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          355 AK----PYLSN--KLALHQIIDEKLGR---N---IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       355 ~~----~~~~~--~~~~~~~~~~~~~~---~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..    .+...  .......+......   .   .....+..+.+++.+||+.||++|||+.+|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            00    00000  00000000000000   0   001236789999999999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-36  Score=299.16  Aligned_cols=253  Identities=24%  Similarity=0.317  Sum_probs=195.2

Q ss_pred             HHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCce
Q 013028          123 GLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNV  199 (451)
Q Consensus       123 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nI  199 (451)
                      +.-+.....|..++-||-|+||.|.++.          +..+...+|.|.+++.+--.   ...+..|..||..-+.+-|
T Consensus       622 kRaKMdKSmFvkik~iGvGAFGeV~Lv~----------KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WV  691 (1034)
T KOG0608|consen  622 KRAKMDKSMFVKIKTIGVGAFGEVCLVR----------KVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWV  691 (1034)
T ss_pred             HHhhccccceEEEeeecccccceeEEEe----------ecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcce
Confidence            3334445678888999999999999954          44446678999988653322   2346789999999999999


Q ss_pred             eeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          200 VKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       200 v~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      |+||-.|.|++++|+||||++||++..+|.+  .+-|.++.+..++.++..|+++.|.  .|+|||||||+|||||.+|+
T Consensus       692 VrLyySFQDkdnLYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHk--mGFIHRDiKPDNILIDrdGH  767 (1034)
T KOG0608|consen  692 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGH  767 (1034)
T ss_pred             EEEEEEeccCCceEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHh--ccceecccCccceEEccCCc
Confidence            9999999999999999999999999999965  4678999999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcc----------------------------------------cccccCCCCccccccccccCC
Q 013028          280 AKISDFGLAKFGPLGDKSH----------------------------------------ISTRVLGTRGYFAPEYIATGH  319 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~----------------------------------------~~~~~~gt~~y~aPE~l~~~~  319 (451)
                      +||+||||+.-+.......                                        .....+||+.|+|||++....
T Consensus       768 IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g  847 (1034)
T KOG0608|consen  768 IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG  847 (1034)
T ss_pred             eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC
Confidence            9999999996221110000                                        011258999999999999999


Q ss_pred             CCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCC
Q 013028          320 LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKN  399 (451)
Q Consensus       320 ~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  399 (451)
                      |+..+|+||.|||||||+.|++||...++.....       ...+|...++-    ......+.++.++|.++.. +++.
T Consensus       848 ~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~-------kv~nw~~~l~~----~~~~~ls~e~~~li~kLc~-sad~  915 (1034)
T KOG0608|consen  848 YTQLCDWWSVGVILYEMLVGQPPFLADTPGETQY-------KVINWRNFLHI----PYQGNLSKEALDLIQKLCC-SADS  915 (1034)
T ss_pred             ccccchhhHhhHHHHHHhhCCCCccCCCCCccee-------eeeehhhcccc----ccccccCHHHHHHHHHHhc-Chhh
Confidence            9999999999999999999999999887753311       11122222222    2233345667777765443 4555


Q ss_pred             CC
Q 013028          400 RP  401 (451)
Q Consensus       400 RP  401 (451)
                      |.
T Consensus       916 RL  917 (1034)
T KOG0608|consen  916 RL  917 (1034)
T ss_pred             hh
Confidence            54

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=8e-36  Score=280.35  Aligned_cols=220  Identities=24%  Similarity=0.271  Sum_probs=176.7

Q ss_pred             cCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEEEEeccC
Q 013028          141 GGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVT  220 (451)
Q Consensus       141 G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV~E~~~  220 (451)
                      |.||.||++.          +..++..+|+|.+....     .+..|...+....||||+++++++.+.+..++||||++
T Consensus         4 g~~~~v~~~~----------~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   68 (237)
T cd05576           4 GVIDKVLLVM----------DTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAE   68 (237)
T ss_pred             cccceEEEEE----------EccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCC
Confidence            8999999955          55567889999997542     22345555555679999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccc
Q 013028          221 RGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS  300 (451)
Q Consensus       221 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  300 (451)
                      ||+|.+++...  ..+++..+..++.|++.||.|||+  +||+||||||+||+++.++.++|+|||.+.....     ..
T Consensus        69 ~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~  139 (237)
T cd05576          69 GGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SC  139 (237)
T ss_pred             CCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----cc
Confidence            99999998553  458999999999999999999999  8999999999999999999999999998764321     12


Q ss_pred             cccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHH
Q 013028          301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQME  380 (451)
Q Consensus       301 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (451)
                      ....++..|+|||.+.+..++.++|+||+|+++|+|++|..++......                   ........++..
T Consensus       140 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------------~~~~~~~~~~~~  200 (237)
T cd05576         140 DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------------------INTHTTLNIPEW  200 (237)
T ss_pred             ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------------cccccccCCccc
Confidence            2345577899999998888999999999999999999999876532111                   000011123334


Q ss_pred             HHHHHHHHHHHccccCCCCCCCH
Q 013028          381 EAQEFAEIILRCLNSDPKNRPTM  403 (451)
Q Consensus       381 ~~~~l~~li~~cl~~dP~~RPt~  403 (451)
                      .+..+.+++.+||+.||++||++
T Consensus       201 ~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         201 VSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             CCHHHHHHHHHHccCCHHHhcCC
Confidence            56789999999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=298.22  Aligned_cols=253  Identities=21%  Similarity=0.247  Sum_probs=209.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++..+.-||-|+||.|=+...++.          ...+|+|++++...   ..++.+..|-.||...+.|+||++|-.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~----------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf  489 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQ----------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF  489 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEeccc----------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence            3555667799999999999765542          22478888876533   2345577899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+..++||+||-|-||+|+..+..  .+.+++..+..++..+++|++|||+  +|||.|||||+|.||+.+|-+||.|||
T Consensus       490 rd~kyvYmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  490 RDSKYVYMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             ccchhhhhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHh--cCceeccCChhheeeccCCceEEeehh
Confidence            999999999999999999999954  5789999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +|+....   +..+-+++||+.|+|||++..+..+.++|.||||+++|||++|.+||.+..+-             ....
T Consensus       566 FAKki~~---g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-------------ktYn  629 (732)
T KOG0614|consen  566 FAKKIGS---GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-------------KTYN  629 (732)
T ss_pred             hHHHhcc---CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-------------HHHH
Confidence            9997443   33455789999999999999999999999999999999999999999865431             1122


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT-----MSEVVAALEQ  412 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~  412 (451)
                      .++...-...+|........+||+++...+|.+|..     +.++-++-..
T Consensus       630 ~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf  680 (732)
T KOG0614|consen  630 LILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF  680 (732)
T ss_pred             HHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence            333333344566777888999999999999999975     6666666544

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=304.87  Aligned_cols=255  Identities=29%  Similarity=0.435  Sum_probs=208.2

Q ss_pred             HHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccce
Q 013028          127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGY  205 (451)
Q Consensus       127 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~  205 (451)
                      ..++.|++.+.||.|.+|.||++          +++..+..+|+|+... .....++++.|.+||+.+. |||++.+||+
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~----------k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~   84 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKG----------RHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGA   84 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEE----------eeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEE
Confidence            34568899999999999999995          4666778899998864 3455677888999999986 9999999999


Q ss_pred             ee-----cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          206 CC-----DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       206 ~~-----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      |.     .++.++||||||.||+.-|++....+..+.|..++.|++.++.||.+||.  ..++|||||-.||||+.++.+
T Consensus        85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~--nkviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN--NKVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             EEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh--cceeeecccCceEEEeccCcE
Confidence            86     35778999999999999999987778899999999999999999999999  789999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA-----TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWA  355 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~  355 (451)
                      ||+|||++.....  ......+.+||++|||||++.     ...|+..+|+||||++..||--|.+|+....+..     
T Consensus       163 KLvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-----  235 (953)
T KOG0587|consen  163 KLVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-----  235 (953)
T ss_pred             EEeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-----
Confidence            9999999975432  222344678999999999994     3467889999999999999999999986543310     


Q ss_pred             ccccchhhhhhHHh-hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          356 KPYLSNKLALHQII-DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       356 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                              .+..+. ++......+...++++.++|..||..|-..||++.++|++
T Consensus       236 --------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  236 --------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             --------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                    001110 1111112345568999999999999999999999998863

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.3e-36  Score=265.72  Aligned_cols=286  Identities=22%  Similarity=0.344  Sum_probs=211.0

Q ss_pred             ccCCCCcccccccchhccccccccchHHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC
Q 013028           97 AARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK  176 (451)
Q Consensus        97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~  176 (451)
                      .++....+..+..+.++.+....+.++    ..++|++.+++|+|.|+.||.|.          +..++..++||+++. 
T Consensus         9 ~ARvya~vn~~rp~eYWdYE~~~i~wg----~~ddYeivrk~GRGKYSEVFeg~----------~~~~~eK~ViKiLKP-   73 (338)
T KOG0668|consen    9 VARVYADVNEERPREYWDYESLVIDWG----NQDDYEIVRKVGRGKYSEVFEGI----------NITNNEKCVIKILKP-   73 (338)
T ss_pred             hhhhhhhccccCchhhcchhheeeecc----ccchHHHHHHHcCccHhhHhccc----------ccCCCceEEEeeech-
Confidence            344444555566666777665555554    35689999999999999999965          445567799999863 


Q ss_pred             CCcCHHHHHHHHHHHHhcC-CCceeeccceeecCC--eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 013028          177 GSQGQDEWENELRFLSRLN-HPNVVKLMGYCCDDQ--HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE  253 (451)
Q Consensus       177 ~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~--~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~  253 (451)
                        ...+.+.+|+.||+.|. ||||++++++..+..  ...||+||+++.+...+.     ..++.-.+...+.+++.||.
T Consensus        74 --VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALd  146 (338)
T KOG0668|consen   74 --VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALD  146 (338)
T ss_pred             --HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHh
Confidence              34567899999999998 999999999998764  457999999887766654     44677778889999999999


Q ss_pred             HHHhCCCCceeCCCCCCceeeCC-CCcEEEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHH
Q 013028          254 HLHTYWRPVIHRDVKASNVLLDD-DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGV  331 (451)
Q Consensus       254 ~LH~~~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGv  331 (451)
                      |||+  +||+|||+||.|+|++. .-.++|+|||+|.++..+..   ..-.+.+.+|.-||++.. ..|+.+-|+|||||
T Consensus       147 yCHS--~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~Gc  221 (338)
T KOG0668|consen  147 YCHS--MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC  221 (338)
T ss_pred             HHHh--cCcccccCCcceeeechhhceeeeeecchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHH
Confidence            9999  99999999999999985 45799999999998654432   334567888999999865 67899999999999


Q ss_pred             HHHHHHhCCCccccccCCCC--CCccc--------cccc-hhhhhhHHhhhhh------------cCCCCHHHHHHHHHH
Q 013028          332 VLLEILSGKTAAMRRTNGLA--GNWAK--------PYLS-NKLALHQIIDEKL------------GRNIQMEEAQEFAEI  388 (451)
Q Consensus       332 il~elltg~~pf~~~~~~~~--~~~~~--------~~~~-~~~~~~~~~~~~~------------~~~~~~~~~~~l~~l  388 (451)
                      +|..|+..+.||+......+  ..-+.        .+.. -...+...++..+            ..+...-.++++.+|
T Consensus       222 mlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDl  301 (338)
T KOG0668|consen  222 MLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDL  301 (338)
T ss_pred             HHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHH
Confidence            99999999999876543321  00000        0000 0000001111101            011111225889999


Q ss_pred             HHHccccCCCCCCCHHHHHHH
Q 013028          389 ILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       389 i~~cl~~dP~~RPt~~evl~~  409 (451)
                      +.+.|..|-.+|+|+.|++.+
T Consensus       302 ldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  302 LDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHhhccccccchHHHhcC
Confidence            999999999999999999864

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=273.43  Aligned_cols=250  Identities=26%  Similarity=0.376  Sum_probs=203.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc---CHHHHHHHHHHHHhc-CCCceeeccc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ---GQDEWENELRFLSRL-NHPNVVKLMG  204 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l-~h~nIv~~~~  204 (451)
                      ...|.++++||+|+|..|.+          ++.+.+++.+|+|++++....   ..+-+..|-.+..+- +||++|.+..
T Consensus       249 l~df~ll~vigrgsyakvl~----------~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs  318 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLL----------VRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS  318 (593)
T ss_pred             cccceeeeeecCcchhhhhh----------eehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh
Confidence            45899999999999999998          556677899999999865332   334456788887776 4999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      +|..+..+++|.||++||+|.-++.+  ...++++.+..+...|..||.|||+  +|||.||||.+|+||+..|++||+|
T Consensus       319 cfqtesrlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~--rgiiyrdlkldnvlldaeghikltd  394 (593)
T KOG0695|consen  319 CFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTD  394 (593)
T ss_pred             hhcccceEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhh--cCeeeeeccccceEEccCCceeecc
Confidence            99999999999999999999877744  6789999999999999999999999  9999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      +|+++..  ...+....+++||+.|.|||++.+..|++.+|+|+|||+++||+.|+.||+--.-+....      .-..-
T Consensus       395 ygmcke~--l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~------ntedy  466 (593)
T KOG0695|consen  395 YGMCKEG--LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDM------NTEDY  466 (593)
T ss_pred             cchhhcC--CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCccc------chhHH
Confidence            9999842  234556678999999999999999999999999999999999999999997543221111      11111


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP  401 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  401 (451)
                      +.+++-+. ...++...+-....++...|++||++|.
T Consensus       467 lfqvilek-qiriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  467 LFQVILEK-QIRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             HHHHHhhh-cccccceeehhhHHHHHHhhcCCcHHhc
Confidence            22332221 2345555666777889999999999985

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=286.63  Aligned_cols=257  Identities=26%  Similarity=0.354  Sum_probs=201.2

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-------cCHHHHHHHHHHHHhcCCCcee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-------QGQDEWENELRFLSRLNHPNVV  200 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~h~nIv  200 (451)
                      +.++|-++.+||+|+|+.||+          |.+....++||||+......       ...+...+|..|-+.|.||.||
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyK----------AFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIV  530 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYK----------AFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIV  530 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHH----------hcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceee
Confidence            357899999999999999999          55677789999999753211       1112356799999999999999


Q ss_pred             eccceee-cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC---C
Q 013028          201 KLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD---D  276 (451)
Q Consensus       201 ~~~~~~~-~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~---~  276 (451)
                      ++|++|. +.+..|-|+|||+|.+|.-+|..  ...+++.++..|+.||+.||.||.+....|||-||||.||||.   .
T Consensus       531 KlYDyfslDtdsFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gta  608 (775)
T KOG1151|consen  531 KLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTA  608 (775)
T ss_pred             eeeeeeeeccccceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcc
Confidence            9999997 45677899999999999999854  5779999999999999999999998656799999999999995   4


Q ss_pred             CCcEEEeecCCcccCCCCCCc-----ccccccCCCCcccccccccc----CCCCcchhhHHHHHHHHHHHhCCCcccccc
Q 013028          277 DFNAKISDFGLAKFGPLGDKS-----HISTRVLGTRGYFAPEYIAT----GHLTLKTDVYSFGVVLLEILSGKTAAMRRT  347 (451)
Q Consensus       277 ~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~----~~~~~~~DiwSlGvil~elltg~~pf~~~~  347 (451)
                      -|.+||+|||++.........     .......||.+|++||.+.-    .+.+.++||||+|||+|..+.|+.||....
T Consensus       609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence            478999999999875543333     23445689999999998843    357889999999999999999999997543


Q ss_pred             CCCCCCccccccchhhhhh--HHhhhh-hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          348 NGLAGNWAKPYLSNKLALH--QIIDEK-LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ..            ...+.  .++... ......+..+.+..+||++||.+--++|....++..
T Consensus       689 sQ------------QdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  689 SQ------------QDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hH------------HHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            21            11111  111111 111223456788999999999999999999888764

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=299.56  Aligned_cols=263  Identities=24%  Similarity=0.375  Sum_probs=215.0

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC-CCcCHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      .+..++||.|+||+||+|.|-.-      ...-..+||+|++... ......++.+|..+|..|+|||++++++++....
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pe------ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPE------GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecC------CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence            34568899999999999998653      3334678999998754 3344578899999999999999999999998776


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                       +-||++|+++|.|.|+++.+ ...+-....+.|+.||++|+.|||+  ++++||||-.+|||+..-..+||+|||+++.
T Consensus       772 -~qlvtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~--qrlVHrdLaaRNVLVksP~hvkitdfgla~l  847 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEE--QRLVHRDLAARNVLVKSPNHVKITDFGLAKL  847 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh--cchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence             78999999999999999765 4567788899999999999999999  8999999999999999999999999999997


Q ss_pred             CCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          291 GPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       291 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ..............-..-|||-|.+....|+.++|||||||++|||+| |..|.++..              ...+..++
T Consensus       848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~--------------~~eI~dll  913 (1177)
T KOG1025|consen  848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP--------------AEEIPDLL  913 (1177)
T ss_pred             cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC--------------HHHhhHHH
Confidence            554333332222333456899999989999999999999999999998 666655432              22334555


Q ss_pred             hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcC
Q 013028          370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG  418 (451)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  418 (451)
                      ........++..+.++.-++.+||..|++.||+++++.+.+..+-.+..
T Consensus       914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence            5555556777888999999999999999999999999999988765543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-35  Score=279.12  Aligned_cols=262  Identities=28%  Similarity=0.415  Sum_probs=198.1

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHh--cCCCceeeccce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSR--LNHPNVVKLMGY  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~~~~~  205 (451)
                      +..+..+.+.||+|.||.||+|.|+            +..||||++..   .....+.+|.+|++.  |+|+||+.|+++
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr------------Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaa  273 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR------------GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAA  273 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc------------CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhc
Confidence            4568889999999999999999887            56799999964   344567889999887  589999999987


Q ss_pred             eecC----CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceeCCCCCCceeeC
Q 013028          206 CCDD----QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTY------WRPVIHRDVKASNVLLD  275 (451)
Q Consensus       206 ~~~~----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------~~~iiHrDlkp~NIll~  275 (451)
                      =..+    ..++||++|.+.|+|+|+|.+   ..++-+..+++++.++.||++||.+      ...|.|||||.+|||+.
T Consensus       274 D~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK  350 (513)
T KOG2052|consen  274 DNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  350 (513)
T ss_pred             cccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence            5433    357899999999999999965   5688899999999999999999962      13499999999999999


Q ss_pred             CCCcEEEeecCCcccCCCC-CCc-ccccccCCCCccccccccccCC----CC--cchhhHHHHHHHHHHHhCC-------
Q 013028          276 DDFNAKISDFGLAKFGPLG-DKS-HISTRVLGTRGYFAPEYIATGH----LT--LKTDVYSFGVVLLEILSGK-------  340 (451)
Q Consensus       276 ~~~~~kl~DFGla~~~~~~-~~~-~~~~~~~gt~~y~aPE~l~~~~----~~--~~~DiwSlGvil~elltg~-------  340 (451)
                      .++...|+|+|||...... +.. -.....+||..|||||+|...-    +.  ..+||||||.|+||+....       
T Consensus       351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e  430 (513)
T KOG2052|consen  351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE  430 (513)
T ss_pred             cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence            9999999999999864432 111 1234568999999999994421    11  2589999999999998532       


Q ss_pred             ---CccccccCCCCCCccccccchhhhhhHHh-hhhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          341 ---TAAMRRTNGLAGNWAKPYLSNKLALHQII-DEKLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       341 ---~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                         .||..-.+.+.         ..+....++ ...+.+.+     ..+....+.++|+.||..||.-|.|+--+-+.|.
T Consensus       431 ey~~Pyyd~Vp~DP---------s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~  501 (513)
T KOG2052|consen  431 EYQLPYYDVVPSDP---------SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLA  501 (513)
T ss_pred             hhcCCcccCCCCCC---------CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence               33332222111         111111111 22222222     3455678899999999999999999999999999


Q ss_pred             HhHHh
Q 013028          412 QLQLN  416 (451)
Q Consensus       412 ~~~~~  416 (451)
                      ++.+.
T Consensus       502 ~l~~~  506 (513)
T KOG2052|consen  502 KLSNS  506 (513)
T ss_pred             HHhcC
Confidence            88653

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=303.71  Aligned_cols=272  Identities=30%  Similarity=0.452  Sum_probs=213.4

Q ss_pred             HHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcC-CCceeec
Q 013028          125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLN-HPNVVKL  202 (451)
Q Consensus       125 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~-h~nIv~~  202 (451)
                      .+...++..+.+.||.|.||.|++|..+.-....   ......||||.+...... ..+.+..|+++|+.+. |+||+.+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~---~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKAL---LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeeccccc---ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhh
Confidence            3444555677789999999999999876421110   123668999999865433 4567899999999996 9999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCC
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNED------------D--TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVK  268 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlk  268 (451)
                      +|++......++|+||+..|+|.+++....            .  ..++....+.++.||+.|++||++  ..+|||||.
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--~~~vHRDLA  445 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--VPCVHRDLA  445 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh--CCccchhhh
Confidence            999999899999999999999999997654            0  138889999999999999999999  899999999


Q ss_pred             CCceeeCCCCcEEEeecCCcccCCCCCCcccccccCC--CCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccc
Q 013028          269 ASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG--TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMR  345 (451)
Q Consensus       269 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~  345 (451)
                      .+|||++.+..+||+|||+|+.......... ..-.|  ...|||||.+....|+.++|||||||+||||++ |..|+.+
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            9999999999999999999985332222111 11122  234999999988999999999999999999998 4444422


Q ss_pred             ccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          346 RTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                      -             .....+.+.+........+..+..++.++++.||+.+|++||++.++.+.|+....
T Consensus       525 ~-------------~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  525 I-------------PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             C-------------CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            0             00112223445555556677788999999999999999999999999999999644

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=5.4e-35  Score=284.01  Aligned_cols=276  Identities=25%  Similarity=0.314  Sum_probs=210.3

Q ss_pred             cccccchHHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC
Q 013028          116 KLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN  195 (451)
Q Consensus       116 ~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~  195 (451)
                      ...||.+...+.+..+|.+....|+|-|++|..|          ++...+..||||+|........ .=..|++||+.|+
T Consensus       418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra----------~D~~r~~~vAiKIIRnNE~M~K-tGl~EleiLkKL~  486 (752)
T KOG0670|consen  418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRA----------RDQARGQEVAIKIIRNNEVMHK-TGLKELEILKKLN  486 (752)
T ss_pred             ccceEEEehhhhhcceeEEEeccccceeeeeeec----------cccCCCCeeEEEEeecchHHhh-hhhHHHHHHHHhh
Confidence            3468888889999999999999999999999994          4555667899999986433322 2246999999995


Q ss_pred             ------CCceeeccceeecCCeeEEEEeccCCCChhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCC
Q 013028          196 ------HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNE-DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVK  268 (451)
Q Consensus       196 ------h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlk  268 (451)
                            --|+++++-.|...+|+|||+|-+ ..+|.+.|... .+..|....+..++.|++.||..|-.  .||+|.|||
T Consensus       487 ~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~--c~vlHaDIK  563 (752)
T KOG0670|consen  487 DADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK--CGVLHADIK  563 (752)
T ss_pred             ccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh--cCeeecccC
Confidence                  238999999999999999999998 56999988643 33567778899999999999999999  799999999


Q ss_pred             CCceeeCCC-CcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccc
Q 013028          269 ASNVLLDDD-FNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRT  347 (451)
Q Consensus       269 p~NIll~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  347 (451)
                      |+|||+++. ..+||||||.|.+...   ..++ -+.-+..|.|||++.|-.|++..|+||+||+||||+||+..|.+.+
T Consensus       564 PDNiLVNE~k~iLKLCDfGSA~~~~e---neit-PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  564 PDNILVNESKNILKLCDFGSASFASE---NEIT-PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             ccceEeccCcceeeeccCcccccccc---cccc-HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence            999999864 5689999999986332   2222 2345677999999999999999999999999999999999998877


Q ss_pred             CCCC--------CCccccccchhhhhhHHhhhhh-------------------------------------cCCCCHHHH
Q 013028          348 NGLA--------GNWAKPYLSNKLALHQIIDEKL-------------------------------------GRNIQMEEA  382 (451)
Q Consensus       348 ~~~~--------~~~~~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~  382 (451)
                      +...        ..+...++....-..+.|+..+                                     ...-.....
T Consensus       640 NN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~  719 (752)
T KOG0670|consen  640 NNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIV  719 (752)
T ss_pred             cHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHH
Confidence            6521        1111100000000001111100                                     111123346


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          383 QEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       383 ~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..|.+|+.+||..||.+|.|..++|.+
T Consensus       720 ~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  720 QQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             HHHHHHHHHHhccChhhcCCHHHHhcC
Confidence            789999999999999999999999864

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.7e-33  Score=286.71  Aligned_cols=276  Identities=17%  Similarity=0.202  Sum_probs=185.0

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhh------hhhcCCCcEEEEEEeccCCCcCHHH--------------HHHHH
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTA------ARRKNADFAVAVKRLRRKGSQGQDE--------------WENEL  188 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~------~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~E~  188 (451)
                      .++|++.++||+|+||+||+|.+.......      ......+..||||.+........++              ...|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            568999999999999999999864432111      1223445689999986433222222              23467


Q ss_pred             HHHHhcCCCce-----eeccceeec--------CCeeEEEEeccCCCChhhhhccCC----------------------C
Q 013028          189 RFLSRLNHPNV-----VKLMGYCCD--------DQHRLLVYEYVTRGSLEDHLLNED----------------------D  233 (451)
Q Consensus       189 ~il~~l~h~nI-----v~~~~~~~~--------~~~~~lV~E~~~gg~L~~~l~~~~----------------------~  233 (451)
                      .++..++|.++     ++++++|..        ....+|||||+++++|.+++....                      .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777776554     667777653        346799999999999999885421                      1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCcccccc
Q 013028          234 TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE  313 (451)
Q Consensus       234 ~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE  313 (451)
                      ..+++..+..++.|++.+|.|||+  .+|+||||||+|||++.++.++|+|||++......... ......+|+.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChh
Confidence            234677888999999999999999  89999999999999999999999999999743221111 111223478999999


Q ss_pred             ccccCC--------------------CC--cchhhHHHHHHHHHHHhCCC-ccccccCCCCCCccccccchhhhhhHHhh
Q 013028          314 YIATGH--------------------LT--LKTDVYSFGVVLLEILSGKT-AAMRRTNGLAGNWAKPYLSNKLALHQIID  370 (451)
Q Consensus       314 ~l~~~~--------------------~~--~~~DiwSlGvil~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (451)
                      ++....                    |+  ...||||+||++|+|++|.. ||........  ....+..+...+.....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~--~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT--ELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh--HHhhccchHHHHHhhcc
Confidence            885322                    11  24699999999999999875 5532211000  00000000111111111


Q ss_pred             hhhcCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 013028          371 EKLGRNIQMEEAQEFAEIILRCLNSDP---KNRPTMSEVVAA  409 (451)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~~  409 (451)
                      ...........++...+|+.+||..+|   .+|+|+.|+|++
T Consensus       459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            111122233456889999999999866   689999999875

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5e-33  Score=259.76  Aligned_cols=237  Identities=32%  Similarity=0.459  Sum_probs=191.7

Q ss_pred             CceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC-HHHHHHHHHHHHhcCCCceeeccceeecCCeeEEEEeccC
Q 013028          142 GFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVT  220 (451)
Q Consensus       142 ~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV~E~~~  220 (451)
                      +||.||+|.+.          .++..+++|++....... .+.+.+|++.++.++|+||+++++++......++||||+.
T Consensus         1 ~~g~v~~~~~~----------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   70 (244)
T smart00220        1 SFGKVYLARDK----------KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCD   70 (244)
T ss_pred             CceEEEEEEEC----------CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCC
Confidence            58999998754          346789999998655444 6788999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccc
Q 013028          221 RGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS  300 (451)
Q Consensus       221 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  300 (451)
                      +++|.+++....  .+++..+..++.+++.++.|||+  .+|+|+||+|+||+++.++.++|+|||.+.......   ..
T Consensus        71 ~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~  143 (244)
T smart00220       71 GGDLFDLLKKRG--RLSEDEARFYARQILSALEYLHS--NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LL  143 (244)
T ss_pred             CCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---cc
Confidence            999999985532  38899999999999999999999  899999999999999999999999999998643221   23


Q ss_pred             cccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHH
Q 013028          301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQME  380 (451)
Q Consensus       301 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (451)
                      ....++..|++||.+.+..++.++||||||+++|+|++|..||.....             .......+...........
T Consensus       144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-------------~~~~~~~~~~~~~~~~~~~  210 (244)
T smart00220      144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-------------LLELFKKIGKPKPPFPPPE  210 (244)
T ss_pred             ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------------HHHHHHHHhccCCCCcccc
Confidence            345678899999999888899999999999999999999988754211             1111111111111111111


Q ss_pred             --HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          381 --EAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       381 --~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                        .+.++.+++.+||..+|++||++.++++
T Consensus       211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence              5578999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=249.28  Aligned_cols=211  Identities=28%  Similarity=0.392  Sum_probs=171.1

Q ss_pred             ccchHHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhc-CC
Q 013028          119 YFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRL-NH  196 (451)
Q Consensus       119 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h  196 (451)
                      +++.+.++...+....+..||+|+||.|-+          .++..++...|+|.+.... .+.++.+.+|+.+..+. ..
T Consensus        35 ~I~~~~~eV~ad~L~~i~elGrGayG~vek----------mrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~C  104 (282)
T KOG0984|consen   35 YIGDRNFEVPADDLVGIEELGRGAYGVVEK----------MRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDC  104 (282)
T ss_pred             EEecCccccchhhhhhhhhhcCCccchhhh----------eeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCC
Confidence            344444555566777788999999999976          5677889999999997543 34456677888886655 59


Q ss_pred             CceeeccceeecCCeeEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee
Q 013028          197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL  274 (451)
Q Consensus       197 ~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll  274 (451)
                      |++|.+||.+..+...++.||.|+ .+|..+...  ..+..+++..+-+|+..+++||.|||+. ..|||||+||+|||+
T Consensus       105 Pf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLI  182 (282)
T KOG0984|consen  105 PFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILI  182 (282)
T ss_pred             CeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEE
Confidence            999999999999999999999995 577766532  2467899999999999999999999995 579999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccc----cCCCCcchhhHHHHHHHHHHHhCCCccc
Q 013028          275 DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA----TGHLTLKTDVYSFGVVLLEILSGKTAAM  344 (451)
Q Consensus       275 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~DiwSlGvil~elltg~~pf~  344 (451)
                      +.+|++|+||||.+.+..   .+-..+...|-..|||||.+.    ...|+.++||||||+.+.||.+++.|+.
T Consensus       183 n~~GqVKiCDFGIsG~L~---dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  183 NYDGQVKICDFGISGYLV---DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             ccCCcEEEcccccceeeh---hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            999999999999997532   122223346778899999984    3479999999999999999999998875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=9.9e-34  Score=296.47  Aligned_cols=268  Identities=19%  Similarity=0.244  Sum_probs=170.2

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccce--
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGY--  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~--  205 (451)
                      ..++|.+.++||+|+||.||+|++....      ...+..||||.+.....  .+.+..|  .++...+.++..++..  
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~------~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~  199 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQ------SKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFL  199 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCc------cccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhh
Confidence            3568999999999999999998865431      12267799998764321  1111111  1222223333333322  


Q ss_pred             ----eecCCeeEEEEeccCCCChhhhhccCCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 013028          206 ----CCDDQHRLLVYEYVTRGSLEDHLLNEDD------------------TELNWERRIKIALGAARGLEHLHTYWRPVI  263 (451)
Q Consensus       206 ----~~~~~~~~lV~E~~~gg~L~~~l~~~~~------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~ii  263 (451)
                          ...+...+|||||+.+++|.+++.....                  .......+..++.||+.||.|||+  ++|+
T Consensus       200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~--~gIi  277 (566)
T PLN03225        200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS--TGIV  277 (566)
T ss_pred             cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH--CCEE
Confidence                2355678999999999999998854321                  011233456799999999999999  8999


Q ss_pred             eCCCCCCceeeCC-CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccC----------------------CC
Q 013028          264 HRDVKASNVLLDD-DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG----------------------HL  320 (451)
Q Consensus       264 HrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~  320 (451)
                      ||||||+|||++. ++.+||+|||+|+..... .........+++.|+|||.+...                      .+
T Consensus       278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~  356 (566)
T PLN03225        278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL  356 (566)
T ss_pred             eCcCCHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence            9999999999985 579999999999753322 12233456889999999966322                      24


Q ss_pred             CcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcC------CCCHHHHHHHHHHHHHccc
Q 013028          321 TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGR------NIQMEEAQEFAEIILRCLN  394 (451)
Q Consensus       321 ~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~  394 (451)
                      +.++|||||||+||||+++..++............ ....+...+...+......      ...........+|+.+||+
T Consensus       357 ~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        357 PDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLK-RNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             CCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHH-hcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            45679999999999999876543321100000000 0000000111111111000      0001112345689999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 013028          395 SDPKNRPTMSEVVAA  409 (451)
Q Consensus       395 ~dP~~RPt~~evl~~  409 (451)
                      .||.+|||+.++|++
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999985

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=261.00  Aligned_cols=265  Identities=23%  Similarity=0.295  Sum_probs=195.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC--CCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +.+..+.||.|+||+||.          +.+..+++.||+|.+...  .....+.+.+|+++|..++|.|++..+++..-
T Consensus        54 Di~PDRPIGYGAFGVVWs----------VTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQP  123 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWS----------VTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQP  123 (449)
T ss_pred             cCCCCCcccccceeEEEe----------ccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCC
Confidence            455568899999999998          446677888999987532  22334668899999999999999999988764


Q ss_pred             CC-----eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          209 DQ-----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       209 ~~-----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      ..     .+|.|+|+|. .+|...+..  ...++.+.+.-+++||++||.|||+  .+|.||||||.|+|++.+..+|||
T Consensus       124 ph~dfFqEiYV~TELmQ-SDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHs--A~ILHRDIKPGNLLVNSNCvLKIC  198 (449)
T KOG0664|consen  124 ANPSFFQELYVLTELMQ-SDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHT--ANILHRDIKPGNLLVNSNCILKIC  198 (449)
T ss_pred             CCchHHHHHHHHHHHHH-hhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhh--cchhhccCCCccEEeccCceEEec
Confidence            42     3578899995 588888743  5778889999999999999999999  899999999999999999999999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc----
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY----  358 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~----  358 (451)
                      |||+++.-...+.. -++.-+-|-+|+|||+++| ..|+.++||||.|||+.||+..+..|....+-.........    
T Consensus       199 DFGLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTP  277 (449)
T KOG0664|consen  199 DFGLARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTP  277 (449)
T ss_pred             ccccccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCC
Confidence            99999964333322 3444567889999999988 57999999999999999999888888765432110000000    


Q ss_pred             -cch-----hhhhhHHhhhhhcC---------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          359 -LSN-----KLALHQIIDEKLGR---------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       359 -~~~-----~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                       .+.     ++.-..++......         ..+.....+..++..+++.+||++|.+..+++..+-
T Consensus       278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence             000     00000011100000         011122456778899999999999999999988654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-32  Score=258.42  Aligned_cols=277  Identities=23%  Similarity=0.342  Sum_probs=219.8

Q ss_pred             chHHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC-HHHHHHHHHHHHhcCCCce
Q 013028          121 CHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNHPNV  199 (451)
Q Consensus       121 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~nI  199 (451)
                      ...++....+++++..++-+|.||.||.|.|..     ..+..+.+.|.+|.++....+. ...+..|--.|..+.|||+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~e-----Edt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nl  349 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWRE-----EDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNL  349 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecc-----cCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCc
Confidence            345667778899999999999999999998764     2333445567788876543332 3456788889999999999


Q ss_pred             eeccceee-cCCeeEEEEeccCCCChhhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCce
Q 013028          200 VKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNE------DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV  272 (451)
Q Consensus       200 v~~~~~~~-~~~~~~lV~E~~~gg~L~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NI  272 (451)
                      +.+.+++. +....+.++.++.-|+|..+|...      ....++-.+...++.|++.|++|||+  .||||.||..+|.
T Consensus       350 l~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~--~~ViHkDiAaRNC  427 (563)
T KOG1024|consen  350 LSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN--HGVIHKDIAARNC  427 (563)
T ss_pred             cceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh--cCcccchhhhhcc
Confidence            99999875 456678899999999999998622      23456777888999999999999999  8999999999999


Q ss_pred             eeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCC
Q 013028          273 LLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLA  351 (451)
Q Consensus       273 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~  351 (451)
                      +|++..++||+|=.+++..-..+.......--....||+||.+....|+.++|+|||||++|||+| |+.|+-.-.    
T Consensus       428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID----  503 (563)
T KOG1024|consen  428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID----  503 (563)
T ss_pred             eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC----
Confidence            999999999999999985433443333333334456999999999999999999999999999998 555543211    


Q ss_pred             CCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcC
Q 013028          352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG  418 (451)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  418 (451)
                                .......+........+..+++++..++..||..+|++||++.|+...|.++...++
T Consensus       504 ----------PfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt  560 (563)
T KOG1024|consen  504 ----------PFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT  560 (563)
T ss_pred             ----------HHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence                      222334555666666788899999999999999999999999999999999876653

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=5.5e-33  Score=256.55  Aligned_cols=257  Identities=26%  Similarity=0.381  Sum_probs=196.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC--CCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .+|.-++.+|.|.- .|..          +.+...+..||+|.+...  .........+|..++..++|+||++++.+|.
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~----------a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ft   85 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVA----------AFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFT   85 (369)
T ss_pred             eeeeeecccCCCCc-eEEe----------cchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccC
Confidence            48888899999998 5544          557777889999987643  2333456788999999999999999999986


Q ss_pred             cC------CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEE
Q 013028          208 DD------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       208 ~~------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~k  281 (451)
                      -.      ...|+|||||. .+|...+.    -.++=+++..|..|++.|+.|||+  .||+||||||+||++..++.+|
T Consensus        86 P~~~l~~~~e~y~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~lK  158 (369)
T KOG0665|consen   86 PQKTLEEFQEVYLVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCTLK  158 (369)
T ss_pred             ccccHHHHHhHHHHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhhee
Confidence            33      45799999995 58888874    345567788999999999999999  8999999999999999999999


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccc-----
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK-----  356 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~-----  356 (451)
                      |.|||+|+.   ......++.++.|.+|.|||++.+..|...+||||+||++.||++|...|.+...-+  .|.+     
T Consensus       159 i~dfg~ar~---e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~id--Q~~ki~~~l  233 (369)
T KOG0665|consen  159 ILDFGLART---EDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHID--QWNKIIEQL  233 (369)
T ss_pred             eccchhhcc---cCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHH--HHHHHHHHh
Confidence            999999984   333346778899999999999999889999999999999999999998887543321  1111     


Q ss_pred             -----cccchhh----------------hhhHHhhhhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          357 -----PYLSNKL----------------ALHQIIDEKLG---RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       357 -----~~~~~~~----------------~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                           .+..+-.                .....+...+-   .+.+......+.+|+.+||-.||++|.++.++|.+
T Consensus       234 gtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  234 GTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             cCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                 0110000                00011110000   00112235678899999999999999999999974

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=280.83  Aligned_cols=244  Identities=32%  Similarity=0.437  Sum_probs=182.7

Q ss_pred             CCcCCcccccCceE-EEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccceeecC
Q 013028          132 FSEKNLIGQGGFGD-VYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYCCDD  209 (451)
Q Consensus       132 y~~~~~LG~G~~g~-Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~  209 (451)
                      |.-.+.+|.|+-|+ ||+|.+.            ++.||||.+-..   ..+-..+|+..|+.-+ |||||++|+.-.+.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye------------~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~  575 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE------------GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDR  575 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC------------CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCC
Confidence            44456799999875 7898875            467999988532   2334578999999886 99999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC---C--CcEEE
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD---D--FNAKI  282 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~---~--~~~kl  282 (451)
                      ...||+.|+|. .+|.+++...  ..........+.+..|++.||++||+  .+||||||||.||||+.   +  ..++|
T Consensus       576 qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~i  652 (903)
T KOG1027|consen  576 QFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKI  652 (903)
T ss_pred             ceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEe
Confidence            99999999995 5999999652  11111113356788999999999999  79999999999999965   3  47899


Q ss_pred             eecCCcccCCCCCCcc-cccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhC-CCccccccCCCCCCccccccc
Q 013028          283 SDFGLAKFGPLGDKSH-ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG-KTAAMRRTNGLAGNWAKPYLS  360 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~  360 (451)
                      +|||+++....+.... ......||.+|+|||++....-+.++|||||||++|..++| ..||........         
T Consensus       653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~---------  723 (903)
T KOG1027|consen  653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA---------  723 (903)
T ss_pred             cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh---------
Confidence            9999998655433222 23456799999999999888888899999999999999997 677764332211         


Q ss_pred             hhhhhhHHhhhhhcC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          361 NKLALHQIIDEKLGR-NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       361 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                            .++...... ........+..+||.+|++.+|..||++.+||.
T Consensus       724 ------NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  724 ------NILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ------hhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence                  111111000 000001117999999999999999999999974

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=274.79  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=205.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|+++..+|.|+||.||+          +++..++...|+|+++........-+..|+-+++..+|+|||-+++.+..
T Consensus        14 ~ddyellqrvgsgTygdvyK----------aRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr   83 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYK----------ARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR   83 (829)
T ss_pred             ccchhheeeecCCcccchhh----------hcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh
Confidence            45899999999999999999          78889999999999987766667777899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      .+.++++||||.||+|.+..+  -...+++.++...++..+.||+|||+  +|=+|||||-.|||+++.|.+|+.|||.+
T Consensus        84 ~dklwicMEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs--~gk~hRdiKGanilltd~gDvklaDfgvs  159 (829)
T KOG0576|consen   84 RDKLWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILLTDEGDVKLADFGVS  159 (829)
T ss_pred             hcCcEEEEEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhc--CCcccccccccceeecccCceeecccCch
Confidence            999999999999999999763  36889999999999999999999999  89999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCcccccccc---ccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYI---ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      -.+.  ........++||++|||||+.   ..+.|...+|||++|+...|+-.-++|.+...+-.             .+
T Consensus       160 aqit--ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------------~l  224 (829)
T KOG0576|consen  160 AQIT--ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------------AL  224 (829)
T ss_pred             hhhh--hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------------HH
Confidence            6432  122223468999999999987   34679999999999999999988777755332210             00


Q ss_pred             hHHhhhhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          366 HQIIDEKLG---RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       366 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      .-+....+.   .......++.+-+|++.+|..+|++|||+..+|.
T Consensus       225 ~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  225 FLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            000011110   1112234677999999999999999999987764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-32  Score=267.61  Aligned_cols=197  Identities=24%  Similarity=0.396  Sum_probs=167.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCH--------HHHHHHHHHHHhcC---CCc
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ--------DEWENELRFLSRLN---HPN  198 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~E~~il~~l~---h~n  198 (451)
                      ..|..++.||.|+||.|++|++          +.....|+||.|.+...-..        -.+-.|++||..|+   |+|
T Consensus       561 s~yttlq~lG~GAyGkV~lai~----------K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N  630 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIH----------KENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN  630 (772)
T ss_pred             ccceeeeeccccccceEEEeee----------cccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence            4699999999999999999764          44477899999875422111        11345999999997   999


Q ss_pred             eeeccceeecCCeeEEEEecc-CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC
Q 013028          199 VVKLMGYCCDDQHRLLVYEYV-TRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD  277 (451)
Q Consensus       199 Iv~~~~~~~~~~~~~lV~E~~-~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~  277 (451)
                      |++++++|++.++.||+||-- +|-+|+++|..  ...+++.++..|+.|++-|+++||+  +||||||||-+|+.++.+
T Consensus       631 IlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~--~~ivhrdikdenvivd~~  706 (772)
T KOG1152|consen  631 ILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHD--QGIVHRDIKDENVIVDSN  706 (772)
T ss_pred             hhhhhheeecCCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccc--cCceecccccccEEEecC
Confidence            999999999999999999975 45689999954  5679999999999999999999999  899999999999999999


Q ss_pred             CcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccc
Q 013028          278 FNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAM  344 (451)
Q Consensus       278 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~  344 (451)
                      |-+||+|||.|.+...    ..+..++||..|.|||++.|.+| +..-|||+||++||.++....||.
T Consensus       707 g~~klidfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  707 GFVKLIDFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             CeEEEeeccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999999986332    23456899999999999988777 567899999999999988877764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3.7e-30  Score=234.32  Aligned_cols=212  Identities=37%  Similarity=0.652  Sum_probs=181.6

Q ss_pred             ccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeecCCeeEEEE
Q 013028          138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVY  216 (451)
Q Consensus       138 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV~  216 (451)
                      ||.|++|.||++....          ++..+++|++...... ..+.+.+|+++++.++|++|+++++++......++||
T Consensus         1 l~~g~~~~v~~~~~~~----------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~   70 (215)
T cd00180           1 LGEGGFGTVYLARDKK----------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVM   70 (215)
T ss_pred             CCcCCceEEEEEEecC----------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEE
Confidence            6899999999987543          4677999998754332 3467889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC-CCcEEEeecCCcccCCCCC
Q 013028          217 EYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD-DFNAKISDFGLAKFGPLGD  295 (451)
Q Consensus       217 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~  295 (451)
                      |++.|++|.+++.... ..+++..+..++.+++.+|.+||+  .|++|+||+|.||+++. ++.++|+|||.+.......
T Consensus        71 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~  147 (215)
T cd00180          71 EYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK  147 (215)
T ss_pred             ecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence            9999999999985432 468899999999999999999999  89999999999999999 8999999999998543221


Q ss_pred             CcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhc
Q 013028          296 KSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG  374 (451)
Q Consensus       296 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (451)
                      .  ......+...|++||.+... .++.++|+|+||+++++|                                      
T Consensus       148 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------  187 (215)
T cd00180         148 S--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------  187 (215)
T ss_pred             c--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------
Confidence            1  23345678889999999776 888999999999999998                                      


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          375 RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       375 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                              ..+.+++..|+..||.+||++.++++.|
T Consensus       188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                    4589999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=4.6e-31  Score=252.22  Aligned_cols=269  Identities=25%  Similarity=0.372  Sum_probs=200.8

Q ss_pred             HHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeecc
Q 013028          125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLM  203 (451)
Q Consensus       125 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~  203 (451)
                      +..+...|..+++||.|+|++||++++..       ....+..||+|.+...  .....+.+|+++|..+. +.||+++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~-------~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~  101 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIE-------QDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLN  101 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhh-------hccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcch
Confidence            34456789999999999999999976422       1336789999998654  33456889999999997 99999999


Q ss_pred             ceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC-CCCcEEE
Q 013028          204 GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKI  282 (451)
Q Consensus       204 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~-~~~~~kl  282 (451)
                      +++..++.+++||||++...-.+++.     .++...+..+++.++.||.++|.  +|||||||||.|+|.+ ..+.-.|
T Consensus       102 ~~~rnnd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~L  174 (418)
T KOG1167|consen  102 GCFRNNDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVL  174 (418)
T ss_pred             hhhccCCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhc--cCccccCCCccccccccccCCceE
Confidence            99999999999999999988888763     46678899999999999999999  8999999999999998 4567899


Q ss_pred             eecCCcccCCCC-------C-------C------------------c----------ccccccCCCCcccccccccc-CC
Q 013028          283 SDFGLAKFGPLG-------D-------K------------------S----------HISTRVLGTRGYFAPEYIAT-GH  319 (451)
Q Consensus       283 ~DFGla~~~~~~-------~-------~------------------~----------~~~~~~~gt~~y~aPE~l~~-~~  319 (451)
                      +|||+|......       .       .                  +          .......||++|.|||++.+ ..
T Consensus       175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~  254 (418)
T KOG1167|consen  175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR  254 (418)
T ss_pred             EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence            999999711000       0       0                  0          00112469999999999976 45


Q ss_pred             CCcchhhHHHHHHHHHHHhCCCccccccCCCC---------------------C---Cccccccch----hhhhhHH-hh
Q 013028          320 LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA---------------------G---NWAKPYLSN----KLALHQI-ID  370 (451)
Q Consensus       320 ~~~~~DiwSlGvil~elltg~~pf~~~~~~~~---------------------~---~~~~~~~~~----~~~~~~~-~~  370 (451)
                      -+.++||||.|||++.+++++.||.....+..                     +   -|.......    ...+..+ +.
T Consensus       255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~  334 (418)
T KOG1167|consen  255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE  334 (418)
T ss_pred             cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence            68899999999999999999999998777643                     1   111111000    0001111 00


Q ss_pred             hhh-------cCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          371 EKL-------GRN-IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       371 ~~~-------~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...       ... .....+..+.+|+.+||..||.+|.|++++|++
T Consensus       335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            000       001 111224589999999999999999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.5e-30  Score=230.39  Aligned_cols=255  Identities=19%  Similarity=0.312  Sum_probs=188.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccc-ee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMG-YC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~-~~  206 (451)
                      .+.|.+.+.||.|.||.+-+          ++++.+...+++|-+.+. .....+|.+|..---.|. |.||+.-|+ .|
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL----------~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF   91 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILL----------AEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAF   91 (378)
T ss_pred             hhhhhHHHHhcccceeeEEe----------eeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHh
Confidence            45899999999999999999          456677888999998643 455778999998877787 899999887 46


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC--CCCcEEEee
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD--DDFNAKISD  284 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~--~~~~~kl~D  284 (451)
                      +..+..+++|||++.|+|..-+.   ...+-+.....++.|++.|+.|+|+  +++||||||.+||||-  +...+||||
T Consensus        92 qt~d~YvF~qE~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKlcD  166 (378)
T KOG1345|consen   92 QTSDAYVFVQEFAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKLCD  166 (378)
T ss_pred             hcCceEEEeeccCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEeee
Confidence            77788899999999999988773   3567788888999999999999999  8999999999999993  445899999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccC-----CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-----HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  359 (451)
                      ||+.+-..    .. -...-.+..|.+||++...     .....+|+|.||+++|.+++|+.||..........|.+.-+
T Consensus       167 FG~t~k~g----~t-V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w  241 (378)
T KOG1345|consen  167 FGLTRKVG----TT-VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW  241 (378)
T ss_pred             cccccccC----ce-ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH
Confidence            99987321    11 1112234569999987432     34678999999999999999999988554443322222111


Q ss_pred             chhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      .      +-....+. ..-...++.+..+.++-|..++++|=...++-+.-.
T Consensus       242 ~------~rk~~~~P-~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  242 L------KRKNPALP-KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             h------cccCccCc-hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            1      10111111 111223577889999999999999944444444433

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=8.2e-29  Score=229.17  Aligned_cols=200  Identities=34%  Similarity=0.494  Sum_probs=170.5

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      |.+.+.||.|++|.||+|....          ++..+++|.+...... ..+.+.+|++.++.++|+|++++++++....
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~----------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~   70 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG----------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE   70 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC----------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC
Confidence            5667899999999999987543          4677999999865544 5678889999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..++++|++++++|.+++..... .+++..+..++.+++.+|.+||+  .+++|+||+|.||+++.++.++|+|||.+..
T Consensus        71 ~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~  147 (225)
T smart00221       71 PLYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS--LGIVHRDLKPENILLGMDGLVKLADFGLARF  147 (225)
T ss_pred             ceEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence            99999999999999999865321 18899999999999999999999  7999999999999999999999999999986


Q ss_pred             CCCCCCcccccccCCCCcccccccc-ccCCCCcchhhHHHHHHHHHHHhCCCcccc
Q 013028          291 GPLGDKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGKTAAMR  345 (451)
Q Consensus       291 ~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~~DiwSlGvil~elltg~~pf~~  345 (451)
                      ..... ........++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       148 ~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      148 IHRDL-AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ecCcc-cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            44322 1122345678889999998 667788899999999999999999999854

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=7.7e-29  Score=271.36  Aligned_cols=197  Identities=19%  Similarity=0.246  Sum_probs=140.4

Q ss_pred             hcCC-Cceeeccceee-------cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 013028          193 RLNH-PNVVKLMGYCC-------DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIH  264 (451)
Q Consensus       193 ~l~h-~nIv~~~~~~~-------~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiH  264 (451)
                      .++| +||+.++++|.       +....+++||++ +++|.++|... ...+++.+++.++.||+.||.|||+  +||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS--QGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh--CCeee
Confidence            3455 58888888872       234567889988 66999999643 4569999999999999999999999  89999


Q ss_pred             CCCCCCceeeCCC-------------------CcEEEeecCCcccCCCCCC--------------cccccccCCCCcccc
Q 013028          265 RDVKASNVLLDDD-------------------FNAKISDFGLAKFGPLGDK--------------SHISTRVLGTRGYFA  311 (451)
Q Consensus       265 rDlkp~NIll~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~a  311 (451)
                      |||||+||||+..                   +.+||+|||+++.......              .......+||+.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            9999999999654                   4455666666643110000              000112468999999


Q ss_pred             ccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHH
Q 013028          312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILR  391 (451)
Q Consensus       312 PE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  391 (451)
                      ||++.+..|+.++|||||||+||||++|.+|+.....               ....+....+ ............+++.+
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------------~~~~~~~~~~-~~~~~~~~~~~~~~~~~  247 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---------------TMSSLRHRVL-PPQILLNWPKEASFCLW  247 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---------------HHHHHHHhhc-ChhhhhcCHHHHHHHHH
Confidence            9999999999999999999999999998877542110               0001110111 11111123456788999


Q ss_pred             ccccCCCCCCCHHHHHHH
Q 013028          392 CLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       392 cl~~dP~~RPt~~evl~~  409 (451)
                      ||+.+|.+||++.|+++.
T Consensus       248 ~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        248 LLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             hCCCChhhCcChHHHhhc
Confidence            999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=7.9e-27  Score=208.73  Aligned_cols=165  Identities=25%  Similarity=0.265  Sum_probs=127.7

Q ss_pred             CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCccccc
Q 013028          222 GSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST  301 (451)
Q Consensus       222 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  301 (451)
                      |+|.+++... ...+++..++.|+.|++.||.|||+  ++      ||+|||++.++.+++  ||++......       
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~--~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHR--QA------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh--cC------CcccEeEcCccceee--ccceEeeccc-------
Confidence            6899988643 4569999999999999999999999  66      999999999999999  9999863321       


Q ss_pred             ccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcC-----C
Q 013028          302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGR-----N  376 (451)
Q Consensus       302 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~  376 (451)
                      ...||+.|+|||++.+..++.++|||||||++|||++|..||......            ...+..+.......     .
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~------------~~~~~~~~~~~~~~~~~~~~  130 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL------------SAILEILLNGMPADDPRDRS  130 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh------------cHHHHHHHHHhccCCccccc
Confidence            126889999999999999999999999999999999999998643211            00111111111111     1


Q ss_pred             CCHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          377 IQMEEAQ--EFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       377 ~~~~~~~--~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      .......  ++.+++.+||..||.+||++.++++.+..+..+
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            1122233  699999999999999999999999999887554

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=6.7e-26  Score=222.68  Aligned_cols=274  Identities=22%  Similarity=0.238  Sum_probs=207.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCC----Cceeecccee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH----PNVVKLMGYC  206 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h----~nIv~~~~~~  206 (451)
                      +|.+.++||+|+||.||++......         ...+|+|............+..|+.+|..+..    .++..+++.+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~---------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G   89 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK---------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHG   89 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC---------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEec
Confidence            7999999999999999998754321         45688888765433322367789999999873    5899999988


Q ss_pred             -ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC-----CcE
Q 013028          207 -CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD-----FNA  280 (451)
Q Consensus       207 -~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~-----~~~  280 (451)
                       ..+...++||+.+ |.+|.++........++..+++.|+.|++.+|.+||+  .|++||||||.|+++...     ..+
T Consensus        90 ~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   90 RSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             cCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCcccceE
Confidence             5778899999999 8899998866667889999999999999999999999  899999999999999754     469


Q ss_pred             EEeecCCcccCC--CCCCc----cc--ccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC
Q 013028          281 KISDFGLAKFGP--LGDKS----HI--STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG  352 (451)
Q Consensus       281 kl~DFGla~~~~--~~~~~----~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  352 (451)
                      .|+|||+++...  .....    ..  .....||..|+++.+..+...+.+.|+||++.++.+|+.|..||.......  
T Consensus       167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~--  244 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD--  244 (322)
T ss_pred             EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc--
Confidence            999999998322  11111    11  223569999999999999999999999999999999999998864332210  


Q ss_pred             CccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCcccccc
Q 013028          353 NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTSLR  426 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~  426 (451)
                              ....+................+.++.++...+-..+...+|....+.+.|+.+....+.....+.+
T Consensus       245 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~d  310 (322)
T KOG1164|consen  245 --------LKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFD  310 (322)
T ss_pred             --------hHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCc
Confidence                    011111111111111112234566777777777799999999999999999998887666554444

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=3.9e-25  Score=205.47  Aligned_cols=266  Identities=20%  Similarity=0.239  Sum_probs=211.5

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~  209 (451)
                      .|+++++||+|+||+.+.|.          +.-.+.+||||.-...  .....+..|....+.|. .++|...|-+..++
T Consensus        29 hyrVGkKIGeGsFG~lf~G~----------Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG   96 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGK----------NLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG   96 (449)
T ss_pred             cceeccccccCcceeeeccc----------ccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence            89999999999999999975          5566889999976433  33455788999999987 79999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC-----CCcEEEee
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD-----DFNAKISD  284 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~-----~~~~kl~D  284 (451)
                      -+..||||++ |-+|.|++ +..+..|+..+++.++.|++.-++|+|+  +.+|.|||||+|+||..     ...+.|+|
T Consensus        97 ~~NiLVidLL-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~--k~LIYRDIKPdNFLIGrp~~k~~n~IhiiD  172 (449)
T KOG1165|consen   97 KYNILVIDLL-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHE--KDLIYRDIKPDNFLIGRPGTKDANVIHIID  172 (449)
T ss_pred             chhhhhhhhh-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHh--cceeecccCccceeecCCCCCCCceEEEEe
Confidence            9999999999 88998865 3457889999999999999999999999  89999999999999953     34689999


Q ss_pred             cCCcccCCCCCCcc-----cccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc
Q 013028          285 FGLAKFGPLGDKSH-----ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       285 FGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  359 (451)
                      ||+|+.+.......     ......||..||+.....++.-+.+.|+-|||-++...|-|..||.+...+.         
T Consensus       173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t---------  243 (449)
T KOG1165|consen  173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT---------  243 (449)
T ss_pred             ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc---------
Confidence            99998655332211     1234679999999999999999999999999999999999999988654321         


Q ss_pred             chhhhhhHHhhhhhcCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCcc
Q 013028          360 SNKLALHQIIDEKLGRN---IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ  422 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~  422 (451)
                       .+...+.+-+..-...   .....+.++...+...-..+-.+-|+.+-+...+..+.+..+.+.+
T Consensus       244 -nK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~D  308 (449)
T KOG1165|consen  244 -NKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDD  308 (449)
T ss_pred             -hHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccc
Confidence             1112222221111111   1223467888888888889999999999999999998888777655

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=6e-26  Score=223.45  Aligned_cols=166  Identities=23%  Similarity=0.239  Sum_probs=126.6

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-----CcCHHHHHHHHHHHHhcCCCceee-
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-----SQGQDEWENELRFLSRLNHPNVVK-  201 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~-  201 (451)
                      +..+|.+.+.||+|+||+||+|.+..         .++..||||++....     ......+.+|+++|+.++|+||+. 
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~---------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~   86 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAG---------DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ   86 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcC---------CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence            45689999999999999999986532         135568999875331     112456889999999999999985 


Q ss_pred             ccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCC-CCCceeeCCCCcE
Q 013028          202 LMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDV-KASNVLLDDDFNA  280 (451)
Q Consensus       202 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDl-kp~NIll~~~~~~  280 (451)
                      +++.    ...||||||++|++|.. +..  ..      ...++.+++++|.|||+  +||+|||| ||+|||++.++.+
T Consensus        87 l~~~----~~~~LVmE~~~G~~L~~-~~~--~~------~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~i  151 (365)
T PRK09188         87 LLAT----GKDGLVRGWTEGVPLHL-ARP--HG------DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEA  151 (365)
T ss_pred             EEEc----CCcEEEEEccCCCCHHH-hCc--cc------hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCE
Confidence            4432    45799999999999963 211  11      14678899999999999  89999999 9999999999999


Q ss_pred             EEeecCCcccCCCCCCccc------ccccCCCCcccccccccc
Q 013028          281 KISDFGLAKFGPLGDKSHI------STRVLGTRGYFAPEYIAT  317 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~------~~~~~gt~~y~aPE~l~~  317 (451)
                      +|+|||+|+..........      -....+++.|+|||.+..
T Consensus       152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9999999986443221111      135678899999999854

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=5.8e-24  Score=205.82  Aligned_cols=253  Identities=33%  Similarity=0.480  Sum_probs=195.5

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCC-ceeeccceee
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHP-NVVKLMGYCC  207 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~-nIv~~~~~~~  207 (451)
                      |.+.+.||.|+||.||++...             ..+++|.+.......   ...+.+|+.++..+.|+ +|+++++.+.
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~   68 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ   68 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe
Confidence            677889999999999998754             568999987654432   56788999999999988 7999999998


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC-cEEEeec
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF-NAKISDF  285 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~-~~kl~DF  285 (451)
                      .....+++++++.+++|.+++..... ..+.......++.|++.++.|+|+  .+++|||+||+||+++..+ .++++||
T Consensus        69 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~~~~~~~~~l~df  146 (384)
T COG0515          69 DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDF  146 (384)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeecCCCCeEEEecc
Confidence            77778999999999999966643221 268899999999999999999999  8999999999999999988 7999999


Q ss_pred             CCcccCCCCCCcc----cccccCCCCcccccccccc---CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          286 GLAKFGPLGDKSH----ISTRVLGTRGYFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       286 Gla~~~~~~~~~~----~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                      |.+..........    ......|+..|+|||++.+   ..++...|+||+|++++++++|..||......         
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---------  217 (384)
T COG0515         147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---------  217 (384)
T ss_pred             CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---------
Confidence            9997433222211    3456789999999999977   57889999999999999999999985543321         


Q ss_pred             cchhhhhhHHhhhhhc----CCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          359 LSNKLALHQIIDEKLG----RNIQ----MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~----~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                       .........+.....    ....    ......+.+++..|+..+|..|.+..+....
T Consensus       218 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         218 -SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             000011111111111    1111    1123578999999999999999998888775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=2e-26  Score=240.95  Aligned_cols=255  Identities=22%  Similarity=0.277  Sum_probs=187.7

Q ss_pred             CcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC--CCcCH----HHHHHHHHHHHhcCCCceeecccee
Q 013028          133 SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQ----DEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       133 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~----~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .....+|.|++|.|+.....          .....++.|.+...  .....    ..+..|+.+-..+.|+|++..+..+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~----------~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~  390 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRR----------SDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIV  390 (601)
T ss_pred             CccceeeecccCceEEEEec----------CCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHH
Confidence            45678999999977765432          12222333332210  11111    1255688888889999999988887


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+.....-+||||++ +|+.++..  ...+...++..++.|++.||.|||+  .||.|||||++|++++.+|.+||+|||
T Consensus       391 ~~~~~~~~~mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  391 QEIDGILQSMEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             hhcccchhhhhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEEecCCceEEeecC
Confidence            776665556999999 99999855  3568888899999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCc--ccccccCCCCccccccccccCCCCc-chhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          287 LAKFGPLGDKS--HISTRVLGTRGYFAPEYIATGHLTL-KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       287 la~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~-~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      .+..+......  .....++|+..|+|||++.+..|+. .+||||.|+++..|.+|+.||..............+..   
T Consensus       466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~---  542 (601)
T KOG0590|consen  466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD---  542 (601)
T ss_pred             cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc---
Confidence            99865544433  5667889999999999999999976 58999999999999999998876554322110000000   


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                         +.-...-...+....+...+.+|.+||+.||.+|.|+.+|++
T Consensus       543 ---~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  543 ---QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ---ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence               000000011123344677899999999999999999999986

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=4.3e-25  Score=196.91  Aligned_cols=268  Identities=22%  Similarity=0.245  Sum_probs=205.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~  207 (451)
                      ..+|.++++||.|+||.+|+|.          ...++..||||+-......  ..+.-|..+.+.|+ -..|..+..++.
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~----------~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~   81 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGI----------SITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGT   81 (341)
T ss_pred             ccceEEEEeecCCchhheeeee----------eccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhcc
Confidence            3589999999999999999965          4556888999987644332  34667999999998 568999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC---CCcEEEee
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD---DFNAKISD  284 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~---~~~~kl~D  284 (451)
                      +..+..||||++ |.+|.+++.- ....++-.+++.++-|++.-++|+|.  +++|||||||+|+|+.-   -..+.|+|
T Consensus        82 e~~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~LID  157 (341)
T KOG1163|consen   82 EKDYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYLID  157 (341)
T ss_pred             ccccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHh--hccccccCCccceeeccccccceEEEEe
Confidence            999999999999 8899987754 35678999999999999999999999  89999999999999963   34799999


Q ss_pred             cCCcccCCCCCC-cc----cccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc
Q 013028          285 FGLAKFGPLGDK-SH----ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       285 FGla~~~~~~~~-~~----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  359 (451)
                      ||+|+.+..... .+    ......||..|.+-....+..-+.+.|+-|+|.+|..+.-|..||.+......        
T Consensus       158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk--------  229 (341)
T KOG1163|consen  158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK--------  229 (341)
T ss_pred             ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH--------
Confidence            999985432211 11    23357899999998877777778899999999999999999999876543211        


Q ss_pred             chhhhhhHHhhhhhcCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCcc
Q 013028          360 SNKLALHQIIDEKLGRN---IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ  422 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~  422 (451)
                        ......+........   .....+.++.-.+..|-..--++-|+..-+.+.++-+...+....+
T Consensus       230 --~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d  293 (341)
T KOG1163|consen  230 --KQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYD  293 (341)
T ss_pred             --HHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCC
Confidence              111112222222111   1222367788888899888888899988888888887776665544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.2e-25  Score=201.86  Aligned_cols=252  Identities=20%  Similarity=0.361  Sum_probs=200.2

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC--CCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ...+..+|.....|..|+|.|-.            ..+++|++.-.  ......+|..|.-.|+.+.||||+.+++.|..
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqg------------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns  258 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQG------------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS  258 (448)
T ss_pred             hhhhhhhhccCCCcccccccccC------------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC
Confidence            34455778999999999998753            23556665432  22334578899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ..++.++..||+.|+|+..+........+-.++..++.++++|++|||+...-|----|....+++|++.+.+|. .+-+
T Consensus       259 ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~  337 (448)
T KOG0195|consen  259 PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADT  337 (448)
T ss_pred             CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccc
Confidence            999999999999999999998877777888899999999999999999963334456789999999999877763 2222


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCC---cchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLT---LKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      ++ .+.     .......+.||+||.+..++-+   .++|+|||+++||||.|...||....+             .+.-
T Consensus       338 kf-sfq-----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp-------------mecg  398 (448)
T KOG0195|consen  338 KF-SFQ-----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP-------------MECG  398 (448)
T ss_pred             ee-eee-----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc-------------hhhh
Confidence            21 111     1123457789999999776544   478999999999999999999865432             2222


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                      ..+.-+.+...+++..+..+.+|+.-|++.||.+||.++.++-+|++++
T Consensus       399 mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  399 MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            3556677888899999999999999999999999999999999999875

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=9.3e-24  Score=194.05  Aligned_cols=173  Identities=14%  Similarity=0.138  Sum_probs=134.3

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHH---------HHHHHHHHHhcCC
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE---------WENELRFLSRLNH  196 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~il~~l~h  196 (451)
                      ..+..+|++.+.||.|+||.||+...            .+..+|||++..........         +++|++.+.++.|
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~------------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~   94 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT------------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRS   94 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec------------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHH
Confidence            45678999999999999999998532            14469999997654443332         6789999999999


Q ss_pred             CceeeccceeecC--------CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCC
Q 013028          197 PNVVKLMGYCCDD--------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVK  268 (451)
Q Consensus       197 ~nIv~~~~~~~~~--------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlk  268 (451)
                      ++|..+.+++.+.        ...+|||||++|.+|.++.      .+++    ....+++.+|..||.  .||+|||+|
T Consensus        95 ~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~--~gi~H~Dik  162 (232)
T PRK10359         95 EGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQ--HGMVSGDPH  162 (232)
T ss_pred             CCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHH--cCCccCCCC
Confidence            9999999886643        3478999999999998763      1222    245689999999999  899999999


Q ss_pred             CCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHH
Q 013028          269 ASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEIL  337 (451)
Q Consensus       269 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell  337 (451)
                      |+||+++.+| ++|+|||...........              ..++....|+.++|+|+||+.+..+.
T Consensus       163 p~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        163 KGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             hHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            9999999988 999999998743211100              01334556778999999999987664

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.5e-22  Score=183.28  Aligned_cols=138  Identities=20%  Similarity=0.171  Sum_probs=106.5

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--C------------------------HHHHHHHH
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--G------------------------QDEWENEL  188 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~  188 (451)
                      ...||+|+||.||+|..          . ++..||||+++.....  .                        ......|+
T Consensus         2 ~~~ig~G~~~~Vy~a~~----------~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   70 (190)
T cd05147           2 NGCISTGKEANVYHATT----------A-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEM   70 (190)
T ss_pred             CCccccccceEEEEEEC----------C-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHH
Confidence            46899999999999753          2 5788999999753211  1                        01224599


Q ss_pred             HHHHhcCCCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeCCC
Q 013028          189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL-HTYWRPVIHRDV  267 (451)
Q Consensus       189 ~il~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~iiHrDl  267 (451)
                      ++|..+.++++.........  ..+|||||++|++|...+..  ...+++..+..++.|++.+|.+| |+  .||+||||
T Consensus        71 ~~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDl  144 (190)
T cd05147          71 RNLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQD--CRLVHADL  144 (190)
T ss_pred             HHHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCC
Confidence            99999988877544433222  23899999998877654322  35688999999999999999999 67  79999999


Q ss_pred             CCCceeeCCCCcEEEeecCCccc
Q 013028          268 KASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       268 kp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ||+|||+++ +.++|+|||+|..
T Consensus       145 kP~NIli~~-~~v~LiDFG~a~~  166 (190)
T cd05147         145 SEYNLLYHD-GKLYIIDVSQSVE  166 (190)
T ss_pred             CHHHEEEEC-CcEEEEEcccccc
Confidence            999999984 6899999999974

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=5.8e-23  Score=215.69  Aligned_cols=246  Identities=22%  Similarity=0.277  Sum_probs=175.6

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHH---HHHHHHhcCCCceeecccee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWEN---ELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~---E~~il~~l~h~nIv~~~~~~  206 (451)
                      .|...+.||++.|=.|.+|.+..            -.|+||++-+... -....+.+   |++ ...++|||.+.+.-+-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e------------G~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~   90 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE------------GLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL   90 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC------------ceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH
Confidence            56667899999999998865433            2489999876553 33344433   444 4556899999999887


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      ......|||-+|+.. +|+|++..  ...+..-+...|+.||+.||.-||.  .||+|||||.+||||+.-.-+.|+||.
T Consensus        91 ~t~kAAylvRqyvkh-nLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~--~gVcHGDIKsENILiTSWNW~~LtDFA  165 (1431)
T KOG1240|consen   91 VTDKAAYLVRQYVKH-NLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHK--LGVCHGDIKSENILITSWNWLYLTDFA  165 (1431)
T ss_pred             HhhHHHHHHHHHHhh-hhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHH--cCccccccccceEEEeeechhhhhccc
Confidence            777788999999965 99999943  4556777788899999999999999  899999999999999998889999997


Q ss_pred             Ccc--cCCCCCCc---ccccccCCCCccccccccccC-----------CCCcchhhHHHHHHHHHHHhC-CCccccccCC
Q 013028          287 LAK--FGPLGDKS---HISTRVLGTRGYFAPEYIATG-----------HLTLKTDVYSFGVVLLEILSG-KTAAMRRTNG  349 (451)
Q Consensus       287 la~--~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~-----------~~~~~~DiwSlGvil~elltg-~~pf~~~~~~  349 (451)
                      .-+  +.+..+..   ..+.+-..-.+|+|||.+...           ..+++.||||+||++.||++- +++|.--.- 
T Consensus       166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-  244 (1431)
T KOG1240|consen  166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-  244 (1431)
T ss_pred             ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-
Confidence            654  22222211   122222334579999988431           157789999999999999985 666642100 


Q ss_pred             CCCCccccccch-hhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          350 LAGNWAKPYLSN-KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       350 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                            -.|... ......++..     +   ....++.++..|++.||.+|.++++.|+.
T Consensus       245 ------~aYr~~~~~~~e~~Le~-----I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  245 ------LAYRSGNADDPEQLLEK-----I---EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ------HhHhccCccCHHHHHHh-----C---cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence                  001110 1111111111     1   12369999999999999999999999987

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5e-22  Score=188.72  Aligned_cols=264  Identities=21%  Similarity=0.283  Sum_probs=179.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhh-------------------------hhhcCCCcEEEEEEeccCCCcC-HHH
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTA-------------------------ARRKNADFAVAVKRLRRKGSQG-QDE  183 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~-------------------------~~~~~~~~~vavK~~~~~~~~~-~~~  183 (451)
                      ++|++++.||+|....||.+.+.+.+...                         -+-.....+.|||++-.....+ ...
T Consensus       157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~~  236 (598)
T KOG4158|consen  157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDAH  236 (598)
T ss_pred             hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchHH
Confidence            47999999999999999998875411100                         0111223456777764332222 111


Q ss_pred             H----HHHHH------H--------HH-------hc-CCCceeeccceeec---------------------------CC
Q 013028          184 W----ENELR------F--------LS-------RL-NHPNVVKLMGYCCD---------------------------DQ  210 (451)
Q Consensus       184 ~----~~E~~------i--------l~-------~l-~h~nIv~~~~~~~~---------------------------~~  210 (451)
                      +    -+|.-      .        .+       +| +|||||++.++|.+                           +.
T Consensus       237 iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~  316 (598)
T KOG4158|consen  237 ILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPK  316 (598)
T ss_pred             HHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCc
Confidence            1    11211      0        11       12 59999999998854                           23


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC--CCC--cEEEeecC
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD--DDF--NAKISDFG  286 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~--~~~--~~kl~DFG  286 (451)
                      .+|+||.-.+. +|.+++..   ...+.....-++.|+++|+.|||.  +||.|||+|.+||||.  +|+  .+.|+|||
T Consensus       317 tlylvMkrY~~-tLr~yl~~---~~~s~r~~~~~laQlLEav~hL~~--hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG  390 (598)
T KOG4158|consen  317 TLYLVMKRYRQ-TLREYLWT---RHRSYRTGRVILAQLLEAVTHLHK--HGVAHRDLKSDNILLELDDDEIPQLVVADFG  390 (598)
T ss_pred             eEEEehhcchh-hHHHHHhc---CCCchHHHHHHHHHHHHHHHHHHH--ccchhhcccccceEEEecCCCCcEEEEcccc
Confidence            57899987754 89888854   345667777899999999999999  8999999999999994  443  47899999


Q ss_pred             CcccCCC----CCCcccccccCCCCccccccccccCC-----CC-cchhhHHHHHHHHHHHhCCCccccccCCCCCCccc
Q 013028          287 LAKFGPL----GDKSHISTRVLGTRGYFAPEYIATGH-----LT-LKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK  356 (451)
Q Consensus       287 la~~~~~----~~~~~~~~~~~gt~~y~aPE~l~~~~-----~~-~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~  356 (451)
                      .+--...    .......-+.-|....||||+....+     .+ .++|.|+.|-+.||++....||....+...     
T Consensus       391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-----  465 (598)
T KOG4158|consen  391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-----  465 (598)
T ss_pred             eeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-----
Confidence            8753211    11111223456788899999985422     11 378999999999999999999976332110     


Q ss_pred             cccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          357 PYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                         +    . ....+...+..+..+++.+++|+...|+.||.+|++..-+.+.|+-
T Consensus       466 ---~----~-r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~L  513 (598)
T KOG4158|consen  466 ---D----T-RTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNL  513 (598)
T ss_pred             ---c----h-hhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence               0    0 0122222344566778889999999999999999998888887765

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=2.3e-22  Score=190.31  Aligned_cols=233  Identities=18%  Similarity=0.281  Sum_probs=148.0

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc---CHHHHHHHHHHHHhcCC----------C
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ---GQDEWENELRFLSRLNH----------P  197 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h----------~  197 (451)
                      .+..++.||.|+++.||.++          +..+++.+|||++......   ..+.+++|.-....+.+          -
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~----------d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~   82 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVT----------DVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHL   82 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEE----------ETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH
T ss_pred             EEEEccccccCCceEEEEEE----------EccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhc
Confidence            44567889999999999965          5566889999998644322   23556666544444322          1


Q ss_pred             ceeecccee---------ecCC--------eeEEEEeccCCCChhhhhcc---CC--CCCCCHHHHHHHHHHHHHHHHHH
Q 013028          198 NVVKLMGYC---------CDDQ--------HRLLVYEYVTRGSLEDHLLN---ED--DTELNWERRIKIALGAARGLEHL  255 (451)
Q Consensus       198 nIv~~~~~~---------~~~~--------~~~lV~E~~~gg~L~~~l~~---~~--~~~l~~~~~~~i~~qi~~aL~~L  255 (451)
                      .++-.++..         ....        +.+++|+-+ .++|.+++..   ..  ...+....++.+..|+++.+++|
T Consensus        83 r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~L  161 (288)
T PF14531_consen   83 RFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANL  161 (288)
T ss_dssp             -B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHH
Confidence            233223322         1111        346788888 4588877531   11  12233445567778999999999


Q ss_pred             HhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCcccccccccc--------CCCCcchhhH
Q 013028          256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT--------GHLTLKTDVY  327 (451)
Q Consensus       256 H~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~Diw  327 (451)
                      |+  .||+|+||+|+|++++.+|.++|+||+......     ........+..|.+||+...        -.++.+.|.|
T Consensus       162 h~--~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g-----~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW  234 (288)
T PF14531_consen  162 HS--YGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAG-----TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAW  234 (288)
T ss_dssp             HH--TTEEEST-SGGGEEE-TTS-EEE--GGGEEETT-----EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHH
T ss_pred             hh--cceEecccceeeEEEcCCCCEEEcChHHHeecC-----ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHH
Confidence            99  899999999999999999999999999886421     11111334577999998743        2578899999


Q ss_pred             HHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCC
Q 013028          328 SFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNR  400 (451)
Q Consensus       328 SlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  400 (451)
                      +||+++|.|+||..||..........|                 .+. ... ..++.++.||..+|+.||.+|
T Consensus       235 ~LG~~ly~lWC~~lPf~~~~~~~~~~~-----------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  235 QLGITLYSLWCGRLPFGLSSPEADPEW-----------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHHSS-STCCCGGGSTSGG-----------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHHccCCCCCCCccccccc-----------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999999999999986554332222                 112 223 678889999999999999987

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.7e-23  Score=206.83  Aligned_cols=237  Identities=26%  Similarity=0.318  Sum_probs=187.1

Q ss_pred             cccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCH--HHHHHHHHHHHhcC-CCceeeccceeecCCeeE
Q 013028          137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ--DEWENELRFLSRLN-HPNVVKLMGYCCDDQHRL  213 (451)
Q Consensus       137 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~  213 (451)
                      .+|.|+||.|+++.       .+.....+..+|+|+..+......  .....|..++...+ ||.+|++.-.++.+..++
T Consensus         1 vlg~g~~gkvfLvr-------k~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~   73 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVR-------KAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLY   73 (612)
T ss_pred             CCCcCCCcchHHHH-------HhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchh
Confidence            37999999999842       244455567788888765432221  13456888999998 999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCC
Q 013028          214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL  293 (451)
Q Consensus       214 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~  293 (451)
                      +++++..||+|...+..  ...+.+.....+...++-+++++|+  .+|+|||+|++||+++.+|++++.|||+++..-.
T Consensus        74 l~ld~~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~--l~iiyrd~k~enilld~~Ghi~~tdfglske~v~  149 (612)
T KOG0603|consen   74 LILDFLRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHK--LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK  149 (612)
T ss_pred             Hhhhhcccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcch--hHHHHhcccccceeecccCccccCCchhhhHhHh
Confidence            99999999999988844  4557777777888899999999999  8999999999999999999999999999985321


Q ss_pred             CCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhh
Q 013028          294 GDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL  373 (451)
Q Consensus       294 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (451)
                      ..      ..+||..|||||++.  ....++|+||||++.+||++|..||...                 ....+..  .
T Consensus       150 ~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-----------------~~~~Il~--~  202 (612)
T KOG0603|consen  150 EK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-----------------TMKRILK--A  202 (612)
T ss_pred             hh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-----------------HHHHHhh--h
Confidence            11      128999999999996  5788999999999999999999998741                 1112222  2


Q ss_pred             cCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHHHHHH
Q 013028          374 GRNIQMEEAQEFAEIILRCLNSDPKNRPTM--SEVVAALE  411 (451)
Q Consensus       374 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl~~L~  411 (451)
                      ....+...+..+.+++..++..+|..|.-.  ..+.++++
T Consensus       203 ~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~  242 (612)
T KOG0603|consen  203 ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ  242 (612)
T ss_pred             ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence            345677788899999999999999999754  44444443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=8.3e-22  Score=210.58  Aligned_cols=257  Identities=22%  Similarity=0.263  Sum_probs=188.0

Q ss_pred             HHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC---CCceee
Q 013028          125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN---HPNVVK  201 (451)
Q Consensus       125 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~  201 (451)
                      .+.....|.+.++||+|+||.||+|...+           ++.||||+-+....-   +|.-=.+++.+|+   -+.|..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-----------~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~  758 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-----------GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMH  758 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC-----------CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHH
Confidence            34556789999999999999999986432           678999986543322   1222244455555   345666


Q ss_pred             ccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC------
Q 013028          202 LMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD------  275 (451)
Q Consensus       202 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~------  275 (451)
                      +..++.-.+..+||+||.+.|+|.+++.  ..+.+++..+..++.|++..++.||.  .+|||+||||+|+||.      
T Consensus       759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~--~~IIHgDiKPDNfll~~~~~~~  834 (974)
T KOG1166|consen  759 ISSAHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHA--MGIIHGDIKPDNFLLRREICAD  834 (974)
T ss_pred             HHHHHccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHh--cceecccCCcceeEeecccCCC
Confidence            6666666677899999999999999996  56789999999999999999999999  8999999999999993      


Q ss_pred             -CCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc
Q 013028          276 -DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW  354 (451)
Q Consensus       276 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  354 (451)
                       +.--++|+|||.|...............++|-.|-.+|+..|+.|++.+|.|.|+-+++.||.|+..-  .  .....|
T Consensus       835 ~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~--~~g~~~  910 (974)
T KOG1166|consen  835 SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--V--KNGSSW  910 (974)
T ss_pred             CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--h--cCCcce
Confidence             23359999999997655455556677788999999999999999999999999999999999998542  0  011111


Q ss_pred             cccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      ...     ..+.....           -+-+-+|+..+|+.|-..=|...++...|+.+....-.
T Consensus       911 ~~~-----~~~~Ry~~-----------~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~  959 (974)
T KOG1166|consen  911 MVK-----TNFPRYWK-----------RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT  959 (974)
T ss_pred             ecc-----ccchhhhh-----------HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence            110     00111111           12356677777774444447778888887777665443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=3.7e-21  Score=173.33  Aligned_cols=190  Identities=16%  Similarity=0.186  Sum_probs=138.0

Q ss_pred             CcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC----HHHHHHHHHHHHhcC-CCceeeccceee
Q 013028          133 SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG----QDEWENELRFLSRLN-HPNVVKLMGYCC  207 (451)
Q Consensus       133 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~il~~l~-h~nIv~~~~~~~  207 (451)
                      .+...|++|+||+||++.            ..+..++.+.+.....-.    ...+.+|+++|++|. |++|++++++  
T Consensus         5 ~~~~~l~~~~f~~v~~~~------------~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--   70 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVR------------GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--   70 (218)
T ss_pred             ccceeecCCCcceEEEee------------cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--
Confidence            345789999999999742            245667766665332211    124688999999996 5889999886  


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCC-CCCceeeCCCCcEEEeecC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDV-KASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDl-kp~NIll~~~~~~kl~DFG  286 (451)
                        +..++||||+.|.+|...+..        . ...++.|++.+|.++|+  +||+|||| ||+|||++.++.++|+|||
T Consensus        71 --~~~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~--~GIvHrDL~kp~NILv~~~g~i~LIDFG  137 (218)
T PRK12274         71 --DGRHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHR--CGVAHNDLAKEANWLVQEDGSPAVIDFQ  137 (218)
T ss_pred             --cCEEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHH--CcCccCCCCCcceEEEcCCCCEEEEECC
Confidence              346999999999988754311        1 13577899999999999  89999999 7999999999999999999


Q ss_pred             CcccCCCCCCc-------cc----ccccCCCCcccccccccc-CCCC-cchhhHHHHHHHHHHHhCCCccccccCC
Q 013028          287 LAKFGPLGDKS-------HI----STRVLGTRGYFAPEYIAT-GHLT-LKTDVYSFGVVLLEILSGKTAAMRRTNG  349 (451)
Q Consensus       287 la~~~~~~~~~-------~~----~~~~~gt~~y~aPE~l~~-~~~~-~~~DiwSlGvil~elltg~~pf~~~~~~  349 (451)
                      +|.........       +.    ..-..+++.|++|+.-.- ...+ ...++++.|+-+|.++|+..+++...++
T Consensus       138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~  213 (218)
T PRK12274        138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG  213 (218)
T ss_pred             CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence            99854322110       00    001235777888874311 1223 5679999999999999999988876654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=4e-21  Score=174.30  Aligned_cols=140  Identities=21%  Similarity=0.152  Sum_probs=109.0

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--------------------------HHHHHHHH
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--------------------------QDEWENEL  188 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~  188 (451)
                      .+.||+|+||.||+|..          . ++..||||++.......                          ...+..|.
T Consensus         2 ~~~ig~G~~~~Vy~a~~----------~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   70 (190)
T cd05145           2 NGCISTGKEANVYHART----------G-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF   70 (190)
T ss_pred             CceeecCCCcEEEEEEc----------C-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH
Confidence            57899999999999753          2 57889999987542110                          11235789


Q ss_pred             HHHHhcCCCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCC
Q 013028          189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVK  268 (451)
Q Consensus       189 ~il~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlk  268 (451)
                      +.+..+.|++|.....+....  .+|||||++|+++......  ...++...+..++.|++.+|.+||+. .||+|||||
T Consensus        71 ~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~-~givHrDlk  145 (190)
T cd05145          71 RNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQE-AGLVHGDLS  145 (190)
T ss_pred             HHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCC
Confidence            999999999886555544332  4899999998765443222  34578888999999999999999984 599999999


Q ss_pred             CCceeeCCCCcEEEeecCCcccC
Q 013028          269 ASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       269 p~NIll~~~~~~kl~DFGla~~~  291 (451)
                      |+|||++ ++.++|+|||++...
T Consensus       146 P~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145         146 EYNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             hhhEEEE-CCCEEEEEcccceec
Confidence            9999999 789999999999853

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=1.1e-20  Score=173.09  Aligned_cols=136  Identities=15%  Similarity=0.236  Sum_probs=105.4

Q ss_pred             CcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-----CCCceeeccceee
Q 013028          133 SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-----NHPNVVKLMGYCC  207 (451)
Q Consensus       133 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~~~~~~~  207 (451)
                      .-.+.||+|+||.||.  +.          .+.. .+||++........+.+.+|+.+++.+     +||||++++|+++
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp----------~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~e   71 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HP----------EDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVE   71 (210)
T ss_pred             CCcceecCCCceEEEE--CC----------CCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEE
Confidence            3457899999999996  21          2233 368988765444567789999999999     5799999999998


Q ss_pred             cCC---eeE-EEEec--cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceeCCCCCCceeeCC----
Q 013028          208 DDQ---HRL-LVYEY--VTRGSLEDHLLNEDDTELNWERRIKIALGAARGL-EHLHTYWRPVIHRDVKASNVLLDD----  276 (451)
Q Consensus       208 ~~~---~~~-lV~E~--~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~~~iiHrDlkp~NIll~~----  276 (451)
                      ++.   .++ +||||  +.+|+|.+++.+   ..+++.  ..++.+++.++ .|||+  ++|+||||||+|||++.    
T Consensus        72 t~~g~g~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~--~~IvhrDlKp~NILl~~~~~~  144 (210)
T PRK10345         72 TDCGTGYVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLD--NRIVTMELKPQNILCQRISES  144 (210)
T ss_pred             eCCCCeEEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEeccCCC
Confidence            864   334 78999  557999999954   235555  35678888888 99999  89999999999999973    


Q ss_pred             CCcEEEeecCCc
Q 013028          277 DFNAKISDFGLA  288 (451)
Q Consensus       277 ~~~~kl~DFGla  288 (451)
                      ++.++|+||+.+
T Consensus       145 ~~~~~LiDg~G~  156 (210)
T PRK10345        145 EVIPVVCDNIGE  156 (210)
T ss_pred             CCcEEEEECCCC
Confidence            347999994443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.83  E-value=2.3e-21  Score=203.67  Aligned_cols=208  Identities=28%  Similarity=0.390  Sum_probs=146.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ..|..++.|..|+||.||+          ++++.+.+.+|+|+-+ ....    +.+   ||.....|++|         
T Consensus        83 ~df~~IklisngAygavyl----------vrh~~trqrfa~kiNk-q~li----lRn---ilt~a~npfvv---------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYL----------VRHKETRQRFAMKINK-QNLI----LRN---ILTFAGNPFVV---------  135 (1205)
T ss_pred             cccceeEeeccCCCCceee----------eeccccccchhhcccc-cchh----hhc---cccccCCccee---------
Confidence            4788899999999999999          5566667778885432 2111    011   33333344444         


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                                  |+=..++..  .+.++.+.        +.+++|||+  .||+|||+||+|.+|+.-|++|++|||++.
T Consensus       136 ------------gDc~tllk~--~g~lPvdm--------vla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLsk  191 (1205)
T KOG0606|consen  136 ------------GDCATLLKN--IGPLPVDM--------VLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLSK  191 (1205)
T ss_pred             ------------chhhhhccc--CCCCcchh--------hHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhhh
Confidence                        232333322  23333322        778999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcc-------------cccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccc
Q 013028          290 FGPLGDKSH-------------ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK  356 (451)
Q Consensus       290 ~~~~~~~~~-------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~  356 (451)
                      .+-......             .....+||+.|+||||+..+.|+..+|||++|+|+||.+.|+.||++.+++..     
T Consensus       192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-----  266 (1205)
T KOG0606|consen  192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-----  266 (1205)
T ss_pred             hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-----
Confidence            432211111             11235899999999999999999999999999999999999999998866410     


Q ss_pred             cccchhhhhhHHh-hhhhcCCCCHHHHHHHHHHHHHccccCCCCCC
Q 013028          357 PYLSNKLALHQII-DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP  401 (451)
Q Consensus       357 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  401 (451)
                              +..++ +.....+-+...+.++++++.++|..+|..|-
T Consensus       267 --------fg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  267 --------FGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             --------HhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                    11111 12222233455678999999999999999995

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=2.3e-19  Score=168.04  Aligned_cols=144  Identities=22%  Similarity=0.166  Sum_probs=108.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc------------------------CHHHHHH
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ------------------------GQDEWEN  186 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~  186 (451)
                      -|.+.+.||.|+||.||+|.+         +..++..||||++......                        ....+.+
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~---------~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALD---------FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK   99 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEe---------cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence            488899999999999999751         2234778999998753211                        0123568


Q ss_pred             HHHHHHhcCCCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-ceeC
Q 013028          187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRP-VIHR  265 (451)
Q Consensus       187 E~~il~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-iiHr  265 (451)
                      |+.++..+.+.+ +.+...+... ..+|||||++|++|......  ...+....+..++.|++.+|.+||+  .| |+|+
T Consensus       100 E~~~L~~L~~~~-i~~p~~~~~~-~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~--~g~iiH~  173 (237)
T smart00090      100 EFRNLQRLYEAG-VPVPKPIAWR-RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYK--EGELVHG  173 (237)
T ss_pred             HHHHHHHHHhcC-CCCCeeeEec-CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHh--cCCEEeC
Confidence            999999997533 2222222222 34899999999888765422  2345666778999999999999999  89 9999


Q ss_pred             CCCCCceeeCCCCcEEEeecCCccc
Q 013028          266 DVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       266 Dlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ||||+||+++ ++.++|+|||.+..
T Consensus       174 Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      174 DLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             CCChhhEEEE-CCCEEEEEChhhhc
Confidence            9999999999 78999999999874

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=8.3e-19  Score=161.63  Aligned_cols=134  Identities=25%  Similarity=0.408  Sum_probs=111.2

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--------HHHHHHHHHHHHhcCCCceeeccceee
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--------QDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +.||+|++|.||+|.+.            +..+++|+........        ...+.+|+.++..+.|++|.....++.
T Consensus         2 ~~l~~G~~~~vy~~~~~------------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~   69 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL------------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV   69 (211)
T ss_pred             cccccCceEEEEEEeeC------------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE
Confidence            67999999999998652            4458899765332211        134678999999999999988888877


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +....++||||++|++|.+++....     . ....++.+++.+|.+||+  .+++|+|++|.|||++ ++.++|+|||+
T Consensus        70 ~~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~-~~~~~liDf~~  140 (211)
T PRK14879         70 DPENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS-GGKIYLIDFGL  140 (211)
T ss_pred             eCCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE-CCCEEEEECCc
Confidence            7788899999999999999884321     1 778899999999999999  8999999999999999 77999999999


Q ss_pred             ccc
Q 013028          288 AKF  290 (451)
Q Consensus       288 a~~  290 (451)
                      +..
T Consensus       141 a~~  143 (211)
T PRK14879        141 AEF  143 (211)
T ss_pred             ccC
Confidence            874

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=1.5e-19  Score=181.54  Aligned_cols=216  Identities=26%  Similarity=0.413  Sum_probs=161.1

Q ss_pred             HHhcCCCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCC
Q 013028          191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKAS  270 (451)
Q Consensus       191 l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~  270 (451)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....+++.=...++++|+.||.|||.. ....|+.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS-PIGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC-cceeeeeeccc
Confidence            4578899999999999999999999999999999999866 356677777889999999999999994 23389999999


Q ss_pred             ceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccC-------CCCcchhhHHHHHHHHHHHhCCCcc
Q 013028          271 NVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-------HLTLKTDVYSFGVVLLEILSGKTAA  343 (451)
Q Consensus       271 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~DiwSlGvil~elltg~~pf  343 (451)
                      |.+++..+.+||+|||+..+..............-..-|.|||++...       ..+.+.||||||++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999998764320000111111123458999998543       1466799999999999999999998


Q ss_pred             ccccCCCCCCccccccchhhhhhHHhh---hhhcCCCC-H-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          344 MRRTNGLAGNWAKPYLSNKLALHQIID---EKLGRNIQ-M-EEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                      .........         .+.+..+.+   ..+.+.+. . ...+.+..++..||..+|.+||++.++-..++.+....
T Consensus       159 ~~~~~~~~~---------~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  159 DLRNLVEDP---------DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccccCCh---------HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            764432211         111111111   00111111 1 33457999999999999999999999999999886654

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=1.7e-18  Score=158.15  Aligned_cols=130  Identities=27%  Similarity=0.438  Sum_probs=104.8

Q ss_pred             cccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--------HHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--------QDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       137 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .||+|+||.||+|.+.            +..+++|.........        ...+.+|++++..+.|+++.....++.+
T Consensus         1 ~ig~G~~~~vy~~~~~------------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~   68 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL------------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD   68 (199)
T ss_pred             CCCCCceEEEEEeecC------------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE
Confidence            4899999999998642            4568999865332111        2446789999999998877666666666


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      .+..++||||++|++|.+++.....         .++.+++.+|.+||+  .|++|+|++|+|||++ ++.++++|||++
T Consensus        69 ~~~~~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~-~~~~~liDfg~a  136 (199)
T TIGR03724        69 PDNKTIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR-DDKLYLIDFGLG  136 (199)
T ss_pred             CCCCEEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE-CCcEEEEECCCC
Confidence            7778999999999999988743210         789999999999999  8999999999999999 789999999998


Q ss_pred             cc
Q 013028          289 KF  290 (451)
Q Consensus       289 ~~  290 (451)
                      ..
T Consensus       137 ~~  138 (199)
T TIGR03724       137 KY  138 (199)
T ss_pred             cC
Confidence            74

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=2.2e-18  Score=180.68  Aligned_cols=137  Identities=26%  Similarity=0.360  Sum_probs=110.0

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-C-------cCHHHHHHHHHHHHhcCCCcee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-S-------QGQDEWENELRFLSRLNHPNVV  200 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~-------~~~~~~~~E~~il~~l~h~nIv  200 (451)
                      ...|...++||+|+||+||+|.+...            .+++|...... .       ...+.+.+|+++++.++|++|+
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~------------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~  399 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR------------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVP  399 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc------------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCC
Confidence            44567789999999999999876432            23333322111 1       1124578899999999999999


Q ss_pred             eccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          201 KLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       201 ~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      .++.++.+....++||||++|++|.+++.          ....++.+++.+|.+||+  .||+||||||+|||+ .++.+
T Consensus       400 ~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~--~giiHrDlkp~NILl-~~~~~  466 (535)
T PRK09605        400 TPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK--AGIVHGDLTTSNFIV-RDDRL  466 (535)
T ss_pred             eeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh--CCCccCCCChHHEEE-ECCcE
Confidence            88877777777899999999999999873          346789999999999999  899999999999999 56799


Q ss_pred             EEeecCCccc
Q 013028          281 KISDFGLAKF  290 (451)
Q Consensus       281 kl~DFGla~~  290 (451)
                      +|+|||+++.
T Consensus       467 ~liDFGla~~  476 (535)
T PRK09605        467 YLIDFGLGKY  476 (535)
T ss_pred             EEEeCccccc
Confidence            9999999975

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=2.1e-19  Score=177.50  Aligned_cols=170  Identities=28%  Similarity=0.372  Sum_probs=129.5

Q ss_pred             CeeEEEEeccCCCChhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLN-EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      .++||.|++|.-.+|.+||.. ......++...+.++.|++.++.|     ++.+|+|+||.||++..+..+||.|||+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhe
Confidence            357899999999999999963 344667788899999999999999     58999999999999999999999999998


Q ss_pred             ccCCCCC----CcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhh
Q 013028          289 KFGPLGD----KSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       289 ~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      .......    .....+..+||..||+||.+.+..|+.++||||||+||+||+. -...|..                ..
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------------~~  467 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------------IA  467 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------------HH
Confidence            7533222    1223456789999999999999999999999999999999987 2222211                00


Q ss_pred             hhhHHhhhhhcCCCCH---HHHHHHHHHHHHccccCCCCCCCHH
Q 013028          364 ALHQIIDEKLGRNIQM---EEAQEFAEIILRCLNSDPKNRPTMS  404 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~  404 (451)
                      .+..+-    ...+++   ...+.-..|+.+||...|.+||++.
T Consensus       468 t~~d~r----~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  468 TLTDIR----DGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             hhhhhh----cCCCChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence            111111    122221   1234556899999999999999433

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=6.8e-18  Score=154.17  Aligned_cols=141  Identities=23%  Similarity=0.173  Sum_probs=107.2

Q ss_pred             HHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc----------------------CHH
Q 013028          125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ----------------------GQD  182 (451)
Q Consensus       125 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~  182 (451)
                      +......|.+.+.||.|+||.||+|...           ++..||||++......                      ...
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   78 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDP-----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRL   78 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcC-----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHH
Confidence            3333345888999999999999997532           4678999987643210                      012


Q ss_pred             HHHHHHHHHHhcCCCc--eeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 013028          183 EWENELRFLSRLNHPN--VVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWR  260 (451)
Q Consensus       183 ~~~~E~~il~~l~h~n--Iv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~  260 (451)
                      ....|+.++..+.|++  ++..++    ....++||||++|++|.+....        .....++.+++.++.++|+  .
T Consensus        79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~--~  144 (198)
T cd05144          79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK--H  144 (198)
T ss_pred             HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH--C
Confidence            3567899999888774  333333    2345899999999998765421        2345788999999999999  8


Q ss_pred             CceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          261 PVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       261 ~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ||+|+||||+||++++++.++|+|||++..
T Consensus       145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144         145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             CCCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence            999999999999999999999999999964

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=8.1e-19  Score=183.95  Aligned_cols=257  Identities=24%  Similarity=0.316  Sum_probs=192.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcC-CCceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLN-HPNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~  207 (451)
                      .|.+.+.||.|+|+.|-+.         .........+|+|.+....  ....+.+..|..+-..+. |+|++.+++...
T Consensus        21 ~~~~~~~ig~gs~~~~~~~---------~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~   91 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALA---------SNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS   91 (601)
T ss_pred             cccccccccccccchhhhh---------hhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC
Confidence            6777888999999999763         2334556677888776543  222344556888888887 999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceeCCCCCCceeeCCCC-cEEEeec
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH-TYWRPVIHRDVKASNVLLDDDF-NAKISDF  285 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~iiHrDlkp~NIll~~~~-~~kl~DF  285 (451)
                      +.+..+++++|..|+++++.+........+...+..++.|+..++.|+| .  .++.|+||||+|.+++..+ .+++.||
T Consensus        92 ~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~--~~~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen   92 SPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE--NGVTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             CCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc--cccccCCCCCccchhccCCCcccCCCc
Confidence            9999999999999999999884222225666677789999999999999 6  7999999999999999999 9999999


Q ss_pred             CCcccCCC-CCCcccccccCC-CCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchh
Q 013028          286 GLAKFGPL-GDKSHISTRVLG-TRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       286 Gla~~~~~-~~~~~~~~~~~g-t~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      |+|..+.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+............  +....
T Consensus       170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~--~~~~~  247 (601)
T KOG0590|consen  170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS--WKSNK  247 (601)
T ss_pred             hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee--ecccc
Confidence            99986554 333334445678 9999999999874 4567899999999999999999988765543221100  00000


Q ss_pred             hhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          363 LALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                              ................+++.+++..+|..|.+.+++-.
T Consensus       248 --------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 --------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             --------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence                    00011122334566888999999999999999887643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=1.3e-16  Score=137.70  Aligned_cols=134  Identities=23%  Similarity=0.244  Sum_probs=110.8

Q ss_pred             cCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCC--CceeeccceeecCCe
Q 013028          134 EKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH--PNVVKLMGYCCDDQH  211 (451)
Q Consensus       134 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~~~~~~~~~~~  211 (451)
                      +.+.||.|.++.||++....            ..+++|.+.....  ...+..|+.+++.+.|  .+++++++++...+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~------------~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~   67 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD------------EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGW   67 (155)
T ss_pred             cceecccccccceEEEEecC------------CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCc
Confidence            45789999999999976432            4689999865433  5678899999999986  588999988888788


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYW-RPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      .+++|||++|+.+..+         +......++.+++.+|.+||... .+++|+|++|+|||++..+.++++|||.+..
T Consensus        68 ~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          68 SYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            9999999998777543         45566778999999999999831 2699999999999999988999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=6.5e-16  Score=144.97  Aligned_cols=134  Identities=20%  Similarity=0.254  Sum_probs=99.9

Q ss_pred             Cccc-ccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-------------CcCHHHHHHHHHHHHhcCCCce--
Q 013028          136 NLIG-QGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-------------SQGQDEWENELRFLSRLNHPNV--  199 (451)
Q Consensus       136 ~~LG-~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~il~~l~h~nI--  199 (451)
                      ..|| .|+.|+||.....            +..++||.+....             ......+.+|+.++..|.|++|  
T Consensus        37 ~~lg~~~g~gtv~~v~~~------------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~v  104 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP------------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPV  104 (239)
T ss_pred             ceeecCCCCccEEEEEeC------------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCC
Confidence            4566 7777777775432            4568888875321             1122457789999999998875  


Q ss_pred             eeccceeecCCe----eEEEEeccCC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee
Q 013028          200 VKLMGYCCDDQH----RLLVYEYVTR-GSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL  274 (451)
Q Consensus       200 v~~~~~~~~~~~----~~lV~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll  274 (451)
                      +.++++......    .++|||+++| .+|.+++..   ..+++.    .+.+|+.+|.+||+  .||+|+||||.|||+
T Consensus       105 P~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~--~GI~HrDlkp~NILv  175 (239)
T PRK01723        105 PRPIAARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHD--AGVYHADLNAHNILL  175 (239)
T ss_pred             ceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHH--CCCCCCCCCchhEEE
Confidence            666766443222    3599999997 688888743   234443    35789999999999  899999999999999


Q ss_pred             CCCCcEEEeecCCccc
Q 013028          275 DDDFNAKISDFGLAKF  290 (451)
Q Consensus       275 ~~~~~~kl~DFGla~~  290 (451)
                      +.++.++|+|||.+..
T Consensus       176 ~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        176 DPDGKFWLIDFDRGEL  191 (239)
T ss_pred             cCCCCEEEEECCCccc
Confidence            9888999999999975

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=5.4e-16  Score=140.07  Aligned_cols=136  Identities=26%  Similarity=0.269  Sum_probs=94.4

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCH--HH----------------------HHHHHHH
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ--DE----------------------WENELRF  190 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~----------------------~~~E~~i  190 (451)
                      .+.||+|+||+||+|...           ++..||||++........  ..                      ...|...
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~   70 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRN   70 (187)
T ss_pred             CcccccccceeEEEEECC-----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHH
Confidence            578999999999997532           467899999874322111  11                      1345666


Q ss_pred             HHhcCCCc--eeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCC
Q 013028          191 LSRLNHPN--VVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVK  268 (451)
Q Consensus       191 l~~l~h~n--Iv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlk  268 (451)
                      +..+.+.+  +.++++.    ...++||||++|+.+.......  .... ..+..++.+++.++.++|.. .+|+|+|||
T Consensus        71 l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~--~~~~-~~~~~~~~~~~~~l~~lh~~-~~ivH~Dl~  142 (187)
T cd05119          71 LKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKD--VRLL-EDPEELYDQILELMRKLYRE-AGLVHGDLS  142 (187)
T ss_pred             HHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhh--hhhc-ccHHHHHHHHHHHHHHHhhc-cCcCcCCCC
Confidence            66654332  3333332    2358999999985543221110  0011 56778999999999999984 589999999


Q ss_pred             CCceeeCCCCcEEEeecCCccc
Q 013028          269 ASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       269 p~NIll~~~~~~kl~DFGla~~  290 (451)
                      |+||+++ ++.++|+|||.+..
T Consensus       143 p~Nili~-~~~~~liDfg~a~~  163 (187)
T cd05119         143 EYNILVD-DGKVYIIDVPQAVE  163 (187)
T ss_pred             hhhEEEE-CCcEEEEECccccc
Confidence            9999999 88999999999974

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=6.3e-15  Score=148.53  Aligned_cols=252  Identities=23%  Similarity=0.279  Sum_probs=183.2

Q ss_pred             cCCCcCCcccc--cCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcC-CCceeeccc
Q 013028          130 RKFSEKNLIGQ--GGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLN-HPNVVKLMG  204 (451)
Q Consensus       130 ~~y~~~~~LG~--G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~-h~nIv~~~~  204 (451)
                      ..+.+...+|.  |.+|.||.+...        ...+...+|+|.-.....  .....=.+|+...+.++ |+|.++.+.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~--------~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~  185 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCT--------NSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP  185 (524)
T ss_pred             hhcccccccccCCCCCceeecccCC--------cccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence            36677788999  999999996531        256778889987432222  22223356777777776 999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceeCCCCCCceeeCCC-Cc
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR----GLEHLHTYWRPVIHRDVKASNVLLDDD-FN  279 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~~~iiHrDlkp~NIll~~~-~~  279 (451)
                      .++..+..|+-+|++ +.+|..+.... ...++...++....+...    ||.++|+  .+++|-|+||.||++..+ ..
T Consensus       186 ~~e~~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~s  261 (524)
T KOG0601|consen  186 AWEGSGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWTS  261 (524)
T ss_pred             ccccCCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheecccccce
Confidence            999999999999999 46888877442 345788888899999998    9999999  899999999999999998 78


Q ss_pred             EEEeecCCcccCCCCCCccc---ccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccc
Q 013028          280 AKISDFGLAKFGPLGDKSHI---STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK  356 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~  356 (451)
                      .+++|||+............   .....|..-|++||++ ..-++...|+|++|.++.+-.++..+......   ..|..
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~---~~W~~  337 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN---SSWSQ  337 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC---CCccc
Confidence            99999999985443332221   2233577789999998 66789999999999999999988765543221   12211


Q ss_pred             cccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          357 PYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                        ..      +..   +..++....+.++..++..|+..+|..|++...++.
T Consensus       338 --~r------~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 --LR------QGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             --cc------ccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence              11      000   111222223445666889999999999998876653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=1.1e-13  Score=140.95  Aligned_cols=147  Identities=20%  Similarity=0.182  Sum_probs=96.7

Q ss_pred             HHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCH-------------------------
Q 013028          127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-------------------------  181 (451)
Q Consensus       127 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------------------------  181 (451)
                      .....|. .+.||.|++|.||+|++.+           +..||||+.........                         
T Consensus       115 ~~F~~fd-~~plasaSigQVh~A~l~~-----------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~  182 (437)
T TIGR01982       115 ELFAEFE-EKPLAAASIAQVHRARLVD-----------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLR  182 (437)
T ss_pred             HHHhhCC-CcceeeeehhheEEEEecC-----------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccC
Confidence            3334444 3679999999999997643           57899999864321100                         


Q ss_pred             ---------------HHHHHHHHHHHhc----CCCceeecccee-ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHH
Q 013028          182 ---------------DEWENELRFLSRL----NHPNVVKLMGYC-CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERR  241 (451)
Q Consensus       182 ---------------~~~~~E~~il~~l----~h~nIv~~~~~~-~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~  241 (451)
                                     -++.+|...+..+    +|.+-+.+-.++ ......+|||||++|++|.+...... ....   .
T Consensus       183 ~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~  258 (437)
T TIGR01982       183 PTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---R  258 (437)
T ss_pred             HHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---H
Confidence                           0133344444444    222222322222 22345689999999999988763221 1122   2


Q ss_pred             HHHHHHHHH-HHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          242 IKIALGAAR-GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       242 ~~i~~qi~~-aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      ..++..++. .+..+|.  .|++|+|++|.||+++.++.++|+|||++...
T Consensus       259 ~~ia~~~~~~~l~ql~~--~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       259 KALAENLARSFLNQVLR--DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             HHHHHHHHHHHHHHHHh--CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            345666655 4678898  89999999999999999999999999999753

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.45  E-value=8.7e-14  Score=130.20  Aligned_cols=205  Identities=22%  Similarity=0.297  Sum_probs=140.0

Q ss_pred             HHHHhcCCCceeeccceeecCC-----eeEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 013028          189 RFLSRLNHPNVVKLMGYCCDDQ-----HRLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWRP  261 (451)
Q Consensus       189 ~il~~l~h~nIv~~~~~~~~~~-----~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~  261 (451)
                      .-|-++.|-|||++..+|.+..     ...++.|||..|+|..+|.+  .....+......+|+.||+.||.|||+....
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            3445567999999999987543     46899999999999999964  3346678888899999999999999996567


Q ss_pred             ceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCc--ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhC
Q 013028          262 VIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS--HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG  339 (451)
Q Consensus       262 iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg  339 (451)
                      |+|+++.-+.|++..+|.+|+.----....+.....  .......+-++|.|||.-...+.+..+|||+||.+..+|..+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            999999999999999998887421111110000000  011123456789999987667778899999999999999877


Q ss_pred             CCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          340 KTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       340 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ..--..-..        .+ .........+        -.....--+.++.+|++..|..||+|.+++-+.
T Consensus       279 Eiq~tnseS--------~~-~~ee~ia~~i--------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  279 EIQSTNSES--------KV-EVEENIANVI--------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             eeccCCCcc--------ee-ehhhhhhhhe--------eeccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence            532110000        00 0001111111        111112245678999999999999999987653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=5.2e-13  Score=118.38  Aligned_cols=127  Identities=20%  Similarity=0.154  Sum_probs=93.9

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCcee-eccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVV-KLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv-~~~~~~~~~~~~~l  214 (451)
                      +.|+.|.++.||++...            +..|++|+...... ....+..|+.+++.+.+.+++ +++.+.  ....++
T Consensus         4 ~~l~~G~~~~vy~~~~~------------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l   68 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA------------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVL   68 (170)
T ss_pred             eecCCcccCceEEEEEC------------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence            56899999999997542            45699998764322 223467899999998755544 444433  334589


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-----ceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRP-----VIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-----iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ||||++|.++.+..       .   ....++.+++++|..||.  .+     ++|+|++|.||+++ ++.++++|||.+.
T Consensus        69 v~e~i~G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~--~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          69 ITEFIEGSELLTED-------F---SDPENLEKIAKLLKKLHS--SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             EEEecCCCcccccc-------c---cCHHHHHHHHHHHHHHhC--CCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            99999998876431       0   112456789999999998  56     49999999999999 5689999999987


Q ss_pred             c
Q 013028          290 F  290 (451)
Q Consensus       290 ~  290 (451)
                      .
T Consensus       136 ~  136 (170)
T cd05151         136 M  136 (170)
T ss_pred             C
Confidence            4

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.44  E-value=9.6e-14  Score=143.19  Aligned_cols=148  Identities=16%  Similarity=0.095  Sum_probs=93.0

Q ss_pred             HHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC------------------------
Q 013028          125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG------------------------  180 (451)
Q Consensus       125 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------  180 (451)
                      ++.....|.. +.||+|++|.||+|++++          +++.||||++++.....                        
T Consensus       115 ~~~~F~~fd~-~PlasaSiaQVh~A~l~~----------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~  183 (537)
T PRK04750        115 VEEWFDDFDI-KPLASASIAQVHFARLKD----------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRR  183 (537)
T ss_pred             HHHHHHhcCh-hhhcCCCccEEEEEEECC----------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCccccc
Confidence            3445567876 789999999999987653          36789999987432110                        


Q ss_pred             ----------HH------HHHHHHHHHHhc----CCCceeeccceeec-CCeeEEEEeccCCCChhhhhccCCCC----C
Q 013028          181 ----------QD------EWENELRFLSRL----NHPNVVKLMGYCCD-DQHRLLVYEYVTRGSLEDHLLNEDDT----E  235 (451)
Q Consensus       181 ----------~~------~~~~E~~il~~l----~h~nIv~~~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~~~----~  235 (451)
                                .+      ++.+|...+.++    .+.+.+.+-.++.+ ....+|||||++|+.|.+.-.-...+    .
T Consensus       184 l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~  263 (537)
T PRK04750        184 LKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL  263 (537)
T ss_pred             CCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH
Confidence                      01      122333333333    23333333333332 34457999999999997742111111    2


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC----cEEEeecCCcccCC
Q 013028          236 LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF----NAKISDFGLAKFGP  292 (451)
Q Consensus       236 l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~----~~kl~DFGla~~~~  292 (451)
                      +.+..+..++.|++       .  .|++|+|++|.||+++.++    .++++|||++...+
T Consensus       264 la~~~v~~~~~Qif-------~--~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        264 LAERGVEVFFTQVF-------R--DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHHHHHHHHHHH-------h--CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            33333333444443       4  6999999999999999888    99999999997543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.44  E-value=2.6e-12  Score=131.04  Aligned_cols=167  Identities=19%  Similarity=0.225  Sum_probs=125.3

Q ss_pred             hcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHH
Q 013028          161 RKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWER  240 (451)
Q Consensus       161 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~  240 (451)
                      .+.++.+|.|..+........+.+.+-++.|+.++||||+++++.++.+.+.|||+|-+.  .|..++...     ....
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~  105 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEE  105 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHH
Confidence            445567788888876555334557888999999999999999999999999999999983  677777442     2556


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCC
Q 013028          241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL  320 (451)
Q Consensus       241 ~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~  320 (451)
                      ....+.||+.||.|||.. .+++|++|.-.-|+++..|..||++|-++........  ......---.|..|+.+...  
T Consensus       106 v~~Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s--  180 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDD-CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS--  180 (690)
T ss_pred             HHHHHHHHHHHHHHHhcc-CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc--
Confidence            667788999999999975 5899999999999999999999999998863221111  01111111135566544221  


Q ss_pred             CcchhhHHHHHHHHHHHhC
Q 013028          321 TLKTDVYSFGVVLLEILSG  339 (451)
Q Consensus       321 ~~~~DiwSlGvil~elltg  339 (451)
                      +...|.|.|||++++++.|
T Consensus       181 ~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccchhhhhHHHHHHHHhCc
Confidence            2467999999999999998

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.41  E-value=1.4e-13  Score=138.90  Aligned_cols=256  Identities=20%  Similarity=0.223  Sum_probs=185.1

Q ss_pred             HHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHH--HHHHHHHHhcC-CCceee
Q 013028          125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW--ENELRFLSRLN-HPNVVK  201 (451)
Q Consensus       125 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~--~~E~~il~~l~-h~nIv~  201 (451)
                      ......+|.++..||.|.|+.|+...         ++...+..+++|.+.+.......++  ..|+.+...+. |.+++.
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~---------~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g  330 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVS---------KRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG  330 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeee---------ecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence            44456689999999999999999853         2334567788888776544444444  46888877776 999999


Q ss_pred             ccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC-CcE
Q 013028          202 LMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD-FNA  280 (451)
Q Consensus       202 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~-~~~  280 (451)
                      ++..|..-...|+--|||+++++...+  .....+.+...+.+..|++.++.++|+  +.++|+|+||+||++..+ +..
T Consensus       331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s--~~~~~~d~~psni~i~~~~~~~  406 (524)
T KOG0601|consen  331 KNSSWSQLRQGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHS--KLFVHLDVKPSNILISNDGFFS  406 (524)
T ss_pred             CCCCccccccccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccc--hhhhcccccccceeeccchhhh
Confidence            998888888888999999999887766  334567778889999999999999999  899999999999999876 778


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCcc-ccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGY-FAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y-~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  359 (451)
                      ++.|||.+........    ...-.+..| .+++.+....+..+.|++|||..+.+.++|...-+....     |     
T Consensus       407 ~~~~~~~~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----~-----  472 (524)
T KOG0601|consen  407 KLGDFGCWTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----S-----  472 (524)
T ss_pred             hccccccccccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCccccc-----c-----
Confidence            9999999863111111    111123334 355555567788999999999999999998754322111     0     


Q ss_pred             chhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                            ..+ ........+... ..+..+...|+..++..||.+.++....+..+.
T Consensus       473 ------~~i-~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  473 ------LTI-RSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             ------eee-ecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence                  011 111111122222 778888999999999999999988877665543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.41  E-value=7.3e-14  Score=147.80  Aligned_cols=244  Identities=24%  Similarity=0.267  Sum_probs=174.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      +.+.+.+-+-+|.++.++.+.          ...++...+.|+......   ...+.+..+-.++-...+|.+++..-.+
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~----------pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~  873 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPAS----------PAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF  873 (1205)
T ss_pred             ccceecccccCCCCcccccCC----------ccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC
Confidence            356677788899999998843          333444444444332111   1122233344444445567777776666


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      ......+|||+|+.|++|...+..  ....+.+.+......+..+++|||.  ..+.|+|++|.|+|...++..+++|||
T Consensus       874 ~~rsP~~L~~~~~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~~~~gh~~l~~~~  949 (1205)
T KOG0606|consen  874 PCRSPLPLVGHYLNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLIAYDGHRPLTDFG  949 (1205)
T ss_pred             CCCCCcchhhHHhccCCchhhhhc--CCCcccccccchhHHHHhhhhcccc--chhhcccccccchhhcccCCcccCccc
Confidence            667788999999999999998854  3456666666777788899999998  569999999999999999999999998


Q ss_pred             CcccCCCC--------C---------------------CcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHH
Q 013028          287 LAKFGPLG--------D---------------------KSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEIL  337 (451)
Q Consensus       287 la~~~~~~--------~---------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell  337 (451)
                      ........        .                     .........||+.|.+||.+.+......+|+|++|++++|.+
T Consensus       950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence            43211000        0                     001122457899999999999999999999999999999999


Q ss_pred             hCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHH
Q 013028          338 SGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMS  404 (451)
Q Consensus       338 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~  404 (451)
                      +|.+||...++.                 +++...+...+     +...+.+.++++...+..+|.+|..+.
T Consensus      1030 ~g~pp~na~tpq-----------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQ-----------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cCCCCCCCcchh-----------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999999877654                 33333333333     233467889999999999999997765

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.38  E-value=3.5e-12  Score=114.95  Aligned_cols=143  Identities=17%  Similarity=0.148  Sum_probs=98.7

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC----------------------CcCHHHH----HHHH
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG----------------------SQGQDEW----ENEL  188 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~----~~E~  188 (451)
                      ...||.|--+.||.|...+..    .....+..+|||+++...                      ......+    ++|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~----~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~   77 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNE----TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEM   77 (197)
T ss_pred             CCccccCcceEEEEEecCccc----ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHH
Confidence            357999999999998633210    001135689999874210                      0011222    3799


Q ss_pred             HHHHhcCC--CceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeC
Q 013028          189 RFLSRLNH--PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL-HTYWRPVIHR  265 (451)
Q Consensus       189 ~il~~l~h--~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~iiHr  265 (451)
                      ..|.++..  -++.+++++    ...+|||||+.+..+..-..  .+..++......+..+++.+|..| |.  .||||+
T Consensus        78 r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L--kd~~~~~~~~~~i~~~i~~~l~~l~H~--~glVHG  149 (197)
T cd05146          78 HNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL--KDAKLNDEEMKNAYYQVLSMMKQLYKE--CNLVHA  149 (197)
T ss_pred             HHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh--hccccCHHHHHHHHHHHHHHHHHHHHh--CCeecC
Confidence            99999863  355666654    45689999997654422111  123455566778889999999999 78  799999


Q ss_pred             CCCCCceeeCCCCcEEEeecCCccc
Q 013028          266 DVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       266 Dlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ||++.|||+++ +.+.|+|||.+..
T Consensus       150 DLs~~NIL~~~-~~v~iIDF~qav~  173 (197)
T cd05146         150 DLSEYNMLWHD-GKVWFIDVSQSVE  173 (197)
T ss_pred             CCCHHHEEEEC-CcEEEEECCCcee
Confidence            99999999974 5899999999974

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=2.3e-11  Score=106.28  Aligned_cols=131  Identities=26%  Similarity=0.389  Sum_probs=99.2

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEec-cCCCcC-------HHHHHHHHHHHHhcCCCceeeccceee
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQG-------QDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~-~~~~~~-------~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ..+++|+-+.+|.+.+..            ..+.+|.=. +.....       .+.-.+|..++..+.--.|...+=++.
T Consensus         2 ~~i~~GAEa~i~~~~~~g------------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv   69 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG------------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV   69 (204)
T ss_pred             chhhCCcceeEEeeeccC------------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE
Confidence            467899999999976542            235555432 211111       123467999999887666666666777


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +.+...|+|||++|..|.+.+...         ...++..+-.-+.-||.  .||+|+||.++||++..++ +.++||||
T Consensus        70 D~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~--~givHGDLTtsNiIl~~~~-i~~IDfGL  137 (204)
T COG3642          70 DPDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHK--AGIVHGDLTTSNIILSGGR-IYFIDFGL  137 (204)
T ss_pred             cCCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHh--cCeecCCCccceEEEeCCc-EEEEECCc
Confidence            888889999999998888888543         24677888888889999  8999999999999998874 99999999


Q ss_pred             ccc
Q 013028          288 AKF  290 (451)
Q Consensus       288 a~~  290 (451)
                      +.+
T Consensus       138 g~~  140 (204)
T COG3642         138 GEF  140 (204)
T ss_pred             ccc
Confidence            974

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.25  E-value=5.2e-10  Score=108.55  Aligned_cols=280  Identities=16%  Similarity=0.197  Sum_probs=179.0

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCce----eecccee
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNV----VKLMGYC  206 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nI----v~~~~~~  206 (451)
                      ...+..||+|+-+.+|---.       +      ...+-|++.......+.+   -+..|... .||-+    +......
T Consensus        13 i~~gr~LgqGgea~ly~l~e-------~------~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L   76 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGE-------V------RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATL   76 (637)
T ss_pred             cCCCccccCCccceeeecch-------h------hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHh
Confidence            34568899999999995211       1      113557777554443322   23333333 35532    2222221


Q ss_pred             e--cC-CeeEEEEeccCCCCh-hhhhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC
Q 013028          207 C--DD-QHRLLVYEYVTRGSL-EDHLL----NEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF  278 (451)
Q Consensus       207 ~--~~-~~~~lV~E~~~gg~L-~~~l~----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~  278 (451)
                      .  ++ ...-+.|..+.|..- .+++.    +..-....|.-.+..++.|+.+.+.||.  .|.+-+|+.++|+|+++++
T Consensus        77 ~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~--~Gh~vGDVn~~~~lVsd~~  154 (637)
T COG4248          77 HGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE--HGHVVGDVNQNSFLVSDDS  154 (637)
T ss_pred             hCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh--cCCcccccCccceeeecCc
Confidence            1  22 225688888877532 22221    1222457788899999999999999999  8999999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHhC-CCccccccCCCCC
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA-----TGHLTLKTDVYSFGVVLLEILSG-KTAAMRRTNGLAG  352 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltg-~~pf~~~~~~~~~  352 (451)
                      .+.|+|=..-..   ..++......+|.+.|.+||.-.     +-.-+...|-|.|||++++|+.| +.||.+.......
T Consensus       155 ~V~LVdsDsfqi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a  231 (637)
T COG4248         155 KVVLVDSDSFQI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA  231 (637)
T ss_pred             eEEEEcccceee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC
Confidence            999998543322   23445556678999999999753     33446789999999999999988 7888765433221


Q ss_pred             Cccccccchhh--hhhHHhhhhh-----cCCCCHH-HHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHhHHhcCCCcc
Q 013028          353 NWAKPYLSNKL--ALHQIIDEKL-----GRNIQME-EAQEFAEIILRCLNSD--PKNRPTMSEVVAALEQLQLNMGSCYQ  422 (451)
Q Consensus       353 ~~~~~~~~~~~--~~~~~~~~~~-----~~~~~~~-~~~~l~~li~~cl~~d--P~~RPt~~evl~~L~~~~~~~~~~~~  422 (451)
                      .-  ++..+.-  .+...-+...     ...++.. .++++..|..+|+...  +.-|||++-++..|..+..++.+|.-
T Consensus       232 p~--p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v  309 (637)
T COG4248         232 PN--PLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTV  309 (637)
T ss_pred             CC--cchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhh
Confidence            00  0000000  0000000000     1112222 2577888888888643  66899999999999999999999999


Q ss_pred             cccc-cccCcCcC
Q 013028          423 TSLR-TSTHTTRT  434 (451)
Q Consensus       423 ~~~~-~~~~~~~~  434 (451)
                      +++. ++..-+.|
T Consensus       310 ~a~H~y~~hl~~C  322 (637)
T COG4248         310 SAMHVYPVHLTDC  322 (637)
T ss_pred             cccccccCCCCCC
Confidence            8887 55444433

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.24  E-value=1e-10  Score=108.15  Aligned_cols=141  Identities=25%  Similarity=0.299  Sum_probs=105.8

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCC--ceeeccceeecC---
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHP--NVVKLMGYCCDD---  209 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~--nIv~~~~~~~~~---  209 (451)
                      +.||.|.++.||++...+           +..+++|....... .....+..|.++++.+.+.  ++.+++.+....   
T Consensus         4 ~~l~~G~~n~~~~v~~~~-----------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~   72 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-----------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVL   72 (223)
T ss_pred             eecCCCccceEEEEEecC-----------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCcc
Confidence            568999999999976432           35689998764322 1345678999999999753  456677766553   


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTY-------------------------------  258 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-------------------------------  258 (451)
                      ...++||||++|.+|.+.+..   ..+++.....++.+++.+|..||+.                               
T Consensus        73 ~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (223)
T cd05154          73 GTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS  149 (223)
T ss_pred             CCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence            256899999999888775521   3467777778888888888888841                               


Q ss_pred             -----------------------CCCceeCCCCCCceeeCC--CCcEEEeecCCccc
Q 013028          259 -----------------------WRPVIHRDVKASNVLLDD--DFNAKISDFGLAKF  290 (451)
Q Consensus       259 -----------------------~~~iiHrDlkp~NIll~~--~~~~kl~DFGla~~  290 (451)
                                             ...++|+|+.|.|||++.  ++.+.|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                   134699999999999998  66789999999874

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.20  E-value=1.4e-10  Score=100.92  Aligned_cols=143  Identities=22%  Similarity=0.289  Sum_probs=105.2

Q ss_pred             cCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEE-eccCCCc-------CHHHHHHHHHHHHhcCCCceeeccce
Q 013028          134 EKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKR-LRRKGSQ-------GQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       134 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~-~~~~~~~-------~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .+..|-+|+-+.|++|.+.            ++...||. +.+....       ......+|.++|.++.--.|.-..=+
T Consensus        11 ~l~likQGAEArv~~~~~~------------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~   78 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS------------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI   78 (229)
T ss_pred             cceeeeccceeeEeeeccC------------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE
Confidence            4577889999999998764            34445553 2222111       12345679999988875566666667


Q ss_pred             eecCCeeEEEEeccCC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC---cEE
Q 013028          206 CCDDQHRLLVYEYVTR-GSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF---NAK  281 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~---~~k  281 (451)
                      |.|...-.|+|||++| .++.+++...............++..|-+.+.-||.  .+|||+||..+||+|..++   .+.
T Consensus        79 ~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~--ndiiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   79 FIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD--NDIIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             EEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh--CCeecccccccceEEecCCCcCceE
Confidence            7788888999999977 477888765544444444457899999999999999  8999999999999996543   458


Q ss_pred             EeecCCccc
Q 013028          282 ISDFGLAKF  290 (451)
Q Consensus       282 l~DFGla~~  290 (451)
                      |+|||++..
T Consensus       157 lIdfgls~~  165 (229)
T KOG3087|consen  157 LIDFGLSSV  165 (229)
T ss_pred             EEeecchhc
Confidence            999999864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.12  E-value=2.3e-09  Score=106.65  Aligned_cols=217  Identities=15%  Similarity=0.190  Sum_probs=150.6

Q ss_pred             CceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee----cCCeeEEEEe
Q 013028          142 GFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC----DDQHRLLVYE  217 (451)
Q Consensus       142 ~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~----~~~~~~lV~E  217 (451)
                      .-.+.|+++          ...++..|++|++.-...........-+++++++.|.|||++.++|.    .+..++||++
T Consensus       288 ~~~Ttyk~~----------s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYD  357 (655)
T KOG3741|consen  288 FSITTYKAT----------SNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYD  357 (655)
T ss_pred             ccceeEeee----------eccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEe
Confidence            346677754          45567889999984322222222345688899999999999999887    3567899999


Q ss_pred             ccCC-CChhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          218 YVTR-GSLEDHLLNE-------------DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       218 ~~~g-g~L~~~l~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      |.++ ++|.++....             .+...++..++.++.||..||.++|+  .|+.-+-|.|.+||++.+.+++|.
T Consensus       358 YyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIriS  435 (655)
T KOG3741|consen  358 YYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIRIS  435 (655)
T ss_pred             cCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEEEe
Confidence            9876 6777766431             23457889999999999999999999  899999999999999999889887


Q ss_pred             ecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      .-|.........         +       |-+.   --.+-|.=.||.+++.|.||..--+...                
T Consensus       436 ~C~i~Dvl~~d~---------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d----------------  480 (655)
T KOG3741|consen  436 GCGIMDVLQEDP---------T-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTD----------------  480 (655)
T ss_pred             cccceeeecCCC---------C-------cchh---HHhhhhHHHHHHHHHHHhhccccccccc----------------
Confidence            766655322111         0       1111   1235689999999999999964221110                


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                          .....-...+....+.++++++......++++ -++.+++.++
T Consensus       481 ----~~~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  481 ----STQSSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             ----chHHHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                00000011233456677888888888888886 6677766544

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.07  E-value=2.9e-09  Score=101.26  Aligned_cols=106  Identities=19%  Similarity=0.199  Sum_probs=82.2

Q ss_pred             HHHHHHHHHHhcCCCceee--ccceeec-----CCeeEEEEeccCCC-ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 013028          183 EWENELRFLSRLNHPNVVK--LMGYCCD-----DQHRLLVYEYVTRG-SLEDHLLNEDDTELNWERRIKIALGAARGLEH  254 (451)
Q Consensus       183 ~~~~E~~il~~l~h~nIv~--~~~~~~~-----~~~~~lV~E~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~  254 (451)
                      .+.+|...+..|..-+|..  ++++++.     ....+||||++++. +|.+++........+......++.+++..+.-
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            4678999998886555443  4555543     23468999999875 78888753223445667778899999999999


Q ss_pred             HHhCCCCceeCCCCCCceeeCC-------CCcEEEeecCCccc
Q 013028          255 LHTYWRPVIHRDVKASNVLLDD-------DFNAKISDFGLAKF  290 (451)
Q Consensus       255 LH~~~~~iiHrDlkp~NIll~~-------~~~~kl~DFGla~~  290 (451)
                      ||.  .||+|+|+++.|||++.       ++.+.|+||+.+..
T Consensus       154 LH~--~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        154 MHA--AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHH--CcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            999  89999999999999975       46899999998863

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=2.2e-09  Score=96.41  Aligned_cols=96  Identities=28%  Similarity=0.362  Sum_probs=64.1

Q ss_pred             HHHHHHHHHhcCCC--ceeeccceeecCCeeEEEEeccC--CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHH-HHhC
Q 013028          184 WENELRFLSRLNHP--NVVKLMGYCCDDQHRLLVYEYVT--RGSLEDHLLNEDDTELNWERRIKIALGAARGLEH-LHTY  258 (451)
Q Consensus       184 ~~~E~~il~~l~h~--nIv~~~~~~~~~~~~~lV~E~~~--gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~  258 (451)
                      ..+|.+.|..+..-  ++.+++++-    ..+|||||++  |..+..+. ..   .++......++.+++..+.. +|. 
T Consensus        55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~---~~~~~~~~~~~~~il~~~~~~~~~-  125 (188)
T PF01163_consen   55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DV---DLSPEEPKELLEEILEEIIKMLHK-  125 (188)
T ss_dssp             HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-HC---GGGGSTHHHHHHHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-hc---cccchhHHHHHHHHHHHHHHHHHh-
Confidence            46799999999855  456666442    3479999998  65554433 21   11133455677788886665 567 


Q ss_pred             CCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          259 WRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       259 ~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                       .||+|+||.+.|||++++ .+.|+|||.+..
T Consensus       126 -~givHGDLs~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  126 -AGIVHGDLSEYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             -TTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred             -cCceecCCChhhEEeecc-eEEEEecCccee
Confidence             899999999999999988 999999999974

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.90  E-value=1.1e-08  Score=94.92  Aligned_cols=135  Identities=24%  Similarity=0.222  Sum_probs=95.3

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC----------------------CcCHHHHHHHH
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG----------------------SQGQDEWENEL  188 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~  188 (451)
                      -+.++.+||-|.-+.||.|...           .+..+|||..+...                      .......++|.
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf  160 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREF  160 (304)
T ss_pred             HHhhccccccCccceEEEEECC-----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHH
Confidence            4677899999999999998654           36678888743110                      00112357899


Q ss_pred             HHHHhcCCC--ceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCC
Q 013028          189 RFLSRLNHP--NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRD  266 (451)
Q Consensus       189 ~il~~l~h~--nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrD  266 (451)
                      ++|..|...  .+.+.+++    +..++||||++|-.|...-.       +.+....++..|++-+.-+-.  .||||+|
T Consensus       161 ~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~--~GiVHGD  227 (304)
T COG0478         161 EALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYR--RGIVHGD  227 (304)
T ss_pred             HHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHH--cCccccC
Confidence            999999754  67777754    45689999999977755321       122233344444444443334  6999999


Q ss_pred             CCCCceeeCCCCcEEEeecCCcc
Q 013028          267 VKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       267 lkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +.+-||+++++|.+.++||-.+.
T Consensus       228 lSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         228 LSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             CchheEEEecCCCEEEEeCcccc
Confidence            99999999999999999998876

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.84  E-value=1.2e-09  Score=112.31  Aligned_cols=150  Identities=21%  Similarity=0.326  Sum_probs=103.8

Q ss_pred             HHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCC------cc-cccccCCCCccccccccccCC
Q 013028          247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK------SH-ISTRVLGTRGYFAPEYIATGH  319 (451)
Q Consensus       247 qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~------~~-~~~~~~gt~~y~aPE~l~~~~  319 (451)
                      +++.||.|+|.. .++||+.|.|++|.++.++.+||+.|+.+........      .. ...-..-...|.|||++....
T Consensus       107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            445899999996 7899999999999999999999999999874322111      00 011123456799999998888


Q ss_pred             CCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCC
Q 013028          320 LTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPK  398 (451)
Q Consensus       320 ~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  398 (451)
                      .+.++|+|||||++|.+.. |+..+........           .......+..-...+....+.++.+-+.+++..++.
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~  254 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----------YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSA  254 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcch-----------hhhhhcccccccccccccCcHHHHHHHHHHhcCCcc
Confidence            8999999999999999994 4444332211111           011111111112223455678899999999999999


Q ss_pred             CCCCHHHHHH
Q 013028          399 NRPTMSEVVA  408 (451)
Q Consensus       399 ~RPt~~evl~  408 (451)
                      -||++.+++.
T Consensus       255 ~rp~~~~l~~  264 (700)
T KOG2137|consen  255 VRPTLDLLLS  264 (700)
T ss_pred             cCcchhhhhc
Confidence            9997776654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.83  E-value=3.1e-08  Score=90.95  Aligned_cols=106  Identities=25%  Similarity=0.319  Sum_probs=83.0

Q ss_pred             HHHHHHHHHHHHhcCCCc--eeeccceeecC----CeeEEEEeccCCC-ChhhhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 013028          181 QDEWENELRFLSRLNHPN--VVKLMGYCCDD----QHRLLVYEYVTRG-SLEDHLLNEDDTELNWERRIKIALGAARGLE  253 (451)
Q Consensus       181 ~~~~~~E~~il~~l~h~n--Iv~~~~~~~~~----~~~~lV~E~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~  253 (451)
                      .....+|...+..|..-+  +.+++++.+..    ...+||+|++++. +|.+++.....  .+......++.+++..+.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence            345678999888886444  34455555542    2358999999884 78888855322  566677889999999999


Q ss_pred             HHHhCCCCceeCCCCCCceeeCCCC---cEEEeecCCccc
Q 013028          254 HLHTYWRPVIHRDVKASNVLLDDDF---NAKISDFGLAKF  290 (451)
Q Consensus       254 ~LH~~~~~iiHrDlkp~NIll~~~~---~~kl~DFGla~~  290 (451)
                      -||.  .||+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       133 ~lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999  8999999999999999887   899999998875

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.78  E-value=1.3e-07  Score=85.66  Aligned_cols=138  Identities=17%  Similarity=0.165  Sum_probs=101.0

Q ss_pred             ccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC------CCcCHHHHHHHHHHHHhcCCCc--eeeccceeec-
Q 013028          138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK------GSQGQDEWENELRFLSRLNHPN--VVKLMGYCCD-  208 (451)
Q Consensus       138 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~il~~l~h~n--Iv~~~~~~~~-  208 (451)
                      -|+||-+.|+.-.+.            +..+-||.-...      -+.....|.+|+..|.+|..-+  +.++. ++.. 
T Consensus        26 ~~rgG~SgV~r~~~~------------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~   92 (216)
T PRK09902         26 YRRNGMSGVQCVERN------------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAV   92 (216)
T ss_pred             cCCCCcceEEEEEeC------------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeee
Confidence            366888889885432            224778875411      1345678999999999986433  44444 3321 


Q ss_pred             ----CCeeEEEEeccCC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc--EE
Q 013028          209 ----DQHRLLVYEYVTR-GSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN--AK  281 (451)
Q Consensus       209 ----~~~~~lV~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~--~k  281 (451)
                          .-..+||+|-++| -+|.+++........+......++.+++..+.-||+  .|+.|+|+.+.|||++.++.  ++
T Consensus        93 k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~  170 (216)
T PRK09902         93 KIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS--VNRQHGCCYVRHIYVKTEGKAEAG  170 (216)
T ss_pred             ccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHhheeecCCCCeeEE
Confidence                1235799997754 588888755444566778788999999999999999  89999999999999986666  99


Q ss_pred             EeecCCccc
Q 013028          282 ISDFGLAKF  290 (451)
Q Consensus       282 l~DFGla~~  290 (451)
                      ++||--++.
T Consensus       171 lIDlEk~r~  179 (216)
T PRK09902        171 FLDLEKSRR  179 (216)
T ss_pred             EEEhhccch
Confidence            999987763

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.60  E-value=6.9e-09  Score=105.64  Aligned_cols=190  Identities=17%  Similarity=0.150  Sum_probs=137.0

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCc-eeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPN-VVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~~~~~~~  207 (451)
                      +.-|.....+++|+++.+++.+          .......+ .+.+...     ....-++++|.+++||| .+..++-++
T Consensus       241 ~kws~~fh~fvK~altknpKkR----------ptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~  304 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKR----------PTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYD  304 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccC----------CChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCC
Confidence            4455666778999999999843          22222222 4444322     34456899999999999 778888888


Q ss_pred             cCCeeEEEEeccCCC-ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          208 DDQHRLLVYEYVTRG-SLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++..++|+++.++ +..... ......+..-+...+++.-+++|+++|+  .-=+|+|    ||+..+ +..+..||+
T Consensus       305 ~E~~~~i~~~i~s~~rs~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~--~~~~~~d----~~l~s~-~~~~~~~~~  376 (829)
T KOG0576|consen  305 GEDYLWIPMRICSTGRSSALEM-TVSEIALEQYQFAYPLRKETRPLAELHS--SYKVHRD----NILGSE-EEVKLLDFA  376 (829)
T ss_pred             cccccchhhhhhcCCccccccC-ChhhHhhhhhhhhhhhhhhccccccccc--ccccCcc----cccccc-ccccccccc
Confidence            889999999999887 222211 1112233444555677788899999998  3348888    888877 478999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccc
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMR  345 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~  345 (451)
                      .....+...   ......+++.++|||+.....+....|.|++|+-..+|--|.+|-..
T Consensus       377 v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  377 VPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             CCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            987543322   34467899999999999899999999999999988888888776554

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.59  E-value=7.6e-07  Score=82.84  Aligned_cols=138  Identities=12%  Similarity=0.125  Sum_probs=85.1

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCc--eeeccceeecCCeeE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPN--VVKLMGYCCDDQHRL  213 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~~~~~~~~~~~~~  213 (451)
                      ..||.|..+.||+..              +..+++|.....  .....+.+|.++++.+..-+  +.+.+++..+.+...
T Consensus         7 ~~i~~G~t~~~y~~~--------------~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~g   70 (226)
T TIGR02172         7 TQTGEGGNGESYTHK--------------TGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLG   70 (226)
T ss_pred             eeecCCCCcceeEec--------------CCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeee
Confidence            568999999999831              224678887542  24456789999999986433  467788877777788


Q ss_pred             EEEeccCCCC-hhhhh---------------------ccCCCCCCCHHHHHH-HHH----------HHHH-HHHHHH--h
Q 013028          214 LVYEYVTRGS-LEDHL---------------------LNEDDTELNWERRIK-IAL----------GAAR-GLEHLH--T  257 (451)
Q Consensus       214 lV~E~~~gg~-L~~~l---------------------~~~~~~~l~~~~~~~-i~~----------qi~~-aL~~LH--~  257 (451)
                      +|||+++|.. +...+                     +.............. +..          .+.. ...+|.  .
T Consensus        71 lv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~  150 (226)
T TIGR02172        71 LIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVP  150 (226)
T ss_pred             eeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCC
Confidence            9999999863 11111                     111001111111000 000          0111 112222  1


Q ss_pred             CCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       258 ~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ....++|+|+.|.||++++++ +.|+||+.+..
T Consensus       151 ~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       151 DTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            113478999999999999888 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.59  E-value=3.6e-07  Score=94.20  Aligned_cols=149  Identities=21%  Similarity=0.238  Sum_probs=89.6

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCH------------------------
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ------------------------  181 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------------  181 (451)
                      +.....|.. ..|+.++-|.||+|++.+           ++.||||+.+..-....                        
T Consensus       122 ee~F~eF~~-~PiAsASIaQVH~A~L~s-----------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l  189 (517)
T COG0661         122 EELFSEFEP-EPIASASIAQVHRAVLKS-----------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRL  189 (517)
T ss_pred             HHHHHHcCC-CchhhhhHhhheeEEecC-----------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccC
Confidence            333444442 679999999999998765           67899999653211100                        


Q ss_pred             ------H----------HHHHHHHHHHhc----C-CCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHH
Q 013028          182 ------D----------EWENELRFLSRL----N-HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWER  240 (451)
Q Consensus       182 ------~----------~~~~E~~il~~l----~-h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~  240 (451)
                            +          ++.+|...+.++    . .++|.-..=+++-....+|+|||++|-.+.+...-.. ...+...
T Consensus       190 ~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~  268 (517)
T COG0661         190 DLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE  268 (517)
T ss_pred             ChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH
Confidence                  0          122233333333    1 2332222222223345689999999988888742222 3344333


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       241 ~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      +.....++.  +..+=.  .|++|.|..|.||+++.+|.+.+.|||+....
T Consensus       269 ia~~~~~~f--~~q~~~--dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         269 LAELLVRAF--LRQLLR--DGFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             HHHHHHHHH--HHHHHh--cCccccCCCccceEEecCCcEEEEcCcceecC
Confidence            222222211  111112  58999999999999999999999999998743

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.46  E-value=1.6e-06  Score=78.96  Aligned_cols=139  Identities=13%  Similarity=0.147  Sum_probs=90.4

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHH---------HHHHHHHHHhcCC
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE---------WENELRFLSRLNH  196 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~il~~l~h  196 (451)
                      .....+|...+.+-......|.+-..            .+..+.+|..+......+..         ..+++..+..+..
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei------------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~   94 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEI------------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRN   94 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEE------------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHH
Confidence            34456788777777777777766432            34668888876544332222         2344554555543


Q ss_pred             Cce---eeccceeec-----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCC
Q 013028          197 PNV---VKLMGYCCD-----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVK  268 (451)
Q Consensus       197 ~nI---v~~~~~~~~-----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlk  268 (451)
                      .++   ..++.+.+-     ....+|||||++|..|.+...      +++    .+...+..++.-||.  .|+.|+|..
T Consensus        95 ~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~--~G~~HGD~h  162 (229)
T PF06176_consen   95 EGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK--HGFYHGDPH  162 (229)
T ss_pred             cCccccccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH--cCCccCCCC
Confidence            332   233333221     234468999999988876531      222    244567778999999  899999999


Q ss_pred             CCceeeCCCCcEEEeecCCcc
Q 013028          269 ASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       269 p~NIll~~~~~~kl~DFGla~  289 (451)
                      |.|++++++ .++++||+..+
T Consensus       163 pgNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  163 PGNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             cCcEEEECC-cEEEEECcccc
Confidence            999999976 49999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.43  E-value=2.1e-06  Score=79.12  Aligned_cols=148  Identities=23%  Similarity=0.239  Sum_probs=93.7

Q ss_pred             HHHHHHhcCCCcCCc---ccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC-------------------
Q 013028          123 GLLEAATRKFSEKNL---IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-------------------  180 (451)
Q Consensus       123 ~~~~~~~~~y~~~~~---LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------  180 (451)
                      ..+..+.++..+...   |+.|.-+.||+|.-           ..+..+|||++......-                   
T Consensus        38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-----------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~  106 (268)
T COG1718          38 ETLRRLLSRGVITELVGCISTGKEANVYLAET-----------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSN  106 (268)
T ss_pred             HHHHHHhcCCceeeeEeeecCCcceEEEeecc-----------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCC
Confidence            344444555555444   55677778999742           346789999986321110                   


Q ss_pred             HHH-----HHHHHHHHHhcC--CCceeeccceeecCCeeEEEEeccCCCCh-hhhhccCCCCCCCHHHHHHHHHHHHHHH
Q 013028          181 QDE-----WENELRFLSRLN--HPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIKIALGAARGL  252 (451)
Q Consensus       181 ~~~-----~~~E~~il~~l~--h~nIv~~~~~~~~~~~~~lV~E~~~gg~L-~~~l~~~~~~~l~~~~~~~i~~qi~~aL  252 (451)
                      ...     ...|+.-|.++.  +=.+.+.+++.    ...|||||+....+ .-.|   .+..+...++..+..++++.+
T Consensus       107 rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~  179 (268)
T COG1718         107 RRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYM  179 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHH
Confidence            111     134666666663  33444555443    34799999954311 1111   223344445667777888888


Q ss_pred             HHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       253 ~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      .-|-.. .++||+||..=|||+. ++.+.|+|||.|..
T Consensus       180 ~~l~~~-a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         180 RRLYKE-AGLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             HHHHHh-cCcccccchhhheEEE-CCeEEEEECccccc
Confidence            776553 6899999999999999 77999999999974

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.38  E-value=4.2e-06  Score=78.79  Aligned_cols=138  Identities=20%  Similarity=0.130  Sum_probs=82.0

Q ss_pred             ccccCc-eEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccceeecCCeeEEE
Q 013028          138 IGQGGF-GDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYCCDDQHRLLV  215 (451)
Q Consensus       138 LG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lV  215 (451)
                      |-.|.+ ..||+...            .+..+.||+.....   ...+.+|+++++.+. +--+.+++++...+...++|
T Consensus         6 ~~~g~~~~~v~~~~~------------~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   70 (244)
T cd05150           6 VTEGQSGATVYRLDG------------KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLL   70 (244)
T ss_pred             cCCCCCcCeEEEEcC------------CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEE
Confidence            444555 78898532            12457888875332   345678999999885 43455777777766678999


Q ss_pred             EeccCCCChhhhhc-------------------cCC--CCCCCHH--HHHHHHH--------------------HHHHHH
Q 013028          216 YEYVTRGSLEDHLL-------------------NED--DTELNWE--RRIKIAL--------------------GAARGL  252 (451)
Q Consensus       216 ~E~~~gg~L~~~l~-------------------~~~--~~~l~~~--~~~~i~~--------------------qi~~aL  252 (451)
                      ||+++|.+|.....                   ...  ...+...  .......                    .+...+
T Consensus        71 ~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (244)
T cd05150          71 TSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELY  150 (244)
T ss_pred             EEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHH
Confidence            99999977764321                   110  0011100  0000000                    011112


Q ss_pred             HHHHh-----CCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          253 EHLHT-----YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       253 ~~LH~-----~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..|-.     ....++|+|+.|.|||+++++.+.|+||+.+.+
T Consensus       151 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         151 AELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            22211     013489999999999999987788999998864

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.27  E-value=4.9e-06  Score=72.66  Aligned_cols=130  Identities=22%  Similarity=0.249  Sum_probs=90.4

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCce-eeccceeecCC
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNV-VKLMGYCCDDQ  210 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~~~~~~~~~~  210 (451)
                      ....+.||+|++|.||+|.|..            ..+|+|+-..  ......+..|.++|..+.-.++ .++|.+..   
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~~------------~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~---   86 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWRG------------GEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGE---   86 (201)
T ss_pred             hhhhhhhhcccccEEEEeeccC------------ceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEech---
Confidence            3456889999999999998763            3689998654  3445678899999998885554 34554433   


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCC-CCceeeCCCCcEEEeecCCcc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVK-ASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlk-p~NIll~~~~~~kl~DFGla~  289 (451)
                       .++.|||+.|-+|.++....     +..    -...+++.---|-.  .||-|+.|. |..++|..++.+.|+||.-|.
T Consensus        87 -~~i~me~i~G~~L~~~~~~~-----~rk----~l~~vlE~a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          87 -DFIRMEYIDGRPLGKLEIGG-----DRK----HLLRVLEKAYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             -hhhhhhhhcCcchhhhhhcc-----cHH----HHHHHHHHHHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchh
Confidence             24569999998887765321     122    23344555333444  799999996 555555555599999999987


Q ss_pred             c
Q 013028          290 F  290 (451)
Q Consensus       290 ~  290 (451)
                      +
T Consensus       155 ~  155 (201)
T COG2112         155 F  155 (201)
T ss_pred             h
Confidence            4

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.24  E-value=5.1e-06  Score=77.00  Aligned_cols=141  Identities=20%  Similarity=0.195  Sum_probs=81.5

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCc--eeeccceeec---CC
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPN--VVKLMGYCCD---DQ  210 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~~~~~~~~---~~  210 (451)
                      +.|+.|..+.||+....+            ..+++|.....  .....+..|..+++.+....  +.+++.....   ..
T Consensus         3 ~~l~~G~~n~~~~v~~~~------------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~   68 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD------------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG   68 (239)
T ss_dssp             EEEEESSSSEEEEEEETT------------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS
T ss_pred             ccCCCCCeeeEEEEEECC------------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc
Confidence            578999999999975432            36899987543  34567889999999986332  4566654322   23


Q ss_pred             eeEEEEeccCCCChhh----------------hh---ccC--CCCCCCHHH---------HHHH------------HHHH
Q 013028          211 HRLLVYEYVTRGSLED----------------HL---LNE--DDTELNWER---------RIKI------------ALGA  248 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~qi  248 (451)
                      ..+++|++++|..+..                .+   ...  ....+....         ....            ...+
T Consensus        69 ~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (239)
T PF01636_consen   69 FPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEEL  148 (239)
T ss_dssp             EEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred             cceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHH
Confidence            4689999999988877                11   011  111111100         0000            0112


Q ss_pred             HH-HHHHHHh-----CCCCceeCCCCCCceeeC-CCCcEEEeecCCccc
Q 013028          249 AR-GLEHLHT-----YWRPVIHRDVKASNVLLD-DDFNAKISDFGLAKF  290 (451)
Q Consensus       249 ~~-aL~~LH~-----~~~~iiHrDlkp~NIll~-~~~~~kl~DFGla~~  290 (451)
                      .. .+..++.     ....++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  149 EERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            22 2333332     124699999999999999 666778999998864

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.17  E-value=6.1e-05  Score=67.90  Aligned_cols=102  Identities=32%  Similarity=0.318  Sum_probs=80.8

Q ss_pred             HHHHHHHHhcCC-CceeeccceeecCCeeEEEEeccCCCChhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-
Q 013028          185 ENELRFLSRLNH-PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-EDDTELNWERRIKIALGAARGLEHLHTYWRP-  261 (451)
Q Consensus       185 ~~E~~il~~l~h-~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-  261 (451)
                      ..|.-+|+.+.+ +++++++|+|-    .++|.||...+++...... ..-...+|..+++|+.++++.+.+|+....| 
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358889999985 69999999993    3789999987766532100 0123578999999999999999999873323 


Q ss_pred             ceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          262 VIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       262 iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      +.-.|++++|+-+++++++|++|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            77899999999999999999999988753

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.16  E-value=1.6e-05  Score=74.41  Aligned_cols=31  Identities=26%  Similarity=0.378  Sum_probs=26.4

Q ss_pred             CCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          260 RPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       260 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      .+++|+|+.+.|||++++...-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3589999999999998776567999998864

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.16  E-value=2.6e-05  Score=86.32  Aligned_cols=82  Identities=17%  Similarity=0.265  Sum_probs=55.6

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcC-CCce--eeccceeecC-
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLN-HPNV--VKLMGYCCDD-  209 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~nI--v~~~~~~~~~-  209 (451)
                      .+.|+.|.++.+|+..+....        ....+++|+..... ......+.+|+++|+.+. |.+|  .+++.++.+. 
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~--------~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~  114 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGG--------SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS  114 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCC--------cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC
Confidence            467899999999986543210        11346677654322 223457889999999996 6665  6777777664 


Q ss_pred             --CeeEEEEeccCCCCh
Q 013028          210 --QHRLLVYEYVTRGSL  224 (451)
Q Consensus       210 --~~~~lV~E~~~gg~L  224 (451)
                        ...|+||||++|..+
T Consensus       115 v~G~~flVME~v~G~~~  131 (822)
T PLN02876        115 VIGTAFYIMEYLEGRIF  131 (822)
T ss_pred             cCCCceEEEEecCCccc
Confidence              357899999988643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.14  E-value=5.8e-05  Score=68.49  Aligned_cols=133  Identities=22%  Similarity=0.293  Sum_probs=90.5

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC----------------CcCHHHHHHHHHHHHhcC---
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG----------------SQGQDEWENELRFLSRLN---  195 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~il~~l~---  195 (451)
                      ...||+|+.-.||.-            .. +....||+.....                .....+..+|+.-...+.   
T Consensus         6 ~~~i~~G~~R~cy~H------------P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~   72 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH------------PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRR   72 (199)
T ss_pred             CcccccCCCceEEEC------------CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhcc
Confidence            467999999999972            11 3346788886544                122355667777666665   


Q ss_pred             ---CCceeeccceeecCCeeEEEEeccCC------CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCC
Q 013028          196 ---HPNVVKLMGYCCDDQHRLLVYEYVTR------GSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRD  266 (451)
Q Consensus       196 ---h~nIv~~~~~~~~~~~~~lV~E~~~g------g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrD  266 (451)
                         +.+|.+++|+.+.+....+|+|.+..      .+|.+++..   ..++. ...   ..+-+-..||-+  .+|+.+|
T Consensus        73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~---~~L~~f~~~l~~--~~Iv~~d  143 (199)
T PF10707_consen   73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELR---QALDEFKRYLLD--HHIVIRD  143 (199)
T ss_pred             CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHH---HHHHHHHHHHHH--cCCeecC
Confidence               78899999999999999999997643      356677633   33444 323   333344456666  6899999


Q ss_pred             CCCCceeeCCC---C-cEEEee-cCCcc
Q 013028          267 VKASNVLLDDD---F-NAKISD-FGLAK  289 (451)
Q Consensus       267 lkp~NIll~~~---~-~~kl~D-FGla~  289 (451)
                      |+|.||++...   . .+.|+| ||...
T Consensus       144 l~~~NIv~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  144 LNPHNIVVQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             CCcccEEEEecCCCceEEEEEeCCCCcc
Confidence            99999999532   2 588888 45443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.97  E-value=5.7e-05  Score=73.22  Aligned_cols=141  Identities=21%  Similarity=0.153  Sum_probs=83.7

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCc--eeeccce------e
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPN--VVKLMGY------C  206 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~~~~~------~  206 (451)
                      .+.|..|....+|+....            +..+++|+...   ...+.+..|+.++..|.+.+  +.+++..      .
T Consensus        19 i~~i~~G~~n~~y~v~~~------------~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~   83 (296)
T cd05153          19 FEGISAGIENTNYFVTTD------------SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLS   83 (296)
T ss_pred             eecccCccccceEEEEeC------------CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEee
Confidence            456778888899985321            23588888754   33456778999998885332  4444432      1


Q ss_pred             ecCCeeEEEEeccCCCChhh----hh----------cc----CCC-----CCCCHHHHH----------HHHHHHHHHHH
Q 013028          207 CDDQHRLLVYEYVTRGSLED----HL----------LN----EDD-----TELNWERRI----------KIALGAARGLE  253 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~----~l----------~~----~~~-----~~l~~~~~~----------~i~~qi~~aL~  253 (451)
                      ..++..++||++++|..+..    .+          +.    ...     ....|....          .....+..++.
T Consensus        84 ~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  163 (296)
T cd05153          84 ELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELA  163 (296)
T ss_pred             eeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHH
Confidence            23445689999999876532    00          00    000     001111100          01111223344


Q ss_pred             HHHh-----CCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          254 HLHT-----YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       254 ~LH~-----~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ++..     ...+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       164 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         164 RQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4432     114799999999999999987778999998874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.96  E-value=4.5e-05  Score=78.70  Aligned_cols=148  Identities=19%  Similarity=0.170  Sum_probs=87.4

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCH------------------------
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ------------------------  181 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------------  181 (451)
                      +.+...|. .+.||..+.|.||+|++++           +..||||+-+..-....                        
T Consensus       158 e~if~~f~-~~piaaASlaQVhrA~L~~-----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~  225 (538)
T KOG1235|consen  158 EDIFSEFD-EEPIAAASLAQVHRARLKN-----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLV  225 (538)
T ss_pred             HHHHHhcC-cchhhhcchhheEEEEecC-----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchh
Confidence            44444444 3679999999999987654           67799998543211110                        


Q ss_pred             -------------HHHHHHHHHHHh----cCCCce---eeccceeec-CCeeEEEEeccCCCChhhhhccCCCCCCCHHH
Q 013028          182 -------------DEWENELRFLSR----LNHPNV---VKLMGYCCD-DQHRLLVYEYVTRGSLEDHLLNEDDTELNWER  240 (451)
Q Consensus       182 -------------~~~~~E~~il~~----l~h~nI---v~~~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~  240 (451)
                                   -+|.+|.+-..+    +.|-++   |.+=.++++ ....+|+||||+|..+.|.-. .....++...
T Consensus       226 ~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~-i~~~gi~~~~  304 (538)
T KOG1235|consen  226 WLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA-IDKRGISPHD  304 (538)
T ss_pred             hHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH-HHHcCCCHHH
Confidence                         012223332222    234441   112222322 345689999999988876532 1123445454


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC----CCCcEEEeecCCccc
Q 013028          241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD----DDFNAKISDFGLAKF  290 (451)
Q Consensus       241 ~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~----~~~~~kl~DFGla~~  290 (451)
                      +..-+.++..-+-+ +   .|++|.|-.|.||++.    .++.+.+.|||+...
T Consensus       305 i~~~l~~~~~~qIf-~---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  305 ILNKLVEAYLEQIF-K---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             HHHHHHHHHHHHHH-h---cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            33333332221112 2   5899999999999998    367899999999874

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.93  E-value=8.4e-05  Score=69.42  Aligned_cols=75  Identities=21%  Similarity=0.155  Sum_probs=46.8

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCc-eeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPN-VVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~~~~~~~~~~~~~l  214 (451)
                      +.|..|-...+|+.....         ..+..|++|+...... ...+..+|+.+++.+...+ ..++++.+.    -.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~---------~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~   69 (235)
T cd05157           4 KRFTGGITNKLVKVSNKE---------DNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGL   69 (235)
T ss_pred             EEcCCcccceEEEEEcCC---------CCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcE
Confidence            567888889999864221         0235688887754322 1223457999999886333 344444432    248


Q ss_pred             EEeccCCCCh
Q 013028          215 VYEYVTRGSL  224 (451)
Q Consensus       215 V~E~~~gg~L  224 (451)
                      ||||++|.++
T Consensus        70 l~e~i~G~~l   79 (235)
T cd05157          70 IYEFIPGRTL   79 (235)
T ss_pred             EEEeeCCCcC
Confidence            9999998766

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.93  E-value=0.00011  Score=66.38  Aligned_cols=125  Identities=27%  Similarity=0.359  Sum_probs=88.8

Q ss_pred             cCCCcCCcccccCc-eEEEEEEEcCcchhhhhhcCCCcEEEEEEecc---CCC------------------cCHHHHHHH
Q 013028          130 RKFSEKNLIGQGGF-GDVYIGYINSCAMTAARRKNADFAVAVKRLRR---KGS------------------QGQDEWENE  187 (451)
Q Consensus       130 ~~y~~~~~LG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E  187 (451)
                      ..++.++.||.|.- |.||+....            +..+|||++..   ...                  .....|..|
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~------------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~E  104 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID------------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCE  104 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC------------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHH
Confidence            58888999999999 999997654            56799999321   000                  111246778


Q ss_pred             HHHHHhcC---CCce--eeccceeecC------------------CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHH
Q 013028          188 LRFLSRLN---HPNV--VKLMGYCCDD------------------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI  244 (451)
Q Consensus       188 ~~il~~l~---h~nI--v~~~~~~~~~------------------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i  244 (451)
                      .+...+|+   +.++  |+++|+..-.                  ....||.||++...           .+.    ..-
T Consensus       105 CRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~  169 (207)
T PF13095_consen  105 CRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRD  169 (207)
T ss_pred             HHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhH
Confidence            88877775   4566  9999987321                  12357888876533           111    234


Q ss_pred             HHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       245 ~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +.+|.+-|..+|.  .||+-+|+++.|..     .-+|+|||.+
T Consensus       170 ~~~~~~dl~~~~k--~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  170 IPQMLRDLKILHK--LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHHHH--CCeeeccCcccccc-----CCEEEecccC
Confidence            5677788889999  89999999999998     5688999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.85  E-value=0.00012  Score=69.49  Aligned_cols=137  Identities=14%  Similarity=0.073  Sum_probs=77.0

Q ss_pred             cccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCce-eeccceeecCCeeEEE
Q 013028          137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNV-VKLMGYCCDDQHRLLV  215 (451)
Q Consensus       137 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~~~~~~~~~~~~~lV  215 (451)
                      .+..|-.+.+|+...            .+..+++|........-.-+..+|..+++.+...++ .+++...  .  .++|
T Consensus         3 ~~~~G~tn~~y~~~~------------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v   66 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH------------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLL   66 (256)
T ss_pred             cCCCcCcCCeEEEEe------------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEE
Confidence            356688889998541            234578887653322211235789999999864333 3344333  2  3699


Q ss_pred             EeccCCCChhhh-----------------hccCC--CCCCCHHH-HHHHHHHH---------HHHHHHHHhC------CC
Q 013028          216 YEYVTRGSLEDH-----------------LLNED--DTELNWER-RIKIALGA---------ARGLEHLHTY------WR  260 (451)
Q Consensus       216 ~E~~~gg~L~~~-----------------l~~~~--~~~l~~~~-~~~i~~qi---------~~aL~~LH~~------~~  260 (451)
                      |||++|..+...                 ++...  ...++... ...+..++         ...+..+-..      ..
T Consensus        67 ~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (256)
T TIGR02721        67 VEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPL  146 (256)
T ss_pred             EEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCC
Confidence            999998765421                 11111  11122211 11111111         1112222110      12


Q ss_pred             CceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          261 PVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       261 ~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      .++|+|+.|.||++++++ +.|+||..|..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            489999999999999876 78999999874

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.80  E-value=5.2e-05  Score=82.89  Aligned_cols=195  Identities=23%  Similarity=0.255  Sum_probs=129.5

Q ss_pred             HHHHHHHHhcCCCceeeccceeecCCeeE----EEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 013028          185 ENELRFLSRLNHPNVVKLMGYCCDDQHRL----LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWR  260 (451)
Q Consensus       185 ~~E~~il~~l~h~nIv~~~~~~~~~~~~~----lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~  260 (451)
                      +-|+..+..+.|+|++.++.+.......-    +..|+|..-++...+..  ....+....+.+..++.+||.|+|+  .
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h~--~  305 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLHS--L  305 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHHH--h
Confidence            44666777888999999998876544333    34567888888887744  5678889999999999999999999  4


Q ss_pred             CceeCCCCCC---ceeeCCCCcEEEe--ecCCcccCCCCCCcccccccCCCCccccccccccCCCCc--chhhHHHHHHH
Q 013028          261 PVIHRDVKAS---NVLLDDDFNAKIS--DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTL--KTDVYSFGVVL  333 (451)
Q Consensus       261 ~iiHrDlkp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~--~~DiwSlGvil  333 (451)
                      ...|.-|..+   +...+.++...++  ||+.+...+......   ...-+..+.++|.+....+..  ..|+|.+|..+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            3444433333   3333455666666  888877544322221   223345577888776555544  47999999999


Q ss_pred             HHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          334 LEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       334 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ..+..|..+-...                    ......+...    ......+...+|+.-++++|+++.+++...
T Consensus       383 ~~~~~~~~i~~~~--------------------~~~~~~l~~~----~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  383 LQLSQGEDISEKS--------------------AVPVSLLDVL----STSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhcCcccccc--------------------cchhhhhccc----cchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            9999886532110                    0001111101    111578888999999999999999998753

>PRK10593 hypothetical protein; Provisional

Probab=97.77  E-value=0.00047  Score=66.97  Aligned_cols=80  Identities=16%  Similarity=0.108  Sum_probs=55.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCC---Cceeeccceee
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH---PNVVKLMGYCC  207 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h---~nIv~~~~~~~  207 (451)
                      ...-.+.||.|..+.||.-...            +..+.+|..+.  ......+..|...|+.|..   -.+.++++++.
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~------------~~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~   80 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDS------------QGNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMT   80 (297)
T ss_pred             hhheeeecCCccceeEEEEEcC------------CCCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEec
Confidence            3444567999999999985321            12366677432  1234578899999999863   35778888775


Q ss_pred             cC---CeeEEEEeccCCCCh
Q 013028          208 DD---QHRLLVYEYVTRGSL  224 (451)
Q Consensus       208 ~~---~~~~lV~E~~~gg~L  224 (451)
                      ++   +..+||||+++|+++
T Consensus        81 ~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         81 HEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             cCCcCCCeEEEEeccCCEec
Confidence            43   557999999998765

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.74  E-value=0.00027  Score=68.78  Aligned_cols=81  Identities=20%  Similarity=0.176  Sum_probs=50.0

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCce-eeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNV-VKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~~~~~~~~~~~~~l  214 (451)
                      +.|..|-...||+.....+.    .....+..+++|+..... ....+..+|.+++..+...++ .++++++.+    .+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~----~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~   74 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDED----ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR   74 (302)
T ss_pred             EEecCcccceeEEEEcCCcc----cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence            45666777899986543211    022335678899876432 233456789999998863333 345555532    36


Q ss_pred             EEeccCCCChh
Q 013028          215 VYEYVTRGSLE  225 (451)
Q Consensus       215 V~E~~~gg~L~  225 (451)
                      ||||++|..+.
T Consensus        75 v~e~i~G~~l~   85 (302)
T cd05156          75 IEEFIPSRTLT   85 (302)
T ss_pred             hhheeCCCcCC
Confidence            89999987664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.71  E-value=0.00064  Score=66.36  Aligned_cols=142  Identities=18%  Similarity=0.125  Sum_probs=81.7

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCc--eeecccee------
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPN--VVKLMGYC------  206 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~~~~~~------  206 (451)
                      .+.++.|....+|+....            +..+++|+....  ...+.+..|++++..|...+  +.+++...      
T Consensus        27 i~~~~~G~~n~~y~v~t~------------~~~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~   92 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD------------VGRYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLS   92 (307)
T ss_pred             ccccCCccccceEEEEeC------------CCcEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeeh
Confidence            456778877899985321            224778887542  23455677888888885322  34444321      


Q ss_pred             ecCCeeEEEEeccCCCChhhh----h----------ccC-CC------C--C-CCHHHHH------------HHHHHHHH
Q 013028          207 CDDQHRLLVYEYVTRGSLEDH----L----------LNE-DD------T--E-LNWERRI------------KIALGAAR  250 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~----l----------~~~-~~------~--~-l~~~~~~------------~i~~qi~~  250 (451)
                      ...+..++||||++|..+...    .          +.. ..      .  . -.|....            .....+..
T Consensus        93 ~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~  172 (307)
T TIGR00938        93 TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDK  172 (307)
T ss_pred             hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHH
Confidence            223456899999998654210    0          100 00      0  0 0111100            00112233


Q ss_pred             HHHHHHh-----CCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          251 GLEHLHT-----YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       251 aL~~LH~-----~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      .++++..     ...++||+|+.+.||+++.++...|+||+.+..
T Consensus       173 ~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       173 ELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            4444532     125799999999999999887778999998863

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.70  E-value=0.00067  Score=66.53  Aligned_cols=140  Identities=18%  Similarity=0.129  Sum_probs=76.9

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCc--eeeccc------eee
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPN--VVKLMG------YCC  207 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~~~~------~~~  207 (451)
                      +.|+.|....+|+....            +..+++|++..   ...+.+..|+.+++.|...+  +.+++.      +..
T Consensus        28 ~~l~~G~~n~~y~v~t~------------~g~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~   92 (319)
T PRK05231         28 KGIAEGIENSNFFLTTT------------QGEYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGE   92 (319)
T ss_pred             chhccccccceEEEEeC------------CCcEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeee
Confidence            55777887889985422            22478898752   23345556777777764222  233332      122


Q ss_pred             cCCeeEEEEeccCCCChhh-----h------h---ccCC-C--------CCCCH-HHHHH------------HHHH-HHH
Q 013028          208 DDQHRLLVYEYVTRGSLED-----H------L---LNED-D--------TELNW-ERRIK------------IALG-AAR  250 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~-----~------l---~~~~-~--------~~l~~-~~~~~------------i~~q-i~~  250 (451)
                      ..+..+++|||++|..+..     .      +   +... .        ..+.+ .....            .+.+ +..
T Consensus        93 ~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  172 (319)
T PRK05231         93 LAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAA  172 (319)
T ss_pred             eCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHH
Confidence            3456789999999875421     1      1   0000 0        01111 11110            1111 111


Q ss_pred             HHHHHHh-----CCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          251 GLEHLHT-----YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       251 aL~~LH~-----~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      .+..+..     ...++||+|+.|.|||++.+...-|+||+.+..
T Consensus       173 ~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        173 QLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            2222221     125899999999999999775568999999874

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.61  E-value=0.00089  Score=67.28  Aligned_cols=76  Identities=21%  Similarity=0.114  Sum_probs=51.8

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-------CcCHHHHHHHHHHHHhcC---CCceeeccce
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-------SQGQDEWENELRFLSRLN---HPNVVKLMGY  205 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~il~~l~---h~nIv~~~~~  205 (451)
                      +.||.|.+..||+....++          ...|.||.-....       ....+....|.+.|+.+.   -.++.+++.+
T Consensus        32 ~elggGn~N~VyrV~~~~g----------~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~  101 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEG----------GKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY  101 (401)
T ss_pred             eEcCCCceEEEEEEEeCCC----------CeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence            6799999999999764321          2468999743211       224456677888888864   2356667766


Q ss_pred             eecCCeeEEEEeccCCCC
Q 013028          206 CCDDQHRLLVYEYVTRGS  223 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~  223 (451)
                        +.+..++|||++++..
T Consensus       102 --D~~~~~lVME~L~~~~  117 (401)
T PRK09550        102 --DEELAVTVMEDLSDHK  117 (401)
T ss_pred             --CCCCCEEEEecCCCcc
Confidence              4466789999998643

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.59  E-value=7e-05  Score=71.55  Aligned_cols=134  Identities=21%  Similarity=0.149  Sum_probs=87.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEecc-----------------CCCcC-----HHHHHHHH
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR-----------------KGSQG-----QDEWENEL  188 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~-----------------~~~~~-----~~~~~~E~  188 (451)
                      -+.+++.||-|.-+.+|.+....+           .+.++|..+.                 ....+     .-...+|+
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G-----------~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEf  161 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEG-----------NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEF  161 (465)
T ss_pred             hhhhccccccccccceEEEecCCC-----------CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHH
Confidence            578899999999999999876543           3344443210                 01111     11235688


Q ss_pred             HHHHhcC-CCc-eeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCC
Q 013028          189 RFLSRLN-HPN-VVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRD  266 (451)
Q Consensus       189 ~il~~l~-h~n-Iv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrD  266 (451)
                      ..|+.|. |.. +.+.+++    +..++|||+++|-.|...-.-     .+..   .+...+..-+--|-.  .|+||+|
T Consensus       162 afmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~---~ly~~lm~~Iv~la~--~GlIHgD  227 (465)
T KOG2268|consen  162 AFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPP---TLYDDLMGLIVRLAN--HGLIHGD  227 (465)
T ss_pred             HHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-----CChH---HHHHHHHHHHHHHHH--cCceecc
Confidence            8888886 433 3444443    456899999999887654311     1112   223333333344555  7999999


Q ss_pred             CCCCceeeCCCCcEEEeecCCcc
Q 013028          267 VKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       267 lkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +.-=||++++++.++++||-...
T Consensus       228 FNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  228 FNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             cchheeEEecCCCEEEeechHhh
Confidence            99999999999999999998765

>PLN02236 choline kinase

Probab=97.34  E-value=0.0022  Score=63.60  Aligned_cols=144  Identities=17%  Similarity=0.179  Sum_probs=82.2

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCce-eeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNV-VKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~~~~~~~~~~~~~l  214 (451)
                      ..|-.|-...+|+..+...      ....+..|++|+........ -+-.+|..+++.+..-++ .++++.+..+    .
T Consensus        42 ~~l~gGlTN~~y~v~~~~~------~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~  110 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTK------EGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----R  110 (344)
T ss_pred             EEcCCcccceeEEEEeCCC------CCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence            4555688899999764321      11234678899876543222 223679999998864333 3556666433    5


Q ss_pred             EEeccCCCChhhh-h----------------ccCC--C-C-CCCHHHHHHHHHHH-----------------HHHHHHH-
Q 013028          215 VYEYVTRGSLEDH-L----------------LNED--D-T-ELNWERRIKIALGA-----------------ARGLEHL-  255 (451)
Q Consensus       215 V~E~~~gg~L~~~-l----------------~~~~--~-~-~l~~~~~~~i~~qi-----------------~~aL~~L-  255 (451)
                      |+||+++.+|... +                +...  . . ...++++..+..++                 ...+..| 
T Consensus       111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~  190 (344)
T PLN02236        111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE  190 (344)
T ss_pred             EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence            8999987666421 0                1110  0 0 11223332332111                 1111112 


Q ss_pred             ---Hh--CCCCceeCCCCCCceeeCC-CCcEEEeecCCccc
Q 013028          256 ---HT--YWRPVIHRDVKASNVLLDD-DFNAKISDFGLAKF  290 (451)
Q Consensus       256 ---H~--~~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~~  290 (451)
                         ..  ....++|+|+++.|||+++ ++.+.|+||..|.+
T Consensus       191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence               11  0135799999999999986 46899999998874

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.29  E-value=3.5e-05  Score=85.99  Aligned_cols=157  Identities=13%  Similarity=0.029  Sum_probs=112.0

Q ss_pred             HHHHHHHhcCCCceeeccceeecC--CeeEEEEeccCCCChhhhhccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 013028          186 NELRFLSRLNHPNVVKLMGYCCDD--QHRLLVYEYVTRGSLEDHLLNEDD--TELNWERRIKIALGAARGLEHLHTYW--  259 (451)
Q Consensus       186 ~E~~il~~l~h~nIv~~~~~~~~~--~~~~lV~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--  259 (451)
                      .|..-++...|+++...+.-....  ...+.+++|+.+|.+++.|.....  ..+...-+.-...+.+.+..-+|+..  
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            355555566899888776554432  345889999999999999865322  22333333333333355666666532  


Q ss_pred             -CCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh
Q 013028          260 -RPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS  338 (451)
Q Consensus       260 -~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt  338 (451)
                       .-.+|++||+-|.+|..+..+++.++|+.+..+  .........++++.|+.|++...-.++.++|+|..|+.+|++.-
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence             126899999999999999999999999998311  11223345678889999999888888989999999999999988


Q ss_pred             CCCccc
Q 013028          339 GKTAAM  344 (451)
Q Consensus       339 g~~pf~  344 (451)
                      |..+|-
T Consensus      1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred             ccHHHH
Confidence            877664

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.03  E-value=0.0062  Score=59.58  Aligned_cols=141  Identities=20%  Similarity=0.175  Sum_probs=93.3

Q ss_pred             CcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC----------------------cCHH----HHHH
Q 013028          133 SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS----------------------QGQD----EWEN  186 (451)
Q Consensus       133 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~----~~~~  186 (451)
                      .+-..|..|.-+.||.++..+           +..+|||+++..-.                      ...+    ..+.
T Consensus       147 ~inGCiSTGKEANVYHat~~d-----------G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEK  215 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEED-----------GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEK  215 (520)
T ss_pred             ecccccccCccceeEeeecCC-----------CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHH
Confidence            344678889999999976443           55699998752100                      0011    1245


Q ss_pred             HHHHHHhcCCCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCC
Q 013028          187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRD  266 (451)
Q Consensus       187 E~~il~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrD  266 (451)
                      |+.-|.+|..-.|.-.--+..  ...+|||+|+.+ +=+-. -...+..++...+..+-.+++.-+.-|-.. .++||.|
T Consensus       216 E~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGr-dgw~a-PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHAD  290 (520)
T KOG2270|consen  216 EMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGR-DGWAA-PKLKDASLSTSKARELYQQCVRIMRRLYQK-CRLVHAD  290 (520)
T ss_pred             HHHHHHHHHhcCCCCCCceee--ecceEeeeeccC-CCCcC-cccccccCChHHHHHHHHHHHHHHHHHHHH-hceeccc
Confidence            777787776555433322222  124799999953 22211 112346677778888888888888887665 4899999


Q ss_pred             CCCCceeeCCCCcEEEeecCCccc
Q 013028          267 VKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       267 lkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      |.-=|+|+-++ .+.|+|-+.+..
T Consensus       291 LSEfN~LyhdG-~lyiIDVSQSVE  313 (520)
T KOG2270|consen  291 LSEFNLLYHDG-KLYIIDVSQSVE  313 (520)
T ss_pred             hhhhhheEECC-EEEEEEcccccc
Confidence            99999998765 899999999873

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.00  E-value=0.0085  Score=58.28  Aligned_cols=120  Identities=20%  Similarity=0.259  Sum_probs=71.9

Q ss_pred             CcEEEEEEec--cCCCcCHHHHHHHHHHHHhcCCC--ceeeccceeecCC--eeEEEEeccCCCChhhhhccCCCCCCCH
Q 013028          165 DFAVAVKRLR--RKGSQGQDEWENELRFLSRLNHP--NVVKLMGYCCDDQ--HRLLVYEYVTRGSLEDHLLNEDDTELNW  238 (451)
Q Consensus       165 ~~~vavK~~~--~~~~~~~~~~~~E~~il~~l~h~--nIv~~~~~~~~~~--~~~lV~E~~~gg~L~~~l~~~~~~~l~~  238 (451)
                      ++.++|. ..  ........+..+|..+++.+.--  -+...++.|.++.  ..|.||+|++|..+.+.+......    
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~----  122 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLG----  122 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccch----
Confidence            4456666 22  12233345667889998887532  2344566666665  669999999985443322111000    


Q ss_pred             HHHHHHH-HHHHHHHHHHH--------------------------------------------------hCC------CC
Q 013028          239 ERRIKIA-LGAARGLEHLH--------------------------------------------------TYW------RP  261 (451)
Q Consensus       239 ~~~~~i~-~qi~~aL~~LH--------------------------------------------------~~~------~~  261 (451)
                         ..++ ..++..|.-||                                                  ...      ..
T Consensus       123 ---~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~  199 (321)
T COG3173         123 ---RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPV  199 (321)
T ss_pred             ---HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCce
Confidence               0111 13333333333                                                  211      24


Q ss_pred             ceeCCCCCCceeeCCCCcEEEeecCCcccCC
Q 013028          262 VIHRDVKASNVLLDDDFNAKISDFGLAKFGP  292 (451)
Q Consensus       262 iiHrDlkp~NIll~~~~~~kl~DFGla~~~~  292 (451)
                      ++|+|+.+.||+++.++.+-|+||+++..+.
T Consensus       200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         200 LVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             eeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            7999999999999998889999999998643

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.99  E-value=0.0068  Score=58.19  Aligned_cols=30  Identities=27%  Similarity=0.531  Sum_probs=25.5

Q ss_pred             CceeCCCCCCceeeCCCCc-EEEeecCCccc
Q 013028          261 PVIHRDVKASNVLLDDDFN-AKISDFGLAKF  290 (451)
Q Consensus       261 ~iiHrDlkp~NIll~~~~~-~kl~DFGla~~  290 (451)
                      .++|+|+.|.|||+++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4799999999999997555 56999999875

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.96  E-value=0.00059  Score=69.05  Aligned_cols=166  Identities=23%  Similarity=0.320  Sum_probs=91.4

Q ss_pred             HHHHHHHHHHHHhcCCCceeeccceeecC-CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 013028          181 QDEWENELRFLSRLNHPNVVKLMGYCCDD-QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYW  259 (451)
Q Consensus       181 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~-~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  259 (451)
                      ...+....++++.+.|+|...++++-... ....+|||++ +.+|++.+.......         . ++.     -    
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~---------~-s~~-----~----   85 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKD---------E-SLL-----A----   85 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccch---------h-hhc-----c----
Confidence            34566788999999999999999887643 3468899999 679999885432110         0 000     1    


Q ss_pred             CCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhC
Q 013028          260 RPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG  339 (451)
Q Consensus       260 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg  339 (451)
                      .++.|-     ||       ++.+| -++..                  |  |-.     ..+++||||+|.++.++.-|
T Consensus        86 ~~~~~~-----~~-------~~~td-~~~t~------------------~--~~~-----~~pKsdVwsl~~i~~el~L~  127 (725)
T KOG1093|consen   86 HGVLHL-----NI-------IYITD-HFLTK------------------Y--PSP-----IGPKSDVWSLGFIILELYLG  127 (725)
T ss_pred             ccccee-----hh-------hhccc-ccccc------------------C--CCC-----CCcchhhhhHHHHHHHHHHh
Confidence            233332     12       33333 11110                  0  101     11499999999999999988


Q ss_pred             CCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013028          340 KTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV  407 (451)
Q Consensus       340 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  407 (451)
                      ...+....+.........+.........+..+.   .+.......+.++..+|+...|..||...++.
T Consensus       128 ~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  128 ISLEAELTESEYLEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             hHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            755432221100000000000000000000000   22334466788899999999999998666554

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.89  E-value=0.0026  Score=58.42  Aligned_cols=120  Identities=22%  Similarity=0.215  Sum_probs=59.3

Q ss_pred             cEEEEEEeccCCCcCHHHHHHHHHHHHhcCC-CceeeccceeecCCeeEEEEeccCCCChhhh-hcc-------------
Q 013028          166 FAVAVKRLRRKGSQGQDEWENELRFLSRLNH-PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH-LLN-------------  230 (451)
Q Consensus       166 ~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~-l~~-------------  230 (451)
                      ..|+|++.... ....-+-..|..+++.+.. ..-.++++.+.++    +|+||++|..|..- +..             
T Consensus         3 ~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~   77 (211)
T PF01633_consen    3 EKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK   77 (211)
T ss_dssp             SEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred             CEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence            45788887654 3344566789999998874 4445666665433    67799977654321 100             


Q ss_pred             -----C---CCCCCCHHHHHHH----------------------HHHHHHHHHHHH----h--CCCCceeCCCCCCceee
Q 013028          231 -----E---DDTELNWERRIKI----------------------ALGAARGLEHLH----T--YWRPVIHRDVKASNVLL  274 (451)
Q Consensus       231 -----~---~~~~l~~~~~~~i----------------------~~qi~~aL~~LH----~--~~~~iiHrDlkp~NIll  274 (451)
                           .   ....-.+..+..+                      ...+..-+..+.    .  ....++|+|+.+.|||+
T Consensus        78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~  157 (211)
T PF01633_consen   78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI  157 (211)
T ss_dssp             HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred             HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence                 0   0000011112111                      011111222221    1  00247899999999999


Q ss_pred             -CCCCcEEEeecCCccc
Q 013028          275 -DDDFNAKISDFGLAKF  290 (451)
Q Consensus       275 -~~~~~~kl~DFGla~~  290 (451)
                       +.++.++|+||..|.+
T Consensus       158 ~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  158 NNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             TSSSSCEEE--GTT-EE
T ss_pred             ccCCCeEEEecHHHHhh
Confidence             7888999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.82  E-value=0.01  Score=58.51  Aligned_cols=143  Identities=15%  Similarity=0.208  Sum_probs=78.6

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCce-eeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNV-VKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~~~~~~~~~~~~~l  214 (451)
                      +.|..|-...+|+....+.       ...+..|++|+...... ..-+-.+|..+++.+..-++ .++++++..+    +
T Consensus        20 ~~l~gGlTN~~~~v~~~~~-------~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~   87 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEE-------NGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----M   87 (330)
T ss_pred             EEeCCcccceEEEEEecCC-------CCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----E
Confidence            4455577888898653221       01233688888764322 22233679999999875444 4556655322    5


Q ss_pred             EEeccCCCChhhh-------h----------ccCC--C-C-CCCHHHHHHHHHHH----------------------HHH
Q 013028          215 VYEYVTRGSLEDH-------L----------LNED--D-T-ELNWERRIKIALGA----------------------ARG  251 (451)
Q Consensus       215 V~E~~~gg~L~~~-------l----------~~~~--~-~-~l~~~~~~~i~~qi----------------------~~a  251 (451)
                      |.+|++|..|...       +          +...  . . .-.+..+..+..++                      ..-
T Consensus        88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  167 (330)
T PLN02421         88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE  167 (330)
T ss_pred             eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence            8999987655210       1          1111  0 0 11123222222111                      111


Q ss_pred             HHH---HH-hC--CCCceeCCCCCCceeeCC-CCcEEEeecCCccc
Q 013028          252 LEH---LH-TY--WRPVIHRDVKASNVLLDD-DFNAKISDFGLAKF  290 (451)
Q Consensus       252 L~~---LH-~~--~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~~  290 (451)
                      +..   +. ..  ..-++|+|+.+.|||+++ ++.++++||..|..
T Consensus       168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            111   11 10  012689999999999974 56899999999874

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.80  E-value=0.013  Score=57.83  Aligned_cols=74  Identities=23%  Similarity=0.241  Sum_probs=46.0

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEecc-------CCCcCHHHHHHHHHHHHhcC--CC-ceeeccce
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR-------KGSQGQDEWENELRFLSRLN--HP-NVVKLMGY  205 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~E~~il~~l~--h~-nIv~~~~~  205 (451)
                      ++||.|....||++....          ....|+||.-..       .-+...+...-|...|+...  -| .+.++|.+
T Consensus         1 ~EigdGnlN~VfrV~~~~----------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~   70 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQE----------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF   70 (370)
T ss_pred             CcCCCCceEEEEEEEcCC----------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE
Confidence            358999999999976321          124688887431       11333455566788887664  34 34444433


Q ss_pred             eecCCeeEEEEeccCC
Q 013028          206 CCDDQHRLLVYEYVTR  221 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~g  221 (451)
                        +.....+|||+++.
T Consensus        71 --D~e~~~~vMEdL~~   84 (370)
T TIGR01767        71 --DTEMAVTVMEDLSH   84 (370)
T ss_pred             --ccccceehHhhCcc
Confidence              55666799999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.58  E-value=0.032  Score=54.48  Aligned_cols=31  Identities=23%  Similarity=0.373  Sum_probs=28.5

Q ss_pred             CCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          260 RPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       260 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      .++||+|+.++|||+++++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4799999999999999999999999999875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.58  E-value=0.038  Score=53.75  Aligned_cols=30  Identities=30%  Similarity=0.457  Sum_probs=26.4

Q ss_pred             CCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          260 RPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       260 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      .+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            57899999999999988 5789999998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.49  E-value=0.013  Score=56.47  Aligned_cols=75  Identities=21%  Similarity=0.262  Sum_probs=47.1

Q ss_pred             CcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC---CCceeeccceeecC
Q 013028          133 SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN---HPNVVKLMGYCCDD  209 (451)
Q Consensus       133 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~~~~~~~~~  209 (451)
                      +-.+.|+.|....+|+..            ..+..+.||+-.   ......|..|.+-|+.|.   --.+.+++++....
T Consensus        20 ~~~~~v~GG~i~~a~~~~------------~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~   84 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD------------TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD   84 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE------------TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S
T ss_pred             eeeEecCCCChhheEEEE------------CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            334668889999999843            345678999876   233346788999998884   34577888888877


Q ss_pred             CeeEEEEeccCCC
Q 013028          210 QHRLLVYEYVTRG  222 (451)
Q Consensus       210 ~~~~lV~E~~~gg  222 (451)
                      +..+|||||++.+
T Consensus        85 ~~~fLlle~l~~~   97 (288)
T PF03881_consen   85 DDAFLLLEFLEMG   97 (288)
T ss_dssp             SCCEEEEE-----
T ss_pred             CCceEEEEeecCC
Confidence            7789999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.36  E-value=0.055  Score=53.13  Aligned_cols=121  Identities=24%  Similarity=0.312  Sum_probs=72.2

Q ss_pred             EEEEEeccCCCcCHHHHHHHHHHHHhcCCCce------eeccc----eeecCCeeEEEEeccCCCChhh-hh--------
Q 013028          168 VAVKRLRRKGSQGQDEWENELRFLSRLNHPNV------VKLMG----YCCDDQHRLLVYEYVTRGSLED-HL--------  228 (451)
Q Consensus       168 vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI------v~~~~----~~~~~~~~~lV~E~~~gg~L~~-~l--------  228 (451)
                      +++|+....  ....++.-|+..|++|.-.+|      ..+=|    ....+...+-|++|++|..+.. .-        
T Consensus        51 ~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG  128 (331)
T COG2334          51 YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELG  128 (331)
T ss_pred             eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHH
Confidence            488888754  566778889999999842222      11111    2222236788999999987772 11        


Q ss_pred             ----------ccCC------CCCCCHHH-------------HHHHHHHHHHHHHHHHhCC-----CC---ceeCCCCCCc
Q 013028          229 ----------LNED------DTELNWER-------------RIKIALGAARGLEHLHTYW-----RP---VIHRDVKASN  271 (451)
Q Consensus       229 ----------~~~~------~~~l~~~~-------------~~~i~~qi~~aL~~LH~~~-----~~---iiHrDlkp~N  271 (451)
                                .+..      .....|..             -.....++...+..+.+..     .+   +||+|+.|.|
T Consensus       129 ~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~N  208 (331)
T COG2334         129 RMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDN  208 (331)
T ss_pred             HHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccc
Confidence                      0000      01122320             0012233444444444310     23   9999999999


Q ss_pred             eeeCCCCc-EEEeecCCccc
Q 013028          272 VLLDDDFN-AKISDFGLAKF  290 (451)
Q Consensus       272 Ill~~~~~-~kl~DFGla~~  290 (451)
                      |+++.+.. ..++|||.++.
T Consensus       209 Vl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         209 VLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             eeEcCCCCeeeEEEcccccc
Confidence            99998874 89999999874

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.15  E-value=0.014  Score=53.25  Aligned_cols=102  Identities=15%  Similarity=0.165  Sum_probs=65.3

Q ss_pred             EEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHH
Q 013028          168 VAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL  246 (451)
Q Consensus       168 vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~  246 (451)
                      ..+|.+...... ...-+.++..++.++.  .|+++..-  ++-..-++.|.|-...           ..    -..++.
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----------i~----~~N~i~  148 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----------IN----FSNFIT  148 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----------cc----hhHHHH
Confidence            345555433323 3344677888887663  57777632  3334458889883211           00    012222


Q ss_pred             HHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       247 qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      -=+++|.-.|++..+.+|+|-.|+|||-|..|.+||.|=+..
T Consensus       149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            225678888976578999999999999999999999996654

The function of this family is unknown.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.06  E-value=0.02  Score=56.01  Aligned_cols=73  Identities=19%  Similarity=0.256  Sum_probs=57.6

Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ..+.|++|++- |++|.- +     ..-.+++++.|+++.+..++-+... -..=|||+.-.||||+ +|++.|+||-++
T Consensus       298 ~~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         298 TLYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             ceEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEEeeee
Confidence            34567888876 556532 2     2345688899999999888888764 3578999999999999 889999999999


Q ss_pred             cc
Q 013028          289 KF  290 (451)
Q Consensus       289 ~~  290 (451)
                      +.
T Consensus       369 Rl  370 (488)
T COG5072         369 RL  370 (488)
T ss_pred             ec
Confidence            84

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.03  E-value=0.068  Score=53.82  Aligned_cols=73  Identities=15%  Similarity=0.106  Sum_probs=47.2

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-------cCHHHHHHHHHHHHhcC---CCceeeccc
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-------QGQDEWENELRFLSRLN---HPNVVKLMG  204 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~---h~nIv~~~~  204 (451)
                      .+.||.|....||+....            +..++||.-.....       .....-..|...|+.+.   ..++.+++.
T Consensus        37 ~~eiggGn~N~VyrV~~~------------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~  104 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS------------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYH  104 (418)
T ss_pred             EEEcCCCceeeEEEEEcC------------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEE
Confidence            467899999999995421            23488887542111       12333345677776654   246777888


Q ss_pred             eeecCCeeEEEEeccCC
Q 013028          205 YCCDDQHRLLVYEYVTR  221 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~g  221 (451)
                      ++.  +..++|||++++
T Consensus       105 ~de--d~~vlvME~L~~  119 (418)
T PLN02756        105 FDR--TMALIGMRYLEP  119 (418)
T ss_pred             ECC--CCCEEEEeecCC
Confidence            776  446889999976

>PRK06148 hypothetical protein; Provisional

Probab=95.91  E-value=0.12  Score=58.77  Aligned_cols=31  Identities=39%  Similarity=0.529  Sum_probs=26.8

Q ss_pred             CCceeCCCCCCceeeCCCC--cEE-EeecCCccc
Q 013028          260 RPVIHRDVKASNVLLDDDF--NAK-ISDFGLAKF  290 (451)
Q Consensus       260 ~~iiHrDlkp~NIll~~~~--~~k-l~DFGla~~  290 (451)
                      .++||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999999775  454 999999974

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.80  E-value=0.045  Score=54.85  Aligned_cols=75  Identities=20%  Similarity=0.188  Sum_probs=48.0

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEecc------CCCcCHHHHHHHHHHHHhcC--CC-ceeeccce
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR------KGSQGQDEWENELRFLSRLN--HP-NVVKLMGY  205 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~~E~~il~~l~--h~-nIv~~~~~  205 (451)
                      .+.||.|.-.-||++....          .+..|+||.-..      .-+-..++..-|.++|+...  -| .+.++|.+
T Consensus        34 ~~eigdGnlN~VfrV~~~~----------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~  103 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ----------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF  103 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC----------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE
Confidence            4689999999999976521          124588886431      11334456667888888764  34 34445543


Q ss_pred             eecCCeeEEEEeccCC
Q 013028          206 CCDDQHRLLVYEYVTR  221 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~g  221 (451)
                        +.....+|||+++.
T Consensus       104 --D~e~~~~vMEdL~~  117 (409)
T PRK12396        104 --DSVMNCCVMEDLSD  117 (409)
T ss_pred             --CcHHhhHHHHhCcc
Confidence              55566788998853

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.79  E-value=0.027  Score=55.92  Aligned_cols=143  Identities=18%  Similarity=0.177  Sum_probs=81.1

Q ss_pred             HHHHhcCCCcCCcccccCceEEEEEEEcCcchhhh-----hhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCc
Q 013028          125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAA-----RRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPN  198 (451)
Q Consensus       125 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~n  198 (451)
                      ++.+...|. -..||.|+-..||+|+.+......+     .++.....+|+|+.....   .+.+...+.||.... -.|
T Consensus       185 ~~eiF~efn-~~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V---~~~ir~Dl~Il~f~Akl~~  260 (565)
T KOG1236|consen  185 IEEIFSEFN-REPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNV---EKQIRLDLGILGFGAKLIN  260 (565)
T ss_pred             HHHHHHhcC-CcccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccH---HHHHHHHHHHHhhhhhhhh
Confidence            344444443 3569999999999998754221111     134445679999976432   223333333333221 111


Q ss_pred             ---------------------------------eeeccceee-------------cCCeeEEEEeccCCCChhhhhccCC
Q 013028          199 ---------------------------------VVKLMGYCC-------------DDQHRLLVYEYVTRGSLEDHLLNED  232 (451)
Q Consensus       199 ---------------------------------Iv~~~~~~~-------------~~~~~~lV~E~~~gg~L~~~l~~~~  232 (451)
                                                       +-++..-|.             ......||-+|..|.++..++... 
T Consensus       261 ~vP~l~wL~l~~~vkqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~-  339 (565)
T KOG1236|consen  261 NVPDLSWLSLPLEVKQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWK-  339 (565)
T ss_pred             hcCccccccCcchHHHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhcc-
Confidence                                             111111111             112345677788888888887543 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC
Q 013028          233 DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD  275 (451)
Q Consensus       233 ~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~  275 (451)
                        ..++.....++.-.+.||--+--. .+++|.|+.|.||++.
T Consensus       340 --~~pe~l~kkva~lg~~AllkMl~v-DNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  340 --SQPEALVKKVAKLGVNALLKMLIV-DNFVHADLHPGNVLIR  379 (565)
T ss_pred             --cChHHHHHHHHHHHHHHHHHHHHh-hcceecccCCCcEEEE
Confidence              344555556666555665544332 5899999999999994

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.47  E-value=0.56  Score=46.14  Aligned_cols=29  Identities=24%  Similarity=0.377  Sum_probs=25.1

Q ss_pred             CCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          260 RPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       260 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      .++||+|+.+.|||++ + .+.|+||+.+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            5789999999999995 4 578999999874

>PTZ00384 choline kinase; Provisional

Probab=95.38  E-value=0.13  Score=51.74  Aligned_cols=81  Identities=14%  Similarity=0.137  Sum_probs=46.1

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCC-ceeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP-NVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~-nIv~~~~~~~~~~~~~l  214 (451)
                      +.|..|-...+|++......    ......+.|.+....... ...-+-.+|+++++.+... .-.++++.+..    ++
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~----~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~  126 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGD----KDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT  126 (383)
T ss_pred             EEeCCcccceEEEEEecCCC----CCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence            45656888999997643211    000011224444432211 1111235699999999744 44566666643    59


Q ss_pred             EEeccCCCChh
Q 013028          215 VYEYVTRGSLE  225 (451)
Q Consensus       215 V~E~~~gg~L~  225 (451)
                      |+||++|..|.
T Consensus       127 l~efIeGr~l~  137 (383)
T PTZ00384        127 IQEWVEGNTMG  137 (383)
T ss_pred             EEEEeccccCC
Confidence            99999987664

>PTZ00296 choline kinase; Provisional

Probab=94.67  E-value=0.28  Score=50.28  Aligned_cols=84  Identities=10%  Similarity=0.033  Sum_probs=49.0

Q ss_pred             cCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCcee-eccceeecCCee
Q 013028          134 EKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVV-KLMGYCCDDQHR  212 (451)
Q Consensus       134 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv-~~~~~~~~~~~~  212 (451)
                      -.+.|..|-.-.+|+........  ......+..|.+++.-.....-. +-..|..+++.+..-+|- ++++.+.    -
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~--~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----g  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETA--NNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----G  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCC--ccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----C
Confidence            34567778888899876543210  00111245688888754332222 345688888888644443 4555553    2


Q ss_pred             EEEEeccCCCCh
Q 013028          213 LLVYEYVTRGSL  224 (451)
Q Consensus       213 ~lV~E~~~gg~L  224 (451)
                      ..|.||++|-.|
T Consensus       182 g~I~efi~g~~l  193 (442)
T PTZ00296        182 GRIEEWLYGDPL  193 (442)
T ss_pred             CEEEEeeCCccC
Confidence            467899988644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	451
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-54
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-53
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-52
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-51
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-39
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-38
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-38
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-36
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-26
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-24
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-23
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-23
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-23
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-23
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-23
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-23
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-23
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-22
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-22
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-22
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-22
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-22
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-22
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-22
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-22
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-22
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-22
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-22
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-22
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-22
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-22
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-22
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-22
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-22
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-22
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-22
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-22
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-22
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-22
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-22
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-22
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-22
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-22
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-22
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-22
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-22
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-22
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-22
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-22
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-22
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-22
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-22
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-22
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-22
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-21
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-21
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-21
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-21
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-21
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-21
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-21
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-21
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-21
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-21
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-21
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-20
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-20
3iok_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-20
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-20
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-20
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-20
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-20
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-20
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-20
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-20
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-20
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-20
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-20
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-20
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-20
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-20
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-19
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-19
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-19
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-19
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-19
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-19
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-19
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-19
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-19
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-19
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-19
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-19
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-19
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-19
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-19
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-19
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-19
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-19
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-19
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-18
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-18
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-18
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-18
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-18
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-18
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-18
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-18
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-18
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-18
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-18
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-17
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-17
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-17
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-17
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-17
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-17
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-17
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-17
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-17
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-17
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-17
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-17
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-17
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-17
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-17
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-17
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-17
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-17
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-17
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-17
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-17
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-16
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-16
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-16
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		7e-16
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-16
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-16
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-16
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-15
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-15
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-15
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-15
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-15
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-15
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-15
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-14
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-14
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-13
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-13
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-13
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-13
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-12
3soa_A	444	Full-Length Human Camkii Length = 444		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-12
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-12
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-12
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-12
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-12
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-12
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-12
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		9e-12
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-12
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-11
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-11
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-11
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-11
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-11
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-11
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-11
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-11
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-11
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-11
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-11
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-11
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-10
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-10
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		7e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-10
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-10
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		7e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-10
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		8e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		3e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  209 bits (533), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 127/321 (39%), Positives = 186/321 (57%), Gaps = 25/321 (7%)
Query: 100 DLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAA 159
           D+PA     D   H  +LK F    L+ A+  FS KN++G+GGFG VY G +    +   
Sbjct: 11  DVPA---EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL--- 64
Query: 160 RRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEY 218
                   VAVKRL+ +  QG + +++ E+  +S   H N+++L G+C     RLLVY Y
Sbjct: 65  --------VAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 116
Query: 219 VTRGSLEDHLLNEDDTE--LNWERRIKIALGAARGLEHLHTYWRP-VIHRDVKASNVLLD 275
           +  GS+   L    +++  L+W +R +IALG+ARGL +LH +  P +IHRDVKA+N+LLD
Sbjct: 117 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 176
Query: 276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLE 335
           ++F A + DFGLAK     D  H+   V GT G+ APEY++TG  + KTDV+ +GV+LLE
Sbjct: 177 EEFEAVVGDFGLAKLMDYKD-XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 235
Query: 336 ILSGKTA--AMRRTNG---LAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIIL 390
           +++G+ A    R  N    +  +W K  L  K  L  ++D  L  N + EE ++  ++ L
Sbjct: 236 LITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVAL 294
Query: 391 RCLNSDPKNRPTMSEVVAALE 411
            C  S P  RP MSEVV  LE
Sbjct: 295 LCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 125/321 (38%), Positives = 185/321 (57%), Gaps = 25/321 (7%)
Query: 100 DLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAA 159
           D+PA     D   H  +LK F    L+ A+  F  KN++G+GGFG VY G +    +   
Sbjct: 3   DVPA---EEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXL--- 56
Query: 160 RRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEY 218
                   VAVKRL+ + +QG + +++ E+  +S   H N+++L G+C     RLLVY Y
Sbjct: 57  --------VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108
Query: 219 VTRGSLEDHLLNEDDTE--LNWERRIKIALGAARGLEHLHTYWRP-VIHRDVKASNVLLD 275
           +  GS+   L    +++  L+W +R +IALG+ARGL +LH +  P +IHRDVKA+N+LLD
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168
Query: 276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLE 335
           ++F A + DFGLAK     D  H+   V G  G+ APEY++TG  + KTDV+ +GV+LLE
Sbjct: 169 EEFEAVVGDFGLAKLMDYKD-XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227
Query: 336 ILSGKTA--AMRRTNG---LAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIIL 390
           +++G+ A    R  N    +  +W K  L  K  L  ++D  L  N + EE ++  ++ L
Sbjct: 228 LITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVAL 286
Query: 391 RCLNSDPKNRPTMSEVVAALE 411
            C  S P  RP MSEVV  LE
Sbjct: 287 LCTQSSPMERPKMSEVVRMLE 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  203 bits (517), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 122/293 (41%), Positives = 175/293 (59%), Gaps = 21/293 (7%)
Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW 184
           LE AT  F  K LIG G FG VY G +   A            VA+KR   + SQG +E+
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGA-----------KVALKRRTPESSQGIEEF 82
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED--DTELNWERRI 242
           E E+  LS   HP++V L+G+C +    +L+Y+Y+  G+L+ HL   D     ++WE+R+
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
           +I +GAARGL +LHT  R +IHRDVK+ N+LLD++F  KI+DFG++K G   D++H+   
Sbjct: 143 EICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV 200
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAM----RRTNGLAGNWAKPY 358
           V GT GY  PEY   G LT K+DVYSFGVVL E+L  ++A +    R    LA  WA   
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA-EWAVES 259
Query: 359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
            +N   L QI+D  L   I+ E  ++F +  ++CL    ++RP+M +V+  LE
Sbjct: 260 HNNG-QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 121/293 (41%), Positives = 174/293 (59%), Gaps = 21/293 (7%)
Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW 184
           LE AT  F  K LIG G FG VY G +   A            VA+KR   + SQG +E+
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGA-----------KVALKRRTPESSQGIEEF 82
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED--DTELNWERRI 242
           E E+  LS   HP++V L+G+C +    +L+Y+Y+  G+L+ HL   D     ++WE+R+
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
           +I +GAARGL +LHT  R +IHRDVK+ N+LLD++F  KI+DFG++K G    ++H+   
Sbjct: 143 EICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV 200
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAM----RRTNGLAGNWAKPY 358
           V GT GY  PEY   G LT K+DVYSFGVVL E+L  ++A +    R    LA  WA   
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA-EWAVES 259
Query: 359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
            +N   L QI+D  L   I+ E  ++F +  ++CL    ++RP+M +V+  LE
Sbjct: 260 HNNG-QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  158 bits (399), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 104/313 (33%), Positives = 168/313 (53%), Gaps = 25/313 (7%)
Query: 109 DEVFHAYKLKYFCHGLLEAATRKFSEK------NLIGQGGFGDVYIGYINSCAMTAARRK 162
           D  FH++         L+  T  F E+      N +G+GGFG VY GY+N+  + A ++ 
Sbjct: 9   DTRFHSFSFYE-----LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKL 62
Query: 163 NADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRG 222
            A   +  + L++       +++ E++ +++  H N+V+L+G+  D     LVY Y+  G
Sbjct: 63  AAMVDITTEELKQ-------QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115
Query: 223 SLEDHLLNEDDTE-LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK 281
           SL D L   D T  L+W  R KIA GAA G+  LH      IHRD+K++N+LLD+ F AK
Sbjct: 116 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAK 173
Query: 282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           ISDFGLA+      ++ + +R++GT  Y APE +  G +T K+D+YSFGVVLLEI++G  
Sbjct: 174 ISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLP 232
Query: 342 AA-MRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNR 400
           A    R   L  +  +     +  +   ID+K+  +      +    +  +CL+     R
Sbjct: 233 AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 401 PTMSEVVAALEQL 413
           P + +V   L+++
Sbjct: 292 PDIKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/313 (33%), Positives = 167/313 (53%), Gaps = 25/313 (7%)
Query: 109 DEVFHAYKLKYFCHGLLEAATRKFSEK------NLIGQGGFGDVYIGYINSCAMTAARRK 162
           D  FH++         L+  T  F E+      N +G+GGFG VY GY+N+  + A ++ 
Sbjct: 9   DTRFHSFSFYE-----LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKL 62
Query: 163 NADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRG 222
            A   +  + L++       +++ E++ +++  H N+V+L+G+  D     LVY Y+  G
Sbjct: 63  AAMVDITTEELKQ-------QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115
Query: 223 SLEDHLLNEDDTE-LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK 281
           SL D L   D T  L+W  R KIA GAA G+  LH      IHRD+K++N+LLD+ F AK
Sbjct: 116 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAK 173
Query: 282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           ISDFGLA+      ++ +  R++GT  Y APE +  G +T K+D+YSFGVVLLEI++G  
Sbjct: 174 ISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLP 232
Query: 342 AA-MRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNR 400
           A    R   L  +  +     +  +   ID+K+  +      +    +  +CL+     R
Sbjct: 233 AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 401 PTMSEVVAALEQL 413
           P + +V   L+++
Sbjct: 292 PDIKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/313 (33%), Positives = 166/313 (53%), Gaps = 25/313 (7%)
Query: 109 DEVFHAYKLKYFCHGLLEAATRKFSEK------NLIGQGGFGDVYIGYINSCAMTAARRK 162
           D  FH++         L+  T  F E+      N +G+GGFG VY GY+N+  + A ++ 
Sbjct: 3   DTRFHSFSFYE-----LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKL 56
Query: 163 NADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRG 222
            A   +  + L++       +++ E++ +++  H N+V+L+G+  D     LVY Y+  G
Sbjct: 57  AAMVDITTEELKQ-------QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 109
Query: 223 SLEDHLLNEDDTE-LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK 281
           SL D L   D T  L+W  R KIA GAA G+  LH      IHRD+K++N+LLD+ F AK
Sbjct: 110 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAK 167
Query: 282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           ISDFGLA+      +  +  R++GT  Y APE +  G +T K+D+YSFGVVLLEI++G  
Sbjct: 168 ISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLP 226
Query: 342 AA-MRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNR 400
           A    R   L  +  +     +  +   ID+K+  +      +    +  +CL+     R
Sbjct: 227 AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKR 285
Query: 401 PTMSEVVAALEQL 413
           P + +V   L+++
Sbjct: 286 PDIKKVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/226 (39%), Positives = 131/226 (57%), Gaps = 18/226 (7%)
Query: 125 LEAATRKFSEK------NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS 178
           L+  T  F E+      N  G+GGFG VY GY+N+  + A ++  A   +  + L++   
Sbjct: 11  LKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELKQ--- 66
Query: 179 QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LN 237
               +++ E++  ++  H N+V+L+G+  D     LVY Y   GSL D L   D T  L+
Sbjct: 67  ----QFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLS 122
Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
           W  R KIA GAA G+  LH      IHRD+K++N+LLD+ F AKISDFGLA+      + 
Sbjct: 123 WHXRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 298 HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAA 343
              +R++GT  Y APE +  G +T K+D+YSFGVVLLEI++G  A 
Sbjct: 181 VXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV 225

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 93/307 (30%), Positives = 151/307 (49%), Gaps = 53/307 (17%)
Query: 124 LLEAATRKFSEKNLIGQGGFGDVYIGYI--NSCAMTAARR-KNADFAVAVKRLRRKGSQG 180
           LLE    + + + +IG GGFG VY  +   +  A+ AAR   + D +  ++ +R+     
Sbjct: 1   LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQ----- 55
Query: 181 QDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNE---DDTELN 237
                 E +  + L HPN++ L G C  + +  LV E+   G L   L  +    D  +N
Sbjct: 56  ------EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVN 109
Query: 238 WERRIKIALGAARGLEHLHT-YWRPVIHRDVKASNVLL-----DDDFN---AKISDFGLA 288
           W  +I      ARG+ +LH     P+IHRD+K+SN+L+     + D +    KI+DFGLA
Sbjct: 110 WAVQI------ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
Query: 289 KFGPLGDKSHISTRV--LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRR 346
           +      + H +T++   G   + APE I     +  +DV+S+GV+L E+L+G+    R 
Sbjct: 164 R------EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV-PFRG 216
Query: 347 TNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
            +GLA   A     NKLAL           I     + FA+++  C N DP +RP+ + +
Sbjct: 217 IDGLAV--AYGVAMNKLALP----------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNI 264
Query: 407 VAALEQL 413
           +  L  +
Sbjct: 265 LDQLTTI 271

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 134/287 (46%), Gaps = 43/287 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG VY G           + + D AV +  +     Q    ++NE+  L +  H 
Sbjct: 20  IGSGSFGTVYKG-----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 68
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N++  MGY    Q  L +      GS   H L+  +T+   ++ I IA   ARG+++LH 
Sbjct: 69  NILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 126
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI-- 315
             + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + APE I  
Sbjct: 127 --KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 316 -ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
             +   + ++DVY+FG+VL E+++G+                PY SN     QII E +G
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQL---------------PY-SNINNRDQII-EMVG 227
Query: 375 RN--------IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           R         ++    +    ++  CL      RP+   ++A +E+L
Sbjct: 228 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 274

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 134/283 (47%), Gaps = 32/283 (11%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K  IG G FG V+           A    +D AV +   +   ++  +E+  E+  + RL
Sbjct: 42  KEKIGAGSFGTVH----------RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT--ELNWERRIKIALGAARGL 252
            HPN+V  MG      +  +V EY++RGSL   LL++     +L+  RR+ +A   A+G+
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            +LH    P++HRD+K+ N+L+D  +  K+ DFGL++          S    GT  + AP
Sbjct: 151 NYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ASXFLXSKXAAGTPEWMAP 208
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E +       K+DVYSFGV+L E+ +           L   W     +  +A      ++
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELAT-----------LQQPWGNLNPAQVVAAVGFKCKR 257
Query: 373 L--GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           L   RN+      + A II  C  ++P  RP+ + ++  L  L
Sbjct: 258 LEIPRNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 136/291 (46%), Gaps = 45/291 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-------DEWENELRF 190
           IG+GGFG V+ G          R       VA+K L    S+G+        E++ E+  
Sbjct: 27  IGKGGFGLVHKG----------RLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           +S LNHPN+VKL G   +     +V E+V  G L   LL++    + W  ++++ L  A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIAL 133
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDD-DFN----AKISDFGLAKFGPLGDKSHISTRVLG 305
           G+E++     P++HRD+++ N+ L   D N    AK++DFGL++        H  + +LG
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 306 TRGYFAPEYIATGH--LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL 363
              + APE I       T K D YSF ++L  IL+G+      + G            K+
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------------KI 236
Query: 364 ALHQII-DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               +I +E L   I  +       +I  C + DPK RP  S +V  L +L
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 34/284 (11%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K  IG G FG V+           A    +D AV +   +   ++  +E+  E+  + RL
Sbjct: 42  KEKIGAGSFGTVH----------RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT--ELNWERRIKIALGAARGL 252
            HPN+V  MG      +  +V EY++RGSL   LL++     +L+  RR+ +A   A+G+
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-VLGTRGYFA 311
            +LH    P++HR++K+ N+L+D  +  K+ DFGL++   L   + +S++   GT  + A
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFLSSKSAAGTPEWMA 207
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE +       K+DVYSFGV+L E+ +           L   W     +  +A      +
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELAT-----------LQQPWGNLNPAQVVAAVGFKCK 256
Query: 372 KL--GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +L   RN+      + A II  C  ++P  RP+ + ++  L  L
Sbjct: 257 RLEIPRNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 134/287 (46%), Gaps = 43/287 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG VY G           + + D AV +  +     Q    ++NE+  L +  H 
Sbjct: 32  IGSGSFGTVYKG-----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N++  MGY    Q  L +      GS   H L+  +T+   ++ I IA   ARG+++LH 
Sbjct: 81  NILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI-- 315
             + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + APE I  
Sbjct: 139 --KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 316 -ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
             +   + ++DVY+FG+VL E+++G+                PY SN     QII E +G
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQL---------------PY-SNINNRDQII-EMVG 239
Query: 375 RN--------IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           R         ++    +    ++  CL      RP+   ++A +E+L
Sbjct: 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 134/287 (46%), Gaps = 43/287 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG VY G           + + D AV +  +     Q    ++NE+  L +  H 
Sbjct: 32  IGSGSFGTVYKG-----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N++  MGY    Q  L +      GS   H L+  +T+   ++ I IA   ARG+++LH 
Sbjct: 81  NILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI-- 315
             + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + APE I  
Sbjct: 139 --KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 316 -ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
             +   + ++DVY+FG+VL E+++G+                PY SN     QII E +G
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQL---------------PY-SNINNRDQII-EMVG 239
Query: 375 RN--------IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           R         ++    +    ++  CL      RP+   ++A +E+L
Sbjct: 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 135/291 (46%), Gaps = 45/291 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-------DEWENELRF 190
           IG+GGFG V+ G          R       VA+K L    S+G+        E++ E+  
Sbjct: 27  IGKGGFGLVHKG----------RLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           +S LNHPN+VKL G   +     +V E+V  G L   LL++    + W  ++++ L  A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIAL 133
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDD-DFN----AKISDFGLAKFGPLGDKSHISTRVLG 305
           G+E++     P++HRD+++ N+ L   D N    AK++DFG ++        H  + +LG
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLG 188
Query: 306 TRGYFAPEYIATGH--LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL 363
              + APE I       T K D YSF ++L  IL+G+      + G            K+
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------------KI 236
Query: 364 ALHQII-DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               +I +E L   I  +       +I  C + DPK RP  S +V  L +L
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 135/291 (46%), Gaps = 45/291 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-------DEWENELRF 190
           IG+GGFG V+ G          R       VA+K L    S+G+        E++ E+  
Sbjct: 27  IGKGGFGLVHKG----------RLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           +S LNHPN+VKL G   +     +V E+V  G L   LL++    + W  ++++ L  A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIAL 133
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDD-DFN----AKISDFGLAKFGPLGDKSHISTRVLG 305
           G+E++     P++HRD+++ N+ L   D N    AK++DF L++        H  + +LG
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLG 188
Query: 306 TRGYFAPEYIATGH--LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL 363
              + APE I       T K D YSF ++L  IL+G+      + G            K+
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------------KI 236
Query: 364 ALHQII-DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               +I +E L   I  +       +I  C + DPK RP  S +V  L +L
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 136/296 (45%), Gaps = 39/296 (13%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           ++G+G FG          A+    R+  +  V +K L R   + Q  +  E++ +  L H
Sbjct: 17  VLGKGCFGQ---------AIKVTHRETGEVMV-MKELIRFDEETQRTFLKEVKVMRCLEH 66
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           PNV+K +G    D+    + EY+  G+L   ++   D++  W +R+  A   A G+ +LH
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF------GPLGDKS------HISTRVL 304
           +    +IHRD+ + N L+ ++ N  ++DFGLA+        P G +S           V+
Sbjct: 126 SM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP-YLSNKL 363
           G   + APE I       K DV+SFG+VL EI+        R N      A P YL   +
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG-------RVN------ADPDYLPRTM 230
Query: 364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
                +   L R         F  I +RC + DP+ RP+  ++   LE L++++  
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 143/300 (47%), Gaps = 33/300 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E      S   ++G G FG+V       C+         + +VA+K L+   ++ Q  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEV-------CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E   + + +HPN+++L G     +  ++V EY+  GSL D  L + D +    + + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
             G A G+++L       +HRD+ A N+L++ +   K+SDFGLA+   L D    +    
Sbjct: 153 LRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLARV--LEDDPEAAYTTR 208
Query: 305 GTR---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
           G +    + +PE IA    T  +DV+S+G+VL E++S                 +PY  +
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------------ERPYWEM 254
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           SN+  + + +DE       M+      +++L C   D  NRP   ++V+ L++L  N GS
Sbjct: 255 SNQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 31/281 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG VY G           + + D AV +  +     Q    ++NE+  L +  H 
Sbjct: 18  IGSGSFGTVYKG-----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 66
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N++  MGY    Q  L +      GS   H L+  +T+    + I IA   A+G+++LH 
Sbjct: 67  NILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 124
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + APE I  
Sbjct: 125 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 182
Query: 318 ---GHLTLKTDVYSFGVVLLEILSGKT--AAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
                 + ++DVY+FG+VL E+++G+   + +   + +     + YLS  L+        
Sbjct: 183 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS-------- 234
Query: 373 LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               ++    +    ++  CL      RP   +++A++E L
Sbjct: 235 ---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 272

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 143/300 (47%), Gaps = 33/300 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E      S   ++G G FG+V       C+         + +VA+K L+   ++ Q  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEV-------CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E   + + +HPN+++L G     +  ++V EY+  GSL D  L + D +    + + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
             G A G+++L       +HRD+ A N+L++ +   K+SDFGL++   L D    +    
Sbjct: 153 LRGIASGMKYLSDM--GFVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTR 208
Query: 305 GTR---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
           G +    + +PE IA    T  +DV+S+G+VL E++S                 +PY  +
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------------ERPYWEM 254
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           SN+  + + +DE       M+      +++L C   D  NRP   ++V+ L++L  N GS
Sbjct: 255 SNQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 143/300 (47%), Gaps = 33/300 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E      S   ++G G FG+V       C+         + +VA+K L+   ++ Q  ++
Sbjct: 39  ELDATNISIDKVVGAGEFGEV-------CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 91
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E   + + +HPN+++L G     +  ++V EY+  GSL D  L + D +    + + +
Sbjct: 92  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 150
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
             G A G+++L       +HRD+ A N+L++ +   K+SDFGL++   L D    +    
Sbjct: 151 LRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTR 206
Query: 305 GTR---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
           G +    + +PE IA    T  +DV+S+G+VL E++S                 +PY  +
Sbjct: 207 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------------ERPYWEM 252
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           SN+  + + +DE       M+      +++L C   D  NRP   ++V+ L++L  N GS
Sbjct: 253 SNQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 311

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 31/281 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG VY G           + + D AV +  +     Q    ++NE+  L +  H 
Sbjct: 16  IGSGSFGTVYKG-----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N++  MGY    Q  L +      GS   H L+  +T+    + I IA   A+G+++LH 
Sbjct: 65  NILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + APE I  
Sbjct: 123 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 318 ---GHLTLKTDVYSFGVVLLEILSGKT--AAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
                 + ++DVY+FG+VL E+++G+   + +   + +     + YLS  L+        
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS-------- 232
Query: 373 LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               ++    +    ++  CL      RP   +++A++E L
Sbjct: 233 ---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 143/300 (47%), Gaps = 33/300 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E      S   ++G G FG+V       C+         + +VA+K L+   ++ Q  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEV-------CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E   + + +HPN+++L G     +  ++V EY+  GSL D  L + D +    + + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
             G A G+++L       +HRD+ A N+L++ +   K+SDFGL++   L D    +    
Sbjct: 153 LRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTR 208
Query: 305 GTR---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
           G +    + +PE IA    T  +DV+S+G+VL E++S                 +PY  +
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------------ERPYWEM 254
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           SN+  + + +DE       M+      +++L C   D  NRP   ++V+ L++L  N GS
Sbjct: 255 SNQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 143/300 (47%), Gaps = 33/300 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E      S   ++G G FG+V       C+         + +VA+K L+   ++ Q  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEV-------CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E   + + +HPN+++L G     +  ++V EY+  GSL D  L + D +    + + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
             G A G+++L       +HRD+ A N+L++ +   K+SDFGL++   L D    +    
Sbjct: 153 LRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTR 208
Query: 305 GTR---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
           G +    + +PE IA    T  +DV+S+G+VL E++S                 +PY  +
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------------ERPYWEM 254
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           SN+  + + +DE       M+      +++L C   D  NRP   ++V+ L++L  N GS
Sbjct: 255 SNQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 143/300 (47%), Gaps = 33/300 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E      S   ++G G FG+V       C+         + +VA+K L+   ++ Q  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEV-------CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E   + + +HPN+++L G     +  ++V EY+  GSL D  L + D +    + + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
             G A G+++L       +HRD+ A N+L++ +   K+SDFGL++   L D    +    
Sbjct: 153 LRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTR 208
Query: 305 GTR---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
           G +    + +PE IA    T  +DV+S+G+VL E++S                 +PY  +
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------------ERPYWEM 254
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           SN+  + + +DE       M+      +++L C   D  NRP   ++V+ L++L  N GS
Sbjct: 255 SNQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 143/300 (47%), Gaps = 33/300 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E      S   ++G G FG+V       C+         + +VA+K L+   ++ Q  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEV-------CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E   + + +HPN+++L G     +  ++V EY+  GSL D  L + D +    + + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
             G A G+++L       +HRD+ A N+L++ +   K+SDFGL++   L D    +    
Sbjct: 153 LRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTR 208
Query: 305 GTR---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
           G +    + +PE IA    T  +DV+S+G+VL E++S                 +PY  +
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------------ERPYWEM 254
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           SN+  + + +DE       M+      +++L C   D  NRP   ++V+ L++L  N GS
Sbjct: 255 SNQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 31/281 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG VY G           + + D AV +  +     Q    ++NE+  L +  H 
Sbjct: 21  IGSGSFGTVYKG-----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 69
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N++  MGY    Q  L +      GS   H L+  +T+    + I IA   A+G+++LH 
Sbjct: 70  NILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 127
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + APE I  
Sbjct: 128 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 318 ---GHLTLKTDVYSFGVVLLEILSGKT--AAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
                 + ++DVY+FG+VL E+++G+   + +   + +     + YLS  L+        
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS-------- 237
Query: 373 LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               ++    +    ++  CL      RP   +++A++E L
Sbjct: 238 ---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 275

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 143/299 (47%), Gaps = 41/299 (13%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           T K  E+  +G G FG+V++GY N               VAVK L+ +GS   D +  E 
Sbjct: 24  TLKLVER--LGAGQFGEVWMGYYNGHT-----------KVAVKSLK-QGSMSPDAFLAEA 69
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L H  +V+L  Y    Q  + ++ EY+  GSL D L      +L   + + +A  
Sbjct: 70  NLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 127
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A G+  +    R  IHRD++A+N+L+ D  + KI+DFGLA+   + D  + +    G +
Sbjct: 128 IAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTARE--GAK 181
Query: 308 ---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I  G  T+K+DV+SFG++L EI++             G    P ++N   
Sbjct: 182 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT------------HGRIPYPGMTNPEV 229
Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
           +  +  E+  R ++ +   +E  +++  C    P++RPT   + + LE         YQ
Sbjct: 230 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 286

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 143/300 (47%), Gaps = 33/300 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E      S   ++G G FG+V       C+         + +VA+K L+   ++ Q  ++
Sbjct: 12  ELDATNISIDKVVGAGEFGEV-------CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E   + + +HPN+++L G     +  ++V EY+  GSL D  L + D +    + + +
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 123
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
             G A G+++L       +HRD+ A N+L++ +   K+SDFGL++   L D    +    
Sbjct: 124 LRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTR 179
Query: 305 GTR---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
           G +    + +PE IA    T  +DV+S+G+VL E++S                 +PY  +
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------------ERPYWEM 225
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           SN+  + + +DE       M+      +++L C   D  NRP   ++V+ L++L  N GS
Sbjct: 226 SNQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 284

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 143/300 (47%), Gaps = 33/300 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E      S   ++G G FG+V       C+         + +VA+K L+   ++ Q  ++
Sbjct: 29  ELDATNISIDKVVGAGEFGEV-------CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 81
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E   + + +HPN+++L G     +  ++V EY+  GSL D  L + D +    + + +
Sbjct: 82  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 140
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
             G A G+++L       +HRD+ A N+L++ +   K+SDFGL++   L D    +    
Sbjct: 141 LRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTR 196
Query: 305 GTR---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
           G +    + +PE IA    T  +DV+S+G+VL E++S                 +PY  +
Sbjct: 197 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------------ERPYWEM 242
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           SN+  + + +DE       M+      +++L C   D  NRP   ++V+ L++L  N GS
Sbjct: 243 SNQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 301

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 31/281 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG VY G           + + D AV +  +     Q    ++NE+  L +  H 
Sbjct: 43  IGSGSFGTVYKG-----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 91
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N++  MGY    Q  L +      GS   H L+  +T+    + I IA   A+G+++LH 
Sbjct: 92  NILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 149
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + APE I  
Sbjct: 150 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 207
Query: 318 ---GHLTLKTDVYSFGVVLLEILSGKT--AAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
                 + ++DVY+FG+VL E+++G+   + +   + +     + YLS  L+        
Sbjct: 208 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS-------- 259
Query: 373 LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               ++    +    ++  CL      RP   +++A++E L
Sbjct: 260 ---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 297

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 31/281 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG VY G           + + D AV +  +     Q    ++NE+  L +  H 
Sbjct: 21  IGSGSFGTVYKG-----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 69
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N++  MGY    Q  L +      GS   H L+  +T+    + I IA   A+G+++LH 
Sbjct: 70  NILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 127
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + APE I  
Sbjct: 128 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 318 ---GHLTLKTDVYSFGVVLLEILSGKT--AAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
                 + ++DVY+FG+VL E+++G+   + +   + +     + YLS  L+        
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS-------- 237
Query: 373 LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               ++    +    ++  CL      RP   +++A++E L
Sbjct: 238 ---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 275

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 31/281 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG VY G           + + D AV +  +     Q    ++NE+  L +  H 
Sbjct: 44  IGSGSFGTVYKG-----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 92
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N++  MGY    Q  L +      GS   H L+  +T+    + I IA   A+G+++LH 
Sbjct: 93  NILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + APE I  
Sbjct: 151 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 318 ---GHLTLKTDVYSFGVVLLEILSGKT--AAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
                 + ++DVY+FG+VL E+++G+   + +   + +     + YLS  L+        
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS-------- 260
Query: 373 LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               ++    +    ++  CL      RP   +++A++E L
Sbjct: 261 ---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 31/281 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG VY G           + + D AV +  +     Q    ++NE+  L +  H 
Sbjct: 16  IGSGSFGTVYKG-----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N++  MGY    Q  L +      GS   H L+  +T+    + I IA   A+G+++LH 
Sbjct: 65  NILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + APE I  
Sbjct: 123 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 318 ---GHLTLKTDVYSFGVVLLEILSGKT--AAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
                 + ++DVY+FG+VL E+++G+   + +   + +     + YLS  L+        
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS-------- 232
Query: 373 LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               ++    +    ++  CL      RP   +++A++E L
Sbjct: 233 ---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 142/300 (47%), Gaps = 33/300 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E      S   ++G G FG+V       C+         + +VA+K L+   ++ Q  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEV-------CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E   + + +HPN+++L G     +  ++V EY+  GSL D  L + D +    + + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
             G A G+++L       +HRD+ A N+L++ +   K+SDFGL +   L D    +    
Sbjct: 153 LRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTR 208
Query: 305 GTR---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
           G +    + +PE IA    T  +DV+S+G+VL E++S                 +PY  +
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------------ERPYWEM 254
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           SN+  + + +DE       M+      +++L C   D  NRP   ++V+ L++L  N GS
Sbjct: 255 SNQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 141/290 (48%), Gaps = 41/290 (14%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           T K  E+  +G G FG+V++GY N               VAVK L+ +GS   D +  E 
Sbjct: 20  TLKLVER--LGAGQFGEVWMGYYNGHT-----------KVAVKSLK-QGSMSPDAFLAEA 65
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L H  +V+L  Y    Q  + ++ EY+  GSL D L      +L   + + +A  
Sbjct: 66  NLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 123
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A G+  +    R  IHRD++A+N+L+ D  + KI+DFGLA+   + D  + +    G +
Sbjct: 124 IAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTARE--GAK 177
Query: 308 ---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I  G  T+K+DV+SFG++L EI++             G    P ++N   
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT------------HGRIPYPGMTNPEV 225
Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  +  E+  R ++ +   +E  +++  C    P++RPT   + + LE  
Sbjct: 226 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 273

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 141/290 (48%), Gaps = 41/290 (14%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           T K  E+  +G G FG+V++GY N               VAVK L+ +GS   D +  E 
Sbjct: 19  TLKLVER--LGAGQFGEVWMGYYNGHT-----------KVAVKSLK-QGSMSPDAFLAEA 64
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L H  +V+L  Y    Q  + ++ EY+  GSL D L      +L   + + +A  
Sbjct: 65  NLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 122
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A G+  +    R  IHRD++A+N+L+ D  + KI+DFGLA+   + D  + +    G +
Sbjct: 123 IAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTARE--GAK 176
Query: 308 ---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I  G  T+K+DV+SFG++L EI++             G    P ++N   
Sbjct: 177 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT------------HGRIPYPGMTNPEV 224
Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  +  E+  R ++ +   +E  +++  C    P++RPT   + + LE  
Sbjct: 225 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 272

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 144/299 (48%), Gaps = 41/299 (13%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           T K  E+  +G G FG+V++GY N               VAVK L+ +GS   D +  E 
Sbjct: 20  TLKLVER--LGAGQFGEVWMGYYNGHT-----------KVAVKSLK-QGSMSPDAFLAEA 65
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L H  +V+L  Y    Q  + ++ EY+  GSL D L      +L   + + +A  
Sbjct: 66  NLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 123
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A G+  +    R  IHRD++A+N+L+ D  + KI+DFGLA+   L + +  + R  G +
Sbjct: 124 IAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXTARE-GAK 177
Query: 308 ---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I  G  T+K+DV+SFG++L EI++             G    P ++N   
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT------------HGRIPYPGMTNPEV 225
Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
           +  +  E+  R ++ +   +E  +++  C    P++RPT   + + LE         YQ
Sbjct: 226 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 282

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 144/299 (48%), Gaps = 41/299 (13%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           T K  E+  +G G FG+V++GY N               VAVK L+ +GS   D +  E 
Sbjct: 22  TLKLVER--LGAGQFGEVWMGYYNGHT-----------KVAVKSLK-QGSMSPDAFLAEA 67
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L H  +V+L  Y    Q  + ++ EY+  GSL D L      +L   + + +A  
Sbjct: 68  NLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 125
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A G+  +    R  IHRD++A+N+L+ D  + KI+DFGLA+   L + +  + R  G +
Sbjct: 126 IAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXTARE-GAK 179
Query: 308 ---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I  G  T+K+DV+SFG++L EI++             G    P ++N   
Sbjct: 180 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT------------HGRIPYPGMTNPEV 227
Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
           +  +  E+  R ++ +   +E  +++  C    P++RPT   + + LE         YQ
Sbjct: 228 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 284

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 71
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 132 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPES 188
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 231
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 232 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 144/299 (48%), Gaps = 41/299 (13%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           T K  E+  +G G FG+V++GY N               VAVK L+ +GS   D +  E 
Sbjct: 14  TLKLVER--LGAGQFGEVWMGYYNGHT-----------KVAVKSLK-QGSMSPDAFLAEA 59
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L H  +V+L  Y    Q  + ++ EY+  GSL D L      +L   + + +A  
Sbjct: 60  NLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A G+  +    R  IHRD++A+N+L+ D  + KI+DFGLA+   L + +  + R  G +
Sbjct: 118 IAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXTARE-GAK 171
Query: 308 ---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I  G  T+K+DV+SFG++L EI++             G    P ++N   
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT------------HGRIPYPGMTNPEV 219
Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
           +  +  E+  R ++ +   +E  +++  C    P++RPT   + + LE         YQ
Sbjct: 220 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 276

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 31/281 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG VY G           + + D AV +  +     Q    ++NE+  L +  H 
Sbjct: 36  IGSGSFGTVYKG-----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 84
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N++  MGY    Q  L +      GS   H L+  +T+    + I IA   A+G+++LH 
Sbjct: 85  NILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 142
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + APE I  
Sbjct: 143 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 200
Query: 318 ---GHLTLKTDVYSFGVVLLEILSGKT--AAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
                 + ++DVY+FG+VL E+++G+   + +   + +     + YLS  L+        
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS-------- 252
Query: 373 LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               ++    +    ++  CL      RP   +++A++E L
Sbjct: 253 ---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 290

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 144/290 (49%), Gaps = 49/290 (16%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 67
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 68  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 127
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF-------GPLGDKSHISTRVLGTR 307
           L    +  IHRD+ A N L+ ++   K++DFGL++         P G K  I        
Sbjct: 128 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK------- 178
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            + APE +A    ++K+DV++FGV+L EI          T G++     PY    + L Q
Sbjct: 179 -WTAPESLAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQ 221
Query: 368 IIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  E L ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 222 VY-ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 142/290 (48%), Gaps = 41/290 (14%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           T K  E+  +G G FG+V++GY N               VAVK L+ +GS   D +  E 
Sbjct: 23  TLKLVER--LGAGQFGEVWMGYYNGHT-----------KVAVKSLK-QGSMSPDAFLAEA 68
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L H  +V+L  Y    Q  + ++ EY+  GSL D L      +L   + + +A  
Sbjct: 69  NLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 126
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A G+  +    R  IHRD++A+N+L+ D  + KI+DFGLA+   L + +  + R  G +
Sbjct: 127 IAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXTARE-GAK 180
Query: 308 ---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I  G  T+K+DV+SFG++L EI++             G    P ++N   
Sbjct: 181 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT------------HGRIPYPGMTNPEV 228
Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  +  E+  R ++ +   +E  +++  C    P++RPT   + + LE  
Sbjct: 229 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 276

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 141/290 (48%), Gaps = 41/290 (14%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           T K  E+  +G G FG+V++GY N               VAVK L+ +GS   D +  E 
Sbjct: 14  TLKLVER--LGAGQFGEVWMGYYNGHT-----------KVAVKSLK-QGSMSPDAFLAEA 59
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L H  +V+L  Y    Q  + ++ EY+  GSL D L      +L   + + +A  
Sbjct: 60  NLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A G+  +    R  IHRD++A+N+L+ D  + KI+DFGLA+   + D  + +    G +
Sbjct: 118 IAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTARE--GAK 171
Query: 308 ---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I  G  T+K+DV+SFG++L EI++             G    P ++N   
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT------------HGRIPYPGMTNPEV 219
Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  +  E+  R ++ +   +E  +++  C    P++RPT   + + LE  
Sbjct: 220 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 31/281 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG VY G           + + D AV +  +     Q    ++NE+  L +  H 
Sbjct: 16  IGSGSFGTVYKG-----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N++  MGY    Q  L +      GS   H L+  +T+    + I IA   A+G+++LH 
Sbjct: 65  NILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + APE I  
Sbjct: 123 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 318 ---GHLTLKTDVYSFGVVLLEILSGKT--AAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
                 + ++DVY+FG+VL E+++G+   + +   + +     + YLS  L+        
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS-------- 232
Query: 373 LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               ++    +    ++  CL      RP   +++A++E L
Sbjct: 233 ---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 141/290 (48%), Gaps = 41/290 (14%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           T K  E+  +G G FG+V++GY N               VAVK L+ +GS   D +  E 
Sbjct: 9   TLKLVER--LGAGQFGEVWMGYYNGHT-----------KVAVKSLK-QGSMSPDAFLAEA 54
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L H  +V+L  Y    Q  + ++ EY+  GSL D L      +L   + + +A  
Sbjct: 55  NLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 112
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A G+  +    R  IHRD++A+N+L+ D  + KI+DFGLA+   + D  + +    G +
Sbjct: 113 IAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTARE--GAK 166
Query: 308 ---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I  G  T+K+DV+SFG++L EI++             G    P ++N   
Sbjct: 167 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT------------HGRIPYPGMTNPEV 214
Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  +  E+  R ++ +   +E  +++  C    P++RPT   + + LE  
Sbjct: 215 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 262

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 31/281 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG VY G           + + D AV +  +     Q    ++NE+  L +  H 
Sbjct: 44  IGSGSFGTVYKG-----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 92
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N++  MGY    Q  L +      GS   H L+  +T+    + I IA   A+G+++LH 
Sbjct: 93  NILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + APE I  
Sbjct: 151 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 318 ---GHLTLKTDVYSFGVVLLEILSGKT--AAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
                 + ++DVY+FG+VL E+++G+   + +   + +     + YLS  L+        
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS-------- 260
Query: 373 LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               ++    +    ++  CL      RP   +++A++E L
Sbjct: 261 ---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 71
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 132 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 188
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 231
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 232 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 67
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 68  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 127
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 128 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPES 184
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 227
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 228 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 142/290 (48%), Gaps = 41/290 (14%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           T K  E+  +G G FG+V++GY N               VAVK L+ +GS   D +  E 
Sbjct: 16  TLKLVER--LGAGQFGEVWMGYYNGHT-----------KVAVKSLK-QGSMSPDAFLAEA 61
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L H  +V+L  Y    Q  + ++ EY+  GSL D L      +L   + + +A  
Sbjct: 62  NLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 119
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A G+  +    R  IHRD++A+N+L+ D  + KI+DFGLA+   L + +  + R  G +
Sbjct: 120 IAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXTARE-GAK 173
Query: 308 ---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I  G  T+K+DV+SFG++L EI++             G    P ++N   
Sbjct: 174 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT------------HGRIPYPGMTNPEV 221
Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  +  E+  R ++ +   +E  +++  C    P++RPT   + + LE  
Sbjct: 222 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 269

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 144/290 (49%), Gaps = 49/290 (16%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 68
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 128
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF-------GPLGDKSHISTRVLGTR 307
           L    +  IHRD+ A N L+ ++   K++DFGL++         P G K  I        
Sbjct: 129 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK------- 179
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            + APE +A    ++K+DV++FGV+L EI          T G++     PY    + L Q
Sbjct: 180 -WTAPESLAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQ 222
Query: 368 IIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  E L ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 223 VY-ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 142/290 (48%), Gaps = 41/290 (14%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           T K  E+  +G G FG+V++GY N               VAVK L+ +GS   D +  E 
Sbjct: 14  TLKLVER--LGAGQFGEVWMGYYNGHT-----------KVAVKSLK-QGSMSPDAFLAEA 59
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L H  +V+L  Y    Q  + ++ EY+  GSL D L      +L   + + +A  
Sbjct: 60  NLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A G+  +    R  IHRD++A+N+L+ D  + KI+DFGLA+   L + +  + R  G +
Sbjct: 118 IAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXTARE-GAK 171
Query: 308 ---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I  G  T+K+DV+SFG++L EI++             G    P ++N   
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT------------HGRIPYPGMTNPEV 219
Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  +  E+  R ++ +   +E  +++  C    P++RPT   + + LE  
Sbjct: 220 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 71
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 72  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 132 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 188
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 231
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 232 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 142/290 (48%), Gaps = 41/290 (14%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           T K  E+  +G G FG+V++GY N               VAVK L+ +GS   D +  E 
Sbjct: 15  TLKLVER--LGAGQFGEVWMGYYNGHT-----------KVAVKSLK-QGSMSPDAFLAEA 60
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L H  +V+L  Y    Q  + ++ EY+  GSL D L      +L   + + +A  
Sbjct: 61  NLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 118
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A G+  +    R  IHRD++A+N+L+ D  + KI+DFGLA+   L + +  + R  G +
Sbjct: 119 IAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXTARE-GAK 172
Query: 308 ---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I  G  T+K+DV+SFG++L EI++             G    P ++N   
Sbjct: 173 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT------------HGRIPYPGMTNPEV 220
Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  +  E+  R ++ +   +E  +++  C    P++RPT   + + LE  
Sbjct: 221 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 268

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 70
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 71  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 130
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 131 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 187
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 230
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 66
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 126
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 127 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 226
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 68
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 128
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 129 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 185
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 228
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 229 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 71
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 132 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 188
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 231
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 232 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 66
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 126
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 127 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 226
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 79
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 80  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 139
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 140 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 196
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 197 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 239
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 240 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 282

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 68
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 128
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 129 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 185
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 228
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 229 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 142/300 (47%), Gaps = 33/300 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E      S   ++G G FG+V       C+         + +VA+K L+   ++ Q  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEV-------CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E   + + +HPN+++L G     +  ++V E +  GSL D  L + D +    + + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
             G A G+++L       +HRD+ A N+L++ +   K+SDFGL++   L D    +    
Sbjct: 153 LRGIASGMKYLSDM--GAVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTR 208
Query: 305 GTR---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
           G +    + +PE IA    T  +DV+S+G+VL E++S                 +PY  +
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------------ERPYWEM 254
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           SN+  + + +DE       M+      +++L C   D  NRP   ++V+ L++L  N GS
Sbjct: 255 SNQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 141/290 (48%), Gaps = 41/290 (14%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           T K  E+  +G G FG+V++GY N               VAVK L+ +GS   D +  E 
Sbjct: 10  TLKLVER--LGAGQFGEVWMGYYNGHT-----------KVAVKSLK-QGSMSPDAFLAEA 55
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L H  +V+L  Y    Q  + ++ EY+  GSL D L      +L   + + +A  
Sbjct: 56  NLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 113
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A G+  +    R  IHR+++A+N+L+ D  + KI+DFGLA+   + D  + +    G +
Sbjct: 114 IAEGMAFIEE--RNYIHRNLRAANILVSDTLSCKIADFGLARL--IEDNEYTARE--GAK 167
Query: 308 ---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I  G  T+K+DV+SFG++L EI++             G    P ++N   
Sbjct: 168 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT------------HGRIPYPGMTNPEV 215
Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  +  E+  R ++ +   +E  +++  C    P++RPT   + + LE  
Sbjct: 216 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 263

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 142/300 (47%), Gaps = 33/300 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E      S   ++G G FG+V       C+         + +VA+K L+   ++ Q  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEV-------CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E   + + +HPN+++L G     +  ++V E +  GSL D  L + D +    + + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
             G A G+++L       +HRD+ A N+L++ +   K+SDFGL++   L D    +    
Sbjct: 153 LRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTR 208
Query: 305 GTR---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
           G +    + +PE IA    T  +DV+S+G+VL E++S                 +PY  +
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------------ERPYWEM 254
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           SN+  + + +DE       M+      +++L C   D  NRP   ++V+ L++L  N GS
Sbjct: 255 SNQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 142/300 (47%), Gaps = 33/300 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E      S   ++G G FG+V       C+         + +VA+K L+   ++ Q  ++
Sbjct: 12  ELDATNISIDKVVGAGEFGEV-------CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E   + + +HPN+++L G     +  ++V E +  GSL D  L + D +    + + +
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGM 123
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
             G A G+++L       +HRD+ A N+L++ +   K+SDFGL++   L D    +    
Sbjct: 124 LRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTR 179
Query: 305 GTR---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
           G +    + +PE IA    T  +DV+S+G+VL E++S                 +PY  +
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------------ERPYWEM 225
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           SN+  + + +DE       M+      +++L C   D  NRP   ++V+ L++L  N GS
Sbjct: 226 SNQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 284

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 66
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E++    + +A   +  +E+
Sbjct: 67  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 127 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 226
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 66
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E++    + +A   +  +E+
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 127 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 226
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 66
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E++    + +A   +  +E+
Sbjct: 67  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 127 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PY--PGIDLSQVY-ELLE 226
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 143/299 (47%), Gaps = 41/299 (13%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           T K  E+  +G G  G+V++GY N               VAVK L+ +GS   D +  E 
Sbjct: 14  TLKLVER--LGAGQAGEVWMGYYNGHT-----------KVAVKSLK-QGSMSPDAFLAEA 59
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             + +L H  +V+L  Y    Q  + ++ EY+  GSL D L      +L   + + +A  
Sbjct: 60  NLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A G+  +    R  IHRD++A+N+L+ D  + KI+DFGLA+   L + +  + R  G +
Sbjct: 118 IAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR---LIEDAEXTARE-GAK 171
Query: 308 ---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I  G  T+K+DV+SFG++L EI++             G    P ++N   
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT------------HGRIPYPGMTNPEV 219
Query: 365 LHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
           +  +  E+  R ++ +   +E  +++  C    P++RPT   + + LE         YQ
Sbjct: 220 IQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 276

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 71
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E++    + +A   +  +E+
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 131
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 132 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 188
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 231
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 232 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 312
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E+N    + +A   +  +E+
Sbjct: 313 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 372
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHR++ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 373 LEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 429
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 430 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 472
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 473 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 515

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 66
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E++    + +A   +  +E+
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 127 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PY--PGIDLSQVY-ELLE 226
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 138/283 (48%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY+G     ++T          VAVK L+   +   +E+  E   +  +
Sbjct: 37  KHKLGGGQYGEVYVGVWKKYSLT----------VAVKTLKED-TMEVEEFLKEAAVMKEI 85
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    +V EY+  G+L D+L   +  E+     + +A   +  +E+
Sbjct: 86  KHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEY 145
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 146 LEK--KNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 202
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+ D  L 
Sbjct: 203 LAYNTFSIKSDVWAFGVLLWEI---------ATYGMS-----PY--PGIDLSQVYD-LLE 245
Query: 375 RNIQMEEAQ----EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  +ME+ +    +  E++  C    P +RP+ +E   A E +
Sbjct: 246 KGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETM 288

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 127/283 (44%), Gaps = 42/283 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           FS+   IG G FG VY           AR       VA+K++   G Q  ++W++   E+
Sbjct: 56  FSDLREIGHGSFGAVYF----------ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 105
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
           RFL +L HPN ++  G    +    LV EY   GS  D LL      L       +  GA
Sbjct: 106 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGA 163
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF-GPLGDKSHISTRVLGTR 307
            +GL +LH++   +IHRDVKA N+LL +    K+ DFG A    P       +   +GT 
Sbjct: 164 LQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTP 214
Query: 308 GYFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
            + APE I     G    K DV+S G+  +E L+ +   +   N ++            A
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMS------------A 261
Query: 365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           L+ I   +         ++ F   +  CL   P++RPT SEV+
Sbjct: 262 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT-SEVL 303

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 89/306 (29%), Positives = 143/306 (46%), Gaps = 34/306 (11%)
Query: 132 FSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN 186
           F E++L     +G+G FG V +   +          N    VAVK+L+  G   Q +++ 
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLG------DNTGALVAVKQLQHSGPDQQRDFQR 73
Query: 187 ELRFLSRLNHPNVVKLMG--YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
           E++ L  L+   +VK  G  Y    Q   LV EY+  G L D  L      L+  R +  
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLY 132
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           +    +G+E+L +  R  +HRD+ A N+L++ + + KI+DFGLAK  PL DK +   R  
Sbjct: 133 SSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREP 189
Query: 305 GTRG--YFAPEYIATGHLTLKTDVYSFGVVLLEILS------GKTAAMRRTNGLAGNWAK 356
           G     ++APE ++    + ++DV+SFGVVL E+ +        +A   R  G   +   
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD--V 247
Query: 357 PYLSNKLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           P LS  L        + G+ +    A   E  E++  C    P++RP+ S +   L+ L 
Sbjct: 248 PALSRLLE-----LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302
Query: 415 LNMGSC 420
                C
Sbjct: 303 SGSRGC 308

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 128/284 (45%), Gaps = 44/284 (15%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           FS+   IG G FG VY           AR       VA+K++   G Q  ++W++   E+
Sbjct: 17  FSDLREIGHGSFGAVYF----------ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
           RFL +L HPN ++  G    +    LV EY   GS  D LL      L       +  GA
Sbjct: 67  RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGA 124
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI--STRVLGT 306
            +GL +LH++   +IHRDVKA N+LL        S+ GL K G  G  S +  +   +GT
Sbjct: 125 LQGLAYLHSH--NMIHRDVKAGNILL--------SEPGLVKLGDFGSASIMAPANXFVGT 174
Query: 307 RGYFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL 363
             + APE I     G    K DV+S G+  +E L+ +   +   N ++            
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMS------------ 221
Query: 364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           AL+ I   +         ++ F   +  CL   P++RPT SEV+
Sbjct: 222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT-SEVL 264

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 138/299 (46%), Gaps = 41/299 (13%)
Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW 184
           +EA+    S +  IG G FG VY G           + + D AV + ++     +    +
Sbjct: 33  IEASEVMLSTR--IGSGSFGTVYKG-----------KWHGDVAVKILKVVDPTPEQFQAF 79
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
            NE+  L +  H N++  MGY   D +  +V ++    SL  HL +  +T+    + I I
Sbjct: 80  RNEVAVLRKTRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHL-HVQETKFQMFQLIDI 137
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           A   A+G+++LH   + +IHRD+K++N+ L +    KI DFGLA        S    +  
Sbjct: 138 ARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT 195
Query: 305 GTRGYFAPEYI---ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTN------GLAGNWA 355
           G+  + APE I        + ++DVYS+G+VL E+++G+       N       +   +A
Sbjct: 196 GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA 255
Query: 356 KPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
            P LS           KL +N      +    ++  C+    + RP   ++++++E LQ
Sbjct: 256 SPDLS-----------KLYKNC----PKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 138/283 (48%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G FG+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 16  KHKLGGGQFGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 64
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E++    + +A   +  +E+
Sbjct: 65  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 125 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPES 181
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI    T  M    G+  +               + E L 
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEI---ATYGMSPYPGIDPS--------------QVYELLE 224
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 225 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 118/228 (51%), Gaps = 19/228 (8%)
Query: 122 HGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ 181
           H +++ +   F ++  IG G FG V++GY            N D  VA+K ++ +GS  +
Sbjct: 21  HMVIDPSELTFVQE--IGSGQFGLVHLGY----------WLNKD-KVAIKTIK-EGSMSE 66
Query: 182 DEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERR 241
           D++  E   + +L+HP +V+L G C +     LV+E++  G L D+L  +       E  
Sbjct: 67  DDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-FAAETL 125
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           + + L    G+ +L      VIHRD+ A N L+ ++   K+SDFG+ +F  L D+   ST
Sbjct: 126 LGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSST 182
Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTN 348
                  + +PE  +    + K+DV+SFGV++ E+ S GK     R+N
Sbjct: 183 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 230

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 90/306 (29%), Positives = 144/306 (47%), Gaps = 34/306 (11%)
Query: 132 FSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN 186
           F E++L     +G+G FG V +   +          N    VAVK+L+  G   Q +++ 
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLG------DNTGALVAVKQLQHSGPDQQRDFQR 60
Query: 187 ELRFLSRLNHPNVVKLMG--YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
           E++ L  L+   +VK  G  Y    Q   LV EY+  G L D  L      L+  R +  
Sbjct: 61  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLY 119
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           +    +G+E+L +  R  +HRD+ A N+L++ + + KI+DFGLAK  PL DK +   R  
Sbjct: 120 SSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREP 176
Query: 305 GTRG--YFAPEYIATGHLTLKTDVYSFGVVLLEILS------GKTAAMRRTNGLAGNWAK 356
           G     ++APE ++    + ++DV+SFGVVL E+ +        +A   R  G   +   
Sbjct: 177 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERD--V 234
Query: 357 PYLSNKLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           P LS  L L      + G+ +    A   E  E++  C    P++RP+ S +   L+ L 
Sbjct: 235 PALSRLLEL-----LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 289
Query: 415 LNMGSC 420
                C
Sbjct: 290 SGSRGC 295

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 144/305 (47%), Gaps = 33/305 (10%)
Query: 131 KFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +F E++L     +G+G FG V +     C     +  N    VAVK+L+    +   ++E
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFE 59
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            E+  L  L H N+VK  G C     R   L+ EY+  GSL D+L    +  ++  + ++
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQ 118
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
                 +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK     + 
Sbjct: 119 YTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEFFKVKE 175
Query: 304 LGTRGYF--APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            G    F  APE +     ++ +DV+SFGVVL E+ +     + ++      + +   ++
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 231
Query: 362 K----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   ++Q+
Sbjct: 232 KQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
Query: 414 QLNMG 418
           + NM 
Sbjct: 290 RDNMA 294

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 144/305 (47%), Gaps = 33/305 (10%)
Query: 131 KFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +F E++L     +G+G FG V +     C     +  N    VAVK+L+    +   ++E
Sbjct: 5   QFEERHLKFLQQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFE 58
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            E+  L  L H N+VK  G C     R   L+ EY+  GSL D+ L +    ++  + ++
Sbjct: 59  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQ 117
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
                 +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK     + 
Sbjct: 118 YTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKE 174
Query: 304 LGTRGYF--APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            G    F  APE +     ++ +DV+SFGVVL E+ +     + ++      + +   ++
Sbjct: 175 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 230
Query: 362 K----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   ++Q+
Sbjct: 231 KQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 288
Query: 414 QLNMG 418
           + NM 
Sbjct: 289 RDNMA 293

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 136/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 17  LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 65  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 123
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 124 --MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 177
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 220
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   DP+ RPT   + A LE
Sbjct: 221 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 136/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 26  LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 73
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 74  KLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 133 --MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 186
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 229
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   DP+ RPT   + A LE
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 144/285 (50%), Gaps = 28/285 (9%)
Query: 133 SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFL 191
           + + +IG G FG+VY G +     T++ +K  +  VA+K L+   ++ Q  ++  E   +
Sbjct: 47  TRQKVIGAGEFGEVYKGMLK----TSSGKK--EVPVAIKTLKAGYTEKQRVDFLGEAGIM 100
Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
            + +H N+++L G     +  +++ EY+  G+L D  L E D E +  + + +  G A G
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---G 308
           +++L       +HRD+ A N+L++ +   K+SDFGL++   L D    +    G +    
Sbjct: 160 MKYLANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIR 215
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           + APE I+    T  +DV+SFG+V+ E++         T G    W    LSN   + + 
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVM---------TYGERPYWE---LSNHEVM-KA 262
Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           I++       M+      +++++C   +   RP  +++V+ L++L
Sbjct: 263 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 136/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 26  LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 73
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 133 --MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 186
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 229
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   DP+ RPT   + A LE
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 136/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 15  LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 62
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 63  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 121
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 122 --MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 175
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 176 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 218
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   DP+ RPT   + A LE
Sbjct: 219 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 89/306 (29%), Positives = 143/306 (46%), Gaps = 34/306 (11%)
Query: 132 FSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN 186
           F E++L     +G+G FG V +   +          N    VAVK+L+  G   Q +++ 
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLG------DNTGALVAVKQLQHSGPDQQRDFQR 61
Query: 187 ELRFLSRLNHPNVVKLMG--YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
           E++ L  L+   +VK  G  Y    Q   LV EY+  G L D  L      L+  R +  
Sbjct: 62  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLY 120
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           +    +G+E+L +  R  +HRD+ A N+L++ + + KI+DFGLAK  PL DK +   R  
Sbjct: 121 SSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREP 177
Query: 305 GTRG--YFAPEYIATGHLTLKTDVYSFGVVLLEILS------GKTAAMRRTNGLAGNWAK 356
           G     ++APE ++    + ++DV+SFGVVL E+ +        +A   R  G   +   
Sbjct: 178 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD--V 235
Query: 357 PYLSNKLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           P L   L L      + G+ +    A   E  E++  C    P++RP+ S +   L+ L 
Sbjct: 236 PALCRLLEL-----LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 290
Query: 415 LNMGSC 420
                C
Sbjct: 291 SGSRGC 296

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 273
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E++    + +A   +  +E+
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHR++ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 334 LEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 390
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI          T G++     PY    + L Q+  E L 
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEI---------ATYGMS-----PYPG--IDLSQVY-ELLE 433
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 138/283 (48%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 64
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E++    + +A   +  +E+
Sbjct: 65  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 125 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPES 181
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI    T  M    G+  +               + E L 
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEI---ATYGMSPYPGIDPS--------------QVYELLE 224
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 225 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 144/305 (47%), Gaps = 33/305 (10%)
Query: 131 KFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +F E++L     +G+G FG V +     C     +  N    VAVK+L+    +   ++E
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFE 59
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            E+  L  L H N+VK  G C     R   L+ EY+  GSL D+ L +    ++  + ++
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQ 118
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
                 +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK     + 
Sbjct: 119 YTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKE 175
Query: 304 LGTRGYF--APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            G    F  APE +     ++ +DV+SFGVVL E+ +     + ++      + +   ++
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 231
Query: 362 K----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   ++Q+
Sbjct: 232 KQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
Query: 414 QLNMG 418
           + NM 
Sbjct: 290 RDNMA 294

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 144/305 (47%), Gaps = 33/305 (10%)
Query: 131 KFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +F E++L     +G+G FG V +     C     +  N    VAVK+L+    +   ++E
Sbjct: 13  QFEERHLKFLQQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFE 66
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            E+  L  L H N+VK  G C     R   L+ EY+  GSL D+L    +  ++  + ++
Sbjct: 67  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQ 125
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
                 +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK     + 
Sbjct: 126 YTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKE 182
Query: 304 LGTRGYF--APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            G    F  APE +     ++ +DV+SFGVVL E+ +     + ++      + +   ++
Sbjct: 183 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 238
Query: 362 K----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   ++Q+
Sbjct: 239 KQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 296
Query: 414 QLNMG 418
           + NM 
Sbjct: 297 RDNMA 301

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 145/305 (47%), Gaps = 33/305 (10%)
Query: 131 KFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +F E++L     +G+G FG V +     C     +  N    VAVK+L+    +   ++E
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFE 59
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            E+  L  L H N+VK  G C     R   L+ EY+  GSL D+L    +  ++  + ++
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQ 118
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
                 +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK     + 
Sbjct: 119 YTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKE 175
Query: 304 LGTRG--YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            G     ++APE +     ++ +DV+SFGVVL E+ +     + ++      + +   ++
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 231
Query: 362 K----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   ++Q+
Sbjct: 232 KQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
Query: 414 QLNMG 418
           + NM 
Sbjct: 290 RDNMA 294

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 110/212 (51%), Gaps = 17/212 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG V++GY            N D  VA+K +R +G+  ++++  E   + +L+HP
Sbjct: 15  IGSGQFGLVHLGY----------WLNKD-KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 62
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C +     LV+E++  G L D+L  +       E  + + L    G+ +L  
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEE 121
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               VIHRD+ A N L+ ++   K+SDFG+ +F  L D+   ST       + +PE  + 
Sbjct: 122 --ASVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSF 178
Query: 318 GHLTLKTDVYSFGVVLLEILS-GKTAAMRRTN 348
              + K+DV+SFGV++ E+ S GK     R+N
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 144/305 (47%), Gaps = 33/305 (10%)
Query: 131 KFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +F E++L     +G+G FG V +     C     +  N    VAVK+L+    +   ++E
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFE 63
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            E+  L  L H N+VK  G C     R   L+ EY+  GSL D+ L +    ++  + ++
Sbjct: 64  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQ 122
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
                 +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK     + 
Sbjct: 123 YTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKE 179
Query: 304 LGTRGYF--APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            G    F  APE +     ++ +DV+SFGVVL E+ +     + ++      + +   ++
Sbjct: 180 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 235
Query: 362 K----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   ++Q+
Sbjct: 236 KQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 293
Query: 414 QLNMG 418
           + NM 
Sbjct: 294 RDNMA 298

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 136/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 26  LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 73
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 74  KLVQLYA-VVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 133 --MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 186
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 229
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   DP+ RPT   + A LE
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 144/305 (47%), Gaps = 33/305 (10%)
Query: 131 KFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +F E++L     +G+G FG V +     C     +  N    VAVK+L+    +   ++E
Sbjct: 12  QFEERHLKFLQQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFE 65
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            E+  L  L H N+VK  G C     R   L+ EY+  GSL D+L    +  ++  + ++
Sbjct: 66  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQ 124
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
                 +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK     + 
Sbjct: 125 YTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKE 181
Query: 304 LGTRGYF--APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            G    F  APE +     ++ +DV+SFGVVL E+ +     + ++      + +   ++
Sbjct: 182 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 237
Query: 362 K----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   ++Q+
Sbjct: 238 KQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 295
Query: 414 QLNMG 418
           + NM 
Sbjct: 296 RDNMA 300

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 113/216 (52%), Gaps = 22/216 (10%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG+V++GY N+              VAVK L+  G+     +  E   +  L H 
Sbjct: 21  LGAGQFGEVWMGYYNNST-----------KVAVKTLK-PGTMSVQAFLEEANLMKTLQHD 68
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   ++ EY+ +GSL D L +++  ++   + I  +   A G+ ++  
Sbjct: 69  KLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 128
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
             +  IHRD++A+NVL+ +    KI+DFGLA+   + D  + +    G +    + APE 
Sbjct: 129 --KNYIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTARE--GAKFPIKWTAPEA 182
Query: 315 IATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNG 349
           I  G  T+K+DV+SFG++L EI++ GK     RTN 
Sbjct: 183 INFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNA 218

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 110/212 (51%), Gaps = 17/212 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG V++GY            N D  VA+K +R +G+  ++++  E   + +L+HP
Sbjct: 13  IGSGQFGLVHLGY----------WLNKD-KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 60
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C +     LV+E++  G L D+L  +       E  + + L    G+ +L  
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEE 119
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               VIHRD+ A N L+ ++   K+SDFG+ +F  L D+   ST       + +PE  + 
Sbjct: 120 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 318 GHLTLKTDVYSFGVVLLEILS-GKTAAMRRTN 348
              + K+DV+SFGV++ E+ S GK     R+N
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 145/305 (47%), Gaps = 33/305 (10%)
Query: 131 KFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +F E++L     +G+G FG V +     C     +  N    VAVK+L+    +   ++E
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFE 62
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            E+  L  L H N+VK  G C     R   L+ EY+  GSL D+L    +  ++  + ++
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQ 121
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
                 +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK     + 
Sbjct: 122 YTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKE 178
Query: 304 LGTRG--YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            G     ++APE +     ++ +DV+SFGVVL E+ +     + ++      + +   ++
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 234
Query: 362 K----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   ++Q+
Sbjct: 235 KQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292
Query: 414 QLNMG 418
           + NM 
Sbjct: 293 RDNMA 297

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 144/305 (47%), Gaps = 33/305 (10%)
Query: 131 KFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +F E++L     +G+G FG V +     C     +  N    VAVK+L+    +   ++E
Sbjct: 11  QFEERHLKFLQQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFE 64
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            E+  L  L H N+VK  G C     R   L+ EY+  GSL D+L    +  ++  + ++
Sbjct: 65  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQ 123
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
                 +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK     + 
Sbjct: 124 YTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKE 180
Query: 304 LGTRGYF--APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            G    F  APE +     ++ +DV+SFGVVL E+ +     + ++      + +   ++
Sbjct: 181 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 236
Query: 362 K----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   ++Q+
Sbjct: 237 KQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 294
Query: 414 QLNMG 418
           + NM 
Sbjct: 295 RDNMA 299

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 110/212 (51%), Gaps = 17/212 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG V++GY            N D  VA+K +R +G+  ++++  E   + +L+HP
Sbjct: 15  IGSGQFGLVHLGY----------WLNKD-KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 62
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C +     LV+E++  G L D+L  +       E  + + L    G+ +L  
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEE 121
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               VIHRD+ A N L+ ++   K+SDFG+ +F  L D+   ST       + +PE  + 
Sbjct: 122 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSF 178
Query: 318 GHLTLKTDVYSFGVVLLEILS-GKTAAMRRTN 348
              + K+DV+SFGV++ E+ S GK     R+N
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 142/308 (46%), Gaps = 28/308 (9%)
Query: 122 HGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ 181
           H + +   R       +G+G FG V +     C     +  N    VAVK+L+    +  
Sbjct: 20  HNMTQFEERHLKFLQQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHL 73
Query: 182 DEWENELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWE 239
            ++E E+  L  L H N+VK  G C     R   L+ EY+  GSL D+ L +    ++  
Sbjct: 74  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHI 132
Query: 240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
           + ++      +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK   
Sbjct: 133 KLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXX 189
Query: 300 STRVLGTRGYF--APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP 357
             +  G    F  APE +     ++ +DV+SFGVVL E+ +     + ++      + + 
Sbjct: 190 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRM 245
Query: 358 YLSNK----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAA 409
             ++K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   
Sbjct: 246 IGNDKQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 303
Query: 410 LEQLQLNM 417
           ++Q++ NM
Sbjct: 304 VDQIRDNM 311

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 110/212 (51%), Gaps = 17/212 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG V++GY            N D  VA+K +R +G+  ++++  E   + +L+HP
Sbjct: 18  IGSGQFGLVHLGY----------WLNKD-KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 65
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C +     LV+E++  G L D+L  +       E  + + L    G+ +L  
Sbjct: 66  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEE 124
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               VIHRD+ A N L+ ++   K+SDFG+ +F  L D+   ST       + +PE  + 
Sbjct: 125 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSF 181
Query: 318 GHLTLKTDVYSFGVVLLEILS-GKTAAMRRTN 348
              + K+DV+SFGV++ E+ S GK     R+N
Sbjct: 182 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213

>pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 142/310 (45%), Gaps = 28/310 (9%)
Query: 122 HGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ 181
           H + +   R       +G+G FG V +     C     +  N    VAVK+L+    +  
Sbjct: 20  HNMTQFEERHLKFLQQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHL 73
Query: 182 DEWENELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWE 239
            ++E E+  L  L H N+VK  G C     R   L+ EY+  GSL D+ L +    ++  
Sbjct: 74  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHI 132
Query: 240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
           + ++      +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK   
Sbjct: 133 KLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXX 189
Query: 300 STRVLGTRGYF--APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP 357
             +  G    F  APE +     ++ +DV+SFGVVL E+ +     + ++      + + 
Sbjct: 190 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRM 245
Query: 358 YLSNK----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAA 409
             ++K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   
Sbjct: 246 IGNDKQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 303
Query: 410 LEQLQLNMGS 419
           ++Q++ NM  
Sbjct: 304 VDQIRDNMAG 313

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 138/283 (48%), Gaps = 35/283 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 64
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E++    + +A   +  +E+
Sbjct: 65  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + APE 
Sbjct: 125 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPES 181
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           +A    ++K+DV++FGV+L EI    T  M    G+  +               + E L 
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEI---ATYGMSPYPGIDPS--------------QVYELLE 224
Query: 375 RNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++ +ME      ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 225 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 146/305 (47%), Gaps = 33/305 (10%)
Query: 131 KFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +F E++L     +G+G FG V +     C     +  N    VAVK+L+    +   ++E
Sbjct: 7   QFEERHLKFLQQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFE 60
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            E+  L  L H N+VK  G C     R   L+ EY+  GSL D+ L +    ++  + ++
Sbjct: 61  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQ 119
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
                 +G+E+L T  +  IHR++   N+L++++   KI DFGL K  P  DK +   + 
Sbjct: 120 YTSQICKGMEYLGT--KRYIHRNLATRNILVENENRVKIGDFGLTKVLP-QDKEYYKVKE 176
Query: 304 LGTRG--YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            G     ++APE +     ++ +DV+SFGVVL E+ +     + ++      + +   ++
Sbjct: 177 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 232
Query: 362 K----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   ++Q+
Sbjct: 233 KQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 290
Query: 414 QLNMG 418
           + NM 
Sbjct: 291 RDNMA 295

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 136/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 19  LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 66
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 67  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 125
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 126 --MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 179
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 180 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 222
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   +P+ RPT   + A LE
Sbjct: 223 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 140/298 (46%), Gaps = 33/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E A  K +    +GQG FG VY G           +   +  VA+K +    S  +  E+
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVV-----KDEPETRVAIKTVNEAASMRERIEF 69
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTEL--- 236
            NE   +   N  +VV+L+G     Q  L++ E +TRG L+ +L +     E++  L   
Sbjct: 70  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
           +  + I++A   A G+ +L+      +HRD+ A N ++ +DF  KI DFG+ +     D 
Sbjct: 130 SLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 187
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + +PE +  G  T  +DV+SFGVVL EI +           LA    +
Sbjct: 188 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LA---EQ 233
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           PY  LSN+  L  +++  L           F E++  C   +PK RP+  E+++++++
Sbjct: 234 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSIKE 290

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 136/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + ++ H 
Sbjct: 26  LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGTMSPEAFLQEAQVMKKIRHE 73
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 133 --MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 186
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 229
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   DP+ RPT   + A LE
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 135/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 26  LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 73
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD+ A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 133 --MNYVHRDLAAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 186
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 229
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   DP+ RPT   + A LE
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 136/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-----------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 322
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 323 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 382 M--NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 435
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 478
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   +P+ RPT   + A LE
Sbjct: 479 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 136/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 26  LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 73
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 74  KLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   L + +  + R  G +    + APE 
Sbjct: 133 M--NYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEXTARQ-GAKFPIKWTAPEA 186
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 229
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   DP+ RPT   + A LE
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 139/281 (49%), Gaps = 37/281 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V +G           +    + VAVK ++ +GS  +DE+  E + + +L+HP
Sbjct: 16  LGSGQFGVVKLG-----------KWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +VK  G C  +    +V EY++ G L ++L +     L   + +++      G+  L +
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLES 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
           +    IHRD+ A N L+D D   K+SDFG+ ++  + D  ++S+  +GT+    + APE 
Sbjct: 123 H--QFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSS--VGTKFPVKWSAPEV 176
Query: 315 IATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL 373
                 + K+DV++FG+++ E+ S GK      TN            +++ L      +L
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN------------SEVVLKVSQGHRL 224
Query: 374 GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
            R     +     +I+  C +  P+ RPT  ++++++E L+
Sbjct: 225 YRPHLASDT--IYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 139/292 (47%), Gaps = 43/292 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-----------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 239
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 240 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 299 --MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 352
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 395
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
           R  +M    E  +   +++ +C   +P+ RPT   + A LE    +    YQ
Sbjct: 396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 447

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 143/302 (47%), Gaps = 41/302 (13%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E A  K +    +GQG FG VY G           +   +  VA+K +    S  +  E+
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVV-----KDEPETRVAIKTVNEAASMRERIEF 60
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTEL--- 236
            NE   +   N  +VV+L+G     Q  L++ E +TRG L+ +L +     E++  L   
Sbjct: 61  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 120
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
           +  + I++A   A G+ +L+      +HRD+ A N ++ +DF  KI DFG+ +     D 
Sbjct: 121 SLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 178
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + +PE +  G  T  +DV+SFGVVL EI +           LA    +
Sbjct: 179 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LA---EQ 224
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILR----CLNSDPKNRPTMSEVVAAL 410
           PY  LSN+  L  +++  L     +++     +++L     C   +PK RP+  E+++++
Sbjct: 225 PYQGLSNEQVLRFVMEGGL-----LDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSI 279
Query: 411 EQ 412
           ++
Sbjct: 280 KE 281

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 144/305 (47%), Gaps = 33/305 (10%)
Query: 131 KFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +F E++L     +G+G FG V +   +        + N    VAVK+L+    +   ++E
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPL------QDNTGEVVAVKKLQHSTEEHLRDFE 62
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            E+  L  L H N+VK  G C     R   L+ EY+  GSL D+L    +  ++  + ++
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAE-RIDHIKLLQ 121
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
                 +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK     + 
Sbjct: 122 YTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKE 178
Query: 304 LGTRGYF--APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            G    F  APE +     ++ +DV+SFGVVL E+ +     + ++      + +   ++
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 234
Query: 362 K----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   ++Q+
Sbjct: 235 KQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292
Query: 414 QLNMG 418
           + NM 
Sbjct: 293 RDNMA 297

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 136/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-----------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 239
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 240 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 299 --MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 352
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 395
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   +P+ RPT   + A LE
Sbjct: 396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 135/286 (47%), Gaps = 39/286 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNH 196
           +G+  FG VY G++   A     +     AVA+K L+ K     ++E+ +E    +RL H
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQ-----AVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL----NEDDTELNWERRIKIAL------ 246
           PNVV L+G    DQ   +++ Y + G L + L+    + D    + +R +K AL      
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 247 ----GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
                 A G+E+L ++   V+H+D+   NVL+ D  N KISD GL +     D   +   
Sbjct: 132 HLVAQIAAGMEYLSSH--HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL--S 360
            L    + APE I  G  ++ +D++S+GVVL E+ S          GL     +PY   S
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS---------YGL-----QPYCGYS 235
Query: 361 NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           N+  +  I + ++        A  +A +++ C N  P  RP   ++
Sbjct: 236 NQDVVEMIRNRQVLPCPDDCPAWVYA-LMIECWNEFPSRRPRFKDI 280

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 135/286 (47%), Gaps = 39/286 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNH 196
           +G+  FG VY G++   A     +     AVA+K L+ K     ++E+ +E    +RL H
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQ-----AVAIKTLKDKAEGPLREEFRHEAMLRARLQH 88
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL----NEDDTELNWERRIKIAL------ 246
           PNVV L+G    DQ   +++ Y + G L + L+    + D    + +R +K AL      
Sbjct: 89  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 247 ----GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
                 A G+E+L ++   V+H+D+   NVL+ D  N KISD GL +     D   +   
Sbjct: 149 HLVAQIAAGMEYLSSH--HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL--S 360
            L    + APE I  G  ++ +D++S+GVVL E+ S          GL     +PY   S
Sbjct: 207 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS---------YGL-----QPYCGYS 252
Query: 361 NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           N+  +  I + ++        A  +A +++ C N  P  RP   ++
Sbjct: 253 NQDVVEMIRNRQVLPCPDDCPAWVYA-LMIECWNEFPSRRPRFKDI 297

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 135/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 26  LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 73
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++G L D L  E    L   + + +A   A G+ ++  
Sbjct: 74  KLVQLYA-VVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 133 --MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 186
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 229
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   DP+ RPT   + A LE
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 136/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-----------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 239
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 240 KLVQLYA-VVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 299 --MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 352
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 395
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   +P+ RPT   + A LE
Sbjct: 396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 135/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 26  LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 73
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++G L D L  E    L   + + +A   A G+ ++  
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 133 --MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 186
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 229
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   DP+ RPT   + A LE
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 136/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 16  LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 63
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 64  KLVQLYA-VVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   L + +  + R  G +    + APE 
Sbjct: 123 M--NYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEXTARQ-GAKFPIKWTAPEA 176
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 177 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 219
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   +P+ RPT   + A LE
Sbjct: 220 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 143/305 (46%), Gaps = 33/305 (10%)
Query: 131 KFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +F E++L     +G+G FG V +     C     +  N    VAVK+L+    +   ++E
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFE 57
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            E+  L  L H N+VK  G C     R   L+ EY+  GSL D+ L +    ++  + ++
Sbjct: 58  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQ 116
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
                 +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK     + 
Sbjct: 117 YTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKE 173
Query: 304 LGTRGYF--APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            G    F  APE +     ++ +DV+SFGVVL E+ +     + ++      + +   ++
Sbjct: 174 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 229
Query: 362 K----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   ++Q+
Sbjct: 230 KQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 287
Query: 414 QLNMG 418
           +  M 
Sbjct: 288 RDQMA 292

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 138/301 (45%), Gaps = 57/301 (18%)
Query: 123 GLLEAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----R 172
           G +E+  R+++ ++      +G+G FG+VY+          AR K + F +A+K     +
Sbjct: 1   GAMESKKRQWALEDFEIGRPLGKGKFGNVYL----------AREKQSKFILALKVLFKAQ 50
Query: 173 LRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED 232
           L + G + Q   E E++  S L HPN+++L GY  D     L+ EY  RG +   L  + 
Sbjct: 51  LEKAGVEHQLRREVEIQ--SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QK 106
Query: 233 DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP 292
            ++ + +R        A  L + H+  + VIHRD+K  N+LL      KI+DFG +   P
Sbjct: 107 LSKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG 352
               S   T + GT  Y  PE I       K D++S GV+  E L GK            
Sbjct: 165 ----SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP----------- 209
Query: 353 NWAKPYLSNKLALHQIIDEKLGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
               P+ +N    +Q   +++ R      +   E A+   ++I R L  +P  RP + EV
Sbjct: 210 ----PFEANT---YQETYKRISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREV 259
Query: 407 V 407
           +
Sbjct: 260 L 260

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 136/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG+V++G             N +  VA+K L+  G+   + +  E + + +L H 
Sbjct: 17  LGNGQFGEVWMG-----------TWNGNTKVAIKTLK-PGTMSPESFLEEAQIMKKLKHD 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+ +GSL D L + +   L     + +A   A G+ ++  
Sbjct: 65  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 123
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                IHRD++++N+L+ +    KI+DFGLA+   L + +  + R  G +    + APE 
Sbjct: 124 M--NYIHRDLRSANILVGNGLICKIADFGLAR---LIEDNEXTARQ-GAKFPIKWTAPEA 177
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+++             G    P ++N+  L Q+      
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELVT------------KGRVPYPGMNNREVLEQV-----E 220
Query: 375 RNIQMEEAQE----FAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M   Q+      E+++ C   DP+ RPT   + + LE
Sbjct: 221 RGYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 29/296 (9%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E A  K +    +GQG FG VY G           +   +  VA+K +    S  +  E+
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVV-----KDEPETRVAIKTVNEAASMRERIEF 75
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTEL--- 236
            NE   +   N  +VV+L+G     Q  L++ E +TRG L+ +L +     E++  L   
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 135
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
           +  + I++A   A G+ +L+      +HRD+ A N ++ +DF  KI DFG+ +     D 
Sbjct: 136 SLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + +PE +  G  T  +DV+SFGVVL EI    T A +   G       
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---ATLAEQPYQG------- 243
Query: 357 PYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
             LSN+  L  +++  L           F E++  C   +PK RP+  E+++++++
Sbjct: 244 --LSNEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSIKE 296

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 140/298 (46%), Gaps = 33/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E A  K +    +GQG FG VY G           +   +  VA+K +    S  +  E+
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVV-----KDEPETRVAIKTVNEAASMRERIEF 68
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTEL--- 236
            NE   +   N  +VV+L+G     Q  L++ E +TRG L+ +L +     E++  L   
Sbjct: 69  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
           +  + I++A   A G+ +L+      +HRD+ A N ++ +DF  KI DFG+ +     D 
Sbjct: 129 SLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + +PE +  G  T  +DV+SFGVVL EI +           LA    +
Sbjct: 187 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LA---EQ 232
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           PY  LSN+  L  +++  L           F E++  C   +PK RP+  E+++++++
Sbjct: 233 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSIKE 289

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 140/298 (46%), Gaps = 33/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E A  K +    +GQG FG VY G           +   +  VA+K +    S  +  E+
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVV-----KDEPETRVAIKTVNEAASMRERIEF 66
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTEL--- 236
            NE   +   N  +VV+L+G     Q  L++ E +TRG L+ +L +     E++  L   
Sbjct: 67  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 126
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
           +  + I++A   A G+ +L+      +HRD+ A N ++ +DF  KI DFG+ +     D 
Sbjct: 127 SLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 184
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + +PE +  G  T  +DV+SFGVVL EI +           LA    +
Sbjct: 185 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LA---EQ 230
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           PY  LSN+  L  +++  L           F E++  C   +PK RP+  E+++++++
Sbjct: 231 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSIKE 287

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 137/292 (46%), Gaps = 34/292 (11%)
Query: 128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWEN 186
           A+R   EK +IG G  G+V  G +             D  VA+K L+   ++ Q  ++ +
Sbjct: 48  ASRIHIEK-IIGSGDSGEVCYGRLRVPG-------QRDVPVAIKALKAGYTERQRRDFLS 99
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           E   + + +HPN+++L G     +  ++V EY+  GSL D  L   D +    + + +  
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLR 158
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
           G   G+ +L       +HRD+ A NVL+D +   K+SDFGL++   L D    +    G 
Sbjct: 159 GVGAGMRYLSDL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAXTTTGG 214
Query: 307 R---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSN 361
           +    + APE IA    +  +DV+SFGVV+ E+L+                 +PY  ++N
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE--------------RPYWNMTN 260
Query: 362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  +   ++E       M       +++L C + D   RP  S++V+ L+ L
Sbjct: 261 RDVISS-VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 140/298 (46%), Gaps = 33/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E A  K +    +GQG FG VY G           +   +  VA+K +    S  +  E+
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVV-----KDEPETRVAIKTVNEAASMRERIEF 68
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTEL--- 236
            NE   +   N  +VV+L+G     Q  L++ E +TRG L+ +L +     E++  L   
Sbjct: 69  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
           +  + I++A   A G+ +L+      +HRD+ A N ++ +DF  KI DFG+ +     D 
Sbjct: 129 SLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + +PE +  G  T  +DV+SFGVVL EI +           LA    +
Sbjct: 187 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LA---EQ 232
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           PY  LSN+  L  +++  L           F E++  C   +PK RP+  E+++++++
Sbjct: 233 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSIKE 289

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 140/298 (46%), Gaps = 33/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E A  K +    +GQG FG VY G           +   +  VA+K +    S  +  E+
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVV-----KDEPETRVAIKTVNEAASMRERIEF 62
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTEL--- 236
            NE   +   N  +VV+L+G     Q  L++ E +TRG L+ +L +     E++  L   
Sbjct: 63  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
           +  + I++A   A G+ +L+      +HRD+ A N ++ +DF  KI DFG+ +     D 
Sbjct: 123 SLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 180
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + +PE +  G  T  +DV+SFGVVL EI +           LA    +
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LA---EQ 226
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           PY  LSN+  L  +++  L           F E++  C   +PK RP+  E+++++++
Sbjct: 227 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSIKE 283

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 140/298 (46%), Gaps = 33/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E A  K +    +GQG FG VY G           +   +  VA+K +    S  +  E+
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVV-----KDEPETRVAIKTVNEAASMRERIEF 69
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTEL--- 236
            NE   +   N  +VV+L+G     Q  L++ E +TRG L+ +L +     E++  L   
Sbjct: 70  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
           +  + I++A   A G+ +L+      +HRD+ A N ++ +DF  KI DFG+ +     D 
Sbjct: 130 SLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 187
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + +PE +  G  T  +DV+SFGVVL EI +           LA    +
Sbjct: 188 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LA---EQ 233
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           PY  LSN+  L  +++  L           F E++  C   +PK RP+  E+++++++
Sbjct: 234 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSIKE 290

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 137/287 (47%), Gaps = 36/287 (12%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           ++   + ++G+G FG V            A+ +  D  VA+K++  +  +    +  ELR
Sbjct: 9   KEIEVEEVVGRGAFGVV----------CKAKWRAKD--VAIKQIESESER--KAFIVELR 54
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-EDDTELNWERRIKIALGA 248
            LSR+NHPN+VKL G C +     LV EY   GSL + L   E          +   L  
Sbjct: 55  QLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 112
Query: 249 ARGLEHLHTYW-RPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTRVLGT 306
           ++G+ +LH+   + +IHRD+K  N+LL       KI DFG A       ++H+ T   G+
Sbjct: 113 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHM-TNNKGS 167
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             + APE     + + K DV+S+G++L E+++ +    +  + + G    P      A+H
Sbjct: 168 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR----KPFDEIGG----PAFRIMWAVH 219
Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
                 L +N+     +    ++ RC + DP  RP+M E+V  +  L
Sbjct: 220 NGTRPPLIKNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 262

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 140/298 (46%), Gaps = 33/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E A  K +    +GQG FG VY G           +   +  VA+K +    S  +  E+
Sbjct: 43  EVAREKITMSRELGQGSFGMVYEGVAKGVV-----KDEPETRVAIKTVNEAASMRERIEF 97
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTEL--- 236
            NE   +   N  +VV+L+G     Q  L++ E +TRG L+ +L +     E++  L   
Sbjct: 98  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 157
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
           +  + I++A   A G+ +L+      +HRD+ A N ++ +DF  KI DFG+ +     D 
Sbjct: 158 SLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 215
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + +PE +  G  T  +DV+SFGVVL EI +           LA    +
Sbjct: 216 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LA---EQ 261
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           PY  LSN+  L  +++  L           F E++  C   +PK RP+  E+++++++
Sbjct: 262 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSIKE 318

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 135/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 193 LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGNMSPEAFLQEAQVMKKLRHE 240
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++  
Sbjct: 241 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 299
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGL +   + D  + + +  G +    + APE 
Sbjct: 300 --MNYVHRDLRAANILVGENLVCKVADFGLGRL--IEDNEYTARQ--GAKFPIKWTAPEA 353
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 354 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 396
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   DP+ RPT   + A LE
Sbjct: 397 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 17/212 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG V++GY            N D  VA+K +R +G+  ++++  E   + +L+HP
Sbjct: 16  IGSGQFGLVHLGY----------WLNKD-KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 63
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C +     LV E++  G L D+L  +       E  + + L    G+ +L  
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEE 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               VIHRD+ A N L+ ++   K+SDFG+ +F  L D+   ST       + +PE  + 
Sbjct: 123 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSF 179
Query: 318 GHLTLKTDVYSFGVVLLEILS-GKTAAMRRTN 348
              + K+DV+SFGV++ E+ S GK     R+N
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 131/277 (47%), Gaps = 41/277 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG+V++   N               VAVK ++  GS   + +  E   +  L H 
Sbjct: 190 LGAGQFGEVWMATYNKHT-----------KVAVKTMK-PGSMSVEAFLAEANVMKTLQHD 237
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +VKL      +   ++  E++ +GSL D L +++ ++    + I  +   A G+  +  
Sbjct: 238 KLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 296
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             R  IHRD++A+N+L+      KI+DFGLA+   +G K  I         + APE I  
Sbjct: 297 --RNYIHRDLRAANILVSASLVCKIADFGLAR---VGAKFPIK--------WTAPEAINF 343
Query: 318 GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNI 377
           G  T+K+DV+SFG++L+EI++             G    P +SN   +  +  E+  R  
Sbjct: 344 GSFTIKSDVWSFGILLMEIVT------------YGRIPYPGMSNPEVIRAL--ERGYRMP 389
Query: 378 QMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           + E   +E   I++RC  + P+ RPT   + + L+  
Sbjct: 390 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 426

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 141/291 (48%), Gaps = 31/291 (10%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSR 193
           + +IG G FG+V  G++        +R   +  VA+K L+   ++ Q  ++ +E   + +
Sbjct: 38  EQVIGAGEFGEVCSGHLK----LPGKR---EIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 90
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
            +HPNV+ L G        +++ E++  GSL D  L ++D +    + + +  G A G++
Sbjct: 91  FDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMK 149
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYF 310
           +L       +HRD+ A N+L++ +   K+SDFGL++F          T  LG +    + 
Sbjct: 150 YLADM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALHQI 368
           APE I     T  +DV+S+G+V+ E++S                 +PY  ++N+  ++  
Sbjct: 208 APEAIQYRKFTSASDVWSYGIVMWEVMSYG--------------ERPYWDMTNQDVINA- 252
Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           I++       M+      +++L C   D  +RP   ++V  L+++  N  S
Sbjct: 253 IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 303

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 143/305 (46%), Gaps = 33/305 (10%)
Query: 131 KFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +F E++L     +G+G FG V +     C     +  N    VAVK+L+    +   ++E
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFE 90
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            E+  L  L H N+VK  G C     R   L+ EY+  GSL D+L    +  ++  + ++
Sbjct: 91  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQ 149
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
                 +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK     + 
Sbjct: 150 YTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKE 206
Query: 304 LGTRGYF--APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            G    F  APE +     ++ +DV+SFGVVL E+ +     + ++      + +   ++
Sbjct: 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 262
Query: 362 K----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   ++Q+
Sbjct: 263 KQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
Query: 414 QLNMG 418
           +  M 
Sbjct: 321 RDQMA 325

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 136/290 (46%), Gaps = 38/290 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG+V++GY N+              VAVK L+  G+     +  E   +  L H 
Sbjct: 20  LGAGQFGEVWMGYYNNST-----------KVAVKTLK-PGTMSVQAFLEEANLMKTLQHD 67
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   ++ E++ +GSL D L +++  ++   + I  +   A G+ ++  
Sbjct: 68  KLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 127
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
             +  IHRD++A+NVL+ +    KI+DFGLA+   + D  + +    G +    + APE 
Sbjct: 128 --KNYIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTARE--GAKFPIKWTAPEA 181
Query: 315 IATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL 373
           I  G  T+K++V+SFG++L EI++ GK     RTN    +          AL Q      
Sbjct: 182 INFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMS----------ALSQGY---- 227
Query: 374 GRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
            R  +ME    E  +I+  C     + RPT   + + L+         YQ
Sbjct: 228 -RMPRMENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATEGQYQ 276

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 135/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 23  LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 70
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+ +GSL D L  E    L   + + ++   A G+ ++  
Sbjct: 71  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER 129
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   + D  + + +  G +    + APE 
Sbjct: 130 --MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 183
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 226
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   +P+ RPT   + A LE
Sbjct: 227 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 137/292 (46%), Gaps = 34/292 (11%)
Query: 128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWEN 186
           A+R   EK +IG G  G+V  G +             D  VA+K L+   ++ Q  ++ +
Sbjct: 48  ASRIHIEK-IIGSGDSGEVCYGRLRVPG-------QRDVPVAIKALKAGYTERQRRDFLS 99
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           E   + + +HPN+++L G     +  ++V EY+  GSL D  L   D +    + + +  
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLR 158
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
           G   G+ +L       +HRD+ A NVL+D +   K+SDFGL++   L D    +    G 
Sbjct: 159 GVGAGMRYLSDL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGG 214
Query: 307 R---GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSN 361
           +    + APE IA    +  +DV+SFGVV+ E+L+                 +PY  ++N
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE--------------RPYWNMTN 260
Query: 362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  +   ++E       M       +++L C + D   RP  S++V+ L+ L
Sbjct: 261 RDVISS-VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 137/287 (47%), Gaps = 36/287 (12%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           ++   + ++G+G FG V            A+ +  D  VA+K++  +  +    +  ELR
Sbjct: 8   KEIEVEEVVGRGAFGVV----------CKAKWRAKD--VAIKQIESESER--KAFIVELR 53
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-EDDTELNWERRIKIALGA 248
            LSR+NHPN+VKL G C +     LV EY   GSL + L   E          +   L  
Sbjct: 54  QLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 249 ARGLEHLHTYW-RPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTRVLGT 306
           ++G+ +LH+   + +IHRD+K  N+LL       KI DFG A       ++H+ T   G+
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHM-TNNKGS 166
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             + APE     + + K DV+S+G++L E+++ +    +  + + G    P      A+H
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR----KPFDEIGG----PAFRIMWAVH 218
Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
                 L +N+     +    ++ RC + DP  RP+M E+V  +  L
Sbjct: 219 NGTRPPLIKNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/296 (27%), Positives = 134/296 (45%), Gaps = 29/296 (9%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E A  K +    +GQG FG VY G           +   +  VA+K +    S  +  E+
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVV-----KDEPETRVAIKTVNEAASMRERIEF 75
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELN------- 237
            NE   +   N  +VV+L+G     Q  L++ E +TRG L+ +L +      N       
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 238 -WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
              + I++A   A G+ +L+      +HRD+ A N ++ +DF  KI DFG+ +     D 
Sbjct: 136 SLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + +PE +  G  T  +DV+SFGVVL EI    T A +   G       
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---ATLAEQPYQG------- 243
Query: 357 PYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
             LSN+  L  +++  L           F E++  C   +PK RP+  E+++++++
Sbjct: 244 --LSNEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSIKE 296

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 144/305 (47%), Gaps = 33/305 (10%)
Query: 131 KFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +F E++L     +G+G FG V +     C     +  N    VAVK+L+    +   ++E
Sbjct: 9   QFEERHLKFLRQLGKGNFGSVEM-----CRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFE 62
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            E+  L  L H N+VK  G C     R   L+ E++  GSL ++ L +    ++  + ++
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREY-LQKHKERIDHIKLLQ 121
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
                 +G+E+L T  +  IHRD+   N+L++++   KI DFGL K  P  DK     + 
Sbjct: 122 YTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKE 178
Query: 304 LGTRGYF--APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            G    F  APE +     ++ +DV+SFGVVL E+ +     + ++      + +   ++
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 234
Query: 362 K----LALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K    +  H I  E L  N ++        E   I+  C N++   RP+  ++   ++Q+
Sbjct: 235 KQGQMIVFHLI--ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292
Query: 414 QLNMG 418
           + NM 
Sbjct: 293 RDNMA 297

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 136/298 (45%), Gaps = 33/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E A  K +    +GQG FG VY G           +   +  VA+K +    S  +  E+
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVV-----KDEPETRVAIKTVNEAASMRERIEF 65
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELN------- 237
            NE   +   N  +VV+L+G     Q  L++ E +TRG L+ +L +      N       
Sbjct: 66  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 125
Query: 238 -WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
              + I++A   A G+ +L+      +HRD+ A N ++ +DF  KI DFG+ +     D 
Sbjct: 126 SLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 183
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + +PE +  G  T  +DV+SFGVVL EI +           LA    +
Sbjct: 184 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LA---EQ 229
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           PY  LSN+  L  +++  L           F E++  C   +PK RP+  E+++++++
Sbjct: 230 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSIKE 286

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 140/291 (48%), Gaps = 31/291 (10%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSR 193
           + +IG G FG+V  G +      A  +K +   VA+K L+   ++ Q  E+ +E   + +
Sbjct: 21  EEVIGAGEFGEVCRGRLK-----APGKKES--CVAIKTLKGGYTERQRREFLSEASIMGQ 73
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
             HPN+++L G   +    +++ E++  G+L D  L  +D +    + + +  G A G+ 
Sbjct: 74  FEHPNIIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLVGMLRGIASGMR 132
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYF 310
           +L       +HRD+ A N+L++ +   K+SDFGL++F          T  LG +    + 
Sbjct: 133 YLAEM--SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALHQI 368
           APE IA    T  +D +S+G+V+ E++S                 +PY  +SN+  ++  
Sbjct: 191 APEAIAFRKFTSASDAWSYGIVMWEVMSFGE--------------RPYWDMSNQDVINA- 235
Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           I++        +      +++L C   D   RP   +VV+AL+++  N  S
Sbjct: 236 IEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPAS 286

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 139/299 (46%), Gaps = 34/299 (11%)
Query: 132 FSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN 186
           F E++L     +G+G FG V +   +          N    VAVK+L+  G   Q +++ 
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLG------DNTGALVAVKQLQHSGPDQQRDFQR 57
Query: 187 ELRFLSRLNHPNVVKLMG--YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
           E++ L  L+   +VK  G  Y        LV EY+  G L D  L      L+  R +  
Sbjct: 58  EIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRD-FLQRHRARLDASRLLLY 116
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           +    +G+E+L +  R  +HRD+ A N+L++ + + KI+DFGLAK  PL DK     R  
Sbjct: 117 SSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDXXVVREP 173
Query: 305 GTRG--YFAPEYIATGHLTLKTDVYSFGVVLLEILS------GKTAAMRRTNGLAGNWAK 356
           G     ++APE ++    + ++DV+SFGVVL E+ +        +A   R  G   +   
Sbjct: 174 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD--V 231
Query: 357 PYLSNKLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           P L   L        + G+ +    A   E  E++  C    P++RP+ S +   L+ L
Sbjct: 232 PALCRLLE-----LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 285

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 134/281 (47%), Gaps = 37/281 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG+V++   N               VAVK ++  GS   + +  E   +  L H 
Sbjct: 23  LGAGQFGEVWMATYNKHT-----------KVAVKTMK-PGSMSVEAFLAEANVMKTLQHD 70
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +VKL       +   ++ E++ +GSL D L +++ ++    + I  +   A G+  +  
Sbjct: 71  KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 129
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
             R  IHRD++A+N+L+      KI+DFGLA+   + D  + +    G +    + APE 
Sbjct: 130 --RNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTARE--GAKFPIKWTAPEA 183
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           I  G  T+K+DV+SFG++L+EI++             G    P +SN   +  +  E+  
Sbjct: 184 INFGSFTIKSDVWSFGILLMEIVT------------YGRIPYPGMSNPEVIRAL--ERGY 229
Query: 375 RNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           R  + E   +E   I++RC  + P+ RPT   + + L+  +
Sbjct: 230 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFE 270

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 140/291 (48%), Gaps = 31/291 (10%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSR 193
           + +IG G FG+V  G +      A  +K +   VA+K L+   ++ Q  E+ +E   + +
Sbjct: 19  EEVIGAGEFGEVCRGRLK-----APGKKES--CVAIKTLKGGYTERQRREFLSEASIMGQ 71
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
             HPN+++L G   +    +++ E++  G+L D  L  +D +    + + +  G A G+ 
Sbjct: 72  FEHPNIIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLVGMLRGIASGMR 130
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYF 310
           +L       +HRD+ A N+L++ +   K+SDFGL++F          T  LG +    + 
Sbjct: 131 YLAEM--SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALHQI 368
           APE IA    T  +D +S+G+V+ E++S                 +PY  +SN+  ++  
Sbjct: 189 APEAIAFRKFTSASDAWSYGIVMWEVMSFGE--------------RPYWDMSNQDVINA- 233
Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           I++        +      +++L C   D   RP   +VV+AL+++  N  S
Sbjct: 234 IEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPAS 284

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 142/302 (47%), Gaps = 41/302 (13%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EW 184
           E A  K +    +GQG FG VY G           +   +  VA+K +    S  +  E+
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVV-----KDEPETRVAIKTVNEAASMRERIEF 62
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTEL--- 236
            NE   +   N  +VV+L+G     Q  L++ E +TRG L+ +L +     E++  L   
Sbjct: 63  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
           +  + I++A   A G+ +L+      +HRD+ A N  + +DF  KI DFG+ +     D 
Sbjct: 123 SLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDY 180
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + +PE +  G  T  +DV+SFGVVL EI +           LA    +
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LA---EQ 226
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILR----CLNSDPKNRPTMSEVVAAL 410
           PY  LSN+  L  +++  L     +++     +++L     C   +PK RP+  E+++++
Sbjct: 227 PYQGLSNEQVLRFVMEGGL-----LDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSI 281
Query: 411 EQ 412
           ++
Sbjct: 282 KE 283

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 135/281 (48%), Gaps = 43/281 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L H 
Sbjct: 23  LGQGCFGEVWMGTWNGTT-----------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 70
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L      ++   +V EY+ +GSL D L  E    L   + + ++   A G+ ++  
Sbjct: 71  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER 129
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
                +HRD++A+N+L+ ++   K++DFGLA+   L + +  + R  G +    + APE 
Sbjct: 130 M--NYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEWTARQ-GAKFPIKWTAPEA 183
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
              G  T+K+DV+SFG++L E+ +             G    P + N+  L Q+      
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTT------------KGRVPYPGMVNREVLDQV-----E 226
Query: 375 RNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
           R  +M    E  +   +++ +C   +P+ RPT   + A LE
Sbjct: 227 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 137/301 (45%), Gaps = 57/301 (18%)
Query: 123 GLLEAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----R 172
           G +E+  R+++ ++      +G+G FG+VY+          AR K + F +A+K     +
Sbjct: 1   GAMESKKRQWALEDFEIGRPLGKGKFGNVYL----------AREKQSKFILALKVLFKAQ 50
Query: 173 LRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED 232
           L + G + Q   E E++  S L HPN+++L GY  D     L+ EY  RG +   L  + 
Sbjct: 51  LEKAGVEHQLRREVEIQ--SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QK 106
Query: 233 DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP 292
            ++ + +R        A  L + H+  + VIHRD+K  N+LL      KI+DFG +   P
Sbjct: 107 LSKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG 352
              +  +     GT  Y  PE I       K D++S GV+  E L GK            
Sbjct: 165 SSRRXXLX----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP----------- 209
Query: 353 NWAKPYLSNKLALHQIIDEKLGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
               P+ +N    +Q   +++ R      +   E A+   ++I R L  +P  RP + EV
Sbjct: 210 ----PFEANT---YQETYKRISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREV 259
Query: 407 V 407
           +
Sbjct: 260 L 260

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 131/284 (46%), Gaps = 33/284 (11%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 96  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 148
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G++ 
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKF 207
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK--FGPLGDKSHISTRVLGTRGYFAP 312
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+  +    D  H  T       + A 
Sbjct: 208 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQIIDE 371
           E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   + +
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYLLQ 311
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 312 --GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 131/284 (46%), Gaps = 33/284 (11%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 42  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 94
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G++ 
Sbjct: 95  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKF 153
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK--FGPLGDKSHISTRVLGTRGYFAP 312
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+  +    D  H  T       + A 
Sbjct: 154 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 211
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQIIDE 371
           E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   + +
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYLLQ 257
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 258 --GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 135/286 (47%), Gaps = 37/286 (12%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 56  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 108
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G+++
Sbjct: 109 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKY 167
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-VLGTR---GYF 310
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+   + DK + S     G +    + 
Sbjct: 168 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 223
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQII 369
           A E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   +
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYL 269
Query: 370 DEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            +  GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 270 LQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 129/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR KN+ F +A+K     +L + G + Q   E E++  S
Sbjct: 16  LGKGKFGNVYL----------AREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 63
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P   ++ +     GT  Y  P
Sbjct: 122 SYCHS--KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPP 175
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQDTYKR 217
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 218 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 255

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 135/286 (47%), Gaps = 37/286 (12%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 29  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 81
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G+++
Sbjct: 82  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKY 140
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-VLGTR---GYF 310
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+   + DK + S     G +    + 
Sbjct: 141 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 196
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQII 369
           A E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   +
Sbjct: 197 ALESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYL 242
Query: 370 DEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            +  GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 243 LQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 138/301 (45%), Gaps = 57/301 (18%)
Query: 123 GLLEAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----R 172
           G +E+  R+++ ++      +G+G FG+VY+          AR K + F +A+K     +
Sbjct: 1   GAMESKKRQWALEDFEIGRPLGKGKFGNVYL----------AREKQSKFILALKVLFKAQ 50
Query: 173 LRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED 232
           L + G + Q   E E++  S L HPN+++L GY  D     L+ EY   G++   L  + 
Sbjct: 51  LEKAGVEHQLRREVEIQ--SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QK 106
Query: 233 DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP 292
            ++ + +R        A  L + H+  + VIHRD+K  N+LL      KI+DFG +   P
Sbjct: 107 LSKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG 352
               S   T + GT  Y  PE I       K D++S GV+  E L GK            
Sbjct: 165 ----SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP----------- 209
Query: 353 NWAKPYLSNKLALHQIIDEKLGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
               P+ +N    +Q   +++ R      +   E A+   ++I R L  +P  RP + EV
Sbjct: 210 ----PFEANT---YQETYKRISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREV 259
Query: 407 V 407
           +
Sbjct: 260 L 260

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 131/284 (46%), Gaps = 33/284 (11%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 37  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G++ 
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKF 148
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK--FGPLGDKSHISTRVLGTRGYFAP 312
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+  +    D  H  T       + A 
Sbjct: 149 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQIIDE 371
           E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   + +
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYLLQ 252
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 253 --GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 131/284 (46%), Gaps = 33/284 (11%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 35  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 87
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G++ 
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKF 146
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK--FGPLGDKSHISTRVLGTRGYFAP 312
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+  +    D  H  T       + A 
Sbjct: 147 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 204
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQIIDE 371
           E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   + +
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYLLQ 250
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 251 --GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 133/280 (47%), Gaps = 37/280 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG+V++   N               VAVK ++  GS   + +  E   +  L H 
Sbjct: 196 LGAGQFGEVWMATYNKHT-----------KVAVKTMK-PGSMSVEAFLAEANVMKTLQHD 243
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +VKL      +   ++  E++ +GSL D L +++ ++    + I  +   A G+  +  
Sbjct: 244 KLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAPEY 314
             R  IHRD++A+N+L+      KI+DFGLA+   + D  + +    G +    + APE 
Sbjct: 303 --RNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTARE--GAKFPIKWTAPEA 356
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
           I  G  T+K+DV+SFG++L+EI++             G    P +SN   +  +  E+  
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVT------------YGRIPYPGMSNPEVIRAL--ERGY 402
Query: 375 RNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           R  + E   +E   I++RC  + P+ RPT   + + L+  
Sbjct: 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 135/286 (47%), Gaps = 37/286 (12%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 34  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 86
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G+++
Sbjct: 87  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKY 145
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-VLGTR---GYF 310
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+   + DK + S     G +    + 
Sbjct: 146 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 201
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQII 369
           A E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   +
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYL 247
Query: 370 DEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            +  GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 248 LQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 131/284 (46%), Gaps = 33/284 (11%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 37  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G++ 
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKF 148
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK--FGPLGDKSHISTRVLGTRGYFAP 312
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+  +    D  H  T       + A 
Sbjct: 149 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQIIDE 371
           E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   + +
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYLLQ 252
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 253 --GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 135/286 (47%), Gaps = 37/286 (12%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 37  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G+++
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKY 148
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-VLGTR---GYF 310
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+   + DK + S     G +    + 
Sbjct: 149 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 204
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQII 369
           A E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   +
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYL 250
Query: 370 DEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            +  GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 251 LQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 131/284 (46%), Gaps = 33/284 (11%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 38  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 90
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G++ 
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKF 149
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK--FGPLGDKSHISTRVLGTRGYFAP 312
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+  +    D  H  T       + A 
Sbjct: 150 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 207
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQIIDE 371
           E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   + +
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYLLQ 253
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 254 --GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 135/286 (47%), Gaps = 37/286 (12%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 37  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G+++
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKY 148
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-VLGTR---GYF 310
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+   + DK + S     G +    + 
Sbjct: 149 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 204
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQII 369
           A E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   +
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYL 250
Query: 370 DEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            +  GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 251 LQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 135/286 (47%), Gaps = 37/286 (12%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 36  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 88
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G+++
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKY 147
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-VLGTR---GYF 310
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+   + DK + S     G +    + 
Sbjct: 148 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 203
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQII 369
           A E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   +
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYL 249
Query: 370 DEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            +  GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 250 LQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 135/286 (47%), Gaps = 37/286 (12%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 32  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 84
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G+++
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKY 143
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-VLGTR---GYF 310
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+   + DK + S     G +    + 
Sbjct: 144 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 199
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQII 369
           A E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   +
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYL 245
Query: 370 DEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            +  GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 246 LQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 135/286 (47%), Gaps = 37/286 (12%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 55  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 107
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G+++
Sbjct: 108 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKY 166
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-VLGTR---GYF 310
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+   + DK + S     G +    + 
Sbjct: 167 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 222
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQII 369
           A E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   +
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYL 268
Query: 370 DEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            +  GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 269 LQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 135/286 (47%), Gaps = 37/286 (12%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 35  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 87
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G+++
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKY 146
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-VLGTR---GYF 310
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+   + DK + S     G +    + 
Sbjct: 147 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 202
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQII 369
           A E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   +
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYL 248
Query: 370 DEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            +  GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 249 LQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 144/301 (47%), Gaps = 54/301 (17%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSR 193
           +++IG+G FG V    I        ++       A+KR++   S+    ++  EL  L +
Sbjct: 30  QDVIGEGNFGQVLKARI--------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 81
Query: 194 L-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--------------LNEDDTELNW 238
           L +HPN++ L+G C    +  L  EY   G+L D L               N   + L+ 
Sbjct: 82  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 239 ERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSH 298
           ++ +  A   ARG+++L    +  IHRD+ A N+L+ +++ AKI+DFGL++    G + +
Sbjct: 142 QQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY 195
Query: 299 ISTRV--LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
           +   +  L  R + A E +     T  +DV+S+GV+L EI+S           L G    
Sbjct: 196 VKKTMGRLPVR-WMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----------LGGT--- 240
Query: 357 PYLSNKLALHQIIDEKLGRNIQMEEA----QEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           PY     A    + EKL +  ++E+      E  +++ +C    P  RP+ ++++ +L +
Sbjct: 241 PYCGMTCAE---LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297
Query: 413 L 413
           +
Sbjct: 298 M 298

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 144/301 (47%), Gaps = 54/301 (17%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSR 193
           +++IG+G FG V    I        ++       A+KR++   S+    ++  EL  L +
Sbjct: 20  QDVIGEGNFGQVLKARI--------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 71
Query: 194 L-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--------------LNEDDTELNW 238
           L +HPN++ L+G C    +  L  EY   G+L D L               N   + L+ 
Sbjct: 72  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 131
Query: 239 ERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSH 298
           ++ +  A   ARG+++L    +  IHRD+ A N+L+ +++ AKI+DFGL++    G + +
Sbjct: 132 QQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY 185
Query: 299 ISTRV--LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
           +   +  L  R + A E +     T  +DV+S+GV+L EI+S           L G    
Sbjct: 186 VKKTMGRLPVR-WMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----------LGGT--- 230
Query: 357 PYLSNKLALHQIIDEKLGRNIQMEEA----QEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           PY     A    + EKL +  ++E+      E  +++ +C    P  RP+ ++++ +L +
Sbjct: 231 PYCGMTCAE---LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 287
Query: 413 L 413
           +
Sbjct: 288 M 288

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 137/286 (47%), Gaps = 33/286 (11%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSRLN 195
           +IG G FG+V       C+         +  VA+K L+   ++ Q  ++  E   + + +
Sbjct: 29  VIGAGEFGEV-------CSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFD 81
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HPN++ L G     +  ++V EY+  GSL D  L ++D +    + + +  G + G+++L
Sbjct: 82  HPNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISAGMKYL 140
Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAP 312
                  +HRD+ A N+L++ +   K+SDFGL++   L D    +    G +    + AP
Sbjct: 141 SDM--GYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAP 196
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALHQIID 370
           E IA    T  +DV+S+G+V+ E++S                 +PY  ++N+  + + ++
Sbjct: 197 EAIAFRKFTSASDVWSYGIVMWEVVSYG--------------ERPYWEMTNQDVI-KAVE 241
Query: 371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN 416
           E       M+      +++L C   +  +RP   E+V  L++L  N
Sbjct: 242 EGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRN 287

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 133/286 (46%), Gaps = 37/286 (12%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 36  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 88
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G+++
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKY 147
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS----HISTRVLGTRGYF 310
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+   + DK     H  T       + 
Sbjct: 148 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEXXSVHNKTGAKLPVKWM 203
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQII 369
           A E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   +
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYL 249
Query: 370 DEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            +  GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 250 LQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 140/291 (48%), Gaps = 31/291 (10%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSR 193
           + +IG G FG+V  G++        +R   +  VA+K L+   ++ Q  ++ +E   + +
Sbjct: 12  EQVIGAGEFGEVCSGHLK----LPGKR---EIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 64
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
            +HPNV+ L G        +++ E++  GSL D  L ++D +    + + +  G A G++
Sbjct: 65  FDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMK 123
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYF 310
           +L       +HR + A N+L++ +   K+SDFGL++F          T  LG +    + 
Sbjct: 124 YLADM--NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALHQI 368
           APE I     T  +DV+S+G+V+ E++S                 +PY  ++N+  ++  
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYG--------------ERPYWDMTNQDVINA- 226
Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           I++       M+      +++L C   D  +RP   ++V  L+++  N  S
Sbjct: 227 IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 277

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 42  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 89
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 147
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 148 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 201
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 243
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 244 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 281

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 135/304 (44%), Gaps = 56/304 (18%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRL- 194
           ++G G FG V    +N+ A   ++       VAVK L+ K    + E   +EL+ +++L 
Sbjct: 52  VLGSGAFGKV----MNATAYGISK-TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 106
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL------LNEDDTE------------- 235
           +H N+V L+G C       L++EY   G L ++L       +ED+ E             
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 236 --LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
             L +E  +  A   A+G+E L   ++  +HRD+ A NVL+      KI DFGLA+   +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLAR-DIM 223
Query: 294 GDKSHISTRVLGTRG-------YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRR 346
            D +++       RG       + APE +  G  T+K+DV+S+G++L EI S        
Sbjct: 224 SDSNYV------VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS-------- 269
Query: 347 TNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                G    P +      +++I      +      +E   I+  C   D + RP+   +
Sbjct: 270 ----LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325
Query: 407 VAAL 410
            + L
Sbjct: 326 TSFL 329

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 16  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 63
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 122 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTELCGTLDYLPP 175
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 217
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 218 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 255

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 33  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 80
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 138
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 139 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 192
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 234
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 235 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 272

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 19  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 66
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 125 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 178
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 220
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 221 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 258

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 129/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 17  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 64
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 122
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P   ++ +S    GT  Y  P
Sbjct: 123 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLDYLPP 176
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 218
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 219 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 256

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 87/298 (29%), Positives = 133/298 (44%), Gaps = 35/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEW 184
           E +  K +    +GQG FG VY G           +  A+  VAVK +    S + + E+
Sbjct: 10  EVSREKITLLRELGQGSFGMVYEGNARDII-----KGEAETRVAVKTVNESASLRERIEF 64
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------NEDDTEL 236
            NE   +      +VV+L+G     Q  L+V E +  G L+ +L         N      
Sbjct: 65  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 124
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
             +  I++A   A G+ +L+   +  +HRD+ A N ++  DF  KI DFG+ +     D 
Sbjct: 125 TLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX 182
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + APE +  G  T  +D++SFGVVL EI S           LA    +
Sbjct: 183 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LA---EQ 228
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILR-CLNSDPKNRPTMSEVVAALE 411
           PY  LSN+  L  ++D   G   Q +   E    ++R C   +PK RPT  E+V  L+
Sbjct: 229 PYQGLSNEQVLKFVMDG--GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNH 196
           +G+G FG V      S              VAVK L+   G Q +  W+ E+  L  L H
Sbjct: 22  LGEGHFGKV------SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYH 75
Query: 197 PNVVKLMGYCCDDQHR---LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
            +++K  G CC+DQ      LV EYV  GSL D+L       +   + +  A     G+ 
Sbjct: 76  EHIIKYKG-CCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMA 131
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG--YFA 311
           +LH+  +  IHR++ A NVLLD+D   KI DFGLAK  P G + +   R  G     ++A
Sbjct: 132 YLHS--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYA 188
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILS 338
           PE +        +DV+SFGV L E+L+
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 87/298 (29%), Positives = 133/298 (44%), Gaps = 35/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEW 184
           E +  K +    +GQG FG VY G           +  A+  VAVK +    S + + E+
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDII-----KGEAETRVAVKTVNESASLRERIEF 67
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------NEDDTEL 236
            NE   +      +VV+L+G     Q  L+V E +  G L+ +L         N      
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
             +  I++A   A G+ +L+   +  +HRD+ A N ++  DF  KI DFG+ +     D 
Sbjct: 128 TLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX 185
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + APE +  G  T  +D++SFGVVL EI S           LA    +
Sbjct: 186 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LA---EQ 231
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILR-CLNSDPKNRPTMSEVVAALE 411
           PY  LSN+  L  ++D   G   Q +   E    ++R C   +PK RPT  E+V  L+
Sbjct: 232 PYQGLSNEQVLKFVMDG--GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 21  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 68
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 126
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 127 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 180
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 222
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 223 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPXLREVL 260

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 16  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 63
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 122 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 175
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 217
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 218 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 255

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 130/284 (45%), Gaps = 33/284 (11%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN 195
           +IG+G FG VY G       T           AVK L R    G+  ++  E   +   +
Sbjct: 38  VIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 90
Query: 196 HPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G++ 
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKF 149
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK--FGPLGDKSHISTRVLGTRGYFAP 312
           L +  +  +HRD+ A N +LD+ F  K++DFGLA+       D  H  T       + A 
Sbjct: 150 LAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMAL 207
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQIIDE 371
           E + T   T K+DV+SFGV+L E++         T G     A PY   N   +   + +
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELM---------TRG-----APPYPDVNTFDITVYLLQ 253
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 254 --GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 21  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 68
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 126
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 127 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPP 180
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 222
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 223 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 260

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 17  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 64
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 122
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 123 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPP 176
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 218
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 219 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 256

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 16  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 63
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 122 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTXLCGTLDYLPP 175
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 217
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 218 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 255

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 16  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 63
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 122 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPP 175
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 217
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 218 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 255

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 90/334 (26%), Positives = 147/334 (44%), Gaps = 76/334 (22%)
Query: 124 LLEAATRKFSEKNLI-----GQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS 178
           +LE    +F  KNL+     G+G FG V    + + A     R      VAVK L+   S
Sbjct: 12  ILEDPKWEFPRKNLVLGKTLGEGEFGKV----VKATAFHLKGRAGYT-TVAVKMLKENAS 66
Query: 179 QGQ-DEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL-------- 229
             +  +  +E   L ++NHP+V+KL G C  D   LL+ EY   GSL   L         
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 230 --------------NEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD 275
                         + D+  L     I  A   ++G+++L      ++HRD+ A N+L+ 
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM--SLVHRDLAARNILVA 184
Query: 276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-----TLKTDVYSFG 330
           +    KISDFGL++     D     + V  ++G    +++A   L     T ++DV+SFG
Sbjct: 185 EGRKMKISDFGLSR-----DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239
Query: 331 VVLLEILSGKTAAMRRTNGLAGNWAKPY-------LSNKLALHQIIDEKLGRNIQMEE-- 381
           V+L EI++           L GN   PY       L N L        K G  ++  +  
Sbjct: 240 VLLWEIVT-----------LGGN---PYPGIPPERLFNLL--------KTGHRMERPDNC 277
Query: 382 AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL 415
           ++E   ++L+C   +P  RP  +++   LE++ +
Sbjct: 278 SEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNH 196
           +G+G FG V      S              VAVK L+   G Q +  W+ E+  L  L H
Sbjct: 22  LGEGHFGKV------SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYH 75
Query: 197 PNVVKLMGYCCDDQHR---LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
            +++K  G CC+DQ      LV EYV  GSL D+L       +   + +  A     G+ 
Sbjct: 76  EHIIKYKG-CCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMA 131
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG--YFA 311
           +LH   +  IHR++ A NVLLD+D   KI DFGLAK  P G + +   R  G     ++A
Sbjct: 132 YLHA--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYA 188
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILS 338
           PE +        +DV+SFGV L E+L+
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNH 196
           +G+G FG V      S              VAVK L+   G Q +  W+ E+  L  L H
Sbjct: 16  LGEGHFGKV------SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYH 69
Query: 197 PNVVKLMGYCCDDQHR---LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
            ++VK  G CC+DQ      LV EYV  GSL D+L       +   + +  A     G+ 
Sbjct: 70  EHIVKYKG-CCEDQGEKSVQLVMEYVPLGSLRDYLPRHC---VGLAQLLLFAQQICEGMA 125
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG--YFA 311
           +LH   +  IHR + A NVLLD+D   KI DFGLAK  P G + +   R  G     ++A
Sbjct: 126 YLHA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYA 182
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEIL----SGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
           PE +        +DV+SFGV L E+L    S ++   + T  +     +      L L +
Sbjct: 183 PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQ---MTVLRLTE 239
Query: 368 IID--EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           +++  E+L R  +     E   ++  C  ++   RPT   +V  L+  Q
Sbjct: 240 LLERGERLPRPDRC--PCEIYHLMKNCWETEASFRPTFQNLVPILQTAQ 286

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 19  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 66
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 125 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 178
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 220
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 221 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 258

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNH 196
           +G+G FG V      S              VAVK L+   G Q +  W+ E+  L  L H
Sbjct: 17  LGEGHFGKV------SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYH 70
Query: 197 PNVVKLMGYCCDDQHR---LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
            ++VK  G CC+DQ      LV EYV  GSL D+L       +   + +  A     G+ 
Sbjct: 71  EHIVKYKG-CCEDQGEKSVQLVMEYVPLGSLRDYLPRHC---VGLAQLLLFAQQICEGMA 126
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG--YFA 311
           +LH   +  IHR + A NVLLD+D   KI DFGLAK  P G + +   R  G     ++A
Sbjct: 127 YLHA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYA 183
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEIL----SGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
           PE +        +DV+SFGV L E+L    S ++   + T  +     +      L L +
Sbjct: 184 PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQ---MTVLRLTE 240
Query: 368 IID--EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           +++  E+L R  +     E   ++  C  ++   RPT   +V  L+  Q
Sbjct: 241 LLERGERLPRPDRC--PCEIYHLMKNCWETEASFRPTFQNLVPILQTAQ 287

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 15  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 62
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 120
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 121 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 174
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 216
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 217 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 254

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 90/335 (26%), Positives = 147/335 (43%), Gaps = 76/335 (22%)
Query: 124 LLEAATRKFSEKNLI-----GQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS 178
           +LE    +F  KNL+     G+G FG V    + + A     R      VAVK L+   S
Sbjct: 12  ILEDPKWEFPRKNLVLGKTLGEGEFGKV----VKATAFHLKGRAGYT-TVAVKMLKENAS 66
Query: 179 QGQ-DEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL-------- 229
             +  +  +E   L ++NHP+V+KL G C  D   LL+ EY   GSL   L         
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 230 --------------NEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD 275
                         + D+  L     I  A   ++G+++L      ++HRD+ A N+L+ 
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM--KLVHRDLAARNILVA 184
Query: 276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-----TLKTDVYSFG 330
           +    KISDFGL++     D     + V  ++G    +++A   L     T ++DV+SFG
Sbjct: 185 EGRKMKISDFGLSR-----DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239
Query: 331 VVLLEILSGKTAAMRRTNGLAGNWAKPY-------LSNKLALHQIIDEKLGRNIQMEE-- 381
           V+L EI++           L GN   PY       L N L        K G  ++  +  
Sbjct: 240 VLLWEIVT-----------LGGN---PYPGIPPERLFNLL--------KTGHRMERPDNC 277
Query: 382 AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN 416
           ++E   ++L+C   +P  RP  +++   LE++ + 
Sbjct: 278 SEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 20  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 67
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 125
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 126 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 179
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 221
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 222 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 259

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 129/277 (46%), Gaps = 32/277 (11%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQDEWENELRF 190
           F++ + IG+G FG+VY G  N          +    VA+K +   +     ++ + E+  
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDN----------HTKEVVAIKIIDLEEAEDEIEDIQQEITV 70
Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           LS+ + P + +  G         ++ EY+  GS  D LL     E  +   I   +   +
Sbjct: 71  LSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREI--LK 127
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GL++LH+  +  IHRD+KA+NVLL +  + K++DFG+A  G L D        +GT  + 
Sbjct: 128 GLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFVGTPFWM 183
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           APE I       K D++S G+  +E+  G+                    + + +  +I 
Sbjct: 184 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL--------------HPMRVLFLIP 229
Query: 371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           +     ++ + ++ F E +  CLN DP+ RPT  E++
Sbjct: 230 KNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELL 266

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 16  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 63
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 122 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPP 175
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 217
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 218 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 255

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 90/335 (26%), Positives = 147/335 (43%), Gaps = 76/335 (22%)
Query: 124 LLEAATRKFSEKNLI-----GQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS 178
           +LE    +F  KNL+     G+G FG V    + + A     R      VAVK L+   S
Sbjct: 12  ILEDPKWEFPRKNLVLGKTLGEGEFGKV----VKATAFHLKGRAGYT-TVAVKMLKENAS 66
Query: 179 QGQ-DEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL-------- 229
             +  +  +E   L ++NHP+V+KL G C  D   LL+ EY   GSL   L         
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 230 --------------NEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD 275
                         + D+  L     I  A   ++G+++L      ++HRD+ A N+L+ 
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM--KLVHRDLAARNILVA 184
Query: 276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-----TLKTDVYSFG 330
           +    KISDFGL++     D     + V  ++G    +++A   L     T ++DV+SFG
Sbjct: 185 EGRKMKISDFGLSR-----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239
Query: 331 VVLLEILSGKTAAMRRTNGLAGNWAKPY-------LSNKLALHQIIDEKLGRNIQMEE-- 381
           V+L EI++           L GN   PY       L N L        K G  ++  +  
Sbjct: 240 VLLWEIVT-----------LGGN---PYPGIPPERLFNLL--------KTGHRMERPDNC 277
Query: 382 AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN 416
           ++E   ++L+C   +P  RP  +++   LE++ + 
Sbjct: 278 SEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR-KGSQGQDEWENELRFLSRLNH 196
           +G+G FG V      S              VAVK L+   G Q +  W+ E+  L  L H
Sbjct: 39  LGEGHFGKV------SLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH 92
Query: 197 PNVVKLMGYCCDDQHRL---LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
            +++K  G CC+D       LV EYV  GSL D+L       +   + +  A     G+ 
Sbjct: 93  EHIIKYKG-CCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMA 148
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG--YFA 311
           +LH   +  IHRD+ A NVLLD+D   KI DFGLAK  P G + +   R  G     ++A
Sbjct: 149 YLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXY-RVREDGDSPVFWYA 205
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILS 338
           PE +        +DV+SFGV L E+L+
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 144/301 (47%), Gaps = 54/301 (17%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSR 193
           +++IG+G FG V    I        ++       A+KR++   S+    ++  EL  L +
Sbjct: 27  QDVIGEGNFGQVLKARI--------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 78
Query: 194 L-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--------------LNEDDTELNW 238
           L +HPN++ L+G C    +  L  EY   G+L D L               N   + L+ 
Sbjct: 79  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 138
Query: 239 ERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSH 298
           ++ +  A   ARG+++L    +  IHR++ A N+L+ +++ AKI+DFGL++    G + +
Sbjct: 139 QQLLHFAADVARGMDYLSQ--KQFIHRNLAARNILVGENYVAKIADFGLSR----GQEVY 192
Query: 299 ISTRV--LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
           +   +  L  R + A E +     T  +DV+S+GV+L EI+S           L G    
Sbjct: 193 VKKTMGRLPVR-WMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----------LGGT--- 237
Query: 357 PYLSNKLALHQIIDEKLGRNIQMEEA----QEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           PY     A    + EKL +  ++E+      E  +++ +C    P  RP+ ++++ +L +
Sbjct: 238 PYCGMTCAE---LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 294
Query: 413 L 413
           +
Sbjct: 295 M 295

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 128/294 (43%), Gaps = 39/294 (13%)
Query: 135 KNLIGQGGFGDVYIG-YINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSR 193
           K  +G+G FG V++    N C       +     VAVK L+      + ++  E   L+ 
Sbjct: 18  KRELGEGAFGKVFLAECYNLCP------EQDKILVAVKTLKDASDNARKDFHREAELLTN 71
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH---------LLNEDD--TELNWERRI 242
           L H ++VK  G C +    ++V+EY+  G L            L+ E +  TEL   + +
Sbjct: 72  LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQML 131
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
            IA   A G+ +L +  +  +HRD+   N L+ ++   KI DFG+++     D   +   
Sbjct: 132 HIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 189
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSN 361
            +    +  PE I     T ++DV+S GVVL EI + GK             W +  LSN
Sbjct: 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-----------WYQ--LSN 236
Query: 362 KLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
              +  I     GR +Q      QE  E++L C   +P  R  +  +   L+ L
Sbjct: 237 NEVIECITQ---GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 18  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 65
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 123
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI++FG +   P    S   T + GT  Y  P
Sbjct: 124 SYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSRRTTLCGTLDYLPP 177
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 219
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 220 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 257

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 87/298 (29%), Positives = 133/298 (44%), Gaps = 35/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEW 184
           E +  K +    +GQG FG VY G           +  A+  VAVK +    S + + E+
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDII-----KGEAETRVAVKTVNESASLRERIEF 67
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------NEDDTEL 236
            NE   +      +VV+L+G     Q  L+V E +  G L+ +L         N      
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
             +  I++A   A G+ +L+   +  +HRD+ A N ++  DF  KI DFG+ +     D 
Sbjct: 128 TLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 185
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + APE +  G  T  +D++SFGVVL EI S           LA    +
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LA---EQ 231
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILR-CLNSDPKNRPTMSEVVAALE 411
           PY  LSN+  L  ++D   G   Q +   E    ++R C   +PK RPT  E+V  L+
Sbjct: 232 PYQGLSNEQVLKFVMDG--GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 87/298 (29%), Positives = 133/298 (44%), Gaps = 35/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEW 184
           E +  K +    +GQG FG VY G           +  A+  VAVK +    S + + E+
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDII-----KGEAETRVAVKTVNESASLRERIEF 66
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------NEDDTEL 236
            NE   +      +VV+L+G     Q  L+V E +  G L+ +L         N      
Sbjct: 67  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 126
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
             +  I++A   A G+ +L+   +  +HRD+ A N ++  DF  KI DFG+ +     D 
Sbjct: 127 TLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 184
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + APE +  G  T  +D++SFGVVL EI S           LA    +
Sbjct: 185 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LA---EQ 230
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILR-CLNSDPKNRPTMSEVVAALE 411
           PY  LSN+  L  ++D   G   Q +   E    ++R C   +PK RPT  E+V  L+
Sbjct: 231 PYQGLSNEQVLKFVMDG--GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 139/291 (47%), Gaps = 33/291 (11%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSR 193
           + +IG G FG+V  G +        +R   +  VA+K L+   +  Q  ++ +E   + +
Sbjct: 34  EKVIGVGEFGEVCSGRLK----VPGKR---EICVAIKTLKAGYTDKQRRDFLSEASIMGQ 86
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
            +HPN++ L G     +  +++ EY+  GSL D  L ++D      + + +  G   G++
Sbjct: 87  FDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMK 145
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYF 310
           +L       +HRD+ A N+L++ +   K+SDFG+++   L D    +    G +    + 
Sbjct: 146 YLSDM--SAVHRDLAARNILVNSNLVCKVSDFGMSRV--LEDDPEAAYTTRGGKIPIRWT 201
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALHQI 368
           APE IA    T  +DV+S+G+V+ E++S                 +PY  +SN+  + + 
Sbjct: 202 APEAIAYRKFTSASDVWSYGIVMWEVMSYG--------------ERPYWDMSNQDVI-KA 246
Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           I+E       M+      +++L C   +  +RP   ++V  L++L  N  S
Sbjct: 247 IEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNS 297

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 19  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 66
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P   ++ +     GT  Y  P
Sbjct: 125 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPP 178
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 220
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 221 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 258

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 135/303 (44%), Gaps = 45/303 (14%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEW 184
           E +  K +    +GQG FG VY G           +  A+  VAVK +    S + + E+
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDII-----KGEAETRVAVKTVNESASLRERIEF 67
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------NEDDTEL 236
            NE   +      +VV+L+G     Q  L+V E +  G L+ +L         N      
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
             +  I++A   A G+ +L+   +  +HRD+ A N ++  DF  KI DFG+ +     D 
Sbjct: 128 TLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DI 180
Query: 297 SHISTRVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA 351
              +    G +G     + APE +  G  T  +D++SFGVVL EI S           LA
Sbjct: 181 YETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LA 229
Query: 352 GNWAKPY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILR-CLNSDPKNRPTMSEVVA 408
               +PY  LSN+  L  ++D   G   Q +   E    ++R C   +PK RPT  E+V 
Sbjct: 230 ---EQPYQGLSNEQVLKFVMDG--GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 284
Query: 409 ALE 411
            L+
Sbjct: 285 LLK 287

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 42  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 89
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 147
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P   +  +     GT  Y  P
Sbjct: 148 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPP 201
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 243
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 244 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 281

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 127/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 18  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 65
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 123
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S     + GT  Y  P
Sbjct: 124 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLCGTLDYLPP 177
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 219
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 220 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 257

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 16  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 63
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P   ++ +     GT  Y  P
Sbjct: 122 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPP 175
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 217
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 218 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 255

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 132/298 (44%), Gaps = 35/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEW 184
           E +  K +    +GQG FG VY G           +  A+  VAVK +    S + + E+
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDII-----KGEAETRVAVKTVNESASLRERIEF 67
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------NEDDTEL 236
            NE   +      +VV+L+G     Q  L+V E +  G L+ +L         N      
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
             +  I++A   A G+ +L+   +  +HRD+ A N ++  DF  KI DFG+ +     D 
Sbjct: 128 TLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX 185
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + APE +  G  T  +D++SFGVVL EI S           LA    +
Sbjct: 186 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LA---EQ 231
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILR-CLNSDPKNRPTMSEVVAALE 411
           PY  LSN+  L  ++D   G   Q +   E    ++R C   +P  RPT  E+V  L+
Sbjct: 232 PYQGLSNEQVLKFVMDG--GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 128/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 19  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 66
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI++FG +   P    S   T + GT  Y  P
Sbjct: 125 SYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSRRTTLCGTLDYLPP 178
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 220
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 221 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 258

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 127/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K   F +A+K     +L + G + Q   E E++  S
Sbjct: 13  LGKGKFGNVYL----------AREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 60
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 118
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T + GT  Y  P
Sbjct: 119 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 172
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 214
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 215 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 252

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 130/272 (47%), Gaps = 40/272 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL---RRKGSQGQDEWENELRFLSRL 194
           +G GG   VY+          A     +  VA+K +    R+  +    +E E+   S+L
Sbjct: 19  LGGGGMSTVYL----------AEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED----DTELNWERRIKIALGAAR 250
           +H N+V ++    +D    LV EY+   +L +++ +      DT +N+  +I        
Sbjct: 69  SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI------LD 122
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST-RVLGTRGY 309
           G++H H     ++HRD+K  N+L+D +   KI DFG+AK   L + S   T  VLGT  Y
Sbjct: 123 GIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQY 178
Query: 310 FAPEYIATGHLTLK-TDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           F+PE  A G  T + TD+YS G+VL E+L G+      T   A + A  ++ + +     
Sbjct: 179 FSPEQ-AKGEATDECTDIYSIGIVLYEMLVGEPPFNGET---AVSIAIKHIQDSVP---- 230
Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNR 400
               +  +++ +  Q  + +ILR    D  NR
Sbjct: 231 ---NVTTDVRKDIPQSLSNVILRATEKDKANR 259

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD--EWENELRFLSRL 194
           ++G+G FG V  G +        +       VAVK ++   S  ++  E+ +E   +   
Sbjct: 41  ILGEGEFGSVMEGNLK-------QEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 195 NHPNVVKLMGYCCDDQHR-----LLVYEYVTRGSLEDHLL----NEDDTELNWERRIKIA 245
           +HPNV++L+G C +   +     +++  ++  G L  +LL          +  +  +K  
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
           +  A G+E+L    R  +HRD+ A N +L DD    ++DFGL+K    GD          
Sbjct: 154 VDIALGMEYLSN--RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211
Query: 306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL 365
              + A E +A    T K+DV++FGV + EI    T  M    G+  +    YL     L
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEI---ATRGMTPYPGVQNHEMYDYL-----L 263
Query: 366 HQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           H       G  ++  E    E  EI+  C  +DP +RPT S +   LE+L
Sbjct: 264 H-------GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 139/291 (47%), Gaps = 33/291 (11%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSR 193
           + +IG G FG+V  G +        +R   +  VA+K L+   +  Q  ++ +E   + +
Sbjct: 19  EKVIGVGEFGEVCSGRLK----VPGKR---EICVAIKTLKAGYTDKQRRDFLSEASIMGQ 71
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
            +HPN++ L G     +  +++ EY+  GSL D  L ++D      + + +  G   G++
Sbjct: 72  FDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMK 130
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYF 310
           +L       +HRD+ A N+L++ +   K+SDFG+++   L D    +    G +    + 
Sbjct: 131 YLSDM--SYVHRDLAARNILVNSNLVCKVSDFGMSRV--LEDDPEAAYTTRGGKIPIRWT 186
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALHQI 368
           APE IA    T  +DV+S+G+V+ E++S                 +PY  +SN+  + + 
Sbjct: 187 APEAIAYRKFTSASDVWSYGIVMWEVMSYGE--------------RPYWDMSNQDVI-KA 231
Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           I+E       M+      +++L C   +  +RP   ++V  L++L  N  S
Sbjct: 232 IEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNS 282

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 17  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 64
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 122
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P   +  +     GT  Y  P
Sbjct: 123 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC----GTLDYLPP 176
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 218
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 219 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 256

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 19  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 66
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P   +  +     GT  Y  P
Sbjct: 125 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPP 178
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 220
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 221 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 258

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 127/281 (45%), Gaps = 52/281 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR K + F +A+K     +L + G + Q   E E++  S
Sbjct: 16  LGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ--S 63
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R        A  L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL      KI+DFG +   P    S     + GT  Y  P
Sbjct: 122 SYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLCGTLDYLPP 175
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K D++S GV+  E L GK                P+ +N    +Q   ++
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT---YQETYKR 217
Query: 373 LGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           + R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 218 ISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 255

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 139/291 (47%), Gaps = 33/291 (11%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSR 193
           + +IG G FG+V  G +        +R   +  VA+K L+   +  Q  ++ +E   + +
Sbjct: 13  EKVIGVGEFGEVCSGRLK----VPGKR---EICVAIKTLKAGYTDKQRRDFLSEASIMGQ 65
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
            +HPN++ L G     +  +++ EY+  GSL D  L ++D      + + +  G   G++
Sbjct: 66  FDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMK 124
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYF 310
           +L       +HRD+ A N+L++ +   K+SDFG+++   L D    +    G +    + 
Sbjct: 125 YLSDM--SYVHRDLAARNILVNSNLVCKVSDFGMSRV--LEDDPEAAYTTRGGKIPIRWT 180
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALHQI 368
           APE IA    T  +DV+S+G+V+ E++S                 +PY  +SN+  + + 
Sbjct: 181 APEAIAYRKFTSASDVWSYGIVMWEVMSYGE--------------RPYWDMSNQDVI-KA 225
Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           I+E       M+      +++L C   +  +RP   ++V  L++L  N  S
Sbjct: 226 IEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNS 276

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 129/291 (44%), Gaps = 52/291 (17%)
Query: 128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQD 182
           A   F     +G+G FG+VY+          AR K + F +A+K     +L + G + Q 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQL 58
Query: 183 EWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI 242
             E E++  S L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R  
Sbjct: 59  RREVEIQ--SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTA 114
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
                 A  L + H+  + VIHRD+K  N+LL      KI+DFG +   P   +  +   
Sbjct: 115 TYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC-- 170
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK 362
             GT  Y  PE I       K D++S GV+  E L GK                P+ +N 
Sbjct: 171 --GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT 213
Query: 363 LALHQIIDEKLGR------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
              +Q   +++ R      +   E A+   ++I R L  +P  RP + EV+
Sbjct: 214 ---YQETYKRISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREVL 258

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +            + N    VAVK L+   ++    +  +E+  +  +  
Sbjct: 36  LGEGAFGQVVLA---EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------------NEDDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L               +  + +L+ +  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +  A   ARG+E+L +  +  IHRD+ A NVL+ +D   KI+DFGLA+     D  HI  
Sbjct: 153 VSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDX 205
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV+L EI +           L G+   
Sbjct: 206 XKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-----------LGGS--- 251
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 252 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 131/301 (43%), Gaps = 40/301 (13%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           R    K  +G+G FG V++    + + T  +       VAVK L+      + +++ E  
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDK-----MLVAVKALKDPTLAARKDFQREAE 69
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLE--------DHLLNEDDT------E 235
            L+ L H ++VK  G C D    ++V+EY+  G L         D ++  D        E
Sbjct: 70  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 236 LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGD 295
           L   + + IA   A G+ +L +  +  +HRD+   N L+  +   KI DFG+++     D
Sbjct: 130 LGLSQMLHIASQIASGMVYLAS--QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 296 KSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNW 354
              +    +    +  PE I     T ++DV+SFGV+L EI + GK             W
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-----------W 236
Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
            +  LSN   +  I     GR ++      +E  +++L C   +P+ R  + E+   L  
Sbjct: 237 FQ--LSNTEVIECITQ---GRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHA 291
Query: 413 L 413
           L
Sbjct: 292 L 292

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 134/290 (46%), Gaps = 45/290 (15%)
Query: 137 LIGQGGFGDVYIG-YINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRL 194
           +IG+G FG VY G YI+        +       A+K L R     Q E +  E   +  L
Sbjct: 28  VIGKGHFGVVYHGEYID--------QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 195 NHPNVVKLMGYCCDDQ---HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
           NHPNV+ L+G     +   H LL   Y+  G L    +         +  I   L  ARG
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLL--PYMCHGDLL-QFIRSPQRNPTVKDLISFGLQVARG 136
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV-----LGT 306
           +E+L    +  +HRD+ A N +LD+ F  K++DFGLA+   + D+ + S +      L  
Sbjct: 137 MEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLAR--DILDREYYSVQQHRHARLPV 192
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY-LSNKLAL 365
           + + A E + T   T K+DV+SFGV+L E+L+      R  +        P+ L++ LA 
Sbjct: 193 K-WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--------PFDLTHFLA- 242
Query: 366 HQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
                   GR +   E       +++ +C  +DP  RPT   +V  +EQ+
Sbjct: 243 -------QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 134/289 (46%), Gaps = 33/289 (11%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSRLN 195
           +IG G FG+V       C+         D AVA+K L+   ++ Q  ++  E   + + +
Sbjct: 50  VIGAGEFGEV-------CSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFD 102
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HPNVV L G     +  ++V E++  G+L D  L + D +    + + +  G A G+ +L
Sbjct: 103 HPNVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYL 161
Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR---GYFAP 312
                  +HRD+ A N+L++ +   K+SDFGL++   + D         G +    + AP
Sbjct: 162 ADM--GYVHRDLAARNILVNSNLVCKVSDFGLSRV--IEDDPEAVYTTTGGKIPVRWTAP 217
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALHQIID 370
           E I     T  +DV+S+G+V+ E++S                 +PY  +SN+  + + I+
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMSYGE--------------RPYWDMSNQDVI-KAIE 262
Query: 371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           E       M+      +++L C   +   RP   ++V  L+++  N  S
Sbjct: 263 EGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIRNPNS 311

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +            + N    VAVK L+   ++    +  +E+  +  +  
Sbjct: 25  LGEGAFGQVVLA---EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------------NEDDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L               +  + +L+ +  
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +  A   ARG+E+L +  +  IHRD+ A NVL+ +D   KI+DFGLA+     D  HI  
Sbjct: 142 VSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 194
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV+L EI +           L G+   
Sbjct: 195 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-----------LGGS--- 240
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 241 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 298

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 126/289 (43%), Gaps = 56/289 (19%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F++   IG+G FG+V+ G  N        R     A+ +  L     + +D  + E+  L
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDN--------RTQKVVAIKIIDLEEAEDEIEDI-QQEITVL 74
Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
           S+ + P V K  G    D    ++ EY+  GS  D L   +   L+  +   I     +G
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKG 131
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
           L++LH+  +  IHRD+KA+NVLL +    K++DFG+A  G L D        +GT  + A
Sbjct: 132 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMA 187
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTA-----------AMRRTN--GLAGNWAKPY 358
           PE I       K D++S G+  +E+  G+              + + N   L GN++KP 
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL 247
Query: 359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                                   +EF E    CLN +P  RPT  E++
Sbjct: 248 ------------------------KEFVE---ACLNKEPSFRPTAKELL 269

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +            + N    VAVK L+   ++    +  +E+  +  +  
Sbjct: 29  LGEGAFGQVVLA---EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------------NEDDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L               +  + +L+ +  
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +  A   ARG+E+L +  +  IHRD+ A NVL+ +D   KI+DFGLA+     D  HI  
Sbjct: 146 VSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 198
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV+L EI +           L G+   
Sbjct: 199 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-----------LGGS--- 244
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 245 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +            + N    VAVK L+   ++    +  +E+  +  +  
Sbjct: 36  LGEGAFGQVVLA---EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L   +              + +L+ +  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +  A   ARG+E+L +  +  IHRD+ A NVL+ +D   KI+DFGLA+     D  HI  
Sbjct: 153 VSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 205
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV+L EI +           L G+   
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-----------LGGS--- 251
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 252 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 22/202 (10%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G FGDV +G           R N    VAVK ++   +     +  E   +++L H 
Sbjct: 20  IGKGEFGDVMLG---------DYRGNK---VAVKCIKNDATA--QAFLAEASVMTQLRHS 65
Query: 198 NVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           N+V+L+G   +++  L +V EY+ +GSL D+L +   + L  +  +K +L     +E+L 
Sbjct: 66  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 125
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA 316
                 +HRD+ A NVL+ +D  AK+SDFGL K       S   T  L  + + APE + 
Sbjct: 126 G--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVK-WTAPEALR 178
Query: 317 TGHLTLKTDVYSFGVVLLEILS 338
               + K+DV+SFG++L EI S
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYS 200

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +            + N    VAVK L+   ++    +  +E+  +  +  
Sbjct: 21  LGEGAFGQVVLA---EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------------NEDDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L               +  + +L+ +  
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +  A   ARG+E+L +  +  IHRD+ A NVL+ +D   KI+DFGLA+     D  HI  
Sbjct: 138 VSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 190
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV+L EI +           L G+   
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-----------LGGS--- 236
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 237 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +            + N    VAVK L+   ++    +  +E+  +  +  
Sbjct: 36  LGEGAFGQVVLA---EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------------NEDDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L               +  + +L+ +  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +  A   ARG+E+L +  +  IHRD+ A NVL+ +D   KI+DFGLA+     D  HI  
Sbjct: 153 VSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 205
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV+L EI +           L G+   
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-----------LGGS--- 251
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 252 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 125/289 (43%), Gaps = 56/289 (19%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F++   IG+G FG+V+ G  N        R     A+ +  L     + +D  + E+  L
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDN--------RTQKVVAIKIIDLEEAEDEIEDI-QQEITVL 59
Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
           S+ + P V K  G    D    ++ EY+  GS  D L   +   L+  +   I     +G
Sbjct: 60  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKG 116
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
           L++LH+  +  IHRD+KA+NVLL +    K++DFG+A  G L D        +GT  + A
Sbjct: 117 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMA 172
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSG----------KTAAMRRTNG---LAGNWAKPY 358
           PE I       K D++S G+  +E+  G          K   +   N    L GN++KP 
Sbjct: 173 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL 232
Query: 359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                                   +EF E    CLN +P  RPT  E++
Sbjct: 233 ------------------------KEFVE---ACLNKEPSFRPTAKELL 254

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +            + N    VAVK L+   ++    +  +E+  +  +  
Sbjct: 28  LGEGAFGQVVLA---EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------------NEDDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L               +  + +L+ +  
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +  A   ARG+E+L +  +  IHRD+ A NVL+ +D   KI+DFGLA+     D  HI  
Sbjct: 145 VSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 197
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV+L EI +           L G+   
Sbjct: 198 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-----------LGGS--- 243
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 244 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +            + N    VAVK L+   ++    +  +E+  +  +  
Sbjct: 36  LGEGAFGQVVLA---EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------------NEDDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L               +  + +L+ +  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +  A   ARG+E+L +  +  IHRD+ A NVL+ +D   KI+DFGLA+     D  HI  
Sbjct: 153 VSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 205
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV+L EI +           L G+   
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-----------LGGS--- 251
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 252 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 125/289 (43%), Gaps = 56/289 (19%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F++   IG+G FG+V+ G  N        R     A+ +  L     + +D  + E+  L
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDN--------RTQKVVAIKIIDLEEAEDEIEDI-QQEITVL 59
Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
           S+ + P V K  G    D    ++ EY+  GS  D L   +   L+  +   I     +G
Sbjct: 60  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKG 116
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
           L++LH+  +  IHRD+KA+NVLL +    K++DFG+A  G L D        +GT  + A
Sbjct: 117 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMA 172
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSG----------KTAAMRRTNG---LAGNWAKPY 358
           PE I       K D++S G+  +E+  G          K   +   N    L GN++KP 
Sbjct: 173 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL 232
Query: 359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                                   +EF E    CLN +P  RPT  E++
Sbjct: 233 ------------------------KEFVE---ACLNKEPSFRPTAKELL 254

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +            + N    VAVK L+   ++    +  +E+  +  +  
Sbjct: 77  LGEGAFGQVVLA---EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------------NEDDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L               +  + +L+ +  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +  A   ARG+E+L +  +  IHRD+ A NVL+ +D   KI+DFGLA+     D  HI  
Sbjct: 194 VSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 246
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV+L EI +           L G+   
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-----------LGGS--- 292
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 293 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 22/202 (10%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G FGDV +G           R N    VAVK ++   +     +  E   +++L H 
Sbjct: 201 IGKGEFGDVMLG---------DYRGNK---VAVKCIKNDATA--QAFLAEASVMTQLRHS 246
Query: 198 NVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           N+V+L+G   +++  L +V EY+ +GSL D+L +   + L  +  +K +L     +E+L 
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA 316
                 +HRD+ A NVL+ +D  AK+SDFGL K       S   T  L  + + APE + 
Sbjct: 307 G--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVK-WTAPEALR 359
Query: 317 TGHLTLKTDVYSFGVVLLEILS 338
               + K+DV+SFG++L EI S
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYS 381

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 131/283 (46%), Gaps = 48/283 (16%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR---RKGSQGQDEWENELRFLSRL 194
           IG+G F +VY     +C +           VA+K+++      ++ + +   E+  L +L
Sbjct: 40  IGRGQFSEVYRA---ACLLDGV-------PVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-EDDTELNWERRI-KIALGAARGL 252
           NHPNV+K      +D    +V E    G L   + + +    L  ER + K  +     L
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           EH+H+  R V+HRD+K +NV +      K+ D GL +F     K+  +  ++GT  Y +P
Sbjct: 150 EHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSP 205
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
           E I       K+D++S G +L E+     AA++           P+  +K+ L+      
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEM-----AALQ----------SPFYGDKMNLYS----- 245
Query: 373 LGRNIQMEE---------AQEFAEIILRCLNSDPKNRPTMSEV 406
           L + I+  +         ++E  +++  C+N DP+ RP ++ V
Sbjct: 246 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 22/202 (10%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G FGDV +G           R N    VAVK ++   +     +  E   +++L H 
Sbjct: 29  IGKGEFGDVMLG---------DYRGNK---VAVKCIKNDATA--QAFLAEASVMTQLRHS 74
Query: 198 NVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           N+V+L+G   +++  L +V EY+ +GSL D+L +   + L  +  +K +L     +E+L 
Sbjct: 75  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA 316
                 +HRD+ A NVL+ +D  AK+SDFGL K       S   T  L  + + APE + 
Sbjct: 135 G--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVK-WTAPEALR 187
Query: 317 TGHLTLKTDVYSFGVVLLEILS 338
               + K+DV+SFG++L EI S
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYS 209

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 125/289 (43%), Gaps = 56/289 (19%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F++   IG+G FG+V+ G  N        R     A+ +  L     + +D  + E+  L
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDN--------RTQKVVAIKIIDLEEAEDEIEDI-QQEITVL 79
Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
           S+ + P V K  G    D    ++ EY+  GS  D L   +   L+  +   I     +G
Sbjct: 80  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKG 136
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
           L++LH+  +  IHRD+KA+NVLL +    K++DFG+A  G L D        +GT  + A
Sbjct: 137 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMA 192
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSG----------KTAAMRRTNG---LAGNWAKPY 358
           PE I       K D++S G+  +E+  G          K   +   N    L GN++KP 
Sbjct: 193 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL 252
Query: 359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                                   +EF E    CLN +P  RPT  E++
Sbjct: 253 ------------------------KEFVE---ACLNKEPSFRPTAKELL 274

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 22/202 (10%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G FGDV +G           R N    VAVK ++   +     +  E   +++L H 
Sbjct: 14  IGKGEFGDVMLG---------DYRGNK---VAVKCIKNDATA--QAFLAEASVMTQLRHS 59
Query: 198 NVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           N+V+L+G   +++  L +V EY+ +GSL D+L +   + L  +  +K +L     +E+L 
Sbjct: 60  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA 316
                 +HRD+ A NVL+ +D  AK+SDFGL K       S   T  L  + + APE + 
Sbjct: 120 G--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVK-WTAPEALR 172
Query: 317 TGHLTLKTDVYSFGVVLLEILS 338
               + K+DV+SFG++L EI S
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYS 194

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 132/262 (50%), Gaps = 30/262 (11%)
Query: 133 SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLS 192
           S+  ++G G FG V+      C  TA   K     +A K ++ +G + ++E +NE+  ++
Sbjct: 92  SKTEILGGGRFGQVH-----KCEETATGLK-----LAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAAR 250
           +L+H N+++L          +LV EYV  G L D +++E  + TEL+    I        
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICE 198
Query: 251 GLEHLHTYWRPVIHRDVKASNVLL--DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           G+ H+H  +  ++H D+K  N+L    D    KI DFGLA+     +K  ++    GT  
Sbjct: 199 GIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGTPE 253
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           + APE +    ++  TD++S GV+   +LSG +  +       G+     L+N LA    
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL-------GDNDAETLNNILACRWD 306
Query: 369 IDEKLGRNIQMEEAQEFAEIIL 390
           ++++  ++I  EEA+EF   +L
Sbjct: 307 LEDEEFQDIS-EEAKEFISKLL 327

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSR 193
           ++++G G F +V +          A  K     VA+K + +K  +G++   ENE+  L +
Sbjct: 23  RDVLGTGAFSEVIL----------AEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 72
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED-DTELNWERRIKIALGAARGL 252
           + HPN+V L        H  L+ + V+ G L D ++ +   TE +  R I   L A + L
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 253 EHLHTYWRPVIHRDVKASNVL---LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
             L      ++HRD+K  N+L   LD+D    ISDFGL+K   + D   + +   GT GY
Sbjct: 133 HDLG-----IVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGY 184
Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            APE +A    +   D +S GV+   +L G
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 25/207 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR + + F +A+K     +L + G + Q   E E++  S
Sbjct: 20  LGKGKFGNVYL----------ARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQ--S 67
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  +  + +R        A  L
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYITELANAL 125
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL  +   KI+DFG +   P    S   T + GT  Y  P
Sbjct: 126 SYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 179
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSG 339
           E I       K D++S GV+  E L G
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 134/290 (46%), Gaps = 40/290 (13%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSR 193
           + +IG G    V   Y   CA    +       VA+KR+  +  Q   DE   E++ +S+
Sbjct: 20  QEVIGSGATAVVQAAY---CAPKKEK-------VAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED---HLLNEDDTE---LNWERRIKIALG 247
            +HPN+V             LV + ++ GS+ D   H++ + + +   L+      I   
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG---DKSHISTRVL 304
              GLE+LH   +  IHRDVKA N+LL +D + +I+DFG++ F   G    ++ +    +
Sbjct: 130 VLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 305 GTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK 362
           GT  + APE +    G+   K D++SFG+  +E+ +G     +           P +   
Sbjct: 188 GTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKY----------PPMKVL 236
Query: 363 LALHQIIDEKLGRNIQMEE-----AQEFAEIILRCLNSDPKNRPTMSEVV 407
           +   Q     L   +Q +E      + F ++I  CL  DP+ RPT +E++
Sbjct: 237 MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 135/293 (46%), Gaps = 40/293 (13%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRF 190
           +  + +IG G    V   Y   CA    +       VA+KR+  +  Q   DE   E++ 
Sbjct: 12  YELQEVIGSGATAVVQAAY---CAPKKEK-------VAIKRINLEKCQTSMDELLKEIQA 61
Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED---HLLNEDDTE---LNWERRIKI 244
           +S+ +HPN+V             LV + ++ GS+ D   H++ + + +   L+      I
Sbjct: 62  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 121
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG---DKSHIST 301
                 GLE+LH   +  IHRDVKA N+LL +D + +I+DFG++ F   G    ++ +  
Sbjct: 122 LREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 179
Query: 302 RVLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
             +GT  + APE +    G+   K D++SFG+  +E+ +G     +           P +
Sbjct: 180 TFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKY----------PPM 228
Query: 360 SNKLALHQIIDEKLGRNIQMEE-----AQEFAEIILRCLNSDPKNRPTMSEVV 407
              +   Q     L   +Q +E      + F ++I  CL  DP+ RPT +E++
Sbjct: 229 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 132/298 (44%), Gaps = 35/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEW 184
           E +  K +    +GQG FG VY G           +  A+  VAVK +    S + + E+
Sbjct: 14  EVSREKITLLRELGQGSFGMVYEGNARDII-----KGEAETRVAVKTVNESASLRERIEF 68
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------NEDDTEL 236
            NE   +      +VV+L+G     Q  L+V E +  G L+ +L         N      
Sbjct: 69  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 128
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
             +  I++A   A G+ +L+   +  +HR++ A N ++  DF  KI DFG+ +     D 
Sbjct: 129 TLQEMIQMAAEIADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY 186
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + APE +  G  T  +D++SFGVVL EI S           LA    +
Sbjct: 187 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LA---EQ 232
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILR-CLNSDPKNRPTMSEVVAALE 411
           PY  LSN+  L  ++D   G   Q +   E    ++R C   +P  RPT  E+V  L+
Sbjct: 233 PYQGLSNEQVLKFVMDG--GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 132/298 (44%), Gaps = 35/298 (11%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEW 184
           E +  K +    +GQG FG VY G           +  A+  VAVK +    S + + E+
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDII-----KGEAETRVAVKTVNESASLRERIEF 67
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------NEDDTEL 236
            NE   +      +VV+L+G     Q  L+V E +  G L+ +L         N      
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
             +  I++A   A G+ +L+   +  +HR++ A N ++  DF  KI DFG+ +     D 
Sbjct: 128 TLQEMIQMAAEIADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY 185
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
                + L    + APE +  G  T  +D++SFGVVL EI S           LA    +
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LA---EQ 231
Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILR-CLNSDPKNRPTMSEVVAALE 411
           PY  LSN+  L  ++D   G   Q +   E    ++R C   +P  RPT  E+V  L+
Sbjct: 232 PYQGLSNEQVLKFVMDG--GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 129/285 (45%), Gaps = 41/285 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNH 196
           IG+G FG+V+ G          R +  +  VAVK  R       + ++  E R L + +H
Sbjct: 122 IGRGNFGEVFSG----------RLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           PN+V+L+G C   Q   +V E V  G     L  E    L  +  +++   AA G+E+L 
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE 230
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK------FGPLGDKSHISTRVLGTRGYF 310
           +  +  IHRD+ A N L+ +    KISDFG+++      +   G    +  +      + 
Sbjct: 231 S--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK------WT 282
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           APE +  G  + ++DV+SFG++L E  S             G    P LSN+     +  
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFS------------LGASPYPNLSNQQTREFV-- 328
Query: 371 EKLGRNIQMEEAQEFA-EIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           EK GR    E   +    ++ +C   +P  RP+ S +   L+ ++
Sbjct: 329 EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G VY           A  K     VA+K++  +      E   E+  + + + P
Sbjct: 37  LGEGSYGSVY----------KAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSP 84
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           +VVK  G    +    +V EY   GS+ D +   + T L  +    I     +GLE+LH 
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLHF 143
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             +  IHRD+KA N+LL+ + +AK++DFG+A  G L D       V+GT  + APE I  
Sbjct: 144 MRK--IHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPFWMAPEVIQE 199
Query: 318 GHLTLKTDVYSFGVVLLEILSGK 340
                  D++S G+  +E+  GK
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGK 222

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 32/290 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQDEWENELRFLSRLNH 196
           +G+G FG V +   +          N    VAVK L+   G     + + E+  L  L H
Sbjct: 17  LGEGHFGKVELCRYD------PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 70
Query: 197 PNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            N+VK  G C +D      L+ E++  GSL+++L  ++  ++N ++++K A+   +G+++
Sbjct: 71  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDY 129
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR--VLGTRGYFAP 312
           L +  R  +HRD+ A NVL++ +   KI DFGL K     DK   + +        ++AP
Sbjct: 130 LGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDDRDSPVFWYAP 186
Query: 313 EYIATGHLTLKTDVYSFGVVLLEIL-------SGKTAAMRRTNGLAGNWAKPYLSNKLAL 365
           E +      + +DV+SFGV L E+L       S     ++      G      L N L  
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL-- 244
Query: 366 HQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
                 K G+ +        E  +++ +C    P NR +   ++   E L
Sbjct: 245 ------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 288

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 135/311 (43%), Gaps = 49/311 (15%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-W 184
           E    + S    +G G FG V    + + A     + +A   VAVK L+      + E  
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKV----VEATAY-GLIKSDAAMTVAVKMLKPSAHLTEREAL 96
Query: 185 ENELRFLSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            +EL+ LS L NH N+V L+G C      L++ EY   G L + L  + D+ +  +    
Sbjct: 97  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 156
Query: 244 I----------------ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
           I                +   A+G+  L +  +  IHRD+ A N+LL      KI DFGL
Sbjct: 157 IMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGL 214
Query: 288 AKFGPLGDKSHISTRVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
           A+     D  + S  V+         + APE I     T ++DV+S+G+ L E+ S    
Sbjct: 215 AR-----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS---- 265
Query: 343 AMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRP 401
                    G+   P +      +++I E   R +  E A  E  +I+  C ++DP  RP
Sbjct: 266 --------LGSSPYPGMPVDSKFYKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRP 316
Query: 402 TMSEVVAALEQ 412
           T  ++V  +E+
Sbjct: 317 TFKQIVQLIEK 327

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 32/290 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQDEWENELRFLSRLNH 196
           +G+G FG V +   +          N    VAVK L+   G     + + E+  L  L H
Sbjct: 29  LGEGHFGKVELCRYD------PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 82
Query: 197 PNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            N+VK  G C +D      L+ E++  GSL+++L  ++  ++N ++++K A+   +G+++
Sbjct: 83  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDY 141
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR--VLGTRGYFAP 312
           L +  R  +HRD+ A NVL++ +   KI DFGL K     DK   + +        ++AP
Sbjct: 142 LGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDDRDSPVFWYAP 198
Query: 313 EYIATGHLTLKTDVYSFGVVLLEIL-------SGKTAAMRRTNGLAGNWAKPYLSNKLAL 365
           E +      + +DV+SFGV L E+L       S     ++      G      L N L  
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL-- 256
Query: 366 HQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
                 K G+ +        E  +++ +C    P NR +   ++   E L
Sbjct: 257 ------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 131/288 (45%), Gaps = 35/288 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRLN- 195
           +G G FG V    + + A    + ++A   VAVK L+      + E   +EL+ +S L  
Sbjct: 46  LGAGAFGKV----VEATAFGLGK-EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 100
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSL--------EDHLLNEDDTELNWERRIKIALG 247
           H N+V L+G C      L++ EY   G L        E  L  ED   L     +  +  
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI---STRVL 304
            A+G+  L +  +  IHRDV A NVLL +   AKI DFGLA+   + D ++I   + R+ 
Sbjct: 161 VAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKGNARL- 216
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I     T+++DV+S+G++L EI S           L  N     L N   
Sbjct: 217 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-----------LGLNPYPGILVNS-K 263
Query: 365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
            ++++ +           +    I+  C   +P +RPT  ++ + L++
Sbjct: 264 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 311

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 132/311 (42%), Gaps = 49/311 (15%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-W 184
           E    + S    +G G FG V              + +A   VAVK L+      + E  
Sbjct: 35  EFPRNRLSFGKTLGAGAFGKVV-----EATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 89
Query: 185 ENELRFLSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            +EL+ LS L NH N+V L+G C      L++ EY   G L + L  + D+ +  +    
Sbjct: 90  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 149
Query: 244 I----------------ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
           I                +   A+G+  L +  +  IHRD+ A N+LL      KI DFGL
Sbjct: 150 IMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGL 207
Query: 288 AKFGPLGDKSHISTRVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
           A+     D  + S  V+         + APE I     T ++DV+S+G+ L E+ S    
Sbjct: 208 AR-----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS---- 258
Query: 343 AMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRP 401
                    G+   P +      +++I E   R +  E A  E  +I+  C ++DP  RP
Sbjct: 259 --------LGSSPYPGMPVDSKFYKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRP 309
Query: 402 TMSEVVAALEQ 412
           T  ++V  +E+
Sbjct: 310 TFKQIVQLIEK 320

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 135/311 (43%), Gaps = 49/311 (15%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-W 184
           E    + S    +G G FG V    + + A     + +A   VAVK L+      + E  
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKV----VEATAY-GLIKSDAAMTVAVKMLKPSAHLTEREAL 73
Query: 185 ENELRFLSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            +EL+ LS L NH N+V L+G C      L++ EY   G L + L  + D+ +  +    
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 244 I----------------ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
           I                +   A+G+  L +  +  IHRD+ A N+LL      KI DFGL
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 288 AKFGPLGDKSHISTRVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
           A+     D  + S  V+         + APE I     T ++DV+S+G+ L E+ S    
Sbjct: 192 AR-----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS---- 242
Query: 343 AMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRP 401
                    G+   P +      +++I E   R +  E A  E  +I+  C ++DP  RP
Sbjct: 243 --------LGSSPYPGMPVDSKFYKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRP 293
Query: 402 TMSEVVAALEQ 412
           T  ++V  +E+
Sbjct: 294 TFKQIVQLIEK 304

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 127/279 (45%), Gaps = 29/279 (10%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNH 196
           IG+G FG+V+ G          R +  +  VAVK  R       + ++  E R L + +H
Sbjct: 122 IGRGNFGEVFSG----------RLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           PN+V+L+G C   Q   +V E V  G     L  E    L  +  +++   AA G+E+L 
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE 230
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA 316
           +  +  IHRD+ A N L+ +    KISDFG+++    G  +           + APE + 
Sbjct: 231 S--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALN 288
Query: 317 TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRN 376
            G  + ++DV+SFG++L E  S             G    P LSN+     +  EK GR 
Sbjct: 289 YGRYSSESDVWSFGILLWETFS------------LGASPYPNLSNQQTREFV--EKGGRL 334
Query: 377 IQMEEAQEFA-EIILRCLNSDPKNRPTMSEVVAALEQLQ 414
              E   +    ++ +C   +P  RP+ S +   L+ ++
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 135/311 (43%), Gaps = 49/311 (15%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-W 184
           E    + S    +G G FG V    + + A     + +A   VAVK L+      + E  
Sbjct: 37  EFPRNRLSFGKTLGAGAFGKV----VEATAY-GLIKSDAAMTVAVKMLKPSAHLTEREAL 91
Query: 185 ENELRFLSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            +EL+ LS L NH N+V L+G C      L++ EY   G L + L  + D+ +  +    
Sbjct: 92  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 151
Query: 244 I----------------ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
           I                +   A+G+  L +  +  IHRD+ A N+LL      KI DFGL
Sbjct: 152 IMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGL 209
Query: 288 AKFGPLGDKSHISTRVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
           A+     D  + S  V+         + APE I     T ++DV+S+G+ L E+ S    
Sbjct: 210 AR-----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS---- 260
Query: 343 AMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRP 401
                    G+   P +      +++I E   R +  E A  E  +I+  C ++DP  RP
Sbjct: 261 --------LGSSPYPGMPVDSKFYKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRP 311
Query: 402 TMSEVVAALEQ 412
           T  ++V  +E+
Sbjct: 312 TFKQIVQLIEK 322

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 131/300 (43%), Gaps = 54/300 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRL-N 195
           +G+G FG V          TA  R      VAVK L+   +  +     +EL+ L  + +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXR-----TVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 196 HPNVVKLMGYCCDDQHRLLVY-EYVTRGSLEDHLLNEDD----------TELNWERRIKI 244
           H NVV L+G C      L+V  E+   G+L  +L ++ +            L  E  I  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI---ST 301
           +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+     D  ++     
Sbjct: 150 SFQVAKGMEFLAS--RKXIHRDLAARNILLSEKNVVKIXDFGLAR-DIYKDPDYVRKGDA 206
Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
           R+     + APE I     T+++DV+SFGV+L EI S                A PY   
Sbjct: 207 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG--------------ASPYPGV 250
Query: 362 KLALHQIIDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K      IDE+  R ++             E  + +L C + +P  RPT SE+V  L  L
Sbjct: 251 K------IDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 131/288 (45%), Gaps = 35/288 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRLN- 195
           +G G FG V    + + A    + ++A   VAVK L+      + E   +EL+ +S L  
Sbjct: 54  LGAGAFGKV----VEATAFGLGK-EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSL--------EDHLLNEDDTELNWERRIKIALG 247
           H N+V L+G C      L++ EY   G L        E  L  ED   L     +  +  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI---STRVL 304
            A+G+  L +  +  IHRDV A NVLL +   AKI DFGLA+   + D ++I   + R+ 
Sbjct: 169 VAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKGNARL- 224
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + APE I     T+++DV+S+G++L EI S           L  N     L N   
Sbjct: 225 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-----------LGLNPYPGILVNS-K 271
Query: 365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
            ++++ +           +    I+  C   +P +RPT  ++ + L++
Sbjct: 272 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 319

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 126/278 (45%), Gaps = 33/278 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF-LSRLNH 196
           +G G FG V+        +  +R     +A+ V +        Q E  N+ R  LS + H
Sbjct: 14  LGTGSFGRVH--------LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P ++++ G   D Q   ++ +Y+  G L   LL +     N   +   A      LE+LH
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKF-YAAEVCLALEYLH 123
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA 316
           +  + +I+RD+K  N+LLD + + KI+DFG AK+ P      ++  + GT  Y APE ++
Sbjct: 124 S--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYXLCGTPDYIAPEVVS 176
Query: 317 TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY---LSNKLALHQIIDEK- 372
           T       D +SFG+++ E+L+G T           N  K Y   L+ +L      +E  
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFY------DSNTMKTYEKILNAELRFPPFFNEDV 230
Query: 373 ---LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
              L R I  + +Q      L+    D KN P   EVV
Sbjct: 231 KDLLSRLITRDLSQRLGN--LQNGTEDVKNHPWFKEVV 266

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 111/215 (51%), Gaps = 23/215 (10%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V  G           +    + VA+K ++ +GS  +DE+  E + +  L+H 
Sbjct: 17  LGTGQFGVVKYG-----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C   +   ++ EY+  G L ++ L E       ++ +++       +E+L +
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES 123
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG---YFAPEY 314
             +  +HRD+ A N L++D    K+SDFGL+++  + D  + S+R  G++    +  PE 
Sbjct: 124 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSR--GSKFPVRWSPPEV 177
Query: 315 IATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTN 348
           +     + K+D+++FGV++ EI S GK    R TN
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 212

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSR 193
           ++++G G F +V +          A  K     VA+K + ++  +G++   ENE+  L +
Sbjct: 23  RDVLGTGAFSEVIL----------AEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK 72
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED-DTELNWERRIKIALGAARGL 252
           + HPN+V L        H  L+ + V+ G L D ++ +   TE +  R I   L A + L
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 253 EHLHTYWRPVIHRDVKASNVL---LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
             L      ++HRD+K  N+L   LD+D    ISDFGL+K   + D   + +   GT GY
Sbjct: 133 HDL-----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGY 184
Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            APE +A    +   D +S GV+   +L G
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 128/292 (43%), Gaps = 39/292 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG V++   ++        +     VAVK L+      + +++ E   L+ L H 
Sbjct: 26  LGEGAFGKVFLAECHNLL-----PEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 80
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----------ED--DTELNWERRIKI 244
           ++V+  G C + +  L+V+EY+  G L   L +           ED     L   + + +
Sbjct: 81  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           A   A G+ +L       +HRD+   N L+      KI DFG+++     D   +  R +
Sbjct: 141 ASQVAAGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 198
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKL 363
               +  PE I     T ++DV+SFGVVL EI + GK             W +  LSN  
Sbjct: 199 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-----------WYQ--LSNTE 245
Query: 364 ALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           A+  I     GR ++   A   E   I+  C   +P+ R ++ +V A L+ L
Sbjct: 246 AIDCITQ---GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 294

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 128/292 (43%), Gaps = 39/292 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG V++   ++        +     VAVK L+      + +++ E   L+ L H 
Sbjct: 20  LGEGAFGKVFLAECHNLL-----PEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 74
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----------ED--DTELNWERRIKI 244
           ++V+  G C + +  L+V+EY+  G L   L +           ED     L   + + +
Sbjct: 75  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           A   A G+ +L       +HRD+   N L+      KI DFG+++     D   +  R +
Sbjct: 135 ASQVAAGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 192
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKL 363
               +  PE I     T ++DV+SFGVVL EI + GK             W +  LSN  
Sbjct: 193 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-----------WYQ--LSNTE 239
Query: 364 ALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           A+  I     GR ++   A   E   I+  C   +P+ R ++ +V A L+ L
Sbjct: 240 AIDCITQ---GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 288

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 128/292 (43%), Gaps = 39/292 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG V++   ++        +     VAVK L+      + +++ E   L+ L H 
Sbjct: 49  LGEGAFGKVFLAECHNLL-----PEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----------ED--DTELNWERRIKI 244
           ++V+  G C + +  L+V+EY+  G L   L +           ED     L   + + +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           A   A G+ +L       +HRD+   N L+      KI DFG+++     D   +  R +
Sbjct: 164 ASQVAAGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKL 363
               +  PE I     T ++DV+SFGVVL EI + GK             W +  LSN  
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-----------WYQ--LSNTE 268
Query: 364 ALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           A+  I     GR ++   A   E   I+  C   +P+ R ++ +V A L+ L
Sbjct: 269 AIDCITQ---GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 131/306 (42%), Gaps = 39/306 (12%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-W 184
           E    + S    +G G FG V    + + A     + +A   VAVK L+      + E  
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKV----VEATAY-GLIKSDAAMTVAVKMLKPSAHLTEREAL 96
Query: 185 ENELRFLSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            +EL+ LS L NH N+V L+G C      L++ EY   G L + L  + D+ +  +    
Sbjct: 97  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 156
Query: 244 I----------------ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
           I                +   A+G+  L +  +  IHRD+ A N+LL      KI DFGL
Sbjct: 157 IMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGL 214
Query: 288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRT 347
           A+         +         + APE I     T ++DV+S+G+ L E+ S         
Sbjct: 215 ARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS--------- 265
Query: 348 NGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEV 406
               G+   P +      +++I E   R +  E A  E  +I+  C ++DP  RPT  ++
Sbjct: 266 ---LGSSPYPGMPVDSKFYKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 321
Query: 407 VAALEQ 412
           V  +E+
Sbjct: 322 VQLIEK 327

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSR 193
           ++++G G F +V +          A  K     VA+K + ++  +G++   ENE+  L +
Sbjct: 23  RDVLGTGAFSEVIL----------AEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK 72
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED-DTELNWERRIKIALGAARGL 252
           + HPN+V L        H  L+ + V+ G L D ++ +   TE +  R I   L A + L
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 253 EHLHTYWRPVIHRDVKASNVL---LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
             L      ++HRD+K  N+L   LD+D    ISDFGL+K   + D   + +   GT GY
Sbjct: 133 HDLG-----IVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGY 184
Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            APE +A    +   D +S GV+   +L G
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 122/276 (44%), Gaps = 30/276 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F++   IG+G FG+V+ G  N        R     A+ +  L     + +D  + E+  L
Sbjct: 25  FTKLERIGKGSFGEVFKGIDN--------RTQQVVAIKIIDLEEAEDEIEDI-QQEITVL 75
Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
           S+ +   V K  G         ++ EY+  GS  D L      E      +K  L   +G
Sbjct: 76  SQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KG 132
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
           L++LH+  +  IHRD+KA+NVLL +  + K++DFG+A  G L D        +GT  + A
Sbjct: 133 LDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMA 188
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I       K D++S G+  +E+  G+                    + + +  +I +
Sbjct: 189 PEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM--------------HPMRVLFLIPK 234
Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                +  +  + F E I  CLN DP  RPT  E++
Sbjct: 235 NNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELL 270

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSR 193
           ++++G G F +V +          A  K     VA+K + ++  +G++   ENE+  L +
Sbjct: 23  RDVLGTGAFSEVIL----------AEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK 72
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED-DTELNWERRIKIALGAARGL 252
           + HPN+V L        H  L+ + V+ G L D ++ +   TE +  R I   L A + L
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 253 EHLHTYWRPVIHRDVKASNVL---LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
             L      ++HRD+K  N+L   LD+D    ISDFGL+K   + D   + +   GT GY
Sbjct: 133 HDLG-----IVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGY 184
Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            APE +A    +   D +S GV+   +L G
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 131/300 (43%), Gaps = 54/300 (18%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRL-N 195
           +G+G FG V          TA  R      VAVK L+   +  +     +EL+ L  + +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXR-----TVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 196 HPNVVKLMGYCCDDQHRLLVY-EYVTRGSLEDHLLNEDD----------TELNWERRIKI 244
           H NVV L+G C      L+V  E+   G+L  +L ++ +            L  E  I  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI---ST 301
           +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+     D  ++     
Sbjct: 150 SFQVAKGMEFLAS--RKXIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVRKGDA 206
Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
           R+     + APE I     T+++DV+SFGV+L EI S                A PY   
Sbjct: 207 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG--------------ASPYPGV 250
Query: 362 KLALHQIIDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K      IDE+  R ++             E  + +L C + +P  RPT SE+V  L  L
Sbjct: 251 K------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFLS 192
           +G+G FG+VY+          AR + + F +A+K     +L + G + Q   E E++  S
Sbjct: 20  LGKGKFGNVYL----------ARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQ--S 67
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            L HPN+++L GY  D     L+ EY   G++   L  +  +  + +R        A  L
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYITELANAL 125
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            + H+  + VIHRD+K  N+LL  +   KI+DFG +   P   +  +     GT  Y  P
Sbjct: 126 SYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC----GTLDYLPP 179
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSG 339
           E I       K D++S GV+  E L G
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V  G           +    + VA+K ++ +GS  +DE+  E + +  L+H 
Sbjct: 32  LGTGQFGVVKYG-----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C   +   ++ EY+  G L ++ L E       ++ +++       +E+L +
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             +  +HRD+ A N L++D    K+SDFGL+++  L D+   S        +  PE +  
Sbjct: 139 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEETSSVGSKFPVRWSPPEVLMY 195
Query: 318 GHLTLKTDVYSFGVVLLEILS-GKTAAMRRTN 348
              + K+D+++FGV++ EI S GK    R TN
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 17/213 (7%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V  G           +    + VA+K ++ +GS  +DE+  E + +  L+H 
Sbjct: 12  LGTGQFGVVKYG-----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 59
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C   +   ++ EY+  G L ++ L E       ++ +++       +E+L +
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             +  +HRD+ A N L++D    K+SDFGL+++  L D+   S        +  PE +  
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 318 GHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNG 349
              + K+D+++FGV++ EI S GK    R TN 
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 130/300 (43%), Gaps = 52/300 (17%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRL-N 195
           +G+G FG V          TA  R      VAVK L+   +  +     +EL+ L  + +
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXR-----TVAVKMLKEGATHSEHRALMSELKILIHIGH 91
Query: 196 HPNVVKLMGYCCDDQHRLLVY-EYVTRGSLEDHLLN----------EDDTE--LNWERRI 242
           H NVV L+G C      L+V  E+   G+L  +L +          ED  +  L  E  I
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHIST 301
             +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+      D      
Sbjct: 152 XYSFQVAKGMEFLAS--RKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
             L  + + APE I     T+++DV+SFGV+L EI S                A PY   
Sbjct: 210 ARLPLK-WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG--------------ASPYPGV 254
Query: 362 KLALHQIIDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           K      IDE+  R ++             E  + +L C + +P  RPT SE+V  L  L
Sbjct: 255 K------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V  G           +    + VA+K ++ +GS  +DE+  E + +  L+H 
Sbjct: 16  LGTGQFGVVKYG-----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 63
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C   +   ++ EY+  G L ++ L E       ++ +++       +E+L +
Sbjct: 64  KLVQLYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             +  +HRD+ A N L++D    K+SDFGL+++  L D+   S        +  PE +  
Sbjct: 123 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMY 179
Query: 318 GHLTLKTDVYSFGVVLLEILS-GKTAAMRRTN 348
              + K+D+++FGV++ EI S GK    R TN
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 211

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V  G           +    + VA+K ++ +GS  +DE+  E + +  L+H 
Sbjct: 17  LGTGQFGVVKYG-----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C   +   ++ EY+  G L ++ L E       ++ +++       +E+L +
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES 123
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             +  +HRD+ A N L++D    K+SDFGL+++  L D+   S        +  PE +  
Sbjct: 124 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMY 180
Query: 318 GHLTLKTDVYSFGVVLLEILS-GKTAAMRRTN 348
              + K+D+++FGV++ EI S GK    R TN
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 212

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 141/298 (47%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +    +  +   + K A   VAVK L+   ++    +  +E+  +  +  
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEA-VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------------LNE-DDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L             +N   + ++ ++  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +      ARG+E+L +  +  IHRD+ A NVL+ ++   KI+DFGLA+     D ++I  
Sbjct: 160 VSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDX 212
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV++ EI +           L G+   
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS--- 258
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V  G           +    + VA+K ++ +GS  +DE+  E + +  L+H 
Sbjct: 32  LGTGQFGVVKYG-----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C   +   ++ EY+  G L ++ L E       ++ +++       +E+L +
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             +  +HRD+ A N L++D    K+SDFGL+++  L D+   S        +  PE +  
Sbjct: 139 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 318 GHLTLKTDVYSFGVVLLEILS-GKTAAMRRTN 348
              + K+D+++FGV++ EI S GK    R TN
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 141/298 (47%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +    +  +   + K A   VAVK L+   ++    +  +E+  +  +  
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEA-VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------------LNE-DDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L             +N   + ++ ++  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +      ARG+E+L +  +  IHRD+ A NVL+ ++   KI+DFGLA+     D ++I  
Sbjct: 160 VSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDX 212
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV++ EI +           L G+   
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS--- 258
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V  G           +    + VA+K ++ +GS  +DE+  E + +  L+H 
Sbjct: 23  LGTGQFGVVKYG-----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 70
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L G C   +   ++ EY+  G L ++ L E       ++ +++       +E+L +
Sbjct: 71  KLVQLYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES 129
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             +  +HRD+ A N L++D    K+SDFGL+++  L D+   S        +  PE +  
Sbjct: 130 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMY 186
Query: 318 GHLTLKTDVYSFGVVLLEILS-GKTAAMRRTN 348
              + K+D+++FGV++ EI S GK    R TN
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 218

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 120/256 (46%), Gaps = 23/256 (8%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           +K++    IGQG  G VY       AM  A  +     VA++++  +    ++   NE+ 
Sbjct: 20  KKYTRFEKIGQGASGTVY------TAMDVATGQE----VAIRQMNLQQQPKKELIINEIL 69
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            +    +PN+V  +          +V EY+  GSL D +    +T ++  +   +     
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL 126
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL-AKFGPLGDKSHISTRVLGTRG 308
           + LE LH+    VIHRD+K+ N+LL  D + K++DFG  A+  P  ++S  ST V GT  
Sbjct: 127 QALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPY 181
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMR----RTNGLAGNWAKPYLSNKLA 364
           + APE +       K D++S G++ +E++ G+   +     R   L      P L N   
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241
Query: 365 LHQIIDEKLGRNIQME 380
           L  I  + L R + M+
Sbjct: 242 LSAIFRDFLNRCLDMD 257

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 141/298 (47%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +    +  +   + K A   VAVK L+   ++    +  +E+  +  +  
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEA-VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------------LNE-DDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L             +N   + ++ ++  
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +      ARG+E+L +  +  IHRD+ A NVL+ ++   KI+DFGLA+     D ++I  
Sbjct: 160 VSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 212
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV++ EI +           L G+   
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS--- 258
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 141/298 (47%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +    +  +   + K A   VAVK L+   ++    +  +E+  +  +  
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEA-VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------------LNE-DDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L             +N   + ++ ++  
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +      ARG+E+L +  +  IHRD+ A NVL+ ++   KI+DFGLA+     D ++I  
Sbjct: 160 VSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 212
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV++ EI +           L G+   
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS--- 258
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 141/298 (47%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +    +  +   + K A   VAVK L+   ++    +  +E+  +  +  
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEA-VTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------------LNE-DDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L             +N   + ++ ++  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +      ARG+E+L +  +  IHRD+ A NVL+ ++   KI+DFGLA+     D ++I  
Sbjct: 160 VSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 212
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV++ EI +           L G+   
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS--- 258
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 98/334 (29%), Positives = 143/334 (42%), Gaps = 69/334 (20%)
Query: 113 HAYKLKYFCHGLLEAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFA 167
           HA +L Y      +A+  +F    L     +G+G FG V          TA  R      
Sbjct: 2   HAERLPY------DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCR-----T 50
Query: 168 VAVKRLRRKGSQGQDE-WENELRFLSRL-NHPNVVKLMGYCCDDQHRLLVY-EYVTRGSL 224
           VAVK L+   +  +     +EL+ L  + +H NVV L+G C      L+V  E+   G+L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 225 EDHLLN------------EDDTE--LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKAS 270
             +L +            ED  +  L  E  I  +   A+G+E L +  R  IHRD+ A 
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAAR 168
Query: 271 NVLLDDDFNAKISDFGLAKFGPLGDKSHI---STRVLGTRGYFAPEYIATGHLTLKTDVY 327
           N+LL +    KI DFGLA+     D  ++     R+     + APE I     T+++DV+
Sbjct: 169 NILLSEKNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVW 225
Query: 328 SFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQM-------- 379
           SFGV+L EI S                A PY   K      IDE+  R ++         
Sbjct: 226 SFGVLLWEIFSLG--------------ASPYPGVK------IDEEFCRRLKEGTRMRAPD 265
Query: 380 EEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               E  + +L C + +P  RPT SE+V  L  L
Sbjct: 266 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 141/298 (47%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +    +  +   + K A   VAVK L+   ++    +  +E+  +  +  
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEA-VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------------LNE-DDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L             +N   + ++ ++  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +      ARG+E+L +  +  IHRD+ A NVL+ ++   KI+DFGLA+     D ++I  
Sbjct: 160 VSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 212
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV++ EI +           L G+   
Sbjct: 213 YKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS--- 258
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 117/220 (53%), Gaps = 24/220 (10%)
Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL----RRKGSQG 180
           +++  +++ + + +G+G F  VY           AR KN +  VA+K++    R +   G
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVY----------KARDKNTNQIVAIKKIKLGHRSEAKDG 54
Query: 181 QDEWE-NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWE 239
            +     E++ L  L+HPN++ L+       +  LV++++    LE  ++ +D++ +   
Sbjct: 55  INRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLE--VIIKDNSLVLTP 111
Query: 240 RRIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSH 298
             IK   L   +GLE+LH +W  ++HRD+K +N+LLD++   K++DFGLAK    G  + 
Sbjct: 112 SHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNR 167
Query: 299 ISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEIL 337
                + TR Y APE +    +  +  D+++ G +L E+L
Sbjct: 168 AYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 132/304 (43%), Gaps = 58/304 (19%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRL-N 195
           +G+G FG V          TA  R      VAVK L+   +  +     +EL+ L  + +
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCR-----TVAVKMLKEGATHSEHRALMSELKILIHIGH 80
Query: 196 HPNVVKLMGYCCDDQHRLLVY-EYVTRGSLEDHLLN------------EDDTE--LNWER 240
           H NVV L+G C      L+V  E+   G+L  +L +            ED  +  L  E 
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI- 299
            I  +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+     D  ++ 
Sbjct: 141 LICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVR 197
Query: 300 --STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP 357
               R+     + APE I     T+++DV+SFGV+L EI S                A P
Sbjct: 198 KGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG--------------ASP 241
Query: 358 YLSNKLALHQIIDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMSEVVAA 409
           Y   K      IDE+  R ++             E  + +L C + +P  RPT SE+V  
Sbjct: 242 YPGVK------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295
Query: 410 LEQL 413
           L  L
Sbjct: 296 LGNL 299

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 98/332 (29%), Positives = 141/332 (42%), Gaps = 65/332 (19%)
Query: 113 HAYKLKYFCHGLLEAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFA 167
           HA +L Y      +A+  +F    L     +G+G FG V          TA  R      
Sbjct: 2   HAERLPY------DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCR-----T 50
Query: 168 VAVKRLRRKGSQGQDE-WENELRFLSRL-NHPNVVKLMGYCCDDQHRLLV-YEYVTRGSL 224
           VAVK L+   +  +     +EL+ L  + +H NVV L+G C      L+V  E+   G+L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 110
Query: 225 EDHLLN------------EDDTE--LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKAS 270
             +L +            ED  +  L  E  I  +   A+G+E L +  R  IHRD+ A 
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAAR 168
Query: 271 NVLLDDDFNAKISDFGLAK-FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSF 329
           N+LL +    KI DFGLA+      D        L  + + APE I     T+++DV+SF
Sbjct: 169 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK-WMAPETIFDRVYTIQSDVWSF 227
Query: 330 GVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQM--------EE 381
           GV+L EI S                A PY   K      IDE+  R ++           
Sbjct: 228 GVLLWEIFSLG--------------ASPYPGVK------IDEEFCRRLKEGTRMRAPDYT 267
Query: 382 AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             E  + +L C + +P  RPT SE+V  L  L
Sbjct: 268 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 119/256 (46%), Gaps = 23/256 (8%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           +K++    IGQG  G VY       AM  A  +     VA++++  +    ++   NE+ 
Sbjct: 20  KKYTRFEKIGQGASGTVY------TAMDVATGQE----VAIRQMNLQQQPKKELIINEIL 69
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            +    +PN+V  +          +V EY+  GSL D +    +T ++  +   +     
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL 126
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL-AKFGPLGDKSHISTRVLGTRG 308
           + LE LH+    VIHRD+K+ N+LL  D + K++DFG  A+  P   K    + ++GT  
Sbjct: 127 QALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPY 181
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMR----RTNGLAGNWAKPYLSNKLA 364
           + APE +       K D++S G++ +E++ G+   +     R   L      P L N   
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241
Query: 365 LHQIIDEKLGRNIQME 380
           L  I  + L R ++M+
Sbjct: 242 LSAIFRDFLNRCLEMD 257

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 119/256 (46%), Gaps = 23/256 (8%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           +K++    IGQG  G VY       AM  A  +     VA++++  +    ++   NE+ 
Sbjct: 21  KKYTRFEKIGQGASGTVY------TAMDVATGQE----VAIRQMNLQQQPKKELIINEIL 70
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            +    +PN+V  +          +V EY+  GSL D +    +T ++  +   +     
Sbjct: 71  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL 127
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL-AKFGPLGDKSHISTRVLGTRG 308
           + LE LH+    VIHRD+K+ N+LL  D + K++DFG  A+  P   K    + ++GT  
Sbjct: 128 QALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPY 182
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMR----RTNGLAGNWAKPYLSNKLA 364
           + APE +       K D++S G++ +E++ G+   +     R   L      P L N   
Sbjct: 183 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 242
Query: 365 LHQIIDEKLGRNIQME 380
           L  I  + L R ++M+
Sbjct: 243 LSAIFRDFLNRCLEMD 258

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 98/332 (29%), Positives = 141/332 (42%), Gaps = 65/332 (19%)
Query: 113 HAYKLKYFCHGLLEAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFA 167
           HA +L Y      +A+  +F    L     +G+G FG V          TA  R      
Sbjct: 2   HAERLPY------DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCR-----T 50
Query: 168 VAVKRLRRKGSQGQDE-WENELRFLSRL-NHPNVVKLMGYCCDDQHRLLVY-EYVTRGSL 224
           VAVK L+   +  +     +EL+ L  + +H NVV L+G C      L+V  E+   G+L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 225 EDHLLN------------EDDTE--LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKAS 270
             +L +            ED  +  L  E  I  +   A+G+E L +  R  IHRD+ A 
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAAR 168
Query: 271 NVLLDDDFNAKISDFGLAK-FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSF 329
           N+LL +    KI DFGLA+      D        L  + + APE I     T+++DV+SF
Sbjct: 169 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK-WMAPETIFDRVYTIQSDVWSF 227
Query: 330 GVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQM--------EE 381
           GV+L EI S                A PY   K      IDE+  R ++           
Sbjct: 228 GVLLWEIFSLG--------------ASPYPGVK------IDEEFCRRLKEGTRMRAPDYT 267
Query: 382 AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             E  + +L C + +P  RPT SE+V  L  L
Sbjct: 268 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 130/301 (43%), Gaps = 53/301 (17%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRL-N 195
           +G+G FG V          TA  R      VAVK L+   +  +     +EL+ L  + +
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCR-----TVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 196 HPNVVKLMGYCCDDQHRLLV-YEYVTRGSLEDHLLN-----------EDDTE--LNWERR 241
           H NVV L+G C      L+V  E+   G+L  +L +           ED  +  L  E  
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHIS 300
           I  +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+      D     
Sbjct: 151 ICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS 360
              L  + + APE I     T+++DV+SFGV+L EI S                A PY  
Sbjct: 209 DARLPLK-WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG--------------ASPYPG 253
Query: 361 NKLALHQIIDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
            K      IDE+  R ++             E  + +L C + +P  RPT SE+V  L  
Sbjct: 254 VK------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307
Query: 413 L 413
           L
Sbjct: 308 L 308

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 132/304 (43%), Gaps = 58/304 (19%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRL-N 195
           +G+G FG V          TA  R      VAVK L+   +  +     +EL+ L  + +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCR-----TVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 196 HPNVVKLMGYCCDDQHRLLV-YEYVTRGSLEDHLLN------------EDDTE--LNWER 240
           H NVV L+G C      L+V  E+   G+L  +L +            ED  +  L  E 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI- 299
            I  +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+     D  ++ 
Sbjct: 150 LICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVR 206
Query: 300 --STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP 357
               R+     + APE I     T+++DV+SFGV+L EI S                A P
Sbjct: 207 KGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG--------------ASP 250
Query: 358 YLSNKLALHQIIDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMSEVVAA 409
           Y   K      IDE+  R ++             E  + +L C + +P  RPT SE+V  
Sbjct: 251 YPGVK------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
Query: 410 LEQL 413
           L  L
Sbjct: 305 LGNL 308

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 132/304 (43%), Gaps = 58/304 (19%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRL-N 195
           +G+G FG V          TA  R      VAVK L+   +  +     +EL+ L  + +
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCR-----TVAVKMLKEGATHSEHRALMSELKILIHIGH 91
Query: 196 HPNVVKLMGYCCDDQHRLLV-YEYVTRGSLEDHLLN------------EDDTE--LNWER 240
           H NVV L+G C      L+V  E+   G+L  +L +            ED  +  L  E 
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEH 151
Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI- 299
            I  +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+     D  ++ 
Sbjct: 152 LICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVR 208
Query: 300 --STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP 357
               R+     + APE I     T+++DV+SFGV+L EI S                A P
Sbjct: 209 KGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG--------------ASP 252
Query: 358 YLSNKLALHQIIDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMSEVVAA 409
           Y   K      IDE+  R ++             E  + +L C + +P  RPT SE+V  
Sbjct: 253 YPGVK------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306
Query: 410 LEQL 413
           L  L
Sbjct: 307 LGNL 310

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 141/298 (47%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +    +  +   + K A   VAVK L+   ++    +  +E+  +  +  
Sbjct: 30  LGEGCFGQVVMA--EAVGIDKDKPKEA-VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------------LNE-DDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L             +N   + ++ ++  
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +      ARG+E+L +  +  IHRD+ A NVL+ ++   KI+DFGLA+     D ++I  
Sbjct: 147 VSCTYQLARGMEYLAS--QKCIHRDLTARNVLVTENNVMKIADFGLAR-----DINNIDY 199
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV++ EI +           L G+   
Sbjct: 200 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS--- 245
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 246 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 303

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 132/304 (43%), Gaps = 58/304 (19%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRL-N 195
           +G+G FG V          TA  R      VAVK L+   +  +     +EL+ L  + +
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCR-----TVAVKMLKEGATHSEHRALMSELKILIHIGH 126
Query: 196 HPNVVKLMGYCCDDQHRLLV-YEYVTRGSLEDHLLN------------EDDTE--LNWER 240
           H NVV L+G C      L+V  E+   G+L  +L +            ED  +  L  E 
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI- 299
            I  +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+     D  ++ 
Sbjct: 187 LICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVR 243
Query: 300 --STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP 357
               R+     + APE I     T+++DV+SFGV+L EI S                A P
Sbjct: 244 KGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG--------------ASP 287
Query: 358 YLSNKLALHQIIDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMSEVVAA 409
           Y   K      IDE+  R ++             E  + +L C + +P  RPT SE+V  
Sbjct: 288 YPGVK------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341
Query: 410 LEQL 413
           L  L
Sbjct: 342 LGNL 345

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 141/298 (47%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +    +  +   + K A   VAVK L+   ++    +  +E+  +  +  
Sbjct: 89  LGEGCFGQVVMA--EAVGIDKDKPKEA-VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------------LNE-DDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L             +N   + ++ ++  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +      ARG+E+L +  +  IHRD+ A NVL+ ++   KI+DFGLA+     D ++I  
Sbjct: 206 VSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 258
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV++ EI +           L G+   
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS--- 304
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 305 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 141/298 (47%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +    +  +   + K A   VAVK L+   ++    +  +E+  +  +  
Sbjct: 35  LGEGCFGQVVMA--EAVGIDKDKPKEA-VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------------LNE-DDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L             +N   + ++ ++  
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +      ARG+E+L +  +  IHRD+ A NVL+ ++   KI+DFGLA+     D ++I  
Sbjct: 152 VSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 204
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV++ EI +           L G+   
Sbjct: 205 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS--- 250
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 251 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 308

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 141/298 (47%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +    +  +   + K A   VAVK L+   ++    +  +E+  +  +  
Sbjct: 32  LGEGCFGQVVMA--EAVGIDKDKPKEA-VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------------LNE-DDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L             +N   + ++ ++  
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +      ARG+E+L +  +  IHRD+ A NVL+ ++   KI+DFGLA+     D ++I  
Sbjct: 149 VSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 201
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV++ EI +           L G+   
Sbjct: 202 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS--- 247
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 248 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 305

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 130/302 (43%), Gaps = 54/302 (17%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRL-N 195
           +G+G FG V          TA  R      VAVK L+   +  +     +EL+ L  + +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCR-----TVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 196 HPNVVKLMGYCCDDQHRLLVY-EYVTRGSLEDHLLN------------EDDTE--LNWER 240
           H NVV L+G C      L+V  E+   G+L  +L +            ED  +  L  E 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHI 299
            I  +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+      D    
Sbjct: 150 LICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 300 STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
               L  + + APE I     T+++DV+SFGV+L EI S                A PY 
Sbjct: 208 GDARLPLK-WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG--------------ASPYP 252
Query: 360 SNKLALHQIIDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
             K      IDE+  R ++             E  + +L C + +P  RPT SE+V  L 
Sbjct: 253 GVK------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306
Query: 412 QL 413
            L
Sbjct: 307 NL 308

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 141/298 (47%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +    +  +   + K A   VAVK L+   ++    +  +E+  +  +  
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEA-VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------------LNE-DDTELNWERR 241
           H N++ L+G C  D    ++ EY ++G+L ++L             +N   + ++ ++  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +      ARG+E+L +  +  IHRD+ A NVL+ ++   +I+DFGLA+     D ++I  
Sbjct: 160 VSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMRIADFGLAR-----DINNIDY 212
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV++ EI +           L G+   
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS--- 258
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 133/296 (44%), Gaps = 41/296 (13%)
Query: 123 GLLEAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK- 176
           G ++   R F E  L     +G G FG V+ G      +     ++    V +K +  K 
Sbjct: 1   GAMKVLARIFKETELRKLKVLGSGVFGTVHKG------VWIPEGESIKIPVCIKVIEDKS 54
Query: 177 GSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNE----- 231
           G Q      + +  +  L+H ++V+L+G C     +L V +Y+  GSL DH+        
Sbjct: 55  GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALG 113
Query: 232 DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG 291
               LNW  +I      A+G+ +L  +   ++HR++ A NVLL      +++DFG+A   
Sbjct: 114 PQLLLNWGVQI------AKGMYYLEEH--GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165
Query: 292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA 351
           P  DK  + +       + A E I  G  T ++DV+S+GV + E++         T G  
Sbjct: 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM---------TFG-- 214
Query: 352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEV 406
              A+PY   +LA    + EK  R  Q +    +   ++++C   D   RPT  E+
Sbjct: 215 ---AEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 267

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 142/303 (46%), Gaps = 53/303 (17%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINS----CAMTAARRK----NADFAVAVKRLRRKGSQGQ- 181
           +++ K+ IG+G +G V + Y  +     AM    +K     A F         + + G  
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 182 -------DEWENELRFLSRLNHPNVVKLMGYCCD--DQHRLLVYEYVTRGSLED----HL 228
                  ++   E+  L +L+HPNVVKL+    D  + H  +V+E V +G + +      
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 229 LNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA 288
           L+ED     ++  IK       G+E+LH  ++ +IHRD+K SN+L+ +D + KI+DFG++
Sbjct: 134 LSEDQARFYFQDLIK-------GIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLK---TDVYSFGVVLLEILSGKTAAMR 345
                     + +  +GT  + APE ++           DV++ GV L   + G+     
Sbjct: 185 N--EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC---- 238
Query: 346 RTNGLAGNWAKPYLSNK-LALH-QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM 403
                      P++  + + LH +I  + L    Q + A++  ++I R L+ +P++R  +
Sbjct: 239 -----------PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV 287
Query: 404 SEV 406
            E+
Sbjct: 288 PEI 290

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 118/256 (46%), Gaps = 23/256 (8%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           +K++    IGQG  G VY       AM  A  +     VA++++  +    ++   NE+ 
Sbjct: 20  KKYTRFEKIGQGASGTVY------TAMDVATGQE----VAIRQMNLQQQPKKELIINEIL 69
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            +    +PN+V  +          +V EY+  GSL D +    +T ++  +   +     
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL 126
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL-AKFGPLGDKSHISTRVLGTRG 308
           + LE LH+    VIHRD+K+ N+LL  D + K++DFG  A+  P   K    + ++GT  
Sbjct: 127 QALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPY 181
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMR----RTNGLAGNWAKPYLSNKLA 364
           + APE +       K D++S G++ +E++ G+   +     R   L      P L N   
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241
Query: 365 LHQIIDEKLGRNIQME 380
           L  I  + L R + M+
Sbjct: 242 LSAIFRDFLNRCLDMD 257

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 121/256 (47%), Gaps = 23/256 (8%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           +K++    IGQG  G VY       AM  A  +     VA++++  +    ++   NE+ 
Sbjct: 21  KKYTRFEKIGQGASGTVY------TAMDVATGQE----VAIRQMNLQQQPKKELIINEIL 70
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            +    +PN+V  +          +V EY+  GSL D +    +T ++  +   +     
Sbjct: 71  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL 127
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL-AKFGPLGDKSHISTRVLGTRG 308
           + LE LH+    VIHR++K+ N+LL  D + K++DFG  A+  P  ++S  ST V GT  
Sbjct: 128 QALEFLHS--NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPY 182
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMR----RTNGLAGNWAKPYLSNKLA 364
           + APE +       K D++S G++ +E++ G+   +     R   L      P L N   
Sbjct: 183 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 242
Query: 365 LHQIIDEKLGRNIQME 380
           L  I  + L R ++M+
Sbjct: 243 LSAIFRDFLNRCLEMD 258

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 133/293 (45%), Gaps = 41/293 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRLN- 195
           +G G FG V    + + A    + ++A   VAVK L+      + E   +EL+ +S L  
Sbjct: 54  LGAGAFGKV----VEATAFGLGK-EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL------LNED------DTELNWERRIK 243
           H N+V L+G C      L++ EY   G L + L      L  D      ++ L+    + 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
            +   A+G+  L +  +  IHRDV A NVLL +   AKI DFGLA+   + D ++I   V
Sbjct: 169 FSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYI---V 222
Query: 304 LGTR----GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
            G       + APE I     T+++DV+S+G++L EI S           L  N     L
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-----------LGLNPYPGIL 271
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
            N    ++++ +           +    I+  C   +P +RPT  ++ + L++
Sbjct: 272 VNS-KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 123/277 (44%), Gaps = 40/277 (14%)
Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD---EWENELRFLS 192
           + +G G FG V IG            +     VAVK L R+  +  D   + + E++ L 
Sbjct: 17  DTLGVGTFGKVKIG----------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
              HP+++KL           +V EYV+ G L D++      E    RR+   + +A   
Sbjct: 67  LFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            H H     V+HRD+K  NVLLD   NAKI+DFGL+    + D   + T   G+  Y AP
Sbjct: 127 CHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTSC-GSPNYAAP 179
Query: 313 EYIATGHLTL--KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI-I 369
           E I +G L    + D++S GV+L  +L G             +   P L  K+      I
Sbjct: 180 EVI-SGRLYAGPEVDIWSCGVILYALLCGTLP--------FDDEHVPTLFKKIRGGVFYI 230
Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
            E L R++        A +++  L  DP  R T+ ++
Sbjct: 231 PEYLNRSV--------ATLLMHMLQVDPLKRATIKDI 259

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 130/302 (43%), Gaps = 54/302 (17%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRL-N 195
           +G+G FG V          TA  R      VAVK L+   +  +     +EL+ L  + +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCR-----TVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 196 HPNVVKLMGYCCDDQHRLLVY-EYVTRGSLEDHLLN------------EDDTE--LNWER 240
           H NVV L+G C      L+V  E+   G+L  +L +            ED  +  L  E 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHI 299
            I  +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+      D    
Sbjct: 150 LICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRK 207
Query: 300 STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
               L  + + APE I     T+++DV+SFGV+L EI S                A PY 
Sbjct: 208 GDARLPLK-WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG--------------ASPYP 252
Query: 360 SNKLALHQIIDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
             K      IDE+  R ++             E  + +L C + +P  RPT SE+V  L 
Sbjct: 253 GVK------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306
Query: 412 QL 413
            L
Sbjct: 307 NL 308

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 123 GLLEAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----R 172
            L E   RKF+  +      +G+G FG+VY+          AR K   F +A+K     +
Sbjct: 2   ALAEMPKRKFTIDDFDIVRPLGKGKFGNVYL----------AREKQNKFIMALKVLFKSQ 51
Query: 173 LRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED 232
           L ++G + Q   E E++  S L HPN++++  Y  D +   L+ E+  RG L   L  + 
Sbjct: 52  LEKEGVEHQLRREIEIQ--SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QK 107
Query: 233 DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP 292
               + +R        A  L + H   R VIHRD+K  N+L+      KI+DFG +   P
Sbjct: 108 HGRFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165
Query: 293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               S     + GT  Y  PE I       K D++  GV+  E L G
Sbjct: 166 ----SLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 111/236 (47%), Gaps = 26/236 (11%)
Query: 115 YKLKYFCHGLLEAATRK---FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNA-DFAVAV 170
           Y L++     LEA       F +  ++G+GGFG+V+     +C M A  +  A       
Sbjct: 167 YFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVF-----ACQMKATGKLYACKKLNKK 221
Query: 171 KRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLL 229
           +  +RKG QG      E + L+++ H   +  + Y  + +  L LV   +  G +  H+ 
Sbjct: 222 RLKKRKGYQGA---MVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277
Query: 230 N--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
           N  ED+      R I        GLEHLH   R +I+RD+K  NVLLDDD N +ISD GL
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 288 A---KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           A   K G    K +      GT G+ APE +         D ++ GV L E+++ +
Sbjct: 336 AVELKAGQTKTKGYA-----GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 111/236 (47%), Gaps = 26/236 (11%)
Query: 115 YKLKYFCHGLLEAATRK---FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNA-DFAVAV 170
           Y L++     LEA       F +  ++G+GGFG+V+     +C M A  +  A       
Sbjct: 167 YFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVF-----ACQMKATGKLYACKKLNKK 221
Query: 171 KRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLL 229
           +  +RKG QG      E + L+++ H   +  + Y  + +  L LV   +  G +  H+ 
Sbjct: 222 RLKKRKGYQGA---MVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277
Query: 230 N--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
           N  ED+      R I        GLEHLH   R +I+RD+K  NVLLDDD N +ISD GL
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 288 A---KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           A   K G    K +      GT G+ APE +         D ++ GV L E+++ +
Sbjct: 336 AVELKAGQTKTKGYA-----GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 111/236 (47%), Gaps = 26/236 (11%)
Query: 115 YKLKYFCHGLLEAATRK---FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNA-DFAVAV 170
           Y L++     LEA       F +  ++G+GGFG+V+     +C M A  +  A       
Sbjct: 167 YFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVF-----ACQMKATGKLYACKKLNKK 221
Query: 171 KRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLL 229
           +  +RKG QG      E + L+++ H   +  + Y  + +  L LV   +  G +  H+ 
Sbjct: 222 RLKKRKGYQGA---MVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277
Query: 230 N--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
           N  ED+      R I        GLEHLH   R +I+RD+K  NVLLDDD N +ISD GL
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 288 A---KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           A   K G    K +      GT G+ APE +         D ++ GV L E+++ +
Sbjct: 336 AVELKAGQTKTKGYA-----GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 123 GLLEAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----R 172
            L E   RKF+  +      +G+G FG+VY+          AR K   F +A+K     +
Sbjct: 3   ALAEMPKRKFTIDDFDIGRPLGKGKFGNVYL----------AREKQNKFIMALKVLFKSQ 52
Query: 173 LRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED 232
           L ++G + Q   E E++  S L HPN++++  Y  D +   L+ E+  RG L   L  + 
Sbjct: 53  LEKEGVEHQLRREIEIQ--SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QK 108
Query: 233 DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP 292
               + +R        A  L + H   R VIHRD+K  N+L+      KI+DFG +   P
Sbjct: 109 HGRFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 166
Query: 293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               S     + GT  Y  PE I       K D++  GV+  E L G
Sbjct: 167 ----SLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F    ++G+G FG V++          A  K  +   A+K L++      D+ E    E 
Sbjct: 20  FELHKMLGKGSFGKVFL----------AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 69
Query: 189 RFLS-RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           R LS    HP +  +       ++   V EY+  G L  H+ +    +L+  R    A  
Sbjct: 70  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYAAE 127
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
              GL+ LH+  + +++RD+K  N+LLD D + KI+DFG+ K   LGD    +    GT 
Sbjct: 128 IILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFCGTP 183
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
            Y APE +         D +SFGV+L E+L G++
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 217

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 111/236 (47%), Gaps = 26/236 (11%)
Query: 115 YKLKYFCHGLLEAATRK---FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNA-DFAVAV 170
           Y L++     LEA       F +  ++G+GGFG+V+     +C M A  +  A       
Sbjct: 167 YFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVF-----ACQMKATGKLYACKKLNKK 221
Query: 171 KRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLL 229
           +  +RKG QG      E + L+++ H   +  + Y  + +  L LV   +  G +  H+ 
Sbjct: 222 RLKKRKGYQGA---MVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277
Query: 230 N--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
           N  ED+      R I        GLEHLH   R +I+RD+K  NVLLDDD N +ISD GL
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 288 A---KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           A   K G    K +      GT G+ APE +         D ++ GV L E+++ +
Sbjct: 336 AVELKAGQTKTKGYA-----GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 113/218 (51%), Gaps = 19/218 (8%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +A   +F    ++GQG FG V++  +   + + AR+       A+K L++   + +D   
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFL--VKKISGSDARQ-----LYAMKVLKKATLKVRDRVR 72
Query: 186 NELR--FLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRI 242
            ++    L  +NHP +VKL  Y    + +L L+ +++  G L   L  E    +  E  +
Sbjct: 73  TKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDV 128
Query: 243 KIALGA-ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           K  L   A  L+HLH+    +I+RD+K  N+LLD++ + K++DFGL+K     +K   S 
Sbjct: 129 KFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS- 185
Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
              GT  Y APE +     T   D +SFGV++ E+L+G
Sbjct: 186 -FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 140/298 (46%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +    +  +   + K A   VAVK L+   ++    +  +E+  +  +  
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEA-VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------------LNE-DDTELNWERR 241
           H N++ L+G C  D    ++  Y ++G+L ++L             +N   + ++ ++  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +      ARG+E+L +  +  IHRD+ A NVL+ ++   KI+DFGLA+     D ++I  
Sbjct: 160 VSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 212
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV++ EI +           L G+   
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS--- 258
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 14/216 (6%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F +  ++G+GGFG+V      +C + A  +  A     +++ R K  +G+    NE + L
Sbjct: 186 FRQYRVLGKGGFGEV-----CACQVRATGKMYA--CKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 192 SRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
            ++N   VV L  Y  + +  L LV   +  G L+ H+ +         R +  A     
Sbjct: 239 EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC 297
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GLE LH     +++RD+K  N+LLDD  + +ISD GLA   P G    I  RV GT GY 
Sbjct: 298 GLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYM 352
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRR 346
           APE +     T   D ++ G +L E+++G++   +R
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLS- 192
           ++G+G FG V++          A  K  +   A+K L++      D+ E    E R LS 
Sbjct: 24  MLGKGSFGKVFL----------AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
              HP +  +       ++   V EY+  G L  H+ +    +L+  R    A     GL
Sbjct: 74  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYAAEIILGL 131
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           + LH+  + +++RD+K  N+LLD D + KI+DFG+ K   LGD    +    GT  Y AP
Sbjct: 132 QFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCGTPDYIAP 187
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           E +         D +SFGV+L E+L G++
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQS 216

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 140/298 (46%), Gaps = 46/298 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLN- 195
           +G+G FG V +    +  +   + K A   VAVK L+   ++    +  +E+  +  +  
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEA-VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------------LNE-DDTELNWERR 241
           H N++ L+G C  D    ++  Y ++G+L ++L             +N   + ++ ++  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +      ARG+E+L +  +  IHRD+ A NVL+ ++   KI+DFGLA+     D ++I  
Sbjct: 160 VSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 212
Query: 302 RVLGTRG-----YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
               T G     + APE +     T ++DV+SFGV++ EI +           L G+   
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS--- 258
Query: 357 PYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 14/216 (6%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F +  ++G+GGFG+V      +C + A  +  A     +++ R K  +G+    NE + L
Sbjct: 186 FRQYRVLGKGGFGEV-----CACQVRATGKMYA--CKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 192 SRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
            ++N   VV L  Y  + +  L LV   +  G L+ H+ +         R +  A     
Sbjct: 239 EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC 297
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GLE LH     +++RD+K  N+LLDD  + +ISD GLA   P G    I  RV GT GY 
Sbjct: 298 GLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYM 352
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRR 346
           APE +     T   D ++ G +L E+++G++   +R
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 30/227 (13%)
Query: 123 GLLEAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----R 172
           G  +  TR F+  +      +G+G FG+VY+          AR K + F VA+K     +
Sbjct: 11  GTPDILTRHFTIDDFEIGRPLGKGKFGNVYL----------AREKKSHFIVALKVLFKSQ 60
Query: 173 LRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED 232
           + ++G + Q   E E++  + L+HPN+++L  Y  D +   L+ EY  RG L   L  + 
Sbjct: 61  IEKEGVEHQLRREIEIQ--AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL--QK 116
Query: 233 DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP 292
               + +R   I    A  L + H   + VIHRD+K  N+LL      KI+DFG +   P
Sbjct: 117 SCTFDEQRTATIMEELADALMYCHG--KKVIHRDIKPENLLLGLKGELKIADFGWSVHAP 174
Query: 293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               S     + GT  Y  PE I       K D++  GV+  E+L G
Sbjct: 175 ----SLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++GQG FG V++       +    R ++    A+K L++   + +D    ++   
Sbjct: 30  FELLKVLGQGSFGKVFL-------VRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERD 82
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
            L+ +NHP VVKL  Y    + +L L+ +++  G L   L  E    +  E  +K  L  
Sbjct: 83  ILADVNHPFVVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAE 138
Query: 249 -ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
            A GL+HLH+    +I+RD+K  N+LLD++ + K++DFGL+K     +K   S    GT 
Sbjct: 139 LALGLDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTV 194
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            Y APE +     +   D +S+GV++ E+L+G
Sbjct: 195 EYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 136/298 (45%), Gaps = 38/298 (12%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFA-VAVKRLRRK--GSQGQDEWEN 186
           ++F+   ++G+G FG V    +        ++++  F  VAVK L+     S   +E+  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQL--------KQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHR------LLVYEYVTRGSLEDHLL----NEDDTEL 236
           E   +   +HP+V KL+G     + +      +++  ++  G L   LL     E+   L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
             +  ++  +  A G+E+L +  R  IHRD+ A N +L +D    ++DFGL++    GD 
Sbjct: 135 PLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWA 355
                       + A E +A    T+ +DV++FGV + EI++ G+T      N    N  
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN-- 250
Query: 356 KPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             YL     L Q            E  +E  +++ +C ++DPK RP+ + +   LE +
Sbjct: 251 --YLIGGNRLKQ----------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 132/282 (46%), Gaps = 34/282 (12%)
Query: 130 RKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           +++     +G+GGF   Y I  +++  + A +       V  K +  K  Q +++   E+
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGK-------VVPKSMLLKPHQ-KEKMSTEI 93
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIKIALG 247
                L++P+VV   G+  DD    +V E   R SL E H   +  TE      ++  + 
Sbjct: 94  AIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI- 152
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHISTRVLGT 306
             +G+++LH     VIHRD+K  N+ L+DD + KI DFGLA K    G++      + GT
Sbjct: 153 --QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT---LCGT 205
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             Y APE +     + + D++S G +L  +L GK                P+ ++ L   
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKP---------------PFETSCLKET 250
Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
            I  +K   ++        + +I R L++DP  RP+++E++ 
Sbjct: 251 YIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPSVAELLT 292

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 132/282 (46%), Gaps = 34/282 (12%)
Query: 130 RKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           +++     +G+GGF   Y I  +++  + A +       V  K +  K  Q +++   E+
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGK-------VVPKSMLLKPHQ-KEKMSTEI 93
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIKIALG 247
                L++P+VV   G+  DD    +V E   R SL E H   +  TE      ++  + 
Sbjct: 94  AIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI- 152
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHISTRVLGT 306
             +G+++LH     VIHRD+K  N+ L+DD + KI DFGLA K    G++      + GT
Sbjct: 153 --QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGT 205
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             Y APE +     + + D++S G +L  +L GK                P+ ++ L   
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKP---------------PFETSCLKET 250
Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
            I  +K   ++        + +I R L++DP  RP+++E++ 
Sbjct: 251 YIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPSVAELLT 292

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD---EWENELRFLS 192
           + +G G FG V +G          + +     VAVK L R+  +  D   +   E++ L 
Sbjct: 22  DTLGVGTFGKVKVG----------KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK 71
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
              HP+++KL           +V EYV+ G L D++      +    RR+   + +  G+
Sbjct: 72  LFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--GV 129
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           ++ H +   V+HRD+K  NVLLD   NAKI+DFGL+     G+    S    G+  Y AP
Sbjct: 130 DYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAP 184
Query: 313 EYIATGHLTL--KTDVYSFGVVLLEILSG 339
           E I +G L    + D++S GV+L  +L G
Sbjct: 185 EVI-SGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 20/217 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD--EWENELRFLSRLN 195
           +G G FG V  G      +   R+K  D A+ V    ++G++  D  E   E + + +L+
Sbjct: 18  LGCGNFGSVRQG------VYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLD 68
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           +P +V+L+G  C  +  +LV E    G L   L+ + + E+      ++    + G+++L
Sbjct: 69  NPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYL 126
Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG-DKSHISTRVLGTR--GYFAP 312
               +  +HRD+ A NVLL +   AKISDFGL+K   LG D S+ + R  G     ++AP
Sbjct: 127 EE--KNFVHRDLAARNVLLVNRHYAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAP 182
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
           E I     + ++DV+S+GV + E LS      ++  G
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENEL 188
           F   NL+G+G F  VY           A   +    VA+K + +K    +      +NE+
Sbjct: 13  FKVGNLLGKGSFAGVY----------RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
           +   +L HP++++L  Y  D  +  LV E    G +  +L N        E R       
Sbjct: 63  KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQI 121
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
             G+ +LH++   ++HRD+  SN+LL  + N KI+DFGLA    +  + H +  + GT  
Sbjct: 122 ITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPN 177
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           Y +PE        L++DV+S G +   +L G+
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 113/218 (51%), Gaps = 19/218 (8%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +A   +F    ++GQG FG V++  +   + + AR+       A+K L++   + +D   
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFL--VKKISGSDARQ-----LYAMKVLKKATLKVRDRVR 73
Query: 186 NELR--FLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRI 242
            ++    L  +NHP +VKL  Y    + +L L+ +++  G L   L  E    +  E  +
Sbjct: 74  TKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDV 129
Query: 243 KIALGA-ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           K  L   A  L+HLH+    +I+RD+K  N+LLD++ + K++DFGL+K     +K   S 
Sbjct: 130 KFYLAELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS- 186
Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
              GT  Y APE +     T   D +SFGV++ E+L+G
Sbjct: 187 -FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 113/218 (51%), Gaps = 19/218 (8%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           +A   +F    ++GQG FG V++  +   + + AR+       A+K L++   + +D   
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFL--VKKISGSDARQ-----LYAMKVLKKATLKVRDRVR 72
Query: 186 NELR--FLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRI 242
            ++    L  +NHP +VKL  Y    + +L L+ +++  G L   L  E    +  E  +
Sbjct: 73  TKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDV 128
Query: 243 KIALGA-ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           K  L   A  L+HLH+    +I+RD+K  N+LLD++ + K++DFGL+K     +K   S 
Sbjct: 129 KFYLAELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS- 185
Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
              GT  Y APE +     T   D +SFGV++ E+L+G
Sbjct: 186 -FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 122/277 (44%), Gaps = 40/277 (14%)
Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD---EWENELRFLS 192
           + +G G FG V IG            +     VAVK L R+  +  D   + + E++ L 
Sbjct: 17  DTLGVGTFGKVKIG----------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
              HP+++KL           +V EYV+ G L D++      E    RR+   + +A   
Sbjct: 67  LFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            H H     V+HRD+K  NVLLD   NAKI+DFGL+     G+    S    G+  Y AP
Sbjct: 127 CHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAP 179
Query: 313 EYIATGHLTL--KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI-I 369
           E I +G L    + D++S GV+L  +L G             +   P L  K+      I
Sbjct: 180 EVI-SGRLYAGPEVDIWSCGVILYALLCGTLP--------FDDEHVPTLFKKIRGGVFYI 230
Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
            E L R++        A +++  L  DP  R T+ ++
Sbjct: 231 PEYLNRSV--------ATLLMHMLQVDPLKRATIKDI 259

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 132/295 (44%), Gaps = 43/295 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRLN- 195
           +G G FG V    + + A    + ++A   VAVK L+      + E   +EL+ +S L  
Sbjct: 54  LGAGAFGKV----VEATAFGLGK-EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--------------LNEDDTELNWERR 241
           H N+V L+G C      L++ EY   G L + L               +  + +L+    
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +  +   A+G+  L +  +  IHRDV A NVLL +   AKI DFGLA+   + D ++I  
Sbjct: 169 LHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYI-- 223
Query: 302 RVLGTR----GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP 357
            V G       + APE I     T+++DV+S+G++L EI S           L  N    
Sbjct: 224 -VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-----------LGLNPYPG 271
Query: 358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
            L N    ++++ +           +    I+  C   +P +RPT  ++ + L++
Sbjct: 272 ILVNS-KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 325

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 132/282 (46%), Gaps = 34/282 (12%)
Query: 130 RKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           +++     +G+GGF   Y I  +++  + A +       V  K +  K  Q +++   E+
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGK-------VVPKSMLLKPHQ-KEKMSTEI 93
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIKIALG 247
                L++P+VV   G+  DD    +V E   R SL E H   +  TE      ++  + 
Sbjct: 94  AIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI- 152
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHISTRVLGT 306
             +G+++LH     VIHRD+K  N+ L+DD + KI DFGLA K    G++      + GT
Sbjct: 153 --QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGT 205
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             Y APE +     + + D++S G +L  +L GK                P+ ++ L   
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKP---------------PFETSCLKET 250
Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
            I  +K   ++        + +I R L++DP  RP+++E++ 
Sbjct: 251 YIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPSVAELLT 292

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 41/290 (14%)
Query: 129 TRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQD 182
            R F E  L     +G G FG V+ G      +     ++    V +K +  K G Q   
Sbjct: 25  ARIFKETELRKLKVLGSGVFGTVHKG------VWIPEGESIKIPVCIKVIEDKSGRQSFQ 78
Query: 183 EWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNE-----DDTELN 237
              + +  +  L+H ++V+L+G C     +L V +Y+  GSL DH+            LN
Sbjct: 79  AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLN 137
Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
           W  +I      A+G+ +L  +   ++HR++ A NVLL      +++DFG+A   P  DK 
Sbjct: 138 WGVQI------AKGMYYLEEH--GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189
Query: 298 HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP 357
            + +       + A E I  G  T ++DV+S+GV + E++         T G     A+P
Sbjct: 190 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM---------TFG-----AEP 235
Query: 358 YLSNKLALHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEV 406
           Y   +LA    + EK  R  Q +    +   ++++C   D   RPT  E+
Sbjct: 236 YAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 285

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G FG           +  +      + +    + R  S+ ++E   E+  L+ + HP
Sbjct: 32  IGEGSFGKA--------ILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSL------EDHLLNEDDTELNWERRIKIALGAARG 251
           N+V+      ++    +V +Y   G L      +  +L ++D  L+W  +I +AL     
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL----- 138
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
            +H+H   R ++HRD+K+ N+ L  D   ++ DFG+A+   L     ++   +GT  Y +
Sbjct: 139 -KHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLS 193
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
           PE         K+D+++ G VL E+ + K A
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 132/293 (45%), Gaps = 41/293 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRLN- 195
           +G G FG V    + + A    + ++A   VAVK L+      + E   +EL+ +S L  
Sbjct: 54  LGAGAFGKV----VEATAFGLGK-EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL------LNED------DTELNWERRIK 243
           H N+V L+G C      L++ EY   G L + L      L  D      ++  +    + 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
            +   A+G+  L +  +  IHRDV A NVLL +   AKI DFGLA+   + D ++I   V
Sbjct: 169 FSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYI---V 222
Query: 304 LGTR----GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
            G       + APE I     T+++DV+S+G++L EI S           L  N     L
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-----------LGLNPYPGIL 271
Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
            N    ++++ +           +    I+  C   +P +RPT  ++ + L++
Sbjct: 272 VNS-KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G  G V I          A  K+    VAVK++  +  Q ++   NE+  +   +H 
Sbjct: 53  IGEGSTGIVCI----------ATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHD 102
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVV +           +V E++  G+L D + +   T +N E+   + L   R L +LH 
Sbjct: 103 NVVDMYSSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHN 159
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + VIHRD+K+ ++LL  D   K+SDFG      +  +      ++GT  + APE I+ 
Sbjct: 160 --QGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKXLVGTPYWMAPEVISR 215
Query: 318 GHLTLKTDVYSFGVVLLEILSGKTA--------AMRR 346
                + D++S G++++E++ G+          AMRR
Sbjct: 216 LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR 252

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 132/282 (46%), Gaps = 34/282 (12%)
Query: 130 RKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
           +++     +G+GGF   Y I  +++  + A +       V  K +  K  Q +++   E+
Sbjct: 26  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGK-------VVPKSMLLKPHQ-KEKMSTEI 77
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIKIALG 247
                L++P+VV   G+  DD    +V E   R SL E H   +  TE      ++  + 
Sbjct: 78  AIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI- 136
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHISTRVLGT 306
             +G+++LH     VIHRD+K  N+ L+DD + KI DFGLA K    G++      + GT
Sbjct: 137 --QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGT 189
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             Y APE +     + + D++S G +L  +L GK                P+ ++ L   
Sbjct: 190 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKP---------------PFETSCLKET 234
Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
            I  +K   ++        + +I R L++DP  RP+++E++ 
Sbjct: 235 YIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPSVAELLT 276

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 139/315 (44%), Gaps = 40/315 (12%)
Query: 119 YFCHGLLEAATRKFSEKNLIGQGG---FGDVY--IGYINSCAMTAARRKNADFAVAVKRL 173
           YF  G++     K + + ++ QG      D Y  IG  ++  +  AR K++   VAVK +
Sbjct: 19  YFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM 78
Query: 174 RRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD 233
             +  Q ++   NE+  +    H NVV++       +   ++ E++  G+L D +     
Sbjct: 79  DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQ 135
Query: 234 TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
             LN E+   +     + L +LH   + VIHRD+K+ ++LL  D   K+SDFG      +
Sbjct: 136 VRLNEEQIATVCEAVLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQI 191
Query: 294 GDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK--------TAAMR 345
                    ++GT  + APE I+      + D++S G++++E++ G+          AM+
Sbjct: 192 SKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251
Query: 346 RTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
           R      +   P L N   +  ++             ++F E   R L  DP+ R T  E
Sbjct: 252 RLR----DSPPPKLKNSHKVSPVL-------------RDFLE---RMLVRDPQERATAQE 291
Query: 406 VVAALEQLQLNMGSC 420
           ++     LQ  +  C
Sbjct: 292 LLDHPFLLQTGLPEC 306

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 131/301 (43%), Gaps = 48/301 (15%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSRLN- 195
           +G G FG V    + + A    + ++A   VAVK L+      + E   +EL+ +S L  
Sbjct: 39  LGAGAFGKV----VEATAFGLGK-EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 93
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL---------------------NEDDT 234
           H N+V L+G C      L++ EY   G L + L                       ED  
Sbjct: 94  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR 153
Query: 235 ELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
            L     +  +   A+G+  L +  +  IHRDV A NVLL +   AKI DFGLA+   + 
Sbjct: 154 PLELRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMN 210
Query: 295 DKSHI---STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA 351
           D ++I   + R+     + APE I     T+++DV+S+G++L EI S           L 
Sbjct: 211 DSNYIVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-----------LG 257
Query: 352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
            N     L N    ++++ +           +    I+  C   +P +RPT  ++ + L+
Sbjct: 258 LNPYPGILVNS-KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 316
Query: 412 Q 412
           +
Sbjct: 317 E 317

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 20/213 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           ++  + ++G+G FG+V +     C      ++ A   ++ +++++K  +  +    E++ 
Sbjct: 33  RYKGQRVLGKGSFGEVIL-----CKDKITGQECAVKVISKRQVKQKTDK--ESLLREVQL 85
Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAA 249
           L +L+HPN++KL  +  D  +  LV E  T G L D +++    +E++  R I+  L   
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS-- 143
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDD---DFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
            G+ ++H     ++HRD+K  N+LL+    D N +I DFGL+       K       +GT
Sbjct: 144 -GITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGT 197
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             Y APE +  G    K DV+S GV+L  +LSG
Sbjct: 198 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 23/219 (10%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-W 184
           E   + F  K  +G G F +V +          A  K      AVK + +K  +G++   
Sbjct: 18  EDIKKIFEFKETLGTGAFSEVVL----------AEEKATGKLFAVKCIPKKALKGKESSI 67
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED-DTELNWERRIK 243
           ENE+  L ++ H N+V L        H  LV + V+ G L D ++ +   TE +    I+
Sbjct: 68  ENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIR 127
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHIS 300
             L A   L  +      ++HRD+K  N+L    D++    ISDFGL+K    GD   + 
Sbjct: 128 QVLDAVYYLHRM-----GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VM 179
Query: 301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           +   GT GY APE +A    +   D +S GV+   +L G
Sbjct: 180 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 32/225 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFA-VAVKRLRRKGSQG-QDEWENELRFLSRLN 195
           IG+G FG V+       A          F  VAVK L+ + S   Q +++ E   ++  +
Sbjct: 55  IGEGAFGRVFQ------ARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 108
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL----------LNEDDTE---------- 235
           +PN+VKL+G C   +   L++EY+  G L + L          L+  D            
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 236 --LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
             L+   ++ IA   A G+ +L    R  +HRD+   N L+ ++   KI+DFGL++    
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 294 GDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS 338
            D             +  PE I     T ++DV+++GVVL EI S
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 111/217 (51%), Gaps = 20/217 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD--EWENELRFLSRLN 195
           +G G FG V  G      +   R+K  D A+ V    ++G++  D  E   E + + +L+
Sbjct: 344 LGCGNFGSVRQG------VYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLD 394
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           +P +V+L+G  C  +  +LV E    G L   L+ + + E+      ++    + G+++L
Sbjct: 395 NPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYL 452
Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG-DKSHISTRVLG--TRGYFAP 312
               +  +HR++ A NVLL +   AKISDFGL+K   LG D S+ + R  G     ++AP
Sbjct: 453 EE--KNFVHRNLAARNVLLVNRHYAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAP 508
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
           E I     + ++DV+S+GV + E LS      ++  G
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 179 QGQDEWENELRF--LSRLNHPNVVKLMGY----CCDDQHRLLVYEYVTRGSLEDHLLNED 232
           Q +  W+NE     L  + H N+++ +G        D    L+  +  +GSL D L    
Sbjct: 58  QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---K 114
Query: 233 DTELNWERRIKIALGAARGLEHLHTYW-------RPVI-HRDVKASNVLLDDDFNAKISD 284
              ++W     IA   ARGL +LH          +P I HRD+K+ NVLL ++  A I+D
Sbjct: 115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-----HLTLKTDVYSFGVVLLEILSG 339
           FGLA     G  +  +   +GTR Y APE +           L+ D+Y+ G+VL E+ S 
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 340 KTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQE 384
            TAA    +G    +  P+           +E++G++  +E+ QE
Sbjct: 235 CTAA----DGPVDEYMLPF-----------EEEIGQHPSLEDMQE 264

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLN 195
           ++G+G FG+VY G            K     VAVK  ++  +   ++++ +E   +  L+
Sbjct: 31  ILGEGFFGEVYEG-------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 83
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HP++VKL+G   +++   ++ E    G L  H L  +   L     +  +L   + + +L
Sbjct: 84  HPHIVKLIGII-EEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYL 141
Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
            +     +HRD+   N+L+      K+ DFGL+++    D    S   L  + + +PE I
Sbjct: 142 ESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-WMSPESI 198
Query: 316 ATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
                T  +DV+ F V + EILS GK                 +L NK  +  +  EK  
Sbjct: 199 NFRRFTTASDVWMFAVCMWEILSFGKQPFF-------------WLENKDVIGVL--EKGD 243
Query: 375 RNIQMEEAQE-FAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           R  + +        ++ RC + DP +RP  +E+V +L  +
Sbjct: 244 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 283

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLN 195
           ++G+G FG+VY G            K     VAVK  ++  +   ++++ +E   +  L+
Sbjct: 15  ILGEGFFGEVYEG-------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 67
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HP++VKL+G   +++   ++ E    G L  H L  +   L     +  +L   + + +L
Sbjct: 68  HPHIVKLIGII-EEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYL 125
Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
            +     +HRD+   N+L+      K+ DFGL+++    D    S   L  + + +PE I
Sbjct: 126 ESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-WMSPESI 182
Query: 316 ATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
                T  +DV+ F V + EILS GK                 +L NK  +  +  EK  
Sbjct: 183 NFRRFTTASDVWMFAVCMWEILSFGKQPFF-------------WLENKDVIGVL--EKGD 227
Query: 375 RNIQMEEAQE-FAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           R  + +        ++ RC + DP +RP  +E+V +L  +
Sbjct: 228 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 267

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 20/213 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           ++  + ++G+G FG+V +     C      ++ A   ++ +++++K  +  +    E++ 
Sbjct: 27  RYKGQRVLGKGSFGEVIL-----CKDKITGQECAVKVISKRQVKQKTDK--ESLLREVQL 79
Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAA 249
           L +L+HPN++KL  +  D  +  LV E  T G L D +++    +E++  R I+  L   
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS-- 137
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDD---DFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
            G+ ++H     ++HRD+K  N+LL+    D N +I DFGL+       K       +GT
Sbjct: 138 -GITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGT 191
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             Y APE +  G    K DV+S GV+L  +LSG
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 95/195 (48%), Gaps = 10/195 (5%)
Query: 148 IGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGY 205
           IG  N   +  AR       VAVK + +    S    +   E+R +  LNHPN+VKL   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHR 265
              ++   LV EY + G + D+L+     +   E R K        +++ H  +  ++HR
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR-QIVSAVQYCHQKF--IVHR 137
Query: 266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE-YIATGHLTLKT 324
           D+KA N+LLD D N KI+DFG +     G+K        G+  Y APE +    +   + 
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 325 DVYSFGVVLLEILSG 339
           DV+S GV+L  ++SG
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLN 195
           ++G+G FG+VY G            K     VAVK  ++  +   ++++ +E   +  L+
Sbjct: 19  ILGEGFFGEVYEG-------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HP++VKL+G   +++   ++ E    G L  H L  +   L     +  +L   + + +L
Sbjct: 72  HPHIVKLIGII-EEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
            +     +HRD+   N+L+      K+ DFGL+++    D    S   L  + + +PE I
Sbjct: 130 ESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-WMSPESI 186
Query: 316 ATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
                T  +DV+ F V + EILS GK                 +L NK  +  +  EK  
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQPFF-------------WLENKDVIGVL--EKGD 231
Query: 375 RNIQMEEAQE-FAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           R  + +        ++ RC + DP +RP  +E+V +L  +
Sbjct: 232 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 20/213 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           ++  + ++G+G FG+V +     C      ++ A   ++ +++++K  +  +    E++ 
Sbjct: 50  RYKGQRVLGKGSFGEVIL-----CKDKITGQECAVKVISKRQVKQKTDK--ESLLREVQL 102
Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAA 249
           L +L+HPN++KL  +  D  +  LV E  T G L D +++    +E++  R I+  L   
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS-- 160
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDD---DFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
            G+ ++H     ++HRD+K  N+LL+    D N +I DFGL+       K       +GT
Sbjct: 161 -GITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGT 214
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             Y APE +  G    K DV+S GV+L  +LSG
Sbjct: 215 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 95/195 (48%), Gaps = 10/195 (5%)
Query: 148 IGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGY 205
           IG  N   +  AR       VAVK + +    S    +   E+R +  LNHPN+VKL   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHR 265
              ++   LV EY + G + D+L+     +   E R K        +++ H  +  ++HR
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR-QIVSAVQYCHQKF--IVHR 137
Query: 266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE-YIATGHLTLKT 324
           D+KA N+LLD D N KI+DFG +     G+K        G+  Y APE +    +   + 
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 325 DVYSFGVVLLEILSG 339
           DV+S GV+L  ++SG
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F    L+G+G FG V +           R K      A+K LR++    +DE  +   E 
Sbjct: 10  FDYLKLLGKGTFGKVIL----------VREKATGRYYAMKILRKEVIIAKDEVAHTVTES 59
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           R L    HP +  L  Y      RL  V EY   G L  HL  E       ER       
Sbjct: 60  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAE 116
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
               LE+LH+  R V++RD+K  N++LD D + KI+DFGL K G + D + + T   GT 
Sbjct: 117 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTP 172
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            Y APE +         D +  GVV+ E++ G+
Sbjct: 173 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG V + Y      T   +K A   +  K L +   QG+   E E+ +L  L HP
Sbjct: 22  LGEGSFGKVKLAY-----HTTTGQKVALKIINKKVLAKSDMQGR--IEREISYLRLLRHP 74
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           +++KL          ++V EY     L D+++  D       RR    + +A    H H 
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 133
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               ++HRD+K  N+LLD+  N KI+DFGL+    + D + + T   G+  Y APE I +
Sbjct: 134 ----IVHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEVI-S 185
Query: 318 GHLTL--KTDVYSFGVVLLEIL 337
           G L    + DV+S GV+L  +L
Sbjct: 186 GKLYAGPEVDVWSCGVILYVML 207

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 20/213 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           ++  + ++G+G FG+V +     C      ++ A   ++ +++++K  +  +    E++ 
Sbjct: 51  RYKGQRVLGKGSFGEVIL-----CKDKITGQECAVKVISKRQVKQKTDK--ESLLREVQL 103
Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAA 249
           L +L+HPN++KL  +  D  +  LV E  T G L D +++    +E++  R I+  L   
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS-- 161
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDD---DFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
            G+ ++H     ++HRD+K  N+LL+    D N +I DFGL+       K       +GT
Sbjct: 162 -GITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGT 215
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             Y APE +  G    K DV+S GV+L  +LSG
Sbjct: 216 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEIXINKMLNHE 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEIXINKMLNHE 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEIXINKMLNHE 65
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 124 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 181
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG V + Y      T   +K A   +  K L +   QG+   E E+ +L  L HP
Sbjct: 12  LGEGSFGKVKLAY-----HTTTGQKVALKIINKKVLAKSDMQGR--IEREISYLRLLRHP 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           +++KL          ++V EY     L D+++  D       RR    + +A    H H 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 123
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               ++HRD+K  N+LLD+  N KI+DFGL+    + D + + T   G+  Y APE I +
Sbjct: 124 ----IVHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEVI-S 175
Query: 318 GHLTL--KTDVYSFGVVLLEIL 337
           G L    + DV+S GV+L  +L
Sbjct: 176 GKLYAGPEVDVWSCGVILYVML 197

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F    L+G+G FG V +           R K      A+K LR++    +DE  +   E 
Sbjct: 7   FDYLKLLGKGTFGKVIL----------VREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           R L    HP +  L  Y      RL  V EY   G L  HL  E       ER       
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAE 113
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
               LE+LH+  R V++RD+K  N++LD D + KI+DFGL K G + D + + T   GT 
Sbjct: 114 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTP 169
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            Y APE +         D +  GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F    L+G+G FG V +           R K      A+K LR++    +DE  +   E 
Sbjct: 7   FDYLKLLGKGTFGKVIL----------VREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           R L    HP +  L  Y      RL  V EY   G L  HL  E       ER       
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAE 113
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
               LE+LH+  R V++RD+K  N++LD D + KI+DFGL K G + D + + T   GT 
Sbjct: 114 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTP 169
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            Y APE +         D +  GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG V + Y      T   +K A   +  K L +   QG+   E E+ +L  L HP
Sbjct: 21  LGEGSFGKVKLAY-----HTTTGQKVALKIINKKVLAKSDMQGR--IEREISYLRLLRHP 73
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           +++KL          ++V EY     L D+++  D       RR    + +A    H H 
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 132
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               ++HRD+K  N+LLD+  N KI+DFGL+    + D + + T   G+  Y APE I +
Sbjct: 133 ----IVHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEVI-S 184
Query: 318 GHLTL--KTDVYSFGVVLLEIL 337
           G L    + DV+S GV+L  +L
Sbjct: 185 GKLYAGPEVDVWSCGVILYVML 206

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L++ + +  G L D++    D       LNW  +I  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 130 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 229
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 230 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 20  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L++ + +  G L D++    D       LNW  +I  
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 130
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 131 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 184
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 185 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 230
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 231 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 280

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 17  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L++ + +  G L D++    D       LNW  +I  
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 127
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 128 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 182 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 227
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 228 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 277

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLN 195
           ++G G FG VY G      +     +     VA+K L    G +   E+ +E   ++ ++
Sbjct: 45  VLGSGAFGTVYKG------IWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 98
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKIALGAAR 250
           HP++V+L+G C     +L V + +  G L +++    D       LNW  +I      A+
Sbjct: 99  HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AK 151
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           G+ +L    R ++HRD+ A NVL+    + KI+DFGLA+     +K + +        + 
Sbjct: 152 GMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 209
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILS 338
           A E I     T ++DV+S+GV + E+++
Sbjct: 210 ALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG V + Y      T   +K A   +  K L +   QG+   E E+ +L  L HP
Sbjct: 16  LGEGSFGKVKLAY-----HTTTGQKVALKIINKKVLAKSDMQGR--IEREISYLRLLRHP 68
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           +++KL          ++V EY     L D+++  D       RR    + +A    H H 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 127
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               ++HRD+K  N+LLD+  N KI+DFGL+    + D + + T   G+  Y APE I +
Sbjct: 128 ----IVHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEVI-S 179
Query: 318 GHLTL--KTDVYSFGVVLLEIL 337
           G L    + DV+S GV+L  +L
Sbjct: 180 GKLYAGPEVDVWSCGVILYVML 201

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L++ + +  G L D++    D       LNW  +I  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 129 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 228
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 229 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L++ + +  G L D++    D       LNW  +I  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 127 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 226
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 227 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           E+R +  LNHPN+VKL      ++   LV EY + G + D+L+     +   E R K   
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR- 121
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
                +++ H  +  ++HRD+KA N+LLD D N KI+DFG +    +G+K        G+
Sbjct: 122 QIVSAVQYCHQKY--IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGS 176
Query: 307 RGYFAPE-YIATGHLTLKTDVYSFGVVLLEILSG 339
             Y APE +    +   + DV+S GV+L  ++SG
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 17  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L++ + +  G L D++    D       LNW  +I  
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQI-- 127
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 128 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 182 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 227
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 228 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 277

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL-RRKGSQGQDEWENELRFLSRLNH 196
           +G+G +G+V +          A  +  + AVAVK +  ++     +  + E+   + LNH
Sbjct: 15  LGEGAYGEVQL----------AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNH 64
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
            NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA 316
                + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE + 
Sbjct: 123 GI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 317 TGHLTLK-TDVYSFGVVLLEILSGK 340
                 +  DV+S G+VL  +L+G+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G  G V I  + S              VAVK++  +  Q ++   NE+  +    H 
Sbjct: 159 IGEGSTGIVCIATVRSSGKL----------VAVKKMDLRKQQRRELLFNEVVIMRDYQHE 208
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVV++           +V E++  G+L D + +   T +N E+   + L   + L  LH 
Sbjct: 209 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA 265
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               VIHRD+K+ ++LL  D   K+SDFG      +  +      ++GT  + APE I+ 
Sbjct: 266 QG--VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISR 321
Query: 318 GHLTLKTDVYSFGVVLLEILSGK 340
                + D++S G++++E++ G+
Sbjct: 322 LPYGPEVDIWSLGIMVIEMVDGE 344

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 13  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHE 63
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 122 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHE 65
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 124 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHE 65
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 124 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 127 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 226
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 227 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHE 65
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 124 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR---KGSQGQDEWENELRFLSRL 194
           +G+G FG V +          A        VA+K + R   K S      E E+ +L  L
Sbjct: 17  LGEGSFGKVKL----------ATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL 66
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HP+++KL          ++V EY   G L D+++ +     +  RR    +  A  +E+
Sbjct: 67  RHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICA--IEY 123
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
            H +   ++HRD+K  N+LLDD+ N KI+DFGL+    + D + + T   G+  Y APE 
Sbjct: 124 CHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEV 178
Query: 315 IATGHLTL--KTDVYSFGVVLLEILSGK 340
           I  G L    + DV+S G+VL  +L G+
Sbjct: 179 I-NGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHE 65
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 124 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 148 IGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGY 205
           IG  N   +  AR       VAVK + +    S    +   E+R +  LNHPN+VKL   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHR 265
              ++   LV EY + G + D+L+     +   E R K        +++ H  +  ++HR
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR-QIVSAVQYCHQKF--IVHR 137
Query: 266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE-YIATGHLTLKT 324
           D+KA N+LLD D N KI+DFG +     G+K        G   Y APE +    +   + 
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDAFCGAPPYAAPELFQGKKYDGPEV 194
Query: 325 DVYSFGVVLLEILSG 339
           DV+S GV+L  ++SG
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHE 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 26  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 136
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 137 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 190
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS 338
               + A E I     T ++DV+S+GV + E+++
Sbjct: 191 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 130 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 229
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 230 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHE 65
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 124 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 10/195 (5%)
Query: 148 IGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGY 205
           IG  N   +  AR       VAV+ + +    S    +   E+R +  LNHPN+VKL   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHR 265
              ++   LV EY + G + D+L+     +   E R K        +++ H  +  ++HR
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR-QIVSAVQYCHQKF--IVHR 137
Query: 266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE-YIATGHLTLKT 324
           D+KA N+LLD D N KI+DFG +     G+K        G+  Y APE +    +   + 
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDEFCGSPPYAAPELFQGKKYDGPEV 194
Query: 325 DVYSFGVVLLEILSG 339
           DV+S GV+L  ++SG
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHE 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 130 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 229
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 230 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 129 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 228
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 229 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 110/222 (49%), Gaps = 20/222 (9%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           EL+ L   N P +V   G    D    +  E++  GSL+  L  +    +  +   K+++
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSI 114
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              +GL +L    + ++HRDVK SN+L++     K+ DFG++  G L D+  ++   +GT
Sbjct: 115 AVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE--MANEFVGT 169
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
           R Y +PE +   H ++++D++S G+ L+E+  G+             + +P ++    L 
Sbjct: 170 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR-------------YPRPPMAIFELLD 216
Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
            I++E   +      + EF + + +CL  +P  R  + +++ 
Sbjct: 217 YIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMV 258

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 127 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS 338
               + A E I     T ++DV+S+GV + E+++
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 41  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 151
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 152 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 205
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 206 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 251
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 252 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 301

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 148 IGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGY 205
           IG  N   +  AR       VAVK + +    S    +   E+R +  LNHPN+VKL   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW----ERRIKIALGAARGLEHLHTYWRP 261
              ++   LV EY + G + D+L+        W    E R K        +++ H  +  
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAH-----GWMKEKEARAKFR-QIVSAVQYCHQKF-- 126
Query: 262 VIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE-YIATGHL 320
           ++HRD+KA N+LLD D N KI+DFG +     G+K        G+  Y APE +    + 
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYD 183
Query: 321 TLKTDVYSFGVVLLEILSG 339
             + DV+S GV+L  ++SG
Sbjct: 184 GPEVDVWSLGVILYTLVSG 202

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHE 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLN 195
           ++G G FG VY G      +     +     VA+K L    G +   E+ +E   ++ ++
Sbjct: 22  VLGSGAFGTVYKG------IWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKIALGAAR 250
           HP++V+L+G C     +L V + +  G L +++    D       LNW  +I      A+
Sbjct: 76  HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AK 128
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           G+ +L    R ++HRD+ A NVL+    + KI+DFGLA+     +K + +        + 
Sbjct: 129 GMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 186
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILS 338
           A E I     T ++DV+S+GV + E+++
Sbjct: 187 ALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 22  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 132
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 133 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 187 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 232
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 233 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 282

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 10/195 (5%)
Query: 148 IGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGY 205
           IG  N   +  AR       VAV+ + +    S    +   E+R +  LNHPN+VKL   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHR 265
              ++   LV EY + G + D+L+     +   E R K        +++ H  +  ++HR
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR-QIVSAVQYCHQKF--IVHR 137
Query: 266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE-YIATGHLTLKT 324
           D+KA N+LLD D N KI+DFG +     G+K        G+  Y APE +    +   + 
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 325 DVYSFGVVLLEILSG 339
           DV+S GV+L  ++SG
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 127 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 226
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 227 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHE 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL-RRKGSQGQDEWENELRFLSRLNH 196
           +G+G +G+V +          A  +  + AVAVK +  ++     +  + E+     LNH
Sbjct: 15  LGEGAYGEVQL----------AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
            NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA 316
                + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE + 
Sbjct: 123 GI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 317 TGHLTLK-TDVYSFGVVLLEILSGK 340
                 +  DV+S G+VL  +L+G+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 10  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 120
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 121 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 220
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 221 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL-RRKGSQGQDEWENELRFLSRLNH 196
           +G+G +G+V +          A  +  + AVAVK +  ++     +  + E+     LNH
Sbjct: 14  LGEGAYGEVQL----------AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
            NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA 316
                + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE + 
Sbjct: 122 GI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 317 TGHLTLK-TDVYSFGVVLLEILSGK 340
                 +  DV+S G+VL  +L+G+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL-RRKGSQGQDEWENELRFLSRLNH 196
           +G+G +G+V +          A  +  + AVAVK +  ++     +  + E+     LNH
Sbjct: 14  LGEGAYGEVQL----------AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
            NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA 316
                + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE + 
Sbjct: 122 GI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 317 TGHLTLK-TDVYSFGVVLLEILSGK 340
                 +  DV+S G+VL  +L+G+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 19  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 130 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS 338
               + A E I     T ++DV+S+GV + E+++
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHE 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHE 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 23  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 134 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 233
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 234 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G +G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHE 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
           ++G+G FG V +          A RK  +   A+K L++      D+ E    E R L+ 
Sbjct: 26  VLGKGSFGKVML----------ADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLAL 75
Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
           L+ P  +  +  C     RL  V EYV  G L  H+  +   +    + +  A   + GL
Sbjct: 76  LDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISIGL 133
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-VLGTRGYFA 311
             LH   R +I+RD+K  NV+LD + + KI+DFG+ K   +     ++TR   GT  Y A
Sbjct: 134 FFLHK--RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMM---DGVTTREFCGTPDYIA 188
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           PE IA        D +++GV+L E+L+G+
Sbjct: 189 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G  G V I  + S              VAVK++  +  Q ++   NE+  +    H 
Sbjct: 37  IGEGSTGIVCIATVRSSGKL----------VAVKKMDLRKQQRRELLFNEVVIMRDYQHE 86
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVV++           +V E++  G+L D + +   T +N E+   + L   + L  LH 
Sbjct: 87  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA 143
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + VIHRD+K+ ++LL  D   K+SDFG      +  +      ++GT  + APE I+ 
Sbjct: 144 --QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISR 199
Query: 318 GHLTLKTDVYSFGVVLLEILSGK 340
                + D++S G++++E++ G+
Sbjct: 200 LPYGPEVDIWSLGIMVIEMVDGE 222

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 123/275 (44%), Gaps = 39/275 (14%)
Query: 152 NSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ- 210
           +S  +   R +  D  V V ++R   ++   ++  E   L   +HPNV+ ++G C     
Sbjct: 22  HSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81
Query: 211 -HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRD-VK 268
            H  L+  ++  GSL + L    +  ++  + +K AL  ARG+  LHT   P+I R  + 
Sbjct: 82  PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALN 140
Query: 269 ASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG-YFAPEYIATGHLTLK---- 323
           + +V++D+D  A+IS     KF               + G  +AP ++A   L  K    
Sbjct: 141 SRSVMIDEDMTARIS-MADVKFS------------FQSPGRMYAPAWVAPEALQKKPEDT 187
Query: 324 ----TDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQM 379
                D++SF V+L E+++ +      +N   G         K+AL     E L   I  
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLSNMEIG--------MKVAL-----EGLRPTIPP 234
Query: 380 EEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
             +   ++++  C+N DP  RP    +V  LE++Q
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 120/279 (43%), Gaps = 30/279 (10%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNH 196
           IG+G FGDV+ G   S        +N   AVA+K  +   S   ++++  E   + + +H
Sbjct: 18  IGEGQFGDVHQGIYMS-------PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P++VKL+G   ++    ++ E  T G L    L      L+    I  A   +  L +L 
Sbjct: 71  PHIVKLIGVITENP-VWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA 316
           +  +  +HRD+ A NVL+  +   K+ DFGL+++         S   L  + + APE I 
Sbjct: 129 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK-WMAPESIN 185
Query: 317 TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRN 376
               T  +DV+ FGV + EIL      ++   G+  N     + N            G  
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL---MHGVKPFQGVKNNDVIGRIEN------------GER 230
Query: 377 IQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           + M          ++ +C   DP  RP  +E+ A L  +
Sbjct: 231 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 36/219 (16%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR----KGSQGQD---------EW 184
           +G G +G+V +           + KN     A+K +++    KG    D         E 
Sbjct: 44  LGSGAYGEVLL----------CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIK 243
            NE+  L  L+HPN++KL     D ++  LV E+   G L + ++N     E +    +K
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD---FNAKISDFGLAKFGPLGDKSHIS 300
             L    G+ +LH +   ++HRD+K  N+LL++     N KI DFGL+ F     K +  
Sbjct: 154 QILS---GICYLHKH--NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDYKL 205
Query: 301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
              LGT  Y APE +   +   K DV+S GV++  +L G
Sbjct: 206 RDRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCG 243

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G  G V I  + S              VAVK++  +  Q ++   NE+  +    H 
Sbjct: 39  IGEGSTGIVCIATVRSSGKL----------VAVKKMDLRKQQRRELLFNEVVIMRDYQHE 88
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVV++           +V E++  G+L D + +   T +N E+   + L   + L  LH 
Sbjct: 89  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA 145
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + VIHRD+K+ ++LL  D   K+SDFG      +  +      ++GT  + APE I+ 
Sbjct: 146 --QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISR 201
Query: 318 GHLTLKTDVYSFGVVLLEILSGK 340
                + D++S G++++E++ G+
Sbjct: 202 LPYGPEVDIWSLGIMVIEMVDGE 224

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 84/154 (54%), Gaps = 7/154 (4%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           EL+ L   N P +V   G    D    +  E++  GSL D +L E    +  E   K+++
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEA-KRIPEEILGKVSI 121
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              RGL +L    + ++HRDVK SN+L++     K+ DFG++  G L D   ++   +GT
Sbjct: 122 AVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 176
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           R Y APE +   H ++++D++S G+ L+E+  G+
Sbjct: 177 RSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G  G V I  + S              VAVK++  +  Q ++   NE+  +    H 
Sbjct: 82  IGEGSTGIVCIATVRSSGKL----------VAVKKMDLRKQQRRELLFNEVVIMRDYQHE 131
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVV++           +V E++  G+L D + +   T +N E+   + L   + L  LH 
Sbjct: 132 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA 188
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + VIHRD+K+ ++LL  D   K+SDFG      +  +      ++GT  + APE I+ 
Sbjct: 189 --QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISR 244
Query: 318 GHLTLKTDVYSFGVVLLEILSGK 340
                + D++S G++++E++ G+
Sbjct: 245 LPYGPEVDIWSLGIMVIEMVDGE 267

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G  G V I  + S              VAVK++  +  Q ++   NE+  +    H 
Sbjct: 28  IGEGSTGIVCIATVRSSGKL----------VAVKKMDLRKQQRRELLFNEVVIMRDYQHE 77
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVV++           +V E++  G+L D + +   T +N E+   + L   + L  LH 
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA 134
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + VIHRD+K+ ++LL  D   K+SDFG      +  +      ++GT  + APE I+ 
Sbjct: 135 --QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISR 190
Query: 318 GHLTLKTDVYSFGVVLLEILSGK 340
                + D++S G++++E++ G+
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 130/290 (44%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 13  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 123
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 124 ----AEGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 178 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 223
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 224 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 273

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 117/229 (51%), Gaps = 33/229 (14%)
Query: 119 YFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS 178
           YF  GL+E    K+ +   +G+G +G VY             + +    VA+KR+R    
Sbjct: 15  YF-QGLME----KYQKLEKVGEGTYGVVY-----------KAKDSQGRIVALKRIRL--- 55
Query: 179 QGQDEWE-----NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD 233
             +DE        E+  L  L+HPN+V L+     ++   LV+E++ +      +L+E+ 
Sbjct: 56  DAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDL--KKVLDENK 113
Query: 234 TELNWERRIKIAL-GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP 292
           T L  + +IKI L    RG+ H H +   ++HRD+K  N+L++ D   K++DFGLA+   
Sbjct: 114 TGLQ-DSQIKIYLYQLLRGVAHCHQH--RILHRDLKPQNLLINSDGALKLADFGLARAFG 170
Query: 293 LGDKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGK 340
           +  +S+  T  + T  Y AP+ +  +   +   D++S G +  E+++GK
Sbjct: 171 IPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 124/284 (43%), Gaps = 40/284 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNH 196
           IG+G FGDV+ G   S        +N   AVA+K  +   S   ++++  E   + + +H
Sbjct: 18  IGEGQFGDVHQGIYMS-------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P++VKL+G   ++    ++ E  T G L    L      L+    I  A   +  L +L 
Sbjct: 71  PHIVKLIGVITENP-VWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG-----YFA 311
           +  +  +HRD+ A NVL+  +   K+ DFGL+++  + D    ST    ++G     + A
Sbjct: 129 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MED----STYYKASKGKLPIKWMA 180
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     T  +DV+ FGV + EIL      ++   G+  N     + N          
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEIL---MHGVKPFQGVKNNDVIGRIEN---------- 227
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             G  + M          ++ +C   DP  RP  +E+ A L  +
Sbjct: 228 --GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 124/284 (43%), Gaps = 40/284 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNH 196
           IG+G FGDV+ G   S        +N   AVA+K  +   S   ++++  E   + + +H
Sbjct: 18  IGEGQFGDVHQGIYMS-------PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P++VKL+G   ++    ++ E  T G L    L      L+    I  A   +  L +L 
Sbjct: 71  PHIVKLIGVITENP-VWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG-----YFA 311
           +  +  +HRD+ A NVL+  +   K+ DFGL+++  + D    ST    ++G     + A
Sbjct: 129 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MED----STYYKASKGKLPIKWMA 180
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     T  +DV+ FGV + EIL      ++   G+  N     + N          
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEIL---MHGVKPFQGVKNNDVIGRIEN---------- 227
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             G  + M          ++ +C   DP  RP  +E+ A L  +
Sbjct: 228 --GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 109/213 (51%), Gaps = 20/213 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           ++  + ++G+G FG+V +     C      ++ A   ++ +++++K  +  +    E++ 
Sbjct: 27  RYKGQRVLGKGSFGEVIL-----CKDKITGQECAVKVISKRQVKQKTDK--ESLLREVQL 79
Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAA 249
           L +L+HPN+ KL  +  D  +  LV E  T G L D +++    +E++  R I+  L   
Sbjct: 80  LKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS-- 137
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDD---DFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
            G+ + H     ++HRD+K  N+LL+    D N +I DFGL+       K       +GT
Sbjct: 138 -GITYXHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK---IGT 191
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             Y APE +  G    K DV+S GV+L  +LSG
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 124/284 (43%), Gaps = 40/284 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNH 196
           IG+G FGDV+ G   S        +N   AVA+K  +   S   ++++  E   + + +H
Sbjct: 20  IGEGQFGDVHQGIYMS-------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 72
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P++VKL+G   ++    ++ E  T G L    L      L+    I  A   +  L +L 
Sbjct: 73  PHIVKLIGVITENP-VWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE 130
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG-----YFA 311
           +  +  +HRD+ A NVL+  +   K+ DFGL+++  + D    ST    ++G     + A
Sbjct: 131 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MED----STYYKASKGKLPIKWMA 182
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     T  +DV+ FGV + EIL      ++   G+  N     + N          
Sbjct: 183 PESINFRRFTSASDVWMFGVCMWEIL---MHGVKPFQGVKNNDVIGRIEN---------- 229
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             G  + M          ++ +C   DP  RP  +E+ A L  +
Sbjct: 230 --GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 271

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 124/284 (43%), Gaps = 40/284 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNH 196
           IG+G FGDV+ G   S        +N   AVA+K  +   S   ++++  E   + + +H
Sbjct: 15  IGEGQFGDVHQGIYMS-------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P++VKL+G   ++    ++ E  T G L    L      L+    I  A   +  L +L 
Sbjct: 68  PHIVKLIGVITENP-VWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG-----YFA 311
           +  +  +HRD+ A NVL+  +   K+ DFGL+++  + D    ST    ++G     + A
Sbjct: 126 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MED----STYYKASKGKLPIKWMA 177
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     T  +DV+ FGV + EIL      ++   G+  N     + N          
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEIL---MHGVKPFQGVKNNDVIGRIEN---------- 224
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             G  + M          ++ +C   DP  RP  +E+ A L  +
Sbjct: 225 --GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 117/229 (51%), Gaps = 33/229 (14%)
Query: 119 YFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS 178
           YF  GL+E    K+ +   +G+G +G VY             + +    VA+KR+R    
Sbjct: 15  YF-QGLME----KYQKLEKVGEGTYGVVY-----------KAKDSQGRIVALKRIRL--- 55
Query: 179 QGQDEWE-----NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD 233
             +DE        E+  L  L+HPN+V L+     ++   LV+E++ +      +L+E+ 
Sbjct: 56  DAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDL--KKVLDENK 113
Query: 234 TELNWERRIKIAL-GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP 292
           T L  + +IKI L    RG+ H H +   ++HRD+K  N+L++ D   K++DFGLA+   
Sbjct: 114 TGLQ-DSQIKIYLYQLLRGVAHCHQH--RILHRDLKPQNLLINSDGALKLADFGLARAFG 170
Query: 293 LGDKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGK 340
           +  +S+  T  + T  Y AP+ +  +   +   D++S G +  E+++GK
Sbjct: 171 IPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 124/284 (43%), Gaps = 40/284 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNH 196
           IG+G FGDV+ G   S        +N   AVA+K  +   S   ++++  E   + + +H
Sbjct: 46  IGEGQFGDVHQGIYMS-------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 98
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P++VKL+G   ++    ++ E  T G L    L      L+    I  A   +  L +L 
Sbjct: 99  PHIVKLIGVITENP-VWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG-----YFA 311
           +  +  +HRD+ A NVL+  +   K+ DFGL+++  + D    ST    ++G     + A
Sbjct: 157 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MED----STYYKASKGKLPIKWMA 208
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     T  +DV+ FGV + EIL      ++   G+  N     + N          
Sbjct: 209 PESINFRRFTSASDVWMFGVCMWEIL---MHGVKPFQGVKNNDVIGRIEN---------- 255
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             G  + M          ++ +C   DP  RP  +E+ A L  +
Sbjct: 256 --GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 297

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G  G V I  + S              VAVK++  +  Q ++   NE+  +    H 
Sbjct: 32  IGEGSTGIVCIATVRSSGKL----------VAVKKMDLRKQQRRELLFNEVVIMRDYQHE 81
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVV++           +V E++  G+L D + +   T +N E+   + L   + L  LH 
Sbjct: 82  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA 138
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
             + VIHRD+K+ ++LL  D   K+SDFG      +  +      ++GT  + APE I+ 
Sbjct: 139 --QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISR 194
Query: 318 GHLTLKTDVYSFGVVLLEILSGK 340
                + D++S G++++E++ G+
Sbjct: 195 LPYGPEVDIWSLGIMVIEMVDGE 217

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 124/284 (43%), Gaps = 40/284 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNH 196
           IG+G FGDV+ G   S        +N   AVA+K  +   S   ++++  E   + + +H
Sbjct: 23  IGEGQFGDVHQGIYMS-------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P++VKL+G   ++    ++ E  T G L    L      L+    I  A   +  L +L 
Sbjct: 76  PHIVKLIGVITENP-VWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG-----YFA 311
           +  +  +HRD+ A NVL+  +   K+ DFGL+++  + D    ST    ++G     + A
Sbjct: 134 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MED----STYYKASKGKLPIKWMA 185
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     T  +DV+ FGV + EIL      ++   G+  N     + N          
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEIL---MHGVKPFQGVKNNDVIGRIEN---------- 232
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             G  + M          ++ +C   DP  RP  +E+ A L  +
Sbjct: 233 --GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F    L+G+G FG V +           R K      A+K LR++    +DE  +   E 
Sbjct: 12  FDYLKLLGKGTFGKVIL----------VREKATGRYYAMKILRKEVIIAKDEVAHTVTES 61
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           R L    HP +  L  Y      RL  V EY   G L  HL  E       ER       
Sbjct: 62  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAE 118
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
               LE+LH+  R V++RD+K  N++LD D + KI+DFGL K G + D + +     GT 
Sbjct: 119 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKX-FCGTP 174
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            Y APE +         D +  GVV+ E++ G+
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F    L+G+G FG V +           R K      A+K LR++    +DE  +   E 
Sbjct: 7   FDYLKLLGKGTFGKVIL----------VREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           R L    HP +  L  Y      RL  V EY   G L  HL  E       ER       
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAE 113
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
               LE+LH+  R V++RD+K  N++LD D + KI+DFGL K G + D + +     GT 
Sbjct: 114 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKX-FCGTP 169
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            Y APE +         D +  GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 124/284 (43%), Gaps = 40/284 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNH 196
           IG+G FGDV+ G   S        +N   AVA+K  +   S   ++++  E   + + +H
Sbjct: 21  IGEGQFGDVHQGIYMS-------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 73
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P++VKL+G   ++    ++ E  T G L    L      L+    I  A   +  L +L 
Sbjct: 74  PHIVKLIGVITENP-VWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE 131
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG-----YFA 311
           +  +  +HRD+ A NVL+  +   K+ DFGL+++  + D    ST    ++G     + A
Sbjct: 132 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MED----STYYKASKGKLPIKWMA 183
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     T  +DV+ FGV + EIL      ++   G+  N     + N          
Sbjct: 184 PESINFRRFTSASDVWMFGVCMWEIL---MHGVKPFQGVKNNDVIGRIEN---------- 230
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             G  + M          ++ +C   DP  RP  +E+ A L  +
Sbjct: 231 --GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 272

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F    L+G+G FG V +           R K      A+K LR++    +DE  +   E 
Sbjct: 7   FDYLKLLGKGTFGKVIL----------VREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           R L    HP +  L  Y      RL  V EY   G L  HL  E       ER       
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAE 113
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
               LE+LH+  R V++RD+K  N++LD D + KI+DFGL K G + D + +     GT 
Sbjct: 114 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKX-FCGTP 169
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            Y APE +         D +  GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---EL 188
           F    L+G+G FG V +           R K      A+K LR++    +DE  +   E 
Sbjct: 7   FDYLKLLGKGTFGKVIL----------VREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           R L    HP +  L  Y      RL  V EY   G L  HL  E       ER       
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAE 113
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
               LE+LH+  R V++RD+K  N++LD D + KI+DFGL K G + D + +     GT 
Sbjct: 114 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKX-FCGTP 169
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            Y APE +         D +  GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 110/222 (49%), Gaps = 10/222 (4%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           EL+ L   N P +V   G    D    +  E++  GSL+  L  +    +  +   K+++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSI 111
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              +GL +L    + ++HRDVK SN+L++     K+ DFG++  G L D   ++   +GT
Sbjct: 112 AVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 166
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
           R Y +PE +   H ++++D++S G+ L+E+  G+          A   ++P ++    L 
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD---AKEDSRPPMAIFELLD 223
Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
            I++E   +      + EF + + +CL  +P  R  + +++ 
Sbjct: 224 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 265

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 104/247 (42%), Gaps = 44/247 (17%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F E  ++GQG FG V            AR        A+K++R    +      +E+  L
Sbjct: 8   FEEIAVLGQGAFGQV----------VKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLL 56
Query: 192 SRLNHP-------------NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW 238
           + LNH              N VK M          +  EY   G+L D + +E+   LN 
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQ 113
Query: 239 ER--RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK------- 289
           +R    ++       L ++H+  + +IHRD+K  N+ +D+  N KI DFGLAK       
Sbjct: 114 QRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 290 -----FGPLGDKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGKTAA 343
                   L   S   T  +GT  Y A E +  TGH   K D+YS G++  E++   +  
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231
Query: 344 MRRTNGL 350
           M R N L
Sbjct: 232 MERVNIL 238

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWER-RIKIA 245
           E+R +  LNHPN+VKL      ++   L+ EY + G + D+L+     +    R + +  
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 120
Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
           + A +     + + + ++HRD+KA N+LLD D N KI+DFG +    +G K        G
Sbjct: 121 VSAVQ-----YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCG 172
Query: 306 TRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILSG 339
           +  Y APE +    +   + DV+S GV+L  ++SG
Sbjct: 173 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 124/284 (43%), Gaps = 40/284 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNH 196
           IG+G FGDV+ G   S        +N   AVA+K  +   S   ++++  E   + + +H
Sbjct: 398 IGEGQFGDVHQGIYMS-------PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P++VKL+G   ++    ++ E  T G L    L      L+    I  A   +  L +L 
Sbjct: 451 PHIVKLIGVITENP-VWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG-----YFA 311
           +  +  +HRD+ A NVL+  +   K+ DFGL+++  + D    ST    ++G     + A
Sbjct: 509 S--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MED----STYYKASKGKLPIKWMA 560
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     T  +DV+ FGV + EIL      ++   G+  N     + N          
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEIL---MHGVKPFQGVKNNDVIGRIEN---------- 607
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             G  + M          ++ +C   DP  RP  +E+ A L  +
Sbjct: 608 --GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G  G+V +  +N     A   K  D   AV           +  + E+     LNH 
Sbjct: 14  LGEGAAGEVQLA-VNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHE 64
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           NVVK  G+  +   + L  EY + G L D +  E D  +      +       G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
               + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y APE +  
Sbjct: 123 I--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 318 GHLTLK-TDVYSFGVVLLEILSGK 340
                +  DV+S G+VL  +L+G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+  LR   S +   E  +E  
Sbjct: 50  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIMELREATSPKANKEILDEAY 103
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 104 VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 160
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 161 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 214
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS 338
               + A E I     T ++DV+S+GV + E+++
Sbjct: 215 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++  G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 23  EFKKIKVLSSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L++ + +  G L D++    D       LNW  +I  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 134 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 233
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 234 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 130/290 (44%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++  G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 16  EFKKIKVLSSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 127 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 226
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 227 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 20  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L++ + +  G L D++    D       LNW  +I  
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 130
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFG AK     +K + +    
Sbjct: 131 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 184
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 185 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 230
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 231 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 280

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L++ + +  G L D++    D       LNW  +I  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFG AK     +K + +    
Sbjct: 129 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 228
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 229 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 89/170 (52%), Gaps = 22/170 (12%)
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
           KIA+   + LEHLH+    VIHRDVK SNVL++     K+ DFG++  G L D S   T 
Sbjct: 157 KIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGIS--GYLVD-SVAKTI 212
Query: 303 VLGTRGYFAPEYI-----ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP 357
             G + Y APE I       G+ ++K+D++S G+ ++E+     A +R       +W  P
Sbjct: 213 DAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIEL-----AILRFP---YDSWGTP 263
Query: 358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           +      L Q+++E   +    + + EF +   +CL  + K RPT  E++
Sbjct: 264 FQQ----LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 309

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 148 IGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGY 205
           IG  N   +  AR       VAVK + +    S    +   E+R    LNHPN+VKL   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHR 265
              ++   LV EY + G + D+L+     +   E R K        +++ H  +  ++HR
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXK-EKEARAKFR-QIVSAVQYCHQKF--IVHR 137
Query: 266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE-YIATGHLTLKT 324
           D+KA N+LLD D N KI+DFG +     G+K        G   Y APE +    +   + 
Sbjct: 138 DLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEV 194
Query: 325 DVYSFGVVLLEILSG 339
           DV+S GV+L  ++SG
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           EL+ L   N P +V   G    D    +  E++  GSL+  L  +    +  +   K+++
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSI 130
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              +GL +L    + ++HRDVK SN+L++     K+ DFG++  G L D   ++   +GT
Sbjct: 131 AVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 185
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
           R Y +PE +   H ++++D++S G+ L+E+  G+      +  +A      Y+ N+    
Sbjct: 186 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPP-- 243
Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
                KL   +   E Q+F     +CL  +P  R  + +++ 
Sbjct: 244 ----PKLPSGVFSLEFQDFVN---KCLIKNPAERADLKQLMV 278

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRL 194
           ++G+G FG+V       C     +++      AVK + +  ++ +D      E+  L +L
Sbjct: 29  MLGKGSFGEVL-----KCKDRITQQE-----YAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGLE 253
           +HPN++KL     D     +V E  T G L D ++     +E +  R IK       G+ 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---GIT 135
Query: 254 HLHTYWRPVIHRDVKASNVLLDD---DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           ++H +   ++HRD+K  N+LL+    D + KI DFGL+        + +  R+ GT  Y 
Sbjct: 136 YMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRI-GTAYYI 190
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSG 339
           APE +  G    K DV+S GV+L  +LSG
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L++ + +  G L D++    D       LNW  +I  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFG AK     +K + +    
Sbjct: 129 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS 338
               + A E I     T ++DV+S+GV + E+++
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 126/278 (45%), Gaps = 32/278 (11%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE--WENE 187
           + F    +IG+G +  V +           R K  D   A+K ++++     ++  W   
Sbjct: 20  QDFDLLRVIGRGSYAKVLL----------VRLKKTDRIYAMKVVKKELVNDDEDIDWVQT 69
Query: 188 LR--FLSRLNHPNVVKLMGYCCDDQHRLL-VYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
            +  F    NHP +V L   C   + RL  V EYV  G L  H+  +        R    
Sbjct: 70  EKHVFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA 128
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG--PLGDKSHISTR 302
            +  A  L +LH   R +I+RD+K  NVLLD + + K++D+G+ K G  P GD    ++ 
Sbjct: 129 EISLA--LNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT---TSX 180
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK 362
             GT  Y APE +         D ++ GV++ E+++G++        + G+   P  + +
Sbjct: 181 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF-----DIVGSSDNPDQNTE 235
Query: 363 LALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNR 400
             L Q+I EK  R I    + + A ++   LN DPK R
Sbjct: 236 DYLFQVILEKQIR-IPRSMSVKAASVLKSFLNKDPKER 272

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 130/290 (44%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++  G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 23  EFKKIKVLSSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +    
Sbjct: 134 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 233
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 234 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 81/155 (52%), Gaps = 10/155 (6%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWER-RIKIA 245
           E+R +  LNHPN+VKL      ++   L+ EY + G + D+L+     +    R + +  
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123
Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
           + A +     + + + ++HRD+KA N+LLD D N KI+DFG +    +G K        G
Sbjct: 124 VSAVQ-----YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCG 175
Query: 306 TRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILSG 339
              Y APE +    +   + DV+S GV+L  ++SG
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 130/290 (44%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFG AK     +K + +    
Sbjct: 127 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 180
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 226
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 227 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 40/284 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNH 196
           IG+G FGDV+ G   S        +N   AVA+K  +   S   ++++  E   + + +H
Sbjct: 18  IGEGQFGDVHQGIYMS-------PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P++VKL+G   ++    ++ E  T G L    L      L+    I  A   +  L +L 
Sbjct: 71  PHIVKLIGVITENP-VWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG-----YFA 311
           +  +  +HRD+ A NVL+      K+ DFGL+++  + D    ST    ++G     + A
Sbjct: 129 S--KRFVHRDIAARNVLVSATDCVKLGDFGLSRY--MED----STYYKASKGKLPIKWMA 180
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     T  +DV+ FGV + EIL      ++   G+  N     + N          
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEIL---MHGVKPFQGVKNNDVIGRIEN---------- 227
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             G  + M          ++ +C   DP  RP  +E+ A L  +
Sbjct: 228 --GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           + F    ++G G F +V++           +++      A+K +++  +      ENE+ 
Sbjct: 9   KTFIFMEVLGSGAFSEVFL----------VKQRLTGKLFALKCIKKSPAFRDSSLENEIA 58
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGA 248
            L ++ H N+V L        H  LV + V+ G L D +L     TE +    I+  L A
Sbjct: 59  VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA 118
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVL-LDDDFNAK--ISDFGLAKFGPLGDKSHISTRVLG 305
            +   +LH     ++HRD+K  N+L L  + N+K  I+DFGL+K     +++ I +   G
Sbjct: 119 VK---YLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACG 169
Query: 306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           T GY APE +A    +   D +S GV+   +L G
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 130/290 (44%), Gaps = 36/290 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 23  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFG AK     +K + +    
Sbjct: 134 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 187
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
               + A E I     T ++DV+S+GV + E++         T G     +KPY     +
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM---------TFG-----SKPYDGIPAS 233
Query: 365 LHQIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
               I EK  R  Q      +   I+++C   D  +RP   E++    ++
Sbjct: 234 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 129/281 (45%), Gaps = 30/281 (10%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLN 195
           ++G G FG VY G      +     +N    VA+K LR   S +   E  +E   ++ + 
Sbjct: 24  VLGSGAFGTVYKG------IWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 77
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
            P V +L+G C     +L V + +  G L DH+  E+   L  +  +   +  A+G+ +L
Sbjct: 78  SPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHV-RENRGRLGSQDLLNWCMQIAKGMSYL 135
Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
                 ++HRD+ A NVL+    + KI+DFGLA+   + +  + +        + A E I
Sbjct: 136 EDV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 193
Query: 316 ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID--EKL 373
                T ++DV+S+GV + E++         T G     AKPY  + +   +I D  EK 
Sbjct: 194 LRRRFTHQSDVWSYGVTVWELM---------TFG-----AKPY--DGIPAREIPDLLEKG 237
Query: 374 GRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            R  Q      +   I+++C   D + RP   E+V+   ++
Sbjct: 238 ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRM 278

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 123/287 (42%), Gaps = 41/287 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQD----EWENELRFLS 192
           IG+G +G V+          A   KN    VA+KR+R + G +G           LR L 
Sbjct: 19  IGEGAYGKVF---------KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 193 RLNHPNVVKLMGYCC----DDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
              HPNVV+L   C     D + +L LV+E+V +  L  +L    +  +  E    +   
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
             RGL+ LH++   V+HRD+K  N+L+      K++DFGLA+           T V+ T 
Sbjct: 129 LLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTL 183
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT-----------AAMRRTNGLAG--NW 354
            Y APE +         D++S G +  E+   K              +    GL G  +W
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFA-EIILRCLNSDPKNR 400
            +     + A H    + + + +   +  E   +++L+CL  +P  R
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVT--DIDELGKDLLLKCLTFNPAKR 288

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 195 NHPNVVKLMGYCCDDQHRLL-VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           NHP +V L   C   + RL  V EYV  G L  H+  +        R     +  A  L 
Sbjct: 111 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LN 167
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG--PLGDKSHISTRVLGTRGYFA 311
           +LH   R +I+RD+K  NVLLD + + K++D+G+ K G  P GD    ++   GT  Y A
Sbjct: 168 YLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT---TSTFCGTPNYIA 221
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE +         D ++ GV++ E+++G++        + G+   P  + +  L Q+I E
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPF-----DIVGSSDNPDQNTEDYLFQVILE 276
Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNR 400
           K  R I    + + A ++   LN DPK R
Sbjct: 277 KQIR-IPRSLSVKAASVLKSFLNKDPKER 304

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELR 189
           +F +  ++G G FG VY G      +     +     VA+K LR   S +   E  +E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKG------LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-----ELNWERRIKI 244
            ++ +++P+V +L+G C     +L+  + +  G L D++    D       LNW  +I  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               A+G+ +L    R ++HRD+ A NVL+    + KI+DFG AK     +K + +    
Sbjct: 129 ----AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS 338
               + A E I     T ++DV+S+GV + E+++
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           ++G+G FG+V       C     R    ++AV V       ++       E+  L +L+H
Sbjct: 29  MLGKGSFGEVL-----KCK---DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGLEHL 255
           PN++KL     D     +V E  T G L D ++     +E +  R IK       G+ ++
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---GITYM 137
Query: 256 HTYWRPVIHRDVKASNVLLDD---DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           H +   ++HRD+K  N+LL+    D + KI DFGL+        + +  R+ GT  Y AP
Sbjct: 138 HKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRI-GTAYYIAP 192
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSG 339
           E +  G    K DV+S GV+L  +LSG
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 27/240 (11%)
Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR----KGSQG 180
           L+     +    +IG+G FG+V +           R K +    A+K L +    K S  
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQL----------VRHKASQKVYAMKLLSKFEMIKRSDS 119
Query: 181 QDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWER 240
              WE E   ++  N P VV+L     DD++  +V EY+  G L + + N D  E  W +
Sbjct: 120 AFFWE-ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAK 177
Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
                +  A  L+ +H+    +IHRDVK  N+LLD   + K++DFG           H  
Sbjct: 178 FYTAEVVLA--LDAIHS--MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCD 233
Query: 301 TRVLGTRGYFAPEYIAT----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
           T V GT  Y +PE + +    G+   + D +S GV L E+L G T      + L G ++K
Sbjct: 234 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY--ADSLVGTYSK 290

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           ++G+G FG+V       C     R    ++AV V       ++       E+  L +L+H
Sbjct: 29  MLGKGSFGEVL-----KCK---DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGLEHL 255
           PN++KL     D     +V E  T G L D ++     +E +  R IK       G+ ++
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---GITYM 137
Query: 256 HTYWRPVIHRDVKASNVLLDD---DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           H +   ++HRD+K  N+LL+    D + KI DFGL+        + +  R+ GT  Y AP
Sbjct: 138 HKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRI-GTAYYIAP 192
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSG 339
           E +  G    K DV+S GV+L  +LSG
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 126/278 (45%), Gaps = 32/278 (11%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE--WENE 187
           + F    +IG+G +  V +           R K  D   A+K ++++     ++  W   
Sbjct: 5   QDFDLLRVIGRGSYAKVLL----------VRLKKTDRIYAMKVVKKELVNDDEDIDWVQT 54
Query: 188 LR--FLSRLNHPNVVKLMGYCCDDQHRLL-VYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
            +  F    NHP +V L   C   + RL  V EYV  G L  H+  +        R    
Sbjct: 55  EKHVFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA 113
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG--PLGDKSHISTR 302
            +  A  L +LH   R +I+RD+K  NVLLD + + K++D+G+ K G  P GD    ++ 
Sbjct: 114 EISLA--LNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT---TSX 165
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK 362
             GT  Y APE +         D ++ GV++ E+++G++        + G+   P  + +
Sbjct: 166 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF-----DIVGSSDNPDQNTE 220
Query: 363 LALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNR 400
             L Q+I EK  R I    + + A ++   LN DPK R
Sbjct: 221 DYLFQVILEKQIR-IPRSLSVKAASVLKSFLNKDPKER 257

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F    L+G G +G VY G          R        A+K +   G + ++E + E+  L
Sbjct: 26  FELVELVGNGTYGQVYKG----------RHVKTGQLAAIKVMDVTGDE-EEEIKQEINML 74
Query: 192 SRLNHP-NVVKLMGYCCD------DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
            + +H  N+    G          D    LV E+   GS+ D + N     L  E    I
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                RGL HLH +   VIHRD+K  NVLL ++   K+ DFG++    L          +
Sbjct: 135 CREILRGLSHLHQH--KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI 190
Query: 305 GTRGYFAPEYIAT-----GHLTLKTDVYSFGVVLLEILSG 339
           GT  + APE IA           K+D++S G+  +E+  G
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 116/285 (40%), Gaps = 33/285 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G +     +      +   VAVK L    S+ QDE +   E   +S+LN
Sbjct: 39  LGHGAFGEVYEGQV-----SGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKLN 92
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 93  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISDFGLAKFGPLGDKSHISTRVLGTR 307
           G ++L       IHRD+ A N LL        AKI DFG+A+              +   
Sbjct: 153 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 210
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            +  PE    G  T KTD +SFGV+L EI S             G    P  SN+  L  
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------LGYMPYPSKSNQEVLEF 258
Query: 368 IIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALE 411
           +     GR    +        I+ +C    P++RP  + ++  +E
Sbjct: 259 VTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 123/287 (42%), Gaps = 41/287 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQD----EWENELRFLS 192
           IG+G +G V+          A   KN    VA+KR+R + G +G           LR L 
Sbjct: 19  IGEGAYGKVF---------KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 193 RLNHPNVVKLMGYCC----DDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
              HPNVV+L   C     D + +L LV+E+V +  L  +L    +  +  E    +   
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
             RGL+ LH++   V+HRD+K  N+L+      K++DFGLA+           T V+ T 
Sbjct: 129 LLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTL 183
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK-----------TAAMRRTNGLAG--NW 354
            Y APE +         D++S G +  E+   K              +    GL G  +W
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFA-EIILRCLNSDPKNR 400
            +     + A H    + + + +   +  E   +++L+CL  +P  R
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVT--DIDELGKDLLLKCLTFNPAKR 288

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 123/287 (42%), Gaps = 41/287 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQD----EWENELRFLS 192
           IG+G +G V+          A   KN    VA+KR+R + G +G           LR L 
Sbjct: 19  IGEGAYGKVF---------KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 193 RLNHPNVVKLMGYCC----DDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
              HPNVV+L   C     D + +L LV+E+V +  L  +L    +  +  E    +   
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
             RGL+ LH++   V+HRD+K  N+L+      K++DFGLA+           T V+ T 
Sbjct: 129 LLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTL 183
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK-----------TAAMRRTNGLAG--NW 354
            Y APE +         D++S G +  E+   K              +    GL G  +W
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFA-EIILRCLNSDPKNR 400
            +     + A H    + + + +   +  E   +++L+CL  +P  R
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVT--DIDELGKDLLLKCLTFNPAKR 288

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENE---L 188
           FS   +IG+GGFG+VY      C      +  A   +  KR++ K  QG+    NE   L
Sbjct: 191 FSVHRIIGRGGFGEVY-----GCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIML 243
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHL-----LNEDDTELNWERRI 242
             +S  + P +V  M Y      +L  + + +  G L  HL      +E D         
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF------ 296
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHIST 301
             A     GLEH+H   R V++RD+K +N+LLD+  + +ISD GLA  F     K H S 
Sbjct: 297 -YAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHAS- 350
Query: 302 RVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
             +GT GY APE +  G       D +S G +L ++L G +
Sbjct: 351 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENE---L 188
           FS   +IG+GGFG+VY      C      +  A   +  KR++ K  QG+    NE   L
Sbjct: 191 FSVHRIIGRGGFGEVY-----GCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIML 243
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHL-----LNEDDTELNWERRI 242
             +S  + P +V  M Y      +L  + + +  G L  HL      +E D         
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF------ 296
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHIST 301
             A     GLEH+H   R V++RD+K +N+LLD+  + +ISD GLA  F     K H S 
Sbjct: 297 -YAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHAS- 350
Query: 302 RVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
             +GT GY APE +  G       D +S G +L ++L G +
Sbjct: 351 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 126/278 (45%), Gaps = 32/278 (11%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE--WENE 187
           + F    +IG+G +  V +           R K  D   A+K ++++     ++  W   
Sbjct: 9   QDFDLLRVIGRGSYAKVLL----------VRLKKTDRIYAMKVVKKELVNDDEDIDWVQT 58
Query: 188 LR--FLSRLNHPNVVKLMGYCCDDQHRLL-VYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
            +  F    NHP +V L   C   + RL  V EYV  G L  H+  +        R    
Sbjct: 59  EKHVFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA 117
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG--PLGDKSHISTR 302
            +  A  L +LH   R +I+RD+K  NVLLD + + K++D+G+ K G  P GD    ++ 
Sbjct: 118 EISLA--LNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT---TSX 169
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK 362
             GT  Y APE +         D ++ GV++ E+++G++        + G+   P  + +
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF-----DIVGSSDNPDQNTE 224
Query: 363 LALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNR 400
             L Q+I EK  R I    + + A ++   LN DPK R
Sbjct: 225 DYLFQVILEKQIR-IPRSLSVKAASVLKSFLNKDPKER 261

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 40/284 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNH 196
           IG+G FGDV+ G   S        +N   AVA+K  +   S   ++++  E   + + +H
Sbjct: 398 IGEGQFGDVHQGIYMS-------PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P++VKL+G   ++    ++ E  T G L    L      L+    I  A   +  L +L 
Sbjct: 451 PHIVKLIGVITENP-VWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG-----YFA 311
           +  +  +HRD+ A NVL+      K+ DFGL+++  + D    ST    ++G     + A
Sbjct: 509 S--KRFVHRDIAARNVLVSATDCVKLGDFGLSRY--MED----STYYKASKGKLPIKWMA 560
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     T  +DV+ FGV + EIL      ++   G+  N     + N          
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEIL---MHGVKPFQGVKNNDVIGRIEN---------- 607
Query: 372 KLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             G  + M          ++ +C   DP  RP  +E+ A L  +
Sbjct: 608 --GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 129/275 (46%), Gaps = 32/275 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR--RKGSQGQDEWENELRFLSRLN 195
           +G G F       +  C      ++ A   +  +RL   R+G   ++E E E+  L  + 
Sbjct: 13  LGSGQFA-----IVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVS-REEIEREVNILREIR 66
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGLEH 254
           HPN++ L     +    +L+ E V+ G L D L  ++  TE    + +K  L    G+ +
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHY 123
Query: 255 LHTYWRPVIHRDVKASNVLLDD----DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           LH+  + + H D+K  N++L D    +   K+ DFG+A     G++      + GT  + 
Sbjct: 124 LHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFV 178
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           APE +    L L+ D++S GV+   +LSG +  +       G   +  L+N  A++   D
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSGASPFL-------GETKQETLTNISAVNYDFD 231
Query: 371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
           E+   N   E A++F   I R L  DPK R T+++
Sbjct: 232 EEYFSNTS-ELAKDF---IRRLLVKDPKRRMTIAQ 262

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENE---L 188
           FS   +IG+GGFG+VY      C      +  A   +  KR++ K  QG+    NE   L
Sbjct: 191 FSVHRIIGRGGFGEVY-----GCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIML 243
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHL-----LNEDDTELNWERRI 242
             +S  + P +V  M Y      +L  + + +  G L  HL      +E D         
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF------ 296
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHIST 301
             A     GLEH+H   R V++RD+K +N+LLD+  + +ISD GLA  F     K H S 
Sbjct: 297 -YAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHAS- 350
Query: 302 RVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
             +GT GY APE +  G       D +S G +L ++L G +
Sbjct: 351 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENE---L 188
           FS   +IG+GGFG+VY      C      +  A   +  KR++ K  QG+    NE   L
Sbjct: 190 FSVHRIIGRGGFGEVY-----GCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIML 242
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHL-----LNEDDTELNWERRI 242
             +S  + P +V  M Y      +L  + + +  G L  HL      +E D         
Sbjct: 243 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF------ 295
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHIST 301
             A     GLEH+H   R V++RD+K +N+LLD+  + +ISD GLA  F     K H S 
Sbjct: 296 -YAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHAS- 349
Query: 302 RVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
             +GT GY APE +  G       D +S G +L ++L G +
Sbjct: 350 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 388

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 116/285 (40%), Gaps = 33/285 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G +     +      +   VAVK L    S+ QDE +   E   +S+LN
Sbjct: 53  LGHGAFGEVYEGQV-----SGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKLN 106
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 107 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISDFGLAKFGPLGDKSHISTRVLGTR 307
           G ++L       IHRD+ A N LL        AKI DFG+A+              +   
Sbjct: 167 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            +  PE    G  T KTD +SFGV+L EI S             G    P  SN+  L  
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------LGYMPYPSKSNQEVLEF 272
Query: 368 IIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALE 411
           +     GR    +        I+ +C    P++RP  + ++  +E
Sbjct: 273 VTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 119/263 (45%), Gaps = 38/263 (14%)
Query: 161 RKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSRLNHPNVVKLMGYCCDDQHRLL--V 215
           R+ +D  + V +    GS  + E +   +E+  L  L HPN+V+      D  +  L  V
Sbjct: 26  RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85
Query: 216 YEY---------VTRGSLEDHLLNEDDTELNWERRIKIALGAA-RGLEHLHTYWRPVIHR 265
            EY         +T+G+ E   L+E+   L    ++ +AL    R  +  HT    V+HR
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRRSDGGHT----VLHR 140
Query: 266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTD 325
           D+K +NV LD   N K+ DFGLA+   L   +  +   +GT  Y +PE +       K+D
Sbjct: 141 DLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSD 198
Query: 326 VYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQIIDEKLGRNIQMEEAQE 384
           ++S G +L E+ +                  P+ + ++  L   I E   R I    + E
Sbjct: 199 IWSLGCLLYELCA---------------LMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 385 FAEIILRCLNSDPKNRPTMSEVV 407
             EII R LN    +RP++ E++
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEIL 266

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 119/263 (45%), Gaps = 38/263 (14%)
Query: 161 RKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSRLNHPNVVKLMGYCCDDQHRLL--V 215
           R+ +D  + V +    GS  + E +   +E+  L  L HPN+V+      D  +  L  V
Sbjct: 26  RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85
Query: 216 YEY---------VTRGSLEDHLLNEDDTELNWERRIKIALGAA-RGLEHLHTYWRPVIHR 265
            EY         +T+G+ E   L+E+   L    ++ +AL    R  +  HT    V+HR
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRRSDGGHT----VLHR 140
Query: 266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTD 325
           D+K +NV LD   N K+ DFGLA+   L   +  +   +GT  Y +PE +       K+D
Sbjct: 141 DLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSD 198
Query: 326 VYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQIIDEKLGRNIQMEEAQE 384
           ++S G +L E+ +                  P+ + ++  L   I E   R I    + E
Sbjct: 199 IWSLGCLLYELCA---------------LMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 385 FAEIILRCLNSDPKNRPTMSEVV 407
             EII R LN    +RP++ E++
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEIL 266

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSR 193
           K  +G GGFG V + +I+         ++    VA+K+ R++ S + ++ W  E++ + +
Sbjct: 20  KERLGTGGFGYV-LRWIH---------QDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK 69
Query: 194 LNHPNVVKL------MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           LNHPNVV        +     +   LL  EY   G L  +L   ++     E  I+  L 
Sbjct: 70  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 129
Query: 248 -AARGLEHLHTYWRPVIHRDVKASNVLLD---DDFNAKISDFGLAKFGPLGDKSHISTRV 303
             +  L +LH     +IHRD+K  N++L         KI D G AK     D+  + T  
Sbjct: 130 DISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEF 184
Query: 304 LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           +GT  Y APE +     T+  D +SFG +  E ++G
Sbjct: 185 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSR 193
           K  +G GGFG V + +I+         ++    VA+K+ R++ S + ++ W  E++ + +
Sbjct: 19  KERLGTGGFGYV-LRWIH---------QDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK 68
Query: 194 LNHPNVVKL------MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           LNHPNVV        +     +   LL  EY   G L  +L   ++     E  I+  L 
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 248 -AARGLEHLHTYWRPVIHRDVKASNVLLD---DDFNAKISDFGLAKFGPLGDKSHISTRV 303
             +  L +LH     +IHRD+K  N++L         KI D G AK     D+  + T  
Sbjct: 129 DISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEF 183
Query: 304 LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           +GT  Y APE +     T+  D +SFG +  E ++G
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 118/263 (44%), Gaps = 38/263 (14%)
Query: 161 RKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSRLNHPNVVKLMGYCCDDQHRLL--V 215
           R+ +D  + V +    GS  + E +   +E+  L  L HPN+V+      D  +  L  V
Sbjct: 26  RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85
Query: 216 YEY---------VTRGSLEDHLLNEDDTELNWERRIKIALGAA-RGLEHLHTYWRPVIHR 265
            EY         +T+G+ E   L+E+   L    ++ +AL    R  +  HT    V+HR
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRRSDGGHT----VLHR 140
Query: 266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTD 325
           D+K +NV LD   N K+ DFGLA+   L      +   +GT  Y +PE +       K+D
Sbjct: 141 DLKPANVFLDGKQNVKLGDFGLARI--LNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSD 198
Query: 326 VYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALHQIIDEKLGRNIQMEEAQE 384
           ++S G +L E+ +                  P+ + ++  L   I E   R I    + E
Sbjct: 199 IWSLGCLLYELCA---------------LMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 385 FAEIILRCLNSDPKNRPTMSEVV 407
             EII R LN    +RP++ E++
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEIL 266

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 115/285 (40%), Gaps = 33/285 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G +     +      +   VAVK L    S+ QDE +   E   +S+ N
Sbjct: 65  LGHGAFGEVYEGQV-----SGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFN 118
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 119 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 178
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLD---DDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
           G ++L       IHRD+ A N LL        AKI DFG+A+              +   
Sbjct: 179 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 236
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            +  PE    G  T KTD +SFGV+L EI S             G    P  SN+  L  
Sbjct: 237 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------LGYMPYPSKSNQEVLEF 284
Query: 368 IIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALE 411
           +     GR    +        I+ +C    P++RP  + ++  +E
Sbjct: 285 VTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 170 VKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED 226
           +K+ R K S+    +++ E E+  L  + HPNV+ L     +    +L+ E V  G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DFNAKI 282
            L  ++   L  E   +       G+ +LH+    + H D+K  N++L D        KI
Sbjct: 104 FLAEKES--LTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
            DFGLA     G++      + GT  + APE +    L L+ D++S GV+   +LSG + 
Sbjct: 160 IDFGLAHKIDFGNEFK---NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            +       G+  +  L+N  A+ ++  DE       +  A++F   I R L  DPK R 
Sbjct: 217 FL-------GDTKQETLANVSAVNYEFEDEYFSNTSAL--AKDF---IRRLLVKDPKKRM 264
Query: 402 TMSE 405
           T+ +
Sbjct: 265 TIQD 268

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 35/286 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G +     +      +   VAVK L    S+ QDE +   E   +S+ N
Sbjct: 56  LGHGAFGEVYEGQV-----SGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFN 109
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 110 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 169
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISDFGLAK-FGPLGDKSHISTRVLGT 306
           G ++L       IHRD+ A N LL        AKI DFG+A+     G        +L  
Sbjct: 170 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 227
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
           + +  PE    G  T KTD +SFGV+L EI S             G    P  SN+  L 
Sbjct: 228 K-WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------LGYMPYPSKSNQEVLE 274
Query: 367 QIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALE 411
            +     GR    +        I+ +C    P++RP  + ++  +E
Sbjct: 275 FVTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 115/285 (40%), Gaps = 33/285 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G +     +      +   VAVK L    S+ QDE +   E   +S+ N
Sbjct: 38  LGHGAFGEVYEGQV-----SGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFN 91
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 92  HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISDFGLAKFGPLGDKSHISTRVLGTR 307
           G ++L       IHRD+ A N LL        AKI DFG+A+              +   
Sbjct: 152 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            +  PE    G  T KTD +SFGV+L EI S             G    P  SN+  L  
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------LGYMPYPSKSNQEVLEF 257
Query: 368 IIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALE 411
           +     GR    +        I+ +C    P++RP  + ++  +E
Sbjct: 258 VTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
           ++G+G FG V +          + RK  D   AVK L++      D+ E    E R L+ 
Sbjct: 348 VLGKGSFGKVML----------SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
              P  +  +  C     RL  V EYV  G L  H+  +          +  A   A GL
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGL 455
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL-GTRGYFA 311
             L +  + +I+RD+K  NV+LD + + KI+DFG+ K         ++T+   GT  Y A
Sbjct: 456 FFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW---DGVTTKXFCGTPDYIA 510
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           PE IA        D ++FGV+L E+L+G+ 
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 115/285 (40%), Gaps = 33/285 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G +     +      +   VAVK L    S+ QDE +   E   +S+ N
Sbjct: 55  LGHGAFGEVYEGQV-----SGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFN 108
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 109 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 168
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISDFGLAKFGPLGDKSHISTRVLGTR 307
           G ++L       IHRD+ A N LL        AKI DFG+A+              +   
Sbjct: 169 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 226
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            +  PE    G  T KTD +SFGV+L EI S             G    P  SN+  L  
Sbjct: 227 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------LGYMPYPSKSNQEVLEF 274
Query: 368 IIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALE 411
           +     GR    +        I+ +C    P++RP  + ++  +E
Sbjct: 275 VTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 117/254 (46%), Gaps = 37/254 (14%)
Query: 103 AVSFHRDEVFHAYKLKYFCHGLLEAATR-KFSEKNLIGQGGFGDVYIGYI-NSCAMTAAR 160
           A+S  R++VF  + L      +   A R ++     +G G  G+V + +   +C   A R
Sbjct: 107 ALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR 166
Query: 161 RKNADFAVAVKRLRRKGSQGQDE----WENELRFLSRLNHPNVVKLMGYCCDDQHRLLVY 216
                  +  KR    GS  + +     E E+  L +LNHP ++K+  +  D +   +V 
Sbjct: 167 -------IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVL 218
Query: 217 EYVTRGSLEDHL-----LNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASN 271
           E +  G L D +     L E   +L + + +         +++LH     +IHRD+K  N
Sbjct: 219 ELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQYLHE--NGIIHRDLKPEN 269
Query: 272 VLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY---IATGHLTLKTD 325
           VLL   ++D   KI+DFG +K   LG+ S + T + GT  Y APE    + T       D
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVD 326
Query: 326 VYSFGVVLLEILSG 339
            +S GV+L   LSG
Sbjct: 327 CWSLGVILFICLSG 340

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 128/296 (43%), Gaps = 56/296 (18%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F E  LIG GGFG V+           A+ +       +KR++    +     E E++ L
Sbjct: 13  FKEIELIGSGGFGQVF----------KAKHRIDGKTYVIKRVKYNNEKA----EREVKAL 58
Query: 192 SRLNHPNVVKLMGYCCD-----------------DQHRLLVYEYVTRGSLEDHLLNEDDT 234
           ++L+H N+V   G C D                  +   +  E+  +G+LE  +      
Sbjct: 59  AKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 235 ELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
           +L+    +++     +G++++H+  + +I+RD+K SN+ L D    KI DFGL       
Sbjct: 118 KLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
            K     R  GT  Y +PE I++     + D+Y+ G++L E+L     A   T+    + 
Sbjct: 176 GK---RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF-ETSKFFTDL 231
Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL 410
               +S+      I D+K    +Q            + L+  P++RP  SE++  L
Sbjct: 232 RDGIISD------IFDKKEKTLLQ------------KLLSKKPEDRPNTSEILRTL 269

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 125/284 (44%), Gaps = 45/284 (15%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD---EWENE 187
           ++    ++G GG  +V++          AR       VAVK LR   ++       +  E
Sbjct: 13  RYELGEILGFGGMSEVHL----------ARDLRLHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHR------LLVYEYVTRGSLEDHLLNEDDTELNWERR 241
            +  + LNHP +V +  Y   +          +V EYV   +L D +  E    +  +R 
Sbjct: 63  AQNAAALNHPAIVAV--YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRA 118
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHIS 300
           I++   A + L   H     +IHRDVK +N+++      K+ DFG+A+     G+    +
Sbjct: 119 IEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS 360
             V+GT  Y +PE      +  ++DVYS G VL E+L+G+                P+  
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE---------------PPFTG 221
Query: 361 N---KLALHQIIDEKLGRNIQMEE-AQEFAEIILRCLNSDPKNR 400
           +    +A   + ++ +  + + E  + +   ++L+ L  +P+NR
Sbjct: 222 DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
           ++G+G FG V +          + RK  D   AVK L++      D+ E    E R L+ 
Sbjct: 27  VLGKGSFGKVML----------SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
              P  +  +  C     RL  V EYV  G L  H+  +          +  A   A GL
Sbjct: 77  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGL 134
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL-GTRGYFA 311
             L +  + +I+RD+K  NV+LD + + KI+DFG+ K         ++T+   GT  Y A
Sbjct: 135 FFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW---DGVTTKXFCGTPDYIA 189
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           PE IA        D ++FGV+L E+L+G+ 
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 115/285 (40%), Gaps = 33/285 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G +     +      +   VAVK L    S+ QDE +   E   +S+ N
Sbjct: 39  LGHGAFGEVYEGQV-----SGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFN 92
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 93  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISDFGLAKFGPLGDKSHISTRVLGTR 307
           G ++L       IHRD+ A N LL        AKI DFG+A+              +   
Sbjct: 153 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 210
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            +  PE    G  T KTD +SFGV+L EI S             G    P  SN+  L  
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------LGYMPYPSKSNQEVLEF 258
Query: 368 IIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALE 411
           +     GR    +        I+ +C    P++RP  + ++  +E
Sbjct: 259 VTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 35/286 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G +     +      +   VAVK L    S+ QDE +   E   +S+ N
Sbjct: 79  LGHGAFGEVYEGQV-----SGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFN 132
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISDFGLAK-FGPLGDKSHISTRVLGT 306
           G ++L       IHRD+ A N LL        AKI DFG+A+     G        +L  
Sbjct: 193 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
           + +  PE    G  T KTD +SFGV+L EI S             G    P  SN+  L 
Sbjct: 251 K-WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------LGYMPYPSKSNQEVLE 297
Query: 367 QIIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALE 411
            +     GR    +        I+ +C    P++RP  + ++  +E
Sbjct: 298 FVTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 83/154 (53%), Gaps = 7/154 (4%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           EL+ L   N P +V   G    D    +  E++  GSL+  L  +    +  +   K+++
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSI 173
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              +GL +L    + ++HRDVK SN+L++     K+ DFG++  G L D   ++   +GT
Sbjct: 174 AVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 228
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           R Y +PE +   H ++++D++S G+ L+E+  G+
Sbjct: 229 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 115/285 (40%), Gaps = 33/285 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G +     +      +   VAVK L    S+ QDE +   E   +S+ N
Sbjct: 38  LGHGAFGEVYEGQV-----SGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFN 91
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 92  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISDFGLAKFGPLGDKSHISTRVLGTR 307
           G ++L       IHRD+ A N LL        AKI DFG+A+              +   
Sbjct: 152 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            +  PE    G  T KTD +SFGV+L EI S             G    P  SN+  L  
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------LGYMPYPSKSNQEVLEF 257
Query: 368 IIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALE 411
           +     GR    +        I+ +C    P++RP  + ++  +E
Sbjct: 258 VTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 117/254 (46%), Gaps = 37/254 (14%)
Query: 103 AVSFHRDEVFHAYKLKYFCHGLLEAATR-KFSEKNLIGQGGFGDVYIGYI-NSCAMTAAR 160
           A+S  R++VF  + L      +   A R ++     +G G  G+V + +   +C   A R
Sbjct: 121 ALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR 180
Query: 161 RKNADFAVAVKRLRRKGSQGQDE----WENELRFLSRLNHPNVVKLMGYCCDDQHRLLVY 216
                  +  KR    GS  + +     E E+  L +LNHP ++K+  +  D +   +V 
Sbjct: 181 -------IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVL 232
Query: 217 EYVTRGSLEDHL-----LNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASN 271
           E +  G L D +     L E   +L + + +         +++LH     +IHRD+K  N
Sbjct: 233 ELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQYLHE--NGIIHRDLKPEN 283
Query: 272 VLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY---IATGHLTLKTD 325
           VLL   ++D   KI+DFG +K   LG+ S + T + GT  Y APE    + T       D
Sbjct: 284 VLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVD 340
Query: 326 VYSFGVVLLEILSG 339
            +S GV+L   LSG
Sbjct: 341 CWSLGVILFICLSG 354

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 115/285 (40%), Gaps = 33/285 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G +     +      +   VAVK L    S+ QDE +   E   +S+ N
Sbjct: 30  LGHGAFGEVYEGQV-----SGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFN 83
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 84  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 143
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISDFGLAKFGPLGDKSHISTRVLGTR 307
           G ++L       IHRD+ A N LL        AKI DFG+A+              +   
Sbjct: 144 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 201
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            +  PE    G  T KTD +SFGV+L EI S             G    P  SN+  L  
Sbjct: 202 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------LGYMPYPSKSNQEVLEF 249
Query: 368 IIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALE 411
           +     GR    +        I+ +C    P++RP  + ++  +E
Sbjct: 250 VTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 115/285 (40%), Gaps = 33/285 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G +     +      +   VAVK L    S+ QDE +   E   +S+ N
Sbjct: 39  LGHGAFGEVYEGQV-----SGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFN 92
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 93  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISDFGLAKFGPLGDKSHISTRVLGTR 307
           G ++L       IHRD+ A N LL        AKI DFG+A+              +   
Sbjct: 153 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPV 210
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            +  PE    G  T KTD +SFGV+L EI S             G    P  SN+  L  
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------LGYMPYPSKSNQEVLEF 258
Query: 368 IIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALE 411
           +     GR    +        I+ +C    P++RP  + ++  +E
Sbjct: 259 VTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 115/285 (40%), Gaps = 33/285 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G +     +      +   VAVK L    S+ QDE +   E   +S+ N
Sbjct: 45  LGHGAFGEVYEGQV-----SGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFN 98
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 99  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 158
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISDFGLAKFGPLGDKSHISTRVLGTR 307
           G ++L       IHRD+ A N LL        AKI DFG+A+              +   
Sbjct: 159 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 216
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            +  PE    G  T KTD +SFGV+L EI S             G    P  SN+  L  
Sbjct: 217 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------LGYMPYPSKSNQEVLEF 264
Query: 368 IIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALE 411
           +     GR    +        I+ +C    P++RP  + ++  +E
Sbjct: 265 VTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 115/285 (40%), Gaps = 33/285 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G +     +      +   VAVK L    S+ QDE +   E   +S+ N
Sbjct: 53  LGHGAFGEVYEGQV-----SGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFN 106
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 107 HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISDFGLAKFGPLGDKSHISTRVLGTR 307
           G ++L       IHRD+ A N LL        AKI DFG+A+              +   
Sbjct: 167 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            +  PE    G  T KTD +SFGV+L EI S             G    P  SN+  L  
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------LGYMPYPSKSNQEVLEF 272
Query: 368 IIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALE 411
           +     GR    +        I+ +C    P++RP  + ++  +E
Sbjct: 273 VTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 125/282 (44%), Gaps = 41/282 (14%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD---EWENE 187
           ++    ++G GG  +V++          AR       VAVK LR   ++       +  E
Sbjct: 13  RYELGEILGFGGMSEVHL----------ARDLRDHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 188 LRFLSRLNHPNVVKL--MGYCCDDQHRL--LVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            +  + LNHP +V +   G        L  +V EYV   +L D +  E    +  +R I+
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIE 120
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHISTR 302
           +   A + L   H     +IHRDVK +N+L+      K+ DFG+A+     G+    +  
Sbjct: 121 VIADACQALNFSHQNG--IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAA 178
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN- 361
           V+GT  Y +PE      +  ++DVYS G VL E+L+G+                P+  + 
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE---------------PPFTGDS 223
Query: 362 --KLALHQIIDEKLGRNIQMEE-AQEFAEIILRCLNSDPKNR 400
              +A   + ++ +  + + E  + +   ++L+ L  +P+NR
Sbjct: 224 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 125/279 (44%), Gaps = 35/279 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD---EWENE 187
           ++    ++G GG  +V++          AR       VAVK LR   ++       +  E
Sbjct: 13  RYELGEILGFGGMSEVHL----------ARDLRDHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 188 LRFLSRLNHPNVVKL--MGYCCDDQHRL--LVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            +  + LNHP +V +   G        L  +V EYV   +L D +  E    +  +R I+
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIE 120
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHISTR 302
           +   A + L   H     +IHRDVK +N+++      K+ DFG+A+     G+    +  
Sbjct: 121 VIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK 362
           V+GT  Y +PE      +  ++DVYS G VL E+L+G+           G+       + 
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-------FTGDS-----PDS 226
Query: 363 LALHQIIDEKLGRNIQMEE-AQEFAEIILRCLNSDPKNR 400
           +A   + ++ +  + + E  + +   ++L+ L  +P+NR
Sbjct: 227 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 35/279 (12%)
Query: 134 EKNLIGQGGFGDVYIGYINSCAMTAARR----KNADFAVAVKRLRRKGSQGQDEWENELR 189
           E   +G G FG V  GY     +         KN     A+K          DE   E  
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEAN 422
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            + +L++P +V+++G  C+ +  +LV E    G L  +L  + +  +  +  I++    +
Sbjct: 423 VMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVS 479
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR-- 307
            G+++L       +HRD+ A NVLL     AKISDFGL+K     D+++   +  G    
Sbjct: 480 MGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPV 536
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            ++APE I     + K+DV+SFGV++ E  S      R   G+ G+     L        
Sbjct: 537 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR---GMKGSEVTAMLEK------ 587
Query: 368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
              E++G        +E  +++  C   D +NRP  + V
Sbjct: 588 --GERMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAV 622

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 35/279 (12%)
Query: 134 EKNLIGQGGFGDVYIGYINSCAMTAARR----KNADFAVAVKRLRRKGSQGQDEWENELR 189
           E   +G G FG V  GY     +         KN     A+K          DE   E  
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEAN 423
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            + +L++P +V+++G  C+ +  +LV E    G L  +L  + +  +  +  I++    +
Sbjct: 424 VMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVS 480
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR-- 307
            G+++L       +HRD+ A NVLL     AKISDFGL+K     D+++   +  G    
Sbjct: 481 MGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPV 537
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            ++APE I     + K+DV+SFGV++ E  S      R   G+ G+     L        
Sbjct: 538 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR---GMKGSEVTAMLEK------ 588
Query: 368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
              E++G        +E  +++  C   D +NRP  + V
Sbjct: 589 --GERMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAV 623

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 103/247 (41%), Gaps = 44/247 (17%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F E  ++GQG FG V            AR        A+K++R    +      +E+  L
Sbjct: 8   FEEIAVLGQGAFGQV----------VKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLL 56
Query: 192 SRLNHP-------------NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW 238
           + LNH              N VK M          +  EY    +L D + +E+   LN 
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSEN---LNQ 113
Query: 239 ER--RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK------- 289
           +R    ++       L ++H+  + +IHRD+K  N+ +D+  N KI DFGLAK       
Sbjct: 114 QRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 290 -----FGPLGDKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGKTAA 343
                   L   S   T  +GT  Y A E +  TGH   K D+YS G++  E++   +  
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231
Query: 344 MRRTNGL 350
           M R N L
Sbjct: 232 MERVNIL 238

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRF 190
           F  K  +G G FGDV++             +++     +K + +  SQ   ++ E E+  
Sbjct: 24  FIFKRKLGSGAFGDVHL----------VEERSSGLERVIKTINKDRSQVPMEQIEAEIEV 73
Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED--DTELNWERRIKIALGA 248
           L  L+HPN++K+     D  +  +V E    G L + +++       L+     ++    
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDD---FNAKISDFGLAKFGPLGDKSHISTRVLG 305
              L + H+  + V+H+D+K  N+L  D       KI DFGLA+   L      ST   G
Sbjct: 134 MNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAAG 188
Query: 306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           T  Y APE +    +T K D++S GVV+  +L+G
Sbjct: 189 TALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G F       +  C    A ++ A   +  K+L  +  Q   + E E R    L HP
Sbjct: 30  LGKGAFS-----VVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHP 81
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           N+V+L     ++ H  L+++ VT G L ED +  E  +E +    I+  L A      LH
Sbjct: 82  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----LH 136
Query: 257 TYWRPVIHRDVKASNVLLDDDFNA---KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE 313
            +   V+HRD+K  N+LL         K++DFGLA    +  +        GT GY +PE
Sbjct: 137 CHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQAWFGFAGTPGYLSPE 194
Query: 314 YIATGHLTLKTDVYSFGVVLLEILSG 339
            +         D+++ GV+L  +L G
Sbjct: 195 VLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 129/309 (41%), Gaps = 69/309 (22%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F E  LIG GGFG V+           A+ +       ++R++    +     E E++ L
Sbjct: 14  FKEIELIGSGGFGQVF----------KAKHRIDGKTYVIRRVKYNNEKA----EREVKAL 59
Query: 192 SRLNHPNVVKLMGYCCD------------------------------DQHRLLVYEYVTR 221
           ++L+H N+V   G C D                               +   +  E+  +
Sbjct: 60  AKLDHVNIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 222 GSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK 281
           G+LE  +      +L+    +++     +G++++H+  + +IHRD+K SN+ L D    K
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLIHRDLKPSNIFLVDTKQVK 176
Query: 282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           I DFGL        K    TR  GT  Y +PE I++     + D+Y+ G++L E+L    
Sbjct: 177 IGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 233
Query: 342 AAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            A   T+    +     +S+      I D+K    +Q            + L+  P++RP
Sbjct: 234 TAF-ETSKFFTDLRDGIISD------IFDKKEKTLLQ------------KLLSKKPEDRP 274
Query: 402 TMSEVVAAL 410
             SE++  L
Sbjct: 275 NTSEILRTL 283

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 170 VKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED 226
           +K+ R K S+    +++ E E+  L  + HPNV+ L     +    +L+ E V  G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DFNAKI 282
            L  ++   L  E   +       G+ +LH+    + H D+K  N++L D        KI
Sbjct: 104 FLAEKES--LTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
            DFGLA     G++      + GT  + APE +    L L+ D++S GV+   +LSG + 
Sbjct: 160 IDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            +       G+  +  L+N  A+ ++  DE       +  A++F   I R L  DPK R 
Sbjct: 217 FL-------GDTKQETLANVSAVNYEFEDEYFSNTSAL--AKDF---IRRLLVKDPKKRM 264
Query: 402 TMSE 405
           T+ +
Sbjct: 265 TIQD 268

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 125/276 (45%), Gaps = 38/276 (13%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFA--VAVKRLRRKGSQGQDEWENELRFLSRL 194
            +G+GGF   +        ++ A  K   FA  +  K L  K  Q +++   E+     L
Sbjct: 48  FLGKGGFAKCF-------EISDADTKEV-FAGKIVPKSLLLKPHQ-REKMSMEISIHRSL 98
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIK-IALGAARGL 252
            H +VV   G+  D+    +V E   R SL E H   +  TE      ++ I LG     
Sbjct: 99  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC---- 154
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHISTRVLGTRGYFA 311
           ++LH     VIHRD+K  N+ L++D   KI DFGLA K    G++  +   + GT  Y A
Sbjct: 155 QYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIA 209
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE ++    + + DV+S G ++  +L GK                P+ ++ L    +  +
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKP---------------PFETSCLKETYLRIK 254
Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           K   +I        A +I + L +DP  RPT++E++
Sbjct: 255 KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 290

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 170 VKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED 226
           +K+ R K S+    +++ E E+  L  + HPNV+ L     +    +L+ E V  G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DFNAKI 282
            L  ++   L  E   +       G+ +LH+    + H D+K  N++L D        KI
Sbjct: 104 FLAEKES--LTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
            DFGLA     G++      + GT  + APE +    L L+ D++S GV+   +LSG + 
Sbjct: 160 IDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            +       G+  +  L+N  A+ ++  DE       +  A++F   I R L  DPK R 
Sbjct: 217 FL-------GDTKQETLANVSAVNYEFEDEYFSNTSAL--AKDF---IRRLLVKDPKKRM 264
Query: 402 TMSE 405
           T+ +
Sbjct: 265 TIQD 268

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 115/285 (40%), Gaps = 33/285 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G +     +      +   VAVK L    S+ QDE +   E   +S+ N
Sbjct: 53  LGHGAFGEVYEGQV-----SGMPNDPSPLQVAVKTLPEVYSE-QDELDFLMEALIISKFN 106
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 107 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISDFGLAKFGPLGDKSHISTRVLGTR 307
           G ++L       IHRD+ A N LL        AKI DFG+A+              +   
Sbjct: 167 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            +  PE    G  T KTD +SFGV+L EI S             G    P  SN+  L  
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------LGYMPYPSKSNQEVLEF 272
Query: 368 IIDEKLGRNIQMEEAQ-EFAEIILRCLNSDPKNRPTMSEVVAALE 411
           +     GR    +        I+ +C    P++RP  + ++  +E
Sbjct: 273 VTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 125/276 (45%), Gaps = 38/276 (13%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFA--VAVKRLRRKGSQGQDEWENELRFLSRL 194
            +G+GGF   +        ++ A  K   FA  +  K L  K  Q +++   E+     L
Sbjct: 46  FLGKGGFAKCF-------EISDADTKEV-FAGKIVPKSLLLKPHQ-REKMSMEISIHRSL 96
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIK-IALGAARGL 252
            H +VV   G+  D+    +V E   R SL E H   +  TE      ++ I LG     
Sbjct: 97  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC---- 152
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHISTRVLGTRGYFA 311
           ++LH     VIHRD+K  N+ L++D   KI DFGLA K    G++  +   + GT  Y A
Sbjct: 153 QYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIA 207
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE ++    + + DV+S G ++  +L GK                P+ ++ L    +  +
Sbjct: 208 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKP---------------PFETSCLKETYLRIK 252
Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           K   +I        A +I + L +DP  RPT++E++
Sbjct: 253 KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 288

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 83/154 (53%), Gaps = 7/154 (4%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           EL+ L   N P +V   G    D    +  E++  GSL+  L  +    +  +   K+++
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSI 138
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              +GL +L    + ++HRDVK SN+L++     K+ DFG++  G L D   ++   +GT
Sbjct: 139 AVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 193
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           R Y +PE +   H ++++D++S G+ L+E+  G+
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 32/275 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR--RKGSQGQDEWENELRFLSRLN 195
           +G G F       +  C      ++ A   +  +RL   R+G   ++E E E+  L  + 
Sbjct: 20  LGSGQFA-----IVRKCRQKGTGKEYAAKFIKKRRLSSSRRGV-SREEIEREVNILREIR 73
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGLEH 254
           HPN++ L     +    +L+ E V+ G L D L  ++  TE    + +K  L    G+ +
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHY 130
Query: 255 LHTYWRPVIHRDVKASNVLLDD----DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           LH+  + + H D+K  N++L D    +   K+ DFG+A     G++      + GT  + 
Sbjct: 131 LHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFV 185
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           APE +    L L+ D++S GV+   +LSG +  +       G   +  L+N  A++   D
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFL-------GETKQETLTNISAVNYDFD 238
Query: 371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
           E+   N   E A++F   I R L  DPK R  +++
Sbjct: 239 EEYFSNTS-ELAKDF---IRRLLVKDPKRRMXIAQ 269

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 118/267 (44%), Gaps = 51/267 (19%)
Query: 179 QGQDEWENELRFLSR--LNHPNVVKLMGY----CCDDQHRLLVYEYVTRGSLEDHLLNED 232
           Q +  W++E    S   + H N+++ +         +    L+  +  +GSL D+L    
Sbjct: 49  QDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYL---K 105
Query: 233 DTELNWERRIKIALGAARGLEHLH--TYW------RPVI-HRDVKASNVLLDDDFNAKIS 283
              + W     +A   +RGL +LH    W      +P I HRD K+ NVLL  D  A ++
Sbjct: 106 GNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLA 165
Query: 284 DFGLA-KFGPLGDKSHISTRVLGTRGYFAPEYIATG-----HLTLKTDVYSFGVVLLEIL 337
           DFGLA +F P G     +   +GTR Y APE +           L+ D+Y+ G+VL E++
Sbjct: 166 DFGLAVRFEP-GKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELV 224
Query: 338 SGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDP 397
           S   AA    +G    +  P+           +E++G++  +EE QE             
Sbjct: 225 SRCKAA----DGPVDEYMLPF-----------EEEIGQHPSLEELQEVV--------VHK 261
Query: 398 KNRPTMSEVV---AALEQLQLNMGSCY 421
           K RPT+ +       L QL + +  C+
Sbjct: 262 KMRPTIKDHWLKHPGLAQLCVTIEECW 288

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 34  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVS 143
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 144 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +     +  +D+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 125/282 (44%), Gaps = 41/282 (14%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD---EWENE 187
           ++    ++G GG  +V++          AR       VAVK LR   ++       +  E
Sbjct: 13  RYELGEILGFGGMSEVHL----------ARDLRLHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 188 LRFLSRLNHPNVVKL--MGYCCDDQHRL--LVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            +  + LNHP +V +   G        L  +V EYV   +L D +  E    +  +R I+
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIE 120
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHISTR 302
           +   A + L   H     +IHRDVK +N+++      K+ DFG+A+     G+    +  
Sbjct: 121 VIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN- 361
           V+GT  Y +PE      +  ++DVYS G VL E+L+G+                P+  + 
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE---------------PPFTGDS 223
Query: 362 --KLALHQIIDEKLGRNIQMEE-AQEFAEIILRCLNSDPKNR 400
              +A   + ++ +  + + E  + +   ++L+ L  +P+NR
Sbjct: 224 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 170 VKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED 226
           +K+ R K S+    +++ E E+  L  + HPNV+ L     +    +L+ E V  G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DFNAKI 282
            L  ++   L  E   +       G+ +LH+    + H D+K  N++L D        KI
Sbjct: 104 FLAEKES--LTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
            DFGLA     G++      + GT  + APE +    L L+ D++S GV+   +LSG + 
Sbjct: 160 IDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            +       G+  +  L+N  A+ ++  DE       +  A++F   I R L  DPK R 
Sbjct: 217 FL-------GDTKQETLANVSAVNYEFEDEYFSNTSAL--AKDF---IRRLLVKDPKKRM 264
Query: 402 TMSE 405
           T+ +
Sbjct: 265 TIQD 268

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 27/271 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V  GY     +             + +        +DE   E   + +L++P
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAV------KILKNEANDPALKDELLAEANVMQQLDNP 88
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+++G  C+ +  +LV E    G L  +L  + +  +  +  I++    + G+++L  
Sbjct: 89  YIVRMIG-ICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEE 145
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR--GYFAPEYI 315
                +HRD+ A NVLL     AKISDFGL+K     D+++   +  G     ++APE I
Sbjct: 146 --SNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 316 ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGR 375
                + K+DV+SFGV++ E  S      R   G+ G+     L           E++G 
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYR---GMKGSEVTAMLEK--------GERMGC 251
Query: 376 NIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                  +E  +++  C   D +NRP  + V
Sbjct: 252 PAGC--PREMYDLMNLCWTYDVENRPGFAAV 280

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 27/271 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V  GY     +             + +        +DE   E   + +L++P
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAV------KILKNEANDPALKDELLAEANVMQQLDNP 88
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+++G  C+ +  +LV E    G L  +L  + +  +  +  I++    + G+++L  
Sbjct: 89  YIVRMIG-ICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEE 145
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR--GYFAPEYI 315
                +HRD+ A NVLL     AKISDFGL+K     D+++   +  G     ++APE I
Sbjct: 146 --SNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 316 ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGR 375
                + K+DV+SFGV++ E  S      R   G+ G+     L           E++G 
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYR---GMKGSEVTAMLEK--------GERMGC 251
Query: 376 NIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                  +E  +++  C   D +NRP  + V
Sbjct: 252 PAGC--PREMYDLMNLCWTYDVENRPGFAAV 280

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G F       +  C    A ++ A   +  K+L  +  Q   + E E R    L HP
Sbjct: 19  LGKGAFS-----VVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KLEREARICRLLKHP 70
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           N+V+L     ++ H  L+++ VT G L ED +  E  +E +    I+  L A      LH
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----LH 125
Query: 257 TYWRPVIHRDVKASNVLLDDDFNA---KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE 313
            +   V+HR++K  N+LL         K++DFGLA    +  +        GT GY +PE
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQAWFGFAGTPGYLSPE 183
Query: 314 YIATGHLTLKTDVYSFGVVLLEILSG 339
            +         D+++ GV+L  +L G
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 125/282 (44%), Gaps = 41/282 (14%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD---EWENE 187
           ++    ++G GG  +V++          AR       VAVK LR   ++       +  E
Sbjct: 13  RYELGEILGFGGMSEVHL----------ARDLRDHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 188 LRFLSRLNHPNVVKL--MGYCCDDQHRL--LVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            +  + LNHP +V +   G        L  +V EYV   +L D +  E    +  +R I+
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIE 120
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHISTR 302
           +   A + L   H     +IHRDVK +N+++      K+ DFG+A+     G+    +  
Sbjct: 121 VIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN- 361
           V+GT  Y +PE      +  ++DVYS G VL E+L+G+                P+  + 
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE---------------PPFTGDS 223
Query: 362 --KLALHQIIDEKLGRNIQMEE-AQEFAEIILRCLNSDPKNR 400
              +A   + ++ +  + + E  + +   ++L+ L  +P+NR
Sbjct: 224 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 12  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 61
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 62  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 121
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 122 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 170 VKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED 226
           +K+ R K S+    +++ E E+  L  + HPNV+ L     +    +L+ E V  G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DFNAKI 282
            L  ++   L  E   +       G+ +LH+    + H D+K  N++L D        KI
Sbjct: 104 FLAEKES--LTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
            DFGLA     G++      + GT  + APE +    L L+ D++S GV+   +LSG + 
Sbjct: 160 IDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            +       G+  +  L+N  A+ ++  DE       +  A++F   I R L  DPK R 
Sbjct: 217 FL-------GDTKQETLANVSAVNYEFEDEYFSNTSAL--AKDF---IRRLLVKDPKKRM 264
Query: 402 TMSE 405
           T+ +
Sbjct: 265 TIQD 268

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 170 VKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED 226
           +K+ R K S+    +++ E E+  L  + HPNV+ L     +    +L+ E V  G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DFNAKI 282
            L  ++   L  E   +       G+ +LH+    + H D+K  N++L D        KI
Sbjct: 104 FLAEKES--LTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
            DFGLA     G++      + GT  + APE +    L L+ D++S GV+   +LSG + 
Sbjct: 160 IDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            +       G+  +  L+N  A+ ++  DE       +  A++F   I R L  DPK R 
Sbjct: 217 FL-------GDTKQETLANVSAVNYEFEDEYFSNTSAL--AKDF---IRRLLVKDPKKRM 264
Query: 402 TMSE 405
           T+ +
Sbjct: 265 TIQD 268

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 87/170 (51%), Gaps = 22/170 (12%)
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
           KIA+   + LEHLH+    VIHRDVK SNVL++     K+ DFG++  G L D       
Sbjct: 113 KIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDDVAKDID 169
Query: 303 VLGTRGYFAPEYI-----ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP 357
             G + Y APE I       G+ ++K+D++S G+ ++E+     A +R       +W  P
Sbjct: 170 A-GCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIEL-----AILRFP---YDSWGTP 219
Query: 358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           +      L Q+++E   +    + + EF +   +CL  + K RPT  E++
Sbjct: 220 FQQ----LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 265

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 22/215 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G      I   A  A   +N    VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQG------IVCAAYDAILERN----VAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKVVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 132 LYQMLVGIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYV 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            TR Y APE I         D++S GV++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 170 VKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED 226
           +K+ R K S+    +++ E E+  L  + HPNV+ L     +    +L+ E V  G L D
Sbjct: 43  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DFNAKI 282
            L  ++   L  E   +       G+ +LH+    + H D+K  N++L D        KI
Sbjct: 103 FLAEKES--LTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 158
Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
            DFGLA     G++      + GT  + APE +    L L+ D++S GV+   +LSG + 
Sbjct: 159 IDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            +       G+  +  L+N  A+ ++  DE       +  A++F   I R L  DPK R 
Sbjct: 216 FL-------GDTKQETLANVSAVNYEFEDEYFSNTSAL--AKDF---IRRLLVKDPKKRM 263
Query: 402 TMSE 405
           T+ +
Sbjct: 264 TIQD 267

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 125/276 (45%), Gaps = 38/276 (13%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFA--VAVKRLRRKGSQGQDEWENELRFLSRL 194
            +G+GGF   +        ++ A  K   FA  +  K L  K  Q +++   E+     L
Sbjct: 22  FLGKGGFAKCF-------EISDADTKEV-FAGKIVPKSLLLKPHQ-REKMSMEISIHRSL 72
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIK-IALGAARGL 252
            H +VV   G+  D+    +V E   R SL E H   +  TE      ++ I LG     
Sbjct: 73  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC---- 128
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHISTRVLGTRGYFA 311
           ++LH     VIHRD+K  N+ L++D   KI DFGLA K    G++  +   + GT  Y A
Sbjct: 129 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIA 183
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE ++    + + DV+S G ++  +L GK                P+ ++ L    +  +
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKP---------------PFETSCLKETYLRIK 228
Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           K   +I        A +I + L +DP  RPT++E++
Sbjct: 229 KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 264

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSRL 194
           IG G  G V   Y       A   +N    VA+K+L R   Q Q   +    EL  +  +
Sbjct: 32  IGSGAQGIVVAAY------DAILERN----VAIKKLSRP-FQNQTHAKRAYRELVLMKVV 80
Query: 195 NHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
           NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +      G+
Sbjct: 81  NHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           +HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  + TR Y AP
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 194
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSG 339
           E I         D++S GV++ E++ G
Sbjct: 195 EVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 11  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 60
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 61  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 120
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 121 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 170 VKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED 226
           +K+ R K S+    +++ E E+  L  + HPNV+ L     +    +L+ E V  G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DFNAKI 282
            L  ++   L  E   +       G+ +LH+    + H D+K  N++L D        KI
Sbjct: 104 FLAEKES--LTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
            DFGLA     G++      + GT  + APE +    L L+ D++S GV+   +LSG + 
Sbjct: 160 IDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            +       G+  +  L+N  A+ ++  DE       +  A++F   I R L  DPK R 
Sbjct: 217 FL-------GDTKQETLANVSAVNYEFEDEYFSNTSAL--AKDF---IRRLLVKDPKKRM 264
Query: 402 TMSE 405
           T+ +
Sbjct: 265 TIQD 268

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 170 VKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED 226
           +K+ R K S+    +++ E E+  L  + HPNV+ L     +    +L+ E V  G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DFNAKI 282
            L  ++   L  E   +       G+ +LH+    + H D+K  N++L D        KI
Sbjct: 104 FLAEKES--LTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
            DFGLA     G++      + GT  + APE +    L L+ D++S GV+   +LSG + 
Sbjct: 160 IDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            +       G+  +  L+N  A+ ++  DE       +  A++F   I R L  DPK R 
Sbjct: 217 FL-------GDTKQETLANVSAVNYEFEDEYFSNTSAL--AKDF---IRRLLVKDPKKRM 264
Query: 402 TMSE 405
           T+ +
Sbjct: 265 TIQD 268

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 35/275 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARR----KNADFAVAVKRLRRKGSQGQDEWENELRFLSR 193
           +G G FG V  GY     +         KN     A+K          DE   E   + +
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEANVMQQ 82
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           L++P +V+++G  C+ +  +LV E    G L  +L  + +  +  +  I++    + G++
Sbjct: 83  LDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMK 139
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR--GYFA 311
           +L       +HRD+ A NVLL     AKISDFGL+K     D+++   +  G     ++A
Sbjct: 140 YLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYA 196
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     + K+DV+SFGV++ E  S      R   G+ G+     L           E
Sbjct: 197 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR---GMKGSEVTAMLEK--------GE 245
Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           ++G        +E  +++  C   D +NRP  + V
Sbjct: 246 RMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAV 278

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 170 VKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED 226
           +K+ R K S+    +++ E E+  L  + HPNV+ L     +    +L+ E V  G L D
Sbjct: 43  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DFNAKI 282
            L  ++   L  E   +       G+ +LH+    + H D+K  N++L D        KI
Sbjct: 103 FLAEKES--LTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 158
Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
            DFGLA     G++      + GT  + APE +    L L+ D++S GV+   +LSG + 
Sbjct: 159 IDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            +       G+  +  L+N  A+ ++  DE       +  A++F   I R L  DPK R 
Sbjct: 216 FL-------GDTKQETLANVSAVNYEFEDEYFSNTSAL--AKDF---IRRLLVKDPKKRM 263
Query: 402 TMSE 405
           T+ +
Sbjct: 264 TIQD 267

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 170 VKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED 226
           +K+ R K S+    +++ E E+  L  + HPNV+ L     +    +L+ E V  G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DFNAKI 282
            L  ++   L  E   +       G+ +LH+    + H D+K  N++L D        KI
Sbjct: 104 FLAEKES--LTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
            DFGLA     G++      + GT  + APE +    L L+ D++S GV+   +LSG + 
Sbjct: 160 IDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            +       G+  +  L+N  A+ ++  DE       +  A++F   I R L  DPK R 
Sbjct: 217 FL-------GDTKQETLANVSAVNYEFEDEYFSNTSAL--AKDF---IRRLLVKDPKKRM 264
Query: 402 TMSE 405
           T+ +
Sbjct: 265 TIQD 268

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 35/275 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARR----KNADFAVAVKRLRRKGSQGQDEWENELRFLSR 193
           +G G FG V  GY     +         KN     A+K          DE   E   + +
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEANVMQQ 68
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           L++P +V+++G  C+ +  +LV E    G L  +L  + +  +  +  I++    + G++
Sbjct: 69  LDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMK 125
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR--GYFA 311
           +L       +HRD+ A NVLL     AKISDFGL+K     D+++   +  G     ++A
Sbjct: 126 YLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYA 182
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     + K+DV+SFGV++ E  S      R   G+ G+     L           E
Sbjct: 183 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR---GMKGSEVTAMLEK--------GE 231
Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           ++G        +E  +++  C   D +NRP  + V
Sbjct: 232 RMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAV 264

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 35/275 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARR----KNADFAVAVKRLRRKGSQGQDEWENELRFLSR 193
           +G G FG V  GY     +         KN     A+K          DE   E   + +
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEANVMQQ 74
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           L++P +V+++G  C+ +  +LV E    G L  +L  + +  +  +  I++    + G++
Sbjct: 75  LDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMK 131
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR--GYFA 311
           +L       +HRD+ A NVLL     AKISDFGL+K     D+++   +  G     ++A
Sbjct: 132 YLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYA 188
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     + K+DV+SFGV++ E  S      R   G+ G+     L           E
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR---GMKGSEVTAMLEK--------GE 237
Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           ++G        +E  +++  C   D +NRP  + V
Sbjct: 238 RMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAV 270

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 10  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 60  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 120 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 170 VKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED 226
           +K+ R K S+    +++ E E+  L  + HPNV+ L     +    +L+ E V  G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DFNAKI 282
            L  ++   L  E   +       G+ +LH+    + H D+K  N++L D        KI
Sbjct: 104 FLAEKES--LTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
            DFGLA     G++      + GT  + APE +    L L+ D++S GV+   +LSG + 
Sbjct: 160 IDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            +       G+  +  L+N  A+ ++  DE       +  A++F   I R L  DPK R 
Sbjct: 217 FL-------GDTKQETLANVSAVNYEFEDEYFSNTSAL--AKDF---IRRLLVKDPKKRM 264
Query: 402 TMSE 405
           T+ +
Sbjct: 265 TIQD 268

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 35/275 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARR----KNADFAVAVKRLRRKGSQGQDEWENELRFLSR 193
           +G G FG V  GY     +         KN     A+K          DE   E   + +
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEANVMQQ 62
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           L++P +V+++G  C+ +  +LV E    G L  +L  + +  +  +  I++    + G++
Sbjct: 63  LDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMK 119
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR--GYFA 311
           +L       +HRD+ A NVLL     AKISDFGL+K     D+++   +  G     ++A
Sbjct: 120 YLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYA 176
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     + K+DV+SFGV++ E  S      R   G+ G+     L           E
Sbjct: 177 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR---GMKGSEVTAMLEK--------GE 225
Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           ++G        +E  +++  C   D +NRP  + V
Sbjct: 226 RMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAV 258

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG VY           A+ K      A K +  K  +  +++  E+  L+  +HP
Sbjct: 27  LGDGAFGKVY----------KAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHP 76
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +VKL+G    D    ++ E+   G++ D ++ E D  L   +   +       L  LH+
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR--VLGTRGYFAPEYI 315
             + +IHRD+KA NVL+  + + +++DFG++      +   +  R   +GT  + APE +
Sbjct: 136 --KRIIHRDLKAGNVLMTLEGDIRLADFGVSA----KNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 316 ATGHLT-----LKTDVYSFGVVLLEI 336
               +       K D++S G+ L+E+
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 32/275 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR--RKGSQGQDEWENELRFLSRLN 195
           +G G F       +  C      ++ A   +  +RL   R+G   ++E E E+  L  + 
Sbjct: 34  LGSGQFA-----IVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVS-REEIEREVNILREIR 87
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGLEH 254
           HPN++ L     +    +L+ E V+ G L D L  ++  TE    + +K  L    G+ +
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHY 144
Query: 255 LHTYWRPVIHRDVKASNVLLDD----DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           LH+  + + H D+K  N++L D    +   K+ DFG+A     G++      + GT  + 
Sbjct: 145 LHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFV 199
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           APE +    L L+ D++S GV+   +LSG +  +       G   +  L+N  A++   D
Sbjct: 200 APEIVNYEPLGLEADMWSIGVITYILLSGASPFL-------GETKQETLTNISAVNYDFD 252
Query: 371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
           E+   N   E A++F   I R L  DPK R  +++
Sbjct: 253 EEYFSNTS-ELAKDF---IRRLLVKDPKRRMXIAQ 283

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 9   FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 58
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 59  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 118
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 119 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 83/154 (53%), Gaps = 7/154 (4%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           EL+ L   N P +V   G    D    +  E++  GSL+  L  +    +  +   K+++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSI 111
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              +GL +L    + ++HRDVK SN+L++     K+ DFG++  G L D   ++   +GT
Sbjct: 112 AVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 166
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           R Y +PE +   H ++++D++S G+ L+E+  G+
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG VY           A+ K      A K +  K  +  +++  E+  L+  +HP
Sbjct: 45  LGDGAFGKVY----------KAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 94
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA-RGLEHLH 256
           N+VKL+     + +  ++ E+   G++ D ++ E +  L  E +I++        L +LH
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLT-ESQIQVVCKQTLDALNYLH 152
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR--VLGTRGYFAPEY 314
                +IHRD+KA N+L   D + K++DFG++      +   I  R   +GT  + APE 
Sbjct: 153 D--NKIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRXIQRRDSFIGTPYWMAPEV 206
Query: 315 IATGH-----LTLKTDVYSFGVVLLEI 336
           +            K DV+S G+ L+E+
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 83/154 (53%), Gaps = 7/154 (4%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           EL+ L   N P +V   G    D    +  E++  GSL+  L  +    +  +   K+++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSI 111
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              +GL +L    + ++HRDVK SN+L++     K+ DFG++  G L D   ++   +GT
Sbjct: 112 AVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 166
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           R Y +PE +   H ++++D++S G+ L+E+  G+
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 119/280 (42%), Gaps = 30/280 (10%)
Query: 133 SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLS 192
            ++ ++G+G +G VY          A R  +    +A+K +  + S+       E+    
Sbjct: 25  GDRVVLGKGTYGIVY----------AGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 74
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA-RG 251
            L H N+V+ +G   ++    +  E V  GSL   L ++     + E+ I         G
Sbjct: 75  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 134
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           L++LH     ++HRD+K  NVL++      KISDFG +K   L   +  +    GT  Y 
Sbjct: 135 LKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGTLQYM 190
Query: 311 APEYIATG--HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           APE I  G        D++S G  ++E+ +GK         L    A  +      +H  
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE----LGEPQAAMFKVGMFKVHPE 246
Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
           I E +       EA+ F   IL+C   DP  R   ++++ 
Sbjct: 247 IPESMS-----AEAKAF---ILKCFEPDPDKRACANDLLV 278

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 111/246 (45%), Gaps = 40/246 (16%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRF 190
           F     +G+GGFG V+           A+ K  D   A+KR+R    +  +++   E++ 
Sbjct: 7   FEPIQCLGRGGFGVVF----------EAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 191 LSRLNHPNVVKLMGYCCDDQ--HRLL-----VYEYVT-----RGSLEDHLLNEDDTELNW 238
           L++L HP +V+      +     +L      VY Y+      + +L+D  +N   T    
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD-WMNGRCTIEER 115
Query: 239 ERRI--KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK------- 289
           ER +   I L  A  +E LH+  + ++HRD+K SN+    D   K+ DFGL         
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 290 ----FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMR 345
                 P+   +  + +V GT+ Y +PE I     + K D++S G++L E+L   +  M 
Sbjct: 174 EQTVLTPMPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQME 232
Query: 346 RTNGLA 351
           R   L 
Sbjct: 233 RVRTLT 238

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 27/271 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V  GY     +             + +        +DE   E   + +L++P
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAV------KILKNEANDPALKDELLAEANVMQQLDNP 68
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+++G  C+ +  +LV E    G L  +L  + +  +  +  I++    + G+++L  
Sbjct: 69  YIVRMIG-ICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR--GYFAPEYI 315
                +HRD+ A NVLL     AKISDFGL+K     D+++   +  G     ++APE I
Sbjct: 126 --SNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 316 ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGR 375
                + K+DV+SFGV++ E  S      R   G+ G+     L           E++G 
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYR---GMKGSEVTAMLEK--------GERMG- 230
Query: 376 NIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                  +E  +++  C   D +NRP  + V
Sbjct: 231 -CPAGCPREMYDLMNLCWTYDVENRPGFAAV 260

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 32  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 82  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 141
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 142 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 42/215 (19%)
Query: 218 YVTRGSLEDHLLN----EDDTE------LNWERRIKIALGAARGLEHLHTYWRPVIHRDV 267
           + + G  ED  L+    E+D++      +  E  I  +   ARG+E L +  R  IHRD+
Sbjct: 168 FASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEFLSS--RKCIHRDL 225
Query: 268 KASNVLLDDDFNAKISDFGLAKFGPLGD--KSHISTRVLGTR---GYFAPEYIATGHLTL 322
            A N+LL ++   KI DFGLA+     D  K+    R   TR    + APE I     + 
Sbjct: 226 AARNILLSENNVVKICDFGLAR-----DIYKNPDYVRKGDTRLPLKWMAPESIFDKIYST 280
Query: 323 KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEA 382
           K+DV+S+GV+L EI S           L G+   PY    + + +    +L   ++M   
Sbjct: 281 KSDVWSYGVLLWEIFS-----------LGGS---PYPG--VQMDEDFCSRLREGMRMRAP 324
Query: 383 Q----EFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +    E  +I+L C + DPK RP  +E+V  L  L
Sbjct: 325 EYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDL 359

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 35  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 84
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 85  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 144
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 145 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG VY           A+ K      A K +  K  +  +++  E+  L+  +HP
Sbjct: 19  LGDGAFGKVY----------KAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHP 68
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +VKL+G    D    ++ E+   G++ D ++ E D  L   +   +       L  LH+
Sbjct: 69  YIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR--VLGTRGYFAPEYI 315
             + +IHRD+KA NVL+  + + +++DFG++      +   +  R   +GT  + APE +
Sbjct: 128 --KRIIHRDLKAGNVLMTLEGDIRLADFGVSA----KNLKTLQKRDSFIGTPYWMAPEVV 181
Query: 316 ATGHLT-----LKTDVYSFGVVLLEI 336
               +       K D++S G+ L+E+
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG VY           A+ K      A K +  K  +  +++  E+  L+  +HP
Sbjct: 45  LGDGAFGKVY----------KAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 94
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA-RGLEHLH 256
           N+VKL+     + +  ++ E+   G++ D ++ E +  L  E +I++        L +LH
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLT-ESQIQVVCKQTLDALNYLH 152
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR--VLGTRGYFAPEY 314
                +IHRD+KA N+L   D + K++DFG++      +   I  R   +GT  + APE 
Sbjct: 153 D--NKIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRXIQRRDXFIGTPYWMAPEV 206
Query: 315 IATGH-----LTLKTDVYSFGVVLLEI 336
           +            K DV+S G+ L+E+
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 170 VKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED 226
           +K+ R K S+    +++ E E+  L  + HPNV+ L     +    +L+ E V  G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DFNAKI 282
            L  ++   L  E   +       G+ +LH+    + H D+K  N++L D        KI
Sbjct: 104 FLAEKES--LTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
            DFGLA     G++      + GT  + APE +    L L+ D++S GV+   +LSG + 
Sbjct: 160 IDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            +       G+  +  L+N  A+ ++  DE       +  A++F   I R L  DPK R 
Sbjct: 217 FL-------GDTKQETLANVSAVNYEFEDEYFSNTSAL--AKDF---IRRLLVKDPKKRM 264
Query: 402 TMSE 405
           T+ +
Sbjct: 265 TIQD 268

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 35  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 84
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 85  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 144
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 145 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 32  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 82  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 141
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 142 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 34  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 143
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 144 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL-- 188
           +F    L+G+G FG V +           + K      A+K L+++    +DE  + L  
Sbjct: 149 EFEYLKLLGKGTFGKVIL----------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 198
Query: 189 -RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
            R L    HP +  L  Y      RL  V EY   G L  HL  E     +  R     +
Sbjct: 199 NRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
            +A  L++LH+  + V++RD+K  N++LD D + KI+DFGL K G + D + + T   GT
Sbjct: 258 VSA--LDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGT 312
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
             Y APE +         D +  GVV+ E++ G+
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/299 (23%), Positives = 125/299 (41%), Gaps = 35/299 (11%)
Query: 128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE--WE 185
           +  K+    L+G+G +G V             R K+    VA+K+          +    
Sbjct: 23  SMEKYENLGLVGEGSYGMV----------MKCRNKDTGRIVAIKKFLESDDDKMVKKIAM 72
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA 245
            E++ L +L H N+V L+  C   +   LV+E+V    L+D  L  +  +    ++    
Sbjct: 73  REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
           +    G  H H     +IHRD+K  N+L+      K+ DFG A+   L     +    + 
Sbjct: 133 IINGIGFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDEVA 186
Query: 306 TRGYFAPEYIATGHLTLK-TDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
           TR Y APE +       K  DV++ G ++ E+  G+      ++          L N + 
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP 246
Query: 365 LHQIIDEK--LGRNIQMEEAQE----------FAEIIL----RCLNSDPKNRPTMSEVV 407
            HQ +  K  +   +++ E +E           +E+++    +CL+ DP  RP  +E++
Sbjct: 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 34  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 143
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 144 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG VY           A+ K      A K +  K  +  +++  E+  L+  +HP
Sbjct: 45  LGDGAFGKVY----------KAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 94
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA-RGLEHLH 256
           N+VKL+     + +  ++ E+   G++ D ++ E +  L  E +I++        L +LH
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLT-ESQIQVVCKQTLDALNYLH 152
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR--VLGTRGYFAPEY 314
                +IHRD+KA N+L   D + K++DFG++      +   I  R   +GT  + APE 
Sbjct: 153 D--NKIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEV 206
Query: 315 IATGH-----LTLKTDVYSFGVVLLEI 336
           +            K DV+S G+ L+E+
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 39  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 88
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 89  DVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 148
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 149 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 34  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 143
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 144 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 37  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 86
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 87  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 146
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 147 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL-- 188
           +F    L+G+G FG V +           + K      A+K L+++    +DE  + L  
Sbjct: 152 EFEYLKLLGKGTFGKVIL----------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 201
Query: 189 -RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
            R L    HP +  L  Y      RL  V EY   G L  HL  E     +  R     +
Sbjct: 202 NRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 260
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
            +A  L++LH+  + V++RD+K  N++LD D + KI+DFGL K G + D + + T   GT
Sbjct: 261 VSA--LDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGT 315
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
             Y APE +         D +  GVV+ E++ G+
Sbjct: 316 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 31  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 80
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 81  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 140
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 141 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 125/279 (44%), Gaps = 33/279 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSRL 194
           IG+G FG V I           ++ +     A+K + ++    ++E  N   EL+ +  L
Sbjct: 23  IGKGSFGKVCI----------VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HP +V L     D++   +V + +  G L  HL  + +     E            L++
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICELVMALDY 130
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L    + +IHRD+K  N+LLD+  +  I+DF +A   P   ++ I+T + GT+ Y APE 
Sbjct: 131 LQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITT-MAGTKPYMAPEM 185
Query: 315 IAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG----LAGNWAKPYLSNKLALHQ 367
            ++      +   D +S GV   E+L G+     R++     +   +    ++   A  Q
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ 245
Query: 368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
            +   L + ++    Q F+++      SD +N P M+++
Sbjct: 246 EMVSLLKKLLEPNPDQRFSQL------SDVQNFPYMNDI 278

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 32  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 82  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 141
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 142 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-----------EI 92
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED------DTELNWERRI 242
           + L R  H N++ +     +D  R    E +    L  HL+  D         L+ +   
Sbjct: 93  KILLRFRHENIIGI-----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHIC 147
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHIST 301
                  RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T
Sbjct: 148 YFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 205
Query: 302 RVLGTRGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
             + TR Y APE +      T   D++S G +L E+LS +
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 119/280 (42%), Gaps = 30/280 (10%)
Query: 133 SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLS 192
            ++ ++G+G +G VY          A R  +    +A+K +  + S+       E+    
Sbjct: 11  GDRVVLGKGTYGIVY----------AGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 60
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA-RG 251
            L H N+V+ +G   ++    +  E V  GSL   L ++     + E+ I         G
Sbjct: 61  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 120
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           L++LH     ++HRD+K  NVL++      KISDFG +K   L   +  +    GT  Y 
Sbjct: 121 LKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGTLQYM 176
Query: 311 APEYIATG--HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           APE I  G        D++S G  ++E+ +GK         L    A  +      +H  
Sbjct: 177 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE----LGEPQAAMFKVGMFKVHPE 232
Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
           I E +       EA+ F   IL+C   DP  R   ++++ 
Sbjct: 233 IPESMS-----AEAKAF---ILKCFEPDPDKRACANDLLV 264

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 83/154 (53%), Gaps = 7/154 (4%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           EL+ L   N P +V   G    D    +  E++  GSL+  L  +    +  +   K+++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSI 111
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              +GL +L    + ++HRDVK SN+L++     K+ DFG++  G L D   ++   +GT
Sbjct: 112 AVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 166
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           R Y +PE +   H ++++D++S G+ L+E+  G+
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 4/149 (2%)
Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +A 
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA- 142
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  Y 
Sbjct: 143 -LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSG 339
           +PE +        +D+++ G ++ ++++G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 83/154 (53%), Gaps = 7/154 (4%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           EL+ L   N P +V   G    D    +  E++  GSL+  L  +    +  +   K+++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSI 111
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              +GL +L    + ++HRDVK SN+L++     K+ DFG++  G L D   ++   +GT
Sbjct: 112 AVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 166
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           R Y +PE +   H ++++D++S G+ L+E+  G+
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 31  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 80
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 81  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 140
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 141 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 27/244 (11%)
Query: 170 VKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED 226
           +K+ R K S+    +++ E E+  L  + HPNV+ L     +    +L+ E V  G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFD 103
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD----DFNAKI 282
            L  ++   L  E   +       G+ +LH+    + H D+K  N++L D        KI
Sbjct: 104 FLAEKES--LTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA 342
            DFGLA     G++      + GT  + APE +    L L+ D++S GV+   +LSG + 
Sbjct: 160 IDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 343 AMRRTNGLAGNWAKPYLSNKLAL-HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
            +       G+  +  L+N  A+ ++  DE       +  A++F   I R L  DPK R 
Sbjct: 217 FL-------GDTKQETLANVSAVNYEFEDEYFSNTSAL--AKDF---IRRLLVKDPKKRM 264
Query: 402 TMSE 405
           T+ +
Sbjct: 265 TIQD 268

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 16  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 65
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 66  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 125
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 126 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 34  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 143
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 144 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR-- 189
           F    ++G+G F  V +          AR        A+K L ++    +++     R  
Sbjct: 34  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 190 -FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +SRL+HP  VKL     DD+       Y   G L  ++      +    R     + +
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 143
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A  LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT  
Sbjct: 144 A--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE +        +D+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 125/282 (44%), Gaps = 41/282 (14%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD---EWENE 187
           ++    ++G GG  +V++          AR       VAVK LR   ++       +  E
Sbjct: 30  RYELGEILGFGGMSEVHL----------ARDLRLHRDVAVKVLRADLARDPSFYLRFRRE 79
Query: 188 LRFLSRLNHPNVVKL--MGYCCDDQHRL--LVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            +  + LNHP +V +   G        L  +V EYV   +L D +  E    +  +R I+
Sbjct: 80  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIE 137
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHISTR 302
           +   A + L   H     +IHRDVK +N+++      K+ DFG+A+     G+    +  
Sbjct: 138 VIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 195
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN- 361
           V+GT  Y +PE      +  ++DVYS G VL E+L+G+                P+  + 
Sbjct: 196 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE---------------PPFTGDS 240
Query: 362 --KLALHQIIDEKLGRNIQMEE-AQEFAEIILRCLNSDPKNR 400
              +A   + ++ +  + + E  + +   ++L+ L  +P+NR
Sbjct: 241 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 282

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 124/276 (44%), Gaps = 38/276 (13%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFA--VAVKRLRRKGSQGQDEWENELRFLSRL 194
            +G+GGF   +        ++ A  K   FA  +  K L  K  Q +++   E+     L
Sbjct: 28  FLGKGGFAKCF-------EISDADTKEV-FAGKIVPKSLLLKPHQ-REKMSMEISIHRSL 78
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIK-IALGAARGL 252
            H +VV   G+  D+    +V E   R SL E H   +  TE      ++ I LG     
Sbjct: 79  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC---- 134
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHISTRVLGTRGYFA 311
           ++LH     VIHRD+K  N+ L++D   KI DFGLA K    G++      + GT  Y A
Sbjct: 135 QYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIA 189
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE ++    + + DV+S G ++  +L GK                P+ ++ L    +  +
Sbjct: 190 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKP---------------PFETSCLKETYLRIK 234
Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           K   +I        A +I + L +DP  RPT++E++
Sbjct: 235 KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 270

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 124/276 (44%), Gaps = 38/276 (13%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFA--VAVKRLRRKGSQGQDEWENELRFLSRL 194
            +G+GGF   +        ++ A  K   FA  +  K L  K  Q +++   E+     L
Sbjct: 24  FLGKGGFAKCF-------EISDADTKEV-FAGKIVPKSLLLKPHQ-REKMSMEISIHRSL 74
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIK-IALGAARGL 252
            H +VV   G+  D+    +V E   R SL E H   +  TE      ++ I LG     
Sbjct: 75  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC---- 130
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHISTRVLGTRGYFA 311
           ++LH     VIHRD+K  N+ L++D   KI DFGLA K    G++      + GT  Y A
Sbjct: 131 QYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIA 185
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE ++    + + DV+S G ++  +L GK                P+ ++ L    +  +
Sbjct: 186 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKP---------------PFETSCLKETYLRIK 230
Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           K   +I        A +I + L +DP  RPT++E++
Sbjct: 231 KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 124/276 (44%), Gaps = 38/276 (13%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFA--VAVKRLRRKGSQGQDEWENELRFLSRL 194
            +G+GGF   +        ++ A  K   FA  +  K L  K  Q +++   E+     L
Sbjct: 24  FLGKGGFAKCF-------EISDADTKEV-FAGKIVPKSLLLKPHQ-REKMSMEISIHRSL 74
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIK-IALGAARGL 252
            H +VV   G+  D+    +V E   R SL E H   +  TE      ++ I LG     
Sbjct: 75  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC---- 130
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHISTRVLGTRGYFA 311
           ++LH     VIHRD+K  N+ L++D   KI DFGLA K    G++      + GT  Y A
Sbjct: 131 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIA 185
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE ++    + + DV+S G ++  +L GK                P+ ++ L    +  +
Sbjct: 186 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKP---------------PFETSCLKETYLRIK 230
Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           K   +I        A +I + L +DP  RPT++E++
Sbjct: 231 KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 77/175 (44%), Gaps = 29/175 (16%)
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
           KI L   + L HL    + +IHRD+K SN+LLD   N K+ DFG++  G L D S   TR
Sbjct: 129 KITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVD-SIAKTR 184
Query: 303 VLGTRGYFAPEYIATGH----LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY 358
             G R Y APE I          +++DV+S G+ L E+ +G+                PY
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF---------------PY 229
Query: 359 LSNKLALHQIIDEKLGRNIQMEEAQE------FAEIILRCLNSDPKNRPTMSEVV 407
                   Q+     G   Q+  ++E      F   +  CL  D   RP   E++
Sbjct: 230 PKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 121/275 (44%), Gaps = 35/275 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARR----KNADFAVAVKRLRRKGSQGQDEWENELRFLSR 193
           +G G FG V  GY     +         KN     A+K          DE   E   + +
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEANVMQQ 68
Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           L++P +V+++G  C+ +  +LV E    G L  +L  + +  +  +  I++    + G++
Sbjct: 69  LDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMK 125
Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR--GYFA 311
           +L       +HRD+ A NVLL     AKISDFGL+K     D++    +  G     ++A
Sbjct: 126 YLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENXYKAQTHGKWPVKWYA 182
Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE I     + K+DV+SFGV++ E  S      R   G+ G+     L           E
Sbjct: 183 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR---GMKGSEVTAMLEK--------GE 231
Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           ++G        +E  +++  C   D +NRP  + V
Sbjct: 232 RMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAV 264

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A RK + F      +R  R           E+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR-----------EI 76
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 137 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 37/274 (13%)
Query: 152 NSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ- 210
           +S  +   R +  D  V V ++R   ++   ++  E   L   +HPNV+ ++G C     
Sbjct: 22  HSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81
Query: 211 -HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRD-VK 268
            H  L+  +   GSL + L    +  ++  + +K AL  ARG   LHT   P+I R  + 
Sbjct: 82  PHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTL-EPLIPRHALN 140
Query: 269 ASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLK----- 323
           + +V +D+D  A+IS             + +          +AP ++A   L  K     
Sbjct: 141 SRSVXIDEDXTARIS------------XADVKFSFQSPGRXYAPAWVAPEALQKKPEDTN 188
Query: 324 ---TDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQME 380
               D +SF V+L E+++ +      +N   G         K+AL     E L   I   
Sbjct: 189 RRSADXWSFAVLLWELVTREVPFADLSNXEIG--------XKVAL-----EGLRPTIPPG 235
Query: 381 EAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
            +   +++   C N DP  RP    +V  LE+ Q
Sbjct: 236 ISPHVSKLXKICXNEDPAKRPKFDXIVPILEKXQ 269

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V   Y       A   +N    VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAY------DAILERN----VAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 132 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            TR Y APE I         D++S G ++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V   Y       A   +N    VA+K+L R   Q Q   +    
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAY------DAILERN----VAIKKLSRP-FQNQTHAKRAYR 73
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 74  ELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 132
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 133 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 187
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            TR Y APE I         D++S G ++ E++ G
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 110/263 (41%), Gaps = 25/263 (9%)
Query: 149 GYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYCC 207
           G  + C     ++ N  FAV +   R + +      + E+  L     HPN+VKL     
Sbjct: 22  GSFSICRKCVHKKSNQAFAVKIISKRMEANT-----QKEITALKLCEGHPNIVKLHEVFH 76
Query: 208 DDQHRLLVYEYVTRGSLEDHLLNE---DDTELNWERRIKIALGAARGLEHLHTYWRPVIH 264
           D  H  LV E +  G L + +  +    +TE ++  R  ++      + H+H     V+H
Sbjct: 77  DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-----AVSHMHDVG--VVH 129
Query: 265 RDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLT 321
           RD+K  N+L    +D+   KI DFG A+  P  D   + T    T  Y APE +      
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPCF-TLHYAAPELLNQNGYD 187
Query: 322 LKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEE 381
              D++S GV+L  +LSG+         L    A   +          + +  +N+    
Sbjct: 188 ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV---- 243
Query: 382 AQEFAEIILRCLNSDPKNRPTMS 404
           +QE  ++I   L  DP  R  MS
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMS 266

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V   Y       A   +N    VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAY------DAILERN----VAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 132 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            TR Y APE I         D++S G ++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR----KGSQGQDEWENELRFLS 192
           +IG+G FG+V +           R K+     A+K L +    K S     WE E   ++
Sbjct: 76  VIGRGAFGEVQL----------VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE-ERDIMA 124
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
             N P VV+L     DD++  +V EY+  G L + + N D  E  W R     +  A  L
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLA--L 181
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           + +H+     IHRDVK  N+LLD   + K++DFG              T V GT  Y +P
Sbjct: 182 DAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 238
Query: 313 EYIAT----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
           E + +    G+   + D +S GV L E+L G T      + L G ++K
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--ADSLVGTYSK 284

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLN 195
           +G G +G+V +           R K      A+K +R+    +    +   E+  L  L+
Sbjct: 45  LGSGAYGEVLL----------CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HPN++KL  +  D ++  LV E    G L D +++    + N      I      G+ +L
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYL 152
Query: 256 HTYWRPVIHRDVKASNVLLDD---DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           H +   ++HRD+K  N+LL+    D   KI DFGL+      ++  +  R LGT  Y AP
Sbjct: 153 HKH--NIVHRDLKPENLLLESKEKDALIKIVDFGLS--AVFENQKKMKER-LGTAYYIAP 207
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSG 339
           E +   +   K DV+S GV+L  +L+G
Sbjct: 208 EVLRKKY-DEKCDVWSIGVILFILLAG 233

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR----KGSQGQDEWENELRFLS 192
           +IG+G FG+V +           R K+     A+K L +    K S     WE E   ++
Sbjct: 81  VIGRGAFGEVQL----------VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE-ERDIMA 129
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
             N P VV+L     DD++  +V EY+  G L + + N D  E  W R     +  A  L
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLA--L 186
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           + +H+     IHRDVK  N+LLD   + K++DFG              T V GT  Y +P
Sbjct: 187 DAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 243
Query: 313 EYIAT----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
           E + +    G+   + D +S GV L E+L G T      + L G ++K
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--ADSLVGTYSK 289

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V   Y       A   +N    VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAY------DAILERN----VAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 132 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPEV 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            TR Y APE I         D++S G ++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G      I   A  A   +N    VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQG------IVCAAYDAILERN----VAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKVVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 132 LYQMLVGIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYV 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            TR Y APE I         D++S G ++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V       CA   A     D  VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQGIV-------CA---AYDAVLDRNVAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKXVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 132 LYQMLXGIKHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYV 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR----KGSQGQDEWENELRFLS 192
           +IG+G FG+V +           R K+     A+K L +    K S     WE E   ++
Sbjct: 81  VIGRGAFGEVQL----------VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE-ERDIMA 129
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
             N P VV+L     DD++  +V EY+  G L + + N D  E  W R     +  A  L
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLA--L 186
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           + +H+     IHRDVK  N+LLD   + K++DFG              T V GT  Y +P
Sbjct: 187 DAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 243
Query: 313 EYIAT----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
           E + +    G+   + D +S GV L E+L G T      + L G ++K
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--ADSLVGTYSK 289

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-----------EI 72
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 73  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 133 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-----------EI 72
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 73  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 133 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 107/240 (44%), Gaps = 26/240 (10%)
Query: 107 HRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF 166
           H D  F++ ++      +L    +++ +   IG G  G V           AA       
Sbjct: 3   HMDSQFYSVQVADSTFTVL----KRYQQLKPIGSGAQGIV----------CAAFDTVLGI 48
Query: 167 AVAVKRLRRKGSQGQDEWEN---ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTR 221
            VAVK+L R   Q Q   +    EL  L  +NH N++ L+      Q  L  ++  Y+  
Sbjct: 49  NVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVM 106
Query: 222 GSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK 281
             ++ +L      EL+ ER   +      G++HLH+    +IHRD+K SN+++  D   K
Sbjct: 107 ELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLK 164
Query: 282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           I DFGLA+       + + T  + TR Y APE I         D++S G ++ E++ G  
Sbjct: 165 ILDFGLAR---TASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 36/218 (16%)
Query: 138 IGQGGFGDVYIGYI-NSCAMTA----ARRKNADFAVAVKRLRRKGSQGQDEWENELRFLS 192
           +G G  G+V + +   +C   A    ++RK   FA+   R     +      E E+  L 
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRK---FAIGSAR----EADPALNVETEIEILK 70
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALG 247
           +LNHP ++K+  +  D +   +V E +  G L D +     L E   +L + + +     
Sbjct: 71  KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML----- 124
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               +++LH     +IHRD+K  NVLL   ++D   KI+DFG +K   LG+ S + T + 
Sbjct: 125 --LAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LC 177
Query: 305 GTRGYFAPEY---IATGHLTLKTDVYSFGVVLLEILSG 339
           GT  Y APE    + T       D +S GV+L   LSG
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-----------EI 72
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 73  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 133 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 36/218 (16%)
Query: 138 IGQGGFGDVYIGYI-NSCAMTA----ARRKNADFAVAVKRLRRKGSQGQDEWENELRFLS 192
           +G G  G+V + +   +C   A    ++RK   FA+   R     +      E E+  L 
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRK---FAIGSAR----EADPALNVETEIEILK 69
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALG 247
           +LNHP ++K+  +  D +   +V E +  G L D +     L E   +L + + +     
Sbjct: 70  KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML----- 123
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               +++LH     +IHRD+K  NVLL   ++D   KI+DFG +K   LG+ S + T + 
Sbjct: 124 --LAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LC 176
Query: 305 GTRGYFAPEY---IATGHLTLKTDVYSFGVVLLEILSG 339
           GT  Y APE    + T       D +S GV+L   LSG
Sbjct: 177 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 36/218 (16%)
Query: 138 IGQGGFGDVYIGYI-NSCAMTA----ARRKNADFAVAVKRLRRKGSQGQDEWENELRFLS 192
           +G G  G+V + +   +C   A    ++RK   FA+   R     +      E E+  L 
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRK---FAIGSAR----EADPALNVETEIEILK 70
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALG 247
           +LNHP ++K+  +  D +   +V E +  G L D +     L E   +L + + +     
Sbjct: 71  KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML----- 124
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               +++LH     +IHRD+K  NVLL   ++D   KI+DFG +K   LG+ S + T + 
Sbjct: 125 --LAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LC 177
Query: 305 GTRGYFAPEY---IATGHLTLKTDVYSFGVVLLEILSG 339
           GT  Y APE    + T       D +S GV+L   LSG
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 36/218 (16%)
Query: 138 IGQGGFGDVYIGYI-NSCAMTA----ARRKNADFAVAVKRLRRKGSQGQDEWENELRFLS 192
           +G G  G+V + +   +C   A    ++RK   FA+   R     +      E E+  L 
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRK---FAIGSAR----EADPALNVETEIEILK 70
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALG 247
           +LNHP ++K+  +  D +   +V E +  G L D +     L E   +L + + +     
Sbjct: 71  KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML----- 124
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               +++LH     +IHRD+K  NVLL   ++D   KI+DFG +K   LG+ S + T + 
Sbjct: 125 --LAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LC 177
Query: 305 GTRGYFAPEY---IATGHLTLKTDVYSFGVVLLEILSG 339
           GT  Y APE    + T       D +S GV+L   LSG
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-----------EI 72
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 73  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 133 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++ +   IG G  G V           AA        VAVK+L R   Q Q   +    
Sbjct: 24  KRYQQLKPIGSGAQGIV----------CAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  L  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLLKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       + + T  +
Sbjct: 132 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYV 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            TR Y APE I         D++S G ++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-----------EI 74
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 75  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 134
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 135 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G      I   A  A   +N    VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQG------IVCAAYDAILERN----VAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKVVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 132 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYV 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            TR Y APE I         D++S G ++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-----------EI 92
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 93  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 152
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 153 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-----------EI 76
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 137 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 36/218 (16%)
Query: 138 IGQGGFGDVYIGYI-NSCAMTA----ARRKNADFAVAVKRLRRKGSQGQDEWENELRFLS 192
           +G G  G+V + +   +C   A    ++RK   FA+   R     +      E E+  L 
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRK---FAIGSAR----EADPALNVETEIEILK 76
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALG 247
           +LNHP ++K+  +  D +   +V E +  G L D +     L E   +L + + +     
Sbjct: 77  KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML----- 130
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
               +++LH     +IHRD+K  NVLL   ++D   KI+DFG +K   LG+ S + T + 
Sbjct: 131 --LAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LC 183
Query: 305 GTRGYFAPEY---IATGHLTLKTDVYSFGVVLLEILSG 339
           GT  Y APE    + T       D +S GV+L   LSG
Sbjct: 184 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-----------EI 70
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 71  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 130
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 131 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G      I   A  A   +N    VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQG------IVCAAYDAILERN----VAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 132 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            TR Y APE I         D++S G ++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-----------EI 70
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 71  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 130
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 131 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG------QDEWENELRFL 191
           +G G F       +  C     R K+     A K ++++ S+       ++E E E+  L
Sbjct: 20  LGSGQFA-----IVKKC-----REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
            ++ HPN++ L     +    +L+ E V+ G L D L  ++   L+ E           G
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDG 127
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDF----NAKISDFGLAKFGPLGDKSHISTRVLGTR 307
           + +LHT  + + H D+K  N++L D      + K+ DFGLA    + D       + GT 
Sbjct: 128 VNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTP 182
Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            + APE +    L L+ D++S GV+   +LSG +  +       G+  +  L+N  A+  
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL-------GDTKQETLANITAVSY 235
Query: 368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
             DE+       E A++F   I + L  + + R T+ E +
Sbjct: 236 DFDEEFFSQTS-ELAKDF---IRKLLVKETRKRLTIQEAL 271

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-----------EI 80
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 81  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 140
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 141 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 199 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-----------EI 72
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 73  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 133 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           +++  + IG+G +G V   Y N   +  A +K + F       R            E++ 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTL---------REIKI 78
Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALGAA 249
           L R  H N++ +           +   Y+ +  +E  L     T+ L+ +          
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGTRG 308
           RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + TR 
Sbjct: 139 RGLKYIHS--ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 309 YFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           Y APE +      T   D++S G +L E+LS +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-----------EI 77
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 78  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 137
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 138 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-----------EI 78
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 79  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 138
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 139 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-----------EI 69
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 70  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 129
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 130 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-----------EI 76
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 137 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G      I   A  A   +N    VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQG------IVCAAYDAILERN----VAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 132 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYV 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            TR Y APE I         D++S G ++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 125/294 (42%), Gaps = 44/294 (14%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           R +S    IG GG   V+              K   +A+    L    +Q  D + NE+ 
Sbjct: 12  RIYSILKQIGSGGSSKVF---------QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 62
Query: 190 FLSRLNHPN--VVKLMGYCCDDQHRLLVYEYVTRGSLE-DHLLNEDDTELNWERRIKIAL 246
           +L++L   +  +++L  Y   DQ+  +V E    G+++ +  L +  +   WER+     
Sbjct: 63  YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSY--- 116
Query: 247 GAARGLEHLHT-YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
                LE +HT +   ++H D+K +N L+ D    K+ DFG+A        S +    +G
Sbjct: 117 -WKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVG 174
Query: 306 TRGYFAPEYI-----------ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
           T  Y  PE I           +   ++ K+DV+S G +L  +  GKT   +  N ++   
Sbjct: 175 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--- 231
Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
                     LH IID            ++  +++  CL  DPK R ++ E++A
Sbjct: 232 ---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 276

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V           AA     D  VA+K+L R   Q Q   +    
Sbjct: 17  KRYQNLKPIGSGAQGIV----------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYR 65
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 66  ELVLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 124
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 125 LYQMLXGIKHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYV 179
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V           AA     D  VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQGIV----------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 132 LYQMLXGIKHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYV 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 138 IGQGGFGDVYIGYINSCA--MTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLS 192
           +G G +G+V +     C   +T A R       A+K +++     +       +E+  L 
Sbjct: 29  LGSGAYGEVLL-----CKDKLTGAER-------AIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH-LLNEDDTELNWERRIKIALGAARG 251
           +L+HPN++KL  +  D ++  LV E    G L D  +L +  +E++    +K  L    G
Sbjct: 77  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS---G 133
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDD---DFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
             +LH +   ++HRD+K  N+LL+    D   KI DFGL+    +G K  +  R LGT  
Sbjct: 134 TTYLHKH--NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKER-LGTAY 188
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y APE +   +   K DV+S GV+L  +L G
Sbjct: 189 YIAPEVLRKKY-DEKCDVWSCGVILYILLCG 218

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V   Y       A   +N    VA+K+L R   Q Q   +    
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAY------DAILERN----VAIKKLSRP-FQNQTHAKRAYR 74
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 75  ELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 133
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S +    +
Sbjct: 134 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMVPFV 188
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            TR Y APE I         D++S G ++ E++ G
Sbjct: 189 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 84/169 (49%), Gaps = 22/169 (13%)
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
           KIA+   + LEHLH+    VIHRDVK SNVL++     K  DFG++  G L D       
Sbjct: 140 KIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKXCDFGIS--GYLVDDVAKDID 196
Query: 303 VLGTRGYFAPEYI-----ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP 357
             G + Y APE I       G+ ++K+D++S G+  +E+     A +R       +W  P
Sbjct: 197 A-GCKPYXAPERINPELNQKGY-SVKSDIWSLGITXIEL-----AILRFP---YDSWGTP 246
Query: 358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           +      L Q+++E   +    + + EF +   +CL  + K RPT  E+
Sbjct: 247 FQQ----LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V           AA     D  VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQGIV----------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKXVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 132 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYV 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 44/299 (14%)
Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW 184
           +    R +S    IG GG   V+              K   +A+    L    +Q  D +
Sbjct: 23  MSVKGRIYSILKQIGSGGSSKVF---------QVLNEKKQIYAIKYVNLEEADNQTLDSY 73
Query: 185 ENELRFLSRLNHPN--VVKLMGYCCDDQHRLLVYEYVTRGSLE-DHLLNEDDTELNWERR 241
            NE+ +L++L   +  +++L  Y   DQ+  +V E    G+++ +  L +  +   WER+
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 130
Query: 242 IKIALGAARGLEHLHT-YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
                     LE +HT +   ++H D+K +N L+ D    K+ DFG+A        S + 
Sbjct: 131 SY----WKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVK 185
Query: 301 TRVLGTRGYFAPEYI-----------ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
              +GT  Y  PE I           +   ++ K+DV+S G +L  +  GKT   +  N 
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
Query: 350 LAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
           ++             LH IID            ++  +++  CL  DPK R ++ E++A
Sbjct: 246 IS------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 85/189 (44%), Gaps = 36/189 (19%)
Query: 236 LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGD 295
           L  E  I  +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+     D
Sbjct: 195 LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKD 251
Query: 296 KSHI---STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG 352
             ++     R+     + APE I     T+++DV+SFGV+L EI S              
Sbjct: 252 PDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG------------ 297
Query: 353 NWAKPYLSNKLALHQIIDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMS 404
             A PY   K      IDE+  R ++             E  + +L C + +P  RPT S
Sbjct: 298 --ASPYPGVK------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 349
Query: 405 EVVAALEQL 413
           E+V  L  L
Sbjct: 350 ELVEHLGNL 358

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 85/189 (44%), Gaps = 36/189 (19%)
Query: 236 LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGD 295
           L  E  I  +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+     D
Sbjct: 190 LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKD 246
Query: 296 KSHI---STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG 352
             ++     R+     + APE I     T+++DV+SFGV+L EI S              
Sbjct: 247 PDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG------------ 292
Query: 353 NWAKPYLSNKLALHQIIDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMS 404
             A PY   K      IDE+  R ++             E  + +L C + +P  RPT S
Sbjct: 293 --ASPYPGVK------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 344
Query: 405 EVVAALEQL 413
           E+V  L  L
Sbjct: 345 ELVEHLGNL 353

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 125/294 (42%), Gaps = 44/294 (14%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           R +S    IG GG   V+              K   +A+    L    +Q  D + NE+ 
Sbjct: 9   RIYSILKQIGSGGSSKVF---------QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 59
Query: 190 FLSRLNHPN--VVKLMGYCCDDQHRLLVYEYVTRGSLE-DHLLNEDDTELNWERRIKIAL 246
           +L++L   +  +++L  Y   DQ+  +V E    G+++ +  L +  +   WER+     
Sbjct: 60  YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSY--- 113
Query: 247 GAARGLEHLHT-YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
                LE +HT +   ++H D+K +N L+ D    K+ DFG+A        S +    +G
Sbjct: 114 -WKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVG 171
Query: 306 TRGYFAPEYI-----------ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
           T  Y  PE I           +   ++ K+DV+S G +L  +  GKT   +  N ++   
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--- 228
Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
                     LH IID            ++  +++  CL  DPK R ++ E++A
Sbjct: 229 ---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL-- 188
           +F    L+G+G FG V +           + K      A+K L+++    +DE  + L  
Sbjct: 10  EFEYLKLLGKGTFGKVIL----------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 59
Query: 189 -RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
            R L    HP +  L  Y      RL  V EY   G L  HL  E     +  R     +
Sbjct: 60  NRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 118
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
            +A  L++LH+  + V++RD+K  N++LD D + KI+DFGL K G + D + +     GT
Sbjct: 119 VSA--LDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKX-FCGT 173
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
             Y APE +         D +  GVV+ E++ G+
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL-- 188
           +F    L+G+G FG V +           + K      A+K L+++    +DE  + L  
Sbjct: 11  EFEYLKLLGKGTFGKVIL----------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 60
Query: 189 -RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
            R L    HP +  L  Y      RL  V EY   G L  HL  E     +  R     +
Sbjct: 61  NRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 119
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
            +A  L++LH+  + V++RD+K  N++LD D + KI+DFGL K G + D + +     GT
Sbjct: 120 VSA--LDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKX-FCGT 174
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
             Y APE +         D +  GVV+ E++ G+
Sbjct: 175 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 125/294 (42%), Gaps = 44/294 (14%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           R +S    IG GG   V+              K   +A+    L    +Q  D + NE+ 
Sbjct: 8   RIYSILKQIGSGGSSKVF---------QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 58
Query: 190 FLSRLNHPN--VVKLMGYCCDDQHRLLVYEYVTRGSLE-DHLLNEDDTELNWERRIKIAL 246
           +L++L   +  +++L  Y   DQ+  +V E    G+++ +  L +  +   WER+     
Sbjct: 59  YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSY--- 112
Query: 247 GAARGLEHLHT-YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
                LE +HT +   ++H D+K +N L+ D    K+ DFG+A        S +    +G
Sbjct: 113 -WKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVG 170
Query: 306 TRGYFAPEYI-----------ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
           T  Y  PE I           +   ++ K+DV+S G +L  +  GKT   +  N ++   
Sbjct: 171 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--- 227
Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
                     LH IID            ++  +++  CL  DPK R ++ E++A
Sbjct: 228 ---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 272

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 85/189 (44%), Gaps = 36/189 (19%)
Query: 236 LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGD 295
           L  E  I  +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+     D
Sbjct: 197 LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKD 253
Query: 296 KSHI---STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG 352
             ++     R+     + APE I     T+++DV+SFGV+L EI S              
Sbjct: 254 PDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG------------ 299
Query: 353 NWAKPYLSNKLALHQIIDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMS 404
             A PY   K      IDE+  R ++             E  + +L C + +P  RPT S
Sbjct: 300 --ASPYPGVK------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 351
Query: 405 EVVAALEQL 413
           E+V  L  L
Sbjct: 352 ELVEHLGNL 360

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 85/189 (44%), Gaps = 36/189 (19%)
Query: 236 LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGD 295
           L  E  I  +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+     D
Sbjct: 188 LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKD 244
Query: 296 KSHI---STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG 352
             ++     R+     + APE I     T+++DV+SFGV+L EI S              
Sbjct: 245 PDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG------------ 290
Query: 353 NWAKPYLSNKLALHQIIDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMS 404
             A PY   K      IDE+  R ++             E  + +L C + +P  RPT S
Sbjct: 291 --ASPYPGVK------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 342
Query: 405 EVVAALEQL 413
           E+V  L  L
Sbjct: 343 ELVEHLGNL 351

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V           AA     D  VA+K+L R   Q Q   +    
Sbjct: 62  KRYQNLKPIGSGAQGIV----------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYR 110
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 111 ELVLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 170 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 224
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V           AA     D  VA+K+L R   Q Q   +    
Sbjct: 17  KRYQNLKPIGSGAQGIV----------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYR 65
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 66  ELVLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 125 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 179
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V           AA     D  VA+K+L R   Q Q   +    
Sbjct: 18  KRYQNLKPIGSGAQGIV----------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYR 66
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 67  ELVLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 125
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 126 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 180
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL-- 188
           +F    L+G+G FG V +           + K      A+K L+++    +DE  + L  
Sbjct: 9   EFEYLKLLGKGTFGKVIL----------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 58
Query: 189 -RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
            R L    HP +  L  Y      RL  V EY   G L  HL  E     +  R     +
Sbjct: 59  NRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 117
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
            +A  L++LH+  + V++RD+K  N++LD D + KI+DFGL K G + D + +     GT
Sbjct: 118 VSA--LDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKX-FCGT 172
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
             Y APE +         D +  GVV+ E++ G+
Sbjct: 173 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V           AA     D  VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQGIV----------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 132 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSRL 194
           IG G  G V           AA     D  VA+K+L R   Q Q   +    EL  +  +
Sbjct: 32  IGSGAQGIV----------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKXV 80
Query: 195 NHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
           NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +      G+
Sbjct: 81  NHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           +HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  + TR Y AP
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 194
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGK 340
           E I         D++S G ++ E++  K
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V           AA     D  VA+K+L R   Q Q   +    
Sbjct: 25  KRYQNLKPIGSGAQGIV----------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYR 73
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 74  ELVLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 132
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 133 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 187
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V           AA     D  VA+K+L R   Q Q   +    
Sbjct: 62  KRYQNLKPIGSGAQGIV----------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYR 110
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 111 ELVLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 170 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 224
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V           AA     D  VA+K+L R   Q Q   +    
Sbjct: 23  KRYQNLKPIGSGAQGIV----------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYR 71
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 72  ELVLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 130
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 131 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 185
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 186 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 32/224 (14%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           +F  + + GQG FG V +G   S  M+ A +K     +   R R +  Q   +       
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK----VIQDPRFRNRELQIMQD------- 72
Query: 191 LSRLNHPNVVKLMG--YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERR------- 241
           L+ L+HPN+V+L    Y   ++ R  +Y  V    + D L        N+ RR       
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTL---HRCCRNYYRRQVAPPPI 129
Query: 242 -IKIAL-GAARGLEHLHTYWRPVIHRDVKASNVLLDD-DFNAKISDFGLA-KFGPLGDKS 297
            IK+ L    R +  LH     V HRD+K  NVL+++ D   K+ DFG A K  P    S
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP----S 185
Query: 298 HISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGK 340
             +   + +R Y APE I    H T   D++S G +  E++ G+
Sbjct: 186 EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V           AA     D  VA+K+L R   Q Q   +    
Sbjct: 18  KRYQNLKPIGSGAQGIV----------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYR 66
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 67  ELVLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 125
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 126 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 180
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V           AA     D  VA+K+L R   Q Q   +    
Sbjct: 25  KRYQNLKPIGSGAQGIV----------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYR 73
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 74  ELVLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 132
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 133 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 187
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V           AA     D  VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQGIV----------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 132 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 138 IGQGGFGDVYIGYINSCA--MTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLS 192
           +G G +G+V +     C   +T A R       A+K +++     +       +E+  L 
Sbjct: 12  LGSGAYGEVLL-----CKDKLTGAER-------AIKIIKKSSVTTTSNSGALLDEVAVLK 59
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH-LLNEDDTELNWERRIKIALGAARG 251
           +L+HPN++KL  +  D ++  LV E    G L D  +L +  +E++    +K  L    G
Sbjct: 60  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS---G 116
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDD---DFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
             +LH +   ++HRD+K  N+LL+    D   KI DFGL+    +G K  +  R LGT  
Sbjct: 117 TTYLHKH--NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKER-LGTAY 171
Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           Y APE +   +   K DV+S GV+L  +L G
Sbjct: 172 YIAPEVLRKKY-DEKCDVWSCGVILYILLCG 201

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 44/294 (14%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           R +S    IG GG   V+              K   +A+    L    +Q  D + NE+ 
Sbjct: 56  RIYSILKQIGSGGSSKVF---------QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 106
Query: 190 FLSRLNH--PNVVKLMGYCCDDQHRLLVYEYVTRGSLE-DHLLNEDDTELNWERRIKIAL 246
           +L++L      +++L  Y   DQ+  +V E    G+++ +  L +  +   WER+     
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSY--- 160
Query: 247 GAARGLEHLHT-YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
                LE +HT +   ++H D+K +N L+ D    K+ DFG+A        S +    +G
Sbjct: 161 -WKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 306 TRGYFAPEYI-----------ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
           T  Y  PE I           +   ++ K+DV+S G +L  +  GKT   +  N ++   
Sbjct: 219 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--- 275
Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
                     LH IID            ++  +++  CL  DPK R ++ E++A
Sbjct: 276 ---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 3   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 52
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E+++   L+D +     T +        
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSY 111
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTR 302
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H    
Sbjct: 112 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 303 VLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
              T  Y APE  +   + +   D++S G +  E+++
Sbjct: 169 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 111/251 (44%), Gaps = 55/251 (21%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           LIG+G +G VY G ++            +  VAVK       Q     +N  R +  + H
Sbjct: 20  LIGRGRYGAVYKGSLD------------ERPVAVKVFSFANRQNFINEKNIYR-VPLMEH 66
Query: 197 PNVVKLMGYCCDDQ-------HRLLVYEYVTRGSLEDHL-LNEDDTELNWERRIKIALGA 248
            N+ + +    D++         LLV EY   GSL  +L L+  D    W    ++A   
Sbjct: 67  DNIARFI--VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD----WVSSCRLAHSV 120
Query: 249 ARGLEHLHT------YWRPVI-HRDVKASNVLLDDDFNAKISDFGLA------KFGPLGD 295
            RGL +LHT      +++P I HRD+ + NVL+ +D    ISDFGL+      +    G+
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 296 KSHISTRVLGTRGYFAPEYIATGHLTLK--------TDVYSFGVVLLEILSGKTAAMRRT 347
           + + +   +GT  Y APE +  G + L+         D+Y+ G++  EI       MR T
Sbjct: 181 EDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF------MRCT 233
Query: 348 NGLAGNWAKPY 358
           +   G     Y
Sbjct: 234 DLFPGESVPEY 244

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V       C+   A  K +   VA+K+L R  +          EL  L  + 
Sbjct: 50  VGSGAYGSV-------CS---AIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 99
Query: 196 HPNVVKLMGYCCDDQHRLLVYE-YVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           H NV+ L+            Y+ Y+    ++  L      E + E+   +     +GL++
Sbjct: 100 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKY 159
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG---TRGYFA 311
           +H+    V+HRD+K  N+ +++D   KI DFGLA+        H    + G   TR Y A
Sbjct: 160 IHS--AGVVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTRWYRA 209
Query: 312 PEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           PE I +  H     D++S G ++ E+L+GKT
Sbjct: 210 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 240

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 125/294 (42%), Gaps = 44/294 (14%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           R +S    IG GG   V+              K   +A+    L    +Q  D + NE+ 
Sbjct: 56  RIYSILKQIGSGGSSKVF---------QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 106
Query: 190 FLSRLNHPN--VVKLMGYCCDDQHRLLVYEYVTRGSLE-DHLLNEDDTELNWERRIKIAL 246
           +L++L   +  +++L  Y   DQ+  +V E    G+++ +  L +  +   WER+     
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSY--- 160
Query: 247 GAARGLEHLHT-YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
                LE +HT +   ++H D+K +N L+ D    K+ DFG+A        S +    +G
Sbjct: 161 -WKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 306 TRGYFAPEYI-----------ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
           T  Y  PE I           +   ++ K+DV+S G +L  +  GKT   +  N ++   
Sbjct: 219 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--- 275
Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
                     LH IID            ++  +++  CL  DPK R ++ E++A
Sbjct: 276 ---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 99/223 (44%), Gaps = 26/223 (11%)
Query: 128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQD-EWE 185
           AT ++     IG G +G VY           AR  ++   VA+K +R   G +G      
Sbjct: 2   ATSRYEPVAEIGVGAYGTVY----------KARDPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 186 NELRFLSRLN---HPNVVKLMGYCC----DDQHRL-LVYEYVTRGSLEDHLLNEDDTELN 237
            E+  L RL    HPNVV+LM  C     D + ++ LV+E+V +  L  +L       L 
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
            E    +     RGL+ LH     ++HRD+K  N+L+      K++DFGLA+   +    
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQ 165
Query: 298 HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
                V+ T  Y APE +         D++S G +  E+   K
Sbjct: 166 MALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 2   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 51
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E+++   L+D +     T +        
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSY 110
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTR 302
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H    
Sbjct: 111 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 303 VLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
              T  Y APE  +   + +   D++S G +  E+++
Sbjct: 168 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 24/214 (11%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NEL 188
           F    ++G+G FG V +          AR K      AVK L++      D+ E    E 
Sbjct: 25  FEFIRVLGKGSFGKVML----------ARVKETGDLYAVKVLKKDVILQDDDVECTMTEK 74
Query: 189 RFLSRL-NHPNVVKLMGYCC--DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA 245
           R LS   NHP + +L  +CC         V E+V  G L  H+  +     +  R    A
Sbjct: 75  RILSLARNHPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYA 130
Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
                 L  LH   + +I+RD+K  NVLLD + + K++DFG+ K G     +  +    G
Sbjct: 131 AEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCG 186
Query: 306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           T  Y APE +         D ++ GV+L E+L G
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V   Y       A   +N    VA+K+L R   Q Q   +    
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAY------DAILERN----VAIKKLSRP-FQNQTHAKRAYR 77
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 78  ELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 136
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 137 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 191
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 192 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V   Y       A   +N    VA+K+L R   Q Q   +    
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAY------DAILERN----VAIKKLSRP-FQNQTHAKRAYR 66
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 67  ELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 125
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+       S + T  +
Sbjct: 126 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 180
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 181 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 23/201 (11%)
Query: 165 DFAVAVKRLRRKGSQGQDEWEN-------ELRFLSRLN-HPNVVKLMGYCCDDQHRLLVY 216
           ++AV +  +   GS   +E +        E+  L +++ HPN+++L      +    LV+
Sbjct: 31  EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 90
Query: 217 EYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAARGLEHLHTYWRPVIHRDVKASNVLLD 275
           + + +G L D+L  +        R+I  AL      L  L+     ++HRD+K  N+LLD
Sbjct: 91  DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLD 145
Query: 276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGH------LTLKTDVYSF 329
           DD N K++DFG +     G+K      V GT  Y APE I             + D++S 
Sbjct: 146 DDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 202
Query: 330 GVVLLEILSGKTAAMRRTNGL 350
           GV++  +L+G      R   L
Sbjct: 203 GVIMYTLLAGSPPFWHRKQML 223

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 127/293 (43%), Gaps = 40/293 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+GGF   Y+  +           +  F  A+KR+     Q ++E + E       NHP
Sbjct: 37  LGEGGFS--YVDLVEGL-------HDGHF-YALKRILCHEQQDREEAQREADMHRLFNHP 86
Query: 198 NVVKLMGYCCDD----QHRLLVYEYVTRGSLEDHL--LNEDDTELNWERRIKIALGAARG 251
           N+++L+ YC  +        L+  +  RG+L + +  L +    L  ++ + + LG  RG
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL---GDKSHISTRVLG--- 305
           LE +H   +   HRD+K +N+LL D+    + D G      +   G +  ++ +      
Sbjct: 147 LEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 306 -TRGYFAPEYIAT-GHLTL--KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            T  Y APE  +   H  +  +TDV+S G VL  ++ G+           G+     + N
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ--KGDSVALAVQN 262
Query: 362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           +L++ Q              +    +++   +  DP  RP +  +++ LE LQ
Sbjct: 263 QLSIPQ----------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 114/277 (41%), Gaps = 40/277 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG               R K A+  VAVK + R G +  +  + E+     L HP
Sbjct: 27  IGAGNFG----------VARLMRDKQANELVAVKYIER-GEKIDENVKREIINHRSLRHP 75
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAARGL 252
           N+V+         H  +V EY + G L + + N     ED+    +++ I        G+
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GV 128
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNA--KISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            + H     V HRD+K  N LLD       KI+DFG +K   L  +       +GT  Y 
Sbjct: 129 SYAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQ---PKSAVGTPAYI 183
Query: 311 APEYIATGHLTLKT-DVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII 369
           APE +       K  DV+S GV L  +L G  A          N+ K        +H+I+
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG--AYPFEDPEEPKNFRK-------TIHRIL 234
Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           + +      +  + E   +I R   +DP  R ++ E+
Sbjct: 235 NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEI 271

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 126/292 (43%), Gaps = 36/292 (12%)
Query: 123 GLLEAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR-- 175
           G L++ T    EK+L     +G G FG V  G  ++ +           +VAVK L+   
Sbjct: 6   GPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPS-------GKTVSVAVKCLKPDV 58
Query: 176 -KGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT 234
               +  D++  E+  +  L+H N+++L G       ++ V E    GSL D L  +   
Sbjct: 59  LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQG 116
Query: 235 ELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                   + A+  A G+ +L +  +  IHRD+ A N+LL      KI DFGL +  P  
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174
Query: 295 DKSHISTRVLGTR-GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN 353
           D  ++          + APE + T   +  +D + FGV L E+    T       GL G+
Sbjct: 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF---TYGQEPWIGLNGS 231
Query: 354 WAKPYLSNKLALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTM 403
                      LH+I  +K G  +   E   Q+   ++++C    P++RPT 
Sbjct: 232 ---------QILHKI--DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 272

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 99/223 (44%), Gaps = 26/223 (11%)
Query: 128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQD-EWE 185
           AT ++     IG G +G VY           AR  ++   VA+K +R   G +G      
Sbjct: 2   ATSRYEPVAEIGVGAYGTVY----------KARDPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 186 NELRFLSRLN---HPNVVKLMGYCC----DDQHRL-LVYEYVTRGSLEDHLLNEDDTELN 237
            E+  L RL    HPNVV+LM  C     D + ++ LV+E+V +  L  +L       L 
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
            E    +     RGL+ LH     ++HRD+K  N+L+      K++DFGLA+   +    
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQ 165
Query: 298 HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
                V+ T  Y APE +         D++S G +  E+   K
Sbjct: 166 MALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 5   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+D +     T +             
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLL 113
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTRVLGTR 307
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H     + T 
Sbjct: 114 QGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTL 167
Query: 308 GYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            Y APE  +   + +   D++S G +  E+++
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-----------EI 76
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYE-----YVTRGSLEDHLLNEDDTE-LNWERRI 242
           + L R  H N++ +     +D  R    E     Y+ +  +E  L      + L+ +   
Sbjct: 77  KILLRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHIC 131
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHIST 301
                  RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T
Sbjct: 132 YFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 302 RVLGTRGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
             + TR Y APE +      T   D++S G +L E+LS +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 138 IGQGGFGDVYIGY-INSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENELRFLSRL 194
           +G G +G V   Y + S    A ++ +  F   +  KR  R           ELR L  +
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-----------ELRLLKHM 107
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGA 248
            H NV+ L+    D        E      L  HL+  D   +   +++       +    
Sbjct: 108 KHENVIGLL----DVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 163
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
            RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR 
Sbjct: 164 LRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRW 216
Query: 309 YFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           Y APE +    H  +  D++S G ++ E+L+G+T
Sbjct: 217 YRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRT 250

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 23/201 (11%)
Query: 165 DFAVAVKRLRRKGSQGQDEWEN-------ELRFLSRLN-HPNVVKLMGYCCDDQHRLLVY 216
           ++AV +  +   GS   +E +        E+  L +++ HPN+++L      +    LV+
Sbjct: 44  EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 103
Query: 217 EYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAARGLEHLHTYWRPVIHRDVKASNVLLD 275
           + + +G L D+L  +        R+I  AL      L  L+     ++HRD+K  N+LLD
Sbjct: 104 DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLD 158
Query: 276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGH------LTLKTDVYSF 329
           DD N K++DFG +     G+K      V GT  Y APE I             + D++S 
Sbjct: 159 DDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 330 GVVLLEILSGKTAAMRRTNGL 350
           GV++  +L+G      R   L
Sbjct: 216 GVIMYTLLAGSPPFWHRKQML 236

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 20/217 (9%)
Query: 133 SEKNLIGQGGF---GDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           S  NL+   G+     + +G  + C     +  N ++AV V  + +      +E E  LR
Sbjct: 19  SHMNLVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKV--IDKSKRDPSEEIEILLR 76
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA- 248
           +     HPN++ L     D +H  LV E +  G L D +L +   +   ER     L   
Sbjct: 77  YG---QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQ---KFFSEREASFVLHTI 130
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVL-LDDDFNA---KISDFGLAKFGPLGDKSHISTRVL 304
            + +E+LH+  + V+HRD+K SN+L +D+  N    +I DFG AK   L  ++ +     
Sbjct: 131 GKTVEYLHS--QGVVHRDLKPSNILYVDESGNPECLRICDFGFAK--QLRAENGLLMTPC 186
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
            T  + APE +         D++S G++L  +L+G T
Sbjct: 187 YTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYT 223

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 117/267 (43%), Gaps = 55/267 (20%)
Query: 119 YFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSC-AMTAARRKNADFAVAVKRLRRKG 177
           YF  G L    +K+  K  IGQG +G V +   N   A+ A +  N +      ++R+  
Sbjct: 15  YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN------KIRQIN 68
Query: 178 SQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--LNEDDT- 234
            +  +  + E+R + +L+HPN+ +L     D+Q+  LV E    G L D L    +D T 
Sbjct: 69  PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 235 -------------------------------ELNWERRIKIALGAAR----GLEHLHTYW 259
                                           L++ +R K+     R     L +LH   
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-- 186
Query: 260 RPVIHRDVKASNVLL--DDDFNAKISDFGLAK-FGPL--GDKSHISTRVLGTRGYFAPEY 314
           + + HRD+K  N L   +  F  K+ DFGL+K F  L  G+   ++T+  GT  + APE 
Sbjct: 187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEV 245
Query: 315 IATGHLTL--KTDVYSFGVVLLEILSG 339
           + T + +   K D +S GV+L  +L G
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLMG 272

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 23/201 (11%)
Query: 165 DFAVAVKRLRRKGSQGQDEWE-------NELRFLSRLN-HPNVVKLMGYCCDDQHRLLVY 216
           ++AV +  +   GS   +E +        E+  L +++ HPN+++L      +    LV+
Sbjct: 44  EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 103
Query: 217 EYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAARGLEHLHTYWRPVIHRDVKASNVLLD 275
           + + +G L D+L  +        R+I  AL      L  L+     ++HRD+K  N+LLD
Sbjct: 104 DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLD 158
Query: 276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGH------LTLKTDVYSF 329
           DD N K++DFG +     G+K      V GT  Y APE I             + D++S 
Sbjct: 159 DDMNIKLTDFGFSCQLDPGEKLR---SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 330 GVVLLEILSGKTAAMRRTNGL 350
           GV++  +L+G      R   L
Sbjct: 216 GVIMYTLLAGSPPFWHRKQML 236

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 99/223 (44%), Gaps = 26/223 (11%)
Query: 128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQD-EWE 185
           AT ++     IG G +G VY           AR  ++   VA+K +R   G +G      
Sbjct: 2   ATSRYEPVAEIGVGAYGTVY----------KARDPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 186 NELRFLSRLN---HPNVVKLMGYCC----DDQHRL-LVYEYVTRGSLEDHLLNEDDTELN 237
            E+  L RL    HPNVV+LM  C     D + ++ LV+E+V +  L  +L       L 
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
            E    +     RGL+ LH     ++HRD+K  N+L+      K++DFGLA+   +    
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQ 165
Query: 298 HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
                V+ T  Y APE +         D++S G +  E+   K
Sbjct: 166 MALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-----------EI 76
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +      + T
Sbjct: 137 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-----------EI 77
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L R  H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 78  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 137
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +      + T
Sbjct: 138 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 4   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E+V +  L+  +     T +             
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLL 112
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+    G      T  + T  Y
Sbjct: 113 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWY 168
Query: 310 FAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            APE  +   + +   D++S G +  E+++
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V       CA   A        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV-------CA---AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDXELKILDFGLARHT--DDE---MTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-----------EI 74
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L    H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 75  KILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 134
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 135 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           ++++   IG+G +G V   Y +      A +K + F      +R  R           E+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR-----------EI 92
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNE-DDTELNWERRIKIALG 247
           + L R  H NV+ +           +   Y+ +  +E  L       +L+ +        
Sbjct: 93  QILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQ 152
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+L++   + KI DFGLA+   P  D +   T  + T
Sbjct: 153 ILRGLKYIHS--ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVAT 210
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 5   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+    G      T  + T  Y
Sbjct: 114 QGLSFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWY 169
Query: 310 FAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            APE  +   + +   D++S G +  E+++
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V       CA   A        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV-------CA---AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 38/286 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFA------VAVKRLRRKGSQGQDEWENELRFL 191
           +GQG F  ++ G          RR+  D+       V +K L +      + +      +
Sbjct: 16  LGQGTFTKIFKG---------VRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-LNEDDTELNWERRIKIALGAAR 250
           S+L+H ++V   G C      +LV E+V  GSL+ +L  N++   + W+  +   L AA 
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAM 126
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-VLGTR-G 308
                +T    +IH +V A N+LL  + + K  +    K    G    +  + +L  R  
Sbjct: 127 HFLEENT----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 309 YFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
           +  PE I    +L L TD +SFG  L EI SG    +   + L       +  ++   HQ
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL---SALDSQRKLQFYEDR---HQ 236
Query: 368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +   K         A E A +I  C++ +P +RP+   ++  L  L
Sbjct: 237 LPAPK---------AAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG      ++ C   A  R         K +       +   +NE+  +++L+HP
Sbjct: 59  LGSGAFG-----VVHRCVEKATGR-----VFVAKFINTPYPLDKYTVKNEISIMNQLHHP 108
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            ++ L     D    +L+ E+++ G L D +  E D +++    I     A  GL+H+H 
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE 167
Query: 258 YWRPVIHRDVKASNVLLDDD--FNAKISDFGLA-KFGPLGDKSHISTRVLGTRGYFAPEY 314
           +   ++H D+K  N++ +     + KI DFGLA K  P      I      T  + APE 
Sbjct: 168 H--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP----DEIVKVTTATAEFAAPEI 221
Query: 315 IATGHLTLKTDVYSFGVVLLEILSG 339
           +    +   TD+++ GV+   +LSG
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 125/299 (41%), Gaps = 44/299 (14%)
Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW 184
           +    R +S    IG GG   V+              K   +A+    L    +Q  D +
Sbjct: 23  MSVKGRIYSILKQIGSGGSSKVF---------QVLNEKKQIYAIKYVNLEEADNQTLDSY 73
Query: 185 ENELRFLSRLNHPN--VVKLMGYCCDDQHRLLVYEYVTRGSLE-DHLLNEDDTELNWERR 241
            NE+ +L++L   +  +++L  Y   DQ+  +V E    G+++ +  L +  +   WER+
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 130
Query: 242 IKIALGAARGLEHLHT-YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
                     LE +HT +   ++H D+K +N L+ D    K+ DFG+A          + 
Sbjct: 131 SY----WKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVK 185
Query: 301 TRVLGTRGYFAPEYI-----------ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
              +GT  Y  PE I           +   ++ K+DV+S G +L  +  GKT   +  N 
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
Query: 350 LAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
           ++             LH IID            ++  +++  CL  DPK R ++ E++A
Sbjct: 246 IS------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 5   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+    G      T  + T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWY 169
Query: 310 FAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            APE  +   + +   D++S G +  E+++
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 4   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+    G      T  + T  Y
Sbjct: 113 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWY 168
Query: 310 FAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            APE  +   + +   D++S G +  E+++
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD----- 182
           AT ++     IG G +G VY           AR  ++   VA+K +R     G       
Sbjct: 7   ATSRYEPVAEIGVGAYGTVY----------KARDPHSGHFVALKSVRVPNGGGGGGGLPI 56
Query: 183 EWENELRFLSRLN---HPNVVKLMGYCC----DDQHRL-LVYEYVTRGSLEDHLLNEDDT 234
               E+  L RL    HPNVV+LM  C     D + ++ LV+E+V +  L  +L      
Sbjct: 57  STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP 115
Query: 235 ELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
            L  E    +     RGL+ LH     ++HRD+K  N+L+      K++DFGLA+   + 
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR---IY 170
Query: 295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
                 T V+ T  Y APE +         D++S G +  E+   K
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 12  FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 61
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 62  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+    G      T  + T  Y
Sbjct: 121 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWY 176
Query: 310 FAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            APE  +   + +   D++S G +  E+++
Sbjct: 177 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKGSQGQDEWENEL 188
           +++  + IG+G +G V   Y N   +  A +K + F      +R  R           E+
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-----------EI 74
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-LNWERRIKIALG 247
           + L    H N++ +           +   Y+ +  +E  L     T+ L+ +        
Sbjct: 75  KILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 134
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG-PLGDKSHISTRVLGT 306
             RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  + T
Sbjct: 135 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 307 RGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGK 340
           R Y APE +      T   D++S G +L E+LS +
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 12  FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 61
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 62  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+    G      T  + T  Y
Sbjct: 121 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWY 176
Query: 310 FAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            APE  +   + +   D++S G +  E+++
Sbjct: 177 RAPEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 4   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+    G      T  + T  Y
Sbjct: 113 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWY 168
Query: 310 FAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            APE  +   + +   D++S G +  E+++
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 5   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+    G      T  + T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWY 169
Query: 310 FAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            APE  +   + +   D++S G +  E+++
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 1   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 50
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +        
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 109
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+    G      T  +
Sbjct: 110 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEV 165
Query: 305 GTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            T  Y APE  +   + +   D++S G +  E+++
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 128 ATRKFSE----KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE 183
           A+ KFS+    K  +G+G F       +  C     +    +FA  +   ++  ++   +
Sbjct: 23  ASTKFSDNYDVKEELGKGAFS-----VVRRCVH---KTTGLEFAAKIINTKKLSARDFQK 74
Query: 184 WENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRI 242
            E E R   +L HPN+V+L     ++    LV++ VT G L ED +  E  +E +    I
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI 134
Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA---KISDFGLAKFGPLGDKSHI 299
           +  L     + + H+    ++HR++K  N+LL         K++DFGLA      +  H 
Sbjct: 135 QQIL---ESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH- 188
Query: 300 STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
                GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 189 --GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 120/296 (40%), Gaps = 54/296 (18%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           LIG+G FG VY G           R + + A+ +  + R        ++ E+    +  H
Sbjct: 40  LIGKGRFGQVYHG-----------RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
            NVV  MG C    H L +   + +G     ++ +    L+  +  +IA    +G+ +LH
Sbjct: 89  ENVVLFMGACMSPPH-LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF------GPLGDKSHISTRVLGTRGYF 310
              + ++H+D+K+ NV  D+     I+DFGL         G   DK  I     G   + 
Sbjct: 148 A--KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQN---GWLCHL 201
Query: 311 APEYIATGH---------LTLKTDVYSFGVVLLEI----LSGKTAAMRRTNGLAGNWAKP 357
           APE I              +  +DV++ G +  E+       KT          G   KP
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261
Query: 358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            LS                 Q+   +E ++I+L C   + + RPT ++++  LE+L
Sbjct: 262 NLS-----------------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 37  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 87  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 143 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADE---MTGYVATRWY 195
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 37  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 87  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 143 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADE---MTGYVATRWY 195
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 37  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 87  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 143 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADE---MTGYVATRWY 195
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 5   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+    G      T  + T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWY 169
Query: 310 FAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            APE  +   + +   D++S G +  E+++
Sbjct: 170 RAPEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           IG G +G V       CA   A        VAVK+L R  +          ELR L  + 
Sbjct: 35  IGSGAYGSV-------CA---AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 84
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 85  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 141 RGLKYIHS--ADIIHRDLKPSNLAVNEDXELKILDFGLARHT--DDE---MTGYVATRWY 193
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 127/295 (43%), Gaps = 52/295 (17%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           EA   ++    L+G+GGFG V+ G+          R      VA+K + R    G     
Sbjct: 27  EAFEAEYRLGPLLGKGGFGTVFAGH----------RLTDRLQVAIKVIPRNRVLGWSPLS 76
Query: 186 N------ELRFLSRLN----HPNVVKLMGYCCDDQHRLLVYE-YVTRGSLEDHLLNEDDT 234
           +      E+  L ++     HP V++L+ +    +  +LV E  +    L D++  +   
Sbjct: 77  DSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPL 136
Query: 235 ELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN-AKISDFGLAKFGPL 293
                R     + AA  ++H H+  R V+HRD+K  N+L+D     AK+ DFG      L
Sbjct: 137 GEGPSRCFFGQVVAA--IQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--L 190
Query: 294 GDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG 352
            D+ +  T   GTR Y  PE+I+      L   V+S G++L +++ G     R       
Sbjct: 191 HDEPY--TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------ 242
Query: 353 NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                         +I++ +L  +     + +   +I RCL   P +RP++ E++
Sbjct: 243 -------------QEILEAEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 9   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 58
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 59  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+    G      T  + T  Y
Sbjct: 118 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWY 173
Query: 310 FAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            APE  +   + +   D++S G +  E+++
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 36/211 (17%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G F  VY G      +  A  +  D        R+     +  ++ E   L  L HP
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQD--------RKLTKSERQRFKEEAEXLKGLQHP 85
Query: 198 NVVKLM--------GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTEL----NWERRIKIA 245
           N+V+          G  C     +LV E  T G+L+ +L      ++    +W R+I   
Sbjct: 86  NIVRFYDSWESTVKGKKC----IVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI--- 138
Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTRVL 304
               +GL+ LHT   P+IHRD+K  N+ +     + KI D GLA       ++  +  V+
Sbjct: 139 ---LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVI 191
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLE 335
           GT  + APE     +     DVY+FG   LE
Sbjct: 192 GTPEFXAPEXYEEKY-DESVDVYAFGXCXLE 221

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           +K+  K++IG+G         ++S       R       AVK +     +   E   E+R
Sbjct: 94  QKYDPKDVIGRG---------VSSVVRRCVHRATGH-EFAVKIMEVTAERLSPEQLEEVR 143
Query: 190 FLSR---------LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWER 240
             +R           HP+++ L+          LV++ + +G L D+L  +        R
Sbjct: 144 EATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR 203
Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
            I  +L  A    H +     ++HRD+K  N+LLDD+   ++SDFG +     G+K    
Sbjct: 204 SIMRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR-- 257
Query: 301 TRVLGTRGYFAPEYIATGH------LTLKTDVYSFGVVLLEILSG 339
             + GT GY APE +             + D+++ GV+L  +L+G
Sbjct: 258 -ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V   Y       A   +N    VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAY------DAILERN----VAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+    G    +   V+
Sbjct: 132 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVV 187
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
            TR Y APE I         D++S G ++ E++  K 
Sbjct: 188 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKI 223

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 125/292 (42%), Gaps = 36/292 (12%)
Query: 123 GLLEAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR-- 175
           G L++ T    EK+L     +G G FG V  G  ++ +           +VAVK L+   
Sbjct: 6   GPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPS-------GKTVSVAVKCLKPDV 58
Query: 176 -KGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT 234
               +  D++  E+  +  L+H N+++L G       ++ V E    GSL D L  +   
Sbjct: 59  LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQG 116
Query: 235 ELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                   + A+  A G+ +L +  +  IHRD+ A N+LL      KI DFGL +  P  
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174
Query: 295 DKSHISTRVLGTR-GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN 353
           D   +          + APE + T   +  +D + FGV L E+    T       GL G+
Sbjct: 175 DDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF---TYGQEPWIGLNGS 231
Query: 354 WAKPYLSNKLALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTM 403
                      LH+I  +K G  +   E   Q+   ++++C    P++RPT 
Sbjct: 232 ---------QILHKI--DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 272

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 131/311 (42%), Gaps = 51/311 (16%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G FG+V+ G          + +  + AV +   R + S  +   E E+     L H 
Sbjct: 12  IGKGRFGEVWRG----------KWRGEEVAVKIFSSREERSWFR---EAEIYQTVMLRHE 58
Query: 198 NVVKLMGYCCDDQ----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           N++  +     D        LV +Y   GSL D+L   +   +  E  IK+AL  A GL 
Sbjct: 59  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLA 115
Query: 254 HLH-----TYWRPVI-HRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHIS-TRVLG 305
           HLH     T  +P I HRD+K+ N+L+  +    I+D GLA +     D   I+    +G
Sbjct: 116 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 175
Query: 306 TRGYFAPEY----IATGHLTL--KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
           T+ Y APE     I   H     + D+Y+ G+V  EI     A      G+  ++  PY 
Sbjct: 176 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI-----ARRCSIGGIHEDYQLPYY 230
Query: 360 -------SNKLALHQIIDEKLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                  S +     + ++KL  NI       E  +  A+I+  C  ++   R T   + 
Sbjct: 231 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 290
Query: 408 AALEQLQLNMG 418
             L QL    G
Sbjct: 291 KTLSQLSQQEG 301

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 131/311 (42%), Gaps = 51/311 (16%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G FG+V+ G          + +  + AV +   R + S  +   E E+     L H 
Sbjct: 11  IGKGRFGEVWRG----------KWRGEEVAVKIFSSREERSWFR---EAEIYQTVMLRHE 57
Query: 198 NVVKLMGYCCDDQ----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           N++  +     D        LV +Y   GSL D+L   +   +  E  IK+AL  A GL 
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLA 114
Query: 254 HLH-----TYWRPVI-HRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHIS-TRVLG 305
           HLH     T  +P I HRD+K+ N+L+  +    I+D GLA +     D   I+    +G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 306 TRGYFAPEY----IATGHLTL--KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
           T+ Y APE     I   H     + D+Y+ G+V  EI     A      G+  ++  PY 
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI-----ARRCSIGGIHEDYQLPYY 229
Query: 360 -------SNKLALHQIIDEKLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                  S +     + ++KL  NI       E  +  A+I+  C  ++   R T   + 
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
Query: 408 AALEQLQLNMG 418
             L QL    G
Sbjct: 290 KTLSQLSQQEG 300

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 113/277 (40%), Gaps = 40/277 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG               R K ++  VAVK + R G +  +  + E+     L HP
Sbjct: 26  IGSGNFG----------VARLMRDKQSNELVAVKYIER-GEKIDENVKREIINHRSLRHP 74
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAARGL 252
           N+V+         H  +V EY + G L + + N     ED+    +++ I        G+
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GV 127
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNA--KISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            + H     V HRD+K  N LLD       KI DFG +K   L  +       +GT  Y 
Sbjct: 128 SYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYI 182
Query: 311 APEYIATGHLTLKT-DVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII 369
           APE +       K  DV+S GV L  +L G  A          N+ K        +H+I+
Sbjct: 183 APEVLLKKEYDGKVADVWSCGVTLYVMLVG--AYPFEDPEEPKNFRK-------TIHRIL 233
Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           + +      +  + E   +I R   +DP  R ++ E+
Sbjct: 234 NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEI 270

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V       C+   A  K +   VA+K+L R  +          EL  L  + 
Sbjct: 32  VGSGAYGSV-------CS---AIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 196 HPNVVKLMGYCCDDQHRLLVYE-YVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           H NV+ L+            Y+ Y+    ++  L      + + E+   +     +GL++
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKY 141
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG---TRGYFA 311
           +H+    V+HRD+K  N+ +++D   KI DFGLA+        H    + G   TR Y A
Sbjct: 142 IHS--AGVVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTRWYRA 191
Query: 312 PEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           PE I +  H     D++S G ++ E+L+GKT
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 46/223 (20%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G +G+V++G          + +    AV V     + S  +   E E+     + H 
Sbjct: 45  IGKGRYGEVWMG----------KWRGEKVAVKVFFTTEEASWFR---ETEIYQTVLMRHE 91
Query: 198 NVVKLMGYCCDD-------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           N+   +G+   D           L+ +Y   GSL D+L     T L+ +  +K+A  +  
Sbjct: 92  NI---LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVS 145
Query: 251 GLEHLHT-----YWRPVI-HRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHI---- 299
           GL HLHT       +P I HRD+K+ N+L+  +    I+D GLA KF  + D + +    
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF--ISDTNEVDIPP 203
Query: 300 STRVLGTRGYFAPEYIATG----HLT--LKTDVYSFGVVLLEI 336
           +TRV GT+ Y  PE +       H    +  D+YSFG++L E+
Sbjct: 204 NTRV-GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 44/294 (14%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           R +S    IG GG   V+              K   +A+    L    +Q  D + NE+ 
Sbjct: 56  RIYSILKQIGSGGSSKVF---------QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 106
Query: 190 FLSRLNHPN--VVKLMGYCCDDQHRLLVYEYVTRGSLE-DHLLNEDDTELNWERRIKIAL 246
           +L++L   +  +++L  Y   DQ+  +V E    G+++ +  L +  +   WER+     
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSY--- 160
Query: 247 GAARGLEHLHT-YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
                LE +HT +   ++H D+K +N L+ D    K+ DFG+A        S +    +G
Sbjct: 161 -WKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 306 TRGYFAPEYI-----------ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
              Y  PE I           +   ++ K+DV+S G +L  +  GKT   +  N ++   
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--- 275
Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
                     LH IID            ++  +++  CL  DPK R ++ E++A
Sbjct: 276 ---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 28/212 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V       C+   AR +     VAVK+L R  +          ELR L  L 
Sbjct: 36  VGSGAYGSV-------CSAYDARLRQK---VAVKKLSRPFQSLIHARRTYRELRLLKHLK 85
Query: 196 HPNVVKLM-----GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           H NV+ L+         +D   + +   +    L + + ++    L+ E    +     R
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQ---ALSDEHVQFLVYQLLR 142
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GL+++H+    +IHRD+K SNV +++D   +I DFGLA+           T  + TR Y 
Sbjct: 143 GLKYIHS--AGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYR 195
Query: 311 APEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           APE +    H     D++S G ++ E+L GK 
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 131/311 (42%), Gaps = 51/311 (16%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G FG+V+ G          + +  + AV +   R + S  +   E E+     L H 
Sbjct: 14  IGKGRFGEVWRG----------KWRGEEVAVKIFSSREERSWFR---EAEIYQTVMLRHE 60
Query: 198 NVVKLMGYCCDDQ----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           N++  +     D        LV +Y   GSL D+L   +   +  E  IK+AL  A GL 
Sbjct: 61  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLA 117
Query: 254 HLH-----TYWRPVI-HRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHIS-TRVLG 305
           HLH     T  +P I HRD+K+ N+L+  +    I+D GLA +     D   I+    +G
Sbjct: 118 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 177
Query: 306 TRGYFAPEY----IATGHLTL--KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
           T+ Y APE     I   H     + D+Y+ G+V  EI     A      G+  ++  PY 
Sbjct: 178 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI-----ARRCSIGGIHEDYQLPYY 232
Query: 360 -------SNKLALHQIIDEKLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                  S +     + ++KL  NI       E  +  A+I+  C  ++   R T   + 
Sbjct: 233 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 292
Query: 408 AALEQLQLNMG 418
             L QL    G
Sbjct: 293 KTLSQLSQQEG 303

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 131/311 (42%), Gaps = 51/311 (16%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G FG+V+ G          + +  + AV +   R + S  +   E E+     L H 
Sbjct: 17  IGKGRFGEVWRG----------KWRGEEVAVKIFSSREERSWFR---EAEIYQTVMLRHE 63
Query: 198 NVVKLMGYCCDDQ----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           N++  +     D        LV +Y   GSL D+L   +   +  E  IK+AL  A GL 
Sbjct: 64  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLA 120
Query: 254 HLH-----TYWRPVI-HRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHIS-TRVLG 305
           HLH     T  +P I HRD+K+ N+L+  +    I+D GLA +     D   I+    +G
Sbjct: 121 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 180
Query: 306 TRGYFAPEY----IATGHLTL--KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
           T+ Y APE     I   H     + D+Y+ G+V  EI     A      G+  ++  PY 
Sbjct: 181 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI-----ARRCSIGGIHEDYQLPYY 235
Query: 360 -------SNKLALHQIIDEKLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                  S +     + ++KL  NI       E  +  A+I+  C  ++   R T   + 
Sbjct: 236 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 295
Query: 408 AALEQLQLNMG 418
             L QL    G
Sbjct: 296 KTLSQLSQQEG 306

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 148 IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC 207
           +G  + C     +  N ++AV V  + +      +E E  LR+     HPN++ L     
Sbjct: 37  VGSYSECKRCVHKATNMEYAVKV--IDKSKRDPSEEIEILLRYG---QHPNIITLKDVYD 91
Query: 208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA-ARGLEHLHTYWRPVIHRD 266
           D +H  LV E +  G L D +L +   +   ER     L    + +E+LH+  + V+HRD
Sbjct: 92  DGKHVYLVTELMRGGELLDKILRQ---KFFSEREASFVLHTIGKTVEYLHS--QGVVHRD 146
Query: 267 VKASNVLLDDDFN----AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTL 322
           +K SN+L  D+       +I DFG AK   L  ++ +      T  + APE +       
Sbjct: 147 LKPSNILYVDESGNPECLRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLKRQGYDE 204
Query: 323 KTDVYSFGVVLLEILSGKT 341
             D++S G++L  +L+G T
Sbjct: 205 GCDIWSLGILLYTMLAGYT 223

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 32  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 81
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 82  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 138 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 190
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V       CA   A        VAVK+L R  +          ELR L  + 
Sbjct: 35  VGSGAYGSV-------CA---AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 84
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 85  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 141 RGLKYIHS--ADIIHRDLKPSNLAVNEDXELKILDFGLARHT--DDE---MTGYVATRWY 193
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G F       +  C       + A   +  K+L  +  Q   + E E R    L H 
Sbjct: 12  IGKGAFS-----VVRRCVKLCTGHEYAAKIINTKKLSARDHQ---KLEREARICRLLKHS 63
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           N+V+L     ++    LV++ VT G L ED +  E  +E +    I+  L A      LH
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----LH 118
Query: 257 TYWRPVIHRDVKASNVLLDDDFNA---KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE 313
            +   V+HRD+K  N+LL         K++DFGLA     GD+        GT GY +PE
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQ-AWFGFAGTPGYLSPE 176
Query: 314 YIATGHLTLKTDVYSFGVVLLEILSG 339
            +         D+++ GV+L  +L G
Sbjct: 177 VLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 131/311 (42%), Gaps = 51/311 (16%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G FG+V+ G          + +  + AV +   R + S  +   E E+     L H 
Sbjct: 50  IGKGRFGEVWRG----------KWRGEEVAVKIFSSREERSWFR---EAEIYQTVMLRHE 96
Query: 198 NVVKLMGYCCDDQ----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           N++  +     D        LV +Y   GSL D+L   +   +  E  IK+AL  A GL 
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLA 153
Query: 254 HLH-----TYWRPVI-HRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHIS-TRVLG 305
           HLH     T  +P I HRD+K+ N+L+  +    I+D GLA +     D   I+    +G
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213
Query: 306 TRGYFAPEY----IATGHLTL--KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
           T+ Y APE     I   H     + D+Y+ G+V  EI     A      G+  ++  PY 
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI-----ARRCSIGGIHEDYQLPYY 268
Query: 360 -------SNKLALHQIIDEKLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                  S +     + ++KL  NI       E  +  A+I+  C  ++   R T   + 
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
Query: 408 AALEQLQLNMG 418
             L QL    G
Sbjct: 329 KTLSQLSQQEG 339

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 37  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 87  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 143 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 195
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V       CA   A        VAVK+L R  +          ELR L  + 
Sbjct: 41  VGSGAYGSV-------CA---AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 90
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 91  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 146
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 147 RGLKYIHS--ADIIHRDLKPSNLAVNEDXELKILDFGLARH-----TDDEMTGYVATRWY 199
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 131/311 (42%), Gaps = 51/311 (16%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G FG+V+ G          + +  + AV +   R + S  +   E E+     L H 
Sbjct: 37  IGKGRFGEVWRG----------KWRGEEVAVKIFSSREERSWFR---EAEIYQTVMLRHE 83
Query: 198 NVVKLMGYCCDDQ----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           N++  +     D        LV +Y   GSL D+L   +   +  E  IK+AL  A GL 
Sbjct: 84  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLA 140
Query: 254 HLH-----TYWRPVI-HRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHIS-TRVLG 305
           HLH     T  +P I HRD+K+ N+L+  +    I+D GLA +     D   I+    +G
Sbjct: 141 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 200
Query: 306 TRGYFAPEY----IATGHLTL--KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
           T+ Y APE     I   H     + D+Y+ G+V  EI     A      G+  ++  PY 
Sbjct: 201 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI-----ARRCSIGGIHEDYQLPYY 255
Query: 360 -------SNKLALHQIIDEKLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                  S +     + ++KL  NI       E  +  A+I+  C  ++   R T   + 
Sbjct: 256 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 315
Query: 408 AALEQLQLNMG 418
             L QL    G
Sbjct: 316 KTLSQLSQQEG 326

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 36  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 85
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 86  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 142 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 194
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 124/289 (42%), Gaps = 45/289 (15%)
Query: 132 FSEKNLIGQGGFGD-VYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           F  K+++G G  G  VY G  +          N D  VAVKR+  +     D     LR 
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFD----------NRD--VAVKRILPECFSFADREVQLLR- 72
Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIKIALGA 248
                HPNV++   Y C ++ R   Y  +     +L++++  +D   L  E  I +    
Sbjct: 73  -ESDEHPNVIR---YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP-ITLLQQT 127
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLD-----DDFNAKISDFGLAKFGPLGDKSHISTR- 302
             GL HLH+    ++HRD+K  N+L+          A ISDFGL K   +G  S  S R 
Sbjct: 128 TSGLAHLHSL--NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS-FSRRS 184
Query: 303 -VLGTRGYFAPEYIATG---HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY 358
            V GT G+ APE ++     + T   D++S G V   ++S  +    ++     N     
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN----I 240
Query: 359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           L    +L  +  EK        E     E+I + +  DP+ RP+   V+
Sbjct: 241 LLGACSLDCLHPEK-------HEDVIARELIEKMIAMDPQKRPSAKHVL 282

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 32  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 81
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 82  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 138 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 190
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 35  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 84
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 85  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 141 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 193
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 118/258 (45%), Gaps = 28/258 (10%)
Query: 160 RRKNADFAVAVKRLRRKGSQG------QDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL 213
           R K+     A K ++++ S+       ++E E E+  L ++ H NV+ L     +    +
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL 273
           L+ E V+ G L D L  ++   L+ E           G+ +LHT  + + H D+K  N++
Sbjct: 92  LILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIM 147
Query: 274 LDDDF----NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSF 329
           L D      + K+ DFGLA    + D       + GT  + APE +    L L+ D++S 
Sbjct: 148 LLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAPEIVNYEPLGLEADMWSI 204
Query: 330 GVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEII 389
           GV+   +LSG +  +       G+  +  L+N  A+    DE+       E A++F   I
Sbjct: 205 GVITYILLSGASPFL-------GDTKQETLANITAVSYDFDEEFFSQTS-ELAKDF---I 253
Query: 390 LRCLNSDPKNRPTMSEVV 407
            + L  + + R T+ E +
Sbjct: 254 RKLLVKETRKRLTIQEAL 271

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGXVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 42  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 91
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 92  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 147
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 148 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 200
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 32  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 81
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 82  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 138 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 190
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 42  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 91
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 92  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 147
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 148 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 200
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 41  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 90
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 91  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 146
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 147 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 199
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 50  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 99
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 100 HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 156 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 208
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 3   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 52
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E+++   L+  +     T +        
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSY 111
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTR 302
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H    
Sbjct: 112 LFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 303 VLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
              T  Y APE  +   + +   D++S G +  E+++
Sbjct: 169 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 27  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 76
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 77  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 132
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 133 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 185
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 218

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 53  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 102
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 103 HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 158
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG---T 306
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+        H    + G   T
Sbjct: 159 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMXGYVAT 208
Query: 307 RGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           R Y APE +    H     D++S G ++ E+L+G+T
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 3   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 52
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E+V +  L+  +     T +        
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSY 111
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTR 302
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H    
Sbjct: 112 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 303 VLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
              T  Y APE  +   + +   D++S G +  E+++
Sbjct: 169 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 35  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 84
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 85  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 141 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 193
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG+V+              K   F  AVK++R +  + +     EL   + L  P
Sbjct: 101 LGRGSFGEVH----------RMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSP 145
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V L G   +     +  E +  GSL   L+ E    L  +R +     A  GLE+LH+
Sbjct: 146 RIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGC-LPEDRALYYLGQALEGLEYLHS 203
Query: 258 YWRPVIHRDVKASNVLLDDD-FNAKISDFGLA---KFGPLGDKSHISTRVLGTRGYFAPE 313
             R ++H DVKA NVLL  D  +A + DFG A   +   LG        + GT  + APE
Sbjct: 204 --RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPE 261
Query: 314 YIATGHLTLKTDVYSFGVVLLEILSG 339
            +       K DV+S   ++L +L+G
Sbjct: 262 VVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAV--KRLRRKGSQGQDEWENELR 189
           F    ++G+GG+G V+                  FA+ V  K +  + ++     + E  
Sbjct: 19  FELLRVLGKGGYGKVF-----QVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNE----DDTELNWERRIKI 244
            L  + HP +V L+ Y      +L L+ EY++ G L   L  E    +DT   +   I +
Sbjct: 74  ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM 132
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           ALG      HLH   + +I+RD+K  N++L+   + K++DFGL K   + D + ++    
Sbjct: 133 ALG------HLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGT-VTHXFC 182
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           GT  Y APE +         D +S G ++ ++L+G
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 29  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 78
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 79  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 134
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 135 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 187
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 188 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 49  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 98
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 99  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 154
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 155 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 207
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAV--KRLRRKGSQGQDEWENELR 189
           F    ++G+GG+G V+                  FA+ V  K +  + ++     + E  
Sbjct: 19  FELLRVLGKGGYGKVF-----QVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNE----DDTELNWERRIKI 244
            L  + HP +V L+ Y      +L L+ EY++ G L   L  E    +DT   +   I +
Sbjct: 74  ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM 132
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           ALG      HLH   + +I+RD+K  N++L+   + K++DFGL K   + D + ++    
Sbjct: 133 ALG------HLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGT-VTHTFC 182
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           GT  Y APE +         D +S G ++ ++L+G
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 36  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 85
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 86  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 142 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 194
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 26  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 76  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 132 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 184
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++     IG G  G V   Y       A   +N    VA+K+L R   Q Q   +    
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAY------DAILERN----VAIKKLSRP-FQNQTHAKRAYR 72
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHLLNEDDTELNWERRIKI 244
           EL  +  +NH N++ L+      Q  L  ++  Y+    ++ +L      EL+ ER   +
Sbjct: 73  ELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                 G++HLH+    +IHRD+K SN+++  D   KI DFGLA+    G    +   V+
Sbjct: 132 LYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVV 187
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            TR Y APE I         D++S G ++ E++  K
Sbjct: 188 -TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G F       +  C      ++ A   +  K+L  +  Q   + E E R    L HP
Sbjct: 39  LGKGAFS-----VVRRCVKKTPTQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHP 90
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           N+V+L     ++    LV++ VT G L ED +  E  +E +    I   L     + H+H
Sbjct: 91  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQIL---ESVNHIH 147
Query: 257 TYWRPVIHRDVKASNVLLDDDFNA---KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE 313
            +   ++HRD+K  N+LL         K++DFGLA    +  +        GT GY +PE
Sbjct: 148 QH--DIVHRDLKPENLLLASKCKGAAVKLADFGLAI--EVQGEQQAWFGFAGTPGYLSPE 203
Query: 314 YIATGHLTLKTDVYSFGVVLLEILSG 339
            +         D+++ GV+L  +L G
Sbjct: 204 VLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 27  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 76
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 77  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 132
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 133 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 185
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 218

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 53  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 102
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 103 HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 158
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 159 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 211
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 1   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 50
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E+++   L+  +     T +        
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSY 109
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTR 302
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H    
Sbjct: 110 LFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 303 VLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
              T  Y APE  +   + +   D++S G +  E+++
Sbjct: 167 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 28  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 77
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 78  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 133
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 134 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 186
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 219

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V       CA   A        VAVK+L R  +          ELR L  + 
Sbjct: 36  VGSGAYGSV-------CA---AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 85
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 86  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 142 RGLKYIHS--ADIIHRDLKPSNLAVNEDSELKILDFGLARHT--DDE---MTGYVATRWY 194
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 118/258 (45%), Gaps = 28/258 (10%)
Query: 160 RRKNADFAVAVKRLRRKGSQG------QDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL 213
           R K+     A K ++++ S+       ++E E E+  L ++ H NV+ L     +    +
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL 273
           L+ E V+ G L D L  ++   L+ E           G+ +LHT  + + H D+K  N++
Sbjct: 92  LILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIM 147
Query: 274 LDDDF----NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSF 329
           L D      + K+ DFGLA    + D       + GT  + APE +    L L+ D++S 
Sbjct: 148 LLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAPEIVNYEPLGLEADMWSI 204
Query: 330 GVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEII 389
           GV+   +LSG +  +       G+  +  L+N  A+    DE+       E A++F   I
Sbjct: 205 GVITYILLSGASPFL-------GDTKQETLANITAVSYDFDEEFFSQTS-ELAKDF---I 253
Query: 390 LRCLNSDPKNRPTMSEVV 407
            + L  + + R T+ E +
Sbjct: 254 RKLLVKETRKRLTIQEAL 271

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V       CA   A        VAVK+L R  +          ELR L  + 
Sbjct: 32  VGSGAYGSV-------CA---AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 81
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 82  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 138 RGLKYIHS--ADIIHRDLKPSNLAVNEDSELKILDFGLARH-----TDDEMTGYVATRWY 190
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 111/257 (43%), Gaps = 53/257 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW-- 184
              R+ +    +G+G +G+V+ G  +              +VAVK      S+ +  W  
Sbjct: 5   TVARQVALVECVGKGRYGEVWRGLWHG------------ESVAVKIF---SSRDEQSWFR 49
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQ-------HRLLVYEYVTRGSLEDHLLNEDDTELN 237
           E E+     L H N+   +G+   D           L+  Y   GSL D L  +    L 
Sbjct: 50  ETEIYNTVLLRHDNI---LGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQ---TLE 103
Query: 238 WERRIKIALGAARGLEHLH-----TYWRPVI-HRDVKASNVLLDDDFNAKISDFGLAKFG 291
               +++A+ AA GL HLH     T  +P I HRD K+ NVL+  +    I+D GLA   
Sbjct: 104 PHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMH 163
Query: 292 PLG-DKSHISTRV-LGTRGYFAPEYIATGHLT------LKTDVYSFGVVLLEILSGKTAA 343
             G D   I     +GT+ Y APE +     T        TD+++FG+VL EI       
Sbjct: 164 SQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI------- 216
Query: 344 MRRT--NGLAGNWAKPY 358
            RRT  NG+  ++  P+
Sbjct: 217 ARRTIVNGIVEDYRPPF 233

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V       C+   AR +     VAVK+L R  +          ELR L  L 
Sbjct: 28  VGSGAYGSV-------CSAYDARLRQK---VAVKKLSRPFQSLIHARRTYRELRLLKHLK 77
Query: 196 HPNVVKLM-----GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           H NV+ L+         +D   + +   +    L + +  +    L+ E    +     R
Sbjct: 78  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQ---ALSDEHVQFLVYQLLR 134
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GL+++H+    +IHRD+K SNV +++D   +I DFGLA+           T  + TR Y 
Sbjct: 135 GLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRWYR 187
Query: 311 APEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           APE +    H     D++S G ++ E+L GK 
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 219

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG+V+              K   F  AVK++R +  + +     EL   + L  P
Sbjct: 82  LGRGSFGEVH----------RMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSP 126
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V L G   +     +  E +  GSL   L+ E    L  +R +     A  GLE+LH+
Sbjct: 127 RIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGC-LPEDRALYYLGQALEGLEYLHS 184
Query: 258 YWRPVIHRDVKASNVLLDDD-FNAKISDFGLA---KFGPLGDKSHISTRVLGTRGYFAPE 313
             R ++H DVKA NVLL  D  +A + DFG A   +   LG        + GT  + APE
Sbjct: 185 --RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPE 242
Query: 314 YIATGHLTLKTDVYSFGVVLLEILSG 339
            +       K DV+S   ++L +L+G
Sbjct: 243 VVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 124/289 (42%), Gaps = 36/289 (12%)
Query: 126 EAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR---KG 177
           ++ T    EK+L     +G G FG V  G  ++ +           +VAVK L+      
Sbjct: 3   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPS-------GKTVSVAVKCLKPDVLSQ 55
Query: 178 SQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELN 237
            +  D++  E+  +  L+H N+++L G       ++ V E    GSL D L       L 
Sbjct: 56  PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL- 113
Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
                + A+  A G+ +L +  +  IHRD+ A N+LL      KI DFGL +  P  D  
Sbjct: 114 LGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171
Query: 298 HISTRVLGTR-GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
           ++          + APE + T   +  +D + FGV L E+    T       GL G+   
Sbjct: 172 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF---TYGQEPWIGLNGS--- 225
Query: 357 PYLSNKLALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTM 403
                   LH+I  +K G  +   E   Q+   ++++C    P++RPT 
Sbjct: 226 ------QILHKI--DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 266

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 145 DVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMG 204
           D+ +G  + C     +  N +FAV  K + +      +E E  LR+     HPN++ L  
Sbjct: 29  DIGVGSYSVCKRCIHKATNMEFAV--KIIDKSKRDPTEEIEILLRYG---QHPNIITLKD 83
Query: 205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAARGLEHLHTYWRPVI 263
              D ++  +V E +  G L D +L +   +   ER     L    + +E+LH   + V+
Sbjct: 84  VYDDGKYVYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHA--QGVV 138
Query: 264 HRDVKASNVLLDDDF----NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGH 319
           HRD+K SN+L  D+     + +I DFG AK   L  ++ +      T  + APE +    
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLERQG 196
Query: 320 LTLKTDVYSFGVVLLEILSGKT 341
                D++S GV+L  +L+G T
Sbjct: 197 YDAACDIWSLGVLLYTMLTGYT 218

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V       CA   A        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV-------CA---AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGL +           T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDSELKILDFGLCRH-----TDDEMTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 102/247 (41%), Gaps = 44/247 (17%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F E  ++GQG FG V            AR        A+K++R    +      +E+  L
Sbjct: 8   FEEIAVLGQGAFGQV----------VKARNALDSRYYAIKKIRHT-EEKLSTILSEVXLL 56
Query: 192 SRLNHPNVVKLMGYCCDDQH-------------RLLVYEYVTRGSLEDHLLNEDDTELNW 238
           + LNH  VV+      + ++               +  EY    +L D + +E+   LN 
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSEN---LNQ 113
Query: 239 ER--RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK------- 289
           +R    ++       L ++H+  + +IHR++K  N+ +D+  N KI DFGLAK       
Sbjct: 114 QRDEYWRLFRQILEALSYIHS--QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 290 -----FGPLGDKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGKTAA 343
                   L   S   T  +GT  Y A E +  TGH   K D YS G++  E +   +  
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTG 231
Query: 344 MRRTNGL 350
             R N L
Sbjct: 232 XERVNIL 238

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 2   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 51
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +        
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 110
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTR 302
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H    
Sbjct: 111 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 303 VLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
              T  Y APE  +   + +   D++S G +  E+++
Sbjct: 168 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 5   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTRVLGTR 307
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H     + T 
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTL 167
Query: 308 GYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            Y APE  +   + +   D++S G +  E+++
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 3   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 52
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +        
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 111
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTR 302
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H    
Sbjct: 112 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 303 VLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
              T  Y APE  +   + +   D++S G +  E+++
Sbjct: 169 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 2   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 51
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +        
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 110
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTR 302
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H    
Sbjct: 111 LFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 303 VLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
              T  Y APE  +   + +   D++S G +  E+++
Sbjct: 168 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 2   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 51
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +        
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 110
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTR 302
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H    
Sbjct: 111 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 303 VLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
              T  Y APE  +   + +   D++S G +  E+++
Sbjct: 168 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 5   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTRVLGTR 307
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H     + T 
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTL 167
Query: 308 GYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            Y APE  +   + +   D++S G +  E+++
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 5   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTRVLGTR 307
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H     + T 
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTL 167
Query: 308 GYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            Y APE  +   + +   D++S G +  E+++
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 112/277 (40%), Gaps = 40/277 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG               R K ++  VAVK + R G +     + E+     L HP
Sbjct: 27  IGSGNFG----------VARLMRDKQSNELVAVKYIER-GEKIAANVKREIINHRSLRHP 75
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAARGL 252
           N+V+         H  +V EY + G L + + N     ED+    +++ I        G+
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GV 128
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNA--KISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            + H     V HRD+K  N LLD       KI DFG +K   L  +       +GT  Y 
Sbjct: 129 SYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYI 183
Query: 311 APEYIATGHLTLKT-DVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII 369
           APE +       K  DV+S GV L  +L G  A          N+ K        +H+I+
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG--AYPFEDPEEPKNFRK-------TIHRIL 234
Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           + +      +  + E   +I R   +DP  R ++ E+
Sbjct: 235 NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEI 271

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G +G V   +     +  A +K +    ++   +R           ELR L  + H 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRT--------YRELRLLKHMKHE 93
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAARG 251
           NV+ L+      +      E      L  HL+  D   +   +++       +     RG
Sbjct: 94  NVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
           L+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y A
Sbjct: 150 LKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRA 202
Query: 312 PEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           PE +    H     D++S G ++ E+L+G+T
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 1   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 50
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +        
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 109
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTR 302
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H    
Sbjct: 110 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 303 VLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
              T  Y APE  +   + +   D++S G +  E+++
Sbjct: 167 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 4   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTRVLGTR 307
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H       T 
Sbjct: 113 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TL 166
Query: 308 GYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            Y APE  +   + +   D++S G +  E+++
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 1   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 50
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +        
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 109
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTR 302
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H    
Sbjct: 110 LFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 303 VLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
              T  Y APE  +   + +   D++S G +  E+++
Sbjct: 167 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V       C+   AR +     VAVK+L R  +          ELR L  L 
Sbjct: 36  VGSGAYGSV-------CSAYDARLRQK---VAVKKLSRPFQSLIHARRTYRELRLLKHLK 85
Query: 196 HPNVVKLM-----GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           H NV+ L+         +D   + +   +    L + +  +    L+ E    +     R
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQ---ALSDEHVQFLVYQLLR 142
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GL+++H+    +IHRD+K SNV +++D   +I DFGLA+           T  + TR Y 
Sbjct: 143 GLKYIHS--AGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYR 195
Query: 311 APEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           APE +    H     D++S G ++ E+L GK 
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 3   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 52
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +        
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 111
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTR 302
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H    
Sbjct: 112 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 303 VLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
              T  Y APE  +   + +   D++S G +  E+++
Sbjct: 169 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 3   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 52
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +        
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSY 111
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTR 302
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H    
Sbjct: 112 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 303 VLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
              T  Y APE  +   + +   D++S G +  E+++
Sbjct: 169 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE 185
            +   F +   IG+G +G VY           AR K     VA+K++R    ++G     
Sbjct: 4   GSMENFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTA 53
Query: 186 -NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E+  L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +        
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 112
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTR 302
                +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H    
Sbjct: 113 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 169
Query: 303 VLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
              T  Y APE  +   + +   D++S G +  E+++
Sbjct: 170 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 4   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTRVLGTR 307
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H       T 
Sbjct: 113 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TL 166
Query: 308 GYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            Y APE  +   + +   D++S G +  E+++
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 26  VGSGAYGSV----------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 76  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 132 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 184
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 6   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 55
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 56  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTRVLGTR 307
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H       T 
Sbjct: 115 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TL 168
Query: 308 GYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            Y APE  +   + +   D++S G +  E+++
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G F       +  C      ++ A   +  K+L  +  Q   + E E R    L HP
Sbjct: 12  LGKGAFS-----VVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHP 63
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           N+V+L     ++    LV++ VT G L ED +  E  +E +    I+  L +       H
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN-----H 118
Query: 257 TYWRPVIHRDVKASNVLLDDDFNA---KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE 313
            +   ++HRD+K  N+LL         K++DFGLA     GD+        GT GY +PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTPGYLSPE 176
Query: 314 YIATGHLTLKTDVYSFGVVLLEILSG 339
            +         D+++ GV+L  +L G
Sbjct: 177 VLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 124/289 (42%), Gaps = 36/289 (12%)
Query: 126 EAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR---RKG 177
           ++ T    EK+L     +G G FG V  G  ++ +           +VAVK L+      
Sbjct: 3   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPS-------GKTVSVAVKCLKPDVLSQ 55
Query: 178 SQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELN 237
            +  D++  E+  +  L+H N+++L G       ++ V E    GSL D L  +      
Sbjct: 56  PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFL 113
Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
                + A+  A G+ +L +  +  IHRD+ A N+LL      KI DFGL +  P  D  
Sbjct: 114 LGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171
Query: 298 HISTRVLGTR-GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
           ++          + APE + T   +  +D + FGV L E+    T       GL G+   
Sbjct: 172 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF---TYGQEPWIGLNGS--- 225
Query: 357 PYLSNKLALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTM 403
                   LH+I  +K G  +   E   Q+   ++++C    P++RPT 
Sbjct: 226 ------QILHKI--DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 266

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 40  VGSGAYGSV----------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 89
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 90  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 145
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 146 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 198
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 231

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+ ++R    ++G       E+ 
Sbjct: 5   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALXKIRLDTETEGVPSTAIREIS 54
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+    G      T  + T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWY 169
Query: 310 FAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            APE  +   + +   D++S G +  E+++
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+ ++R    ++G       E+ 
Sbjct: 4   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALXKIRLDTETEGVPSTAIREIS 53
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+    G      T  + T  Y
Sbjct: 113 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWY 168
Query: 310 FAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            APE  +   + +   D++S G +  E+++
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 36  VGSGAYGSV----------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 85
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 86  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 142 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 194
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 119/258 (46%), Gaps = 28/258 (10%)
Query: 160 RRKNADFAVAVKRLRRKGSQG------QDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL 213
           R K+     A K ++++ S+       ++E E E+  L ++ H NV+ L     +    +
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL 273
           L+ E V+ G L D L  ++   L+ E           G+ +LHT  + + H D+K  N++
Sbjct: 92  LILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIM 147
Query: 274 LDDDF----NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSF 329
           L D      + K+ DFGLA    + D       + GT  + APE +    L L+ D++S 
Sbjct: 148 LLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAPEIVNYEPLGLEADMWSI 204
Query: 330 GVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEII 389
           GV+   +LSG +  +       G+  +  L+N  ++    DE+   +   E A++F   I
Sbjct: 205 GVITYILLSGASPFL-------GDTKQETLANITSVSYDFDEEFFSHTS-ELAKDF---I 253
Query: 390 LRCLNSDPKNRPTMSEVV 407
            + L  + + R T+ E +
Sbjct: 254 RKLLVKETRKRLTIQEAL 271

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 50  VGSGAYGSV----------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 99
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 100 HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG---T 306
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+        H    + G   T
Sbjct: 156 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMXGXVAT 205
Query: 307 RGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           R Y APE +    H     D++S G ++ E+L+G+T
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 50  VGSGAYGSV----------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 99
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 100 HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 156 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 208
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 129 TRKFSE----KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW 184
           + KFS+    K  +G+G F       +  C     +    +FA  +   ++  ++   + 
Sbjct: 1   STKFSDNYDVKEELGKGAFS-----VVRRCVH---KTTGLEFAAKIINTKKLSARDFQKL 52
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIK 243
           E E R   +L HPN+V+L     ++    LV++ VT G L ED +  E  +E +    I+
Sbjct: 53  EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ 112
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA---KISDFGLAKFGPLGDKSHIS 300
             L     + + H+    ++HR++K  N+LL         K++DFGLA      +  H  
Sbjct: 113 QIL---ESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH-- 165
Query: 301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 166 -GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWE-NELR 189
           F +   IG+G +G VY           AR K     VA+K++R    ++G       E+ 
Sbjct: 5   FQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +             
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSHISTRVLGTR 307
           +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+ FG P+    H     + T 
Sbjct: 114 QGLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTL 167
Query: 308 GYFAPE-YIATGHLTLKTDVYSFGVVLLEILS 338
            Y APE  +   + +   D++S G +  E+++
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG---T 306
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+        H    + G   T
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVAT 185
Query: 307 RGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           R Y APE +    H     D++S G ++ E+L+G+T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 129 TRKFSE----KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW 184
           + KFS+    K  +G+G F       +  C     +    +FA  +   ++  ++   + 
Sbjct: 1   STKFSDNYDVKEELGKGAFS-----VVRRCVH---KTTGLEFAAKIINTKKLSARDFQKL 52
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIK 243
           E E R   +L HPN+V+L     ++    LV++ VT G L ED +  E  +E +    I+
Sbjct: 53  EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ 112
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA---KISDFGLAKFGPLGDKSHIS 300
             L     + + H+    ++HR++K  N+LL         K++DFGLA      +  H  
Sbjct: 113 QIL---ESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH-- 165
Query: 301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 166 -GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 49  VGSGAYGSV----------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 98
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 99  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 154
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+           T  + TR Y
Sbjct: 155 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 207
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG---T 306
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+        H    + G   T
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVAT 185
Query: 307 RGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           R Y APE +    H     D++S G ++ E+L+G+T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI D+GLA+     D+    T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDYGLARHT--DDE---MTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 31/272 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR---KGSQGQDEWENELRFLSRL 194
           +G G FG V  G  ++ +           +VAVK L+       +  D++  E+  +  L
Sbjct: 16  LGDGSFGVVRRGEWDAPS-------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           +H N+++L G       ++ V E    GSL D L  +           + A+  A G+ +
Sbjct: 69  DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR-GYFAPE 313
           L +  +  IHRD+ A N+LL      KI DFGL +  P  D  ++          + APE
Sbjct: 127 LES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 314 YIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL 373
            + T   +  +D + FGV L E+    T       GL G+           LH+I  +K 
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMF---TYGQEPWIGLNGS---------QILHKI--DKE 230
Query: 374 GRNIQMEE--AQEFAEIILRCLNSDPKNRPTM 403
           G  +   E   Q+   ++++C    P++RPT 
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 262

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 119/258 (46%), Gaps = 28/258 (10%)
Query: 160 RRKNADFAVAVKRLRRKGSQG------QDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL 213
           R K+     A K ++++ S+       ++E E E+  L ++ H NV+ L     +    +
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL 273
           L+ E V+ G L D L  ++   L+ E           G+ +LHT  + + H D+K  N++
Sbjct: 92  LILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIM 147
Query: 274 LDDDF----NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSF 329
           L D      + K+ DFGLA    + D       + GT  + APE +    L L+ D++S 
Sbjct: 148 LLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAPEIVNYEPLGLEADMWSI 204
Query: 330 GVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEII 389
           GV+   +LSG +  +       G+  +  L+N  ++    DE+   +   E A++F   I
Sbjct: 205 GVITYILLSGASPFL-------GDTKQETLANITSVSYDFDEEFFSHTS-ELAKDF---I 253
Query: 390 LRCLNSDPKNRPTMSEVV 407
            + L  + + R T+ E +
Sbjct: 254 RKLLVKETRKRLTIQEAL 271

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 119/258 (46%), Gaps = 28/258 (10%)
Query: 160 RRKNADFAVAVKRLRRKGSQG------QDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL 213
           R K+     A K ++++ S+       ++E E E+  L ++ H NV+ L     +    +
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL 273
           L+ E V+ G L D L  ++   L+ E           G+ +LHT  + + H D+K  N++
Sbjct: 92  LILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIM 147
Query: 274 LDDDF----NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSF 329
           L D      + K+ DFGLA    + D       + GT  + APE +    L L+ D++S 
Sbjct: 148 LLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAPEIVNYEPLGLEADMWSI 204
Query: 330 GVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEII 389
           GV+   +LSG +  +       G+  +  L+N  ++    DE+   +   E A++F   I
Sbjct: 205 GVITYILLSGASPFL-------GDTKQETLANITSVSYDFDEEFFSHTS-ELAKDF---I 253
Query: 390 LRCLNSDPKNRPTMSEVV 407
            + L  + + R T+ E +
Sbjct: 254 RKLLVKETRKRLTIQEAL 271

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 26  VGSGAYGSV----------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 76  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG---T 306
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+        H    + G   T
Sbjct: 132 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVAT 181
Query: 307 RGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           R Y APE +    H     D++S G ++ E+L+G+T
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 131 KFSE----KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN 186
           KFS+    K  +G+G F       +  C     +    +FA  +   ++  ++   + E 
Sbjct: 2   KFSDNYDVKEELGKGAFS-----VVRRCVH---KTTGLEFAAKIINTKKLSARDFQKLER 53
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIKIA 245
           E R   +L HPN+V+L     ++    LV++ VT G L ED +  E  +E +    I+  
Sbjct: 54  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 113
Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA---KISDFGLAKFGPLGDKSHISTR 302
           L     + + H+    ++HR++K  N+LL         K++DFGLA      +  H    
Sbjct: 114 L---ESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---G 165
Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 166 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 31/272 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR---RKGSQGQDEWENELRFLSRL 194
           +G G FG V  G  ++ +           +VAVK L+       +  D++  E+  +  L
Sbjct: 16  LGDGSFGVVRRGEWDAPS-------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           +H N+++L G       ++ V E    GSL D L  +           + A+  A G+ +
Sbjct: 69  DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR-GYFAPE 313
           L +  +  IHRD+ A N+LL      KI DFGL +  P  D  ++          + APE
Sbjct: 127 LES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 314 YIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL 373
            + T   +  +D + FGV L E+    T       GL G+           LH+I  +K 
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMF---TYGQEPWIGLNGS---------QILHKI--DKE 230
Query: 374 GRNIQMEE--AQEFAEIILRCLNSDPKNRPTM 403
           G  +   E   Q+   ++++C    P++RPT 
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 262

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G F       +  C      ++ A   +  K+L  +  Q   + E E R    L HP
Sbjct: 12  LGKGAFS-----VVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHP 63
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           N+V+L     ++    LV++ VT G L ED +  E  +E +    I+  L +       H
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN-----H 118
Query: 257 TYWRPVIHRDVKASNVLLDDDFNA---KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE 313
            +   ++HRD+K  N+LL         K++DFGLA     GD+        GT GY +PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTPGYLSPE 176
Query: 314 YIATGHLTLKTDVYSFGVVLLEILSG 339
            +         D+++ GV+L  +L G
Sbjct: 177 VLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG+V+            + K   F  AVK++R +  + +     EL   + L+ P
Sbjct: 82  VGRGSFGEVH----------RMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSP 126
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V L G   +     +  E +  GSL   L+ +    L  +R +     A  GLE+LHT
Sbjct: 127 RIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGC-LPEDRALYYLGQALEGLEYLHT 184
Query: 258 YWRPVIHRDVKASNVLLDDDFN-AKISDFGLA---KFGPLGDKSHISTRVLGTRGYFAPE 313
             R ++H DVKA NVLL  D + A + DFG A   +   LG        + GT  + APE
Sbjct: 185 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 242
Query: 314 YIATGHLTLKTDVYSFGVVLLEILSG 339
            +       K D++S   ++L +L+G
Sbjct: 243 VVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN 186
           A    F    +IG+G FG V +          AR K  +   AVK L++K    + E ++
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLL----------ARHKAEEVFYAVKVLQKKAILKKKEEKH 84
Query: 187 ELR----FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI 242
            +      L  + HP +V L            V +Y+  G L  HL  E       E R 
Sbjct: 85  IMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE---RCFLEPRA 141
Query: 243 KI-ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           +  A   A  L +LH+    +++RD+K  N+LLD   +  ++DFGL K     +  H ST
Sbjct: 142 RFYAAEIASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNST 195
Query: 302 --RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
                GT  Y APE +         D +  G VL E+L G
Sbjct: 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG+V+            + K   F  AVK++R +  + +     EL   + L+ P
Sbjct: 66  VGRGSFGEVH----------RMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSP 110
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V L G   +     +  E +  GSL   L+ +    L  +R +     A  GLE+LHT
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGC-LPEDRALYYLGQALEGLEYLHT 168
Query: 258 YWRPVIHRDVKASNVLLDDDFN-AKISDFGLA---KFGPLGDKSHISTRVLGTRGYFAPE 313
             R ++H DVKA NVLL  D + A + DFG A   +   LG        + GT  + APE
Sbjct: 169 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 314 YIATGHLTLKTDVYSFGVVLLEILSG 339
            +       K D++S   ++L +L+G
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 40/287 (13%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFA------VAVKRLRRKGSQGQDEWENELRFL 191
           +GQG F  ++ G          RR+  D+       V +K L +      + +      +
Sbjct: 16  LGQGTFTKIFKG---------VRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 192 SRLNHPNVVKLMGYC-CDDQHRLLVYEYVTRGSLEDHL-LNEDDTELNWERRIKIALGAA 249
           S+L+H ++V   G C C D++ +LV E+V  GSL+ +L  N++   + W+  +   L  A
Sbjct: 67  SKLSHKHLVLNYGVCFCGDEN-ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA 125
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-VLGTR- 307
                 +T    +IH +V A N+LL  + + K  +    K    G    +  + +L  R 
Sbjct: 126 MHFLEENT----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181
Query: 308 GYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
            +  PE I    +L L TD +SFG  L EI SG    +   +             KL  +
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS----------QRKLQFY 231
Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  D      +   +A E A +I  C++ +P +RP+   ++  L  L
Sbjct: 232 E--DR---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 26  VGSGAYGSV----------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED------DTELNWERRIKIALGAA 249
           H NV+ L+      +      E      L  HL+  D        +L  +    +     
Sbjct: 76  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQIL 131
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DFGLA+     D+    T  + TR Y
Sbjct: 132 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE---MTGYVATRWY 184
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG+V+            + K   F  AVK++R +  + +     EL   + L+ P
Sbjct: 80  LGRGSFGEVH----------RMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSP 124
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V L G   +     +  E +  GSL   L+ +    L  +R +     A  GLE+LHT
Sbjct: 125 RIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGC-LPEDRALYYLGQALEGLEYLHT 182
Query: 258 YWRPVIHRDVKASNVLLDDDFN-AKISDFGLA---KFGPLGDKSHISTRVLGTRGYFAPE 313
             R ++H DVKA NVLL  D + A + DFG A   +   LG        + GT  + APE
Sbjct: 183 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 240
Query: 314 YIATGHLTLKTDVYSFGVVLLEILSG 339
            +       K D++S   ++L +L+G
Sbjct: 241 VVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G GG G V+    N C          D  VA+K++     Q       E++ + RL+H 
Sbjct: 19  LGCGGNGLVFSAVDNDC----------DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHD 68
Query: 198 NVVKLM-------GYCCDDQHRL--LVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-G 247
           N+VK+            DD   L  L   Y+ +  +E  L N  +     E   ++ +  
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ 128
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDFGLAKFGP--LGDKSHISTRVL 304
             RGL+++H+    V+HRD+K +N+ ++ +D   KI DFGLA+        K H+S  ++
Sbjct: 129 LLRGLKYIHS--ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 305 GTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKT 341
            T+ Y +P  + +  + T   D+++ G +  E+L+GKT
Sbjct: 187 -TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 114/257 (44%), Gaps = 53/257 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW-- 184
              R+ +    +G+G +G+V+ G        + + +N    VAVK      S+ +  W  
Sbjct: 34  TVARQITLLECVGKGRYGEVWRG--------SWQGEN----VAVKIF---SSRDEKSWFR 78
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHR----LLVYEYVTRGSLEDHLLNEDDTELNWER 240
           E EL     L H N++  +      +H      L+  Y   GSL D+L     T L+   
Sbjct: 79  ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVS 135
Query: 241 RIKIALGAARGLEHLH-----TYWRPVI-HRDVKASNVLLDDDFNAKISDFGLAKFGP-- 292
            ++I L  A GL HLH     T  +P I HRD+K+ N+L+  +    I+D GLA      
Sbjct: 136 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 195
Query: 293 -----LGDKSHISTRVLGTRGYFAPEYI-ATGHLTL-----KTDVYSFGVVLLEILSGKT 341
                +G+   +     GT+ Y APE +  T  +       + D+++FG+VL E+     
Sbjct: 196 TNQLDVGNNPRV-----GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV----- 245
Query: 342 AAMRRTNGLAGNWAKPY 358
           A    +NG+  ++  P+
Sbjct: 246 ARRMVSNGIVEDYKPPF 262

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 145 DVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMG 204
           D+ +G  + C     +  N +FAV  K + +      +E E  LR+     HPN++ L  
Sbjct: 29  DIGVGSYSVCKRCIHKATNXEFAV--KIIDKSKRDPTEEIEILLRYG---QHPNIITLKD 83
Query: 205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAARGLEHLHTYWRPVI 263
              D ++  +V E    G L D +L +   +   ER     L    + +E+LH   + V+
Sbjct: 84  VYDDGKYVYVVTELXKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHA--QGVV 138
Query: 264 HRDVKASNVLLDDDF----NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGH 319
           HRD+K SN+L  D+     + +I DFG AK   L  ++ +      T  + APE +    
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLXTPCYTANFVAPEVLERQG 196
Query: 320 LTLKTDVYSFGVVLLEILSGKT 341
                D++S GV+L   L+G T
Sbjct: 197 YDAACDIWSLGVLLYTXLTGYT 218

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 113/257 (43%), Gaps = 53/257 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW-- 184
              R  +    +G+G +G+V+ G        + + +N    VAVK      S+ +  W  
Sbjct: 5   TVARDITLLECVGKGRYGEVWRG--------SWQGEN----VAVKIF---SSRDEKSWFR 49
Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHR----LLVYEYVTRGSLEDHLLNEDDTELNWER 240
           E EL     L H N++  +      +H      L+  Y   GSL D+L     T L+   
Sbjct: 50  ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVS 106
Query: 241 RIKIALGAARGLEHLH-----TYWRPVI-HRDVKASNVLLDDDFNAKISDFGLAKFGP-- 292
            ++I L  A GL HLH     T  +P I HRD+K+ N+L+  +    I+D GLA      
Sbjct: 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 166
Query: 293 -----LGDKSHISTRVLGTRGYFAPEYI-ATGHLTL-----KTDVYSFGVVLLEILSGKT 341
                +G+   +     GT+ Y APE +  T  +       + D+++FG+VL E+     
Sbjct: 167 TNQLDVGNNPRV-----GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV----- 216
Query: 342 AAMRRTNGLAGNWAKPY 358
           A    +NG+  ++  P+
Sbjct: 217 ARRMVSNGIVEDYKPPF 233

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 42/226 (18%)
Query: 127 AATRKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           A   +F     IG G FG V  + ++ +    A +  +    V +K++            
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------L 89
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     K++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIKVADFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 112/277 (40%), Gaps = 40/277 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG               R K ++  VAVK + R G +  +  + E+     L HP
Sbjct: 27  IGSGNFG----------VARLMRDKQSNELVAVKYIER-GEKIDENVKREIINHRSLRHP 75
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAARGL 252
           N+V+         H  +V EY + G L + + N     ED+    +++ I        G+
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GV 128
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNA--KISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            + H     V HRD+K  N LLD       KI  FG +K   L  +       +GT  Y 
Sbjct: 129 SYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ---PKSTVGTPAYI 183
Query: 311 APEYIATGHLTLKT-DVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII 369
           APE +       K  DV+S GV L  +L G  A          N+ K        +H+I+
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG--AYPFEDPEEPKNFRK-------TIHRIL 234
Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           + +      +  + E   +I R   +DP  R ++ E+
Sbjct: 235 NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEI 271

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V       C+    R       VA+K+L R  +          ELR L  + 
Sbjct: 33  VGSGAYGAV-------CSAVDGRTGAK---VAIKKLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 196 HPNVVKLMGYCCDDQ--------HRLLVYEYVTRGSLEDH-LLNEDDTELNWERRIKIAL 246
           H NV+ L+     D+        + ++ +     G L  H  L ED  +        +  
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF-------LVY 135
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              +GL ++H     +IHRD+K  N+ +++D   KI DFGLA+       S +   V+ T
Sbjct: 136 QMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMXGXVV-T 188
Query: 307 RGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
           R Y APE I      T   D++S G ++ E+++GKT
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           ++ +N IG+G +G+V I          A +K      A K++ +   +  D ++ E+  +
Sbjct: 11  YTLENTIGRGSWGEVKI----------AVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAAR 250
             L+HPN+++L     D+    LV E  T G L + ++++    E +  R +K  L A  
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA 120
Query: 251 GLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGL-AKFGPLGDKSHISTRVLGT 306
               L+     V HRD+K  N L      D   K+ DFGL A+F P      + T+V GT
Sbjct: 121 YCHKLN-----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKV-GT 171
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             Y +P+ +  G    + D +S GV++  +L G
Sbjct: 172 PYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 53/246 (21%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW--ENELRFLSRLN 195
           +G+G +G+V+ G        + + +N    VAVK      S+ +  W  E EL     L 
Sbjct: 16  VGKGRYGEVWRG--------SWQGEN----VAVKIF---SSRDEKSWFRETELYNTVMLR 60
Query: 196 HPNVVKLMGYCCDDQHR----LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
           H N++  +      +H      L+  Y   GSL D+L     T L+    ++I L  A G
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASG 117
Query: 252 LEHLH-----TYWRPVI-HRDVKASNVLLDDDFNAKISDFGLAKFGP-------LGDKSH 298
           L HLH     T  +P I HRD+K+ N+L+  +    I+D GLA           +G+   
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 299 ISTRVLGTRGYFAPEYI-ATGHLTL-----KTDVYSFGVVLLEILSGKTAAMRRTNGLAG 352
           +     GT+ Y APE +  T  +       + D+++FG+VL E+     A    +NG+  
Sbjct: 178 V-----GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV-----ARRMVSNGIVE 227
Query: 353 NWAKPY 358
           ++  P+
Sbjct: 228 DYKPPF 233

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           ++ +N IG+G +G+V I          A +K      A K++ +   +  D ++ E+  +
Sbjct: 28  YTLENTIGRGSWGEVKI----------AVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 77
Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAAR 250
             L+HPN+++L     D+    LV E  T G L + ++++    E +  R +K  L A  
Sbjct: 78  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA 137
Query: 251 GLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGL-AKFGPLGDKSHISTRVLGT 306
               L+     V HRD+K  N L      D   K+ DFGL A+F P      + T+V GT
Sbjct: 138 YCHKLN-----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKV-GT 188
Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             Y +P+ +  G    + D +S GV++  +L G
Sbjct: 189 PYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 31/272 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR---KGSQGQDEWENELRFLSRL 194
           +G G FG V  G  ++ +           +VAVK L+       +  D++  E+  +  L
Sbjct: 16  LGDGSFGVVRRGEWDAPS-------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           +H N+++L G       ++ V E    GSL D L  +           + A+  A G+ +
Sbjct: 69  DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR-GYFAPE 313
           L +  +  IHRD+ A N+LL      KI DFGL +  P  D   +          + APE
Sbjct: 127 LES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 184
Query: 314 YIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL 373
            + T   +  +D + FGV L E+    T       GL G+           LH+I  +K 
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMF---TYGQEPWIGLNGS---------QILHKI--DKE 230
Query: 374 GRNIQMEE--AQEFAEIILRCLNSDPKNRPTM 403
           G  +   E   Q+   ++++C    P++RPT 
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 262

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 112/277 (40%), Gaps = 40/277 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG               R K ++  VAVK + R G +  +  + E+     L HP
Sbjct: 27  IGSGNFG----------VARLMRDKQSNELVAVKYIER-GEKIDENVKREIINHRSLRHP 75
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAARGL 252
           N+V+         H  +V EY + G L + + N     ED+    +++ I        G+
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GV 128
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNA--KISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            + H     V HRD+K  N LLD       KI  FG +K   L  +       +GT  Y 
Sbjct: 129 SYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ---PKDTVGTPAYI 183
Query: 311 APEYIATGHLTLKT-DVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII 369
           APE +       K  DV+S GV L  +L G  A          N+ K        +H+I+
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG--AYPFEDPEEPKNFRK-------TIHRIL 234
Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           + +      +  + E   +I R   +DP  R ++ E+
Sbjct: 235 NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEI 271

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 135/308 (43%), Gaps = 56/308 (18%)
Query: 123 GLLEAATRKFSEKNLIGQGGFGDVY--IGYINSCAMTAARRKNADFAVAVKRLRRKGSQG 180
           G+    T +F E   IG G FG V+  +  ++ C              A+KR ++  +  
Sbjct: 4   GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIY------------AIKRSKKPLAGS 51
Query: 181 QDEWENELRFLSRL----NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTEL 236
            DE +N LR +        H +VV+      +D H L+  EY   GSL D  ++E+   +
Sbjct: 52  VDE-QNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLAD-AISENYRIM 109
Query: 237 NW--ERRIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLL-----------DDDFNAKI 282
           ++  E  +K + L   RGL ++H+    ++H D+K SN+ +           + D +   
Sbjct: 110 SYFKEAELKDLLLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167
Query: 283 SDFGLAKFGPLGDKSHISTRVL--GTRGYFAPEYIATGHLTL-KTDVYSFGVVLLEILSG 339
           S+  + K G LG  + IS+  +  G   + A E +   +  L K D+++  + +      
Sbjct: 168 SNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV------ 221
Query: 340 KTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKN 399
                     +    A+P   N    H+I   +L R  Q+  +QEF E++   ++ DP+ 
Sbjct: 222 ----------VCAAGAEPLPRNGDQWHEIRQGRLPRIPQV-LSQEFTELLKVMIHPDPER 270
Query: 400 RPTMSEVV 407
           RP+   +V
Sbjct: 271 RPSAMALV 278

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI  FGLA+           T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILGFGLARH-----TDDEMTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 56/302 (18%)
Query: 129 TRKFSEKNLIGQGGFGDVY--IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN 186
           T +F E   IG G FG V+  +  ++ C              A+KR ++  +   DE +N
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIY------------AIKRSKKPLAGSVDE-QN 52
Query: 187 ELRFLSRL----NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW--ER 240
            LR +        H +VV+      +D H L+  EY   GSL D  ++E+   +++  E 
Sbjct: 53  ALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLAD-AISENYRIMSYFKEA 111
Query: 241 RIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLL-----------DDDFNAKISDFGLA 288
            +K + L   RGL ++H+    ++H D+K SN+ +           + D +   S+  + 
Sbjct: 112 ELKDLLLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 169
Query: 289 KFGPLGDKSHISTRVL--GTRGYFAPEYIATGHLTL-KTDVYSFGVVLLEILSGKTAAMR 345
           K G LG  + IS+  +  G   + A E +   +  L K D+++  + ++           
Sbjct: 170 KIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVXA--------- 220
Query: 346 RTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
                AG  A+P   N    H+I   +L R  Q+  +QEF E++   ++ DP+ RP+   
Sbjct: 221 -----AG--AEPLPRNGDQWHEIRQGRLPRIPQV-LSQEFTELLKVMIHPDPERRPSAMA 272
Query: 406 VV 407
           +V
Sbjct: 273 LV 274

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     QG+     EL+ +
Sbjct: 22  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QGKAFKNRELQIM 67
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLY 127
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 128 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 181
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 182 XICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 220

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 133/302 (44%), Gaps = 56/302 (18%)
Query: 129 TRKFSEKNLIGQGGFGDVY--IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN 186
           T +F E   IG G FG V+  +  ++ C              A+KR ++  +   DE +N
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIY------------AIKRSKKPLAGSVDE-QN 54
Query: 187 ELRFLSRL----NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW--ER 240
            LR +        H +VV+      +D H L+  EY   GSL D  ++E+   +++  E 
Sbjct: 55  ALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLAD-AISENYRIMSYFKEA 113
Query: 241 RIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLL-----------DDDFNAKISDFGLA 288
            +K + L   RGL ++H+    ++H D+K SN+ +           + D +   S+  + 
Sbjct: 114 ELKDLLLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 171
Query: 289 KFGPLGDKSHISTRVL--GTRGYFAPEYIATGHLTL-KTDVYSFGVVLLEILSGKTAAMR 345
           K G LG  + IS+  +  G   + A E +   +  L K D+++  + +            
Sbjct: 172 KIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV------------ 219
Query: 346 RTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
               +    A+P   N    H+I   +L R  Q+  +QEF E++   ++ DP+ RP+   
Sbjct: 220 ----VCAAGAEPLPRNGDQWHEIRQGRLPRIPQV-LSQEFTELLKVMIHPDPERRPSAMA 274
Query: 406 VV 407
           +V
Sbjct: 275 LV 276

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     QG+     EL+ +
Sbjct: 22  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QGKAFKNRELQIM 67
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 128 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 181
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 182 YICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     QG+     EL+ +
Sbjct: 22  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QGKAFKNRELQIM 67
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 128 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 181
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 182 YICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 220

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 133/302 (44%), Gaps = 56/302 (18%)
Query: 129 TRKFSEKNLIGQGGFGDVY--IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN 186
           T +F E   IG G FG V+  +  ++ C              A+KR ++  +   DE +N
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIY------------AIKRSKKPLAGSVDE-QN 54
Query: 187 ELRFLSRL----NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW--ER 240
            LR +        H +VV+      +D H L+  EY   GSL D  ++E+   +++  E 
Sbjct: 55  ALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLAD-AISENYRIMSYFKEA 113
Query: 241 RIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLL-----------DDDFNAKISDFGLA 288
            +K + L   RGL ++H+    ++H D+K SN+ +           + D +   S+  + 
Sbjct: 114 ELKDLLLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 171
Query: 289 KFGPLGDKSHISTRVL--GTRGYFAPEYIATGHLTL-KTDVYSFGVVLLEILSGKTAAMR 345
           K G LG  + IS+  +  G   + A E +   +  L K D+++  + +            
Sbjct: 172 KIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV------------ 219
Query: 346 RTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
               +    A+P   N    H+I   +L R  Q+  +QEF E++   ++ DP+ RP+   
Sbjct: 220 ----VCAAGAEPLPRNGDQWHEIRQGRLPRIPQV-LSQEFTELLKVMIHPDPERRPSAMA 274
Query: 406 VV 407
           +V
Sbjct: 275 LV 276

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 42/226 (18%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 59  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 108
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 109 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 157
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 158 RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 210
Query: 295 DKSHISTRVL-GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            +   +T  L GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 211 -RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI-KI 244
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIGRF 138
Query: 245 ALGAAR--------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
           A   AR          E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 139 AEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 25  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 74
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 75  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 123
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D+    +++DFG AK     
Sbjct: 124 RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDEQGYIQVTDFGFAK----- 176
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 177 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI D GLA+     D+    T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDAGLARHT--DDE---MTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 42/226 (18%)
Query: 127 AATRKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           A   +F     IG G FG V  + ++ +    A +  +    V +K++            
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------L 89
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EY+  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     K++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIKVADFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKI 244
            E+  L RL+HPN++KL           LV E VT G L D ++ +   +E +    +K 
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ 156
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDD---DFNAKISDFGLAKFGPLGDKSHIST 301
            L A   + +LH     ++HRD+K  N+L      D   KI+DFGL+K   + +   +  
Sbjct: 157 ILEA---VAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMK 208
Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            V GT GY APE +       + D++S G++   +L G
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 136
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 39  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 88
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 137
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 138 RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 190
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 191 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI D GLA+     D+    T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDRGLARHT--DDE---MTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 42/226 (18%)
Query: 127 AATRKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           A   +F     IG G FG V  + ++ +    A +  +    V +K++            
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------L 89
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EY+  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     K++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIKVADFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 136
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI D GLA+           T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDGGLARH-----TDDEMTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 136
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 136
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 137 RFXEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 136
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 137 RFXEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 87/210 (41%), Gaps = 31/210 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG G FG               R K     VAVK + R G+   +  + E+     L HP
Sbjct: 28  IGSGNFG----------VARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHP 76
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAARGL 252
           N+V+         H  ++ EY + G L + + N     ED+    +++ +        G+
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-------GV 129
Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNA--KISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            + H+    + HRD+K  N LLD       KI DFG +K   L  +       +GT  Y 
Sbjct: 130 SYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYI 184
Query: 311 APEYIATGHLTLK-TDVYSFGVVLLEILSG 339
           APE +       K  DV+S GV L  +L G
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR--KGSQGQDEWENELRFLSRLN 195
           +G G +G V           AA        VAVK+L R  +          ELR L  + 
Sbjct: 30  VGSGAYGSV----------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------IALGAA 249
           H NV+ L+      +      E      L  HL+  D   +   +++       +     
Sbjct: 80  HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           RGL+++H+    +IHRD+K SN+ +++D   KI DF LA+     D+    T  + TR Y
Sbjct: 136 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFYLARHT--DDE---MTGYVATRWY 188
Query: 310 FAPEYIATG-HLTLKTDVYSFGVVLLEILSGKT 341
            APE +    H     D++S G ++ E+L+G+T
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 136
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 33  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 82
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 83  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 131
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 132 RFXEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 184
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 185 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 136
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 137 RFXEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 136
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 59  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 108
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 109 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 157
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 158 RFXEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 210
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 211 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F  K+L+G+G +G V            A +K   F   +  LR            E++ L
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL---------REIKIL 63
Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAAR 250
               H N++ +      D        Y+ +  ++  L     T++  +  I+  +    R
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR 123
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF---------GPLGDKSHIST 301
            ++ LH     VIHRD+K SN+L++ + + K+ DFGLA+           P G +S + T
Sbjct: 124 AVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-T 180
Query: 302 RVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEIL 337
             + TR Y APE + T    +   DV+S G +L E+ 
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F  K+L+G+G +G V            A +K   F   +  LR            E++ L
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL---------REIKIL 63
Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAAR 250
               H N++ +      D        Y+ +  ++  L     T++  +  I+  +    R
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR 123
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF---------GPLGDKSHIST 301
            ++ LH     VIHRD+K SN+L++ + + K+ DFGLA+           P G +S + T
Sbjct: 124 AVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-T 180
Query: 302 RVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEIL 337
             + TR Y APE + T    +   DV+S G +L E+ 
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 115/278 (41%), Gaps = 30/278 (10%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           +IG+G F       +  C      ++ A   V V +         ++ + E      L H
Sbjct: 31  VIGKGAFS-----VVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL- 255
           P++V+L+     D    +V+E++    L   ++   D    +   +  +    + LE L 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA-SHYMRQILEALR 144
Query: 256 HTYWRPVIHRDVKASNVLLDDDFNA---KISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           + +   +IHRDVK  NVLL    N+   K+ DFG+A    LG+   ++   +GT  + AP
Sbjct: 145 YCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAI--QLGESGLVAGGRVGTPHFMAP 202
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ-IIDE 371
           E +         DV+  GV+L  +LSG                 P+   K  L + II  
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 247
Query: 372 KLGRNI-QMEEAQEFA-EIILRCLNSDPKNRPTMSEVV 407
           K   N  Q     E A +++ R L  DP  R T+ E +
Sbjct: 248 KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 285

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 42/226 (18%)
Query: 127 AATRKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           A   +F     +G G FG V  + ++ +    A +  +    V +K++            
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------L 90
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 139
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 140 XEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 190
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 42/226 (18%)
Query: 127 AATRKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           A   +F     +G G FG V  + ++ +    A +  +    V +K++            
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------L 89
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EY   G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+++D     K++DFGLAK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLMIDQQGYIKVTDFGLAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 139
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 140 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 190
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 42/226 (18%)
Query: 127 AATRKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           A   +F     +G G FG V  + ++ +    A +  +    V +K++            
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------L 90
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 139
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 140 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 190
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 139
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 140 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 190
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 42/222 (18%)
Query: 131 KFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           +F     +G G FG V  + ++ +    A +  +    V +K++            NE R
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------LNEKR 94
Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK------ 243
            L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI       
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRFSEPH 143
Query: 244 ---IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
               A       E+LH+    +I+RD+K  N+L+D     +++DFG AK         + 
Sbjct: 144 ARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVK 193
Query: 301 TR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
            R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 194 GRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 42/226 (18%)
Query: 127 AATRKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           A   +F     +G G FG V  + ++ +    A +  +    V +K++            
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------L 89
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 139 XEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 42/226 (18%)
Query: 127 AATRKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           A   +F     +G G FG V  + ++ +    A +  +    V +K++            
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------L 89
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 139
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 140 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 190
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 42/226 (18%)
Query: 127 AATRKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           A   +F     +G G FG V  + ++ +    A +  +    V +K++            
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------L 89
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 42/226 (18%)
Query: 127 AATRKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           A   +F     +G G FG V  + ++ +    A +  +    V +K++            
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------L 89
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 139 XEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 127 AATRKFSEKNLIGQGGFGDVY-IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           A   +F     +G G FG V  + ++ +    A +  +    V +K++            
Sbjct: 24  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------L 75
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 76  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 124
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK      K
Sbjct: 125 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVK 178
Query: 297 SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               T + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 179 GRTWT-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+++D     +++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLIIDQQGYIQVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G +G VY          A       FA+   RL ++          E+  L  L H 
Sbjct: 10  IGEGTYGVVY---------KAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N+VKL       +  +LV+E++ +      LL+  +  L         L    G+ + H 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI-A 316
             R V+HRD+K  N+L++ +   KI+DFGLA+    G      T  + T  Y AP+ +  
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 317 TGHLTLKTDVYSFGVVLLEILSG 339
           +   +   D++S G +  E+++G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 159
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 160 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 210
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 211 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 83  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 131
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 132 XEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 182
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 183 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F    ++G G +G V++    S   T    K     V  K    + ++  +    E + L
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTG---KLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 192 SRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG-AA 249
             +     +  + Y    + +L L+ +Y+  G L  HL      E   E  ++I +G   
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIV 169
Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
             LEHLH     +I+RD+K  N+LLD + +  ++DFGL+K   + D++  +    GT  Y
Sbjct: 170 LALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEY 226
Query: 310 FAPEYI---ATGHLTLKTDVYSFGVVLLEILSGKT 341
            AP+ +    +GH     D +S GV++ E+L+G +
Sbjct: 227 MAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTGAS 260

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI   
Sbjct: 83  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-----------RRIGRF 131
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     +++DFG AK       
Sbjct: 132 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 182
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 183 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 122/285 (42%), Gaps = 32/285 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V+            R    +FA   K +       ++    E++ +S L HP
Sbjct: 59  LGTGAFGVVH--------RVTERATGNNFAA--KFVMTPHESDKETVRKEIQTMSVLRHP 108
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V L     DD   +++YE+++ G L + + +E + +++ +  ++      +GL H+H 
Sbjct: 109 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHE 167
Query: 258 YWRPVIHRDVKASNVLLDDDFN--AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
                +H D+K  N++     +   K+ DFGL     L  K  +     GT  + APE  
Sbjct: 168 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKV-TTGTAEFAAPEVA 222
Query: 316 ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGR 375
               +   TD++S GV+   +LSG +          G      L N  +    +D+    
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSGLSP-------FGGENDDETLRNVKSCDWNMDDSAFS 275
Query: 376 NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSC 420
            I  E+ ++F   I + L +DP  R T+ +   ALE   L  G+ 
Sbjct: 276 GIS-EDGKDF---IRKLLLADPNTRMTIHQ---ALEHPWLTPGNA 313

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 107/236 (45%), Gaps = 22/236 (9%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           E++ +S L HP +V L     DD   +++YE+++ G L + + +E + +++ +  ++   
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMR 262
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN--AKISDFGLAKFGPLGDKSHISTRVL 304
              +GL H+H      +H D+K  N++     +   K+ DFGL     L  K  +     
Sbjct: 263 QVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKV-TT 317
Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
           GT  + APE      +   TD++S GV+   +LSG +          G      L N  +
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP-------FGGENDDETLRNVKS 370
Query: 365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSC 420
               +D+     I  E+ ++F   I + L +DP  R T+ +   ALE   L  G+ 
Sbjct: 371 CDWNMDDSAFSGIS-EDGKDF---IRKLLLADPNTRMTIHQ---ALEHPWLTPGNA 419

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G +G VY          A       FA+   RL ++          E+  L  L H 
Sbjct: 10  IGEGTYGVVY---------KAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N+VKL       +  +LV+E++ +      LL+  +  L         L    G+ + H 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI-A 316
             R V+HRD+K  N+L++ +   KI+DFGLA+    G      T  + T  Y AP+ +  
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 317 TGHLTLKTDVYSFGVVLLEILSG 339
           +   +   D++S G +  E+++G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 136
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT  Y APE I +       D ++ GV++ ++ +G
Sbjct: 190 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G +G VY          A       FA+   RL ++          E+  L  L H 
Sbjct: 10  IGEGTYGVVY---------KAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N+VKL       +  +LV+E++ +      LL+  +  L         L    G+ + H 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI-A 316
             R V+HRD+K  N+L++ +   KI+DFGLA+    G      T  + T  Y AP+ +  
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 317 TGHLTLKTDVYSFGVVLLEILSG 339
           +   +   D++S G +  E+++G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--ELRFLSRLN 195
           IG G +G V          ++ARR+     VA+K++        +      EL+ L    
Sbjct: 63  IGNGAYGVV----------SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK 112
Query: 196 HPNVVKLMGYCCDDQHRLLVYE-----YVTRGSLED--HLLNEDDTELNWERRIKIALGA 248
           H N++ +     D     + Y      YV    +E   H +      L  E         
Sbjct: 113 HDNIIAIK----DILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQL 168
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK---FGPLGDKSHISTRVLG 305
            RGL+++H+    VIHRD+K SN+L++++   KI DFG+A+     P  +  +  T  + 
Sbjct: 169 LRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP-AEHQYFMTEYVA 225
Query: 306 TRGYFAPEYIATGH-LTLKTDVYSFGVVLLEILS 338
           TR Y APE + + H  T   D++S G +  E+L+
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 56  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 101
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 161
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 162 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 215
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 216 XICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 254

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 86/212 (40%), Gaps = 19/212 (8%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENEL 188
           K+ +   IG+G +G V+            R ++    VA+K+          +     E+
Sbjct: 4   KYEKIGKIGEGSYGVVF----------KCRNRDTGQIVAIKKFLESEDDPVIKKIALREI 53
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
           R L +L HPN+V L+      +   LV+EY     L +    +     +  + I      
Sbjct: 54  RMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A    H H      IHRDVK  N+L+      K+ DFG A+   L   S      + TR 
Sbjct: 114 AVNFCHKHN----CIHRDVKPENILITKHSVIKLCDFGFARL--LTGPSDYYDDEVATRW 167
Query: 309 YFAPE-YIATGHLTLKTDVYSFGVVLLEILSG 339
           Y +PE  +         DV++ G V  E+LSG
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 56  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 101
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 161
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 162 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 215
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 216 YICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 254

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 73/166 (43%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EY   G +  HL           RRI   
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----------RRIGRF 139
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+++D     K++DFG AK       
Sbjct: 140 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLMIDQQGYIKVTDFGFAK------- 190
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSRLNH 196
           +G+G +  VY G          + K  D  VA+K +R +  +G       E+  L  L H
Sbjct: 10  LGEGTYATVYKG----------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 59
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAARGLEHL 255
            N+V L      ++   LV+EY+ +  L+ +L  +D   +     +K+ L    RGL + 
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE-Y 314
           H   + V+HRD+K  N+L+++    K++DFGLA+   +  K++ +  V  T  Y  P+  
Sbjct: 117 HR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDIL 172
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGK 340
           + +   + + D++  G +  E+ +G+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 22  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 67
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 128 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 181
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 182 XICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 220

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 58  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 103
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 104 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 163
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 164 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 217
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 218 YICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 256

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 34  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 79
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 80  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 139
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 140 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 193
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 194 XICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 232

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EY   G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+++D     +++DFGLAK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLMIDQQGYIQVTDFGLAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 73/166 (43%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EY   G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+++D     K++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLMIDQQGYIKVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 73/166 (43%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EY   G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+++D     K++DFG AK       
Sbjct: 139 XEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLMIDQQGYIKVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           F  K+L+G+G +G V            A +K   F   +  LR            E++ L
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL---------REIKIL 63
Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAAR 250
               H N++ +      D        Y+ +  ++  L     T++  +  I+  +    R
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR 123
Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF---------GPLGDKSHIST 301
            ++ LH     VIHRD+K SN+L++ + + K+ DFGLA+           P G +S +  
Sbjct: 124 AVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-V 180
Query: 302 RVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEIL 337
             + TR Y APE + T    +   DV+S G +L E+ 
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 50  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 95
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 96  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 155
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 156 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 209
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 210 YICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 248

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 41  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 86
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 87  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 146
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 147 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 200
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 201 XICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 239

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 23  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 68
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 69  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 128
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 129 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 182
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 183 XICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 22  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 67
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 128 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 181
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 182 XICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 27  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 72
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 73  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 132
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 133 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 186
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 187 YICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 225

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--ELRFLSRLN 195
           IG G +G V          ++ARR+     VA+K++        +      EL+ L    
Sbjct: 62  IGNGAYGVV----------SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK 111
Query: 196 HPNVVKLMGYCCDDQHRLLVYE-----YVTRGSLED--HLLNEDDTELNWERRIKIALGA 248
           H N++ +     D     + Y      YV    +E   H +      L  E         
Sbjct: 112 HDNIIAIK----DILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQL 167
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK---FGPLGDKSHISTRVLG 305
            RGL+++H+    VIHRD+K SN+L++++   KI DFG+A+     P  +  +  T  + 
Sbjct: 168 LRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP-AEHQYFMTEYVA 224
Query: 306 TRGYFAPEYIATGH-LTLKTDVYSFGVVLLEILS 338
           TR Y APE + + H  T   D++S G +  E+L+
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 34  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 79
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 80  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 139
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 140 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 193
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 194 XICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 232

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 60  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 105
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 106 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 165
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 166 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 219
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 220 YICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 258

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 30  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 75
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 76  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 135
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 136 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 189
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 190 XICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 228

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 101 YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 146
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 147 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 206
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 207 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 260
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 261 YICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 299

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 35  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 80
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 81  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 140
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 141 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 194
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 195 YICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 233

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 22  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 67
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 128 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 181
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 182 YICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 26  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 71
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D+ +  LV +YV  T   +  H      T      ++ 
Sbjct: 72  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 131
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 132 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 185
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 186 XICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 224

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 136
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT  Y AP  I +       D ++ GV++ E+ +G
Sbjct: 190 ---RVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 119/289 (41%), Gaps = 57/289 (19%)
Query: 160 RRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-------HPNVVKLMGYCCDDQHR 212
           R +     +AVK++RR G++     E   R L  L+        P +V+  G    +   
Sbjct: 45  RFRKTGHVIAVKQMRRSGNK-----EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99
Query: 213 LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV 272
            +  E +  G+  + L       +      K+ +   + L +L      VIHRDVK SN+
Sbjct: 100 FIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNI 156
Query: 273 LLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLT-----LKTDVY 327
           LLD+    K+ DFG++  G L D      R  G   Y APE I     T     ++ DV+
Sbjct: 157 LLDERGQIKLCDFGIS--GRLVD-DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVW 213
Query: 328 SFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEE------ 381
           S G+ L+E+ +G+                PY + K        E L + +Q E       
Sbjct: 214 SLGISLVELATGQF---------------PYKNCKTDF-----EVLTKVLQEEPPLLPGH 253
Query: 382 ---AQEFAEIILRCLNSDPKNRPTMSEV-----VAALEQLQLNMGSCYQ 422
              + +F   +  CL  D + RP  +++     +   E L++++ S ++
Sbjct: 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFK 302

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P +VKL     D+ +  +V EY   G +  HL           RRI   
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----------RRIGRF 138
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+++D     +++DFG AK       
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLMIDQQGYIQVTDFGFAK------- 189
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 190 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 72/166 (43%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P + KL     D+ +  +V EY   G +  HL           RRI   
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----------RRIGRF 139
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+++D     K++DFG AK       
Sbjct: 140 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLMIDQQGYIKVTDFGFAK------- 190
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 72/166 (43%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P + KL     D+ +  +V EY   G +  HL           RRI   
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----------RRIGRF 139
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+++D     K++DFG AK       
Sbjct: 140 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLMIDQQGYIKVTDFGFAK------- 190
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 72/166 (43%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R L  +N P + KL     D+ +  +V EY   G +  HL           RRI   
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-----------RRIGRF 139
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+++D     K++DFG AK       
Sbjct: 140 XEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLMIDQQGYIKVTDFGFAK------- 190
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 46/228 (20%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           A   +F     +G G FG V +           + K +    A+K L ++      + E 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 186 --NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
             NE R L  +N P +VKL     D+ +  +V EYV  G +  HL           RRI 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIG 136
Query: 244 ---------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                     A       E+LH+    +I+RD+K  N+L+D     +++DFG AK     
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 295 DKSHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
               +  R   + GT    APE I +       D ++ GV++ E+ +G
Sbjct: 190 ---RVKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 19/178 (10%)
Query: 120 FCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ 179
           F    +E    +   + ++ +GGF  VY           A+   +    A+KRL     +
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVY----------EAQDVGSGREYALKRLLSNEEE 67
Query: 180 GQDEWENELRFLSRLN-HPNVVKLMGYCC-------DDQHRLLVYEYVTRGSLEDHLLN- 230
                  E+ F+ +L+ HPN+V+               Q   L+   + +G L + L   
Sbjct: 68  KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM 127
Query: 231 EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA 288
           E    L+ +  +KI     R ++H+H    P+IHRD+K  N+LL +    K+ DFG A
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 72/166 (43%), Gaps = 33/166 (19%)
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-- 243
           NE R    +N P +VKL     D+ +  +V EY   G +  HL           RRI   
Sbjct: 91  NEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHL-----------RRIGRF 139
Query: 244 -------IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
                   A       E+LH+    +I+RD+K  N+L+D     K++DFG AK       
Sbjct: 140 SEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIKVADFGFAK------- 190
Query: 297 SHISTR---VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
             +  R   + GT  Y APE I +       D ++ GV++ E+ +G
Sbjct: 191 -RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 32/220 (14%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++     Q +     EL+ +
Sbjct: 22  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL----QDKRFKNRELQIM 67
Query: 192 SRLNHPNVVKL------MGYCCDDQHRLLVYEYV--TRGSLEDHLLNEDDTELNWERRIK 243
            +L+H N+V+L       G   D  +  LV +YV  T   +  H      T      ++ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHISTR 302
           +     R L ++H++   + HRD+K  N+LLD D    K+ DFG AK    G+    +  
Sbjct: 128 M-YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 181
Query: 303 VLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +R Y APE I  AT + T   DV+S G VL E+L G+
Sbjct: 182 XICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 220

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 31/225 (13%)
Query: 127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE- 185
           +++ +F +   +G G +  VY G            K     VA+K ++    +G      
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGL----------NKTTGVYVALKEVKLDSEEGTPSTAI 51
Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA 245
            E+  +  L H N+V+L      +    LV+E++    L+ ++  +  T  N  R +++ 
Sbjct: 52  REISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYM--DSRTVGNTPRGLELN 108
Query: 246 L------GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKS 297
           L         +GL   H     ++HRD+K  N+L++     K+ DFGLA+ FG P+   +
Sbjct: 109 LVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV---N 163
Query: 298 HISTRVLGTRGYFAPEYIATGHLTLKT--DVYSFGVVLLEILSGK 340
             S+ V+ T  Y AP+ +  G  T  T  D++S G +L E+++GK
Sbjct: 164 TFSSEVV-TLWYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-----------F 290
           + I +  A  +E LH+  + ++HRD+K SN+    D   K+ DFGL              
Sbjct: 167 LHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 291 GPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRT 347
            P+   +    +V GT+ Y +PE I   + + K D++S G++L E+L   +  M R 
Sbjct: 225 TPMPAYATHXGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV 280

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 106/241 (43%), Gaps = 58/241 (24%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD--EWENELRFLS 192
           K+LIG+G +G VY+ Y           KNA+  VA+K++ R      D      E+  L+
Sbjct: 33  KHLIGRGSYGYVYLAY----------DKNANKNVAIKKVNRMFEDLIDCKRILREITILN 82
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELN---------WERRIK 243
           RL    +++L        H L++ E + +      +L   D++L           E+ +K
Sbjct: 83  RLKSDYIIRL--------HDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVK 134
Query: 244 IAL-GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF------------ 290
             L     G + +H     +IHRD+K +N LL+ D + KI DFGLA+             
Sbjct: 135 TILYNLLLGEKFIHE--SGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVND 192
Query: 291 ----------GPLGD--KSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEIL 337
                     GP     K  +++ V+ TR Y APE I    + T   D++S G +  E+L
Sbjct: 193 LEEKEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251
Query: 338 S 338
           +
Sbjct: 252 N 252

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE---WENEL 188
           F    +IG+G FG+V +           + KNAD   A+K L +     + E   +  E 
Sbjct: 76  FEILKVIGRGAFGEVAV----------VKLKNADKVFAMKILNKWEMLKRAETACFREER 125
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA--L 246
             L   +   +  L     DD +  LV +Y   G L   L   +D       R  +A  +
Sbjct: 126 DVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMV 185
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
            A   +  LH      +HRD+K  N+L+D + + +++DFG +    + D +  S+  +GT
Sbjct: 186 IAIDSVHQLH-----YVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGT 239
Query: 307 RGYFAPEYI-----ATGHLTLKTDVYSFGVVLLEILSGKT 341
             Y +PE +       G    + D +S GV + E+L G+T
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 43/232 (18%)
Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD--EWENELRFLS 192
           K+LIG+G +G VY+ Y           KN +  VA+K++ R      D      E+  L+
Sbjct: 31  KHLIGRGSYGYVYLAY----------DKNTEKNVAIKKVNRMFEDLIDCKRILREITILN 80
Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYE--YVTRGSLEDHL--LNEDDTELNWERRIKIALGA 248
           RL    +++L      D   LL ++  Y+     +  L  L +    L  E    I    
Sbjct: 81  RLKSDYIIRLYDLIIPDD--LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF------------------ 290
             G   +H     +IHRD+K +N LL+ D + K+ DFGLA+                   
Sbjct: 139 LLGENFIHE--SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 291 -GPLGD--KSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILS 338
            GP     K  +++ V+ TR Y APE I    + T   D++S G +  E+L+
Sbjct: 197 PGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 108/239 (45%), Gaps = 47/239 (19%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--E 187
           RK+     +G+G +G V+          +  R+  +  VAVK++        D      E
Sbjct: 9   RKYELVKKLGKGAYGIVW---------KSIDRRTGE-VVAVKKIFDAFQNSTDAQRTFRE 58
Query: 188 LRFLSRLN-HPNVVKLMGYCCDDQHR--LLVYEYV---TRGSLEDHLLNEDDTELNWERR 241
           +  L+ L+ H N+V L+     D  R   LV++Y+       +  ++L     +    + 
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL 118
Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG---------- 291
           IK+       +++LH+    ++HRD+K SN+LL+ + + K++DFGL++            
Sbjct: 119 IKV-------IKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 292 PLG---------DKSHISTRVLGTRGYFAPEY-IATGHLTLKTDVYSFGVVLLEILSGK 340
           PL          D   I T  + TR Y APE  + +   T   D++S G +L EIL GK
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH- 196
           +G+G F       +  C    ++    ++A    + RR+G   + E  +E+  L      
Sbjct: 37  LGRGKFA-----VVRQCI---SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC 88
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P V+ L     +    +L+ EY   G +    L E    ++    I++      G+ +LH
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 257 TYWRPVIHRDVKASNVLLDDDF---NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE 313
                ++H D+K  N+LL   +   + KI DFG+++   +G    +   ++GT  Y APE
Sbjct: 149 Q--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--KIGHACELR-EIMGTPEYLAPE 203
Query: 314 YIATGHLTLKTDVYSFGVVLLEILS 338
            +    +T  TD+++ G++   +L+
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           ++   +IG G FG V+   +      A ++   D     KR + +          EL+ +
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNR----------ELQIM 86
Query: 192 SRLNHPNVVKLMGYCC------DDQHRLLVYEYVT----RGSLEDHLLNEDDTELNWERR 241
             + HPNVV L  +        D+    LV EYV     R S     L +    L     
Sbjct: 87  RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML----L 142
Query: 242 IKIAL-GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLAKFGPLGDKSHI 299
           IK+ +    R L ++H+    + HRD+K  N+LLD      K+ DFG AK    G+    
Sbjct: 143 IKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--- 197
Query: 300 STRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGK 340
           +   + +R Y APE I    + T   D++S G V+ E++ G+
Sbjct: 198 NVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 113/278 (40%), Gaps = 30/278 (10%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           +IG+G F       +  C      ++ A   V V +         ++ + E      L H
Sbjct: 33  VIGKGPFS-----VVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL- 255
           P++V+L+     D    +V+E++    L   ++   D    +   +  +    + LE L 
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA-SHYMRQILEALR 146
Query: 256 HTYWRPVIHRDVKASNVLLDDDFNA---KISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           + +   +IHRDVK   VLL    N+   K+  FG+A    LG+   ++   +GT  + AP
Sbjct: 147 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI--QLGESGLVAGGRVGTPHFMAP 204
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ-IIDE 371
           E +         DV+  GV+L  +LSG                 P+   K  L + II  
Sbjct: 205 EVVKREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 249
Query: 372 KLGRNI-QMEEAQEFA-EIILRCLNSDPKNRPTMSEVV 407
           K   N  Q     E A +++ R L  DP  R T+ E +
Sbjct: 250 KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 287

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENE 187
           +K+ +   IG+G +G V+           A+ +     VA+KR+R              E
Sbjct: 2   QKYEKLEKIGEGTYGTVF----------KAKNRETHEIVALKRVRLDDDDEGVPSSALRE 51
Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           +  L  L H N+V+L      D+   LV+E+  +  L+ +  +  + +L+ E        
Sbjct: 52  ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQ 109
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
             +GL   H+  R V+HRD+K  N+L++ +   K++DFGLA+    G      +  + T 
Sbjct: 110 LLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLADFGLAR--AFGIPVRCYSAEVVTL 165
Query: 308 GYFAPEYIATGHL-TLKTDVYSFGVVLLEI 336
            Y  P+ +    L +   D++S G +  E+
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 113/278 (40%), Gaps = 30/278 (10%)
Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
           +IG+G F       +  C      ++ A   V V +         ++ + E      L H
Sbjct: 31  VIGKGPFS-----VVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL- 255
           P++V+L+     D    +V+E++    L   ++   D    +   +  +    + LE L 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA-SHYMRQILEALR 144
Query: 256 HTYWRPVIHRDVKASNVLLDDDFNA---KISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
           + +   +IHRDVK   VLL    N+   K+  FG+A    LG+   ++   +GT  + AP
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI--QLGESGLVAGGRVGTPHFMAP 202
Query: 313 EYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ-IIDE 371
           E +         DV+  GV+L  +LSG                 P+   K  L + II  
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 247
Query: 372 KLGRNI-QMEEAQEFA-EIILRCLNSDPKNRPTMSEVV 407
           K   N  Q     E A +++ R L  DP  R T+ E +
Sbjct: 248 KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 285

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 23/172 (13%)
Query: 180 GQDEWENELRFLSRLNHPNVVKLMG--YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELN 237
           G+   + E++ L RL H NV++L+   Y  + Q   +V EY   G  E  +L+       
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVP---- 102
Query: 238 WERRIKIALGAAR------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-F 290
            E+R  +            GLE+LH+  + ++H+D+K  N+LL      KIS  G+A+  
Sbjct: 103 -EKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
Query: 291 GPLGDKSHISTRVLGTRGYFAPEYIATGHLT---LKTDVYSFGVVLLEILSG 339
            P       + R       F P  IA G  T    K D++S GV L  I +G
Sbjct: 160 HPFAADD--TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 32/271 (11%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG V+      C  T++++         K ++ KG+  Q   + E+  L+   H 
Sbjct: 13  LGRGEFGIVH-----RCVETSSKK-----TYMAKFVKVKGTD-QVLVKKEISILNIARHR 61
Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
           N++ L       +  ++++E+++   + + + N    ELN    +         L+ LH+
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 258 YWRPVIHRDVKASNVLLDD--DFNAKISDFGLAKFGPLGDKSHISTRVLGTR-GYFAPEY 314
           +   + H D++  N++         KI +FG A+    GD    + R+L T   Y+APE 
Sbjct: 121 H--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEV 174
Query: 315 IATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG 374
                ++  TD++S G ++  +LSG    +  TN       +  + N +      DE+  
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAEYTFDEEAF 227
Query: 375 RNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
           + I + EA +F +   R L  + K+R T SE
Sbjct: 228 KEISI-EAMDFVD---RLLVKERKSRMTASE 254

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 18/185 (9%)
Query: 169 AVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH 227
           AVK + ++    +     E+  L +   + N+++L+ +  DD    LV+E +  GS+  H
Sbjct: 42  AVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAH 101
Query: 228 LLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISD 284
           +  +     N     ++    A  L+ LHT  + + HRD+K  N+L +        KI D
Sbjct: 102 I--QKQKHFNEREASRVVRDVAAALDFLHT--KGIAHRDLKPENILCESPEKVSPVKICD 157
Query: 285 FGLAKFGPLGDK-SHISTRVL----GTRGYFAPEYIA--TGHLTL---KTDVYSFGVVLL 334
           F L     L +  + I+T  L    G+  Y APE +   T   T    + D++S GVVL 
Sbjct: 158 FDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLY 217
Query: 335 EILSG 339
            +LSG
Sbjct: 218 IMLSG 222

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 104/246 (42%), Gaps = 51/246 (20%)
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEY-VTRGSLEDHL--LNEDDTELNWERR---IKIALGA 248
           +HPNV++   YC +   R L     +   +L+D +   N  D  L  ++    I +    
Sbjct: 67  DHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLD-------------DDFNAKISDFGLAKFGPLGD 295
           A G+ HLH+    +IHRD+K  N+L+              ++    ISDFGL K    G 
Sbjct: 125 ASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 296 KSHIS--TRVLGTRGYFAPEYIATGH-------LTLKTDVYSFGVVLLEILS-GK----T 341
            S  +      GT G+ APE +   +       LT   D++S G V   ILS GK     
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 342 AAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
              R +N + G ++   L     LH   D  L          E  ++I + ++ DP  RP
Sbjct: 243 KYSRESNIIRGIFS---LDEMKCLH---DRSL--------IAEATDLISQMIDHDPLKRP 288
Query: 402 TMSEVV 407
           T  +V+
Sbjct: 289 TAMKVL 294

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/249 (22%), Positives = 104/249 (41%), Gaps = 37/249 (14%)
Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-- 186
           ++K+S  + +G G FG V+            + KN +  V   +  +K    +D W    
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTA--------VDKEKNKEVVV---KFIKKEKVLEDCWIEDP 71
Query: 187 -------ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRG-----SLEDHLLNEDDT 234
                  E+  LSR+ H N++K++    +     LV E    G      ++ H   ++  
Sbjct: 72  KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL 131
Query: 235 ELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
                R++  A+G  R         + +IHRD+K  N+++ +DF  K+ DFG A +    
Sbjct: 132 ASYIFRQLVSAVGYLR--------LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---L 180
Query: 295 DKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN 353
           ++  +     GT  Y APE +    +   + +++S GV L  ++  +         +   
Sbjct: 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAA 240
Query: 354 WAKPYLSNK 362
              PYL +K
Sbjct: 241 IHPPYLVSK 249

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 82/160 (51%), Gaps = 13/160 (8%)
Query: 182 DEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH-----LLNEDDTEL 236
           D+++NEL+ ++ + +   +   G   +     ++YEY+   S+        +L+++ T  
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 237 NWERRIKIALGAA-RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGD 295
              + IK  + +      ++H   + + HRDVK SN+L+D +   K+SDFG +++  + D
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEY--MVD 204
Query: 296 KSHISTRVLGTRGYFAPEYIA--TGHLTLKTDVYSFGVVL 333
           K    +R  GT  +  PE+ +  + +   K D++S G+ L
Sbjct: 205 KKIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 49/243 (20%)
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEY-VTRGSLEDHL--LNEDDTELNWERR---IKIALGA 248
           +HPNV++   YC +   R L     +   +L+D +   N  D  L  ++    I +    
Sbjct: 85  DHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLD-------------DDFNAKISDFGLAK---FGP 292
           A G+ HLH+    +IHRD+K  N+L+              ++    ISDFGL K    G 
Sbjct: 143 ASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 293 LGDKSHISTRVLGTRGYFAPEYIATG---HLTLKTDVYSFGVVLLEILS-GK----TAAM 344
              + +++    GT G+ APE +       LT   D++S G V   ILS GK        
Sbjct: 201 XXFRXNLNNPS-GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 259
Query: 345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS 404
           R +N + G ++   L     LH   D  L          E  ++I + ++ DP  RPT  
Sbjct: 260 RESNIIRGIFS---LDEMKCLH---DRSL--------IAEATDLISQMIDHDPLKRPTAM 305
Query: 405 EVV 407
           +V+
Sbjct: 306 KVL 308

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 49/243 (20%)
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEY-VTRGSLEDHL--LNEDDTELNWERR---IKIALGA 248
           +HPNV++   YC +   R L     +   +L+D +   N  D  L  ++    I +    
Sbjct: 85  DHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLD-------------DDFNAKISDFGLAK---FGP 292
           A G+ HLH+    +IHRD+K  N+L+              ++    ISDFGL K    G 
Sbjct: 143 ASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 293 LGDKSHISTRVLGTRGYFAPEYIATG---HLTLKTDVYSFGVVLLEILS-GK----TAAM 344
              + +++    GT G+ APE +       LT   D++S G V   ILS GK        
Sbjct: 201 XXFRXNLNNPS-GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 259
Query: 345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS 404
           R +N + G ++   L     LH   D  L          E  ++I + ++ DP  RPT  
Sbjct: 260 RESNIIRGIFS---LDEMKCLH---DRSL--------IAEATDLISQMIDHDPLKRPTAM 305
Query: 405 EVV 407
           +V+
Sbjct: 306 KVL 308

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENE 187
           +K+ +   IG+G +G V+           A+ +     VA+KR+R              E
Sbjct: 2   QKYEKLEKIGEGTYGTVF----------KAKNRETHEIVALKRVRLDDDDEGVPSSALRE 51
Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           +  L  L H N+V+L      D+   LV+E+  +  L+ +  +  + +L+ E        
Sbjct: 52  ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQ 109
Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
             +GL   H+  R V+HRD+K  N+L++ +   K+++FGLA+    G      +  + T 
Sbjct: 110 LLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLAR--AFGIPVRCYSAEVVTL 165
Query: 308 GYFAPEYIATGHL-TLKTDVYSFGVVLLEI 336
            Y  P+ +    L +   D++S G +  E+
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 28/221 (12%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE---WENEL 188
           F    +IG+G FG+V +           + KN +   A+K L +     + E   +  E 
Sbjct: 92  FEIIKVIGRGAFGEVAV----------VKMKNTERIYAMKILNKWEMLKRAETACFREER 141
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA--L 246
             L   +   +  L     D+ H  LV +Y   G L   L   +D       R  I   +
Sbjct: 142 DVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMV 201
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV-LG 305
            A   +  LH      +HRD+K  NVLLD + + +++DFG      + D   + + V +G
Sbjct: 202 LAIDSIHQLH-----YVHRDIKPDNVLLDVNGHIRLADFGSCL--KMNDDGTVQSSVAVG 254
Query: 306 TRGYFAPEYI-----ATGHLTLKTDVYSFGVVLLEILSGKT 341
           T  Y +PE +       G    + D +S GV + E+L G+T
Sbjct: 255 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 295

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 28/221 (12%)
Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE---WENEL 188
           F    +IG+G FG+V +           + KN +   A+K L +     + E   +  E 
Sbjct: 76  FEIIKVIGRGAFGEVAV----------VKMKNTERIYAMKILNKWEMLKRAETACFREER 125
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA--L 246
             L   +   +  L     D+ H  LV +Y   G L   L   +D       R  I   +
Sbjct: 126 DVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMV 185
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV-LG 305
            A   +  LH      +HRD+K  NVLLD + + +++DFG      + D   + + V +G
Sbjct: 186 LAIDSIHQLH-----YVHRDIKPDNVLLDVNGHIRLADFGSCL--KMNDDGTVQSSVAVG 238
Query: 306 TRGYFAPEYI-----ATGHLTLKTDVYSFGVVLLEILSGKT 341
           T  Y +PE +       G    + D +S GV + E+L G+T
Sbjct: 239 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 279

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/83 (37%), Positives = 42/83 (50%), Gaps = 13/83 (15%)
Query: 264 HRDVKASNVLLDDDFNAKISDFGLA------KFGPLGDKSHISTRVLGTRGYFAPEYIAT 317
           HRDVK  N+L+  D  A + DFG+A      K   LG+        +GT  Y APE  + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-------TVGTLYYXAPERFSE 209
Query: 318 GHLTLKTDVYSFGVVLLEILSGK 340
            H T + D+Y+   VL E L+G 
Sbjct: 210 SHATYRADIYALTCVLYECLTGS 232

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 106/247 (42%), Gaps = 53/247 (21%)
Query: 195 NHPNVVKLMGYCCDDQHRLLVYEY-VTRGSLEDHL--LNEDDTELNWERR---IKIALGA 248
           +HPNV++   YC +   R L     +   +L+D +   N  D  L  ++    I +    
Sbjct: 67  DHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLD-------------DDFNAKISDFGLAK---FGP 292
           A G+ HLH+    +IHRD+K  N+L+              ++    ISDFGL K    G 
Sbjct: 125 ASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 293 LGDKSHISTRVLGTRGYFAPEYIATGH-------LTLKTDVYSFGVVLLEILS-GK---- 340
              + +++    GT G+ APE +   +       LT   D++S G V   ILS GK    
Sbjct: 183 XXFRXNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 341 TAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNR 400
               R +N + G ++   L     LH   D  L          E  ++I + ++ DP  R
Sbjct: 242 DKYSRESNIIRGIFS---LDEMKCLH---DRSL--------IAEATDLISQMIDHDPLKR 287
Query: 401 PTMSEVV 407
           PT  +V+
Sbjct: 288 PTAMKVL 294

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 34/201 (16%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NEL 188
           K+ +   IGQG FG+V+           AR +     VA+K++  +  +         E+
Sbjct: 19  KYEKLAKIGQGTFGEVF----------KARHRKTGQKVALKKVLMENEKEGFPITALREI 68
Query: 189 RFLSRLNHPNVVKLMGYC---------CDDQHRLLV--YEYVTRGSLEDHLLNEDDTELN 237
           + L  L H NVV L+  C         C     L+    E+   G L + L+    +E+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI- 127
Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
            +R +++ L    GL ++H     ++HRD+KA+NVL+  D   K++DFGLA+   L   S
Sbjct: 128 -KRVMQMLLN---GLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 298 H---ISTRVLGTRGYFAPEYI 315
                  RV+ T  Y  PE +
Sbjct: 182 QPNRYXNRVV-TLWYRPPELL 201

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 34/201 (16%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NEL 188
           K+ +   IGQG FG+V+           AR +     VA+K++  +  +         E+
Sbjct: 18  KYEKLAKIGQGTFGEVF----------KARHRKTGQKVALKKVLMENEKEGFPITALREI 67
Query: 189 RFLSRLNHPNVVKLMGYC---------CDDQHRLLV--YEYVTRGSLEDHLLNEDDTELN 237
           + L  L H NVV L+  C         C     L+    E+   G L + L+    +E+ 
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI- 126
Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
            +R +++ L    GL ++H     ++HRD+KA+NVL+  D   K++DFGLA+   L   S
Sbjct: 127 -KRVMQMLLN---GLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 298 H---ISTRVLGTRGYFAPEYI 315
                  RV+ T  Y  PE +
Sbjct: 181 QPNRYXNRVV-TLWYRPPELL 200

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 42/238 (17%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD--EWENEL 188
           ++  ++LIG G +G V   Y           K     VA+K++ R      D      E+
Sbjct: 54  RYEIRHLIGTGSYGHVCEAY----------DKLEKRVVAIKKILRVFEDLIDCKRILREI 103
Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW-ERRIKIAL- 246
             L+RLNH +VVK++              YV     +        T +   E  IK  L 
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY 163
Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-------------FGPL 293
               G++++H+    ++HRD+K +N L++ D + K+ DFGLA+               P 
Sbjct: 164 NLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 294 GDKSHIST---------RVLG---TRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILS 338
            D  ++ T         ++ G   TR Y APE I    + T   DV+S G +  E+L+
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 34/201 (16%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NEL 188
           K+ +   IGQG FG+V+           AR +     VA+K++  +  +         E+
Sbjct: 19  KYEKLAKIGQGTFGEVF----------KARHRKTGQKVALKKVLMENEKEGFPITALREI 68
Query: 189 RFLSRLNHPNVVKLMGYC---------CDDQHRLLV--YEYVTRGSLEDHLLNEDDTELN 237
           + L  L H NVV L+  C         C     L+    E+   G L + L+    +E+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI- 127
Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
            +R +++ L    GL ++H     ++HRD+KA+NVL+  D   K++DFGLA+   L   S
Sbjct: 128 -KRVMQMLLN---GLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 298 H---ISTRVLGTRGYFAPEYI 315
                  RV+ T  Y  PE +
Sbjct: 182 QPNRYXNRVV-TLWYRPPELL 201

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 34/201 (16%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NEL 188
           K+ +   IGQG FG+V+           AR +     VA+K++  +  +         E+
Sbjct: 19  KYEKLAKIGQGTFGEVF----------KARHRKTGQKVALKKVLMENEKEGFPITALREI 68
Query: 189 RFLSRLNHPNVVKLMGYC---------CDDQHRLLV--YEYVTRGSLEDHLLNEDDTELN 237
           + L  L H NVV L+  C         C     L+    E+   G L + L+    +E+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI- 127
Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
            +R +++ L    GL ++H     ++HRD+KA+NVL+  D   K++DFGLA+   L   S
Sbjct: 128 -KRVMQMLLN---GLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 298 H---ISTRVLGTRGYFAPEYI 315
                  RV+ T  Y  PE +
Sbjct: 182 QPNRYXNRVV-TLWYRPPELL 201

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 117/286 (40%), Gaps = 52/286 (18%)
Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR- 189
           ++  K  I  GG G +Y+         A  R      V +K L   G           R 
Sbjct: 81  QYEVKGCIAHGGLGWIYL---------ALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQ 131
Query: 190 FLSRLNHPNVVKLMGYC-CDDQH----RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
           FL+ + HP++V++  +    D+H      +V EYV   SL+         +L     I  
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK----RSKGQKLPVAEAIAY 187
Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG-LAKFGPLGDKSHISTRV 303
            L     L +LH+    +++ D+K  N++L ++   K+ D G +++    G        +
Sbjct: 188 LLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG-------YL 237
Query: 304 LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL 363
            GT G+ APE + TG  T+ TD+Y+ G      L+  T  +   NG              
Sbjct: 238 YGTPGFQAPEIVRTGP-TVATDIYTVG----RTLAALTLDLPTRNG-------------- 278
Query: 364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA 409
              + +D     +  ++    +  ++ R ++ DP+ R T +E ++A
Sbjct: 279 ---RYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 86/194 (44%), Gaps = 24/194 (12%)
Query: 187 ELRFLSRLNHPNVVKLMGYCCD--DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
           E+  L  L HPNV+ L        D+   L+++Y        H++         ++ +++
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQL 125
Query: 245 ALGAAR--------GLEHLHTYWRPVIHRDVKASNVLL----DDDFNAKISDFGLAKF-- 290
             G  +        G+ +LH  W  V+HRD+K +N+L+     +    KI+D G A+   
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 291 GPLGDKSHISTRVLGTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
            PL   + +   V+ T  Y APE  +   H T   D+++ G +  E+L+ +     R   
Sbjct: 184 SPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 242
Query: 350 LAGNWAKPYLSNKL 363
           +    + PY  ++L
Sbjct: 243 IKT--SNPYHHDQL 254

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 37/214 (17%)
Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR----RKGSQGQDEWENELRFLSR 193
           +G+G +G+VY           A     +  VA+KR+R     +G  G      E+  L  
Sbjct: 42  LGEGTYGEVY----------KAIDTVTNETVAIKRIRLEHEEEGVPGTAI--REVSLLKE 89
Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL-GAARG 251
           L H N+++L        HRL L++EY     L+ ++    D  +   R IK  L     G
Sbjct: 90  LQHRNIIELKS-VIHHNHRLHLIFEY-AENDLKKYMDKNPDVSM---RVIKSFLYQLING 144
Query: 252 LEHLHTYWRPVIHRDVKASNVLL-----DDDFNAKISDFGLAK-FG-PLGDKSHISTRVL 304
           +   H+  R  +HRD+K  N+LL      +    KI DFGLA+ FG P+   +H     +
Sbjct: 145 VNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH----EI 198
Query: 305 GTRGYFAPE-YIATGHLTLKTDVYSFGVVLLEIL 337
            T  Y  PE  + + H +   D++S   +  E+L
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 73/172 (42%), Gaps = 32/172 (18%)
Query: 214 LVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVK 268
           LV+E +  GS+  H+      NE +  +       +    A  L+ LH   + + HRD+K
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASV-------VVQDVASALDFLHN--KGIAHRDLK 138
Query: 269 ASNVLLDDDFN---AKISDFGLAKFGPL-GDKSHISTRVL----GTRGYFAPEYI----- 315
             N+L +        KI DFGL     L GD S IST  L    G+  Y APE +     
Sbjct: 139 PENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198
Query: 316 ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW----AKPYLSNKL 363
                  + D++S GV+L  +LSG    + R     G W    A P   N L
Sbjct: 199 EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG-WDRGEACPACQNML 249

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 122/304 (40%), Gaps = 74/304 (24%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           E    ++    L+G GGFG VY G           R + +  VA+K + +       E  
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGI----------RVSDNLPVAIKHVEKDRISDWGELP 81
Query: 186 N------ELRFLSRLN--HPNVVKLMGYCCDDQHRLLV----------YEYVT-RGSLED 226
           N      E+  L +++     V++L+ +       +L+          ++++T RG+L++
Sbjct: 82  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE 141
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDF 285
            L         W+      L A R     H +   V+HRD+K  N+L+D +    K+ DF
Sbjct: 142 ELARS----FFWQ-----VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKT-DVYSFGVVLLEILSGKTAAM 344
           G         K  + T   GTR Y  PE+I       ++  V+S G++L +++ G     
Sbjct: 188 GSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI--- 240
Query: 345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPT 402
                       P+  +        +E +G  +   +  + E   +I  CL   P +RPT
Sbjct: 241 ------------PFEHD--------EEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPT 280
Query: 403 MSEV 406
             E+
Sbjct: 281 FEEI 284

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 70/304 (23%), Positives = 122/304 (40%), Gaps = 74/304 (24%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           E    ++    L+G GGFG VY G           R + +  VA+K + +       E  
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGI----------RVSDNLPVAIKHVEKDRISDWGELP 81
Query: 186 N------ELRFLSRLN--HPNVVKLMGYCCDDQHRLLV----------YEYVT-RGSLED 226
           N      E+  L +++     V++L+ +       +L+          ++++T RG+L++
Sbjct: 82  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE 141
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDF 285
            L         W+      L A R   H H     V+HRD+K  N+L+D +    K+ DF
Sbjct: 142 ELARS----FFWQ-----VLEAVR---HCHNC--GVLHRDIKDENILIDLNRGELKLIDF 187
Query: 286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKT-DVYSFGVVLLEILSGKTAAM 344
           G         K  + T   GTR Y  PE+I       ++  V+S G++L +++ G     
Sbjct: 188 GSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI--- 240
Query: 345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPT 402
                       P+  +        +E +G  +   +  + E   +I  CL   P +RPT
Sbjct: 241 ------------PFEHD--------EEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPT 280
Query: 403 MSEV 406
             E+
Sbjct: 281 FEEI 284

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 122/304 (40%), Gaps = 74/304 (24%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           E    ++    L+G GGFG VY G           R + +  VA+K + +       E  
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGI----------RVSDNLPVAIKHVEKDRISDWGELP 82
Query: 186 N------ELRFLSRLN--HPNVVKLMGYCCDDQHRLLV----------YEYVT-RGSLED 226
           N      E+  L +++     V++L+ +       +L+          ++++T RG+L++
Sbjct: 83  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE 142
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDF 285
            L         W+      L A R     H +   V+HRD+K  N+L+D +    K+ DF
Sbjct: 143 ELARS----FFWQ-----VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKT-DVYSFGVVLLEILSGKTAAM 344
           G         K  + T   GTR Y  PE+I       ++  V+S G++L +++ G     
Sbjct: 189 GSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI--- 241
Query: 345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPT 402
                       P+  +        +E +G  +   +  + E   +I  CL   P +RPT
Sbjct: 242 ------------PFEHD--------EEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPT 281
Query: 403 MSEV 406
             E+
Sbjct: 282 FEEI 285

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 122/304 (40%), Gaps = 74/304 (24%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           E    ++    L+G GGFG VY G           R + +  VA+K + +       E  
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGI----------RVSDNLPVAIKHVEKDRISDWGELP 81
Query: 186 N------ELRFLSRLN--HPNVVKLMGYCCDDQHRLLV----------YEYVT-RGSLED 226
           N      E+  L +++     V++L+ +       +L+          ++++T RG+L++
Sbjct: 82  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE 141
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDF 285
            L         W+      L A R     H +   V+HRD+K  N+L+D +    K+ DF
Sbjct: 142 ELARS----FFWQ-----VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKT-DVYSFGVVLLEILSGKTAAM 344
           G         K  + T   GTR Y  PE+I       ++  V+S G++L +++ G     
Sbjct: 188 GSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI--- 240
Query: 345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPT 402
                       P+  +        +E +G  +   +  + E   +I  CL   P +RPT
Sbjct: 241 ------------PFEHD--------EEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPT 280
Query: 403 MSEV 406
             E+
Sbjct: 281 FEEI 284

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 122/304 (40%), Gaps = 74/304 (24%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           E    ++    L+G GGFG VY G           R + +  VA+K + +       E  
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGI----------RVSDNLPVAIKHVEKDRISDWGELP 82
Query: 186 N------ELRFLSRLN--HPNVVKLMGYCCDDQHRLLV----------YEYVT-RGSLED 226
           N      E+  L +++     V++L+ +       +L+          ++++T RG+L++
Sbjct: 83  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE 142
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDF 285
            L         W+      L A R     H +   V+HRD+K  N+L+D +    K+ DF
Sbjct: 143 ELARS----FFWQ-----VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKT-DVYSFGVVLLEILSGKTAAM 344
           G         K  + T   GTR Y  PE+I       ++  V+S G++L +++ G     
Sbjct: 189 GSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI--- 241
Query: 345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPT 402
                       P+  +        +E +G  +   +  + E   +I  CL   P +RPT
Sbjct: 242 ------------PFEHD--------EEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPT 281
Query: 403 MSEV 406
             E+
Sbjct: 282 FEEI 285

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 122/304 (40%), Gaps = 74/304 (24%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           E    ++    L+G GGFG VY G           R + +  VA+K + +       E  
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGI----------RVSDNLPVAIKHVEKDRISDWGELP 82
Query: 186 N------ELRFLSRLN--HPNVVKLMGYCCDDQHRLLV----------YEYVT-RGSLED 226
           N      E+  L +++     V++L+ +       +L+          ++++T RG+L++
Sbjct: 83  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE 142
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDF 285
            L         W+      L A R     H +   V+HRD+K  N+L+D +    K+ DF
Sbjct: 143 ELARS----FFWQ-----VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKT-DVYSFGVVLLEILSGKTAAM 344
           G         K  + T   GTR Y  PE+I       ++  V+S G++L +++ G     
Sbjct: 189 GSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI--- 241
Query: 345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPT 402
                       P+  +        +E +G  +   +  + E   +I  CL   P +RPT
Sbjct: 242 ------------PFEHD--------EEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPT 281
Query: 403 MSEV 406
             E+
Sbjct: 282 FEEI 285

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 70/304 (23%), Positives = 122/304 (40%), Gaps = 74/304 (24%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           E    ++    L+G GGFG VY G           R + +  VA+K + +       E  
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGI----------RVSDNLPVAIKHVEKDRISDWGELP 82
Query: 186 N------ELRFLSRLN--HPNVVKLMGYCCDDQHRLLV----------YEYVT-RGSLED 226
           N      E+  L +++     V++L+ +       +L+          ++++T RG+L++
Sbjct: 83  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE 142
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDF 285
            L         W+      L A R   H H     V+HRD+K  N+L+D +    K+ DF
Sbjct: 143 ELARS----FFWQ-----VLEAVR---HCHNC--GVLHRDIKDENILIDLNRGELKLIDF 188
Query: 286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKT-DVYSFGVVLLEILSGKTAAM 344
           G         K  + T   GTR Y  PE+I       ++  V+S G++L +++ G     
Sbjct: 189 GSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI--- 241
Query: 345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPT 402
                       P+  +        +E +G  +   +  + E   +I  CL   P +RPT
Sbjct: 242 ------------PFEHD--------EEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPT 281
Query: 403 MSEV 406
             E+
Sbjct: 282 FEEI 285

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 19/200 (9%)
Query: 213 LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV 272
           L+V E +  G L   + +  D         +I       +++LH+    + HRDVK  N+
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 154
Query: 273 LLDDDF-NA--KISDFGLAKFGPLGDKSHIS-TRVLGTRGYFAPEYIATGHLTLKTDVYS 328
           L      NA  K++DFG AK       SH S T    T  Y APE +         D++S
Sbjct: 155 LYTSKRPNAILKLTDFGFAK----ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 210
Query: 329 FGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEI 388
            GV++  +L G        +GLA     P +  ++ + Q        N +  E  E  ++
Sbjct: 211 LGVIMYILLCG-YPPFYSNHGLA---ISPGMKTRIRMGQY----EFPNPEWSEVSEEVKM 262
Query: 389 ILR-CLNSDPKNRPTMSEVV 407
           ++R  L ++P  R T++E +
Sbjct: 263 LIRNLLKTEPTQRMTITEFM 282

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 19/200 (9%)
Query: 213 LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV 272
           L+V E +  G L   + +  D         +I       +++LH+    + HRDVK  N+
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 153
Query: 273 LLDDDF-NA--KISDFGLAKFGPLGDKSHIS-TRVLGTRGYFAPEYIATGHLTLKTDVYS 328
           L      NA  K++DFG AK       SH S T    T  Y APE +         D++S
Sbjct: 154 LYTSKRPNAILKLTDFGFAK----ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 209
Query: 329 FGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEI 388
            GV++  +L G        +GLA     P +  ++ + Q        N +  E  E  ++
Sbjct: 210 LGVIMYILLCG-YPPFYSNHGLA---ISPGMKTRIRMGQY----EFPNPEWSEVSEEVKM 261
Query: 389 ILR-CLNSDPKNRPTMSEVV 407
           ++R  L ++P  R T++E +
Sbjct: 262 LIRNLLKTEPTQRMTITEFM 281

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 19/200 (9%)
Query: 213 LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV 272
           L+V E +  G L   + +  D         +I       +++LH+    + HRDVK  N+
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 162
Query: 273 LLDD---DFNAKISDFGLAKFGPLGDKSHIS-TRVLGTRGYFAPEYIATGHLTLKTDVYS 328
           L      +   K++DFG AK       SH S T    T  Y APE +         D++S
Sbjct: 163 LYTSKRPNAILKLTDFGFAK----ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 218
Query: 329 FGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEI 388
            GV++  +L G        +GLA     P +  ++ + Q        N +  E  E  ++
Sbjct: 219 LGVIMYILLCG-YPPFYSNHGLA---ISPGMKTRIRMGQYEFP----NPEWSEVSEEVKM 270
Query: 389 ILR-CLNSDPKNRPTMSEVV 407
           ++R  L ++P  R T++E +
Sbjct: 271 LIRNLLKTEPTQRMTITEFM 290

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 19/200 (9%)
Query: 213 LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV 272
           L+V E +  G L   + +  D         +I       +++LH+    + HRDVK  N+
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 152
Query: 273 LLDDDF-NA--KISDFGLAKFGPLGDKSHIS-TRVLGTRGYFAPEYIATGHLTLKTDVYS 328
           L      NA  K++DFG AK       SH S T    T  Y APE +         D++S
Sbjct: 153 LYTSKRPNAILKLTDFGFAK----ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 208
Query: 329 FGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEI 388
            GV++  +L G        +GLA     P +  ++ + Q        N +  E  E  ++
Sbjct: 209 LGVIMYILLCG-YPPFYSNHGLA---ISPGMKTRIRMGQY----EFPNPEWSEVSEEVKM 260
Query: 389 ILR-CLNSDPKNRPTMSEVV 407
           ++R  L ++P  R T++E +
Sbjct: 261 LIRNLLKTEPTQRMTITEFM 280

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 121/305 (39%), Gaps = 76/305 (24%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           E    ++    L+G GGFG VY G           R + +  VA+K + +       E  
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGI----------RVSDNLPVAIKHVEKDRISDWGELP 81
Query: 186 N------ELRFLSRLN--HPNVVKLMGYCCDDQHRLLV----------YEYVT-RGSLED 226
           N      E+  L +++     V++L+ +       +L+          ++++T RG+L++
Sbjct: 82  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE 141
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDF 285
            L         W+      L A R   H H     V+HRD+K  N+L+D +    K+ DF
Sbjct: 142 ELARS----FFWQ-----VLEAVR---HCHNC--GVLHRDIKDENILIDLNRGELKLIDF 187
Query: 286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKT-DVYSFGVVLLEILSGKTAAM 344
           G         K  + T   GTR Y  PE+I       ++  V+S G++L +++ G     
Sbjct: 188 GSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI--- 240
Query: 345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRN---IQMEEAQEFAEIILRCLNSDPKNRP 401
                       P+           DE++ R     +   + E   +I  CL   P +RP
Sbjct: 241 ------------PFEH---------DEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 279
Query: 402 TMSEV 406
           T  E+
Sbjct: 280 TFEEI 284

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 119/305 (39%), Gaps = 76/305 (24%)
Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE 185
           E    ++    L+G GGFG VY G           R + +  VA+K + +       E  
Sbjct: 19  EPLESQYQVGPLLGSGGFGSVYSGI----------RVSDNLPVAIKHVEKDRISDWGELP 68
Query: 186 N------ELRFLSRLN--HPNVVKLMGYCCDDQHRLLV----------YEYVT-RGSLED 226
           N      E+  L +++     V++L+ +       +L+          ++++T RG+L++
Sbjct: 69  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE 128
Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDF 285
            L         W+      L A R   H H     V+HRD+K  N+L+D +    K+ DF
Sbjct: 129 ELARS----FFWQ-----VLEAVR---HCHNC--GVLHRDIKDENILIDLNRGELKLIDF 174
Query: 286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKT-DVYSFGVVLLEILSGKTAAM 344
           G         K  + T   GTR Y  PE+I       ++  V+S G++L +++ G     
Sbjct: 175 GSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 230
Query: 345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRN---IQMEEAQEFAEIILRCLNSDPKNRP 401
                                    DE++ R     +   + E   +I  CL   P +RP
Sbjct: 231 H------------------------DEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 266
Query: 402 TMSEV 406
           T  E+
Sbjct: 267 TFEEI 271

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 19/200 (9%)
Query: 213 LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV 272
           L+V E +  G L   + +  D         +I       +++LH+    + HRDVK  N+
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 146
Query: 273 LLDD---DFNAKISDFGLAKFGPLGDKSHIS-TRVLGTRGYFAPEYIATGHLTLKTDVYS 328
           L      +   K++DFG AK       SH S T    T  Y APE +         D++S
Sbjct: 147 LYTSKRPNAILKLTDFGFAK----ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWS 202
Query: 329 FGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEI 388
            GV++  +L G        +GLA     P +  ++ + Q        N +  E  E  ++
Sbjct: 203 LGVIMYILLCG-YPPFYSNHGLA---ISPGMKTRIRMGQY----EFPNPEWSEVSEEVKM 254
Query: 389 ILR-CLNSDPKNRPTMSEVV 407
           ++R  L ++P  R T++E +
Sbjct: 255 LIRNLLKTEPTQRMTITEFM 274
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	451
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-146
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-143
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-131
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-86
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-73
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-70
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-69
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-69
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-69
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-69
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-68
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-68
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-66
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-65
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-62
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-62
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-61
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-60
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-52
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-47
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-46
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-46
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-45
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-45
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-45
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-45
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-45
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-45
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-45
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-44
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-44
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-44
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-44
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-44
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-44
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-44
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-44
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-44
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-43
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-43
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-43
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-43
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-43
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-43
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-43
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-43
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-43
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-43
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-43
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-43
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-43
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-43
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-43
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-43
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-43
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-42
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-42
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-42
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-42
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-42
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-42
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-42
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-41
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-41
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-41
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-41
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-40
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-39
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-39
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-39
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-39
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-38
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-38
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-36
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-36
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-36
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-35
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-35
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-35
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-35
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-35
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-34
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-34
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-34
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-33
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-33
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-33
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-33
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-33
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-32
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-32
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-32
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-32
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-31
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-31
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-31
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-30
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-30
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-30
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-30
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-29
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-29
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-29
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-29
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-29
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-28
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-28
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-28
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-28
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-28
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-28
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-28
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-27
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-27
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-27
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-27
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-27
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-26
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-26
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-25
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-25
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-24
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-24
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-23
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-23
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-23
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-23
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-21
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-20
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-19
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-18
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-06

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  417 bits (1075), Expect = e-146
 Identities = 104/312 (33%), Positives = 163/312 (52%), Gaps = 30/312 (9%)

Query: 116 KLKYFCHGLLEAATRKFSEK------NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVA 169
           +   F    L+  T  F E+      N +G+GGFG VY GY+N            +  VA
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN------------NTTVA 58

Query: 170 VKRLR----RKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLE 225
           VK+L         + + +++ E++ +++  H N+V+L+G+  D     LVY Y+  GSL 
Sbjct: 59  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118

Query: 226 DHLLNEDDTE-LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD 284
           D L   D T  L+W  R KIA GAA G+  LH      IHRD+K++N+LLD+ F AKISD
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILLDEAFTAKISD 176

Query: 285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTA-- 342
           FGLA+      ++ +++R++GT  Y APE +  G +T K+D+YSFGVVLLEI++G  A  
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235

Query: 343 AMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT 402
             R    L     +     +  +   ID+K+  +      +    +  +CL+     RP 
Sbjct: 236 EHREPQLLLD-IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPD 293

Query: 403 MSEVVAALEQLQ 414
           + +V   L+++ 
Sbjct: 294 IKKVQQLLQEMT 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  411 bits (1059), Expect = e-143
 Identities = 123/299 (41%), Positives = 177/299 (59%), Gaps = 24/299 (8%)

Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW 184
           LE AT  F  K LIG G FG VY G +                VA+KR   + SQG +E+
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRD-----------GAKVALKRRTPESSQGIEEF 82

Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--NEDDTELNWERRI 242
           E E+  LS   HP++V L+G+C +    +L+Y+Y+  G+L+ HL   +     ++WE+R+
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142

Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
           +I +GAARGL +LHT  R +IHRDVK+ N+LLD++F  KI+DFG++K G   D++H+ST 
Sbjct: 143 EICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200

Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAA-MRRTNG---LAGNWAKPY 358
           V GT GY  PEY   G LT K+DVYSFGVVL E+L  ++A           LA  WA   
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA-EWAVES 259

Query: 359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE---QLQ 414
            +N   L QI+D  L   I+ E  ++F +  ++CL    ++RP+M +V+  LE   +LQ
Sbjct: 260 HNNG-QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  380 bits (979), Expect = e-131
 Identities = 126/321 (39%), Positives = 188/321 (58%), Gaps = 25/321 (7%)

Query: 100 DLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAA 159
           D+PA     D   H  +LK F    L+ A+  FS KN++G+GGFG VY G +    +   
Sbjct: 3   DVPA---EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL--- 56

Query: 160 RRKNADFAVAVKRLRRKGSQGQD-EWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEY 218
                   VAVKRL+ + +QG + +++ E+  +S   H N+++L G+C     RLLVY Y
Sbjct: 57  --------VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108

Query: 219 VTRGSLEDHLLNEDDTE--LNWERRIKIALGAARGLEHLHTYWRP-VIHRDVKASNVLLD 275
           +  GS+   L    +++  L+W +R +IALG+ARGL +LH +  P +IHRDVKA+N+LLD
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168

Query: 276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLE 335
           ++F A + DFGLAK       +H++T V GT G+ APEY++TG  + KTDV+ +GV+LLE
Sbjct: 169 EEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227

Query: 336 ILSGKTAA-MRRTNGLAG----NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIIL 390
           +++G+ A  + R          +W K  L  K  L  ++D  L  N + EE ++  ++ L
Sbjct: 228 LITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVAL 286

Query: 391 RCLNSDPKNRPTMSEVVAALE 411
            C  S P  RP MSEVV  LE
Sbjct: 287 LCTQSSPMERPKMSEVVRMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  265 bits (679), Expect = 4e-86
 Identities = 78/318 (24%), Positives = 124/318 (38%), Gaps = 45/318 (14%)

Query: 124 LLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE 183
            L   +       +  +G FG V+   + +              VAVK       Q +  
Sbjct: 18  NLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY------------VAVKIFP---IQDKQS 62

Query: 184 W--ENELRFLSRLNHPNVVKLMGYC----CDDQHRLLVYEYVTRGSLEDHLLNEDDTELN 237
           W  E E+  L  + H N+++ +G        D    L+  +  +GSL D L       ++
Sbjct: 63  WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVS 119

Query: 238 WERRIKIALGAARGLEHLHTYWR--------PVIHRDVKASNVLLDDDFNAKISDFGLAK 289
           W     IA   ARGL +LH             + HRD+K+ NVLL ++  A I+DFGLA 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179

Query: 290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHL-----TLKTDVYSFGVVLLEILSGKTAA- 343
               G  +  +   +GTR Y APE +           L+ D+Y+ G+VL E+ S  TAA 
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

Query: 344 -MRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNI------QMEEAQEFAEIILRCLNSD 396
                  L          +   + +++  K  R +      +        E I  C + D
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299

Query: 397 PKNRPTMSEVVAALEQLQ 414
            + R +   V   + Q+Q
Sbjct: 300 AEARLSAGCVGERITQMQ 317

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  230 bits (589), Expect = 8e-73
 Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 38/292 (13%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ--DEWENE 187
              + K  IG G FG V+    +               VAVK L  +    +  +E+  E
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEWH------------GSDVAVKILMEQDFHAERVNEFLRE 84

Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIAL 246
           +  + RL HPN+V  MG      +  +V EY++RGSL   L       +L+  RR+ +A 
Sbjct: 85  VAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAY 144

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
             A+G+ +LH    P++HR++K+ N+L+D  +  K+ DFGL++          S    GT
Sbjct: 145 DVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGT 202

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             + APE +       K+DVYSFGV+L E+ + +                P+    L   
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ---------------PW--GNLNPA 245

Query: 367 QIIDEKLGRNIQME----EAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           Q++     +  ++E       + A II  C  ++P  RP+ + ++  L  L 
Sbjct: 246 QVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  222 bits (568), Expect = 4e-70
 Identities = 66/293 (22%), Positives = 124/293 (42%), Gaps = 45/293 (15%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENEL 188
            F  K  + +   G+++ G          R +  D  + VK L+ +   ++   ++  E 
Sbjct: 13  NFLTK--LNENHSGELWKG----------RWQGND--IVVKVLKVRDWSTRKSRDFNEEC 58

Query: 189 RFLSRLNHPNVVKLMGYCCD--DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
             L   +HPNV+ ++G C      H  L+  ++  GSL + L    +  ++  + +K AL
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
             ARG+  LHT    +    + + +V++D+D  A+IS   +         S  S   +  
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYA 171

Query: 307 RGYFAPEYI---ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSN 361
             + APE +            D++SF V+L E+++ +                P+  LSN
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV---------------PFADLSN 216

Query: 362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
                ++  E L   I    +   ++++  C+N DP  RP    +V  LE++Q
Sbjct: 217 MEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  223 bits (570), Expect = 1e-69
 Identities = 69/329 (20%), Positives = 114/329 (34%), Gaps = 56/329 (17%)

Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW 184
                       LIG+G +G VY G ++               VAVK         +  +
Sbjct: 8   PSLDLDNLKLLELIGRGRYGAVYKGSLDERP------------VAVKVFS---FANRQNF 52

Query: 185 ENELR--FLSRLNHPNVVKLMGYCC-----DDQHRLLVYEYVTRGSLEDHLLNEDDTELN 237
            NE     +  + H N+ + +              LLV EY   GSL  +L        +
Sbjct: 53  INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSD 109

Query: 238 WERRIKIALGAARGLEHLHT-------YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF 290
           W    ++A    RGL +LHT       Y   + HRD+ + NVL+ +D    ISDFGL+  
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169

Query: 291 ------GPLGDKSHISTRVLGTRGYFAPEYI-------ATGHLTLKTDVYSFGVVLLEIL 337
                    G++ + +   +GT  Y APE +              + D+Y+ G++  EI 
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

Query: 338 SGKTAAMRRTNG----LAGNWAKPYLSNKLALHQIIDEKLGR-------NIQMEEAQEFA 386
              T      +     +A             +  ++  +  R              +   
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289

Query: 387 EIILRCLNSDPKNRPTMSEVVAALEQLQL 415
           E I  C + D + R T       + +L +
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMM 318

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  221 bits (565), Expect = 2e-69
 Identities = 81/301 (26%), Positives = 133/301 (44%), Gaps = 51/301 (16%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-------E 183
           +   +  IG+GGFG V+ G          R       VA+K L    S+G+        E
Sbjct: 20  EIEYEKQIGKGGFGLVHKG----------RLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69

Query: 184 WENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
           ++ E+  +S LNHPN+VKL G   +     +V E+V  G L   LL++    + W  +++
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH-PIKWSVKLR 126

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLD-----DDFNAKISDFGLAKFGPLGDKSH 298
           + L  A G+E++     P++HRD+++ N+ L          AK++DFGL++        H
Sbjct: 127 LMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVH 181

Query: 299 ISTRVLGTRGYFAPEYIATGHL--TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
             + +LG   + APE I       T K D YSF ++L  IL+G+                
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE---------------G 226

Query: 357 PYLSNKLALHQIIDEKLGRNIQMEEAQ----EFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           P+        + I+      ++    +        +I  C + DPK RP  S +V  L +
Sbjct: 227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286

Query: 413 L 413
           L
Sbjct: 287 L 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  222 bits (567), Expect = 2e-69
 Identities = 73/300 (24%), Positives = 125/300 (41%), Gaps = 37/300 (12%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
             ++G+G FG                 +     + +K L R   + Q  +  E++ +  L
Sbjct: 15  GEVLGKGCFGQAIKV----------THRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPNV+K +G    D+    + EY+  G+L   + +  D++  W +R+  A   A G+ +
Sbjct: 65  EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAY 123

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF------------GPLGDKSHISTR 302
           LH+    +IHRD+ + N L+ ++ N  ++DFGLA+                         
Sbjct: 124 LHS--MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK 362
           V+G   + APE I       K DV+SFG+VL EI+    A               YL   
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA------------DPDYLPRT 229

Query: 363 LALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
           +     +   L R         F  I +RC + DP+ RP+  ++   LE L++++     
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  221 bits (564), Expect = 5e-69
 Identities = 77/308 (25%), Positives = 128/308 (41%), Gaps = 44/308 (14%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           +   + ++G+G FG V             + +  D  VA+K++  +    +  +  ELR 
Sbjct: 9   EIEVEEVVGRGAFGVVCKA----------KWRAKD--VAIKQIESE--SERKAFIVELRQ 54

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT-ELNWERRIKIALGAA 249
           LSR+NHPN+VKL G C       LV EY   GSL + L   +          +   L  +
Sbjct: 55  LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 250 RGLEHLHTY-WRPVIHRDVKASNVLLDDDFN-AKISDFGLAKFGPLGDKSHISTRVLGTR 307
           +G+ +LH+   + +IHRD+K  N+LL       KI DFG A      D     T   G+ 
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSA 167

Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            + APE     + + K DV+S+G++L E+++ +               KP+         
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR---------------KPF-DEIGGPAF 211

Query: 368 IIDEKLGRNIQMEEAQ----EFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQT 423
            I   +    +    +        ++ RC + DP  RP+M E+V  +  L        + 
Sbjct: 212 RIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

Query: 424 SLRTSTHT 431
                 H+
Sbjct: 272 LQYPCQHS 279

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  218 bits (557), Expect = 7e-68
 Identities = 67/323 (20%), Positives = 125/323 (38%), Gaps = 61/323 (18%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ--DEWENELRFLS 192
             LIG+G FG VY G  +               VA++ +  +         ++ E+    
Sbjct: 38  GELIGKGRFGQVYHGRWHG-------------EVAIRLIDIERDNEDQLKAFKREVMAYR 84

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
           +  H NVV  MG C    H  ++       +L   + +     L+  +  +IA    +G+
Sbjct: 85  QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGM 143

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF---GPLGDKSHISTRVLGTRGY 309
            +LH   + ++H+D+K+ NV  D+     I+DFGL         G +        G   +
Sbjct: 144 GYLHA--KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200

Query: 310 FAPEYI---------ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS 360
            APE I              +  +DV++ G +  E+ + +                P+  
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW---------------PF-- 243

Query: 361 NKLALHQIIDEKLGRNIQMEEAQ-----EFAEIILRCLNSDPKNRPTMSEVVAALEQLQL 415
                  II  ++G  ++   +Q     E ++I+L C   + + RPT ++++  LE+L  
Sbjct: 244 KTQPAEAII-WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP- 301

Query: 416 NMGSCYQTSLRTSTHTTRTRSFE 438
                 + + R S      +S E
Sbjct: 302 ------KRNRRLSHPGHFWKSAE 318

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  217 bits (554), Expect = 8e-68
 Identities = 83/290 (28%), Positives = 129/290 (44%), Gaps = 47/290 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           IG G FG VY G  +               VAVK L       Q      NE+  L +  
Sbjct: 32  IGSGSFGTVYKGKWHG-------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           H N++  MG         +V ++    SL  HL   + T+   ++ I IA   ARG+++L
Sbjct: 79  HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYL 136

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
           H   + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + APE I
Sbjct: 137 HA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 316 A---TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK 372
               +   + ++DVY+FG+VL E+++G+                PY SN     QII E 
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQL---------------PY-SNINNRDQII-EM 237

Query: 373 LGRNIQMEEA--------QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           +GR     +         +    ++  CL      RP+   ++A +E+L 
Sbjct: 238 VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  212 bits (542), Expect = 3e-66
 Identities = 77/303 (25%), Positives = 126/303 (41%), Gaps = 56/303 (18%)

Query: 131 KFSE---KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG----SQGQDE 183
            F+E   + +IG GGFG VY                 +  VAVK  R       SQ  + 
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRA----------FWIGDE--VAVKAARHDPDEDISQTIEN 52

Query: 184 WENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
              E +  + L HPN++ L G C  + +  LV E+   G L   L  +    +  +  + 
Sbjct: 53  VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVN 109

Query: 244 IALGAARGLEHLHTY-WRPVIHRDVKASNVLLDDDF--------NAKISDFGLAKFGPLG 294
            A+  ARG+ +LH     P+IHRD+K+SN+L+              KI+DFGLA+     
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---- 165

Query: 295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
                     G   + APE I     +  +DV+S+GV+L E+L+G+              
Sbjct: 166 WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV------------- 212

Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQ----EFAEIILRCLNSDPKNRPTMSEVVAAL 410
             P+    +    +        + +         FA+++  C N DP +RP+ + ++  L
Sbjct: 213 --PF--RGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

Query: 411 EQL 413
             +
Sbjct: 269 TTI 271

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  202 bits (515), Expect = 6e-62
 Identities = 68/310 (21%), Positives = 116/310 (37%), Gaps = 55/310 (17%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW--ENELRFLSR 193
             +G+G +G+V+ G                  VAVK      S+ +  W  E EL     
Sbjct: 14  ECVGKGRYGEVWRGSWQGEN------------VAVKIFS---SRDEKSWFRETELYNTVM 58

Query: 194 LNHPNVVKLMGYCCDDQHR----LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
           L H N++  +      +H      L+  Y   GSL D+L     T L+    ++I L  A
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIA 115

Query: 250 RGLEHLHTYWR------PVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSH--IST 301
            GL HLH           + HRD+K+ N+L+  +    I+D GLA             + 
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 302 RVLGTRGYFAPE------YIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWA 355
             +GT+ Y APE       +       + D+++FG+VL E+     +     NG+  ++ 
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS-----NGIVEDYK 230

Query: 356 KPY---LSNKLALHQIIDEKLGRNI---------QMEEAQEFAEIILRCLNSDPKNRPTM 403
            P+   + N  +   +                          A+++  C   +P  R T 
Sbjct: 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290

Query: 404 SEVVAALEQL 413
             +   L ++
Sbjct: 291 LRIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  201 bits (514), Expect = 3e-61
 Identities = 65/317 (20%), Positives = 120/317 (37%), Gaps = 55/317 (17%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           ++      IG+G +G+V++G                  VAVK      +  +  W  E  
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKWRGEK------------VAVKVFF---TTEEASWFRETE 81

Query: 190 F--LSRLNHPNVVKLMGYCCDDQHR----LLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
                 + H N++  +              L+ +Y   GSL D+L     T L+ +  +K
Sbjct: 82  IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLK 138

Query: 244 IALGAARGLEHLHT------YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
           +A  +  GL HLHT          + HRD+K+ N+L+  +    I+D GLA         
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198

Query: 298 H--ISTRVLGTRGYFAPE----YIATGHL--TLKTDVYSFGVVLLEILSGKTAAMRRTNG 349
                   +GT+ Y  PE     +   H    +  D+YSFG++L E+          + G
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV-----SGG 253

Query: 350 LAGNWAKPY---LSNKLALHQIIDEKLGRNI---------QMEEAQEFAEIILRCLNSDP 397
           +   +  PY   + +  +   + +    + +           E  ++  +++  C   +P
Sbjct: 254 IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313

Query: 398 KNRPTMSEVVAALEQLQ 414
            +R T   V   L ++ 
Sbjct: 314 ASRLTALRVKKTLAKMS 330

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  200 bits (509), Expect = 2e-60
 Identities = 79/315 (25%), Positives = 122/315 (38%), Gaps = 55/315 (17%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW--ENELRFLSR 193
             IG+G FG+V+ G                  VAVK      S+ +  W  E E+     
Sbjct: 48  ESIGKGRFGEVWRGKWRGEE------------VAVKIFS---SREERSWFREAEIYQTVM 92

Query: 194 LNHPNVVKLMGYCCDDQ----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
           L H N++  +     D        LV +Y   GSL D+L   +   +  E  IK+AL  A
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTA 149

Query: 250 RGLEHLHTYWR------PVIHRDVKASNVLLDDDFNAKISDFGLAKF--GPLGDKSHIST 301
            GL HLH           + HRD+K+ N+L+  +    I+D GLA               
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209

Query: 302 RVLGTRGYFAPE----YIATGHL--TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWA 355
             +GT+ Y APE     I   H     + D+Y+ G+V  EI            G+  ++ 
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC-----SIGGIHEDYQ 264

Query: 356 KPY---LSNKLALHQIID----EKL-----GRNIQMEEAQEFAEIILRCLNSDPKNRPTM 403
            PY   + +  ++ ++      +KL      R    E  +  A+I+  C  ++   R T 
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324

Query: 404 SEVVAALEQLQLNMG 418
             +   L QL    G
Sbjct: 325 LRIKKTLSQLSQQEG 339

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  178 bits (455), Expect = 3e-52
 Identities = 78/289 (26%), Positives = 127/289 (43%), Gaps = 49/289 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLNH 196
           IG+G FG+V+ G +          +  +  VAVK  R         ++  E R L + +H
Sbjct: 122 IGRGNFGEVFSGRL----------RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH 171

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           PN+V+L+G C   Q   +V E V  G     L  E    L  +  +++   AA G+E+L 
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLE 230

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF-----A 311
           +  +  IHRD+ A N L+ +    KISDFG+++    G  +       G          A
Sbjct: 231 S--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS-----GGLRQVPVKWTA 283

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALHQII 369
           PE +  G  + ++DV+SFG++L E           + G     A PY  LSN+     + 
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETF---------SLG-----ASPYPNLSNQQTREFV- 328

Query: 370 DEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
            EK GR   +            ++ +C   +P  RP+ S +   L+ ++
Sbjct: 329 -EKGGR---LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  163 bits (415), Expect = 4e-47
 Identities = 74/293 (25%), Positives = 131/293 (44%), Gaps = 28/293 (9%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG V +   +        + N    VAVK+L+    +   ++E E+  L  L H 
Sbjct: 18  LGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 71

Query: 198 NVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           N+VK  G C     R   L+ EY+  GSL D+L    +  ++  + ++      +G+E+L
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL 130

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF----- 310
            T  +  IHRD+   N+L++++   KI DFGL K  P   +           G       
Sbjct: 131 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWY 184

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQII 369
           APE +     ++ +DV+SFGVVL E+ +  + +       +            + +  +I
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ--MIVFHLI 242

Query: 370 DEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG 418
            E L  N ++        E   I+  C N++   RP+  ++   ++Q++ NM 
Sbjct: 243 -ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  162 bits (411), Expect = 2e-46
 Identities = 75/295 (25%), Positives = 127/295 (43%), Gaps = 25/295 (8%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG V +   +          N    VAVK+L+  G   Q +++ E++ L  L+  
Sbjct: 31  LGKGNFGSVELCRYD------PLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSD 84

Query: 198 NVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
            +VK  G       +   LV EY+  G L D L       L+  R +  +    +G+E+L
Sbjct: 85  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYL 143

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF----- 310
            +  R  +HRD+ A N+L++ + + KI+DFGLAK  PL    ++        G       
Sbjct: 144 GS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWY 197

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILS-GKT-AAMRRTNGLAGNWAKPYLSNKLALHQI 368
           APE ++    + ++DV+SFGVVL E+ +      +            +   +    L  +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257

Query: 369 IDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
             E+  R         E  E++  C    P++RP+ S +   L+ L      C  
Sbjct: 258 --EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  161 bits (409), Expect = 5e-46
 Identities = 71/291 (24%), Positives = 130/291 (44%), Gaps = 26/291 (8%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG V +   +        + N    VAVK+L+    +   ++E E+  L  L H 
Sbjct: 49  LGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 102

Query: 198 NVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           N+VK  G C     R   L+ EY+  GSL D+L    +  ++  + ++      +G+E+L
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL 161

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF----- 310
            T  +  IHRD+   N+L++++   KI DFGL K  P   + +         G       
Sbjct: 162 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWY 215

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQ 367
           APE +     ++ +DV+SFGVVL E+ +  + +       +          +     +  
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275

Query: 368 IIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM 417
           +  +  GR  + +    E   I+  C N++   RP+  ++   ++Q++  M
Sbjct: 276 L--KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  158 bits (402), Expect = 2e-45
 Identities = 73/288 (25%), Positives = 139/288 (48%), Gaps = 45/288 (15%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K+ +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  +
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEI 66

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            HPN+V+L+G C  +    ++ E++T G+L D+L   +  E++    + +A   +  +E+
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF---- 310
           L    +  IHRD+ A N L+ ++   K++DFGL++   +   ++ +         F    
Sbjct: 127 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAH----AGAKFPIKW 178

Query: 311 -APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALH 366
            APE +A    ++K+DV++FGV+L EI + G +               PY  +       
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYE 223

Query: 367 QIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            +  EK  R  + E   ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 224 LL--EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  163 bits (415), Expect = 2e-45
 Identities = 72/282 (25%), Positives = 136/282 (48%), Gaps = 35/282 (12%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN 195
           + +G G +G+VY G     ++T          VAVK L+ + +   +E+  E   +  + 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLT----------VAVKTLK-EDTMEVEEFLKEAAVMKEIK 274

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HPN+V+L+G C  +    ++ E++T G+L D+L   +  E++    + +A   +  +E+L
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
               +  IHR++ A N L+ ++   K++DFGL++    GD             + APE +
Sbjct: 335 EK--KNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESL 391

Query: 316 ATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQIIDEK 372
           A    ++K+DV++FGV+L EI + G +               PY  +        +  EK
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELL--EK 434

Query: 373 LGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             R  + E   ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 435 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  159 bits (403), Expect = 2e-45
 Identities = 69/295 (23%), Positives = 127/295 (43%), Gaps = 26/295 (8%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR-KGSQGQDEWENEL 188
           R       +G+G FG V +   +          N    VAVK L+   G     + + E+
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDP------EGDNTGEQVAVKSLKPESGGNHIADLKKEI 74

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
             L  L H N+VK  G C +D      L+ E++  GSL+++L    + ++N ++++K A+
Sbjct: 75  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAV 133

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              +G+++L +  R  +HRD+ A NVL++ +   KI DFGL K      + +        
Sbjct: 134 QICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----D 187

Query: 307 RGYF-----APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
                    APE +      + +DV+SFGV L E+L+   +               +  +
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247

Query: 360 SNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +    ++ +  ++  R         E  +++ +C    P NR +   ++   E L
Sbjct: 248 TVTRLVNTL--KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  159 bits (404), Expect = 3e-45
 Identities = 77/295 (26%), Positives = 131/295 (44%), Gaps = 47/295 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLNH 196
           +GQG FG VY G           +   +  VA+K +    S  +  E+ NE   +   N 
Sbjct: 33  LGQGSFGMVYEGVAKGVV-----KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL--------NEDDTELNWERRIKIALGA 248
            +VV+L+G     Q  L++ E +TRG L+ +L         N      +  + I++A   
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           A G+ +L+      +HRD+ A N ++ +DF  KI DFG+ +     D         G +G
Sbjct: 148 ADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKG 200

Query: 309 YF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LS 360
                  +PE +  G  T  +DV+SFGVVL EI +  +                PY  LS
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---------------PYQGLS 245

Query: 361 NKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           N+  L  +++   G   + +       E++  C   +PK RP+  E+++++++  
Sbjct: 246 NEQVLRFVMEG--GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  158 bits (401), Expect = 7e-45
 Identities = 72/304 (23%), Positives = 128/304 (42%), Gaps = 49/304 (16%)

Query: 126 EAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG 180
           +A  R   E        +G G FG VY G            +     VA+K LR + +  
Sbjct: 6   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIP------EGEKVKIPVAIKELR-EATSP 58

Query: 181 QDEWE--NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW 238
           +   E  +E   ++ +++P+V +L+G  C      L+ + +  G L D++    D  +  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKD-NIGS 116

Query: 239 ERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSH 298
           +  +   +  A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K +
Sbjct: 117 QYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

Query: 299 ISTRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAG 352
            +    G +        A E I     T ++DV+S+GV + E+++ G             
Sbjct: 175 HAE---GGK--VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS------------ 217

Query: 353 NWAKPY--LSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAA 409
              KPY  +        +  EK  R  Q      +   I+ +C   D  +RP   E++  
Sbjct: 218 ---KPYDGIPASEISSIL--EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272

Query: 410 LEQL 413
             ++
Sbjct: 273 FSKM 276

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  157 bits (400), Expect = 9e-45
 Identities = 70/316 (22%), Positives = 126/316 (39%), Gaps = 48/316 (15%)

Query: 119 YFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS 178
           YF   ++    + +     +G+GGF  V +              +     A+KR+     
Sbjct: 18  YFQGHMVIIDNKHYLFIQKLGEGGFSYVDL----------VEGLHDGHFYALKRILCHEQ 67

Query: 179 QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHR----LLVYEYVTRGSLEDHL--LNED 232
           Q ++E + E       NHPN+++L+ YC  ++       L+  +  RG+L + +  L + 
Sbjct: 68  QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK 127

Query: 233 DTELNWERRI-KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG 291
              L  E +I  + LG  RGLE +H   +   HRD+K +N+LL D+    + D G     
Sbjct: 128 GNFLT-EDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184

Query: 292 PLGDKSHISTRVL-------GTRGYFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGKT 341
            +  +       L        T  Y APE  +      +  +TDV+S G VL  ++ G+ 
Sbjct: 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244

Query: 342 AAMRRTNGLAGNWAKPY---LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPK 398
                          PY        ++   +  +L        +    +++   +  DP 
Sbjct: 245 ---------------PYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPH 289

Query: 399 NRPTMSEVVAALEQLQ 414
            RP +  +++ LE LQ
Sbjct: 290 QRPHIPLLLSQLEALQ 305

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  156 bits (397), Expect = 9e-45
 Identities = 83/297 (27%), Positives = 135/297 (45%), Gaps = 53/297 (17%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG+V++GY N               VAVK L+ +GS   D +  E   + +L H 
Sbjct: 21  LGAGQFGEVWMGYYN-----------GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +V+L       +   ++ EY+  GSL D L      +L   + + +A   A G+  +  
Sbjct: 69  RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF-----AP 312
             R  IHRD++A+N+L+ D  + KI+DFGLA+      + +  T   G +  F     AP
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAK--FPIKWTAP 179

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQII 369
           E I  G  T+K+DV+SFG++L EI++ G+                PY  ++N   +  + 
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNL- 223

Query: 370 DEKLGRNIQMEEAQ----EFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
            E+  R   M        E  +++  C    P++RPT   + + LE         YQ
Sbjct: 224 -ERGYR---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 276

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  156 bits (397), Expect = 1e-44
 Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 56/286 (19%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNAD--FAVAVK--RLRRKGSQGQDEWENELRFLS 192
            IG+G F  VY G             + +    VA    + R+     +  ++ E   L 
Sbjct: 33  EIGRGSFKTVYKGL------------DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 80

Query: 193 RLNHPNVVKLMGYCCD---DQHRLLVY-EYVTRGSLEDHL-----LNEDDTELNWERRIK 243
            L HPN+V+           +  +++  E +T G+L+ +L     +       +W R+I 
Sbjct: 81  GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR-SWCRQI- 138

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDFGLAKFGPLGDKSHISTR 302
                 +GL+ LHT   P+IHRD+K  N+ +     + KI D GLA       ++  +  
Sbjct: 139 -----LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKA 189

Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LS 360
           V+GT  + APE     +     DVY+FG+ +LE+ + +                PY    
Sbjct: 190 VIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEY---------------PYSECQ 233

Query: 361 NKLALHQII-DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
           N   +++ +       +       E  EII  C+  +   R ++ +
Sbjct: 234 NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  157 bits (398), Expect = 2e-44
 Identities = 77/291 (26%), Positives = 119/291 (40%), Gaps = 34/291 (11%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR-KGSQGQDEWENELRFLSRLNH 196
           +G+G FG V +   +               VAVK L+   G Q +  W+ E+  L  L H
Sbjct: 39  LGEGHFGKVSLYCYDP------TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH 92

Query: 197 PNVVKLMGYCCDDQHR--LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
            +++K  G C D       LV EYV  GSL D+L       +   + +  A     G+ +
Sbjct: 93  EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAY 149

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF---- 310
           LH   +  IHRD+ A NVLLD+D   KI DFGLAK  P G + +         G      
Sbjct: 150 LHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR----EDGDSPVFW 203

Query: 311 -APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALHQ 367
            APE +        +DV+SFGV L E+L+   ++                 ++       
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263

Query: 368 IIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           +  E+  R   +        E   ++  C  ++   RPT   ++  L+ + 
Sbjct: 264 L--ERGER---LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  160 bits (406), Expect = 2e-44
 Identities = 80/296 (27%), Positives = 138/296 (46%), Gaps = 47/296 (15%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN 195
             +G G FG+V++   N               VAVK ++  GS   + +  E   +  L 
Sbjct: 194 KKLGAGQFGEVWMATYNKHT-----------KVAVKTMK-PGSMSVEAFLAEANVMKTLQ 241

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           H  +VKL       +   ++ E++ +GSL D L +++ ++    + I  +   A G+  +
Sbjct: 242 HDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF----- 310
               R  IHRD++A+N+L+      KI+DFGLA+   + D  +  T   G +  F     
Sbjct: 301 EQ--RNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGAK--FPIKWT 352

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQ 367
           APE I  G  T+K+DV+SFG++L+EI++ G+                PY  +SN   +  
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRI---------------PYPGMSNPEVIRA 397

Query: 368 IIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
           +  E+  R  + E   +E   I++RC  + P+ RPT   + + L+       S Y+
Sbjct: 398 L--ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYE 451

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  156 bits (397), Expect = 3e-44
 Identities = 69/311 (22%), Positives = 130/311 (41%), Gaps = 54/311 (17%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLS 192
             ++G+G FG V             +   +   VAVK L+       D  E   E   + 
Sbjct: 28  GRMLGKGEFGSVREA-------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80

Query: 193 RLNHPNVVKLMGYCCDDQHR------LLVYEYVTRGSLEDHL----LNEDDTELNWERRI 242
             +HP+V KL+G     + +      +++  ++  G L   L    + E+   L  +  +
Sbjct: 81  EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140

Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
           +  +  A G+E+L +  R  IHRD+ A N +L +D    ++DFGL++             
Sbjct: 141 RFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYY 193

Query: 303 VLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAK 356
             G          A E +A    T+ +DV++FGV + EI++ G+T               
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT--------------- 238

Query: 357 PY--LSNKLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           PY  + N    + +I    G  ++      +E  +++ +C ++DPK RP+ + +   LE 
Sbjct: 239 PYAGIENAEIYNYLIG---GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN 295

Query: 413 LQLNMGSCYQT 423
           +  ++     +
Sbjct: 296 ILGHLSVLSTS 306

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  155 bits (393), Expect = 3e-44
 Identities = 75/310 (24%), Positives = 129/310 (41%), Gaps = 49/310 (15%)

Query: 134 EKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFL 191
               +G G FG V  G            +     VA+K L+ +G++  D  E   E + +
Sbjct: 14  ADIELGCGNFGSVRQGVYRM--------RKKQIDVAIKVLK-QGTEKADTEEMMREAQIM 64

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
            +L++P +V+L+G C  +   +LV E    G L   L+ + + E+      ++    + G
Sbjct: 65  HQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMG 122

Query: 252 LEHL--HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +++L    +    +HRD+ A NVLL +   AKISDFGL+K     D  + +     + G 
Sbjct: 123 MKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR----SAGK 174

Query: 310 F-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSN 361
           +     APE I     + ++DV+S+GV + E LS G+               KPY  +  
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ---------------KPYKKMKG 219

Query: 362 KLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSC 420
              +  I  E+  R     E   E   ++  C     ++RP    V   +     ++ S 
Sbjct: 220 PEVMAFI--EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277

Query: 421 YQTSLRTSTH 430
            +       H
Sbjct: 278 VEGHHHHHHH 287

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  155 bits (394), Expect = 4e-44
 Identities = 77/292 (26%), Positives = 125/292 (42%), Gaps = 43/292 (14%)

Query: 134 EKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFL 191
              +IG+G FG VY G           +       A+K L  + ++ Q       E   +
Sbjct: 25  SDRVIGKGHFGVVYHG-------EYIDQAQNRIQCAIKSLS-RITEMQQVEAFLREGLLM 76

Query: 192 SRLNHPNVVKLMGYCCDDQ-HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
             LNHPNV+ L+G     +    ++  Y+  G L   + +        +  I   L  AR
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-NPTVKDLISFGLQVAR 135

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           G+E+L    +  +HRD+ A N +LD+ F  K++DFGLA+   + D+ + S +        
Sbjct: 136 GMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQ-HRHARL 190

Query: 311 -----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNK 362
                A E + T   T K+DV+SFGV+L E+L+ G                 PY  +   
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP---------------PYRHIDPF 235

Query: 363 LALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
              H +   +  R  Q E       +++ +C  +DP  RPT   +V  +EQ+
Sbjct: 236 DLTHFL--AQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  155 bits (393), Expect = 4e-44
 Identities = 68/300 (22%), Positives = 117/300 (39%), Gaps = 64/300 (21%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +GQG F  ++ G            +     V +K L +      + +      +S+L+H 
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHE---TEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL-- 255
           ++V   G C      +LV E+V  GSL+ +L    +  +N   ++++A   A  +  L  
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEE 131

Query: 256 HTYWRPVIHRDVKASNVLLDDDFN--------AKISDFGLAKFGPLGDKSHISTRVLGTR 307
           +T     IH +V A N+LL  + +         K+SD G++               +  +
Sbjct: 132 NTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------------ITVLPK 174

Query: 308 GYF-------APEYIATG-HLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY 358
                      PE I    +L L TD +SFG  L EI S G                KP 
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD---------------KPL 219

Query: 359 --LSNKLALHQIIDEKLGRNIQME--EAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
             L ++  L     E   +   +   +A E A +I  C++ +P +RP+   ++  L  L 
Sbjct: 220 SALDSQRKLQFY--EDRHQ---LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  155 bits (394), Expect = 7e-44
 Identities = 78/301 (25%), Positives = 126/301 (41%), Gaps = 57/301 (18%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G+G FG V++   ++        +     VAVK L+      + +++ E   L+ L H 
Sbjct: 49  LGEGAFGKVFLAECHN-----LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-------------LNEDDTELNWERRIKI 244
           ++V+  G C + +  L+V+EY+  G L   L              +     L   + + +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           A   A G+ +L       +HRD+   N L+      KI DFG+++     D      RV 
Sbjct: 164 ASQVAAGMVYLAG--LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRV- 216

Query: 305 GTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY 358
           G R         PE I     T ++DV+SFGVVL EI + GK                P+
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ---------------PW 261

Query: 359 --LSNKLALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
             LSN  A+  I     GR  ++E       E   I+  C   +P+ R ++ +V A L+ 
Sbjct: 262 YQLSNTEAIDCITQ---GR--ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316

Query: 413 L 413
           L
Sbjct: 317 L 317

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  154 bits (392), Expect = 8e-44
 Identities = 78/291 (26%), Positives = 129/291 (44%), Gaps = 45/291 (15%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRL 194
            +IG+G FG VY G       T           AVK L R    G+  ++  E   +   
Sbjct: 31  EVIGRGHFGCVYHG-------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 83

Query: 195 NHPNVVKLMGYCCDDQH-RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           +HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G++
Sbjct: 84  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMK 142

Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF--- 310
           +L +  +  +HRD+ A N +LD+ F  K++DFGLA+     +       V    G     
Sbjct: 143 YLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPV 196

Query: 311 ---APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLA 364
              A E + T   T K+DV+SFGV+L E+++ G                 PY  ++    
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP---------------PYPDVNTFDI 241

Query: 365 LHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
              ++    GR +   E       E++L+C +   + RP+ SE+V+ +  +
Sbjct: 242 TVYLLQ---GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  154 bits (391), Expect = 1e-43
 Identities = 72/310 (23%), Positives = 123/310 (39%), Gaps = 65/310 (20%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
              F E  ++GQG FG V            AR        A+K++R    +      +E+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVK----------ARNALDSRYYAIKKIRHTEEK-LSTILSEV 53

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-------------LVYEYVTRGSLEDHL-----LN 230
             L+ LNH  VV+      + ++ +             +  EY   G+L D +       
Sbjct: 54  MLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113

Query: 231 EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF 290
           + D      R+I         L ++H+  + +IHRD+K  N+ +D+  N KI DFGLAK 
Sbjct: 114 QRDEYWRLFRQI------LEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165

Query: 291 -------------GPLGDKSHISTRVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEI 336
                           G   ++++ + GT  Y A E +  TGH   K D+YS G++  E+
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

Query: 337 LSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSD 396
           +   +  M R N          +  KL   + +  +   +    + +   +II   ++ D
Sbjct: 225 IYPFSTGMERVN----------ILKKL---RSVSIEFPPDFDDNKMKVEKKIIRLLIDHD 271

Query: 397 PKNRPTMSEV 406
           P  RP    +
Sbjct: 272 PNKRPGARTL 281

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  153 bits (388), Expect = 1e-43
 Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 47/288 (16%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
              IG G FG V++GY  +              VA+K +R +G+  ++++  E   + +L
Sbjct: 13  VQEIGSGQFGLVHLGYWLN-----------KDKVAIKTIR-EGAMSEEDFIEEAEVMMKL 60

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           +HP +V+L G C +     LV E++  G L D+ L         E  + + L    G+ +
Sbjct: 61  SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAY 119

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF---- 310
           L      VIHRD+ A N L+ ++   K+SDFG+ +F          T   GT+  F    
Sbjct: 120 LEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTK--FPVKW 171

Query: 311 -APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALH 366
            +PE  +    + K+DV+SFGV++ E+ S GK                PY   SN   + 
Sbjct: 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI---------------PYENRSNSEVVE 216

Query: 367 QIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            I      R  +   A     +I+  C    P++RP  S ++  L ++
Sbjct: 217 DI--STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  157 bits (400), Expect = 1e-43
 Identities = 75/291 (25%), Positives = 137/291 (47%), Gaps = 37/291 (12%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN 195
             +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L 
Sbjct: 190 VKLGQGCFGEVWMGTWNG-----------TTRVAIKTLK-PGTMSPEAFLQEAQVMKKLR 237

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           H  +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++
Sbjct: 238 HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
                  +HRD++A+N+L+ ++   K++DFGLA+     + +         + + APE  
Sbjct: 297 ER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAA 353

Query: 316 ATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQIIDEK 372
             G  T+K+DV+SFG++L E+ + G+                PY  + N+  L Q+  E+
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQV--ER 396

Query: 373 LGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
             R     E  +   +++ +C   +P+ RPT   + A LE    +    YQ
Sbjct: 397 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 447

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  157 bits (400), Expect = 1e-43
 Identities = 77/289 (26%), Positives = 128/289 (44%), Gaps = 53/289 (18%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
              IG+G FGDV +G                  VAVK +  K       +  E   +++L
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNK------------VAVKCI--KNDATAQAFLAEASVMTQL 243

Query: 195 NHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
            H N+V+L+G   +++  L +V EY+ +GSL D+L +   + L  +  +K +L     +E
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303

Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF--- 310
           +L       +HRD+ A NVL+ +D  AK+SDFGL K          S+     +      
Sbjct: 304 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGK--LPVK 351

Query: 311 --APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLAL 365
             APE +     + K+DV+SFG++L EI S G+                PY  +  K  +
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV---------------PYPRIPLKDVV 396

Query: 366 HQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            ++  EK  +    +       +++  C + D   RPT  ++   LE +
Sbjct: 397 PRV--EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  153 bits (389), Expect = 2e-43
 Identities = 67/288 (23%), Positives = 126/288 (43%), Gaps = 47/288 (16%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
              +G G FG V  G                + VA+K ++ +GS  +DE+  E + +  L
Sbjct: 29  LKELGTGQFGVVKYGKWRG-----------QYDVAIKMIK-EGSMSEDEFIEEAKVMMNL 76

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           +H  +V+L G C   +   ++ EY+  G L ++ L E       ++ +++       +E+
Sbjct: 77  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEY 135

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF---- 310
           L +  +  +HRD+ A N L++D    K+SDFGL+++          T  +G++  F    
Sbjct: 136 LES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSK--FPVRW 187

Query: 311 -APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALH 366
             PE +     + K+D+++FGV++ EI S GK                PY   +N     
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAE 232

Query: 367 QIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            I   +  R  +   A ++   I+  C +     RPT   +++ +  +
Sbjct: 233 HI--AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  154 bits (391), Expect = 2e-43
 Identities = 76/300 (25%), Positives = 125/300 (41%), Gaps = 53/300 (17%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLS 192
             ++G+G FG V  G          +       VAVK ++   S  ++  E  +E   + 
Sbjct: 39  GKILGEGEFGSVMEG-------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91

Query: 193 RLNHPNVVKLMGYCCDDQ-----HRLLVYEYVTRGSLEDHL----LNEDDTELNWERRIK 243
             +HPNV++L+G C +         +++  ++  G L  +L    L      +  +  +K
Sbjct: 92  DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
             +  A G+E+L    R  +HRD+ A N +L DD    ++DFGL+K              
Sbjct: 152 FMVDIALGMEYLSN--RNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYR 204

Query: 304 LGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKP 357
            G          A E +A    T K+DV++FGV + EI + G T               P
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT---------------P 249

Query: 358 Y--LSNKLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           Y  + N      ++    G  ++  E    E  EI+  C  +DP +RPT S +   LE+L
Sbjct: 250 YPGVQNHEMYDYLLH---GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  152 bits (387), Expect = 2e-43
 Identities = 75/285 (26%), Positives = 136/285 (47%), Gaps = 47/285 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           +G G FG V +G                + VAVK ++ +GS  +DE+  E + + +L+HP
Sbjct: 16  LGSGQFGVVKLGKWKG-----------QYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHT 257
            +VK  G C  +    +V EY++ G L ++L +     L   + +++      G+  L +
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLES 122

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF-----AP 312
                IHRD+ A N L+D D   K+SDFG+ ++  + D  ++S+   GT+  F     AP
Sbjct: 123 --HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSV--GTK--FPVKWSAP 174

Query: 313 EYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQII 369
           E       + K+DV++FG+++ E+ S GK                PY   +N   + ++ 
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGK---------------MPYDLYTNSEVVLKV- 218

Query: 370 DEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             +  R  +   A     +I+  C +  P+ RPT  ++++++E L
Sbjct: 219 -SQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  153 bits (390), Expect = 3e-43
 Identities = 71/305 (23%), Positives = 133/305 (43%), Gaps = 54/305 (17%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLS 192
              +G+G FG V +            +      VAVK L+   +  +D  +  +E+  + 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGID---KDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMK 95

Query: 193 RL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--------------LNEDDTELN 237
            +  H N++ L+G C  D    ++ EY ++G+L ++L                  + ++ 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
           ++  +      ARG+E+L +  +  IHRD+ A NVL+ ++   KI+DFGLA+     D +
Sbjct: 156 FKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR-----DIN 208

Query: 298 HISTRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLA 351
           +I      T G       APE +     T ++DV+SFGV++ EI + G +          
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS---------- 258

Query: 352 GNWAKPY--LSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVA 408
                PY  +  +     + +    R  +      E   ++  C ++ P  RPT  ++V 
Sbjct: 259 -----PYPGIPVEELFKLLKEG--HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

Query: 409 ALEQL 413
            L+++
Sbjct: 312 DLDRI 316

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  153 bits (389), Expect = 3e-43
 Identities = 79/301 (26%), Positives = 118/301 (39%), Gaps = 55/301 (18%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+VY G ++           +   VAVK L  +    QDE +   E   +S+ N
Sbjct: 38  LGHGAFGEVYEGQVSGM-----PNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN 91

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDDTELNWERRIKIALGAAR 250
           H N+V+ +G       R ++ E +  G L+  L          + L     + +A   A 
Sbjct: 92  HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLD---DDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
           G ++L       IHRD+ A N LL        AKI DFG+A+     D    S    G  
Sbjct: 152 GCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGC 204

Query: 308 GYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--L 359
                    PE    G  T KTD +SFGV+L EI S G                 PY   
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM---------------PYPSK 249

Query: 360 SNKLALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL 415
           SN+  L  +     G   +M+           I+ +C    P++RP  + ++  +E    
Sbjct: 250 SNQEVLEFVTS---GG--RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304

Query: 416 N 416
           +
Sbjct: 305 D 305

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  152 bits (387), Expect = 4e-43
 Identities = 75/303 (24%), Positives = 124/303 (40%), Gaps = 54/303 (17%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K  +G+G FG V++    +              VAVK L+      + +++ E   L+ L
Sbjct: 20  KRELGEGAFGKVFLAECYNL-----SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--------------LNEDDTELNWER 240
            H ++VK  G C D    ++V+EY+  G L   L                +   EL   +
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
            + IA   A G+ +L +  +  +HRD+   N L+  +   KI DFG+++     D     
Sbjct: 135 MLHIASQIASGMVYLAS--QHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTD 187

Query: 301 TRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNW 354
              +G           PE I     T ++DV+SFGV+L EI + GK              
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ------------- 234

Query: 355 AKPY--LSNKLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAAL 410
             P+  LSN   +  I     GR ++      +E  +++L C   +P+ R  + E+   L
Sbjct: 235 --PWFQLSNTEVIECITQ---GRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289

Query: 411 EQL 413
             L
Sbjct: 290 HAL 292

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  153 bits (389), Expect = 4e-43
 Identities = 71/289 (24%), Positives = 135/289 (46%), Gaps = 46/289 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           IG G FG+VY G + +           +  VA+K L+  G   +   +   E   + + +
Sbjct: 52  IGAGEFGEVYKGMLKT------SSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFS 104

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           H N+++L G     +  +++ EY+  G+L+  L  +D  E +  + + +  G A G+++L
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYL 163

Query: 256 --HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF--- 310
               Y    +HRD+ A N+L++ +   K+SDFGL++   L D    +    G +      
Sbjct: 164 ANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGK--IPIR 215

Query: 311 --APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLAL 365
             APE I+    T  +DV+SFG+V+ E+++ G+               +PY  LSN   +
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE---------------RPYWELSNHEVM 260

Query: 366 HQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             I      R     +      +++++C   +   RP  +++V+ L++L
Sbjct: 261 KAI--NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  154 bits (392), Expect = 4e-43
 Identities = 87/377 (23%), Positives = 151/377 (40%), Gaps = 51/377 (13%)

Query: 57  KHRRRDYRLREWKTS----VFSSSQKEKHSKKYRERTMPESLPVAARDLPAVSFHRDEVF 112
            H    +  R    +    V   S          E +        + +L     +   + 
Sbjct: 8   GHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHID 67

Query: 113 HAY----KLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAV 168
            +      ++   H ++  ++       +IG+G FG VY G       T           
Sbjct: 68  LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHG-------TLLDNDGKKIHC 120

Query: 169 AVKRLRRKGSQGQ-DEWENELRFLSRLNHPNVVKLMGYCCDDQH-RLLVYEYVTRGSLED 226
           AVK L R    G+  ++  E   +   +HPNV+ L+G C   +   L+V  Y+  G L +
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 180

Query: 227 HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG 286
            + NE       +  I   L  A+G++ L +  +  +HRD+ A N +LD+ F  K++DFG
Sbjct: 181 FIRNETH-NPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFG 237

Query: 287 LAKFGPLGDKSHISTRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GK 340
           LA+   + DK   S     T         A E + T   T K+DV+SFGV+L E+++ G 
Sbjct: 238 LARD--MYDKEFDSVHN-KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 294

Query: 341 TAAMRRTNGLAGNWAKPY--LSNKLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSD 396
                           PY  ++       ++    GR +   E       E++L+C +  
Sbjct: 295 P---------------PYPDVNTFDITVYLLQ---GRRLLQPEYCPDPLYEVMLKCWHPK 336

Query: 397 PKNRPTMSEVVAALEQL 413
            + RP+ SE+V+ +  +
Sbjct: 337 AEMRPSFSELVSRISAI 353

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  158 bits (400), Expect = 5e-43
 Identities = 75/291 (25%), Positives = 137/291 (47%), Gaps = 37/291 (12%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN 195
             +GQG FG+V++G  N               VA+K L+  G+   + +  E + + +L 
Sbjct: 273 VKLGQGCFGEVWMGTWNG-----------TTRVAIKTLK-PGTMSPEAFLQEAQVMKKLR 320

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           H  +V+L      ++   +V EY+++GSL D L  E    L   + + +A   A G+ ++
Sbjct: 321 HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
                  +HRD++A+N+L+ ++   K++DFGLA+     + +         + + APE  
Sbjct: 380 ER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAA 436

Query: 316 ATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQIIDEK 372
             G  T+K+DV+SFG++L E+ + G+                PY  + N+  L Q+  E+
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQV--ER 479

Query: 373 LGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
             R     E  +   +++ +C   +P+ RPT   + A LE    +    YQ
Sbjct: 480 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 530

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  152 bits (387), Expect = 6e-43
 Identities = 75/309 (24%), Positives = 130/309 (42%), Gaps = 63/309 (20%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G+G FG V             + +     VAVK L+ + +   +  +  +E   L ++N
Sbjct: 31  LGEGEFGKVVKATAFHL-----KGRAGYTTVAVKMLK-ENASPSELRDLLSEFNVLKQVN 84

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN----------------------EDD 233
           HP+V+KL G C  D   LL+ EY   GSL   L                         D+
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144

Query: 234 TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
             L     I  A   ++G+++L      ++HRD+ A N+L+ +    KISDFGL++    
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAE--MKLVHRDLAARNILVAEGRKMKISDFGLSR---- 198

Query: 294 GDKSHISTRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRT 347
            D     + V  ++G       A E +     T ++DV+SFGV+L EI++ G        
Sbjct: 199 -DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN------ 251

Query: 348 NGLAGNWAKPY--LSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMS 404
                    PY  +  +   + +      R  + +   +E   ++L+C   +P  RP  +
Sbjct: 252 ---------PYPGIPPERLFNLLKTG--HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300

Query: 405 EVVAALEQL 413
           ++   LE++
Sbjct: 301 DISKDLEKM 309

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  151 bits (384), Expect = 7e-43
 Identities = 77/289 (26%), Positives = 128/289 (44%), Gaps = 53/289 (18%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
              IG+G FGDV +G                  VAVK +  K       +  E   +++L
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNK------------VAVKCI--KNDATAQAFLAEASVMTQL 71

Query: 195 NHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
            H N+V+L+G   +++  L +V EY+ +GSL D+L +   + L  +  +K +L     +E
Sbjct: 72  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131

Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF--- 310
           +L       +HRD+ A NVL+ +D  AK+SDFGL K          S+     +      
Sbjct: 132 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGK--LPVK 179

Query: 311 --APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLAL 365
             APE +     + K+DV+SFG++L EI S G+                PY  +  K  +
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV---------------PYPRIPLKDVV 224

Query: 366 HQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            ++  EK  +    +       E++  C + D   RP+  ++   LE +
Sbjct: 225 PRV--EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  154 bits (390), Expect = 7e-43
 Identities = 83/403 (20%), Positives = 155/403 (38%), Gaps = 68/403 (16%)

Query: 36  STVEEKRTPSDSSKAVQENRRKHRRRDYRLREWKTSVFSSSQKEKHSKKYRERTMPESLP 95
           S+        D     +  +R   RR   +    +S  +S+            T    + 
Sbjct: 3   SSHHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPML 62

Query: 96  VAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCA 155
               +       + E     KL                    +G+G FG V +       
Sbjct: 63  AGVSEYELPEDPKWEFPRD-KLTL---------------GKPLGEGCFGQVVMAEAVGID 106

Query: 156 MTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRL-NHPNVVKLMGYCCDDQHR 212
                +      VAVK L+   +  +D  +  +E+  +  +  H N++ L+G C  D   
Sbjct: 107 KD---KPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162

Query: 213 LLVYEYVTRGSLEDHLLN--------------EDDTELNWERRIKIALGAARGLEHLHTY 258
            ++ EY ++G+L ++L                  + ++ ++  +      ARG+E+L + 
Sbjct: 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS- 221

Query: 259 WRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF-----APE 313
            +  IHRD+ A NVL+ ++   KI+DFGLA+     D ++I      T G       APE
Sbjct: 222 -QKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDYYKKTTNGRLPVKWMAPE 275

Query: 314 YIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALHQIIDE 371
            +     T ++DV+SFGV++ EI +           L G+   PY  +  +     + + 
Sbjct: 276 ALFDRVYTHQSDVWSFGVLMWEIFT-----------LGGS---PYPGIPVEELFKLLKEG 321

Query: 372 KLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
              R  +      E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 322 --HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  151 bits (383), Expect = 9e-43
 Identities = 71/298 (23%), Positives = 126/298 (42%), Gaps = 50/298 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G+G FG+VY G   +        K     VAVK  + K     ++ +  +E   +  L+
Sbjct: 20  LGEGFFGEVYEGVYTN-------HKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMKNLD 71

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HP++VKL+G   +++   ++ E    G L  +L    +  L     +  +L   + + +L
Sbjct: 72  HPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYL 129

Query: 256 --HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF--- 310
                    +HRD+   N+L+      K+ DFGL+++  + D+ +       TR      
Sbjct: 130 ESINC----VHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS--VTR--LPIK 179

Query: 311 --APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLAL 365
             +PE I     T  +DV+ F V + EILS GK               +P+  L NK  +
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGK---------------QPFFWLENKDVI 224

Query: 366 HQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
             +  EK  R  + +        ++ RC + DP +RP  +E+V +L  +         
Sbjct: 225 GVL--EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 280

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  154 bits (390), Expect = 1e-42
 Identities = 78/304 (25%), Positives = 137/304 (45%), Gaps = 52/304 (17%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLS 192
              +G+G FG V +            + N    VAVK L+   +  +D  +  +E+  + 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLD---KDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMK 129

Query: 193 RL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--------------LNEDDTELN 237
            +  H N++ L+G C  D    ++ EY ++G+L ++L               +  + +L+
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189

Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
            +  +  A   ARG+E+L +  +  IHRD+ A NVL+ +D   KI+DFGLA+     D  
Sbjct: 190 SKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIH 242

Query: 298 HISTRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG 352
           HI      T G       APE +     T ++DV+SFGV+L EI +           L G
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-----------LGG 291

Query: 353 NWAKPY--LSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAA 409
           +   PY  +  +     +  ++  R  +      E   ++  C ++ P  RPT  ++V  
Sbjct: 292 S---PYPGVPVEELFKLL--KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346

Query: 410 LEQL 413
           L+++
Sbjct: 347 LDRI 350

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  152 bits (386), Expect = 1e-42
 Identities = 75/286 (26%), Positives = 132/286 (46%), Gaps = 41/286 (14%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLNH 196
           IG G  G+V  G +             D  VA+K L+   ++ Q  ++ +E   + + +H
Sbjct: 57  IGSGDSGEVCYGRLRV-------PGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH 109

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           PN+++L G     +  ++V EY+  GSL+  L   D  +    + + +  G   G+ +L 
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLS 168

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF-----A 311
                 +HRD+ A NVL+D +   K+SDFGL++   L D    +    G +        A
Sbjct: 169 D--LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGK--IPIRWTA 222

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQI 368
           PE IA    +  +DV+SFGVV+ E+L+ G+               +PY  ++N+  +  +
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGE---------------RPYWNMTNRDVISSV 267

Query: 369 IDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             E+  R            +++L C + D   RP  S++V+ L+ L
Sbjct: 268 --EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  152 bits (387), Expect = 2e-42
 Identities = 87/378 (23%), Positives = 134/378 (35%), Gaps = 65/378 (17%)

Query: 71  SVFSSSQKEKHSKKYRERTMPESLPVAARDLPAVSFHR---DEVFHAYKLKYFCHGLLEA 127
           S +       +     E    +    +    P     +     +   Y   Y   G   +
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSS 61

Query: 128 ATRK--FSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG 180
            +       KN+     +G G FG+VY G ++           +   VAVK L  +    
Sbjct: 62  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM-----PNDPSPLQVAVKTLP-EVCSE 115

Query: 181 QDEWE--NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN-----EDD 233
           QDE +   E   +S+ NH N+V+ +G       R ++ E +  G L+  L          
Sbjct: 116 QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 175

Query: 234 TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD---DDFNAKISDFGLAKF 290
           + L     + +A   A G ++L       IHRD+ A N LL        AKI DFG+A+ 
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 232

Query: 291 GPLGDKSHISTRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAM 344
               D         G           PE    G  T KTD +SFGV+L EI S G     
Sbjct: 233 ----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM--- 285

Query: 345 RRTNGLAGNWAKPY--LSNKLALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPK 398
                       PY   SN+  L  +     GR   M+           I+ +C    P+
Sbjct: 286 ------------PYPSKSNQEVLEFVTSG--GR---MDPPKNCPGPVYRIMTQCWQHQPE 328

Query: 399 NRPTMSEVVAALEQLQLN 416
           +RP  + ++  +E    +
Sbjct: 329 DRPNFAIILERIEYCTQD 346

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  151 bits (384), Expect = 2e-42
 Identities = 79/304 (25%), Positives = 127/304 (41%), Gaps = 57/304 (18%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRL-N 195
           +G G FG V              + +A   VAVK L+       ++   +EL+ LS L N
Sbjct: 31  LGAGAFGKVVEATAYGL-----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL----------------LNEDDTELNWE 239
           H N+V L+G C      L++ EY   G L + L                + +D+  L+ E
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
             +  +   A+G+  L +  +  IHRD+ A N+LL      KI DFGLA+     D  + 
Sbjct: 146 DLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLAR-----DIKND 198

Query: 300 STRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGN 353
           S  V+           APE I     T ++DV+S+G+ L E+ S G +            
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------ 246

Query: 354 WAKPYLSNKLALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAA 409
              PY    + +     + +    +M        E  +I+  C ++DP  RPT  ++V  
Sbjct: 247 ---PYPG--MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 410 LEQL 413
           +E+ 
Sbjct: 302 IEKQ 305

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  150 bits (382), Expect = 5e-42
 Identities = 79/303 (26%), Positives = 127/303 (41%), Gaps = 53/303 (17%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLS 192
              +G G FG V              +++A   VAVK L+   +   ++    +EL+ +S
Sbjct: 51  GKTLGAGAFGKVVEATA-----FGLGKEDAVLKVAVKMLK-STAHADEKEALMSELKIMS 104

Query: 193 RL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL------------LNEDDTELNWE 239
            L  H N+V L+G C      L++ EY   G L + L                ++  +  
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164

Query: 240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
             +  +   A+G+  L +  +  IHRDV A NVLL +   AKI DFGLA+     D  + 
Sbjct: 165 DLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMND 217

Query: 300 STRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
           S  ++           APE I     T+++DV+S+G++L EI S           L  N 
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-----------LGLN- 265

Query: 355 AKPY---LSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAAL 410
             PY   L N      + D    +  Q   A +    I+  C   +P +RPT  ++ + L
Sbjct: 266 --PYPGILVNSKFYKLVKDG--YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

Query: 411 EQL 413
           ++ 
Sbjct: 322 QEQ 324

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  150 bits (381), Expect = 6e-42
 Identities = 75/305 (24%), Positives = 135/305 (44%), Gaps = 62/305 (20%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLS 192
           +++IG+G FG V    I         +       A+KR++ + +   D  +   EL  L 
Sbjct: 30  QDVIGEGNFGQVLKARIK--------KDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 80

Query: 193 RL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--------------LNEDDTELN 237
           +L +HPN++ L+G C    +  L  EY   G+L D L               N   + L+
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
            ++ +  A   ARG+++L    +  IHRD+ A N+L+ +++ AKI+DFGL++        
Sbjct: 141 SQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQ------ 192

Query: 298 HISTRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLA 351
                V  T G       A E +     T  +DV+S+GV+L EI+S G T          
Sbjct: 193 --EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------- 240

Query: 352 GNWAKPY--LSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVA 408
                PY  ++      ++   +  R  +      E  +++ +C    P  RP+ ++++ 
Sbjct: 241 -----PYCGMTCAELYEKL--PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293

Query: 409 ALEQL 413
           +L ++
Sbjct: 294 SLNRM 298

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  149 bits (378), Expect = 6e-42
 Identities = 75/307 (24%), Positives = 121/307 (39%), Gaps = 59/307 (19%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSR 193
              +G+  FG VY G++   A           AVA+K L+ K     ++E+ +E    +R
Sbjct: 14  MEELGEDRFGKVYKGHLFGPA-----PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--------------LNEDDTELNWE 239
           L HPNVV L+G    DQ   +++ Y + G L + L                   + L   
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
             + +    A G+E+L +    V+H+D+   NVL+ D  N KISD GL +     +    
Sbjct: 129 DFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAA 181

Query: 300 STRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGN 353
               L           APE I  G  ++ +D++S+GVVL E+ S G              
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ------------ 229

Query: 354 WAKPY--LSNKLALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVV 407
              PY   SN+  +  I +        +            +++ C N  P  RP   ++ 
Sbjct: 230 ---PYCGYSNQDVVEMIRNR--QV---LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIH 281

Query: 408 AALEQLQ 414
           + L    
Sbjct: 282 SRLRAWG 288

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  150 bits (381), Expect = 1e-41
 Identities = 73/287 (25%), Positives = 134/287 (46%), Gaps = 43/287 (14%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG+V  G +             + +VA+K L+  G   +   +   E   + + +
Sbjct: 53  VGAGEFGEVCSGRLKL-------PSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFD 104

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HPN+++L G     +  ++V EY+  GSL D  L + D +    + + +  G A G+++L
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF----- 310
                  +HRD+ A N+L++ +   K+SDFGL +   L D    +    G +        
Sbjct: 164 SD--MGYVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGK--IPIRWT 217

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQ 367
           +PE IA    T  +DV+S+G+VL E++S G+               +PY  +SN+  +  
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE---------------RPYWEMSNQDVIKA 262

Query: 368 IIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  ++  R     +      +++L C   D  NRP   ++V+ L++L
Sbjct: 263 V--DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  147 bits (374), Expect = 2e-41
 Identities = 65/293 (22%), Positives = 123/293 (41%), Gaps = 54/293 (18%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
             F E  LIG GGFG V+           A+ +       +KR++       ++ E E++
Sbjct: 11  MDFKEIELIGSGGFGQVFK----------AKHRIDGKTYVIKRVKYN----NEKAEREVK 56

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRL----------------LVYEYVTRGSLEDHLLNEDD 233
            L++L+H N+V   G      +                  +  E+  +G+LE  +     
Sbjct: 57  ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116

Query: 234 TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
            +L+    +++     +G++++H+  + +I+RD+K SN+ L D    KI DFGL     L
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--L 172

Query: 294 GDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN 353
            +    +    GT  Y +PE I++     + D+Y+ G++L E+L     A   +      
Sbjct: 173 KNDGKRTRSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----- 226

Query: 354 WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                    L    II +           ++   ++ + L+  P++RP  SE+
Sbjct: 227 -----FFTDL-RDGIISDIFD--------KKEKTLLQKLLSKKPEDRPNTSEI 265

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  148 bits (376), Expect = 2e-41
 Identities = 62/282 (21%), Positives = 98/282 (34%), Gaps = 39/282 (13%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENEL 188
            F   + +G G +G+V+            R K      AVKR      G + +     E+
Sbjct: 58  SFQRLSRLGHGSYGEVF----------KVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV 107

Query: 189 RFLSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-IAL 246
               ++  HP  V+L     +     L  E     SL+ H        L  E ++     
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLP-EAQVWGYLR 164

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
                L HLH+  + ++H DVK +N+ L      K+ DFGL     LG       +  G 
Sbjct: 165 DTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GD 219

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             Y APE +   +     DV+S G+ +LE+                              
Sbjct: 220 PRYMAPELLQGSY-GTAADVFSLGLTILEVACN----------------MELPHGGEGWQ 262

Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
           Q+    L        + E   +++  L  DPK R T   ++A
Sbjct: 263 QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  149 bits (378), Expect = 2e-41
 Identities = 68/314 (21%), Positives = 123/314 (39%), Gaps = 67/314 (21%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSR 193
              IG+G FG V+                    VAVK L+ + S   Q +++ E   ++ 
Sbjct: 52  VRDIGEGAFGRVFQARAPGL-----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL----------------------LNE 231
            ++PN+VKL+G C   +   L++EY+  G L + L                       + 
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 232 DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG 291
               L+   ++ IA   A G+ +L    R  +HRD+   N L+ ++   KI+DFGL++  
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADFGLSR-- 222

Query: 292 PLGDKSHISTRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMR 345
              +                     PE I     T ++DV+++GVVL EI S G      
Sbjct: 223 ---NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ---- 275

Query: 346 RTNGLAGNWAKPY--LSNKLALHQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKN 399
                      PY  ++++  ++ + D        +        E   ++  C +  P +
Sbjct: 276 -----------PYYGMAHEEVIYYVRDG--NI---LACPENCPLELYNLMRLCWSKLPAD 319

Query: 400 RPTMSEVVAALEQL 413
           RP+   +   L+++
Sbjct: 320 RPSFCSIHRILQRM 333

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  148 bits (376), Expect = 3e-41
 Identities = 72/304 (23%), Positives = 128/304 (42%), Gaps = 49/304 (16%)

Query: 126 EAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG 180
           +A  R   E        +G G FG VY G            +     VA+K LR + +  
Sbjct: 6   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIP------EGEKVKIPVAIKELR-EATSP 58

Query: 181 QDEWE--NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW 238
           +   E  +E   ++ +++P+V +L+G  C      L+ + +  G L D++    D  +  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDN-IGS 116

Query: 239 ERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSH 298
           +  +   +  A+G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K +
Sbjct: 117 QYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

Query: 299 ISTRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAG 352
            +       G       A E I     T ++DV+S+GV + E+++ G             
Sbjct: 175 HA-----EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS------------ 217

Query: 353 NWAKPY--LSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAA 409
              KPY  +        +  EK  R  Q      +   I+++C   D  +RP   E++  
Sbjct: 218 ---KPYDGIPASEISSIL--EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272

Query: 410 LEQL 413
             ++
Sbjct: 273 FSKM 276

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  147 bits (373), Expect = 3e-41
 Identities = 72/289 (24%), Positives = 118/289 (40%), Gaps = 50/289 (17%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           IG+G FGDV+ G            +N   AVA+K  +   +      +   E   + + +
Sbjct: 23  IGEGQFGDVHQG-------IYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFD 74

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HP++VKL+G    +    ++ E  T G L   L       L+    I  A   +  L +L
Sbjct: 75  HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYL 132

Query: 256 --HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF--- 310
               +    +HRD+ A NVL+  +   K+ DFGL+++  + D ++       ++G     
Sbjct: 133 ESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKA----SKGKLPIK 182

Query: 311 --APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLAL 365
             APE I     T  +DV+ FGV + EIL  G                KP+  + N   +
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGV---------------KPFQGVKNNDVI 227

Query: 366 HQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            +I  E   R             ++ +C   DP  RP  +E+ A L  +
Sbjct: 228 GRI--ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  148 bits (375), Expect = 4e-41
 Identities = 73/306 (23%), Positives = 128/306 (41%), Gaps = 47/306 (15%)

Query: 123 GLLEAATRKFSEKNL-----IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK- 176
           G ++   R F E  L     +G G FG V+ G            ++    V +K +  K 
Sbjct: 1   GAMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIP------EGESIKIPVCIKVIEDKS 54

Query: 177 GSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTEL 236
           G Q      + +  +  L+H ++V+L+G  C      LV +Y+  GSL DH+       L
Sbjct: 55  GRQSFQAVTDHMLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRG-AL 112

Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK 296
             +  +   +  A+G+ +L      ++HR++ A NVLL      +++DFG+A   P  DK
Sbjct: 113 GPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170

Query: 297 SHISTRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGL 350
             + +     +        A E I  G  T ++DV+S+GV + E+++ G           
Sbjct: 171 QLLYS---EAK--TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA---------- 215

Query: 351 AGNWAKPY--LSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVV 407
                +PY  L        +  EK  R  Q +    +   ++++C   D   RPT  E+ 
Sbjct: 216 -----EPYAGLRLAEVPDLL--EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELA 268

Query: 408 AALEQL 413
               ++
Sbjct: 269 NEFTRM 274

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  146 bits (371), Expect = 8e-41
 Identities = 72/290 (24%), Positives = 122/290 (42%), Gaps = 45/290 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSRL 194
           +G G FG V  G  ++             +VAVK L+       +  ++   E+  +  L
Sbjct: 26  LGDGSFGVVRRGEWDA-------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEH 254
           +H N+++L G         +V E    GSL D L              + A+  A G+ +
Sbjct: 79  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGY 136

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF---- 310
           L +  +  IHRD+ A N+LL      KI DFGL +  P  D  ++       +       
Sbjct: 137 LES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRK--VPFAW 190

Query: 311 -APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALH 366
            APE + T   +  +D + FGV L E+ + G+               +P+  L+    LH
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ---------------EPWIGLNGSQILH 235

Query: 367 QIIDEKLG-RNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           +I  +K G R  + E+  Q+   ++++C    P++RPT   +   L + Q
Sbjct: 236 KI--DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  146 bits (370), Expect = 1e-40
 Identities = 84/304 (27%), Positives = 127/304 (41%), Gaps = 58/304 (19%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRL- 194
           +G+G FG V          TA  R      VAVK L+ +G+   +     +EL+ L  + 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRT-----VAVKMLK-EGATHSEHRALMSELKILIHIG 88

Query: 195 NHPNVVKLMGYCCD-DQHRLLVYEYVTRGSLEDHL--------------LNEDDTELNWE 239
           +H NVV L+G C       +++ E+   G+L  +L               +     L  E
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
             I  +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+     D    
Sbjct: 149 HLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKD 201

Query: 300 STRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGN 353
              V            APE I     T+++DV+SFGV+L EI S G +            
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------------ 249

Query: 354 WAKPY---LSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAA 409
              PY     ++    ++ +    R    +    E  + +L C + +P  RPT SE+V  
Sbjct: 250 ---PYPGVKIDEEFCRRLKEG--TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

Query: 410 LEQL 413
           L  L
Sbjct: 305 LGNL 308

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  145 bits (367), Expect = 2e-40
 Identities = 77/293 (26%), Positives = 125/293 (42%), Gaps = 45/293 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLN 195
           +G G FG V  GY           K     VAVK L+ + +    +DE   E   + +L+
Sbjct: 25  LGSGNFGTVKKGYYQM--------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 76

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           +P +V+++G C  +   +LV E    G L  +L       +  +  I++    + G+++L
Sbjct: 77  NPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYL 133

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF----- 310
                  +HRD+ A NVLL     AKISDFGL+K     +  + +     T G +     
Sbjct: 134 EE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWY 187

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQ 367
           APE I     + K+DV+SFGV++ E  S G+               KPY  +        
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAM 232

Query: 368 IIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
           +  EK  R        +E  +++  C   D +NRP  + V   L     ++ +
Sbjct: 233 L--EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  146 bits (370), Expect = 3e-40
 Identities = 78/313 (24%), Positives = 124/313 (39%), Gaps = 64/313 (20%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLS 192
             ++G G FG V              +      VAVK L+ + +   +     +EL+ ++
Sbjct: 50  GKVLGSGAFGKVMNATAYGI-----SKTGVSIQVAVKMLK-EKADSSEREALMSELKMMT 103

Query: 193 RL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN--------------------- 230
           +L +H N+V L+G C       L++EY   G L ++L +                     
Sbjct: 104 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163

Query: 231 EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF 290
           ED   L +E  +  A   A+G+E L    +  +HRD+ A NVL+      KI DFGLA+ 
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLAR- 220

Query: 291 GPLGDKSHISTRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAM 344
               D    S  V+           APE +  G  T+K+DV+S+G++L EI S G     
Sbjct: 221 ----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--- 273

Query: 345 RRTNGLAGNWAKPY---LSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNR 400
                       PY     +      I +    +  Q   A +E   I+  C   D + R
Sbjct: 274 ------------PYPGIPVDANFYKLIQNG--FKMDQPFYATEEIYIIMQSCWAFDSRKR 319

Query: 401 PTMSEVVAALEQL 413
           P+   + + L   
Sbjct: 320 PSFPNLTSFLGCQ 332

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  146 bits (370), Expect = 3e-40
 Identities = 60/325 (18%), Positives = 122/325 (37%), Gaps = 40/325 (12%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NE 187
           K+     IG+G FG   +           +         +K +         E E    E
Sbjct: 25  KYVRLQKIGEGSFGKAIL----------VKSTEDGRQYVIKEIN-ISRMSSKEREESRRE 73

Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI-KIAL 246
           +  L+ + HPN+V+      ++    +V +Y   G L   +  +       E +I    +
Sbjct: 74  VAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ-EDQILDWFV 132

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
                L+H+H   R ++HRD+K+ N+ L  D   ++ DFG+A+   L     ++   +GT
Sbjct: 133 QICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGT 188

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             Y +PE         K+D+++ G VL E+ + K A                  +   L 
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF--------------EAGSMKNLV 234

Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE------VVAALEQLQLNMGSC 420
             I       + +  + +   ++ +    +P++RP+++       +   +E+        
Sbjct: 235 LKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIA 294

Query: 421 YQTSLRTSTHTTRTRSFEQRPLKQR 445
            +  L+T +         +RP   +
Sbjct: 295 EEFCLKTFSKFGSQPIPAKRPASGQ 319

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  145 bits (367), Expect = 3e-40
 Identities = 64/300 (21%), Positives = 115/300 (38%), Gaps = 52/300 (17%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELR 189
            F     +G+GGFG V+           A+ K  D   A+KR+R    +   ++   E++
Sbjct: 6   DFEPIQCLGRGGFGVVFE----------AKNKVDDCNYAIKRIRLPNRELAREKVMREVK 55

Query: 190 FLSRLNHPNVVKLMGYCCDD---------QHRLLVY---EYVTRGSLEDHLLNEDDTELN 237
            L++L HP +V+      +            ++ +Y   +   + +L+D +      E  
Sbjct: 56  ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115

Query: 238 WERRI-KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK------- 289
                  I L  A  +E LH+  + ++HRD+K SN+    D   K+ DFGL         
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173

Query: 290 ---FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRR 346
                         T  +GT+ Y +PE I     + K D++S G++L E+L   +  M R
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMER 233

Query: 347 TNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                             L  + + K    +  ++      ++   L+  P  RP    +
Sbjct: 234 ---------------VRTLTDVRNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINI 277

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  143 bits (364), Expect = 1e-39
 Identities = 67/282 (23%), Positives = 118/282 (41%), Gaps = 32/282 (11%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NE 187
            F  +  IG+G F +VY           A        VA+K+++               E
Sbjct: 33  NFRIEKKIGRGQFSEVYR----------AACLLDGVPVALKKVQIFDLMDAKARADCIKE 82

Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--LNEDDTELNWERRI-KI 244
           +  L +LNHPNV+K      +D    +V E    G L   +    +    +  ER + K 
Sbjct: 83  IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP-ERTVWKY 141

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
            +     LEH+H+  R V+HRD+K +NV +      K+ D GL +F     K+  +  ++
Sbjct: 142 FVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLV 197

Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
           GT  Y +PE I       K+D++S G +L E+ + ++            +    ++    
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP-----------FYGDKMNLYSL 246

Query: 365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
             +I             ++E  +++  C+N DP+ RP ++ V
Sbjct: 247 CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  144 bits (365), Expect = 1e-39
 Identities = 66/317 (20%), Positives = 117/317 (36%), Gaps = 49/317 (15%)

Query: 120 FCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ 179
           F    +E    +   + ++ +GGF  VY           A+   +    A+KRL     +
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYE----------AQDVGSGREYALKRLLSNEEE 67

Query: 180 GQDEWENELRFLSRL-NHPNVVKLMGYCCDDQHR-------LLVYEYVTRGSLEDHLLNE 231
                  E+ F+ +L  HPN+V+        +          L+   + +G L + L   
Sbjct: 68  KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM 127

Query: 232 DDTELNWERRI-KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF 290
           +         + KI     R ++H+H    P+IHRD+K  N+LL +    K+ DFG A  
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187

Query: 291 ---GPLGDKSHISTRVL-------GTRGYFAPEYIAT---GHLTLKTDVYSFGVVLLEIL 337
               P    S     ++        T  Y  PE I       +  K D+++ G +L  + 
Sbjct: 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247

Query: 338 SGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDP 397
             +                     KL    I++ K        +   F  +I   L  +P
Sbjct: 248 FRQHPF--------------EDGAKLR---IVNGKYSIPPHDTQYTVFHSLIRAMLQVNP 290

Query: 398 KNRPTMSEVVAALEQLQ 414
           + R +++EVV  L+++ 
Sbjct: 291 EERLSIAEVVHQLQEIA 307

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  145 bits (367), Expect = 5e-39
 Identities = 72/291 (24%), Positives = 120/291 (41%), Gaps = 49/291 (16%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
            F  K+++G G  G +             R    +  VAVKR+  +        + E++ 
Sbjct: 25  SFCPKDVLGHGAEGTIV-----------YRGMFDNRDVAVKRILPECFSFA---DREVQL 70

Query: 191 LSRLN-HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
           L   + HPNV++      D Q + +  E     +L++++  +D   L  E    +     
Sbjct: 71  LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTT 128

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLL-----DDDFNAKISDFGLAKFGPLGDKS-HISTRV 303
            GL HLH+    ++HRD+K  N+L+          A ISDFGL K   +G  S    + V
Sbjct: 129 SGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186

Query: 304 LGTRGYFAPEYI---ATGHLTLKTDVYSFGVVLLEILSGKT-----AAMRRTNGLAGNWA 355
            GT G+ APE +      + T   D++S G V   ++S  +     +  R+ N L G  +
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS 246

Query: 356 KPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
              L  +    +  D           A+E    I + +  DP+ RP+   V
Sbjct: 247 LDCLHPE----KHED---------VIAREL---IEKMIAMDPQKRPSAKHV 281

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  148 bits (375), Expect = 5e-39
 Identities = 72/292 (24%), Positives = 119/292 (40%), Gaps = 56/292 (19%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           IG+G FGDV+ G            +N   AVA+K  +   +      +   E   + + +
Sbjct: 398 IGEGQFGDVHQG-------IYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFD 449

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HP++VKL+G    +    ++ E  T G L   L       L+    I  A   +  L +L
Sbjct: 450 HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYL 507

Query: 256 --HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF--- 310
               +    +HRD+ A NVL+  +   K+ DFGL+++  + D ++       ++G     
Sbjct: 508 ESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKA----SKGKLPIK 557

Query: 311 --APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLAL 365
             APE I     T  +DV+ FGV + EIL  G                KP+  + N   +
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGV---------------KPFQGVKNNDVI 602

Query: 366 HQIIDEKLGRNIQMEE----AQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            +I  E   R   +            ++ +C   DP  RP  +E+ A L  +
Sbjct: 603 GRI--ENGER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  146 bits (369), Expect = 2e-38
 Identities = 74/296 (25%), Positives = 129/296 (43%), Gaps = 45/296 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NELRFLSRLN 195
           +G G FG V  G          R +     VA+K L+ +G++  D  E   E + + +L+
Sbjct: 344 LGCGNFGSVRQGVY--------RMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLD 394

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           +P +V+L+G C  +   +LV E    G L   L+ + + E+      ++    + G+++L
Sbjct: 395 NPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYL 452

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF----- 310
               +  +HR++ A NVLL +   AKISDFGL+K     D  + +     + G +     
Sbjct: 453 EE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR----SAGKWPLKWY 506

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY--LSNKLALHQ 367
           APE I     + ++DV+S+GV + E LS G+               KPY  +     +  
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQ---------------KPYKKMKGPEVMAF 551

Query: 368 IIDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
           I  E+  R     E   E   ++  C     ++RP    V   +     ++ S  +
Sbjct: 552 I--EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  140 bits (354), Expect = 2e-38
 Identities = 78/289 (26%), Positives = 126/289 (43%), Gaps = 45/289 (15%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-----WENELRFL 191
            +G GG   VY           A     +  VA+K +       + E     +E E+   
Sbjct: 18  KLGGGGMSTVY----------LAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNS 65

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
           S+L+H N+V ++    +D    LV EY+   +L +++  E    L+ +  I        G
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDG 123

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST-RVLGTRGYF 310
           ++H H     ++HRD+K  N+L+D +   KI DFG+AK   L + S   T  VLGT  YF
Sbjct: 124 IKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYF 179

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN---KLALHQ 367
           +PE          TD+YS G+VL E+L G+                P+       +A+  
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGE---------------PPFNGETAVSIAIKH 224

Query: 368 IIDE--KLGRNIQMEEAQEFAEIILRCLNSDPKNRP-TMSEVVAALEQL 413
           I D    +  +++ +  Q  + +ILR    D  NR  T+ E+   L  +
Sbjct: 225 IQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  138 bits (350), Expect = 7e-38
 Identities = 71/293 (24%), Positives = 120/293 (40%), Gaps = 64/293 (21%)

Query: 134 EKNLIGQGGFGDVYIGYINSCAMTAARRKNAD--FAVAVKRLRRKGSQGQDEWENELRFL 191
           ++ ++G+G +G VY G             +      +A+K +  + S+       E+   
Sbjct: 26  DRVVLGKGTYGIVYAGR------------DLSNQVRIAIKEIPERDSRYSQPLHEEIALH 73

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI----ALG 247
             L H N+V+ +G   ++    +  E V  GSL   L ++     + E+ I       L 
Sbjct: 74  KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL- 132

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
              GL++LH     ++HRD+K  NVL++      KISDFG +K   L   +  +    GT
Sbjct: 133 --EGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGT 186

Query: 307 RGYFAPEYI---ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSN 361
             Y APE I     G+     D++S G  ++E+ +GK                P+  L  
Sbjct: 187 LQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGK---------------PPFYELGE 230

Query: 362 KL-ALHQI--------IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
              A+ ++        I E +       EA+ F   IL+C   DP  R   ++
Sbjct: 231 PQAAMFKVGMFKVHPEIPESMS-----AEAKAF---ILKCFEPDPDKRACAND 275

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  138 bits (349), Expect = 7e-38
 Identities = 70/293 (23%), Positives = 114/293 (38%), Gaps = 39/293 (13%)

Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK--RLRRKGSQGQD 182
           + +    +     IG G +G               RRK+    +  K           + 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQK----------IRRKSDGKILVWKELDYGSMTEAEKQ 50

Query: 183 EWENELRFLSRLNHPNVVKLMGYCCDDQHRLL--VYEYVTRGSLEDHL--LNEDDTELNW 238
              +E+  L  L HPN+V+      D  +  L  V EY   G L   +    ++   L+ 
Sbjct: 51  MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD- 109

Query: 239 ERRI-KIALGAARGLEHLH---TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
           E  + ++       L+  H        V+HRD+K +NV LD   N K+ DFGLA+   L 
Sbjct: 110 EEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LN 167

Query: 295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
             +  +   +GT  Y +PE +       K+D++S G +L E+ +                
Sbjct: 168 HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM-------------- 213

Query: 355 AKPYL-SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
             P+   ++  L   I E   R I    + E  EII R LN    +RP++ E+
Sbjct: 214 -PPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  141 bits (357), Expect = 1e-36
 Identities = 60/285 (21%), Positives = 103/285 (36%), Gaps = 53/285 (18%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADF-AVAVKRLRRKGSQG-QDEWENELRFLSRL 194
            I  GG G +Y           A  +N +   V +K L   G    Q     E +FL+ +
Sbjct: 87  CIAHGGLGWIY----------LALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV 136

Query: 195 NHPNVVKLMGYCCDDQHRL-----LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            HP++V++  +             +V EYV   SL+         +L     I   L   
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEIL 192

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
             L +LH+    +++ D+K  N++L ++   K+ D G      +    +    + GT G+
Sbjct: 193 PALSYLHS--IGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSFGY----LYGTPGF 243

Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII 369
            APE I     T+ TD+Y+ G  L  +                          +      
Sbjct: 244 QAPE-IVRTGPTVATDIYTVGRTLAALTLDLP---------------TRNGRYVDGLPED 287

Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-TMSEVVAALEQL 413
           D  L           +  ++ R ++ DP+ R  T  E+ A L  +
Sbjct: 288 DPVLKT------YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  136 bits (345), Expect = 3e-36
 Identities = 58/317 (18%), Positives = 103/317 (32%), Gaps = 59/317 (18%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSR 193
            +++GQG   +V+            R K      A+K           D    E   L +
Sbjct: 14  SDILGQGATANVFR----------GRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 194 LNHPNVVKLMGY--CCDDQHRLLVYEYVTRGSLEDHL--------LNEDDTELNWERRIK 243
           LNH N+VKL         +H++L+ E+   GSL   L        L E +        + 
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF-----LIVL 118

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLL----DDDFNAKISDFGLAKFGPLGDKSHI 299
             +     + HL      ++HR++K  N++     D     K++DFG A+   L D    
Sbjct: 119 RDVVGG--MNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQF 172

Query: 300 STRVLGTRGYFAPEYIATGHL--------TLKTDVYSFGVVLLEILSGK----------- 340
            +   GT  Y  P+      L            D++S GV      +G            
Sbjct: 173 VSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231

Query: 341 -TAAMRR--TNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDP 397
               M +  T   +G  +    +    +    D  +  ++          ++   L +D 
Sbjct: 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291

Query: 398 KNRPTMSEVVAALEQLQ 414
           +      +  A    + 
Sbjct: 292 EKCWGFDQFFAETSDIL 308

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  134 bits (340), Expect = 3e-36
 Identities = 64/295 (21%), Positives = 114/295 (38%), Gaps = 50/295 (16%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD--EWENE 187
           R +S    IG GG   V+        +            A+K +  + +  Q    + NE
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQI-----------YAIKYVNLEEADNQTLDSYRNE 76

Query: 188 LRFLSRLNHPN--VVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA 245
           + +L++L   +  +++L  Y   DQ+  +V E      L   L  +    ++   R    
Sbjct: 77  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERKSYW 133

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
                 +  +H     ++H D+K +N L+ D    K+ DFG+A        S +    +G
Sbjct: 134 KNMLEAVHTIHQ--HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 190

Query: 306 TRGYFAPEYI-----------ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
           T  Y  PE I           +   ++ K+DV+S G +L  +  GKT             
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------------- 237

Query: 355 AKPY---LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
             P+   ++    LH IID            ++  +++  CL  DPK R ++ E+
Sbjct: 238 --PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  134 bits (340), Expect = 4e-36
 Identities = 57/309 (18%), Positives = 101/309 (32%), Gaps = 59/309 (19%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSR 193
            +++GQG   +V+            R K      A+K           D    E   L +
Sbjct: 14  SDILGQGATANVFR----------GRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 194 LNHPNVVKLMGY--CCDDQHRLLVYEYVTRGSLEDHL--------LNEDDTELNWERRIK 243
           LNH N+VKL         +H++L+ E+   GSL   L        L E +        + 
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF-----LIVL 118

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLL----DDDFNAKISDFGLAKFGPLGDKSHI 299
             +     + HL      ++HR++K  N++     D     K++DFG A+   L D    
Sbjct: 119 RDVVGG--MNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQF 172

Query: 300 STRVLGTRGYFAPEYIATGHL--------TLKTDVYSFGVVLLEILSGK----------- 340
            +   GT  Y  P+      L            D++S GV      +G            
Sbjct: 173 VSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231

Query: 341 -TAAMRR--TNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDP 397
               M +  T   +G  +    +    +    D  +  ++          ++   L +D 
Sbjct: 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291

Query: 398 KNRPTMSEV 406
           +      + 
Sbjct: 292 EKCWGFDQF 300

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  135 bits (341), Expect = 4e-36
 Identities = 70/293 (23%), Positives = 109/293 (37%), Gaps = 59/293 (20%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNAD--FAVAVKRLRRKGSQGQDEWEN 186
               + +  +G+G FG+V+               +    F  AVK++R +  +       
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMK------------DKQTGFQCAVKKVRLEVFR-----VE 99

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           EL   + L+ P +V L G   +     +  E +  GSL   L+ +       E R    L
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLP--EDRALYYL 156

Query: 247 GAA-RGLEHLHTYWRPVIHRDVKASNVLLDDD-FNAKISDFGLAK-FGPLGDKSHISTR- 302
           G A  GLE+LHT  R ++H DVKA NVLL  D   A + DFG A    P G    + T  
Sbjct: 157 GQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214

Query: 303 -VLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGK--------TAAMRRTNGLAG 352
            + GT  + APE +        K D++S   ++L +L+G              +      
Sbjct: 215 YIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI----A 269

Query: 353 NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
           +   P           I              +    I   L  +P +R +  E
Sbjct: 270 SEPPPIRE--------IPPSCA-----PLTAQA---IQEGLRKEPVHRASAME 306

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  134 bits (340), Expect = 5e-36
 Identities = 65/295 (22%), Positives = 115/295 (38%), Gaps = 50/295 (16%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENE 187
           R +S    IG GG   V+        +            A+K +  +   +Q  D + NE
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQI-----------YAIKYVNLEEADNQTLDSYRNE 57

Query: 188 LRFLSRLNHPN--VVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA 245
           + +L++L   +  +++L  Y   DQ+  +V E      L   L  +    ++   R    
Sbjct: 58  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERKSYW 114

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
                 +  +H     ++H D+K +N L+ D    K+ DFG+A        S +    +G
Sbjct: 115 KNMLEAVHTIHQ--HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 171

Query: 306 TRGYFAPEYI-----------ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
           T  Y  PE I           +   ++ K+DV+S G +L  +  GKT             
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------------- 218

Query: 355 AKPY---LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
             P+   ++    LH IID            ++  +++  CL  DPK R ++ E+
Sbjct: 219 --PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  133 bits (336), Expect = 7e-36
 Identities = 67/304 (22%), Positives = 112/304 (36%), Gaps = 62/304 (20%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWEN 186
           T +F E   IG G FG V+             ++      A+KR ++   GS  +     
Sbjct: 10  TTEFHELEKIGSGEFGSVF----------KCVKRLDGCIYAIKRSKKPLAGSVDEQNALR 59

Query: 187 ELRFLSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW-ERRIK- 243
           E+   + L  H +VV+      +D H L+  EY   GSL D +         + E  +K 
Sbjct: 60  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD-------------------FNAKISD 284
           + L   RGL ++H+    ++H D+K SN+ +                         KI D
Sbjct: 120 LLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA--TGHLTLKTDVYSFGVVLLEILSGKTA 342
            G          S       G   + A E +     HL  K D+++  + ++        
Sbjct: 178 LGHVT-----RISSPQVEE-GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGA--- 227

Query: 343 AMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT 402
                        +P   N    H+I   +L R I    +QEF E++   ++ DP+ RP+
Sbjct: 228 -------------EPLPRNGDQWHEIRQGRLPR-IPQVLSQEFTELLKVMIHPDPERRPS 273

Query: 403 MSEV 406
              +
Sbjct: 274 AMAL 277

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  134 bits (338), Expect = 2e-35
 Identities = 64/295 (21%), Positives = 114/295 (38%), Gaps = 50/295 (16%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENE 187
           R +S    IG GG   V+        +            A+K +  +   +Q  D + NE
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQI-----------YAIKYVNLEEADNQTLDSYRNE 104

Query: 188 LRFLSRLNHPN--VVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA 245
           + +L++L   +  +++L  Y   DQ+  +V E      L   L  +    ++   R    
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWL--KKKKSIDPWERKSYW 161

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
                 +  +H     ++H D+K +N L+ D    K+ DFG+A        S +    +G
Sbjct: 162 KNMLEAVHTIHQ--HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 218

Query: 306 TRGYFAPEYI-----------ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
              Y  PE I           +   ++ K+DV+S G +L  +  GKT             
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------------- 265

Query: 355 AKPY---LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
             P+   ++    LH IID            ++  +++  CL  DPK R ++ E+
Sbjct: 266 --PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  131 bits (332), Expect = 4e-35
 Identities = 71/295 (24%), Positives = 127/295 (43%), Gaps = 50/295 (16%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-----WENELRFL 191
           ++G GG  +V+           AR       VAVK LR      +D      +  E +  
Sbjct: 19  ILGFGGMSEVH----------LARDLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNA 66

Query: 192 SRLNHPNVVKLMGYCCDDQHRL----LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           + LNHP +V +      +        +V EYV   +L D +    +  +  +R I++   
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIAD 124

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR---VL 304
           A + L   H     +IHRDVK +N+++      K+ DFG+A+   + D  +  T+   V+
Sbjct: 125 ACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVI 180

Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN--- 361
           GT  Y +PE      +  ++DVYS G VL E+L+G+                P+  +   
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE---------------PPFTGDSPV 225

Query: 362 KLALHQIIDE-KLGRNIQMEEAQEFAEIILRCLNSDPKNRP-TMSEVVAALEQLQ 414
            +A   + ++           + +   ++L+ L  +P+NR  T +E+ A L ++ 
Sbjct: 226 SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  131 bits (332), Expect = 4e-35
 Identities = 69/286 (24%), Positives = 107/286 (37%), Gaps = 43/286 (15%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-----WENELRFL 191
           L+G+GG GDVY           A     +  VA+K +    +   D       + E R  
Sbjct: 41  LVGRGGMGDVY----------EAEDTVRERIVALKLMSE--TLSSDPVFRTRMQREARTA 88

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
            RL  P+VV +  +   D    +    +    L   L       L   R + I       
Sbjct: 89  GRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSA 146

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST-RVLGTRGYF 310
           L+  H       HRDVK  N+L+  D  A + DFG+A      D+        +GT  Y 
Sbjct: 147 LDAAHA--AGATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYM 202

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL---HQ 367
           APE  +  H T + D+Y+   VL E L+G                 PY  ++L++   H 
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSP---------------PYQGDQLSVMGAHI 247

Query: 368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNR-PTMSEVVAALEQ 412
                    ++      F  +I R +  +P++R  T  ++ AA   
Sbjct: 248 NQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHA 293

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  130 bits (329), Expect = 5e-35
 Identities = 79/290 (27%), Positives = 114/290 (39%), Gaps = 58/290 (20%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDE-WENE 187
            F     +G+G FG+VY+          AR K + F +A+K L +      G +     E
Sbjct: 10  DFEIGRPLGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLRRE 59

Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRI 242
           +   S L HPN+++L GY  D     L+ EY   G++   L      +E  T        
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------- 112

Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
                 A  L + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T 
Sbjct: 113 TYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTD 166

Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP-YLSN 361
           + GT  Y  PE I       K D++S GV+  E L GK                P   + 
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANT 211

Query: 362 KLALHQIIDEKLGRNIQM-----EEAQEFAEIILRCLNSDPKNRPTMSEV 406
               ++ I               E A++    I R L  +P  RP + EV
Sbjct: 212 YQETYKRI---SRVEFTFPDFVTEGARDL---ISRLLKHNPSQRPMLREV 255

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  132 bits (334), Expect = 5e-35
 Identities = 52/358 (14%), Positives = 104/358 (29%), Gaps = 43/358 (12%)

Query: 102 PAVSFHRDEVFHAYKLKYFCHGL-LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAAR 160
             VS + +      KL         +  ++     +L+G+G F  VY            +
Sbjct: 36  KPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNK 95

Query: 161 RKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVT 220
           +K       +K  +             +  L        +K           +LV E  +
Sbjct: 96  QK-----FVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150

Query: 221 RGSLEDHL---LNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL--- 274
            G+L + +    N  +  +     I  A+     +E +H     +IH D+K  N +L   
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNG 208

Query: 275 --------DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDV 326
                   D      + D G +    L  K  I T    T G+   E ++      + D 
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268

Query: 327 YSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFA 386
           +     +  +L G    ++   G                    +    R   ++    + 
Sbjct: 269 FGVAATVYCMLFGTYMKVKNEGG----------------ECKPEGLFRRLPHLD---MWN 309

Query: 387 EIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTSLRTSTHTTRTRSFEQRPLKQ 444
           E     LN    +     +++     L+      Y   +R   +       E +  ++
Sbjct: 310 EFFHVMLNIPDCHHLPSLDLLRQK--LKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 365

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  130 bits (330), Expect = 5e-35
 Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 66/297 (22%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEW 184
           R++     +G+GGF   +               +     A K      L +   + +   
Sbjct: 15  RRYVRGRFLGKGGFAKCFE----------ISDADTKEVFAGKIVPKSLLLKPHQREK--M 62

Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWE 239
             E+     L H +VV   G+  D+    +V E   R SL +       L E +      
Sbjct: 63  SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA----- 117

Query: 240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSH 298
           R     +    G ++LH     VIHRD+K  N+ L++D   KI DFGLA K    G++  
Sbjct: 118 RYYLRQI--VLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 173

Query: 299 ISTRVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGK----TAAMRRT--NGLA 351
           +     GT  Y APE ++  GH + + DV+S G ++  +L GK    T+ ++ T      
Sbjct: 174 VLC---GTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 229

Query: 352 GNWAKP-YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
             ++ P +++                     A     +I + L +DP  RPT++E++
Sbjct: 230 NEYSIPKHIN-------------------PVAA---SLIQKMLQTDPTARPTINELL 264

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  135 bits (342), Expect = 1e-34
 Identities = 72/285 (25%), Positives = 111/285 (38%), Gaps = 46/285 (16%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELRFLSR 193
           K  +G GGFG V               ++    VA+K+ R++ S    E W  E++ + +
Sbjct: 19  KERLGTGGFGYVLR----------WIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK 68

Query: 194 LNHPNVVKL------MGYCCDDQHRLLVYEYVTRGSLEDHLL-NEDDTELNWERRIKIAL 246
           LNHPNVV        +     +   LL  EY   G L  +L   E+   L  E  I+  L
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK-EGPIRTLL 127

Query: 247 GA-ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA---KISDFGLAKFGPLGDKSHISTR 302
              +  L +LH     +IHRD+K  N++L         KI D G AK   L      +  
Sbjct: 128 SDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEF 183

Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL--S 360
           V GT  Y APE +     T+  D +SFG +  E ++G                 P+L   
Sbjct: 184 V-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR---------------PFLPNW 227

Query: 361 NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
             +  H  + EK   +I + +      +    +   P +   +  
Sbjct: 228 QPVQWHGKVREKSNEHIVVYD-DLTGAVKFSSVLPTPNHLSGILA 271

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  131 bits (330), Expect = 1e-34
 Identities = 53/303 (17%), Positives = 105/303 (34%), Gaps = 55/303 (18%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW------------- 184
           + QG F  + +            + N     A+K+  +   + + ++             
Sbjct: 39  LNQGKFNKIIL----------CEKDN--KFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86

Query: 185 ----ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWER 240
               +NEL+ ++ + +   +   G   +     ++YEY+   S+          + N+  
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146

Query: 241 RIKIALGA------ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
            I I +             ++H   + + HRDVK SN+L+D +   K+SDFG +++    
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNE-KNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-- 203

Query: 295 DKSHISTRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVLLEILSGK--------TAAM 344
               I     GT  +  PE+ +    +   K D++S G+ L  +               +
Sbjct: 204 -DKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261

Query: 345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQM-EEAQEFAEIILRCLNSDPKNRPTM 403
              N    N   P   N         +    N  +  E  +F   +   L  +P  R T 
Sbjct: 262 FN-NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDF---LKLFLRKNPAERITS 317

Query: 404 SEV 406
            + 
Sbjct: 318 EDA 320

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  130 bits (329), Expect = 2e-34
 Identities = 69/298 (23%), Positives = 115/298 (38%), Gaps = 68/298 (22%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEW 184
           R++     +G+GGF   +               +     A K      L +   + +   
Sbjct: 41  RRYVRGRFLGKGGFAKCFE----------ISDADTKEVFAGKIVPKSLLLKPHQREK--M 88

Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWE 239
             E+     L H +VV   G+  D+    +V E   R SL +       L E +      
Sbjct: 89  SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA----- 143

Query: 240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSH 298
           R     +    G ++LH     VIHRD+K  N+ L++D   KI DFGLA K    G++  
Sbjct: 144 RYYLRQI--VLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 199

Query: 299 ISTRVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGK-------TAAMRRTNGL 350
               + GT  Y APE ++  GH + + DV+S G ++  +L GK                 
Sbjct: 200 --V-LCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-RIK 254

Query: 351 AGNWAKP-YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
              ++ P +++                     A     +I + L +DP  RPT++E++
Sbjct: 255 KNEYSIPKHIN-------------------PVAA---SLIQKMLQTDPTARPTINELL 290

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  129 bits (326), Expect = 2e-34
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 51/288 (17%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
            +K++    IGQG  G VY           A        VA++++  +    ++   NE+
Sbjct: 19  KKKYTRFEKIGQGASGTVYT----------AMDVATGQEVAIRQMNLQQQPKKELIINEI 68

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI-KIALG 247
             +    +PN+V  +          +V EY+  GSL D +     T ++ E +I  +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMD-EGQIAAVCRE 124

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
             + LE LH     VIHRD+K+ N+LL  D + K++DFG      +  +    + ++GT 
Sbjct: 125 CLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTP 180

Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK-----TAAMR-----RTNGLAGNWAKP 357
            + APE +       K D++S G++ +E++ G+        +R      TNG       P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG------TP 234

Query: 358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
            L N         EKL        +  F + + RCL  D + R +  E
Sbjct: 235 ELQNP--------EKL--------SAIFRDFLNRCLEMDVEKRGSAKE 266

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  131 bits (332), Expect = 3e-34
 Identities = 71/310 (22%), Positives = 117/310 (37%), Gaps = 64/310 (20%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
                + ++G G  G V             +       VAVKR+        D    E++
Sbjct: 15  NLVVSEKILGYGSSGTVV-----------FQGSFQGRPVAVKRMLI---DFCDIALMEIK 60

Query: 190 FLSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLED-----HLLNEDDTELNWERRIK 243
            L+   +HPNV++       D+   +  E     +L+D     ++ +E+         I 
Sbjct: 61  LLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPIS 119

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLD-------------DDFNAKISDFGLAKF 290
           +    A G+ HLH+    +IHRD+K  N+L+              ++    ISDFGL K 
Sbjct: 120 LLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 291 GPLGDKSHISTR--VLGTRGYFAPEYI-------ATGHLTLKTDVYSFGVVLLEILSGKT 341
              G  S  +      GT G+ APE +           LT   D++S G V   ILS   
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 342 -----AAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSD 396
                   R +N + G ++   +               R++ + EA +    I + ++ D
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDEM----------KCLHDRSL-IAEATDL---ISQMIDHD 283

Query: 397 PKNRPTMSEV 406
           P  RPT  +V
Sbjct: 284 PLKRPTAMKV 293

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  127 bits (320), Expect = 2e-33
 Identities = 78/296 (26%), Positives = 118/296 (39%), Gaps = 68/296 (22%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--- 185
              F++   IG+G FG+V+                    VA+K +  +  + +DE E   
Sbjct: 21  EELFTKLEKIGKGSFGEVF----------KGIDNRTQKVVAIKIIDLE--EAEDEIEDIQ 68

Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA 245
            E+  LS+ + P V K  G    D    ++ EY+  GS  D L      E       +IA
Sbjct: 69  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET------QIA 122

Query: 246 L---GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
                  +GL++LH+     IHRD+KA+NVLL +    K++DFG+A  G L D       
Sbjct: 123 TILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNT 178

Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK-----TAAMR--------RTNG 349
            +GT  + APE I       K D++S G+  +E+  G+        M+            
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT 238

Query: 350 LAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
           L GN++K                              E +  CLN +P  RPT  E
Sbjct: 239 LEGNYSK---------------------------PLKEFVEACLNKEPSFRPTAKE 267

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  126 bits (319), Expect = 2e-33
 Identities = 69/285 (24%), Positives = 112/285 (39%), Gaps = 60/285 (21%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDE-WENELRFLSR 193
            +G+G FG+VY+          AR K   F +A+K L +     +G +     E+   S 
Sbjct: 21  PLGKGKFGNVYL----------AREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALGA 248
           L HPN++++  Y  D +   L+ E+  RG L   L      +E  +         +    
Sbjct: 71  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS------ATFMEE-L 123

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL-GTR 307
           A  L + H   R VIHRD+K  N+L+      KI+DFG +   P      +  R + GT 
Sbjct: 124 ADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-----SLRRRTMCGTL 176

Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP-YLSNKLALH 366
            Y  PE I       K D++  GV+  E L G                 P    +    H
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP---------------PFDSPSHTETH 221

Query: 367 QIIDEKLGRNIQM-----EEAQEFAEIILRCLNSDPKNRPTMSEV 406
           + I   +  +++      + +++    I + L   P  R  +  V
Sbjct: 222 RRI---VNVDLKFPPFLSDGSKDL---ISKLLRYHPPQRLPLKGV 260

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  127 bits (320), Expect = 2e-33
 Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 51/288 (17%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
                    IG+G  G V +          AR K++   VAVK +  +  Q ++   NE+
Sbjct: 44  RLLLDSYVKIGEGSTGIVCL----------AREKHSGRQVAVKMMDLRKQQRRELLFNEV 93

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI-KIALG 247
             +    H NVV++       +   ++ E++  G+L D +       LN E +I  +   
Sbjct: 94  VIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLN-EEQIATVCEA 149

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
             + L +LH   + VIHRD+K+ ++LL  D   K+SDFG      +         ++GT 
Sbjct: 150 VLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTP 205

Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK-----TAAMR-----RTNGLAGNWAKP 357
            + APE I+      + D++S G++++E++ G+      + ++     R +        P
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP------PP 259

Query: 358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
            L N          K+        +    + + R L  DP+ R T  E
Sbjct: 260 KLKNS--------HKV--------SPVLRDFLERMLVRDPQERATAQE 291

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  127 bits (321), Expect = 3e-33
 Identities = 43/321 (13%), Positives = 79/321 (24%), Gaps = 60/321 (18%)

Query: 124 LLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE 183
           LL    RK      +  G    V+            R        A+K         + E
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVF----------LVRDVERLEDFALKVFTMGAENSRSE 105

Query: 184 WEN---ELRFLSRLNHPNVVKLMGYC--------------------------CDDQHRLL 214
            E         +RL   +  +                                   + LL
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165

Query: 215 VYEYVTRGSLED-----HLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKA 269
           +        LE        +     +        +     R   +L +    ++H     
Sbjct: 166 LMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTP 222

Query: 270 SNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL--TLKTDVY 327
            N+ +  D    + D        +G +   S+       Y   E++       T   + +
Sbjct: 223 DNLFIMPDGRLMLGDVSALW--KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAW 277

Query: 328 SFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAE 387
             G+ +  +          T G+ G+W +P       L     + L              
Sbjct: 278 QLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS------LRVPGTDSLAFGSCTPLPDFVKT 331

Query: 388 IILRCLNSDPKNRPTMSEVVA 408
           +I R LN D + R    E + 
Sbjct: 332 LIGRFLNFDRRRRLLPLEAME 352

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  129 bits (325), Expect = 6e-33
 Identities = 73/303 (24%), Positives = 128/303 (42%), Gaps = 59/303 (19%)

Query: 124 LLEAATRKFSEK----NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ 179
            ++ +T  FS++     ++G+G FG+V +           + K      AVK + ++  +
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVIL----------CKDKITGQECAVKVISKRQVK 65

Query: 180 GQDEWE---NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TE 235
            + + E    E++ L +L+HPN++KL  +  D  +  LV E  T G L D +++    +E
Sbjct: 66  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125

Query: 236 LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGP 292
           ++  R I+  L     + ++H     ++HRD+K  N+LL     D N +I DFGL+    
Sbjct: 126 VDAARIIRQVLSG---ITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-- 178

Query: 293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG 352
             + S      +GT  Y APE +  G    K DV+S GV+L  +LSG             
Sbjct: 179 -FEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGANE---- 232

Query: 353 NWAKPYLSNKLALHQIIDEKLGRNIQM---------EEAQEFAEIILRCLNSDPKNRPTM 403
                        + I+ +                 E A++    I + L   P  R + 
Sbjct: 233 -------------YDILKKVEKGKYTFELPQWKKVSESAKDL---IRKMLTYVPSMRISA 276

Query: 404 SEV 406
            + 
Sbjct: 277 RDA 279

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  129 bits (325), Expect = 7e-33
 Identities = 68/287 (23%), Positives = 112/287 (39%), Gaps = 54/287 (18%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE--WENELRFLS 192
              +G G +G+V +           R K      A+K +R+             E+  L 
Sbjct: 42  VKKLGSGAYGEVLL----------CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK 91

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARG 251
            L+HPN++KL  +  D ++  LV E    G L D +++     E++    IK  L     
Sbjct: 92  LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG--- 148

Query: 252 LEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           + +LH     ++HRD+K  N+LL   + D   KI DFGL+      +        LGT  
Sbjct: 149 VTYLHK--HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAY 203

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           Y APE +       K DV+S GV+L  +L+G      +T+                  +I
Sbjct: 204 YIAPEVL-RKKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----------------QEI 245

Query: 369 IDEKLGRNIQM---------EEAQEFAEIILRCLNSDPKNRPTMSEV 406
           + +                 E A++    I + L  D + R +  + 
Sbjct: 246 LRKVEKGKYTFDSPEWKNVSEGAKDL---IKQMLQFDSQRRISAQQA 289

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  124 bits (314), Expect = 8e-33
 Identities = 72/290 (24%), Positives = 128/290 (44%), Gaps = 67/290 (23%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELRFL 191
           L+G+G F  VY           A   +    VA+K      + + G   +   +NE++  
Sbjct: 18  LLGKGSFAGVYR----------AESIHTGLEVAIKMIDKKAMYKAGMVQR--VQNEVKIH 65

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL------LNEDDTELNWERRIKIA 245
            +L HP++++L  Y  D  +  LV E    G +  +L       +E++      R     
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA-----RHFMHQ 120

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-KFGPLGDKSHISTRVL 304
           +    G+ +LH+    ++HRD+  SN+LL  + N KI+DFGLA +     +K +  T + 
Sbjct: 121 I--ITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY--T-LC 173

Query: 305 GTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGK----TAAMRRT--NGLAGNWAKP 357
           GT  Y +PE    + H  L++DV+S G +   +L G+    T  ++ T    +  ++  P
Sbjct: 174 GTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP 232

Query: 358 -YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
            +LS                    EA++    I + L  +P +R ++S V
Sbjct: 233 SFLS-------------------IEAKDL---IHQLLRRNPADRLSLSSV 260

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  124 bits (314), Expect = 1e-32
 Identities = 64/293 (21%), Positives = 120/293 (40%), Gaps = 54/293 (18%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
              +     +G G FG VY           A+ K      A K +  K  +  +++  E+
Sbjct: 18  NEVWEIVGELGDGAFGKVYK----------AKNKETGALAAAKVIETKSEEELEDYIVEI 67

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-IALG 247
             L+  +HP +VKL+G    D    ++ E+   G+++  ++ E D  L  E +I+ +   
Sbjct: 68  EILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLT-EPQIQVVCRQ 125

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
               L  LH+  + +IHRD+KA NVL+  + + +++DFG++               +GT 
Sbjct: 126 MLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTP 181

Query: 308 GYFAPEYIATGHLT-----LKTDVYSFGVVLLEILSGK-----TAAMR-----RTNGLAG 352
            + APE +    +       K D++S G+ L+E+   +        MR       +    
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--- 238

Query: 353 NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
               P L            K         + EF + +   L+ +P+ RP+ ++
Sbjct: 239 ---PPTLLTP--------SKW--------SVEFRDFLKIALDKNPETRPSAAQ 272

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  124 bits (313), Expect = 2e-32
 Identities = 75/291 (25%), Positives = 119/291 (40%), Gaps = 57/291 (19%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--- 185
              F     +G+G +G VY           A  K     VA+K++       + + +   
Sbjct: 28  EEVFDVLEKLGEGSYGSVYK----------AIHKETGQIVAIKQVPV-----ESDLQEII 72

Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-I 244
            E+  + + + P+VVK  G    +    +V EY   GS+ D ++   +  L  E  I  I
Sbjct: 73  KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLT-EDEIATI 130

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
                +GLE+LH      IHRD+KA N+LL+ + +AK++DFG+A  G L D       V+
Sbjct: 131 LQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTMAKRNTVI 186

Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK-----TAAMR-----RTNGLAGNW 354
           GT  + APE I         D++S G+  +E+  GK        MR      TN      
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP----- 241

Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
             P             E          +  F + + +CL   P+ R T ++
Sbjct: 242 -PPTFRKP--------ELW--------SDNFTDFVKQCLVKSPEQRATATQ 275

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  124 bits (313), Expect = 6e-32
 Identities = 86/390 (22%), Positives = 150/390 (38%), Gaps = 68/390 (17%)

Query: 31  RQNRTSTVEEKRTPSDSSKAVQENRRKHRRRDYRLREWKTSVFSSSQKEKHSKKYRERTM 90
             + +S V+                +  R      +E  ++   + +    SK+     +
Sbjct: 5   HHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAV 64

Query: 91  PESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGY 150
               P A  D   V+  +  V   Y +               S+  ++G G FG V+   
Sbjct: 65  DIPAPPAPFDHRIVTAKQGAVNSFYTV---------------SKTEILGGGRFGQVHK-- 107

Query: 151 INSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ 210
                            +A K ++ +G + ++E +NE+  +++L+H N+++L        
Sbjct: 108 --------CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN 159

Query: 211 HRLLVYEYVTRGSL------EDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIH 264
             +LV EYV  G L      E + L E DT       +K       G+ H+H     ++H
Sbjct: 160 DIVLVMEYVDGGELFDRIIDESYNLTELDT----ILFMKQICE---GIRHMHQ--MYILH 210

Query: 265 RDVKASNVLL--DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTL 322
            D+K  N+L    D    KI DFGLA+      +  +     GT  + APE +    ++ 
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNF-GTPEFLAPEVVNYDFVSF 267

Query: 323 KTDVYSFGVVLLEILSG------KTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRN 376
            TD++S GV+   +LSG         A    N LA  W              ++++  ++
Sbjct: 268 PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD-------------LEDEEFQD 314

Query: 377 IQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           I  EEA+EF   I + L  +   R + SE 
Sbjct: 315 IS-EEAKEF---ISKLLIKEKSWRISASEA 340

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  123 bits (310), Expect = 6e-32
 Identities = 59/336 (17%), Positives = 110/336 (32%), Gaps = 77/336 (22%)

Query: 130 RKFSEKNLIGQGGFGDVY------------IGYINSCAMTAARRKNADFAVAVKRLRRKG 177
             F     +G+GGFG V+            I  I       AR K      A+ +L   G
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 178 ------------------------------------SQGQDEWENELRFLSRLNHPNVVK 201
                                                   D    ++R +   +  N V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 202 LMGYCCDDQHRLLVYEYVTRGSLEDHLLNE-DDTELNWERRIKIALGAARGLEHLHTYWR 260
            +       +  +  +   + +L+D +       +      + I +  A  +E LH+  +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--K 183

Query: 261 PVIHRDVKASNVLLDDDFNAKISDFGLAK----------FGPLGDKSHISTRVLGTRGYF 310
            ++HRD+K SN+    D   K+ DFGL                       T  +GT+ Y 
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           +PE I   + + K D++S G++L E+L   +  M R                  +  + +
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR---------------IITDVRN 288

Query: 371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
            K       ++  +   ++   L+  P  RP  +++
Sbjct: 289 LKFPLLFT-QKYPQEHMMVQDMLSPSPTERPEATDI 323

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  122 bits (309), Expect = 7e-32
 Identities = 69/294 (23%), Positives = 117/294 (39%), Gaps = 70/294 (23%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
             ++G G F +V++           +++      A+K +++  +      ENE+  L ++
Sbjct: 14  MEVLGSGAFSEVFL----------VKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI 63

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL-----NEDDTELNWERRIKIALGAA 249
            H N+V L        H  LV + V+ G L D +L      E D        I+  L A 
Sbjct: 64  KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA----SLVIQQVLSA- 118

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
             +++LH     ++HRD+K  N+L    +++    I+DFGL+K     +++ I +   GT
Sbjct: 119 --VKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGT 170

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
            GY APE +A    +   D +S GV+   +L G                 P+        
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYP---------------PFYEET---- 211

Query: 367 QIIDEKLGRNIQM--------------EEAQEFAEIILRCLNSDPKNRPTMSEV 406
              + KL   I+               E A++F   I   L  DP  R T  + 
Sbjct: 212 ---ESKLFEKIKEGYYEFESPFWDDISESAKDF---ICHLLEKDPNERYTCEKA 259

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  125 bits (315), Expect = 2e-31
 Identities = 71/284 (25%), Positives = 120/284 (42%), Gaps = 48/284 (16%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE--WENELRFLS 192
             ++G+G FG+V             + +      AVK + +  ++ +D      E+  L 
Sbjct: 27  VCMLGKGSFGEVLK----------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARG 251
           +L+HPN++KL     D     +V E  T G L D ++     +E +  R IK        
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG--- 133

Query: 252 LEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           + ++H     ++HRD+K  N+LL   + D + KI DFGL+       ++      +GT  
Sbjct: 134 ITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAY 188

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           Y APE +  G    K DV+S GV+L  +LSG              + K   +    L ++
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP----------PFYGK---NEYDILKRV 234

Query: 369 IDEKLG------RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
              K        R I  ++A++    I + L   P  R T ++ 
Sbjct: 235 ETGKYAFDLPQWRTIS-DDAKDL---IRKMLTFHPSLRITATQC 274

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  124 bits (314), Expect = 2e-31
 Identities = 73/295 (24%), Positives = 120/295 (40%), Gaps = 59/295 (20%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-------------GSQGQ 181
              +G G +G+V +           + KN     A+K +++                +  
Sbjct: 41  VRKLGSGAYGEVLL----------CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90

Query: 182 DEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWER 240
           +E  NE+  L  L+HPN++KL     D ++  LV E+   G L + ++N     E +   
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN 150

Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKS 297
            +K  L     + +LH     ++HRD+K  N+LL   +   N KI DFGL+ F     K 
Sbjct: 151 IMKQILSG---ICYLHK--HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF---FSKD 202

Query: 298 HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP 357
           +     LGT  Y APE +       K DV+S GV++  +L G                + 
Sbjct: 203 YKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYP----------PFGGQ- 250

Query: 358 YLSNKLALHQIIDEKLG------RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
             +++  + ++   K        +NI  +EA+E    I   L  D   R T  E 
Sbjct: 251 --NDQDIIKKVEKGKYYFDFNDWKNIS-DEAKEL---IKLMLTYDYNKRCTAEEA 299

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  120 bits (303), Expect = 4e-31
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 48/295 (16%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR-RKGSQGQDEWENELRF 190
           +  + +IG G    V           AA        VA+KR+   K     DE   E++ 
Sbjct: 17  YELQEVIGSGATAVVQ----------AAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQA 66

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW-----ERRIKIA 245
           +S+ +HPN+V             LV + ++ GS+ D + +      +      E  I   
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126

Query: 246 L-GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL-AKFGPLGDKSHISTR- 302
           L     GLE+LH      IHRDVKA N+LL +D + +I+DFG+ A     GD +    R 
Sbjct: 127 LREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184

Query: 303 -VLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSG-----KTAAMR-----RTNGL 350
             +GT  + APE +        K D++SFG+  +E+ +G     K   M+       N  
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND- 243

Query: 351 AGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
                 P L   +   + + +K G+         F ++I  CL  DP+ RPT +E
Sbjct: 244 -----PPSLETGVQDKE-MLKKYGK--------SFRKMISLCLQKDPEKRPTAAE 284

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  120 bits (304), Expect = 7e-31
 Identities = 86/296 (29%), Positives = 121/296 (40%), Gaps = 65/296 (21%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--- 185
            + FS+   IG G FG VY           AR       VA+K++   G Q  ++W+   
Sbjct: 53  EKLFSDLREIGHGSFGAVYF----------ARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102

Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-I 244
            E+RFL +L HPN ++  G    +    LV EY   GS  D LL      L  E  I  +
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQ-EVEIAAV 159

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR-- 302
             GA +GL +LH+    +IHRDVKA N+LL +    K+ DFG A        S ++    
Sbjct: 160 THGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANS 209

Query: 303 VLGTRGYFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGK-----TAAMR-----RTNG 349
            +GT  + APE I     G    K DV+S G+  +E+   K       AM        N 
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269

Query: 350 LAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
                  P L +                    ++ F   +  CL   P++RPT   
Sbjct: 270 ------SPALQSG-----------------HWSEYFRNFVDSCLQKIPQDRPTSEV 302

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  118 bits (299), Expect = 9e-31
 Identities = 70/281 (24%), Positives = 113/281 (40%), Gaps = 50/281 (17%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP 197
           IG+G +G+V I          A +K      A K++ +   +  D ++ E+  +  L+HP
Sbjct: 17  IGRGSWGEVKI----------AVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 66

Query: 198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGLEHLH 256
           N+++L     D+    LV E  T G L + ++++    E +  R +K  L A   + + H
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA---VAYCH 123

Query: 257 TYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE 313
                V HRD+K  N L      D   K+ DFGLA          + T+V GT  Y +P+
Sbjct: 124 K--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPYYVSPQ 178

Query: 314 YIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP-YLSNKLALHQII--- 369
            +  G    + D +S GV++  +L G                 P        +   I   
Sbjct: 179 -VLEGLYGPECDEWSAGVMMYVLLCGYP---------------PFSAPTDSEVMLKIREG 222

Query: 370 ----DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                EK   N+   +A+     I R L   PK R T  + 
Sbjct: 223 TFTFPEKDWLNVS-PQAESL---IRRLLTKSPKQRITSLQA 259

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  118 bits (299), Expect = 1e-30
 Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 56/286 (19%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW-ENELRFLSRLNH 196
           +G G FGDV++             +++     +K + +  SQ   E  E E+  L  L+H
Sbjct: 30  LGSGAFGDVHL----------VEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-----TELNWERRIKIALGAARG 251
           PN++K+     D  +  +V E    G L + +++        +E      +K  + A   
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA--- 136

Query: 252 LEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           L + H+  + V+H+D+K  N+L          KI DFGLA+        H +    GT  
Sbjct: 137 LAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAA-GTAL 191

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           Y APE +    +T K D++S GVV+  +L+G       +                   ++
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-----------------EEV 233

Query: 369 IDEKLGRNIQM--------EEAQEFAEIILRCLNSDPKNRPTMSEV 406
             +   +             +A +    + + L  DP+ RP+ ++V
Sbjct: 234 QQKATYKEPNYAVECRPLTPQAVDL---LKQMLTKDPERRPSAAQV 276

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (304), Expect = 1e-30
 Identities = 63/320 (19%), Positives = 106/320 (33%), Gaps = 56/320 (17%)

Query: 129 TRKFSEKNLIGQG--GFGDVYIGYINSCAMTAARRKNADFAVAVKR--LRRKGSQGQDEW 184
              +    +IG+G      V            AR K     V V+R  L    ++     
Sbjct: 24  GGCYELLTVIGKGFEDLMTVN----------LARYKPTGEYVTVRRINLEACSNEMVTFL 73

Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
           + EL      NHPN+V        D    +V  ++  GS +D L+     +   E  I  
Sbjct: 74  QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAY 132

Query: 245 AL-GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG-LAKFGPLGDK----SH 298
            L G  + L+++H      +HR VKAS++L+  D    +S           G +      
Sbjct: 133 ILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190

Query: 299 ISTRVLGTRGYFAPEYIATGHL--TLKTDVYSFGV-------------------VLLEIL 337
                +    + +PE +         K+D+YS G+                   +LLE L
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250

Query: 338 SGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQ------------EF 385
           +G    +  T+ +         S  +A   + D       +                  F
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310

Query: 386 AEIILRCLNSDPKNRPTMSE 405
              + +CL  +P  RP+ S 
Sbjct: 311 HHFVEQCLQRNPDARPSAST 330

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  119 bits (301), Expect = 2e-30
 Identities = 66/305 (21%), Positives = 122/305 (40%), Gaps = 49/305 (16%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRF 190
           F + + +G G  G V+              K +   +A K +  +     +++   EL+ 
Sbjct: 35  FEKISELGAGNGGVVF----------KVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 84

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI-KIALGAA 249
           L   N P +V   G    D    +  E++  GSL+  L          E+ + K+++   
Sbjct: 85  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVI 141

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +GL +L      ++HRDVK SN+L++     K+ DFG++  G L D S  ++ V GTR Y
Sbjct: 142 KGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLID-SMANSFV-GTRSY 196

Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSGK-------TAAMRRTNGLAGNWAKPYLSNK 362
            +PE +   H ++++D++S G+ L+E+  G+          +    G            +
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256

Query: 363 LALHQIIDEKLGRNIQMEEA----------------------QEFAEIILRCLNSDPKNR 400
                    K G + +   A                       EF + + +CL  +P  R
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316

Query: 401 PTMSE 405
             + +
Sbjct: 317 ADLKQ 321

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  119 bits (300), Expect = 2e-30
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 45/283 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRL-N 195
           IG+G +G V               K +   +AVKR+R     + Q +   +L  + R  +
Sbjct: 30  IGRGAYGSVN----------KMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSD 79

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW--ERRI-KIALGAARGL 252
            P +V+  G    +    +  E ++  S +           +   E  + KI L   + L
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAP 312
            HL    + +IHRD+K SN+LLD   N K+ DFG++  G L D S   TR  G R Y AP
Sbjct: 139 NHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVD-SIAKTRDAGCRPYMAP 194

Query: 313 EYIATGHL----TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL---AL 365
           E I          +++DV+S G+ L E+ +G+                PY         L
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRF---------------PYPKWNSVFDQL 239

Query: 366 HQIIDE---KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
            Q++     +L  + + E +  F   +  CL  D   RP   E
Sbjct: 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  119 bits (299), Expect = 2e-30
 Identities = 77/298 (25%), Positives = 109/298 (36%), Gaps = 58/298 (19%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--- 185
              F    L+G G +G VY            R        A+K +   G    DE E   
Sbjct: 23  AGIFELVELVGNGTYGQVY----------KGRHVKTGQLAAIKVMDVTG----DEEEEIK 68

Query: 186 NELRFLSRL-NHPNVVKLMG-----YCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNW 238
            E+  L +  +H N+    G            +L LV E+   GS+ D + N     L  
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK- 127

Query: 239 ERRIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS 297
           E  I  I     RGL HLH     VIHRD+K  NVLL ++   K+ DFG++    L    
Sbjct: 128 EEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTV 183

Query: 298 HISTRVLGTRGYFAPEYIATGHLT-----LKTDVYSFGVVLLEILSGK-----TAAMRRT 347
                 +GT  + APE IA           K+D++S G+  +E+  G         MR  
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-- 241

Query: 348 NGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
                           AL  I      R    + +++F   I  CL  +   RP   +
Sbjct: 242 ----------------ALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  120 bits (302), Expect = 2e-30
 Identities = 42/315 (13%), Positives = 90/315 (28%), Gaps = 61/315 (19%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGY-----------INSCAMTAARRKNADFAVAVKRLRR-K 176
            R      ++GQ                     +                  V RLR  +
Sbjct: 77  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136

Query: 177 GSQGQDEWENELRFLS---RLNHPNVVKLMGYCCDDQHRLLVYEYV----TRGSLEDHL- 228
           G + Q + +  LRF+     +  P   K++    D++   ++  +      + +L+    
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196

Query: 229 ----LNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD 284
                +     L    R+++ L   R L  LH     ++H  ++  +++LD      ++ 
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVFLTG 254

Query: 285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA----------TGHLTLKTDVYSFGVVLL 334
           F        G     S      RG+  PE  A             +T   D ++ G+ + 
Sbjct: 255 FEHLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308

Query: 335 EILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLN 394
            I                    P   +  A     +        + +      ++   L 
Sbjct: 309 WIWCADL---------------PNTDD--AALGGSEWIFRSCKNIPQ--PVRALLEGFLR 349

Query: 395 SDPKNRPTMSEVVAA 409
              ++R    + +  
Sbjct: 350 YPKEDRLLPLQAMET 364

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  119 bits (300), Expect = 3e-30
 Identities = 39/326 (11%), Positives = 90/326 (27%), Gaps = 86/326 (26%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK--------------RLR 174
            R      ++GQ                  A  +    +  V               +++
Sbjct: 72  PRTLVRGTVLGQEDPYAYLE----------ATDQETGESFEVHVPYFTERPPSNAIKQMK 121

Query: 175 R--------KGSQGQDEWENELRF------LSRLNHPNVVKLMGYCCDDQHRLLVYEY-V 219
                    +G + Q + +  LRF      +       ++++     D       + Y  
Sbjct: 122 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR 181

Query: 220 TRGSLEDHL-----LNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL 274
            + +L+         +     L    R+++ L   R L  LH     ++H  ++  +++L
Sbjct: 182 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVL 239

Query: 275 DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-----------GHLTLK 323
           D      ++ F          +         +RG+  PE  A              +T  
Sbjct: 240 DQRGGVFLTGFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293

Query: 324 TDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP-YLSNKLALHQIIDEKLGRNIQM-EE 381
            D ++ G+V+  I                    P      L   + I         + + 
Sbjct: 294 FDAWALGLVIYWIWCADL---------------PITKDAALGGSEWI---FRSCKNIPQP 335

Query: 382 AQEFAEIILRCLNSDPKNRPTMSEVV 407
            +    ++   L    ++R    + +
Sbjct: 336 VR---ALLEGFLRYPKEDRLLPLQAM 358

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  121 bits (306), Expect = 4e-30
 Identities = 81/374 (21%), Positives = 141/374 (37%), Gaps = 56/374 (14%)

Query: 49  KAVQENRRKHRRRDYRLREWKTSV-FSSSQKEKHSKKYRERTMPESLPVAARDLPAVS-- 105
               + R+   R   +     T          +      +R          ++L  ++  
Sbjct: 92  VTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHE 151

Query: 106 FHRDEVFHAYKLKYFCHGLLEAATRK--------FSEKNLIGQGGFGDVYIGYINSCAMT 157
           +     F  Y    + +  L+    +        F +  ++G+GGFG+V           
Sbjct: 152 YLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVC---------- 201

Query: 158 AARRKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSRLNHPNVVKLMGYCCDDQHRL- 213
           A + +      A K+L +K  + +       NE + L ++N   VV L  Y  + +  L 
Sbjct: 202 ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALC 260

Query: 214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL 273
           LV   +  G L+ H+ +         R +  A     GLE LH     +++RD+K  N+L
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENIL 318

Query: 274 LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVL 333
           LDD  + +ISD GLA   P G       RV GT GY APE +     T   D ++ G +L
Sbjct: 319 LDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLL 375

Query: 334 LEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEA-------QEFA 386
            E+++G++               P+   K    +I  E++ R ++            +  
Sbjct: 376 YEMIAGQS---------------PFQQRK---KKIKREEVERLVKEVPEEYSERFSPQAR 417

Query: 387 EIILRCLNSDPKNR 400
            +  + L  DP  R
Sbjct: 418 SLCSQLLCKDPAER 431

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  117 bits (296), Expect = 4e-30
 Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 48/282 (17%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR-KGSQGQDEWENELRFLSRL-N 195
           +G G  G V+            R +     +AVK++RR    +       +L  + +  +
Sbjct: 33  MGSGTCGQVW----------KMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI-KIALGAARGLEH 254
            P +V+  G    +    +  E +   + +     +       ER + K+ +   + L +
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIP---ERILGKMTVAIVKALYY 139

Query: 255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEY 314
           L      VIHRDVK SN+LLD+    K+ DFG++  G L D      R  G   Y APE 
Sbjct: 140 LKEK-HGVIHRDVKPSNILLDERGQIKLCDFGIS--GRLVD-DKAKDRSAGCAAYMAPER 195

Query: 315 IATGHL-----TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL---ALH 366
           I           ++ DV+S G+ L+E+ +G+                PY + K     L 
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQF---------------PYKNCKTDFEVLT 240

Query: 367 QIIDE---KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
           +++ E    L  ++    + +F   +  CL  D + RP  ++
Sbjct: 241 KVLQEEPPLLPGHMGF--SGDFQSFVKDCLTKDHRKRPKYNK 280

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  121 bits (304), Expect = 6e-30
 Identities = 77/377 (20%), Positives = 140/377 (37%), Gaps = 63/377 (16%)

Query: 49  KAVQENRRKHRRRDYRLREWKTSVFSSSQKEKHSKKYRERTMPESLPVAARDLPAVSFHR 108
            A    R +  +          +    S  +  +         + L         ++   
Sbjct: 97  TADDALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRA-VLAHLG 155

Query: 109 DEVFHAYKLKYFCHGLLEAATRK--------FSEKNLIGQGGFGDVYIGYINSCAMTAAR 160
              F  +    +    L+    +        F +  ++G+GGFG+V+          A +
Sbjct: 156 QAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVF----------ACQ 205

Query: 161 RKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSRLNHPNVVKLMGYCCDDQHRL-LVY 216
            K      A K+L +K  + +  ++    E + L++++   +V L  Y  + +  L LV 
Sbjct: 206 MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVM 264

Query: 217 EYVTRGSLEDHLLNEDDTELNW-ERRIK-----IALGAARGLEHLHTYWRPVIHRDVKAS 270
             +  G +  H+ N D+    + E R       I  G    LEHLH   R +I+RD+K  
Sbjct: 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQ--RNIIYRDLKPE 318

Query: 271 NVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFG 330
           NVLLDDD N +ISD GLA     G          GT G+ APE +         D ++ G
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMAPELLLGEEYDFSVDYFALG 376

Query: 331 VVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEE-------AQ 383
           V L E+++ +                P+ +      ++ +++L + +  +        + 
Sbjct: 377 VTLYEMIAARG---------------PFRARG---EKVENKELKQRVLEQAVTYPDKFSP 418

Query: 384 EFAEIILRCLNSDPKNR 400
              +     L  DP+ R
Sbjct: 419 ASKDFCEALLQKDPEKR 435

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  116 bits (292), Expect = 9e-30
 Identities = 73/286 (25%), Positives = 122/286 (42%), Gaps = 52/286 (18%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE--WENELRFLS 192
             ++G+G FG+V             + +      AVK + +  ++ +D      E+  L 
Sbjct: 27  VCMLGKGSFGEVLK----------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARG 251
           +L+HPN++KL     D     +V E  T G L D ++     +E +  R IK        
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG--- 133

Query: 252 LEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           + ++H     ++HRD+K  N+LL   + D + KI DFGL+        + +  R+ GT  
Sbjct: 134 ITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRI-GTAY 188

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP-YLSNKLALHQ 367
           Y APE +  G    K DV+S GV+L  +LSG                 P Y  N+  + +
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP---------------PFYGKNEYDILK 232

Query: 368 II-------DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
            +       D    R I  ++A++    I + L   P  R T ++ 
Sbjct: 233 RVETGKYAFDLPQWRTIS-DDAKDL---IRKMLTFHPSLRITATQC 274

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  115 bits (291), Expect = 2e-29
 Identities = 74/282 (26%), Positives = 117/282 (41%), Gaps = 47/282 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRF-LSRLN 195
           +G+G +G V             R   +   +AVKR+R   + Q Q     +L   +  ++
Sbjct: 15  LGRGAYGVVE----------KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW-ERRI-KIALGAARGLE 253
            P  V   G    +    +  E +   SL+       D      E  + KIA+   + LE
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE 313
           HLH+    VIHRDVK SNVL++     K+ DFG++  G L D         G + Y APE
Sbjct: 124 HLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDDVAKDIDA-GCKPYMAPE 179

Query: 314 YIATGHL----TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL---ALH 366
            I         ++K+D++S G+ ++E+   +                PY S       L 
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRF---------------PYDSWGTPFQQLK 224

Query: 367 QIIDE---KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
           Q+++E   +L  +    E  +F     +CL  + K RPT  E
Sbjct: 225 QVVEEPSPQLPADKFSAEFVDF---TSQCLKKNSKERPTYPE 263

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  117 bits (296), Expect = 2e-29
 Identities = 65/345 (18%), Positives = 126/345 (36%), Gaps = 62/345 (17%)

Query: 80  KHSKKYRERTMPESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEK---- 135
           + S  +              D P ++ +       +K   +    +E       +     
Sbjct: 2   RGSHHHHHHGSK---VRGKYDGPKINDYDKFYEDIWK--KYVPQPVEVKQGSVYDYYDIL 56

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN 195
             +G G FG V+              K        K +       +   +NE+  +++L+
Sbjct: 57  EELGSGAFGVVHR----------CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSL------EDHLLNEDDTELNWERRIKIALGAA 249
           HP ++ L     D    +L+ E+++ G L      ED+ ++E +        ++ A    
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV----INYMRQACE-- 160

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNA--KISDFGLAKFGPLGDKSHISTRVLGTR 307
            GL+H+H     ++H D+K  N++ +    +  KI DFGLA    L     +      T 
Sbjct: 161 -GLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTT-ATA 214

Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG------LAGNWAKPYLSN 361
            + APE +    +   TD+++ GV+   +LSG +      +          +W       
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE------ 268

Query: 362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                   DE    ++   EA++F   I   L  +P+ R T+ + 
Sbjct: 269 -------FDEDAFSSVS-PEAKDF---IKNLLQKEPRKRLTVHDA 302

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  119 bits (301), Expect = 2e-29
 Identities = 67/352 (19%), Positives = 124/352 (35%), Gaps = 49/352 (13%)

Query: 69  KTSVFSSSQKEKHSKKYRERTMPESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAA 128
           K    ++       ++ R R                     + +     K +    +E  
Sbjct: 92  KPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIK 151

Query: 129 TRKFSEK----NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW 184
                +       +G G FG V+              +      A K +       ++  
Sbjct: 152 HDHVLDHYDIHEELGTGAFGVVHR----------VTERATGNNFAAKFVMTPHESDKETV 201

Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD--TELNWERRI 242
             E++ +S L HP +V L     DD   +++YE+++ G L + + +E +  +E      +
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 261

Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLL--DDDFNAKISDFGLAKFGPLGDKSHIS 300
           +       GL H+H      +H D+K  N++         K+ DFGL     L  K  + 
Sbjct: 262 RQVCK---GLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVK 314

Query: 301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG------KTAAMRRTNGLAGNW 354
               GT  + APE      +   TD++S GV+   +LSG      +       N  + +W
Sbjct: 315 VTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 373

Query: 355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                         +D+     I  E+ ++F   I + L +DP  R T+ + 
Sbjct: 374 N-------------MDDSAFSGIS-EDGKDF---IRKLLLADPNTRMTIHQA 408

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  116 bits (292), Expect = 3e-29
 Identities = 66/292 (22%), Positives = 110/292 (37%), Gaps = 56/292 (19%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWENELR 189
             +IG+G F  V               +      AVK     +         ++ + E  
Sbjct: 29  CEVIGKGPFSVVRR----------CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW-ERR----IKI 244
               L HP++V+L+     D    +V+E++    L   ++   D    + E      ++ 
Sbjct: 79  ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHIST 301
            L A   L + H     +IHRDVK   VLL   ++    K+  FG+A    LG+   ++ 
Sbjct: 139 ILEA---LRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAG 191

Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
             +GT  + APE +         DV+  GV+L  +LSG                 P+   
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL---------------PFYGT 236

Query: 362 KLALHQII-------DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           K  L + I       + +   +I  E A++    + R L  DP  R T+ E 
Sbjct: 237 KERLFEGIIKGKYKMNPRQWSHIS-ESAKDL---VRRMLMLDPAERITVYEA 284

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  117 bits (295), Expect = 4e-29
 Identities = 74/297 (24%), Positives = 116/297 (39%), Gaps = 70/297 (23%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL-RRKGSQGQDEW-------ENELR 189
           +G G  G+V +          A  +     VA++ + +RK + G           E E+ 
Sbjct: 143 LGSGACGEVKL----------AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKI 244
            L +LNHP ++K+  +  D +   +V E +  G L D +     L E        +    
Sbjct: 193 ILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC-----KLYFY 246

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHIST 301
            +     +++LH     +IHRD+K  NVLL   ++D   KI+DFG +K   LG+ S + T
Sbjct: 247 QM--LLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT 300

Query: 302 RVLGTRGYFAPEYIATGHL---TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY 358
              GT  Y APE + +          D +S GV+L   LSG                 P 
Sbjct: 301 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG----------------YPP 343

Query: 359 LSNKLALHQIIDEKLGRNIQM---------EEAQEFAEIILRCLNSDPKNRPTMSEV 406
            S       + D+                 E+A +    + + L  DPK R T  E 
Sbjct: 344 FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL---VKKLLVVDPKARFTTEEA 397

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  114 bits (287), Expect = 8e-29
 Identities = 67/312 (21%), Positives = 118/312 (37%), Gaps = 47/312 (15%)

Query: 123 GLLEAATRKFSE-----KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG 177
           G  ++ + +F +     ++++G+G    V                      AVK + ++ 
Sbjct: 1   GSTDSFSGRFEDVYQLQEDVLGEGAHARVQT----------CINLITSQEYAVKIIEKQP 50

Query: 178 SQGQDEWENELRFLSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TE 235
              +     E+  L +   H NV++L+ +  ++    LV+E +  GS+  H+       E
Sbjct: 51  GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE 110

Query: 236 LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAK-FG 291
           L     ++    A   L+ LH   + + HRD+K  N+L    +     KI DF L     
Sbjct: 111 LEASVVVQDVASA---LDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165

Query: 292 PLGDKSHISTRVL----GTRGYFAPEYIATGHLTLKT-----DVYSFGVVLLEILSGKT- 341
             GD S IST  L    G+  Y APE +              D++S GV+L  +LSG   
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

Query: 342 -AAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLG------RNIQMEEAQEFAEIILRCLN 394
                 ++              +    I + K         +I    A++    I + L 
Sbjct: 226 FVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHIS-CAAKDL---ISKLLV 281

Query: 395 SDPKNRPTMSEV 406
            D K R + ++V
Sbjct: 282 RDAKQRLSAAQV 293

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  113 bits (286), Expect = 2e-28
 Identities = 74/358 (20%), Positives = 126/358 (35%), Gaps = 90/358 (25%)

Query: 74  SSSQKEKHSKKYRERTMPESLPVAARDLPAVSF---HRDEVFHAYKLKYFCHGLLEAATR 130
                E    +        + P  A  +P       +RD +   ++++            
Sbjct: 11  VDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVE------------ 58

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
                + +G+G    VY            ++K      A+K L++     +     E+  
Sbjct: 59  -----SELGRGATSIVYR----------CKQKGTQKPYALKVLKKT--VDKKIVRTEIGV 101

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL-----NEDDTELNWERRIKIA 245
           L RL+HPN++KL           LV E VT G L D ++     +E D        +K  
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA----ADAVKQI 157

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTR 302
           L A   + +LH     ++HRD+K  N+L      D   KI+DFGL+K   +  +  + T 
Sbjct: 158 LEA---VAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTV 210

Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK 362
             GT GY APE +       + D++S G++   +L G                       
Sbjct: 211 C-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-------------- 255

Query: 363 LALHQIIDEKLGRNIQM--------------EEAQEFAEIILRCLNSDPKNRPTMSEV 406
                  D+ + R I                  A++    + + +  DPK R T  + 
Sbjct: 256 -------DQFMFRRILNCEYYFISPWWDEVSLNAKDL---VRKLIVLDPKKRLTTFQA 303

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  111 bits (281), Expect = 3e-28
 Identities = 68/306 (22%), Positives = 111/306 (36%), Gaps = 75/306 (24%)

Query: 129 TRKFSEK----NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE- 183
           + KFS+       +G+G F  V               K      A K +  K    +D  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRR----------CVHKTTGLEFAAKIINTKKLSARDFQ 50

Query: 184 -WENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELN 237
             E E R   +L HPN+V+L     ++    LV++ VT G L + +      +E D    
Sbjct: 51  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA--- 107

Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLG 294
               I+  L +   + + H+    ++HR++K  N+LL         K++DFGLA    + 
Sbjct: 108 -SHCIQQILES---IAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VN 159

Query: 295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
           D         GT GY +PE +     +   D+++ GV+L  +L G               
Sbjct: 160 DSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP------------- 205

Query: 355 AKPYLSNKLALHQIIDEKLGRNIQM--------------EEAQEFAEIILRCLNSDPKNR 400
             P+             +L   I+                EA+     I   L  +PK R
Sbjct: 206 --PFWDED-------QHRLYAQIKAGAYDYPSPEWDTVTPEAKSL---IDSMLTVNPKKR 253

Query: 401 PTMSEV 406
            T  + 
Sbjct: 254 ITADQA 259

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  113 bits (284), Expect = 3e-28
 Identities = 66/342 (19%), Positives = 111/342 (32%), Gaps = 102/342 (29%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDE 183
            +K+  K  IGQG +G V +          A         A+K     ++R+   +  + 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRV----------AIENQTRAIRAIKIMNKNKIRQINPKDVER 74

Query: 184 WENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            + E+R + +L+HPN+ +L     D+Q+  LV E    G L D L    D          
Sbjct: 75  IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134

Query: 244 IALG-------------------------------AAR-------GLEHLHTYWRPVIHR 265
           +                                   +         L +LH   + + HR
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN--QGICHR 192

Query: 266 DVKASNVLLDDDFNA--KISDFGLAKF---GPLGDKSHISTRVLGTRGYFAPEYIATGHL 320
           D+K  N L   + +   K+ DFGL+K       G+   ++T+  GT  + APE + T + 
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNE 251

Query: 321 --TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQ 378
               K D +S GV+L  +L G                 P+           D      + 
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAV---------------PFPGVN-------DADTISQVL 289

Query: 379 M--------------EEAQEFAEIILRCLNSDPKNRPTMSEV 406
                            A++    +   LN +   R      
Sbjct: 290 NKKLCFENPNYNVLSPLARDL---LSNLLNRNVDERFDAMRA 328

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  112 bits (281), Expect = 6e-28
 Identities = 64/290 (22%), Positives = 108/290 (37%), Gaps = 68/290 (23%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN------ELRF 190
           L+G GGFG VY          +  R + +  VA+K + +       E  N      E+  
Sbjct: 50  LLGSGGFGSVY----------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 99

Query: 191 LSRLNH--PNVVKLMGYCCDDQHRLLVYEYVT-RGSLEDHL-----LNEDDTELNWERRI 242
           L +++     V++L+ +       +L+ E       L D +     L E+       R  
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-----RSF 154

Query: 243 --KIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDFGLAKFGPLGDKSHI 299
             ++       + H H     V+HRD+K  N+L+D +    K+ DFG          +  
Sbjct: 155 FWQVL----EAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVY 205

Query: 300 STRVLGTRGYFAPEYIATGHL--TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN-WAK 356
           +    GTR Y  PE+I   H        V+S G++L +++ G          + G  + +
Sbjct: 206 TDFD-GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 263

Query: 357 PYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
             +S                    E Q    +I  CL   P +RPT  E+
Sbjct: 264 QRVS-------------------SECQ---HLIRWCLALRPSDRPTFEEI 291

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  112 bits (282), Expect = 8e-28
 Identities = 78/409 (19%), Positives = 139/409 (33%), Gaps = 89/409 (21%)

Query: 32  QNRTSTVEEKRTPSDSSKAVQENRRKHRRRDYRLREWKTSVFSSSQKEKHSKKYRERTMP 91
            +  S+  + +   +  +A +E R        + R +  S+     +  +     ++   
Sbjct: 4   HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLND 63

Query: 92  ESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYI 151
                            DE+      K F         +K+  K++IG+G    V     
Sbjct: 64  AQPKGTENLYFQSMGPEDELPDWAAAKEF--------YQKYDPKDVIGRGVSSVVRR--- 112

Query: 152 NSCAMTAARRKNADFAVAVK-----RLRRKGSQGQDEWE---NELRFLSRL-NHPNVVKL 202
                     +      AVK       R    Q ++  E    E   L ++  HP+++ L
Sbjct: 113 -------CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165

Query: 203 MGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALGAARGLEHLHT 257
           +          LV++ + +G L D+L     L+E +T     R I  +L     +  LH 
Sbjct: 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET-----RSIMRSL--LEAVSFLHA 218

Query: 258 YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE---- 313
               ++HRD+K  N+LLDD+   ++SDFG +    L     +     GT GY APE    
Sbjct: 219 --NNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRELC-GTPGYLAPEILKC 273

Query: 314 --YIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
                      + D+++ GV+L  +L+G                 P+   +         
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSP---------------PFWHRR-------QI 311

Query: 372 KLGRNIQM--------------EEAQEFAEIILRCLNSDPKNRPTMSEV 406
            + R I                   ++    I R L  DP+ R T  + 
Sbjct: 312 LMLRMIMEGQYQFSSPEWDDRSSTVKDL---ISRLLQVDPEARLTAEQA 357

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  111 bits (280), Expect = 8e-28
 Identities = 55/288 (19%), Positives = 109/288 (37%), Gaps = 46/288 (15%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
             K+     +G+G FG V+               ++      K ++ KG   Q   + E+
Sbjct: 4   YEKYMIAEDLGRGEFGIVHR----------CVETSSKKTYMAKFVKVKG-TDQVLVKKEI 52

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD--TELNWERRIKIAL 246
             L+   H N++ L       +  ++++E+++   + + +        E      +    
Sbjct: 53  SILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA--KISDFGLAKFGPLGDKSHISTRVL 304
                L+ LH+    + H D++  N++     ++  KI +FG A+   L    +      
Sbjct: 113 E---ALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLF- 164

Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG------LAGNWAKPY 358
               Y+APE      ++  TD++S G ++  +LSG    +  TN       +   +    
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--- 221

Query: 359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                      DE+  + I   EA +F   + R L  + K+R T SE 
Sbjct: 222 ----------FDEEAFKEIS-IEAMDF---VDRLLVKERKSRMTASEA 255

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  113 bits (285), Expect = 1e-27
 Identities = 66/297 (22%), Positives = 109/297 (36%), Gaps = 60/297 (20%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE--WEN 186
           T ++     +G+G F  V              +  A    A   +  K    +D    E 
Sbjct: 10  TEEYQLFEELGKGAFSVVRR----------CVKVLAGQEYAAMIINTKKLSARDHQKLER 59

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLL-----NEDDTELNWERR 241
           E R    L HPN+V+L     ++ H  L+++ VT G L + ++     +E D        
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA----SHC 115

Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSH 298
           I+  L A   + H H     V+HR++K  N+LL         K++DFGLA     G++  
Sbjct: 116 IQQILEA---VLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQA 169

Query: 299 ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY 358
                 GT GY +PE +         D+++ GV+L  +L G                   
Sbjct: 170 WFGFA-GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---------- 218

Query: 359 LSNKLALHQIIDEKLGRNIQM---------EEAQEFAEIILRCLNSDPKNRPTMSEV 406
                  H++  +                  EA++    I + L  +P  R T +E 
Sbjct: 219 -------HRLYQQIKAGAYDFPSPEWDTVTPEAKDL---INKMLTINPSKRITAAEA 265

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  111 bits (279), Expect = 1e-27
 Identities = 69/291 (23%), Positives = 114/291 (39%), Gaps = 68/291 (23%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN------ELRF 190
           L+G+GGFG V+          A  R      VA+K + R    G     +      E+  
Sbjct: 38  LLGKGGFGTVF----------AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVAL 87

Query: 191 LSRLN----HPNVVKLMGYCCDDQHRLLVYEYVTRGS-LEDHL-----LNEDDTELNWER 240
           L ++     HP V++L+ +    +  +LV E       L D++     L E  +     R
Sbjct: 88  LWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS-----R 142

Query: 241 RI--KIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDFGLAKFGPLGDKS 297
               ++       ++H H+  R V+HRD+K  N+L+D     AK+ DFG           
Sbjct: 143 CFFGQVV----AAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DE 193

Query: 298 HISTRVLGTRGYFAPEYIATGHLT-LKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK 356
             +    GTR Y  PE+I+      L   V+S G++L +++ G     R    L      
Sbjct: 194 PYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHF 252

Query: 357 P-YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           P ++S                    +      +I RCL   P +RP++ E+
Sbjct: 253 PAHVS-------------------PDCC---ALIRRCLAPKPSSRPSLEEI 281

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  111 bits (279), Expect = 1e-27
 Identities = 70/291 (24%), Positives = 115/291 (39%), Gaps = 57/291 (19%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
              +G+G F                  K ++ A AVK + ++    +   + E+  L   
Sbjct: 16  DKPLGEGSFSICRK----------CVHKKSNQAFAVKIISKRM---EANTQKEITALKLC 62

Query: 195 -NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGL 252
             HPN+VKL     D  H  LV E +  G L + +  +   +E      ++  + A   +
Sbjct: 63  EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSA---V 119

Query: 253 EHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
            H+H     V+HRD+K  N+L    +D+   KI DFG A+  P  D   + T    T  Y
Sbjct: 120 SHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPC-FTLHY 175

Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII 369
            APE +         D++S GV+L  +LSG+                P+ S+  +L    
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQV---------------PFQSHDRSLTCTS 220

Query: 370 DEKLGRNIQM--------------EEAQEFAEIILRCLNSDPKNRPTMSEV 406
             ++ + I+               +EA++    I   L  DP  R  MS +
Sbjct: 221 AVEIMKKIKKGDFSFEGEAWKNVSQEAKDL---IQGLLTVDPNKRLKMSGL 268

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  110 bits (278), Expect = 2e-27
 Identities = 77/302 (25%), Positives = 118/302 (39%), Gaps = 80/302 (26%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL-RRKGSQGQDEW-------ENELR 189
           +G G  G+V +          A  +     VA+K + +RK + G           E E+ 
Sbjct: 18  LGSGACGEVKL----------AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKI 244
            L +LNHP ++K+  +  D +   +V E +  G L D +     L E   +         
Sbjct: 68  ILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK----LYFYQ 122

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHIST 301
            L A   +++LH     +IHRD+K  NVLL   ++D   KI+DFG +K   LG+ S + T
Sbjct: 123 MLLA---VQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT 175

Query: 302 RVLGTRGYFAPEYIATGHL---TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY 358
              GT  Y APE + +          D +S GV+L   LSG                 P+
Sbjct: 176 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP---------------PF 219

Query: 359 LSNKLALHQIIDEKLGRNIQM--------------EEAQEFAEIILRCLNSDPKNRPTMS 404
             ++          L   I                E+A +    + + L  DPK R T  
Sbjct: 220 SEHR------TQVSLKDQITSGKYNFIPEVWAEVSEKALDL---VKKLLVVDPKARFTTE 270

Query: 405 EV 406
           E 
Sbjct: 271 EA 272

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  110 bits (276), Expect = 2e-27
 Identities = 68/313 (21%), Positives = 114/313 (36%), Gaps = 82/313 (26%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---------GSQ 179
              +  K ++G+G    V               K      AVK +              +
Sbjct: 16  YENYEPKEILGRGVSSVVRR----------CIHKPTCKEYAVKIIDVTGGGSFSAEEVQE 65

Query: 180 GQDEWENELRFLSRLN-HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDD 233
            ++    E+  L +++ HPN+++L      +    LV++ + +G L D+L     L+E +
Sbjct: 66  LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE 125

Query: 234 TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
           T     R+I  AL     +  LH     ++HRD+K  N+LLDDD N K++DFG +    L
Sbjct: 126 T-----RKIMRAL--LEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--L 174

Query: 294 GDKSHISTRVLGTRGYFAPEYIATGHLTLKT------DVYSFGVVLLEILSGKTAAMRRT 347
                +     GT  Y APE I               D++S GV++  +L+G        
Sbjct: 175 DPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------ 227

Query: 348 NGLAGNWAKPYLSNKLALHQIIDEKLGRNIQM--------------EEAQEFAEIILRCL 393
                    P+   K          + R I                +  ++    + R L
Sbjct: 228 ---------PFWHRK-------QMLMLRMIMSGNYQFGSPEWDDYSDTVKDL---VSRFL 268

Query: 394 NSDPKNRPTMSEV 406
              P+ R T  E 
Sbjct: 269 VVQPQKRYTAEEA 281

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  109 bits (275), Expect = 2e-27
 Identities = 68/294 (23%), Positives = 115/294 (39%), Gaps = 68/294 (23%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW------ENELRFL 191
           +G G F  V             R+K      A K ++++              E E+  L
Sbjct: 13  LGSGQFAIVRK----------CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAAR 250
             + HPN++ L     +    +L+ E V+ G L D L  ++  TE    + +K  L    
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD--- 119

Query: 251 GLEHLHTYWRPVIHRDVKASNVLL----DDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
           G+ +LH+  + + H D+K  N++L      +   K+ DFG+A    +   +       GT
Sbjct: 120 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF-GT 174

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             + APE +    L L+ D++S GV+   +LSG +               P+L       
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---------------PFLGET---- 215

Query: 367 QIIDEKLGRNIQM--------------EEAQEFAEIILRCLNSDPKNRPTMSEV 406
               ++   NI                E A++F   I R L  DPK R T+++ 
Sbjct: 216 ---KQETLTNISAVNYDFDEEYFSNTSELAKDF---IRRLLVKDPKRRMTIAQS 263

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  110 bits (278), Expect = 3e-27
 Identities = 68/292 (23%), Positives = 111/292 (38%), Gaps = 63/292 (21%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE--WENELRFLS 192
           K  +G+G F  V               K      A K +  K    +D    E E R   
Sbjct: 34  KEELGKGAFSVVRR----------CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 83

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALG 247
           +L HPN+V+L     ++    LV++ VT G L + +      +E D        I+  L 
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA----SHCIQQILE 139

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVL 304
           +   + + H+    ++HR++K  N+LL         K++DFGLA    + D         
Sbjct: 140 S---IAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA- 191

Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP-YLSNKL 363
           GT GY +PE +     +   D+++ GV+L  +L G                 P +  ++ 
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP---------------PFWDEDQH 236

Query: 364 ALHQIIDEKLGR---------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
            L+  I  K G           +   EA+     I   L  +PK R T  + 
Sbjct: 237 RLYAQI--KAGAYDYPSPEWDTVT-PEAKSL---IDSMLTVNPKKRITADQA 282

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  108 bits (273), Expect = 3e-27
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 32/213 (15%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL-RRKGSQGQDEWENELRFLSRLN 195
            +G+G +G+V +          A  +  + AVAVK +  ++     +  + E+     LN
Sbjct: 14  TLGEGAYGEVQL----------AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR----- 250
           H NVVK  G+  +   + L  EY + G L D +          E  I +    A+     
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI----------EPDIGMPEPDAQRFFHQ 113

Query: 251 ---GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
              G+ +LH     + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT 
Sbjct: 114 LMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 308 GYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSG 339
            Y APE +          DV+S G+VL  +L+G
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  109 bits (275), Expect = 3e-27
 Identities = 63/296 (21%), Positives = 108/296 (36%), Gaps = 72/296 (24%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR----KGSQGQDEWENELRFLS 192
           L+G+G +G V                      AVK L++    +   G+   + E++ L 
Sbjct: 12  LLGEGSYGKVKE----------VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61

Query: 193 RLNHPNVVKL--MGYCCDDQHRLLVYEYVTRGSLE--DHLLNEDDTELNWERRIKIALGA 248
           RL H NV++L  + Y  + Q   +V EY   G  E  D +          E+R  +    
Sbjct: 62  RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP---------EKRFPVC--Q 110

Query: 249 AR--------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
           A         GLE+LH+  + ++H+D+K  N+LL      KIS  G+A+           
Sbjct: 111 AHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168

Query: 301 TRVLGTRGYFAPEYIATGHL--TLKTDVYSFGVVLLEILSGK-------TAAMRRTNGLA 351
               G+  +  PE           K D++S GV L  I +G           +   N   
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE-NIGK 227

Query: 352 GNWAKP-YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           G++A P                             ++++   L  +P  R ++ ++
Sbjct: 228 GSYAIPGDCG----------------------PPLSDLLKGMLEYEPAKRFSIRQI 261

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  108 bits (273), Expect = 9e-27
 Identities = 63/293 (21%), Positives = 110/293 (37%), Gaps = 68/293 (23%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVK--RLRRKGSQGQDEWENELRFLSRLN 195
           +G+G F  V               K+     A K  + RR+G   + E  +E+  L    
Sbjct: 37  LGRGKFAVVRQ----------CISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 196 H-PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERR----IKIALGAAR 250
             P V+ L     +    +L+ EY   G +    L E    ++ E      IK  L    
Sbjct: 87  SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS-ENDVIRLIKQILE--- 142

Query: 251 GLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
           G+ +LH     ++H D+K  N+LL       + KI DFG+++   +G    +   + GT 
Sbjct: 143 GVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM-GTP 197

Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            Y APE +    +T  TD+++ G++   +L+  +               P++        
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTS---------------PFVGED----- 237

Query: 368 IIDEKLGRNIQM--------------EEAQEFAEIILRCLNSDPKNRPTMSEV 406
             +++   NI                + A +F   I   L  +P+ RPT    
Sbjct: 238 --NQETYLNISQVNVDYSEETFSSVSQLATDF---IQSLLVKNPEKRPTAEIC 285

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  109 bits (275), Expect = 9e-27
 Identities = 69/294 (23%), Positives = 116/294 (39%), Gaps = 68/294 (23%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW------ENELRFL 191
           +G G F  V             R K+     A K ++++ S+           E E+  L
Sbjct: 20  LGSGQFAIVKK----------CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAAR 250
            ++ HPN++ L     +    +L+ E V+ G L D L  ++  +E      IK  L    
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD--- 126

Query: 251 GLEHLHTYWRPVIHRDVKASNVLL----DDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
           G+ +LHT  + + H D+K  N++L        + K+ DFGLA    + D         GT
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GT 181

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             + APE +    L L+ D++S GV+   +LSG +               P+L +     
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---------------PFLGDT---- 222

Query: 367 QIIDEKLGRNIQM--------------EEAQEFAEIILRCLNSDPKNRPTMSEV 406
               ++   NI                E A++F   I + L  + + R T+ E 
Sbjct: 223 ---KQETLANITAVSYDFDEEFFSQTSELAKDF---IRKLLVKETRKRLTIQEA 270

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  108 bits (273), Expect = 1e-26
 Identities = 72/284 (25%), Positives = 119/284 (41%), Gaps = 59/284 (20%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLN 195
           IG+G F  V +          AR       VA+K + +         +   E+R +  LN
Sbjct: 23  IGKGNFAKVKL----------ARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN 72

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALGAAR 250
           HPN+VKL      ++   L+ EY + G + D+L     + E +      R     + +A 
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----RSKFRQIVSA- 126

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            +++ H   + ++HRD+KA N+LLD D N KI+DFG +    +G K  +     G   Y 
Sbjct: 127 -VQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFC-GAPPYA 180

Query: 311 APEYIA-TGHLTLKTDVYSFGVVLLEILSGK------TAAMRRTNGLAGNWAKP-YLSNK 362
           APE      +   + DV+S GV+L  ++SG            R   L G +  P Y+S  
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS-- 238

Query: 363 LALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                             + +    ++ R L  +P  R T+ ++
Sbjct: 239 -----------------TDCE---NLLKRFLVLNPIKRGTLEQI 262

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  108 bits (272), Expect = 1e-26
 Identities = 69/294 (23%), Positives = 115/294 (39%), Gaps = 68/294 (23%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW------ENELRFL 191
           +G G F  V             R K+     A K ++++ S+           E E+  L
Sbjct: 20  LGSGQFAIVKK----------CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAAR 250
            ++ H NV+ L     +    +L+ E V+ G L D L  ++  +E      IK  L    
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD--- 126

Query: 251 GLEHLHTYWRPVIHRDVKASNVLL----DDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
           G+ +LHT  + + H D+K  N++L        + K+ DFGLA    + D         GT
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GT 181

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
             + APE +    L L+ D++S GV+   +LSG +               P+L +     
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---------------PFLGDT---- 222

Query: 367 QIIDEKLGRNIQM--------------EEAQEFAEIILRCLNSDPKNRPTMSEV 406
               ++   NI                E A++F   I + L  + + R T+ E 
Sbjct: 223 ---KQETLANITSVSYDFDEEFFSHTSELAKDF---IRKLLVKETRKRLTIQEA 270

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  106 bits (267), Expect = 3e-26
 Identities = 76/312 (24%), Positives = 127/312 (40%), Gaps = 79/312 (25%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAA---------RRKNADFAVAVKRLRRKGSQGQDEWE 185
           K+ IG+G +G V + Y  +     A          R+         R  R    G  +  
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 186 N-------ELRFLSRLNHPNVVKLMGY----CCDDQHRLLVYEYVTRGSLEDHL----LN 230
                   E+  L +L+HPNVVKL         ++ H  +V+E V +G + +      L+
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS 135

Query: 231 EDDTELNWERRIKIALGAAR--------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI 282
           ED                AR        G+E+LH   + +IHRD+K SN+L+ +D + KI
Sbjct: 136 EDQ---------------ARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHIKI 178

Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLT---LKTDVYSFGVVLLEILSG 339
           +DFG++     G  + +S  V GT  + APE ++           DV++ GV L   + G
Sbjct: 179 ADFGVSNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236

Query: 340 KTAAMRRTNGLAGNWAKPYL----SNKLALHQ-IIDEKLGRNIQMEEAQEFAEIILRCLN 394
                                      + LH  I  + L    Q + A++  ++I R L+
Sbjct: 237 ------------------QCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLD 278

Query: 395 SDPKNRPTMSEV 406
            +P++R  + E+
Sbjct: 279 KNPESRIVVPEI 290

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  107 bits (268), Expect = 3e-26
 Identities = 69/291 (23%), Positives = 116/291 (39%), Gaps = 66/291 (22%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL-RRKGSQGQDEWENELRFLSRLN 195
            +G+G +G+V +          A  +  + AVAVK +  ++     +  + E+     LN
Sbjct: 14  TLGEGAYGEVQL----------AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALGAAR 250
           H NVVK  G+  +   + L  EY + G L D +     + E D               A+
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---------------AQ 108

Query: 251 --------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
                   G+ +LH     + HRD+K  N+LLD+  N KISDFGLA      ++  +  +
Sbjct: 109 RFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 303 VLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL-- 359
           + GT  Y APE +          DV+S G+VL  +L+G                   L  
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG------------------ELPW 208

Query: 360 ----SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                +        ++K   N   +       ++ + L  +P  R T+ ++
Sbjct: 209 DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 259

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  106 bits (268), Expect = 4e-26
 Identities = 70/286 (24%), Positives = 112/286 (39%), Gaps = 52/286 (18%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK------GSQGQDEWENELRFL 191
           +G G F  V             R K+     A K ++++          +++ E E+  L
Sbjct: 19  LGSGQFAVVKK----------CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAAR 250
             + HPNV+ L     +    +L+ E V  G L D L  ++  TE      +K  L    
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG-- 126

Query: 251 GLEHLHTYWRPVIHRDVKASNVLL----DDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
            + +LH+    + H D+K  N++L          KI DFGLA    +   +       GT
Sbjct: 127 -VYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF-GT 180

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG------KTAAMRRTNGLAGNWAKPYLS 360
             + APE +    L L+ D++S GV+   +LSG       T      N  A N+      
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----- 235

Query: 361 NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                    +++   N     A++F   I R L  DPK R T+ + 
Sbjct: 236 --------FEDEYFSNTS-ALAKDF---IRRLLVKDPKKRMTIQDS 269

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  108 bits (271), Expect = 2e-25
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 39/224 (17%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NEL 188
           FS   +IG+GGFG+VY            R+ +     A+K L +K  + +       NE 
Sbjct: 191 FSVHRIIGRGGFGEVY----------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240

Query: 189 RFLSRLN---HPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIK- 243
             LS ++    P +V +  Y      +L  + + +  G L  HL          E  ++ 
Sbjct: 241 IMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRF 296

Query: 244 ----IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
               I LG    LEH+H   R V++RD+K +N+LLD+  + +ISD GLA       K H 
Sbjct: 297 YAAEIILG----LEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH- 348

Query: 300 STRVLGTRGYFAPEYIA--TGHLTLKTDVYSFGVVLLEILSGKT 341
              V GT GY APE +     +     D +S G +L ++L G +
Sbjct: 349 -ASV-GTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGHS 389

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  104 bits (262), Expect = 2e-25
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 37/223 (16%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NEL 188
           F    ++G+G F  V +          AR        A+K L ++    +++      E 
Sbjct: 32  FKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRER 81

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             +SRL+HP  VKL  +   D  +L     Y   G L  ++           +       
Sbjct: 82  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI----------RKIGSFDET 130

Query: 248 AAR--------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
             R         LE+LH   + +IHRD+K  N+LL++D + +I+DFG AK      K   
Sbjct: 131 CTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188

Query: 300 STRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKT 341
           +   +GT  Y +PE +         +D+++ G ++ ++++G  
Sbjct: 189 ANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLP 230

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  105 bits (263), Expect = 2e-25
 Identities = 59/290 (20%), Positives = 110/290 (37%), Gaps = 66/290 (22%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---------EL 188
           +G G FG V+           A  K  +  V VK ++++    +D W           E+
Sbjct: 32  LGSGAFGFVWT----------AVDKEKNKEVVVKFIKKE-KVLEDCWIEDPKLGKVTLEI 80

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYE-YVTRGSLEDHL-----LNEDDTELNWERRI 242
             LSR+ H N++K++    +     LV E + +   L   +     L+E          I
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA-----SYI 135

Query: 243 --KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
             ++       + +L    + +IHRD+K  N+++ +DF  K+ DFG A +   G   +  
Sbjct: 136 FRQLV----SAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF 189

Query: 301 TRVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP-Y 358
               GT  Y APE +    +   + +++S GV L  ++  +         +      P  
Sbjct: 190 C---GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYL 246

Query: 359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
           +S                      +E   ++   L   P+ R T+ ++V 
Sbjct: 247 VS----------------------KELMSLVSGLLQPVPERRTTLEKLVT 274

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  104 bits (262), Expect = 3e-25
 Identities = 69/344 (20%), Positives = 120/344 (34%), Gaps = 83/344 (24%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K ++G G  G V               +      A+K L         +   E+    + 
Sbjct: 34  KQVLGLGVNGKVLE----------CFHRRTGQKCALKLLYDS-----PKARQEVDHHWQA 78

Query: 195 -NHPNVVKLMGYCCDDQHR----LLVYEYVTRGSLEDHLLNEDDTELNWERR----IKIA 245
              P++V ++    +  H     L++ E +  G L   +    D     ER     ++  
Sbjct: 79  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT-EREAAEIMRDI 137

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTR 302
             A   ++ LH+    + HRDVK  N+L    + D   K++DFG AK         + T 
Sbjct: 138 GTA---IQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTP 189

Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK 362
              T  Y APE +         D++S GV++  +L G                 P+ SN 
Sbjct: 190 C-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP---------------PFYSNT 233

Query: 363 LALHQIIDEKLGRNIQM--------------EEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
               Q I   + R I++              E+A++    I   L +DP  R T+++   
Sbjct: 234 ---GQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQL---IRLLLKTDPTERLTITQF-- 285

Query: 409 ALEQLQ----LNMGSCYQTSLRTSTHTTRTRSFEQRPLKQRMSN 448
               +            QT L T+      +      +K+ M++
Sbjct: 286 ----MNHPWINQSMVVPQTPLHTARVLQEDKDH-WDEVKEEMTS 324

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  104 bits (262), Expect = 4e-25
 Identities = 63/283 (22%), Positives = 108/283 (38%), Gaps = 45/283 (15%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           K  IG G +                  K  +   AVK + +      +E    L      
Sbjct: 27  KEDIGVGSYSVCKR----------CIHKATNMEFAVKIIDKSKRDPTEE-IEILLRYG-- 73

Query: 195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGLE 253
            HPN++ L     D ++  +V E +  G L D +L +   +E      +         +E
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT---VE 130

Query: 254 HLHTYWRPVIHRDVKASNVLL----DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
           +LH   + V+HRD+K SN+L      +  + +I DFG AK     +   + T    T  +
Sbjct: 131 YLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPC-YTANF 186

Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII 369
            APE +         D++S GV+L  +L+G T               P  + +  L +I 
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF----------ANGPDDTPEEILARIG 236

Query: 370 DEKLG------RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
             K         ++  + A++    + + L+ DP  R T + V
Sbjct: 237 SGKFSLSGGYWNSVS-DTAKDL---VSKMLHVDPHQRLTAALV 275

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  102 bits (256), Expect = 8e-25
 Identities = 72/295 (24%), Positives = 113/295 (38%), Gaps = 78/295 (26%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
            +G G FG V I             +     VAVK L R+  +  D       E++ L  
Sbjct: 18  TLGVGTFGKVKI----------GEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL 67

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALGA 248
             HP+++KL           +V EYV+ G L D++     + E +               
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEME--------------- 112

Query: 249 AR--------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
           AR         +++ H     V+HRD+K  NVLLD   NAKI+DFGL+     G+    S
Sbjct: 113 ARRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 170

Query: 301 TRVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGK-------TAAMRRTNGLAG 352
               G+  Y APE I+   +   + D++S GV+L  +L G           + +     G
Sbjct: 171 C---GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK-KIRGG 226

Query: 353 NWAKP-YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
            +  P YL+                           +++  L  DP  R T+ ++
Sbjct: 227 VFYIPEYLN-------------------RSVA---TLLMHMLQVDPLKRATIKDI 259

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  103 bits (258), Expect = 2e-24
 Identities = 68/281 (24%), Positives = 119/281 (42%), Gaps = 57/281 (20%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
            IG+G FG V I           ++ +     A+K + ++    ++E  N   EL+ +  
Sbjct: 22  AIGKGSFGKVCI----------VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71

Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIA-L 246
           L HP +V L  Y   D+  + +V + +  G L  HL       E+        ++ I  L
Sbjct: 72  LEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV------KLFICEL 124

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
             A  L++L    + +IHRD+K  N+LLD+  +  I+DF +A   P   +    T + GT
Sbjct: 125 VMA--LDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177

Query: 307 RGYFAPEYIA----TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP-YLSN 361
           + Y APE  +     G+ +   D +S GV   E+L G+                P ++ +
Sbjct: 178 KPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRR---------------PYHIRS 221

Query: 362 KLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNR 400
             +  +I+       +    A  QE   ++ + L  +P  R
Sbjct: 222 STSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  102 bits (256), Expect = 5e-24
 Identities = 70/347 (20%), Positives = 122/347 (35%), Gaps = 82/347 (23%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
             ++G G  G V               K      A+K L+        +   E+    R 
Sbjct: 67  SQVLGLGINGKVLQ----------IFNKRTQEKFALKMLQDC-----PKARREVELHWRA 111

Query: 195 -NHPNVVKLMGYCCD----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERR----IKIA 245
              P++V+++    +     +  L+V E +  G L   + +  D     ER     +K  
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKSI 170

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTR 302
             A   +++LH+    + HRDVK  N+L      +   K++DFG AK     +   ++T 
Sbjct: 171 GEA---IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTP 223

Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK 362
              T  Y APE +         D++S GV++  +L G                 P+ SN 
Sbjct: 224 C-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP---------------PFYSNH 267

Query: 363 LALHQIIDEKLGRNIQM--------------EEAQEFAEIILRCLNSDPKNRPTMSEVVA 408
                 I   +   I+M              EE +     I   L ++P  R T++E   
Sbjct: 268 ---GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML---IRNLLKTEPTQRMTITEF-- 319

Query: 409 ALEQLQ----LNMGSCYQTSLRTSTHTTRTRSFEQRPLKQRMSNLVI 451
               +     +      QT L TS    +        +K+ M++ + 
Sbjct: 320 ----MNHPWIMQSTKVPQTPLHTS-RVLKEDKERWEDVKEEMTSALA 361

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  100 bits (250), Expect = 5e-24
 Identities = 42/284 (14%), Positives = 79/284 (27%), Gaps = 65/284 (22%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSR 193
             G       +           A     D  VA+  +  +G    D  +   +    LSR
Sbjct: 38  FHGGVPPLQFW----------QALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSR 87

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE 253
           ++ P V +++         L+V E++  GSL++      DT  +    I+     A   +
Sbjct: 88  IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAAD 143

Query: 254 HLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPE 313
             H     V       S V +  D        G                 L         
Sbjct: 144 AAHR--AGVALSIDHPSRVRVSID--------GDVV--------------LAYPATMPDA 179

Query: 314 YIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRT--NGLAGNWAKPYLSNKLALHQIIDE 371
                    + D+   G  L  +L  +         +GLA               +    
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAG 220

Query: 372 KLG--RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +     +I  +   + + +  R +  D   R   S ++  ++Q 
Sbjct: 221 QPIEPADIDRDIPFQISAVAARSVQGDGGIRSA-STLLNLMQQA 263

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  101 bits (254), Expect = 1e-23
 Identities = 50/229 (21%), Positives = 82/229 (35%), Gaps = 42/229 (18%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NEL 188
           F    +IG+G F +V +           + K      A+K + +     + E      E 
Sbjct: 63  FEILKVIGRGAFSEVAV----------VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREER 112

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             L   +   + +L  +   D++ L LV EY   G L   L    +         +I   
Sbjct: 113 DVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGE---------RIPAE 162

Query: 248 AAR--------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
            AR         ++ +H      +HRD+K  N+LLD   + +++DFG             
Sbjct: 163 MARFYLAEIVMAIDSVHRL--GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220

Query: 300 STRVLGTRGYFAPEYIATGHLTLKTDVY-------SFGVVLLEILSGKT 341
              V GT  Y +PE +        T  Y       + GV   E+  G+T
Sbjct: 221 LVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  100 bits (252), Expect = 1e-23
 Identities = 59/219 (26%), Positives = 87/219 (39%), Gaps = 47/219 (21%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
            IG G FG   +           R K     VAVK +  +G+   +  + E+     L H
Sbjct: 27  DIGSGNFGVARL----------MRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRH 75

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALGAAR- 250
           PN+V+         H  ++ EY + G L + +      +ED+               AR 
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDE---------------ARF 120

Query: 251 -------GLEHLHTYWRPVIHRDVKASNVLLDDDF--NAKISDFGLAKFGPLGDKSHIST 301
                  G+ + H+    + HRD+K  N LLD       KI DFG +K   L  +    +
Sbjct: 121 FFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--S 176

Query: 302 RVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSG 339
            V GT  Y APE +    +     DV+S GV L  +L G
Sbjct: 177 TV-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  100 bits (250), Expect = 4e-23
 Identities = 72/295 (24%), Positives = 115/295 (38%), Gaps = 78/295 (26%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
            +G G FG V +           + +     VAVK L R+  +  D       E++ L  
Sbjct: 23  TLGVGTFGKVKV----------GKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKL 72

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALGA 248
             HP+++KL           +V EYV+ G L D++     L+E +               
Sbjct: 73  FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE--------------- 117

Query: 249 AR--------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
           +R        G+++ H     V+HRD+K  NVLLD   NAKI+DFGL+     G+    S
Sbjct: 118 SRRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 175

Query: 301 TRVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGK-------TAAMRRTNGLAG 352
               G+  Y APE I+   +   + D++S GV+L  +L G           + +     G
Sbjct: 176 C---GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK-KICDG 231

Query: 353 NWAKP-YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
            +  P YL+                           ++   L  DP  R T+ ++
Sbjct: 232 IFYTPQYLN----------------------PSVISLLKHMLQVDPMKRATIKDI 264

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 98.8 bits (246), Expect = 5e-23
 Identities = 57/198 (28%), Positives = 84/198 (42%), Gaps = 32/198 (16%)

Query: 225 EDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD 284
           E+   +     L  E  I  +   A+G+E L +  R  IHRD+ A N+LL +    KI D
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICD 236

Query: 285 FGLAKFGPLGDKSHISTRVLGTRGYF-----APEYIATGHLTLKTDVYSFGVVLLEILSG 339
           FGLA+     D       V            APE I     T+++DV+SFGV+L EI S 
Sbjct: 237 FGLAR-----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS- 290

Query: 340 KTAAMRRTNGLAGNWAKPY---LSNKLALHQIIDEKLGRNIQMEEA-QEFAEIILRCLNS 395
                     L  +   PY     ++    ++ +    R    +    E  + +L C + 
Sbjct: 291 ----------LGAS---PYPGVKIDEEFCRRLKEG--TRMRAPDYTTPEMYQTMLDCWHG 335

Query: 396 DPKNRPTMSEVVAALEQL 413
           +P  RPT SE+V  L  L
Sbjct: 336 EPSQRPTFSELVEHLGNL 353

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.1 bits (135), Expect = 8e-09
 Identities = 29/100 (29%), Positives = 44/100 (44%), Gaps = 8/100 (8%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSR 193
              +G+G FG V          TA  R      VAVK L+   +        +EL+ L  
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRT-----VAVKMLKEGATHSEHRALMSELKILIH 81

Query: 194 L-NHPNVVKLMGYCCDDQHRLLV-YEYVTRGSLEDHLLNE 231
           + +H NVV L+G C      L+V  E+   G+L  +L ++
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 30/213 (14%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
           L+G+G FG V +           + K      A+K L+++    +DE  +   E R L  
Sbjct: 155 LLGKGTFGKVIL----------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204

Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIK-----IALG 247
             HP +  L  Y      RL  V EY   G L  HL  E       E R +     I   
Sbjct: 205 SRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFS---EDRARFYGAEIVSA 260

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
               L++LH+  + V++RD+K  N++LD D + KI+DFGL K G + D + + T   GT 
Sbjct: 261 ----LDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTP 313

Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
            Y APE +         D +  GVV+ E++ G+
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 98.3 bits (245), Expect = 2e-22
 Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 26/220 (11%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NEL 188
           F    +IG+G FG+V +           + KNAD   A+K L +     + E      E 
Sbjct: 76  FEILKVIGRGAFGEVAV----------VKLKNADKVFAMKILNKWEMLKRAETACFREER 125

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIA-L 246
             L   +   +  L  Y   D + L LV +Y   G L   L   +D       R  +A +
Sbjct: 126 DVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
             A  ++ +H      +HRD+K  N+L+D + + +++DFG             S  V GT
Sbjct: 185 VIA--IDSVHQL--HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GT 239

Query: 307 RGYFAPEYIATGHLTLKT-----DVYSFGVVLLEILSGKT 341
             Y +PE +              D +S GV + E+L G+T
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 97.1 bits (242), Expect = 4e-22
 Identities = 60/226 (26%), Positives = 91/226 (40%), Gaps = 41/226 (18%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NEL 188
           +    +IG+G FG+V +           R K+     A+K L +     + +      E 
Sbjct: 71  YEVVKVIGRGAFGEVQL----------VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
             ++  N P VV+L  Y   D   L +V EY+  G L + +               +   
Sbjct: 121 DIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM-----------SNYDVPEK 168

Query: 248 AAR--------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI 299
            AR         L+ +H+     IHRDVK  N+LLD   + K++DFG             
Sbjct: 169 WARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226

Query: 300 STRVLGTRGYFAPEYI----ATGHLTLKTDVYSFGVVLLEILSGKT 341
            T V GT  Y +PE +      G+   + D +S GV L E+L G T
Sbjct: 227 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 95.0 bits (237), Expect = 8e-22
 Identities = 73/295 (24%), Positives = 118/295 (40%), Gaps = 79/295 (26%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
            +G+G FG V +          A        VA+K + R+  +  D       E+ +L  
Sbjct: 16  TLGEGSFGKVKL----------ATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL 65

Query: 194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL-----LNEDDTELNWERRIKIALGA 248
           L HP+++KL          ++V EY   G L D++     + ED+               
Sbjct: 66  LRHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDE--------------- 109

Query: 249 AR--------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
            R         +E+ H     ++HRD+K  N+LLDD+ N KI+DFGL+     G+    S
Sbjct: 110 GRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167

Query: 301 TRVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGK-------TAAMRRTNGLAG 352
               G+  Y APE I    +   + DV+S G+VL  +L G+          + +    + 
Sbjct: 168 C---GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-KVNSC 223

Query: 353 NWAKP-YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
            +  P +LS                     AQ    +I R + +DP  R T+ E+
Sbjct: 224 VYVMPDFLS-------------------PGAQ---SLIRRMIVADPMQRITIQEI 256

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 69/214 (32%), Positives = 98/214 (45%), Gaps = 33/214 (15%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
           L+G+G FG V +           R K      A+K LR++    +DE  +   E R L  
Sbjct: 12  LLGKGTFGKVIL----------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 194 LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIK-----IALG 247
             HP +  L  Y      RL  V EY   G L  HL  E       E R +     I   
Sbjct: 62  TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARFYGAEIVSA 117

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
               LE+LH+  R V++RD+K  N++LD D + KI+DFGL K G + D + + T   GT 
Sbjct: 118 ----LEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTP 169

Query: 308 GYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGK 340
            Y APE +    +     D +  GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 70/284 (24%), Positives = 125/284 (44%), Gaps = 61/284 (21%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NEL 188
           F     +G G FG V++           R ++     A+K L+++      + E   +E 
Sbjct: 8   FQILRTLGTGSFGRVHL----------IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 57

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIK---- 243
             LS + HP ++++      D  ++ ++ +Y+  G L   L              K    
Sbjct: 58  LMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAA 113

Query: 244 -IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
            + L     LE+LH+  + +I+RD+K  N+LLD + + KI+DFG AK+  + D     T 
Sbjct: 114 EVCLA----LEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDV----TY 161

Query: 303 VL-GTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP-YL 359
            L GT  Y APE ++T  +     D +SFG+++ E+L+G T               P Y 
Sbjct: 162 TLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYT---------------PFYD 205

Query: 360 SNKLAL-HQIIDEKLG--RNIQMEEAQEFAEIILRCLNSDPKNR 400
           SN +    +I++ +L        E+ +   +++ R +  D   R
Sbjct: 206 SNTMKTYEKILNAELRFPPFFN-EDVK---DLLSRLITRDLSQR 245

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 42/221 (19%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NEL 188
           F     +G G FG V +           + K +    A+K L ++      + E   NE 
Sbjct: 43  FDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
           R L  +N P +VKL     D+ +  +V EYV  G +  HL           R  + +   
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----------RRIGRFSEPH 142

Query: 249 AR--------GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
           AR          E+LH+    +I+RD+K  N+L+D     +++DFG AK   +  +    
Sbjct: 143 ARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGR---- 194

Query: 301 TRVL-GTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSG 339
           T  L GT    APE I + G+     D ++ GV++ E+ +G
Sbjct: 195 TWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAG 234

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 45/226 (19%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---- 186
           K+ +   IG+G +G V+            R ++    VA+K+         D        
Sbjct: 4   KYEKIGKIGEGSYGVVF----------KCRNRDTGQIVAIKKFLESE---DDPVIKKIAL 50

Query: 187 -ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK-I 244
            E+R L +L HPN+V L+      +   LV+EY    ++   L  +       E  +K I
Sbjct: 51  REIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSI 107

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDKSH-IST 301
                + +   H +    IHRDVK  N+L+      K+ DFG A+    P       ++T
Sbjct: 108 TWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165

Query: 302 R-------VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           R       ++G   Y  P            DV++ G V  E+LSG 
Sbjct: 166 RWYRSPELLVGDTQYGPP-----------VDVWAIGCVFAELLSGV 200

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 51/235 (21%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---- 186
           K+ +   IGQG FG+V+           AR +     VA+K++       ++E E     
Sbjct: 18  KYEKLAKIGQGTFGEVF----------KARHRKTGQKVALKKVLM-----ENEKEGFPIT 62

Query: 187 ---ELRFLSRLNHPNVVKLMGYCCDDQHRL--------LVYEYVTRGSLEDH----LLNE 231
              E++ L  L H NVV L+  C               LV+++       +H    LL+ 
Sbjct: 63  ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSN 116

Query: 232 DDTELNWERRIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-K 289
              +      IK +      GL ++H     ++HRD+KA+NVL+  D   K++DFGLA  
Sbjct: 117 VLVKFT-LSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARA 173

Query: 290 FG-PLGDKSHIST-RVLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
           F      + +  T RV+ T  Y  PE +           D++  G ++ E+ +  
Sbjct: 174 FSLAKNSQPNRYTNRVV-TLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRS 226

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 41/226 (18%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---- 186
           +F +   +G G +  VY              K     VA+K ++        + E     
Sbjct: 6   QFKQLEKLGNGTYATVY----------KGLNKTTGVYVALKEVKL-------DSEEGTPS 48

Query: 187 ----ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVT---RGSLEDHLLNEDDTELNWE 239
               E+  +  L H N+V+L      +    LV+E++    +  ++   +      L   
Sbjct: 49  TAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLE-L 107

Query: 240 RRIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGDK 296
             +K       +GL   H     ++HRD+K  N+L++     K+ DFGLA+ FG P+   
Sbjct: 108 NLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165

Query: 297 SHISTRVLGTRGYFAPEYIATG--HLTLKTDVYSFGVVLLEILSGK 340
           S     V+ T  Y AP+ +  G    +   D++S G +L E+++GK
Sbjct: 166 SS---EVV-TLWYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 90.3 bits (225), Expect = 3e-20
 Identities = 64/228 (28%), Positives = 117/228 (51%), Gaps = 44/228 (19%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN--- 186
           +++ + + +G+G F  VY           AR KN +  VA+K+++      + E ++   
Sbjct: 10  KRYEKLDFLGEGQFATVY----------KARDKNTNQIVAIKKIKL---GHRSEAKDGIN 56

Query: 187 -----ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH----LLNEDDTELN 237
                E++ L  L+HPN++ L+       +  LV++++      +     ++ ++   L 
Sbjct: 57  RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM------ETDLEVIIKDNSLVLT 110

Query: 238 WERRIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLG 294
               IK   L   +GLE+LH +W  ++HRD+K +N+LLD++   K++DFGLAK FG P  
Sbjct: 111 -PSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167

Query: 295 DKSHISTRVLGTRGYFAPE--YIATGHLTLKTDVYSFGVVLLEILSGK 340
             +H   +V+ TR Y APE  + A     +  D+++ G +L E+L   
Sbjct: 168 AYTH---QVV-TRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRV 210

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 90.5 bits (225), Expect = 5e-20
 Identities = 68/249 (27%), Positives = 106/249 (42%), Gaps = 68/249 (27%)

Query: 121 CHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG 180
             G        +++  +IG G FG VY           A+  ++   VA+K++       
Sbjct: 45  GQGPDRPQEVSYTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVL------ 88

Query: 181 QD-EWEN-ELRFLSRLNHPNVVKLMGY------CCDDQHRLLVYEYVTRGSLEDHLLNED 232
           QD  ++N EL+ + +L+H N+V+L  +        D+ +  LV +YV             
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------- 135

Query: 233 DTELNWERRIKIALGAA----------------RGLEHLHTYWRPVIHRDVKASNVLLDD 276
              +   R  +    A                 R L ++H++   + HRD+K  N+LLD 
Sbjct: 136 PETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDP 191

Query: 277 DFNA-KISDFGLAKFGPLGDK--SHISTRVLGTRGYFAPEYI--ATGHLTLKTDVYSFGV 331
           D    K+ DFG AK    G+   S+I +R      Y APE I  AT   T   DV+S G 
Sbjct: 192 DTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGAT-DYTSSIDVWSAGC 245

Query: 332 VLLEILSGK 340
           VL E+L G+
Sbjct: 246 VLAELLLGQ 254

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 88.8 bits (221), Expect = 9e-20
 Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 33/220 (15%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---- 186
           K+    L+G+G +G V             R K+    VA+K+         D+       
Sbjct: 26  KYENLGLVGEGSYGMVM----------KCRNKDTGRIVAIKKFLESD---DDKMVKKIAM 72

Query: 187 -ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH----LLNEDDTELNWERR 241
            E++ L +L H N+V L+  C   +   LV+E+V      DH     L      L+++  
Sbjct: 73  REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV------DHTILDDLELFPNGLDYQVV 126

Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
            K       G+   H++   +IHRD+K  N+L+      K+ DFG A+   L     +  
Sbjct: 127 QKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYD 182

Query: 302 RVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGK 340
             + TR Y APE +          DV++ G ++ E+  G+
Sbjct: 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 61/260 (23%), Positives = 102/260 (39%), Gaps = 66/260 (25%)

Query: 107 HRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF 166
            RD  F++ ++            +++     IG G  G V           AA     + 
Sbjct: 6   KRDNNFYSVEI----GDSTFTVLKRYQNLKPIGSGAQGIVC----------AAYDAILER 51

Query: 167 AVAVKRLRRKGSQGQDEWEN---------ELRFLSRLNHPNVVKLM-----GYCCDDQHR 212
            VA+K+L R        ++N         EL  +  +NH N++ L+         ++   
Sbjct: 52  NVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104

Query: 213 L-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA----------RGLEHLHTYWRP 261
           + +V E +             D  L   + I++ L              G++HLH+    
Sbjct: 105 VYIVMELM-------------DANLC--QVIQMELDHERMSYLLYQMLCGIKHLHS--AG 147

Query: 262 VIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLT 321
           +IHRD+K SN+++  D   KI DFGLA        S + T  + TR Y APE I      
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVILGMGYK 204

Query: 322 LKTDVYSFGVVLLEILSGKT 341
              D++S G ++ E++ G  
Sbjct: 205 ENVDIWSVGCIMGEMIKGGV 224

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 89.9 bits (223), Expect = 1e-19
 Identities = 60/231 (25%), Positives = 92/231 (39%), Gaps = 48/231 (20%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-- 186
            +++     IG G  G V           AA     D  VA+K+L R             
Sbjct: 61  LKRYQNLKPIGSGAQGIVC----------AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR 110

Query: 187 ELRFLSRLNHPNVVKLM------GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWER 240
           EL  +  +NH N++ L+          + Q   LV E +             D  L   +
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-------------DANLC--Q 155

Query: 241 RIKIALGAA----------RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF 290
            I++ L              G++HLH+    +IHRD+K SN+++  D   KI DFGLA+ 
Sbjct: 156 VIQMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR- 212

Query: 291 GPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
                 S + T  + TR Y APE I         D++S G ++ E++  K 
Sbjct: 213 --TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 34/214 (15%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
           ++G+G FG V++          A  K  +   A+K L++      D+ E    E R LS 
Sbjct: 24  MLGKGSFGKVFL----------AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73

Query: 194 -LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIK-----IAL 246
              HP +  +       +  L  V EY+  G L  H+ +    +     R       I L
Sbjct: 74  AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD---LSRATFYAAEIIL 129

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL-G 305
           G    L+ LH+  + +++RD+K  N+LLD D + KI+DFG+ K   LGD     T    G
Sbjct: 130 G----LQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNTFCG 180

Query: 306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSG 339
           T  Y APE +         D +SFGV+L E+L G
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 46/227 (20%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNA--DFAVAVKRLRRKGSQGQDEWENELRFLSRLN 195
           +G+G +G VY           A+RK+   D   A+K++   G         E+  L  L 
Sbjct: 29  VGRGTYGHVY----------KAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELK 76

Query: 196 HPNVVKLMGYCCDDQHRL--LVYEYVTRGSLEDH----LLNEDDTELNWERRIKIALGAA 249
           HPNV+ L         R   L+++Y       +H    ++         ++ +++  G  
Sbjct: 77  HPNVISLQKVFLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPRGMV 130

Query: 250 --------RGLEHLHTYWRPVIHRDVKASNVLLDDDFNA----KISDFGLA-KFG-PLGD 295
                    G+ +LH  W  V+HRD+K +N+L+  +       KI+D G A  F  PL  
Sbjct: 131 KSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188

Query: 296 KSHISTRVLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
            + +   V+ T  Y APE +  A  H T   D+++ G +  E+L+ +
Sbjct: 189 LADLDPVVV-TFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSE 233

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 59/239 (24%), Positives = 96/239 (40%), Gaps = 58/239 (24%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
             +F  + + GQG FG V             + K+   +VA+K++ +       E +  +
Sbjct: 22  MDRFQVERMAGQGTFGTVQ----------LGKEKSTGMSVAIKKVIQDPRFRNRELQ-IM 70

Query: 189 RFLSRLNHPNVVKLMGY-------CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERR 241
           + L+ L+HPN+V+L  Y          D +  +V EYV                L+  R 
Sbjct: 71  QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-------------PDTLH--RC 115

Query: 242 IKIALGA----------------ARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISD 284
            +                      R +  LH     V HRD+K  NVL++  D   K+ D
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175

Query: 285 FGLAK-FGPLGDKSHISTRVLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
           FG AK   P   + +++     +R Y APE I     H T   D++S G +  E++ G+
Sbjct: 176 FGSAKKLSP--SEPNVAYIC--SRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGE 229

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 59/228 (25%), Positives = 92/228 (40%), Gaps = 39/228 (17%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENE--- 187
           ++     IG G +G VY           AR  ++   VA+K +R                
Sbjct: 10  RYEPVAEIGVGAYGTVY----------KARDPHSGHFVALKSVR---VPNGGGGGGGLPI 56

Query: 188 --------LRFLSRLNHPNVVKL----MGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDT 234
                   LR L    HPNVV+L         D + ++ LV+E+V +  L  +L      
Sbjct: 57  STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP 115

Query: 235 ELNWERRIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGP 292
            L     IK +     RGL+ LH     ++HRD+K  N+L+      K++DFGLA+ +  
Sbjct: 116 GLP-AETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSY 172

Query: 293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
               +     V+ T  Y APE +         D++S G +  E+   K
Sbjct: 173 QMALTP---VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 74/280 (26%), Positives = 125/280 (44%), Gaps = 50/280 (17%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSR 193
           +IG+G +  V +           R K  D   A+K ++++     ++ +    E     +
Sbjct: 16  VIGRGSYAKVLL----------VRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65

Query: 194 -LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIK-----IAL 246
             NHP +V L   C   + RL  V EYV  G L  H+  +       E   +     I+L
Sbjct: 66  ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP---EEHARFYSAEISL 121

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
                L +LH   R +I+RD+K  NVLLD + + K++D+G+ K G L      ST   GT
Sbjct: 122 A----LNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG-LRPGDTTST-FCGT 173

Query: 307 RGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL 365
             Y APE +    +     D ++ GV++ E+++G++        + G+   P  + +  L
Sbjct: 174 PNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFD-----IVGSSDNPDQNTEDYL 227

Query: 366 HQIIDEKLGRNIQM-----EEAQEFAEIILRCLNSDPKNR 400
            Q+I   L + I++      +A     ++   LN DPK R
Sbjct: 228 FQVI---LEKQIRIPRSLSVKAA---SVLKSFLNKDPKER 261

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 86.4 bits (215), Expect = 4e-19
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 52/217 (23%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENE--- 187
           K+ +   IG+G +G V+           A+ +     VA+KR+R        + ++E   
Sbjct: 3   KYEKLEKIGEGTYGTVF----------KAKNRETHEIVALKRVRL-------DDDDEGVP 45

Query: 188 ---LR---FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH----LLNEDDTELN 237
              LR    L  L H N+V+L      D+   LV+E+       D       +  + +L+
Sbjct: 46  SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC------DQDLKKYFDSCNGDLD 99

Query: 238 WERRIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLG 294
               +K       +GL   H+    V+HRD+K  N+L++ +   K+++FGLA+ FG P+ 
Sbjct: 100 -PEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156

Query: 295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGV 331
             S     V+ T  Y  P+      +     +YS  +
Sbjct: 157 CYSA---EVV-TLWYRPPD------VLFGAKLYSTSI 183

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 86.5 bits (215), Expect = 5e-19
 Identities = 64/228 (28%), Positives = 112/228 (49%), Gaps = 50/228 (21%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENE--- 187
           K+ +   +G+G +G VY           A+       VA+KR+R        + E+E   
Sbjct: 22  KYQKLEKVGEGTYGVVY----------KAKDSQGRI-VALKRIRL-------DAEDEGIP 63

Query: 188 ---LR---FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH----LLNEDDTELN 237
              +R    L  L+HPN+V L+     ++   LV+E++      +     +L+E+ T L 
Sbjct: 64  STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM------EKDLKKVLDENKTGLQ 117

Query: 238 WERRIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLG 294
            + +IK       RG+ H H +   ++HRD+K  N+L++ D   K++DFGLA+ FG P+ 
Sbjct: 118 -DSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174

Query: 295 DKSHISTRVLGTRGYFAPEYIATG--HLTLKTDVYSFGVVLLEILSGK 340
             +H    V+ T  Y AP+ +  G    +   D++S G +  E+++GK
Sbjct: 175 SYTH---EVV-TLWYRAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 88.5 bits (219), Expect = 6e-19
 Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 24/210 (11%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSR 193
           ++G+G FG V +          + RK  D   AVK L++      D+ E    E R L+ 
Sbjct: 348 VLGKGSFGKVML----------SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397

Query: 194 LN-HPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKI-ALGAAR 250
               P + +L   C     RL  V EYV  G L  H+      +   E      A   A 
Sbjct: 398 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK---EPHAVFYAAEIAI 453

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GL  L +  + +I+RD+K  NV+LD + + KI+DFG+ K   + D     T   GT  Y 
Sbjct: 454 GLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN-IWDGVTTKT-FCGTPDYI 509

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGK 340
           APE IA        D ++FGV+L E+L+G+
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 86.4 bits (215), Expect = 7e-19
 Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 35/216 (16%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARR---KNADFAVAVKRLRRKGSQGQDEWE--NELRFL 191
           ++GQG FG V++           ++    +A    A+K L++   + +D      E   L
Sbjct: 31  VLGQGSFGKVFL----------VKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80

Query: 192 SRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIK-----IA 245
             +NHP +VKL  Y    + +L L+ +++  G L   L  E       E  +K     +A
Sbjct: 81  VEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT---EEDVKFYLAELA 136

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
           L     L+HLH+    +I+RD+K  N+LLD++ + K++DFGL+K     +K   +    G
Sbjct: 137 LA----LDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCG 188

Query: 306 TRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGK 340
           T  Y APE +   GH T   D +SFGV++ E+L+G 
Sbjct: 189 TVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 86.1 bits (214), Expect = 8e-19
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 39/219 (17%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARR---KNADFAVAVKRLRRKGS--QGQDEWEN---EL 188
           ++G+GG+G V+            R+    N     A+K L+ K    +   +  +   E 
Sbjct: 24  VLGKGGYGKVFQ----------VRKVTGANTGKIFAMKVLK-KAMIVRNAKDTAHTKAER 72

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIK---- 243
             L  + HP +V L+ Y      +L L+ EY++ G L   L  E       E        
Sbjct: 73  NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFM---EDTACFYLA 128

Query: 244 -IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
            I++     L HLH   + +I+RD+K  N++L+   + K++DFGL K   + D +   T 
Sbjct: 129 EISMA----LGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGTVTHT- 180

Query: 303 VLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGK 340
             GT  Y APE +  +GH     D +S G ++ ++L+G 
Sbjct: 181 FCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 86.5 bits (215), Expect = 8e-19
 Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 34/215 (15%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSR 193
           +IG+G FG V +          AR K  +   AVK L++K    + E +   +E   L +
Sbjct: 45  VIGKGSFGKVLL----------ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94

Query: 194 -LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIK-----IAL 246
            + HP +V L  +      +L  V +Y+  G L  HL  E       E R +     IA 
Sbjct: 95  NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFL---EPRARFYAAEIAS 150

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
                L +LH+    +++RD+K  N+LLD   +  ++DFGL K   +   S  ST   GT
Sbjct: 151 A----LGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNSTTST-FCGT 202

Query: 307 RGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGK 340
             Y APE +    +     D +  G VL E+L G 
Sbjct: 203 PEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 86.5 bits (215), Expect = 8e-19
 Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 36/216 (16%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
           ++G+G FG V +          + RK  D   AVK L++      D+ E    E R L+ 
Sbjct: 27  VLGKGSFGKVML----------SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76

Query: 194 -LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIK-----IAL 246
               P + +L   C     RL  V EYV  G L  H+      +   E         IA+
Sbjct: 77  PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK---EPHAVFYAAEIAI 132

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVL-G 305
           G    L  L +  + +I+RD+K  NV+LD + + KI+DFG+ K          +T+   G
Sbjct: 133 G----LFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCG 183

Query: 306 TRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGK 340
           T  Y APE IA   +     D ++FGV+L E+L+G+
Sbjct: 184 TPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 87.0 bits (216), Expect = 9e-19
 Identities = 73/280 (26%), Positives = 125/280 (44%), Gaps = 50/280 (17%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NELRFLSR 193
           +IG+G +  V +           R K  D   A++ ++++     ++ +    E     +
Sbjct: 59  VIGRGSYAKVLL----------VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108

Query: 194 -LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIK-----IAL 246
             NHP +V L   C   + RL  V EYV  G L  H+  +       E   +     I+L
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP---EEHARFYSAEISL 164

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
                L +LH   R +I+RD+K  NVLLD + + K++D+G+ K G L      ST   GT
Sbjct: 165 A----LNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG-LRPGDTTST-FCGT 216

Query: 307 RGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL 365
             Y APE +    +     D ++ GV++ E+++G++        + G+   P  + +  L
Sbjct: 217 PNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFD-----IVGSSDNPDQNTEDYL 270

Query: 366 HQIIDEKLGRNIQM-----EEAQEFAEIILRCLNSDPKNR 400
            Q+I   L + I++      +A     ++   LN DPK R
Sbjct: 271 FQVI---LEKQIRIPRSLSVKAA---SVLKSFLNKDPKER 304

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 86.1 bits (214), Expect = 9e-19
 Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 34/215 (15%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---ELRFLSR 193
           ++G+G FG V +          AR K      AVK L++      D+ E    E R LS 
Sbjct: 30  VLGKGSFGKVML----------ARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79

Query: 194 -LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIK-----IAL 246
             NHP + +L   C     RL  V E+V  G L  H+      +   E R +     I  
Sbjct: 80  ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARFYAAEIIS 135

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
                L  LH   + +I+RD+K  NVLLD + + K++DFG+ K G + +    +T   GT
Sbjct: 136 A----LMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG-ICNGVTTAT-FCGT 187

Query: 307 RGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGK 340
             Y APE +    +     D ++ GV+L E+L G 
Sbjct: 188 PDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGH 221

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 84.5 bits (210), Expect = 2e-18
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 50/228 (21%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENE--- 187
           K+     IG+G +G VY           A+    +   A+K++R        E E+E   
Sbjct: 3   KYHGLEKIGEGTYGVVY----------KAQNNYGET-FALKKIRL-------EKEDEGIP 44

Query: 188 ---LR---FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH----LLNEDDTELN 237
              +R    L  L H N+VKL       +  +LV+E++      D     LL+  +  L 
Sbjct: 45  STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL------DQDLKKLLDVCEGGLE 98

Query: 238 WERRIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLG 294
                K   L    G+ + H     V+HRD+K  N+L++ +   KI+DFGLA+ FG P+ 
Sbjct: 99  -SVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155

Query: 295 DKSHISTRVLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
             +H    ++ T  Y AP+ +  +    +   D++S G +  E+++G 
Sbjct: 156 KYTH---EIV-TLWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGT 198

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 45/230 (19%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAAR-RKNADFAVAVKRLRRKGSQGQDEWENE-- 187
           ++     IG+G +G V+           AR  KN    VA+KR+R        +   E  
Sbjct: 12  QYECVAEIGEGAYGKVF----------KARDLKNGGRFVALKRVRV-------QTGEEGM 54

Query: 188 ----------LRFLSRLNHPNVVKL----MGYCCDDQHRL-LVYEYVTRGSLEDHLLNED 232
                     LR L    HPNVV+L         D + +L LV+E+V +  L  +L    
Sbjct: 55  PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVP 113

Query: 233 DTELNWERRIK-IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-F 290
           +  +     IK +     RGL+ LH++   V+HRD+K  N+L+      K++DFGLA+ +
Sbjct: 114 EPGVP-TETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIY 170

Query: 291 GPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK 340
                 +     V+ T  Y APE +         D++S G +  E+   K
Sbjct: 171 SFQMALTS---VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 48/227 (21%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN---- 186
            + + + +G+G +  VY            + K  D  VA+K +R        E E     
Sbjct: 3   TYIKLDKLGEGTYATVY----------KGKSKLTDNLVALKEIRL-------EHEEGAPC 45

Query: 187 ----ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH----LLNEDDTELNW 238
               E+  L  L H N+V L      ++   LV+EY+      D      L++    +N 
Sbjct: 46  TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNIIN- 98

Query: 239 ERRIKIALG-AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FG-PLGD 295
              +K+ L    RGL + H     V+HRD+K  N+L+++    K++DFGLA+    P   
Sbjct: 99  MHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156

Query: 296 KSHISTRVLGTRGYFAPEYIATG--HLTLKTDVYSFGVVLLEILSGK 340
             +    V+ T  Y  P+ I  G    + + D++  G +  E+ +G+
Sbjct: 157 YDN---EVV-TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 56/239 (23%), Positives = 98/239 (41%), Gaps = 65/239 (27%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-- 186
            + +     +G G +G V           +A  K +   VA+K+L R        +++  
Sbjct: 23  PKTYVSPTHVGSGAYGSVC----------SAIDKRSGEKVAIKKLSRP-------FQSEI 65

Query: 187 -------ELRFLSRLNHPNVVKLM-----GYCCDDQHRL-LVYEYVTRGSLEDHLLNEDD 233
                  EL  L  + H NV+ L+          + +   LV  ++              
Sbjct: 66  FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-------------Q 112

Query: 234 TELNWERRIKIALGAA----------RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS 283
           T+L   + + +               +GL+++H+    V+HRD+K  N+ +++D   KI 
Sbjct: 113 TDLQ--KIMGLKFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKIL 168

Query: 284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGKT 341
           DFGLA+           T  + TR Y APE I +  H     D++S G ++ E+L+GKT
Sbjct: 169 DFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 59/298 (19%), Positives = 99/298 (33%), Gaps = 92/298 (30%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
             ++G G  G V               K      A+K L+        +   E+    R 
Sbjct: 23  SQVLGLGINGKVLQ----------IFNKRTQEKFALKMLQDC-----PKARREVELHWRA 67

Query: 195 -NHPNVVKLMGYCCD----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERR----IKIA 245
              P++V+++    +     +  L+V E +  G L   + +  D     ER     +K  
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKSI 126

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTR 302
             A   +++LH+    + HRDVK  N+L      +   K++DFG AK             
Sbjct: 127 GEA---IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------E 169

Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK 362
             G   Y               D++S GV++  +L G                 P+ SN 
Sbjct: 170 TTG-EKY-----------DKSCDMWSLGVIMYILLCGYP---------------PFYSNH 202

Query: 363 LALHQIIDEKLGRNIQM--------------EEAQEFAEIILRCLNSDPKNRPTMSEV 406
                 I   +   I+M              EE +     I   L ++P  R T++E 
Sbjct: 203 ---GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML---IRNLLKTEPTQRMTITEF 254

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 62/236 (26%), Positives = 98/236 (41%), Gaps = 63/236 (26%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD-EWEN-EL 188
            ++   +IG G FG V+           A+   +D  VA+K++       QD  ++N EL
Sbjct: 41  AYTNCKVIGNGSFGVVF----------QAKLVESD-EVAIKKVL------QDKRFKNREL 83

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRL------LVYEYVTRGSLEDHLLNEDDT---ELNWE 239
           + +  + HPNVV L  +   +  +       LV EYV             +T        
Sbjct: 84  QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV------------PETVYRASRHY 131

Query: 240 RRIKIALGAA----------RGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-KISDFGLA 288
            ++K  +             R L ++H+    + HRD+K  N+LLD      K+ DFG A
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189

Query: 289 K-FGPLGDKSH-ISTRVLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGK 340
           K           I +R      Y APE I  AT + T   D++S G V+ E++ G+
Sbjct: 190 KILIAGEPNVSYICSRY-----YRAPELIFGAT-NYTTNIDIWSTGCVMAELMQGQ 239

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 47/229 (20%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENE--- 187
           ++     +G+G +G+VY           A     +  VA+KR+R        E E E   
Sbjct: 35  RYRRITKLGEGTYGEVY----------KAIDTVTNETVAIKRIRL-------EHEEEGVP 77

Query: 188 ---LR---FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERR 241
              +R    L  L H N+++L      +    L++EY     L+ ++  + + +++  R 
Sbjct: 78  GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM--DKNPDVS-MRV 133

Query: 242 IKIALG-AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-----KISDFGLAK-FG-PL 293
           IK  L     G+   H+     +HRD+K  N+LL     +     KI DFGLA+ FG P+
Sbjct: 134 IKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191

Query: 294 GDKSHISTRVLGTRGYFAPEYIATG--HLTLKTDVYSFGVVLLEILSGK 340
              +H    ++ T  Y  PE I  G  H +   D++S   +  E+L   
Sbjct: 192 RQFTH---EII-TLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 68/346 (19%), Positives = 111/346 (32%), Gaps = 113/346 (32%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW--EN 186
              ++ +  I  G +G V       CA      +     VA+KR+    S G+      +
Sbjct: 21  QSPYTVQRFISSGSYGAV-------CA--GVDSEGIP--VAIKRVFNTVSDGRTVNILSD 69

Query: 187 ---------ELRFLSRLNHPNVVKLMG----YCCDDQHRL-LVYEYVTRGSLEDHLLNED 232
                    E+R L+  +HPN++ L      +     H+L LV E +             
Sbjct: 70  SFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM------------- 116

Query: 233 DTELNWERRIKIALGAA-------------RGLEHLHTYWRPVIHRDVKASNVLLDDDFN 279
            T+L   + I                     GL  LH     V+HRD+   N+LL D+ +
Sbjct: 117 RTDLA--QVIHDQRIVISPQHIQYFMYHILLGLHVLHE--AGVVHRDLHPGNILLADNND 172

Query: 280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILS 338
             I DF LA+           T  +  R Y APE +      T   D++S G V+ E+ +
Sbjct: 173 ITICDFNLAR---EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

Query: 339 GKTAAMRRTNGLAGNWAKPYLSNKLALHQI--IDEKLG-------RNIQMEEAQEFAEII 389
                            K         +Q+  I E +G              A+++    
Sbjct: 230 R----------------KALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNS 273

Query: 390 L------------------------RCLNSDPKNRPTMSEVVAALE 411
           L                        + L  +P+ R +  +   AL 
Sbjct: 274 LSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ---ALR 316

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 56/261 (21%), Positives = 91/261 (34%), Gaps = 68/261 (26%)

Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRL----RRKGSQG 180
           LE +++K+S    +G G FG V                 +    A+K++    R K    
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVC----------EVFDIESGKRFALKKVLQDPRYK---- 47

Query: 181 QDEWENELRFLSRLNHPNVVKL--------------MGYCCDDQHRLLVYEYVTRGSLED 226
                 EL  +  L+H N++KL                   D          V       
Sbjct: 48  ----NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSV 103

Query: 227 HLLNEDDTELN--WE-------RRIKIALGAA----------------RGLEHLHTYWRP 261
            +    +  LN   E       + +K  + +                 R +  +H+    
Sbjct: 104 IVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--LG 161

Query: 262 VIHRDVKASNVLLD-DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-H 319
           + HRD+K  N+L++  D   K+ DFG AK       S  S   + +R Y APE +     
Sbjct: 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAK---KLIPSEPSVAYICSRFYRAPELMLGATE 218

Query: 320 LTLKTDVYSFGVVLLEILSGK 340
            T   D++S G V  E++ GK
Sbjct: 219 YTPSIDLWSIGCVFGELILGK 239

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 56/264 (21%), Positives = 107/264 (40%), Gaps = 54/264 (20%)

Query: 94  LPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINS 153
           +P  AR    V+ HR   +  Y+     H +       +     +G+G + +V+      
Sbjct: 4   VPSRARVYTDVNTHRPREYWDYES----HVVEWGNQDDYQLVRKLGRGKYSEVF------ 53

Query: 154 CAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYCCDDQHR 212
                A     +  V VK L+      + + + E++ L  L   PN++ L     D   R
Sbjct: 54  ----EAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSR 106

Query: 213 --LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA----------RGLEHLHTYWR 260
              LV+E+V            ++T+    +++   L             + L++ H+   
Sbjct: 107 TPALVFEHV------------NNTDF---KQLYQTLTDYDIRFYMYEILKALDYCHS--M 149

Query: 261 PVIHRDVKASNVLLD-DDFNAKISDFGLAKFG-PLGDKSHISTRVLGTRGYFAPEYIATG 318
            ++HRDVK  NV++D +    ++ D+GLA+F  P  + +    RV  +R +  PE +   
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV---RV-ASRYFKGPELLVDY 205

Query: 319 -HLTLKTDVYSFGVVLLEILSGKT 341
                  D++S G +L  ++  K 
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKE 229

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 80.8 bits (200), Expect = 7e-17
 Identities = 57/240 (23%), Positives = 101/240 (42%), Gaps = 62/240 (25%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-- 186
             +++  + IG+G +G V           +A        VA+K++          +E+  
Sbjct: 26  GPRYTNLSYIGEGAYGMVC----------SAYDNLNKVRVAIKKISP--------FEHQT 67

Query: 187 -------ELRFLSRLNHPNVVKLM-----GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT 234
                  E++ L R  H N++ +            +   +V + +             +T
Sbjct: 68  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-------------ET 114

Query: 235 ELNWERRIKI-ALGAA----------RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS 283
           +L   + +K   L             RGL+++H+    V+HRD+K SN+LL+   + KI 
Sbjct: 115 DLY--KLLKTQHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKIC 170

Query: 284 DFGLAK-FGPLGDKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGKT 341
           DFGLA+   P  D +   T  + TR Y APE +  +   T   D++S G +L E+LS + 
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 58/285 (20%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARR---KNADFAVAVKRLRRKGSQGQDEW----ENELR 189
           ++G G +G V++           R+    +     A+K L++     + +       E +
Sbjct: 61  VLGTGAYGKVFL----------VRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110

Query: 190 FLSRLNH-PNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIK---- 243
            L  +   P +V L  Y    + +L L+ +Y+  G L  HL   +      E  ++    
Sbjct: 111 VLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFT---EHEVQIYVG 166

Query: 244 -IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
            I L     LEHLH     +I+RD+K  N+LLD + +  ++DFGL+K     +       
Sbjct: 167 EIVLA----LEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD- 219

Query: 303 VLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGK---TAAMRRTNGLAGNWAK 356
             GT  Y AP+ +    +GH     D +S GV++ E+L+G    T    + +       +
Sbjct: 220 FCGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTGASPFTVDGEKNS-------Q 271

Query: 357 PYLSNKLALHQIIDEKLGRNIQM-EEAQEFAEIILRCLNSDPKNR 400
             +S +     I+  +     +M   A+   ++I R L  DPK R
Sbjct: 272 AEISRR-----ILKSEPPYPQEMSALAK---DLIQRLLMKDPKKR 308

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 55/245 (22%), Positives = 103/245 (42%), Gaps = 63/245 (25%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKR------------LRRK 176
             ++ +   +G GG G V        +   A   + D  VA+K+            LR  
Sbjct: 10  GSRYMDLKPLGCGGNGLV-------FS---AVDNDCDKRVAIKKIVLTDPQSVKHALR-- 57

Query: 177 GSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD----QHRLLVYEYVTRGSLEDHLLNED 232
                     E++ + RL+H N+VK+      +        L  +  +   L    + ++
Sbjct: 58  ----------EIKIIRRLDHDNIVKVF-----EILGPSGSQLTDDVGSLTELNSVYIVQE 102

Query: 233 --DTELNWERRIKI-ALGAA----------RGLEHLHTYWRPVIHRDVKASNVLLD-DDF 278
             +T+L     ++   L             RGL+++H+    V+HRD+K +N+ ++ +D 
Sbjct: 103 YMETDLA--NVLEQGPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFINTEDL 158

Query: 279 NAKISDFGLAK-FGPLGDKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEI 336
             KI DFGLA+   P        +  L T+ Y +P  + +  + T   D+++ G +  E+
Sbjct: 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218

Query: 337 LSGKT 341
           L+GKT
Sbjct: 219 LTGKT 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 66/240 (27%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-- 186
             ++   + +G G +G V           AA        VAVK+L R        +++  
Sbjct: 28  PERYQNLSPVGSGAYGSVC----------AAFDTKTGLRVAVKKLSRP-------FQSII 70

Query: 187 -------ELRFLSRLNHPNVVKLM-----GYCCDDQHRL-LVYEYVTRGSLEDHLLNEDD 233
                  ELR L  + H NV+ L+         ++ + + LV   +              
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-------------G 117

Query: 234 TELNWERRIKI-ALGAA----------RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI 282
            +LN    +K   L             RGL+++H+    +IHRD+K SN+ +++D   KI
Sbjct: 118 ADLN--NIVKCQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKI 173

Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGKT 341
            DFGLA+       +   T  + TR Y APE +    H     D++S G ++ E+L+G+T
Sbjct: 174 LDFGLAR-----HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 77.8 bits (192), Expect = 7e-16
 Identities = 61/326 (18%), Positives = 120/326 (36%), Gaps = 78/326 (23%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSR 193
            +G G F  V++          A+    +  VA+K +R         +DE    ++ L R
Sbjct: 26  KLGWGHFSTVWL----------AKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQR 71

Query: 194 LN-----------HPNVVKLMGY----CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNW 238
           +N             +++KL+ +      +  H ++V+E V   +L   +   +   +  
Sbjct: 72  VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPL 130

Query: 239 ERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD------DFNAKISDFGLAKFGP 292
               +I+     GL+++H     +IH D+K  NVL++           KI+D G A +  
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY- 188

Query: 293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT----------- 341
                   T  + TR Y +PE +         D++S   ++ E+++G             
Sbjct: 189 ----DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244

Query: 342 ------AAMRRTNG-------LAGNWAKPYLSNKLALHQIIDEK-------LGRNIQM-- 379
                 A +    G         G + + + +++  L  I   K       L    +   
Sbjct: 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304

Query: 380 EEAQEFAEIILRCLNSDPKNRPTMSE 405
           +EA+E ++ +   L  DP+ R     
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGG 330

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 78.3 bits (193), Expect = 8e-16
 Identities = 71/372 (19%), Positives = 120/372 (32%), Gaps = 124/372 (33%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-- 186
              +  K+LIG+G +G VY           A  KN +  VA+K++          +E+  
Sbjct: 25  PDNYIIKHLIGRGSYGYVY----------LAYDKNTEKNVAIKKV-------NRMFEDLI 67

Query: 187 -------ELRFLSRLNHPNVVKLM-----GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT 234
                  E+  L+RL    +++L                +V E               D+
Sbjct: 68  DCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-------------DS 114

Query: 235 ELNWERRIKIALGAA----------RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD 284
           +L    +  I L              G   +H     +IHRD+K +N LL+ D + K+ D
Sbjct: 115 DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCSVKVCD 172

Query: 285 FGLA--------------------KFGPLGDKSHISTRVLGTRGYFAPEYI-ATGHLTLK 323
           FGLA                          +     T  + TR Y APE I    + T  
Sbjct: 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232

Query: 324 TDVYSFGVVLLEILSGKTAAMRRTNG------------LAGNWAKPYLSNKLALHQI--I 369
            D++S G +  E+L+   + +                 L+ +     +  K    Q+  I
Sbjct: 233 IDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNII 292

Query: 370 DEKLG-------RNIQMEEAQE------------FAEI-----------ILRCLNSDPKN 399
              +G       +NI   E  +              +            +   L  +P  
Sbjct: 293 FNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNK 352

Query: 400 RPTMSEVVAALE 411
           R T+ +   AL+
Sbjct: 353 RITIDQ---ALD 361

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 72/350 (20%), Positives = 120/350 (34%), Gaps = 121/350 (34%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-- 186
           +  F  K+L+G+G +G V       C+   A  K     VA+K++          ++   
Sbjct: 10  SSDFQLKSLLGEGAYGVV-------CS---ATHKPTGEIVAIKKIEP--------FDKPL 51

Query: 187 -------ELRFLSRLNHPNVVKLM-----GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT 234
                  E++ L    H N++ +          +     ++ E +              T
Sbjct: 52  FALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-------------QT 98

Query: 235 ELNWERRIKI-ALGAA----------RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS 283
           +L+  R I    L             R ++ LH     VIHRD+K SN+L++ + + K+ 
Sbjct: 99  DLH--RVISTQMLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVC 154

Query: 284 DFGLA--------KFGPLGDKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLL 334
           DFGLA               +       + TR Y APE +  +   +   DV+S G +L 
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214

Query: 335 EILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI--IDEKLG--------RNIQMEEAQE 384
           E+   +                P    +   HQ+  I   +G        R I+   A+E
Sbjct: 215 ELFLRR----------------PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRARE 258

Query: 385 ------------FAEI-----------ILRCLNSDPKNRPTMSEVVAALE 411
                         ++           + R L  DP  R T  E   ALE
Sbjct: 259 YIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE---ALE 305

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 60/240 (25%), Positives = 96/240 (40%), Gaps = 66/240 (27%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-- 186
              + +   +G G +G V           +A        VA+K+L R        +++  
Sbjct: 24  RAVYRDLQPVGSGAYGAVC----------SAVDGRTGAKVAIKKLYRP-------FQSEL 66

Query: 187 -------ELRFLSRLNHPNVVKLM-----GYCCDDQHRL-LVYEYVTRGSLEDHLLNEDD 233
                  ELR L  + H NV+ L+         DD     LV  ++              
Sbjct: 67  FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-------------G 113

Query: 234 TELNWERRIKI-ALGAA----------RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI 282
           T+L   + +K   LG            +GL ++H     +IHRD+K  N+ +++D   KI
Sbjct: 114 TDLG--KLMKHEKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKI 169

Query: 283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGKT 341
            DFGLA+           T  + TR Y APE I      T   D++S G ++ E+++GKT
Sbjct: 170 LDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.5 bits (178), Expect = 6e-14
 Identities = 59/325 (18%), Positives = 106/325 (32%), Gaps = 86/325 (26%)

Query: 75  SSQKEKHSKKYRERTMPESLPVAARDLPAVSFHRDEVFHAYKLKYFCHGLLEAATRKFSE 134
           SS +   ++++   T                 H  +   +                ++  
Sbjct: 2   SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRP----HSDWQIPDRYEI 57

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-------- 186
           ++LIG G +G V            A  K     VA+K++          +E+        
Sbjct: 58  RHLIGTGSYGHVC----------EAYDKLEKRVVAIKKIL-------RVFEDLIDCKRIL 100

Query: 187 -ELRFLSRLNHPNVVKLM-----GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWER 240
            E+  L+RLNH +VVK++               +V E               D++     
Sbjct: 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-------------DSDFKKLF 147

Query: 241 RIKIALGAA----------RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA-K 289
           R  + L              G++++H+    ++HRD+K +N L++ D + K+ DFGLA  
Sbjct: 148 RTPVYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGLART 205

Query: 290 FGPLGDKSHISTRVLG------------------------TRGYFAPEYI-ATGHLTLKT 324
                + +                                TR Y APE I    + T   
Sbjct: 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI 265

Query: 325 DVYSFGVVLLEILSGKTAAMRRTNG 349
           DV+S G +  E+L+     +     
Sbjct: 266 DVWSIGCIFAELLNMIKENVAYHAD 290

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 58/260 (22%), Positives = 104/260 (40%), Gaps = 87/260 (33%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN-- 186
            RK+     +G+G +G V            +  +     VAVK++        D ++N  
Sbjct: 8   LRKYELVKKLGKGAYGIV-------WK---SIDRRTGEVVAVKKI-------FDAFQNST 50

Query: 187 -------ELRFLSRLN-HPNVVKLMGYCC--DDQHRLLVYEY-------VTRGSL--EDH 227
                  E+  L+ L+ H N+V L+      +D+   LV++Y       V R ++    H
Sbjct: 51  DAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH 110

Query: 228 -------LLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA 280
                  L+                    + +++LH+    ++HRD+K SN+LL+ + + 
Sbjct: 111 KQYVVYQLI--------------------KVIKYLHS--GGLLHRDMKPSNILLNAECHV 148

Query: 281 KISDFGLAKFGPLGDKSHISTRVLG-------------------TRGYFAPEYI-ATGHL 320
           K++DFGL++      +   +  +                     TR Y APE +  +   
Sbjct: 149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY 208

Query: 321 TLKTDVYSFGVVLLEILSGK 340
           T   D++S G +L EIL GK
Sbjct: 209 TKGIDMWSLGCILGEILCGK 228

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 66/360 (18%), Positives = 111/360 (30%), Gaps = 114/360 (31%)

Query: 148 IGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-----NHPN---V 199
           +G+ +   +  +        VA+K ++       +   +E+R L  +     N PN   V
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 200 VKLMGYCCDD--------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
           V+L+    DD         H  +V+E V    L   ++  +   L      KI     +G
Sbjct: 104 VQLL----DDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158

Query: 252 LEHLHTYWRPVIHRDVKASNVLL------------------------------------- 274
           L++LHT  R +IH D+K  N+LL                                     
Sbjct: 159 LDYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217

Query: 275 ------------DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTL 322
                        +    KI+D G A +        I TR      Y + E +       
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNT 272

Query: 323 KTDVYSFGVVLLEILSGKT-----------------AAMRRTNGL--------------- 350
             D++S   +  E+ +G                   A +    G                
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 351 ---AGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
               G+           L +++ EK       EEA  F + +L  L   P+ R T +E +
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 32/176 (18%), Positives = 61/176 (34%), Gaps = 24/176 (13%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAV-----------AVKRLRRKGS 178
           R++  K+   +   G +Y     S     +  +   F++                +R   
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 179 QGQDEWENELRFLSRLNHPNVVKLMGYCC---DDQHRLLVYEYVTRGSLEDHLLNEDDTE 235
             Q     +L     L  P              D++R LV   + R SL+  L       
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTC-----MGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHV 155

Query: 236 LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI--SDFGLAK 289
           L+    +++A      LE LH      +H +V A N+ +D +  +++  + +G A 
Sbjct: 156 LSERSVLQVACRLLDALEFLHE--NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 48/236 (20%), Positives = 86/236 (36%), Gaps = 51/236 (21%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH 196
            IGQGGFG +Y+  +NS     +          VK               EL+F  R   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAP-----CVVKVEPSDNGP----LFTELKFYQRAAK 92

Query: 197 PNVV---------------KLMGY----CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELN 237
           P  +               K  G          +R ++ +      L+  +   +    +
Sbjct: 93  PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQK-IYEANAKRFS 150

Query: 238 WERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI--SDFGLAK-FGPLG 294
            +  ++++L     LE++H      +H D+KASN+LL+     ++   D+GLA  + P G
Sbjct: 151 RKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

Query: 295 DKSHISTR----VLGTRGYFAPEY--IATGHL----TLKTDVYSFGVVLLEILSGK 340
                +        GT      E+  I   H     + + D+   G  +++ L+G 
Sbjct: 209 VHKAYAADPKRCHDGT-----IEFTSIDA-HNGVAPSRRGDLEILGYCMIQWLTGH 258

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 58/216 (26%), Positives = 87/216 (40%), Gaps = 33/216 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH- 196
           IG G FGD+Y+G              A   VA+K    K    Q     E +    +   
Sbjct: 17  IGSGSFGDIYLG----------TDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGG 64

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
             +  +     +  + ++V E +   SLED L N    + + +  + +A      +E++H
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELLGP-SLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAK---ISDFGLAK-FGPLGDKSHISTR----VLGTRG 308
           +  +  IHRDVK  N L+          I DFGLAK +       HI  R    + GT  
Sbjct: 123 S--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180

Query: 309 YFAPEYIATGHL----TLKTDVYSFGVVLLEILSGK 340
           Y A   I T HL    + + D+ S G VL+    G 
Sbjct: 181 Y-AS--INT-HLGIEQSRRDDLESLGYVLMYFNLGS 212

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 63/324 (19%), Positives = 112/324 (34%), Gaps = 77/324 (23%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSR 193
           +IG+G FG V            A        VA+K +R +     Q  +E    +R L  
Sbjct: 104 VIGKGSFGQVV----------KAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEH 149

Query: 194 LNH------PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           L         NV+ ++       H  + +E ++  +L + +        +     K A  
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHS 208

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA--KISDFGLAKFGPLGDKSHISTRVLG 305
             + L+ LH     +IH D+K  N+LL     +  K+ DFG + +    +   + T  + 
Sbjct: 209 ILQCLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYT-YIQ 261

Query: 306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT-----------AAMRRTNGLAGNW 354
           +R Y APE I      +  D++S G +L E+L+G             A M    G+    
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321

Query: 355 ----------------------------AKPYLSNKLALHQIIDE-----KLGRNIQMEE 381
                                           L+   +    +       + G  ++  +
Sbjct: 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCD 381

Query: 382 AQEFAEIILRCLNSDPKNRPTMSE 405
              F + + +CL  DP  R T  +
Sbjct: 382 DPLFLDFLKQCLEWDPAVRMTPGQ 405

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 33/216 (15%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-H 196
           IG G FG++Y+G               +  VA+K    K    Q     E +    L   
Sbjct: 15  IGSGSFGEIYLG----------TNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGG 62

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
             +  +  +  +  + +LV + +   SLED L N    +L+ +  + +A      +E +H
Sbjct: 63  TGIPNVRWFGVEGDYNVLVMDLLGP-SLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAK---ISDFGLAK-FGPLGDKSHISTR----VLGTRG 308
           +  +  +HRD+K  N L+     A    I DFGLAK +       HI  R    + GT  
Sbjct: 121 S--KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178

Query: 309 YFAPEYIATGHL----TLKTDVYSFGVVLLEILSGK 340
           Y A   + T HL    + + D+ S G VL+  L G 
Sbjct: 179 Y-AS--VNT-HLGIEQSRRDDLESLGYVLMYFLRGS 210

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 50/218 (22%), Positives = 87/218 (39%), Gaps = 35/218 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NH 196
           IG+G FG ++ G               +  VA+K   R+    Q   E   R    L   
Sbjct: 18  IGEGSFGVIFEG----------TNLLNNQQVAIKFEPRRSDAPQLRDEY--RTYKLLAGC 65

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
             +  +  +  +  H +LV + +   SLED LL+    + + +     A      ++ +H
Sbjct: 66  TGIPNVYYFGQEGLHNVLVIDLLGP-SLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAK-----ISDFGLAK-FGPLGDKSHISTR----VLGT 306
              + +++RD+K  N L+    +       + DFG+ K +     K HI  R    + GT
Sbjct: 124 E--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181

Query: 307 RGYFAPEYIATGHL----TLKTDVYSFGVVLLEILSGK 340
             Y +   I T HL    + + D+ + G V +  L G 
Sbjct: 182 ARYMS---INT-HLGREQSRRDDLEALGHVFMYFLRGS 215

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 73/330 (22%), Positives = 117/330 (35%), Gaps = 80/330 (24%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLS 192
           +LIG+G FG V            A  +     VA+K ++ K +   Q Q E    +R L 
Sbjct: 60  SLIGKGSFGQVV----------KAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLE 105

Query: 193 RLNHP------NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
            +N         +V L  +     H  LV+E ++  +L D L N +   ++     K A 
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQ 164

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA--KISDFGLAKFGPLGDKSHISTRVL 304
                L  L T    +IH D+K  N+LL +   +  KI DFG +          I    +
Sbjct: 165 QMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQ-YI 219

Query: 305 GTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT-----------AAMRRTNG---- 349
            +R Y +PE +      L  D++S G +L+E+ +G+              +    G    
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279

Query: 350 ----------------LAGNWAKPYLSNKLA---------LHQIIDEKLGRNIQM----- 379
                             G W      +            LH I+  + G          
Sbjct: 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGES 339

Query: 380 ----EEAQEFAEIILRCLNSDPKNRPTMSE 405
                +  +F ++ILR L+ DPK R     
Sbjct: 340 GHTVADYLKFKDLILRMLDYDPKTRIQPYY 369

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 61.4 bits (148), Expect = 3e-10
 Identities = 70/456 (15%), Positives = 141/456 (30%), Gaps = 130/456 (28%)

Query: 13  NRQLD--IARPPAAGVTR----IPRQNRTSTVEEKRTPSDSSKAVQENRRKHRRRDYRLR 66
             ++D  I    A   T          +   V+         K V+E  R     +Y   
Sbjct: 48  KEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQ---------KFVEEVLRI----NY--- 91

Query: 67  EWKTSVFS--SSQKEKHSKKY---RERTMPESLPVAARDLPAVSFHRDEVFHAYKLKYFC 121
           ++  S       Q    ++ Y   R+R   ++   A  ++      R + +   KL+   
Sbjct: 92  KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-----RLQPYL--KLR--- 141

Query: 122 HGLLEAATRKFSEKNLI--GQGGFGDVYIGYINSC-AMTAAR----RKNADFAVAVKRLR 174
             LLE        KN++  G  G G        +  A+        +   DF +      
Sbjct: 142 QALLELR----PAKNVLIDGVLGSG-------KTWVALDVCLSYKVQCKMDFKIF----- 185

Query: 175 RKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL-----LVYEYVTRGSLEDHLL 229
                    W         LN       +  C   +  L     L+Y+      ++ +  
Sbjct: 186 ---------W---------LN-------LKNCNSPETVLEMLQKLLYQ------IDPNWT 214

Query: 230 NEDDTELNWERRIKIALGAARGLEHLHTYWRP-VIHRDVKASNVLLDDDFNAKI----SD 284
           +  D   N + RI       R L     Y    ++  +V+ +      + + KI      
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRF 274

Query: 285 FGLAKFGPLGDKSHIST--RVLG-----TRGYFAPEYIATGHLTLKTDVYSFGVVLLEIL 337
             +  F      +HIS     +       +     +Y+      L  +V +     L I+
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL-KYLDCRPQDLPREVLTTNPRRLSII 333

Query: 338 SGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQE-FAEI-ILRCLNS 395
           +    ++R       NW K    +K  L  II+  L   ++  E ++ F  + +      
Sbjct: 334 A---ESIRDGLATWDNW-KHVNCDK--LTTIIESSL-NVLEPAEYRKMFDRLSVF----- 381

Query: 396 DPKNRPTMSEVVAAL------EQLQLNMGSCYQTSL 425
            P +    + +++ +        + + +   ++ SL
Sbjct: 382 -PPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL 416

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 35/202 (17%), Positives = 68/202 (33%), Gaps = 52/202 (25%)

Query: 130 RKFSEKNLIGQGGFGDVYIGY-INSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
            ++     IG GGFG +Y+ +  N            D    VK   ++         +EL
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNK--------PEKDARHVVKVEYQENGP----LFSEL 84

Query: 189 RFLSRLNHPNVV---------------KLMGY----CCDDQHRLLVYEYVTRGSLEDHLL 229
           +F  R+   + +                  G          +R +V E +    L+    
Sbjct: 85  KFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKI-- 141

Query: 230 NEDDTELNWERR------IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI- 282
                             +++ +     LE++H      +H D+KA+N+LL      ++ 
Sbjct: 142 ------SGQNGTFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYKNPDQVY 193

Query: 283 -SDFGLAK-FGPLGDKSHISTR 302
            +D+GL+  + P G+       
Sbjct: 194 LADYGLSYRYCPNGNHKQYQEN 215

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.1 bits (142), Expect = 7e-10
 Identities = 54/324 (16%), Positives = 84/324 (25%), Gaps = 78/324 (24%)

Query: 128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE---- 183
            T K      IG+G FG+V+            +       VA+K +  +G    +     
Sbjct: 18  PTEKLQRCEKIGEGVFGEVF------------QTIADHTPVAIKIIAIEGPDLVNGSHQK 65

Query: 184 -------------WENELRFLSRLNHPNVVKLMGYCC--DDQHRLLVYEY----VTRGSL 224
                          + L           + L    C       LL+  +     T+GS 
Sbjct: 66  TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125

Query: 225 EDH---------------------LLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVI 263
            D                      L        +      I       L       R   
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR-FE 184

Query: 264 HRDVKASNVLLDDDFNAKISDFGLAK------FG---PLGDKSHISTRVLGTRGY---FA 311
           HRD+   NVLL      K+      K       G    + D +       G   +     
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
            E + TG    + D+Y    +  E  +        +N L   W   YL++K+        
Sbjct: 245 DEDLFTGDGDYQFDIYRL--MKKENNNRWGEYHPYSNVL---WLH-YLTDKMLKQMTFKT 298

Query: 372 KLGRNIQ---MEEAQEFAEIILRC 392
           K           + QEF   +L  
Sbjct: 299 KCNTPAMKQIKRKIQEFHRTMLNF 322

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 35/218 (16%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NH 196
           IG G FG++ +G          +    +  VA+K    K    Q   E   RF  +L + 
Sbjct: 17  IGCGNFGELRLG----------KNLYTNEYVAIKLEPMKSRAPQLHLEY--RFYKQLGSG 64

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
             + ++  +    ++  +V E +   SLED L +  D   + +  + IA+     +E++H
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELLGP-SLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAK-----ISDFGLAK-FGPLGDKSHISTR----VLGT 306
           +  + +I+RDVK  N L+    N       I DF LAK +     K HI  R    + GT
Sbjct: 123 S--KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180

Query: 307 RGYFAPEYIATGHL----TLKTDVYSFGVVLLEILSGK 340
             Y     I T HL    + + D+ + G + +  L G 
Sbjct: 181 ARY-MS--INT-HLGKEQSRRDDLEALGHMFMYFLRGS 214

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 61/330 (18%), Positives = 101/330 (30%), Gaps = 86/330 (26%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSR 193
            +G+G FG V         +           VA+K +R  G      + E    +  L +
Sbjct: 26  NLGEGTFGKV---------VECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKK 72

Query: 194 LNHP------NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           +           V +  +     H  + +E + + +  + L   +           +A  
Sbjct: 73  IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQ 131

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-------------------KISDFGLA 288
               L  LH     + H D+K  N+L  +                       +++DFG A
Sbjct: 132 LCHALRFLHEN--QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLK----TDVYSFGVVLLEILSGKT--- 341
            F    D  H +T ++ TR Y  PE I    L L      DV+S G +L E   G T   
Sbjct: 190 TF----DHEHHTT-IVATRHYRPPEVI----LELGWAQPCDVWSIGCILFEYYRGFTLFQ 240

Query: 342 --------AAMRRTNGL------------------AGNWAKPYLSNKLALHQIIDEKLGR 375
                     M +  G                      W +     +         K   
Sbjct: 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYM 300

Query: 376 NIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
                E  +  +++ R L  DP  R T++E
Sbjct: 301 LQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 70/330 (21%), Positives = 111/330 (33%), Gaps = 86/330 (26%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSR 193
            +G+G FG V               K     VAVK ++         + E    ++ L  
Sbjct: 21  TLGEGAFGKVV---------ECIDHKAGGRHVAVKIVKNVDRYCEAARSE----IQVLEH 67

Query: 194 LNHP------NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           LN          V+++ +     H  +V+E +   S  D +          +   K+A  
Sbjct: 68  LNTTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQ 126

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-------------------KISDFGLA 288
             + +  LH+    + H D+K  N+L                          K+ DFG A
Sbjct: 127 ICKSVNFLHSN--KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184

Query: 289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLK----TDVYSFGVVLLEILSGKT--- 341
            +    D  H ST ++ TR Y APE I    L L      DV+S G +L+E   G T   
Sbjct: 185 TY----DDEHHST-LVSTRHYRAPEVI----LALGWSQPCDVWSIGCILIEYYLGFTVFP 235

Query: 342 --------AAMRRTNGL-------AGNWAKPYLSNKLALHQIIDEK---------LGRNI 377
                   A M R  G             K +  ++L   +              L   +
Sbjct: 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM 295

Query: 378 QME--EAQEFAEIILRCLNSDPKNRPTMSE 405
             +  E +   ++I + L  DP  R T+ E
Sbjct: 296 LSQDVEHERLFDLIQKMLEYDPAKRITLRE 325

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 69/337 (20%), Positives = 109/337 (32%), Gaps = 94/337 (27%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSR 193
            +G G FG V             +  +     AVK +R         + E       L +
Sbjct: 42  KMGDGTFGRVL----------LCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKK 87

Query: 194 LNH-----PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
           + +      N+VK  G      H  L++E     SL + +   +    + E      +  
Sbjct: 88  IQNDDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEI 146

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA-------------------------KIS 283
            + L +L      + H D+K  N+LLDD +                           K+ 
Sbjct: 147 LKALNYLRKM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLK----TDVYSFGVVLLEILSG 339
           DFG A F       +  + ++ TR Y APE I    L L     +D++SFG VL E+ +G
Sbjct: 205 DFGCATF----KSDYHGS-IINTRQYRAPEVI----LNLGWDVSSDMWSFGCVLAELYTG 255

Query: 340 KT-----------AAMRRTNGL--------AGNWAKPYLSNKLALHQIIDE--------- 371
                        A M              A         NK  L     E         
Sbjct: 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIK 315

Query: 372 ---KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
              K     ++ + + F + +   L  DP  RP+ +E
Sbjct: 316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	451
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.19
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.1
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.79
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.62
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.55
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.52
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.44
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.36
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.31
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.25
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.85
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.84
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.73
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.67
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.67
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.54
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.52
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.49
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.32
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.31
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.25
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.04
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.02
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.02
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.76
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.14
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.28
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.26

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.8e-59  Score=451.30  Aligned_cols=266  Identities=26%  Similarity=0.442  Sum_probs=220.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|.+.++||+|+||+||+|.+...     ....++..||||++........++|.+|+++|++|+|||||+++|+|.++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~-----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNL-----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSC-----C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCc-----ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            4788999999999999999987542     23345788999999866555567899999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNE-----------DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF  278 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~  278 (451)
                      +..|||||||+||+|.++|...           ....+++..++.|+.||+.||.|||+  ++||||||||+||||+.++
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEEECCCC
Confidence            9999999999999999999643           23579999999999999999999999  8999999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCcccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  357 (451)
                      .+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.....         
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---------  236 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---------  236 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---------
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence            999999999986433333333344578999999999999999999999999999999998 8999865322         


Q ss_pred             ccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                           ..+...+........+...++++.+|+.+||+.||++|||+.+|++.|+++...
T Consensus       237 -----~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          237 -----NEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             -----HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                 111222223333445666788999999999999999999999999999998654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-58  Score=452.65  Aligned_cols=266  Identities=26%  Similarity=0.435  Sum_probs=214.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|.+.++||+|+||+||+|.+...     .+..++..||||++........++|.+|+++|++++|||||+++|+|.++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~-----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNL-----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSS-----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCc-----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            4677889999999999999987642     23456788999999866555567899999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNED-------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD  276 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~  276 (451)
                      +..|||||||++|+|.+++....             ...+++.+++.|+.||+.||.|||+  ++||||||||+||||++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEET
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhEEECC
Confidence            99999999999999999986532             2469999999999999999999999  89999999999999999


Q ss_pred             CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCcc
Q 013028          277 DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWA  355 (451)
Q Consensus       277 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~  355 (451)
                      ++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |+.||.....       
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------  266 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------  266 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------
Confidence            99999999999986543333344456789999999999999999999999999999999999 8999864321       


Q ss_pred             ccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          356 KPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                             ..+...+........+...++++.+|+.+||+.||++|||+.||++.|+.+...
T Consensus       267 -------~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          267 -------TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             -------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------HHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                   111222333334455667789999999999999999999999999999998653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-58  Score=454.15  Aligned_cols=252  Identities=20%  Similarity=0.388  Sum_probs=207.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|+++++||+|+||+||+|.          +..+++.||||++......  ..+.+.+|+++|+.|+|||||+++++|+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~----------~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~   93 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVK----------STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE   93 (350)
T ss_dssp             CCEEEEEEC------CEEEEE----------ETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEE----------ECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE
Confidence            589999999999999999965          4556788999999754332  3456889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +++.+|||||||+||+|.++|.......+++..++.|+.||+.||.|||+  +|||||||||+||||+.+|.+||+|||+
T Consensus        94 ~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGl  171 (350)
T 4b9d_A           94 ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGI  171 (350)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEEEccccc
Confidence            99999999999999999999977666778999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      |+...  .........+||+.|||||++.+..|+.++|||||||+||||++|+.||......             ..+..
T Consensus       172 a~~~~--~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-------------~~~~~  236 (350)
T 4b9d_A          172 ARVLN--STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-------------NLVLK  236 (350)
T ss_dssp             ESCCC--HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------------HHHHH
T ss_pred             ceeec--CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------------HHHHH
Confidence            98532  1122345678999999999999999999999999999999999999999754321             11122


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +.... ....+...+.++.+||.+||..||++|||+.|+|+.
T Consensus       237 i~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          237 IISGS-FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             HHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHcCC-CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            22222 123445567899999999999999999999999874

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.4e-58  Score=444.15  Aligned_cols=262  Identities=27%  Similarity=0.439  Sum_probs=215.8

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .+++.++||+|+||+||+|.+..     ..+..++..||||++.... ....++|.+|+.+|++++|||||+++|+|.++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~-----~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFG-----PAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC------------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HCeEeeEeccCCCcEEEEEEEcC-----CccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            56778999999999999998754     2234557889999997543 33457899999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD  275 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~  275 (451)
                      +..+||||||++|+|.++|....              ...+++..++.|+.||+.||.|||+  ++||||||||+||||+
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccceEEC
Confidence            99999999999999999995432              2468999999999999999999999  8999999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCc
Q 013028          276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNW  354 (451)
Q Consensus       276 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~  354 (451)
                      +++.+||+|||+|+..............+||+.|||||++.++.|+.++|||||||++|||+| |..||.....      
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------  253 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------  253 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------
Confidence            999999999999986433333334455789999999999999999999999999999999998 8889864322      


Q ss_pred             cccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                              ..+...+........+..++..+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus       254 --------~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          254 --------QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             --------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --------HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                    112233333333455667789999999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3e-57  Score=438.55  Aligned_cols=260  Identities=27%  Similarity=0.473  Sum_probs=207.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|.+.++||+|+||+||+|.++.             .||||+++....  ...+.|.+|+.+|++++|||||++++++.
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~-------------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~  102 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG-------------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT  102 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS-------------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC-------------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            478889999999999999987542             389999874432  23467899999999999999999999886


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      + +.++||||||+||+|.++|... ...+++..++.|+.||+.||+|||+  ++||||||||+||||++++.+||+|||+
T Consensus       103 ~-~~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DFGl  178 (307)
T 3omv_A          103 K-DNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGL  178 (307)
T ss_dssp             S-SSCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred             C-CeEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeeccC
Confidence            5 5689999999999999999654 3569999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCcccccccccc---CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      |+..............+||+.|||||++.+   ..|+.++|||||||+||||+||+.||......             ..
T Consensus       179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------------~~  245 (307)
T 3omv_A          179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------------DQ  245 (307)
T ss_dssp             CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------------HH
T ss_pred             ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------------HH
Confidence            986543333344556789999999999954   46899999999999999999999999653321             11


Q ss_pred             hhHHhhhhhc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          365 LHQIIDEKLG----RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       365 ~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      +...+.....    ...+...++++.+|+.+||+.||++|||+.||++.|+.++..+.+
T Consensus       246 ~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          246 IIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             HHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence            1122222111    123445678899999999999999999999999999999876643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.2e-57  Score=447.13  Aligned_cols=249  Identities=25%  Similarity=0.374  Sum_probs=211.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ..|+++++||+|+||+||+|.          +..+++.||||++........+.+.+|+.+|+.++|||||+++++|.++
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~----------~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  143 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIAT----------VRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG  143 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEE----------ETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             HhcEEeEEeecCcCeEEEEEE----------ECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            479999999999999999965          4456788999999866666667789999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +.+|||||||+||+|.+++..   ..+++..+..++.||+.||.|||+  +|||||||||+||||+.+|.+||+|||+|+
T Consensus       144 ~~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~  218 (346)
T 4fih_A          144 DELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCA  218 (346)
T ss_dssp             TEEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEecCcCce
Confidence            999999999999999998864   469999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ....  ........+||+.|||||++.+..|+.++|||||||++|||++|.+||......              .....+
T Consensus       219 ~~~~--~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------------~~~~~i  282 (346)
T 4fih_A          219 QVSK--EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------------KAMKMI  282 (346)
T ss_dssp             ECCS--SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------------HHHHHH
T ss_pred             ecCC--CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------------HHHHHH
Confidence            6432  223345689999999999999999999999999999999999999999753221              111112


Q ss_pred             hhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          370 DEKLG--RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       370 ~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .....  .......++++.+||.+||..||++|||+.|++++
T Consensus       283 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          283 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             HHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11111  12234557899999999999999999999999874

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2e-58  Score=446.17  Aligned_cols=251  Identities=23%  Similarity=0.344  Sum_probs=214.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++++.||+|+||+||+|.          +..+++.||||++.+.   .....+.+.+|+++|+.|+|||||+++++|
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~----------~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  101 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLAR----------ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF  101 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEE----------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEE----------ECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            379999999999999999965          5566889999999753   234457789999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      ++++++|||||||+||+|.+++..  ...+++..+..++.||+.||.|||+  +|||||||||+||||+.++.+||+|||
T Consensus       102 ~~~~~~yivmEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          102 QDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EeCCEEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEcC
Confidence            999999999999999999999965  4679999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +|+..............+||+.|||||++.+..|+.++|||||||++|+|++|.+||......             ..+.
T Consensus       178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------------~~~~  244 (311)
T 4aw0_A          178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-------------LIFA  244 (311)
T ss_dssp             TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HHHH
T ss_pred             CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------------HHHH
Confidence            998765444444556789999999999999999999999999999999999999999753321             1112


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+...  ...++...++++.+||.+||..||++|||+.|++..
T Consensus       245 ~i~~~--~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          245 KIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             HHHHT--CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             HHHcC--CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence            22222  223455667889999999999999999999997644

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.2e-57  Score=441.22  Aligned_cols=258  Identities=28%  Similarity=0.316  Sum_probs=212.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +.|.+.++||+|+||+||+|.          ++.++..||||++......     .+|+.+|+.|+|||||+++++|.++
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~----------~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~  122 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMK----------DKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREG  122 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEE----------ETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEET
T ss_pred             hheEeCcEeccCCCeEEEEEE----------ECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            367888999999999999965          4556788999999754322     4699999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC-cEEEeecCCc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF-NAKISDFGLA  288 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~-~~kl~DFGla  288 (451)
                      +.+|||||||+||+|.+++..  ...+++..+..++.||+.||.|||+  +|||||||||+||||+.+| .+||+|||+|
T Consensus       123 ~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~~vKl~DFGla  198 (336)
T 4g3f_A          123 PWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHA  198 (336)
T ss_dssp             TEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred             CEEEEEEeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence            999999999999999999965  3579999999999999999999999  8999999999999999887 6999999999


Q ss_pred             ccCCCCCCc---ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          289 KFGPLGDKS---HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       289 ~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      +........   ......+||+.|||||++.+..|+.++|||||||++|||++|.+||.......       .      .
T Consensus       199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~------~  265 (336)
T 4g3f_A          199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-------L------C  265 (336)
T ss_dssp             EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-------C------H
T ss_pred             eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-------H------H
Confidence            864432211   12234689999999999999999999999999999999999999997543321       0      1


Q ss_pred             hHHhhhhh-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          366 HQIIDEKL-GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       366 ~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      ..+..... ...++...++.+.+||.+||..||.+|||+.|+++.|.......+.
T Consensus       266 ~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~  320 (336)
T 4g3f_A          266 LKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG  320 (336)
T ss_dssp             HHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred             HHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence            11221111 1234556678999999999999999999999999999998877653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-56  Score=449.59  Aligned_cols=250  Identities=25%  Similarity=0.372  Sum_probs=212.8

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+.|+++++||+|+||+||+|.          +..+++.||||++........+.+.+|+.+|+.++|||||+++++|.+
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~----------~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  219 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIAT----------VRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV  219 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEE----------ETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEE----------ECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE
Confidence            3579999999999999999965          445678899999987666667778999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++.+|||||||+||+|.+++..   ..+++..+..|+.||+.||.|||+  +|||||||||+||||+.+|.+||+|||+|
T Consensus       220 ~~~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~~~g~vKl~DFGla  294 (423)
T 4fie_A          220 GDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC  294 (423)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred             CCEEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEecCccc
Confidence            9999999999999999999854   459999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      +....  ........+||+.|||||++.+..|+.++|||||||++|||++|.+||......              .....
T Consensus       295 ~~~~~--~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------------~~~~~  358 (423)
T 4fie_A          295 AQVSK--EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------------KAMKM  358 (423)
T ss_dssp             EECCS--SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------------HHHHH
T ss_pred             eECCC--CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------------HHHHH
Confidence            86432  223345679999999999999999999999999999999999999999753321              11111


Q ss_pred             hhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          369 IDEKLG--RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       369 ~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +.....  .......++++.+||.+||..||++|||+.|+|++
T Consensus       359 i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          359 IRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             HHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            211111  12233457889999999999999999999999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.3e-56  Score=423.85  Aligned_cols=247  Identities=26%  Similarity=0.401  Sum_probs=195.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++++.||+|+||+||+|.          +..+++.||||++.+..   ......+.+|+++|+.++|||||++++++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~----------~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~   82 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAY----------HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI   82 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEE----------CTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEE----------ECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence            489999999999999999965          55668899999997542   23356789999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++..||||||| +|+|.+++..  ...+++..+..++.||+.||+|||+  +||+||||||+||||+.++.+||+|||
T Consensus        83 ~~~~~~~ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~DFG  157 (275)
T 3hyh_A           83 KSKDEIIMVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFG  157 (275)
T ss_dssp             ECSSEEEEEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred             EECCEEEEEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEeecC
Confidence            9999999999999 6799999865  4679999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      +|+....   .......+||+.|+|||++.+..| +.++|||||||++|+|++|+.||......             ...
T Consensus       158 la~~~~~---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-------------~~~  221 (275)
T 3hyh_A          158 LSNIMTD---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-------------VLF  221 (275)
T ss_dssp             CC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HHH
T ss_pred             CCeecCC---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-------------HHH
Confidence            9986332   233446789999999999988776 58999999999999999999999643211             111


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..+...  ...++...++++.+|+.+||+.||++|||+.|++++
T Consensus       222 ~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          222 KNISNG--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             HHHHHT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             HHHHcC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            122211  123445567889999999999999999999999874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.1e-56  Score=427.45  Aligned_cols=245  Identities=25%  Similarity=0.408  Sum_probs=198.3

Q ss_pred             CcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeec--
Q 013028          133 SEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCD--  208 (451)
Q Consensus       133 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--  208 (451)
                      ++.++||+|+||+||+|.+          ..++..||+|++.....  ...+.|.+|+.+|+.|+|||||+++++|.+  
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~----------~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   98 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLD----------TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEE----------CCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence            6677899999999999764          44578899999975432  234568999999999999999999999875  


Q ss_pred             --CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--ceeCCCCCCceeeC-CCCcEEEe
Q 013028          209 --DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRP--VIHRDVKASNVLLD-DDFNAKIS  283 (451)
Q Consensus       209 --~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~--iiHrDlkp~NIll~-~~~~~kl~  283 (451)
                        +..+|||||||+||+|.+++..  ...+++..+..|+.||+.||.|||+  ++  ||||||||+||||+ .++.+||+
T Consensus        99 ~~~~~~~lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~--~~~~IiHRDlKp~NILl~~~~g~vKl~  174 (290)
T 3fpq_A           99 KGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             TTEEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred             CCCcEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCCCEEecccChhheeEECCCCCEEEE
Confidence              3568999999999999999965  4679999999999999999999999  67  99999999999998 47899999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      |||+|+...    .......+||+.|||||++. +.|+.++|||||||++|||++|+.||......             .
T Consensus       175 DFGla~~~~----~~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------------~  236 (290)
T 3fpq_A          175 DLGLATLKR----ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-------------A  236 (290)
T ss_dssp             CTTGGGGCC----TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------------H
T ss_pred             eCcCCEeCC----CCccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-------------H
Confidence            999998532    23345678999999999985 56999999999999999999999999643221             1


Q ss_pred             hhhHHhhhhh-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          364 ALHQIIDEKL-GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       364 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+...+.... ....+...++++.+||.+||..||++|||+.|++++
T Consensus       237 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          237 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             HHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1111111111 111223345789999999999999999999999863

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.7e-56  Score=439.75  Aligned_cols=272  Identities=28%  Similarity=0.387  Sum_probs=223.5

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCC-Cceeecc
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNH-PNVVKLM  203 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h-~nIv~~~  203 (451)
                      +...++|+++++||+|+||+||+|.+....     .....+.||||++...... ..+.|.+|+++|.+++| ||||+++
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~-----~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGID-----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSS-----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCC-----cccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            334578999999999999999999876431     2334567999999754433 24568899999999975 8999999


Q ss_pred             ceeec-CCeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCC
Q 013028          204 GYCCD-DQHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVK  268 (451)
Q Consensus       204 ~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlk  268 (451)
                      |+|.+ +..++||||||++|+|.++|....              ...+++..++.++.||+.||.|||+  ++|||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHRDLK  212 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLA  212 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCS
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecCccC
Confidence            99865 456899999999999999996432              2458999999999999999999999  899999999


Q ss_pred             CCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccc
Q 013028          269 ASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRT  347 (451)
Q Consensus       269 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~  347 (451)
                      |+||||++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |..||....
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999986543333334455679999999999999999999999999999999998 899986532


Q ss_pred             CCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          348 NGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                      ..             ..+...+........+...++++.+|+.+||+.||++|||+.||+++|+.+....
T Consensus       293 ~~-------------~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          293 ID-------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             CS-------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HH-------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            21             1223344444455566677889999999999999999999999999999987643

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.6e-56  Score=431.06  Aligned_cols=251  Identities=26%  Similarity=0.356  Sum_probs=202.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++++.||+|+||+||+|....       +..+++.||||++.+...  .....+.+|+++|+.++|||||+++++|.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~-------~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~   96 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKIS-------GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ   96 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECS-------STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEcc-------CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            479999999999999999986422       334678899999975321  22345788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +++.+|||||||+||+|.+++..  ...+++..+..++.||+.||.|||+  +|||||||||+|||++.+|.+||+|||+
T Consensus        97 ~~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGl  172 (304)
T 3ubd_A           97 TEGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGL  172 (304)
T ss_dssp             ETTEEEEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEeccccc
Confidence            99999999999999999999965  4579999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      |+....  ........+||+.|||||++.+..|+.++|||||||++|||++|..||......             ..+..
T Consensus       173 a~~~~~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-------------~~~~~  237 (304)
T 3ubd_A          173 SKESID--HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-------------ETMTM  237 (304)
T ss_dssp             EEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HHHHH
T ss_pred             ceeccC--CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-------------HHHHH
Confidence            985322  223344678999999999999999999999999999999999999999754321             11122


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM-----SEVVA  408 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~  408 (451)
                      +...  ...++...++++.+||.+||+.||++|||+     +|+++
T Consensus       238 i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          238 ILKA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HHcC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            2222  223455667899999999999999999984     56654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.9e-54  Score=419.05  Aligned_cols=273  Identities=27%  Similarity=0.362  Sum_probs=201.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|.+.++||+|+||+||+|.++            +..||||++.... ......+.|+..+..++|||||++++++.++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~------------g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~   69 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR------------GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKD   69 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET------------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC------------CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEec
Confidence            46888999999999999998763            4679999996432 1112234566666788999999999999865


Q ss_pred             C----eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceeCCCCCCceeeCCCCc
Q 013028          210 Q----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTY------WRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       210 ~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------~~~iiHrDlkp~NIll~~~~~  279 (451)
                      +    .+|||||||+||+|.+++..   ..++++.+..++.|++.||.|||+.      ..+||||||||+||||+.++.
T Consensus        70 ~~~~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~  146 (303)
T 3hmm_A           70 NGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  146 (303)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CCCceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC
Confidence            4    57999999999999999965   4589999999999999999999972      128999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCc--ccccccCCCCccccccccccC------CCCcchhhHHHHHHHHHHHhCCCccccccCCCC
Q 013028          280 AKISDFGLAKFGPLGDKS--HISTRVLGTRGYFAPEYIATG------HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA  351 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~------~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  351 (451)
                      +||+|||+|+........  ......+||+.|||||++.+.      .|+.++|||||||+||||+||.+||........
T Consensus       147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~  226 (303)
T 3hmm_A          147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence            999999999864332221  122346899999999999654      467899999999999999999988765433211


Q ss_pred             CCccc-cccchhhhhh-HHhhhhhcCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcC
Q 013028          352 GNWAK-PYLSNKLALH-QIIDEKLGRNIQ-----MEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG  418 (451)
Q Consensus       352 ~~~~~-~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  418 (451)
                      ..... +.......+. .+....+...++     ...+..+.+|+.+||+.||++|||+.||++.|+++..+.+
T Consensus       227 p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~  300 (303)
T 3hmm_A          227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence            10000 0000111111 122223333333     2356789999999999999999999999999999976543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.2e-53  Score=413.38  Aligned_cols=248  Identities=23%  Similarity=0.396  Sum_probs=188.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++++.||+|+||+||+|.          ++.++..||||++...... ..+.+.+|+++|+.|+|||||+++++|.+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~----------~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~   74 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAK----------NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE   74 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEE----------ETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             hhCEEeeEEecCCCeEEEEEE----------ECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            368999999999999999965          4456788999999754332 34568899999999999999999999875


Q ss_pred             CC------------eeEEEEeccCCCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC
Q 013028          209 DQ------------HRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD  275 (451)
Q Consensus       209 ~~------------~~~lV~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~  275 (451)
                      .+            ++|||||||+||+|.+++..... ...++..++.++.||+.||+|||+  +|||||||||+||||+
T Consensus        75 ~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl~  152 (299)
T 4g31_A           75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFT  152 (299)
T ss_dssp             EC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEC
T ss_pred             cCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEEC
Confidence            44            37999999999999999965422 335567788999999999999999  8999999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCCCc----------ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccc
Q 013028          276 DDFNAKISDFGLAKFGPLGDKS----------HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMR  345 (451)
Q Consensus       276 ~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~  345 (451)
                      .++.+||+|||+|+........          ......+||+.|||||++.+..|+.++|||||||++|||++   ||..
T Consensus       153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            9999999999999864432211          12234689999999999999999999999999999999996   5542


Q ss_pred             ccCCCCCCccccccchhhhhhHHhhhhhcCCCCH---HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          346 RTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQM---EEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ..+               . ...+........+.   ..++.+.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~~---------------~-~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          230 QME---------------R-VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHH---------------H-HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccH---------------H-HHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            211               0 01111111222222   23466789999999999999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.5e-52  Score=415.64  Aligned_cols=265  Identities=21%  Similarity=0.295  Sum_probs=201.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|+++++||+|+||+||+|.          +..+++.||||++......  ..+.+.+|+++|+.|+|||||++++++.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~----------~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  123 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSAR----------RRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR  123 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEE----------ETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             CCeEEEEEEecccCeEEEEEE----------ECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence            489999999999999999965          4556888999999754332  2346789999999999999999999875


Q ss_pred             c------CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEE
Q 013028          208 D------DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       208 ~------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~k  281 (451)
                      .      ..++|||||||+ |+|.+++..  ...+++..+..++.||+.||.|||+  +|||||||||+|||++.++.+|
T Consensus       124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~~~~~~~K  198 (398)
T 4b99_A          124 PTVPYGEFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLVNENCELK  198 (398)
T ss_dssp             CSSCTTTCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEE
T ss_pred             cccccccCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCccccccCCCCCEE
Confidence            3      467899999996 689999954  5679999999999999999999999  8999999999999999999999


Q ss_pred             EeecCCcccCCCC--CCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCC-------
Q 013028          282 ISDFGLAKFGPLG--DKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-------  351 (451)
Q Consensus       282 l~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-------  351 (451)
                      |+|||+|+.....  .........+||+.|+|||++.+. .|+.++||||+||++|||++|.+||.+......       
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~  278 (398)
T 4b99_A          199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV  278 (398)
T ss_dssp             ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred             EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence            9999999854322  122334567999999999998774 569999999999999999999999975432100       


Q ss_pred             -CCccccccch--hhhhhHHhhhhh-cCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 -GNWAKPYLSN--KLALHQIIDEKL-GRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 -~~~~~~~~~~--~~~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                       ..........  .......+.... ....     ....++++.+||.+||..||.+|||+.|+|++
T Consensus       279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             0000000000  000000000000 0000     11235789999999999999999999999874

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.8e-51  Score=408.30  Aligned_cols=266  Identities=23%  Similarity=0.320  Sum_probs=200.5

Q ss_pred             HHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeeccce
Q 013028          127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGY  205 (451)
Q Consensus       127 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~  205 (451)
                      .+.++|++.++||+|+||+||+|....       +..+++.||||.+...  .....+.+|+++|+.+ +|||||+++++
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~-------~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~   88 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQL-------QVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYC   88 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEB-------TTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcc-------cCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence            346789999999999999999986421       2245678999998653  3455688999999998 59999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC-CcEEEee
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD-FNAKISD  284 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~-~~~kl~D  284 (451)
                      |.+.+++|||||||+||+|.+++     ..+++.++..++.||+.||.|||+  +|||||||||+|||++.+ +.+||+|
T Consensus        89 ~~~~~~~~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~kl~D  161 (361)
T 4f9c_A           89 FRKNDHVVIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYALVD  161 (361)
T ss_dssp             EEETTEEEEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             EEECCEEEEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEEECc
Confidence            99999999999999999999998     248999999999999999999999  899999999999999876 7999999


Q ss_pred             cCCcccCCCCCC--------------------------cccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHH
Q 013028          285 FGLAKFGPLGDK--------------------------SHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEIL  337 (451)
Q Consensus       285 FGla~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell  337 (451)
                      ||+|+.......                          .......+||+.|+|||++.+. .|+.++||||+||++|||+
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell  241 (361)
T 4f9c_A          162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL  241 (361)
T ss_dssp             CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence            999975332111                          1112346899999999999775 5899999999999999999


Q ss_pred             hCCCccccccCCCCC--------------------------CccccccchhhhhhHHhh---------------hhhcCC
Q 013028          338 SGKTAAMRRTNGLAG--------------------------NWAKPYLSNKLALHQIID---------------EKLGRN  376 (451)
Q Consensus       338 tg~~pf~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~---------------~~~~~~  376 (451)
                      +|+.||.........                          ....+.. +...+.+.+.               ......
T Consensus       242 ~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  320 (361)
T 4f9c_A          242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQ-DLRKLCERLRGMDSSTPKLTSDIQGHATNLE  320 (361)
T ss_dssp             HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCC-CHHHHHHHHC---------------------
T ss_pred             HCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcch-hhhHHHHhhcccccccccccccccccccccc
Confidence            999999654321000                          0000000 0000000000               000001


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          377 IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       377 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .....++++.+|+.+||..||++|||+.|+|++
T Consensus       321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            112345789999999999999999999999863

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.2e-51  Score=428.36  Aligned_cols=252  Identities=21%  Similarity=0.335  Sum_probs=210.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++++.||+|+||+||+|.          ++.++..||+|++........+.+.+|+.+|+.|+|||||+++++|.+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~----------~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  225 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVT----------ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED  225 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEE----------ETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEE----------ECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            4689999999999999999965          455678899999986655556778899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC--CcEEEeecC
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD--FNAKISDFG  286 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~--~~~kl~DFG  286 (451)
                      +..+|||||||+||+|.++|... ...+++..+..++.||+.||.|||+  +||+||||||+|||++.+  +.+||+|||
T Consensus       226 ~~~~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~DFG  302 (573)
T 3uto_A          226 DNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFG  302 (573)
T ss_dssp             SSEEEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred             CCEEEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEeecc
Confidence            99999999999999999998543 3579999999999999999999999  899999999999999854  899999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +|+....   .......+||+.|||||++.+..|+.++|||||||++|||++|.+||......             ..+.
T Consensus       303 ~a~~~~~---~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------------~~~~  366 (573)
T 3uto_A          303 LTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------------ETLR  366 (573)
T ss_dssp             SCEECCT---TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------------HHHH
T ss_pred             ceeEccC---CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------------HHHH
Confidence            9986432   23345678999999999999999999999999999999999999999754321             1111


Q ss_pred             HHhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIIDEKLG--RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+......  .......++++.+||.+||..||.+|||+.|+|++
T Consensus       367 ~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          367 NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             HHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            22211111  11122346889999999999999999999999873

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-50  Score=423.70  Aligned_cols=251  Identities=26%  Similarity=0.341  Sum_probs=204.0

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHH---HHHHHHhcCCCceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWEN---ELRFLSRLNHPNVVKL  202 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~il~~l~h~nIv~~  202 (451)
                      .++|++++.||+|+||+||+|.          ++.++..||||++.+..   ......+.+   ++.+++.++|||||++
T Consensus       188 lddf~i~k~LG~G~fG~V~la~----------~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l  257 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCR----------KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM  257 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEE----------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCE
T ss_pred             hHHeEEEEEEecccCeEEEEEE----------ECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEE
Confidence            3679999999999999999965          55668899999997431   222333333   4566777899999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      +++|.+.+++|||||||+||+|.++|..  ...+++..+..++.||+.||.|||+  +|||||||||+||||+.+|.+||
T Consensus       258 ~~~f~~~~~lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~--~gIiHRDLKPeNILld~~G~vKL  333 (689)
T 3v5w_A          258 SYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRI  333 (689)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEEECCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHeEEeCCCCEEe
Confidence            9999999999999999999999999965  4679999999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      +|||+|+....    ......+||+.|||||++.+ ..|+.++|||||||++|||++|.+||........          
T Consensus       334 ~DFGlA~~~~~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~----------  399 (689)
T 3v5w_A          334 SDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----------  399 (689)
T ss_dssp             CCCTTCEECSS----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH----------
T ss_pred             cccceeeecCC----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----------
Confidence            99999986432    22345799999999999964 5799999999999999999999999975432200          


Q ss_pred             hhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013028          362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT-----MSEVVAA  409 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~  409 (451)
                      ......+.  .....++...++++.+||.+||..||.+|++     +.||+++
T Consensus       400 ~~i~~~i~--~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          400 HEIDRMTL--TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             HHHHHHHH--HCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             HHHHHhhc--CCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            00011111  1223455667889999999999999999998     6887764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.7e-48  Score=379.95  Aligned_cols=278  Identities=42%  Similarity=0.708  Sum_probs=226.2

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ..++|.+.+.||+|+||.||+|.+.           ++..||||.+........+.+.+|+.+++.++||||+++++++.
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR-----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT-----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             HHhccCccceeecCCCeeEEEEEEC-----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            4579999999999999999998642           36789999988766666778999999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNED--DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.+..++||||+++|+|.+++....  ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCCHHHEEECCCCCEEEeec
Confidence            9999999999999999999986543  2458999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc--cchhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKL  363 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~--~~~~~  363 (451)
                      |++................||..|+|||++.+..++.++|||||||++|+|++|+.||....+..........  .....
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            9998644333333344556899999999998899999999999999999999999999765443221100000  00011


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcC
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG  418 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  418 (451)
                      .+...++...........+..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence            1122233333445667788999999999999999999999999999999876543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.5e-48  Score=374.03  Aligned_cols=265  Identities=27%  Similarity=0.453  Sum_probs=217.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|.+.++||+|+||+||+|.+.          .++..||+|.+........+.+.+|+++++.++||||+++++++.++
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~----------~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   79 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHR----------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD   79 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEET----------TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             hHeeccceecCCCCEEEEEEEEC----------CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence            48899999999999999997643          45778999998765555667889999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++|+|.+++... ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  156 (310)
T 3s95_A           80 KRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLAR  156 (310)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred             CeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeecccce
Confidence            9999999999999999999654 4569999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCCcc------------cccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc
Q 013028          290 FGPLGDKSH------------ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       290 ~~~~~~~~~------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~  357 (451)
                      .........            ......||+.|+|||++.+..++.++|||||||++|+|++|..|+..........    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----  232 (310)
T 3s95_A          157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----  232 (310)
T ss_dssp             ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----
T ss_pred             ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----
Confidence            643221111            1124679999999999999999999999999999999999998876543321100    


Q ss_pred             ccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                          ..........    ..+...+..+.+|+.+||+.||.+|||+.++++.|+.++..+..
T Consensus       233 ----~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          233 ----GLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             ----SBCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             ----hhhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence                0111122221    22344556799999999999999999999999999999887654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3e-47  Score=368.80  Aligned_cols=251  Identities=25%  Similarity=0.387  Sum_probs=210.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.+.||+|+||+||+|.          +..++..||||++........+.+.+|+.+++.++||||+++++++.+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   88 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAM----------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV   88 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEE----------BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEE----------ECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE
Confidence            4589999999999999999965          445678899999986666667788999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++..++||||++||+|.+++..   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           89 GDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (297)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCEEEEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            9999999999999999999865   358999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ......  ........||+.|+|||++.+..++.++|||||||++|+|++|..||......             .....+
T Consensus       164 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------------~~~~~~  228 (297)
T 3fxz_A          164 AQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------------RALYLI  228 (297)
T ss_dssp             EECCST--TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------------HHHHHH
T ss_pred             eecCCc--ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------------HHHHHH
Confidence            764322  22234568999999999999999999999999999999999999998643211             011111


Q ss_pred             hh-hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          369 ID-EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       369 ~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .. .......+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          229 ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             HHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11 111122344567889999999999999999999999874

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.2e-47  Score=380.09  Aligned_cols=269  Identities=25%  Similarity=0.418  Sum_probs=219.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhc-CCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRL-NHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~h~nIv~~~~~~~  207 (451)
                      ++|.+++.||+|+||.||+|.+....   ......+..||||++...... ..+.+.+|+.+|+.+ +||||+++++++.
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~---~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCS---TTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEeccc---CcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            58999999999999999999864321   012234567999999754322 245688999999999 7999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcee
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL  273 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIl  273 (451)
                      +....|+||||+++|+|.+++....              ...+++..++.++.||+.||.|||+  +||+||||||+|||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIl  235 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL  235 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchhhEE
Confidence            9999999999999999999986542              2458999999999999999999999  89999999999999


Q ss_pred             eCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCC
Q 013028          274 LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAG  352 (451)
Q Consensus       274 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~  352 (451)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||......   
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---  312 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---  312 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence            99999999999999986443333233344567889999999999999999999999999999999 98888643211   


Q ss_pred             CccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          353 NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                                 .+...+........+...+.++.+|+.+||+.||.+|||+.|+++.|+.+....
T Consensus       313 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          313 -----------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             -----------GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence                       112223333334455566788999999999999999999999999999987654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.6e-47  Score=373.49  Aligned_cols=284  Identities=41%  Similarity=0.706  Sum_probs=227.7

Q ss_pred             cccccccchHHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHH
Q 013028          114 AYKLKYFCHGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLS  192 (451)
Q Consensus       114 ~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~  192 (451)
                      ......+...+++...++|.+.+.||+|+||.||+|.+           .++..||||++..... .....+.+|+.+++
T Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~   82 (326)
T 3uim_A           14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-----------ADGTLVAVKRLKEERTQGGELQFQTEVEMIS   82 (326)
T ss_dssp             -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-----------SSSCCEEEEECCC-----CCCHHHHHHHGGG
T ss_pred             cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEe-----------cCCCEEEEEEeccccCchHHHHHHHHHHHHH
Confidence            34456778888999999999999999999999999742           2367799999975432 22336889999999


Q ss_pred             hcCCCceeeccceeecCCeeEEEEeccCCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCC---CceeCCC
Q 013028          193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED--DTELNWERRIKIALGAARGLEHLHTYWR---PVIHRDV  267 (451)
Q Consensus       193 ~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~---~iiHrDl  267 (451)
                      .++||||+++++++.+....++||||+++|+|.+++....  ...+++..+..++.|++.||.|||+  +   ||+||||
T Consensus        83 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~ivH~Dl  160 (326)
T 3uim_A           83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD--HCDPKIIHRDV  160 (326)
T ss_dssp             TCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH--SSSSCEECCCC
T ss_pred             hccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEeCCC
Confidence            9999999999999999999999999999999999996543  3459999999999999999999999  7   9999999


Q ss_pred             CCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccc
Q 013028          268 KASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRT  347 (451)
Q Consensus       268 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  347 (451)
                      ||+|||++.++.+||+|||++...... .........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       161 kp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  239 (326)
T 3uim_A          161 KAANILLDEEFEAVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR  239 (326)
T ss_dssp             SGGGEEECTTCCEEECCCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHH
T ss_pred             chhhEEECCCCCEEeccCccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccc
Confidence            999999999999999999999864422 2233445669999999999988899999999999999999999999996432


Q ss_pred             CCCCC-----CccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          348 NGLAG-----NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       348 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                      .....     .|...... ...+..+.+...........+..+.+|+.+||+.||.+|||+.||++.|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          240 LANDDDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             HTTTSCSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             cccccchhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            21110     01000000 111223334444455677788999999999999999999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=370.93  Aligned_cols=268  Identities=27%  Similarity=0.440  Sum_probs=216.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|.+.+.||+|+||.||+|.+...       ...+..||||++..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  120 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVP-------GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT  120 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCT-------TSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecC-------CCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            35899999999999999999886532       23356799999975432 23456889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++...++||||++||+|.+++... ...+++..++.++.||+.||.|||+  .||+||||||+|||++.++.+||+|||+
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  197 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFGL  197 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEECCCCCEEECCCCc
Confidence            999999999999999999998543 3579999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCC-cccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhh
Q 013028          288 AKFGPLGDK-SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       288 a~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      ++....... ........+|..|+|||++.+..++.++|||||||++|+|++ |..||.....              ..+
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------------~~~  263 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------------RDV  263 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------------HHH
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------------HHH
Confidence            986443221 112223456778999999988999999999999999999999 9999864322              111


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCC
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSC  420 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~  420 (451)
                      ...+........+...+..+.+|+.+||..||.+|||+.+|++.|+.+.....+.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~  318 (325)
T 3kul_A          264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL  318 (325)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred             HHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence            2222333334455566788999999999999999999999999999998776553

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.6e-47  Score=369.09  Aligned_cols=263  Identities=29%  Similarity=0.429  Sum_probs=205.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|++.+.||+|+||+||+|.+.            +..||||++......  ..+.+.+|+.+|+.++||||+++++++
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWH------------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET------------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEEC------------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            458999999999999999998643            456999999755332  235688999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCC--ceeCCCCCCceeeCCCCcEEEe
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGLEHLHTYWRP--VIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~--iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      .+....++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+  +|  |+||||||+|||++.++.+||+
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT--SSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc--CCCCEECCCCChhhEEEeCCCcEEEC
Confidence            999999999999999999999965321 238999999999999999999999  78  9999999999999999999999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      |||+++.....  ........||+.|+|||++.+..++.++|||||||++|+|++|..||......             .
T Consensus       182 Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------------~  246 (309)
T 3p86_A          182 DFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-------------Q  246 (309)
T ss_dssp             CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------------H
T ss_pred             CCCCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------H
Confidence            99999753221  12233567999999999999999999999999999999999999998643221             1


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCC
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSC  420 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~  420 (451)
                      ....+.........+...+..+.+|+.+||..||.+|||+.++++.|+.+.......
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~  303 (309)
T 3p86_A          247 VVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP  303 (309)
T ss_dssp             HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence            111111122233445566788999999999999999999999999999998765543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.8e-47  Score=378.00  Aligned_cols=272  Identities=28%  Similarity=0.389  Sum_probs=220.0

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhc-CCCceeecc
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRL-NHPNVVKLM  203 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~h~nIv~~~  203 (451)
                      +...++|++.+.||+|+||.||+|.+...     .+..++..||||++...... ..+.+.+|++++.++ +||||++++
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGI-----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESS-----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccceeeceeecCCCCceEEEEEeccc-----cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            34467999999999999999999876531     24456788999999754332 235688999999999 699999999


Q ss_pred             ceeecCC-eeEEEEeccCCCChhhhhccCCC-------------------------------------------------
Q 013028          204 GYCCDDQ-HRLLVYEYVTRGSLEDHLLNEDD-------------------------------------------------  233 (451)
Q Consensus       204 ~~~~~~~-~~~lV~E~~~gg~L~~~l~~~~~-------------------------------------------------  233 (451)
                      +++.+.. ..++||||+++|+|.+++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            9998755 48999999999999999965432                                                 


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcc
Q 013028          234 ---------------TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSH  298 (451)
Q Consensus       234 ---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  298 (451)
                                     ..+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++..........
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                           128999999999999999999999  899999999999999999999999999998643333333


Q ss_pred             cccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCC
Q 013028          299 ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNI  377 (451)
Q Consensus       299 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (451)
                      ......||..|+|||++.+..++.++|||||||++|+|++ |..||......             ..+...+........
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------------~~~~~~~~~~~~~~~  317 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------------EEFCRRLKEGTRMRA  317 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-------------HHHHHHHHHTCCCCC
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-------------HHHHHHHHcCCCCCC
Confidence            3445678899999999999999999999999999999998 99998643321             112233333333445


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          378 QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       378 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                      +...++++.+++.+||+.||.+|||+.|+++.|+.+....
T Consensus       318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            5556788999999999999999999999999999997653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.7e-46  Score=373.43  Aligned_cols=248  Identities=25%  Similarity=0.363  Sum_probs=206.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc------CHHHHHHHHHHHHhcCCCceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ------GQDEWENELRFLSRLNHPNVVKL  202 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~nIv~~  202 (451)
                      .++|.+++.||+|+||+||+|..          ..++..||||++......      ..+.+.+|+.+|+.++||||+++
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~----------~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l   80 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCRE----------KSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL   80 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEE----------CCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcE
Confidence            46899999999999999999764          455788999999764332      34678999999999999999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC----
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF----  278 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~----  278 (451)
                      +++|.+....++||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++    
T Consensus        81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~~  156 (361)
T 2yab_A           81 HDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIP  156 (361)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSC
T ss_pred             EEEEEeCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCCcc
Confidence            9999999999999999999999999954  4679999999999999999999999  8999999999999998776    


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                      .+||+|||++.....   .......+||+.|+|||++.+..++.++|||||||++|+|++|..||......         
T Consensus       157 ~vkl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---------  224 (361)
T 2yab_A          157 HIKLIDFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---------  224 (361)
T ss_dssp             CEEECCCSSCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---------
T ss_pred             CEEEEecCCceEcCC---CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---------
Confidence            799999999986432   22234568999999999998889999999999999999999999999753321         


Q ss_pred             cchhhhhhHHhhhhhcCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          359 LSNKLALHQIIDEKLGRNIQ----MEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                          ..+..+....  ...+    ...+..+.+||.+||..||.+|||+.|+++
T Consensus       225 ----~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          225 ----ETLANITAVS--YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             ----HHHHHHHTTC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----HHHHHHHhcC--CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                1111111111  1112    123578999999999999999999999986

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.6e-47  Score=372.19  Aligned_cols=248  Identities=24%  Similarity=0.363  Sum_probs=207.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++.+.||+|+||.||+|.+          ..++..||||++.....  ...+.+.+|+++|+.++||||+++++++.
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   84 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARH----------ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE   84 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCEEEEEEEeeCCCEEEEEEEE----------CCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            4899999999999999999764          45578899999975432  23456789999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +....|+||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~  160 (328)
T 3fe3_A           85 TEKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGF  160 (328)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred             ECCEEEEEEECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEeeccC
Confidence            99999999999999999999865  3569999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCC-cchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLT-LKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +.....   .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||......             ....
T Consensus       161 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------------~~~~  224 (328)
T 3fe3_A          161 SNEFTV---GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-------------ELRE  224 (328)
T ss_dssp             CGGGSS---SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HHHH
T ss_pred             ceecCC---CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-------------HHHH
Confidence            975432   2234567899999999999887775 7999999999999999999998653211             0111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+...  ....+...+.++.+|+.+||..||.+|||+.|+++.
T Consensus       225 ~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          225 RVLRG--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HHHHC--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             HHHhC--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11111  123444567889999999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.3e-47  Score=367.49  Aligned_cols=281  Identities=25%  Similarity=0.414  Sum_probs=216.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|+++++||+|+||+||+|.+..      .+..++..||||++........+.+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDP------LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECT------TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEec------ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3589999999999999999987642      2455688999999986555555678999999999999999999999864


Q ss_pred             --CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          209 --DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       209 --~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                        ....++||||+++|+|.+++... ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeEEEccCc
Confidence              45689999999999999999654 3458999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc-c-cchhh
Q 013028          287 LAKFGPLGDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP-Y-LSNKL  363 (451)
Q Consensus       287 la~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~-~-~~~~~  363 (451)
                      ++......... .......++..|+|||++.+..++.++||||||+++|+|++|..|+.............. . .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            99864322211 122334577789999999999999999999999999999999988764322100000000 0 00001


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcC
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG  418 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  418 (451)
                      .+...+........+...+.++.+|+.+||+.||.+|||+.|+++.|+.+++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            1122223333334455667899999999999999999999999999999988764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=375.08  Aligned_cols=276  Identities=26%  Similarity=0.396  Sum_probs=223.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|.+.++||+|+||.||+|.+....   .........||||++...... ....+.+|+++++.+ +||||+++++++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~---~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLD---KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSS---TTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheEeeeEEecCCCeEEEEEEEcccc---ccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            358999999999999999999864321   112233467999999754322 235688999999999 899999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCce
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV  272 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NI  272 (451)
                      .++...++||||+++|+|.+++....              ...+++..++.++.||+.||.|||+  +||+||||||+||
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNV  222 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCcceE
Confidence            99999999999999999999996543              2459999999999999999999999  8999999999999


Q ss_pred             eeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCC
Q 013028          273 LLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLA  351 (451)
Q Consensus       273 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~  351 (451)
                      ||+.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|+|++ |..||.....   
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---  299 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---  299 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence            999999999999999986543333233444567889999999999999999999999999999999 9888754321   


Q ss_pred             CCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCccc
Q 013028          352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQT  423 (451)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~  423 (451)
                                 ..+...+........+...+.++.+|+.+||+.||.+|||+.||++.|+.+..........
T Consensus       300 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~  360 (382)
T 3tt0_A          300 -----------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG  360 (382)
T ss_dssp             -----------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC--
T ss_pred             -----------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCC
Confidence                       1222333333334445566788999999999999999999999999999998877654443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-46  Score=369.05  Aligned_cols=270  Identities=27%  Similarity=0.360  Sum_probs=210.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|++.++||+|+||+||+|.+.            +..||||++.... ........|+.+|+.++||||+++++++.+.
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~------------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL------------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRG   90 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET------------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC------------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence            58999999999999999998653            4679999996432 2234456789999999999999999999875


Q ss_pred             C----eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----------CceeCCCCCCceeeC
Q 013028          210 Q----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWR----------PVIHRDVKASNVLLD  275 (451)
Q Consensus       210 ~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~----------~iiHrDlkp~NIll~  275 (451)
                      .    ..++||||+++|+|.+++..   ..+++..+..++.|++.||.|||+  .          ||+||||||+|||++
T Consensus        91 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~--~~~~l~~~~~~~ivH~Dlkp~Nill~  165 (322)
T 3soc_A           91 TSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHE--DIPGLKDGHKPAISHRDIKSKNVLLK  165 (322)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTC--CEEEETTEEECEEECSCCSGGGEEEC
T ss_pred             CCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHh--hccccccccCCCEEeCCCChHhEEEC
Confidence            4    36999999999999999965   359999999999999999999999  7          999999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCCCcccccccCCCCcccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCccccccCCC
Q 013028          276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGL  350 (451)
Q Consensus       276 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  350 (451)
                      .++.+||+|||+++...............||+.|+|||++.+     ..++.++|||||||++|||++|..||.......
T Consensus       166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~  245 (322)
T 3soc_A          166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY  245 (322)
T ss_dssp             TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred             CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence            999999999999986543333333445689999999999976     356678999999999999999999997655432


Q ss_pred             CCCccccccc--hhhhhhHHh-hhhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          351 AGNWAKPYLS--NKLALHQII-DEKLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       351 ~~~~~~~~~~--~~~~~~~~~-~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                      ...+......  ....+...+ ........     ....+..+.+|+.+||+.||++|||+.||++.|+.+++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            2222111000  011111111 11111111     1234677999999999999999999999999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-47  Score=378.34  Aligned_cols=269  Identities=26%  Similarity=0.371  Sum_probs=215.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|++.+.||+|+||+||+|.+...     .+..++..||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGM-----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC----------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccC-----CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            35899999999999999999986542     2445677899999964322 23346889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC---c
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNED-----DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF---N  279 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~---~  279 (451)
                      +....++||||++||+|.+++....     ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++   .
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCC
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCCCCce
Confidence            9999999999999999999986532     2468999999999999999999999  8999999999999999554   5


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  358 (451)
                      +||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.....          
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~----------  292 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----------  292 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----------
Confidence            99999999974321122222334567899999999989999999999999999999998 9888864321          


Q ss_pred             cchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcC
Q 013028          359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG  418 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  418 (451)
                          ..+...+........+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.....
T Consensus       293 ----~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          293 ----QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             ----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             ----HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence                11222233333334455567889999999999999999999999999999977543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.1e-46  Score=369.18  Aligned_cols=254  Identities=26%  Similarity=0.365  Sum_probs=205.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++++.||+|+||+||+|.+          ..++..||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   76 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE   76 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEE----------CCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            5899999999999999999764          44578899999974432 234568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++..++||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg~a  152 (323)
T 3tki_A           77 GNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLA  152 (323)
T ss_dssp             SSEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEeecc
Confidence            9999999999999999999854  4569999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ................||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......            .....
T Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------------~~~~~  220 (323)
T 3tki_A          153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------QEYSD  220 (323)
T ss_dssp             EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS------------HHHHH
T ss_pred             ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH------------HHHHH
Confidence            85433333333446789999999999987765 788999999999999999999996543210            01111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..............+..+.+|+.+||..||.+|||+.|+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            111111111123456789999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.6e-46  Score=363.90  Aligned_cols=267  Identities=27%  Similarity=0.411  Sum_probs=218.8

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|.+.+.||+|+||.||+|....     ......+..||||++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFH-----LKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEET-----GGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hhheeeeeeecccCCeeEEEEEEec-----cCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            3589999999999999999998643     22344567899999975432 23456889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDD----------------------TELNWERRIKIALGAARGLEHLHTYWRPVIHR  265 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHr  265 (451)
                      +....++||||+++|+|.+++.....                      ..+++..++.++.||+.||.|||+  +||+||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~  174 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHR  174 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--TTEECC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--CCCccc
Confidence            99999999999999999999965432                      348999999999999999999999  899999


Q ss_pred             CCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccc
Q 013028          266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAM  344 (451)
Q Consensus       266 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~  344 (451)
                      ||||+|||++.++.+||+|||++................+|..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986443322222334567888999999988899999999999999999999 999886


Q ss_pred             cccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      .....              .+...+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       255 ~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          255 GIPPE--------------RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             TCCGG--------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCHH--------------HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            43221              12223333333344556678899999999999999999999999999998754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.9e-46  Score=363.31  Aligned_cols=270  Identities=28%  Similarity=0.422  Sum_probs=221.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|++.+.||+|+||.||+|.+..     ..+..++..||||++..... ...+.+.+|+.+++.+ +||||+++++++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYG-----LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEES-----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhHHHhhCccCCcceEEEEEee-----ccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            3589999999999999999987543     12345577899999975433 2346788999999999 899999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDD----------------TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKAS  270 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~  270 (451)
                      .+++..++||||+++|+|.+++.....                ..+++..++.++.||+.||.|||+  +||+||||||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~  174 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAAR  174 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGG
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccc
Confidence            999999999999999999999965432                258999999999999999999999  89999999999


Q ss_pred             ceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCC
Q 013028          271 NVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNG  349 (451)
Q Consensus       271 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~  349 (451)
                      |||++.++.+||+|||++................||..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            99999999999999999986543333223334567888999999988999999999999999999999 99888643221


Q ss_pred             CCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcC
Q 013028          350 LAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG  418 (451)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  418 (451)
                                   ......+........+...+..+.+|+.+||..||.+|||+.++++.|+++..+..
T Consensus       255 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          255 -------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             -------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             -------------hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence                         11223333333334445567889999999999999999999999999999887654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.3e-45  Score=356.43  Aligned_cols=282  Identities=35%  Similarity=0.619  Sum_probs=222.0

Q ss_pred             cccchHHHHHHhcCCCcC------CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC----CcCHHHHHHH
Q 013028          118 KYFCHGLLEAATRKFSEK------NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG----SQGQDEWENE  187 (451)
Q Consensus       118 ~~~~~~~~~~~~~~y~~~------~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E  187 (451)
                      ..|...++..++..|...      +.||+|+||.||+|.+            .+..||||++....    ....+.+.+|
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~------------~~~~vavK~~~~~~~~~~~~~~~~~~~E   80 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV------------NNTTVAVKKLAAMVDITTEELKQQFDQE   80 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES------------SSCEEEEEEECCCTTSCTTTHHHHHHHH
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE------------CCceEEEEEEecccCcchHHHHHHHHHH
Confidence            456677778888777766      8999999999999863            25679999987532    2234678899


Q ss_pred             HHHHHhcCCCceeeccceeecCCeeEEEEeccCCCChhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCC
Q 013028          188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNE-DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRD  266 (451)
Q Consensus       188 ~~il~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrD  266 (451)
                      +.+++.++||||+++++++.+.+..++||||+++++|.+++... ....+++..++.++.||+.||.|||+  +||+|||
T Consensus        81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~d  158 (307)
T 2nru_A           81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRD  158 (307)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSC
T ss_pred             HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecCC
Confidence            99999999999999999999999999999999999999998643 23569999999999999999999999  8999999


Q ss_pred             CCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccc
Q 013028          267 VKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRR  346 (451)
Q Consensus       267 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~  346 (451)
                      |||+|||++.++.++|+|||++................||+.|+|||++. +.++.++||||||+++|+|++|..||...
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred             CCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccC
Confidence            99999999999999999999998644333333344567999999999985 45899999999999999999999999764


Q ss_pred             cCCCCC-CccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          347 TNGLAG-NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       347 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                      ...... .+..........+...++..+ ...+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          238 REPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             BSSSBTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             cchHHHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            432110 000000000111122222221 23456778899999999999999999999999999998854

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-46  Score=354.36  Aligned_cols=257  Identities=27%  Similarity=0.451  Sum_probs=213.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|++.+.||+|+||.||+|.+.+           +..||+|++... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~-----------~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLN-----------KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   77 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-----------TEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hhceeeheecCCCccEEEEEEecC-----------CCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            589999999999999999987542           456999999754 34467789999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ...++||||+++++|.+++... ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++.++|+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  154 (269)
T 4hcu_A           78 APICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTR  154 (269)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred             CceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEEcCCCCEEeccccccc
Confidence            9999999999999999998653 3568999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHH
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ..... .........+|..|+|||++.+..++.++||||||+++|+|++ |..||......              .....
T Consensus       155 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--------------~~~~~  219 (269)
T 4hcu_A          155 FVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------------EVVED  219 (269)
T ss_dssp             GBCCH-HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------------HHHHH
T ss_pred             ccccc-ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--------------HHHHH
Confidence            53321 1112234456778999999988999999999999999999999 88888643211              11122


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      +........+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          220 ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            222223334445578899999999999999999999999999998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.7e-46  Score=368.56  Aligned_cols=249  Identities=28%  Similarity=0.373  Sum_probs=208.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++++.||+|+||+||+|.          +..++..||||++.+.   .......+.+|+.+|+.++||||+++++++
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~   74 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVR----------EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF   74 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEE----------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEE----------ECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence            489999999999999999965          4456788999999753   234456788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+.+..|+||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG  150 (337)
T 1o6l_A           75 QTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFG  150 (337)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999999865  3578999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +++....  ........+||+.|+|||++.+..++.++|||||||++|||++|..||......             ....
T Consensus       151 ~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------------~~~~  215 (337)
T 1o6l_A          151 LCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------------RLFE  215 (337)
T ss_dssp             TCBCSCC--TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HHHH
T ss_pred             chhhccc--CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-------------HHHH
Confidence            9985321  122344578999999999999999999999999999999999999998643211             1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      .+...  ...++...+.++.+||.+||..||.+||     ++.|++++
T Consensus       216 ~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          216 LILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            12211  2234455678899999999999999999     89999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-46  Score=366.29  Aligned_cols=251  Identities=21%  Similarity=0.280  Sum_probs=207.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|.+.+.||+|+||+||+|.+          ..++..||+|.+... ......+.+|+.+|+.++||||+++++++.+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~----------~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   72 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVE----------TSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFES   72 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEE----------CCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEec
Confidence            46899999999999999999764          445778999998743 2334568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC--CCcEEEeecC
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD--DFNAKISDFG  286 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~--~~~~kl~DFG  286 (451)
                      .+..++||||++||+|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.  ++.+||+|||
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           73 MEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             TTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             CCEEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence            99999999999999999998543 3569999999999999999999999  89999999999999986  7899999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++.....   ........||+.|+|||++.+..++.++|||||||++|+|++|..||......             ..+.
T Consensus       150 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------------~~~~  213 (321)
T 1tki_A          150 QARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------------QIIE  213 (321)
T ss_dssp             TCEECCT---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------------HHHH
T ss_pred             CCeECCC---CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-------------HHHH
Confidence            9986432   22334567999999999998888999999999999999999999998753321             1111


Q ss_pred             HHhhhhhcCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          367 QIIDEKLGRNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       367 ~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      .+.....  ..+.    ..+.++.+|+.+||..||.+|||+.|+++.--
T Consensus       214 ~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  260 (321)
T 1tki_A          214 NIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             HHHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             HHHcCCC--CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence            2221111  1111    23678999999999999999999999998543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-46  Score=368.81  Aligned_cols=269  Identities=26%  Similarity=0.422  Sum_probs=216.0

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|.+.+.||+|+||.||+|.+...     .....+..||||++.... ....+.+.+|+.++..+ +||||+++++++
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGI-----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESC-----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHceeeeeecCCCCceeEEeeeecc-----ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            46899999999999999999886321     123456789999997542 33456789999999999 899999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDD---------------------TELNWERRIKIALGAARGLEHLHTYWRPVIHR  265 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHr  265 (451)
                      .+.+..++||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||+  +||+||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~  196 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHR  196 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEET
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCcccC
Confidence            999999999999999999999965432                     247999999999999999999999  899999


Q ss_pred             CCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccc
Q 013028          266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAM  344 (451)
Q Consensus       266 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~  344 (451)
                      ||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999985433322223344567889999999988999999999999999999998 999886


Q ss_pred             cccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                      .....             ......+........+...+..+.+|+.+||..||.+|||+.++++.|+.+....
T Consensus       277 ~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          277 GIPVD-------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             TCCCS-------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cCCcH-------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            54321             1122333333344445556788999999999999999999999999999986554

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-46  Score=368.60  Aligned_cols=270  Identities=24%  Similarity=0.374  Sum_probs=214.8

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|++.+.||+|+||.||+|.+...     ....++..||||++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGL-----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETS-----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCc-----CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            46899999999999999999886531     11234578999999754322 2456889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNED----------------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHR  265 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHr  265 (451)
                      ++...++||||+++|+|.+++....                      ...+++..++.++.||+.||.|||+  +||+||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~ivH~  198 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHR  198 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCS
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecC
Confidence            9999999999999999999986532                      1578999999999999999999999  899999


Q ss_pred             CCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccc
Q 013028          266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAM  344 (451)
Q Consensus       266 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~  344 (451)
                      ||||+|||++.++.+||+|||++................+|..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999975432222222334567889999999988899999999999999999999 988886


Q ss_pred             cccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      .....              .+...+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+......
T Consensus       279 ~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~  339 (343)
T 1luf_A          279 GMAHE--------------EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG  339 (343)
T ss_dssp             TSCHH--------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred             CCChH--------------HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence            43211              11111222222234455678899999999999999999999999999998765543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6e-46  Score=364.53  Aligned_cols=263  Identities=24%  Similarity=0.393  Sum_probs=210.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++.++||+|+||+||+|.+...+      ......||+|.+.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   88 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEG------EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCC------ceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            48999999999999999999865432      1223457899886432 3455778999999999999999999999987


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +. .++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~-~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           89 ST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             CC-eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEccCcce
Confidence            65 78999999999999998664 3569999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +...............+|..|+|||++.+..++.++|||||||++|+|++ |..||.....              ..+..
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------------~~~~~  230 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------------SEISS  230 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------------GGHHH
T ss_pred             eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--------------HHHHH
Confidence            86543333333344567889999999999999999999999999999999 9999864322              11223


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      .+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+..+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            3433334445556678899999999999999999999999999998754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=362.52  Aligned_cols=249  Identities=26%  Similarity=0.390  Sum_probs=206.0

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc------CHHHHHHHHHHHHhcCCCceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ------GQDEWENELRFLSRLNHPNVVKL  202 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~nIv~~  202 (451)
                      .++|.+.+.||+|+||.||+|..          ..++..||||++......      ..+.+.+|+.+|+.++||||+++
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~   79 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCRE----------KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL   79 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEE----------TTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccceEeceEEeeCCCeEEEEEEE----------CCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcE
Confidence            45799999999999999999764          445788999999754322      35778999999999999999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC----
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF----  278 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~----  278 (451)
                      ++++.+....++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++    
T Consensus        80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~  155 (326)
T 2y0a_A           80 HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKP  155 (326)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSSC
T ss_pred             EEEEEeCCEEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCCC
Confidence            9999999999999999999999999954  4679999999999999999999999  8999999999999999877    


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                      .+||+|||++......   .......||+.|+|||++.+..++.++|||||||++|+|++|..||......         
T Consensus       156 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------  223 (326)
T 2y0a_A          156 RIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---------  223 (326)
T ss_dssp             CEEECCCTTCEECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---------
T ss_pred             CEEEEECCCCeECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---------
Confidence            8999999999864322   2234567999999999998889999999999999999999999998643211         


Q ss_pred             cchhhhhhHHhhhhhcCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          359 LSNKLALHQIIDEKLGRNIQ----MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                          ..+..+...  ....+    ...+..+.+|+.+||..||.+|||+.|+++.
T Consensus       224 ----~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          224 ----ETLANVSAV--NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ----HHHHHHHHT--CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----HHHHHHHhc--CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                111111111  11111    1235789999999999999999999999974

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7.5e-46  Score=358.39  Aligned_cols=262  Identities=27%  Similarity=0.407  Sum_probs=207.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .++|++.+.||+|+||.||+|.          +..++..||+|++.......   .+.+.+|+.+++.++||||++++++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~   79 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAE----------DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDV   79 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEE----------ETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEE----------ECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEe
Confidence            4589999999999999999975          44457889999986543333   3567899999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.+++..++||||++|++|.+++..  ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Df  155 (294)
T 4eqm_A           80 DEEDDCYYLVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDF  155 (294)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eeeCCeEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEeC
Confidence            9999999999999999999999865  3569999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |++...... .........||+.|+|||++.+..++.++|||||||++|+|++|..||......             ...
T Consensus       156 g~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------------~~~  221 (294)
T 4eqm_A          156 GIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------------SIA  221 (294)
T ss_dssp             SSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------------HHH
T ss_pred             CCccccccc-cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------------HHH
Confidence            999854322 112233467999999999999999999999999999999999999998653321             000


Q ss_pred             hHHhhhh---hcCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHHhcC
Q 013028          366 HQIIDEK---LGRNIQMEEAQEFAEIILRCLNSDPKNRP-TMSEVVAALEQLQLNMG  418 (451)
Q Consensus       366 ~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~~  418 (451)
                      ...+...   .........++.+.+++.+||+.||.+|| ++.++++.|+.+.....
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          222 IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             HHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             HHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            0111100   00112233467899999999999999998 89999999987754433

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.1e-45  Score=362.89  Aligned_cols=267  Identities=21%  Similarity=0.217  Sum_probs=213.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~  207 (451)
                      .++|++.+.||+|+||.||+|..          ..++..||||++.....  .+.+.+|+.+++.+ +||||+++++++.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~   75 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKN----------LYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGP   75 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEE----------TTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEE----------CCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEe
Confidence            35899999999999999999764          44578899999875432  34578999999999 8999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc-----EEE
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN-----AKI  282 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~-----~kl  282 (451)
                      ++...++||||+ +++|.+++... ...+++..++.++.||+.||.|||+  .||+||||||+|||++.++.     +||
T Consensus        76 ~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~kl  151 (330)
T 2izr_A           76 CGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHI  151 (330)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred             cCCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceEEE
Confidence            999999999999 99999998654 4679999999999999999999999  89999999999999998887     999


Q ss_pred             eecCCcccCCCCCCcc-----cccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc
Q 013028          283 SDFGLAKFGPLGDKSH-----ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~  357 (451)
                      +|||+++.........     ......||+.|+|||++.+..++.++|||||||++|+|++|..||........      
T Consensus       152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~------  225 (330)
T 2izr_A          152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL------  225 (330)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH------
T ss_pred             EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH------
Confidence            9999998543222111     12456899999999999999999999999999999999999999975432100      


Q ss_pred             ccchhhhhhHHhhhhhcCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCcc
Q 013028          358 YLSNKLALHQIIDEKLGRN---IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ  422 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~  422 (451)
                          ......+........   .....+ ++.+|+..||..||.+||++.+|++.|+.+....+....
T Consensus       226 ----~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~  288 (330)
T 2izr_A          226 ----KERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFD  288 (330)
T ss_dssp             ----HHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred             ----HHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Confidence                011111111111100   011123 899999999999999999999999999999988766544

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.5e-46  Score=368.36  Aligned_cols=252  Identities=23%  Similarity=0.317  Sum_probs=206.1

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      ..++|.+.+.||+|+||.||+|..          ..++..||||++......  ..+.+.+|+.+++.++||||++++++
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~   96 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVH----------KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS   96 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEE----------CCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            356899999999999999999764          445788999999754332  23568899999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC---CcEEE
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD---FNAKI  282 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~---~~~kl  282 (451)
                      +.++...|+||||+.||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.+   +.+||
T Consensus        97 ~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~kl  172 (362)
T 2bdw_A           97 IQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKL  172 (362)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred             EEeCCEEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEE
Confidence            9999999999999999999999854  4578999999999999999999999  899999999999999764   45999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchh
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      +|||++.....   ........||+.|+|||++.+..++.++|||||||++|+|++|.+||......             
T Consensus       173 ~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------------  236 (362)
T 2bdw_A          173 ADFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------------  236 (362)
T ss_dssp             CCCTTCBCCTT---CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------
T ss_pred             eecCcceEecC---CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------------
Confidence            99999986432   22234568999999999998889999999999999999999999998653211             


Q ss_pred             hhhhHHhhhhhcCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          363 LALHQIIDEKLGRN--IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       363 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .....+........  .....+.++.+|+.+||..||.+|||+.++++.
T Consensus       237 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          237 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11111111111111  112346889999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-45  Score=351.91  Aligned_cols=258  Identities=26%  Similarity=0.435  Sum_probs=211.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.+.||+|+||.||+|.+..           +..||||++... ....+.+.+|+++++.++||||+++++++.+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKG-----------QYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK   74 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-----------TEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhheeeeeeeccCCCceEEEEEecC-----------ceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            4589999999999999999986543           456999999754 3345778999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+++++|.+++... ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++.++|+|||++
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~  151 (268)
T 3sxs_A           75 EYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMT  151 (268)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred             CCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCccc
Confidence            99999999999999999998653 3458999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ....... ........+|..|+|||++.+..++.++||||||+++|+|++ |..||......              ....
T Consensus       152 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------------~~~~  216 (268)
T 3sxs_A          152 RYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------------EVVL  216 (268)
T ss_dssp             EECCTTC-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------------HHHH
T ss_pred             eecchhh-hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--------------HHHH
Confidence            8643222 122233456778999999988899999999999999999999 99888543211              1111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      .+........+...++.+.+++.+||+.||.+|||+.++++.|+.++..
T Consensus       217 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          217 KVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             HHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             HHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            1222222233444567899999999999999999999999999988643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-46  Score=376.50  Aligned_cols=261  Identities=26%  Similarity=0.415  Sum_probs=211.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|.+.+.||+|+||.||+|.+.          .++..||||++...... ..+.+.+|+++|+.++||||+++++++.
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  182 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLR----------ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT  182 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET----------TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEe----------cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            358899999999999999998754          34678999998754221 2245778999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++...++||||+++|+|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus       183 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~DfG~  259 (377)
T 3cbl_A          183 QKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGM  259 (377)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             cCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence            999999999999999999998643 3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....              ....
T Consensus       260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------------~~~~  325 (377)
T 3cbl_A          260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------------QQTR  325 (377)
T ss_dssp             CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------------HHHH
T ss_pred             ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------------HHHH
Confidence            985322111111111234667999999988899999999999999999998 8888754321              1122


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      ..+........+...+..+.+|+.+||+.||.+|||+.++++.|+.++..
T Consensus       326 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          326 EFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            23333333344555678899999999999999999999999999999764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.9e-45  Score=352.82  Aligned_cols=258  Identities=24%  Similarity=0.404  Sum_probs=210.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.+.||+|+||+||+|.+..           +..||||++... ....+.+.+|+++++.++||||+++++++.+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   90 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRG-----------QYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK   90 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETT-----------TEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcC-----------CCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence            3589999999999999999986542           456999999754 3345778999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ....++||||+++++|.+++... ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++.++|+|||++
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~  167 (283)
T 3gen_A           91 QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLS  167 (283)
T ss_dssp             SSSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred             CCCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEcccccc
Confidence            99999999999999999998653 3569999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ...... .........+|..|+|||++.+..++.++||||||+++|+|++ |..||.....              .....
T Consensus       168 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------------~~~~~  232 (283)
T 3gen_A          168 RYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------------SETAE  232 (283)
T ss_dssp             GGBCCH-HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------------HHHHH
T ss_pred             cccccc-ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--------------hHHHH
Confidence            854321 1111223456778999999988899999999999999999998 9988864321              11112


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      .+........+...++.+.+|+.+||+.||.+|||+.++++.|+.+..+
T Consensus       233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          233 HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            2223333334455578899999999999999999999999999998765

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=375.79  Aligned_cols=253  Identities=23%  Similarity=0.299  Sum_probs=206.2

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      ..++|++.++||+|+||+||+|.          +..++..||+|++......  ..+.+.+|+.+++.++||||++++++
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~----------~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~   78 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCV----------KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS   78 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEE----------ETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEE----------ECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEE
Confidence            45689999999999999999965          4455788999999754332  23568899999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC---CCCcEEE
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD---DDFNAKI  282 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~---~~~~~kl  282 (451)
                      +.++...|+||||+.||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++   .++.+||
T Consensus        79 ~~~~~~~~lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL  154 (444)
T 3soa_A           79 ISEEGHHYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKL  154 (444)
T ss_dssp             EECSSEEEEEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred             EEECCEEEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEE
Confidence            9999999999999999999999865  3569999999999999999999999  8999999999999998   5678999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchh
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      +|||++......  ........||+.|+|||++.+..|+.++|||||||++|+|++|.+||......             
T Consensus       155 ~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-------------  219 (444)
T 3soa_A          155 ADFGLAIEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-------------  219 (444)
T ss_dssp             CCCSSCBCCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------------
T ss_pred             ccCceeEEecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-------------
Confidence            999999754322  22234578999999999998889999999999999999999999998653221             


Q ss_pred             hhhhHHhhhhhcC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          363 LALHQIIDEKLGR--NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       363 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .....+.......  ......++++.+|+.+||..||.+|||+.|+|+.
T Consensus       220 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          220 RLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            1111222211111  1112456889999999999999999999999984

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=371.63  Aligned_cols=249  Identities=25%  Similarity=0.357  Sum_probs=202.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhc-CCCceeeccc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRL-NHPNVVKLMG  204 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~nIv~~~~  204 (451)
                      .++|++++.||+|+||+||+|..          ..++..||||++.+.   .....+.+.+|..+|..+ +||||+++++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~----------~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~   91 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARV----------KETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFC   91 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEE----------cCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEE
Confidence            35899999999999999999764          455788999999753   223445678899999988 6999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      ++.+.+..||||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+||||+.++.+||+|
T Consensus        92 ~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL~D  167 (353)
T 3txo_A           92 CFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLAD  167 (353)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEEcc
Confidence            99999999999999999999999865  3569999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ||+|+....  ........+||+.|+|||++.+..|+.++|||||||++|||++|..||......             ..
T Consensus       168 FG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------------~~  232 (353)
T 3txo_A          168 FGMCKEGIC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-------------DL  232 (353)
T ss_dssp             CTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HH
T ss_pred             ccceeeccc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-------------HH
Confidence            999985321  223344678999999999998889999999999999999999999998653321             11


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM------SEVVA  408 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~  408 (451)
                      ...+...  ...++...+..+.+|+.+||..||.+||++      .++++
T Consensus       233 ~~~i~~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          233 FEAILND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHHHcC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            1222222  123344567889999999999999999998      77765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.6e-46  Score=362.18  Aligned_cols=269  Identities=25%  Similarity=0.418  Sum_probs=198.8

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|++.+.||+|+||+||+|.+...       ......||||++....  ....+.+.+|+++++.++||||+++++++
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQE-------DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC--------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             hhHeEEeceecccCCeEEEEEEEccc-------CCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            45899999999999999999875432       1122479999997542  33356788999999999999999999999


Q ss_pred             ecCCee------EEEEeccCCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC
Q 013028          207 CDDQHR------LLVYEYVTRGSLEDHLLNE----DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD  276 (451)
Q Consensus       207 ~~~~~~------~lV~E~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~  276 (451)
                      .+....      ++||||+++|+|.+++...    ....+++..++.++.||+.||.|||+  +||+||||||+|||++.
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIli~~  172 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAE  172 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECT
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEEEcC
Confidence            877655      9999999999999998532    22368999999999999999999999  89999999999999999


Q ss_pred             CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCcc
Q 013028          277 DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWA  355 (451)
Q Consensus       277 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~  355 (451)
                      ++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......      
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------  246 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA------  246 (323)
T ss_dssp             TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------
T ss_pred             CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH------
Confidence            99999999999986433332223334556788999999999999999999999999999999 88888643321      


Q ss_pred             ccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCC
Q 013028          356 KPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSC  420 (451)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~  420 (451)
                              .....+........+...+..+.+|+.+||..||.+|||+.++++.|+++.....-.
T Consensus       247 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~  303 (323)
T 3qup_A          247 --------EIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL  303 (323)
T ss_dssp             --------GHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred             --------HHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence                    111222222223345556788999999999999999999999999999998766443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-45  Score=356.04  Aligned_cols=260  Identities=21%  Similarity=0.305  Sum_probs=209.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|.+.++||+|+||+||+|.+.          .++..||||++.... ....+.+.+|+++|+.++||||+++++++.+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHK----------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEET----------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCEEEEEEecCCCCeEEEEEEEC----------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence            58999999999999999997644          457789999997543 3345678899999999999999999999986


Q ss_pred             CC--eeEEEEeccCCCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee----CCCCcEE
Q 013028          209 DQ--HRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL----DDDFNAK  281 (451)
Q Consensus       209 ~~--~~~lV~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll----~~~~~~k  281 (451)
                      ..  ..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+  +||+||||||+|||+    +.++.+|
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~k  156 (319)
T 4euu_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYK  156 (319)
T ss_dssp             TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEEE
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceEE
Confidence            65  78999999999999999965422 349999999999999999999999  899999999999999    7788899


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCccccccccc--------cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA--------TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN  353 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  353 (451)
                      |+|||+++.....   .......||..|+|||++.        +..++.++|||||||++|+|++|..||........  
T Consensus       157 L~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--  231 (319)
T 4euu_A          157 LTDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--  231 (319)
T ss_dssp             ECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--
T ss_pred             EccCCCceecCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--
Confidence            9999999864322   2233567999999999985        57889999999999999999999999974332111  


Q ss_pred             ccccccchhhhhhHHhhh-----------------------hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          354 WAKPYLSNKLALHQIIDE-----------------------KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                             ....+..++..                       ..........+..+.+|+.+||..||++|||+.|+++..
T Consensus       232 -------~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          232 -------NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             -------CHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             -------hHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence                   00001111110                       011234567788999999999999999999999999998


Q ss_pred             HHh
Q 013028          411 EQL  413 (451)
Q Consensus       411 ~~~  413 (451)
                      .+.
T Consensus       305 ~d~  307 (319)
T 4euu_A          305 SDI  307 (319)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.5e-46  Score=365.07  Aligned_cols=284  Identities=26%  Similarity=0.411  Sum_probs=220.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee--
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC--  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--  207 (451)
                      ++|++.+.||+|+||.||+|.+..      .+..++..||||++........+.+.+|+++++.++||||+++++++.  
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDP------LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECT------TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhccCCCCeEEEEEEecc------CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            489999999999999999987642      245668899999998665555667899999999999999999999886  


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +....++||||+++++|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             CCceEEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCCEEEccccc
Confidence            456789999999999999998653 2458999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccc-cccchhhhh
Q 013028          288 AKFGPLGDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK-PYLSNKLAL  365 (451)
Q Consensus       288 a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~-~~~~~~~~~  365 (451)
                      +......... .......||..|+|||++.+..++.++|||||||++|+|++|..||..........+.. ........+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            9865432221 12234568888999999988899999999999999999999999987543321100000 000111222


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCcc
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ  422 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~  422 (451)
                      ...+........+...++.+.+|+.+||..||.+|||+.++++.|+.+......+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  310 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET  310 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence            233334444445666778999999999999999999999999999999887766554

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.1e-45  Score=361.46  Aligned_cols=273  Identities=25%  Similarity=0.408  Sum_probs=217.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|++.+.||+|+||.||+|.+....   ......+..||||++..... .....+.+|+.+++.+ +||||+++++++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCS---TTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HhHeEEeeEEeecCceeEEEeEecccc---ccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            358999999999999999999865321   11224567899999975432 2345688999999999 799999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCce
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV  272 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NI  272 (451)
                      .+.+..++||||+++|+|.+++....              ...+++..++.++.||+.||.|||+  +||+||||||+||
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNV  188 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGE
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCccceE
Confidence            99999999999999999999996543              1348999999999999999999999  8999999999999


Q ss_pred             eeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCC
Q 013028          273 LLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLA  351 (451)
Q Consensus       273 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~  351 (451)
                      |++.++.+||+|||++................+|..|+|||++.+..++.++|||||||++|+|++ |..||.....   
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---  265 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---  265 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence            999999999999999986443322222334567888999999988889999999999999999999 9888764321   


Q ss_pred             CCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCC
Q 013028          352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSC  420 (451)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~  420 (451)
                                 ..+...+........+...+..+.+|+.+||..||.+|||+.++++.|+.+.......
T Consensus       266 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~  323 (334)
T 2pvf_A          266 -----------EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE  323 (334)
T ss_dssp             -----------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             -----------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence                       1112222233333445556788999999999999999999999999999998766543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-45  Score=370.62  Aligned_cols=252  Identities=25%  Similarity=0.370  Sum_probs=202.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhc-CCCceeeccce
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRL-NHPNVVKLMGY  205 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~h~nIv~~~~~  205 (451)
                      ++|+++++||+|+||+||+|..          ..++..||||++.+...   ...+.+.+|..+|..+ +||||++++++
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~----------~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~  121 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRL----------KKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC  121 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEE----------CCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence            4899999999999999999764          44578899999975432   2234578899999887 79999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      |.+....||||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+||||+.++.+||+||
T Consensus       122 ~~~~~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DF  197 (396)
T 4dc2_A          122 FQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDY  197 (396)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEeec
Confidence            9999999999999999999999865  3569999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |+|+...  .........+||+.|+|||++.+..++.++|||||||++|||++|..||..........     ......+
T Consensus       198 Gla~~~~--~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~-----~~~~~~~  270 (396)
T 4dc2_A          198 GMCKEGL--RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-----QNTEDYL  270 (396)
T ss_dssp             TTCBCCC--CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----------CCHHHH
T ss_pred             ceeeecc--cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc-----hhhHHHH
Confidence            9998522  12233456789999999999999999999999999999999999999996432211100     0001111


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM  403 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  403 (451)
                      ...+. .....++...+.++.+||.+||+.||.+||++
T Consensus       271 ~~~i~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          271 FQVIL-EKQIRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHH-HCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             HHHHh-ccccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            11111 11233455667889999999999999999985

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.5e-45  Score=352.45  Aligned_cols=273  Identities=18%  Similarity=0.214  Sum_probs=218.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~  207 (451)
                      .++|++.+.||+|+||.||+|..          ..++..||||++....  ..+.+.+|+.+++.+ +|+||+++++++.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~   76 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTN----------LLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ   76 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEE----------TTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEE----------CCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence            45899999999999999999764          3457789999986432  234578899999999 6999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc-----EEE
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN-----AKI  282 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~-----~kl  282 (451)
                      ++...++||||+ +++|.+++... ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.     +||
T Consensus        77 ~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~kl  152 (298)
T 1csn_A           77 EGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYV  152 (298)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             CCceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeEEE
Confidence            999999999999 99999999654 3469999999999999999999999  89999999999999987766     999


Q ss_pred             eecCCcccCCCCCCc-----ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc
Q 013028          283 SDFGLAKFGPLGDKS-----HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       283 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~  357 (451)
                      +|||++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||........      
T Consensus       153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~------  226 (298)
T 1csn_A          153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN------  226 (298)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH------
T ss_pred             EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc------
Confidence            999999864432211     123456799999999999999999999999999999999999999875432100      


Q ss_pred             ccchhhhhhHHhhhhhcC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCccccccc
Q 013028          358 YLSNKLALHQIIDEKLGR---NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTSLRT  427 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~  427 (451)
                          ...+..+.......   ......+.++.+|+.+||+.||.+|||+.+|++.|+++............+-
T Consensus       227 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  295 (298)
T 1csn_A          227 ----KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  295 (298)
T ss_dssp             ----HHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             ----HHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence                11111111111111   1112346789999999999999999999999999999999888766655443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1e-45  Score=362.39  Aligned_cols=263  Identities=23%  Similarity=0.385  Sum_probs=210.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++.+.||+|+||+||+|.+...+      ......||+|.+.... ......+.+|+.+++.++||||+++++++. 
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   85 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEG------ESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-   85 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTT------CSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCC------ceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence            48999999999999999998865431      1223348888886432 233345678999999999999999999986 


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEECCCCcc
Confidence            45689999999999999998653 3568899999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +...............||..|+|||++.+..++.++|||||||++|+|++ |..||......              .+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------------~~~~  228 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--------------EVPD  228 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--------------HHHH
T ss_pred             cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--------------HHHH
Confidence            87654444444455678889999999988999999999999999999999 99998753321              1122


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      .+........+...+..+.+|+.+||..||.+|||+.++++.|+.+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          229 LLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             HHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             HHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            2333333334445567799999999999999999999999999998544

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.5e-45  Score=368.37  Aligned_cols=265  Identities=26%  Similarity=0.471  Sum_probs=205.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+|.+.+.||+|+||.||+|.+..       ....+..||||++..... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  117 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKL-------PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK  117 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBC-------TTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hhceeeeEEeeCCCeEEEEEEEec-------CCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            489999999999999999976432       123466799999975432 234578899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+++|+|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence            99999999999999999998653 4569999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          289 KFGPLGDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       289 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.....              ..+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------------~~~~  260 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------------QDVI  260 (373)
T ss_dssp             -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------------HHHH
T ss_pred             cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------------HHHH
Confidence            864322111 11122345678999999998999999999999999999998 9999864321              1122


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcC
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG  418 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  418 (451)
                      ..+........+...+..+.+|+.+||+.||.+||++.+|++.|+.+..+..
T Consensus       261 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  312 (373)
T 2qol_A          261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG  312 (373)
T ss_dssp             HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred             HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence            3333333334455667889999999999999999999999999999987643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5e-45  Score=357.15  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=206.6

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCCe
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQH  211 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~  211 (451)
                      |...+.||+|+||.||+|..          ..++..||||++........+.+.+|+.+++.++||||+++++++..++.
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~----------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLARE----------KHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE  116 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             hhccEEeccCCCeEEEEEEE----------CCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence            67778999999999999764          34577899999987666677889999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          212 RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       212 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .++||||++|++|.+++..   ..+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|||++...
T Consensus       117 ~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  191 (321)
T 2c30_A          117 LWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI  191 (321)
T ss_dssp             EEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCcEEEeeeeeeeec
Confidence            9999999999999998853   469999999999999999999999  89999999999999999999999999999754


Q ss_pred             CCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          292 PLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       292 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ...  ........||+.|+|||++.+..++.++|||||||++|+|++|..||......             .....+...
T Consensus       192 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-------------~~~~~~~~~  256 (321)
T 2c30_A          192 SKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-------------QAMKRLRDS  256 (321)
T ss_dssp             CSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------------HHHHHHHHS
T ss_pred             ccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------HHHHHHhcC
Confidence            322  12234568999999999999899999999999999999999999998643211             011111111


Q ss_pred             hh-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          372 KL-GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       372 ~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      .. ........+..+.+|+.+||..||.+|||+.++++.-
T Consensus       257 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          257 PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             SCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            10 0111233467899999999999999999999999853

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-45  Score=354.80  Aligned_cols=262  Identities=25%  Similarity=0.428  Sum_probs=220.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.+.||+|+||+||+|.+.          .++..||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~----------~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   80 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWK----------KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   80 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEG----------GGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccceeEEeecCCCCceeEEEeEec----------CCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            458999999999999999997754          34678999999743 3345678899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||++|++|.+++.......+++..++.++.||+.||.|||+  +||+|+||||+|||++.++.++|+|||++
T Consensus        81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEEcCCCCEEEccCccc
Confidence            9999999999999999999987666779999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ...... .........+|..|+|||++.+..++.++||||||+++|+|++ |..||.....              .....
T Consensus       159 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--------------~~~~~  223 (288)
T 3kfa_A          159 RLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------------SQVYE  223 (288)
T ss_dssp             GTSCSS-SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------------GGHHH
T ss_pred             eeccCC-ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------------HHHHH
Confidence            864422 2222334557888999999988999999999999999999999 8888764321              11223


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcC
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG  418 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  418 (451)
                      .+........+...+..+.+|+.+||..||.+|||+.++++.|+.+..+..
T Consensus       224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          224 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            333333444555667889999999999999999999999999999877654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-45  Score=356.81  Aligned_cols=275  Identities=25%  Similarity=0.416  Sum_probs=215.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+|++.+.||+|+||.||+|.+..      .+..++..||||++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDP------EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECT------TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhccCCCCceEEEEEEEcc------ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            478999999999999999987642      245678899999997543 3345778999999999999999999999987


Q ss_pred             C--CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          209 D--QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       209 ~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .  ...++||||+++|+|.+++... ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++.++|+|||
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCEEECccc
Confidence            6  6789999999999999998543 3569999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc--cchhh
Q 013028          287 LAKFGPLGDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKL  363 (451)
Q Consensus       287 la~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~--~~~~~  363 (451)
                      ++......... .......||..|+|||++.+..++.++|||||||++|+|++|..|+......... ...+.  .....
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~  250 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK-MIGPTHGQMTVT  250 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCGGGHHH
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhh-ccCCcccccCHH
Confidence            99864432211 2233456888899999998999999999999999999999999886533211000 00000  01111


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                      .+...+........+...++.+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            222223333334455566789999999999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-45  Score=360.53  Aligned_cols=277  Identities=27%  Similarity=0.419  Sum_probs=219.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec-
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD-  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-  208 (451)
                      .|+++++||+|+||+||++.+.      +.+..++..||||++..... ...+.+.+|+++|+.++||||+++++++.+ 
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~------~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYD------PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEC------SCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             HHhhhheecCCCCeEEEEEEEc------cCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            3489999999999999998765      34566788999999975432 234568899999999999999999999987 


Q ss_pred             -CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          209 -DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       209 -~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                       ....++||||+++|+|.+++...   .+++..++.++.||+.||.|||+  .||+||||||+|||++.++.+||+|||+
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             CCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCEEECCccc
Confidence             46789999999999999998653   48999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC--Cccccccchhhh
Q 013028          288 AKFGPLGDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG--NWAKPYLSNKLA  364 (451)
Q Consensus       288 a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~  364 (451)
                      +......... .......||..|+|||++.+..++.++|||||||++|+|++|..||.........  .+... ......
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~  259 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG-QMTVLR  259 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCH-HHHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccccc-chhHHH
Confidence            9865432221 2233456888899999998889999999999999999999999998754321100  00000 001112


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      +...+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.+...+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  314 (318)
T 3lxp_A          260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG  314 (318)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence            2333344444455666778999999999999999999999999999999887654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.6e-45  Score=373.82  Aligned_cols=253  Identities=28%  Similarity=0.433  Sum_probs=211.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.+.||+|+||.||+|.+.            +..||||++....  ..+.+.+|+.+|+.++||||+++++++.+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~------------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~  257 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR------------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE  257 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET------------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec------------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence            468899999999999999998754            4579999997543  55778999999999999999999999876


Q ss_pred             CC-eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          209 DQ-HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       209 ~~-~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      .. ..+|||||+++|+|.+++.......+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus       258 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~  335 (450)
T 1k9a_A          258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGL  335 (450)
T ss_dssp             TTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence            65 78999999999999999976555568999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++.....     .....++..|+|||++.+..++.++|||||||++|||++ |..||......              .+.
T Consensus       336 a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------------~~~  396 (450)
T 1k9a_A          336 TKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------------DVV  396 (450)
T ss_dssp             CEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--------------THH
T ss_pred             ccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------------HHH
Confidence            9853211     122356888999999999999999999999999999998 99988643221              111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      ..+........+...+..+.+||.+||+.||.+|||+.++++.|+.++..
T Consensus       397 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          397 PRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            22223333445566778999999999999999999999999999998764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-45  Score=352.89  Aligned_cols=262  Identities=26%  Similarity=0.382  Sum_probs=201.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|++.+.||+|+||.||+|.+...       ...+..||+|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSP-------ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC---------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecC-------CCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            45899999999999999999886432       23356799999875432 23456889999999999999999999985


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                       ++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGL  162 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred             -cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECcccc
Confidence             45789999999999999998653 3568999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +....... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||......              ...
T Consensus       163 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--------------~~~  227 (281)
T 1mp8_A          163 SRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------------DVI  227 (281)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------------GHH
T ss_pred             ccccCccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--------------HHH
Confidence            98543221 111223456788999999988899999999999999999997 88888643221              111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      ..+........+...+..+.+++.+||..||.+|||+.++++.|+.+..+
T Consensus       228 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          228 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            11222222334555678899999999999999999999999999998765

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=9.9e-46  Score=373.08  Aligned_cols=253  Identities=22%  Similarity=0.269  Sum_probs=194.1

Q ss_pred             cCCCcC-CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHh-cCCCceeeccceee
Q 013028          130 RKFSEK-NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSR-LNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~-l~h~nIv~~~~~~~  207 (451)
                      ++|.+. ++||+|+||+||+|.+          ..++..||||++..     ...+.+|+.++.+ .+||||++++++|.
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~----------~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~  125 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFN----------KRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYE  125 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEE----------CCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence            366665 6899999999999764          45578899999963     2456789998755 47999999999987


Q ss_pred             c----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC---CCcE
Q 013028          208 D----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD---DFNA  280 (451)
Q Consensus       208 ~----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~---~~~~  280 (451)
                      .    ..++||||||++||+|.+++.......+++..+..|+.||+.||.|||+  .||+||||||+|||++.   ++.+
T Consensus       126 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~  203 (400)
T 1nxk_A          126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAIL  203 (400)
T ss_dssp             EEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCE
T ss_pred             ecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccE
Confidence            5    5678999999999999999977555679999999999999999999999  89999999999999987   7899


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS  360 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  360 (451)
                      ||+|||+++....   .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||..........       
T Consensus       204 kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------  273 (400)
T 1nxk_A          204 KLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------  273 (400)
T ss_dssp             EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-------
T ss_pred             EEEecccccccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-------
Confidence            9999999985332   222345689999999999999999999999999999999999999997543321100       


Q ss_pred             hhhhhhHHhhhhhcC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          361 NKLALHQIIDEKLGR--NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       361 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                        .....+.......  ......+.++.+||.+||..||.+|||+.|++++--
T Consensus       274 --~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  324 (400)
T 1nxk_A          274 --GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  324 (400)
T ss_dssp             --SHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             --HHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence              0001111111111  111345678999999999999999999999998644

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.1e-45  Score=363.08  Aligned_cols=251  Identities=23%  Similarity=0.298  Sum_probs=204.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC-----CCcCHHHHHHHHHHHHhcCCCceeecc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-----GSQGQDEWENELRFLSRLNHPNVVKLM  203 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~nIv~~~  203 (451)
                      .++|++.+.||+|+||+||+|..          ..++..||||++...     .....+.+.+|+.+++.++||||++++
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~   92 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCIN----------RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL   92 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEE----------CCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEE
Confidence            45899999999999999999764          445788999998632     123467789999999999999999999


Q ss_pred             ceeecCCeeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc--
Q 013028          204 GYCCDDQHRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN--  279 (451)
Q Consensus       204 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~--  279 (451)
                      +++.+....|+||||++||+|.+++...  ....+++..+..++.||+.||.|||+  +||+||||||+|||++.++.  
T Consensus        93 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~  170 (351)
T 3c0i_A           93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSA  170 (351)
T ss_dssp             EEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTC
T ss_pred             EEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCC
Confidence            9999999999999999999998887542  23468999999999999999999999  89999999999999986554  


Q ss_pred             -EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          280 -AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       280 -~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                       +||+|||++.....  ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.....          
T Consensus       171 ~vkl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------  238 (351)
T 3c0i_A          171 PVKLGGFGVAIQLGE--SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----------  238 (351)
T ss_dssp             CEEECCCTTCEECCT--TSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----------
T ss_pred             cEEEecCcceeEecC--CCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----------
Confidence             99999999986432  22223456899999999999988999999999999999999999999864211          


Q ss_pred             cchhhhhhHHhhhhhcCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          359 LSNKLALHQIIDEKLGRNIQ----MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                          .....+.....  ...    ...+.++.+|+.+||..||.+|||+.|++++
T Consensus       239 ----~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          239 ----RLFEGIIKGKY--KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             ----HHHHHHHHTCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----HHHHHHHcCCC--CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                11111111111  111    1236789999999999999999999999874

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=367.59  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=205.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++++.||+|+||.||++..          ..++..||+|++.+.   .......+.+|+.+|+.++||||++++++|
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~----------~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   84 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQK----------NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF   84 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEE----------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEE----------CCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4899999999999999999664          455788999998643   234456788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+....|+||||+.||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+||||+.++.+||+|||
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG  160 (384)
T 4fr4_A           85 QDEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFN  160 (384)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EeCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEeccc
Confidence            999999999999999999999964  4679999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCcccccccccc---CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      ++.....   .......+||+.|+|||++.+   ..|+.++|||||||++|+|++|..||.......           ..
T Consensus       161 ~a~~~~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-----------~~  226 (384)
T 4fr4_A          161 IAAMLPR---ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-----------SK  226 (384)
T ss_dssp             TCEECCT---TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-----------HH
T ss_pred             eeeeccC---CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-----------HH
Confidence            9986432   233456789999999999963   458999999999999999999999986433210           00


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT-MSEVVA  408 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~  408 (451)
                      .+...+ .......+...+..+.+||.+||..||.+||+ +.++++
T Consensus       227 ~~~~~~-~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          227 EIVHTF-ETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHHH-HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHHHH-hhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            111111 11123345556788999999999999999998 666654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.2e-46  Score=364.92  Aligned_cols=249  Identities=25%  Similarity=0.343  Sum_probs=205.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|.+.+.||+|+||.||+|.+          ..++..||||++...   .......+.+|+.+++.++||||+++++++
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~   78 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATH----------YKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI   78 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEE----------CCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            4899999999999999999764          445778999998643   223345788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+....++||||+ +|+|.+++..  ...+++..+..++.||+.||.|||+  .||+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~~~~lv~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~DFG  153 (336)
T 3h4j_B           79 TTPTDIVMVIEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFG  153 (336)
T ss_dssp             ECSSEEEEEECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred             EeCCEEEEEEECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEEcCCCCEEEEEec
Confidence            9999999999999 7899998865  3569999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      ++.....   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........   .       
T Consensus       154 ~s~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---i-------  220 (336)
T 3h4j_B          154 LSNIMTD---GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---V-------  220 (336)
T ss_dssp             CTBTTTT---SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---C-------
T ss_pred             cceeccC---CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---H-------
Confidence            9986432   233345689999999999988776 7899999999999999999999975433211000   0       


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                          . ......+...+..+.+|+.+||..||.+|||+.|+++.--
T Consensus       221 ----~-~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  261 (336)
T 3h4j_B          221 ----N-SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW  261 (336)
T ss_dssp             ----C-SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred             ----H-cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence                0 0011233445678999999999999999999999998643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.7e-45  Score=357.66  Aligned_cols=263  Identities=24%  Similarity=0.393  Sum_probs=208.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC-CCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++.++||+|+||+||+|.+...+      ......||+|.+... .....+.+.+|+.+++.++||||+++++++.+
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   88 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEG------EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTT------CSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCC------ceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence            58999999999999999998865432      122334788888643 33456788999999999999999999999987


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +. .++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~-~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           89 ST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             SS-EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             CC-ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence            65 78999999999999998654 3569999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ................+|..|+|||++.+..++.++|||||||++|+|++ |..||......              .+..
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------------~~~~  230 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------------EISS  230 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------------GHHH
T ss_pred             eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------------HHHH
Confidence            86443333333334567888999999999999999999999999999999 99998653321              1223


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      .+........+...+.++.+|+.+||..||.+|||+.|+++.|+.+...
T Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          231 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            3333333445556678899999999999999999999999999998643

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-45  Score=378.49  Aligned_cols=262  Identities=26%  Similarity=0.448  Sum_probs=214.6

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ..++|.+.+.||+|+||.||+|.++.           +..||||++... ....+.+.+|+.+|+.++||||+++++++.
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----------~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~  253 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNK-----------HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT  253 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETT-----------TEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECC-----------ccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            45689999999999999999997643           456999999754 345778999999999999999999999986


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                       .+..++||||+.+|+|.+++.......+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       254 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~  330 (454)
T 1qcf_A          254 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGL  330 (454)
T ss_dssp             -SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred             -CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence             5678999999999999999965444568899999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++...... ........++..|+|||++....++.++|||||||++|||++ |..||.....              ..+.
T Consensus       331 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------------~~~~  395 (454)
T 1qcf_A          331 ARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------------PEVI  395 (454)
T ss_dssp             GGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------------HHHH
T ss_pred             ceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------------HHHH
Confidence            98643211 111223446778999999988999999999999999999999 9998864321              1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      ..+........+...++.+.+||.+||..||.+|||+.+|++.|+.+.....+
T Consensus       396 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~  448 (454)
T 1qcf_A          396 RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES  448 (454)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence            22233333344556678899999999999999999999999999988654443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-45  Score=359.80  Aligned_cols=246  Identities=25%  Similarity=0.399  Sum_probs=207.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++.+.||+|+||.||+|.          +..++..||+|++.+.   .....+.+.+|+.+++.++||||+++++++
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~----------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~   75 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIR----------SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF   75 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEE----------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEE----------ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence            489999999999999999965          4455788999999753   223456778999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+....|+||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        76 ~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg  151 (318)
T 1fot_A           76 QDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFG  151 (318)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecC
Confidence            999999999999999999999965  4568999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++.....     .....+||+.|+|||++.+..++.++|||||||++|||++|..||.....             .....
T Consensus       152 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------------~~~~~  213 (318)
T 1fot_A          152 FAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------------MKTYE  213 (318)
T ss_dssp             SCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------------HHHHH
T ss_pred             cceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------------HHHHH
Confidence            9985331     23356899999999999999999999999999999999999999864321             11112


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      .+....  ...+...+.++.+|+.+||..||.+||     ++.+++++
T Consensus       214 ~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          214 KILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             HHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            222221  234455678899999999999999999     88888854

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-45  Score=359.17  Aligned_cols=272  Identities=28%  Similarity=0.388  Sum_probs=217.9

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhc-CCCceeeccce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRL-NHPNVVKLMGY  205 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~h~nIv~~~~~  205 (451)
                      ..++|++.+.||+|+||+||+|.+...     .+..++..||||++...... ....+.+|+.++..+ +||||++++++
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGI-----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESS-----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecC-----CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            356899999999999999999876431     13455688999999754332 235688999999999 59999999999


Q ss_pred             eecCC-eeEEEEeccCCCChhhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCC
Q 013028          206 CCDDQ-HRLLVYEYVTRGSLEDHLLNEDD--------------TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKAS  270 (451)
Q Consensus       206 ~~~~~-~~~lV~E~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~  270 (451)
                      +...+ ..++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+  +||+||||||+
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~  177 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAAR  177 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGG
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCcccccCccc
Confidence            87654 58999999999999999965432              228899999999999999999999  89999999999


Q ss_pred             ceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCC
Q 013028          271 NVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNG  349 (451)
Q Consensus       271 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~  349 (451)
                      |||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            99999999999999999986443332233344567889999999989999999999999999999998 99888643221


Q ss_pred             CCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          350 LAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                                   ..+...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus       258 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  314 (316)
T 2xir_A          258 -------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ  314 (316)
T ss_dssp             -------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             -------------HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcc
Confidence                         111122222223334455678899999999999999999999999999999876543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=354.64  Aligned_cols=250  Identities=28%  Similarity=0.410  Sum_probs=197.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--------------------------CHHH
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--------------------------GQDE  183 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~  183 (451)
                      ++|++.+.||+|+||.||+|..          ..++..||||++......                          ..+.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYN----------ENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ   82 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEE----------TTTTEEEEEEEEECC-------------------------------CH
T ss_pred             cceEEEeEEeecCCEEEEEEEE----------CCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence            5899999999999999999754          445788999998754311                          1245


Q ss_pred             HHHHHHHHHhcCCCceeeccceeec--CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 013028          184 WENELRFLSRLNHPNVVKLMGYCCD--DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRP  261 (451)
Q Consensus       184 ~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~  261 (451)
                      +.+|+++|+.++||||+++++++.+  +...++||||+++++|.+++.   ...+++..+..++.||+.||.|||+  +|
T Consensus        83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~~  157 (298)
T 2zv2_A           83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHY--QK  157 (298)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH--CC
Confidence            7899999999999999999999986  568899999999999988653   3579999999999999999999999  89


Q ss_pred             ceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCC---CCcchhhHHHHHHHHHHHh
Q 013028          262 VIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGH---LTLKTDVYSFGVVLLEILS  338 (451)
Q Consensus       262 iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~DiwSlGvil~ellt  338 (451)
                      |+||||||+|||++.++.+||+|||++......  ........||+.|+|||++.+..   ++.++|||||||++|+|++
T Consensus       158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~  235 (298)
T 2zv2_A          158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF  235 (298)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred             eeccCCCHHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence            999999999999999999999999999864322  22234568999999999997654   4788999999999999999


Q ss_pred             CCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          339 GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       339 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      |..||......             .....+.............+..+.+|+.+||+.||.+|||+.|++++
T Consensus       236 g~~pf~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          236 GQCPFMDERIM-------------CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSCSSCCSSHH-------------HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CCCCCCCccHH-------------HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            99998643210             00111111111112223456789999999999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-45  Score=368.64  Aligned_cols=252  Identities=23%  Similarity=0.337  Sum_probs=207.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.+.||+|+||.||+|..          ..++..||+|++..........+.+|+.+|+.++||||+++++++.+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~----------~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~  119 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVE----------KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED  119 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEE----------CCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe
Confidence            35899999999999999999764          44577899999976544445678899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC--CCcEEEeecC
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD--DFNAKISDFG  286 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~--~~~~kl~DFG  286 (451)
                      +...++||||++||+|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.  ++.+||+|||
T Consensus       120 ~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          120 KYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             SSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEecc
Confidence            99999999999999999988543 3569999999999999999999999  89999999999999974  5789999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++......   .......||+.|+|||++.+..++.++|||||||++|+|++|..||......             ..+.
T Consensus       197 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------------~~~~  260 (387)
T 1kob_A          197 LATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------------ETLQ  260 (387)
T ss_dssp             TCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------------HHHH
T ss_pred             cceecCCC---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-------------HHHH
Confidence            99864322   2233457999999999999899999999999999999999999998653211             1111


Q ss_pred             HHhhhh--hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIIDEK--LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+....  .........+.++.+||.+||..||.+|||+.|+++.
T Consensus       261 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          261 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             HHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            111111  1112223456889999999999999999999999975

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.1e-45  Score=365.78  Aligned_cols=255  Identities=25%  Similarity=0.328  Sum_probs=197.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|++.+.||+|+||+||++.          +..++..||||++.... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~----------~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   88 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMR----------DKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTP   88 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEE----------ETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CcEEEEEEeccCCCEEEEEEE----------ECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence            489999999999999999965          44567889999997543 3346788999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc--EEEeecCC
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN--AKISDFGL  287 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~--~kl~DFGl  287 (451)
                      ...++||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.  +||+|||+
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~  164 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGY  164 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred             CEEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeecCc
Confidence            999999999999999999854  3569999999999999999999999  89999999999999987665  99999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcc-hhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLK-TDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++...   .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||........         ....+.
T Consensus       165 a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---------~~~~~~  232 (361)
T 3uc3_A          165 SKSSV---LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---------YRKTIQ  232 (361)
T ss_dssp             C------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---------HHHHHH
T ss_pred             ccccc---ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---------HHHHHH
Confidence            97422   1222345679999999999988887655 8999999999999999999975432100         011111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      .+.............+..+.+||.+||..||.+|||+.|++++--
T Consensus       233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  277 (361)
T 3uc3_A          233 RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW  277 (361)
T ss_dssp             HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred             HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence            222222222222234678999999999999999999999998743

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.6e-45  Score=348.75  Aligned_cols=252  Identities=23%  Similarity=0.361  Sum_probs=209.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|.+.+.||+|+||.||+|.+.            +..||||++......  ..+.+.+|+.+++.++||||+++++++.
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~------------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   77 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ------------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ   77 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET------------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC------------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence            48999999999999999998753            556999999754322  2456889999999999999999999998


Q ss_pred             cC--CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--ceeCCCCCCceeeCCCCcEEEe
Q 013028          208 DD--QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRP--VIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       208 ~~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~--iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      +.  ...++||||+++|+|.+++.......+++..++.++.||+.||.|||+  ++  |+||||||+|||++.++.++|+
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~~i~H~dikp~Nil~~~~~~~~l~  155 (271)
T 3kmu_A           78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT--LEPLIPRHALNSRSVMIDEDMTARIS  155 (271)
T ss_dssp             TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT--SSSCCTTCCCSGGGEEECTTSCEEEE
T ss_pred             cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc--CCCceecCCCccceEEEcCCcceeEE
Confidence            87  788999999999999999977655579999999999999999999999  78  9999999999999999999999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCccccccccccCCCCc---chhhHHHHHHHHHHHhCCCccccccCCCCCCccccccc
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTL---KTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS  360 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~---~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  360 (451)
                      |||++....       .....||+.|+|||++.+..++.   ++|||||||++|+|++|..||.....            
T Consensus       156 ~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------------  216 (271)
T 3kmu_A          156 MADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------------  216 (271)
T ss_dssp             GGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------------
T ss_pred             eccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------------
Confidence            999876321       12356899999999997765544   79999999999999999999864321            


Q ss_pred             hhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          361 NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                       ................+...+..+.+|+.+||+.||.+|||+.++++.|+.+++
T Consensus       217 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          217 -MEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -HHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence             111223333333444556677889999999999999999999999999998853

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.3e-45  Score=349.92  Aligned_cols=253  Identities=32%  Similarity=0.556  Sum_probs=206.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCH-------HHHHHHHHHHHhcCCCceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-------DEWENELRFLSRLNHPNVVKL  202 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~E~~il~~l~h~nIv~~  202 (451)
                      ++|++.+.||+|+||+||+|.+.          .++..||||++........       +.+.+|+.+++.++||||+++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   88 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLV----------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL   88 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEET----------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred             ccceehhccccCCceeEEEEEEc----------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence            48999999999999999997643          4577899999875433221       568899999999999999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--ceeCCCCCCceeeCCCCc-
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRP--VIHRDVKASNVLLDDDFN-  279 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~--iiHrDlkp~NIll~~~~~-  279 (451)
                      ++++.+..  ++||||+++|+|.+++... ...+++..++.++.|++.||.|||+  +|  |+||||||+|||++.++. 
T Consensus        89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~--~~~~ivH~dikp~Nil~~~~~~~  163 (287)
T 4f0f_A           89 YGLMHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQN--QNPPIVHRDLRSPNIFLQSLDEN  163 (287)
T ss_dssp             EEEETTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCSCCSGGGEEESCCCTT
T ss_pred             heeecCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHh--CCCCeecCCCCcceEEEeccCCC
Confidence            99997665  6999999999999888653 4579999999999999999999999  78  999999999999988776 


Q ss_pred             ----EEEeecCCcccCCCCCCcccccccCCCCcccccccc--ccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC
Q 013028          280 ----AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI--ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN  353 (451)
Q Consensus       280 ----~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  353 (451)
                          +||+|||++....     .......||+.|+|||++  ....++.++|||||||++|+|++|..||......    
T Consensus       164 ~~~~~kl~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----  234 (287)
T 4f0f_A          164 APVCAKVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG----  234 (287)
T ss_dssp             CSCCEEECCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC----
T ss_pred             CceeEEeCCCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc----
Confidence                9999999997422     223456799999999998  4456789999999999999999999998643321    


Q ss_pred             ccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          354 WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                             .................+...++.+.+|+.+||+.||.+|||+.++++.|+++
T Consensus       235 -------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          235 -------KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -------HHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -------HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                   01111222233334445566778999999999999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-45  Score=362.67  Aligned_cols=269  Identities=26%  Similarity=0.394  Sum_probs=217.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|.+.+.||+|+||.||+|.+...+     .......||+|.+..... ...+.+.+|+.+++.+ +||||+++++++
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLG-----KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCS-----SSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCC-----cccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            458999999999999999999865432     123345799999975432 2345688999999999 799999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL  274 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll  274 (451)
                      .++...++||||+++|+|.+++....            ...+++..++.++.||+.||.|||+  +||+||||||+|||+
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLL  197 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGCEE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccceEEE
Confidence            99999999999999999999985421            3468999999999999999999999  899999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCC
Q 013028          275 DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGN  353 (451)
Q Consensus       275 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~  353 (451)
                      +.++.+||+|||++................||..|+|||++.+..++.++|||||||++|+|++ |..||......    
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----  273 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN----  273 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS----
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh----
Confidence            9999999999999985432222222334557788999999988999999999999999999998 88887643221    


Q ss_pred             ccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          354 WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                               ......+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       274 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          274 ---------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             ---------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence                     1122333333333444555788999999999999999999999999999987654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.8e-45  Score=348.28  Aligned_cols=250  Identities=30%  Similarity=0.500  Sum_probs=197.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC----cCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS----QGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      ++|++.+.||+|+||.||+|.+.            +..||||++.....    ...+.+.+|+++++.++||||++++++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI------------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV   74 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET------------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc------------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            58999999999999999998753            45699999875422    234678899999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC---ceeCCCCCCceeeCC------
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRP---VIHRDVKASNVLLDD------  276 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~---iiHrDlkp~NIll~~------  276 (451)
                      +.++...++||||+++++|.+++.   ...+++..++.++.|++.||.|||+  +|   |+||||||+|||++.      
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~--~~~~~i~H~dikp~Nil~~~~~~~~~  149 (271)
T 3dtc_A           75 CLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHD--EAIVPIIHRDLKSSNILILQKVENGD  149 (271)
T ss_dssp             ECCC--CEEEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHH--SSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred             EecCCceEEEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCchHHEEEeccccccc
Confidence            999999999999999999999884   3579999999999999999999999  78   899999999999986      


Q ss_pred             --CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc
Q 013028          277 --DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW  354 (451)
Q Consensus       277 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  354 (451)
                        ++.++|+|||++......    ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....      
T Consensus       150 ~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------  219 (271)
T 3dtc_A          150 LSNKILKITDFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------  219 (271)
T ss_dssp             CSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------
T ss_pred             ccCcceEEccCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------
Confidence              678999999999753321    12245789999999999889999999999999999999999999864321      


Q ss_pred             cccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                             ................+...++.+.+|+.+||+.||.+|||+.|+++.|+.+
T Consensus       220 -------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          220 -------LAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -------HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -------HHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                   1111222223333344556678899999999999999999999999999854

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.7e-45  Score=363.43  Aligned_cols=290  Identities=19%  Similarity=0.185  Sum_probs=215.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCH-----------HHHHHHHHHHHhcCCC
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-----------DEWENELRFLSRLNHP  197 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~il~~l~h~  197 (451)
                      .++|++.++||+|+||.||+|.+..+.     ....+..||||++........           ..+..|+..+..++||
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~  108 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSE-----SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYL  108 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSS-----CCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCcc-----ccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence            358999999999999999999876531     223457799999875432111           1233455566777899


Q ss_pred             ceeeccceeecC----CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcee
Q 013028          198 NVVKLMGYCCDD----QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL  273 (451)
Q Consensus       198 nIv~~~~~~~~~----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIl  273 (451)
                      ||+++++++.+.    .+.+|||||+ |++|.+++... ...+++..++.|+.||+.||.|||+  +||+||||||+|||
T Consensus       109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Nil  184 (364)
T 3op5_A          109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLL  184 (364)
T ss_dssp             CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEE
T ss_pred             CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHEE
Confidence            999999998764    5589999999 99999998653 4679999999999999999999999  89999999999999


Q ss_pred             eC--CCCcEEEeecCCcccCCCCCCc-----ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccc
Q 013028          274 LD--DDFNAKISDFGLAKFGPLGDKS-----HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRR  346 (451)
Q Consensus       274 l~--~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~  346 (451)
                      ++  .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            98  8899999999999754321111     1123456999999999999989999999999999999999999999854


Q ss_pred             cCCCCCCcccccc-chhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCccccc
Q 013028          347 TNGLAGNWAKPYL-SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTSL  425 (451)
Q Consensus       347 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~  425 (451)
                      .....  +..... .....+..+++..+.   ....+.++.+|+..||..||.+||++.+|++.|+.+....+.......
T Consensus       265 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~  339 (364)
T 3op5_A          265 LKDPK--YVRDSKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKL  339 (364)
T ss_dssp             TTCHH--HHHHHHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             ccCHH--HHHHHHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCcc
Confidence            32200  000000 000111122222211   123357899999999999999999999999999999999988887776


Q ss_pred             ccccCcC
Q 013028          426 RTSTHTT  432 (451)
Q Consensus       426 ~~~~~~~  432 (451)
                      +.....+
T Consensus       340 dw~~~~~  346 (364)
T 3op5_A          340 DLSVVEN  346 (364)
T ss_dssp             CC-----
T ss_pred             ceEeccC
Confidence            6654443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.2e-45  Score=380.57  Aligned_cols=258  Identities=25%  Similarity=0.432  Sum_probs=216.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ..+|.+.++||+|+||.||+|.+..          ++..||||++... ....+.+.+|+.+|+.++||||+++++++.+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  287 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKK----------YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR  287 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGG----------GTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcC----------CCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            4578889999999999999987643          3577999999754 3456789999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ....+|||||+++|+|.+++.......+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus       288 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecccc
Confidence            9999999999999999999977666779999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +..... .........++..|+|||++.+..++.++|||||||++|||++ |..||.....              ..+..
T Consensus       366 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--------------~~~~~  430 (495)
T 1opk_A          366 RLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------------SQVYE  430 (495)
T ss_dssp             ECCTTC-CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------------GGHHH
T ss_pred             eeccCC-ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--------------HHHHH
Confidence            864321 1122233456778999999988899999999999999999999 8888764321              11223


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                      .+........+...+..+.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus       431 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          431 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            33344444455667789999999999999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=348.18  Aligned_cols=268  Identities=26%  Similarity=0.379  Sum_probs=214.6

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .|.+.++||+|+||+||+|.+...       ......||+|.+...... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   94 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQ-------AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP   94 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECS-------SSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred             EEccCceeccCCCceEEEEEEecC-------CCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence            567779999999999999876432       223457999999754332 346688999999999999999999999876


Q ss_pred             Cee-EEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          210 QHR-LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       210 ~~~-~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +.. ++||||+.+|+|.+++... ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~  171 (298)
T 3pls_A           95 EGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLA  171 (298)
T ss_dssp             SSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred             CCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCcCCCc
Confidence            665 9999999999999998653 4678999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCC--CcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          289 KFGPLGD--KSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       289 ~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +......  .........++..|+|||++.+..++.++|||||||++|+|++|..|++.....             ..+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-------------~~~~  238 (298)
T 3pls_A          172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-------------FDLT  238 (298)
T ss_dssp             CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-------------GGHH
T ss_pred             ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-------------HHHH
Confidence            7533211  111223456788999999999999999999999999999999976665432211             1122


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCc
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCY  421 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~  421 (451)
                      ..+........+...+..+.+|+.+||..||.+|||+.++++.|+.+...+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~  293 (298)
T 3pls_A          239 HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH  293 (298)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred             HHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence            2333333334445567889999999999999999999999999999998876643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6e-45  Score=351.23  Aligned_cols=252  Identities=22%  Similarity=0.325  Sum_probs=200.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--HHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++.++||+|+||+||+|..          ..++..||||++.......  ...+.+|+.+++.++||||+++++++.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   71 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKN----------RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH   71 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEE----------TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEE----------CCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE
Confidence            4799999999999999999764          4457889999997543332  366789999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++...++||||+++ +|.+.+... ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg~  147 (292)
T 3o0g_A           72 SDKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             ETTEEEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            99999999999975 666665443 4679999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCC-CCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +.....  .........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......            ..+.
T Consensus       148 ~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~------------~~~~  213 (292)
T 3o0g_A          148 ARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD------------DQLK  213 (292)
T ss_dssp             CEECCS--CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH------------HHHH
T ss_pred             ceecCC--ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH------------HHHH
Confidence            986432  222334567899999999997755 8999999999999999999988865332210            0000


Q ss_pred             HHhh---------------------------hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIID---------------------------EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~---------------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .++.                           ...........+..+.+|+.+||+.||++|||+.|++++
T Consensus       214 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            1000                           000011122356789999999999999999999999863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.3e-45  Score=349.61  Aligned_cols=261  Identities=28%  Similarity=0.469  Sum_probs=212.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.+.||+|+||.||+|.+..           +..||||.+... ....+.+.+|+++++.++||||+++++++.+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   79 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNG-----------HTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ   79 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-----------TEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcC-----------CcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC
Confidence            4589999999999999999987542           456999999754 3456788999999999999999999999864


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                       +..++||||+++++|.+++.......+++..++.++.|++.||.|||+  +||+||||||+|||++.++.++|+|||++
T Consensus        80 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLA  156 (279)
T ss_dssp             -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             -CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCccc
Confidence             468999999999999999865433469999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||......              ....
T Consensus       157 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------------~~~~  221 (279)
T 1qpc_A          157 RLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--------------EVIQ  221 (279)
T ss_dssp             EECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------------HHHH
T ss_pred             ccccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--------------HHHH
Confidence            8643221 122234456788999999988889999999999999999999 88887543211              1112


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      .+........+...+..+.+|+.+||..||.+|||+.++++.|+.+......
T Consensus       222 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          222 NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             HHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence            2222223334455678899999999999999999999999999999876554

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-45  Score=365.30  Aligned_cols=249  Identities=26%  Similarity=0.414  Sum_probs=206.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhc-CCCceeeccc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRL-NHPNVVKLMG  204 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~  204 (451)
                      .++|.+.+.||+|+||.||+|.+          ..++..||||++.+..   ....+.+..|..++..+ +||||+++++
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~   85 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEF----------KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFC   85 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEE----------TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEE----------CCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEE
Confidence            45899999999999999999764          4457889999997532   33456678899999887 8999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      ++.+....|+||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~D  161 (345)
T 1xjd_A           86 TFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIAD  161 (345)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEEEeE
Confidence            99999999999999999999999865  3568999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ||+++.....  .......+||+.|+|||++.+..++.++|||||||++|||++|..||......             ..
T Consensus       162 FG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------------~~  226 (345)
T 1xjd_A          162 FGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------------EL  226 (345)
T ss_dssp             CTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HH
T ss_pred             ChhhhhcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-------------HH
Confidence            9999853221  22344678999999999999999999999999999999999999998643211             11


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS-EVVA  408 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~  408 (451)
                      ...+...  ...++...+.++.+|+.+||..||.+||++. ++++
T Consensus       227 ~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          227 FHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             HHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HHHHHhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence            1122111  2234445678899999999999999999997 6653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.3e-45  Score=361.86  Aligned_cols=251  Identities=24%  Similarity=0.329  Sum_probs=191.2

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +.++|++.+.||+|+||.||+|.+.          .++..||||++....  ..+.+.+|+.+|+.++||||+++++++.
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~  118 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQK----------GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE  118 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEET----------TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEEC----------CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe
Confidence            3468999999999999999997643          456789999997542  3456788999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC---CCcEEEee
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD---DFNAKISD  284 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~---~~~~kl~D  284 (451)
                      +....++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+  .||+||||||+|||++.   ++.+||+|
T Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          119 TPTEISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             cCCeEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEcc
Confidence            99999999999999999999854  4568999999999999999999999  89999999999999975   88999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ||+++....   ........||+.|+|||++.+..++.++|||||||++|+|++|..||......            ...
T Consensus       195 fg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------------~~~  259 (349)
T 2w4o_A          195 FGLSKIVEH---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------------QFM  259 (349)
T ss_dssp             CC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------------HHH
T ss_pred             CccccccCc---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------------HHH
Confidence            999985322   22234567999999999999889999999999999999999999998643221            111


Q ss_pred             hhHHhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          365 LHQIIDEKLG--RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +..+......  .......+.++.+|+.+||..||++|||+.|+++.
T Consensus       260 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          260 FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             HHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1122221111  11123456789999999999999999999999874

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.7e-45  Score=360.95  Aligned_cols=258  Identities=26%  Similarity=0.373  Sum_probs=205.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhc-CCCceeeccce
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRL-NHPNVVKLMGY  205 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l-~h~nIv~~~~~  205 (451)
                      ++|++++.||+|+||.||+|.+          ..++..||||++.+.....   .+.+.+|+.++..+ +||||++++++
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~   78 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRL----------KKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC   78 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEE----------CCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence            4799999999999999999764          4457889999998653332   34577899999988 79999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.+....|+||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus        79 ~~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DF  154 (345)
T 3a8x_A           79 FQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDY  154 (345)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCG
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEEec
Confidence            9999999999999999999999865  3569999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |+++....  ........+||+.|+|||++.+..++.++|||||||++|||++|..||........     +.......+
T Consensus       155 G~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~~~~~~  227 (345)
T 3a8x_A          155 GMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN-----PDQNTEDYL  227 (345)
T ss_dssp             GGCBCSCC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------------CHHHH
T ss_pred             cccccccC--CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccc-----cccccHHHH
Confidence            99985321  12234467899999999999999999999999999999999999999964321110     000001111


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM------SEVVAA  409 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~  409 (451)
                      ...+.. ....++...+.++.+|+.+||..||.+||++      .+++++
T Consensus       228 ~~~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          228 FQVILE-KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             HHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             HHHHHc-CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            111111 1223455567889999999999999999995      566543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.9e-45  Score=366.49  Aligned_cols=268  Identities=19%  Similarity=0.256  Sum_probs=204.2

Q ss_pred             cCCCcCCccccc--CceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          130 RKFSEKNLIGQG--GFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       130 ~~y~~~~~LG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      ++|+++++||+|  +||+||+|..          ..++..||||++.....  ...+.+.+|+.+++.++||||++++++
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   94 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARY----------KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT   94 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEE----------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEE----------cCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence            489999999999  9999999764          44578899999975432  223567889999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.+++..++||||+++|+|.+++.......+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~df  172 (389)
T 3gni_B           95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGL  172 (389)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCG
T ss_pred             EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEccc
Confidence            9999999999999999999999977656779999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCC-----CcccccccCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC--Cccc
Q 013028          286 GLAKFGPLGD-----KSHISTRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG--NWAK  356 (451)
Q Consensus       286 Gla~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~--~~~~  356 (451)
                      |++.......     .........||..|+|||++.+  ..++.++|||||||++|+|++|..||.........  .+..
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            9986321111     1112223578999999999977  67999999999999999999999999754332110  0000


Q ss_pred             c---ccchh-----------------hhhhHHh---------hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013028          357 P---YLSNK-----------------LALHQII---------DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV  407 (451)
Q Consensus       357 ~---~~~~~-----------------~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  407 (451)
                      .   .....                 ..+...+         ............+..+.+|+.+||+.||.+|||+.|++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell  332 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL  332 (389)
T ss_dssp             -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            0   00000                 0000000         00000012233467899999999999999999999999


Q ss_pred             HH
Q 013028          408 AA  409 (451)
Q Consensus       408 ~~  409 (451)
                      +.
T Consensus       333 ~h  334 (389)
T 3gni_B          333 NH  334 (389)
T ss_dssp             TS
T ss_pred             cC
Confidence            75

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.9e-45  Score=351.16  Aligned_cols=254  Identities=25%  Similarity=0.411  Sum_probs=208.8

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ...+|++.+.||+|+||.||+|.+.          .++..||||++....    +.+.+|+++++.++||||+++++++.
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~   74 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHR----------IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD   74 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEET----------TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hccccceeeeeccCCceEEEEEEEc----------CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEe
Confidence            4568999999999999999997643          457789999997542    34678999999999999999999886


Q ss_pred             c----------------CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCc
Q 013028          208 D----------------DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASN  271 (451)
Q Consensus       208 ~----------------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~N  271 (451)
                      .                ....++||||+++++|.+++.......+++..++.++.||+.||.|||+  +||+|+||||+|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~N  152 (284)
T 2a19_B           75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSN  152 (284)
T ss_dssp             EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGG
T ss_pred             ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHH
Confidence            4                4457999999999999999976555679999999999999999999999  899999999999


Q ss_pred             eeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC
Q 013028          272 VLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA  351 (451)
Q Consensus       272 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  351 (451)
                      ||++.++.++|+|||++......   .......||+.|+|||++.+..++.++||||||+++|+|++|..|+....    
T Consensus       153 il~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----  225 (284)
T 2a19_B          153 IFLVDTKQVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----  225 (284)
T ss_dssp             EEEEETTEEEECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----
T ss_pred             EEEcCCCCEEECcchhheecccc---ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----
Confidence            99999999999999999864322   12334578999999999988899999999999999999999998865321    


Q ss_pred             CCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                                     ...........+...+..+.+|+.+||..||.+|||+.|+++.|+.++.....
T Consensus       226 ---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          226 ---------------KFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             ---------------HHHHHHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             ---------------HHHHHhhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence                           11111112223344567799999999999999999999999999998765544

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.6e-44  Score=351.53  Aligned_cols=267  Identities=27%  Similarity=0.428  Sum_probs=203.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|.+.+.||+|+||.||+|.+..       +..++..||||++......  ..+.+.+|+.+++.++||||+++++++
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQ-------EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEEC-------TTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHHeeeccceeecCCeEEEEEEEec-------cCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            4589999999999999999987543       2334568999998754322  235688999999999999999999999


Q ss_pred             ecCC-----eeEEEEeccCCCChhhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC
Q 013028          207 CDDQ-----HRLLVYEYVTRGSLEDHLLN----EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD  277 (451)
Q Consensus       207 ~~~~-----~~~lV~E~~~gg~L~~~l~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~  277 (451)
                      .+..     ..++||||+++|+|.+++..    .....+++..++.++.||+.||.|||+  +||+||||||+|||++.+
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCSGGGEEECTT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCC
Confidence            8754     35999999999999998843    234679999999999999999999999  899999999999999999


Q ss_pred             CcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccc
Q 013028          278 FNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAK  356 (451)
Q Consensus       278 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~  356 (451)
                      +.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......       
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------  256 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-------  256 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-------
Confidence            9999999999985433222222334567889999999999999999999999999999999 88887543221       


Q ss_pred             cccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcC
Q 013028          357 PYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG  418 (451)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  418 (451)
                             .....+........+...+..+.+|+.+||..||.+|||+.++++.|+.+...+.
T Consensus       257 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          257 -------EMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             -------GHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             -------HHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence                   1111122222233445566889999999999999999999999999999987653

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-44  Score=344.08  Aligned_cols=257  Identities=27%  Similarity=0.441  Sum_probs=211.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|++.+.||+|+||.||+|.+.+           +..||+|++.... ...+.+.+|+++++.++||||+++++++.+.
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~-----------~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   75 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLN-----------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   75 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETT-----------TEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hheeeeeEecCCCceeEEEEEecC-----------CCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            589999999999999999987542           4569999997543 3457789999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +..++||||+++++|.+++... ...+++..+..++.|++.||.|||+  +||+|+||||+||+++.++.++|+|||++.
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  152 (267)
T 3t9t_A           76 APICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTR  152 (267)
T ss_dssp             SSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred             CCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEccccccc
Confidence            9999999999999999998654 3568999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHH
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ..... .........++..|+|||++.+..++.++||||||+++|+|++ |..||......              .....
T Consensus       153 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------------~~~~~  217 (267)
T 3t9t_A          153 FVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------------EVVED  217 (267)
T ss_dssp             GBCCH-HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------------HHHHH
T ss_pred             ccccc-cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--------------HHHHH
Confidence            54321 1112233457788999999988899999999999999999999 88887643211              11111


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      +........+...+..+.+++.+||..||.+|||+.++++.|+.+...
T Consensus       218 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          218 ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            222222333445578899999999999999999999999999998763

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-45  Score=372.92  Aligned_cols=254  Identities=24%  Similarity=0.299  Sum_probs=207.0

Q ss_pred             HHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecc
Q 013028          127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLM  203 (451)
Q Consensus       127 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~  203 (451)
                      ...++|+++++||+|+||+||+|..          ..++..||+|++.+.   .......+.+|+.++..++||||++++
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~----------~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~  135 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRH----------KSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF  135 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEE----------CCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3457899999999999999999764          445788999998642   122234477899999999999999999


Q ss_pred             ceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          204 GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       204 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      ++|.++...||||||++||+|.+++..   ..+++..+..++.||+.||.|||+  +||+||||||+||||+.++.+||+
T Consensus       136 ~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~  210 (410)
T 3v8s_A          136 YAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLA  210 (410)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeECCCCCEEEe
Confidence            999999999999999999999999854   358999999999999999999999  899999999999999999999999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCccccccccccCC----CCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGH----LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  359 (451)
                      |||+|+..... ........+||+.|+|||++.+..    |+.++|||||||++|||++|..||.....           
T Consensus       211 DFG~a~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----------  278 (410)
T 3v8s_A          211 DFGTCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----------  278 (410)
T ss_dssp             CCTTCEECCTT-SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----------
T ss_pred             ccceeEeeccC-CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----------
Confidence            99999864322 112234678999999999997655    88999999999999999999999974321           


Q ss_pred             chhhhhhHHhhhhhcCCCC--HHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 013028          360 SNKLALHQIIDEKLGRNIQ--MEEAQEFAEIILRCLNSDPKN--RPTMSEVVAA  409 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  409 (451)
                        ......+.........+  ...+.++.+||.+||..+|.+  ||++.||+++
T Consensus       279 --~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          279 --VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             --HHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             --hhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence              11222333222112222  245788999999999999988  9999999976

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.9e-44  Score=351.37  Aligned_cols=263  Identities=24%  Similarity=0.325  Sum_probs=198.8

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|+++++||+|+||+||+|.+.           .+..||||++......  ....+.+|+++++.++||||+++++++
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   88 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI   88 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            468999999999999999998642           2678999999754322  235678999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .++...++||||+++ +|.+.+... ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg  164 (311)
T 3niz_A           89 HSERCLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFG  164 (311)
T ss_dssp             CCSSCEEEEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ccCCEEEEEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccCc
Confidence            999999999999975 888877543 3569999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc--------ccc
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW--------AKP  357 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~--------~~~  357 (451)
                      ++......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........        ...
T Consensus       165 ~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  242 (311)
T 3niz_A          165 LARAFGIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR  242 (311)
T ss_dssp             TCEETTSC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred             CceecCCC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChH
Confidence            99864321  222344678999999999876 5689999999999999999999999975443211000        000


Q ss_pred             ccchhhhhhHHhhhhhc--C-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          358 YLSNKLALHQIIDEKLG--R-----NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~--~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      .+.....+.........  .     ......++++.+|+.+||..||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00000000000000000  0     011123568999999999999999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=355.36  Aligned_cols=267  Identities=24%  Similarity=0.450  Sum_probs=209.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .+|.+.+.||+|+||.||+|.+...      ....+..||||++...... ....+.+|+.+++.++||||+++++++.+
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTS------SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             HHhhcccEEecCCCeEEEEEEEecC------CCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            4788899999999999999986532      1223456999999754322 34568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ....++||||+++|+|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLS  194 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEECCCCcEEECCCCcc
Confidence            99999999999999999998653 4579999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          289 KFGPLGDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       289 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ......... .......+|..|+|||++.+..++.++|||||||++|+|++ |..||.....              ..+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------------~~~~  260 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------------HEVM  260 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------------HHHH
T ss_pred             hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------------HHHH
Confidence            864322111 11223346788999999988899999999999999999999 9998864321              1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      ..+........+...+..+.+|+.+||+.||.+||++.++++.|+.+......
T Consensus       261 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  313 (333)
T 1mqb_A          261 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  313 (333)
T ss_dssp             HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             HHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence            22222223334455678899999999999999999999999999999876554

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.5e-45  Score=374.97  Aligned_cols=257  Identities=22%  Similarity=0.290  Sum_probs=207.9

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeec
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKL  202 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~  202 (451)
                      ....++|+++++||+|+||+||+|.+.          .++..||||++.+.   .......+.+|+.++..++||||+++
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~----------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l  139 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLK----------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL  139 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEET----------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCE
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEc----------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            344578999999999999999997644          45778999999642   11222347889999999999999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      +++|.++...||||||++||+|.+++... ...+++..+..++.||+.||.|||+  +||+||||||+||||+.++.+||
T Consensus       140 ~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl~~~g~vkL  216 (437)
T 4aw2_A          140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRL  216 (437)
T ss_dssp             EEEEECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeEcCCCCEEE
Confidence            99999999999999999999999999653 3569999999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA-----TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~  357 (451)
                      +|||+|+..... ........+||+.|+|||++.     ...|+.++|||||||++|||++|..||.....         
T Consensus       217 ~DFGla~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---------  286 (437)
T 4aw2_A          217 ADFGSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---------  286 (437)
T ss_dssp             CCCTTCEECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---------
T ss_pred             cchhhhhhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---------
Confidence            999999754322 222234568999999999996     56789999999999999999999999975322         


Q ss_pred             ccchhhhhhHHhhhhhcCCCC---HHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 013028          358 YLSNKLALHQIIDEKLGRNIQ---MEEAQEFAEIILRCLNSDPKN--RPTMSEVVAA  409 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  409 (451)
                          ......++.......++   ...++++.+||.+||..+|++  ||++.|++++
T Consensus       287 ----~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          287 ----VETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             ----HHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ----hHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence                11122232222112222   235788999999999988888  9999999874

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.5e-45  Score=362.82  Aligned_cols=250  Identities=25%  Similarity=0.332  Sum_probs=206.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhc-CCCceeeccc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRL-NHPNVVKLMG  204 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~nIv~~~~  204 (451)
                      .++|++++.||+|+||.||+|...          .++..||||++.+.   .....+.+..|..+|..+ +||||+++++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~----------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~   88 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERK----------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS   88 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEET----------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEEC----------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence            358999999999999999997643          44678999999753   234456678899999988 6999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      ++.+.+..||||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~D  164 (353)
T 2i0e_A           89 CFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIAD  164 (353)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEEEe
Confidence            99999999999999999999999865  3569999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ||++.....  ........+||+.|+|||++.+..++.++|||||||++|||++|..||.....             ...
T Consensus       165 FG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------------~~~  229 (353)
T 2i0e_A          165 FGMCKENIW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------------DEL  229 (353)
T ss_dssp             CTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHH
T ss_pred             CCccccccc--CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-------------HHH
Confidence            999985221  12234467899999999999999999999999999999999999999864321             111


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT-----MSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~  409 (451)
                      ...+...  ...++...+.++.+|+.+||..||.+||+     +.+++++
T Consensus       230 ~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          230 FQSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             HHHHHhC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1222222  22344556788999999999999999995     5777654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.2e-45  Score=374.31  Aligned_cols=262  Identities=25%  Similarity=0.428  Sum_probs=210.4

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ..++|++.++||+|+||.||+|.+..           ...||||++.... ...+.+.+|+.+|+.++||||+++++++.
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  249 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS  249 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-----------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            34688999999999999999997653           3459999997543 44678999999999999999999999987


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      + ...+|||||+++|+|.+++.......+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus       250 ~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~  326 (452)
T 1fmk_A          250 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGL  326 (452)
T ss_dssp             S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             C-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCcc
Confidence            6 678999999999999999965444568999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||.....              ..+.
T Consensus       327 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------------~~~~  391 (452)
T 1fmk_A          327 ARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------------REVL  391 (452)
T ss_dssp             TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------------HHHH
T ss_pred             ceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------------HHHH
Confidence            98543211 112223456788999999988999999999999999999999 8888764321              1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      ..+........+...+..+.+|+.+||..||++|||+.+|++.|+.+......
T Consensus       392 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          392 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence            22223333344556778899999999999999999999999999988655444

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=351.30  Aligned_cols=263  Identities=26%  Similarity=0.370  Sum_probs=200.8

Q ss_pred             HHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-----CcCHHHHHHHHHHHHhcC---CCc
Q 013028          127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-----SQGQDEWENELRFLSRLN---HPN  198 (451)
Q Consensus       127 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~---h~n  198 (451)
                      ...++|++.++||+|+||+||+|.          +..++..||||++....     ......+.+|+.+++.++   |||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~----------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~n   75 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKAR----------DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN   75 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEE----------CTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTT
T ss_pred             ccccceEEEEEEecCCCeEEEEEE----------ECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCC
Confidence            346799999999999999999965          45567889999987432     122356778888887775   999


Q ss_pred             eeeccceeecCC-----eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcee
Q 013028          199 VVKLMGYCCDDQ-----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL  273 (451)
Q Consensus       199 Iv~~~~~~~~~~-----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIl  273 (451)
                      |+++++++.+..     ..++||||+. ++|.+++.......+++..+..++.||+.||.|||+  +||+||||||+|||
T Consensus        76 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil  152 (308)
T 3g33_A           76 VVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENIL  152 (308)
T ss_dssp             BCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEE
T ss_pred             eEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEE
Confidence            999999998765     5799999996 599999977666669999999999999999999999  89999999999999


Q ss_pred             eCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--
Q 013028          274 LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--  351 (451)
Q Consensus       274 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--  351 (451)
                      ++.++.+||+|||++.....   ........||+.|+|||++.+..++.++|||||||++|+|++|.+||........  
T Consensus       153 ~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  229 (308)
T 3g33_A          153 VTSGGTVKLADFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG  229 (308)
T ss_dssp             ECTTSCEEECSCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH
T ss_pred             EcCCCCEEEeeCccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999985432   2223456899999999999999999999999999999999999999865432100  


Q ss_pred             -----------CCccccccchhhhhhHHhhhhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 -----------GNWAKPYLSNKLALHQIIDEKLG---RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 -----------~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                                 ..|........    ..+.....   .......+..+.+|+.+||+.||++|||+.|+|++
T Consensus       230 ~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          230 KIFDLIGLPPEDDWPRDVSLPR----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHHHHCCCCTTTSCSSCSSCG----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhCCCChhhccchhhccc----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence                       00000000000    00000000   00012245789999999999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.4e-45  Score=359.12  Aligned_cols=253  Identities=26%  Similarity=0.385  Sum_probs=200.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCC--Cceeeccc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNH--PNVVKLMG  204 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h--~nIv~~~~  204 (451)
                      .++|++.+.||+|+||.||++...           ++..||||++......  ..+.+.+|+.+|..++|  +||+++++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   76 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   76 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEee
Confidence            357999999999999999997532           3677999998754332  23568899999999986  99999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      ++.++...+||||+ .+++|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++ ++.+||+|
T Consensus        77 ~~~~~~~~~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~D  150 (343)
T 3dbq_A           77 YEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLID  150 (343)
T ss_dssp             EEECSSEEEEEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEECC
T ss_pred             eEeeCCEEEEEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEee
Confidence            99999999999995 57899999965  4578999999999999999999999  8999999999999997 56899999


Q ss_pred             cCCcccCCCCCCcccccccCCCCcccccccccc-----------CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-----------GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN  353 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  353 (451)
                      ||+++..............+||+.|+|||++.+           ..++.++|||||||++|+|++|..||.....     
T Consensus       151 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----  225 (343)
T 3dbq_A          151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----  225 (343)
T ss_dssp             CSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----
T ss_pred             cccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----
Confidence            999986543333333445689999999999864           6789999999999999999999999864221     


Q ss_pred             ccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          354 WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                             ....+...++.......+...+..+.+|+.+||..||.+|||+.|+++..
T Consensus       226 -------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          226 -------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             -------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -------HHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                   12223344444444445555567899999999999999999999999764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.7e-45  Score=355.82  Aligned_cols=250  Identities=24%  Similarity=0.425  Sum_probs=197.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|++.+.||+|+||.||+|.+          ..++..||||++..... ...+.+.+|+.+|+.++||||++++++|.
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~----------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   74 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKN----------KVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL   74 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEE----------TTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEE
T ss_pred             hhcCceeeEecCCCCeEEEEEEE----------cCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            45899999999999999999764          44578899999975433 34567899999999999999999999986


Q ss_pred             cCC---------------------------------------------------------eeEEEEeccCCCChhhhhcc
Q 013028          208 DDQ---------------------------------------------------------HRLLVYEYVTRGSLEDHLLN  230 (451)
Q Consensus       208 ~~~---------------------------------------------------------~~~lV~E~~~gg~L~~~l~~  230 (451)
                      +..                                                         ..++||||++||+|.+++..
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  154 (332)
T 3qd2_B           75 ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR  154 (332)
T ss_dssp             ECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHT
T ss_pred             EeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhc
Confidence            543                                                         37999999999999999965


Q ss_pred             CCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCc----------cc
Q 013028          231 EDD-TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKS----------HI  299 (451)
Q Consensus       231 ~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~  299 (451)
                      ... ...++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++.........          ..
T Consensus       155 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~  232 (332)
T 3qd2_B          155 RCSLEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT  232 (332)
T ss_dssp             CCSGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------C
T ss_pred             ccCccchhhHHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccc
Confidence            432 345667789999999999999999  89999999999999999999999999999864432111          12


Q ss_pred             ccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCC-
Q 013028          300 STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQ-  378 (451)
Q Consensus       300 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  378 (451)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..|+....                   ...........+ 
T Consensus       233 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------------------~~~~~~~~~~~~~  293 (332)
T 3qd2_B          233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------------------RIITDVRNLKFPL  293 (332)
T ss_dssp             CCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------------------HHHHHHHTTCCCH
T ss_pred             ccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------------------HHHHHhhccCCCc
Confidence            234579999999999999999999999999999999999877653211                   111111111222 


Q ss_pred             --HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          379 --MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       379 --~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                        ...++.+.+|+.+||+.||.+|||+.|+++.
T Consensus       294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             ccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence              2345778999999999999999999999863

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-44  Score=349.74  Aligned_cols=256  Identities=25%  Similarity=0.409  Sum_probs=198.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHh--cCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSR--LNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~~~~~~  206 (451)
                      .++|++.+.||+|+||+||+|.+.            +..||||++...   ....+..|.+++..  ++||||+++++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~   71 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQ------------GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASD   71 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEET------------TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEEC------------CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEee
Confidence            458999999999999999998652            567999998642   34556667777776  7899999999986


Q ss_pred             ec----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceeCCCCCCceee
Q 013028          207 CD----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH--------TYWRPVIHRDVKASNVLL  274 (451)
Q Consensus       207 ~~----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~iiHrDlkp~NIll  274 (451)
                      .+    ....++||||+++|+|.+++..   ..+++..++.++.||+.||.|||        +  ++|+||||||+|||+
T Consensus        72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~Nill  146 (301)
T 3q4u_A           72 MTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK--PAIAHRDLKSKNILV  146 (301)
T ss_dssp             EEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB--CEEECSCCCGGGEEE
T ss_pred             ccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC--CCeecCCCChHhEEE
Confidence            54    3567999999999999999943   46999999999999999999999        7  899999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCcc--cccccCCCCccccccccccC------CCCcchhhHHHHHHHHHHHhC-------
Q 013028          275 DDDFNAKISDFGLAKFGPLGDKSH--ISTRVLGTRGYFAPEYIATG------HLTLKTDVYSFGVVLLEILSG-------  339 (451)
Q Consensus       275 ~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~~~~~DiwSlGvil~elltg-------  339 (451)
                      +.++.+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|       
T Consensus       147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  226 (301)
T 3q4u_A          147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV  226 (301)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence            999999999999997533222111  12335799999999999766      456799999999999999999       


Q ss_pred             ---CCccccccCCCCCCccccccchhhhhhHHhh-hhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          340 ---KTAAMRRTNGLAGNWAKPYLSNKLALHQIID-EKLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       340 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                         ..||........         .......... .......     ....+..+.+|+.+||+.||.+|||+.+|++.|
T Consensus       227 ~~~~~pf~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L  297 (301)
T 3q4u_A          227 EDYKPPFYDVVPNDP---------SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL  297 (301)
T ss_dssp             CCCCCTTTTTSCSSC---------CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             ccccccccccCCCCc---------chhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence               666543322110         0011111111 1111111     234678899999999999999999999999999


Q ss_pred             HHh
Q 013028          411 EQL  413 (451)
Q Consensus       411 ~~~  413 (451)
                      +.+
T Consensus       298 ~~i  300 (301)
T 3q4u_A          298 TKI  300 (301)
T ss_dssp             HHH
T ss_pred             hcc
Confidence            986

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.9e-45  Score=357.10  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=199.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC----CcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG----SQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      ++|++.+.||+|+||.||++....       ...++..||||++.+..    ......+.+|+.+|+.++||||++++++
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   89 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVT-------GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA   89 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECS-------STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEec-------cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence            589999999999999999986531       23567889999997542    2233457789999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.+++..|+||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~Df  165 (327)
T 3a62_A           90 FQTGGKLYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDF  165 (327)
T ss_dssp             EECSSCEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEECCC
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEEeC
Confidence            9999999999999999999999865  3568999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |++.....  ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.....             ....
T Consensus       166 g~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------~~~~  230 (327)
T 3a62_A          166 GLCKESIH--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-------------KKTI  230 (327)
T ss_dssp             SCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------------HHHH
T ss_pred             Cccccccc--CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-------------HHHH
Confidence            99974221  12233456899999999999889999999999999999999999999864321             1111


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      ..+...  ....+...+..+.+|+.+||..||.+||     ++.+++++
T Consensus       231 ~~i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          231 DKILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             HHHHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             HHHHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            222222  2234455678899999999999999999     78888764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.8e-44  Score=350.16  Aligned_cols=264  Identities=22%  Similarity=0.331  Sum_probs=201.5

Q ss_pred             cCCCcC-CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeeccceee
Q 013028          130 RKFSEK-NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~  207 (451)
                      ++|.+. +.||+|+||+||+|.          +..++..||||++..........+.+|++++.++ +||||+++++++.
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~----------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~   81 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCI----------NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE   81 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEE----------CSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEE----------EcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            578885 789999999999965          4456788999999876666678899999999985 6999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc---EEEee
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISD  284 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~---~kl~D  284 (451)
                      +++..++||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.   +||+|
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~kl~D  157 (316)
T 2ac3_A           82 EEDRFYLVFEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICD  157 (316)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceEEEE
Confidence            99999999999999999999965  3568999999999999999999999  89999999999999988765   99999


Q ss_pred             cCCcccCCCCCC-----cccccccCCCCcccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc
Q 013028          285 FGLAKFGPLGDK-----SHISTRVLGTRGYFAPEYIAT-----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW  354 (451)
Q Consensus       285 FGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  354 (451)
                      ||++........     ........||..|+|||++.+     ..++.++|||||||++|+|++|..||........ .|
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~  236 (316)
T 2ac3_A          158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC-GW  236 (316)
T ss_dssp             TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS-CC
T ss_pred             ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc-cc
Confidence            999975332111     111224569999999999864     5689999999999999999999999976543321 11


Q ss_pred             ccccc-ch-hhhhhHHhhhhhcCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          355 AKPYL-SN-KLALHQIIDEKLGRNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       355 ~~~~~-~~-~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..... .. ...+...+... ....+.    ..+..+.+|+.+||..||.+|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          237 DRGEACPACQNMLFESIQEG-KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             ----CCHHHHHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cccccchhHHHHHHHHHhcc-CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11100 00 00111111111 111222    235789999999999999999999999874

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.1e-45  Score=362.02  Aligned_cols=246  Identities=24%  Similarity=0.299  Sum_probs=206.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++++.||+|+||.||+|..          ..++..||||++.+.   .....+.+.+|+.+|+.++||||+++++++
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  110 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKH----------KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF  110 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE----------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEE----------CCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            4899999999999999999764          445788999998643   223456788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+....|+||||++||+|.+++...  ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus       111 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFg  186 (350)
T 1rdq_E          111 KDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEcccc
Confidence            9999999999999999999999653  569999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +++....     .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.....             .....
T Consensus       187 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------------~~~~~  248 (350)
T 1rdq_E          187 FAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------------IQIYE  248 (350)
T ss_dssp             TCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHH
T ss_pred             cceeccC-----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-------------HHHHH
Confidence            9985332     12356799999999999999999999999999999999999999864321             11111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT-----MSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~  409 (451)
                      .+...  ....+...+.++.+||.+||+.||.+||+     +.+++++
T Consensus       249 ~i~~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          249 KIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            22222  12344556788999999999999999998     8888764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.4e-45  Score=349.50  Aligned_cols=257  Identities=29%  Similarity=0.513  Sum_probs=195.8

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|++.++||+|+||+||+|.+..             .||||++......  ..+.+.+|+.+++.++||||+++++++
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-------------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   89 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG-------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS   89 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS-------------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC-------------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence            4589999999999999999986432             3999999754332  235688999999999999999999965


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                       .....++||||+++++|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.++|+|||
T Consensus        90 -~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg  165 (289)
T 3og7_A           90 -TAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFG  165 (289)
T ss_dssp             -CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             -cCCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEccce
Confidence             556689999999999999988543 4669999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      ++................||+.|+|||++.   +..++.++|||||||++|+|++|..||......             .
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------------~  232 (289)
T 3og7_A          166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------------D  232 (289)
T ss_dssp             ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-------------H
T ss_pred             eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-------------H
Confidence            997544333333344567999999999986   567899999999999999999999998643221             1


Q ss_pred             hhhHHhhhhh-c---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          364 ALHQIIDEKL-G---RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       364 ~~~~~~~~~~-~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                      .+...+.... .   .......+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          233 QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            1112221111 1   11233556889999999999999999999999999998743

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.3e-44  Score=347.85  Aligned_cols=266  Identities=26%  Similarity=0.401  Sum_probs=207.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee-
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC-  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~-  207 (451)
                      .+|.+.++||+|+||+||+|.+..       .......+|+|.+..... ...+.+.+|+.+++.++||||+++++++. 
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLD-------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR   97 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC------------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             eehhhcceeeecCCceEEEEEEec-------CCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence            378899999999999999987643       223355689999875432 23456889999999999999999999854 


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      .+...++||||+++|+|.+++... ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        98 ~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~  174 (298)
T 3f66_A           98 SEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFGL  174 (298)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred             CCCceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEECcccc
Confidence            556789999999999999999653 4568999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCC--cccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCC-ccccccCCCCCCccccccchhhh
Q 013028          288 AKFGPLGDK--SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT-AAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       288 a~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      +........  ........||+.|+|||++.+..++.++||||||+++|+|++|.. ||......              .
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--------------~  240 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--------------D  240 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--------------T
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--------------H
Confidence            985432211  112234567888999999988999999999999999999999554 44322111              1


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      ....+........+...+..+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          241 ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            1111222222233444567899999999999999999999999999999887654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-44  Score=347.33  Aligned_cols=262  Identities=24%  Similarity=0.392  Sum_probs=209.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|.+.+.||+|+||+||+|.+..       ....+..||||.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTN-------HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEC-------TTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcC-------CCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            3589999999999999999987643       223455799999975422 33567889999999999999999999987


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++ ..++||||+++++|.+++... ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDFGL  159 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred             CC-CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCccCC
Confidence            54 568999999999999998653 3568999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||......              ...
T Consensus       160 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--------------~~~  224 (281)
T 3cc6_A          160 SRYIEDED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--------------DVI  224 (281)
T ss_dssp             GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--------------GHH
T ss_pred             Cccccccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--------------HHH
Confidence            98543221 112233457888999999988899999999999999999998 99998643221              111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      ..+........+...++.+.+|+.+||..||.+|||+.++++.|+.+...
T Consensus       225 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          225 GVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            22222222334445678899999999999999999999999999998654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1e-45  Score=355.63  Aligned_cols=265  Identities=24%  Similarity=0.354  Sum_probs=208.8

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|.+.+.||+|+||+||+|.+...+..   .......||+|++........+.+.+|+.+++.++||||+++++++.+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~---~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDY---GQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGG---GCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEeccccc---ccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            35899999999999999999876543211   111235699999976666667789999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc--------E
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN--------A  280 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~--------~  280 (451)
                      ++..++||||++||+|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.        +
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCccccccccee
Confidence            99999999999999999999653 3448999999999999999999999  89999999999999998877        9


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  359 (451)
                      ||+|||++....      ......||..|+|||++.+ ..++.++|||||||++|+|++|..|+......          
T Consensus       161 kl~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~----------  224 (289)
T 4fvq_A          161 KLSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS----------  224 (289)
T ss_dssp             EECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----------
T ss_pred             eeccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch----------
Confidence            999999997422      1223457889999999977 77999999999999999999976554432211          


Q ss_pred             chhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCC
Q 013028          360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSC  420 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~  420 (451)
                         .........  ....+...+.++.+|+.+||+.||.+|||+.++++.|+.+....+..
T Consensus       225 ---~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~  280 (289)
T 4fvq_A          225 ---QRKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP  280 (289)
T ss_dssp             ---HHHHHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred             ---HHHHHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence               001111111  12233334567999999999999999999999999999997766553

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=359.20  Aligned_cols=262  Identities=17%  Similarity=0.210  Sum_probs=212.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC---CCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN---HPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~~~~~  205 (451)
                      .++|.+.++||+|+||+||+|.+..     ..+..++..||||++...   ...++..|+++++.++   |+||+.++++
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGD-----LNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC------------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecC-----CcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            4589999999999999999986533     134566888999999643   4567788888888887   9999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC------
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNE---DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD------  276 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~------  276 (451)
                      +...+..+|||||++||+|.+++...   ....+++..++.|+.||+.||.|||+  +||+||||||+||||+.      
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGGGTCC-
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEecccccCcc
Confidence            99999999999999999999999632   34679999999999999999999999  89999999999999988      


Q ss_pred             -----CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC
Q 013028          277 -----DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA  351 (451)
Q Consensus       277 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  351 (451)
                           ++.+||+|||+|+..............+||+.|+|||++.+..|+.++|||||||++|||++|+.||........
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  293 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC  293 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence                 899999999999754333334455667899999999999999999999999999999999999999875433210


Q ss_pred             CCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHhHHhcCC
Q 013028          352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNR-PTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~~~~~~~  419 (451)
                         .             +...+.. .  ...+.+.+++..||+.+|.+| |++.++.+.|+.+.....+
T Consensus       294 ---~-------------~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~  343 (365)
T 3e7e_A          294 ---K-------------PEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT  343 (365)
T ss_dssp             ---E-------------ECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred             ---e-------------echhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence               0             0000000 0  235678899999999999999 6899999999998776543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.5e-44  Score=354.25  Aligned_cols=267  Identities=27%  Similarity=0.467  Sum_probs=213.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCc--EEEEEEeccCC-CcCHHHHHHHHHHHHhc-CCCceeeccce
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADF--AVAVKRLRRKG-SQGQDEWENELRFLSRL-NHPNVVKLMGY  205 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~  205 (451)
                      ++|++.+.||+|+||.||+|.+.          .++.  .+|||.+.... ....+.+.+|+.+++.+ +||||++++++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   94 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIK----------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA   94 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEE----------ETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEc----------cCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence            48999999999999999997653          2344  35999887432 23345688999999999 79999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCc
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASN  271 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~N  271 (451)
                      +.+.+..++||||+++|+|.+++....              ...+++..++.++.||+.||.|||+  +||+||||||+|
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~N  172 (327)
T 1fvr_A           95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARN  172 (327)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGG
T ss_pred             eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccce
Confidence            999999999999999999999986532              2479999999999999999999999  899999999999


Q ss_pred             eeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCC
Q 013028          272 VLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGL  350 (451)
Q Consensus       272 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  350 (451)
                      ||++.++.+||+|||++.....   ........++..|+|||++.+..++.++|||||||++|+|++ |..||.....  
T Consensus       173 Il~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--  247 (327)
T 1fvr_A          173 ILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--  247 (327)
T ss_dssp             EEECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred             EEEcCCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--
Confidence            9999999999999999974221   111223456888999999988889999999999999999998 9999864321  


Q ss_pred             CCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCccccc
Q 013028          351 AGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTSL  425 (451)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~  425 (451)
                                  ..+...+........+...+..+.+|+.+||..||.+|||+.++++.|+.+........+..+
T Consensus       248 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~  310 (327)
T 1fvr_A          248 ------------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTL  310 (327)
T ss_dssp             ------------HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCBC
T ss_pred             ------------HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccccch
Confidence                        111122222223334455678899999999999999999999999999999988766555444

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.2e-44  Score=353.61  Aligned_cols=262  Identities=20%  Similarity=0.334  Sum_probs=190.0

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|++++.||+|+||.||+|.          +..++..||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   73 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGL----------NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH   73 (317)
T ss_dssp             ---------------CEEEEEE----------CSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC
T ss_pred             ccceeEeeEECCCCCEEEEEEE----------ECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE
Confidence            3589999999999999999965          44567889999997543 234467889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNE----DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      +++..++||||++ |+|.+++...    ....+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+
T Consensus        74 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~  150 (317)
T 2pmi_A           74 TENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLG  150 (317)
T ss_dssp             CTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEEC
T ss_pred             ECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEEC
Confidence            9999999999997 5999888532    22468999999999999999999999  899999999999999999999999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----------
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----------  351 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----------  351 (451)
                      |||++......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........           
T Consensus       151 Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  228 (317)
T 2pmi_A          151 DFGLARAFGIP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP  228 (317)
T ss_dssp             CCSSCEETTSC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             cCccceecCCC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999864321  122335678999999999976 4689999999999999999999999965432100           


Q ss_pred             --CCccccc-----c-----chhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 --GNWAKPY-----L-----SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 --~~~~~~~-----~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                        ..|....     .     .....+.+.+.    .......+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQ----PHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHG----GGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ChhHhhhhhhhhhcccccccccchhHHHhhc----ccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence              0000000     0     00000001111    11112345789999999999999999999999874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-44  Score=371.89  Aligned_cols=261  Identities=26%  Similarity=0.363  Sum_probs=194.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC--CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|++++.||+|+||+||+|.          +..++..||||++...  .....+.+.+|+.+|+.++||||+++++++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~----------~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  130 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAY----------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF  130 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEE----------ETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             cCCeEEEEEeecCCCeEEEEEE----------ECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4689999999999999999965          4455788999999754  222345678999999999999999999999


Q ss_pred             ecC------CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          207 CDD------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       207 ~~~------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      ...      ...||||||+++ +|.+.+.    ..+++..+..++.||+.||.|||+  +||+||||||+||||+.++.+
T Consensus       131 ~~~~~~~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll~~~~~~  203 (464)
T 3ttj_A          131 TPQKTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL  203 (464)
T ss_dssp             CSCCSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCE
T ss_pred             ccCCccccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEEeCCCCE
Confidence            654      457999999976 5767663    348999999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--------C
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--------G  352 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--------~  352 (451)
                      ||+|||+|+...   ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+......        .
T Consensus       204 kl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg  280 (464)
T 3ttj_A          204 KILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG  280 (464)
T ss_dssp             EECCCCCC--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEEEEEeeeecC---CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999998533   22234557899999999999999999999999999999999999999975432100        0


Q ss_pred             Cccccccch-hhhh---------------hHHhhhhhcCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          353 NWAKPYLSN-KLAL---------------HQIIDEKLGRNI---QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       353 ~~~~~~~~~-~~~~---------------~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .-...+... ....               ...+...+....   ....+.++.+|+.+||..||++|||+.|+|++
T Consensus       281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000 0000               000000000000   11126789999999999999999999999975

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.9e-45  Score=356.19  Aligned_cols=280  Identities=25%  Similarity=0.410  Sum_probs=218.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|++++.||+|+||.||+|.+..      .+..++..||||++........+.+.+|+.+++.++||||+++++++...
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDP------LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECT------TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             HHceeeeeeccCCCeEEEEEEecc------ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            478999999999999999987542      24556889999999876555567889999999999999999999998764


Q ss_pred             C--eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          210 Q--HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       210 ~--~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      .  ..++||||+++++|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEEEecCcc
Confidence            4  789999999999999999654 3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC--Cccccccchhhh
Q 013028          288 AKFGPLGDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG--NWAKPYLSNKLA  364 (451)
Q Consensus       288 a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~  364 (451)
                      +......... .......++..|+|||++.+..++.++|||||||++|+|++|..|+.........  ............
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            9864432211 1122345677899999998888999999999999999999999887643211000  000000000011


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcC
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG  418 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  418 (451)
                      +...+........+...+.++.+|+.+||..||.+|||+.++++.|+.++..+.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            222233322334455667889999999999999999999999999999988753

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.7e-45  Score=356.74  Aligned_cols=268  Identities=26%  Similarity=0.376  Sum_probs=208.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|.+.+.||+|+||.||+|.+...     .+..++..||||.+..... .....+.+|+.+++.++||||+++++++.
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGM-----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC-------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCC-----CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            35899999999999999999875431     1345678899999974422 23456889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC---CCc
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDD-----TELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD---DFN  279 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~---~~~  279 (451)
                      +....++||||+++++|.+++.....     ..+++..++.++.||+.||.|||+  +||+||||||+|||++.   +..
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCCCcce
Confidence            99999999999999999999965432     458999999999999999999999  89999999999999984   446


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  358 (451)
                      ++|+|||++................||..|+|||++.+..++.++|||||||++|+|++ |..||.....          
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----------  251 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----------  251 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH----------
Confidence            99999999974322222222334567889999999988999999999999999999998 8888754321          


Q ss_pred             cchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                          ..+...+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       252 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          252 ----QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             ----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             ----HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence                1111222222223344556788999999999999999999999999999987644

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.4e-45  Score=360.38  Aligned_cols=267  Identities=27%  Similarity=0.397  Sum_probs=212.6

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ..++|++.+.||+|+||.||+|.+...     ....++..||||++..... .....+.+|+.+++.++||||+++++++
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGV-----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEE-----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCc-----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            356899999999999999999876421     1223457799999975432 2234688999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED--------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF  278 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~  278 (451)
                      .++...++||||+++|+|.+++....        ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTC
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEcCCC
Confidence            99999999999999999999985421        2467899999999999999999999  8999999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCcccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  357 (451)
                      .+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....         
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---------  246 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---------  246 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---------
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---------
Confidence            999999999975332222222234456889999999988899999999999999999999 7888754321         


Q ss_pred             ccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                           ......+........+...+..+.+|+.+||..||.+|||+.++++.|+.+..
T Consensus       247 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          247 -----EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -----HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                 11111111111223445567889999999999999999999999999987643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2e-44  Score=352.54  Aligned_cols=249  Identities=26%  Similarity=0.360  Sum_probs=205.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc------CHHHHHHHHHHHHhcCCCceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ------GQDEWENELRFLSRLNHPNVVKL  202 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~nIv~~  202 (451)
                      .++|++.+.||+|+||.||+|..          ..++..||||++......      ..+.+.+|+.+++.++||||+++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   80 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCRE----------KSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL   80 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hccEEEeeEeeecCCEEEEEEEE----------CCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceE
Confidence            45899999999999999999764          445788999999754322      35778999999999999999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC----
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF----  278 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~----  278 (451)
                      ++++.+....++||||+++++|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++    
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~~  156 (321)
T 2a2a_A           81 HDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIP  156 (321)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSC
T ss_pred             EEEEecCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCcC
Confidence            9999999999999999999999999954  4578999999999999999999999  8999999999999999887    


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                      .++|+|||++......   .......||+.|+|||++.+..++.++|||||||++|+|++|..||......         
T Consensus       157 ~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------  224 (321)
T 2a2a_A          157 HIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---------  224 (321)
T ss_dssp             CEEECCCTTCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---------
T ss_pred             CEEEccCccceecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---------
Confidence            7999999999864322   2234567999999999998899999999999999999999999998643211         


Q ss_pred             cchhhhhhHHhhhhhcCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          359 LSNKLALHQIIDEKLGRNIQ----MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                          ..+..+...  ....+    ...+..+.+|+.+||..||.+|||+.|+++.
T Consensus       225 ----~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          225 ----ETLANITSV--SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             ----HHHHHHHTT--CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ----HHHHHHHhc--ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                111111111  11111    1235779999999999999999999999874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.7e-44  Score=345.05  Aligned_cols=249  Identities=23%  Similarity=0.344  Sum_probs=206.6

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ..++|++.+.||+|+||.||+|...          .++..||+|.+........+.+.+|+++++.++||||+++++++.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQK----------GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE   76 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET----------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeC----------CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3468999999999999999997643          456789999998766667788999999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee---CCCCcEEEee
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISD  284 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll---~~~~~~kl~D  284 (451)
                      ++...++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  +||+||||||+|||+   +.++.++|+|
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~D  152 (277)
T 3f3z_A           77 DNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLID  152 (277)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCeEEEEEeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEe
Confidence            99999999999999999998865  3568999999999999999999999  899999999999999   7888999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ||++.....   ........||+.|+|||++.+ .++.++||||||+++|+|++|..||......             ..
T Consensus       153 fg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------------~~  215 (277)
T 3f3z_A          153 FGLAARFKP---GKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-------------EV  215 (277)
T ss_dssp             CTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HH
T ss_pred             cccceeccC---ccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH-------------HH
Confidence            999986432   223345679999999999854 5999999999999999999999998643221             11


Q ss_pred             hhHHhhhhhcCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          365 LHQIIDEKLGRNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...+...  ....+.    ..++.+.+|+.+||+.||.+|||+.++++.
T Consensus       216 ~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          216 MLKIREG--TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHHHhC--CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111111  111222    236789999999999999999999999974

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.7e-45  Score=359.48  Aligned_cols=262  Identities=25%  Similarity=0.288  Sum_probs=204.0

Q ss_pred             HHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC-----CCcCHHHHHHHHHHHHhcCCC
Q 013028          123 GLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-----GSQGQDEWENELRFLSRLNHP  197 (451)
Q Consensus       123 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~  197 (451)
                      +.+..+.++|++.+.||+|+||+||+|..          ..++..||+|++...     .....+.+.+|+.+++.++||
T Consensus        19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp   88 (345)
T 3hko_A           19 GSLLELQKKYHLKGAIGQGSYGVVRVAIE----------NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP   88 (345)
T ss_dssp             BCHHHHHHHEEEEEEEEECSSCEEEEEEE----------TTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCT
T ss_pred             chhhhhhhheeecceeeecCCeEEEEEEE----------CCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCC
Confidence            34566778999999999999999999764          445778999998643     234456789999999999999


Q ss_pred             ceeeccceeecCCeeEEEEeccCCCChhhhhccCC--------------------------------------CCCCCHH
Q 013028          198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED--------------------------------------DTELNWE  239 (451)
Q Consensus       198 nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------------------------------~~~l~~~  239 (451)
                      ||+++++++.+....++||||++||+|.+++....                                      ...+++.
T Consensus        89 niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (345)
T 3hko_A           89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREK  168 (345)
T ss_dssp             TBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHH
T ss_pred             CcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHH
Confidence            99999999999999999999999999999884210                                      1223577


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC--cEEEeecCCcccCCCCCC--cccccccCCCCcccccccc
Q 013028          240 RRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF--NAKISDFGLAKFGPLGDK--SHISTRVLGTRGYFAPEYI  315 (451)
Q Consensus       240 ~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l  315 (451)
                      .+..++.||+.||.|||+  +||+||||||+|||++.++  .+||+|||++........  ........||+.|+|||++
T Consensus       169 ~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  246 (345)
T 3hko_A          169 LISNIMRQIFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL  246 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhh
Confidence            788999999999999999  8999999999999998776  899999999975322111  1123456799999999999


Q ss_pred             cc--CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCC--CHHHHHHHHHHHHH
Q 013028          316 AT--GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNI--QMEEAQEFAEIILR  391 (451)
Q Consensus       316 ~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~  391 (451)
                      .+  ..++.++|||||||++|+|++|..||.....             ......+.........  ....+..+.+|+.+
T Consensus       247 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  313 (345)
T 3hko_A          247 NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND-------------ADTISQVLNKKLCFENPNYNVLSPLARDLLSN  313 (345)
T ss_dssp             TCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHH
T ss_pred             ccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh-------------HHHHHHHHhcccccCCcccccCCHHHHHHHHH
Confidence            65  6789999999999999999999999864322             1112222222211111  11246789999999


Q ss_pred             ccccCCCCCCCHHHHHHH
Q 013028          392 CLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       392 cl~~dP~~RPt~~evl~~  409 (451)
                      ||..||.+|||+.++++.
T Consensus       314 ~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHS
T ss_pred             HcCCChhHCCCHHHHhcC
Confidence            999999999999999874

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.5e-45  Score=355.17  Aligned_cols=247  Identities=23%  Similarity=0.276  Sum_probs=194.2

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCH--HHHHHHHHHHHhc-CCCceeeccc
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ--DEWENELRFLSRL-NHPNVVKLMG  204 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~il~~l-~h~nIv~~~~  204 (451)
                      ..++|++.++||+|+||+||+|.+          ..++..||||++........  ..+..|+..+..+ +|+||+++++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~  124 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRS----------KEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ  124 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEE----------TTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEE----------CCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEE
Confidence            346899999999999999999764          34578899999865433322  2344566665555 7999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      +|.++...++||||+ +++|.+++... ...+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus       125 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~D  200 (311)
T 3p1a_A          125 AWEEGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGD  200 (311)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECC
T ss_pred             EEEeCCEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEcc
Confidence            999999999999999 67999888654 3569999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ||++.....   ........||+.|+|||++.+ .++.++|||||||++|||++|..++.....                
T Consensus       201 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------------  260 (311)
T 3p1a_A          201 FGLLVELGT---AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------------  260 (311)
T ss_dssp             CTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------------
T ss_pred             ceeeeeccc---CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------------
Confidence            999986432   222345579999999999865 799999999999999999999776643211                


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      +..+.........+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          261 WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            11111111111112234578999999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.7e-44  Score=344.48  Aligned_cols=255  Identities=26%  Similarity=0.360  Sum_probs=206.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|++.+.||+|+||.||+|..          ..++..||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR   75 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEE----------TTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEE----------CCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE
Confidence            35899999999999999999764          3457789999997443 233567889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++...++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  +||+|+||||+||+++.++.++|+|||+
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~  151 (276)
T 2yex_A           76 EGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGL  151 (276)
T ss_dssp             ETTEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCEEEEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeCCC
Confidence            99999999999999999999854  4569999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +................||..|+|||++.+..+ +.++||||||+++|+|++|..||.......            ....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------------~~~~  219 (276)
T 2yex_A          152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------QEYS  219 (276)
T ss_dssp             CEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS------------HHHH
T ss_pred             ccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH------------HHHH
Confidence            975432222223345679999999999977665 789999999999999999999987543210            0111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...............+..+.+|+.+||..||.+|||+.|+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          220 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence            1111111111123456789999999999999999999999863

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=347.05  Aligned_cols=266  Identities=25%  Similarity=0.387  Sum_probs=214.3

Q ss_pred             cCCCcCC-cccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKN-LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|.+.+ .||+|+||.||+|.+..        ...+..||||++..... ...+.+.+|+++++.++||||+++++++ 
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~--------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-   79 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRM--------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-   79 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             HHhhhhhccccccCceeEEEeEecc--------CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence            4666666 99999999999987542        23467899999976432 2346688999999999999999999999 


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ..+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+  .||+||||||+|||++.++.++|+|||+
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~  156 (287)
T 1u59_A           80 QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGL  156 (287)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             cCCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECcccc
Confidence            455689999999999999998543 4569999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhh
Q 013028          288 AKFGPLGDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       288 a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      +......... .......+|..|+|||++.+..++.++|||||||++|+|++ |..||......              .+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------------~~  222 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------------EV  222 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------------HH
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------------HH
Confidence            9864322211 11223456889999999988889999999999999999998 99998643221              11


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCc
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCY  421 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~  421 (451)
                      ...+........+...+..+.+|+.+||..||.+||++.++++.|+.+..+.....
T Consensus       223 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  278 (287)
T 1u59_A          223 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  278 (287)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence            12222222334455667899999999999999999999999999999988876643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=8.4e-45  Score=360.65  Aligned_cols=203  Identities=26%  Similarity=0.335  Sum_probs=176.5

Q ss_pred             HHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-----CCce
Q 013028          125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-----HPNV  199 (451)
Q Consensus       125 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----h~nI  199 (451)
                      ...+.++|.+.++||+|+||+||+|.+          ..++..||||++... ......+..|+.+++.+.     ||||
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQH----------IDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEE----------CCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            334467999999999999999999764          345778999999632 233456778999999986     9999


Q ss_pred             eeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC---
Q 013028          200 VKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD---  276 (451)
Q Consensus       200 v~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~---  276 (451)
                      +++++++...+..++||||+ +++|.+++.......+++..+..++.||+.||.|||+  +||+||||||+|||++.   
T Consensus        99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A           99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCTTC
T ss_pred             ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccEEEccccc
Confidence            99999999999999999999 8999999987666679999999999999999999999  89999999999999975   


Q ss_pred             ----------------------CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHH
Q 013028          277 ----------------------DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLL  334 (451)
Q Consensus       277 ----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~  334 (451)
                                            ++.+||+|||++.....     ......||+.|+|||++.+..++.++|||||||++|
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  250 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence                                  78999999999985332     223567899999999999999999999999999999


Q ss_pred             HHHhCCCccccc
Q 013028          335 EILSGKTAAMRR  346 (451)
Q Consensus       335 elltg~~pf~~~  346 (451)
                      +|++|..||...
T Consensus       251 ell~g~~pf~~~  262 (360)
T 3llt_A          251 ELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHSSCSCCCS
T ss_pred             HHHHCCCCCCCC
Confidence            999999999653

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.4e-45  Score=358.72  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=202.7

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      ..++|++.+.||+|+||.||+|..          ..++..||||++.+....    ..+|++++.++ +||||+++++++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~   85 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIH----------KATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVY   85 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEE----------CCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEE
Confidence            346899999999999999999764          445788999999765433    34688888888 699999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC----CcEEE
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD----FNAKI  282 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~----~~~kl  282 (451)
                      .++...|+||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||+.++    +.+||
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           86 DDGKYVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEE
Confidence            999999999999999999999865  4579999999999999999999999  899999999999998533    35999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchh
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      +|||++......  .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......          ...
T Consensus       162 ~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----------~~~  229 (342)
T 2qr7_A          162 CDFGFAKQLRAE--NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD----------TPE  229 (342)
T ss_dssp             CCCTTCEECBCT--TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS----------CHH
T ss_pred             EECCCcccCcCC--CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC----------CHH
Confidence            999999854322  22334568999999999998888999999999999999999999999743211          001


Q ss_pred             hhhhHHhhhhh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          363 LALHQIIDEKL--GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       363 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      ..+..+.....  ........+.++.+|+.+||..||.+|||+.+++++--
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  280 (342)
T 2qr7_A          230 EILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW  280 (342)
T ss_dssp             HHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             HHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence            11111111111  11122345788999999999999999999999998643

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.3e-44  Score=349.99  Aligned_cols=267  Identities=24%  Similarity=0.392  Sum_probs=202.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc---CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ---GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .+|++.+.||+|+||.||+|...          .++..||||++......   ....+.+|+.+++.++||||+++++++
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~  101 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACL----------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF  101 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEET----------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEc----------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            47999999999999999997643          45778999999753322   245678999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      .+.+..++||||+++++|.+++..  .....+++..++.++.||+.||.|||+  +||+|+||||+|||++.++.++|+|
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~D  179 (310)
T 2wqm_A          102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGD  179 (310)
T ss_dssp             EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECC
T ss_pred             EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEe
Confidence            999999999999999999998853  234668999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ||++......  ........|+..|+|||++.+..++.++||||||+++|+|++|..||......            ...
T Consensus       180 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------------~~~  245 (310)
T 2wqm_A          180 LGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------------LYS  245 (310)
T ss_dssp             C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------------HHH
T ss_pred             ccceeeecCC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------------HHH
Confidence            9999753321  12233457899999999998899999999999999999999999998643211            001


Q ss_pred             hhHHh-hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCcc
Q 013028          365 LHQII-DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ  422 (451)
Q Consensus       365 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~  422 (451)
                      +...+ ............+.++.+|+.+||..||.+|||+.+|++.|++++....++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~  304 (310)
T 2wqm_A          246 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE  304 (310)
T ss_dssp             HHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred             HHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence            11111 11111111234567899999999999999999999999999999998877543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-44  Score=371.26  Aligned_cols=248  Identities=27%  Similarity=0.383  Sum_probs=206.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|.+++.||+|+||.||+|.+          ..++..||||++....   ......+.+|+.+|+.++||||+++++++
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~----------~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~   85 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKH----------ELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI   85 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEE----------TTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEE----------CCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4899999999999999999764          4457889999997432   23456788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+....++||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DFG  161 (476)
T 2y94_A           86 STPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFG  161 (476)
T ss_dssp             ECSSEEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEecc
Confidence            999999999999999999999954  4679999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      ++.....   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......             ...
T Consensus       162 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------------~~~  225 (476)
T 2y94_A          162 LSNMMSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-------------TLF  225 (476)
T ss_dssp             SCEECCT---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-------------HHH
T ss_pred             chhhccc---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-------------HHH
Confidence            9986432   223345689999999999987765 78999999999999999999998643211             111


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..+....  ...+...+.++.+|+.+||..||.+|||+.|++++
T Consensus       226 ~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          226 KKICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             HHHHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            1222211  12334456789999999999999999999999984

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.8e-44  Score=346.42  Aligned_cols=263  Identities=27%  Similarity=0.418  Sum_probs=210.9

Q ss_pred             cCCCcCC-cccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--HHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKN-LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .+|.+.+ .||+|+||+||+|.+.        ....+..||||++.......  .+.+.+|+.+++.++||||+++++++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~--------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQ--------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEE--------CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhhhccCccccccCeeeEeeeec--------CCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            4788888 9999999999998643        23446789999997543322  46788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                       ..+..++||||+++++|.+++..  ...+++..++.++.||+.||.|||+  .||+||||||+|||++.++.++|+|||
T Consensus        88 -~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           88 -EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             -CCCCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEccCC
Confidence             56678999999999999999965  3569999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhh
Q 013028          287 LAKFGPLGDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       287 la~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ++......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.....              ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------------~~  228 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------------SE  228 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------------HH
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------------HH
Confidence            99864432221 11223346788999999988889999999999999999999 9998864321              11


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      +...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+..+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          229 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence            2222333323344556678899999999999999999999999999999776543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.5e-44  Score=344.87  Aligned_cols=273  Identities=22%  Similarity=0.263  Sum_probs=211.7

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeecccee-
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYC-  206 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-  206 (451)
                      ..++|++.+.||+|+||+||+|..          ..++..||||++.....  ...+.+|+.+++.++|++++..+..+ 
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTD----------IAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG   74 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEE----------TTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEE----------cCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeec
Confidence            356899999999999999999764          34577899998764322  23478899999999988877766655 


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee---CCCCcEEEe
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKIS  283 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll---~~~~~~kl~  283 (451)
                      .++...++||||+ +++|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||+   +.++.+||+
T Consensus        75 ~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL~  150 (296)
T 4hgt_A           75 AEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred             CCCCceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEEe
Confidence            6677889999999 99999998643 3569999999999999999999999  899999999999999   788999999


Q ss_pred             ecCCcccCCCCCCc-----ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          284 DFGLAKFGPLGDKS-----HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       284 DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                      |||++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||..........     
T Consensus       151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----  225 (296)
T 4hgt_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-----  225 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-----
T ss_pred             cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh-----
Confidence            99999864332211     12235679999999999999999999999999999999999999997543321110     


Q ss_pred             cchhhhhhHHhhhhhcCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCcccccc
Q 013028          359 LSNKLALHQIIDEKLGRN---IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTSLR  426 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~  426 (451)
                           ....+........   .....++++.+|+.+||+.||.+|||+.++++.|+.+....+.......+
T Consensus       226 -----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~d  291 (296)
T 4hgt_A          226 -----KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD  291 (296)
T ss_dssp             -----HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCG
T ss_pred             -----hhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccc
Confidence                 1111111111111   11223578999999999999999999999999999999998877665544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-44  Score=377.66  Aligned_cols=255  Identities=26%  Similarity=0.417  Sum_probs=211.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .++|.+.+.||+|+||.||+|..          ..++..||||++.+.   .......+.+|+.+|+.++||||++++++
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~----------~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~  252 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQV----------RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA  252 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEE----------CCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence            46799999999999999999764          445788999999643   23345667899999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.+.+..||||||++||+|.+++.......+++..+..++.||+.||.|||+  +||+||||||+||||+.++.+||+||
T Consensus       253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~DF  330 (576)
T 2acx_A          253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDL  330 (576)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEec
Confidence            9999999999999999999999976655669999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |++......   ......+||+.|+|||++.+..|+.++|||||||++|||++|..||........          ...+
T Consensus       331 Gla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----------~~~i  397 (576)
T 2acx_A          331 GLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----------REEV  397 (576)
T ss_dssp             TTCEECCTT---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC----------HHHH
T ss_pred             ccceecccC---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh----------HHHH
Confidence            999864322   223456899999999999988999999999999999999999999975432100          1111


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      ...+. .....++...+.++.+||.+||..||.+||     ++.||+++
T Consensus       398 ~~~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          398 ERLVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             HHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             HHHhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            11111 112334455678999999999999999999     78888864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=355.05  Aligned_cols=264  Identities=23%  Similarity=0.359  Sum_probs=207.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee-
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC-  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-  207 (451)
                      .++|++.+.||+|+||.||++..          ..++..||||++........+.+.+|+.+++.++||||+++++++. 
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEG----------LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLR   97 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEE----------TTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEe----------cCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence            35899999999999999999754          4457889999987655555677889999999999999999999987 


Q ss_pred             ---cCCeeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          208 ---DDQHRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       208 ---~~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                         .....++||||+++|+|.+++...  ....+++..++.++.||+.||.|||+  +||+||||||+|||++.++.++|
T Consensus        98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl  175 (317)
T 2buj_A           98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVL  175 (317)
T ss_dssp             EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEE
T ss_pred             ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEE
Confidence               345789999999999999988642  34679999999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCCcc-------cccccCCCCccccccccccCC---CCcchhhHHHHHHHHHHHhCCCccccccCCCCC
Q 013028          283 SDFGLAKFGPLGDKSH-------ISTRVLGTRGYFAPEYIATGH---LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG  352 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~---~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  352 (451)
                      +|||++..........       ......||..|+|||++.+..   ++.++|||||||++|+|++|..||........ 
T Consensus       176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-  254 (317)
T 2buj_A          176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-  254 (317)
T ss_dssp             CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-
T ss_pred             EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-
Confidence            9999987532111100       012345799999999986543   68999999999999999999999864322100 


Q ss_pred             CccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          353 NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                                 .....+............+..+.+|+.+||+.||.+|||+.++++.|+.++..
T Consensus       255 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          255 -----------SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             -----------CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             -----------hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence                       11111112222222344567899999999999999999999999999988543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=361.95  Aligned_cols=246  Identities=26%  Similarity=0.398  Sum_probs=197.6

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCCeeEE
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  214 (451)
                      .+.||+|+||.||+|..          ..++..||+|++........+.+.+|+.+|+.++||||+++++++.+.+..+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~----------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEE----------TATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             EEECC-----CEEEEEE----------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEecCcCEEEEEEEE----------cCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            57899999999999764          34577899999986555556778999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee--CCCCcEEEeecCCcccCC
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL--DDDFNAKISDFGLAKFGP  292 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll--~~~~~~kl~DFGla~~~~  292 (451)
                      ||||+++++|.+++... ...+++..++.++.||+.||.|||+  .||+||||||+|||+  +.++.+||+|||+++...
T Consensus       164 v~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             EEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            99999999999988643 3468999999999999999999999  899999999999999  567899999999998643


Q ss_pred             CCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhh
Q 013028          293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEK  372 (451)
Q Consensus       293 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (451)
                      ..   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....             ...+..++...
T Consensus       241 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------------~~~~~~i~~~~  304 (373)
T 2x4f_A          241 PR---EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-------------AETLNNILACR  304 (373)
T ss_dssp             TT---CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-------------HHHHHHHHHTC
T ss_pred             Cc---cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------------HHHHHHHHhcc
Confidence            22   223345799999999999888999999999999999999999999865322             11122222221


Q ss_pred             hcC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          373 LGR--NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       373 ~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...  ......+.++.+|+.+||..||.+|||+.|+++.
T Consensus       305 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          305 WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             CCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111  1112346789999999999999999999999983

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=8.8e-45  Score=353.52  Aligned_cols=261  Identities=25%  Similarity=0.373  Sum_probs=197.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .++|++.+.||+|+||.||+|.+          ..++..||||++.......   ...+.+|+.+++.++||||++++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   80 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARD----------LRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT   80 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEE----------CCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEe
Confidence            35899999999999999999654          4457889999997654333   2467899999999999999999999


Q ss_pred             eecCCe----eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEE
Q 013028          206 CCDDQH----RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       206 ~~~~~~----~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~k  281 (451)
                      +.....    .|+||||++|++|.+++..  ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~k  156 (311)
T 3ork_A           81 GEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVK  156 (311)
T ss_dssp             EEEEETTEEEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCEE
T ss_pred             eeccCCCCcccEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCEE
Confidence            876543    4999999999999999865  3569999999999999999999999  8999999999999999999999


Q ss_pred             EeecCCcccCCCCCC-cccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccc
Q 013028          282 ISDFGLAKFGPLGDK-SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS  360 (451)
Q Consensus       282 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  360 (451)
                      |+|||++........ ........||+.|+|||++.+..++.++|||||||++|+|++|..||......           
T Consensus       157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----------  225 (311)
T 3ork_A          157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----------  225 (311)
T ss_dssp             ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------
T ss_pred             EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----------
Confidence            999999975432211 12233467999999999999999999999999999999999999998643221           


Q ss_pred             hhhhhhHHhhhhhcC--CCCHHHHHHHHHHHHHccccCCCCCCCHHH-HHHHHHHhHHh
Q 013028          361 NKLALHQIIDEKLGR--NIQMEEAQEFAEIILRCLNSDPKNRPTMSE-VVAALEQLQLN  416 (451)
Q Consensus       361 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-vl~~L~~~~~~  416 (451)
                        .............  ......+.++.+|+.+||+.||.+||++.+ +...|..+...
T Consensus       226 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          226 --SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             --HHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             --HHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence              0001111110000  001124678999999999999999996555 55566655443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2e-44  Score=362.42  Aligned_cols=252  Identities=26%  Similarity=0.387  Sum_probs=200.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcC--CCceeeccce
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLN--HPNVVKLMGY  205 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~--h~nIv~~~~~  205 (451)
                      .+|.+++.||+|+||+||+|...           .+..||||++.....  ...+.+.+|+.+|+.++  ||||++++++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~-----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~  124 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE-----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY  124 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcC-----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence            36999999999999999997532           267899999975432  23466889999999997  5999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +..++..||||| +.+++|.+++...  ..+++..+..++.||+.||.|||+  +||+||||||+|||++ ++.+||+||
T Consensus       125 ~~~~~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~-~~~~kl~DF  198 (390)
T 2zmd_A          125 EITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDF  198 (390)
T ss_dssp             EECSSEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCCGGGEEES-SSCEEECCC
T ss_pred             EecCCEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEEE-CCeEEEEec
Confidence            999999999999 5588999999653  478999999999999999999999  8999999999999996 579999999


Q ss_pred             CCcccCCCCCCcccccccCCCCcccccccccc-----------CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-----------GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW  354 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  354 (451)
                      |+++..............+||+.|+|||++.+           ..++.++|||||||++|+|++|..||.....      
T Consensus       199 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------  272 (390)
T 2zmd_A          199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------  272 (390)
T ss_dssp             SSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC------
T ss_pred             CccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH------
Confidence            99986443322223445689999999999864           4689999999999999999999999864321      


Q ss_pred             cccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                            ....+..+++.......+...+..+.+|+.+||..||.+|||+.|+++.-
T Consensus       273 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          273 ------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             ------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ------HHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence                  11223344444433344444567899999999999999999999998753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.3e-45  Score=364.80  Aligned_cols=247  Identities=25%  Similarity=0.334  Sum_probs=195.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHH-HHhcCCCceeeccce
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRF-LSRLNHPNVVKLMGY  205 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~i-l~~l~h~nIv~~~~~  205 (451)
                      ++|++++.||+|+||.||+|..          ..++..||||++.+...   .....+..|..+ ++.++||||++++++
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~----------~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~  107 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARH----------KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS  107 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEE----------TTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEE----------cCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence            4899999999999999999654          45578899999975432   223445667776 567899999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      |.+.+..|+||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.+|.+||+||
T Consensus       108 ~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~DF  183 (373)
T 2r5t_A          108 FQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDF  183 (373)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEeeC
Confidence            9999999999999999999999865  3568999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |+++....  ........+||+.|+|||++.+..++.++|||||||++|||++|..||.....             ....
T Consensus       184 G~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------------~~~~  248 (373)
T 2r5t_A          184 GLCKENIE--HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------------AEMY  248 (373)
T ss_dssp             CBCGGGBC--CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-------------HHHH
T ss_pred             cccccccc--CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------------HHHH
Confidence            99975221  12234467899999999999999999999999999999999999999864321             1111


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV  407 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  407 (451)
                      ..++...  ...+...+..+.+|+.+||+.||.+||++.+.+
T Consensus       249 ~~i~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          249 DNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             HHHHHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             HHHHhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            2222221  223445678899999999999999999985433

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-44  Score=346.49  Aligned_cols=250  Identities=25%  Similarity=0.374  Sum_probs=198.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|.+.++||+|+||.||+|..          ..++..||+|++.... ....+.+.+|+++|+.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   90 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEE----------RSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE   90 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEE----------TTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEE----------ccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee
Confidence            35899999999999999999654          4457789999987543 345678899999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee---CCCCcEEE
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKI  282 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll---~~~~~~kl  282 (451)
                      +....++||||+++|+|.+++...  ....+++..+..++.||+.||.|||+  +||+||||||+|||+   +.++.+||
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl  168 (285)
T 3is5_A           91 DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKI  168 (285)
T ss_dssp             CSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred             cCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEE
Confidence            999999999999999999988542  23679999999999999999999999  899999999999999   45678999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchh
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      +|||++.....   ........||+.|+|||++ ...++.++|||||||++|+|++|..||......             
T Consensus       169 ~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~-~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-------------  231 (285)
T 3is5_A          169 IDFGLAELFKS---DEHSTNAAGTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-------------  231 (285)
T ss_dssp             CCCCCCCC-------------CTTGGGCCHHHH-TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------
T ss_pred             EeeecceecCC---cccCcCcccccCcCChHHh-ccCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-------------
Confidence            99999975332   2223456799999999998 467899999999999999999999998643211             


Q ss_pred             hhhhHHhhhh-h-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          363 LALHQIIDEK-L-GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       363 ~~~~~~~~~~-~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                       ......... . ........++.+.+|+.+||+.||.+|||+.|+++
T Consensus       232 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          232 -EVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -HHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -HHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000111000 0 00011124578999999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-45  Score=369.38  Aligned_cols=256  Identities=21%  Similarity=0.264  Sum_probs=205.1

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeec
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKL  202 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~  202 (451)
                      ....++|++.+.||+|+||.||+|..          ..++..||||++.+..   ....+.+.+|..++..++||||+++
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~----------~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l  126 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKM----------KQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL  126 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEE----------TTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEE----------CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            34457899999999999999999654          4557889999996421   1122347889999999999999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      +++|.+.+..||||||++||+|.+++... ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||
T Consensus       127 ~~~~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILld~~g~vkL  203 (412)
T 2vd5_A          127 HFAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIRL  203 (412)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeeecCCCCEEE
Confidence            99999999999999999999999999653 2469999999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCccccccccc-------cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcc
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA-------TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWA  355 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~  355 (451)
                      +|||++....... .......+||+.|+|||++.       +..|+.++|||||||++|||++|..||.....       
T Consensus       204 ~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------  275 (412)
T 2vd5_A          204 ADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-------  275 (412)
T ss_dssp             CCCTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-------
T ss_pred             eechhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-------
Confidence            9999998643221 12233568999999999996       35789999999999999999999999965322       


Q ss_pred             ccccchhhhhhHHhhhhhcCCC---CHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 013028          356 KPYLSNKLALHQIIDEKLGRNI---QMEEAQEFAEIILRCLNSDPKNR---PTMSEVVAA  409 (451)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~  409 (451)
                            ......++........   +...+.++.+||.+||. +|.+|   |++.|++++
T Consensus       276 ------~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          276 ------AETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             ------HHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             ------HHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence                  1111222221111112   23457889999999999 99998   589998764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-43  Score=347.57  Aligned_cols=272  Identities=24%  Similarity=0.359  Sum_probs=203.7

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc--CCCceeecc
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL--NHPNVVKLM  203 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~h~nIv~~~  203 (451)
                      ....++|++.++||+|+||.||+|.+.            +..||||++...   ....+..|.+++..+  +||||++++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~   97 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR------------GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFI   97 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET------------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC------------CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEE
Confidence            344569999999999999999998653            567999998632   234455666666654  899999999


Q ss_pred             ceeecC----CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC--------CceeCCCCCCc
Q 013028          204 GYCCDD----QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWR--------PVIHRDVKASN  271 (451)
Q Consensus       204 ~~~~~~----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~--------~iiHrDlkp~N  271 (451)
                      +++.+.    ...++||||+++|+|.+++..   ..+++..++.++.|++.||.|||+  .        ||+||||||+|
T Consensus        98 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~~~~ivH~Dikp~N  172 (337)
T 3mdy_A           98 AADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHT--EIFSTQGKPAIAHRDLKSKN  172 (337)
T ss_dssp             EEEEESCGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHS--CBCSTTCBCCEECSCCCGGG
T ss_pred             EEEccCCCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH--hhhhhccCCCEEecccchHH
Confidence            999877    788999999999999999954   368999999999999999999998  6        99999999999


Q ss_pred             eeeCCCCcEEEeecCCcccCCCCCCcc--cccccCCCCccccccccccCCCCcc------hhhHHHHHHHHHHHhCCCcc
Q 013028          272 VLLDDDFNAKISDFGLAKFGPLGDKSH--ISTRVLGTRGYFAPEYIATGHLTLK------TDVYSFGVVLLEILSGKTAA  343 (451)
Q Consensus       272 Ill~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~------~DiwSlGvil~elltg~~pf  343 (451)
                      ||++.++.+||+|||++..........  ......||+.|+|||++.+..++..      +|||||||++|||++|..|+
T Consensus       173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~  252 (337)
T 3mdy_A          173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG  252 (337)
T ss_dssp             EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence            999999999999999997543222111  1224579999999999977666654      99999999999999995554


Q ss_pred             ccccCCCCCCcccc--ccchhhhhhHHh-hhhhcCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          344 MRRTNGLAGNWAKP--YLSNKLALHQII-DEKLGRNIQ-----MEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       344 ~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                      ........ .|...  ...........+ ........+     ...+.++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       253 ~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          253 GIVEEYQL-PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             TBCCCCCC-TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccccccc-cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence            32211110 00000  000001111111 111222222     2567889999999999999999999999999999987


Q ss_pred             hcC
Q 013028          416 NMG  418 (451)
Q Consensus       416 ~~~  418 (451)
                      +..
T Consensus       332 ~~~  334 (337)
T 3mdy_A          332 SQD  334 (337)
T ss_dssp             TTT
T ss_pred             hcc
Confidence            654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=359.42  Aligned_cols=266  Identities=27%  Similarity=0.407  Sum_probs=201.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceee-c
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCC-D  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~  208 (451)
                      .|.+.+.||+|+||+||+|.+...       ......||||.+.... ....+.+.+|+.+++.++||||+++++++. .
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  162 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDN-------DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS  162 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEET-------TTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECC-------CCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence            577889999999999999876321       1223568999987532 233467889999999999999999999865 4


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+++|+|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus       163 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DFG~a  239 (373)
T 3c1x_A          163 EGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLA  239 (373)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CCCeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEeecccc
Confidence            56789999999999999998653 4568899999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCc--ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhh
Q 013028          289 KFGPLGDKS--HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       289 ~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      +........  .......+|..|+|||++.+..++.++|||||||++|||++ |.+||......              ..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--------------~~  305 (373)
T 3c1x_A          240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--------------DI  305 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--------------CH
T ss_pred             ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--------------HH
Confidence            854322111  11234467788999999999999999999999999999999 56665432211              01


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCC
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSC  420 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~  420 (451)
                      ...+........+...+..+.+++.+||..||.+|||+.++++.|+.+.......
T Consensus       306 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          306 TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence            1111122222334455678999999999999999999999999999998877654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=357.92  Aligned_cols=280  Identities=18%  Similarity=0.200  Sum_probs=213.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceee--------
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVK--------  201 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~--------  201 (451)
                      ++|.+.+.||+|+||.||+|.+..+...  .....+..||||++...     +.+.+|+++++.++||||++        
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~--~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTC--DSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccc--cccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            4899999999999999999887543110  01113678999998743     35788999999999999998        


Q ss_pred             -------ccceeec-CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcee
Q 013028          202 -------LMGYCCD-DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL  273 (451)
Q Consensus       202 -------~~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIl  273 (451)
                             +++++.. +...++||||+ +++|.+++.......+++..++.++.||+.||.|||+  +||+||||||+|||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIl  191 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE--NEYVHGNVTAENIF  191 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCGGGEE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEE
Confidence                   4566655 67889999999 9999999976545779999999999999999999999  89999999999999


Q ss_pred             eCCCC--cEEEeecCCcccCCCCCC-----cccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccc
Q 013028          274 LDDDF--NAKISDFGLAKFGPLGDK-----SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRR  346 (451)
Q Consensus       274 l~~~~--~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~  346 (451)
                      ++.++  .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  899999999975432111     11123457999999999998889999999999999999999999998764


Q ss_pred             cCCCCCCccccccchhhhhhHHhhhhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCc
Q 013028          347 TNGLAGNWAKPYLSNKLALHQIIDEKLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCY  421 (451)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~  421 (451)
                      ....         .........+........     ....+..+.+|+.+||..||.+|||+.++++.|+.+....+...
T Consensus       272 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~  342 (352)
T 2jii_A          272 LPNT---------EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP  342 (352)
T ss_dssp             TTCH---------HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred             CcCH---------HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence            3210         000000011111100000     01236889999999999999999999999999999999988776


Q ss_pred             ccccccc
Q 013028          422 QTSLRTS  428 (451)
Q Consensus       422 ~~~~~~~  428 (451)
                      ....+.+
T Consensus       343 ~~~~dw~  349 (352)
T 2jii_A          343 YDPIGLP  349 (352)
T ss_dssp             TSCCCCC
T ss_pred             CccccCc
Confidence            6655443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4e-44  Score=367.59  Aligned_cols=196  Identities=28%  Similarity=0.390  Sum_probs=153.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++++.||+|+||+||+|.+          ..++..||||++......  ..+.+.+|+.+|+.++||||+++++++.
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  122 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYD----------KLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI  122 (458)
T ss_dssp             TTEEECCC-------CEEEEEE----------CC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             CCeEEeeEeeecCCeEEEEEEE----------CCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence            5899999999999999999764          445788999999754322  2356889999999999999999999984


Q ss_pred             c-----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          208 D-----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       208 ~-----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      .     ...+|+||||+ +++|.+++..  ...+++..+..++.||+.||.|||+  +|||||||||+||||+.++.+||
T Consensus       123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl~~~~~~kl  197 (458)
T 3rp9_A          123 PKDVEKFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKV  197 (458)
T ss_dssp             CSCTTTCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEE
T ss_pred             cCCcccCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEECCCCCEee
Confidence            3     35789999998 5699998854  4679999999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCCc-------------------------ccccccCCCCcccccccc-ccCCCCcchhhHHHHHHHHHH
Q 013028          283 SDFGLAKFGPLGDKS-------------------------HISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEI  336 (451)
Q Consensus       283 ~DFGla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~~DiwSlGvil~el  336 (451)
                      +|||+|+........                         ......+||+.|+|||++ .+..|+.++|||||||++|||
T Consensus       198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el  277 (458)
T 3rp9_A          198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL  277 (458)
T ss_dssp             CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred             cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence            999999864322111                         123456889999999986 456799999999999999999


Q ss_pred             HhCC
Q 013028          337 LSGK  340 (451)
Q Consensus       337 ltg~  340 (451)
                      ++|.
T Consensus       278 ltg~  281 (458)
T 3rp9_A          278 LNMI  281 (458)
T ss_dssp             HTTS
T ss_pred             HHhc
Confidence            9943

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-44  Score=345.41  Aligned_cols=252  Identities=28%  Similarity=0.428  Sum_probs=202.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|++.+.||+|+||+||+|.+.            +..||||++...  ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~------------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR------------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE   86 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET------------TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             hhceEEeEEecCCCceEEEEEEc------------CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            58999999999999999998643            567999999643  3456789999999999999999999987554


Q ss_pred             -CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          210 -QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       210 -~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                       ...++||||+++++|.+++.......+++..++.++.|++.||.|||+  +||+||||||+|||++.++.++|+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeecccc
Confidence             578999999999999999965433448899999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      ......     .....++..|+|||++.+..++.++||||||+++|+|++ |..||......              ....
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------------~~~~  225 (278)
T 1byg_A          165 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------------DVVP  225 (278)
T ss_dssp             ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--------------GHHH
T ss_pred             cccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------------HHHH
Confidence            743211     223457889999999988899999999999999999998 99888643211              1112


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      .+........+...+..+.+++.+||+.||.+|||+.++++.|+.++..
T Consensus       226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          226 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            2222223344555678899999999999999999999999999999765

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=361.67  Aligned_cols=265  Identities=20%  Similarity=0.293  Sum_probs=212.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|.+.++||+|+||+||+|.+.          .++..||||++.... ....+.+.+|+++|+.++||||+++++++.
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   77 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHK----------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEE   77 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEET----------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEEC----------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeec
Confidence            358999999999999999997643          457789999997543 234567789999999999999999999998


Q ss_pred             cCC--eeEEEEeccCCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee----CCCCcE
Q 013028          208 DDQ--HRLLVYEYVTRGSLEDHLLNED-DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL----DDDFNA  280 (451)
Q Consensus       208 ~~~--~~~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll----~~~~~~  280 (451)
                      +..  ..++||||++||+|.+++.... ...+++..++.++.||+.||.|||+  +||+||||||+|||+    +.++.+
T Consensus        78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             CTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEE
T ss_pred             cCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeE
Confidence            755  7799999999999999986532 2349999999999999999999999  899999999999999    777889


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCcccccccccc--------CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT--------GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG  352 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  352 (451)
                      ||+|||+++....   ........||..|+|||++.+        ..++.++|||||||++|+|++|..||.........
T Consensus       156 kL~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~  232 (396)
T 4eut_A          156 KLTDFGAARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (396)
T ss_dssp             EECCGGGCEECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred             EEecCCCceEccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence            9999999986432   223345679999999999864        56788999999999999999999999753321110


Q ss_pred             CccccccchhhhhhHHhh-----------------------hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          353 NWAKPYLSNKLALHQIID-----------------------EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                               ...+..++.                       ...........+..+.+++.+||..||++||++.++++.
T Consensus       233 ---------~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          233 ---------KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             ---------HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             ---------HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence                     000001110                       001123446778899999999999999999999999999


Q ss_pred             HHHhHHhc
Q 013028          410 LEQLQLNM  417 (451)
Q Consensus       410 L~~~~~~~  417 (451)
                      |+.+....
T Consensus       304 l~~il~~~  311 (396)
T 4eut_A          304 TSDILHRM  311 (396)
T ss_dssp             HHHHHTCE
T ss_pred             HHHHhhce
Confidence            99986643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-44  Score=362.57  Aligned_cols=264  Identities=24%  Similarity=0.346  Sum_probs=191.1

Q ss_pred             HHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcC-CCceeecc
Q 013028          127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLN-HPNVVKLM  203 (451)
Q Consensus       127 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~-h~nIv~~~  203 (451)
                      ...++|++++.||+|+||.||+|.          +..++..||||++.....  .....+.+|+.+|+.+. ||||++++
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~----------~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~   75 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSI----------DRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL   75 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEE----------ETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEE----------ECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeee
Confidence            456799999999999999999975          445578899999864322  23355778999999998 99999999


Q ss_pred             ceeecCC--eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEE
Q 013028          204 GYCCDDQ--HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       204 ~~~~~~~--~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~k  281 (451)
                      +++...+  ..|+||||++ ++|.+++..   ..+++..+..++.||+.||.|||+  .||+||||||+|||++.++.+|
T Consensus        76 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~k  149 (388)
T 3oz6_A           76 NVLRADNDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVK  149 (388)
T ss_dssp             EEEECTTSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEE
T ss_pred             eEEecCCCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEE
Confidence            9997544  7899999997 589988864   468999999999999999999999  8999999999999999999999


Q ss_pred             EeecCCcccCCCC-------------------CCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCC
Q 013028          282 ISDFGLAKFGPLG-------------------DKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKT  341 (451)
Q Consensus       282 l~DFGla~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~  341 (451)
                      |+|||+|+.....                   .........+||+.|+|||++.+ ..++.++|||||||++|||++|.+
T Consensus       150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~  229 (388)
T 3oz6_A          150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP  229 (388)
T ss_dssp             ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence            9999999854221                   11122345689999999999976 679999999999999999999999


Q ss_pred             ccccccCCCC--------------------CCccccccchh---------------hhhhHHhhhhhcCCCCHHHHHHHH
Q 013028          342 AAMRRTNGLA--------------------GNWAKPYLSNK---------------LALHQIIDEKLGRNIQMEEAQEFA  386 (451)
Q Consensus       342 pf~~~~~~~~--------------------~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~  386 (451)
                      ||........                    ..+...+....               ..+.....   ........+.++.
T Consensus       230 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  306 (388)
T 3oz6_A          230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLL---KINPKADCNEEAL  306 (388)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHH---HHCTTCCCCHHHH
T ss_pred             CCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcc---cccccccCCHHHH
Confidence            9965432100                    00000000000               00000000   0000113357899


Q ss_pred             HHHHHccccCCCCCCCHHHHHHH
Q 013028          387 EIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       387 ~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +|+.+||..||.+|||+.|++++
T Consensus       307 dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          307 DLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHhhccCcccCCCHHHHhCC
Confidence            99999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.4e-44  Score=346.54  Aligned_cols=257  Identities=28%  Similarity=0.440  Sum_probs=202.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|++.+.||+|+||+||+|.+.            +..||||.+..  ....+.+.+|+++|+.++||||+++++++.+ 
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~------------~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-   72 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR------------AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN-   72 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET------------TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-
T ss_pred             hHeeeeeEeecCCCceEEEEEEC------------CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence            47899999999999999998653            45699999863  2345678899999999999999999999874 


Q ss_pred             CeeEEEEeccCCCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC-CCceeCCCCCCceeeCCCCc-EEEeecC
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDD-TELNWERRIKIALGAARGLEHLHTYW-RPVIHRDVKASNVLLDDDFN-AKISDFG  286 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~-~~iiHrDlkp~NIll~~~~~-~kl~DFG  286 (451)
                       ..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.. +||+||||||+|||++.++. +||+|||
T Consensus        73 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg  151 (307)
T 2eva_A           73 -PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG  151 (307)
T ss_dssp             -TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred             -CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence             47999999999999999965432 35788999999999999999999832 47999999999999988876 7999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++.....     ......||..|+|||++.+..++.++|||||||++|+|++|..||......            .....
T Consensus       152 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------~~~~~  214 (307)
T 2eva_A          152 TACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP------------AFRIM  214 (307)
T ss_dssp             C-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS------------HHHHH
T ss_pred             ccccccc-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc------------HHHHH
Confidence            9974321     123446899999999999889999999999999999999999998643211            00111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      ...............+..+.+|+.+||+.||.+|||+.++++.|+.+......
T Consensus       215 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          215 WAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             HHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             HHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            11111222233344567899999999999999999999999999999877654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.4e-44  Score=353.01  Aligned_cols=250  Identities=26%  Similarity=0.364  Sum_probs=180.1

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccceeecCCeeE
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYCCDDQHRL  213 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~  213 (451)
                      .+.||+|+||+||+|.+          ..++..||||++...   ....+.+|+.+++.+. ||||+++++++.++...|
T Consensus        16 ~~~lG~G~~g~V~~~~~----------~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~   82 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVH----------KKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF   82 (325)
T ss_dssp             SCCSEEETTEEEEEEEE----------TTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CCccccCCCeEEEEEEE----------CCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence            47899999999999764          445788999999643   3566789999999997 999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC---cEEEeecCCccc
Q 013028          214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF---NAKISDFGLAKF  290 (451)
Q Consensus       214 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~---~~kl~DFGla~~  290 (451)
                      +||||++||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++   .+||+|||++..
T Consensus        83 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           83 LVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             EEECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EEEEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            99999999999999965  4679999999999999999999999  8999999999999997665   899999999985


Q ss_pred             CCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhh
Q 013028          291 GPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID  370 (451)
Q Consensus       291 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (451)
                      ....  .......+||+.|+|||++.+..++.++|||||||++|+|++|..||..........      ........+..
T Consensus       159 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~~~~~~~~i~~  230 (325)
T 3kn6_A          159 KPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT------SAVEIMKKIKK  230 (325)
T ss_dssp             CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC------CHHHHHHHHTT
T ss_pred             cCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc------cHHHHHHHHHc
Confidence            4322  222345678999999999999999999999999999999999999997543321100      00011111111


Q ss_pred             hhhcCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          371 EKLGRN--IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       371 ~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ......  .....++++.+|+.+||..||.+|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            111000  012346889999999999999999999999854

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.4e-45  Score=372.92  Aligned_cols=250  Identities=26%  Similarity=0.353  Sum_probs=197.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|+++++||+|+||.||+|.          +..++..||||++...   .......+.+|+.+|+.++||||++++++|
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~  217 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVK----------EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF  217 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEE----------ETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEE----------EcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence            579999999999999999965          4456788999999753   233345577899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+.+..+|||||++||+|.+++..  ...+++..+..++.||+.||.|||+. +||+||||||+||||+.++.+||+|||
T Consensus       218 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlkp~NIll~~~~~~kl~DFG  294 (446)
T 4ejn_A          218 QTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFG  294 (446)
T ss_dssp             EETTEEEEEECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred             eeCCEEEEEEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhc-CCEEECCCCHHHEEECCCCCEEEccCC
Confidence            999999999999999999999865  35789999999999999999999962 589999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +|+....  ........+||+.|+|||++.+..++.++|||||||++|+|++|..||......             ....
T Consensus       295 ~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------------~~~~  359 (446)
T 4ejn_A          295 LCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------------KLFE  359 (446)
T ss_dssp             CCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HHHH
T ss_pred             CceeccC--CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------------HHHH
Confidence            9975321  222344578999999999999999999999999999999999999998643211             1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      .+...  ...++...++++.+||.+||..||.+||     ++.|++++
T Consensus       360 ~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          360 LILME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             HHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHhC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            11111  2234455678899999999999999999     99999873

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.9e-44  Score=345.33  Aligned_cols=249  Identities=29%  Similarity=0.453  Sum_probs=204.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .++|++.+.||+|+||+||+|.+          ..++..||||++....   ......+.+|+.+++.++||||++++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   77 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLARE----------KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY   77 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEE----------ccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhhe
Confidence            35899999999999999999764          3457789999986431   2334668899999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.+....++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Df  153 (279)
T 3fdn_A           78 FHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADF  153 (279)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSC
T ss_pred             EecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEec
Confidence            99999999999999999999998653  568999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |++.....    .......||..|+|||++.+..++.++||||||+++|+|++|..||......             ...
T Consensus       154 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------~~~  216 (279)
T 3fdn_A          154 GWSVHAPS----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------------ETY  216 (279)
T ss_dssp             CEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------------HHH
T ss_pred             cccccCCc----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-------------HHH
Confidence            99864321    2234567899999999999899999999999999999999999998643211             011


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ..+  .......+...+..+.+|+.+||+.||.+|||+.|+++.-
T Consensus       217 ~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          217 KRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             HHH--HHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             HHH--HhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            111  1122334455678899999999999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.3e-44  Score=377.48  Aligned_cols=267  Identities=24%  Similarity=0.379  Sum_probs=213.2

Q ss_pred             CCCcCC-cccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKN-LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++.+.+ +||+|+||.||+|.+..        ...+..||||++.... ....+.+.+|+++|+.++|||||++++++.+
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~--------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRM--------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEEC--------SSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             ceeEcCcEEecCCCcEEEEEEEec--------CCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            444444 79999999999997642        2335679999997643 3356789999999999999999999999976


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                       +..+|||||+++|+|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+||||+.++.+||+|||++
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGla  483 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLS  483 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence             5689999999999999998643 4569999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          289 KFGPLGDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       289 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +........ .......++..|+|||++.+..++.++|||||||++|||++ |..||......              .+.
T Consensus       484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------------~~~  549 (613)
T 2ozo_A          484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------------EVM  549 (613)
T ss_dssp             TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------------HHH
T ss_pred             ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------------HHH
Confidence            864322111 11122345678999999988999999999999999999998 99998653321              122


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCccc
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQT  423 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~  423 (451)
                      ..+........+...+.++.+||.+||..||.+||++.+|++.|+.+..........
T Consensus       550 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~  606 (613)
T 2ozo_A          550 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG  606 (613)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCC
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCC
Confidence            233333334455667889999999999999999999999999999998888775443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=356.54  Aligned_cols=244  Identities=23%  Similarity=0.338  Sum_probs=203.3

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--------CHHHHHHHHHHHHhcCCCce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--------GQDEWENELRFLSRLNHPNV  199 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~h~nI  199 (451)
                      ..++|++.+.||+|+||+||+|.          +..++..||||++......        ....+.+|+.+|+.++||||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~----------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I   91 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAV----------DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI   91 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEE----------ETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTB
T ss_pred             cccceEEEeEEEecCCEEEEEEE----------ECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCE
Confidence            35689999999999999999975          4455788999999754321        22346789999999999999


Q ss_pred             eeccceeecCCeeEEEEeccCCC-ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC
Q 013028          200 VKLMGYCCDDQHRLLVYEYVTRG-SLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF  278 (451)
Q Consensus       200 v~~~~~~~~~~~~~lV~E~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~  278 (451)
                      +++++++.+....++||||+.+| +|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++
T Consensus        92 v~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~  167 (335)
T 3dls_A           92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDF  167 (335)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTS
T ss_pred             eeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCCC
Confidence            99999999999999999999766 99998854  4569999999999999999999999  8999999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~  357 (451)
                      .+||+|||++.....   ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||......        
T Consensus       168 ~~kL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------  236 (335)
T 3dls_A          168 TIKLIDFGSAAYLER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------  236 (335)
T ss_dssp             CEEECCCTTCEECCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------
T ss_pred             cEEEeecccceECCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------
Confidence            999999999986432   223345679999999999988776 88999999999999999999998643211        


Q ss_pred             ccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                                 ....  ...+...+.++.+|+.+||..||.+|||+.++++.
T Consensus       237 -----------~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 -----------VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----------TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----------Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       1110  11222345779999999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1e-44  Score=378.92  Aligned_cols=261  Identities=25%  Similarity=0.427  Sum_probs=212.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.++||+|+||.||+|.+..           ...||||++.... ...+.+.+|+++|+.++|+||+++++++.+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  333 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE  333 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-----------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            4567888899999999999997653           3459999997543 446789999999999999999999999876


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                       ...+|||||+++|+|.+++.......+++..++.|+.||+.||.|||+  ++|+||||||+||||+.++.+||+|||++
T Consensus       334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a  410 (535)
T 2h8h_A          334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLA  410 (535)
T ss_dssp             -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred             -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence             678999999999999999965444568999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +..... .........++..|+|||++.+..++.++|||||||+||||++ |..||.....              ..+..
T Consensus       411 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------------~~~~~  475 (535)
T 2h8h_A          411 RLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------------REVLD  475 (535)
T ss_dssp             TTCCCH-HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------------HHHHH
T ss_pred             eecCCC-ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------------HHHHH
Confidence            853311 1111223456778999999988999999999999999999999 8888764321              11112


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      .+........+...+..+.+||.+||..||++|||+.+|++.|+.+......
T Consensus       476 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          476 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  527 (535)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence            2223333344556678899999999999999999999999999988654443

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.5e-43  Score=341.52  Aligned_cols=272  Identities=22%  Similarity=0.261  Sum_probs=214.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeecccee-e
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYC-C  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-~  207 (451)
                      .++|++.+.||+|+||.||+|..          ..++..||||++.....  ...+.+|+.+++.++|++++..+..+ .
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTD----------IAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA   75 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE----------TTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEE----------cCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccC
Confidence            45899999999999999999764          34577899999865432  34588999999999988877666555 5


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee---CCCCcEEEee
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISD  284 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll---~~~~~~kl~D  284 (451)
                      ++...++||||+ +++|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||+   +.++.+||+|
T Consensus        76 ~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~D  151 (296)
T 3uzp_A           76 EGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             CCCceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEEee
Confidence            677889999999 89999998643 3569999999999999999999999  899999999999999   4788999999


Q ss_pred             cCCcccCCCCCCc-----ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc
Q 013028          285 FGLAKFGPLGDKS-----HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       285 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  359 (451)
                      ||++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........       
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------  224 (296)
T 3uzp_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-------  224 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-------
T ss_pred             CCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh-------
Confidence            9999864332211     1124567999999999999989999999999999999999999999754322111       


Q ss_pred             chhhhhhHHhhhhhcCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCcccccc
Q 013028          360 SNKLALHQIIDEKLGRN---IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTSLR  426 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~  426 (451)
                         ..+..+........   .....++++.+|+.+||+.||.+|||+.++++.|+.+....+.......+
T Consensus       225 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~d  291 (296)
T 3uzp_A          225 ---QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD  291 (296)
T ss_dssp             ---SHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCG
T ss_pred             ---hhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccc
Confidence               01111111111111   11234578999999999999999999999999999999988876555443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.5e-44  Score=342.10  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=204.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|++.+.||+|+||.||+|..          ..++..||+|++.....  ...+.+.+|+.+++.++||||+++++++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVH----------KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI   74 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEE----------cCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence            46899999999999999999764          34577899999975432  2235678999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc---EEEe
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN---AKIS  283 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~---~kl~  283 (451)
                      .++...++||||+++++|.+.+..  ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.   +||+
T Consensus        75 ~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           75 QEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EcCCEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence            999999999999999999988855  3568999999999999999999999  89999999999999976655   9999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      |||++.....   ........||+.|+|||++.+..++.++||||||+++|+|++|..||......             .
T Consensus       151 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------------~  214 (284)
T 3kk8_A          151 DFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------------R  214 (284)
T ss_dssp             CCTTCEECCS---SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------H
T ss_pred             eceeeEEccc---CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-------------H
Confidence            9999975432   22234567999999999999999999999999999999999999998643211             1


Q ss_pred             hhhHHhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          364 ALHQIIDEKLG--RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       364 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ....+......  .......++++.+|+.+||+.||.+|||+.|+++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          215 LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            11111111111  11112446789999999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=354.03  Aligned_cols=266  Identities=23%  Similarity=0.339  Sum_probs=195.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccceee-
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYCC-  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~-  207 (451)
                      .+|++.++||+|+||.||+|.+          ..++..||||++..........+.+|+.++..+. ||||+++++++. 
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQD----------VGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEE----------TTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ceEEEEEEEccCCceEEEEEEE----------CCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            4899999999999999999764          3457789999987655555567889999999996 999999999984 


Q ss_pred             -------cCCeeEEEEeccCCCChhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--ceeCCCCCCceeeCCC
Q 013028          208 -------DDQHRLLVYEYVTRGSLEDHLLN-EDDTELNWERRIKIALGAARGLEHLHTYWRP--VIHRDVKASNVLLDDD  277 (451)
Q Consensus       208 -------~~~~~~lV~E~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~--iiHrDlkp~NIll~~~  277 (451)
                             .....++||||+. |+|.+++.. .....+++..++.++.||+.||.|||+  .|  |+||||||+|||++.+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~~~ivH~Dikp~NIl~~~~  174 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR--QKPPIIHRDLKVENLLLSNQ  174 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCCCCCGGGCEECTT
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCEEEccCCcccEEECCC
Confidence                   3345799999995 699888854 234569999999999999999999999  78  9999999999999999


Q ss_pred             CcEEEeecCCcccCCCCCCcc----------cccccCCCCcccccccc---ccCCCCcchhhHHHHHHHHHHHhCCCccc
Q 013028          278 FNAKISDFGLAKFGPLGDKSH----------ISTRVLGTRGYFAPEYI---ATGHLTLKTDVYSFGVVLLEILSGKTAAM  344 (451)
Q Consensus       278 ~~~kl~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~l---~~~~~~~~~DiwSlGvil~elltg~~pf~  344 (451)
                      +.+||+|||++..........          ......||+.|+|||++   .+..++.++|||||||++|+|++|..||.
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            999999999998643221110          11245689999999998   56778999999999999999999999986


Q ss_pred             cccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCcccc
Q 013028          345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTS  424 (451)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~  424 (451)
                      .....                 .+.............+..+.+|+.+||+.||.+|||+.|+++.|+.+..........+
T Consensus       255 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~  317 (337)
T 3ll6_A          255 DGAKL-----------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSP  317 (337)
T ss_dssp             ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred             chhHH-----------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCcc
Confidence            43221                 1111111222222334568999999999999999999999999999988766554443


Q ss_pred             c
Q 013028          425 L  425 (451)
Q Consensus       425 ~  425 (451)
                      .
T Consensus       318 ~  318 (337)
T 3ll6_A          318 I  318 (337)
T ss_dssp             C
T ss_pred             H
Confidence            3

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.8e-44  Score=352.64  Aligned_cols=258  Identities=22%  Similarity=0.296  Sum_probs=207.2

Q ss_pred             HHHHHhcCCCcC-CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcC-CCce
Q 013028          124 LLEAATRKFSEK-NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLN-HPNV  199 (451)
Q Consensus       124 ~~~~~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-h~nI  199 (451)
                      ..+...++|.+. ++||+|+||+||+|..          ..++..||||++....  ......+.+|+.++..+. ||||
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i   91 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCIS----------KSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV   91 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTB
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEE----------CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCE
Confidence            345566788887 8999999999999764          4457889999987532  334577889999999996 7999


Q ss_pred             eeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC---
Q 013028          200 VKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD---  276 (451)
Q Consensus       200 v~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~---  276 (451)
                      +++++++.+....++||||+++|+|.+++.......+++..++.++.||+.||.|||+  +||+||||||+|||++.   
T Consensus        92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~~~  169 (327)
T 3lm5_A           92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYP  169 (327)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCBTT
T ss_pred             EEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecCCC
Confidence            9999999999999999999999999999876656789999999999999999999999  89999999999999987   


Q ss_pred             CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccc
Q 013028          277 DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK  356 (451)
Q Consensus       277 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~  356 (451)
                      ++.+||+|||++.....   ........||+.|+|||++.+..++.++|||||||++|+|++|..||......       
T Consensus       170 ~~~~kL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------  239 (327)
T 3lm5_A          170 LGDIKIVDFGMSRKIGH---ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------  239 (327)
T ss_dssp             BCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------
T ss_pred             CCcEEEeeCccccccCC---ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------
Confidence            78999999999986432   22233467999999999999899999999999999999999999998643221       


Q ss_pred             cccchhhhhhHHhhh--hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          357 PYLSNKLALHQIIDE--KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       357 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                            .....+...  ..........+..+.+|+.+||..||.+|||+.++++.
T Consensus       240 ------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          240 ------ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             ------HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ------HHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                  111111111  11112223456789999999999999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.7e-44  Score=346.09  Aligned_cols=257  Identities=24%  Similarity=0.346  Sum_probs=196.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++++.||+|+||+||+|..           .++..||||++.....  .....+.+|+.+++.++||||+++++++.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   70 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-----------NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH   70 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-----------TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-----------CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc
Confidence            4799999999999999999764           2367799999865432  23467889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +++..++||||+++ +|.+++... ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        71 ~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           71 TKKRLVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             CSSCEEEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             cCCeEEEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECcc
Confidence            99999999999975 898888643 3568999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-------------CC
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-------------GN  353 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-------------~~  353 (451)
                      +......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........             ..
T Consensus       147 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (288)
T 1ob3_A          147 ARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN  224 (288)
T ss_dssp             HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccCcc--ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhh
Confidence            9753321  122334578999999999965 4689999999999999999999999865322100             00


Q ss_pred             ccccccchhhhhhHHhhhhhc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          354 WAKPYLSNKLALHQIIDEKLG-------RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      |..  ...   . ..++....       .......+.++.+|+.+||+.||++|||+.|+++.
T Consensus       225 ~~~--~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          225 WPN--VTE---L-PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             STT--GGG---S-TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             chh--hhc---c-cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000  000   0 00000000       01112346789999999999999999999999863

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.1e-44  Score=347.41  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=204.0

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +.++|.+.+.||+|+||.||+|..          ..++..||||++........+.+.+|+.+++.++||||+++++++.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQ----------RLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE   76 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEE----------CCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc
Confidence            346899999999999999999654          4457889999998655445567889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee---CCCCcEEEee
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISD  284 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll---~~~~~~kl~D  284 (451)
                      +....++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  .||+||||||+|||+   +.++.++|+|
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~D  152 (304)
T 2jam_A           77 STTHYYLVMQLVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITD  152 (304)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred             cCCEEEEEEEcCCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEcc
Confidence            99999999999999999998854  3568999999999999999999999  899999999999999   7888999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ||++.....    .......||+.|+|||++.+..++.++|||||||++|+|++|..||......             ..
T Consensus       153 fg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------------~~  215 (304)
T 2jam_A          153 FGLSKMEQN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-------------KL  215 (304)
T ss_dssp             CSTTCCCCC----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-------------HH
T ss_pred             CCcceecCC----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------------HH
Confidence            999975321    2233457899999999999899999999999999999999999998643211             01


Q ss_pred             hhHHhhhhh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          365 LHQIIDEKL--GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...+.....  ........+..+.+|+.+||..||.+|||+.++++.
T Consensus       216 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          216 FEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             HHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111111111  111223456889999999999999999999999975

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=356.57  Aligned_cols=271  Identities=17%  Similarity=0.197  Sum_probs=200.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-----------CHHHHHHHHHHHHhcCCCc
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-----------GQDEWENELRFLSRLNHPN  198 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~il~~l~h~n  198 (451)
                      ++|.+.+.||+|+||.||+|.+...       ...+..+|||++......           ....+.+|+.++..++|||
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n  109 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNK-------PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG  109 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSS-------CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCC-------CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence            5899999999999999999886542       123567999998754322           1123567888899999999


Q ss_pred             eeeccceeec----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee
Q 013028          199 VVKLMGYCCD----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL  274 (451)
Q Consensus       199 Iv~~~~~~~~----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll  274 (451)
                      |+++++++.+    ....++||||+ +++|.+++...  ..+++..++.++.||+.||.|||+  +||+||||||+|||+
T Consensus       110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll  184 (345)
T 2v62_A          110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLL  184 (345)
T ss_dssp             CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE
T ss_pred             cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEE
Confidence            9999999987    67889999999 99999998653  379999999999999999999999  899999999999999


Q ss_pred             CCCC--cEEEeecCCcccCCCCC-----CcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccc
Q 013028          275 DDDF--NAKISDFGLAKFGPLGD-----KSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRT  347 (451)
Q Consensus       275 ~~~~--~~kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  347 (451)
                      +.++  .+||+|||+++......     .........||..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  264 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL  264 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred             ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            8777  99999999997543211     1112245679999999999998899999999999999999999999996432


Q ss_pred             CCCCCCccccccchhhhhhHHhhhhhcC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          348 NGLAGNWAKPYLSNKLALHQIIDEKLGR-NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                      ....     ............+...... ......+.++.+|+.+||..||++|||+.+|++.|+.+....
T Consensus       265 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  330 (345)
T 2v62_A          265 KDPV-----AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL  330 (345)
T ss_dssp             TCHH-----HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred             cccH-----HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence            2100     0000000000000000000 001134568999999999999999999999999999875433

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.8e-44  Score=346.26  Aligned_cols=264  Identities=23%  Similarity=0.314  Sum_probs=196.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--HHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|+++++||+|+||+||+|.+          ..++..||||++.......  .+.+.+|+.+++.++||||+++++++.
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   72 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRN----------RDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR   72 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEe----------CCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee
Confidence            5899999999999999999764          4457789999986543322  355778999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +....++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.++|+|||+
T Consensus        73 ~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  148 (311)
T 4agu_A           73 RKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGF  148 (311)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             cCCeEEEEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence            99999999999999999888754  4569999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch-hhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN-KLAL  365 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~  365 (451)
                      +.....  .........||..|+|||++.+ ..++.++|||||||++|+|++|..||.................. ....
T Consensus       149 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (311)
T 4agu_A          149 ARLLTG--PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH  226 (311)
T ss_dssp             CEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             chhccC--cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccc
Confidence            986432  1222345678999999999976 67899999999999999999999998654321000000000000 0000


Q ss_pred             hHHhhh-----hhcC----C-C-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          366 HQIIDE-----KLGR----N-I-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       366 ~~~~~~-----~~~~----~-~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...+..     ....    . .     ....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000000     0000    0 0     01245679999999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=9.5e-44  Score=360.76  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=193.4

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--------cCHHHHHHHHHHHHhcCCC
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--------QGQDEWENELRFLSRLNHP  197 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~  197 (451)
                      ....++|.+.+.||+|+||+||+|..          ..++..||||++.....        .....+.+|+.+|+.++||
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  200 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFE----------RKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP  200 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEE----------TTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCT
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEE----------CCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCC
Confidence            45578999999999999999999764          44577899999875321        1122478999999999999


Q ss_pred             ceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC
Q 013028          198 NVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD  277 (451)
Q Consensus       198 nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~  277 (451)
                      ||+++++++.. ...++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.+
T Consensus       201 niv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~  275 (419)
T 3i6u_A          201 CIIKIKNFFDA-EDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQ  275 (419)
T ss_dssp             TBCCCCEEEES-SEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSS
T ss_pred             CEeeEEEEEec-CceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecC
Confidence            99999999864 457999999999999998854  4679999999999999999999999  899999999999999754


Q ss_pred             ---CcEEEeecCCcccCCCCCCcccccccCCCCcccccccccc---CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC
Q 013028          278 ---FNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA  351 (451)
Q Consensus       278 ---~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  351 (451)
                         +.+||+|||+++...   ........+||+.|+|||++.+   ..++.++|||||||++|+|++|..||....... 
T Consensus       276 ~~~~~~kl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-  351 (419)
T 3i6u_A          276 EEDCLIKITDFGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-  351 (419)
T ss_dssp             SSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-
T ss_pred             CCcceEEEeecccceecC---CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-
Confidence               459999999998643   2233445789999999999853   678899999999999999999999986532210 


Q ss_pred             CCccccccchhhhhhHHhhhhhcCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 GNWAKPYLSNKLALHQIIDEKLGRNIQ---MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                                  .+...+........+   ...+..+.+|+.+||+.||.+|||+.|++++
T Consensus       352 ------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          352 ------------SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             ------------CHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ------------HHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                        011111111100011   1235789999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=348.65  Aligned_cols=274  Identities=25%  Similarity=0.346  Sum_probs=199.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHH--HHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF--LSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~i--l~~l~h~nIv~~~~~~~  207 (451)
                      ++|++.+.||+|+||.||+|.+            ++..||||++...   ....+..|.++  +..++||||+++++.+.
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~------------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~   77 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL------------DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDE   77 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE------------TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE------------CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheeccc
Confidence            4899999999999999999864            2567999998643   23444445554  44589999999998553


Q ss_pred             -----cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC---------CceeCCCCCCcee
Q 013028          208 -----DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWR---------PVIHRDVKASNVL  273 (451)
Q Consensus       208 -----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~---------~iiHrDlkp~NIl  273 (451)
                           .....++||||+++|+|.+++...   ..++..+..++.||+.||.|||+  .         ||+||||||+|||
T Consensus        78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~--~~~~~~~~~~~ivH~Dikp~Nil  152 (336)
T 3g2f_A           78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHT--ELPRGDHYKPAISHRDLNSRNVL  152 (336)
T ss_dssp             EECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHC--CBCCGGGCBCCEECSSCSGGGEE
T ss_pred             ccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHh--hhccccccccceeecccccceEE
Confidence                 233578999999999999999553   35889999999999999999999  7         9999999999999


Q ss_pred             eCCCCcEEEeecCCcccCCCCC------CcccccccCCCCcccccccccc-------CCCCcchhhHHHHHHHHHHHhCC
Q 013028          274 LDDDFNAKISDFGLAKFGPLGD------KSHISTRVLGTRGYFAPEYIAT-------GHLTLKTDVYSFGVVLLEILSGK  340 (451)
Q Consensus       274 l~~~~~~kl~DFGla~~~~~~~------~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwSlGvil~elltg~  340 (451)
                      ++.++.+||+|||++.......      .........||..|+|||++.+       ..++.++|||||||++|||++|.
T Consensus       153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~  232 (336)
T 3g2f_A          153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC  232 (336)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence            9999999999999998543211      1122334579999999999976       45678999999999999999998


Q ss_pred             CccccccCCCCCCcccc--cc--chhhhhhHHhh-hhhcCCC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          341 TAAMRRTNGLAGNWAKP--YL--SNKLALHQIID-EKLGRNI------QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       341 ~pf~~~~~~~~~~~~~~--~~--~~~~~~~~~~~-~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .||..............  ..  .........+. ......+      ....+..+.+||.+||..||++|||+.|+++.
T Consensus       233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~  312 (336)
T 3g2f_A          233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER  312 (336)
T ss_dssp             GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence            88765433211111000  00  00001111111 1111111      22356789999999999999999999999999


Q ss_pred             HHHhHHhcCCCccc
Q 013028          410 LEQLQLNMGSCYQT  423 (451)
Q Consensus       410 L~~~~~~~~~~~~~  423 (451)
                      |+.+.......-..
T Consensus       313 L~~ll~~~~~~~~~  326 (336)
T 3g2f_A          313 MAELMMIWERNKSV  326 (336)
T ss_dssp             HHHHHHCCCC----
T ss_pred             HHHHHHHHHhcccC
Confidence            99998777664433

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.5e-44  Score=368.35  Aligned_cols=250  Identities=25%  Similarity=0.378  Sum_probs=203.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC--CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|+++++||+|+||+||+|..          ..++..||||++...  .......+.+|+.+|+.++||||+++++++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   90 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKD----------RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL   90 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEE----------TTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEE----------CCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence            45899999999999999999754          445788999998643  234467789999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC---CCCcEEEe
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD---DDFNAKIS  283 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~---~~~~~kl~  283 (451)
                      .+....++||||+.||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++   .++.+||+
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~  166 (486)
T 3mwu_A           91 EDSSSFYIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKII  166 (486)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred             EcCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEE
Confidence            999999999999999999998855  3569999999999999999999999  8999999999999995   55689999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      |||++.....   .......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||......             .
T Consensus       167 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------------~  229 (486)
T 3mwu_A          167 DFGLSTCFQQ---NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------------D  229 (486)
T ss_dssp             SCSCTTTBCC---C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------H
T ss_pred             ECCcCeECCC---CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------H
Confidence            9999985432   222345679999999999964 6999999999999999999999998653221             1


Q ss_pred             hhhHHhhhhhcCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          364 ALHQIIDEKLGRN--IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       364 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+..+........  .....++++.+||.+||..||.+|||+.++|+.
T Consensus       230 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          230 ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             HHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1112211111111  112346889999999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9e-44  Score=362.38  Aligned_cols=266  Identities=25%  Similarity=0.359  Sum_probs=198.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|++.+.||+|+||+||+|.+          ..++..||||++......  ..+.+.+|+.+|+.++||||+++++++
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~----------~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~   94 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYD----------KNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLI   94 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEE----------TTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEE----------CCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEE
Confidence            35899999999999999999764          445788999999754222  235688999999999999999999999


Q ss_pred             ecC-----CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEE
Q 013028          207 CDD-----QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       207 ~~~-----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~k  281 (451)
                      ...     ...|+||||++ |+|.+++..  ...+++..+..++.||+.||.|||+  .||+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl~~~~~~k  169 (432)
T 3n9x_A           95 IPDDLLKFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCSVK  169 (432)
T ss_dssp             CCSCTTTCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEE
T ss_pred             ecCCCCcCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEECCCCCEE
Confidence            766     57899999996 599999854  4679999999999999999999999  8999999999999999999999


Q ss_pred             EeecCCcccCCCCCCc--------------------ccccccCCCCcccccccc-ccCCCCcchhhHHHHHHHHHHHhCC
Q 013028          282 ISDFGLAKFGPLGDKS--------------------HISTRVLGTRGYFAPEYI-ATGHLTLKTDVYSFGVVLLEILSGK  340 (451)
Q Consensus       282 l~DFGla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~~DiwSlGvil~elltg~  340 (451)
                      |+|||+|+........                    ......+||+.|+|||++ ....|+.++|||||||++|||++|.
T Consensus       170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~  249 (432)
T 3n9x_A          170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML  249 (432)
T ss_dssp             ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred             EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence            9999999864322211                    123567899999999986 5667999999999999999999976


Q ss_pred             CccccccCCCCCCcccc----c--------c---chhhhhhHHhhh----------------------hh--cCCCC---
Q 013028          341 TAAMRRTNGLAGNWAKP----Y--------L---SNKLALHQIIDE----------------------KL--GRNIQ---  378 (451)
Q Consensus       341 ~pf~~~~~~~~~~~~~~----~--------~---~~~~~~~~~~~~----------------------~~--~~~~~---  378 (451)
                      .||.........-+...    .        .   .....+..++..                      .+  ....+   
T Consensus       250 ~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (432)
T 3n9x_A          250 QSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQ  329 (432)
T ss_dssp             TTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH
T ss_pred             cccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHH
Confidence            66654322211111000    0        0   000001011000                      00  00000   


Q ss_pred             --HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          379 --MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       379 --~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                        ...++++.+|+.+||..||.+|||+.|+|++
T Consensus       330 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  362 (432)
T 3n9x_A          330 KYPSISDDGINLLESMLKFNPNKRITIDQALDH  362 (432)
T ss_dssp             HSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred             HCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              2246789999999999999999999999984

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.5e-44  Score=369.57  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=200.0

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|+++++||+|+||+||+|..          ..++..||||++....  ......+.+|+.+|+.++||||++++++|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  105 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRD----------KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF  105 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEE----------TTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEE----------CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            45899999999999999999764          4457889999997543  33456788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC---CCcEEEe
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD---DFNAKIS  283 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~---~~~~kl~  283 (451)
                      .+....|+||||+.||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.   ++.+||+
T Consensus       106 ~~~~~~~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~  181 (494)
T 3lij_A          106 EDKRNYYLVMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKIV  181 (494)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EeCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEEE
Confidence            999999999999999999998855  3568999999999999999999999  89999999999999975   4559999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      |||++.....   .......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||......             .
T Consensus       182 DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------------~  244 (494)
T 3lij_A          182 DFGLSAVFEN---QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-------------E  244 (494)
T ss_dssp             CCTTCEECBT---TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------H
T ss_pred             ECCCCeECCC---CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------------H
Confidence            9999986432   22334567999999999985 67999999999999999999999998653321             1


Q ss_pred             hhhHHhhhhhcCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          364 ALHQIIDEKLGRN--IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       364 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+..+........  .....+..+.+|+.+||..||.+|||+.|+|++
T Consensus       245 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          245 ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             HHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            1111111111111  112346789999999999999999999999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-43  Score=368.71  Aligned_cols=248  Identities=27%  Similarity=0.401  Sum_probs=201.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-------------cCHHHHHHHHHHHHhcC
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-------------QGQDEWENELRFLSRLN  195 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~il~~l~  195 (451)
                      .++|.++++||+|+||+||+|..          ..++..||||++.....             ...+.+.+|+.+|+.++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  104 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKE----------KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD  104 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEE----------TTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred             ccceEEEeEecccCCeEEEEEEE----------CCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence            46899999999999999999764          44577899999975431             23467889999999999


Q ss_pred             CCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC
Q 013028          196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD  275 (451)
Q Consensus       196 h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~  275 (451)
                      ||||+++++++.++...++|||||+||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++
T Consensus       105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~  180 (504)
T 3q5i_A          105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHK--HNIVHRDIKPENILLE  180 (504)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEES
T ss_pred             CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEEEe
Confidence            99999999999999999999999999999998865  3569999999999999999999999  8999999999999998


Q ss_pred             CCC---cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC
Q 013028          276 DDF---NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG  352 (451)
Q Consensus       276 ~~~---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  352 (451)
                      .++   .+||+|||++.....   ........||+.|+|||++. ..++.++|||||||++|+|++|..||......   
T Consensus       181 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---  253 (504)
T 3q5i_A          181 NKNSLLNIKIVDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---  253 (504)
T ss_dssp             STTCCSSEEECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred             cCCCCccEEEEECCCCEEcCC---CCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence            775   699999999986432   22334567999999999985 57999999999999999999999998753321   


Q ss_pred             CccccccchhhhhhHHhhhhhcCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          353 NWAKPYLSNKLALHQIIDEKLGRNIQ----MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                                ..+..+.....  ..+    ...+.++.+|+.+||..||.+|||+.|+|+.
T Consensus       254 ----------~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          254 ----------DIIKKVEKGKY--YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             ----------HHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----------HHHHHHHcCCC--CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                      11111111111  111    1236789999999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.6e-44  Score=370.51  Aligned_cols=251  Identities=25%  Similarity=0.379  Sum_probs=206.8

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .++|++.+.||+|+||.||+|.          +..++..||||++....   ....+.+.+|+.+|+.++||||++++++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~----------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   94 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCK----------DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF   94 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEE----------ETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEE----------ECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            4589999999999999999965          44557889999997543   3446778999999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee---CCCCcEEE
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKI  282 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll---~~~~~~kl  282 (451)
                      +.+....++||||+.||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||+   +.++.+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl  170 (484)
T 3nyv_A           95 FEDKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRI  170 (484)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEeCCEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcEEE
Confidence            9999999999999999999999855  4579999999999999999999999  899999999999999   56789999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchh
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      +|||++......   ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||......             
T Consensus       171 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------------  233 (484)
T 3nyv_A          171 IDFGLSTHFEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-------------  233 (484)
T ss_dssp             CCTTHHHHBCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------
T ss_pred             EeeeeeEEcccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-------------
Confidence            999999864322   23345679999999999955 7999999999999999999999998653321             


Q ss_pred             hhhhHHhhhhhcCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          363 LALHQIIDEKLGRN--IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       363 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ..+..+........  .....++.+.+|+.+||..||.+|||+.|++++-
T Consensus       234 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~  283 (484)
T 3nyv_A          234 DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE  283 (484)
T ss_dssp             HHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             HHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence            11112221111111  1124568899999999999999999999999853

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.5e-44  Score=353.21  Aligned_cols=249  Identities=31%  Similarity=0.448  Sum_probs=202.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|.+.+.||+|+||+||+|..          ..++..||||++.......   .+.+.+|+.+|+.++||||+++++++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  123 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARD----------VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY  123 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEE----------ccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4689999999999999999763          4457889999997543322   24678999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++..++||||+. |+|.+++... ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus       124 ~~~~~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG  199 (348)
T 1u5q_A          124 LREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFG  199 (348)
T ss_dssp             EETTEEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             EECCeEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEeecc
Confidence            99999999999997 5888877543 3579999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      ++.....      .....||+.|+|||++.   +..++.++|||||||++|||++|..||.....             ..
T Consensus       200 ~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------------~~  260 (348)
T 1u5q_A          200 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------------MS  260 (348)
T ss_dssp             TCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------------HH
T ss_pred             CceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------------HH
Confidence            9975321      23467999999999984   56789999999999999999999999864321             11


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      .+..+.............+..+.+|+.+||+.||.+|||+.++++..-
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          261 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence            111222211111223345678999999999999999999999997644

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.2e-43  Score=346.29  Aligned_cols=266  Identities=28%  Similarity=0.417  Sum_probs=208.4

Q ss_pred             HHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHh--cCCCceee
Q 013028          124 LLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSR--LNHPNVVK  201 (451)
Q Consensus       124 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~  201 (451)
                      ....+.++|.+.+.||+|+||.||+|.+.            +..||||++..   .....+.+|++++..  ++||||++
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~  100 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKWR------------GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILG  100 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEET------------TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCC
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEEc------------CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEE
Confidence            34556779999999999999999998642            56799999864   234567889999888  68999999


Q ss_pred             ccceeecCC----eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceeCCCCC
Q 013028          202 LMGYCCDDQ----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH--------TYWRPVIHRDVKA  269 (451)
Q Consensus       202 ~~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~iiHrDlkp  269 (451)
                      +++++....    ..++||||+++|+|.+++..   ..+++..++.++.|++.||.|||        +  .||+||||||
T Consensus       101 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp  175 (342)
T 1b6c_B          101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK--PAIAHRDLKS  175 (342)
T ss_dssp             EEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB--CEEECSCCSG
T ss_pred             EEeeecccCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc--CCeeeCCCCH
Confidence            999998776    78999999999999999964   35899999999999999999999        7  8999999999


Q ss_pred             CceeeCCCCcEEEeecCCcccCCCCCCcc--cccccCCCCccccccccccC------CCCcchhhHHHHHHHHHHHhC--
Q 013028          270 SNVLLDDDFNAKISDFGLAKFGPLGDKSH--ISTRVLGTRGYFAPEYIATG------HLTLKTDVYSFGVVLLEILSG--  339 (451)
Q Consensus       270 ~NIll~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~~~~~DiwSlGvil~elltg--  339 (451)
                      +|||++.++.+||+|||++..........  ......||..|+|||++.+.      .++.++|||||||++|+|++|  
T Consensus       176 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~  255 (342)
T 1b6c_B          176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS  255 (342)
T ss_dssp             GGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccC
Confidence            99999999999999999997543222111  22345799999999999665      334789999999999999999  


Q ss_pred             --------CCccccccCCCCCCccccccchhhhhhH-HhhhhhcCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHH
Q 013028          340 --------KTAAMRRTNGLAGNWAKPYLSNKLALHQ-IIDEKLGRNIQ-----MEEAQEFAEIILRCLNSDPKNRPTMSE  405 (451)
Q Consensus       340 --------~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~e  405 (451)
                              ..||.......         .....+.. +....+....+     ...+..+.+|+.+||+.||.+|||+.+
T Consensus       256 ~~~~~~~~~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~  326 (342)
T 1b6c_B          256 IGGIHEDYQLPYYDLVPSD---------PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR  326 (342)
T ss_dssp             BTTBCCCCCCTTTTTSCSS---------CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             cCCcccccccCccccCcCc---------ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence                    44443322110         00111111 11222222222     355678999999999999999999999


Q ss_pred             HHHHHHHhHHhcC
Q 013028          406 VVAALEQLQLNMG  418 (451)
Q Consensus       406 vl~~L~~~~~~~~  418 (451)
                      |++.|+.+..+.+
T Consensus       327 i~~~L~~i~~~~~  339 (342)
T 1b6c_B          327 IKKTLSQLSQQEG  339 (342)
T ss_dssp             HHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHhc
Confidence            9999999987654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.5e-44  Score=348.32  Aligned_cols=261  Identities=25%  Similarity=0.336  Sum_probs=201.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++.+.||+|+||.||+|..          ..++..||||++.......   .+.+.+|+.+++.++||||+++++++
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~  103 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAED----------TVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG  103 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEE----------TTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEE----------cCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence            5899999999999999999764          3457789999997543322   36688999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++..++||||++|++|.+++..  ...+++..++.++.||+.||.|||+  +||+|+||||+|||++.++.+||+|||
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~Dfg  179 (309)
T 2h34_A          104 EIDGQLYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDFG  179 (309)
T ss_dssp             EETTEEEEEEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred             eeCCeEEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEecCc
Confidence            999999999999999999999865  3568999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++....... ........|+..|+|||++.+..++.++||||||+++|+|++|..||......              .+.
T Consensus       180 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------------~~~  244 (309)
T 2h34_A          180 IASATTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--------------VMG  244 (309)
T ss_dssp             C-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------------HHH
T ss_pred             cCccccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------------HHH
Confidence            997543221 12233457899999999998899999999999999999999999998643211              111


Q ss_pred             HHhhhhh--cCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHHhcCC
Q 013028          367 QIIDEKL--GRNIQMEEAQEFAEIILRCLNSDPKNRP-TMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       367 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~~~  419 (451)
                      ..+....  ....+...+..+.+|+.+||..||.+|| ++.++++.|+.+......
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          245 AHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             HHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             HHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence            1111111  1122334567899999999999999999 999999999988655543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1e-43  Score=377.92  Aligned_cols=255  Identities=27%  Similarity=0.417  Sum_probs=206.7

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeecCCeeE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL  213 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~  213 (451)
                      ++||+|+||.||+|.+.        ....+..||||++.....  ...+.+.+|+++|+.++|||||++++++.+ +..+
T Consensus       375 ~~LG~G~fG~Vy~~~~~--------~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~  445 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQ--------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM  445 (635)
T ss_dssp             EEEEECSSEEEEEEEEE--------CSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             CEeccCCCEEEEEEEEc--------CCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence            47999999999998753        234467899999975432  335789999999999999999999999965 4578


Q ss_pred             EEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCC
Q 013028          214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL  293 (451)
Q Consensus       214 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~  293 (451)
                      |||||+++|+|.+++..  ...+++..++.|+.||+.||.|||+  +||+||||||+||||+.++.+||+|||+++....
T Consensus       446 lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~  521 (635)
T 4fl3_A          446 LVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  521 (635)
T ss_dssp             EEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred             EEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence            99999999999999964  4679999999999999999999999  8999999999999999999999999999986433


Q ss_pred             CCC-cccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          294 GDK-SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       294 ~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      ... ........+|..|+|||++.+..++.++|||||||++|||++ |..||.....              ..+...+..
T Consensus       522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------------~~~~~~i~~  587 (635)
T 4fl3_A          522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------------SEVTAMLEK  587 (635)
T ss_dssp             -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------------HHHHHHHHT
T ss_pred             CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------------HHHHHHHHc
Confidence            221 112233456788999999998999999999999999999998 9999864322              122233334


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhc
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM  417 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  417 (451)
                      ......+...+.++.+||.+||+.||++|||+.+|++.|+.+..++
T Consensus       588 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          588 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            4344456667889999999999999999999999999999987664

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=338.83  Aligned_cols=252  Identities=25%  Similarity=0.381  Sum_probs=202.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecCC
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDDQ  210 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  210 (451)
                      .|.....||+|+||.||+|.+          ..++..||||.+........+.+.+|+.+++.++||||+++++++.+..
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   92 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRD----------LSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG   92 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEE----------TTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             CCCCcEEEeecCcEEEEEEEE----------CCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence            455567899999999999764          3457789999998766666678899999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC-CCcEEEeecCCc
Q 013028          211 HRLLVYEYVTRGSLEDHLLNED-DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD-DFNAKISDFGLA  288 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~-~~~~kl~DFGla  288 (451)
                      ..++||||+++++|.+++.... ...+++..+..++.||+.||.|||+  +||+|+||||+|||++. ++.++|+|||++
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~  170 (295)
T 2clq_A           93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTS  170 (295)
T ss_dssp             EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred             cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeecccc
Confidence            9999999999999999986542 3457789999999999999999999  89999999999999987 899999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccC--CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATG--HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ......  ........||..|+|||++.+.  .++.++||||||+++|+|++|..||......            .....
T Consensus       171 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------~~~~~  236 (295)
T 2clq_A          171 KRLAGI--NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------------QAAMF  236 (295)
T ss_dssp             EESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH------------HHHHH
T ss_pred             cccCCC--CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch------------hHHHH
Confidence            864321  1223356789999999999664  3889999999999999999999998643211            01111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ...........+...+.++.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          237 KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             hhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111112233445566788999999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-43  Score=369.38  Aligned_cols=255  Identities=27%  Similarity=0.400  Sum_probs=208.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .++|.+.+.||+|+||.||+|..          ..++..||||++.+..   ......+.+|+.+|+.++||||++++++
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~----------~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~  253 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQM----------KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA  253 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE----------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEE----------CCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            36799999999999999999764          4457889999996432   2345678899999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNED--DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      |.+....|+||||++||+|.+++....  ...+++..+..++.||+.||.|||+  +||+||||||+||||+.+|.+||+
T Consensus       254 ~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~  331 (543)
T 3c4z_A          254 FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRIS  331 (543)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEEC
T ss_pred             EeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEe
Confidence            999999999999999999999986543  4579999999999999999999999  899999999999999999999999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      |||+++.....  .......+||+.|+|||++.+..|+.++|||||||++|||++|..||........         ...
T Consensus       332 DFGla~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~---------~~~  400 (543)
T 3c4z_A          332 DLGLAVELKAG--QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---------NKE  400 (543)
T ss_dssp             CCTTCEECCTT--CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC---------HHH
T ss_pred             ecceeeeccCC--CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh---------HHH
Confidence            99999864322  1223446899999999999999999999999999999999999999975432100         011


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM-----SEVVA  408 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~  408 (451)
                      ....+...  ....+...+..+.+|+.+||..||.+||++     .++++
T Consensus       401 ~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          401 LKQRVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             HHHHHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            11112211  223455667889999999999999999975     66664

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.1e-43  Score=346.13  Aligned_cols=257  Identities=21%  Similarity=0.289  Sum_probs=199.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~  208 (451)
                      ++|++.++||+|+||+||+|..          ..++..||||++..   ...+.+.+|+.+++.++ ||||+++++++.+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~  102 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAIN----------ITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD  102 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             CceEEEEEecccCCeEEEEEEE----------CCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence            5899999999999999999764          44577899999863   34577899999999997 9999999999987


Q ss_pred             --CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC-cEEEeec
Q 013028          209 --DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF-NAKISDF  285 (451)
Q Consensus       209 --~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~-~~kl~DF  285 (451)
                        ....++||||+.+++|.+++.     .+++..+..++.||+.||.|||+  +||+||||||+|||++.++ .+||+||
T Consensus       103 ~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~~kl~Df  175 (330)
T 3nsz_A          103 PVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDW  175 (330)
T ss_dssp             TTTCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CCCCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence              677899999999999999883     38899999999999999999999  8999999999999999766 8999999


Q ss_pred             CCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      |++......   .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.....................
T Consensus       176 g~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~  252 (330)
T 3nsz_A          176 GLAEFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED  252 (330)
T ss_dssp             TTCEECCTT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred             CCceEcCCC---CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCch
Confidence            999864322   22344678999999999977 67999999999999999999999998543221000000000000000


Q ss_pred             hhHHhhh-----------------------hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          365 LHQIIDE-----------------------KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +...+..                       ..........+.++.+|+.+||+.||.+|||+.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000000                       00111122246889999999999999999999999873

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=342.52  Aligned_cols=253  Identities=23%  Similarity=0.321  Sum_probs=202.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC----CcCHHHHHHHHHHHHhcCCCceeeccc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG----SQGQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      .++|.+.+.||+|+||.||+|.          +..++..||||++....    ......+.+|+.+++.++||||+++++
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~----------~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   73 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVL----------DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD   73 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEE----------BTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             ccceeEeeEEecCCCeEEEEEE----------ECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEE
Confidence            4689999999999999999965          44557889999997432    234567899999999999999999999


Q ss_pred             eee--cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          205 YCC--DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       205 ~~~--~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      ++.  +....++||||++++ |.+++.......+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++|
T Consensus        74 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~kl  150 (305)
T 2wtk_C           74 VLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKI  150 (305)
T ss_dssp             EEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEEe
Confidence            984  456789999999876 7787766666789999999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCccccccccccCC--CCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccc
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGH--LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS  360 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  360 (451)
                      +|||++................||..|+|||++.+..  ++.++||||||+++|+|++|..||......           
T Consensus       151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------  219 (305)
T 2wtk_C          151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-----------  219 (305)
T ss_dssp             CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------
T ss_pred             eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-----------
Confidence            9999998654333333344567999999999997643  478999999999999999999998643210           


Q ss_pred             hhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          361 NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                        .....+...  ....+...+..+.+|+.+||..||.+|||+.|+++.
T Consensus       220 --~~~~~i~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          220 --KLFENIGKG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             --HHHHHHHHC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --HHHHHHhcC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              011111111  122344556789999999999999999999999976

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.2e-44  Score=340.17  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=184.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|.+.+.||+|+||.||+|..          ..++..||||++....   ....+.+.+|+.+++.++||||+++++++
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   80 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAES----------IHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF   80 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEE----------ccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE
Confidence            4799999999999999999764          3457789999986431   23346788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+.+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+  +||+|+||||+|||++.++.++|+|||
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg  157 (278)
T 3cok_A           81 EDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFG  157 (278)
T ss_dssp             ECSSEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEECCCT
T ss_pred             ccCCeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEEeec
Confidence            9999999999999999999998643 3578999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++.......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||........             +.
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------------~~  222 (278)
T 3cok_A          158 LATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------------LN  222 (278)
T ss_dssp             TCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------
T ss_pred             ceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-------------HH
Confidence            998643221  122345789999999999888899999999999999999999999865432110             00


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+...  ....+...+.++.+|+.+||..||.+|||+.++++.
T Consensus       223 ~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          223 KVVLA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             -CCSS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHhhc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            00000  112233456789999999999999999999999873

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.2e-43  Score=338.30  Aligned_cols=256  Identities=24%  Similarity=0.370  Sum_probs=205.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC------cCHHHHHHHHHHHHhcCCCceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS------QGQDEWENELRFLSRLNHPNVVKL  202 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~nIv~~  202 (451)
                      .++|++.+.||+|+||.||+|..          ..++..||+|++.....      ...+.+.+|+.+++.++||||+++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   73 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQ----------KGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL   73 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhhhHHhhcccCceEEEEEEE----------cCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeeh
Confidence            45799999999999999999764          34577899999875422      135778999999999999999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC----
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF----  278 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~----  278 (451)
                      ++++.+....++||||+++++|.+++..  ...+++..+..++.||+.||.|||+  +||+|+||||+||+++.++    
T Consensus        74 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~  149 (283)
T 3bhy_A           74 HDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNP  149 (283)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSC
T ss_pred             hheecCCCeEEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCC
Confidence            9999999999999999999999999854  3568999999999999999999999  8999999999999998877    


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                      .++|+|||++.....   ........|++.|+|||++.+..++.++||||||+++|+|++|..||......         
T Consensus       150 ~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------  217 (283)
T 3bhy_A          150 RIKLIDFGIAHKIEA---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---------  217 (283)
T ss_dssp             CEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---------
T ss_pred             ceEEEecccceeccC---CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---------
Confidence            899999999985432   12233457899999999998889999999999999999999999998643211         


Q ss_pred             cchhhhhhHHhhhhhcCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhHHh
Q 013028          359 LSNKLALHQIIDEKLGRNIQ----MEEAQEFAEIILRCLNSDPKNRPTMSEVVA--ALEQLQLN  416 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~  416 (451)
                          ..+..+...  ....+    ...+..+.+|+.+||..||.+|||+.++++  .++.++..
T Consensus       218 ----~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          218 ----ETLTNISAV--NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             ----HHHHHHHTT--CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             ----HHHHHhHhc--ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence                011111111  11111    123577999999999999999999999998  45555443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9e-44  Score=341.47  Aligned_cols=247  Identities=26%  Similarity=0.401  Sum_probs=206.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|.+.+.||+|+||.||+|..          ..++..||||++...   .......+.+|+.+++.++||||+++++++
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   83 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLARE----------KQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF   83 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEE----------cCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            4899999999999999999764          345678999998643   223456788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .++...++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+  +||+|+||||+|||++.++.++|+|||
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg  159 (284)
T 2vgo_A           84 HDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFG  159 (284)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EcCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEeccc
Confidence            9999999999999999999998653  468999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++......    ......|+..|+|||++.+..++.++||||||+++|+|++|..||.....             .....
T Consensus       160 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------------~~~~~  222 (284)
T 2vgo_A          160 WSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-------------TETHR  222 (284)
T ss_dssp             TCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------------HHHHH
T ss_pred             ccccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-------------hHHHH
Confidence            99753321    22346789999999999988999999999999999999999999864321             11111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+...  ....+...+..+.+|+.+||..||.+|||+.++++.
T Consensus       223 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          223 RIVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             HHHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             HHhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            22211  223444567889999999999999999999999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.2e-43  Score=340.77  Aligned_cols=254  Identities=27%  Similarity=0.413  Sum_probs=210.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +.|++.+.||+|+||.||+|..          ..++..||||++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   91 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGID----------NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK   91 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEE----------TTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEE----------CCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            4799999999999999999764          3457789999997543 3445788999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ....++||||+++++|.+++..   ..+++..+..++.||+.||.|||+  .||+|+||||+|||++.++.++|+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~  166 (303)
T 3a7i_A           92 DTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVA  166 (303)
T ss_dssp             TTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeecccc
Confidence            9999999999999999999853   568999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ......  ........||..|+|||++.+..++.++||||||+++|+|++|..||.....              ......
T Consensus       167 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------------~~~~~~  230 (303)
T 3a7i_A          167 GQLTDT--QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------------MKVLFL  230 (303)
T ss_dssp             EECBTT--BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------------HHHHHH
T ss_pred             eecCcc--ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--------------HHHHHH
Confidence            754321  1223356789999999999989999999999999999999999999864221              111112


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                      +........+...+..+.+|+.+||..||.+|||+.++++..-...
T Consensus       231 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          231 IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             HHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             hhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence            2222223344455678999999999999999999999999765443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.6e-44  Score=340.69  Aligned_cols=247  Identities=23%  Similarity=0.337  Sum_probs=200.0

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhc-CCCceeeccc
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRL-NHPNVVKLMG  204 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l-~h~nIv~~~~  204 (451)
                      ..++|++.+.||+|+||+||+|.+          ..++..||||++......  ....+.+|+.++..+ +||||+++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~   78 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVK----------RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS   78 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEE----------cCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence            346899999999999999999764          345788999999754332  345678899999999 8999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC-----
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNED--DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD-----  277 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~-----  277 (451)
                      ++.+.+..++||||+++++|.+++....  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.+     
T Consensus        79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~  156 (289)
T 1x8b_A           79 AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNA  156 (289)
T ss_dssp             EEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC-------
T ss_pred             eeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCcc
Confidence            9999999999999999999999986432  2568999999999999999999999  899999999999999844     


Q ss_pred             --------------CcEEEeecCCcccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCc
Q 013028          278 --------------FNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTA  342 (451)
Q Consensus       278 --------------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~p  342 (451)
                                    ..++|+|||++......      ....||..|+|||++.+. .++.++|||||||++|+|++|.++
T Consensus       157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~  230 (289)
T 1x8b_A          157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL  230 (289)
T ss_dssp             -------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence                          47999999999864321      234589999999999765 667899999999999999999876


Q ss_pred             cccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          343 AMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       343 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +....                ....+ ........+...+..+.+|+.+||..||.+|||+.++++.
T Consensus       231 ~~~~~----------------~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          231 PRNGD----------------QWHEI-RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             CSSSH----------------HHHHH-HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             Ccchh----------------HHHHH-HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            53211                11111 1222233444567889999999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.4e-44  Score=357.66  Aligned_cols=261  Identities=23%  Similarity=0.322  Sum_probs=203.8

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC--------CCce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN--------HPNV  199 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--------h~nI  199 (451)
                      ..++|++.++||+|+||+||+|..          ..++..||||++... ....+.+.+|+.+|+.++        |+||
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~i  103 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWD----------IQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMV  103 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEe----------cCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence            346899999999999999999754          445788999999643 233466789999999985        7889


Q ss_pred             eeccceee----cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceeCCCCCCceee
Q 013028          200 VKLMGYCC----DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWR-PVIHRDVKASNVLL  274 (451)
Q Consensus       200 v~~~~~~~----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~iiHrDlkp~NIll  274 (451)
                      +++++++.    ++...+|||||+ +++|.+.+.......+++..+..++.||+.||.|||+  + ||+||||||+||||
T Consensus       104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIll  180 (397)
T 1wak_A          104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILL  180 (397)
T ss_dssp             CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEEE
T ss_pred             eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHeeE
Confidence            99999987    567889999999 6688777766555779999999999999999999999  7 99999999999999


Q ss_pred             CCCC-------------------------------------------------cEEEeecCCcccCCCCCCcccccccCC
Q 013028          275 DDDF-------------------------------------------------NAKISDFGLAKFGPLGDKSHISTRVLG  305 (451)
Q Consensus       275 ~~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~g  305 (451)
                      +.++                                                 .+||+|||++.....     ......|
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~g  255 (397)
T 1wak_A          181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQ  255 (397)
T ss_dssp             CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCS
T ss_pred             eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCC
Confidence            9775                                                 799999999986432     1334579


Q ss_pred             CCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC------------------------ccccccch
Q 013028          306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN------------------------WAKPYLSN  361 (451)
Q Consensus       306 t~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~------------------------~~~~~~~~  361 (451)
                      |+.|+|||++.+..++.++|||||||++|+|++|..||..........                        +...++..
T Consensus       256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  335 (397)
T 1wak_A          256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK  335 (397)
T ss_dssp             CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred             CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence            999999999999999999999999999999999999997544321100                        00000000


Q ss_pred             hh-----------hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          362 KL-----------ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       362 ~~-----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..           .+...+..  ....+...+..+.+|+.+||..||.+|||+.|+|++
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          336 KGDLKHITKLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             TSSBSSCCCCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             ccccccccccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            00           00000000  123456678899999999999999999999999863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.1e-43  Score=349.06  Aligned_cols=257  Identities=24%  Similarity=0.397  Sum_probs=205.6

Q ss_pred             HHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--------HHHHHHHHHHHHhc
Q 013028          123 GLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--------QDEWENELRFLSRL  194 (451)
Q Consensus       123 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~il~~l  194 (451)
                      .......++|.+.+.||+|+||.||+|.+.          .++..||||++.......        .+.+.+|+.+++.+
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~----------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  156 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHR----------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV  156 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEET----------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEEC----------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHh
Confidence            344556678999999999999999997643          457789999987543211        34577899999999


Q ss_pred             -CCCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcee
Q 013028          195 -NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL  273 (451)
Q Consensus       195 -~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIl  273 (451)
                       +||||+++++++......++||||++|++|.+++..  ...+++..+..++.||+.||.|||+  .||+|+||||+|||
T Consensus       157 ~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl  232 (365)
T 2y7j_A          157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENIL  232 (365)
T ss_dssp             TTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEE
T ss_pred             cCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEE
Confidence             799999999999999999999999999999999864  3568999999999999999999999  89999999999999


Q ss_pred             eCCCCcEEEeecCCcccCCCCCCcccccccCCCCcccccccccc------CCCCcchhhHHHHHHHHHHHhCCCcccccc
Q 013028          274 LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT------GHLTLKTDVYSFGVVLLEILSGKTAAMRRT  347 (451)
Q Consensus       274 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~DiwSlGvil~elltg~~pf~~~~  347 (451)
                      ++.++.++|+|||++......   .......||+.|+|||++.+      ..++.++|||||||++|+|++|..||....
T Consensus       233 ~~~~~~ikl~DfG~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  309 (365)
T 2y7j_A          233 LDDNMQIRLSDFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR  309 (365)
T ss_dssp             ECTTCCEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ECCCCCEEEEecCcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence            999999999999999864322   22345689999999999853      358899999999999999999999986432


Q ss_pred             CCCCCCccccccchhhhhhHHhhhhhcCCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          348 NGLAGNWAKPYLSNKLALHQIIDEKLGRNIQ--MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ..             ..+..+.........+  ...+..+.+|+.+||..||.+|||+.++++.
T Consensus       310 ~~-------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          310 QI-------------LMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HH-------------HHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HH-------------HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11             1111111111110000  1235679999999999999999999999873

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.7e-43  Score=340.58  Aligned_cols=248  Identities=25%  Similarity=0.395  Sum_probs=198.1

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .|.+.+.||+|+||+||+|.+.          .++..||+|.+....  ....+.+.+|+.+++.++||||+++++++.+
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~----------~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDT----------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES   96 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEET----------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEec----------CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence            5788899999999999997643          457789999987543  2234568899999999999999999999875


Q ss_pred             ----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--ceeCCCCCCceeeC-CCCcEE
Q 013028          209 ----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRP--VIHRDVKASNVLLD-DDFNAK  281 (451)
Q Consensus       209 ----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~--iiHrDlkp~NIll~-~~~~~k  281 (451)
                          ....++||||+++++|.+++..  ...+++..++.++.||+.||.|||+  .+  |+|+||||+|||++ .++.+|
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~~~i~H~dikp~Nil~~~~~~~~k  172 (290)
T 1t4h_A           97 TVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVK  172 (290)
T ss_dssp             ESSSCEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred             ccCCCceEEEEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHc--CCCCEEECCCCHHHEEEECCCCCEE
Confidence                4568999999999999999965  3568999999999999999999999  78  99999999999997 788999


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      |+|||++.....    .......||+.|+|||++. ..++.++|||||||++|+|++|..||......            
T Consensus       173 l~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------  235 (290)
T 1t4h_A          173 IGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------------  235 (290)
T ss_dssp             ECCTTGGGGCCT----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------------
T ss_pred             EeeCCCcccccc----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------------
Confidence            999999975322    2234567999999999885 56999999999999999999999998643221            


Q ss_pred             hhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ......+.........+...++++.+|+.+||..||.+|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          236 AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            001111111111111222334679999999999999999999999863

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.4e-44  Score=355.59  Aligned_cols=265  Identities=22%  Similarity=0.346  Sum_probs=205.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|++.++||+|+||+||+|.+.          .++..||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  101 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHK----------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY  101 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET----------TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEEC----------CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence            458999999999999999997643          4578899999975432 23456889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceeCCCCCCceeeCCCCcEEEeecC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWR-PVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      ++...++||||++|++|.+++..  ...+++..+..++.|++.||.|||+  + ||+||||||+|||++.++.++|+|||
T Consensus       102 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  177 (360)
T 3eqc_A          102 SDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG  177 (360)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             ECCEEEEEEECCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECC
Confidence            99999999999999999999965  3468999999999999999999998  5 89999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC------------CCc
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA------------GNW  354 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~------------~~~  354 (451)
                      ++....    ........||+.|+|||++.+..++.++|||||||++|+|++|..||........            ...
T Consensus       178 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3eqc_A          178 VSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET  253 (360)
T ss_dssp             CCHHHH----HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------
T ss_pred             CCcccc----cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCC
Confidence            996421    1123346799999999999999999999999999999999999999865332100            000


Q ss_pred             c-----------------ccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          355 A-----------------KPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       355 ~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      .                 .+.......+..+.............+.++.+|+.+||..||.+|||+.|++++--
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  327 (360)
T 3eqc_A          254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  327 (360)
T ss_dssp             --------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             CCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence            0                 00000000111111111111122234678999999999999999999999998643

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.2e-44  Score=343.84  Aligned_cols=263  Identities=26%  Similarity=0.377  Sum_probs=200.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++.+.||+|+||+||+|.+...       ......||||++....   ....+.+.+|+.+++.++||||+++++++
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   90 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAP-------SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV   90 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECT-------TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccC-------CCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            4899999999999999999875431       1223468999987542   23346788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .++. .++||||+++++|.+++... ...+++..+..++.||+.||.|||+  +||+|+||||+|||++.++.+||+|||
T Consensus        91 ~~~~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           91 LTPP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             CSSS-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             ccCC-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEcccc
Confidence            8765 89999999999999998653 3568999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcc-cccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhh
Q 013028          287 LAKFGPLGDKSH-ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       287 la~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ++.......... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.....             ...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------------~~~  233 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------------SQI  233 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------------HHH
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-------------HHH
Confidence            998644322211 2234567888999999988889999999999999999999 9998864321             111


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      ...+.........+...+..+.+++.+||..||.+|||+.++++.|+.++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          234 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            1122222222233445678899999999999999999999999999988643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.8e-44  Score=349.77  Aligned_cols=261  Identities=21%  Similarity=0.327  Sum_probs=191.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|++.++||+|+||+||+|.          +..++..||||++......  ....+.+|+.+|+.++||||+++++++
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAI----------DTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI  102 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEE----------ETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEE----------ECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE
Confidence            3589999999999999999975          4455788999999754322  234567899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC-----CCCcEE
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-----DDFNAK  281 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~-----~~~~~k  281 (451)
                      .++...++||||+++ +|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++     .++.+|
T Consensus       103 ~~~~~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~k  177 (329)
T 3gbz_A          103 HHNHRLHLIFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLK  177 (329)
T ss_dssp             EETTEEEEEEECCSE-EHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEE
T ss_pred             ecCCEEEEEEecCCC-CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEE
Confidence            999999999999974 99999865  3469999999999999999999999  8999999999999994     455699


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCC---------
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA---------  351 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~---------  351 (451)
                      |+|||++......  ........||..|+|||++.+. .++.++|||||||++|+|++|..||........         
T Consensus       178 l~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  255 (329)
T 3gbz_A          178 IGDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG  255 (329)
T ss_dssp             ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ECcCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence            9999999754321  2223445789999999999764 589999999999999999999999865432100         


Q ss_pred             ----CCccccccchhhhhhHHh----hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          352 ----GNWAKPYLSNKLALHQII----DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       352 ----~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                          ..|..  ......+...+    ...+........+.++.+|+.+||..||.+|||+.|+++
T Consensus       256 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          256 LPDDTTWPG--VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCTTTSTT--GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhh--hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                00000  00000000000    000000001113578999999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-43  Score=349.56  Aligned_cols=250  Identities=25%  Similarity=0.366  Sum_probs=206.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|.+.+.||+|+||.||++.+          ..++..||+|++.....   ...+.+.+|+.+++.++||||+++++++
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~----------~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  110 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISD----------ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF  110 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEE----------CCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            5899999999999999999764          34577899999875432   2345678999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+.+..++||||+++++|.+++..  ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg  186 (335)
T 2owb_A          111 EDNDFVFVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFG  186 (335)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             ecCCeEEEEEecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEeecc
Confidence            999999999999999999998854  3568999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++......  ........||..|+|||++.+..++.++|||||||++|+|++|..||......             ....
T Consensus       187 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------------~~~~  251 (335)
T 2owb_A          187 LATKVEYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------------ETYL  251 (335)
T ss_dssp             TCEECCST--TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------------HHHH
T ss_pred             CceecccC--cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-------------HHHH
Confidence            99864322  22234567999999999998889999999999999999999999998643210             1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      .+...  ....+...+..+.+|+.+||+.||.+|||+.|+++.-
T Consensus       252 ~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~  293 (335)
T 2owb_A          252 RIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  293 (335)
T ss_dssp             HHHHT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             HHhcC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            11111  1223445567899999999999999999999999853

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-43  Score=348.58  Aligned_cols=253  Identities=25%  Similarity=0.350  Sum_probs=196.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC-----HHHHHHHHHHHHhcCCCceeecc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-----QDEWENELRFLSRLNHPNVVKLM  203 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~il~~l~h~nIv~~~  203 (451)
                      .++|.+.+.||+|+||.||+|.          +..++..||||++.......     ...+.+|+.+++.++||||++++
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~----------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   78 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKAR----------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL   78 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEE----------CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hcccEEEeEEeecCCEEEEEEE----------ECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence            4689999999999999999965          44557889999987432211     23578899999999999999999


Q ss_pred             ceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          204 GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       204 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      +++.+....++||||+++ +|.+++... ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+
T Consensus        79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~kl~  154 (346)
T 1ua2_A           79 DAFGHKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLA  154 (346)
T ss_dssp             EEECCTTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEEeeCCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCEEEE
Confidence            999999999999999976 888887543 3568899999999999999999999  899999999999999999999999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchh
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      |||++.....  .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......             
T Consensus       155 Dfg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-------------  219 (346)
T 1ua2_A          155 DFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-------------  219 (346)
T ss_dssp             CCGGGSTTTS--CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------
T ss_pred             ecccceeccC--CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-------------
Confidence            9999985432  2223345678999999999965 45899999999999999999999988653321             


Q ss_pred             hhhhHHhhhh---------------------hcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          363 LALHQIIDEK---------------------LGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       363 ~~~~~~~~~~---------------------~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ..+..++...                     .....     ....+.++.+|+.+||..||.+|||+.|+++.-
T Consensus       220 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          220 DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             HHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            0001111000                     00000     123357899999999999999999999999853

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.1e-44  Score=349.28  Aligned_cols=262  Identities=22%  Similarity=0.331  Sum_probs=193.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC-HHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|.++++||+|+||+||+|..          ..++..||||++....... ...+.+|+.+|+.++||||+++++++.+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKS----------KLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT   71 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEE----------CCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee
Confidence            4799999999999999999764          3457789999986433221 1234579999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||++ |+|.+++... ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  147 (324)
T 3mtl_A           72 EKSLTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLA  147 (324)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred             CCEEEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCccc
Confidence            999999999997 5898888654 3568999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-------------CCc
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-------------GNW  354 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-------------~~~  354 (451)
                      .....  .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........             ..|
T Consensus       148 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  225 (324)
T 3mtl_A          148 RAKSI--PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW  225 (324)
T ss_dssp             ECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccC--CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhc
Confidence            75322  1222334578999999999876 6789999999999999999999999965432110             001


Q ss_pred             cccccchhhhhhHHhhhhhcC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          355 AKPYLSNKLALHQIIDEKLGR----NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ......  .............    ......+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       226 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          226 PGILSN--EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             TTGGGC--HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhcc--hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000000  0000000000000    0011235778999999999999999999999983

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.8e-43  Score=378.50  Aligned_cols=249  Identities=26%  Similarity=0.341  Sum_probs=207.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhc-CCCceeeccc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRL-NHPNVVKLMG  204 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~nIv~~~~  204 (451)
                      .++|++++.||+|+||.||+|.+          ..++..||||++.+.   .....+.+..|..+|..+ +||||+++++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~----------~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~  409 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSER----------KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS  409 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEE----------SSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEE----------CCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            46899999999999999999664          455788999999743   233456678899999988 5999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      ++.+.+.+||||||++||+|.+++...  ..+++..+..++.||+.||.|||+  +|||||||||+||||+.++.+||+|
T Consensus       410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL~D  485 (674)
T 3pfq_A          410 CFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIAD  485 (674)
T ss_dssp             ECBCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEECC
T ss_pred             EEEeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEEee
Confidence            999999999999999999999999653  569999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ||+|+....  ........+||+.|+|||++.+..|+.++|||||||++|||++|..||.....             ...
T Consensus       486 FGla~~~~~--~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-------------~~~  550 (674)
T 3pfq_A          486 FGMCKENIW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------------DEL  550 (674)
T ss_dssp             CTTCEECCC--TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHH
T ss_pred             cceeecccc--CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-------------HHH
Confidence            999985322  12234567899999999999999999999999999999999999999975322             111


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM-----SEVVA  408 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~  408 (451)
                      ...+...  ...++...+.++.+||.+||..||.+||++     .||++
T Consensus       551 ~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          551 FQSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHHHHSS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHHHHhC--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            2222222  123455667899999999999999999997     66664

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.4e-43  Score=341.95  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=207.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .++|.+.+.||+|+||.||+|..          ..++..||+|++.....   ...+.+.+|+.+++.++||||++++++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~----------~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   83 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISD----------ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF   83 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEE----------CCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeee
Confidence            35899999999999999999764          44577899999875432   234567889999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.+.+..++||||+++++|.+++..  ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.++|+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~df  159 (294)
T 2rku_A           84 FEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDF  159 (294)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             eccCCEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEEec
Confidence            9999999999999999999998854  3568999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |++......  ........||..|+|||++.+..++.++||||||+++|+|++|..||......             ...
T Consensus       160 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------------~~~  224 (294)
T 2rku_A          160 GLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------------ETY  224 (294)
T ss_dssp             TTCEECCST--TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------------HHH
T ss_pred             cCceecccC--ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------HHH
Confidence            999864321  22234467899999999998888999999999999999999999998643211             111


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      ..+...  ....+...+..+.+|+.+||+.||.+|||+.++++.--
T Consensus       225 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~  268 (294)
T 2rku_A          225 LRIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF  268 (294)
T ss_dssp             HHHHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             HHHhhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence            111111  12234455678999999999999999999999998643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.8e-44  Score=341.59  Aligned_cols=254  Identities=26%  Similarity=0.367  Sum_probs=204.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++.+.||+|+||.||+|..          ..++..||+|.+.....  ...+.+.+|+.+++.++||||+++++++.
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRR----------KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII   75 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE----------TTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEE----------CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            5899999999999999999764          44578899999975432  23456889999999999999999999875


Q ss_pred             --cCCeeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-----ceeCCCCCCceeeCCCC
Q 013028          208 --DDQHRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLHTYWRP-----VIHRDVKASNVLLDDDF  278 (451)
Q Consensus       208 --~~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-----iiHrDlkp~NIll~~~~  278 (451)
                        .....++||||+++++|.+++...  ....+++..++.++.|++.||.|||+  .+     |+||||||+|||++.++
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~ivH~dl~p~NIl~~~~~  153 (279)
T 2w5a_A           76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR--RSDGGHTVLHRDLKPANVFLDGKQ  153 (279)
T ss_dssp             EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HC------CCCCCSGGGEEECSSS
T ss_pred             cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc--ccCCCCeeEEeccchhhEEEcCCC
Confidence              467889999999999999998642  23559999999999999999999999  78     99999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                      .+||+|||++......  ........||..|+|||++.+..++.++||||||+++|+|++|..||.....          
T Consensus       154 ~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------  221 (279)
T 2w5a_A          154 NVKLGDFGLARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----------  221 (279)
T ss_dssp             CEEECCCCHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------
T ss_pred             CEEEecCchheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH----------
Confidence            9999999999853321  1223345789999999999888999999999999999999999999864321          


Q ss_pred             cchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                          ..+...+........+...+.++.+++.+||+.||.+|||+.|+++.+.
T Consensus       222 ----~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          222 ----KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             ----HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ----HHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                1111222222222344556788999999999999999999999998664

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.1e-44  Score=360.45  Aligned_cols=250  Identities=16%  Similarity=0.176  Sum_probs=192.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHH---HHhcCCCceeecc
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRF---LSRLNHPNVVKLM  203 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~i---l~~l~h~nIv~~~  203 (451)
                      ++|.+.+.||+|+||+||+|.+          ..++..||||++...   .....+.+.+|+.+   |+.++|||||+++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~  142 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATD----------QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH  142 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-----------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred             ceEEEcceeecCCCEEEEEEEE----------CCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence            5899999999999999999763          445788999999743   23345678899954   5555799999998


Q ss_pred             -------ceeecCC-----------------eeEEEEeccCCCChhhhhccCC-----CCCCCHHHHHHHHHHHHHHHHH
Q 013028          204 -------GYCCDDQ-----------------HRLLVYEYVTRGSLEDHLLNED-----DTELNWERRIKIALGAARGLEH  254 (451)
Q Consensus       204 -------~~~~~~~-----------------~~~lV~E~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~  254 (451)
                             +++.+.+                 ..||||||+ +|+|.+++....     ...+++..++.|+.||+.||.|
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~  221 (377)
T 3byv_A          143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS  221 (377)
T ss_dssp             HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence                   5555443                 378999999 679999986421     1223358888999999999999


Q ss_pred             HHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccC-----------CCCcc
Q 013028          255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-----------HLTLK  323 (451)
Q Consensus       255 LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~  323 (451)
                      ||+  +||+||||||+|||++.++.+||+|||+++...     .......| +.|+|||++.+.           .++.+
T Consensus       222 LH~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~  293 (377)
T 3byv_A          222 LHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS  293 (377)
T ss_dssp             HHH--TTEECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred             HHh--CCeecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChh
Confidence            999  899999999999999999999999999998522     23345677 999999999877           89999


Q ss_pred             hhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 013028          324 TDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTM  403 (451)
Q Consensus       324 ~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  403 (451)
                      +|||||||++|||++|..||..........             .+..      .....+.++.+|+.+||..||.+|||+
T Consensus       294 ~DvwSlG~il~elltg~~Pf~~~~~~~~~~-------------~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          294 FDAWALGLVIYWIWCADLPITKDAALGGSE-------------WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHHHHHHHHHHHHHHSSCCC------CCSG-------------GGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             hhHHHHHHHHHHHHHCCCCCcccccccchh-------------hhhh------hccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            999999999999999999987543321100             0100      112335779999999999999999999


Q ss_pred             HHHHH--HHHHhHHhc
Q 013028          404 SEVVA--ALEQLQLNM  417 (451)
Q Consensus       404 ~evl~--~L~~~~~~~  417 (451)
                      .++++  .++.++...
T Consensus       355 ~e~l~hp~f~~~~~~~  370 (377)
T 3byv_A          355 LQAMETPEYEQLRTEL  370 (377)
T ss_dssp             HHHHTSHHHHHHHHHH
T ss_pred             HHHhhChHHHHHHHHH
Confidence            99997  556555443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-43  Score=349.92  Aligned_cols=260  Identities=25%  Similarity=0.323  Sum_probs=194.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|++.+.||+|+||.||+|..          ..++..||||++......  ..+.+.+|+.+|+.++||||+++++++
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~   93 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVD----------GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF   93 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEE----------TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred             cceEEEeEEeeecCCeEEEEEEE----------CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeE
Confidence            35899999999999999999764          455788999999654322  235678999999999999999999999


Q ss_pred             ecCC------eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          207 CDDQ------HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       207 ~~~~------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      ....      ..|+||||+ +++|.+++..   ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~  167 (367)
T 1cm8_A           94 TPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCEL  167 (367)
T ss_dssp             CSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCE
T ss_pred             ecCCccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEcCCCCE
Confidence            7653      459999999 8899998865   468999999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--------
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--------  351 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--------  351 (451)
                      ||+|||+++....     .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........        
T Consensus       168 kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~  242 (367)
T 1cm8_A          168 KILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT  242 (367)
T ss_dssp             EECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEEeeeccccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999986332     2345688999999999877 7899999999999999999999999975432100        


Q ss_pred             CCccccccch--hhhhhHHhhhhh------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 GNWAKPYLSN--KLALHQIIDEKL------GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ~~~~~~~~~~--~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ......+...  .......+....      ........++.+.+|+.+||..||.+|||+.|++++
T Consensus       243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0000000000  000000000000      001122346789999999999999999999999984

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.5e-43  Score=340.69  Aligned_cols=250  Identities=26%  Similarity=0.384  Sum_probs=196.8

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--------cCHHHHHHHHHHHHhcCCCce
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--------QGQDEWENELRFLSRLNHPNV  199 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~nI  199 (451)
                      +.++|.+.+.||+|+||.||+|.+          ..++..||||++.....        .....+.+|+++|+.++||||
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   77 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFE----------RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI   77 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTB
T ss_pred             hhhceeEeeEEecCCCEEEEEEEE----------cCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCC
Confidence            456899999999999999999764          34577899999875321        122347899999999999999


Q ss_pred             eeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          200 VKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       200 v~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      +++++++..+. .++||||+++++|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.
T Consensus        78 ~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~  152 (322)
T 2ycf_A           78 IKIKNFFDAED-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEE  152 (322)
T ss_dssp             CCEEEEEESSS-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSS
T ss_pred             ceEeeEEcCCc-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCC
Confidence            99999997665 8999999999999998854  4679999999999999999999999  89999999999999987654


Q ss_pred             ---EEEeecCCcccCCCCCCcccccccCCCCccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC
Q 013028          280 ---AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN  353 (451)
Q Consensus       280 ---~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  353 (451)
                         +||+|||++....   .........||+.|+|||++.   ...++.++|||||||++|+|++|..||.......   
T Consensus       153 ~~~~kl~Dfg~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---  226 (322)
T 2ycf_A          153 DCLIKITDFGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---  226 (322)
T ss_dssp             SCCEEECCCTTCEECC---CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---
T ss_pred             CCeEEEccCccceecc---cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---
Confidence               9999999998643   222234567999999999974   4678999999999999999999999986533210   


Q ss_pred             ccccccchhhhhhHHhhhhhcCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          354 WAKPYLSNKLALHQIIDEKLGRNI---QMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                                .+...+........   ....+..+.+|+.+||..||.+|||+.++++
T Consensus       227 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          227 ----------SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             ----------CHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----------HHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                      01111111100000   1123578999999999999999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.6e-43  Score=350.09  Aligned_cols=262  Identities=24%  Similarity=0.337  Sum_probs=191.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|++++.||+|+||.||+|..          ..++..||||++.....  ...+.+.+|+.+++.++||||+++++++
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   93 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYD----------AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF   93 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheeEeeeeEecCCEEEEEEEE----------CCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEee
Confidence            35899999999999999999754          44577899999975432  2235678999999999999999999999


Q ss_pred             ecCC------eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          207 CDDQ------HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       207 ~~~~------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      ....      ..++||||+++ +|.+.+.    ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~~  166 (371)
T 2xrw_A           94 TPQKSLEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL  166 (371)
T ss_dssp             CSCCSTTTCCEEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCE
T ss_pred             ccccccccccceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCE
Confidence            7654      78999999975 7888874    358999999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----CCcc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----GNWA  355 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----~~~~  355 (451)
                      ||+|||+++....   ........||+.|+|||++.+..++.++|||||||++|+|++|..||........     ....
T Consensus       167 kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  243 (371)
T 2xrw_A          167 KILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG  243 (371)
T ss_dssp             EECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CC
T ss_pred             EEEEeeccccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999999985321   2223456799999999999999999999999999999999999999975432100     0000


Q ss_pred             c---cccch-h---------------hhhhHHhhhhhcCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          356 K---PYLSN-K---------------LALHQIIDEKLGRN---IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       356 ~---~~~~~-~---------------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      .   .+... .               ..+...+.......   .....+..+.+|+.+||..||.+|||+.|+++.-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence            0   00000 0               00000000000000   0122367899999999999999999999999853

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=344.12  Aligned_cols=253  Identities=28%  Similarity=0.423  Sum_probs=198.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~  207 (451)
                      .++|++.+.||+|+||.||+|.+.          .++..||||++... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           23 AGIFELVELVGNGTYGQVYKGRHV----------KTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET----------TTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEEC----------CCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            458999999999999999997643          45678999999743 33456788999999999 6999999999998


Q ss_pred             c------CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEE
Q 013028          208 D------DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       208 ~------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~k  281 (451)
                      .      ....++||||+++|+|.+++.......+++..++.++.||+.||.|||+  .||+|+||||+|||++.++.+|
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCCCCEE
Confidence            6      4678999999999999999976555679999999999999999999999  8999999999999999999999


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccc
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA-----TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK  356 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~  356 (451)
                      |+|||++......  ........||..|+|||++.     +..++.++|||||||++|+|++|..||......       
T Consensus       170 l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------  240 (326)
T 2x7f_A          170 LVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------  240 (326)
T ss_dssp             ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------
T ss_pred             EeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------
Confidence            9999999753321  11233457899999999986     567899999999999999999999998543210       


Q ss_pred             cccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          357 PYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                            .....+.............+..+.+|+.+||..||.+|||+.++++.
T Consensus       241 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          241 ------RALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             ------HHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ------HHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                  11111111111111233446789999999999999999999999984

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-43  Score=350.85  Aligned_cols=259  Identities=24%  Similarity=0.322  Sum_probs=205.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC----CcCHHHHHHHHHHHHhc-CCCceeeccc
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG----SQGQDEWENELRFLSRL-NHPNVVKLMG  204 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~h~nIv~~~~  204 (451)
                      ++|++.+.||+|+||.||+|....       ...++..||||++....    ....+.+.+|+++|+.+ +||||+++++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  126 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKIS-------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY  126 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECS-------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcc-------cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence            489999999999999999987532       23467889999986432    22345567899999999 5999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      ++.++...+|||||+++|+|.+++...  ..+++..+..++.||+.||.|||+  +||+||||||+||||+.++.+||+|
T Consensus       127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~D  202 (355)
T 1vzo_A          127 AFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTD  202 (355)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESC
T ss_pred             EEeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEEee
Confidence            999999999999999999999999653  468999999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      ||+++..... ........+||+.|+|||++.+  ..++.++|||||||++|+|++|..||........          .
T Consensus       203 fG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----------~  271 (355)
T 1vzo_A          203 FGLSKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----------Q  271 (355)
T ss_dssp             SSEEEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----------H
T ss_pred             CCCCeecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----------H
Confidence            9999853321 1222345679999999999975  4578999999999999999999999864332100          0


Q ss_pred             hhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 013028          363 LALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAALE  411 (451)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~  411 (451)
                      ..+...+. ......+...+..+.+||.+||..||.+||     |+.|+++..-
T Consensus       272 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          272 AEISRRIL-KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             HHHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             HHHHHHHh-ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence            01111111 112234455678899999999999999999     9999988653

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.9e-43  Score=355.96  Aligned_cols=200  Identities=25%  Similarity=0.371  Sum_probs=172.8

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc------CCCceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL------NHPNVVKL  202 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l------~h~nIv~~  202 (451)
                      ..+|+++++||+|+||+||+|..          ..++..||||++... ......+.+|+.+++.+      +|+||+++
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~----------~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~  164 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYD----------HKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHM  164 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEE----------TTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred             cCcEEEEEEcccCccEEEEEEEE----------CCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence            45899999999999999999764          445778999999642 22335677888888877      57799999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc--E
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN--A  280 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~--~  280 (451)
                      ++++......++||||+. ++|.+++.......+++..+..++.||+.||.|||+  +||+||||||+||||+.++.  +
T Consensus       165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~~~~~~~v  241 (429)
T 3kvw_A          165 LENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRSGI  241 (429)
T ss_dssp             EEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEESSTTSCCE
T ss_pred             EeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEccCCCcce
Confidence            999999999999999995 699999977666679999999999999999999999  89999999999999999887  9


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRT  347 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  347 (451)
                      ||+|||+++....     .....+||+.|+|||++.+..++.++|||||||++|||++|.+||....
T Consensus       242 kL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          242 KVIDFGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EECCCTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEeecccceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999975321     2234689999999999999999999999999999999999999986543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-43  Score=353.56  Aligned_cols=258  Identities=24%  Similarity=0.318  Sum_probs=198.6

Q ss_pred             HHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       127 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ...++|++++.||+|+||+||+|..          ..++..||||++......    ..+|+++|+.++||||++++++|
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~----------~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~   69 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFD----------IESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYF   69 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEE----------TTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccceEEEEEEEEeccCEEEEEEEE----------CCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhhee
Confidence            4457999999999999999999764          455788999998654322    24799999999999999999998


Q ss_pred             ec--------------------------------------CCeeEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHH
Q 013028          207 CD--------------------------------------DQHRLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIAL  246 (451)
Q Consensus       207 ~~--------------------------------------~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~  246 (451)
                      ..                                      ....++||||++ |+|.+.+..  .....+++..+..++.
T Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~  148 (383)
T 3eb0_A           70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY  148 (383)
T ss_dssp             EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred             eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence            43                                      345889999997 587777643  2356799999999999


Q ss_pred             HHHHHHHHHHhCCCCceeCCCCCCceeeC-CCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccC-CCCcch
Q 013028          247 GAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKT  324 (451)
Q Consensus       247 qi~~aL~~LH~~~~~iiHrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~  324 (451)
                      ||+.||.|||+  +||+||||||+|||++ .++.+||+|||+|......   .......||+.|+|||++.+. .++.++
T Consensus       149 qi~~aL~~LH~--~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~  223 (383)
T 3eb0_A          149 QLFRAVGFIHS--LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSI  223 (383)
T ss_dssp             HHHHHHHHHHT--TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred             HHHHHHHHHHH--CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcch
Confidence            99999999999  8999999999999997 6889999999999864322   223456789999999998764 589999


Q ss_pred             hhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhh---------------------------hhhcCCC
Q 013028          325 DVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID---------------------------EKLGRNI  377 (451)
Q Consensus       325 DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~  377 (451)
                      |||||||++|+|++|..||.......             .+..++.                           ..+....
T Consensus       224 DiwslG~il~ell~g~~pf~~~~~~~-------------~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (383)
T 3eb0_A          224 DLWSIGCVFGELILGKPLFSGETSID-------------QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL  290 (383)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHH-------------HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHS
T ss_pred             hhhhHHHHHHHHHhCCCCCCCCChHH-------------HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhC
Confidence            99999999999999999997543210             0001100                           0000012


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhHHhc
Q 013028          378 QMEEAQEFAEIILRCLNSDPKNRPTMSEVVA--ALEQLQLNM  417 (451)
Q Consensus       378 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~  417 (451)
                      +...+.++.+|+.+||..||.+|||+.|+++  .++.++...
T Consensus       291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  332 (383)
T 3eb0_A          291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSY  332 (383)
T ss_dssp             CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHHC-
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHhhc
Confidence            2334678999999999999999999999995  355555433

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.4e-43  Score=346.04  Aligned_cols=265  Identities=23%  Similarity=0.315  Sum_probs=198.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|+++++||+|+||+||+|..          ..++..||||++.....  .....+.+|+.+++.++||||+++++++.
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   86 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARH----------RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR   86 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEE----------TTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cceeEEEEEecCCCcEEEEEEE----------CCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheee
Confidence            4899999999999999999764          44577899999865432  23456789999999999999999999998


Q ss_pred             c--------CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          208 D--------DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       208 ~--------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      +        ....++||||+++ +|.+.+... ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.
T Consensus        87 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~  162 (351)
T 3mi9_A           87 TKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGV  162 (351)
T ss_dssp             EC--------CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSC
T ss_pred             ccccccccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCC
Confidence            6        4468999999975 777777543 3569999999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCC--CcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----
Q 013028          280 AKISDFGLAKFGPLGD--KSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----  351 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----  351 (451)
                      +||+|||+++......  .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||........     
T Consensus       163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  242 (351)
T 3mi9_A          163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS  242 (351)
T ss_dssp             EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            9999999998644222  1222345678999999999876 5689999999999999999999999875432100     


Q ss_pred             ---CCccccccchhhhhhHHhhhh---hcCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 ---GNWAKPYLSNKLALHQIIDEK---LGRNIQ-------MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ---~~~~~~~~~~~~~~~~~~~~~---~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                         .......+...... ......   ......       ...++.+.+|+.+||..||.+|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          243 QLCGSITPEVWPNVDNY-ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHHCCCCTTTSTTGGGC-GGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhCCCChhhccccccc-hhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence               00000000000000 000000   000000       0114668999999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.6e-43  Score=342.39  Aligned_cols=252  Identities=23%  Similarity=0.388  Sum_probs=199.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.+.||+|+||.||+|.+.          .++..||+|++........+.+.+|+.+++.++||||+++++++.+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~----------~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNK----------ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH   87 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEET----------TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEc----------CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence            458999999999999999997643          4577899999987666677889999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      +...++||||+++++|.+++... ...+++..+..++.||+.||.|||+  .||+||||||+|||++.++.++|+|||++
T Consensus        88 ~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  164 (302)
T 2j7t_A           88 DGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVS  164 (302)
T ss_dssp             C-CEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred             CCeEEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECCCCCEEEEECCCC
Confidence            99999999999999999987543 3569999999999999999999999  89999999999999999999999999997


Q ss_pred             ccCCCCCCcccccccCCCCcccccccc-----ccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYI-----ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l-----~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      ....  ..........||..|+|||++     .+..++.++||||||+++|+|++|..||......             .
T Consensus       165 ~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------~  229 (302)
T 2j7t_A          165 AKNL--KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------------R  229 (302)
T ss_dssp             HHHH--HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------------H
T ss_pred             cccc--ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------------H
Confidence            5311  001112345789999999998     3677899999999999999999999998643211             0


Q ss_pred             hhhHHhhhhh-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          364 ALHQIIDEKL-GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       364 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ....+..... ....+...+..+.+|+.+||..||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          230 VLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1111111111 11123445678999999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4e-43  Score=335.18  Aligned_cols=248  Identities=27%  Similarity=0.381  Sum_probs=196.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|.+.+.||+|+||.||+|.+.          .++..||||++...   .....+.+.+|+.+++.++||||+++++++
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   80 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQ----------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI   80 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEEC----------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            58999999999999999997643          45778999998643   233456788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+....++||||+++++|.+++...  ..+++..+..++.||+.||.|||+  +||+|+||||+|||++.++.++|+|||
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg  156 (276)
T 2h6d_A           81 STPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFG  156 (276)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH--HCSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred             ecCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChhhEEECCCCCEEEeecc
Confidence            9999999999999999999998653  468999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      ++.....   ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||......              ..
T Consensus       157 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------------~~  219 (276)
T 2h6d_A          157 LSNMMSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--------------TL  219 (276)
T ss_dssp             GGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------------HH
T ss_pred             cccccCC---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------------HH
Confidence            9986432   222334578999999999987665 68999999999999999999998642210              11


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...+... ....+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       220 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          220 FKKIRGG-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHhhcC-cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1111111 112344456789999999999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-42  Score=357.64  Aligned_cols=268  Identities=22%  Similarity=0.289  Sum_probs=211.0

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCC-Cceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH-PNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~  207 (451)
                      .++|+++++||+|+||.||+|.+          ..++..||||++......  ..+..|+++++.|+| ++|..+..++.
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~----------~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~   73 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTN----------IQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGV   73 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEE----------TTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEE----------CCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            45899999999999999999764          345778999998654332  347889999999986 55666666777


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee---CCCCcEEEee
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISD  284 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll---~~~~~~kl~D  284 (451)
                      +....+|||||+ +++|.+++... ...+++..++.|+.||+.||.|||+  +|||||||||+||||   +.++.+||+|
T Consensus        74 ~~~~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL~D  149 (483)
T 3sv0_A           74 EGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIID  149 (483)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred             eCCEEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEEEe
Confidence            888899999999 89999998643 3579999999999999999999999  899999999999999   5888999999


Q ss_pred             cCCcccCCCCCCc-----ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc
Q 013028          285 FGLAKFGPLGDKS-----HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       285 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  359 (451)
                      ||+++........     .......||..|+|||++.+..++.++|||||||+||+|++|..||........        
T Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--------  221 (483)
T 3sv0_A          150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--------  221 (483)
T ss_dssp             CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--------
T ss_pred             CCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--------
Confidence            9999864432211     112356899999999999999999999999999999999999999975432110        


Q ss_pred             chhhhhhHHhhhhhcCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCcc
Q 013028          360 SNKLALHQIIDEKLGRN---IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ  422 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~  422 (451)
                        ...+..+........   .....+.++.+|+..||..||++||++.+|++.|+.+....+....
T Consensus       222 --~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~  285 (483)
T 3sv0_A          222 --KQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFD  285 (483)
T ss_dssp             --HHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred             --HHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCcc
Confidence              111111111111111   1122357899999999999999999999999999999887765544

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.3e-43  Score=339.11  Aligned_cols=253  Identities=25%  Similarity=0.336  Sum_probs=189.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC-H-HHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-Q-DEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|++.+.||+|+||+||+|..          ..++..||||++....... . ..+..+...++.++||||+++++++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   75 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRH----------VPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL   75 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEe----------cCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee
Confidence            45899999999999999999764          4457889999997542221 2 2234455557888999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceeCCCCCCceeeCCCCcEEEe
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWR-PVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      .++...++||||++ |+|.+++..  .....+++..++.++.||+.||.|||+  + ||+||||||+|||++.++.+||+
T Consensus        76 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~  152 (290)
T 3fme_A           76 FREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMC  152 (290)
T ss_dssp             ECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HSCCCCCCCSGGGCEECTTCCEEBC
T ss_pred             eccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEe
Confidence            99999999999997 488777643  235679999999999999999999999  7 99999999999999999999999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCcccccccc----ccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI----ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  359 (451)
                      |||++.....   ........||+.|+|||++    .+..++.++|||||||++|+|++|..||.....           
T Consensus       153 Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------  218 (290)
T 3fme_A          153 DFGISGYLVD---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----------  218 (290)
T ss_dssp             CC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----------
T ss_pred             ecCCcccccc---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----------
Confidence            9999975332   2223345799999999996    566789999999999999999999999863211           


Q ss_pred             chhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                       ....+...+............+.++.+|+.+||+.||++|||+.|+++.
T Consensus       219 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          219 -PFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             -HHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -hHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence             1112223333222222233457889999999999999999999999983

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.9e-43  Score=344.84  Aligned_cols=264  Identities=22%  Similarity=0.361  Sum_probs=197.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--HHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++.+.||+|+||.||+|..          ..++..||||++.......  .+.+.+|+.+++.++||||+++++++.
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   94 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRN----------KDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK   94 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEE----------TTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEE----------CCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence            4899999999999999999764          4457889999986543322  345778999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +....++||||+++++|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  170 (331)
T 4aaa_A           95 KKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGF  170 (331)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             cCCEEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEEEEeCCC
Confidence            99999999999999888887643  3569999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc-cchhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY-LSNKLAL  365 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~  365 (451)
                      +.....  .........||..|+|||++.+. .++.++|||||||++|+|++|..||............... .......
T Consensus       171 ~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (331)
T 4aaa_A          171 ARTLAA--PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH  248 (331)
T ss_dssp             C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ceeecC--CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence            975332  12233456789999999999765 7899999999999999999999998654321000000000 0000000


Q ss_pred             hHHhhh----------hhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          366 HQIIDE----------KLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       366 ~~~~~~----------~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...+..          ......     ....++.+.+|+.+||..||.+|||+.|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000000          000000     11246789999999999999999999999874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=338.41  Aligned_cols=251  Identities=26%  Similarity=0.386  Sum_probs=200.6

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ..++|++.+.||+|+||.||+|.+.          .++..||||.+...  ...+.+.+|+.+++.++||||+++++++.
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   94 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHK----------ETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYF   94 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEET----------TTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEEC----------CCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            3568999999999999999997643          45778999999753  34567889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +....++||||+++++|.+++... ...+++..+..++.||+.||.|||+  .||+|+||||+|||++.++.++|+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~  171 (314)
T 3com_A           95 KNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGV  171 (314)
T ss_dssp             ETTEEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             eCCEEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeeccc
Confidence            999999999999999999998532 4578999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +......  ........||..|+|||++.+..++.++||||||+++|+|++|..||......             ... .
T Consensus       172 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------~~~-~  235 (314)
T 3com_A          172 AGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-------------RAI-F  235 (314)
T ss_dssp             CEECBTT--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------------HHH-H
T ss_pred             chhhhhh--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-------------HHH-H
Confidence            9753321  12233457899999999998889999999999999999999999998643210             000 0


Q ss_pred             Hhhhhh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          368 IIDEKL--GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       368 ~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+....  ....+...+..+.+|+.+||..||.+|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          236 MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             HHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             HHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            111111  111233346789999999999999999999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.3e-43  Score=352.22  Aligned_cols=269  Identities=22%  Similarity=0.299  Sum_probs=185.1

Q ss_pred             hcCCCc-CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSE-KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~-~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .+.|.+ +++||+|+||+||+|.+.+        ..++..||||++...  .....+.+|+.+|+.++||||+++++++.
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~--------~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~   88 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKD--------GKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFL   88 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESS--------SSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEcc--------CCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence            345666 5689999999999987542        235678999999643  33456889999999999999999999995


Q ss_pred             --cCCeeEEEEeccCCCChhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee----
Q 013028          208 --DDQHRLLVYEYVTRGSLEDHLLNE-------DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL----  274 (451)
Q Consensus       208 --~~~~~~lV~E~~~gg~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll----  274 (451)
                        .+...+|||||+. |+|.+++...       ....+++..+..++.||+.||.|||+  +||+||||||+||||    
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~  165 (405)
T 3rgf_A           89 SHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEG  165 (405)
T ss_dssp             ETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSS
T ss_pred             cCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCC
Confidence              4678999999996 5888877421       22359999999999999999999999  899999999999999    


Q ss_pred             CCCCcEEEeecCCcccCCCCCC-cccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC
Q 013028          275 DDDFNAKISDFGLAKFGPLGDK-SHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG  352 (451)
Q Consensus       275 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  352 (451)
                      +.++.+||+|||+++....... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.........
T Consensus       166 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  245 (405)
T 3rgf_A          166 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT  245 (405)
T ss_dssp             TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred             CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccc
Confidence            6778999999999986432211 122345689999999999977 45899999999999999999999999765432110


Q ss_pred             ----------------------Cccccc-cchhhhhhHHhhhhhcCC---------CCHHHHHHHHHHHHHccccCCCCC
Q 013028          353 ----------------------NWAKPY-LSNKLALHQIIDEKLGRN---------IQMEEAQEFAEIILRCLNSDPKNR  400 (451)
Q Consensus       353 ----------------------~~~~~~-~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~R  400 (451)
                                            .|.... ......+...+.......         .....+..+.+||.+||..||.+|
T Consensus       246 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R  325 (405)
T 3rgf_A          246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR  325 (405)
T ss_dssp             -CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred             cccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence                                  010000 000000000000000000         000114678999999999999999


Q ss_pred             CCHHHHHHHH
Q 013028          401 PTMSEVVAAL  410 (451)
Q Consensus       401 Pt~~evl~~L  410 (451)
                      ||+.|+|++-
T Consensus       326 ~ta~e~L~hp  335 (405)
T 3rgf_A          326 ITSEQAMQDP  335 (405)
T ss_dssp             CCHHHHHTSG
T ss_pred             CCHHHHhcCh
Confidence            9999999863

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=8.4e-44  Score=355.30  Aligned_cols=261  Identities=15%  Similarity=0.109  Sum_probs=185.9

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc---CHHHHHHHHHHHHhc--CCCceeecc--
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ---GQDEWENELRFLSRL--NHPNVVKLM--  203 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l--~h~nIv~~~--  203 (451)
                      .|.+.+.||+|+||+||+|.+.          .++..||||++......   ..+.+.+|+.+++.|  +||||++++  
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~  132 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDV----------ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR  132 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEET----------TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------C
T ss_pred             eeeeeeeccCCCCEEEEEEEEC----------CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhcee
Confidence            6889999999999999997643          45778999999865432   234567785555444  699988755  


Q ss_pred             -----ceeecC-----------------CeeEEEEeccCCCChhhhhccCCCCCCCHHHH------HHHHHHHHHHHHHH
Q 013028          204 -----GYCCDD-----------------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERR------IKIALGAARGLEHL  255 (451)
Q Consensus       204 -----~~~~~~-----------------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~------~~i~~qi~~aL~~L  255 (451)
                           +++...                 ...||||||++ |+|.+++... ...+++..+      ..++.||+.||.||
T Consensus       133 ~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~L  210 (371)
T 3q60_A          133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANL  210 (371)
T ss_dssp             BCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence                 344322                 34799999998 8999999653 223445555      67889999999999


Q ss_pred             HhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCcccccccccc--CCCCcchhhHHHHHHH
Q 013028          256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVL  333 (451)
Q Consensus       256 H~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil  333 (451)
                      |+  +||+||||||+||||+.++.+||+|||+|+...     .......+|+.|+|||++.+  ..++.++|||||||++
T Consensus       211 H~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il  283 (371)
T 3q60_A          211 QS--KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI  283 (371)
T ss_dssp             HH--TTEEETTCSGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred             HH--CCCccCcCCHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence            99  899999999999999999999999999998532     11224567799999999977  7899999999999999


Q ss_pred             HHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHH
Q 013028          334 LEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA--ALE  411 (451)
Q Consensus       334 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~  411 (451)
                      |+|++|..||..........+.......      ..............+..+.+|+.+||+.||++|||+.++++  .++
T Consensus       284 ~elltg~~Pf~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  357 (371)
T 3q60_A          284 YRVWCLFLPFGLVTPGIKGSWKRPSLRV------PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL  357 (371)
T ss_dssp             HHHHHSSCSTTBCCTTCTTCCCBCCTTS------CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred             HHHHhCCCCCCCcCcccccchhhhhhhh------ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence            9999999999876554332222111100      00001111112244678999999999999999999999986  344


Q ss_pred             HhHHh
Q 013028          412 QLQLN  416 (451)
Q Consensus       412 ~~~~~  416 (451)
                      .+...
T Consensus       358 ~~~~~  362 (371)
T 3q60_A          358 QLQNE  362 (371)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            44443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=343.05  Aligned_cols=261  Identities=23%  Similarity=0.354  Sum_probs=200.0

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|++.+.||+|+||.||+|.+..             .+|+|++....  ....+.+.+|+.+++.++||||+++++++
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~-------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   98 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG-------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC   98 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS-------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC-------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            3589999999999999999987542             38999987432  22334577899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+....++||||++|++|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++ ++.++|+|||
T Consensus        99 ~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~Dfg  174 (319)
T 2y4i_B           99 MSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFG  174 (319)
T ss_dssp             ECSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred             ecCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEeecC
Confidence            9999999999999999999998653 3568999999999999999999999  8999999999999998 6799999999


Q ss_pred             CcccCCCCC---CcccccccCCCCcccccccccc---------CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc
Q 013028          287 LAKFGPLGD---KSHISTRVLGTRGYFAPEYIAT---------GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW  354 (451)
Q Consensus       287 la~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~---------~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  354 (451)
                      ++.......   .........||..|+|||++.+         ..++.++|||||||++|+|++|..||......     
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----  249 (319)
T 2y4i_B          175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-----  249 (319)
T ss_dssp             CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-----
T ss_pred             CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence            987532111   1122334568999999999864         45789999999999999999999998643211     


Q ss_pred             cccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                              .....+.............+.++.+++.+||..||.+|||+.++++.|+.+......
T Consensus       250 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~  306 (319)
T 2y4i_B          250 --------AIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR  306 (319)
T ss_dssp             --------HHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred             --------HHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                    011111111111111223456799999999999999999999999999999876544

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-42  Score=345.79  Aligned_cols=265  Identities=23%  Similarity=0.321  Sum_probs=199.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ..+|++++.||+|+||.||+|..          ..++..||||++...... ....+.+|+++|+.++||||+++++++.
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   95 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYD----------NLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIR   95 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred             cccEEEEEEeecCCCeEEEEEEE----------CCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEe
Confidence            35899999999999999999764          445778999999753322 2356889999999999999999999987


Q ss_pred             cC-----CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          208 DD-----QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       208 ~~-----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      ..     ...++||||++ |+|.+++..   ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl  169 (364)
T 3qyz_A           96 APTIEQMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKI  169 (364)
T ss_dssp             CSSTTTCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEE
T ss_pred             cCCccccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCCCCEEE
Confidence            54     46899999996 599998854   459999999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCC-cccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCc------
Q 013028          283 SDFGLAKFGPLGDK-SHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW------  354 (451)
Q Consensus       283 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~------  354 (451)
                      +|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........      
T Consensus       170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  249 (364)
T 3qyz_A          170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG  249 (364)
T ss_dssp             CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred             EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence            99999986432211 112345689999999998754 5589999999999999999999999865432210000      


Q ss_pred             --cccccch--hhhhhHHhhhhh-cCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          355 --AKPYLSN--KLALHQIIDEKL-GRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       355 --~~~~~~~--~~~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                        .......  ............ ....     ....+.++.+|+.+||..||.+|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              0000000  000000000000 0000     12235779999999999999999999999974

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.5e-42  Score=334.95  Aligned_cols=250  Identities=27%  Similarity=0.385  Sum_probs=203.0

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---------cCHHHHHHHHHHHHhcC-CCc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---------QGQDEWENELRFLSRLN-HPN  198 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~il~~l~-h~n  198 (451)
                      .++|.+.+.||+|+||.||+|..          ..++..||||++.....         ...+.+.+|+.+++.+. |||
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~   85 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIH----------KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN   85 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             hhccceeeeecCCCceEEEEEEE----------cCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            45899999999999999999764          34577899999975431         11345778999999996 999


Q ss_pred             eeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC
Q 013028          199 VVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF  278 (451)
Q Consensus       199 Iv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~  278 (451)
                      |+++++++.+....++||||+++++|.+++..  ...+++..+..++.||+.||.|||+  +||+|+||||+|||++.++
T Consensus        86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~  161 (298)
T 1phk_A           86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDM  161 (298)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTC
T ss_pred             EeeeeeeeccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcCCC
Confidence            99999999999999999999999999999865  3568999999999999999999999  8999999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccc------cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIA------TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG  352 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  352 (451)
                      .++|+|||++......   .......|+..|+|||++.      ...++.++||||||+++|+|++|..||.....    
T Consensus       162 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----  234 (298)
T 1phk_A          162 NIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----  234 (298)
T ss_dssp             CEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred             cEEEecccchhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH----
Confidence            9999999999864322   2234567899999999984      45688999999999999999999999864321    


Q ss_pred             CccccccchhhhhhHHhhhhhcCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          353 NWAKPYLSNKLALHQIIDEKLGRN--IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                               ......+........  .....+..+.+|+.+||..||.+|||+.|+++
T Consensus       235 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          235 ---------MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             ---------HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ---------HHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                     111111111111111  11345678999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.1e-42  Score=343.70  Aligned_cols=270  Identities=23%  Similarity=0.314  Sum_probs=196.4

Q ss_pred             hHHHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC-----------HHHHHHHHHH
Q 013028          122 HGLLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-----------QDEWENELRF  190 (451)
Q Consensus       122 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~i  190 (451)
                      ...+....++|.+.+.||+|+||.||+|...           .+..||||++.......           .+.+.+|+.+
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   82 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS-----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL   82 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECT-----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHH
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECC-----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHH
Confidence            4566778899999999999999999997632           26789999986432221           2678899999


Q ss_pred             HHhcCCCceeeccceeec-----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeC
Q 013028          191 LSRLNHPNVVKLMGYCCD-----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHR  265 (451)
Q Consensus       191 l~~l~h~nIv~~~~~~~~-----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHr  265 (451)
                      ++.++||||+++++++..     ....++||||++ |+|.+++... ...+++..+..++.||+.||.|||+  +||+||
T Consensus        83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~  158 (362)
T 3pg1_A           83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHE--AGVVHR  158 (362)
T ss_dssp             HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCC
T ss_pred             HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CcCEec
Confidence            999999999999999853     346899999997 5888887643 4579999999999999999999999  899999


Q ss_pred             CCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccc
Q 013028          266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAM  344 (451)
Q Consensus       266 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~  344 (451)
                      ||||+|||++.++.+||+|||++....   .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus       159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  235 (362)
T 3pg1_A          159 DLHPGNILLADNNDITICDFNLAREDT---ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR  235 (362)
T ss_dssp             CCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCChHHEEEcCCCCEEEEecCcccccc---cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence            999999999999999999999997422   2222345678999999999876 779999999999999999999999987


Q ss_pred             cccCCCCCCcc-----ccccc-----hhhhhhHHhhhhhcC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013028          345 RRTNGLAGNWA-----KPYLS-----NKLALHQIIDEKLGR-------NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV  407 (451)
Q Consensus       345 ~~~~~~~~~~~-----~~~~~-----~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  407 (451)
                      ...........     .+...     ........+......       ......++.+.+|+.+||+.||.+|||+.|++
T Consensus       236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  315 (362)
T 3pg1_A          236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL  315 (362)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence            54321000000     00000     000000000000000       01122357799999999999999999999998


Q ss_pred             HH
Q 013028          408 AA  409 (451)
Q Consensus       408 ~~  409 (451)
                      +.
T Consensus       316 ~h  317 (362)
T 3pg1_A          316 RH  317 (362)
T ss_dssp             TS
T ss_pred             cC
Confidence            74

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.4e-43  Score=340.92  Aligned_cols=256  Identities=27%  Similarity=0.444  Sum_probs=185.8

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|++.+.||+|+||.||+|..          ..++..||||.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   83 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYC----------APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV   83 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC--------------CEEEEECCC----------------CCCCCCCTTBCCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEE----------CCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence            46899999999999999999753          3456789999986432 233456789999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEE
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLN------EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~k  281 (451)
                      +.+..++||||+++++|.+++..      .....+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~k  161 (303)
T 2vwi_A           84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQ  161 (303)
T ss_dssp             SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEE
T ss_pred             ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCEE
Confidence            99999999999999999999853      134568999999999999999999999  8999999999999999999999


Q ss_pred             EeecCCcccCCCCC---CcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc
Q 013028          282 ISDFGLAKFGPLGD---KSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       282 l~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~  357 (451)
                      |+|||++.......   .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........      
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------  235 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------  235 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------
Confidence            99999997543221   1112234579999999999865 5789999999999999999999999875432100      


Q ss_pred             ccchhhhhhHHhhhh--------hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          358 YLSNKLALHQIIDEK--------LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                             ........        .........+..+.+|+.+||+.||.+|||+.++++.
T Consensus       236 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          236 -------LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             -------HHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             -------HHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                   00000000        0011122345789999999999999999999999873

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.2e-42  Score=368.91  Aligned_cols=262  Identities=26%  Similarity=0.382  Sum_probs=209.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|++.+.||+|+||.||+|.+...       ......||||.+...... ..+.+.+|+.+++.++||||+++++++.
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSP-------ENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCS-------SSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecC-------CCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            46899999999999999999987532       234567999998754322 2367889999999999999999999985


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                       ++..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus       462 -~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          462 -ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             -cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEecCC
Confidence             45689999999999999998653 3568999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      ++...... ........+|..|+|||++.+..++.++|||||||++|||++ |..||......              ...
T Consensus       538 a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--------------~~~  602 (656)
T 2j0j_A          538 SRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------------DVI  602 (656)
T ss_dssp             CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------------HHH
T ss_pred             CeecCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--------------HHH
Confidence            98643221 112223456789999999988899999999999999999997 88888643211              111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      ..+........+...+..+.+|+.+||..||.+|||+.++++.|+.+...
T Consensus       603 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          603 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            22222223334556678899999999999999999999999999998754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.7e-42  Score=339.99  Aligned_cols=263  Identities=23%  Similarity=0.315  Sum_probs=203.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCC------ceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP------NVVKL  202 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~------nIv~~  202 (451)
                      .++|++.+.||+|+||+||+|...         ...+..||||++... ....+.+.+|+.+++.++|+      +|+++
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~   82 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDH---------KAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQM   82 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET---------TTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred             cCceEEEEEEecCCCeEEEEEEec---------CCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence            459999999999999999997642         234678999999643 23345678899999988655      49999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC------
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD------  276 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~------  276 (451)
                      ++++.+....++||||+ +++|.+++.......+++..+..++.||+.||.|||+  +||+||||||+|||++.      
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~  159 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTEA  159 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCEEEE
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEeccccccc
Confidence            99999999999999999 8899999977665679999999999999999999999  89999999999999987      


Q ss_pred             -------------CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCcc
Q 013028          277 -------------DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAA  343 (451)
Q Consensus       277 -------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf  343 (451)
                                   ++.+||+|||++.....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  234 (339)
T 1z57_A          160 YNPKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF  234 (339)
T ss_dssp             EC----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cCCccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence                         66899999999986322     123467899999999999989999999999999999999999998


Q ss_pred             ccccCCCC--------CCccccc----------------cchhhhhhHHhhhh-----hcCCCCHHHHHHHHHHHHHccc
Q 013028          344 MRRTNGLA--------GNWAKPY----------------LSNKLALHQIIDEK-----LGRNIQMEEAQEFAEIILRCLN  394 (451)
Q Consensus       344 ~~~~~~~~--------~~~~~~~----------------~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~  394 (451)
                      ........        .......                +.........+...     .........++.+.+|+.+||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  314 (339)
T 1z57_A          235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE  314 (339)
T ss_dssp             CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence            65332100        0000000                00000000000000     0011234457889999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 013028          395 SDPKNRPTMSEVVAA  409 (451)
Q Consensus       395 ~dP~~RPt~~evl~~  409 (451)
                      .||.+|||+.|+++.
T Consensus       315 ~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          315 YDPAKRITLREALKH  329 (339)
T ss_dssp             SSTTTSCCHHHHTTS
T ss_pred             cCcccccCHHHHhcC
Confidence            999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.6e-43  Score=348.96  Aligned_cols=260  Identities=24%  Similarity=0.344  Sum_probs=182.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|++++.||+|+||.||+|..          ..++..||||++.....  .....+.+|+.+|+.++||||+++++++
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   97 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFD----------TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   97 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEE----------TTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             CCceEEeeEEeecCCeEEEEEEE----------CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            35899999999999999999754          45578899999975422  2245678999999999999999999998


Q ss_pred             ecC------CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          207 CDD------QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       207 ~~~------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      ...      ...++||||+ +++|.+++..   ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~  171 (367)
T 2fst_X           98 TPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCEL  171 (367)
T ss_dssp             CSCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCE
T ss_pred             ecCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCCE
Confidence            654      5679999999 7899888753   569999999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC-------
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG-------  352 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~-------  352 (451)
                      ||+|||+++....     .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........       
T Consensus       172 kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~  246 (367)
T 2fst_X          172 KILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  246 (367)
T ss_dssp             EECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999999985321     2345689999999999876 68999999999999999999999999654321000       


Q ss_pred             -Cccccccch--hhhhhHHhhhhhc-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          353 -NWAKPYLSN--KLALHQIIDEKLG-RNIQ-----MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       353 -~~~~~~~~~--~~~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                       .-.......  .......+..... ....     ...++.+.+|+.+||..||.+|||+.|+|++
T Consensus       247 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence             000000000  0000000000000 0001     1235779999999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.2e-42  Score=352.70  Aligned_cols=258  Identities=26%  Similarity=0.311  Sum_probs=191.2

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec--
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD--  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--  208 (451)
                      +|++.+.||+|+||+||+|.+.          .++..||||++.....    .+.+|+++|+.++||||++++++|..  
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~----------~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~  120 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLC----------DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG  120 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEET----------TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEEC----------CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence            7899999999999999997653          4577899999865322    23479999999999999999998853  


Q ss_pred             ----CCeeEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC-CcEE
Q 013028          209 ----DQHRLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD-FNAK  281 (451)
Q Consensus       209 ----~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~-~~~k  281 (451)
                          ..++++||||+++ +|.+.+..  .....+++..+..++.||+.||.|||+  +||+||||||+||||+.+ +.+|
T Consensus       121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~~k  197 (420)
T 1j1b_A          121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLK  197 (420)
T ss_dssp             TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTEEE
T ss_pred             CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCeEE
Confidence                2246799999975 66665532  234679999999999999999999999  899999999999999955 6789


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCCC-Ccccccc
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG-NWAKPYL  359 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~  359 (451)
                      |+|||+++.....   ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||......... .......
T Consensus       198 l~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg  274 (420)
T 1j1b_A          198 LCDFGSAKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG  274 (420)
T ss_dssp             ECCCTTCEECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             eccchhhhhcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999999864322   223356889999999998664 7999999999999999999999998754321000 0000000


Q ss_pred             -chhhhhhHHhhhhh-------------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          360 -SNKLALHQIIDEKL-------------GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       360 -~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                       .....+... ....             ...+....+.++.+|+.+||..||.+|||+.|++++
T Consensus       275 ~p~~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          275 TPTREQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             SCCHHHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence             000000000 0000             000122345789999999999999999999999974

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.7e-42  Score=345.27  Aligned_cols=252  Identities=22%  Similarity=0.332  Sum_probs=200.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-----------CCc
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-----------HPN  198 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------h~n  198 (451)
                      ++|.+.+.||+|+||+||+|..          ..++..||||++... ....+.+.+|+.+++.++           |+|
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKD----------MVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             CeEEEEEeeeecCCeEEEEEEe----------cCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccch
Confidence            5899999999999999999764          445788999999642 233456788999999886           889


Q ss_pred             eeeccceeecCC----eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceeCCCCCCcee
Q 013028          199 VVKLMGYCCDDQ----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWR-PVIHRDVKASNVL  273 (451)
Q Consensus       199 Iv~~~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~iiHrDlkp~NIl  273 (451)
                      |+++++++....    ..++||||+ +++|.+++.......+++..+..++.||+.||.|||+  + ||+||||||+|||
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~NIl  164 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVL  164 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEE
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChHHeE
Confidence            999999998654    789999999 8899999977666779999999999999999999999  7 9999999999999


Q ss_pred             eC------CCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccc
Q 013028          274 LD------DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRT  347 (451)
Q Consensus       274 l~------~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  347 (451)
                      ++      ..+.+||+|||++.....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       165 l~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          165 MEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             EEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EeccCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            94      445899999999985432     2234578999999999999999999999999999999999999997543


Q ss_pred             CCCCCCccccccchhhhh------------------------------------------hHHhhhhhcCCCCHHHHHHH
Q 013028          348 NGLAGNWAKPYLSNKLAL------------------------------------------HQIIDEKLGRNIQMEEAQEF  385 (451)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~~~~~~l  385 (451)
                      ....       ......+                                          ......  ....+...+.++
T Consensus       240 ~~~~-------~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  310 (373)
T 1q8y_A          240 GHSY-------TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEI  310 (373)
T ss_dssp             ------------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHH
T ss_pred             cccc-------CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHH
Confidence            2110       0000000                                          011111  123456778999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHH
Q 013028          386 AEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       386 ~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+||.+||..||.+|||+.|+++.
T Consensus       311 ~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          311 SDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             HHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HHHHHHHhccCccccCCHHHHhhC
Confidence            999999999999999999999884

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.5e-42  Score=342.48  Aligned_cols=250  Identities=18%  Similarity=0.277  Sum_probs=202.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC-----------------HHHHHHHHHHHH
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-----------------QDEWENELRFLS  192 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~il~  192 (451)
                      ++|++.+.||+|+||.||+|.+            ++..||||++.......                 .+.+.+|+.+++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   98 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK------------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT   98 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE------------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred             CceEEEEEEcCCCCeEEEEEEc------------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence            5899999999999999999764            46789999987432111                 178899999999


Q ss_pred             hcCCCceeeccceeecCCeeEEEEeccCCCChhhh------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCC
Q 013028          193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH------LLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRD  266 (451)
Q Consensus       193 ~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~------l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrD  266 (451)
                      .++||||+++++++.+.+..++||||+++|+|.++      +.......+++..++.++.||+.||.|||+. +||+|+|
T Consensus        99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~i~H~d  177 (348)
T 2pml_X           99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE-KNICHRD  177 (348)
T ss_dssp             TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-SCEECCC
T ss_pred             hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc-CCEeecC
Confidence            99999999999999999999999999999999998      6544467899999999999999999999973 5899999


Q ss_pred             CCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccC-CCCc-chhhHHHHHHHHHHHhCCCccc
Q 013028          267 VKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTL-KTDVYSFGVVLLEILSGKTAAM  344 (451)
Q Consensus       267 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-~~DiwSlGvil~elltg~~pf~  344 (451)
                      |||+|||++.++.++|+|||++......    ......||..|+|||++.+. .++. ++|||||||++|+|++|..||.
T Consensus       178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  253 (348)
T 2pml_X          178 VKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS  253 (348)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999853221    33456799999999999776 6666 9999999999999999999997


Q ss_pred             cccCCCCCCccccccchhhhhhHHhhhhhc-----------------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013028          345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLG-----------------RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV  407 (451)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  407 (451)
                      ......            .....+......                 .......+..+.+|+.+||+.||.+|||+.|++
T Consensus       254 ~~~~~~------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l  321 (348)
T 2pml_X          254 LKISLV------------ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL  321 (348)
T ss_dssp             CSSCSH------------HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             CCCcHH------------HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            543310            000000000000                 001134567899999999999999999999998


Q ss_pred             H
Q 013028          408 A  408 (451)
Q Consensus       408 ~  408 (451)
                      +
T Consensus       322 ~  322 (348)
T 2pml_X          322 K  322 (348)
T ss_dssp             T
T ss_pred             c
Confidence            7

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.3e-42  Score=335.41  Aligned_cols=253  Identities=26%  Similarity=0.383  Sum_probs=198.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcC--CCceeeccc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLN--HPNVVKLMG  204 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~--h~nIv~~~~  204 (451)
                      .++|++.+.||+|+||.||++...           .+..||||++......  ..+.+.+|+.++..++  |+||+++++
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            458999999999999999997532           2678999999754322  3466889999999997  599999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      ++.++...++||| +.+++|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||+++ +.+||+|
T Consensus        96 ~~~~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A           96 YEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             EEECSSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEEECC
T ss_pred             EeecCCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEEEee
Confidence            9999999999999 557899999965  3578999999999999999999999  89999999999999965 7999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCcccccccccc-----------CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-----------GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN  353 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  353 (451)
                      ||++................||+.|+|||++.+           ..++.++|||||||++|+|++|..||.....     
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----  244 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----  244 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----
Confidence            999986433222222345679999999999865           4788999999999999999999999864321     


Q ss_pred             ccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          354 WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                             ....+...++.......+...+..+.+|+.+||..||.+|||+.|+++.-
T Consensus       245 -------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          245 -------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             -------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -------HHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence                   11222333333333344444567899999999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.4e-42  Score=341.88  Aligned_cols=253  Identities=21%  Similarity=0.276  Sum_probs=175.4

Q ss_pred             hcCCCcCC-cccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKN-LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|.+.+ .||+|+||+||+|.+          ..++..||||++...    ..........++.++||||+++++++.
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~----------~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~   92 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFH----------RRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYE   92 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEE----------CCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHh
Confidence            45888855 699999999999764          445788999998642    222223333456678999999999987


Q ss_pred             c----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC---CCcE
Q 013028          208 D----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD---DFNA  280 (451)
Q Consensus       208 ~----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~---~~~~  280 (451)
                      .    +...++||||++||+|.+++.......+++..++.++.||+.||.|||+  +||+||||||+|||++.   ++.+
T Consensus        93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~~  170 (336)
T 3fhr_A           93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVL  170 (336)
T ss_dssp             EEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCE
T ss_pred             hccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCceE
Confidence            6    4568999999999999999977666689999999999999999999999  89999999999999976   4559


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS  360 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  360 (451)
                      ||+|||++.....    .......||+.|+|||++.+..++.++|||||||++|+|++|..||............     
T Consensus       171 kl~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-----  241 (336)
T 3fhr_A          171 KLTDFGFAKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-----  241 (336)
T ss_dssp             EECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred             EEeccccceeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH-----
Confidence            9999999985331    2233467899999999998888999999999999999999999999754432110000     


Q ss_pred             hhhhhhHHhhh--hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          361 NKLALHQIIDE--KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       361 ~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                          ...+...  ..........+.++.+|+.+||..||.+|||+.|+++.-
T Consensus       242 ----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          242 ----KRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             ----HHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence                0000000  011111234567899999999999999999999999854

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.4e-42  Score=336.77  Aligned_cols=264  Identities=25%  Similarity=0.374  Sum_probs=200.8

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhc---CCCceeecc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRL---NHPNVVKLM  203 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~h~nIv~~~  203 (451)
                      .++|++.+.||+|+||.||+|.+.         ..++..||||++....  ......+.+|+.+++.+   +||||++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~   80 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDL---------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF   80 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET---------TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             hhceeeeeeecccccEEEEEEEec---------CCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence            458999999999999999998652         1346789999986432  22233566788887776   899999999


Q ss_pred             ceee-----cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC
Q 013028          204 GYCC-----DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF  278 (451)
Q Consensus       204 ~~~~-----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~  278 (451)
                      +++.     .....++||||++ |+|.+++.......+++..+..++.||+.||.|||+  +||+||||||+|||++.++
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~~~  157 (326)
T 1blx_A           81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSG  157 (326)
T ss_dssp             EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTC
T ss_pred             eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcCCC
Confidence            9987     5567899999997 599999977666679999999999999999999999  8999999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-------
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-------  351 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-------  351 (451)
                      .+||+|||++....   .........||..|+|||++.+..++.++|||||||++|+|++|..||........       
T Consensus       158 ~~kl~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~  234 (326)
T 1blx_A          158 QIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV  234 (326)
T ss_dssp             CEEECSCCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CEEEecCccccccc---CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            99999999997532   22233456789999999999888999999999999999999999999875432100       


Q ss_pred             ------CCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          352 ------GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       352 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                            ..|............. .............+..+.+|+.+||..||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          235 IGLPGEEDWPRDVALPRQAFHS-KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCC-CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCCcccCccccccchhhhcc-cCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                  0000000000000000 0000000112334678999999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.7e-42  Score=344.51  Aligned_cols=257  Identities=25%  Similarity=0.353  Sum_probs=195.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--HHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--QDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|.+.+.||+|+||.||+|.+          ..++..||||++.......  ...+.+|+.+++.++||||+++++++
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  110 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAID----------KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVF  110 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             cccEEEEeEEecCCCeEEEEEEE----------CCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence            45899999999999999999764          4457889999997543222  35678999999999999999999999


Q ss_pred             ecCCee------EEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          207 CDDQHR------LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       207 ~~~~~~------~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      ......      ++||||+. ++|.+++    ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+
T Consensus       111 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~  183 (371)
T 4exu_A          111 TPASSLRNFYDFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCEL  183 (371)
T ss_dssp             CSCSSSTTCCCCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCE
T ss_pred             eccCCcccceeEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCCE
Confidence            877655      99999996 5888877    3459999999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--------
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--------  351 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--------  351 (451)
                      ||+|||+++...     .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........        
T Consensus       184 kL~Dfg~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~  258 (371)
T 4exu_A          184 KILDFGLARHAD-----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  258 (371)
T ss_dssp             EECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEEecCcccccc-----cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            999999997532     12335678999999999977 7899999999999999999999999975331100        


Q ss_pred             ----CCccccccchhhhhhHHhhhhhcCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 ----GNWAKPYLSNKLALHQIIDEKLGRN------IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ----~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                          ..+.....  ...............      .....+..+.+|+.+||..||.+|||+.|+++.
T Consensus       259 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          259 GVPGTEFVQKLN--DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CCCCHHHHTTCS--CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCcHHHHHHhh--hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                00000000  000000000000000      012236789999999999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.5e-42  Score=340.06  Aligned_cols=267  Identities=24%  Similarity=0.308  Sum_probs=186.9

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccce
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      ....++|.+.+.||+|+||+||+|.+          ..++..||||++.... .......+|++.+..++||||++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~   87 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKE----------KSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSY   87 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEE----------TTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEE----------CCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHh
Confidence            34567999999999999999999764          3457789999986543 233455678888999999999999999


Q ss_pred             eecCCe-------eEEEEeccCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceeCCCCCCceee
Q 013028          206 CCDDQH-------RLLVYEYVTRGSLEDHLLN--EDDTELNWERRIKIALGAARGLEHLH--TYWRPVIHRDVKASNVLL  274 (451)
Q Consensus       206 ~~~~~~-------~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~~~iiHrDlkp~NIll  274 (451)
                      |.....       .++||||+++ +|.+.+..  .....+++..+..++.|++.||.|||  +  +||+||||||+|||+
T Consensus        88 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~ivH~Dlkp~NIll  164 (360)
T 3e3p_A           88 FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS--VNVCHRDIKPHNVLV  164 (360)
T ss_dssp             EEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT--TCCBCSCCCGGGEEE
T ss_pred             hhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC--CCeecCcCCHHHEEE
Confidence            865332       7899999976 55544432  34567899999999999999999999  7  899999999999999


Q ss_pred             CC-CCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCCC
Q 013028          275 DD-DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG  352 (451)
Q Consensus       275 ~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  352 (451)
                      +. ++.+||+|||++.....   ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus       165 ~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  241 (360)
T 3e3p_A          165 NEADGTLKLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL  241 (360)
T ss_dssp             ETTTTEEEECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             eCCCCcEEEeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH
Confidence            96 89999999999986432   2223356789999999998654 4899999999999999999999998754321000


Q ss_pred             C-ccccccc-hhhhhhHHh---------------hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          353 N-WAKPYLS-NKLALHQII---------------DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       353 ~-~~~~~~~-~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      . ....... ....+..+.               ............+.++.+|+.+||+.||.+|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0 0000000 000000000               0000111222356789999999999999999999999974

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.4e-42  Score=346.13  Aligned_cols=202  Identities=27%  Similarity=0.311  Sum_probs=171.8

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CC-----ceee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HP-----NVVK  201 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~-----nIv~  201 (451)
                      ..++|++.+.||+|+||+||+|..          ..++..||||++... ......+..|+.+++.++ |+     +|++
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~----------~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~  120 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYD----------RVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVH  120 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEE----------TTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEE----------cCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence            356999999999999999999764          445778999999742 223456778999998886 55     4999


Q ss_pred             ccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC--CCCc
Q 013028          202 LMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD--DDFN  279 (451)
Q Consensus       202 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~--~~~~  279 (451)
                      +++++...+..+|||||+. |+|.+++.......+++..+..++.||+.||.|||++..||+||||||+|||++  .++.
T Consensus       121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~  199 (382)
T 2vx3_A          121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA  199 (382)
T ss_dssp             EEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCC
T ss_pred             eeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCc
Confidence            9999999999999999996 599999977655679999999999999999999995336999999999999995  4778


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRR  346 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~  346 (451)
                      +||+|||+++....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       200 ~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          200 IKIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEEeccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999986432     223567999999999999999999999999999999999999999754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.7e-42  Score=330.16  Aligned_cols=252  Identities=25%  Similarity=0.377  Sum_probs=202.3

Q ss_pred             HHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC--CCcCHHHHHHHHHHHHhcCCCceeeccc
Q 013028          127 AATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMG  204 (451)
Q Consensus       127 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~  204 (451)
                      ...++|++.+.||+|+||.||+|..          ..++..||||++...  .....+.+.+|+++++.++||||+++++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~----------~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   88 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKD----------RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE   88 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEE----------cCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEE
Confidence            3456899999999999999999764          345778999998653  2345677899999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC---CcEE
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD---FNAK  281 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~---~~~k  281 (451)
                      ++.+....++||||+++++|.+++..  ...+++..++.++.||+.||.|||+  +||+|+||||+|||++.+   +.+|
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~k  164 (287)
T 2wei_A           89 ILEDSSSFYIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIK  164 (287)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             EEeCCCeEEEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEE
Confidence            99999999999999999999998854  3468999999999999999999999  899999999999999754   4799


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      |+|||++......   .......||..|+|||++.+ .++.++||||||+++|+|++|..||......            
T Consensus       165 L~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------------  228 (287)
T 2wei_A          165 IIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------------  228 (287)
T ss_dssp             ECSTTGGGTBCCC---SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------------
T ss_pred             EeccCcceeecCC---CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------------
Confidence            9999999854322   11223457889999999854 5899999999999999999999998643211            


Q ss_pred             hhhhhHHhhhhhcCCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          362 KLALHQIIDEKLGRNIQ--MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       362 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                       .....+.........+  ...+.++.+|+.+||..||.+|||+.++++.
T Consensus       229 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          229 -DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             -HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence             0111111111111111  2346789999999999999999999999984

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=335.57  Aligned_cols=264  Identities=24%  Similarity=0.344  Sum_probs=193.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceee-
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCC-  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-  207 (451)
                      .++|++++.||+|+||.||+|...          .++..||||++........+.+.+|+.+++.++||||+++++++. 
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   79 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDN----------DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGP   79 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEET----------TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECT
T ss_pred             CCceeEEEEeccCCCeEEEEEEEC----------CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccc
Confidence            358999999999999999997643          457789999997655555577889999999999999999998873 


Q ss_pred             -------------cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee
Q 013028          208 -------------DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL  274 (451)
Q Consensus       208 -------------~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll  274 (451)
                                   +....++||||++ |+|.+++..   ..+++..+..++.||+.||.|||+  +||+||||||+|||+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~  153 (320)
T 2i6l_A           80 SGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFI  153 (320)
T ss_dssp             TSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEE
T ss_pred             cccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEE
Confidence                         3467899999997 599998843   568999999999999999999999  899999999999999


Q ss_pred             C-CCCcEEEeecCCcccCCCCC-CcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC
Q 013028          275 D-DDFNAKISDFGLAKFGPLGD-KSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA  351 (451)
Q Consensus       275 ~-~~~~~kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  351 (451)
                      + +++.+||+|||++....... .........+|..|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  233 (320)
T 2i6l_A          154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ  233 (320)
T ss_dssp             ETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             cCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            7 56799999999998543211 1112234567899999998865 6789999999999999999999999875432100


Q ss_pred             CC-ccc--cccchhhhhhHH-------hhhhhc-CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 GN-WAK--PYLSNKLALHQI-------IDEKLG-RN-----IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ~~-~~~--~~~~~~~~~~~~-------~~~~~~-~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .. ...  +... .....++       +..... ..     .....+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          234 MQLILESIPVVH-EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHHHHHSCCCC-HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhcCCCc-hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            00 000  0000 0000000       000000 00     112246789999999999999999999999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=337.24  Aligned_cols=257  Identities=24%  Similarity=0.338  Sum_probs=195.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|.+.+.||+|+||.||+|..          ..++..||||++......  ....+.+|+.+++.++||||+++++++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   92 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAID----------KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVF   92 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE----------TTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             CceEEEeeeEecCCCeEEEEEEE----------CCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheE
Confidence            35899999999999999999764          445788999999754322  235678999999999999999999999


Q ss_pred             ecCCe------eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          207 CDDQH------RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       207 ~~~~~------~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      .....      .++||||+. ++|.+++.    ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+
T Consensus        93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~~  165 (353)
T 3coi_A           93 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCEL  165 (353)
T ss_dssp             CSCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCCE
T ss_pred             ecccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCcE
Confidence            87654      499999997 58888773    359999999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--------
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--------  351 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--------  351 (451)
                      ||+|||++.....     ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........        
T Consensus       166 kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~  240 (353)
T 3coi_A          166 KILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  240 (353)
T ss_dssp             EECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHH
T ss_pred             EEeecccccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999999975321     1334678999999999876 6789999999999999999999999875432100        


Q ss_pred             ----CCccccccchhhhhhHHhhhh---hc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 ----GNWAKPYLSNKLALHQIIDEK---LG---RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ----~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                          ..+......  ......+...   ..   .......+..+.+|+.+||..||.+|||+.++++.
T Consensus       241 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          241 GVPGTEFVQKLND--KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CBCCHHHHTTCSC--HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCCHHHHHHHhh--HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                000000000  0000000000   00   11223457889999999999999999999999874

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.5e-42  Score=337.70  Aligned_cols=263  Identities=21%  Similarity=0.281  Sum_probs=200.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCc------eeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPN------VVKL  202 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n------Iv~~  202 (451)
                      .++|++.+.||+|+||+||+|.....         .+..||||++... ....+.+.+|+.+++.++|++      ++.+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~   87 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHAR---------GKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLM   87 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTT---------TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCC---------CceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence            46999999999999999999865432         2367999999642 233456788999999987655      8999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee--------
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL--------  274 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll--------  274 (451)
                      ++++......++||||+ +++|.+++.......+++..+..++.||+.||.|||+  +||+||||||+|||+        
T Consensus        88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~~~  164 (355)
T 2eu9_A           88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEFETL  164 (355)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCEEEE
T ss_pred             eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeccccccc
Confidence            99999999999999999 6788888876655679999999999999999999999  899999999999999        


Q ss_pred             -----------CCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCcc
Q 013028          275 -----------DDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAA  343 (451)
Q Consensus       275 -----------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf  343 (451)
                                 +.++.+||+|||++.....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (355)
T 2eu9_A          165 YNEHKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF  239 (355)
T ss_dssp             ECCC-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence                       5678999999999985322     123467999999999999999999999999999999999999999


Q ss_pred             ccccCCCC--------CCccccc----------------cchhhhhhHHhhhh-----hcCCCCHHHHHHHHHHHHHccc
Q 013028          344 MRRTNGLA--------GNWAKPY----------------LSNKLALHQIIDEK-----LGRNIQMEEAQEFAEIILRCLN  394 (451)
Q Consensus       344 ~~~~~~~~--------~~~~~~~----------------~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~  394 (451)
                      ........        ......+                +.............     .........+..+.+|+.+||.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  319 (355)
T 2eu9_A          240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE  319 (355)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence            75432100        0000000                00000000000000     0011223446789999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 013028          395 SDPKNRPTMSEVVAA  409 (451)
Q Consensus       395 ~dP~~RPt~~evl~~  409 (451)
                      .||.+|||+.|+++.
T Consensus       320 ~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          320 FDPAQRITLAEALLH  334 (355)
T ss_dssp             SSTTTSCCHHHHTTS
T ss_pred             CChhhCcCHHHHhcC
Confidence            999999999999853

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.9e-42  Score=345.45  Aligned_cols=259  Identities=24%  Similarity=0.311  Sum_probs=189.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      .+|++.++||+|+||+||+|.+..          ++ .||+|++......    ..+|+++|+.++||||++++++|...
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~----------~~-~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~  104 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVE----------SD-EVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSN  104 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT----------TE-EEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECC----------CC-eEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEec
Confidence            479999999999999999987543          22 3788877543222    23699999999999999999998543


Q ss_pred             C------eeEEEEeccCCCChhhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC-CCCcE
Q 013028          210 Q------HRLLVYEYVTRGSLEDHLL--NEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNA  280 (451)
Q Consensus       210 ~------~~~lV~E~~~gg~L~~~l~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~-~~~~~  280 (451)
                      .      ..++||||++++ |...+.  ......+++..+..++.||+.||.|||+  +||+||||||+|||++ .++.+
T Consensus       105 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~  181 (394)
T 4e7w_A          105 GDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVL  181 (394)
T ss_dssp             SSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEE
T ss_pred             CCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcE
Confidence            3      378999999764 443332  1234679999999999999999999999  8999999999999998 79999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC-ccccc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN-WAKPY  358 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~  358 (451)
                      ||+|||+|+.....   .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.......... .....
T Consensus       182 kL~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~  258 (394)
T 4e7w_A          182 KLIDFGSAKILIAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL  258 (394)
T ss_dssp             EECCCTTCEECCTT---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEeeCCCcccccCC---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            99999999864322   223356789999999998664 59999999999999999999999997543210000 00000


Q ss_pred             -cchhhhhhHHhhhh------------hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          359 -LSNKLALHQIIDEK------------LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       359 -~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                       ......+...-...            +........++++.+|+.+||..||.+|||+.|++++
T Consensus       259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence             00000000000000            0000122245789999999999999999999999974

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.9e-42  Score=331.32  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=191.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.+.||+|+||.||+|..          ..++..||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   73 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARN----------ALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLE   73 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             cccchhhheeccCCcEEEEEEEE----------cCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHh
Confidence            45899999999999999999764          445788999999642 2334568899999999999999999998865


Q ss_pred             -------------CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC
Q 013028          209 -------------DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD  275 (451)
Q Consensus       209 -------------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~  275 (451)
                                   ....++||||+++|+|.+++... ...+++..++.++.||+.||.|||+  +||+||||||+|||++
T Consensus        74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~~  150 (303)
T 1zy4_A           74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFID  150 (303)
T ss_dssp             CCCCCC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEC
T ss_pred             hcchhhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEEc
Confidence                         35679999999999999999653 3567889999999999999999999  8999999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCC------------CcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCc
Q 013028          276 DDFNAKISDFGLAKFGPLGD------------KSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTA  342 (451)
Q Consensus       276 ~~~~~kl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~p  342 (451)
                      .++.++|+|||++.......            .........||..|+|||++.+. .++.++|||||||++|+|++   |
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p  227 (303)
T 1zy4_A          151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P  227 (303)
T ss_dssp             TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred             CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence            99999999999997543211            01122345789999999999754 78999999999999999998   3


Q ss_pred             cccccCCCCCCccccccchhhhhhHHhh--hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          343 AMRRTNGLAGNWAKPYLSNKLALHQIID--EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       343 f~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      |....            ........+..  .......+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       228 ~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          228 FSTGM------------ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             CSSHH------------HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cCCch------------hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            32110            00001111111  111223344556789999999999999999999999873

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.9e-42  Score=341.17  Aligned_cols=264  Identities=22%  Similarity=0.287  Sum_probs=197.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|.+.+.||+|+||.||+|.+.          .++..||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   79 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHK----------PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQR   79 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEET----------TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEEC----------CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeec
Confidence            458999999999999999997643          4577899999964322 22356779999999999999999999876


Q ss_pred             cC-----CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          208 DD-----QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       208 ~~-----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      ..     ...++||||+. ++|.+++..   ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||
T Consensus        80 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~~kl  153 (353)
T 2b9h_A           80 PDSFENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKV  153 (353)
T ss_dssp             CSCSTTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEE
T ss_pred             ccccCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCcEEE
Confidence            54     67899999996 589988854   468999999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCCcc--------cccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--
Q 013028          283 SDFGLAKFGPLGDKSH--------ISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--  351 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--  351 (451)
                      +|||++..........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........  
T Consensus       154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  233 (353)
T 2b9h_A          154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL  233 (353)
T ss_dssp             CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            9999998643221110        1224578999999998754 7789999999999999999999999875432100  


Q ss_pred             ----------CCccccccchhhhhhHHhhhhhc-C-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 ----------GNWAKPYLSNKLALHQIIDEKLG-R-----NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ----------~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                                ........ ........+..... .     ......+.++.+|+.+||..||.+|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          234 LIFGIIGTPHSDNDLRCI-ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHHHHCCCCSTTTTTTC-CCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhCCCchhcccccc-ccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                      00000000 00000111110000 0     0012346789999999999999999999999973

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-42  Score=334.50  Aligned_cols=245  Identities=28%  Similarity=0.460  Sum_probs=193.1

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC------HHHHHHHHHHHHhc----C
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG------QDEWENELRFLSRL----N  195 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~il~~l----~  195 (451)
                      +...++|++.+.||+|+||.||+|.          +..++..||||++.......      ...+.+|+.++..+    +
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~----------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   96 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGH----------RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG   96 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEE----------CTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCC
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEE----------EccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCC
Confidence            3445689999999999999999975          44457889999997543221      22345799999998    8


Q ss_pred             CCceeeccceeecCCeeEEEEec-cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceee
Q 013028          196 HPNVVKLMGYCCDDQHRLLVYEY-VTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLL  274 (451)
Q Consensus       196 h~nIv~~~~~~~~~~~~~lV~E~-~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll  274 (451)
                      |+||+++++++.+.+..++|||+ +.+++|.+++..  ...+++..++.++.||+.||.|||+  +||+||||||+|||+
T Consensus        97 h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~  172 (312)
T 2iwi_A           97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILI  172 (312)
T ss_dssp             CSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH--HTEECCCCSGGGEEE
T ss_pred             CCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChhhEEE
Confidence            99999999999999999999999 789999999965  3468999999999999999999999  899999999999999


Q ss_pred             C-CCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccccccCCCCC
Q 013028          275 D-DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG  352 (451)
Q Consensus       275 ~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  352 (451)
                      + .++.++|+|||++......    ......||..|+|||++.+..+ +.++|||||||++|+|++|..||....     
T Consensus       173 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----  243 (312)
T 2iwi_A          173 DLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----  243 (312)
T ss_dssp             ETTTTEEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred             eCCCCeEEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----
Confidence            9 8899999999999864322    2335678999999999977666 458999999999999999999985321     


Q ss_pred             CccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          353 NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                                    .+...  ....+...+..+.+|+.+||..||.+|||+.|+++.
T Consensus       244 --------------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          244 --------------EILEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             --------------HHHHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --------------HHhhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                          11111  122334456789999999999999999999999874

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.9e-42  Score=338.49  Aligned_cols=245  Identities=25%  Similarity=0.401  Sum_probs=200.6

Q ss_pred             HHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc------CHHHHHHHHHHHHhcC--CC
Q 013028          126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ------GQDEWENELRFLSRLN--HP  197 (451)
Q Consensus       126 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~--h~  197 (451)
                      +...++|++.+.||+|+||.||+|..          ..++..||||++......      ....+.+|+.+++.++  |+
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~  108 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIR----------VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS  108 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEE----------TTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSC
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEE----------CCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCC
Confidence            34467999999999999999999764          345788999999754322      2234667999999996  59


Q ss_pred             ceeeccceeecCCeeEEEEeccCC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC-
Q 013028          198 NVVKLMGYCCDDQHRLLVYEYVTR-GSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-  275 (451)
Q Consensus       198 nIv~~~~~~~~~~~~~lV~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~-  275 (451)
                      ||+++++++.+++..++|||++.+ ++|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++ 
T Consensus       109 ~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~  184 (320)
T 3a99_A          109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDL  184 (320)
T ss_dssp             SBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEET
T ss_pred             CceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeC
Confidence            999999999999999999999976 899999865  3578999999999999999999999  8999999999999999 


Q ss_pred             CCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccccccCCCCCCc
Q 013028          276 DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW  354 (451)
Q Consensus       276 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  354 (451)
                      +++.+||+|||++.....    .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||....       
T Consensus       185 ~~~~~kL~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------  253 (320)
T 3a99_A          185 NRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------  253 (320)
T ss_dssp             TTTEEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred             CCCCEEEeeCcccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------
Confidence            788999999999986432    22334679999999999977665 788999999999999999999985421       


Q ss_pred             cccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          355 AKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                                  .....  ....+...+.++.+|+.+||..||.+|||+.++++.
T Consensus       254 ------------~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          254 ------------EIIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ------------HHHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------------hhhcc--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        11111  111223345789999999999999999999999873

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=9.7e-42  Score=334.12  Aligned_cols=256  Identities=25%  Similarity=0.373  Sum_probs=178.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHH-HHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELR-FLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~-il~~l~h~nIv~~~~~~~  207 (451)
                      ++|.+.+.||+|+||.||+|...          .++..||||++...... ....+..|+. +++.++||||+++++++.
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~   91 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHK----------PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF   91 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEET----------TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEc----------CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence            58999999999999999997643          45778999999754322 2334555666 677789999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceeCCCCCCceeeCCCCcEEEe
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLN---EDDTELNWERRIKIALGAARGLEHLHTYWR-PVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      +++..++||||+++ +|.+++..   .....+++..+..++.|++.||.|||+  . ||+||||||+|||++.++.+||+
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl~  168 (327)
T 3aln_A           92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLC  168 (327)
T ss_dssp             CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred             eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEEc
Confidence            99999999999975 78777642   235679999999999999999999999  7 99999999999999999999999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCcccccccc----ccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccccc
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI----ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL  359 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  359 (451)
                      |||++......   .......||..|+|||++    .+..++.++|||||||++|+|++|..||........  ......
T Consensus       169 Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~  243 (327)
T 3aln_A          169 DFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QLTQVV  243 (327)
T ss_dssp             CCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCC
T ss_pred             cCCCceecccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HHHHHh
Confidence            99999753321   122334789999999998    466789999999999999999999999864322100  000000


Q ss_pred             chhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      ..       ....+........+..+.+|+.+||..||.+|||+.++++.-
T Consensus       244 ~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  287 (327)
T 3aln_A          244 KG-------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP  287 (327)
T ss_dssp             CS-------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             cC-------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence            00       000011111123467899999999999999999999998853

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.5e-41  Score=326.31  Aligned_cols=251  Identities=23%  Similarity=0.354  Sum_probs=179.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC-H-HHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-Q-DEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++.+.||+|+||.||+|.+.          .++..||||++....... . ..+..+..+++.++||||+++++++.
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~   94 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFR----------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI   94 (318)
T ss_dssp             GGEEEEEEC------CEEEEEET----------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             ccccccceeeecCCeeEEEEEEe----------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence            48999999999999999997643          457789999997543222 1 23344555788889999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceeCCCCCCceeeCCCCcEEEeecC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWR-PVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      +++..++||||+ ++.+..+.. .....+++..+..++.||+.||.|||+  + ||+|+||||+|||++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg  170 (318)
T 2dyl_A           95 TNTDVFIAMELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFG  170 (318)
T ss_dssp             CSSEEEEEECCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCcEEEEEecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECC
Confidence            999999999999 545544443 234679999999999999999999998  6 99999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccch
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIA-----TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN  361 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  361 (451)
                      ++.....   ........||+.|+|||++.     ...++.++|||||||++|+|++|..||......            
T Consensus       171 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------  235 (318)
T 2dyl_A          171 ISGRLVD---DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------------  235 (318)
T ss_dssp             TC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------------
T ss_pred             CchhccC---CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------------
Confidence            9975332   12233457899999999984     567899999999999999999999998642211            


Q ss_pred             hhhhhHHhhhhhc-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          362 KLALHQIIDEKLG-RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       362 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...+..+...... .......+.++.+|+.+||..||.+|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          236 FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             HHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1111122111110 01112346789999999999999999999999974

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.3e-41  Score=340.30  Aligned_cols=247  Identities=28%  Similarity=0.367  Sum_probs=184.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~  208 (451)
                      +.|.+.+.||+|+||+||.+.           ..++..||||++...   ..+.+.+|+.+|+.+ +||||+++++++.+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-----------~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   80 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-----------SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETT   80 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-----------ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEE-----------EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence            466777899999999998642           234778999998642   345678899999986 79999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCC------
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTE-----LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD------  277 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~------  277 (451)
                      +...+|||||+. |+|.+++.......     .++..++.++.||+.||.|||+  +||+||||||+|||++.+      
T Consensus        81 ~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~  157 (434)
T 2rio_A           81 DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTAD  157 (434)
T ss_dssp             SSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSC
T ss_pred             CCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCcccccc
Confidence            999999999995 69999996532211     1233457899999999999999  899999999999999654      


Q ss_pred             -------CcEEEeecCCcccCCCCCCc--ccccccCCCCcccccccccc-------CCCCcchhhHHHHHHHHHHHh-CC
Q 013028          278 -------FNAKISDFGLAKFGPLGDKS--HISTRVLGTRGYFAPEYIAT-------GHLTLKTDVYSFGVVLLEILS-GK  340 (451)
Q Consensus       278 -------~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwSlGvil~ellt-g~  340 (451)
                             +.+||+|||++.........  .......||+.|+|||++.+       ..++.++|||||||++|||++ |.
T Consensus       158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence                   48999999999864432211  11234679999999999965       678999999999999999999 88


Q ss_pred             CccccccCCCCCCccccccchhhhhhHHhhhhh-----cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          341 TAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL-----GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       341 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      .||......            .   ..++....     ........+.++.+|+.+||+.||.+|||+.++++
T Consensus       238 ~Pf~~~~~~------------~---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          238 HPFGDKYSR------------E---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             CTTCSTTTH------------H---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCchhh------------H---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            888543211            0   01111111     11123456789999999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.1e-40  Score=315.42  Aligned_cols=235  Identities=15%  Similarity=0.095  Sum_probs=185.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++.+.||+|+||.||+|.+          ..++..||||++.......   .+.+.+|+.++..++||||+++++++
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~----------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~  100 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALD----------TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV  100 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEE----------TTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEe----------cCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence            5899999999999999999764          3457789999998654433   25688999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++..|+||||++|++|.+++..    ......+..|+.||+.||.|||+  +||+||||||+|||++.++.+||+++|
T Consensus       101 ~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          101 HTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             EETTEEEEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             EECCcEEEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEEcCCCCEEEEecc
Confidence            999999999999999999999843    24566788999999999999999  899999999999999999999998543


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                                            |++       .++.++|||||||++|+|++|+.||...................... 
T Consensus       175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-  224 (286)
T 3uqc_A          175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE-  224 (286)
T ss_dssp             ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCC-
T ss_pred             ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCC-
Confidence                                  333       36889999999999999999999998654432110000000000000 


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcC
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG  418 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  418 (451)
                         ..    ......+.++.+|+.+||+.||.+| |+.|+++.|+.+.....
T Consensus       225 ---~~----~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          225 ---PA----DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             ---HH----HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             ---hh----hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence               00    0112345779999999999999999 99999999999876544

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=9.9e-41  Score=352.06  Aligned_cols=269  Identities=25%  Similarity=0.349  Sum_probs=201.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++.++||+|+||+||+|          .+..++..||||++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus        14 grY~i~~~LG~G~fG~Vyla----------~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~   83 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRW----------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDG   83 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCC----------CCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTT
T ss_pred             CCeEEEEEEeeCCCeEEEEE----------EECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecc
Confidence            58999999999999999995          455667889999987542 2234568899999999999999999998765


Q ss_pred             ------CCeeEEEEeccCCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc--
Q 013028          209 ------DQHRLLVYEYVTRGSLEDHLLNED-DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN--  279 (451)
Q Consensus       209 ------~~~~~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~--  279 (451)
                            +...++||||++||+|.+++.... ...+++..++.++.||+.||.|||+  .||+||||||+|||++.++.  
T Consensus        84 ~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~~  161 (676)
T 3qa8_A           84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRL  161 (676)
T ss_dssp             TCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSSC
T ss_pred             cccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCce
Confidence                  677899999999999999996533 2468999999999999999999999  89999999999999987665  


Q ss_pred             -EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          280 -AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       280 -~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                       ++|+|||++......   .......||..|+|||++.+..++.++|||||||++|+|++|..||.......  .|....
T Consensus       162 ~vKL~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~--~~~~~i  236 (676)
T 3qa8_A          162 IHKIIDLGYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV--QWHGKV  236 (676)
T ss_dssp             EEEECSCCCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH--HSSTTC
T ss_pred             eEEEcccccccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh--hhhhhh
Confidence             999999999864322   23345689999999999999999999999999999999999999996532110  000000


Q ss_pred             cchhh-------hhhHH--hhh--hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHhHH
Q 013028          359 LSNKL-------ALHQI--IDE--KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE-----VVAALEQLQL  415 (451)
Q Consensus       359 ~~~~~-------~~~~~--~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-----vl~~L~~~~~  415 (451)
                      .....       .....  +..  ..........+..+.+|+.+||..||.+|||+.+     +++.++.+..
T Consensus       237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            00000       00000  000  0112244557889999999999999999999988     4455555543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=337.36  Aligned_cols=247  Identities=26%  Similarity=0.391  Sum_probs=183.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~  208 (451)
                      .+|.+.+.||+|+||+||..           ...++..||||++.....   ..+.+|+++|+.+ +|||||++++++.+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~-----------~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~   89 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYR-----------GMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKD   89 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEE-----------EESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEEE-----------EEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence            36888999999999996542           223467899999965332   2346899999999 69999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC-----CCcEEEe
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD-----DFNAKIS  283 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~-----~~~~kl~  283 (451)
                      ....||||||+. |+|.+++.... ..+.+..++.++.||+.||.|||+  +||+||||||+|||++.     ...+||+
T Consensus        90 ~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~  165 (432)
T 3p23_A           90 RQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMIS  165 (432)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred             CCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence            999999999996 59999986543 334555667899999999999999  89999999999999953     2358899


Q ss_pred             ecCCcccCCCCCCc-ccccccCCCCccccccccc---cCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccc
Q 013028          284 DFGLAKFGPLGDKS-HISTRVLGTRGYFAPEYIA---TGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       284 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  358 (451)
                      |||+++........ .......||+.|+|||++.   ...++.++|||||||++|+|++ |..||......         
T Consensus       166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---------  236 (432)
T 3p23_A          166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---------  236 (432)
T ss_dssp             CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---------
T ss_pred             cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---------
Confidence            99999864322211 2234567999999999997   4667889999999999999999 88887532211         


Q ss_pred             cchhhhhhHHhhhhh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          359 LSNKLALHQIIDEKL--GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                           ..........  ........+..+.+|+.+||+.||.+|||+.+|++
T Consensus       237 -----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          237 -----QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -----HHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----HHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                 0000110000  01112334667899999999999999999999994

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.7e-40  Score=353.37  Aligned_cols=244  Identities=24%  Similarity=0.361  Sum_probs=195.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|++.+.||+|+||+||+|.+..         .++..||||++..... .....+.+|+++|..++||||+++++++.
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  149 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRN---------VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVE  149 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGG---------GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcC---------CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence            4689999999999999999986532         2467899999865322 23456789999999999999999999998


Q ss_pred             cCCe-----eEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          208 DDQH-----RLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       208 ~~~~-----~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      +.+.     .||||||++|++|.+++.    ..+++..++.|+.||+.||.|||+  +|||||||||+|||++.+ .+||
T Consensus       150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~----~~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~~~-~~kl  222 (681)
T 2pzi_A          150 HTDRHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLKL  222 (681)
T ss_dssp             EECTTSCEEEEEEEECCCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSS-CEEE
T ss_pred             ecCCCCCceeEEEEEeCCCCcHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEeCC-cEEE
Confidence            7655     699999999999988763    269999999999999999999999  899999999999999986 8999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchh
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      +|||++......      ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.........       .  
T Consensus       223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-------~--  286 (681)
T 2pzi_A          223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-------E--  286 (681)
T ss_dssp             CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-------T--
T ss_pred             EecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc-------c--
Confidence            999999864321      346799999999998654 589999999999999999999887653321100       0  


Q ss_pred             hhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHHh
Q 013028          363 LALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-TMSEVVAALEQLQLN  416 (451)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~  416 (451)
                                  .......+..+.+||.+||..||.+|| ++.++...|..+...
T Consensus       287 ------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          287 ------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             ------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             ------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence                        000112346799999999999999999 577777777776544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.5e-40  Score=316.16  Aligned_cols=229  Identities=21%  Similarity=0.288  Sum_probs=180.9

Q ss_pred             cCCCcC-CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHH-HhcCCCceeeccceee
Q 013028          130 RKFSEK-NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL-SRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il-~~l~h~nIv~~~~~~~  207 (451)
                      ++|.+. +.||+|+||.||+|..          ..++..||||++..     ...+.+|+.++ +.++||||+++++++.
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~----------~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~   81 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFN----------KRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYE   81 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEE----------cCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhh
Confidence            467776 7899999999999764          44578899999863     34567899988 5567999999999988


Q ss_pred             c----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC---CCcE
Q 013028          208 D----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD---DFNA  280 (451)
Q Consensus       208 ~----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~---~~~~  280 (451)
                      +    ....++||||++||+|.+++.......+++..++.++.||+.||.|||+  +||+||||||+|||++.   ++.+
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~  159 (299)
T 3m2w_A           82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAIL  159 (299)
T ss_dssp             EEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCE
T ss_pred             hhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCCCcE
Confidence            6    6778999999999999999987666689999999999999999999999  89999999999999997   7899


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC-cccccc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN-WAKPYL  359 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~  359 (451)
                      +|+|||++....                        +..++.++|||||||++|+|++|..||.......... ......
T Consensus       160 kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  215 (299)
T 3m2w_A          160 KLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  215 (299)
T ss_dssp             EECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSC
T ss_pred             EEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHh
Confidence            999999986421                        2457889999999999999999999996543221100 000000


Q ss_pred             chhhhhhHHhhhhhcCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          360 SNKLALHQIIDEKLGRNIQ----MEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      .          .  ....+    ...+.++.+|+.+||+.||.+|||+.|+++.--
T Consensus       216 ~----------~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~  259 (299)
T 3m2w_A          216 M----------G--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  259 (299)
T ss_dssp             T----------T--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             h----------c--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence            0          0  00111    123578999999999999999999999998533

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.9e-40  Score=332.83  Aligned_cols=249  Identities=16%  Similarity=0.164  Sum_probs=185.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCC-Cceeecc--
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNH-PNVVKLM--  203 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h-~nIv~~~--  203 (451)
                      ..|...+.||+|+||+||+|.+          ..++..||||++.....   ...+.+.+|+.+++.++| .|+....  
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~----------~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~  147 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATD----------QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH  147 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEE----------TTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred             eeEEEecccccCCCEEEEEEEe----------cCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHh
Confidence            3577889999999999999764          44577899999874322   235678999999999987 3221111  


Q ss_pred             -------------------ceeec-----CCeeEEEEeccCCCChhhhhc-----cCCCCCCCHHHHHHHHHHHHHHHHH
Q 013028          204 -------------------GYCCD-----DQHRLLVYEYVTRGSLEDHLL-----NEDDTELNWERRIKIALGAARGLEH  254 (451)
Q Consensus       204 -------------------~~~~~-----~~~~~lV~E~~~gg~L~~~l~-----~~~~~~l~~~~~~~i~~qi~~aL~~  254 (451)
                                         .++..     ....+++|+++ +++|.+++.     ......+++..++.++.||+.||.|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  226 (413)
T 3dzo_A          148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS  226 (413)
T ss_dssp             TCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHH
Confidence                               11111     22457788876 679998884     2234567888999999999999999


Q ss_pred             HHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCcccccccc----------ccCCCCcch
Q 013028          255 LHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI----------ATGHLTLKT  324 (451)
Q Consensus       255 LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~~~  324 (451)
                      ||+  +||+||||||+||||+.++.+||+|||+++...     ......+| +.|+|||++          .+..++.++
T Consensus       227 LH~--~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~  298 (413)
T 3dzo_A          227 LHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF  298 (413)
T ss_dssp             HHH--TTEECSCCCGGGEEECTTCCEEECCGGGCEETT-----EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred             HHh--CCcccCCcccceEEEecCCeEEEEeccceeecC-----CccccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence            999  899999999999999999999999999998532     11345677 999999999          556688999


Q ss_pred             hhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 013028          325 DVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS  404 (451)
Q Consensus       325 DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  404 (451)
                      |||||||++|+|++|+.||........             ...++..      ....++.+.+|+.+||..||++|||+.
T Consensus       299 DvwSlGvil~elltg~~Pf~~~~~~~~-------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~  359 (413)
T 3dzo_A          299 DTWTLGLAIYWIWCADLPNTDDAALGG-------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPL  359 (413)
T ss_dssp             HHHHHHHHHHHHHHSSCCCCTTGGGSC-------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hHHHHHHHHHHHHHCCCCCCCcchhhh-------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHH
Confidence            999999999999999999975432211             0011110      112347799999999999999999998


Q ss_pred             HHHHH--HHHhHHh
Q 013028          405 EVVAA--LEQLQLN  416 (451)
Q Consensus       405 evl~~--L~~~~~~  416 (451)
                      ++++.  ++.++..
T Consensus       360 ~~l~~~~~~~~~~~  373 (413)
T 3dzo_A          360 QAMETPEYEQLRTE  373 (413)
T ss_dssp             HHTTSHHHHHHHHH
T ss_pred             HHHhCHHHHHHHHH
Confidence            88764  4444433

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.3e-40  Score=324.72  Aligned_cols=236  Identities=17%  Similarity=0.188  Sum_probs=182.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--------cCHHHHHHHHHHHHhcC------
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--------QGQDEWENELRFLSRLN------  195 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~------  195 (451)
                      ++|++.+.||+|+||+||+|.+            ++..||||++.....        ...+.+.+|+.+|+.++      
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~------------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~   87 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA------------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV   87 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE------------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred             ccchheeeecccCceEEEEEEe------------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence            5799999999999999999864            257899999975432        23477889999999886      


Q ss_pred             --------------------CCceeeccceeec-------------CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHH
Q 013028          196 --------------------HPNVVKLMGYCCD-------------DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRI  242 (451)
Q Consensus       196 --------------------h~nIv~~~~~~~~-------------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~  242 (451)
                                          ||||++++++|.+             ....||||||+++|++.+.+..   ..+++..+.
T Consensus        88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~  164 (336)
T 2vuw_A           88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAK  164 (336)
T ss_dssp             SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHH
T ss_pred             cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHH
Confidence                                5555666666554             7889999999999987777733   568999999


Q ss_pred             HHHHHHHHHHHHHH-hCCCCceeCCCCCCceeeCCCC--------------------cEEEeecCCcccCCCCCCccccc
Q 013028          243 KIALGAARGLEHLH-TYWRPVIHRDVKASNVLLDDDF--------------------NAKISDFGLAKFGPLGDKSHIST  301 (451)
Q Consensus       243 ~i~~qi~~aL~~LH-~~~~~iiHrDlkp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~  301 (451)
                      .++.||+.||.||| +  +||+||||||+||||+.++                    .+||+|||+|+....       .
T Consensus       165 ~i~~qi~~aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~  235 (336)
T 2vuw_A          165 SILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------G  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------T
T ss_pred             HHHHHHHHHHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------C
Confidence            99999999999999 8  8999999999999999887                    899999999985331       1


Q ss_pred             ccCCCCccccccccccCCCCcchhhHHHHHH-HHHHHhCCCccccccCCCCCCccccccchhhhhhHHhhhhh-----cC
Q 013028          302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVV-LLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKL-----GR  375 (451)
Q Consensus       302 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvi-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~  375 (451)
                      ..+||+.|+|||++.+.. +.++||||||++ .+++++|..||....      |.      ......++....     ..
T Consensus       236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~------~~~~~~~~~~~~~~~~~~~  302 (336)
T 2vuw_A          236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WL------HYLTDKMLKQMTFKTKCNT  302 (336)
T ss_dssp             EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HH------HHHHHHHHHTCCCSSCCCS
T ss_pred             cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hh------hHHHHhhhhhhccCcccch
Confidence            347999999999997665 899999998777 778889998875311      00      000011111000     01


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013028          376 NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV  407 (451)
Q Consensus       376 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  407 (451)
                      ......++++.+||.+||+.|     |+.|+|
T Consensus       303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          303 PAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            112356889999999999977     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=8.4e-34  Score=297.64  Aligned_cols=176  Identities=22%  Similarity=0.195  Sum_probs=131.8

Q ss_pred             hhhcCCCcEEEEEEeccCCC----------cCHHHHHHHHHHHHhc-CCCceeeccceeecCCeeEEEEeccCCCChhhh
Q 013028          159 ARRKNADFAVAVKRLRRKGS----------QGQDEWENELRFLSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDH  227 (451)
Q Consensus       159 ~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~  227 (451)
                      ++....+..++||++.+...          ...++|.+|+++|+++ .|+||++++++++++...||||||++|++|.++
T Consensus       253 ~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~  332 (569)
T 4azs_A          253 SRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDM  332 (569)
T ss_dssp             CEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHH
T ss_pred             cccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHH
Confidence            45566678899999975421          1124688999999999 599999999999999999999999999999999


Q ss_pred             hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCC
Q 013028          228 LLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR  307 (451)
Q Consensus       228 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~  307 (451)
                      |..  ...+++.   .|+.||+.||.|||+  +|||||||||+||||+.+|.+||+|||+|+....  ........+||+
T Consensus       333 i~~--~~~l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--~~~~~~t~vGTp  403 (569)
T 4azs_A          333 LAA--GEEIDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--DCSWPTNLVQSF  403 (569)
T ss_dssp             HHT--TCCCCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHH
T ss_pred             HHh--CCCCCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEECCCCCEEEeecccCeeCCC--CCccccCceech
Confidence            965  4566654   488999999999999  8999999999999999999999999999985432  223345678999


Q ss_pred             ccccccccccCCCCcchhhHHHHHHHHHHHhCCCccc
Q 013028          308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAM  344 (451)
Q Consensus       308 ~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~  344 (451)
                      +|+|||++.+ .+...+|+||+|+++++|.++..++.
T Consensus       404 ~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~~  439 (569)
T 4azs_A          404 FVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNWL  439 (569)
T ss_dssp             HHHHHHHC------------------CCCCTTHHHHH
T ss_pred             hhccHHHhCC-CCCCcccccccccchhhhccccchhH
Confidence            9999999954 57788999999999998877765553

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=5.4e-29  Score=259.68  Aligned_cols=186  Identities=22%  Similarity=0.302  Sum_probs=141.5

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC--------HHHHHHHHHHHHhcCCCceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG--------QDEWENELRFLSRLNHPNVVKL  202 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~il~~l~h~nIv~~  202 (451)
                      .+...++||+|+||+||+|.+.            +..+++|.........        .+.+.+|+++|+.++||||+++
T Consensus       337 ~~~~~~~LG~G~fg~Vy~~~~~------------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~  404 (540)
T 3en9_A          337 RKIPEHLIGKGAEADIKRDSYL------------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAP  404 (540)
T ss_dssp             -----------CCEEEEEEECS------------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCC
T ss_pred             cCCCCCEEeeCCCEEEEEEEEC------------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCce
Confidence            3345678999999999997432            4568888865432221        2347899999999999999977


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      ..++.+.+..||||||++|++|.+++..          +..++.|++.||.|||+  +||+||||||+|||++.  .+||
T Consensus       405 ~~~~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl~~--~~kL  470 (540)
T 3en9_A          405 YIFDVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIFDK--DLYI  470 (540)
T ss_dssp             CEEEEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEESS--SEEE
T ss_pred             EEEEEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEECC--eEEE
Confidence            7777777788999999999999999854          45899999999999999  89999999999999999  9999


Q ss_pred             eecCCcccCCCCCCcc-----cccccCCCCcccccccccc--CCCCcchhhHHHHHHHHHHHhCCCc
Q 013028          283 SDFGLAKFGPLGDKSH-----ISTRVLGTRGYFAPEYIAT--GHLTLKTDVYSFGVVLLEILSGKTA  342 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltg~~p  342 (451)
                      +|||+|+.........     ......||+.|+|||++..  ..|+..+|+|+..+-..+.+.++.+
T Consensus       471 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r  537 (540)
T 3en9_A          471 IDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR  537 (540)
T ss_dssp             CCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred             EECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence            9999998643221111     1235689999999999976  6688889999998888887766543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=3e-25  Score=212.69  Aligned_cols=162  Identities=17%  Similarity=0.125  Sum_probs=125.6

Q ss_pred             HHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc------------------CHHHHHH
Q 013028          125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ------------------GQDEWEN  186 (451)
Q Consensus       125 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~  186 (451)
                      +......|.+++.||+|+||.||+|.+           .++..||||++......                  ....+.+
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-----------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~  153 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYS-----------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN  153 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEE-----------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHH
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEe-----------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHH
Confidence            334455778889999999999999865           34678999999643211                  2345789


Q ss_pred             HHHHHHhcCCCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCC
Q 013028          187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRD  266 (451)
Q Consensus       187 E~~il~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrD  266 (451)
                      |+.+|+.++  | +++++++.. +..++||||++|++|.+ +..        .....++.|++.||.|||+  .||+|||
T Consensus       154 E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~--~giiHrD  218 (282)
T 1zar_A          154 EFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH--RGIVHGD  218 (282)
T ss_dssp             HHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH--TTEECSC
T ss_pred             HHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH--CCCEeCC
Confidence            999999999  5 777776654 55699999999999988 421        1245799999999999999  8999999


Q ss_pred             CCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCcccccccccc----------CCCCcchhhHH
Q 013028          267 VKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT----------GHLTLKTDVYS  328 (451)
Q Consensus       267 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----------~~~~~~~DiwS  328 (451)
                      |||+|||++ ++.+||+|||+|+.               +..+.|||++.+          ..|+..+|+|.
T Consensus       219 lkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          219 LSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             CSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             CCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            999999999 99999999999973               234789998743          34555566654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=3.2e-21  Score=182.21  Aligned_cols=137  Identities=20%  Similarity=0.164  Sum_probs=103.7

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcE--EEEEEeccCCCcC------------------------HHHH
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFA--VAVKRLRRKGSQG------------------------QDEW  184 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~--vavK~~~~~~~~~------------------------~~~~  184 (451)
                      .|.+.+.||+|+||.||+|.+          ..++..  ||||++.......                        ...+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~----------~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  117 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADG----------VFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWT  117 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEE----------EETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEE----------cCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHH
Confidence            367889999999999999764          233667  9999975431110                        1257


Q ss_pred             HHHHHHHHhcCCCce--eeccceeecCCeeEEEEeccCC-C----ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-
Q 013028          185 ENELRFLSRLNHPNV--VKLMGYCCDDQHRLLVYEYVTR-G----SLEDHLLNEDDTELNWERRIKIALGAARGLEHLH-  256 (451)
Q Consensus       185 ~~E~~il~~l~h~nI--v~~~~~~~~~~~~~lV~E~~~g-g----~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-  256 (451)
                      .+|+.+|..+.|++|  ..+++.    ...+|||||+.+ |    +|.+....     .++..+..++.|++.+|.||| 
T Consensus       118 ~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~  188 (258)
T 1zth_A          118 EKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ  188 (258)
T ss_dssp             HHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH
Confidence            889999999988764  233322    356899999942 3    66665422     234457789999999999999 


Q ss_pred             hCCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       257 ~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      +  .||+||||||+|||++.  .++|+|||+|..
T Consensus       189 ~--~givHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          189 E--AELVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             T--SCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             H--CCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence            8  89999999999999998  899999999974

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=2.7e-18  Score=169.55  Aligned_cols=137  Identities=16%  Similarity=0.129  Sum_probs=96.3

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--------------cCHHHH--------HHHH
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--------------QGQDEW--------ENEL  188 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~  188 (451)
                      -|+++..||.|+||.||+|...           .+..||||+++....              ......        ..|.
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~  164 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEF  164 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHH
T ss_pred             EEEecCEeeeCCceEEEEEECC-----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHH
Confidence            4999999999999999997632           367899999753210              011111        2355


Q ss_pred             HHHHhcCCCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCC
Q 013028          189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVK  268 (451)
Q Consensus       189 ~il~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlk  268 (451)
                      ..|.++.+.++.-..-+..  ...+|||||++|++|.++...        .....++.||+.+|.+||+  .||||||||
T Consensus       165 ~nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~--~gIVHrDLK  232 (397)
T 4gyi_A          165 AFMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAK--HGLIHGDFN  232 (397)
T ss_dssp             HHHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHH--TTEECSCCS
T ss_pred             HHHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHH--CCCcCCCCC
Confidence            5555554333321111111  123799999999888765421        1245688999999999999  899999999


Q ss_pred             CCceeeCCCC----------cEEEeecCCccc
Q 013028          269 ASNVLLDDDF----------NAKISDFGLAKF  290 (451)
Q Consensus       269 p~NIll~~~~----------~~kl~DFGla~~  290 (451)
                      |.|||+++++          .+.|+||+.+..
T Consensus       233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             HHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999998776          389999999874

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.40  E-value=7.7e-13  Score=124.50  Aligned_cols=144  Identities=15%  Similarity=0.042  Sum_probs=111.8

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeecccee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYC  206 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~  206 (451)
                      ....|++...++.|+.+.||+...            .+..+++|+...........+.+|+.+|+.+. +..+.++++++
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~------------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~   79 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVG------------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE   79 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEEC------------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEEC------------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            345788888899999999999642            14579999986532233346889999999996 67788999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYW---------------------------  259 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------------------------  259 (451)
                      .+....|+||||++|.+|.+.+..       ......++.+++.+|..||+..                           
T Consensus        80 ~~~~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T 3tm0_A           80 RHDGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             EETTEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             ecCCceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccc
Confidence            888899999999999999876421       1123467889999999999810                           


Q ss_pred             ------------------------------CCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          260 ------------------------------RPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       260 ------------------------------~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                                                    ..++|+|++|.|||++++..+.|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                          2489999999999998766667999998863

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.26  E-value=9.1e-12  Score=116.45  Aligned_cols=136  Identities=16%  Similarity=0.078  Sum_probs=97.4

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCc--eeeccceeec
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPN--VVKLMGYCCD  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~~~~~~~~  208 (451)
                      .|.+....+.|..+.||+...           .++..++||+....   ....+.+|+.+++.+.+.+  +.++++++.+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-----------~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~   86 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-----------QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE   86 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-----------TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred             CCceEecccCCCCceEEEEec-----------CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC
Confidence            344433334666799999642           22456899997643   2245788999999996444  5568888888


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYW-----------------------------  259 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----------------------------  259 (451)
                      ++..++||||++|.+|.  ...     ..   ...++.+++..|..||+..                             
T Consensus        87 ~~~~~~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (264)
T 1nd4_A           87 AGRDWLLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD  156 (264)
T ss_dssp             SSCEEEEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred             CCCCEEEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence            78889999999998884  211     11   2256778888888888721                             


Q ss_pred             ---------------------------CCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          260 ---------------------------RPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       260 ---------------------------~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                                                 .+++|+|++|.|||+++++.+.|+|||.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                       1289999999999998876677999999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.19  E-value=5.5e-11  Score=117.15  Aligned_cols=141  Identities=16%  Similarity=0.226  Sum_probs=104.5

Q ss_pred             cCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEec--cCC-CcCHHHHHHHHHHHHhcC--CCceeeccceeec
Q 013028          134 EKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLR--RKG-SQGQDEWENELRFLSRLN--HPNVVKLMGYCCD  208 (451)
Q Consensus       134 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~il~~l~--h~nIv~~~~~~~~  208 (451)
                      ..+.|+.|.++.||+....            +..+++|+..  ... ......+.+|+.+++.|.  +..+.+++.++.+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~------------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~  109 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP------------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCED  109 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS------------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECC
T ss_pred             eEEEcCCcccceEEEEEEC------------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCC
Confidence            3567899999999996432            3457888765  221 123456789999999997  4457888888876


Q ss_pred             C---CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------
Q 013028          209 D---QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTY---------------------------  258 (451)
Q Consensus       209 ~---~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------------------------  258 (451)
                      .   ...|+||||++|..+.+..    ...++......++.+++..|..||..                           
T Consensus       110 ~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (359)
T 3dxp_A          110 ESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ  185 (359)
T ss_dssp             TTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred             CCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence            6   3479999999998775422    23467888889999999999999972                           


Q ss_pred             -----------------------------CCCceeCCCCCCceeeCCCCc--EEEeecCCccc
Q 013028          259 -----------------------------WRPVIHRDVKASNVLLDDDFN--AKISDFGLAKF  290 (451)
Q Consensus       259 -----------------------------~~~iiHrDlkp~NIll~~~~~--~kl~DFGla~~  290 (451)
                                                   ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                         136899999999999997653  68999999975

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.10  E-value=9.6e-11  Score=112.73  Aligned_cols=183  Identities=19%  Similarity=0.218  Sum_probs=120.6

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCc--eeeccceeecCC-
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPN--VVKLMGYCCDDQ-  210 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~n--Iv~~~~~~~~~~-  210 (451)
                      .+.++.|.+..||+.          .     ..+++|+....  .....+.+|..+|+.+. +..  +.+++....... 
T Consensus        25 i~~~~~G~~n~v~~v----------~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~   87 (304)
T 3sg8_A           25 IEISGEGNDCIAYEI----------N-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSET   87 (304)
T ss_dssp             CCEEEECSSEEEEES----------T-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSS
T ss_pred             eEecCCCCcceEEEE----------C-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCC
Confidence            456899999999983          1     34888886422  23467889999999884 333  334444433332 


Q ss_pred             --eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 013028          211 --HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYW-----------------------------  259 (451)
Q Consensus       211 --~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----------------------------  259 (451)
                        ..|+|||+++|.+|.+...    ..++..+...++.+++..|..||+..                             
T Consensus        88 ~~~~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (304)
T 3sg8_A           88 YQMSFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR  163 (304)
T ss_dssp             CSCSCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCcceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence              3489999999988865432    34677777888888888888888510                             


Q ss_pred             ---------------------------CCceeCCCCCCceeeCC--CCcEEEeecCCcccCCCCCCcccccccCCCCcc-
Q 013028          260 ---------------------------RPVIHRDVKASNVLLDD--DFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY-  309 (451)
Q Consensus       260 ---------------------------~~iiHrDlkp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y-  309 (451)
                                                 ..++|+|++|.|||+++  +..+.|+||+.+.......      +......+ 
T Consensus       164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~  237 (304)
T 3sg8_A          164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDD  237 (304)
T ss_dssp             TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTT
T ss_pred             cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhc
Confidence                                       23799999999999998  5567899999987533210      00000111 


Q ss_pred             --ccccccc----c-C---------CCCcchhhHHHHHHHHHHHhCCCccc
Q 013028          310 --FAPEYIA----T-G---------HLTLKTDVYSFGVVLLEILSGKTAAM  344 (451)
Q Consensus       310 --~aPE~l~----~-~---------~~~~~~DiwSlGvil~elltg~~pf~  344 (451)
                        ..|+...    . +         ......+.|++|.++|.+.+|..+|.
T Consensus       238 ~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          238 EEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             TSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             cccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence              1222210    0 0         11223689999999999999987654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.62  E-value=1.4e-07  Score=90.66  Aligned_cols=135  Identities=21%  Similarity=0.224  Sum_probs=91.8

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCC---ceeeccceee-cCC
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP---NVVKLMGYCC-DDQ  210 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~---nIv~~~~~~~-~~~  210 (451)
                      .+.++.|....||+.               +..++||+..  .......+.+|..+|+.|.+.   .+.+++.+.. ...
T Consensus        24 v~~l~~G~~n~v~~v---------------g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g   86 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---------------NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDG   86 (306)
T ss_dssp             EEEEEECSSEEEEEE---------------TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTS
T ss_pred             eeecCCCcceeEEEE---------------CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCC
Confidence            356888999999984               2347888753  122345788999999999743   2455666654 345


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------
Q 013028          211 HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTY--------------------------------  258 (451)
Q Consensus       211 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------------------------------  258 (451)
                      ..++|||+++|..|.+...    ..++......++.+++..|..||+.                                
T Consensus        87 ~~~~v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~  162 (306)
T 3tdw_A           87 NPFVGYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFP  162 (306)
T ss_dssp             CEEEEEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGG
T ss_pred             ceEEEEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccc
Confidence            6789999999988866321    1234444555555555555555541                                


Q ss_pred             --------------------------CCCceeCCCCCCceeeCC---CCc-EEEeecCCccc
Q 013028          259 --------------------------WRPVIHRDVKASNVLLDD---DFN-AKISDFGLAKF  290 (451)
Q Consensus       259 --------------------------~~~iiHrDlkp~NIll~~---~~~-~kl~DFGla~~  290 (451)
                                                ...++|+|++|.|||++.   ++. +.|+||+.+..
T Consensus       163 ~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          163 LLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             GSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             ccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                      124699999999999987   455 48999999875

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.55  E-value=2.1e-07  Score=87.39  Aligned_cols=134  Identities=17%  Similarity=0.110  Sum_probs=93.2

Q ss_pred             ccccCce-EEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccceeecCCeeEEE
Q 013028          138 IGQGGFG-DVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYCCDDQHRLLV  215 (451)
Q Consensus       138 LG~G~~g-~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lV  215 (451)
                      +..|..| .||+-..          ...+..++||+-..   ....++.+|..+|+.|. +--+.++++++.+++..++|
T Consensus        32 ~~~G~S~~~v~rl~~----------~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           32 DNVGQSGATIYRLYG----------KPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             EECSSSSCEEEEEEC----------CTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             ccCCCcCCeEEEEEe----------cCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            4445555 6887432          23345688888642   23567889999999886 33467788888888999999


Q ss_pred             EeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 013028          216 YEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYW------------------------------------  259 (451)
Q Consensus       216 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------  259 (451)
                      ||+++|.++.+.....      ......++.+++..|.-||...                                    
T Consensus        99 me~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             EECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             EEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            9999998877654221      1122345556666666666310                                    


Q ss_pred             --------------------CCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          260 --------------------RPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       260 --------------------~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                                          ..++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                0268999999999999887778999998874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.36  E-value=6.7e-07  Score=87.56  Aligned_cols=88  Identities=7%  Similarity=0.007  Sum_probs=54.6

Q ss_pred             CCcc-cccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHHHHHHHHhcC-C--Cceeeccceee
Q 013028          135 KNLI-GQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWENELRFLSRLN-H--PNVVKLMGYCC  207 (451)
Q Consensus       135 ~~~L-G~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h--~nIv~~~~~~~  207 (451)
                      .+.| +.|....+|+.......    .....+..+++|+.....   ......+.+|+.+|+.|. +  -.+.+++.++.
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~----~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~  100 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQ----DGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIET  100 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEE----TTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred             EEECCCCCccceEEEEEEeccc----CCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence            3567 88999999986532000    000013457888765322   112245788999999885 3  24667777776


Q ss_pred             cC---CeeEEEEeccCCCChhh
Q 013028          208 DD---QHRLLVYEYVTRGSLED  226 (451)
Q Consensus       208 ~~---~~~~lV~E~~~gg~L~~  226 (451)
                      +.   ...++|||+++|..+.+
T Consensus       101 ~~~~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          101 TGDVLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSTTTSSCEEEEECCCCBCCCB
T ss_pred             CCCccCCceEEEEecCCCChhh
Confidence            55   34689999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.31  E-value=1.5e-06  Score=86.54  Aligned_cols=76  Identities=22%  Similarity=0.202  Sum_probs=48.6

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-------cCHHHHHHHHHHHHhcCC--Cc-eeeccc
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-------QGQDEWENELRFLSRLNH--PN-VVKLMG  204 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~h--~n-Iv~~~~  204 (451)
                      .+.||.|.++.||++...          ..+..++||.......       ...+.+..|.++|+.+..  +. +.+++.
T Consensus        35 ~~~lg~G~~n~vyrv~~~----------~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~  104 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQ----------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY  104 (397)
T ss_dssp             EEECCSSSSEEEEEEEC--------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE
T ss_pred             EEECCCCceEEEEEEEEC----------CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE
Confidence            467999999999997532          1245689998643211       223456789999988742  33 334554


Q ss_pred             eeecCCeeEEEEeccCCC
Q 013028          205 YCCDDQHRLLVYEYVTRG  222 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg  222 (451)
                      +  +.+..++|||+++|.
T Consensus       105 ~--d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          105 S--DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             E--ETTTTEEEECCCTTS
T ss_pred             E--cCCccEEEEEeCCCc
Confidence            3  445568999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.25  E-value=9.8e-06  Score=78.34  Aligned_cols=139  Identities=17%  Similarity=0.204  Sum_probs=79.5

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCC--Cceeeccc------eee
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH--PNVVKLMG------YCC  207 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~~~~------~~~  207 (451)
                      +.|+.|..+.||+....            +..+++|+...    ....+..|..+++.|..  -.+.+++.      +..
T Consensus        38 ~~l~gG~~n~~~~v~~~------------~~~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~  101 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD------------SGAVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSK  101 (346)
T ss_dssp             EECC----CEEEEEEET------------TEEEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEE
T ss_pred             eeccccccCcEEEEEeC------------CCCEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEE
Confidence            44666788999986432            22488998864    23455567777776641  12344443      223


Q ss_pred             cCCeeEEEEeccCCCChh--------------hhhcc----C--CC------CCCCHHHH--------------------
Q 013028          208 DDQHRLLVYEYVTRGSLE--------------DHLLN----E--DD------TELNWERR--------------------  241 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~--------------~~l~~----~--~~------~~l~~~~~--------------------  241 (451)
                      ++...++||+|++|..+.              ..++.    .  ..      ....|...                    
T Consensus       102 ~~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  181 (346)
T 2q83_A          102 HGSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKE  181 (346)
T ss_dssp             ETTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSS
T ss_pred             ECCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccC
Confidence            456789999999986542              00110    0  00      00112110                    


Q ss_pred             -----------HHHHHHHHHHHHHHHh-----------CCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          242 -----------IKIALGAARGLEHLHT-----------YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       242 -----------~~i~~qi~~aL~~LH~-----------~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                                 ..+...+..++.+|+.           ....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          182 DPFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence                       0111123345556652           126799999999999998788999999998864

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.85  E-value=3.9e-05  Score=76.81  Aligned_cols=77  Identities=22%  Similarity=0.354  Sum_probs=48.4

Q ss_pred             CCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCC--CCccccccccccC---CCCcchhhHHHHHHHH
Q 013028          260 RPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG--TRGYFAPEYIATG---HLTLKTDVYSFGVVLL  334 (451)
Q Consensus       260 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~---~~~~~~DiwSlGvil~  334 (451)
                      ..++|+|+++.|||++.++ +.|+||+.+.+.+....  .. ....  ...|++|+.....   .-....++..+...+|
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            6799999999999999876 99999999986331100  00 0011  1235666544211   1122355668888888


Q ss_pred             HHHhCC
Q 013028          335 EILSGK  340 (451)
Q Consensus       335 elltg~  340 (451)
                      +.+.+.
T Consensus       308 ~~y~~~  313 (420)
T 2pyw_A          308 NLFNKR  313 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            887753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.84  E-value=6.2e-05  Score=72.22  Aligned_cols=75  Identities=20%  Similarity=0.190  Sum_probs=58.2

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC---CCceeeccceeecCCe
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN---HPNVVKLMGYCCDDQH  211 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~~~~~~~~~~~  211 (451)
                      .+.|+.|....+|+...            .+..++||+....   ....+..|...|+.|.   ...+.+++.+......
T Consensus        41 ~~~l~gG~~n~~y~v~~------------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~  105 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND------------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGH  105 (312)
T ss_dssp             EEEECCSSSSEEEEEES------------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSE
T ss_pred             eEEeCCccceeeeEEEE------------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCc
Confidence            46789999999999542            2456888987532   3567889999999885   2567888888887788


Q ss_pred             eEEEEeccCCCCh
Q 013028          212 RLLVYEYVTRGSL  224 (451)
Q Consensus       212 ~~lV~E~~~gg~L  224 (451)
                      .++||||++|..+
T Consensus       106 ~~lvme~l~G~~~  118 (312)
T 3jr1_A          106 SFLLLEALNKSKN  118 (312)
T ss_dssp             EEEEEECCCCCCC
T ss_pred             eEEEEEeccCCCC
Confidence            9999999998765

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.73  E-value=6.9e-05  Score=71.35  Aligned_cols=71  Identities=11%  Similarity=0.039  Sum_probs=44.7

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCce-eeccceeecCCeeE
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNV-VKLMGYCCDDQHRL  213 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~~~~~~~~~~~~~  213 (451)
                      .+.|+.|....+|+.                ..+++|+....... ..+..+|+.+++.+...++ .+++++  +.+.-+
T Consensus        23 i~~l~gG~tN~~~~~----------------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~   83 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----------------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGV   83 (301)
T ss_dssp             CEEEESCSSEEEEEE----------------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCC
T ss_pred             eeEcCCcccccccee----------------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCE
Confidence            577999999999984                23788887643211 1123568888888753233 345543  344457


Q ss_pred             EEEecc-CCCCh
Q 013028          214 LVYEYV-TRGSL  224 (451)
Q Consensus       214 lV~E~~-~gg~L  224 (451)
                      +|+||+ +|.+|
T Consensus        84 ~v~e~i~~g~~l   95 (301)
T 3dxq_A           84 MVTRYIAGAQTM   95 (301)
T ss_dssp             EEEECCTTCEEC
T ss_pred             EEEeecCCCccC
Confidence            899999 66544

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.67  E-value=0.00022  Score=68.35  Aligned_cols=154  Identities=14%  Similarity=0.096  Sum_probs=83.9

Q ss_pred             HHHHHHhcCCCc-----CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCC
Q 013028          123 GLLEAATRKFSE-----KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP  197 (451)
Q Consensus       123 ~~~~~~~~~y~~-----~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~  197 (451)
                      ..+.....+|.+     .+.|+.|....+|+....+           + .+++|+....  ...+.+..|+.+++.|...
T Consensus        10 ~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-----------g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~   75 (322)
T 2ppq_A           10 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-----------D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAK   75 (322)
T ss_dssp             HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-----------C-CEEEEEECC-----CCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-----------c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHC
Confidence            334444445654     2346778889999865321           2 4789988642  1234567788888887522


Q ss_pred             c--eeeccce------eecCCeeEEEEeccCCCChhh----h----------hcc----CCCC---CCC---HHHHHH--
Q 013028          198 N--VVKLMGY------CCDDQHRLLVYEYVTRGSLED----H----------LLN----EDDT---ELN---WERRIK--  243 (451)
Q Consensus       198 n--Iv~~~~~------~~~~~~~~lV~E~~~gg~L~~----~----------l~~----~~~~---~l~---~~~~~~--  243 (451)
                      +  +.+++..      ....+..++||+|++|..+..    .          ++.    ....   ...   |.....  
T Consensus        76 g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~  155 (322)
T 2ppq_A           76 GLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKS  155 (322)
T ss_dssp             TCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHH
T ss_pred             CCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHH
Confidence            2  3334322      123356789999999865421    0          110    0000   011   111000  


Q ss_pred             ----------HHHHHHHHHHHHHhC-----CCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          244 ----------IALGAARGLEHLHTY-----WRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       244 ----------i~~qi~~aL~~LH~~-----~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                                +...+...+..++..     ..+++|+|+.+.|||+++++.+.|+||+.+..
T Consensus       156 ~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          156 EERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             GGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                      001133445555421     14689999999999999876668999998863

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.67  E-value=0.00017  Score=68.20  Aligned_cols=80  Identities=20%  Similarity=0.197  Sum_probs=56.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCC---ceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP---NVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~---nIv~~~~~~  206 (451)
                      ......+.+|.|..+.||+.+..           +++.|.||+...........+..|...|+.|..-   -+.+++++ 
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~-----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~-   82 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA-----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW-   82 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET-----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE-
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC-----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec-
Confidence            45566788999999999997654           3567999987654444455688999999988522   23344443 


Q ss_pred             ecCCeeEEEEeccCCCCh
Q 013028          207 CDDQHRLLVYEYVTRGSL  224 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L  224 (451)
                       +  ..++||||++++..
T Consensus        83 -~--~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           83 -D--DRTLAMEWVDERPP   97 (288)
T ss_dssp             -E--TTEEEEECCCCCCC
T ss_pred             -c--CceEEEEeecccCC
Confidence             2  23799999987654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.54  E-value=0.00019  Score=70.77  Aligned_cols=147  Identities=14%  Similarity=0.109  Sum_probs=83.4

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~l  214 (451)
                      +.|..|....+|+....+..   ......+..+.+|+... .......+.+|..+++.|. +.-..++++++.+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~---~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHL---PSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTS---CCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCc---cccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            56777888999997643210   00012346788888643 2234667789999999886 3334566666554    29


Q ss_pred             EEeccCCCChhhh-h----------------ccCC---CCCC--CHHHHHHHHHHHHH-------------------HHH
Q 013028          215 VYEYVTRGSLEDH-L----------------LNED---DTEL--NWERRIKIALGAAR-------------------GLE  253 (451)
Q Consensus       215 V~E~~~gg~L~~~-l----------------~~~~---~~~l--~~~~~~~i~~qi~~-------------------aL~  253 (451)
                      ||||++|..|..- +                +...   ....  -+.++..+..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999998655311 0                1110   1112  23444444433321                   223


Q ss_pred             HH----HhC--CCCceeCCCCCCceeeCCC----CcEEEeecCCccc
Q 013028          254 HL----HTY--WRPVIHRDVKASNVLLDDD----FNAKISDFGLAKF  290 (451)
Q Consensus       254 ~L----H~~--~~~iiHrDlkp~NIll~~~----~~~kl~DFGla~~  290 (451)
                      .|    ...  ...++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33    221  1248999999999999876    7899999998863

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.52  E-value=0.00039  Score=62.30  Aligned_cols=98  Identities=17%  Similarity=0.135  Sum_probs=63.7

Q ss_pred             ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccc
Q 013028          223 SLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR  302 (451)
Q Consensus       223 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  302 (451)
                      +|.+.|... +.++++++++.++.|.+.+|.-+-.. +.-..+=+.|..|+|..+|.+.+.+ +.+.             
T Consensus        34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARR-RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhc-ccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            677877544 58899999999999999998876210 1111223357899999999988764 2211             


Q ss_pred             cCCCCccccccccccCCCCcchhhHHHHHHHHHHHh
Q 013028          303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS  338 (451)
Q Consensus       303 ~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt  338 (451)
                       .....+.|||.+. ...+.+.=|||||++||.-+-
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence             1122377888863 445678899999999998774

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.49  E-value=0.00026  Score=71.02  Aligned_cols=81  Identities=15%  Similarity=0.133  Sum_probs=51.4

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCce-eeccceeecCCeeE
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNV-VKLMGYCCDDQHRL  213 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~~~~~~~~~~~~~  213 (451)
                      .+.|+.|....||+........   .....+..+++|+....  ...+.+.+|..+++.|...++ .++++.+.+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~---~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYP---PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSC---CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEeCCCcccceEEEEeCCCcc---ccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            4568889999999976542100   00112467889988432  222566789999998863333 566666543    3


Q ss_pred             EEEeccCCCCh
Q 013028          214 LVYEYVTRGSL  224 (451)
Q Consensus       214 lV~E~~~gg~L  224 (451)
                      +||||++|..|
T Consensus       149 ~v~e~l~G~~l  159 (429)
T 1nw1_A          149 RLEEYIPSRPL  159 (429)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEeCCccc
Confidence            89999987444

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.32  E-value=0.00032  Score=67.65  Aligned_cols=33  Identities=33%  Similarity=0.439  Sum_probs=28.5

Q ss_pred             CCceeCCCCCCceeeCCC----CcEEEeecCCcccCC
Q 013028          260 RPVIHRDVKASNVLLDDD----FNAKISDFGLAKFGP  292 (451)
Q Consensus       260 ~~iiHrDlkp~NIll~~~----~~~kl~DFGla~~~~  292 (451)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+..++
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            469999999999999874    689999999998643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.31  E-value=0.0022  Score=61.37  Aligned_cols=140  Identities=16%  Similarity=0.128  Sum_probs=79.6

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCc--eeeccce-----eec
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPN--VVKLMGY-----CCD  208 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~~~~~-----~~~  208 (451)
                      ..|+ |....||+...           ..+..+++|..... ......+..|..+++.|...+  +++++..     ...
T Consensus        32 ~~l~-g~~n~~y~v~~-----------~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~   98 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-----------EDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH   98 (328)
T ss_dssp             EEEC-CSSSEEEEECC-----------TTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE
T ss_pred             Eeec-CcccceEEEEc-----------CCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEE
Confidence            3466 88889998532           12346899998632 224567788999998885222  4445443     122


Q ss_pred             CCeeEEEEeccCCCChhh----h----------hc----cCC---CCCCCHHHH----------------------HHHH
Q 013028          209 DQHRLLVYEYVTRGSLED----H----------LL----NED---DTELNWERR----------------------IKIA  245 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~----~----------l~----~~~---~~~l~~~~~----------------------~~i~  245 (451)
                      ++..++||++++|..+..    .          ++    ...   ...++....                      ...+
T Consensus        99 ~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  178 (328)
T 1zyl_A           99 QGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKAT  178 (328)
T ss_dssp             TTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHH
T ss_pred             CCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHH
Confidence            445688999998754321    0          00    000   011222111                      0111


Q ss_pred             HHHHHHHHHHHh--CCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          246 LGAARGLEHLHT--YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       246 ~qi~~aL~~LH~--~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..++..+.-+-.  ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       179 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          179 DELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            122222222210  114589999999999999 4 899999998875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.25  E-value=0.00077  Score=68.11  Aligned_cols=75  Identities=15%  Similarity=0.033  Sum_probs=47.2

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCce-eeccceeecCCeeE
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNV-VKLMGYCCDDQHRL  213 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~~~~~~~~~~~~~  213 (451)
                      .+.|+.|-...+|+.....          .+..+++|+...... ..-+..+|..+++.|...++ .++++.+.  +  .
T Consensus       113 i~~lsgG~tN~~y~v~~~~----------~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G  177 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMS----------KQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--G  177 (458)
T ss_dssp             EEEECC--CEEEEEEEETT----------TTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--E
T ss_pred             EEEcCCCeEeEEEEEEECC----------CCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--e
Confidence            3568889999999976432          135688888754321 11123589999999975444 56676663  2  3


Q ss_pred             EEEeccCCCCh
Q 013028          214 LVYEYVTRGSL  224 (451)
Q Consensus       214 lV~E~~~gg~L  224 (451)
                      +||||++|..|
T Consensus       178 ~v~e~I~G~~l  188 (458)
T 2qg7_A          178 RIEEFMDGYAL  188 (458)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEeeCCccC
Confidence            59999988544

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.04  E-value=0.0013  Score=64.29  Aligned_cols=82  Identities=9%  Similarity=0.022  Sum_probs=44.6

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCc-eeeccceeecCCeeEE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPN-VVKLMGYCCDDQHRLL  214 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~~~~~~~~~~~~~l  214 (451)
                      +.|+.|....+|+........  ......+..+++|+...... ...+...|..+++.|...+ +.++++.+  .  -++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~--~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~  111 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETA--NNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR  111 (369)
T ss_dssp             EEC----CCEEEEEEECHHHH--TTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEeCCcccceEEEEEeCCCCc--ccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence            567888889999976432100  00001235688888754211 1112467899998886333 34566544  2  378


Q ss_pred             EEeccCCCCh
Q 013028          215 VYEYVTRGSL  224 (451)
Q Consensus       215 V~E~~~gg~L  224 (451)
                      ||||++|..+
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999988544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.02  E-value=0.0038  Score=60.33  Aligned_cols=31  Identities=26%  Similarity=0.377  Sum_probs=27.9

Q ss_pred             CCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          260 RPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       260 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                      ..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4689999999999999888899999998875

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.76  E-value=0.026  Score=56.24  Aligned_cols=82  Identities=11%  Similarity=0.023  Sum_probs=49.0

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccceeecCCeeE
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYCCDDQHRL  213 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~  213 (451)
                      .+.|..|....+|+.........   ....+..+++++..... ...-+..+|..+++.+. +.-..++++.+.    -+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~---~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMS---LSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EG  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC--------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred             EEEcCCCcccceEEEEeCCCccc---ccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence            35677888999999775421100   01114668888865432 22223467999998886 333345555332    27


Q ss_pred             EEEeccCCCCh
Q 013028          214 LVYEYVTRGSL  224 (451)
Q Consensus       214 lV~E~~~gg~L  224 (451)
                      +||||++|..|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.14  E-value=0.068  Score=52.72  Aligned_cols=29  Identities=24%  Similarity=0.510  Sum_probs=25.1

Q ss_pred             ceeCCCCCCceee------CCCCcEEEeecCCccc
Q 013028          262 VIHRDVKASNVLL------DDDFNAKISDFGLAKF  290 (451)
Q Consensus       262 iiHrDlkp~NIll------~~~~~~kl~DFGla~~  290 (451)
                      ++|+|+.+.|||+      +++..+.|+||-+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567899999999874

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.28  E-value=0.65  Score=41.29  Aligned_cols=127  Identities=9%  Similarity=0.061  Sum_probs=86.3

Q ss_pred             HHHHHHhcCCCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCC
Q 013028          187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRD  266 (451)
Q Consensus       187 E~~il~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrD  266 (451)
                      |+.+|. ..||+++.. .+-++++.+.+.++.-+.+--+..+     ..++....+.++..|+....++++    =+|--
T Consensus        36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~----r~tf~  104 (215)
T 4ann_A           36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRT----RYTFV  104 (215)
T ss_dssp             GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGS----SEECC
T ss_pred             HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcC----ceEEE
Confidence            344433 358888876 5666777777777765433223333     447788899999999887755554    57888


Q ss_pred             CCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccc
Q 013028          267 VKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRR  346 (451)
Q Consensus       267 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~  346 (451)
                      |.|+||+++.++.+++.=-|+-..                   ++|.     .++...-+-.+=|++..+++++..|...
T Consensus       105 L~P~NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l  160 (215)
T 4ann_A          105 LAPDELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL  160 (215)
T ss_dssp             CSGGGEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred             EecceEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            999999999999999986665331                   1221     2344444557888999999998888754


Q ss_pred             cC
Q 013028          347 TN  348 (451)
Q Consensus       347 ~~  348 (451)
                      ..
T Consensus       161 ~~  162 (215)
T 4ann_A          161 VE  162 (215)
T ss_dssp             HH
T ss_pred             Hc
Confidence            43

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.26  E-value=1.2  Score=39.68  Aligned_cols=117  Identities=10%  Similarity=0.087  Sum_probs=79.7

Q ss_pred             CCCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCceeCCCCCCcee
Q 013028          195 NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLE-HLHTYWRPVIHRDVKASNVL  273 (451)
Q Consensus       195 ~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~-~LH~~~~~iiHrDlkp~NIl  273 (451)
                      .||++  -..+-.+++.+.+.++.-+++.-+..+     ..++...++.++..|+.... +++    .-+|--|.|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~----~r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSA----RRLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCS----SSEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhh----CceeEEEeCceEE
Confidence            47777  444456777777877766444434444     34677888888888887555 444    3678889999999


Q ss_pred             eCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccc
Q 013028          274 LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRR  346 (451)
Q Consensus       274 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~  346 (451)
                      ++.++.++|.-.|+-..                   ++|.     .++..-=+-.+=|++..++.++..|...
T Consensus       117 f~~~~~p~i~hRGi~~~-------------------lpP~-----e~~ee~fl~qyKali~all~~K~~Fe~l  165 (219)
T 4ano_A          117 FNRALEPFFLHVGVKES-------------------LPPD-----EWDDERLLREVKATVLALTEGEYRFDEY  165 (219)
T ss_dssp             ECTTCCEEESCCEETTT-------------------BSSC-----SCCHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred             EeCCCcEEEEEcCCccc-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            99999999987765431                   2222     1233334456788888999988777643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	451
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-79
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-69
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-68
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-68
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-68
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-68
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-67
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-67
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-67
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-67
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-67
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-66
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-66
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-66
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-65
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-65
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-64
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-64
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-64
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-63
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-63
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-62
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-61
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-61
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-61
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-60
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-59
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-59
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-58
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-56
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-55
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-54
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-54
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-51
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-50
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-49
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-48
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-48
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-48
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-46
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-46
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-46
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-45
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-45
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-43
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-43
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-40
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-33
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-17

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (624), Expect = 5e-79
 Identities = 74/296 (25%), Positives = 135/296 (45%), Gaps = 39/296 (13%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           + +    IG G FG VY G           + + D AV +  +     Q    ++NE+  
Sbjct: 9   QITVGQRIGSGSFGTVYKG-----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGV 57

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           L +  H N++  MGY        +V ++    SL  HL +  +T+    + I IA   A+
Sbjct: 58  LRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQ 115

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           G+++LH   + +IHRD+K++N+ L +D   KI DFGLA        SH   ++ G+  + 
Sbjct: 116 GMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173

Query: 311 APEYIAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLAL 365
           APE I        + ++DVY+FG+VL E+++G+                PY  ++N+  +
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---------------LPYSNINNRDQI 218

Query: 366 HQIIDEKLGR----NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM 417
             ++           ++    +    ++  CL      RP   +++A++E L  ++
Sbjct: 219 IFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (555), Expect = 8e-69
 Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 29/281 (10%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
                  +G G FG+V++GY N               VAVK L+ +GS   D +  E   
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNG-----------HTKVAVKSLK-QGSMSPDAFLAEANL 61

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           + +L H  +V+L      +    ++ EY+  GSL D L      +L   + + +A   A 
Sbjct: 62  MKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           G+  +    R  IHRD++A+N+L+ D  + KI+DFGLA+     ++            + 
Sbjct: 121 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWT 177

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           APE I  G  T+K+DV+SFG++L EI++             G    P ++N   + Q ++
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTH------------GRIPYPGMTNP-EVIQNLE 224

Query: 371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE 411
                       +E  +++  C    P++RPT   + + LE
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  218 bits (557), Expect = 1e-68
 Identities = 71/303 (23%), Positives = 137/303 (45%), Gaps = 38/303 (12%)

Query: 125 LEAATRKFSEK---------NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR 175
              A R+F+++          +IG G FG+V  G++             +  VA+K L+ 
Sbjct: 12  PNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLK-------LPGKREIFVAIKTLKS 64

Query: 176 KGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDT 234
             + + + ++ +E   + + +HPNV+ L G        +++ E++  GSL D  L ++D 
Sbjct: 65  GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDG 123

Query: 235 ELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
           +    + + +  G A G+++L       +HRD+ A N+L++ +   K+SDFGL++F    
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 295 DKSHISTRVLG---TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA 351
                 T  LG      + APE I     T  +DV+S+G+V+ E++S             
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 352 GNWAKPYLS-NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL 410
               +PY       +   I++       M+      +++L C   D  +RP   ++V  L
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

Query: 411 EQL 413
           +++
Sbjct: 288 DKM 290

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  217 bits (554), Expect = 2e-68
 Identities = 67/283 (23%), Positives = 134/283 (47%), Gaps = 27/283 (9%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
             + K+ +G G +G+VY G            K     VAVK L+ + +   +E+  E   
Sbjct: 18  DITMKHKLGGGQYGEVYEG----------VWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 66

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           +  + HPN+V+L+G C  +    ++ E++T G+L D+L   +  E++    + +A   + 
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
            +E+L    +  IHRD+ A N L+ ++   K++DFGL++    GD             + 
Sbjct: 127 AMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT 183

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           APE +A    ++K+DV++FGV+L EI +                +     +   ++++++
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYG-------------MSPYPGIDLSQVYELLE 230

Query: 371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +           ++  E++  C   +P +RP+ +E+  A E +
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 6e-68
 Identities = 63/312 (20%), Positives = 128/312 (41%), Gaps = 47/312 (15%)

Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDE 183
           +E     F + + +G G  G V+              K +   +A K +  +     +++
Sbjct: 1   MELKDDDFEKISELGAGNGGVVF----------KVSHKPSGLVMARKLIHLEIKPAIRNQ 50

Query: 184 WENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
              EL+ L   N P +V   G    D    +  E++  GSL+  L  +    +  +   K
Sbjct: 51  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGK 108

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRV 303
           +++   +GL +L    + ++HRDVK SN+L++     K+ DFG++          ++   
Sbjct: 109 VSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSF 163

Query: 304 LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT---------------------- 341
           +GTR Y +PE +   H ++++D++S G+ L+E+  G+                       
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223

Query: 342 -------AAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLN 394
                      R     G  ++P ++    L  I++E   +      + EF + + +CL 
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283

Query: 395 SDPKNRPTMSEV 406
            +P  R  + ++
Sbjct: 284 KNPAERADLKQL 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 8e-68
 Identities = 61/284 (21%), Positives = 122/284 (42%), Gaps = 29/284 (10%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           +  +    +G G FG V  G           +    + VA+K ++ +GS  +DE+  E +
Sbjct: 4   KDLTFLKELGTGQFGVVKYG-----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAK 51

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            +  L+H  +V+L G C   +   ++ EY+  G L ++L          ++ +++     
Sbjct: 52  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVC 110

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
             +E+L    +  +HRD+ A N L++D    K+SDFGL+++    D+   S        +
Sbjct: 111 EAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRW 167

Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII 369
             PE +     + K+D+++FGV++ EI S             G       +N     + I
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSL------------GKMPYERFTNS-ETAEHI 214

Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            + L        +++   I+  C +     RPT   +++ +  +
Sbjct: 215 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 1e-67
 Identities = 69/283 (24%), Positives = 124/283 (43%), Gaps = 29/283 (10%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
            +    IG G FG V++G             N D  VA+K +R +G+  ++++  E   +
Sbjct: 7   LTFVQEIGSGQFGLVHLG----------YWLNKDK-VAIKTIR-EGAMSEEDFIEEAEVM 54

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
            +L+HP +V+L G C +     LV+E++  G L D+L  +       E  + + L    G
Sbjct: 55  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEG 113

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
           + +L      VIHRD+ A N L+ ++   K+SDFG+ +F    D+   ST       + +
Sbjct: 114 MAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWAS 170

Query: 312 PEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE 371
           PE  +    + K+DV+SFGV++ E+ S                      +   + + I  
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-------------RSNSEVVEDIST 217

Query: 372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
                     +    +I+  C    P++RP  S ++  L ++ 
Sbjct: 218 GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 2e-67
 Identities = 73/286 (25%), Positives = 129/286 (45%), Gaps = 35/286 (12%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELR 189
           ++      IG+G FGDV +G            +     VAVK ++   +     +  E  
Sbjct: 7   KELKLLQTIGKGEFGDVMLG----------DYRGNK--VAVKCIKNDATA--QAFLAEAS 52

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
            +++L H N+V+L+G   +++  L +V EY+ +GSL D+L +   + L  +  +K +L  
Sbjct: 53  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
              +E+L       +HRD+ A NVL+ +D  AK+SDFGL K     + S           
Sbjct: 113 CEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVK 165

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           + APE +     + K+DV+SFG++L EI S             G    P +  K  +   
Sbjct: 166 WTAPEALREKKFSTKSDVWSFGILLWEIYSF------------GRVPYPRIPLK-DVVPR 212

Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           +++    +          E++  C + D   RP+  ++   LE ++
Sbjct: 213 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  215 bits (548), Expect = 2e-67
 Identities = 70/314 (22%), Positives = 126/314 (40%), Gaps = 47/314 (14%)

Query: 125 LEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDE 183
           LE           IG+G FG V+                    VAVK L+ + S   Q +
Sbjct: 8   LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTM-----VAVKMLKEEASADMQAD 62

Query: 184 WENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNED----------- 232
           ++ E   ++  ++PN+VKL+G C   +   L++EY+  G L + L +             
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 233 -----------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK 281
                         L+   ++ IA   A G+ +L    R  +HRD+   N L+ ++   K
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVK 180

Query: 282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT 341
           I+DFGL++     D             +  PE I     T ++DV+++GVVL EI S   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG- 239

Query: 342 AAMRRTNGLAGNWAKPY--LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKN 399
                         +PY  ++++  ++ + D  +          E   ++  C +  P +
Sbjct: 240 -------------LQPYYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPAD 285

Query: 400 RPTMSEVVAALEQL 413
           RP+   +   L+++
Sbjct: 286 RPSFCSIHRILQRM 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 3e-67
 Identities = 63/290 (21%), Positives = 138/290 (47%), Gaps = 24/290 (8%)

Query: 126 EAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEW 184
           E      + + +IG G FG+VY G + +           +  VA+K L+   ++ Q  ++
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKT------SSGKKEVPVAIKTLKAGYTEKQRVDF 56

Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             E   + + +H N+++L G     +  +++ EY+  G+L+  L  E D E +  + + +
Sbjct: 57  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGM 115

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHISTRV 303
             G A G+++L       +HRD+ A N+L++ +   K+SDFGL++      + ++ ++  
Sbjct: 116 LRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173

Query: 304 LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL 363
                + APE I+    T  +DV+SFG+V+ E+++                   +  +  
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG-------------ERPYWELSNH 220

Query: 364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            + + I++       M+      +++++C   +   RP  +++V+ L++L
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 4e-67
 Identities = 73/304 (24%), Positives = 121/304 (39%), Gaps = 42/304 (13%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELR 189
                 ++G G FG V              +      VAVK L+ K    + +   +EL+
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGI-----SKTGVSIQVAVKMLKEKADSSEREALMSELK 92

Query: 190 FLSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLN------------------ 230
            +++L +H N+V L+G C       L++EY   G L ++L +                  
Sbjct: 93  MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152

Query: 231 ---EDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL 287
              ED   L +E  +  A   A+G+E L    +  +HRD+ A NVL+      KI DFGL
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRT 347
           A+         +         + APE +  G  T+K+DV+S+G++L EI S         
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL-------- 262

Query: 348 NGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
               G    P +      +++I      +      +E   I+  C   D + RP+   + 
Sbjct: 263 ----GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318

Query: 408 AALE 411
           + L 
Sbjct: 319 SFLG 322

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 3e-66
 Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 29/287 (10%)

Query: 134 EKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ--DEWENELRFL 191
           E   +G G FG V  GY         + K     VAVK L+ + +     DE   E   +
Sbjct: 11  EDKELGSGNFGTVKKGYY--------QMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62

Query: 192 SRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
            +L++P +V+++G C  +   +LV E    G L  +L  + +  +  +  I++    + G
Sbjct: 63  QQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMG 119

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHISTRVLGTRGYF 310
           +++L       +HRD+ A NVLL     AKISDFGL+K      +     T       ++
Sbjct: 120 MKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           APE I     + K+DV+SFGV++ E  S      R   G               +  +++
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------------SEVTAMLE 224

Query: 371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNM 417
           +           +E  +++  C   D +NRP  + V   L     ++
Sbjct: 225 KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 5e-66
 Identities = 77/301 (25%), Positives = 124/301 (41%), Gaps = 37/301 (12%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELR 189
           + S    +G G FG V              + +A   VAVK L+      + +   +EL+
Sbjct: 24  RLSFGKTLGAGAFGKVVEAT-----AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78

Query: 190 FLSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL----------------LNED 232
            LS L NH N+V L+G C      L++ EY   G L + L                + +D
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 233 DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP 292
           +  L+ E  +  +   A+G+  L    +  IHRD+ A N+LL      KI DFGLA+   
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196

Query: 293 LGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG 352
                 +         + APE I     T ++DV+S+G+ L E+ S             G
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL------------G 244

Query: 353 NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ 412
           +   P +      +++I E            E  +I+  C ++DP  RPT  ++V  +E+
Sbjct: 245 SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 413 L 413
            
Sbjct: 305 Q 305

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 9e-66
 Identities = 68/283 (24%), Positives = 129/283 (45%), Gaps = 29/283 (10%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
               +  +GQG FG+V++G  N               VA+K L+  G+   + +  E + 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR-----------VAIKTLK-PGTMSPEAFLQEAQV 65

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           + +L H  +V+L     ++    +V EY+++GSL D L  E    L   + + +A   A 
Sbjct: 66  MKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           G+ ++       +HRD++A+N+L+ ++   K++DFGLA+     ++            + 
Sbjct: 125 GMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWT 181

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           APE    G  T+K+DV+SFG++L E+ +             G    P + N+  +   ++
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTK------------GRVPYPGMVNR-EVLDQVE 228

Query: 371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
                    E  +   +++ +C   +P+ RPT   + A LE  
Sbjct: 229 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 4e-65
 Identities = 67/284 (23%), Positives = 120/284 (42%), Gaps = 27/284 (9%)

Query: 138 IGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSRLNH 196
           +G G FG V  G          R +     VA+K L++   +   +E   E + + +L++
Sbjct: 17  LGCGNFGSVRQGVY--------RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68

Query: 197 PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH 256
           P +V+L+G  C  +  +LV E    G L   L+ + + E+      ++    + G+++L 
Sbjct: 69  PYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLE 126

Query: 257 TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF-GPLGDKSHISTRVLGTRGYFAPEYI 315
              +  +HRD+ A NVLL +   AKISDFGL+K  G         +       ++APE I
Sbjct: 127 --EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 316 ATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDEKLGR 375
                + ++DV+S+GV + E LS      ++  G               +   I++    
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------------PEVMAFIEQGKRM 231

Query: 376 NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS 419
               E   E   ++  C     ++RP    V   +     ++ S
Sbjct: 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  209 bits (532), Expect = 9e-65
 Identities = 77/287 (26%), Positives = 121/287 (42%), Gaps = 43/287 (14%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--- 185
            + FS+   IG G FG VY           AR       VA+K++   G Q  ++W+   
Sbjct: 14  EKLFSDLREIGHGSFGAVYF----------ARDVRNSEVVAIKKMSYSGKQSNEKWQDII 63

Query: 186 NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA 245
            E+RFL +L HPN ++  G    +    LV EY    + +   +++    L       + 
Sbjct: 64  KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVT 121

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
            GA +GL +LH+    +IHRDVKA N+LL +    K+ DFG A           +   +G
Sbjct: 122 HGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVG 173

Query: 306 TRGYFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LS 360
           T  + APE I     G    K DV+S G+  +E+   K                P   ++
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP---------------PLFNMN 218

Query: 361 NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
              AL+ I   +         ++ F   +  CL   P++RPT   ++
Sbjct: 219 AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 1e-64
 Identities = 73/283 (25%), Positives = 121/283 (42%), Gaps = 27/283 (9%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELRFLSR 193
             +IG+G FG VY G +                 AVK L R    G+  ++  E   +  
Sbjct: 32  NEVIGRGHFGCVYHGTL-------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84

Query: 194 LNHPNVVKLMGYCCDDQ-HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
            +HPNV+ L+G C   +   L+V  Y+  G L + + NE       +  I   L  A+G+
Sbjct: 85  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGM 143

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF--GPLGDKSHISTRVLGTRGYF 310
           + L    +  +HRD+ A N +LD+ F  K++DFGLA+       D  H  T       + 
Sbjct: 144 KFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID 370
           A E + T   T K+DV+SFGV+L E+++         N                +   + 
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-------------FDITVYLL 248

Query: 371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +               E++L+C +   + RP+ SE+V+ +  +
Sbjct: 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 1e-64
 Identities = 66/284 (23%), Positives = 125/284 (44%), Gaps = 26/284 (9%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRF 190
           F +  ++G G FG VY G            +     VA+K LR   S +   E  +E   
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIP------EGEKVKIPVAIKELREATSPKANKEILDEAYV 64

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           ++ +++P+V +L+G C     +L + + +  G L D++    D     +  +   +  A+
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAK 122

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           G+ +L    R ++HRD+ A NVL+    + KI+DFGLAK     +K + +        + 
Sbjct: 123 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL-ALHQII 369
           A E I     T ++DV+S+GV + E+++  +              KPY       +  I+
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSIL 226

Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           ++            +   I+++C   D  +RP   E++    ++
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 2e-64
 Identities = 71/299 (23%), Positives = 132/299 (44%), Gaps = 44/299 (14%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRF 190
              +++IG+G FG V    I        ++       A+KR++   S     ++  EL  
Sbjct: 12  IKFQDVIGEGNFGQVLKARI--------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 63

Query: 191 LSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTE-------------- 235
           L +L +HPN++ L+G C    +  L  EY   G+L D L      E              
Sbjct: 64  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123

Query: 236 LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGD 295
           L+ ++ +  A   ARG+++L    +  IHRD+ A N+L+ +++ AKI+DFGL++   +  
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181

Query: 296 KSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWA 355
           K  +         + A E +     T  +DV+S+GV+L EI+S                 
Sbjct: 182 KKTMGR---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL--------------GG 224

Query: 356 KPYLS-NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
            PY       L++ + +       +    E  +++ +C    P  RP+ ++++ +L ++
Sbjct: 225 TPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 1e-63
 Identities = 69/278 (24%), Positives = 119/278 (42%), Gaps = 28/278 (10%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELR 189
            +     +G+G +G+V +          A  +  + AVAVK +  K +    E  + E+ 
Sbjct: 6   DWDLVQTLGEGAYGEVQL----------AVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 55

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
               LNH NVVK  G+  +   + L  EY + G L D +  E D  +      +      
Sbjct: 56  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLM 113

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
            G+ +LH     + HRD+K  N+LLD+  N KISDFGLA      ++  +  ++ GT  Y
Sbjct: 114 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171

Query: 310 FAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
            APE +          DV+S G+VL  +L+G+    + ++            +       
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD------------SCQEYSDW 219

Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
            ++K   N   +       ++ + L  +P  R T+ ++
Sbjct: 220 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 2e-63
 Identities = 73/305 (23%), Positives = 115/305 (37%), Gaps = 41/305 (13%)

Query: 135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL 194
           +  IG+G FG+V+ G                  VAVK    +  +     E E+     L
Sbjct: 8   QESIGKGRFGEVWRGKWRGEE------------VAVKIFSSREERSWFR-EAEIYQTVML 54

Query: 195 NHPNVVKLMGYCCDDQ----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
            H N++  +     D        LV +Y   GSL D+L   +   +  E  IK+AL  A 
Sbjct: 55  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTAS 111

Query: 251 GLEHLHTYW------RPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDK--SHISTR 302
           GL HLH           + HRD+K+ N+L+  +    I+D GLA                
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171

Query: 303 VLGTRGYFAPEYIAT------GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG--NW 354
            +GT+ Y APE +             + D+Y+ G+V  EI    +      +      + 
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231

Query: 355 AKPYLSNKLALHQIIDEKLGRNIQ-----MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA 409
                S +     + ++KL  NI       E  +  A+I+  C  ++   R T   +   
Sbjct: 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291

Query: 410 LEQLQ 414
           L QL 
Sbjct: 292 LSQLS 296

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 3e-63
 Identities = 75/292 (25%), Positives = 129/292 (44%), Gaps = 29/292 (9%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENELR 189
           K +    +GQG FG VY G           +   +  VA+K +    S  +  E+ NE  
Sbjct: 21  KITMSRELGQGSFGMVYEGVA-----KGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 75

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--------LNEDDTELNWERR 241
            +   N  +VV+L+G     Q  L++ E +TRG L+ +L         N      +  + 
Sbjct: 76  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
           I++A   A G+ +L+      +HRD+ A N ++ +DF  KI DFG+ +     D      
Sbjct: 136 IQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
           + L    + +PE +  G  T  +DV+SFGVVL EI +                    LSN
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL------------AEQPYQGLSN 241

Query: 362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           +  L  +++  L  +          E++  C   +PK RP+  E+++++++ 
Sbjct: 242 EQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (511), Expect = 4e-62
 Identities = 63/284 (22%), Positives = 109/284 (38%), Gaps = 38/284 (13%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENEL 188
           KF  +  IG+G F  VY                    VA   L+ +      +  ++ E 
Sbjct: 12  KFDIE--IGRGSFKTVY----------KGLDTETTVEVAWCELQDRKLTKSERQRFKEEA 59

Query: 189 RFLSRLNHPNVVKLMGYCCD----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
             L  L HPN+V+            +  +LV E +T G+L+ +L  +    +  +     
Sbjct: 60  EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSW 117

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDD-DFNAKISDFGLAKFGPLGDKSHISTRV 303
                +GL+ LHT   P+IHRD+K  N+ +     + KI D GLA       ++  +  V
Sbjct: 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAV 173

Query: 304 LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL 363
           +GT  + APE           DVY+FG+ +LE+ + +       N               
Sbjct: 174 IGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQN------------AAQ 220

Query: 364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
              ++       +       E  EII  C+  +   R ++ +++
Sbjct: 221 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 1e-61
 Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 27/289 (9%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWEN 186
           +       +G G FG V  G  +              +VAVK L+       +  D++  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWD-------APSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60

Query: 187 ELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIAL 246
           E+  +  L+H N+++L G       + +V E    GSL D L              + A+
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAV 118

Query: 247 GAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHI-STRVLG 305
             A G+ +L +  +  IHRD+ A N+LL      KI DFGL +  P  D  ++       
Sbjct: 119 QVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176

Query: 306 TRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL 365
              + APE + T   +  +D + FGV L E+ +             G      L+    L
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY------------GQEPWIGLNGSQIL 224

Query: 366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
           H+I  E        +  Q+   ++++C    P++RPT   +   L + Q
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 1e-61
 Identities = 71/288 (24%), Positives = 115/288 (39%), Gaps = 39/288 (13%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD--EWENEL 188
            +     IG G +G               RRK+    +  K L        +     +E+
Sbjct: 5   DYEVLYTIGTGSYGRCQ----------KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEV 54

Query: 189 RFLSRLNHPNVVKLMGYCCD--DQHRLLVYEYVTRGSLEDHL--LNEDDTELNWERRIKI 244
             L  L HPN+V+      D  +    +V EY   G L   +    ++   L+ E  +++
Sbjct: 55  NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 114

Query: 245 ALGAARGLEHLH---TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
                  L+  H        V+HRD+K +NV LD   N K+ DFGLA+   L   +  + 
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAK 172

Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--L 359
             +GT  Y +PE +       K+D++S G +L E+ +                  P+   
Sbjct: 173 AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP---------------PFTAF 217

Query: 360 SNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
           S K    +I + K  R I    + E  EII R LN    +RP++ E++
Sbjct: 218 SQKELAGKIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 1e-61
 Identities = 63/279 (22%), Positives = 114/279 (40%), Gaps = 38/279 (13%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN 195
             +G G FG VY           A+ K      A K +  K  +  +++  E+  L+  +
Sbjct: 18  GELGDGAFGKVYK----------AQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67

Query: 196 HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHL 255
           HPN+VKL+     + +  ++ E+   G++ D ++ E +  L   +   +       L +L
Sbjct: 68  HPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 256 HTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYI 315
           H     +IHRD+KA N+L   D + K++DFG++               +GT  + APE +
Sbjct: 127 HD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVV 182

Query: 316 AT-----GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALHQI 368
                       K DV+S G+ L+E+   +                P+  L+    L +I
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEP---------------PHHELNPMRVLLKI 227

Query: 369 IDEKLGRNIQMEEA-QEFAEIILRCLNSDPKNRPTMSEV 406
              +     Q       F + + +CL  +   R T S++
Sbjct: 228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 3e-60
 Identities = 65/281 (23%), Positives = 118/281 (41%), Gaps = 35/281 (12%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENEL 188
            +K++    IGQG  G VY           A        VA++++  +    ++   NE+
Sbjct: 19  KKKYTRFEKIGQGASGTVY----------TAMDVATGQEVAIRQMNLQQQPKKELIINEI 68

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             +    +PN+V  +          +V EY+  GSL D +           +   +    
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCREC 125

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
            + LE LH+    VIHRD+K+ N+LL  D + K++DFG      +  +    + ++GT  
Sbjct: 126 LQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPY 181

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALH 366
           + APE +       K D++S G++ +E++ G+                PY   +   AL+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP---------------PYLNENPLRALY 226

Query: 367 QIIDEKLGRNIQMEE-AQEFAEIILRCLNSDPKNRPTMSEV 406
            I           E+ +  F + + RCL+ D + R +  E+
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-59
 Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 45/288 (15%)

Query: 130 RKFSEKN-----LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQ 181
           R+++ ++      +G+G FG+VY+          AR K + F +A+K L +     +  +
Sbjct: 1   RQWALEDFEIGRPLGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVE 50

Query: 182 DEWENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERR 241
            +   E+   S L HPN+++L GY  D     L+ EY   G++   L  +  ++ + +R 
Sbjct: 51  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRT 108

Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
                  A  L + H+  + VIHRD+K  N+LL      KI+DFG +   P    S   T
Sbjct: 109 ATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRT 162

Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            + GT  Y  PE I       K D++S GV+  E L GK                P+ +N
Sbjct: 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEAN 207

Query: 362 KLA--LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVV 407
                  +I   +      + E     ++I R L  +P  RP + EV+
Sbjct: 208 TYQETYKRISRVEFTFPDFVTE--GARDLISRLLKHNPSQRPMLREVL 253

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 3e-59
 Identities = 67/284 (23%), Positives = 120/284 (42%), Gaps = 26/284 (9%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELR 189
           +      IG+G FGDV+ G            +N   AVA+K  +   S   ++++  E  
Sbjct: 8   RIELGRCIGEGQFGDVHQG-------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            + + +HP++VKL+G   ++    ++ E  T G L   L     + L+    I  A   +
Sbjct: 61  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLS 118

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGY 309
             L +L    +  +HRD+ A NVL+  +   K+ DFGL+++       + +++      +
Sbjct: 119 TALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKW 175

Query: 310 FAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII 369
            APE I     T  +DV+ FGV + EIL              G      + N   + +I 
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMH------------GVKPFQGVKNNDVIGRIE 223

Query: 370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
           + +    +          ++ +C   DP  RP  +E+ A L  +
Sbjct: 224 NGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 4e-58
 Identities = 73/300 (24%), Positives = 134/300 (44%), Gaps = 36/300 (12%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELR 189
           +      +G+G FG V +            + N    VAVK L+   ++    +  +E+ 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIG---LDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70

Query: 190 FLSRL-NHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHL--------------LNEDDT 234
            +  +  H N++ L+G C  D    ++ EY ++G+L ++L               +  + 
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 235 ELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLG 294
           +L+ +  +  A   ARG+E+L +  +  IHRD+ A NVL+ +D   KI+DFGLA+     
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 295 DKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
           D    +T       + APE +     T ++DV+SFGV+L EI +   +            
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------ 236

Query: 355 AKPYLSNKL-ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
             PY    +  L +++ E    +       E   ++  C ++ P  RPT  ++V  L+++
Sbjct: 237 --PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 6e-56
 Identities = 60/289 (20%), Positives = 110/289 (38%), Gaps = 36/289 (12%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NE 187
            F    ++G+G F  V +          AR        A+K L ++    +++      E
Sbjct: 9   DFKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKRHIIKENKVPYVTRE 58

Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
              +SRL+HP  VKL     DD+       Y   G L  ++        +          
Sbjct: 59  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAE 116

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
               LE+LH     +IHRD+K  N+LL++D + +I+DFG AK      K   +   +GT 
Sbjct: 117 IVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174

Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLAL 365
            Y +PE +        +D+++ G ++ ++++G                 P+   +  L  
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP---------------PFRAGNEYLIF 219

Query: 366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ 414
            +II  +     +     +  +++ + L  D   R    E+        
Sbjct: 220 QKIIKLEYDFPEKFFP--KARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 1e-55
 Identities = 80/300 (26%), Positives = 119/300 (39%), Gaps = 36/300 (12%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-QDEWENELR 189
           +      +G+G FG V          TA  R      VAVK L+   +        +EL+
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRT-----VAVKMLKEGATHSEHRALMSELK 68

Query: 190 FLSR-LNHPNVVKLMGYCCDDQHRL-LVYEYVTRGSLEDHLLNEDDTE------------ 235
            L    +H NVV L+G C      L ++ E+   G+L  +L ++ +              
Sbjct: 69  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128

Query: 236 --LNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL 293
             L  E  I  +   A+G+E L +  R  IHRD+ A N+LL +    KI DFGLA+    
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 294 GDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN 353
                          + APE I     T+++DV+SFGV+L EI S               
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG------------A 234

Query: 354 WAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL 413
              P +       + + E            E  + +L C + +P  RPT SE+V  L  L
Sbjct: 235 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  183 bits (465), Expect = 2e-54
 Identities = 59/278 (21%), Positives = 111/278 (39%), Gaps = 29/278 (10%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
            +     +G G FG V+              +      A K +       ++    E++ 
Sbjct: 27  HYDIHEELGTGAFGVVH----------RVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           +S L HP +V L     DD   +++YE+++ G L + + +E +  ++ +  ++      +
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCK 135

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFN--AKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           GL H+H      +H D+K  N++     +   K+ DFGL       D         GT  
Sbjct: 136 GLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAE 190

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           + APE      +   TD++S GV+   +LSG +          G      L N  +    
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP-------FGGENDDETLRNVKSCDWN 243

Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           +D+     I    +++  + I + L +DP  R T+ + 
Sbjct: 244 MDDSAFSGI----SEDGKDFIRKLLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  182 bits (463), Expect = 4e-54
 Identities = 68/327 (20%), Positives = 122/327 (37%), Gaps = 35/327 (10%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
            +     +G G FG V+              K        K +       +   +NE+  
Sbjct: 30  YYDILEELGSGAFGVVH----------RCVEKATGRVFVAKFINTPYPLDKYTVKNEISI 79

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           +++L+HP ++ L     D    +L+ E+++ G L D +  ED   ++    I     A  
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACE 138

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLD--DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           GL+H+H     ++H D+K  N++ +     + KI DFGLA      +   I      T  
Sbjct: 139 GLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAE 193

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           + APE +    +   TD+++ GV+   +LSG +         AG      L N       
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP-------FAGEDDLETLQNVKRCDWE 246

Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA------ALEQLQLNMGSCYQ 422
            DE    ++    + E  + I   L  +P+ R T+ + +           L   + S   
Sbjct: 247 FDEDAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRY 302

Query: 423 TSLRTSTHTTRTRSFEQRPLKQRMSNL 449
             +R             +P   R++N 
Sbjct: 303 NKIRQKIKEKYADWPAPQPAIGRIANF 329

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 3e-51
 Identities = 66/321 (20%), Positives = 131/321 (40%), Gaps = 35/321 (10%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           K+     +G+G FG V+               ++      K ++ KG+  Q   + E+  
Sbjct: 6   KYMIAEDLGRGEFGIVH----------RCVETSSKKTYMAKFVKVKGTD-QVLVKKEISI 54

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           L+   H N++ L       +  ++++E+++   + +  +N    ELN    +        
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFER-INTSAFELNEREIVSYVHQVCE 113

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNA--KISDFGLAKFGPLGDKSHISTRVLGTRG 308
            L+ LH+    + H D++  N++     ++  KI +FG A+    GD   +         
Sbjct: 114 ALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPE 168

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           Y+APE      ++  TD++S G ++  +LSG    +  TN       +  + N +     
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAEYT 221

Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ--LQLNMGSCYQTSLR 426
            DE+  + I    + E  + + R L  + K+R T SE   AL+   L+  +       +R
Sbjct: 222 FDEEAFKEI----SIEAMDFVDRLLVKERKSRMTASE---ALQHPWLKQKIERVSTKVIR 274

Query: 427 TSTHTTRTRSFEQRPLKQRMS 447
           T  H     +  ++ L   +S
Sbjct: 275 TLKHRRYYHTLIKKDLNMVVS 295

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  171 bits (435), Expect = 6e-51
 Identities = 72/297 (24%), Positives = 127/297 (42%), Gaps = 42/297 (14%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD---EWENE 187
           ++    ++G GG  +V++          AR       VAVK LR   ++       +  E
Sbjct: 8   RYELGEILGFGGMSEVHL----------ARDLRLHRDVAVKVLRADLARDPSFYLRFRRE 57

Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRL----LVYEYVTRGSLEDHLLNEDDTELNWERRIK 243
            +  + LNHP +V +      +        +V EYV   +L D +    +  +  +R I+
Sbjct: 58  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIE 115

Query: 244 IALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHISTR 302
           +   A + L   H     +IHRDVK +N+++      K+ DFG+A+     G+    +  
Sbjct: 116 VIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173

Query: 303 VLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LS 360
           V+GT  Y +PE      +  ++DVYS G VL E+L+G+                P+   S
Sbjct: 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---------------PFTGDS 218

Query: 361 NKLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRP-TMSEVVAALEQLQ 414
                +Q + E         E    +   ++L+ L  +P+NR  T +E+ A L ++ 
Sbjct: 219 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (435), Expect = 1e-50
 Identities = 72/325 (22%), Positives = 134/325 (41%), Gaps = 43/325 (13%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-WENELR 189
            +  ++++G G F +V +          A  K     VA+K + +K  +G++   ENE+ 
Sbjct: 10  IYDFRDVLGTGAFSEVIL----------AEDKRTQKLVAIKCIAKKALEGKEGSMENEIA 59

Query: 190 FLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
            L ++ HPN+V L        H  L+ + V+ G L D ++ +           ++     
Sbjct: 60  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVL 117

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLL---DDDFNAKISDFGLAKFGPLGDKSHISTRVLGT 306
             +++LH     ++HRD+K  N+L    D+D    ISDFGL+K     D   + +   GT
Sbjct: 118 DAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 172

Query: 307 RGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLA 364
            GY APE +A    +   D +S GV+   +L G                 P+   ++   
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP---------------PFYDENDAKL 217

Query: 365 LHQIIDEKLGRNIQMEE--AQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ 422
             QI+  +   +    +  +    + I   +  DP+ R T  +   AL+   +   +   
Sbjct: 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQ---ALQHPWIAGDTALD 274

Query: 423 TSLRTSTHTTRTRSFEQRPLKQRMS 447
            ++  S      ++F +   KQ  +
Sbjct: 275 KNIHQSVSEQIKKNFAKSKWKQAFN 299

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-49
 Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 39/280 (13%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NEL 188
           F    ++G+G FG V+           A  K  +   A+K L++      D+ E    E 
Sbjct: 4   FILHKMLGKGSFGKVF----------LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53

Query: 189 RFLSR-LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
           R LS    HP +  +       ++   V EY+  G L  H+  +   + +  R    A  
Sbjct: 54  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAE 111

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
              GL+ LH   + +++RD+K  N+LLD D + KI+DFG+ K   LGD         GT 
Sbjct: 112 IILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTP 167

Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLAL 365
            Y APE +         D +SFGV+L E+L G++               P+     +   
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS---------------PFHGQDEEELF 212

Query: 366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
           H I  +       +E+  E  +++++    +P+ R  +  
Sbjct: 213 HSIRMDNPFYPRWLEK--EAKDLLVKLFVREPEKRLGVRG 250

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 1e-48
 Identities = 66/290 (22%), Positives = 124/290 (42%), Gaps = 35/290 (12%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDE-----WENELRF 190
           + +G+G F  VY           AR KN +  VA+K+++        +        E++ 
Sbjct: 4   DFLGEGQFATVYK----------ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 53

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           L  L+HPN++ L+       +  LV++++        ++ ++   L         L   +
Sbjct: 54  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQ 111

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           GLE+LH +W  ++HRD+K +N+LLD++   K++DFGLAK    G  +   T  + TR Y 
Sbjct: 112 GLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYR 167

Query: 311 APEYIATGHL-TLKTDVYSFGVVLLEILSGKT--------AAMRRTNGLAGNWAKPYLSN 361
           APE +    +  +  D+++ G +L E+L              + R     G   +    +
Sbjct: 168 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227

Query: 362 KLALHQIIDEKLGRNIQMEEA-----QEFAEIILRCLNSDPKNRPTMSEV 406
             +L   +  K    I +         +  ++I      +P  R T ++ 
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  165 bits (418), Expect = 2e-48
 Identities = 67/294 (22%), Positives = 115/294 (39%), Gaps = 48/294 (16%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---------QGQ 181
            +  K ++G+G    V               K      AVK +   G          + +
Sbjct: 4   NYEPKEILGRGVSSVVR----------RCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR 53

Query: 182 DEWENELRFLSRLN-HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWER 240
           +    E+  L +++ HPN+++L      +    LV++ + +G L D+L   +   L+ + 
Sbjct: 54  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKE 111

Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
             KI       +  LH     ++HRD+K  N+LLDDD N K++DFG +      D     
Sbjct: 112 TRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKL 166

Query: 301 TRVLGTRGYFAPEYIATGHL------TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNW 354
             V GT  Y APE I             + D++S GV++  +L+G      R        
Sbjct: 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-------- 218

Query: 355 AKPYLSNKLALHQII--DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                   L L  I+  + + G     + +    +++ R L   P+ R T  E 
Sbjct: 219 -----KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  166 bits (422), Expect = 4e-48
 Identities = 69/285 (24%), Positives = 107/285 (37%), Gaps = 37/285 (12%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENE- 187
           FS   +IG+GGFG+VY            R+ +     A+K L +K     QG+    NE 
Sbjct: 6   FSVHRIIGRGGFGEVY----------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 55

Query: 188 --LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA 245
             L  +S  + P +V +            + + +  G L  HL        +       A
Sbjct: 56  IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYA 113

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
                GLEH+H   R V++RD+K +N+LLD+  + +ISD GLA               +G
Sbjct: 114 AEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVG 167

Query: 306 TRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA 364
           T GY APE +  G       D +S G +L ++L G +   +          +  L+  + 
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 227

Query: 365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA 409
           L                  E   ++   L  D   R       A 
Sbjct: 228 LPDSFSP------------ELRSLLEGLLQRDVNRRLGCLGRGAQ 260

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 7e-47
 Identities = 62/293 (21%), Positives = 115/293 (39%), Gaps = 32/293 (10%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENEL 188
            F +   IG+G +G VY           AR K     VA+K++R              E+
Sbjct: 3   NFQKVEKIGEGTYGVVY----------KARNKLTGEVVALKKIRLDTETEGVPSTAIREI 52

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             L  LNHPN+VKL+     +    LV+E++ +  L+  +     T +            
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQL 111

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
            +GL   H++   V+HRD+K  N+L++ +   K++DFGLA+    G      T  + T  
Sbjct: 112 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLW 167

Query: 309 YFAPE-YIATGHLTLKTDVYSFGVVLLEILSGKT--------AAMRRTNGLAGNWAKPYL 359
           Y APE  +   + +   D++S G +  E+++ +           + R     G   +   
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227

Query: 360 SNKLALHQIIDE------KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
               ++            +    +     ++   ++ + L+ DP  R +    
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 5e-46
 Identities = 67/301 (22%), Positives = 113/301 (37%), Gaps = 37/301 (12%)

Query: 128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE-- 185
           A +++     IG+G +G V+              KN    VA+KR+R +  +        
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKAR---------DLKNGGRFVALKRVRVQTGEEGMPLSTI 55

Query: 186 ---NELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVT----RGSLEDHLLNEDDTELNW 238
                LR L    HPNVV+L   C   +        +        L  +L    +  +  
Sbjct: 56  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 115

Query: 239 ERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSH 298
           E    +     RGL+ LH+    V+HRD+K  N+L+      K++DFGLA+         
Sbjct: 116 ETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQM 170

Query: 299 ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT-----------AAMRRT 347
             T V+ T  Y APE +         D++S G +  E+   K              +   
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230

Query: 348 NGLAG--NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
            GL G  +W +     + A H    + +      +  +   +++L+CL  +P  R +   
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289

Query: 406 V 406
            
Sbjct: 290 A 290

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 7e-46
 Identities = 63/280 (22%), Positives = 107/280 (38%), Gaps = 48/280 (17%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWEN------ELRF 190
           L+G GGFG VY          +  R + +  VA+K + +       E  N      E+  
Sbjct: 11  LLGSGGFGSVY----------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60

Query: 191 LSRLN--HPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
           L +++     V++L+ +       +L+ E           + E    L  E         
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 119

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
              + H H     V+HRD+K  N+L+D +    K+ DFG         K  + T   GTR
Sbjct: 120 LEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTR 173

Query: 308 GYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH 366
            Y  PE+I    +      V+S G++L +++ G                 P+  +     
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI---------------PFEHD----E 214

Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
           +II  ++    +   + E   +I  CL   P +RPT  E+
Sbjct: 215 EIIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 8e-46
 Identities = 66/286 (23%), Positives = 109/286 (38%), Gaps = 38/286 (13%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW------ 184
            +     +G G F  V             R K+     A K ++++ ++           
Sbjct: 11  YYDTGEELGSGQFAVVK----------KCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60

Query: 185 ENELRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKI 244
           E E+  L  + HPNV+ L     +    +L+ E V  G L D     +   L  E   + 
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEF 118

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD----FNAKISDFGLAKFGPLGDKSHIS 300
                 G+ +LH+    + H D+K  N++L D        KI DFGLA     G++    
Sbjct: 119 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 173

Query: 301 TRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS 360
             + GT  + APE +    L L+ D++S GV+   +LSG +  +  T             
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----------Q 222

Query: 361 NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
             LA    ++ +         +    + I R L  DPK R T+ + 
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-45
 Identities = 63/300 (21%), Positives = 115/300 (38%), Gaps = 36/300 (12%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQ-DEWENE 187
             +++  + IG+G +G V           +A        VA+K++     Q        E
Sbjct: 7   GPRYTNLSYIGEGAYGMVC----------SAYDNVNKVRVAIKKISPFEHQTYCQRTLRE 56

Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVT---RGSLEDHLLNEDDTELNWERRIKI 244
           ++ L R  H N++ +           +   Y+     G+    LL      L+ +     
Sbjct: 57  IKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYF 114

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF-GPLGDKSHISTRV 303
                RGL+++H+    V+HRD+K SN+LL+   + KI DFGLA+   P  D +   T  
Sbjct: 115 LYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172

Query: 304 LGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKT-----------AAMRRTNGLA 351
           + TR Y APE +      T   D++S G +L E+LS +              +    G  
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232

Query: 352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEA-----QEFAEIILRCLNSDPKNRPTMSEV 406
                  + N  A + ++       +           +  +++ + L  +P  R  + + 
Sbjct: 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (400), Expect = 1e-45
 Identities = 57/297 (19%), Positives = 98/297 (32%), Gaps = 32/297 (10%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           ++     IG G FGD+Y+               A   VA+K    K      +   E + 
Sbjct: 8   RYRLGRKIGSGSFGDIYL----------GTDIAAGEEVAIKLECVK--TKHPQLHIESKI 55

Query: 191 LSRLNHPNVVKLMGYCC-DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
              +     +  + +C  +  + ++V E +  G   + L N    + + +  + +A    
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMI 113

Query: 250 RGLEHLHTYWRPVIHRDVKASNVL---LDDDFNAKISDFGLAKFGPLGD-----KSHIST 301
             +E++H+  +  IHRDVK  N L           I DFGLAK               + 
Sbjct: 114 SRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171

Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSN 361
            + GT  Y +         + + D+ S G VL+    G                + Y   
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA---ATKRQKYERI 228

Query: 362 KLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG 418
                    E L +        EFA  +  C +    ++P  S +      L    G
Sbjct: 229 SEKKMSTPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  157 bits (397), Expect = 5e-45
 Identities = 64/283 (22%), Positives = 119/283 (42%), Gaps = 41/283 (14%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NEL 188
           F     +G G FG V++           R ++     A+K L+++      + E   +E 
Sbjct: 6   FQILRTLGTGSFGRVHL----------IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 55

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             LS + HP ++++ G   D Q   ++ +Y+  G L   L           +     +  
Sbjct: 56  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-- 113

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
              LE+LH   + +I+RD+K  N+LLD + + KI+DFG AK+ P      ++  + GT  
Sbjct: 114 CLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPD 166

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSNKLALH 366
           Y APE ++T       D +SFG+++ E+L+G                 P+   +      
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY---------------TPFYDSNTMKTYE 211

Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA 409
           +I++ +L       E  +  +++ R +  D   R    +    
Sbjct: 212 KILNAELRFPPFFNE--DVKDLLSRLITRDLSQRLGNLQNGTE 252

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 6e-45
 Identities = 63/297 (21%), Positives = 106/297 (35%), Gaps = 40/297 (13%)

Query: 132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFL 191
           +++  +IG G FG VY           A+  ++   VA+K++ +     +     EL+ +
Sbjct: 22  YTDTKVIGNGSFGVVY----------QAKLCDSGELVAIKKVLQD----KRFKNRELQIM 67

Query: 192 SRLNHPNVVKLMGYCC------DDQHRLLVYEYVTRGSLEDHL-LNEDDTELNWERRIKI 244
            +L+H N+V+L  +        D+ +  LV +YV           +     L        
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127

Query: 245 ALGAARGLEHLHTYWRPVIHRDVKASNVLLDDD-FNAKISDFGLAKFGPLGDKSHISTRV 303
                R L ++H+    + HRD+K  N+LLD D    K+ DFG AK   L       + +
Sbjct: 128 MYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYI 183

Query: 304 LGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT-----------AAMRRTNGLAG 352
                            T   DV+S G VL E+L G+              + +  G   
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 353 NWAKPYLS---NKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
                 ++    +    QI      +  +     E   +  R L   P  R T  E 
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  153 bits (386), Expect = 1e-43
 Identities = 47/303 (15%), Positives = 97/303 (32%), Gaps = 42/303 (13%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
            +     IG+G FG ++                 +  VA+K   R+      +  +E R 
Sbjct: 6   HYKVGRRIGEGSFGVIF----------EGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRT 53

Query: 191 LSRLNH-PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAA 249
              L     +  +  +  +  H +LV + +  G   + LL+    + + +     A    
Sbjct: 54  YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQML 111

Query: 250 RGLEHLHTYWRPVIHRDVKASNVLLDDDFN-----AKISDFGLAKFGPLGDKS-----HI 299
             ++ +H   + +++RD+K  N L+    +       + DFG+ KF              
Sbjct: 112 ARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169

Query: 300 STRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYL 359
              + GT  Y +         + + D+ + G V +  L G              W     
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL-----------PWQGLKA 218

Query: 360 SNKLALHQIIDEKLGRNIQMEEA----QEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL 415
           +     ++ I EK       E      +EF + +    N      P    +     ++  
Sbjct: 219 ATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

Query: 416 NMG 418
            + 
Sbjct: 279 RLN 281

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-43
 Identities = 54/278 (19%), Positives = 97/278 (34%), Gaps = 35/278 (12%)

Query: 137 LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-N 195
           ++G G  G V               K      A+K L+        +   E+    R   
Sbjct: 19  VLGLGINGKVL----------QIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQ 63

Query: 196 HPNVVKLMGYCCD----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARG 251
            P++V+++    +     +  L+V E +  G L   + +  D         +I       
Sbjct: 64  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123

Query: 252 LEHLHTYWRPVIHRDVKASNVLLDDDFN---AKISDFGLAKFGPLGDKSHISTRVLGTRG 308
           +++LH+    + HRDVK  N+L          K++DFG AK     +          T  
Sbjct: 124 IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPY 178

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI 368
           Y APE +         D++S GV++  +L G             N             ++
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP-------FYSNHGLAISPGMKTRIRM 231

Query: 369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
              +       E ++E   +I   L ++P  R T++E 
Sbjct: 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  151 bits (382), Expect = 3e-43
 Identities = 58/290 (20%), Positives = 108/290 (37%), Gaps = 28/290 (9%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           K+     IG+G +G VY                  FA+   RL ++          E+  
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQ---------NNYGETFALKKIRLEKEDEGIPSTTIREISI 53

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAAR 250
           L  L H N+VKL       +  +LV+E++ +      LL+  +  L         L    
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLN 111

Query: 251 GLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYF 310
           G+ + H   R V+HRD+K  N+L++ +   KI+DFGLA+   +  + +    ++      
Sbjct: 112 GIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRA 168

Query: 311 APEYIATGHLTLKTDVYSFGVVLLEILSGKT--------AAMRRTNGLAGNWAKPYLSNK 362
               + +   +   D++S G +  E+++G            + R   + G        N 
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228

Query: 363 LALHQIIDEKLGRNIQMEEA------QEFAEIILRCLNSDPKNRPTMSEV 406
             L +             E+      +   +++ + L  DP  R T  + 
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 5e-43
 Identities = 73/284 (25%), Positives = 103/284 (36%), Gaps = 38/284 (13%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NE 187
            F    L+G+G FG V +           R K      A+K LR++    +DE      E
Sbjct: 6   DFDYLKLLGKGTFGKVIL----------VREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55

Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
            R L    HP +  L            V EY   G L  HL  E       ER       
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAE 113

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
               LE+LH   R V++RD+K  N++LD D + KI+DFGL K G             GT 
Sbjct: 114 IVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKTFCGTP 169

Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ 367
            Y APE +         D +  GVV+ E++ G+     + +                  +
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----------------ER 212

Query: 368 IIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAA 409
           + +  L   I+       E   ++   L  DPK R       A 
Sbjct: 213 LFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 256

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-41
 Identities = 62/306 (20%), Positives = 112/306 (36%), Gaps = 44/306 (14%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE--NEL 188
           K+ +   IGQG FG+V+           AR +     VA+K++  +  +         E+
Sbjct: 11  KYEKLAKIGQGTFGEVF----------KARHRKTGQKVALKKVLMENEKEGFPITALREI 60

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHR--------LLVYEYVTRGSLEDHLLNEDDTELNWER 240
           + L  L H NVV L+  C               LV+++                +     
Sbjct: 61  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSE 118

Query: 241 RIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIS 300
             ++      GL ++H     ++HRD+KA+NVL+  D   K++DFGLA+   L   S  +
Sbjct: 119 IKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176

Query: 301 --TRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKT-----------AAMRR 346
             T  + T  Y  PE +          D++  G ++ E+ +              A + +
Sbjct: 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236

Query: 347 TNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQ------EFAEIILRCLNSDPKNR 400
             G       P + N     ++   K  +    +  +         ++I + L  DP  R
Sbjct: 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 296

Query: 401 PTMSEV 406
               + 
Sbjct: 297 IDSDDA 302

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-40
 Identities = 56/293 (19%), Positives = 110/293 (37%), Gaps = 32/293 (10%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENEL 188
           K+ +   IG+G +G V+           A+ +     VA+KR+R              E+
Sbjct: 3   KYEKLEKIGEGTYGTVF----------KAKNRETHEIVALKRVRLDDDDEGVPSSALREI 52

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGA 248
             L  L H N+V+L      D+   LV+E+  +   +    +  + +L+ E         
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF--DSCNGDLDPEIVKSFLFQL 110

Query: 249 ARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRG 308
            +GL   H   R V+HRD+K  N+L++ +   K+++FGLA+   +  + + S  V+    
Sbjct: 111 LKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWY 167

Query: 309 YFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT---------AAMRRTNGLAGNWAKPYL 359
                       +   D++S G +  E+ +              ++R   L G   +   
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227

Query: 360 SNKLALHQIIDEKLG------RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEV 406
            +   L       +        N+  +      +++   L  +P  R +  E 
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 2e-37
 Identities = 67/301 (22%), Positives = 117/301 (38%), Gaps = 46/301 (15%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENEL 188
            + +   +G G +G V           +A        VA+K+L R             EL
Sbjct: 19  VYRDLQPVGSGAYGAVC----------SAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68

Query: 189 RFLSRLNHPNVVKLMGYCCDDQHR------LLVYEYVTRGSLEDHLLNEDDTELNWERRI 242
           R L  + H NV+ L+     D+         LV  ++  G+    L+  +  +L  +R  
Sbjct: 69  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE--KLGEDRIQ 124

Query: 243 KIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTR 302
            +     +GL ++H       HRD+K  N+ +++D   KI DFGLA+           T 
Sbjct: 125 FLVYQMLKGLRYIHAAGII--HRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTG 177

Query: 303 VLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGKT-----------AAMRRTNGL 350
            + TR Y APE I      T   D++S G ++ E+++GKT             + +  G 
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 351 AGNWAKPYLSNKLALHQI-----IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
                   L +  A + +     +++K   +I    +     ++ + L  D + R T  E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297

Query: 406 V 406
            
Sbjct: 298 A 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  135 bits (340), Expect = 2e-36
 Identities = 61/275 (22%), Positives = 106/275 (38%), Gaps = 39/275 (14%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWE---NE 187
           +F     +G G FG V +           + K +    A+K L ++      + E   NE
Sbjct: 42  QFDRIKTLGTGSFGRVML----------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91

Query: 188 LRFLSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALG 247
            R L  +N P +VKL     D+ +  +V EYV  G +  HL        +       A  
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQ 149

Query: 248 AARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTR 307
                E+LH     +I+RD+K  N+L+D     +++DFG AK          +  + GT 
Sbjct: 150 IVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTP 202

Query: 308 GYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS-NKLALH 366
              APE I +       D ++ GV++ E+ +G                 P+ +   + ++
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP---------------PFFADQPIQIY 247

Query: 367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP 401
           + I     R      + +  +++   L  D   R 
Sbjct: 248 EKIVSGKVR-FPSHFSSDLKDLLRNLLQVDLTKRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-34
 Identities = 63/290 (21%), Positives = 109/290 (37%), Gaps = 38/290 (13%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRR----KGSQGQDEWEN 186
            F    ++G G +G V++              +     A+K L++    + ++  +    
Sbjct: 25  NFELLKVLGTGAYGKVFLVR-------KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77

Query: 187 ELRFLSRLNH-PNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIA 245
           E + L  +   P +V L      +    L+ +Y+  G L  HL                 
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQIYV 135

Query: 246 LGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLG 305
                 LEHLH     +I+RD+K  N+LLD + +  ++DFGL+K     D++  +    G
Sbjct: 136 GEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCG 192

Query: 306 TRGYFAPEYIATGH--LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY--LSN 361
           T  Y AP+ +  G        D +S GV++ E+L+G +               P+     
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---------------PFTVDGE 237

Query: 362 KLALHQIIDEKLGRNIQMEEA--QEFAEIILRCLNSDPKNRPTMSEVVAA 409
           K +  +I    L       +       ++I R L  DPK R       A 
Sbjct: 238 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 8e-34
 Identities = 61/301 (20%), Positives = 116/301 (38%), Gaps = 42/301 (13%)

Query: 129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQD--EWEN 186
             ++   + +G G +G V           AA        VAVK+L R             
Sbjct: 17  PERYQNLSPVGSGAYGSVC----------AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 66

Query: 187 ELRFLSRLNHPNVVKLMGYCCD-----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERR 241
           ELR L  + H NV+ L+          + + + +  ++    L +        +L  +  
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHV 123

Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
             +     RGL+++H+      HRD+K SN+ +++D   KI DFGLA+        +++T
Sbjct: 124 QFLIYQILRGLKYIHSADII--HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 181

Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT-----------AAMRRTNGL 350
           R            +   H     D++S G ++ E+L+G+T             + R  G 
Sbjct: 182 RW----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237

Query: 351 AGNWAKPYLSNKLALHQI-----IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSE 405
            G      +S++ A + I     + +    N+ +       +++ + L  D   R T ++
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297

Query: 406 V 406
            
Sbjct: 298 A 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  127 bits (319), Expect = 1e-33
 Identities = 58/299 (19%), Positives = 110/299 (36%), Gaps = 51/299 (17%)

Query: 136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN 195
             +G+G + +V+           A     +  V VK L+      + + + E++ L  L 
Sbjct: 41  RKLGRGKYSEVF----------EAINITNNEKVVVKILKPVK---KKKIKREIKILENLR 87

Query: 196 -HPNVVKLMGYCCDDQHRL--LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
             PN++ L     D   R   LV+E+V     +          L             + L
Sbjct: 88  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKAL 142

Query: 253 EHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA 311
           ++ H     ++HRDVK  NV++D +    ++ D+GLA+F   G +       + +R +  
Sbjct: 143 DYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKG 197

Query: 312 PEYIAT-GHLTLKTDVYSFGVVLLEILSGKT----------AAMRRTNGLAGNWAKPYLS 360
           PE +          D++S G +L  ++  K             +R    L       Y+ 
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257

Query: 361 N-KLALHQIIDEKLGRNIQMEEAQ------------EFAEIILRCLNSDPKNRPTMSEV 406
              + L    ++ LGR+ +    +            E  + + + L  D ++R T  E 
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-33
 Identities = 69/312 (22%), Positives = 114/312 (36%), Gaps = 55/312 (17%)

Query: 130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENE 187
           +++     IG G  G V           AA     D  VA+K+L R             E
Sbjct: 17  KRYQNLKPIGSGAQGIVC----------AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66

Query: 188 LRFLSRLNHPNVVKLMGYCC------DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERR 241
           L  +  +NH N++ L+          + Q   LV E +     +   +  D      ER 
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERM 121

Query: 242 IKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHIST 301
             +      G++HLH+     IHRD+K SN+++  D   KI DFGLA+       S + T
Sbjct: 122 SYLLYQMLCGIKHLHSAGI--IHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMT 176

Query: 302 RVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTN------------- 348
             + TR Y APE I         D++S G ++ E++  K     R               
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 349 ------GLAGNWAKPYLSNKLALHQIIDEKLGRN--------IQMEEAQEFAEIILRCLN 394
                        + Y+ N+     +   KL  +            +A +  +++ + L 
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 395 SDPKNRPTMSEV 406
            DP  R ++ + 
Sbjct: 297 IDPAKRISVDDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (292), Expect = 8e-30
 Identities = 54/324 (16%), Positives = 111/324 (34%), Gaps = 60/324 (18%)

Query: 131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRF 190
           ++     +G G F  V++          A+    +  VA+K +R       +  E+E++ 
Sbjct: 14  RYILVRKLGWGHFSTVWL----------AKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKL 62

Query: 191 LSRLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSL--------------EDHLLNEDDTEL 236
           L R+N  +  K      +   +LL +      +                  +   +   +
Sbjct: 63  LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122

Query: 237 NWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD-DDFNAKISDFGLAKFGPLGD 295
                 +I+     GL+++H     +IH D+K  NVL++  D    +    +A  G    
Sbjct: 123 PLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181

Query: 296 KSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT-------------- 341
                T  + TR Y +PE +         D++S   ++ E+++G                
Sbjct: 182 YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241

Query: 342 ---AAMRRTNG-------LAGNWAKPYLSNKLALHQIIDEKL---------GRNIQMEEA 382
              A +    G         G + + + +++  L  I   K                +EA
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301

Query: 383 QEFAEIILRCLNSDPKNRPTMSEV 406
           +E ++ +   L  DP+ R     +
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGL 325

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 76.4 bits (187), Expect = 7e-17
 Identities = 34/204 (16%), Positives = 69/204 (33%), Gaps = 22/204 (10%)

Query: 136 NLIGQGGFGDVYIGYINS---CAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLS 192
            L+G+G    V+  Y      C +   +  +  F    K+++ K   G   +       +
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSF----KKVKEKRDYGDLHFSVLAIRSA 61

Query: 193 RLNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGL 252
           R     + KL G           Y +     L + +  ++   +  E   ++       +
Sbjct: 62  RNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116

Query: 253 EHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK-FGPLGDKSHISTRVLGTRGYFA 311
              +     ++H D+   NVL+  +    I DF  +   G  G +  +   V     YF+
Sbjct: 117 AKFYHRG--IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173

Query: 312 PEYIATGHLTLKTDVYSFGVVLLE 335
             Y        + D+ S    +L+
Sbjct: 174 RTY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	451
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.74
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.01
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.98
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.44
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.0
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.97

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=426.16  Aligned_cols=253  Identities=26%  Similarity=0.369  Sum_probs=206.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++++.||+|+||+||+|.          ++.++..||||++..... ...+.+.+|+++|+.++|||||++++++.+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~----------~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~   74 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAV----------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE   74 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEE----------ETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEE----------ECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence            479999999999999999966          445578899999975432 334568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++..|||||||+||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+|
T Consensus        75 ~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG~a  150 (271)
T d1nvra_          75 GNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLA  150 (271)
T ss_dssp             TTEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CceeEEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccchhh
Confidence            9999999999999999999954  5679999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +..............+||+.|+|||++.+..+ +.++|||||||++|||++|+.||......            ......
T Consensus       151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~------------~~~~~~  218 (271)
T d1nvra_         151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------------CQEYSD  218 (271)
T ss_dssp             EECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT------------SHHHHH
T ss_pred             eeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH------------HHHHHH
Confidence            86543333344556789999999999988776 57899999999999999999999654321            001111


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ..............++++.+|+.+||+.||++|||+.|+++
T Consensus       219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         219 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11111111222345688999999999999999999999976

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=423.49  Aligned_cols=250  Identities=25%  Similarity=0.393  Sum_probs=211.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|++.++||+|+||+||+|.          +..++..||||++........+.+.+|+.+|+.++|||||+++++|.++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~----------~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   89 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAM----------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG   89 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEE----------BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cccEEEEEEecCcCcEEEEEE----------ECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC
Confidence            489999999999999999965          5556788999999876666678899999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +..|||||||+||+|.+++..   ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+|+
T Consensus        90 ~~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~DFG~a~  164 (293)
T d1yhwa1          90 DELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (293)
T ss_dssp             TEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeeccchhhe
Confidence            999999999999999998754   469999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      .....  .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......             ..+..+.
T Consensus       165 ~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------------~~~~~~~  229 (293)
T d1yhwa1         165 QITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------------RALYLIA  229 (293)
T ss_dssp             ECCST--TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------------HHHHHHH
T ss_pred             eeccc--cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-------------HHHHHHH
Confidence            64322  22344668999999999999999999999999999999999999999643211             1111121


Q ss_pred             hh-hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          370 DE-KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       370 ~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .. ......+...++++.+||.+||..||++|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             HHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             hCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11 11223345567889999999999999999999999863

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=420.53  Aligned_cols=260  Identities=28%  Similarity=0.492  Sum_probs=207.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|+++++||+|+||+||+|.++.             .||||++....  ....+.|.+|+.+|++++|||||++++++
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-------------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~   73 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG-------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS   73 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS-------------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC-------------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence            3589999999999999999986432             49999997542  33456789999999999999999999987


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+ +..+||||||+||+|.+++... ...+++..++.|+.||+.||+|||+  ++||||||||+||||+.++.+||+|||
T Consensus        74 ~~-~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          74 TA-PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             CS-SSCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             ec-cEEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEcccc
Confidence            54 5689999999999999998653 3569999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCcccccccccc---CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      +|+...............||+.|+|||++.+   ..|+.++|||||||++|||++|+.||......             .
T Consensus       150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------------~  216 (276)
T d1uwha_         150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------------D  216 (276)
T ss_dssp             CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------------H
T ss_pred             ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------------H
Confidence            9986544333444556789999999999854   35899999999999999999999998753321             1


Q ss_pred             hhhHHhhhhhc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcC
Q 013028          364 ALHQIIDEKLG----RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG  418 (451)
Q Consensus       364 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  418 (451)
                      .+...+.....    ...+...++++.+|+.+||+.||++|||+.||++.|+.+++++.
T Consensus       217 ~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         217 QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             HHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            11122221111    12344557889999999999999999999999999999987653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-55  Score=422.26  Aligned_cols=260  Identities=25%  Similarity=0.427  Sum_probs=220.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.++||+|+||+||+|.+.          .++..||||++... ....+.+.+|+++|+.++|||||+++++|.+
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~----------~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWK----------KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   84 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEG----------GGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEC----------CCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence            357889999999999999998754          34678999998754 4456789999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++..+||||||++|+|.+++.......+++..++.|+.||+.||.|||+  +||+||||||+||||+.++.+||+|||+|
T Consensus        85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEccccce
Confidence            9999999999999999999977667889999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      +..... .........|+..|+|||++.+..|+.++|||||||++|||++|..||.....             ...+...
T Consensus       163 ~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------------~~~~~~~  228 (287)
T d1opja_         163 RLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------------LSQVYEL  228 (287)
T ss_dssp             TTCCSS-SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------------HHHHHHH
T ss_pred             eecCCC-CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-------------HHHHHHH
Confidence            864422 22233345688999999999999999999999999999999998777643221             1223344


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                      +........+...++++.+|+.+||+.||++|||+.||++.|+.+..
T Consensus       229 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             HhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            44555556666778899999999999999999999999999988754

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=416.02  Aligned_cols=247  Identities=29%  Similarity=0.457  Sum_probs=209.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++++.||+|+||+||+|.          ++.++..||||++.+.   .....+.+.+|+++|+.++|||||++++++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~----------~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~   75 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAR----------EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF   75 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEE----------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEE----------ECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence            479999999999999999966          4456788999998642   234456788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++..|||||||+||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        76 ~~~~~~~ivmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~DFG  151 (263)
T d2j4za1          76 HDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFG  151 (263)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             EECCEEEEEEeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecccc
Confidence            999999999999999999999865  4569999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +|.....    .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||......             ..+.
T Consensus       152 ~a~~~~~----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------------~~~~  214 (263)
T d2j4za1         152 WSVHAPS----SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------------ETYK  214 (263)
T ss_dssp             SCSCCCC----CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------------HHHH
T ss_pred             eeeecCC----CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-------------HHHH
Confidence            9985432    2234568999999999999999999999999999999999999998643221             1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+..  ....++...++++.+|+.+||+.||++|||+.|++++
T Consensus       215 ~i~~--~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         215 RISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             HHHT--TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHc--CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            1111  1223455567899999999999999999999999873

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-55  Score=412.13  Aligned_cols=258  Identities=26%  Similarity=0.426  Sum_probs=205.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|+++++||+|+||+||+|.+.+           +..||||++... ....+++.+|+++++.++|||||+++|+|.++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-----------~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-----------KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   72 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-----------TEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-----------CCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccC
Confidence            478899999999999999987643           456999999753 44567899999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+|+
T Consensus        73 ~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          73 APICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             CceEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchhe
Confidence            9999999999999999988653 4668999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ...... ........||..|+|||++.+..|+.++|||||||++|||+|+..|+.....             ...+...+
T Consensus       150 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------------~~~~~~~i  215 (263)
T d1sm2a_         150 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------------NSEVVEDI  215 (263)
T ss_dssp             ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------------HHHHHHHH
T ss_pred             eccCCC-ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------------HHHHHHHH
Confidence            643222 2223346789999999999999999999999999999999996544432111             11122233


Q ss_pred             hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      ........+...++++.+|+.+||+.||++|||++||++.|++++++
T Consensus       216 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         216 STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            33344445566678999999999999999999999999999999764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-55  Score=418.70  Aligned_cols=252  Identities=23%  Similarity=0.374  Sum_probs=209.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +.|++++.||+|+||+||+|.          +..++..||||++........+.+.+|+++|+.++|||||++++++.++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~----------~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~   81 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQ----------NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE   81 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEE----------ETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cCeEEeEEEeeCCCcEEEEEE----------ECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            478999999999999999976          4455788999999876666667889999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +..+||||||+||+|.+++... ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+|+
T Consensus        82 ~~~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~  158 (288)
T d2jfla1          82 NNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSA  158 (288)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CeEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCEEEEechhhh
Confidence            9999999999999999987543 3569999999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIA-----TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      ....  ........+||+.|+|||++.     +..|+.++|||||||++|||++|..||......             ..
T Consensus       159 ~~~~--~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-------------~~  223 (288)
T d2jfla1         159 KNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-------------RV  223 (288)
T ss_dssp             ECHH--HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-------------GH
T ss_pred             ccCC--CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-------------HH
Confidence            4221  112234578999999999983     466899999999999999999999998754321             11


Q ss_pred             hhHHhhhhh-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          365 LHQIIDEKL-GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       365 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +..+..... ....+...++++.+||.+||+.||++|||+.|++++
T Consensus       224 ~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         224 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             HHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            112221111 122334567889999999999999999999999863

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=411.49  Aligned_cols=258  Identities=28%  Similarity=0.457  Sum_probs=213.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++.++||+|+||+||+|.+++           +..||||++... ....+.+.+|+++|++++|||||++++++.+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~-----------~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~   79 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNG-----------HTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ   79 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-----------TEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECC-----------CCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence            3588999999999999999987643           457999999753 4456789999999999999999999998765


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                       +..+|||||+++|+|.+++.......+++..++.|+.||+.||.|||+  ++|+||||||+||||++++.+||+|||+|
T Consensus        80 -~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla  156 (272)
T d1qpca_          80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLA  156 (272)
T ss_dssp             -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccce
Confidence             567999999999999998865545579999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      +..... .........||..|+|||++.+..++.++|||||||++|||+||..|+.....             ...+...
T Consensus       157 ~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------------~~~~~~~  222 (272)
T d1qpca_         157 RLIEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------------NPEVIQN  222 (272)
T ss_dssp             EECSSS-CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------------HHHHHHH
T ss_pred             EEccCC-ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------------HHHHHHH
Confidence            865422 22233456789999999999889999999999999999999997665442211             1112223


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQL  415 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  415 (451)
                      +........+...++++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       223 i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         223 LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            33334444556677899999999999999999999999999998754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-54  Score=416.72  Aligned_cols=263  Identities=25%  Similarity=0.446  Sum_probs=206.3

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|++.++||+|+||+||+|.+...+       .....||||.+..... ...+.|.+|+++|++++|||||+++|++.+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   98 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPG-------KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK   98 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC----------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCC-------CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            47888999999999999999865321       2234689999865433 234578999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ++..++|||||++|+|.+++... ...+++..++.++.||+.||.|||+  ++|+||||||+||||+.++.+||+|||+|
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla  175 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLS  175 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhh--CCCccCccccceEEECCCCcEEECCcccc
Confidence            99999999999999999987643 4569999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcc---cccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhh
Q 013028          289 KFGPLGDKSH---ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       289 ~~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      +.........   ......||+.|+|||++.+..++.++|||||||++|||+| |..||.....              ..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--------------~~  241 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--------------QD  241 (299)
T ss_dssp             --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------------HH
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--------------HH
Confidence            8644322211   1223457899999999999999999999999999999998 8988864322              11


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      +...+........+...+.++.+|+.+||+.||++|||+.||++.|+.+..+
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         242 VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            2223333344455666788999999999999999999999999999998664

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-55  Score=420.53  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=208.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++++.||+|+||+||+|.          +..++..||||++.+.   .....+.+.+|+++|++++|||||+++++|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~----------~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~   77 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLAR----------ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF   77 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEE----------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEE----------ECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE
Confidence            479999999999999999965          4455788999998743   234456789999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++..|||||||+||+|.+++..  ...+++..+..++.|++.||.|||+  +|||||||||+|||+++++.+||+|||
T Consensus        78 ~~~~~~~ivmEy~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DFG  153 (288)
T d1uu3a_          78 QDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFG  153 (288)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EECCEEEEEEEccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEecccc
Confidence            999999999999999999998854  4679999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +|+..............+||+.|+|||++.+..|+.++|||||||++|+|++|..||......             ....
T Consensus       154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------------~~~~  220 (288)
T d1uu3a_         154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-------------LIFQ  220 (288)
T ss_dssp             TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HHHH
T ss_pred             cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-------------HHHH
Confidence            998755444444455678999999999999999999999999999999999999999753211             1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAAL  410 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  410 (451)
                      .+...  ...++...++++.+||.+||..||.+|||+.|+++..
T Consensus       221 ~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~  262 (288)
T d1uu3a_         221 KIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG  262 (288)
T ss_dssp             HHHTT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred             HHHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence            22221  2234556678899999999999999999999987653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=422.92  Aligned_cols=263  Identities=27%  Similarity=0.431  Sum_probs=215.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC-CCcCHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|+++++||+|+||+||+|++....     .......||+|.+... .......+.+|+.+|.++ +|||||+++++|
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGIS-----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCS-----SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCC-----cccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            358999999999999999999875421     2223456999998654 333456788999999998 799999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED---------------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHR  265 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHr  265 (451)
                      .+.+..+||||||+||+|.+++....                     ...+++..++.++.||+.||.|||+  ++||||
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~IiHR  188 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHR  188 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEET
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeec
Confidence            99999999999999999999996532                     1358999999999999999999999  899999


Q ss_pred             CCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccc
Q 013028          266 DVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAM  344 (451)
Q Consensus       266 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~  344 (451)
                      ||||+|||++.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++ |.+||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986443333333445678999999999999999999999999999999997 899986


Q ss_pred             cccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 013028          345 RRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALE  411 (451)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  411 (451)
                      .....             ..+..++........+...++++.+||.+||+.||++|||++||+++|.
T Consensus       269 ~~~~~-------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVD-------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCS-------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHH-------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            53321             1223444444455566677889999999999999999999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-55  Score=427.87  Aligned_cols=264  Identities=23%  Similarity=0.375  Sum_probs=206.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|+++++||+|+||+||+|.+          ..++..||+|++..... ...+.+.+|+.+|+.++|||||+++++|.
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~----------~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~   74 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSH----------KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY   74 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEE----------TTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEE----------CCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            46899999999999999999764          45578899999975433 33467889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++++.||||||++||+|.+++..  ...+++..+..++.||+.||.|||+. +||+||||||+||||+.++.+||+|||+
T Consensus        75 ~~~~~~iVmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGl  151 (322)
T d1s9ja_          75 SDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGV  151 (322)
T ss_dssp             CSSEEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCC
Confidence            99999999999999999999965  35699999999999999999999971 3899999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC---------CCc----
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA---------GNW----  354 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~---------~~~----  354 (451)
                      |+...    .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........         ...    
T Consensus       152 a~~~~----~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  227 (322)
T d1s9ja_         152 SGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP  227 (322)
T ss_dssp             CHHHH----HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------
T ss_pred             ccccC----CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCC
Confidence            98532    1223457899999999999999999999999999999999999999976432210         000    


Q ss_pred             ---------cccccch---hhhhhHHhhhhh---cCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          355 ---------AKPYLSN---KLALHQIIDEKL---GRNI-QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       355 ---------~~~~~~~---~~~~~~~~~~~~---~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                               .......   .....+......   .... ....+.++.+|+.+||..||.+|||+.|+|++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                     0000000   000011111111   0111 12235789999999999999999999999984

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-55  Score=413.21  Aligned_cols=251  Identities=27%  Similarity=0.396  Sum_probs=196.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|++++.||+|+||+||+|.          ++.++..||||.+......  ..+.+.+|+++|+.++|||||++++++.
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~----------~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   73 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIR----------RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII   73 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEE----------ETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEE----------ECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence            579999999999999999965          4456788999999765332  2356889999999999999999999986


Q ss_pred             c--CCeeEEEEeccCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-----ceeCCCCCCceeeCCCC
Q 013028          208 D--DQHRLLVYEYVTRGSLEDHLLNE--DDTELNWERRIKIALGAARGLEHLHTYWRP-----VIHRDVKASNVLLDDDF  278 (451)
Q Consensus       208 ~--~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-----iiHrDlkp~NIll~~~~  278 (451)
                      +  ...+|||||||+||+|.+++...  ....+++..++.++.||+.||.|||+  ++     ||||||||+||||+.++
T Consensus        74 ~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~--~~~~~~~IiHrDiKp~NIll~~~~  151 (269)
T d2java1          74 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR--RSDGGHTVLHRDLKPANVFLDGKQ  151 (269)
T ss_dssp             C----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--HCC---------CCGGGEEECTTS
T ss_pred             eCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH--hcCCCCCEEeCcCchhhcCcCCCC
Confidence            5  45689999999999999988532  34679999999999999999999998  55     99999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                      .+||+|||+|+....  ........+||+.|+|||++.+..|+.++|||||||++|||++|..||......         
T Consensus       152 ~vkl~DFG~a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---------  220 (269)
T d2java1         152 NVKLGDFGLARILNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---------  220 (269)
T ss_dssp             CEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---------
T ss_pred             cEEEeeccceeeccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---------
Confidence            999999999986432  222344678999999999999999999999999999999999999998643211         


Q ss_pred             cchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                           .+...+.......++...++++.+|+.+||+.||++|||+.|+++
T Consensus       221 -----~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         221 -----ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -----HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                 111222222223445566789999999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.1e-55  Score=420.70  Aligned_cols=252  Identities=24%  Similarity=0.402  Sum_probs=193.9

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      +.++|++.+.||+|+||+||+|.          +..+++.||||++.+.... ....+.+|+.+|+.++|||||++++++
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~----------~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~   76 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAE----------DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY   76 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEE----------ETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEE----------ECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            45689999999999999999965          4456788999999754332 345678999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC---CCCcEEEe
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD---DDFNAKIS  283 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~---~~~~~kl~  283 (451)
                      .+++..|||||||+||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||+.   +++.+||+
T Consensus        77 ~~~~~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~  152 (307)
T d1a06a_          77 ESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMIS  152 (307)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EECCEEEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEe
Confidence            999999999999999999999954  4679999999999999999999999  8999999999999994   57899999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      |||+|+...   ........+||+.|+|||++.+..|+.++|||||||++|+|++|..||......             .
T Consensus       153 DFG~a~~~~---~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------------~  216 (307)
T d1a06a_         153 DFGLSKMED---PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------------K  216 (307)
T ss_dssp             CC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------------H
T ss_pred             ccceeEEcc---CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-------------H
Confidence            999998533   223344578999999999999999999999999999999999999998643221             1


Q ss_pred             hhhHHhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          364 ALHQIIDEKLG--RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       364 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ....+......  .......++++.+|+.+||..||++|||+.|++++
T Consensus       217 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         217 LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             HHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            11122222111  12233457889999999999999999999999874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=408.75  Aligned_cols=267  Identities=25%  Similarity=0.384  Sum_probs=216.8

Q ss_pred             cCCCcCC-cccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKN-LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|.+.+ +||+|+||+||+|.+..        ...+..||||++..... ...+.|.+|+++|++++|||||+++|++.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~--------~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~   79 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRM--------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ   79 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEec--------CCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence            4566667 49999999999997642        23456799999975433 23467899999999999999999999987


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      + +..|||||||+||+|.+++... ...+++..++.++.||+.||.|||+  ++|+||||||+||||+.++.+||+|||+
T Consensus        80 ~-~~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGl  155 (285)
T d1u59a_          80 A-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGL  155 (285)
T ss_dssp             S-SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             c-CeEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchh
Confidence            5 4689999999999999987543 4579999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhh
Q 013028          288 AKFGPLGDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       288 a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |+........ .......||+.|+|||++.+..++.++|||||||++|||+| |..||......              .+
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--------------~~  221 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------------EV  221 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------------HH
T ss_pred             hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--------------HH
Confidence            9865432221 22234568999999999988999999999999999999998 89998643211              12


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCcc
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQ  422 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~  422 (451)
                      ...+........+...++++.+|+.+||+.||++|||+.+|++.|+.+..++.+..+
T Consensus       222 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~  278 (285)
T d1u59a_         222 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE  278 (285)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccc
Confidence            233333334456667788999999999999999999999999999998877655443

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-53  Score=399.29  Aligned_cols=253  Identities=25%  Similarity=0.417  Sum_probs=214.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|+++++||+|+||+||+|.+++           +..||||++... ....+++.+|+.++++++||||++++|+|.++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~-----------~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~   71 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRG-----------QYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   71 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETT-----------TEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred             HHCEEeEEEecCCCeEEEEEEECC-----------CCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence            488999999999999999987642           567999999754 44567899999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +..++||||+++|+|.+++... ...+++..+..++.|+++||.|||+  +||+||||||+|||++.++.+||+|||+++
T Consensus        72 ~~~~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          72 RPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             SSEEEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             CceEEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhhe
Confidence            9999999999999999987543 3568899999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHH
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQI  368 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  368 (451)
                      ...... ........||..|+|||++.+..++.++|||||||++|||+| |+.||.....              ..+...
T Consensus       149 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--------------~~~~~~  213 (258)
T d1k2pa_         149 YVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------------SETAEH  213 (258)
T ss_dssp             BCSSSS-CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------------HHHHHH
T ss_pred             eccCCC-ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--------------HHHHHH
Confidence            644322 222334678999999999999999999999999999999998 7888764332              112233


Q ss_pred             hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 013028          369 IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQ  412 (451)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  412 (451)
                      +........+...+.++.+|+.+||+.||++|||+.++++.|.+
T Consensus       214 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         214 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            33344445566677899999999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-54  Score=407.39  Aligned_cols=245  Identities=25%  Similarity=0.406  Sum_probs=197.1

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceeec-
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCCD-  208 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-  208 (451)
                      |++.++||+|+||+||+|.+          ..++..||+|.+.....  ...+.+.+|+++|++++|||||+++++|.+ 
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~----------~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   80 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLD----------TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   80 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEE----------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEE----------CCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec
Confidence            36667899999999999764          44577899999875432  234568899999999999999999999875 


Q ss_pred             ---CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--ceeCCCCCCceeeC-CCCcEEE
Q 013028          209 ---DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRP--VIHRDVKASNVLLD-DDFNAKI  282 (451)
Q Consensus       209 ---~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~--iiHrDlkp~NIll~-~~~~~kl  282 (451)
                         ...+||||||++||+|.+++..  ...+++..+..++.||+.||+|||+  ++  |+||||||+||||+ +++.+||
T Consensus        81 ~~~~~~~~ivmE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~--~~~~IiHrDiKp~NILl~~~~~~~Kl  156 (270)
T d1t4ha_          81 VKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVKI  156 (270)
T ss_dssp             SSSCEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred             cccCCEEEEEEeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHH--CCCCEEeCCcChhhceeeCCCCCEEE
Confidence               3567999999999999999965  3579999999999999999999999  67  99999999999996 5789999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchh
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      +|||+|+...    .......+||+.|+|||++. +.|+.++|||||||++|||++|+.||......             
T Consensus       157 ~DFGla~~~~----~~~~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-------------  218 (270)
T d1t4ha_         157 GDLGLATLKR----ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-------------  218 (270)
T ss_dssp             CCTTGGGGCC----TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------------
T ss_pred             eecCcceecc----CCccCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCcccH-------------
Confidence            9999998532    22334678999999999985 46999999999999999999999998643221             


Q ss_pred             hhhhHHhhhh-hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          363 LALHQIIDEK-LGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       363 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      ..+...+... .....+...++++.+|+.+||+.||++|||+.|+++
T Consensus       219 ~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         219 AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            1111111111 111222334678999999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-53  Score=418.91  Aligned_cols=252  Identities=21%  Similarity=0.335  Sum_probs=210.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++++.||+|+||+||+|.          +..++..||||++........+.+.+|+.+|+.++|||||+++++|.+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~----------~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   94 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVT----------ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED   94 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEE----------ETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEE----------ECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            3589999999999999999965          445578899999976655556778899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC--CCCcEEEeecC
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD--DDFNAKISDFG  286 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~--~~~~~kl~DFG  286 (451)
                      ++..|||||||+||+|.+++... ...+++..+..|+.||+.||.|||+  +|||||||||+||||+  .++.+||+|||
T Consensus        95 ~~~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DFG  171 (350)
T d1koaa2          95 DNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFG  171 (350)
T ss_dssp             TTEEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeecc
Confidence            99999999999999999998543 3569999999999999999999999  8999999999999996  46789999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +|+....   ........||+.|+|||++.+..|+.++|||||||++|+|++|..||......             ..+.
T Consensus       172 ~a~~~~~---~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------------~~~~  235 (350)
T d1koaa2         172 LTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------------ETLR  235 (350)
T ss_dssp             TCEECCT---TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HHHH
T ss_pred             hheeccc---ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-------------HHHH
Confidence            9986432   23344578999999999999999999999999999999999999998653221             1112


Q ss_pred             HHhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIIDEKLG--RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+......  .......++++.+||.+||+.||++|||+.|+|++
T Consensus       236 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         236 NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             HHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            22222111  11123456889999999999999999999999884

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-53  Score=404.68  Aligned_cols=265  Identities=23%  Similarity=0.437  Sum_probs=210.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      +.|++.++||+|+||+||+|.+...+      ......||||++...... ....|.+|+.+|++++|||||+++|++.+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~   80 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSS------GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK   80 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCC------CEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence            47888999999999999999876431      223357999999754332 33568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      ....++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+  ++|+||||||+||||+.++.+||+|||+|
T Consensus        81 ~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla  157 (283)
T d1mqba_          81 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLS  157 (283)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             CCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEcccchh
Confidence            99999999999999999877543 4679999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCC-cccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDK-SHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +....... ........||..|+|||++.+..++.++|||||||++|||++|..|+.....             ...+..
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-------------~~~~~~  224 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------NHEVMK  224 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------------HHHHHH
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-------------HHHHHH
Confidence            86433221 2223345689999999999999999999999999999999997666543211             112223


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      .+........+...+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus       225 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            4444445556666788999999999999999999999999999998764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=404.16  Aligned_cols=254  Identities=28%  Similarity=0.420  Sum_probs=205.8

Q ss_pred             CcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceeecCCeeE
Q 013028          136 NLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCCDDQHRL  213 (451)
Q Consensus       136 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~  213 (451)
                      ++||+|+||+||+|.+..        ...++.||||++......  ..+.+.+|+++|++++|||||+++++|.++ ..+
T Consensus        13 k~iG~G~fG~Vy~~~~~~--------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~   83 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQM--------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWM   83 (277)
T ss_dssp             EEEEECSSEEEEEEEEEC--------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEE
T ss_pred             CCcccCCCeEEEEEEEcc--------CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEE
Confidence            469999999999998643        234577999999754322  346789999999999999999999998654 578


Q ss_pred             EEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCCC
Q 013028          214 LVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGPL  293 (451)
Q Consensus       214 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~  293 (451)
                      |||||+++|+|.+++..  ...+++..++.|+.||+.||.|||+  ++|+||||||+||||+.++.+||+|||+|+....
T Consensus        84 lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~  159 (277)
T d1xbba_          84 LVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  159 (277)
T ss_dssp             EEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhhccc
Confidence            99999999999999865  4679999999999999999999999  8999999999999999999999999999986443


Q ss_pred             CCCc-ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhHHhhh
Q 013028          294 GDKS-HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQIIDE  371 (451)
Q Consensus       294 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (451)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.....              ..+...+..
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------------~~~~~~i~~  225 (277)
T d1xbba_         160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------------SEVTAMLEK  225 (277)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------------HHHHHHHHT
T ss_pred             cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--------------HHHHHHHHc
Confidence            3222 22334578999999999999999999999999999999998 8998864321              112233333


Q ss_pred             hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          372 KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      ......+...++++.+|+.+||+.||++|||+.+|++.|+....+
T Consensus       226 ~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            334455666788999999999999999999999999999887544

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.7e-53  Score=419.09  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=210.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|+++++||+|+||+||+|.          +..++..||||++..........+.+|+.+|+.++|||||+++++|.++
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~----------~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   98 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCV----------EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK   98 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEE----------ETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred             cceEEEEEEecCCCeEEEEEE----------ECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            589999999999999999965          4456788999999865545556788999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC--CCCcEEEeecCC
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD--DDFNAKISDFGL  287 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~--~~~~~kl~DFGl  287 (451)
                      +..|||||||+||+|.+++... ...+++.++..|+.||+.||.|||+  +|||||||||+||||+  .++.+||+|||+
T Consensus        99 ~~~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~DFGl  175 (352)
T d1koba_          99 YEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGL  175 (352)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             CEEEEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEeeccc
Confidence            9999999999999999887543 4569999999999999999999999  8999999999999997  678999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhH
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      |.....   ........||+.|+|||++.+..|+.++|||||||++|+|++|..||......             ..+..
T Consensus       176 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------------~~~~~  239 (352)
T d1koba_         176 ATKLNP---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------------ETLQN  239 (352)
T ss_dssp             CEECCT---TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------------HHHHH
T ss_pred             ceecCC---CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------------HHHHH
Confidence            986432   23345578999999999999999999999999999999999999999653321             11112


Q ss_pred             Hhhhhh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          368 IIDEKL--GRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       368 ~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      +.....  ........++++.+||.+||+.||.+|||+.|+|++
T Consensus       240 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         240 VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             HHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            222111  122334567889999999999999999999999874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-53  Score=411.90  Aligned_cols=246  Identities=30%  Similarity=0.448  Sum_probs=203.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      +.|+.+++||+|+||+||+|.          +..++..||||++.......   .+.+.+|+++|+.++|||||++++++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~----------~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~   84 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFAR----------DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY   84 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEE----------ETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEE----------ECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE
Confidence            369999999999999999975          44557889999997654332   24578999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++..|||||||.+|+|..++..  ...+++..+..++.||+.||.|||+  +|||||||||+||||+.++.+||+|||
T Consensus        85 ~~~~~~~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DFG  160 (309)
T d1u5ra_          85 LREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFG  160 (309)
T ss_dssp             EETTEEEEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             EECCEEEEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeecc
Confidence            999999999999999998766644  4679999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCcccccccccc---CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIAT---GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKL  363 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  363 (451)
                      +|.....      .....||+.|+|||++.+   ..|+.++|||||||++|||++|..||.....             ..
T Consensus       161 ~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------------~~  221 (309)
T d1u5ra_         161 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------------MS  221 (309)
T ss_dssp             TCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------------HH
T ss_pred             cccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------------HH
Confidence            9985321      234689999999999854   4689999999999999999999999864321             11


Q ss_pred             hhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          364 ALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      .+..+.........+...++.+.+||.+||..||.+|||+.|+|+
T Consensus       222 ~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            112222222222233445788999999999999999999999987

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-53  Score=405.05  Aligned_cols=251  Identities=25%  Similarity=0.372  Sum_probs=206.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC------cCHHHHHHHHHHHHhcCCCceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS------QGQDEWENELRFLSRLNHPNVVKL  202 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~nIv~~  202 (451)
                      .++|++++.||+|+||+||+|.          +..++..||||++.+...      ...+.+.+|+.+|+.++|||||++
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~----------~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~   78 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCR----------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL   78 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEE----------ETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccCEEEeEEEecCCCeEEEEEE----------ECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcE
Confidence            4689999999999999999965          445678899999975322      235778999999999999999999


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC----
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF----  278 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~----  278 (451)
                      +++|.+++..|||||||+||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++    
T Consensus        79 ~~~~~~~~~~~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~  154 (293)
T d1jksa_          79 HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKP  154 (293)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSC
T ss_pred             EEEEEECCEEEEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCccc
Confidence            9999999999999999999999999865  3579999999999999999999999  8999999999999998776    


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  358 (451)
                      .+||+|||+|.....   ........||+.|+|||++.+..++.++|||||||++|||++|..||......         
T Consensus       155 ~vkl~DfG~a~~~~~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---------  222 (293)
T d1jksa_         155 RIKIIDFGLAHKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---------  222 (293)
T ss_dssp             CEEECCCTTCEECTT---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------
T ss_pred             ceEecchhhhhhcCC---CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---------
Confidence            599999999986432   23344568999999999999899999999999999999999999999754321         


Q ss_pred             cchhhhhhHHhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          359 LSNKLALHQIIDEKLG--RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                          ..+..+......  .......+..+.+||.+||+.||++|||+.|++++
T Consensus       223 ----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         223 ----ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             ----HHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----HHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                111111111110  00112346789999999999999999999999863

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-53  Score=411.63  Aligned_cols=249  Identities=28%  Similarity=0.371  Sum_probs=210.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++++.||+|+||+||+|.          ++.++..||||++.+.   .....+.+.+|+.+|+.++||||++++++|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~----------~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   74 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVR----------EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF   74 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEE----------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEE----------ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee
Confidence            479999999999999999965          5566889999999753   234456788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++.+|+|||||+||+|.+++..  ...+++..+..++.||+.||.|||+  +|||||||||+|||++.+|.+||+|||
T Consensus        75 ~~~~~~~iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~DFG  150 (337)
T d1o6la_          75 QTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFG  150 (337)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             ccccccccceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEeecc
Confidence            999999999999999999999865  4678999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +|+....  ........+||+.|+|||++.+..|+.++|||||||++|||++|.+||......             ....
T Consensus       151 ~a~~~~~--~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-------------~~~~  215 (337)
T d1o6la_         151 LCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------------RLFE  215 (337)
T ss_dssp             TCBCSCC--TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HHHH
T ss_pred             ccccccc--CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-------------HHHH
Confidence            9985432  223345678999999999999999999999999999999999999998754321             1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPT-----MSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~  409 (451)
                      .+...  ...++...++++.+||.+||+.||.+|++     +.|++++
T Consensus       216 ~i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         216 LILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHhcC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            11111  23445567788999999999999999994     8888874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=399.03  Aligned_cols=262  Identities=26%  Similarity=0.383  Sum_probs=204.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|++++.||+|+||+||+|.+...       ......||||.+...... ..+.+.+|+++|+.++|||||++++++.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~-------~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~   78 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSP-------ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   78 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC---------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecC-------CceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            45899999999999999999986532       233567999998654333 2456889999999999999999999996


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                       ++..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        79 -~~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          79 -ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred             -cCeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEccchh
Confidence             46789999999999999987543 4578999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhh
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      |+..... .........||+.|+|||++.+..|+.++|||||||++|||++ |.+||......              .+.
T Consensus       155 a~~~~~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--------------~~~  219 (273)
T d1mp8a_         155 SRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------------DVI  219 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------------GHH
T ss_pred             heeccCC-cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--------------HHH
Confidence            9864322 2223345678999999999999999999999999999999998 78887654321              111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      ..+........+...++++.+||.+||+.||++|||+.||++.|+.+..+
T Consensus       220 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         220 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            22223333445666788999999999999999999999999999998765

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=404.88  Aligned_cols=268  Identities=28%  Similarity=0.378  Sum_probs=208.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|+++++||+|+||.||+|.+...     .+..+++.||||++...... ..+.+.+|+.++.++ +|+||+.+++++
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~-----~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGI-----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEEST-----TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCC-----CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            45899999999999999999987642     23445678999999754332 345577888888887 488999999987


Q ss_pred             ecC-CeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCc
Q 013028          207 CDD-QHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASN  271 (451)
Q Consensus       207 ~~~-~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~N  271 (451)
                      .+. ...++|||||++|+|.+++....              ...+++..++.++.||+.||.|||+  ++||||||||+|
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDlKp~N  164 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARN  164 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGG
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcCCccc
Confidence            654 56899999999999999985432              2458999999999999999999999  899999999999


Q ss_pred             eeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCC-ccccccCCC
Q 013028          272 VLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT-AAMRRTNGL  350 (451)
Q Consensus       272 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~-pf~~~~~~~  350 (451)
                      |||+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|.. ||.....  
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~--  242 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--  242 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC--
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH--
Confidence            9999999999999999986544444444556789999999999999999999999999999999999754 5543221  


Q ss_pred             CCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          351 AGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                                 ...+...+........+...++++.+|+.+||+.||++|||+.||+++|+++...
T Consensus       243 -----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         243 -----------DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             -----------SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                       1122334444444556666788999999999999999999999999999998653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=401.39  Aligned_cols=258  Identities=25%  Similarity=0.423  Sum_probs=209.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      ++|++.+.||+|+||+||+|.+++           ...||||++... ....+.|.+|+.+|++++|||||++++++.+ 
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~-----------~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-   83 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNG-----------TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-   83 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-----------TEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECC-----------CCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence            589999999999999999997654           245999999643 4456789999999999999999999999865 


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      +..++||||+++|+|..++.......+++..++.++.||+.||.|||+  +||+||||||+||||+.++.+||+|||+|+
T Consensus        84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla~  161 (285)
T d1fmka3          84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLAR  161 (285)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchhh
Confidence            457999999999999999876555679999999999999999999999  899999999999999999999999999998


Q ss_pred             cCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHh
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQII  369 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (451)
                      ...... ........||+.|+|||++.++.++.++|||||||++|||++|..|+.....             ...+...+
T Consensus       162 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------------~~~~~~~i  227 (285)
T d1fmka3         162 LIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------------NREVLDQV  227 (285)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------------HHHHHHHH
T ss_pred             hccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------------HHHHHHHH
Confidence            643222 2223446789999999999999999999999999999999997766543221             11122333


Q ss_pred             hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          370 DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      ........+...++++.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         228 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            33444456677788999999999999999999999999998886543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-52  Score=403.48  Aligned_cols=263  Identities=24%  Similarity=0.395  Sum_probs=211.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC-CCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      ++|+++++||+|+||+||+|.+...+      ......||+|.+... .....+.+.+|+.+|+.++|||||+++|+|.+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEG------EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCC------CEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            36999999999999999999876432      122346999998753 33456789999999999999999999999987


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      + ..++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+  ++||||||||+||||+.++.+||+|||+|
T Consensus        83 ~-~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~DFGla  158 (317)
T d1xkka_          83 S-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLA  158 (317)
T ss_dssp             S-SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred             C-CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeeccccc
Confidence            5 567889999999999987654 4679999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +...............||..|+|||++.++.|+.++|||||||++|||+| |.+||.....              ..+..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--------------~~~~~  224 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------------SEISS  224 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--------------GGHHH
T ss_pred             eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--------------HHHHH
Confidence            87554444334445678999999999999999999999999999999998 6777654321              11234


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      .+........+...+.++.+|+.+||+.||.+|||+.|+++.|+.+..+
T Consensus       225 ~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             HHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            4444444556667788999999999999999999999999999988654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-52  Score=404.59  Aligned_cols=266  Identities=24%  Similarity=0.372  Sum_probs=215.9

Q ss_pred             HhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          128 ATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       128 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .+++|++.++||+|+||+||+|.+...     .+..++..||||++...... ..+++.+|+++|++++||||++++++|
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~-----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGL-----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETS-----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCC-----ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            356899999999999999999987541     23445678999999754333 245689999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED----------------------DTELNWERRIKIALGAARGLEHLHTYWRPVIH  264 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiH  264 (451)
                      .+....++||||+++|+|.+++....                      ...+++..++.|+.||+.||+|||+  ++|||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~ivH  163 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVH  163 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CCeEe
Confidence            99999999999999999999985321                      2358899999999999999999999  89999


Q ss_pred             CCCCCCceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCC-Ccc
Q 013028          265 RDVKASNVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK-TAA  343 (451)
Q Consensus       265 rDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~-~pf  343 (451)
                      |||||+||||+.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++|. +||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999999999999999999998543333333344567899999999999999999999999999999999996 455


Q ss_pred             ccccCCCCCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 013028          344 MRRTNGLAGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQ  414 (451)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  414 (451)
                      .....             .. +...+........+...++++.+|+.+||+.||++|||+.||++.|+++.
T Consensus       244 ~~~~~-------------~e-~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMAH-------------EE-VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSCH-------------HH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCH-------------HH-HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            43221             11 11222222234455667789999999999999999999999999999874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=393.67  Aligned_cols=252  Identities=28%  Similarity=0.426  Sum_probs=204.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec-
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD-  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-  208 (451)
                      ++|++++.||+|+||.||+|.++            +..||||+++.  ....+.+.+|++++++++||||++++|++.+ 
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~------------~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR------------GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEE   72 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET------------TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC------------CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence            47888999999999999998764            45699999964  3445779999999999999999999999865 


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCc
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLA  288 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla  288 (451)
                      .+..+|||||+++|+|.+++.......+++..++.|+.||+.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s  150 (262)
T d1byga_          73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLT  150 (262)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeecccccc
Confidence            4568999999999999999965444568999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhhhhH
Q 013028          289 KFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLALHQ  367 (451)
Q Consensus       289 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  367 (451)
                      +....     ......+|..|+|||++.+..++.++|||||||++|||++ |.+||......              .+..
T Consensus       151 ~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--------------~~~~  211 (262)
T d1byga_         151 KEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------------DVVP  211 (262)
T ss_dssp             ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--------------GHHH
T ss_pred             eecCC-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--------------HHHH
Confidence            85321     2234567889999999999999999999999999999998 67666532211              1222


Q ss_pred             HhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          368 IIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                      .+........+...++++.+|+.+||..||++|||+.++++.|+.++..
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         212 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            3333444556666778999999999999999999999999999998754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.4e-52  Score=402.77  Aligned_cols=246  Identities=25%  Similarity=0.393  Sum_probs=208.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++++.||+|+||+||+|.          ++.++..||||++.+.   .....+.+.+|+.+|+.++|||||++++++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~----------~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~   73 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIR----------SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF   73 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEE----------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEE----------ECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE
Confidence            479999999999999999965          4456788999999643   234456788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+++..|+|||||+||+|..++..  ...+++..+..++.||+.||.|||+  +|||||||||+||||+.+|.+||+|||
T Consensus        74 ~~~~~~~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NILl~~~g~vkL~DFG  149 (316)
T d1fota_          74 QDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFG  149 (316)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eeCCeeeeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhcc--CcEEccccCchheeEcCCCCEEEecCc
Confidence            999999999999999999998855  4668899999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +|+....     .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||......             ....
T Consensus       150 ~a~~~~~-----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-------------~~~~  211 (316)
T d1fota_         150 FAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------------KTYE  211 (316)
T ss_dssp             SCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------------HHHH
T ss_pred             cceEecc-----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-------------HHHH
Confidence            9986432     234578999999999999999999999999999999999999999653211             1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  409 (451)
                      .+...  ....+...++++.+++.+||..||.+|+     |+++++++
T Consensus       212 ~i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         212 KILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             HHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHcC--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            22222  2234555678899999999999999996     89999874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-52  Score=401.13  Aligned_cols=269  Identities=28%  Similarity=0.414  Sum_probs=223.8

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|+++++||+|+||.||+|.+..     ..+..++..||||++...... ....+.+|+.++..+ +|||||++++++
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~-----~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYG-----LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEES-----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEec-----cccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            3589999999999999999998754     223456788999999754332 345688999999999 599999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED----------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKAS  270 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~  270 (451)
                      .+....+||||||++|+|.+++....                ...+++..+..++.||+.||.|||+  ++||||||||+
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrDLKp~  174 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAAR  174 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccccc
Confidence            99999999999999999999986432                2368999999999999999999999  89999999999


Q ss_pred             ceeeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCC
Q 013028          271 NVLLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGL  350 (451)
Q Consensus       271 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  350 (451)
                      |||++.++.++|+|||+++...............||+.|+|||++.+..++.++|||||||++|||+++..|++....  
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~--  252 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--  252 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC--
Confidence            999999999999999999875544444444557889999999999999999999999999999999995554432211  


Q ss_pred             CCCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          351 AGNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                                ....+..++........+...+.++.+||.+||+.||++|||+.+|++.|+++..+
T Consensus       253 ----------~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         253 ----------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             ----------SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------HHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence                      12234455666666666677788999999999999999999999999999987654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=397.40  Aligned_cols=269  Identities=27%  Similarity=0.414  Sum_probs=216.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-CHHHHHHHHHHHHhc-CCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-GQDEWENELRFLSRL-NHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~h~nIv~~~~~~  206 (451)
                      .++|++++.||+|+||.||+|.+......   .......||||++...... ...++.+|+..+.++ +|||||+++++|
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~---~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKD---KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC-------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcc---cccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            35899999999999999999987654211   1233467999999764432 346678899999888 699999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCce
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNED--------------DTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNV  272 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NI  272 (451)
                      .++...++||||+++|+|.+++....              ...+++..++.++.||+.||+|||+  ++||||||||+||
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrDiKp~Ni  166 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNV  166 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGE
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEeeeecccce
Confidence            99999999999999999999996442              2468999999999999999999999  8999999999999


Q ss_pred             eeCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCC
Q 013028          273 LLDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLA  351 (451)
Q Consensus       273 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~  351 (451)
                      |++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||.....   
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---  243 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---  243 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence            999999999999999986544444444556788999999999999999999999999999999998 6777653221   


Q ss_pred             CCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHh
Q 013028          352 GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLN  416 (451)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  416 (451)
                                 ..+...+........+...++++.+||.+||+.||.+|||+.||++.|+++.+.
T Consensus       244 -----------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         244 -----------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             -----------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence                       122234444455556666788999999999999999999999999999998654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.9e-52  Score=394.84  Aligned_cols=260  Identities=25%  Similarity=0.388  Sum_probs=203.7

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---HHHHHHHHHHHHhcCCCceeeccce
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---QDEWENELRFLSRLNHPNVVKLMGY  205 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~  205 (451)
                      .++|++.+.||+|+||+||+|.          +..+++.||||++.......   ...+.+|+++|+.++|||||+++++
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~----------~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~   75 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLAR----------DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT   75 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEE----------ETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEE----------ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccce
Confidence            4689999999999999999965          44567889999997654333   3468899999999999999999999


Q ss_pred             eecCC----eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEE
Q 013028          206 CCDDQ----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       206 ~~~~~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~k  281 (451)
                      +.+.+    ..||||||++||+|.+++..  ...+++.++..++.||+.||.|||+  +||+||||||+|||++.++..+
T Consensus        76 ~~~~~~~~~~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~  151 (277)
T d1o6ya_          76 GEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVK  151 (277)
T ss_dssp             EEEECSSSEEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEE
T ss_pred             eeeccCCCceEEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCcccccCccccce
Confidence            97654    37899999999999998855  4579999999999999999999999  8999999999999999999999


Q ss_pred             EeecCCcccCCCCC-CcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccc
Q 013028          282 ISDFGLAKFGPLGD-KSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS  360 (451)
Q Consensus       282 l~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  360 (451)
                      |+|||.+....... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||......           
T Consensus       152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----------  220 (277)
T d1o6ya_         152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----------  220 (277)
T ss_dssp             ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------
T ss_pred             eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----------
Confidence            99999987533222 222344568999999999999899999999999999999999999998653321           


Q ss_pred             hhhhhhHHhhhhh--cCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHH
Q 013028          361 NKLALHQIIDEKL--GRNIQMEEAQEFAEIILRCLNSDPKNRP-TMSEVVAALEQLQL  415 (451)
Q Consensus       361 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~  415 (451)
                        ..+...+....  ........++++.+||.+||+.||.+|| |++++++.|.++++
T Consensus       221 --~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         221 --SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             --HHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             --HHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence              11111111111  0112234568899999999999999999 89999999988763

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=400.51  Aligned_cols=249  Identities=21%  Similarity=0.303  Sum_probs=206.3

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD  208 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  208 (451)
                      .++|++++.||+|+||+||+|.          +..++..||||++.... .....+.+|+++|+.++|||||+++++|++
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~----------~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   72 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCV----------ETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES   72 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEE----------ETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEE----------ECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            4689999999999999999965          44557889999997543 234567899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC--CCcEEEeecC
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD--DFNAKISDFG  286 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~--~~~~kl~DFG  286 (451)
                      ++++|||||||+||+|.+++... ...+++.++..|+.||+.||.|||+  +||+||||||+|||++.  .+.+||+|||
T Consensus        73 ~~~~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          73 MEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             TTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcccc
Confidence            99999999999999999998543 3469999999999999999999999  89999999999999984  4589999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +++....   ........||+.|+|||++.+..|+.++|||||||++|+|++|..||......             ..+.
T Consensus       150 ~~~~~~~---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-------------~~~~  213 (321)
T d1tkia_         150 QARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------------QIIE  213 (321)
T ss_dssp             TCEECCT---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------------HHHH
T ss_pred             hhhcccc---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-------------HHHH
Confidence            9986432   23344567899999999999999999999999999999999999999754321             1111


Q ss_pred             HHhhhhhcCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          367 QIIDEKLGRNIQM----EEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       367 ~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      .+.....  ..+.    ..++++.+|+.+||..||++|||+.|++++
T Consensus       214 ~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         214 NIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHhCCC--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2222111  1122    246789999999999999999999999984

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=395.95  Aligned_cols=260  Identities=26%  Similarity=0.376  Sum_probs=203.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC---cCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS---QGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++.+.||+|+||.||+|.++..       ......||||++.+...   ...++|.+|+.+|+.++|||||+++|++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~-------~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~   80 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAP-------SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV   80 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECT-------TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECC-------CCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            4799999999999999999986532       22345799999875422   2346789999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .++ ..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+  ++|+||||||+||||+.++.+||+|||
T Consensus        81 ~~~-~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          81 LTP-PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             CSS-SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             eec-chheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeeccch
Confidence            764 678999999999999887653 3569999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcc-cccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccccccCCCCCCccccccchhhh
Q 013028          287 LAKFGPLGDKSH-ISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILS-GKTAAMRRTNGLAGNWAKPYLSNKLA  364 (451)
Q Consensus       287 la~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  364 (451)
                      +++......... ......|+..|+|||++.+..++.++|||||||++|||++ |..||.....             ...
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-------------~~~  223 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------------SQI  223 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------------HHH
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-------------HHH
Confidence            998654333222 2334567889999999999999999999999999999998 8998864322             112


Q ss_pred             hhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          365 LHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                      ...+.........+...+.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus       224 ~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            2233334344445566678999999999999999999999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=402.79  Aligned_cols=251  Identities=22%  Similarity=0.296  Sum_probs=200.1

Q ss_pred             cCCCcCC-cccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhc-CCCceeeccceee
Q 013028          130 RKFSEKN-LIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRL-NHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~  207 (451)
                      ++|.+.. .||+|+||+||+|.          +..++..||||++..     ...+.+|+.++.++ +|||||+++++|.
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~----------~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~   75 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIF----------NKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYE   75 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEE----------ETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEE----------ECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            5788775 59999999999965          445678899999863     34578899987655 7999999999987


Q ss_pred             c----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC---CCcE
Q 013028          208 D----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD---DFNA  280 (451)
Q Consensus       208 ~----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~---~~~~  280 (451)
                      +    ..++|||||||+||+|.+++.......+++.++..|+.||+.||.|||+  +||+||||||+|||++.   ++.+
T Consensus        76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~  153 (335)
T d2ozaa1          76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAIL  153 (335)
T ss_dssp             EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCE
T ss_pred             ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH--cCCccccccccccccccccccccc
Confidence            5    4678999999999999999976555679999999999999999999999  89999999999999975   5679


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccc
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS  360 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  360 (451)
                      ||+|||+|+.....   ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||..............   
T Consensus       154 Kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~---  227 (335)
T d2ozaa1         154 KLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---  227 (335)
T ss_dssp             EECCCTTCEECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------
T ss_pred             cccccceeeeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH---
Confidence            99999999864332   233457899999999999999999999999999999999999999976543211000000   


Q ss_pred             hhhhhhHHhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          361 NKLALHQIIDEKLG--RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       361 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                            .+......  .......++++.+||.+||+.||++|||+.|++++
T Consensus       228 ------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         228 ------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ------HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                  00000000  00112346789999999999999999999999884

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-51  Score=395.17  Aligned_cols=262  Identities=26%  Similarity=0.440  Sum_probs=210.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC-CCcCHHHHHHHHHHHHhc-CCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-GSQGQDEWENELRFLSRL-NHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~  207 (451)
                      ++|++.++||+|+||+||+|.+..++        ....||||.+... .....+.+.+|+++|.++ +|||||+++++|.
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~   81 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDG--------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE   81 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETT--------EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCC--------eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence            48889999999999999998865431        1235788888643 333456789999999999 6999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcee
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNE--------------DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL  273 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIl  273 (451)
                      +++..++||||++||+|.+++...              ....+++..+..++.||+.||.|||+  ++|+||||||+|||
T Consensus        82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NIL  159 (309)
T d1fvra_          82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNIL  159 (309)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEE
T ss_pred             cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceEE
Confidence            999999999999999999998643              24679999999999999999999999  89999999999999


Q ss_pred             eCCCCcEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCC-ccccccCCCCC
Q 013028          274 LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKT-AAMRRTNGLAG  352 (451)
Q Consensus       274 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~-pf~~~~~~~~~  352 (451)
                      ++.++.+||+|||+|+....   ........||..|+|||.+.+..|+.++|||||||++|||++|.. ||.....    
T Consensus       160 ~~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~----  232 (309)
T d1fvra_         160 VGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----  232 (309)
T ss_dssp             ECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----
T ss_pred             EcCCCceEEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH----
Confidence            99999999999999985332   222234568999999999999999999999999999999999765 4433211    


Q ss_pred             CccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcC
Q 013028          353 NWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMG  418 (451)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  418 (451)
                                ..+...+........+...++++.+||.+||+.||++|||+.||++.|+.+..+..
T Consensus       233 ----------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         233 ----------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             ----------HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             ----------HHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence                      11222233333445566678899999999999999999999999999999986543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-51  Score=403.69  Aligned_cols=245  Identities=24%  Similarity=0.301  Sum_probs=207.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHHhcCCCceeecccee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      ++|++++.||+|+||+||+|.          ++.++..||||++.+.   .....+.+.+|+++|+.++|||||++++++
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~----------~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~  110 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVK----------HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF  110 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEE----------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEE----------ECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc
Confidence            489999999999999999965          4456788999998642   234456788999999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecC
Q 013028          207 CDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFG  286 (451)
Q Consensus       207 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFG  286 (451)
                      .+....++||||+.||+|.+++..  ...+++..+..++.||+.||.|||+  +|||||||||+||||+.++.+||+|||
T Consensus       111 ~~~~~~~~v~e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         111 KDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ccccccccccccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeece
Confidence            999999999999999999999865  3579999999999999999999999  899999999999999999999999999


Q ss_pred             CcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhh
Q 013028          287 LAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALH  366 (451)
Q Consensus       287 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  366 (451)
                      +|+....     ......||+.|+|||++.+..|+.++|||||||++|+|++|..||......             ..+.
T Consensus       187 ~a~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------------~~~~  248 (350)
T d1rdqe_         187 FAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------------QIYE  248 (350)
T ss_dssp             TCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HHHH
T ss_pred             eeeeccc-----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-------------HHHH
Confidence            9986432     233568999999999999999999999999999999999999999643211             1111


Q ss_pred             HHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 013028          367 QIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVA  408 (451)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  408 (451)
                      .+...  ....+...++++.+||.+||..||.+|+     |+.++++
T Consensus       249 ~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         249 KIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHhcC--CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            22222  2234455678899999999999999994     8999987

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.1e-51  Score=386.86  Aligned_cols=250  Identities=26%  Similarity=0.383  Sum_probs=206.5

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC---------HHHHHHHHHHHHhcC-CCce
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG---------QDEWENELRFLSRLN-HPNV  199 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~il~~l~-h~nI  199 (451)
                      ++|++.+.||+|+||+||+|.          +..+++.||||++.+.....         .+.+.+|+.+|+.++ ||||
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~----------~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI   72 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCI----------HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI   72 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEE----------ETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred             ccCEEceEEecCcCeEEEEEE----------ECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe
Confidence            589999999999999999965          44567889999997643221         235778999999997 9999


Q ss_pred             eeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          200 VKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       200 v~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      |++++++.++++.|||||||+||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.
T Consensus        73 v~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~  148 (277)
T d1phka_          73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMN  148 (277)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCC
T ss_pred             EEEEeecccCcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCC
Confidence            9999999999999999999999999999965  4579999999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCcccccccccc------CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCC
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT------GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGN  353 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  353 (451)
                      +||+|||+++....   .......+||..|+|||++.+      ..++.++||||+||++|+|++|+.||......    
T Consensus       149 ~kl~DFG~a~~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~----  221 (277)
T d1phka_         149 IKLTDFGFSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM----  221 (277)
T ss_dssp             EEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----
T ss_pred             eEEccchheeEccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH----
Confidence            99999999986443   223445789999999999843      45788999999999999999999999754321    


Q ss_pred             ccccccchhhhhhHHhhhhhc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          354 WAKPYLSNKLALHQIIDEKLG--RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                               .....+......  .......++++.+|+.+||+.||.+|||+.||+++
T Consensus       222 ---------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         222 ---------LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ---------HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ---------HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                     111222222221  12223567899999999999999999999999764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.5e-51  Score=403.79  Aligned_cols=248  Identities=27%  Similarity=0.356  Sum_probs=201.2

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC---CcCHHHHHH---HHHHHHhcCCCceeecc
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG---SQGQDEWEN---ELRFLSRLNHPNVVKLM  203 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~il~~l~h~nIv~~~  203 (451)
                      ++|+++++||+|+||.||+|.          +..++..||||++.+..   ......+.+   |+.+++.++|||||+++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~----------~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~   73 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCR----------KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS   73 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEE----------ETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred             HhCeeeeEEecCCCeEEEEEE----------ECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEE
Confidence            489999999999999999965          44567889999986421   122233333   46777788899999999


Q ss_pred             ceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEe
Q 013028          204 GYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKIS  283 (451)
Q Consensus       204 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~  283 (451)
                      ++|.+++..|||||||+||+|.+++..  ...+++..+..++.||+.||.|||+  +|||||||||+||||+.+|.+||+
T Consensus        74 ~~~~~~~~~~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~  149 (364)
T d1omwa3          74 YAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRIS  149 (364)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEEC
T ss_pred             EEEEECCEEEEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEe
Confidence            999999999999999999999999965  4678999999999999999999999  899999999999999999999999


Q ss_pred             ecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchh
Q 013028          284 DFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       284 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      |||+|+.....    .....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.......            
T Consensus       150 DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------------  213 (364)
T d1omwa3         150 DLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------------  213 (364)
T ss_dssp             CCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC------------
T ss_pred             eeceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH------------
Confidence            99999864322    2345689999999999964 568999999999999999999999997543210            


Q ss_pred             hhhhHHhhhh--hcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013028          363 LALHQIIDEK--LGRNIQMEEAQEFAEIILRCLNSDPKNRPT-----MSEVVAA  409 (451)
Q Consensus       363 ~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~  409 (451)
                        ...+....  .....+...++++.+||.+||..||.+|||     +.|++++
T Consensus       214 --~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         214 --KHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             --HHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             --HHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence              01111111  122334456788999999999999999999     6888763

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-51  Score=397.53  Aligned_cols=248  Identities=26%  Similarity=0.413  Sum_probs=205.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC---CCcCHHHHHHHHHHHH-hcCCCceeeccce
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK---GSQGQDEWENELRFLS-RLNHPNVVKLMGY  205 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~-~l~h~nIv~~~~~  205 (451)
                      ++|++++.||+|+||+||+|.          +..+++.||||++.+.   .....+.+..|..++. .++|||||+++++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~----------~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~   71 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAE----------FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT   71 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEE----------ETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEE----------ECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEE
Confidence            479999999999999999965          4456788999999743   2334556677777765 6899999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeec
Q 013028          206 CCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDF  285 (451)
Q Consensus       206 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DF  285 (451)
                      +.+++..|||||||+||+|.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus        72 ~~~~~~~yivmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          72 FQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EccCCceeEEEeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceeecCCCceecccc
Confidence            9999999999999999999999965  4568999999999999999999999  89999999999999999999999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhh
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLAL  365 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  365 (451)
                      |+|+.....  ........||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+....             ...
T Consensus       148 G~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------------~~~  212 (320)
T d1xjda_         148 GMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------------ELF  212 (320)
T ss_dssp             TTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HHH
T ss_pred             chhhhcccc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-------------HHH
Confidence            999854322  23344578999999999999999999999999999999999999999754321             011


Q ss_pred             hHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 013028          366 HQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMS-EVVA  408 (451)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~  408 (451)
                      ..+...  ...++...++++.+||.+||..||.+|||+. ++++
T Consensus       213 ~~i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         213 HSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             HHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HHHHcC--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            111111  2334455678899999999999999999995 7764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-50  Score=386.97  Aligned_cols=262  Identities=27%  Similarity=0.433  Sum_probs=208.9

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC-CcCHHHHHHHHHHHHhcCCCceeeccceeec-CCee
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG-SQGQDEWENELRFLSRLNHPNVVKLMGYCCD-DQHR  212 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~  212 (451)
                      .++||+|+||+||+|.+...       ......||||.+.+.. ....++|.+|+++|++++|||||+++|++.+ +...
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~  104 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDN-------DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  104 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC-----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred             ceEEeecCCeEEEEEEEECC-------CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCce
Confidence            47899999999999987542       1234579999997532 2334678999999999999999999999875 4678


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcccCC
Q 013028          213 LLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFGP  292 (451)
Q Consensus       213 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~  292 (451)
                      ++|||||++|+|.+++... ...+++..++.++.|++.||.|||+  .+|+||||||+||||++++.+||+|||+++...
T Consensus       105 ~lv~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             EEEEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            9999999999999988653 4567888999999999999999999  899999999999999999999999999998644


Q ss_pred             CCCCc--ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchhhhhhHHhh
Q 013028          293 LGDKS--HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNKLALHQIID  370 (451)
Q Consensus       293 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (451)
                      .....  .......||..|+|||++.+..++.++||||||+++|||++|..||.......             .+...+.
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-------------~~~~~i~  248 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------------DITVYLL  248 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------------CHHHHH
T ss_pred             ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-------------HHHHHHH
Confidence            32221  22334678999999999999999999999999999999999888876432210             0111122


Q ss_pred             hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          371 EKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      .......+...++++.+||.+||+.||++||++.||++.|+.++.....
T Consensus       249 ~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             cCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence            2223334455678899999999999999999999999999999876544

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-51  Score=392.94  Aligned_cols=254  Identities=24%  Similarity=0.313  Sum_probs=193.3

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcC-----HHHHHHHHHHHHhcCCCceeeccceeecC
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQG-----QDEWENELRFLSRLNHPNVVKLMGYCCDD  209 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~il~~l~h~nIv~~~~~~~~~  209 (451)
                      +++||+|+||+||+|.          +..+++.||||++.......     .+.+.+|+.+|+.++|||||++++++.++
T Consensus         3 l~~lG~G~fg~Vy~~~----------~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~   72 (299)
T d1ua2a_           3 LDFLGEGQFATVYKAR----------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   72 (299)
T ss_dssp             EEEEEEETTEEEEEEE----------CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             ceEeccCcCeEEEEEE----------ECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence            5789999999999965          55568889999987543221     24578999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCCcc
Q 013028          210 QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGLAK  289 (451)
Q Consensus       210 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~  289 (451)
                      ++.||||||+.++++..++.  ....+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+||+|||+|+
T Consensus        73 ~~~~ivmE~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~  148 (299)
T d1ua2a_          73 SNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAK  148 (299)
T ss_dssp             TCCEEEEECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             CceeehhhhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCcccc
Confidence            99999999999887776653  35678999999999999999999999  899999999999999999999999999997


Q ss_pred             cCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-------------CCcc
Q 013028          290 FGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-------------GNWA  355 (451)
Q Consensus       290 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-------------~~~~  355 (451)
                      .....  .......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||....+...             ..|.
T Consensus       149 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~  226 (299)
T d1ua2a_         149 SFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  226 (299)
T ss_dssp             TTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ccCCC--cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            54322  223345689999999999865 5689999999999999999999999865432100             0000


Q ss_pred             ccccchhhhhhHHhhhhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          356 KPYLSNKLALHQIIDEKLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...     ..............     ....++++.+|+.+||..||++|||+.|+|++
T Consensus       227 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         227 DMC-----SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             STT-----SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chh-----ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            000     00000000000000     11235789999999999999999999999863

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-51  Score=386.92  Aligned_cols=242  Identities=25%  Similarity=0.403  Sum_probs=198.6

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc------CHHHHHHHHHHHHhcC--CCcee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ------GQDEWENELRFLSRLN--HPNVV  200 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~--h~nIv  200 (451)
                      .++|+++++||+|+||+||+|.          +..++..||||++.+....      ....+.+|+.+|+.++  |||||
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~----------~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv   72 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGI----------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI   72 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEE----------ETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             CCeEEEeEEEeeCCCeEEEEEE----------ECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCcc
Confidence            3589999999999999999966          4456788999998753221      1223568999999997  89999


Q ss_pred             eccceeecCCeeEEEEeccCC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC-CC
Q 013028          201 KLMGYCCDDQHRLLVYEYVTR-GSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD-DF  278 (451)
Q Consensus       201 ~~~~~~~~~~~~~lV~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~-~~  278 (451)
                      ++++++.+.+..++||||+.+ +++.+++..  ...+++..+..++.||+.||.|||+  +||+||||||+|||++. ++
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~  148 (273)
T d1xwsa_          73 RLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRG  148 (273)
T ss_dssp             CEEEEEECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTT
T ss_pred             EEEEEEeeCCeEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCCC
Confidence            999999999999999999976 577777754  4579999999999999999999999  89999999999999984 57


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHL-TLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~  357 (451)
                      .+||+|||+|+....    .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||....          
T Consensus       149 ~vkl~DFG~a~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------  214 (273)
T d1xwsa_         149 ELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------  214 (273)
T ss_dssp             EEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------
T ss_pred             eEEECccccceeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------
Confidence            999999999986332    23446789999999999977665 677999999999999999999986421          


Q ss_pred             ccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          358 YLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                               .+...  ...++...++++.+||.+||..||++|||+.|++++
T Consensus       215 ---------~i~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         215 ---------EIIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ---------HHHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---------HHhhc--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                     11111  112333456889999999999999999999999873

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-50  Score=387.20  Aligned_cols=265  Identities=22%  Similarity=0.317  Sum_probs=200.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|+++++||+|+||+||+|.          +..++..||||++.....  ...+.+.+|+++|++++|||||+++++|.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~----------~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~   71 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKAR----------NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH   71 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEE----------ETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEE----------ECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc
Confidence            589999999999999999966          445678899999964432  23567889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      ++.+.|+||||+.+ ++.+++.......+++..+..++.||+.||.|||+  +|||||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          72 TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             ETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             cccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCc
Confidence            99999999999965 55566655556779999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCC-CCcchhhHHHHHHHHHHHhCCCccccccCCCC-----------CCcc
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----------GNWA  355 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----------~~~~  355 (451)
                      |+....  .........||+.|+|||++.... ++.++|||||||++|+|++|+.||........           ....
T Consensus       149 a~~~~~--~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  226 (298)
T d1gz8a_         149 ARAFGV--PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV  226 (298)
T ss_dssp             HHHHCC--CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ceeccC--CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence            986432  223344568999999999986655 58899999999999999999999965432100           0000


Q ss_pred             ccccchhhhhhHHhhhhhcC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          356 KPYLSNKLALHQIIDEKLGR---NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ++..................   ......+.++.+|+.+||..||++|||+.|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00000000000000000000   0011235789999999999999999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-50  Score=387.59  Aligned_cols=264  Identities=27%  Similarity=0.401  Sum_probs=213.5

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|.++++||+|+||+||+|.++..     .....+..||||++..... .....+.+|++++++++|||||++++++.
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~-----~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGV-----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEE-----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCc-----ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            35889999999999999999987542     1223346799999975432 22345889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNE--------DDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      .++..++||||+++|+|.+++...        ....+++..+..++.|++.||.|||+  ++|+||||||+||||+.++.
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecCCce
Confidence            999999999999999999988532        22457899999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCC-CccccccCCCCCCccccc
Q 013028          280 AKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGK-TAAMRRTNGLAGNWAKPY  358 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~  358 (451)
                      +||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. +||.....          
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~----------  241 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------  241 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----------
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH----------
Confidence            9999999998644333333344557899999999999999999999999999999999986 55432211          


Q ss_pred             cchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 013028          359 LSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQL  413 (451)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  413 (451)
                         ...+..+. .......+...+..+.+||.+||+.||++|||+.+|++.|+..
T Consensus       242 ---~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         242 ---EQVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             ---HHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ---HHHHHHHH-hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence               11122222 2223444556678999999999999999999999999998765

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=383.88  Aligned_cols=272  Identities=28%  Similarity=0.378  Sum_probs=203.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHH--HHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEW--ENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~--~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      +.|.+.++||+|+||.||+|+++            +..||||++...   ....+  +.|+..+..++|||||++++++.
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~------------g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~   67 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR------------GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN   67 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET------------TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC------------CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEE
Confidence            47888899999999999998753            567999998643   23333  34555556789999999999998


Q ss_pred             cCC----eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceeCCCCCCceeeCCC
Q 013028          208 DDQ----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTY------WRPVIHRDVKASNVLLDDD  277 (451)
Q Consensus       208 ~~~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------~~~iiHrDlkp~NIll~~~  277 (451)
                      +.+    ..+|||||+++|+|.+++.+   ..+++..++.++.|++.||.|||+.      .+|||||||||+||||+.+
T Consensus        68 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~  144 (303)
T d1vjya_          68 KDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  144 (303)
T ss_dssp             EECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred             eCCCcceEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC
Confidence            654    57999999999999999965   3589999999999999999999962      1589999999999999999


Q ss_pred             CcEEEeecCCcccCCCCCCc--ccccccCCCCccccccccccCC------CCcchhhHHHHHHHHHHHhCCCccccccCC
Q 013028          278 FNAKISDFGLAKFGPLGDKS--HISTRVLGTRGYFAPEYIATGH------LTLKTDVYSFGVVLLEILSGKTAAMRRTNG  349 (451)
Q Consensus       278 ~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~------~~~~~DiwSlGvil~elltg~~pf~~~~~~  349 (451)
                      +.+||+|||++.........  ......+||+.|+|||++.+..      ++.++|||||||+||||++|..||......
T Consensus       145 ~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~  224 (303)
T d1vjya_         145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  224 (303)
T ss_dssp             SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred             CCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccc
Confidence            99999999999864332221  1234578999999999986542      577899999999999999999887654433


Q ss_pred             CCCCcccc-ccchhhhh-hHHhhhhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCC
Q 013028          350 LAGNWAKP-YLSNKLAL-HQIIDEKLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGS  419 (451)
Q Consensus       350 ~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  419 (451)
                      ........ ........ .......+...+     .......+.+|+.+||..||++|||+.||++.|+++..+.+.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~  301 (303)
T d1vjya_         225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  301 (303)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred             ccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence            22111100 00011111 122222222222     223456799999999999999999999999999999877653

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-49  Score=378.72  Aligned_cols=265  Identities=24%  Similarity=0.349  Sum_probs=198.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhc---CCCceeecc
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRL---NHPNVVKLM  203 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~h~nIv~~~  203 (451)
                      .++|+++++||+|+||+||+|.+..         ..++.||||++....  ......+.+|+.+|+.|   +||||++++
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~   76 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLK---------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF   76 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT---------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEEC---------CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceee
Confidence            3589999999999999999976432         225679999986432  22233466788887776   799999999


Q ss_pred             ceeec-----CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC
Q 013028          204 GYCCD-----DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF  278 (451)
Q Consensus       204 ~~~~~-----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~  278 (451)
                      ++|..     ....++||||++++.+.... ......+++..+..++.|++.||+|||+  +|||||||||+|||++.++
T Consensus        77 ~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~~  153 (305)
T d1blxa_          77 DVCTVSRTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSG  153 (305)
T ss_dssp             EEEEEEECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTC
T ss_pred             eeecccccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCCC
Confidence            99853     35679999999886664433 3445779999999999999999999999  8999999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC-------
Q 013028          279 NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-------  351 (451)
Q Consensus       279 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-------  351 (451)
                      .+||+|||++...   ..........||+.|+|||++.+..|+.++|||||||++|||++|++||........       
T Consensus       154 ~~kl~dfg~~~~~---~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  230 (305)
T d1blxa_         154 QIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV  230 (305)
T ss_dssp             CEEECSCCSCCCC---CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             Ceeecchhhhhhh---cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence            9999999999853   233345567899999999999999999999999999999999999999975432100       


Q ss_pred             ------CCccccccchhhhhhHHhhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 ------GNWAKPYLSNKLALHQIIDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                            ..|.............. ............++.+.+|+.+||..||++|||+.|+|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         231 IGLPGEEDWPRDVALPRQAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCC-CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hCCCchhcccccccchhhhhccc-cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                  00000000000000000 0000011122345789999999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.1e-48  Score=374.75  Aligned_cols=262  Identities=23%  Similarity=0.285  Sum_probs=197.4

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC--CcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG--SQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|+++++||+|+||+||+|.+.           +++.||||++....  ....+.+.+|+.+|++++|||||+++++|.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   70 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH   70 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc
Confidence            58999999999999999998643           35789999997542  233567899999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +++..++||||+.++.+..+..  ....+++..+..++.||+.||+|||+  +|||||||||+|||++.++.+||+|||+
T Consensus        71 ~~~~~~i~~e~~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          71 TKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             CSSCEEEEEECCSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             cCCceeEEEEeehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeEcCCCCEEeccccc
Confidence            9999999999998776666653  35779999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--------CCccccc
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--------GNWAKPY  358 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--------~~~~~~~  358 (451)
                      |......  ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||........        .......
T Consensus       147 a~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~  224 (286)
T d1ob3a_         147 ARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN  224 (286)
T ss_dssp             HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ceecccC--ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhh
Confidence            9864322  222344578999999999865 5679999999999999999999999965422100        0000000


Q ss_pred             cchhhhhhHH---h---hhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          359 LSNKLALHQI---I---DEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       359 ~~~~~~~~~~---~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                      +.........   .   ............++++.+|+.+||..||++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000000   0   000001112234578999999999999999999999985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.5e-47  Score=373.96  Aligned_cols=256  Identities=20%  Similarity=0.297  Sum_probs=196.8

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~  208 (451)
                      ++|+++++||+|+||+||+|.          +..++..||||++..   ...+.+.+|+++|+.++ ||||++++++|..
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~----------~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~  101 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAI----------NITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD  101 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEE----------ETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             cCeEEEEEEecCcCeEEEEEE----------ECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence            589999999999999999965          445678899999964   34567889999999996 9999999999974


Q ss_pred             --CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC-cEEEeec
Q 013028          209 --DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF-NAKISDF  285 (451)
Q Consensus       209 --~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~-~~kl~DF  285 (451)
                        ..+.++|||||.+++|..+.     ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++ .+||+||
T Consensus       102 ~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~~~~~vkl~DF  174 (328)
T d3bqca1         102 PVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDW  174 (328)
T ss_dssp             TTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCG
T ss_pred             cCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcCCCCeeeeccc
Confidence              45689999999999987764     459999999999999999999999  8999999999999998654 6999999


Q ss_pred             CCcccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccc-cccch--
Q 013028          286 GLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAK-PYLSN--  361 (451)
Q Consensus       286 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~-~~~~~--  361 (451)
                      |+|+.....   ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||............. .....  
T Consensus       175 G~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~  251 (328)
T d3bqca1         175 GLAEFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED  251 (328)
T ss_dssp             GGCEECCTT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred             ccceeccCC---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCch
Confidence            999864322   233456799999999998764 57999999999999999999999987543211000000 00000  


Q ss_pred             ------------hhhhhHH--------hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013028          362 ------------KLALHQI--------IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVA  408 (451)
Q Consensus       362 ------------~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  408 (451)
                                  .......        .............++++.+||.+||..||++|||++|+|+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                        0000000        0000111112234678999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.9e-47  Score=366.20  Aligned_cols=268  Identities=22%  Similarity=0.237  Sum_probs=204.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCcee-eccceeec
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVV-KLMGYCCD  208 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv-~~~~~~~~  208 (451)
                      ++|++++.||+|+||+||+|.+          ..+++.||||++.....  .+.+..|+++++.++|+|++ .+.+++.+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~----------~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~   74 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTD----------IAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE   74 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE----------TTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEE----------CCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEec
Confidence            4899999999999999999764          34577899999875432  23478899999999876655 55566678


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC---CCCcEEEeec
Q 013028          209 DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD---DDFNAKISDF  285 (451)
Q Consensus       209 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~---~~~~~kl~DF  285 (451)
                      ++..++||||+ +++|.+.+... ...+++..+..++.|++.||+|||+  +|||||||||+|||++   .+..++|+||
T Consensus        75 ~~~~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl~DF  150 (299)
T d1ckia_          75 GDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDF  150 (299)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             CCEEEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeeeecc
Confidence            88899999999 55776665433 4679999999999999999999999  8999999999999985   4557999999


Q ss_pred             CCcccCCCCCCc-----ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccc
Q 013028          286 GLAKFGPLGDKS-----HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLS  360 (451)
Q Consensus       286 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  360 (451)
                      |+|+........     .......||+.|+|||++.+..++.++|||||||++|||++|..||...........      
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~------  224 (299)
T d1ckia_         151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK------  224 (299)
T ss_dssp             SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------------
T ss_pred             CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH------
Confidence            999864432211     123456899999999999999999999999999999999999999975443211100      


Q ss_pred             hhhhhhHHhhhhhcC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCccc
Q 013028          361 NKLALHQIIDEKLGR---NIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQT  423 (451)
Q Consensus       361 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~  423 (451)
                          ...........   ......++++.+|+.+||+.||.+||++.++.+.|+.+....+.....
T Consensus       225 ----~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~  286 (299)
T d1ckia_         225 ----YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY  286 (299)
T ss_dssp             ----HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSC
T ss_pred             ----HHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCC
Confidence                00111111100   112234578999999999999999999999999999987666554443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.9e-47  Score=363.33  Aligned_cols=271  Identities=18%  Similarity=0.222  Sum_probs=214.1

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCC-Cceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNH-PNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~  207 (451)
                      .++|+++++||+|+||+||+|.+          ..+++.||||++.....  ...+.+|+++++.|+| +||+.+++++.
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~----------~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~   71 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTN----------LLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQ   71 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEE----------TTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEE----------CCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEee
Confidence            35899999999999999999764          44578899999865432  2346789999999985 89999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCC-----CCcEEE
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDD-----DFNAKI  282 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~-----~~~~kl  282 (451)
                      ++...++||||+ +++|.+++... ...+++..+..++.|++.||+|||+  +||+||||||+|||++.     ++.+||
T Consensus        72 ~~~~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          72 EGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             cCCccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCceEE
Confidence            999999999999 78999887553 4579999999999999999999999  89999999999999964     578999


Q ss_pred             eecCCcccCCCCCCc-----ccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCcccc
Q 013028          283 SDFGLAKFGPLGDKS-----HISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKP  357 (451)
Q Consensus       283 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~  357 (451)
                      +|||+|+........     ......+||+.|+|||++.+..++.++|||||||++|||++|..||........      
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~------  221 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN------  221 (293)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH------
T ss_pred             cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH------
Confidence            999999864322111     123356899999999999999999999999999999999999999975432211      


Q ss_pred             ccchhhhhhHHhhhhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHHhcCCCccccc
Q 013028          358 YLSNKLALHQIIDEKLG---RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAALEQLQLNMGSCYQTSL  425 (451)
Q Consensus       358 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~  425 (451)
                          ......+......   .......++++.+++..|+..+|++||++..+.+.|+++....+...+...
T Consensus       222 ----~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~  288 (293)
T d1csna_         222 ----KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF  288 (293)
T ss_dssp             ----HHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCC
T ss_pred             ----HHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCC
Confidence                0111111111110   011123457899999999999999999999999999999887776655443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=371.23  Aligned_cols=264  Identities=22%  Similarity=0.264  Sum_probs=194.6

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC--CCcCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK--GSQGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|+++++||+|+||+||+|.+          ..+++.||||++...  .......+.+|+++|+.++||||+++++++.
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~----------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~   79 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARH----------RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR   79 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE----------TTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCEEEEEEEecCcCeEEEEEEE----------CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence            5899999999999999999764          455788999998644  2334567889999999999999999999885


Q ss_pred             c--------CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCc
Q 013028          208 D--------DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFN  279 (451)
Q Consensus       208 ~--------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~  279 (451)
                      .        +.+.++||||+.++.+....  .....+++..+..++.||+.||.|||+  +||+||||||+|||++.++.
T Consensus        80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~~  155 (318)
T d3blha1          80 TKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGV  155 (318)
T ss_dssp             C----------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSC
T ss_pred             cccccccccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCCCc
Confidence            5        34689999999876665444  335678999999999999999999999  89999999999999999999


Q ss_pred             EEEeecCCcccCCCCCC--cccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCC-----
Q 013028          280 AKISDFGLAKFGPLGDK--SHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA-----  351 (451)
Q Consensus       280 ~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-----  351 (451)
                      +||+|||++........  .......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||........     
T Consensus       156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~  235 (318)
T d3blha1         156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS  235 (318)
T ss_dssp             EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence            99999999975442221  1223346799999999998764 689999999999999999999999965332100     


Q ss_pred             -------CCccccccchhhhhhHHhhhhhcCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          352 -------GNWAKPYLSNKLALHQIIDEKLGRNIQ-------MEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       352 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                             ..+...... . .....+.........       ...++.+.+|+.+||..||++|||+.|+|++
T Consensus       236 ~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         236 QLCGSITPEVWPNVDN-Y-ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHHCCCCTTTSTTCCC-C--------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcCCCChhhccccch-h-hhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence                   000000000 0 000000000000000       1124678899999999999999999999964

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=376.68  Aligned_cols=266  Identities=25%  Similarity=0.282  Sum_probs=195.5

Q ss_pred             CCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCceeeccceeec--
Q 013028          131 KFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNVVKLMGYCCD--  208 (451)
Q Consensus       131 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--  208 (451)
                      +|..+++||+|+||+||+|.          +..+++.||||++......    +.+|+++|++++||||++++++|..  
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~----------~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~   86 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAK----------LCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSG   86 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEE----------ETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             CcEeeeEEeeCcCeEEEEEE----------ECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecC
Confidence            68888999999999999965          4456788999999754322    2479999999999999999999853  


Q ss_pred             ----CCeeEEEEeccCCCChhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCC-cEEE
Q 013028          209 ----DQHRLLVYEYVTRGSLEDHLL-NEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDF-NAKI  282 (451)
Q Consensus       209 ----~~~~~lV~E~~~gg~L~~~l~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~-~~kl  282 (451)
                          ..+++||||||+++.+..+.. ......+++..+..++.||+.||+|||+  +||+||||||+||||+.++ .+||
T Consensus        87 ~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl  164 (350)
T d1q5ka_          87 EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKL  164 (350)
T ss_dssp             -CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEE
T ss_pred             ccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeE
Confidence                345799999997654333322 1245679999999999999999999999  8999999999999999765 8999


Q ss_pred             eecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC-Ccccccc-
Q 013028          283 SDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG-NWAKPYL-  359 (451)
Q Consensus       283 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~-  359 (451)
                      +|||++.....   .......+||..|+|||++.+ ..|+.++|||||||++|||++|.+||......... ....... 
T Consensus       165 ~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~  241 (350)
T d1q5ka_         165 CDFGSAKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT  241 (350)
T ss_dssp             CCCTTCEECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ecccchhhccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999986432   223345689999999998765 57899999999999999999999999654321000 0000000 


Q ss_pred             chhhhhhHHhhh------------hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhHH
Q 013028          360 SNKLALHQIIDE------------KLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA--LEQLQL  415 (451)
Q Consensus       360 ~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~  415 (451)
                      .....+......            ..........++++.+|+.+||..||++|||+.|+|++  |+.++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            000000000000            00001122346789999999999999999999999974  555543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=377.17  Aligned_cols=264  Identities=25%  Similarity=0.341  Sum_probs=194.9

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|+++++||+|+||+||+|.          +..+++.||||++.+....  ..+.+.+|+++|+.++|||||+++++|
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~----------~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~   86 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAV----------DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF   86 (346)
T ss_dssp             BSSEEEEEEC------CEEEEE----------ETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred             CCcEEEEEEEecCCCeEEEEEE----------ECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEe
Confidence            4699999999999999999975          4456788999999754332  234678999999999999999999999


Q ss_pred             ecCC------eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcE
Q 013028          207 CDDQ------HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNA  280 (451)
Q Consensus       207 ~~~~------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~  280 (451)
                      ...+      +.||||||+ +.+|..++..   ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~~  160 (346)
T d1cm8a_          87 TPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCEL  160 (346)
T ss_dssp             CSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCE
T ss_pred             ccCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhccccccc
Confidence            7654      569999999 6677776643   469999999999999999999999  899999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcccccccCCCCcccccccccc-CCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--------
Q 013028          281 KISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIAT-GHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--------  351 (451)
Q Consensus       281 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--------  351 (451)
                      ||+|||+|+....     ..+...||+.|+|||++.+ ..++.++|||||||++|+|++|.+||........        
T Consensus       161 kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~  235 (346)
T d1cm8a_         161 KILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT  235 (346)
T ss_dssp             EECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             ccccccceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhcc
Confidence            9999999986432     2345689999999999876 4578999999999999999999999975432110        


Q ss_pred             CCccccccch-hhhhhHHhhhhhc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHh
Q 013028          352 GNWAKPYLSN-KLALHQIIDEKLG-------RNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA--LEQL  413 (451)
Q Consensus       352 ~~~~~~~~~~-~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~  413 (451)
                      ......+... ...........+.       .......++.+.+||.+||..||.+|||+.|+|++  |+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            0000000000 0000000000000       01122345788999999999999999999999985  5443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-47  Score=371.51  Aligned_cols=265  Identities=22%  Similarity=0.304  Sum_probs=194.4

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC-cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS-QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      .++|+++++||+|+||+||+|..          ..++..||||++.+... ...+.+.+|+++|++++||||+++++++.
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~----------~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~   76 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYD----------NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIR   76 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEE----------TTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEE----------CCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEe
Confidence            45899999999999999999764          45578899999975432 23456789999999999999999999987


Q ss_pred             cCC-----eeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEE
Q 013028          208 DDQ-----HRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKI  282 (451)
Q Consensus       208 ~~~-----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl  282 (451)
                      ...     +.|++ +|+.||+|.+++..   ..+++..+..++.||+.||.|||+  +|||||||||+||||+.++.+||
T Consensus        77 ~~~~~~~~~~~l~-~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~~~~kl  150 (345)
T d1pmea_          77 APTIEQMKDVYLV-THLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKI  150 (345)
T ss_dssp             CSSTTTCCCEEEE-EECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEE
T ss_pred             eccccccceEEEE-EeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCCCCEEE
Confidence            643     34455 55668999999864   369999999999999999999999  89999999999999999999999


Q ss_pred             eecCCcccCCCCCC-cccccccCCCCccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCccccccCCCCC--------
Q 013028          283 SDFGLAKFGPLGDK-SHISTRVLGTRGYFAPEYIA-TGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAG--------  352 (451)
Q Consensus       283 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~--------  352 (451)
                      +|||+|........ .......+||+.|+|||++. +..++.++||||+||++|+|++|..||.........        
T Consensus       151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~  230 (345)
T d1pmea_         151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG  230 (345)
T ss_dssp             CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhcc
Confidence            99999986432211 12234567999999999984 456789999999999999999999998654321100        


Q ss_pred             Cccccc--cchhhhhhH-HhhhhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          353 NWAKPY--LSNKLALHQ-IIDEKLGRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       353 ~~~~~~--~~~~~~~~~-~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ......  ......... ..........     ....+.++.+|+.+||..||.+|||+.|+|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000000  000000000 0000000001     11234679999999999999999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-47  Score=369.05  Aligned_cols=254  Identities=24%  Similarity=0.334  Sum_probs=205.0

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCC----CcCHHHHHHHHHHHHhcCC-Cceeeccc
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKG----SQGQDEWENELRFLSRLNH-PNVVKLMG  204 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h-~nIv~~~~  204 (451)
                      ++|+++++||+|+||+||+|...       ....++..||||++.+..    ....+.+.+|+++|++++| |||+++++
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~-------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~   96 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKI-------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY   96 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEEC-------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEEC-------ccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeee
Confidence            47999999999999999998652       234568899999986432    2334567789999999976 89999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEee
Q 013028          205 YCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISD  284 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~D  284 (451)
                      ++.+....++||||+.||+|.+++..  ...+++..+..++.||+.||.|||+  ++|+||||||+||||+.++.+||+|
T Consensus        97 ~~~~~~~~~~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~D  172 (322)
T d1vzoa_          97 AFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTD  172 (322)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESC
T ss_pred             eeccCCceeeeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEee
Confidence            99999999999999999999999865  3567889999999999999999999  8999999999999999999999999


Q ss_pred             cCCcccCCCCCCcccccccCCCCccccccccccC--CCCcchhhHHHHHHHHHHHhCCCccccccCCCCCCccccccchh
Q 013028          285 FGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG--HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLAGNWAKPYLSNK  362 (451)
Q Consensus       285 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  362 (451)
                      ||+|+..... .........|++.|+|||.+.+.  .++.++|||||||+||+|++|..||........           
T Consensus       173 FG~a~~~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-----------  240 (322)
T d1vzoa_         173 FGLSKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-----------  240 (322)
T ss_dssp             SSEEEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-----------
T ss_pred             ccchhhhccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-----------
Confidence            9999864322 22234456899999999998654  578899999999999999999999976543210           


Q ss_pred             hhhhHHhhh--hhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 013028          363 LALHQIIDE--KLGRNIQMEEAQEFAEIILRCLNSDPKNRP-----TMSEVVA  408 (451)
Q Consensus       363 ~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  408 (451)
                        ...+...  .....++...++++.+|+.+||..||++||     |++|+++
T Consensus       241 --~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         241 --QAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             --HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             --HHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence              1111111  112334556788999999999999999999     5788876

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-47  Score=362.56  Aligned_cols=264  Identities=20%  Similarity=0.281  Sum_probs=202.7

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCC--cCHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGS--QGQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|+++++||+|+||+||+|+          +..++..||||++.....  .....+.+|+.+|+.++||||++++++|.
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~----------~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   71 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAK----------NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH   71 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEE----------ETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEE----------ECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc
Confidence            589999999999999999976          445678899999975433  23467889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEEEeecCC
Q 013028          208 DDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAKISDFGL  287 (451)
Q Consensus       208 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl  287 (451)
                      +....++|||++.+++|..++..  ...+++..+..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||.
T Consensus        72 ~~~~~~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG~  147 (292)
T d1unla_          72 SDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             CSSEEEEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             cccceeEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecch
Confidence            99999999999999988887743  5678999999999999999999999  8999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCccccccccccCC-CCcchhhHHHHHHHHHHHhCCCccccccCCCC---------CCcccc
Q 013028          288 AKFGPLGDKSHISTRVLGTRGYFAPEYIATGH-LTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA---------GNWAKP  357 (451)
Q Consensus       288 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltg~~pf~~~~~~~~---------~~~~~~  357 (451)
                      |......  ........++..|+|||++.+.. ++.++|||||||++|||++|..||........         ......
T Consensus       148 a~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (292)
T d1unla_         148 ARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE  225 (292)
T ss_dssp             CEECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             hhcccCC--CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChh
Confidence            9864322  22233456788999999987654 69999999999999999999999754322110         000000


Q ss_pred             ccchhhhhhHH------hhhhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          358 YLSNKLALHQI------IDEKLGRNIQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       358 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ...........      .............++.+.+|+.+||+.||++|||+.|+|++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000000000      00000111223345789999999999999999999999863

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-46  Score=367.02  Aligned_cols=260  Identities=26%  Similarity=0.355  Sum_probs=189.9

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeeccceee
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYCC  207 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~  207 (451)
                      ++|+++++||+|+||+||+|.          +..++..||||++......  ....+.+|+.+|++++|||||+++++|.
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~----------d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~   86 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAY----------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT   86 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEE----------ETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CCeEEEEEeecCcCeEEEEEE----------ECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Confidence            589999999999999999976          4456788999999754332  2345789999999999999999999996


Q ss_pred             c------CCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEE
Q 013028          208 D------DQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       208 ~------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~k  281 (451)
                      .      ..+.|+|||||.++ |.+.+    ...+++..+..++.||+.||.|||+  +||+||||||+|||++.++.++
T Consensus        87 ~~~~~~~~~~~~iv~Ey~~~~-l~~~~----~~~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~~k  159 (355)
T d2b1pa1          87 PQKTLEEFQDVYLVMELMDAN-LCQVI----QMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLK  159 (355)
T ss_dssp             SCCSTTTCCEEEEEEECCSEE-HHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEE
T ss_pred             cccccccCceeEEEEeccchH-HHHhh----hcCCCHHHHHHHHHHHHHHHHHhhh--cccccccCCcccccccccccee
Confidence            3      46889999999764 54545    2458999999999999999999999  8999999999999999999999


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCCCC--------CC
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--------GN  353 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--------~~  353 (451)
                      ++|||+++...   ........+||+.|+|||++.+..++.++||||+||++|+|++|++||........        ..
T Consensus       160 l~df~~~~~~~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~  236 (355)
T d2b1pa1         160 ILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  236 (355)
T ss_dssp             ECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             eechhhhhccc---cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence            99999988533   22334456799999999999999999999999999999999999999965432110        00


Q ss_pred             ccccccc-hhhhhh---------------HHhhhhhcCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          354 WAKPYLS-NKLALH---------------QIIDEKLGRN---IQMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       354 ~~~~~~~-~~~~~~---------------~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ....++. ......               ..+.......   .....+.++.+|+.+||..||++|||++|||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000000 000000               1111111111   122347889999999999999999999999965

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-46  Score=365.22  Aligned_cols=261  Identities=24%  Similarity=0.351  Sum_probs=193.2

Q ss_pred             hcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc--CHHHHHHHHHHHHhcCCCceeecccee
Q 013028          129 TRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ--GQDEWENELRFLSRLNHPNVVKLMGYC  206 (451)
Q Consensus       129 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~  206 (451)
                      .++|+++++||+|+||+||+|.          +..+++.||||++.+....  ..+.+.+|+++|++++|||||++++++
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~----------~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~   86 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAF----------DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   86 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEE----------ETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             CCCeEEEEEEecCCCeEEEEEE----------ECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            4589999999999999999965          4556889999999755332  234678999999999999999999998


Q ss_pred             ecC-----CeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeCCCCcEE
Q 013028          207 CDD-----QHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLDDDFNAK  281 (451)
Q Consensus       207 ~~~-----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~~~~~~k  281 (451)
                      ...     ...++||+|+.||+|.+++..   ..+++..+..++.||+.||.|||+  +||+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~k  161 (348)
T d2gfsa1          87 TPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELK  161 (348)
T ss_dssp             CSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEE
T ss_pred             eeccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCcccccccccccc
Confidence            633     334566677789999998843   469999999999999999999999  8999999999999999999999


Q ss_pred             EeecCCcccCCCCCCcccccccCCCCccccccccccC-CCCcchhhHHHHHHHHHHHhCCCccccccCCCC--------C
Q 013028          282 ISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATG-HLTLKTDVYSFGVVLLEILSGKTAAMRRTNGLA--------G  352 (451)
Q Consensus       282 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--------~  352 (451)
                      ++|||++....     .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||........        .
T Consensus       162 l~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~  236 (348)
T d2gfsa1         162 ILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  236 (348)
T ss_dssp             ECCC----CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccchhcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            99999997422     233456789999999987664 568999999999999999999999965432100        0


Q ss_pred             Cccccccc--hhhhhhHHhhhhh-cCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013028          353 NWAKPYLS--NKLALHQIIDEKL-GRNI-----QMEEAQEFAEIILRCLNSDPKNRPTMSEVVAA  409 (451)
Q Consensus       353 ~~~~~~~~--~~~~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  409 (451)
                      ........  ............. ....     ....++++.+||.+||..||.+|||+.|+|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            00000000  0000000000000 0000     11235779999999999999999999999974

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.3e-41  Score=332.12  Aligned_cols=261  Identities=21%  Similarity=0.272  Sum_probs=191.1

Q ss_pred             cCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-----------CCc
Q 013028          130 RKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-----------HPN  198 (451)
Q Consensus       130 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------h~n  198 (451)
                      .+|+++++||+|+||+||+|.          +..++..||||+++... ...+.+.+|+++|+.++           |+|
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~----------~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~   81 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAK----------DMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH   81 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEE----------ETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             CcEEEEEEEeeCCCeEEEEEE----------ECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence            369999999999999999965          44567889999997432 23456788999988875           578


Q ss_pred             eeeccceeec--CCeeEEEEeccCCCCh-hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCceeeC
Q 013028          199 VVKLMGYCCD--DQHRLLVYEYVTRGSL-EDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVLLD  275 (451)
Q Consensus       199 Iv~~~~~~~~--~~~~~lV~E~~~gg~L-~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIll~  275 (451)
                      |+++++++..  ....++||+++..+.. ...........+++..+..++.||+.||.|||+. .||+||||||+||||+
T Consensus        82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~-~~IvHrDlKp~NIll~  160 (362)
T d1q8ya_          82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLME  160 (362)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEE
T ss_pred             eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh-cCcccccCChhHeeee
Confidence            9999998764  3566677776655443 3333444567889999999999999999999974 6899999999999998


Q ss_pred             CCC------cEEEeecCCcccCCCCCCcccccccCCCCccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccccCC
Q 013028          276 DDF------NAKISDFGLAKFGPLGDKSHISTRVLGTRGYFAPEYIATGHLTLKTDVYSFGVVLLEILSGKTAAMRRTNG  349 (451)
Q Consensus       276 ~~~------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  349 (451)
                      .++      .++|+|||.|....     ......+||+.|+|||++.+..++.++||||+||++++|++|+.||......
T Consensus       161 ~~~~~~~~~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~  235 (362)
T d1q8ya_         161 IVDSPENLIQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  235 (362)
T ss_dssp             EEETTTTEEEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ccCcccccceeeEeecccccccc-----cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccc
Confidence            654      39999999998532     1234567999999999999999999999999999999999999998754322


Q ss_pred             CCCCccccc--------------cchh---------------------hhhhHHhhhhhcCCCCHHHHHHHHHHHHHccc
Q 013028          350 LAGNWAKPY--------------LSNK---------------------LALHQIIDEKLGRNIQMEEAQEFAEIILRCLN  394 (451)
Q Consensus       350 ~~~~~~~~~--------------~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  394 (451)
                      .........              ....                     ........  .........+.++.+|+.+||.
T Consensus       236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~dll~~mL~  313 (362)
T d1q8ya_         236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQ  313 (362)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGC
T ss_pred             cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc--cccccCcccCHHHHHHHHHHCC
Confidence            110000000              0000                     00000000  1123455678899999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 013028          395 SDPKNRPTMSEVVAA  409 (451)
Q Consensus       395 ~dP~~RPt~~evl~~  409 (451)
                      .||.+|||++|+|++
T Consensus       314 ~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         314 LDPRKRADAGGLVNH  328 (362)
T ss_dssp             SSTTTCBCHHHHHTC
T ss_pred             CChhHCcCHHHHhcC
Confidence            999999999999874

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=5.6e-25  Score=196.38  Aligned_cols=164  Identities=18%  Similarity=0.139  Sum_probs=117.3

Q ss_pred             CCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCc-------------C-----HHHHHHHHHHHHh
Q 013028          132 FSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQ-------------G-----QDEWENELRFLSR  193 (451)
Q Consensus       132 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~-----~~~~~~E~~il~~  193 (451)
                      +.++++||+|+||+||+|...           ++..||||+++.....             .     ......|...+.+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~   70 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK   70 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred             chhCCEeeeCcceEEEEEECC-----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHH
Confidence            456789999999999998643           3678999987532110             0     1224568889999


Q ss_pred             cCCCceeeccceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcee
Q 013028          194 LNHPNVVKLMGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTYWRPVIHRDVKASNVL  273 (451)
Q Consensus       194 l~h~nIv~~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDlkp~NIl  273 (451)
                      +.|.+++..+++..    .++||||+++..+.+         ++...+..++.|++.+|.|||+  +||+||||||+|||
T Consensus        71 l~~~~v~~~~~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NIL  135 (191)
T d1zara2          71 LQGLAVPKVYAWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVL  135 (191)
T ss_dssp             TTTSSSCCEEEEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEE
T ss_pred             ccCCCcceEEEecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhhee
Confidence            99999988876532    379999998865543         2233456799999999999999  89999999999999


Q ss_pred             eCCCCcEEEeecCCcccCCCCCCcccccccCCCCcccc------ccccccCCCCcchhhHHHHHHH
Q 013028          274 LDDDFNAKISDFGLAKFGPLGDKSHISTRVLGTRGYFA------PEYIATGHLTLKTDVYSFGVVL  333 (451)
Q Consensus       274 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a------PE~l~~~~~~~~~DiwSlGvil  333 (451)
                      ++++ .++|+|||+|+........          .|..      .+.+ .+.|+.++|+||+.--+
T Consensus       136 v~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         136 VSEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             eeCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            9976 5899999999753211110          0111      1112 46789999999975433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.74  E-value=1.6e-08  Score=92.31  Aligned_cols=148  Identities=16%  Similarity=0.062  Sum_probs=101.4

Q ss_pred             HHHHHhcCCCcCCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeec
Q 013028          124 LLEAATRKFSEKNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKL  202 (451)
Q Consensus       124 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~  202 (451)
                      ++......|+..+..+.|+.+.||+...            .+..+.||+...........+.+|..+++.+. +--+.++
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~------------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~v   75 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG------------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKV   75 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC------------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe------------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcE
Confidence            3455556777777666566678998542            24457888887554445556788999998885 4336777


Q ss_pred             cceeecCCeeEEEEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------
Q 013028          203 MGYCCDDQHRLLVYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLHTY------------------------  258 (451)
Q Consensus       203 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------------------------  258 (451)
                      +.+..+++..++||++++|..+.+.....    ..   ...++.+++..+..||+.                        
T Consensus        76 l~~~~~~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (263)
T d1j7la_          76 LHFERHDGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN  148 (263)
T ss_dssp             EEEEEETTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred             EEEEecCCceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence            88888888999999999998876554211    11   222444555555555531                        


Q ss_pred             -----------------------------C----CCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          259 -----------------------------W----RPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       259 -----------------------------~----~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                                                   .    ..++|+|+.|.|||+++++..-|+||+.+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                         0    1268999999999999876667999998864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.01  E-value=1.5e-05  Score=71.52  Aligned_cols=129  Identities=17%  Similarity=0.091  Sum_probs=80.9

Q ss_pred             ccccCc-eEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCC--ceeeccceeecCCeeEE
Q 013028          138 IGQGGF-GDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHP--NVVKLMGYCCDDQHRLL  214 (451)
Q Consensus       138 LG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~--nIv~~~~~~~~~~~~~l  214 (451)
                      +..|.. +.||+....           .+..+++|......   ...+..|...|+.+...  .+.+++.+..+++..++
T Consensus        18 ~~~G~s~~~v~r~~~~-----------~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~   83 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ-----------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   83 (255)
T ss_dssp             CSCTTSSCEEEEEECT-----------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             cCCcccCCeEEEEEeC-----------CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence            344443 678985422           24457888765332   33467889888887532  35667888888888999


Q ss_pred             EEeccCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 013028          215 VYEYVTRGSLEDHLLNEDDTELNWERRIKIALGAARGLEHLH--------------------------------------  256 (451)
Q Consensus       215 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------------------------------  256 (451)
                      ||++++|.++.+..       ....   .++.++...|.-||                                      
T Consensus        84 v~~~i~G~~~~~~~-------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (255)
T d1nd4a_          84 LLGEVPGQDLLSSH-------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  153 (255)
T ss_dssp             EEECCSSEETTTSC-------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEEeeecccccccc-------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence            99999986654321       1111   11122222222222                                      


Q ss_pred             -------------hC-----CCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          257 -------------TY-----WRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       257 -------------~~-----~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                                   ..     ...++|+|+.|.|||++++..+-|+||+.+..
T Consensus       154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                         10     01269999999999999876678999998863

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.98  E-value=9.1e-06  Score=78.39  Aligned_cols=78  Identities=22%  Similarity=0.164  Sum_probs=48.3

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccC-------CCcCHHHHHHHHHHHHhcC-C--Cceeeccc
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRK-------GSQGQDEWENELRFLSRLN-H--PNVVKLMG  204 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~il~~l~-h--~nIv~~~~  204 (451)
                      .+.||.|....||+...          ...++.++||.-...       -....+....|.++|+.+. +  ..+.+++.
T Consensus        31 ~~eig~G~~N~vfrV~~----------~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~  100 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYD----------QEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY  100 (392)
T ss_dssp             EEECCSSSSEEEEEEEC--------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE
T ss_pred             EEEeCCCceEeEEEEEe----------CCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE
Confidence            35789999999999643          233567888864321       1223345567888888764 3  23455554


Q ss_pred             eeecCCeeEEEEeccCCCCh
Q 013028          205 YCCDDQHRLLVYEYVTRGSL  224 (451)
Q Consensus       205 ~~~~~~~~~lV~E~~~gg~L  224 (451)
                      +  ++...++|||++.+..+
T Consensus       101 ~--d~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         101 S--DTEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             E--ETTTTEEEECCCTTSEE
T ss_pred             E--cCCCCEEEEeccCCccc
Confidence            3  45566899999976543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.44  E-value=0.00019  Score=68.80  Aligned_cols=81  Identities=15%  Similarity=0.110  Sum_probs=54.9

Q ss_pred             CCcccccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC-CCceeeccceeecCCeeE
Q 013028          135 KNLIGQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN-HPNVVKLMGYCCDDQHRL  213 (451)
Q Consensus       135 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~  213 (451)
                      ++.|+.|-.-.+|+....+..   ...+..+..|.+++...  .....+..+|..+++.+. +.-..++++++.+    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~---~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVY---PPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTS---CCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEcCCccccceEEEEeCCCC---ccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            357888999999998765431   11223345677877752  334556778999999986 4434577777643    6


Q ss_pred             EEEeccCCCCh
Q 013028          214 LVYEYVTRGSL  224 (451)
Q Consensus       214 lV~E~~~gg~L  224 (451)
                      +||||++|..|
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            89999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.00  E-value=0.00087  Score=62.19  Aligned_cols=135  Identities=17%  Similarity=0.138  Sum_probs=76.3

Q ss_pred             ceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcCCCce--eecc-----ceeecCCeeEEE
Q 013028          143 FGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLNHPNV--VKLM-----GYCCDDQHRLLV  215 (451)
Q Consensus       143 ~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI--v~~~-----~~~~~~~~~~lV  215 (451)
                      --.||+...           .++..|++|+.+.. ..+.+.+..|+..+..|...+|  +..+     ..+..+...+.|
T Consensus        35 EN~vy~v~~-----------~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l  102 (325)
T d1zyla1          35 ENRVYQFQD-----------EDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  102 (325)
T ss_dssp             SSEEEEECC-----------TTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             cceeEEEEc-----------CCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEE
Confidence            357888643           33567899998643 3456778889999988853222  1111     123445667889


Q ss_pred             EeccCCCChhh----hh----------c----cC---CCCCCCH-------------------H---HHHHHHHHHHHHH
Q 013028          216 YEYVTRGSLED----HL----------L----NE---DDTELNW-------------------E---RRIKIALGAARGL  252 (451)
Q Consensus       216 ~E~~~gg~L~~----~l----------~----~~---~~~~l~~-------------------~---~~~~i~~qi~~aL  252 (451)
                      +++++|..+..    .+          .    ..   ....++.                   .   .....+..+...+
T Consensus       103 ~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l  182 (325)
T d1zyla1         103 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  182 (325)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHH
Confidence            99997743321    00          0    00   0011111                   1   1122223333333


Q ss_pred             HHHH--hCCCCceeCCCCCCceeeCCCCcEEEeecCCcccC
Q 013028          253 EHLH--TYWRPVIHRDVKASNVLLDDDFNAKISDFGLAKFG  291 (451)
Q Consensus       253 ~~LH--~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~  291 (451)
                      .-+-  ....++||+|+.+.|||++++  ..++||+.++..
T Consensus       183 ~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~g  221 (325)
T d1zyla1         183 TAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARNG  221 (325)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred             HHhccccCCceeecCCCCcccEEEeCC--ceEEechhcccC
Confidence            2221  111468999999999999754  458999999853

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.97  E-value=0.0024  Score=58.51  Aligned_cols=156  Identities=12%  Similarity=0.018  Sum_probs=82.1

Q ss_pred             chHHHHHHhcCCCcCCcc-----cccCceEEEEEEEcCcchhhhhhcCCCcEEEEEEeccCCCcCHHHHHHHHHHHHhcC
Q 013028          121 CHGLLEAATRKFSEKNLI-----GQGGFGDVYIGYINSCAMTAARRKNADFAVAVKRLRRKGSQGQDEWENELRFLSRLN  195 (451)
Q Consensus       121 ~~~~~~~~~~~y~~~~~L-----G~G~~g~Vy~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~  195 (451)
                      +.++++....+|.+++..     ..|---+.|+....+            ..+++|++...  ...+++..|++++.+|.
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~------------g~yVLri~~~~--~~~~~l~~~~~~l~~L~   69 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK------------DPLILTLYEKR--VEKNDLPFFLGLMQHLA   69 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS------------CCEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC------------CcEEEEEcCCC--CCHHHHHHHHHHHHhhh
Confidence            345666677788876554     356667788865332            23899998643  23345667888888875


Q ss_pred             CCce--eeccc------eeecCCeeEEEEeccCCCChhhhh--------------c----cC---CCCCCCHH-------
Q 013028          196 HPNV--VKLMG------YCCDDQHRLLVYEYVTRGSLEDHL--------------L----NE---DDTELNWE-------  239 (451)
Q Consensus       196 h~nI--v~~~~------~~~~~~~~~lV~E~~~gg~L~~~l--------------~----~~---~~~~l~~~-------  239 (451)
                      ..++  ...+-      +.........++.++.|......-              .    ..   ........       
T Consensus        70 ~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (316)
T d2ppqa1          70 AKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWD  149 (316)
T ss_dssp             HTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHH
T ss_pred             hccccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhh
Confidence            3222  11111      122234456667776654332110              0    00   00000000       


Q ss_pred             -----------HHHHHHHHHHHHHHHHHh--CCCCceeCCCCCCceeeCCCCcEEEeecCCccc
Q 013028          240 -----------RRIKIALGAARGLEHLHT--YWRPVIHRDVKASNVLLDDDFNAKISDFGLAKF  290 (451)
Q Consensus       240 -----------~~~~i~~qi~~aL~~LH~--~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~  290 (451)
                                 .....+..+...+.-.+.  ...|+||+|+.++||+++.+...-|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         150 KSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             HHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence                       011112222222222221  124799999999999999887778999999873